PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Yoon, JH; Jung, PK; Roh, J; Seok, H; Won, JU				Yoon, Jin-Ha; Jung, Pil Kyun; Roh, Jaehoon; Seok, Hongdeok; Won, Jong-Uk			Relationship between Long Working Hours and Suicidal Thoughts: Nationwide Data from the 4th and 5th Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							RISK-FACTORS; SOCIOECONOMIC-STATUS; DEPRESSIVE SYMPTOMS; PREVALENCE; STRESS; ASSOCIATION; POPULATION; INEQUALITY; IDEATION; COHORT	Background Long working hours are a worldwide problem and may increase the risk of various health issues. However, the health effects of long working hours on suicidal thoughts have not been frequently studied. Our goal was to investigate the relationship between long working hours and suicidal thoughts in the rapidly developing country of Korea. Methods Data from 12,076 participants (7,164 men, 4,912 women) from the 4th and 5th Korean National Health and Nutrition Examination Surveys were used for the current analysis. Multivariate logistic regression models were used to estimate odds ratios and 95% confidence intervals for suicidal thoughts. Combined effects of long working hours and lower socioeconomic status or sleep disturbance were also estimated. Results Compared to groups who worked less than 52 hours per week, odds ratios (95% confidence intervals) for suicidal thoughts in groups who worked 60 hours or more per week were 1.36 (1.09-1.70) for males and 1.38 (1.11-1.72) for females, even after controlling for household income, marital status, history of hypertension or diabetes mellitus, health-related behaviors, and past two weeks' experience of injury, intoxication, or acute or chronic diseases, as well as type of work. The combined effects of long working hours with lower socioeconomic status, or with sleep disturbance, were also significantly higher compared to participants who worked less than 52 hours per week with higher socioeconomic status, or with 6-8 hours of nighttime sleep. Conclusion In this study, long working hours were linked to suicidal thoughts for both genders. Additionally, the odds of those suicidal thoughts were higher for lower socioeconomic groups. To prevent adverse psychological health problems such as suicidal thoughts, a strategy regarding long working hours should be investigated.	[Yoon, Jin-Ha; Jung, Pil Kyun; Roh, Jaehoon; Seok, Hongdeok; Won, Jong-Uk] Yonsei Univ, Coll Med, Inst Occupat Hlth, Seoul 120749, South Korea; [Yoon, Jin-Ha; Jung, Pil Kyun; Roh, Jaehoon; Seok, Hongdeok; Won, Jong-Uk] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul 120749, South Korea; [Yoon, Jin-Ha; Jung, Pil Kyun; Roh, Jaehoon; Seok, Hongdeok; Won, Jong-Uk] Yonsei Univ, Coll Med, Grad Sch Publ Hlth, Seoul 120749, South Korea; [Yoon, Jin-Ha; Roh, Jaehoon; Won, Jong-Uk] Incheon Workers Hlth Ctr, Inchon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Won, JU (corresponding author), Yonsei Univ, Coll Med, Inst Occupat Hlth, Seoul 120749, South Korea.	juwon@yuhs.ac		Won, Jong-Uk/0000-0002-9200-3297; Yoon, Jin-Ha/0000-0003-4198-2955				Aluoja A, 2004, J AFFECT DISORDERS, V78, P27, DOI 10.1016/S0165-0327(02)00179-9; Andersen I, 2009, J EPIDEMIOL COMMUN H, V63, P575, DOI 10.1136/jech.2008.082719; Artazcoz L, 2009, J EPIDEMIOL COMMUN H, V63, P521, DOI 10.1136/jech.2008.082123; Bannai A, 2014, SCAND J WORK ENV HEA, V40, P5, DOI 10.5271/sjweh.3388; Bell DNF, 1998, J ROY STAT SOC A STA, V161, P327, DOI 10.1111/1467-985X.00112; Bell LA, 2001, LABOUR ECON, V8, P181, DOI 10.1016/S0927-5371(01)00030-6; Brent DA, 1999, J AM ACAD CHILD PSY, V38, P1497, DOI 10.1097/00004583-199912000-00010; Bultmann U, 2012, EVID-BASED MENT HEAL, V15, P58, DOI 10.1136/ebmental-2012-100653; Conwell Y, 2002, BIOL PSYCHIAT, V52, P193, DOI 10.1016/S0006-3223(02)01347-1; Gazmararian Julie A., 1995, Annals of Epidemiology, V5, P455, DOI 10.1016/1047-2797(95)00061-5; Goodman E, 2003, AM J PUBLIC HEALTH, V93, P1844, DOI 10.2105/AJPH.93.11.1844; Hiyama T, 2008, OCCUP ENVIRON MED, V65, P428, DOI 10.1136/oem.2007.037473; Jansen NWH, 2003, ERGONOMICS, V46, P664, DOI 10.1080/0014013031000085662; Ke Der-Shin, 2012, Acta Neurol Taiwan, V21, P54; 김기웅, 2012, Annals of Occupational and Environmental Medicine, V24, P339; Kim I, 2013, SCAND J WORK ENV HEA, V39, P515, DOI 10.5271/sjweh.3356; Kim SW, 2013, J KOREAN MED SCI, V28, P345, DOI 10.3346/jkms.2013.28.3.345; Kopp MS, 2000, SOC SCI MED, V51, P1351, DOI 10.1016/S0277-9536(00)00097-6; Kosidou K, 2011, J AFFECT DISORDERS, V134, P160, DOI 10.1016/j.jad.2011.05.024; Magnusson S, 2010, PSYCHOL REP, V107, P157, DOI 10.2466/02.12.13.17.PR0.107.4.157-162; Mausner-Dorsch H, 2000, AM J PUBLIC HEALTH, V90, P1765, DOI 10.2105/AJPH.90.11.1765; Nakashima M, 2011, J SLEEP RES, V20, P110, DOI 10.1111/j.1365-2869.2010.00852.x; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; OECD, OECD FACTB 2013; OLKINUORA M, 1992, SCAND J WORK ENV HEA, V18, P110; Roberts RE, 2000, AM J PSYCHIAT, V157, P81, DOI 10.1176/ajp.157.1.81; Schraedley PK, 1999, J ADOLESCENT HEALTH, V25, P98, DOI 10.1016/S1054-139X(99)00038-5; Siegrist J, 2008, EUR ARCH PSY CLIN N, V258, P115, DOI 10.1007/s00406-008-5024-0; Sterud T, 2008, J OCCUP HEALTH, V50, P406, DOI 10.1539/joh.L8025; Takeuchi A, 2014, IND HLTH; Totterdell Peter, 2003, J Occup Health Psychol, V8, P55, DOI 10.1037/1076-8998.8.1.55; Virtanen M, 2011, PSYCHOL MED, V41, P2485, DOI 10.1017/S0033291711000171; Virtanen M, 2009, SLEEP, V32, P737, DOI 10.1093/sleep/32.6.737; YOON JIN HA, 2011, Annals of Occupational and Environmental Medicine, V23, P173; Yoon JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094125; Yoon SL, 2013, J NURS SCHOLARSHIP, V45, P169, DOI 10.1111/jnu.12018; Zapf D., 2002, HUM RESOUR MANAG REV, V12, P237, DOI DOI 10.1016/S1053-4822(02)00048-7	37	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129142	10.1371/journal.pone.0129142	http://dx.doi.org/10.1371/journal.pone.0129142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9EB	26080022	Green Submitted, Green Published, gold			2022-12-27	WOS:000356542300015
J	Georgiadis, V; Stephanou, A; Townsend, PA; Jackson, TR				Georgiadis, Vassilis; Stephanou, Anastasis; Townsend, Paul A.; Jackson, Thomas R.			MultiElec: A MATLAB Based Application for MEA Data Analysis	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MICROELECTRODE ARRAYS; BRAIN-SLICES; CARDIOMYOCYTES; STIMULATION; PROPAGATION; GENERATION; CONDUCTION; MYOCYTES; PLATFORM	We present MultiElec, an open source MATLAB based application for data analysis of microelectrode array (MEA) recordings. MultiElec displays an extremely user-friendly graphic user interface (GUI) that allows the simultaneous display and analysis of voltage traces for 60 electrodes and includes functions for activation-time determination, the production of activation-time heat maps with activation time and isoline display. Furthermore, local conduction velocities are semi-automatically calculated along with their corresponding vector plots. MultiElec allows ad hoc signal suppression, enabling the user to easily and efficiently handle signal artefacts and for incomplete data sets to be analysed. Voltage traces and heat maps can be simply exported for figure production and presentation. In addition, our platform is able to produce 3D videos of signal progression over all 60 electrodes. Functions are controlled entirely by a single GUI with no need for command line input or any understanding of MATLAB code. MultiElec is open source under the terms of the GNU General Public License as published by the Free Software Foundation, version 3. Both the program and source code are available to download from http://www.cancer.manchester.ac.uk/MultiElec/.	[Georgiadis, Vassilis; Stephanou, Anastasis] UCL, Inst Child Hlth, London, England; [Townsend, Paul A.; Jackson, Thomas R.] Univ Manchester, Inst Canc Sci, Manchester, Lancs, England; [Townsend, Paul A.; Jackson, Thomas R.] Univ Manchester, Fac Med & Human Sci, Manchester Canc Res Ctr, Manchester Ctr Cellular Metab, Manchester, Lancs, England	University of London; University College London; University of Manchester; University of Manchester	Jackson, TR (corresponding author), Univ Manchester, Inst Canc Sci, Manchester, Lancs, England.	tom.jackson-2@manchester.ac.uk	Townsend, Paul/AAF-8234-2020; Georgiadis, Vassilis/D-9434-2013	Townsend, Paul/0000-0001-8956-9508; Georgiadis, Vassilis/0000-0002-2530-2377	New Horizons Research Grant Program of the British Heart Foundation [NH/11/3/29033]; University of Manchester	New Horizons Research Grant Program of the British Heart Foundation; University of Manchester	VG and AS gratefully acknowledge funding provided by the New Horizons Research Grant Program of the British Heart Foundation (NH/11/3/29033, https://www.bhf.org.uk/). TJ and PT gratefully acknowledge funding provided by the University of Manchester (Project Diamond, http://www.manchester.ac.uk/).	Bayly PV, 1998, IEEE T BIO-MED ENG, V45, P563, DOI 10.1109/10.668746; Bayly PV, 1998, CHAOS, V8, P103, DOI 10.1063/1.166291; Besl B, 2002, EUR J NEUROSCI, V15, P999, DOI 10.1046/j.1460-9568.2002.01943.x; BROMBA MUA, 1981, ANAL CHEM, V53, P1583, DOI 10.1021/ac00234a011; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Dunlop J, 2008, NAT REV DRUG DISCOV, V7, P358, DOI 10.1038/nrd2552; Egashira T, 2012, CARDIOVASC RES, V95, P419, DOI 10.1093/cvr/cvs206; Egert U, 1998, BRAIN RES PROTOC, V2, P229, DOI 10.1016/S1385-299X(98)00013-0; Egert U, 2002, J NEUROSCI METH, V117, P33, DOI 10.1016/S0165-0270(02)00045-6; Feld Y, 2002, CIRCULATION, V105, P522, DOI 10.1161/hc0402.102661; Grumet AE, 2000, J NEUROSCI METH, V101, P31, DOI 10.1016/S0165-0270(00)00246-6; Heuschkel MO, 2002, J NEUROSCI METH, V114, P135, DOI 10.1016/S0165-0270(01)00514-3; Johnstone AFM, 2010, NEUROTOXICOLOGY, V31, P331, DOI 10.1016/j.neuro.2010.04.001; Kehat I, 2002, CIRC RES, V91, P659, DOI 10.1161/01.RES.0000039084.30342.9B; Kujala VJ, 2011, COMPUT METH PROG BIO, V104, P199, DOI 10.1016/j.cmpb.2011.04.001; Lahti AL, 2012, DIS MODEL MECH, V5, P220, DOI 10.1242/dmm.008409; Matsa E, 2011, EUR HEART J, V32, P952, DOI 10.1093/eurheartj/ehr073; Matsuura K, 2012, BIOCHEM BIOPH RES CO, V425, P321, DOI 10.1016/j.bbrc.2012.07.089; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Meiry G, 2001, J CARDIOVASC ELECTR, V12, P1269, DOI 10.1046/j.1540-8167.2001.01269.x; Morefield SI, 2000, BIOSENS BIOELECTRON, V15, P383, DOI 10.1016/S0956-5663(00)00095-6; Natarajan A, 2011, BIOMATERIALS, V32, P4267, DOI 10.1016/j.biomaterials.2010.12.022; Pradhapan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073637; Rajala K, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/383709; Reppel M, 2007, CELL PHYSIOL BIOCHEM, V19, P213, DOI 10.1159/000100628; Ronn LCB, 1999, NAT BIOTECHNOL, V17, P1000, DOI 10.1038/13697; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schafer RW, 2011, IEEE SIGNAL PROC MAG, V28, P111, DOI 10.1109/MSP.2011.941097; Stett A, 2003, ANAL BIOANAL CHEM, V377, P486, DOI 10.1007/s00216-003-2149-x; Tanaka T, 2009, BIOCHEM BIOPH RES CO, V385, P497, DOI 10.1016/j.bbrc.2009.05.073; Teukolsky S.A., 1990, COMPUT PHYS, V4, P669, DOI [10.1063/1.4822961, DOI 10.1063/1.4822961]; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005; Wagenaar DA, 2004, J NEUROSCI METH, V138, P27, DOI 10.1016/j.jneumeth.2004.03.005; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	34	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129389	10.1371/journal.pone.0129389	http://dx.doi.org/10.1371/journal.pone.0129389			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076010	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900067
J	Kusakina, J; Rutterford, Z; Cotter, S; Marti, MC; Laurie, DA; Greenland, AJ; Hall, A; Webb, AAR				Kusakina, Jelena; Rutterford, Zoe; Cotter, Sean; Marti, Maria C.; Laurie, David A.; Greenland, Andy J.; Hall, Anthony; Webb, Alex A. R.			Barley Hv CIRCADIAN CLOCK ASSOCIATED 1 and Hv PHOTOPERIOD H1 Are Circadian Regulators That Can Affect Circadian Rhythms in Arabidopsis	PLOS ONE			English	Article							PSEUDO-RESPONSE REGULATORS; CLOCK; TIME; EXPRESSION; GENES; TRANSCRIPTION; CONSERVATION	Circadian clocks regulate many aspects of plant physiology and development that contribute to essential agronomic traits. Circadian clocks contain transcriptional feedback loops that are thought to generate circadian timing. There is considerable similarity in the genes that comprise the transcriptional and translational feedback loops of the circadian clock in the plant Kingdom. Functional characterisation of circadian clock genes has been restricted to a few model species. Here we provide a functional characterisation of the Hordeum vulgare (barley) circadian clock genes Hv CIRCADIAN CLOCK ASSOCIATED 1(HvCCA1) and Hv PHOTOPERIODH1, which are respectively most similar to Arabidopsis thaliana CIRCADIAN CLOCK ASSOCIATED 1 (AtCCA1) and PSEUDO RESPONSE REGULATOR 7 (AtPRR7). This provides insight into the circadian regulation of one of the major crop species of Northern Europe. Through a combination of physiological assays of circadian rhythms in barley and heterologous expression in wild type and mutant strains of A. thaliana we demonstrate that HvCCA1 has a conserved function to AtCCA1. We find that Hv PHOTOPERIOD H1 has AtPRR7-like functionality in A. thaliana and that the effects of the Hv photoperiod h1 mutation on photoperiodism and circadian rhythms are genetically separable.	[Kusakina, Jelena; Cotter, Sean; Hall, Anthony] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Rutterford, Zoe; Marti, Maria C.; Webb, Alex A. R.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Rutterford, Zoe; Greenland, Andy J.] Natl Inst Agr Bot, Cambridge, England; [Laurie, David A.] John Innes Ctr, Norwich, Norfolk, England	University of Liverpool; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Webb, AAR (corresponding author), Univ Cambridge, Dept Plant Sci, Downing St, Cambridge, England.	alex.webb@plantsci.cam.ac.uk	Ruiz, María Carmen Martí/AAB-2564-2019; Marti, Carmen/ABD-8806-2020; Hall, Anthony/D-2844-2009	Hall, Anthony/0000-0002-1806-020X; Marti Ruiz, Maria Carmen/0000-0003-1698-1168	National Institute of Agricultural Botany; Marie Curie Early Stage Training project [MEST-CT-2005-020526]; Biology and the Biological Sciences Research Council Doctoral Training Programme; BBSRC [BB/M006212/1]; BBSRC [BB/K018078/1, BB/H022333/1, BB/L011786/1, BB/H006826/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M006212/1, BB/K018078/1, BB/H006826/1, BB/H022333/1, BB/L011786/1] Funding Source: researchfish	National Institute of Agricultural Botany; Marie Curie Early Stage Training project; Biology and the Biological Sciences Research Council Doctoral Training Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	ZR is grateful to the National Institute of Agricultural Botany for the award of a Scholarship. The authors acknowledge funding from a Marie Curie Early Stage Training project MEST-CT-2005-020526 for JK, and the Biology and the Biological Sciences Research Council Doctoral Training Programme for SC. AARW and MCM are grateful to the BBSRC for the award of BBSRC Grant BB/M006212/1, which supported aspects of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campoli C, 2013, NEW PHYTOL, V199, P1045, DOI 10.1111/nph.12346; Campoli C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-97; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dodd AN, 2004, NEW PHYTOL, V162, P63, DOI 10.1111/j.1469-8137.2004.01005.x; Dodd AN, 2006, PLANT J, V48, P962, DOI 10.1111/j.1365-313X.2006.02933.x; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; Faure S, 2012, P NATL ACAD SCI USA, V109, P8328, DOI 10.1073/pnas.1120496109; Gendron JM, 2012, P NATL ACAD SCI USA, V109, P3167, DOI 10.1073/pnas.1200355109; Gould PD, 2009, PLANT J, V58, P893, DOI 10.1111/j.1365-313X.2009.03819.x; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Herrero E, 2012, PLANT CELL, V24, P428, DOI 10.1105/tpc.111.093807; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Johnson CH, 2007, ANN PLANT REV, V21, P237; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; LeClere S, 2001, PLANT MOL BIOL, V46, P695, DOI 10.1023/A:1011699722052; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; Murakami M, 2007, BIOSCI BIOTECH BIOCH, V71, P1107, DOI 10.1271/bbb.70048; Ogiso E, 2010, PLANT PHYSIOL, V152, P808, DOI 10.1104/pp.109.148908; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Schultz TF, 2001, PLANT CELL, V13, P2659, DOI 10.1105/tpc.13.12.2659; Serikawa M, 2008, PLANT PHYSIOL, V146, P1952, DOI 10.1104/pp.107.114611; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6	28	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0127449	10.1371/journal.pone.0127449	http://dx.doi.org/10.1371/journal.pone.0127449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076005	Green Published, gold			2022-12-27	WOS:000356329900013
J	Rozanov, D; Cheltsov, A; Sergienko, E; Vasile, S; Golubkov, V; Aleshin, AE; Levin, T; Traer, E; Hann, B; Freimuth, J; Alexeev, N; Alekseyev, MA; Budko, SP; Bachinger, HP; Spellman, P				Rozanov, Dmitri; Cheltsov, Anton; Sergienko, Eduard; Vasile, Stefan; Golubkov, Vladislav; Aleshin, Alexander E.; Levin, Trevor; Traer, Elie; Hann, Byron; Freimuth, Julia; Alexeev, Nikita; Alekseyev, Max A.; Budko, Sergey P.; Baechinger, Hans Peter; Spellman, Paul			TRAIL-Based High Throughput Screening Reveals a Link between TRAIL-Mediated Apoptosis and Glutathione Reductase, a Key Component of Oxidative Stress Response	PLOS ONE			English	Article							PERINUCLEOLAR COMPARTMENT PREVALENCE; PROSTATE-CANCER CELLS; IN-VIVO; CHEMOTHERAPEUTIC DRUGS; THIOREDOXIN REDUCTASE; RESISTANT MELANOMA; DOWN-REGULATION; UP-REGULATION; LIGAND; BREAST	A high throughput screen for compounds that induce TRAIL-mediated apoptosis identified ML100 as an active chemical probe, which potentiated TRAIL activity in prostate carcinoma PPC-1 and melanoma MDA-MB-435 cells. Follow-up in silico modeling and profiling in cell-based assays allowed us to identify NSC130362, pharmacophore analog of ML100 that induced 65-95% cytotoxicity in cancer cells and did not affect the viability of human primary hepatocytes. In agreement with the activation of the apoptotic pathway, both ML100 and NSC130362 synergistically with TRAIL induced caspase-3/7 activity in MDA-MB-435 cells. Subsequent affinity chromatography and inhibition studies convincingly demonstrated that glutathione reductase (GSR), a key component of the oxidative stress response, is a target of NSC130362. In accordance with the role of GSR in the TRAIL pathway, GSR gene silencing potentiated TRAIL activity in MDA-MB-435 cells but not in human hepatocytes. Inhibition of GSR activity resulted in the induction of oxidative stress, as was evidenced by an increase in intracellular reactive oxygen species (ROS) and peroxidation of mitochondrial membrane after NSC130362 treatment in MDA-MB-435 cells but not in human hepatocytes. The antioxidant reduced glutathione (GSH) fully protected MDA-MB-435 cells from cell lysis induced by NSC130362 and TRAIL, thereby further confirming the interplay between GSR and TRAIL. As a consequence of activation of oxidative stress, combined treatment of different oxidativestress inducers and NSC130362 promoted cell death in a variety of cancer cells but not in hepatocytes in cell-based assays and in in vivo, in a mouse tumor xenograft model.	[Rozanov, Dmitri; Spellman, Paul] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Cheltsov, Anton; Sergienko, Eduard] Q MOL LLC, San Diego, CA USA; [Vasile, Stefan] Sanford Burnham Med Res Inst, Conrad Prebys Ctr Chem Genom, Orlando, FL USA; [Golubkov, Vladislav; Aleshin, Alexander E.] Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, La Jolla, CA USA; [Levin, Trevor] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Traer, Elie] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Hann, Byron; Freimuth, Julia] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Alexeev, Nikita; Alekseyev, Max A.] George Washington Univ, Computat Biol Inst, Ashburn, VA USA; [Alexeev, Nikita] St Petersburg State Univ, Dept Math & Mech, St Petersburg 199034, Russia; [Budko, Sergey P.; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97201 USA; [Budko, Sergey P.; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	Oregon Health & Science University; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; George Washington University; Saint Petersburg State University; Oregon Health & Science University	Rozanov, D (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA.	rozanov@ohsu.edu	Golubkov, Vladislav/L-6828-2017; Alekseyev, Max/D-9362-2016; Alexeev, Nikita/K-4106-2014	Alekseyev, Max/0000-0002-5140-8095; Alexeev, Nikita/0000-0003-3415-9565	NIH Roadmap Initiatives [U54HG003916, U54HG005033]; NIH [RO3 MH081232-01]; Department of Defense [W81XWH-09-1-0601]; National Science Foundation [IIS-1462107]; Oregon Health & Science University (OHSU) strategic investment fund; OHSU School of Medicine faculty innovation fund; Q-MOL LLC; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG005033, U54HG003916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH081232] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1462107] Funding Source: National Science Foundation	NIH Roadmap Initiatives(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Science Foundation(National Science Foundation (NSF)); Oregon Health & Science University (OHSU) strategic investment fund; OHSU School of Medicine faculty innovation fund; Q-MOL LLC; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by NIH Roadmap Initiatives grants U54HG003916 and U54HG005033, NIH screening grant RO3 MH081232-01, Department of Defense grant W81XWH-09-1-0601, National Science Foundation grant IIS-1462107, Oregon Health & Science University (OHSU) strategic investment fund, and OHSU School of Medicine faculty innovation fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We also state that Q-MOL LLC provided support in the form of salary for author AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Bodmer JL, 2000, J BIOL CHEM, V275, P20632, DOI 10.1074/jbc.M909721199; Chen WS, 2007, CARCINOGENESIS, V28, P2114, DOI 10.1093/carcin/bgm133; Cullingford TE, 2006, J MOL CELL CARDIOL, V40, P157, DOI 10.1016/j.yjmcc.2005.10.004; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Fawcett H, 2005, INT J ONCOL, V27, P1717; Garber K, 2006, J NATL CANCER I, V98, P512, DOI 10.1093/jnci/djj174; Gessner PK, 1995, TOXICOLOGY, V105, P161, DOI 10.1016/0300-483X(95)03210-7; Gibellini Lara, 2010, Cancers (Basel), V2, P1288, DOI 10.3390/cancers2021288; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; Inoue T, 2013, FREE RADICAL BIO MED, V61, P273, DOI 10.1016/j.freeradbiomed.2013.04.020; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kamath RV, 2005, CANCER RES, V65, P246; KARPLUS PA, 1989, J MOL BIOL, V210, P163, DOI 10.1016/0022-2836(89)90298-2; Kelley SK, 2001, J PHARMACOL EXP THER, V299, P31; Kim JY, 2008, J CELL BIOCHEM, V105, P1386, DOI 10.1002/jcb.21958; Kim J, 2010, P NATL ACAD SCI USA, V107, P13432, DOI 10.1073/pnas.1006822107; Kim YH, 2007, J CELL BIOCHEM, V100, P998, DOI 10.1002/jcb.21098; Kleeff J, 2000, INT J CANCER, V86, P399, DOI 10.1002/(SICI)1097-0215(20000501)86:3<399::AID-IJC15>3.0.CO;2-G; Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li TWH, 2006, MOL CELL BIOL, V26, P5284, DOI 10.1128/MCB.00105-06; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Lu J, 2006, CANCER RES, V66, P4410, DOI 10.1158/0008-5472.CAN-05-3310; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Luu HH, 2004, CURR CANCER DRUG TAR, V4, P653, DOI 10.2174/1568009043332709; Medema JP, 1999, J EXP MED, V190, P1033, DOI 10.1084/jem.190.7.1033; Naka T, 2002, CANCER RES, V62, P5800; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; NORDHOFF A, 1993, BIOCHEMISTRY-US, V32, P4060, DOI 10.1021/bi00066a029; Norton JT, 2008, CANCER-AM CANCER SOC, V113, P861, DOI 10.1002/cncr.23632; PURI RN, 1983, P NATL ACAD SCI-BIOL, V80, P5258, DOI 10.1073/pnas.80.17.5258; Ramadori G, 2010, ANN HEPATOL, V9, P133, DOI 10.1016/S1665-2681(19)31651-5; Ray S, 2003, CANCER RES, V63, P4713; Remacle AG, 2012, CANCER RES, V72, P2339, DOI 10.1158/0008-5472.CAN-11-4149; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rodriguez-Antona C, 2006, ONCOGENE, V25, P1679, DOI 10.1038/sj.onc.1209377; Rozanov DV, 2009, MOL CANCER THER, V8, P1515, DOI 10.1158/1535-7163.MCT-09-0202; Shankar S, 2005, PROSTATE, V62, P165, DOI 10.1002/pros.20126; Singh TR, 2003, CANCER RES, V63, P5390; Srivastava RK, 2001, NEOPLASIA, V3, P535, DOI 10.1038/sj.neo.7900203; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Suzuki-Karasaki M, 2014, INT J ONCOL, V44, P616, DOI 10.3892/ijo.2013.2215; Suzuki-Karasaki Y, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00128; Tochigi M, 2013, INT J ONCOL, V42, P863, DOI 10.3892/ijo.2013.1769; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Traverso N, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/972913; Tse AKW, 2014, J INVEST DERMATOL, V134, P1397, DOI 10.1038/jid.2013.471; Voelkel-Johnson C, 2002, CANCER GENE THER, V9, P164, DOI 10.1038/sj.cgt.7700420; Wang G, 2009, ANAL CHEM, V81, P146, DOI 10.1021/ac801664q; Wenger T, 2006, CELL DEATH DIFFER, V13, P1740, DOI 10.1038/sj.cdd.4401867; White-Gilbertson SJ, 2009, J UROLOGY, V182, P1178, DOI 10.1016/j.juro.2009.05.005; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wilmarth Phillip A, 2009, J Ocul Biol Dis Infor, V2, P223; Yagita H, 2004, CANCER SCI, V95, P777, DOI 10.1111/j.1349-7006.2004.tb02181.x; Yang L, 2013, APOPTOSIS, V18, P618, DOI 10.1007/s10495-013-0808-8; Zhang HQ, 2005, METHOD ENZYMOL, V401, P468, DOI 10.1016/S0076-6879(05)01028-1; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhang R, 2008, APOPTOSIS, V13, P1465, DOI 10.1007/s10495-008-0278-6; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313	63	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129566	10.1371/journal.pone.0129566	http://dx.doi.org/10.1371/journal.pone.0129566			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075913	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900084
J	van Kampen, SC; Susanto, NH; Simon, S; Astiti, SD; Chandra, R; Burhan, E; Farid, MN; Chittenden, K; Mustikawati, DE; Alisjahbana, B				van Kampen, Sanne C.; Susanto, Nugroho H.; Simon, Sumanto; Astiti, Shinta D.; Chandra, Roni; Burhan, Erlina; Farid, Muhammad N.; Chittenden, Kendra; Mustikawati, Dyah E.; Alisjahbana, Bachti			Effects of Introducing Xpert MTB/RIF on Diagnosis and Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention Study	PLOS ONE			English	Article							POSITIVE RIFAMPICIN RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS; IMPLEMENTATION; ASSAY	Background In March 2012, the Xpert MTB/RIF assay (Xpert) was introduced in three provincial public hospitals in Indonesia as a novel diagnostic to detect tuberculosis and rifampicin resistance among high risk individuals. Objective This study assessed the effects of using Xpert in place of conventional solid and liquid culture and drug-susceptibility testing on case detection rates, treatment initiation rates, and health system delays among drug-resistant tuberculosis (TB) patients. Methods Cohort data on registration, test results and treatment initiation were collected from routine presumptive patient registers one year before and one year after Xpert was introduced. Proportions of case detection and treatment initiation were compared using the Pearson Chi square test and median time delays using the Mood's Median test. Results A total of 975 individuals at risk of drug-resistant TB were registered in the pre-intervention year and 1,442 in the post-intervention year. After Xpert introduction, TB positivity rate increased by 15%, while rifampicin resistance rate reduced by 23% among TB positive cases and by 9% among all tested. Second-line TB treatment initiation rate among rifampicin resistant patients increased by 19%. Time from client registration to diagnosis was reduced by 74 days to a median of a single day (IQR 0-4) and time from diagnosis to treatment start was reduced by 27 days to a median of 15 days (IQR 7-51). All findings were significant with p<0.001. Conclusion Compared to solid and liquid culture and drug-susceptibility testing, Xpert detected more TB and less rifampicin resistance, increased second-line treatment initiation rates and shortened time to diagnosis and treatment. This test holds promise to improve rapid case finding and management of drug-resistant TB patients in Indonesia.	[van Kampen, Sanne C.] KNCV TB Fdn, Access Lab Serv Team, The Hague, Netherlands; [Susanto, Nugroho H.; Alisjahbana, Bachti] Padjadjaran State Univ, Fac Med, Bandung, Indonesia; [Susanto, Nugroho H.; Simon, Sumanto; Astiti, Shinta D.; Farid, Muhammad N.; Alisjahbana, Bachti] Minist Hlth, TB Operat Res Grp, Jakarta, Indonesia; [Simon, Sumanto] Univ Atmadjaja, Fac Med, Jakarta, Indonesia; [Chandra, Roni] KNCV TB Fdn, Lab Team TB CARE 1, Jakarta, Indonesia; [Burhan, Erlina] Persahabatan Hosp, Dept Lung & Resp Hlth, Jakarta, Indonesia; [Farid, Muhammad N.] Cent Bur Stat, Subdirectorate Stat & Design, Jakarta, Indonesia; [Chittenden, Kendra] US Agcy Int Dev, Hlth Div, Jakarta, Indonesia; [Mustikawati, Dyah E.] Minist Hlth, Natl TB Control Program, Jakarta, Indonesia	KNCV Tuberculosis Foundation; Universitas Padjadjaran; Ministry of Health - Indonesia; KNCV Tuberculosis Foundation; Persahabatan Hospital; United States Agency for International Development (USAID); Ministry of Health - Indonesia	van Kampen, SC (corresponding author), KNCV TB Fdn, Access Lab Serv Team, The Hague, Netherlands.	sanne.vankampen@kncvtbc.org	Burhan, Erlina/AAR-6425-2021; Mustikawati, Dyah Erti/K-2437-2019	Burhan, Erlina/0000-0002-6617-499X; van Kampen, Sanne/0000-0002-1519-5248	United States Agency for International Development under the USAID Tuberculosis CARE I [AID-OAA-A-10-000020]	United States Agency for International Development under the USAID Tuberculosis CARE I(United States Agency for International Development (USAID))	This study was funded by the United States Agency for International Development under the USAID Tuberculosis CARE I, Cooperative Agreement No. AID-OAA-A-10-000020. As author on this paper, KC was involved in conception of the study design and preparation of the manuscript.	Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boyles TH, 2014, INT J TUBERC LUNG D, V18, P876, DOI 10.5588/ijtld.13.0853; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Clouse K, 2012, SAMJ S AFR MED J, V102, P805, DOI [10.7196/SAMJ.5851, 10.7196/samj.5851]; Creswell J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-2; Hanrahan CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065421; National Tuberculosis Control Program, 2011, NAT ACT PLAN PROGR M; Rigouts L, 2013, J CLIN MICROBIOL, V51, P2641, DOI 10.1128/JCM.02741-12; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Van Deun A, 2013, J CLIN MICROBIOL, V51, P2633, DOI 10.1128/JCM.00553-13; Van Rie A, 2013, INT J TUBERC LUNG D, V17, P368, DOI 10.5588/ijtld.12.0392; Van Rie A, 2012, INT J TUBERC LUNG D, V16, P206, DOI 10.5588/ijtld.11.0395; WHO, 2011, POL STAT AUT REAL TI; Williamson DA, 2012, DIAGN MICR INFEC DIS, V74, P207, DOI 10.1016/j.diagmicrobio.2012.06.013; World Health Organization, 2014, XPERT MTB RIF IMPL M; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; Yoon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048599	18	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0123536	10.1371/journal.pone.0123536	http://dx.doi.org/10.1371/journal.pone.0123536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075722	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900002
J	Solca, F; Poletti, B; Zago, S; Crespi, C; Sassone, F; Lafronza, A; Maraschi, AM; Sassone, J; Silani, V; Ciammola, A				Solca, Federica; Poletti, Barbara; Zago, Stefano; Crespi, Chiara; Sassone, Francesca; Lafronza, Annalisa; Maraschi, Anna Maria; Sassone, Jenny; Silani, Vincenzo; Ciammola, Andrea			Counterfactual Thinking Deficit in Huntington's Disease	PLOS ONE			English	Article							PREFRONTAL CORTEX; ATROPHY; PROGRESSION	Background and Objective Counterfactual thinking (CFT) refers to the generation of mental simulations of alternatives to past events, actions and outcomes. CFT is a pervasive cognitive feature in every-day life and is closely related to decision-making, planning and problem-solving - all of which are cognitive processes linked to unimpaired frontal lobe functioning. Huntington's Disease (HD) is a neurodegenerative disorder characterised by motor, behavioral and cognitive dysfunctions. Because an impairment in frontal and executive functions has been described in HD, we hypothesised that HD patients may have a CFT impairment. Methods Tests of spontaneous counterfactual thoughts and counterfactual-derived inferences were administered to 24 symptomatic HD patients and 24 age- and sex-matched healthy subjects. Results Our results show a significant impairment in the spontaneous generation of CFT and low performance on the Counterfactual Inference Test (CIT) in HD patients. Low performance on the spontaneous CFT test significantly correlates with impaired attention abilities, verbal fluency and frontal lobe efficiency, as measured by Trail Making Test - Part A, Phonemic Verbal Fluency Test and FAB. Conclusions Spontaneous CFT and the use of this type of reasoning are impaired in HD patients. This deficit may be related to frontal lobe dysfunction, which is a hallmark of HD. Because CFT has a pervasive role in patients' daily lives regarding their planning, decision making and problem solving skills, cognitive rehabilitation may improve HD patients' ability to analyse current behaviors and future actions.	[Solca, Federica; Poletti, Barbara; Sassone, Francesca; Lafronza, Annalisa; Maraschi, Anna Maria; Sassone, Jenny; Silani, Vincenzo; Ciammola, Andrea] IRCCS Ist Auxol Italiano, Dept Neurol & Lab Neurosci, Milan, Italy; [Zago, Stefano] Univ Milan, Dept Neurosci & Mental Hlth, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Milan, Italy; [Crespi, Chiara] Univ Vita Salute San Raffaele, Milan, Italy; [Crespi, Chiara] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Silani, Vincenzo] Univ Milan, Dept Pathophysiol & Transplantat, Dino Ferrari Ctr, Milan, Italy	IRCCS Istituto Auxologico Italiano; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan	Poletti, B (corresponding author), IRCCS Ist Auxol Italiano, Dept Neurol & Lab Neurosci, Milan, Italy.	b.poletti@auxologico.it	Crespi, Chiara/M-9039-2019; Silani, Vincenzo/P-4421-2017; Zago, Stefano/I-5838-2015; Zago, Stefano/AAW-8595-2021; Crespi, Chiara/K-6484-2016; Poletti, Barbara/W-6917-2019; Crespi, Chiara/H-5251-2018	Crespi, Chiara/0000-0002-7851-9887; Silani, Vincenzo/0000-0002-7698-3854; Zago, Stefano/0000-0001-6578-4385; Zago, Stefano/0000-0001-6578-4385; Crespi, Chiara/0000-0002-7851-9887; Poletti, Barbara/0000-0003-4398-2051; Crespi, Chiara/0000-0002-7851-9887; Maraschi, Anna Maria/0000-0002-0766-1384				Backman L, 1997, BRAIN, V120, P2207, DOI 10.1093/brain/120.12.2207; Barbarotto R, 1998, ITAL J NEUROL SCI, V19, P161, DOI 10.1007/BF00831566; Barbey AK, 2009, PHILOS T R SOC B, V364, P1291, DOI 10.1098/rstb.2008.0315; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beldarrain MG, 2005, COGNITIVE BRAIN RES, V24, P723, DOI 10.1016/j.cogbrainres.2005.03.013; Bruyn GW, 1968, HDB CLIN NEUROLOGY, V16, P298; Bullinger M, 1998, J CLIN EPIDEMIOL, V51, P913, DOI 10.1016/S0895-4356(98)00082-1; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; CAPRARA G.V., 1993, BFQ BIG 5 QUESTIONNA; Damasio A.R., 2005, DESCARTES ERROR EMOT; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Derogatis LR., 1983, SCL90 ADM SCORING PR; Dierks T, 1999, PSYCHIAT RES-NEUROIM, V90, P65; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galer S, 2015, BRAIN TOPOGR, V28, P95, DOI 10.1007/s10548-014-0367-5; Gomez-Beldarrain M, 2004, J COGNITIVE NEUROSCI, V16, P74, DOI 10.1162/089892904322755575; Hetts JJ, 2000, PSYCHOL MARKET, V17, P345, DOI 10.1002/(SICI)1520-6793(200004)17:4<345::AID-MAR5>3.0.CO;2-M; Hobbs NZ, 2010, J NEUROL NEUROSUR PS, V81, P756, DOI 10.1136/jnnp.2009.190702; Hooker C, 2000, PSYCHIATRY, V63, P326, DOI 10.1080/00332747.2000.11024925; Kahneman D., 1982, JUDGMENT UNCERTAINTY, DOI [10.1017/CBO9780511809477, DOI 10.1017/CBO9780511809477]; Kassubek J, 2004, J NEUROL NEUROSUR PS, V75, P213; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Knight Robert T., 1995, P1357; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; McNamara P, 2003, J NEUROL NEUROSUR PS, V74, P1065, DOI 10.1136/jnnp.74.8.1065; MONDINI S, 2003, ESAME NEUROPSICOLOGI; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; Rahm C, 2013, SCAND J PSYCHOL, V54, P66, DOI 10.1111/sjop.12023; Raven J. C., 1986, MANUAL RAVENS PROGR; Rey A, 1964, LEXAMEN CLINIQUE PSY; Roese NJ, 1997, PSYCHOL BULL, V121, P133, DOI 10.1037/0033-2909.121.1.133; Roese NJ, 1997, ADV EXP SOC PSYCHOL, V29, P1, DOI 10.1016/S0065-2601(08)60015-5; Roese NJ, 1997, SOC COGNITION, V15, P274, DOI 10.1521/soco.1997.15.4.274; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Smith A., 1982, SYMBOL DIGIT MODALIT; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Squitieri F, 2009, CNS NEUROSCI THER, V15, P1, DOI 10.1111/j.1755-5949.2008.00068.x; van Duijn E, 2014, NEURODEGENER DIS, V13, P9, DOI 10.1159/000343210; Van Hoeck N, 2013, SOC COGN AFFECT NEUR, V8, P556, DOI 10.1093/scan/nss031; White RF, 1992, CLIN SYNDROMES ADULT, P213; Zago S, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/256089	44	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0126773	10.1371/journal.pone.0126773	http://dx.doi.org/10.1371/journal.pone.0126773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070155	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000003
J	Bonenberger, M; Aikins, M; Akweongo, P; Bosch-Capblanch, X; Wyss, K				Bonenberger, Marc; Aikins, Moses; Akweongo, Patricia; Bosch-Capblanch, Xavier; Wyss, Kaspar			What Do District Health Managers in Ghana Use Their Working Time for? A Case Study of Three Districts	PLOS ONE			English	Article							JOB-SATISFACTION; MIXED-METHODS; BEHAVIOR; MOTION; CARE; IMMUNIZATION; MOTIVATION; EXPERIENCE; ALLOCATION; PHYSICIANS	Background Ineffective district health management potentially impacts on health system performance and service delivery. However, little is known about district health managing practices and time allocation in resource-constrained health systems. Therefore, a time use study was conducted in order to understand current time use practices of district health managers in Ghana. Methods All 21 district health managers working in three districts of the Eastern Region were included in the study and followed for a period of three months. Daily retrospective interviews about their time use were conducted, covering 1182 person-days of observation. Total time use of the sample population was assessed as well as time use stratified by managerial position. Differences of time use over time were also evaluated. Results District health managers used most of their working time for data management (16.6%), attending workshops (12.3%), financial management (8.7%), training of staff (7.1%), drug and supply management (5.0%), and travelling (9.6%). The study found significant variations of time use across the managerial cadres as well as high weekly variations of time use impulsed mainly by a national vertical program. Conclusions District health managers in Ghana use substantial amounts of their working time in only few activities and vertical programs greatly influence their time use. Our findings suggest that efficiency gains are possible for district health managers. However, these are unlikely to be achieved without improvements within the general health system, as inefficiencies seem to be largely caused by external factors.	[Bonenberger, Marc; Bosch-Capblanch, Xavier; Wyss, Kaspar] Swiss Trop & Publ Hlth Inst, Swiss Ctr Int Hlth, Basel, Switzerland; [Bonenberger, Marc; Bosch-Capblanch, Xavier; Wyss, Kaspar] Univ Basel, Basel, Switzerland; [Aikins, Moses; Akweongo, Patricia] Univ Ghana, Sch Publ Hlth, Legon, Ghana	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Ghana	Bonenberger, M (corresponding author), Swiss Trop & Publ Hlth Inst, Swiss Ctr Int Hlth, Basel, Switzerland.	marc.bonenberger@unibas.ch	Bonenberger, Marc/D-9474-2011; Bosch-Capblanch, Xavier/ABD-7059-2020	Bonenberger, Marc/0000-0001-5643-3698; Bosch-Capblanch, Xavier/0000-0002-4469-0395; AKWEONGO, PATRICIA/0000-0001-6728-3365; Wyss, Kaspar/0000-0003-0156-5989; Aikins, Moses/0000-0002-2370-4006	European Commission [266334]; Freiwillige Akademische Gesellschaft (FAG) Basel, Switzerland	European Commission(European CommissionEuropean Commission Joint Research Centre); Freiwillige Akademische Gesellschaft (FAG) Basel, Switzerland	Funding for the project was received from the European Commission's Seventh Framework Programme (FP7 Theme Health: 2010.3.4-1, grant agreement number 266334). MB received additional funds for fieldwork from the Freiwillige Akademische Gesellschaft (FAG) Basel, Switzerland. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyepong IA, 2004, INT J HEALTH PLAN M, V19, P319, DOI 10.1002/hpm.770; Amoakoh-Coleman Mary, 2015, BMC Res Notes, V8, P114, DOI 10.1186/s13104-015-1058-3; Ansong D, 2014, J VACCINES IMMUN, V2, P7; Ayee J, 2010, COMP ASSESSMENT DECE; Blaauw D, 2013, GLOBAL HEALTH ACTION, V6, P127, DOI 10.3402/gha.v6i0.19287; Bonenberger M, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-43; Bossert TJ, 2002, HEALTH POLICY PLANN, V17, P14, DOI 10.1093/heapol/17.1.14; Braithwaite J, 2011, INT J HEALTH PLAN M, V26, P56, DOI 10.1002/hpm.1033; Bratt JH, 1999, HEALTH POLICY PLANN, V14, P374, DOI 10.1093/heapol/14.4.374; Buchanan DA, 2013, SERV DELIV RES, V1, P268; Budlender D., 2007, GENDER DEV PROGRAMME, V2, P48; Burke TA, 2000, J NURS ADMIN, V30, P118, DOI 10.1097/00005110-200003000-00003; Chang A, 2011, AUST J PSYCHOL, V63, P187, DOI 10.1111/j.1742-9536.2011.00008.x; Claessens BJC, 2004, J ORGAN BEHAV, V25, P937, DOI 10.1002/job.292; Claessens BJC, 2007, PERS REV, V36, P255, DOI 10.1108/00483480710726136; Closser S, 2014, J INFECT DIS, V210, pS504, DOI 10.1093/infdis/jit232; Conn CP, 1996, HEALTH POLICY PLANN, V11, P64, DOI 10.1093/heapol/11.1.64; Daire J, 2014, HEALTH POLICY PLANN, V29, P82, DOI 10.1093/heapol/czu075; Dieleman Marjolein, 2006, Hum Resour Health, V4, P2, DOI 10.1186/1478-4491-4-2; Dorgan S., 2010, MANAGEMENT HEALTHCAR; Ghana Health Service, 2005, JOB DESCR DIR; Graham R, 2013, J PUBLIC HEALTH MAN, V19, P562, DOI 10.1097/PHH.0b013e3182902384; Hales C, 2001, BUS STRATEG REV, V12, P50, DOI DOI 10.1111/1467-8616.00174; Heslop L, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-52; Hoekstra EJ, 2011, J INFECT DIS, V204, pS190, DOI 10.1093/infdis/jir073; Kayode GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104053; Koram KA, 2014, EFFECTIVE DIS CONTRO, V2; Mallidou AA, 2013, INT J NURS STUD, V50, P1229, DOI 10.1016/j.ijnurstu.2012.12.009; Mangham-Jefferies L, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-61; Mkoka DA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-333; Mshelia C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003625; Oliveira-Cruz V., 2003, J INT DEV, V15, P67, DOI [DOI 10.1002/JID.966, 10.1002/jid.966]; Peeters MAG, 2005, J OCCUP HEALTH PSYCH, V10, P64, DOI 10.1037/1076-8998.10.1.64; Rouleau D, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-9; Russo G, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-51; Shinder GA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-370; SMITH DL, 1988, SOC SCI MED, V26, P909, DOI 10.1016/0277-9536(88)90411-X; Sonnenberg B, 2012, SOC SCI RES, V41, P1037, DOI 10.1016/j.ssresearch.2012.03.013; Thylefors I, 2012, J INTERPROF CARE, V26, P269, DOI 10.3109/13561820.2011.653609; Weigl M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-110; West MA, 2002, INT J HUM RESOUR MAN, V13, P1299, DOI 10.1080/09585190210156521; Whittington D, 2000, J Psychiatr Ment Health Nurs, V7, P259, DOI 10.1046/j.1365-2850.2000.00291.x; Zheng K, 2011, J AM MED INFORM ASSN, V18, P704, DOI 10.1136/amiajnl-2011-000083	43	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130633	10.1371/journal.pone.0130633	http://dx.doi.org/10.1371/journal.pone.0130633			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK3FB	26068907	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000356100900107
J	Zhou, AB; Jiang, YF; Chen, JM; Wei, JL; Dang, BB; Li, SF; Xu, QY				Zhou, Aibao; Jiang, Yanfei; Chen, Jianming; Wei, Jianlan; Dang, Baobao; Li, Shifeng; Xu, Qiongying			Neural Mechanisms of Selective Attention in Children with Amblyopia	PLOS ONE			English	Article							TOP-DOWN MODULATION; CONFLICT ADAPTATION; STROOP INTERFERENCE; RESPONSE CONFLICT; STIMULUS-STIMULUS; POTENTIAL N270; INHIBITION; CORTEX; ADULTS; TIME	Previous studies have indicated that amblyopia might affect children's attention. We recruited amblyopic children and normal children aged 9-11 years as study subjects and compared selective attention between the two groups of children. Chinese characters denoting colors were used in the Stroop task, and the event-related potential (ERP) was analyzed. The results show that the accuracy of both groups in the congruent condition was higher than the incongruent condition, and the reaction time (RT) of amblyopic children was longer. The latency of the occipital P1 in the incongruent condition was shorter than the neutral condition for both groups; the peak of the occipital P1 elicited by the incongruent stimuli in amblyopic children was higher. In both groups, the N1 peak was higher in the occipital region than frontal and central regions. The N1 latency of normal children was shorter in the congruent and neutral conditions and longer in the incongruent condition; the N1 peak of normal children was higher. The N270 latencies of normal children in the congruent and neutral conditions were shorter; the N270 peak was higher in parietal and occipital regions than frontal and central regions for both groups. The N450 latency of normal children was shorter; in both groups, the N450 average amplitude was significantly higher in the parietal region than central and frontal regions. The accuracy was the same for both groups, but the response of amblyopic children was significantly slower. The two groups showed differences in both stages of the Stroop task. Normal children showed advantages in processing speed on both stimulus and response conflict stages. Brain regions activated during the Stroop task were consistent between groups, in line with their age characteristics.	[Zhou, Aibao; Jiang, Yanfei; Dang, Baobao; Xu, Qiongying] Northwest Normal Univ, Sch Psychol, Lanzhou, Gansu, Peoples R China; [Chen, Jianming; Wei, Jianlan] Rehabil Hosp Ctr Gansu, Lanzhou, Gansu, Peoples R China; [Li, Shifeng] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Northwest Normal University - China; Beijing Normal University	Jiang, YF (corresponding author), Northwest Normal Univ, Sch Psychol, Lanzhou, Gansu, Peoples R China.	jiangyanfei_2006@126.com; ersi@163.com	Li, Shifeng/AAH-3055-2021		National Natural Science Foundation of Gansu province [1010RJZA166]	National Natural Science Foundation of Gansu province	This work was supported by The National Natural Science Foundation of Gansu province (1010RJZA166).	Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; Akshoomoff N, 2002, DEV NEUROPSYCHOL, V22, P625, DOI 10.1207/S15326942DN2203_4; Akyurek EG, 2013, BIOL PSYCHOL, V93, P269, DOI 10.1016/j.biopsycho.2013.02.009; Bonhomme GR, 2006, J AAPOS, V10, P540, DOI 10.1016/j.jaapos.2006.07.008; Branch of Chinese Medical Association Ophthalmology Pediatric Ophthalmology and Strabismus group, 2011, CHINESE J OPHTHALMOL, V8, P768; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Brodeur DA, 2004, COGNITIVE DEV, V19, P241, DOI 10.1016/j.cogdev.2004.01.002; Brown M, 2001, MEM COGNITION, V29, P903, DOI 10.3758/BF03196419; Brown TL, 2002, J EXP PSYCHOL GEN, V131, P220, DOI 10.1037//0096-3445.131.2.220; Chen AT, 2011, INT J PSYCHOPHYSIOL, V80, P129, DOI 10.1016/j.ijpsycho.2011.02.012; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; COHEN JD, 1992, AM J PSYCHOL, V105, P239, DOI 10.2307/1423029; De Houwer J, 2003, MEM COGNITION, V31, P353, DOI 10.3758/BF03194393; [杜寒剑 DU Hanjian], 2008, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V24, P201; Esposito AG, 2013, COGNITIVE DEV, V28, P354, DOI 10.1016/j.cogdev.2013.09.002; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Hess Robert F, 2001, Clin Exp Optom, V84, P321; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hopf JM, 2002, J NEUROPHYSIOL, V88, P2088, DOI 10.1152/jn.2002.88.4.2088; Hsieh YH, 2008, KAOHSIUNG J MED SCI, V24, P197, DOI 10.1016/S1607-551X(08)70117-7; Ibanez A, 2012, SOC NEUROSCI-UK, V7, P632, DOI 10.1080/17470919.2012.691078; Killikelly C, 2013, CORTEX, V49, P2888, DOI 10.1016/j.cortex.2013.08.017; Lange K, 2014, BRAIN COGNITION, V84, P153, DOI 10.1016/j.bandc.2013.12.001; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Lee JK, 2014, J BEHAV THER EXP PSY, V45, P208, DOI 10.1016/j.jbtep.2013.10.008; Levi DM, 2011, VISION RES, V51, P48, DOI 10.1016/j.visres.2010.09.029; Li FM, 2005, CHINESE OPHTHALOMOLO; Li HR, 2013, CHINESE J STRABISMUS, V03, P38; Li LP, 2003, BRAIN DEV-JPN, V25, P507, DOI 10.1016/S0387-7604(03)00059-7; Lin B, 2012, CHINESE J OPHTHALMOL, V12, P263; Liu HC, 2007, PSYCHOL SCI, V2, P365; Liu HY, 2010, PSYCHOL RES, V5, P42; LIU Z, 2007, PSYCHOL EXPLOR, V27, P48; LOGAN GD, 1980, COGNITIVE PSYCHOL, V12, P523, DOI 10.1016/0010-0285(80)90019-5; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; MacLeod CM, 1998, MEM COGNITION, V26, P201, DOI 10.3758/BF03201133; Mao W, 2008, INT J PSYCHOPHYSIOL, V67, P47, DOI 10.1016/j.ijpsycho.2007.10.003; [毛薇 Mao Wei], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P150; Melara RD, 2003, PSYCHOL REV, V110, P422, DOI 10.1037/0033-295X.110.3.422; Melcher T, 2009, CORTEX, V45, P189, DOI 10.1016/j.cortex.2007.06.004; Mendola JD, 2005, HUM BRAIN MAPP, V25, P222, DOI 10.1002/hbm.20109; Merikle PM, 1997, CONSCIOUS COGN, V6, P219, DOI 10.1006/ccog.1997.0310; Nixon E, 2013, INT J PSYCHOPHYSIOL, V87, P313, DOI 10.1016/j.ijpsycho.2012.11.014; PENG DL, 2004, SCI TECH ENG, V4, P84; Protopapas A, 2014, ACTA PSYCHOL, V148, P204, DOI 10.1016/j.actpsy.2014.02.006; Qi L, 2013, INT J OPHTHALMOLOGY, V09, P1931; Schmidt JR, 2005, CAN J EXP PSYCHOL, V59, P132, DOI 10.1037/h0087468; Soltesz F, 2011, LEARN INDIVID DIFFER, V21, P662, DOI 10.1016/j.lindif.2010.10.004; Sternberg RJ, 2006, COGNITIVE PSYCHOL; Szucs D, 2010, BRAIN RES, V1325, P63, DOI 10.1016/j.brainres.2010.02.011; Taylor MJ, 2000, INT J PSYCHOPHYSIOL, V37, P135, DOI 10.1016/S0167-8760(00)00084-2; [王海燕 Wang Haiyan], 2003, [中国心理卫生杂志, Chinese Mental Health Journal], V17, P273; Wang K, 2010, NEUROSCIENCE, V165, P101, DOI 10.1016/j.neuroscience.2009.09.070; Wang YP, 2000, NEUROSCI LETT, V293, P17, DOI 10.1016/S0304-3940(00)01480-4; Wang YP, 2002, NEUROSCI LETT, V332, P25, DOI 10.1016/S0304-3940(02)00906-0; Wei RJ, 2013, INT EYE SCI, V7, P1432, DOI [10.1016/j.ophtha.2012.12.040, DOI 10.1016/J.OPHTHA.2012.12.040]; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; West R, 2004, PSYCHOPHYSIOLOGY, V41, P739, DOI 10.1111/j.1469-8986.2004.00205.x; Yan H, 2008, AMBLYOPIA; Yang L, 2013, RECENT ADV OPHTHALMO, V5, P443; Yang L, 2012, RECENTADVANCES OPHTH, V09, P893; Yasumura A, 2014, BRAIN DEV-JPN, V36, P97, DOI 10.1016/j.braindev.2013.01.005; Zang L, 2009, J JILIN I PHYSICALED, V5, P92; Zhao BY, 2012, INT EYE SCI, V12, P2302; Zhao L, 2010, ERPS EXPT COURSE; [朱晓明 Zhu Xiaoming], 2004, [眼视光学杂志, Chinese Journal of Optometry & Ophthalmology], V6, P261	70	3	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0125370	10.1371/journal.pone.0125370	http://dx.doi.org/10.1371/journal.pone.0125370			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067259	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900006
J	He, ZQ; Zhang, HL; Olk, DC				He, Zhongqi; Zhang, Hailin; Olk, Dan C.			Chemical Composition of Defatted Cottonseed and Soy Meal Products	PLOS ONE			English	Article							PROTEIN ADHESIVES; AMINO-COMPOUNDS; SOILS; DIGESTIBILITY; MANAGEMENT; FRACTIONS; IMPROVE; MAPLE; WATER; ACID	Chemical composition is critical information for product quality and exploration of new use. Hence defatted cottonseed meals from both glanded (with gossypol) and glandless (without gossypol) cotton seeds were separated into water soluble and insoluble fractions, or water soluble, alkali soluble as well as total protein isolates. The contents of gossypol, total protein and amino acids, fiber and carbohydrates, and selected macro and trace elements in these products were determined and compared with each other and with those of soy meal products. Data reported in this work improved our understanding on the chemical composition of different cottonseed meal products that is helpful for more economical utilization of these products. These data would also provide a basic reference for product standards and quality control when the production of the cottonseed meal products comes to pilot and industrial scales.	[He, Zhongqi] USDA ARS, So Reg Res Ctr, New Orleans, LA 70122 USA; [Zhang, Hailin] Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA; [Olk, Dan C.] USDA ARS, Natl Lab Agr & Environm, Ames, IA USA	United States Department of Agriculture (USDA); Oklahoma State University System; Oklahoma State University - Stillwater; United States Department of Agriculture (USDA)	He, ZQ (corresponding author), USDA ARS, So Reg Res Ctr, New Orleans, LA 70122 USA.	Zhongqi.He@ars.usda.gov		zhang, hailin/0000-0002-8545-1032				[Anonymous], 1969, FOOD TECHNOL-CHICAGO; Bellaloui N, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00516; Bertrand JA, 2005, J DAIRY SCI, V88, P1470, DOI 10.3168/jds.S0022-0302(05)72815-0; Broderick GA, 2013, J DAIRY SCI, V96, P2374, DOI 10.3168/jds.2012-5723; Campbell BT, 2014, CSSA SPEC PUBL, V33, P13, DOI 10.2135/cssaspecpub33.c2; Chen MZ, 2015, BIORESOURCES, V10, P41; Cheng HN, 2013, IND CROP PROD, V46, P399, DOI 10.1016/j.indcrop.2013.02.021; Dowd M.K., 2010, COTTON TECHNOLOGY 21, P437; Gao DD, 2010, J SCI FOOD AGR, V90, P1855, DOI 10.1002/jsfa.4024; HAN YW, 1988, J AGR FOOD CHEM, V36, P1181, DOI 10.1021/jf00084a014; He Z., 2012, CAPILLARY ELECTROPHO, P131; He Z, 2011, ENV CHEM ANIMAL MANU, P179; He Z, 2015, JOVE-J VIS EXP, V97, DOI DOI 10.3791/52557; He Z. Q., 2014, Modern Applied Science, V8, P97; He ZQ, 2014, PEDOSPHERE, V24, P178, DOI 10.1016/S1002-0160(14)60004-7; He ZQ, 2014, IND CROP PROD, V61, P398, DOI 10.1016/j.indcrop.2014.07.031; He ZQ, 2014, J AM OIL CHEM SOC, V91, P1489, DOI 10.1007/s11746-014-2495-1; He ZQ, 2014, INT J ADHES ADHES, V50, P102, DOI 10.1016/j.ijadhadh.2014.01.019; He ZQ, 2014, J AM OIL CHEM SOC, V91, P151, DOI 10.1007/s11746-013-2349-2; He ZhongQi, 2013, Modern Applied Science, V7, P79; He ZQ, 2013, AGRON J, V105, P341, DOI 10.2134/agronj2012.0351; Hettiarachchy NS, 1995, J AM OIL CHEM SOC, V72, P1461, DOI 10.1007/BF02577838; KING EE, 1980, PHYTOCHEMISTRY, V19, P1647, DOI 10.1016/S0031-9422(00)83786-3; Li JT, 2012, ASIAN AUSTRAL J ANIM, V25, P1430, DOI 10.5713/ajas.2012.12201; Martens DA, 2002, SOIL BIOL BIOCHEM, V34, P1393, DOI 10.1016/S0038-0717(02)00082-2; MARTENS DA, 1990, CHROMATOGRAPHIA, V29, P7, DOI 10.1007/BF02261130; MARTINEZ WH, 1970, J AGR FOOD CHEM, V18, P961, DOI 10.1021/jf60172a039; Nida DL, 1996, J AGR FOOD CHEM, V44, P1967, DOI 10.1021/jf950565s; Nordqvist P, 2012, J APPL POLYM SCI, V123, P1530, DOI 10.1002/app.34312; Olk DC, 2008, SOIL SCI SOC AM J, V72, P1672, DOI 10.2136/sssaj2007.0406; Perez PG, 2015, J SOIL SEDIMENT, V15, P890, DOI 10.1007/s11368-014-1049-3; Pettigrew WT, 2014, J COTTON SCI, V18, P410; Pettigrew WT, 2011, CROP SCI, V51, P2155, DOI 10.2135/cropsci2011.02.0085; Qi GY, 2013, J AM OIL CHEM SOC, V90, P1917, DOI 10.1007/s11746-013-2343-8; Singh VK, 2014, J BIOBASED MATER BIO, V8, P338, DOI 10.1166/jbmb.2014.1445; Tazisong IA, 2013, SOIL SCI, V178, P231, DOI 10.1097/SS.0b013e31829cf464; Tong XJ, 2015, IND CROP PROD, V67, P11, DOI 10.1016/j.indcrop.2014.12.063; Voet D, 1990, BIOCHEMISTRY-US, P59; Wanapat M, 2013, ASIAN AUSTRAL J ANIM, V26, P529, DOI 10.5713/ajas.2012.12607; Wolfrum EJ, 2009, CELLULOSE, V16, P577, DOI 10.1007/s10570-009-9318-9; Yue HB, 2012, GREEN CHEM, V14, P2009, DOI 10.1039/c2gc35509d; Zhang BuNing, 2009, Modern Applied Science, V3, P77; Zhang BN, 2010, INT J POLYM MATER, V59, P1018, DOI 10.1080/00914031003760709; [No title captured]	44	55	56	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129933	10.1371/journal.pone.0129933	http://dx.doi.org/10.1371/journal.pone.0129933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079931	Green Published, gold, Green Submitted			2022-12-27	WOS:000356542300036
J	Wang, LM; Zhu, YM; Hu, WJ; Zhang, XY; Cai, CP; Guo, WZ				Wang, Liman; Zhu, Youmin; Hu, Wenjing; Zhang, Xueying; Cai, Caiping; Guo, Wangzhen			Comparative Transcriptomics Reveals Jasmonic Acid-Associated Metabolism Related to Cotton Fiber Initiation	PLOS ONE			English	Article							ALLENE OXIDE CYCLASE; TRANSFER PROTEIN GENE; CELL ELONGATION; UPLAND COTTON; TRICHOME FORMATION; MOLECULAR-CLONING; EXPRESSION; BIOSYNTHESIS; GROWTH; NITROGEN	Analysis of mutants and gene expression patterns provides a powerful approach for investigating genes involved in key stages of plant fiber development. In this study, lintless-fuzzless XinWX and linted-fuzzless XinFLM with a single genetic locus difference for lint were used to identify differentially expressed genes. Scanning electron microscopy showed fiber initiation in XinFLM at 0 days post anthesis (DPA). Fiber transcriptional profiling of the lines at three initiation developmental stages (-1, 0, 1 DPA) was performed using an oligonucleotide microarray. Loop comparisons of the differentially expressed genes within and between the lines was carried out, and functional classification and enrichment analysis showed that gene expression patterns during fiber initiation were heavily associated with hormone metabolism, transcription factor regulation, lipid transport, and asparagine biosynthetic processes, as previously reported. Further, four members of the allene-oxide cyclase (AOC) family that function in jasmonate biosynthesis were parallel up-regulation in fiber initiation, especially at -1 DPA, compared to other tissues and organs in linted-fuzzed TM-1. Real time-quantitative PCR (RT-qPCR) analysis in different fiber mutant lines revealed that AOCs were up-regulated higher at -1 DPA in lintless-fuzzless than that in linted-fuzzless and linted-fuzzed materials, and transcription of the AOCs was increased under jasmonic acid (JA) treatment. Expression analysis of JA biosynthesis-associated genes between XinWX and XinFLM showed that they were up-regulated during fiber initiation in the fuzzless-lintless mutant. Taken together, jasmonic acid-associated metabolism was related to cotton fiber initiation. Parallel up-regulation of AOCs expression may be important for normal fiber initiation development, while overproduction of AOCs might disrupt normal fiber development.	[Wang, Liman; Zhu, Youmin; Hu, Wenjing; Zhang, Xueying; Cai, Caiping; Guo, Wangzhen] Nanjing Agr Univ, MOE, Hybrid Cotton R&D Engn Res Ctr, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Guo, WZ (corresponding author), Nanjing Agr Univ, MOE, Hybrid Cotton R&D Engn Res Ctr, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	moelab@njau.edu.cn			National Natural Science Foundation of China [31471539]; Priority Academic Program Development of Jiangsu Higher Education Institutions [010-809001]; Jiangsu Collaborative Innovation Center for Modern Crop Production [10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Collaborative Innovation Center for Modern Crop Production	This program was financially supported in part by National Natural Science Foundation of China (31471539), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (010-809001), and Jiangsu Collaborative Innovation Center for Modern Crop Production (No. 10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpat AB, 2004, PLANT MOL BIOL, V54, P911, DOI 10.1007/s11103-004-0392-y; BEASLEY CA, 1973, SCIENCE, V179, P1003, DOI 10.1126/science.179.4077.1003; BEASLEY CA, 1974, AM J BOT, V61, P188, DOI 10.2307/2441189; Chien JC, 1996, PLANT PHYSIOL, V111, P1321, DOI 10.1104/pp.111.4.1321; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; DILWORTH MF, 1978, PLANT PHYSIOL, V61, P698, DOI 10.1104/pp.61.4.698; [丁业掌 DING Yezhang], 2007, [棉花学报, Cotton Science], V19, P179; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Endrizzi JE, 1985, COTTON; Feng JX, 2004, ACTA BIOCH BIOPH SIN, V36, P51, DOI 10.1093/abbs/36.1.51; Gou JY, 2007, CELL RES, V17, P422, DOI 10.1038/sj.cr.7310150; Gutierrez L, 2012, PLANT CELL, V24, P2515, DOI 10.1105/tpc.112.099119; Hao J, 2012, J EXP BOT, V63, P6267, DOI 10.1093/jxb/ers278; Howe GA, 2000, PLANT PHYSIOL, V123, P711, DOI 10.1104/pp.123.2.711; Isayenkov S, 2005, PLANT PHYSIOL, V139, P1401, DOI 10.1104/pp.105.069054; Ji SJ, 2002, BIOCHEM BIOPH RES CO, V296, P1245, DOI 10.1016/S0006-291X(02)02069-7; Ji SJ, 2003, NUCLEIC ACIDS RES, V31, P2534, DOI 10.1093/nar/gkg358; [蒋建雄 Jiang Jianxiong], 2003, [棉花学报, Cotton Science], V15, P166; John ME, 1996, P NATL ACAD SCI USA, V93, P12768, DOI 10.1073/pnas.93.23.12768; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; KOHEL RJ, 1972, CROP SCI, V12, P66, DOI 10.2135/cropsci1972.0011183X001200010022x; KOHEL RJ, 1990, CROP SCI, V30, P419, DOI 10.2135/cropsci1990.0011183X003000020038x; Lee JJ, 2006, PLANTA, V223, P418, DOI 10.1007/s00425-005-0098-7; Lee J, 2010, PLANTA, V232, P1191, DOI 10.1007/s00425-010-1246-2; Liu K, 2012, J PROTEOMICS, V75, P845, DOI 10.1016/j.jprot.2011.09.025; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Luo M, 2007, PLANT J, V51, P419, DOI 10.1111/j.1365-313X.2007.03144.x; MA DP, 1995, BBA-LIPID LIPID MET, V1257, P81, DOI 10.1016/0005-2760(95)00077-P; Ma DP, 1997, BBA-LIPID LIPID MET, V1344, P111, DOI 10.1016/S0005-2760(96)00166-X; Machado A, 2009, PLANT J, V59, P52, DOI 10.1111/j.1365-313X.2009.03847.x; Maucher H, 2000, PLANT J, V21, P199, DOI 10.1046/j.1365-313x.2000.00669.x; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; NARBUTH EV, 1990, J HERED, V81, P131; Padmalatha KV, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-624; Pang CY, 2010, MOL CELL PROTEOMICS, V9, P2019, DOI 10.1074/mcp.M110.000349; Perazza D, 1998, PLANT PHYSIOL, V117, P375, DOI 10.1104/pp.117.2.375; Percival AE, 1987, S COOP SER B, P321; Percy R.G., 1999, COTTON ORIGIN HIST T; Read JJ, 2006, EUR J AGRON, V24, P282, DOI 10.1016/j.eja.2005.10.004; Reddy KR, 2004, AGRON J, V96, P1148, DOI 10.2134/agronj2004.1148; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stenzel I, 2003, PLANT J, V33, P577, DOI 10.1046/j.1365-313X.2003.01647.x; Strassner J, 2002, PLANT J, V32, P585, DOI 10.1046/j.1365-313X.2002.01449.x; Sun Y, 2005, PLANT CELL PHYSIOL, V46, P1384, DOI 10.1093/pcp/pci150; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; Tabata R, 2010, PLANT CELL PHYSIOL, V51, P164, DOI 10.1093/pcp/pcp176; Tan JF, 2012, J PLANT GROWTH REGUL, V31, P599, DOI 10.1007/s00344-012-9260-1; Telfer A, 1997, DEVELOPMENT, V124, P645; Traw MB, 2003, PLANT PHYSIOL, V133, P1367, DOI 10.1104/pp.103.027086; Turley RB, 2002, CROP SCI, V42, P994, DOI 10.2135/cropsci2002.994a; Turley RB, 2008, PLANT PHYSIOL BIOCH, V46, P780, DOI 10.1016/j.plaphy.2008.04.016; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; VICK BA, 1983, BIOCHEM BIOPH RES CO, V111, P470, DOI 10.1016/0006-291X(83)90330-3; Walford SA, 2012, PLANT J, V71, P464, DOI 10.1111/j.1365-313X.2012.05003.x; Wang C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-94; Wang LM, 2014, J INTEGR AGR, V13, P2113, DOI 10.1016/S2095-3119(13)60666-8; Wilkins TA, 2005, PHYSIOL PLANTARUM, V124, P295, DOI 10.1111/j.1399-3054.2005.00514.x; Wu YR, 2006, PLANT CELL PHYSIOL, V47, P107, DOI 10.1093/pcp/pci228; Xiao YH, 2010, J PLANT PHYSIOL, V167, P829, DOI 10.1016/j.jplph.2010.01.003; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; Yang YH, 2003, INST MATH S, V40, P403; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang DY, 2010, J PLANT PHYSIOL, V167, P393, DOI 10.1016/j.jplph.2009.10.005; Zhang HP, 2009, ACTA PHYSIOL PLANT, V31, P979, DOI 10.1007/s11738-009-0313-4; Zhang TZ, 1991, JIANGSU J AGR SCI, V7, P13; Ziegler J, 2000, J BIOL CHEM, V275, P19132, DOI 10.1074/jbc.M002133200	70	15	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129854	10.1371/journal.pone.0129854	http://dx.doi.org/10.1371/journal.pone.0129854			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079621	gold, Green Submitted, Green Published			2022-12-27	WOS:000356542300033
J	Hu, QD; Tan, HR; Irwin, DM				Hu, Qingda; Tan, Huanran; Irwin, David M.			Evolution of the Vertebrate Resistin Gene Family	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; INSULIN-RESISTANCE; DEATH EVOLUTION; MOLECULE-BETA; WEB SERVER; MOUSE; IDENTIFICATION; PHYLOGENOMICS; INFLAMMATION; EXPRESSION	Resistin (encoded by Retn) was previously identified in rodents as a hormone associated with diabetes; however human resistin is instead linked to inflammation. Resistin is a member of a small gene family that includes the resistin-like peptides (encoded by Retnl genes) in mammals. Genomic searches of available genome sequences of diverse vertebrates and phylogenetic analyses were conducted to determine the size and origin of the resistin-like gene family. Genes encoding peptides similar to resistin were found in Mammalia, Sauria, Amphibia, and Actinistia (coelacanth, a lobe-finned fish), but not in Aves or fish from Actinopterygii, Chondrichthyes, or Agnatha. Retnl originated by duplication and transposition from Retn on the early mammalian lineage after divergence of the platypus, but before the placental and marsupial mammal divergence. The resistin-like gene family illustrates an instance where the locus of origin of duplicated genes can be identified, with Retn continuing to reside at this location. Mammalian species typically have a single copy Retn gene, but are much more variable in their numbers of Retnl genes, ranging from 0 to 9. Since Retn is located at the locus of origin, thus likely retained the ancestral expression pattern, largely maintained its copy number, and did not display accelerated evolution, we suggest that it is more likely to have maintained an ancestral function, while Retnl, which transposed to a new location, displays accelerated evolution, and shows greater variability in gene number, including gene loss, likely evolved new, but potentially lineage-specific, functions.	[Hu, Qingda; Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Tan, Huanran; Irwin, David M.] Peking Univ, Dept Pharmacol, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Irwin, David M.] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON, Canada	University of Toronto; Peking University; University of Toronto	Irwin, DM (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	david.irwin@utoronto.ca		Irwin, David/0000-0001-6131-4933	National Science Foundation of China (NSFC) - Canadian Institutes of Health Research (CIHR) China - Canada Joint Health Research Initiative grant from the Canadian Institutes of Health Research [CCI 109605]	National Science Foundation of China (NSFC) - Canadian Institutes of Health Research (CIHR) China - Canada Joint Health Research Initiative grant from the Canadian Institutes of Health Research	This work was funded by a National Science Foundation of China (NSFC) - Canadian Institutes of Health Research (CIHR) China - Canada Joint Health Research Initiative grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), grant number CCI 109605 to DMI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Banerjee RR, 2001, J BIOL CHEM, V276, P25970, DOI 10.1074/jbc.M103109200; Benomar Y, 2013, DIABETES, V62, P102, DOI 10.2337/db12-0237; Chumakov AM, 2004, ONCOGENE, V23, P3414, DOI 10.1038/sj.onc.1207126; Codoner-Franch P, 2015, CLIN CHIM ACTA, V438, P46, DOI 10.1016/j.cca.2014.07.043; Dakovic N, 2014, MOL BIOL EVOL, V31, P2637, DOI 10.1093/molbev/msu208; Dalamaga M, 2014, BIOMARK MED, V8, P107, DOI 10.2217/bmm.13.99; Daquinag AC, 2011, CELL STEM CELL, V9, P74, DOI 10.1016/j.stem.2011.05.017; Ding QX, 2011, TRENDS CARDIOVAS MED, V21, P20, DOI 10.1016/j.tcm.2012.01.004; Eirin-Lopez JM, 2012, GENOME DYNAM, V7, P170, DOI 10.1159/000337119; Fan C, 2015, AM J RESP C IN PRESS; Fang C, 2012, EUR RESPIR J, V39, P458, DOI 10.1183/09031936.00107811; Gerstmayer B, 2003, GENOMICS, V81, P588, DOI 10.1016/S0888-7543(03)00070-3; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Ghosh S, 2003, GENE, V305, P27, DOI 10.1016/S0378-1119(02)01213-1; GORR T, 1991, NATURE, V351, P394, DOI 10.1038/351394a0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Han MV, 2009, GENOME RES, V19, P859, DOI 10.1101/gr.085951.108; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Irwin DM, 2006, COMP BIOCHEM PHYS D, V1, P385, DOI 10.1016/j.cbd.2006.09.001; Irwin DM, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0188-x; Irwin DM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-166; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim KH, 2000, J BIOL CHEM, V276, P11252; Krimi RB, 2008, INFLAMM BOWEL DIS, V14, P931, DOI 10.1002/ibd.20420; Kurokawa T, 2005, PEPTIDES, V26, P745, DOI 10.1016/j.peptides.2004.12.017; Kushiyama A, 2013, ARTERIOSCL THROM VAS, V33, P1986, DOI 10.1161/ATVBAHA.113.301546; Lee MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5410; Lee Sang Eun, 2012, Journal of Smooth Muscle Research, V48, P27; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; MEYER A, 1990, J MOL EVOL, V31, P359, DOI 10.1007/BF02106050; Morgan CC, 2013, MOL BIOL EVOL, V30, P2145, DOI 10.1093/molbev/mst117; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Osborne LC, 2013, J IMMUNOL, V190, P2292, DOI 10.4049/jimmunol.1200706; Park HK, 2013, DIABETES METAB J, V37, P404, DOI [10.4093/dmj.2013.37.6.404, 10.4093/dmj.2013.37.2.113]; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Pegueroles C, 2013, MOL BIOL EVOL, V30, P1830, DOI 10.1093/molbev/mst083; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Romiguier J, 2013, MOL BIOL EVOL, V30, P2134, DOI 10.1093/molbev/mst116; Sanchez-Solana B, 2012, MOL ENDOCRINOL, V26, P110, DOI 10.1210/me.2011-1027; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Smit A, 1996, REPEATMASKER OPEN 30; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060896; Yang RZ, 2003, BIOCHEM BIOPH RES CO, V310, P927, DOI 10.1016/j.bbrc.2003.09.093	50	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130188	10.1371/journal.pone.0130188	http://dx.doi.org/10.1371/journal.pone.0130188			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076481	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900152
J	Mercer, JL; Argus, JP; Crabtree, DM; Keenan, MM; Wilks, MQ; Chi, JTA; Bensinger, SJ; Lavau, CP; Wechsler, DS				Mercer, Jacob L.; Argus, Joseph P.; Crabtree, Donna M.; Keenan, Melissa M.; Wilks, Moses Q.; Chi, Jen-Tsan Ashley; Bensinger, Steven J.; Lavau, Catherine P.; Wechsler, Daniel S.			Modulation of PICALM Levels Perturbs Cellular Cholesterol Homeostasis	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; MYELOID-LEUKEMIA CALM; ALZHEIMERS-DISEASE; UBIQUITIN LIGASE; COATED PITS; PROTEIN; RECEPTOR; FUSION; GENE; TRAFFICKING	PICALM (Phosphatidyl Inositol Clathrin Assembly Lymphoid Myeloid protein) is a ubiquitously expressed protein that plays a role in clathrin-mediated endocytosis. PICALM also affects the internalization and trafficking of SNAREs and modulates macroautophagy. Chromosomal translocations that result in the fusion of PICALM to heterologous proteins cause leukemias, and genome-wide association studies have linked PICALM Single Nucleotide Polymorphisms (SNPs) to Alzheimer's disease. To obtain insight into the biological role of PICALM, we performed gene expression studies of PICALM-deficient and PICALM-expressing cells. Pathway analysis demonstrated that PICALM expression influences the expression of genes that encode proteins involved in cholesterol biosynthesis and lipoprotein uptake. Gas Chromatography-Mass Spectrometry (GC-MS) studies indicated that loss of PICALM increases cellular cholesterol pool size. Isotopic labeling studies revealed that loss of PICALM alters increased net scavenging of cholesterol. Flow cytometry analyses confirmed that internalization of the LDL receptor is enhanced in PICALM-deficient cells as a result of higher levels of LDLR expression. These findings suggest that PICALM is required for cellular cholesterol homeostasis and point to a novel mechanism by which PICALM alterations may contribute to disease.	[Mercer, Jacob L.; Wechsler, Daniel S.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27705 USA; [Argus, Joseph P.; Bensinger, Steven J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Mol & Med Pharmacol, Los Angeles, CA USA; [Crabtree, Donna M.; Lavau, Catherine P.; Wechsler, Daniel S.] Duke Univ, Dept Pediat, Div Pediat Hematol Oncol, Durham, NC 27706 USA; [Keenan, Melissa M.; Chi, Jen-Tsan Ashley] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA; [Keenan, Melissa M.; Chi, Jen-Tsan Ashley] Duke Univ, Ctr Genom & Computat Biol, Durham, NC USA; [Wilks, Moses Q.] Massachusetts Gen Hosp, Dept Radiol, Ctr Adv Med Imaging Sci, Boston, MA 02114 USA	Duke University; University of California System; University of California Los Angeles; Duke University; Duke University; Duke University; Harvard University; Massachusetts General Hospital	Wechsler, DS (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27705 USA.	dan.wechsler@duke.edu	Lavau, Catherine/Q-2928-2019; Chi, Jen-Tsan/AAI-4125-2020	Chi, Jen-Tsan/0000-0003-3433-903X; Lavau, Catherine/0000-0003-4800-1320	National Institutes of Health CBI Grant [T32 GM008469]; University of California Los Angeles Graduate Division (JPA); Sontag Foundation; National Institutes of Health [AI093768]; V Foundation/Applebee's Research Grant; St. Baldrick's Research Grant; Hyundai Hope On Wheels Grant; Schiffman Family Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754, T32GM007184] Funding Source: NIH RePORTER	National Institutes of Health CBI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Los Angeles Graduate Division (JPA); Sontag Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation/Applebee's Research Grant; St. Baldrick's Research Grant; Hyundai Hope On Wheels Grant; Schiffman Family Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health CBI Grant (T32 GM008469) and the University of California Los Angeles Graduate Division (JPA); the Sontag Foundation and the National Institutes of Health (AI093768 - SJB); and a V Foundation/Applebee's Research Grant, a St. Baldrick's Research Grant, a Hyundai Hope On Wheels Grant and a Schiffman Family Award (to DSW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhaleem M, 2007, LEUKEMIA, V21, P352, DOI 10.1038/sj.leu.2404503; Anderson RGW, 2003, TRENDS CELL BIOL, V13, P534, DOI 10.1016/j.tcb.2003.08.007; Ando K, 2013, ACTA NEUROPATHOL, V125, P861, DOI 10.1007/s00401-013-1111-z; Baig S, 2010, J NEUROPATH EXP NEUR, V69, P1071, DOI 10.1097/NEN.0b013e3181f52e01; Bhattacharyya R, 2010, BBA-MOL CELL BIOL L, V1801, P960, DOI 10.1016/j.bbalip.2010.04.003; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Bohlander SK, 2000, LEUKEMIA, V14, P93, DOI 10.1038/sj.leu.2401614; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Conway AE, 2015, LEUKEMIA, V29, P423, DOI 10.1038/leu.2014.221; Conway AE, 2013, BLOOD, V121, P4758, DOI 10.1182/blood-2012-06-435792; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Du CC, 1999, BLOOD, V94, P793, DOI 10.1182/blood.V94.2.793.414k43_793_802; Eden ER, 2007, HUM MOL GENET, V16, P2751, DOI 10.1093/hmg/ddm232; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Garuti R, 2005, J BIOL CHEM, V280, P40996, DOI 10.1074/jbc.M509394200; Gatza ML, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2899; Girard E, 2014, TRAFFIC, V15, P309, DOI 10.1111/tra.12143; Girard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029042; Goedeke L, 2012, CELL MOL LIFE SCI, V69, P915, DOI 10.1007/s00018-011-0857-5; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Harel A, 2008, TRAFFIC, V9, P417, DOI 10.1111/j.1600-0854.2007.00694.x; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; HAWLEY RG, 1994, GENE THER, V1, P136; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Ikonen E, 2006, PHYSIOL REV, V86, P1237, DOI 10.1152/physrev.00022.2005; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Kanatsu K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4386; Karasinska JM, 2011, NAT REV NEUROL, V7, P561, DOI 10.1038/nrneurol.2011.132; KELLEHER JK, 1992, AM J PHYSIOL, V262, pE118, DOI 10.1152/ajpendo.1992.262.1.E118; Kingston R E, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1013s31; Klebig ML, 2003, P NATL ACAD SCI USA, V100, P8360, DOI 10.1073/pnas.1432634100; Koo SJ, 2011, P NATL ACAD SCI USA, V108, P13540, DOI 10.1073/pnas.1107067108; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Legendre-Guillemin V, 2004, J CELL SCI, V117, P9, DOI 10.1242/jcs.00928; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Maurer ME, 2006, J CELL SCI, V119, P4235, DOI 10.1242/jcs.03217; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Miller SE, 2011, CELL, V147, P1118, DOI 10.1016/j.cell.2011.10.038; Moreau K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5998; Moreau K, 2013, TRENDS BIOCHEM SCI, V38, P57, DOI 10.1016/j.tibs.2012.11.004; Morgen K, 2014, ALZHEIMERS DEMENT, V10, pS269, DOI 10.1016/j.jalz.2013.11.001; Mori T, 2001, J NEUROPATH EXP NEUR, V60, P778, DOI 10.1093/jnen/60.8.778; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Peake KB, 2010, FEBS LETT, V584, P2731, DOI 10.1016/j.febslet.2010.04.047; Qi YP, 1997, J NEUROSCI, V17, P1217; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rai S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109441; Robinet P, 2006, TRAFFIC, V7, P811, DOI 10.1111/j.1600-0854.2006.00435.x; Sahlender DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064514; Sarkar S, 2014, AUTOPHAGY, V10, P1137, DOI 10.4161/auto.28623; Sarkar S, 2013, CELL REP, V5, P1302, DOI 10.1016/j.celrep.2013.10.042; Scotland PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044252; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; SURI C, 1993, J NEUROSCI, V13, P1280; Suzuki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031854; Tang XH, 2012, CANCER RES, V72, P491, DOI 10.1158/0008-5472.CAN-11-2076; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Thomas RS, 2011, BIOCHEM BIOPH RES CO, V415, P656, DOI 10.1016/j.bbrc.2011.10.131; Vance JE, 2006, FEBS LETT, V580, P5518, DOI 10.1016/j.febslet.2006.06.008; Vecchi M, 2001, J CELL BIOL, V153, P1511, DOI 10.1083/jcb.153.7.1511; Williams KJ, 2013, CANCER RES, V73, P2850, DOI 10.1158/0008-5472.CAN-13-0382-T; Xiao QL, 2012, J BIOL CHEM, V287, P21279, DOI 10.1074/jbc.M111.338376; Xu W, 2015, MOL NEUROBIOL, V52, P399, DOI 10.1007/s12035-014-8878-3; Yu LQ, 2003, J BIOL CHEM, V278, P15565, DOI 10.1074/jbc.M301311200; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9	81	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129776	10.1371/journal.pone.0129776	http://dx.doi.org/10.1371/journal.pone.0129776			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075887	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900102
J	Schell, C; Kretz, O; Bregenzer, A; Rogg, M; Helmstadter, M; Lisewski, U; Gotthardt, M; Tharaux, PL; Huber, TB; Grahammer, F				Schell, Christoph; Kretz, Oliver; Bregenzer, Andreas; Rogg, Manuel; Helmstaedter, Martin; Lisewski, Ulrike; Gotthardt, Michael; Tharaux, Pierre-Louis; Huber, Tobias B.; Grahammer, Florian			Podocyte-Specific Deletion of Murine CXADR Does Not Impair Podocyte Development, Function or Stress Response	PLOS ONE			English	Article							ADENOVIRUS RECEPTOR CAR; CONGENITAL NEPHROTIC SYNDROME; TIGHT JUNCTION; GLOMERULAR PROTEIN; ADHESION MOLECULE; TRANSGENIC MICE; FOOT PROCESSES; CELL-ADHESION; SESTRIN 2; COXSACKIEVIRUS	The coxsackie-and adenovirus receptor (CXADR) is a member of the immunoglobulin protein superfamily, present in various epithelial cells including glomerular epithelial cells. Beside its known function as a virus receptor, it also constitutes an integral part of cell-junctions. Previous studies in the zebrafish pronephros postulated a potential role of CXADR for the terminal differentiation of glomerular podocytes and correct patterning of the elaborated foot process architecture. However, due to early embryonic lethality of constitutive Cxadr knockout mice, mammalian data on kidney epithelial cells have been lacking. Interestingly, Cxadr is robustly expressed during podocyte development and in adulthood in response to glomerular injury. We therefore used a conditional transgenic approach to elucidate the function of Cxadr for podocyte development and stress response. Surprisingly, we could not discern a developmental phenotype in podocyte specific Cxadr knock-out mice. In addition, despite a significant up regulation of CXADR during toxic, genetic and immunologic podocyte injury, we could not detect any impact of Cxadr on these injury models. Thus these data indicate that in contrast to lower vertebrate models, mammalian podocytes have acquired molecular programs to compensate for the loss of Cxadr.	[Schell, Christoph; Kretz, Oliver; Bregenzer, Andreas; Rogg, Manuel; Helmstaedter, Martin; Huber, Tobias B.; Grahammer, Florian] Univ Med Ctr Freiburg, Div Renal, Freiburg, Germany; [Schell, Christoph; Huber, Tobias B.] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79106 Freiburg, Germany; [Schell, Christoph] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Kretz, Oliver] Univ Freiburg, Dept Neuroanat, D-79106 Freiburg, Germany; [Lisewski, Ulrike; Gotthardt, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany; [Tharaux, Pierre-Louis] INSERM, Paris Ctr Rech Cardiovasc, Paris, France; [Huber, Tobias B.] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Freiburg	Huber, TB (corresponding author), Univ Med Ctr Freiburg, Div Renal, Freiburg, Germany.	tobias.huber@uniklinik-freiburg.de	Grahammer, Florian/ABB-7775-2021; Tharaux, Pierre-Louis/A-9155-2009; Gotthardt, Michael/ABE-8274-2021	Tharaux, Pierre-Louis/0000-0002-6062-5905; Gotthardt, Michael/0000-0003-1788-3172; Huber, Tobias B./0000-0001-7175-5062; Rogg, Manuel/0000-0002-6658-9159; Kretz, Oliver/0000-0003-1152-5956	German Research Foundation (DFG) [CRC 1140, CRC 992]; Else Kroner Stiftung; Fritz-Thyssen-Stiftung; European Research Council (ERC); BMBF-Joint transnational Grant; Excellence Initiative of the German Federal and State Governments [EXC 294]	German Research Foundation (DFG)(German Research Foundation (DFG)); Else Kroner Stiftung; Fritz-Thyssen-Stiftung; European Research Council (ERC)(European Research Council (ERC)); BMBF-Joint transnational Grant; Excellence Initiative of the German Federal and State Governments	This study was supported by the German Research Foundation (DFG): CRC 1140 (to FG, TBH), Heisenberg program and CRC 992 (to TBH); by the Else Kroner Stiftung (to FG and TBH); by the Fritz-Thyssen-Stiftung (to FG and TBH); by the European Research Council (ERC grant to TBH); by the BMBF-Joint transnational Grant (TBH) and by the Excellence Initiative of the German Federal and State Governments (EXC 294 to TBH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechtel W, 2013, J AM SOC NEPHROL, V24, P727, DOI 10.1681/ASN.2012070700; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Boerries M, 2013, KIDNEY INT, V83, P1052, DOI 10.1038/ki.2012.487; Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; BRAY DF, 1993, MICROSC RES TECHNIQ, V26, P489, DOI 10.1002/jemt.1070260603; Carson SD, 1997, BIOCHEM BIOPH RES CO, V233, P325, DOI 10.1006/bbrc.1997.6449; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Coyne CB, 2004, J BIOL CHEM, V279, P48079, DOI 10.1074/jbc.M409061200; Dorner AA, 2005, J CELL SCI, V118, P3509, DOI 10.1242/jcs.02476; Excoffon KJDA, 2004, J CELL SCI, V117, P4401, DOI 10.1242/jcs.01300; Fechner H, 2003, CIRCULATION, V107, P876, DOI 10.1161/01.CIR.0000050150.27478.C5; Fukasawa H, 2009, J AM SOC NEPHROL, V20, P1491, DOI 10.1681/ASN.2008101117; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Grahammer F, 2013, NAT REV NEPHROL, V9, P587, DOI 10.1038/nrneph.2013.169; Hamatani H, 2014, AM J PHYSIOL-RENAL, V307, pF708, DOI 10.1152/ajprenal.00625.2013; Honda T, 2000, MOL BRAIN RES, V77, P19, DOI 10.1016/S0169-328X(00)00036-X; Ito M, 2000, CIRC RES, V86, P275, DOI 10.1161/01.RES.86.3.275; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Lisewski U, 2008, J EXP MED, V205, P2369, DOI 10.1084/jem.20080897; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Moeller MJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015614.68893.0B; Nagai M, 2003, LAB INVEST, V83, P901, DOI 10.1097/01.LAB.0000073307.82991.CC; Noutsias M, 2001, CIRCULATION, V104, P275; Papeta N, 2010, J CLIN INVEST, V120, P4055, DOI 10.1172/JCI43721; Raschperger E, 2008, DEV BIOL, V313, P455, DOI 10.1016/j.ydbio.2007.10.049; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Schell C, 2013, J AM SOC NEPHROL, V24, P713, DOI 10.1681/ASN.2012080844; Schreiber Jadwiga, 2014, Adv Neurobiol, V8, P21; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Shono A, 2007, J AM SOC NEPHROL, V18, P2525, DOI 10.1681/ASN.2006101084; Smeets B, 2014, AM J PHYSIOL-RENAL, V307, pF798, DOI 10.1152/ajprenal.00435.2014; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014	35	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129424	10.1371/journal.pone.0129424	http://dx.doi.org/10.1371/journal.pone.0129424			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076477	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000356329900071
J	Yang, J; Qu, Z; Chang, H				Yang, Jian; Qu, Zhao; Chang, Hui			Investigation on Law and Economics Based on Complex Network and Time Series Analysis	PLOS ONE			English	Article							TRANSITIONS	The research focuses on the cooperative relationship and the strategy tendency among three mutually interactive parties in financing: small enterprises, commercial banks and micro-credit companies. Complex network theory and time series analysis were applied to figure out the quantitative evidence. Moreover, this paper built up a fundamental model describing the particular interaction among them through evolutionary game. Combining the results of data analysis and current situation, it is justifiable to put forward reasonable legislative recommendations for regulations on lending activities among small enterprises, commercial banks and micro-credit companies. The approach in this research provides a framework for constructing mathematical models and applying econometrics and evolutionary game in the issue of corporation financing.	[Yang, Jian; Chang, Hui] Tianjin Univ, Dept Law, Tianjin 300072, Peoples R China; [Qu, Zhao] Tianjin Univ, Dept English, Tianjin 300072, Peoples R China	Tianjin University; Tianjin University	Chang, H (corresponding author), Tianjin Univ, Dept Law, Tianjin 300072, Peoples R China.	changhui@tju.edu.cn			Tianjin University [2013XRG-0106]; Tianjin Planning Leading Group Office of Philosophy and Social Science [TJFX13-008]	Tianjin University; Tianjin Planning Leading Group Office of Philosophy and Social Science	This work was supported by 2013XRG-0106 Tianjin University (HC) and TJFX13-008 Tianjin Planning Leading Group Office of Philosophy and Social Science (HC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Donges JF, 2011, P NATL ACAD SCI USA, V108, P20422, DOI 10.1073/pnas.1117052108; Drake D, 2014, J CORP ACCOUNT FINAN, V25, P29, DOI 10.1002/jcaf.21951; Felipe C, 2014, J SUSTAINABLE FINANC, V4, P192; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/50004; Gao ZK, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032910; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Ghaffari HO, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/48003; Ghaffari HO, 2012, NONLINEAR PROC GEOPH, V19, P215, DOI 10.5194/npg-19-215-2012; Hempel S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.054101; Lacasa L, 2008, P NATL ACAD SCI USA, V105, P4972, DOI 10.1073/pnas.0709247105; Lehnertz K, 2014, PHYSICA D, V267, P7, DOI 10.1016/j.physd.2013.06.009; Li B, 2011, INT BUSINESS MANAGEM, V2, P24; Ma ZQ, 2011, INT J MOD PHYS C, V22, P1257, DOI 10.1142/S0129183111016877; Marwan N, 2009, PHYS LETT A, V373, P4246, DOI 10.1016/j.physleta.2009.09.042; Walker DM, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S021812741230042X; Walker DM, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011304; Wang J, 2012, CHINESE SCI BULL, V57, P724, DOI 10.1007/s11434-011-4890-4; Wang WD, 2011, J INEQUAL APPL, DOI 10.1186/1029-242X-2011-6; Wang WX, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/48006; Wang WX, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.154101; Wu XQ, 2008, PHYSICA A, V387, P997, DOI 10.1016/j.physa.2007.10.030; Wu XQ, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.046106; Wu XQ, 2011, CHAOS, V21, DOI 10.1063/1.3664396; Xia CY, 2009, INT J MOD PHYS B, V23, P2203, DOI 10.1142/S021797920905211X; Xia CY, 2012, NONLINEAR DYNAM, V69, P927, DOI 10.1007/s11071-011-0313-y; Xu XK, 2008, P NATL ACAD SCI USA, V105, P19601, DOI 10.1073/pnas.0806082105; Zhang J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238701; Zhang JJ, 2012, FRONT PHYS-BEIJING, V7, P366, DOI 10.1007/s11467-011-0208-x; Zhuang E, 2014, PHYSICA A, V410, P483, DOI 10.1016/j.physa.2014.05.058	32	40	41	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0127001	10.1371/journal.pone.0127001	http://dx.doi.org/10.1371/journal.pone.0127001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076460	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900007
J	Dellafiore, MA; Montserrat, JM; Iribarren, AM				Dellafiore, Maria A.; Montserrat, Javier M.; Iribarren, Adolfo M.			Exploring the Use of a Guanine-Rich Catalytic DNA for Sulfoxide Preparation	PLOS ONE			English	Article							PEROXIDASE-ACTIVITY; DNAZYME; APTAMERS; SULFIDES	A guanine-rich DNA oligonucleotide complexed with hemin was used to catalyze controlled oxygen transfer reactions to different sulfides for sulfoxide preparation in the presence of H2O2. Comparable activities were obtained when using fully modified L-DNA. In addition, oligonucleotide immobilization led to an active catalyst which could be successfully recovered and reused without loss of activity.	[Dellafiore, Maria A.; Montserrat, Javier M.; Iribarren, Adolfo M.] Consejo Nacl Invest Cient & Tecn, INGEBI, Lab Quim Acidos Nucle, RA-1033 Buenos Aires, DF, Argentina; [Montserrat, Javier M.] Univ Nacl Gral Sarmiento, Inst Ciencias, Los Polvorines, Provincia De Bu, Argentina; [Iribarren, Adolfo M.] Univ Nacl Quilmes, Lab Biotransformac, Bernal, Provincia De Bu, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Montserrat, JM (corresponding author), Consejo Nacl Invest Cient & Tecn, INGEBI, Lab Quim Acidos Nucle, RA-1033 Buenos Aires, DF, Argentina.	jmontser@ungs.edu.ar		MONTSERRAT, Josep Maria/0000-0003-3098-4605	Agencia Nacional de Promocion de la Ciencia y la Tecnologia (ANPCyT), Argentina [PICT2011-0367]	Agencia Nacional de Promocion de la Ciencia y la Tecnologia (ANPCyT), Argentina	This work was supported by the Agencia Nacional de Promocion de la Ciencia y la Tecnologia (ANPCyT), Argentina, Grant Number: PICT2011-0367. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetumjbi MA, 1983, MED HYPOTHESES, V12, P222; CARRENO MC, 1995, CHEM REV, V95, P1717, DOI 10.1021/cr00038a002; Garnock-Jones KP, 2009, CNS DRUGS, V23, P793, DOI 10.2165/1120329-000000000-00000; Kosman J, 2011, ANAL CHIM ACTA, V707, P7, DOI 10.1016/j.aca.2011.08.050; KOTELANSKI B, 1973, CLIN PHARMACOL THER, V14, P427; Kowalski P, 2005, TETRAHEDRON, V61, P1933, DOI 10.1016/j.tet.2004.11.041; Kumar ABVK, 2009, J KOREAN SOC APPL BI, V52, P34, DOI 10.3839/jksabc.2009.006; Li BL, 2009, ANAL CHIM ACTA, V651, P234, DOI 10.1016/j.aca.2009.09.009; Li C, 2012, CHEM COMMUN, V48, P8347, DOI 10.1039/c2cc32919k; Li YF, 1997, BIOCHEMISTRY-US, V36, P5589, DOI 10.1021/bi962694n; Li YF, 1996, BIOCHEMISTRY-US, V35, P6911, DOI 10.1021/bi960038h; MARINO JP, 1991, J ORG CHEM, V56, P1349, DOI 10.1021/jo00004a002; Padmanabhan S, 2001, BIOORG MED CHEM LETT, V11, P501, DOI 10.1016/S0960-894X(00)00695-8; Poon LCH, 2011, J AM CHEM SOC, V133, P1877, DOI 10.1021/ja108571a; Riddell D, 1996, BIOCHEM PHARMACOL, V52, P1177, DOI 10.1016/0006-2952(96)00455-8; Rojas AM, 2007, BIOTECHNOL LETT, V29, P227, DOI 10.1007/s10529-006-9228-y; Schwartz IF, 2002, CLIN SCI, V102, P487, DOI 10.1042/CS20010221; Sen D, 2011, CRIT REV BIOCHEM MOL, V46, P478, DOI 10.3109/10409238.2011.618220; Spencer CM, 2000, DRUGS, V60, P321, DOI 10.2165/00003495-200060020-00006; Taylor D, 2014, CHEMOSPHERE, V115, P95, DOI 10.1016/j.chemosphere.2014.01.011; Travascio P, 1998, CHEM BIOL, V5, P505, DOI 10.1016/S1074-5521(98)90006-0; Zhang M, 2012, CHEM BIODIVERS, V9, P170, DOI 10.1002/cbdv.201100040	22	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129695	10.1371/journal.pone.0129695	http://dx.doi.org/10.1371/journal.pone.0129695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066510	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000099
J	Dumoulin, PC; Trop, SA; Ma, JX; Zhang, H; Sherman, MA; Levitskaya, J				Dumoulin, Peter C.; Trop, Stefanie A.; Ma, Jinxia; Zhang, Hao; Sherman, Matthew A.; Levitskaya, Jelena			Flow Cytometry Based Detection and Isolation of Plasmodium falciparum Liver Stages In Vitro	PLOS ONE			English	Article							MALARIA CIRCUMSPOROZOITE PROTEIN; HEPARAN-SULFATE PROTEOGLYCANS; BERGHEI SPOROZOITE INVASION; HEPATIC STAGES; PARASITE; ANTIBODIES; INFECTION; VACCINE; CELLS; AUTOFLUORESCENCE	Malaria, the disease caused by Plasmodium parasites, remains a major global health burden. The liver stage of Plasmodium falciparum infection is a leading target for immunological and pharmacological interventions. Therefore, novel approaches providing specific detection and isolation of live P. falciparum exoerythrocytic forms (EEFs) are warranted. Utilizing a recently generated parasite strain expressing green fluorescent protein (GFP) we established a method which, allows for detection and isolation of developing live P. falciparum liver stages by flow cytometry. Using this technique we compared the susceptibility of five immortalized human hepatocyte cell lines and primary hepatocyte cultures from three donors to infection by P. falciparum sporozoites. Here, we show that EEFs can be detected and isolated from in vitro infected cultures of the HC-04 cell line and primary human hepatocytes. We confirmed the presence of developing parasites in sorted live human hepatocytes and characterized their morphology by fluorescence microscopy. Finally, we validated the practical applications of our approach by re-examining the importance of host ligand CD81 for hepatocyte infection by P. falciparum sporozoites in vitro and assessment of the inhibitory activity of anti-sporozoite antibodies. This methodology provides us with the tools to study both, the basic biology of the P. falciparum liver stage and the effects of host-derived factors on the development of P. falciparum EEFs.	[Dumoulin, Peter C.; Trop, Stefanie A.; Ma, Jinxia; Zhang, Hao; Levitskaya, Jelena] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Sherman, Matthew A.] Triangle Res Labs, Durham, NC 27709 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Levitskaya, J (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	lelena1@jhu.edu		Trop, Stefanie/0000-0003-0094-248X	JHMRI; Bloomberg Philanthropies; National Institutes of Health [RR00052]	JHMRI; Bloomberg Philanthropies; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Triangle Research Labs provided support in the form of salaries for authors [MS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by a pilot grant from the JHMRI and the Bloomberg Philanthropies. The supply of human blood was supported by the National Institutes of Health, Grant RR00052. Funders did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; ANKER R, 1990, EUR J IMMUNOL, V20, P2757, DOI 10.1002/eji.1830201233; Baum J, 2013, PATHOG GLOB HEALTH, V107, P107, DOI 10.1179/2047772413Z.000000000121; Behet MC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-136; Bei AK, 2012, INT J PARASITOL, V42, P575, DOI 10.1016/j.ijpara.2012.03.006; Butler NS, 2012, TRENDS IMMUNOL, V33, P247, DOI 10.1016/j.it.2012.02.001; Costa FTM, 2006, BRAZ J MED BIOL RES, V39, P1525, DOI 10.1590/S0100-879X2006001200003; Croce AC, 2010, LASER SURG MED, V42, P371, DOI 10.1002/lsm.20923; Croce AC, 2004, PHOTOCH PHOTOBIO SCI, V3, P920, DOI 10.1039/b407358d; Deal C, 2014, P NATL ACAD SCI USA, V111, P12528, DOI 10.1073/pnas.1407362111; Duffy PE, 2012, EXPERT REV VACCINES, V11, P1261, DOI [10.1586/ERV.12.92, 10.1586/erv.12.92]; Foquet L, 2014, J CLIN INVEST, V124, P140, DOI 10.1172/JCI70349; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Frevert U, 1996, MOL BIOCHEM PARASIT, V76, P257, DOI 10.1016/0166-6851(95)02563-4; FREVERT U, 1993, J EXP MED, V177, P1287, DOI 10.1084/jem.177.5.1287; Hafalla JC, 2011, IMMUNOL REV, V240, P297, DOI 10.1111/j.1600-065X.2010.00988.x; HOLLINGDALE MR, 1983, AM J TROP MED HYG, V32, P682, DOI 10.4269/ajtmh.1983.32.682; Hugel FU, 1996, MOL BIOCHEM PARASIT, V81, P151, DOI 10.1016/0166-6851(96)02701-6; Ishino T, 2005, CELL MICROBIOL, V7, P199, DOI 10.1111/j.1462-5822.2004.00447.x; Li FQ, 2012, J IMMUNOL METHODS, V386, P101, DOI 10.1016/j.jim.2012.08.014; Ma JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075321; Macete EV, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-11; March S, 2013, CELL HOST MICROBE, V14, P104, DOI 10.1016/j.chom.2013.06.005; MAZIER D, 1985, SCIENCE, V227, P440, DOI 10.1126/science.3880923; Mota MM, 2000, EXP PARASITOL, V96, P257, DOI 10.1006/expr.2000.4570; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; NARDIN EH, 1982, J EXP MED, V156, P20, DOI 10.1084/jem.156.1.20; PFEIFER AMA, 1993, P NATL ACAD SCI USA, V90, P5123, DOI 10.1073/pnas.90.11.5123; Pinzon-Ortiz C, 2001, J BIOL CHEM, V276, P26784, DOI 10.1074/jbc.M104038200; Pradel G, 2002, MOL MICROBIOL, V45, P637, DOI 10.1046/j.1365-2958.2002.03057.x; Prudencio M, 2008, CELL MICROBIOL, V10, P218, DOI 10.1111/j.1462-5822.2007.01032.x; Prudencio M, 2011, TRENDS PARASITOL, V27, P565, DOI 10.1016/j.pt.2011.09.004; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Sacci JB, 2006, INT J PARASITOL, V36, P353, DOI 10.1016/j.ijpara.2005.10.014; SACCI JB, 1992, P NATL ACAD SCI USA, V89, P3701, DOI 10.1073/pnas.89.9.3701; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; Schoone GJ, 2000, J CLIN MICROBIOL, V38, P4072, DOI 10.1128/JCM.38.11.4072-4075.2000; Schwenk RJ, 2011, TRENDS PARASITOL, V27, P306, DOI 10.1016/j.pt.2011.02.002; Sidjanski S, 1997, AM J TROP MED HYG, V57, P426, DOI 10.4269/ajtmh.1997.57.426; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; Silvie O, 2006, CELL MICROBIOL, V8, P1134, DOI 10.1111/j.1462-5822.2006.00697.x; Spence PJ, 2012, CURR OPIN IMMUNOL, V24, P444, DOI 10.1016/j.coi.2012.05.003; STEWART MJ, 1986, INFECT IMMUN, V51, P859, DOI 10.1128/IAI.51.3.859-864.1986; Talman AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009156; Tarun AS, 2006, INT J PARASITOL, V36, P1283, DOI 10.1016/j.ijpara.2006.06.009; Tavares Joana, 2013, Methods Mol Biol, V923, P401; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tran TM, 2013, CLIN INFECT DIS, V57, P40, DOI 10.1093/cid/cit174; Tse SW, 2011, MEM I OSWALDO CRUZ, V106, P172, DOI 10.1590/S0074-02762011000900022; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; VANDERBERG JP, 1974, J PROTOZOOL, V21, P527, DOI 10.1111/j.1550-7408.1974.tb03693.x; Vaughan AM, 2008, CELL HOST MICROBE, V4, P209, DOI 10.1016/j.chom.2008.08.010; Vaughan AM, 2012, J CLIN INVEST, V122, P3618, DOI 10.1172/JCI62684; World Health Organization, 2013, WORLD MAL REP 2013 G; Young L, 2010, NAT PROTOC, V5, P929, DOI 10.1038/nprot.2010.43; ZAVALA F, 1985, SCIENCE, V228, P1436, DOI 10.1126/science.2409595	57	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129623	10.1371/journal.pone.0129623	http://dx.doi.org/10.1371/journal.pone.0129623			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070149	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000097
J	Ioerger, M; Henry, KL; Chen, PY; Cigularov, KP; Tomazic, RG				Ioerger, Michael; Henry, Kimberly L.; Chen, Peter Y.; Cigularov, Konstantin P.; Tomazic, Rocco G.			Beyond Same-Sex Attraction: Gender-Variant-Based Victimization Is Associated with Suicidal Behavior and Substance Use for Other-Sex Attracted Adolescents	PLOS ONE			English	Article							TRANSGENDER YOUTH; SCHOOL VICTIMIZATION; GAY; ORIENTATION; STUDENTS; OUTCOMES; HEALTH; RISK; HETERONORMATIVITY; ATYPICALITY	Gender-variant-based victimization is victimization based on the way others perceive an individual to convey masculine, feminine, and androgynous characteristics through their appearance, mannerisms, and behaviors. Previous work identifies gender-variant-based victimization as a risk factor for health-risking outcomes among same-sex attracted youths. The current study seeks to examine this relationship among other-sex attracted youths and same-sex attracted youth, and determine if gender-variant-based victimization is similarly or differentially associated with poor outcomes between these two groups. Anonymous data from a school-based survey of 2,438 racially diverse middle and high school students in the Eastern U.S. was examined. For other-sex attracted adolescents, gender-variantbased victimization was associated with a higher odds of suicidal thoughts and behaviors, regular use of cigarettes, and drug use. When compared to same-sex attracted adolescents, the harmful relationship between gender-variant-based victimization and each of these outcomes was similar in nature. These findings suggest that gender-variant-based victimization has potentially serious implications for the psychological wellbeing and substance use of other-sex attracted adolescents, not just same-sex attracted adolescents, supporting the need to address gender expression as a basis for victimization separate from sexuality- or gender-minority status. The impact that gender-variant-based victimization has on all adolescents should not be overlooked in research and interventions aimed at addressing sexual orientation-based and gender-variant-based victimization, substance use, and suicide prevention.	[Ioerger, Michael] Syracuse Univ, Dept Psychol, Syracuse, NY 13244 USA; [Henry, Kimberly L.] Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA; [Chen, Peter Y.] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA; [Cigularov, Konstantin P.] Old Dominion Univ, Dept Psychol, Norfolk, VA USA; [Tomazic, Rocco G.] Borough Freehold Publ Sch, Freehold, NJ USA	Syracuse University; Colorado State University; Auburn University System; Auburn University; Old Dominion University	Ioerger, M (corresponding author), Syracuse Univ, Dept Psychol, Syracuse, NY 13244 USA.	mkioerge@syr.edu	Ioerger, Michael/G-5074-2017	Ioerger, Michael/0000-0002-2282-4022; Henry, Kimberly/0000-0002-2303-3759	Colorado State University Libraries Open Access Research and Scholarship Fund	Colorado State University Libraries Open Access Research and Scholarship Fund	Colorado State University Libraries Open Access Research and Scholarship Fund.	Berlan ED, 2010, J ADOLESCENT HEALTH, V46, P366, DOI 10.1016/j.jadohealth.2009.10.015; Birkett M, 2009, J YOUTH ADOLESCENCE, V38, P989, DOI 10.1007/s10964-008-9389-1; Collier KL, 2013, J SEX RES, V50, P299, DOI 10.1080/00224499.2012.750639; D'Augelli AR, 2006, J INTERPERS VIOLENCE, V21, P1462, DOI 10.1177/0886260506293482; Greytak EA, 2009, HARSH REALITIES THE; Grossman AH, 2006, J HOMOSEXUAL, V51, P111, DOI 10.1300/J082v51n01_06; Hendricks ML, 2012, PROF PSYCHOL-RES PR, V43, P460, DOI 10.1037/a0029597; Joiner T.E, 2010, MYTHS ABOUT SUICIDE; Kitzinger C, 2005, SOC PROBL, V52, P477, DOI 10.1525/sp.2005.52.4.477; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Lee EAE, 2011, SEX ROLES, V64, P90, DOI 10.1007/s11199-010-9883-2; Lewinsohn PM, 1996, CLIN PSYCHOL-SCI PR, V3, P25, DOI 10.1111/j.1468-2850.1996.tb00056.x; McCann PD, 2010, HEALTH SOCIOL REV, V19, P505; McGuire JK, 2010, J YOUTH ADOLESCENCE, V39, P1175, DOI 10.1007/s10964-010-9540-7; MEYER IH, 1995, J HEALTH SOC BEHAV, V36, P38, DOI 10.2307/2137286; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Nayak A, 1996, J GENDER STUD, V5, P211, DOI 10.1080/09589236.1996.9960644; Pascoe C. J., 2005, SEXUALITIES, V8, P329, DOI [DOI 10.1177/1363460705053337, 10.1177/1363460705053337]; Phoenix A, 2003, J SOC ISSUES, V59, P179, DOI 10.1111/1540-4560.t01-1-00011; Ploderl M, 2010, J HOMOSEXUAL, V57, P819, DOI 10.1080/00918369.2010.493401; Poteat VP, 2007, J EARLY ADOLESCENCE, V27, P175, DOI 10.1177/0272431606294839; Rieger G, 2012, ARCH SEX BEHAV, V41, P611, DOI 10.1007/s10508-011-9738-0; Robinson JP, 2011, EDUC RESEARCHER, V40, P315, DOI 10.3102/0013189X11422112; Russell ST, 2001, AM J PUBLIC HEALTH, V91, P1276, DOI 10.2105/AJPH.91.8.1276; Russell ST, 2011, J SCHOOL HEALTH, V81, P223, DOI 10.1111/j.1746-1561.2011.00583.x; Stoudt BG, 2006, MEN MASC, V8, P273, DOI 10.1177/1097184X05282070; Swearer SM, 2008, SCHOOL PSYCHOL REV, V37, P160; Toomey RB, 2012, J ADOLESCENCE, V35, P187, DOI 10.1016/j.adolescence.2011.03.001; Toomey RB, 2010, DEV PSYCHOL, V46, P1580, DOI 10.1037/a0020705; Carrera MV, 2011, EDUC PSYCHOL REV, V23, P479, DOI 10.1007/s10648-011-9171-x; Wilkinson L, 2009, GENDER SOC, V23, P542, DOI 10.1177/0891243209339913; Young R, 2004, SEX ROLES, V50, P525, DOI 10.1023/B:SERS.0000023072.53886.86; Yu L, 2010, SEX ROLES, V62, P100, DOI 10.1007/s11199-009-9709-2	34	10	10	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129976	10.1371/journal.pone.0129976	http://dx.doi.org/10.1371/journal.pone.0129976			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26068796	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000130
J	Tobo, A; Tobo, M; Nakakura, T; Ebara, M; Tomura, H; Mogi, C; Im, DS; Murata, N; Kuwabara, A; Ito, S; Fukuda, H; Arisawa, M; Shuto, S; Nakaya, M; Kurose, H; Sato, K; Okajima, F				Tobo, Ayaka; Tobo, Masayuki; Nakakura, Takashi; Ebara, Masashi; Tomura, Hideaki; Mogi, Chihiro; Im, Dong-Soon; Murata, Naoya; Kuwabara, Atsushi; Ito, Saki; Fukuda, Hayato; Arisawa, Mitsuhiro; Shuto, Satoshi; Nakaya, Michio; Kurose, Hitoshi; Sato, Koichi; Okajima, Fumikazu			Characterization of Imidazopyridine Compounds as Negative Allosteric Modulators of Proton-Sensing GPR4 in Extracellular Acidification-Induced Responses	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ACIDIC PH; MEDIATED INTERNALIZATION; OGR1; G2A; PSYCHOSINE; AGONIST; SPHINGOSYLPHOSPHORYLCHOLINE; ACCUMULATION; INHIBITION	G protein-coupled receptor 4 (GPR4), previously proposed as the receptor for sphingosylphosphorylcholine, has recently been identified as the proton-sensing G protein-coupled receptor (GPCR) coupling to multiple intracellular signaling pathways, including the G(s) protein/cAMP and G(13) protein/Rho. In the present study, we characterized some imidazopyridine compounds as GPR4 modulators that modify GPR4 receptor function. In the cells that express proton-sensing GPCRs, including GPR4, OGR1, TDAG8, and G2A, extracellular acidification stimulates serum responsive element (SRE)-driven transcriptional activity, which has been shown to reflect Rho activity, with different proton sensitivities. Imidazopyridine compounds inhibited the moderately acidic pH-induced SRE activity only in GPR4-expressing cells. Acidic pH-stimulated cAMP accumulation, mRNA expression of inflammatory genes, and GPR4 internalization within GPR4-expressing cells were all inhibited by the GPR4 modulator. We further compared the inhibition property of the imidazopyridine compound with psychosine, which has been shown to selectively inhibit actions induced by proton-sensing GPCRs, including GPR4. In the GPR4 mutant, in which certain histidine residues were mutated to phenylalanine, proton sensitivity was significantly shifted to the right, and psychosine failed to further inhibit acidic pH-induced SRE activation. On the other hand, the imidazopyridine compound almost completely inhibited acidic pH-induced action in mutant GPR4. We conclude that some imidazopyridine compounds show specificity to GPR4 as negative allosteric modulators with a different action mode from psychosine, an antagonist susceptible to histidine residues, and are useful for characterizing GPR4-mediated acidic pH-induced biological actions.	[Tobo, Ayaka; Tobo, Masayuki; Nakakura, Takashi; Ebara, Masashi; Tomura, Hideaki; Mogi, Chihiro; Murata, Naoya; Kuwabara, Atsushi; Sato, Koichi; Okajima, Fumikazu] Gunma Univ, Inst Mol & Cellular Regulat, Lab Signal Transduct, Maebashi, Gunma 371, Japan; [Im, Dong-Soon] Pusan Natl Univ, Coll Pharm, Pharmacol Lab, Busan, South Korea; [Ito, Saki; Fukuda, Hayato; Arisawa, Mitsuhiro; Shuto, Satoshi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 060, Japan; [Shuto, Satoshi] Hokkaido Univ, Ctr Res & Educ Drug Discovery, Sapporo, Hokkaido, Japan; [Nakaya, Michio; Kurose, Hitoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Fukuoka 812, Japan	Gunma University; Pusan National University; Hokkaido University; Hokkaido University; Kyushu University	Sato, K (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Lab Signal Transduct, Maebashi, Gunma 371, Japan.	kosato@gunma-u.ac.jp; okajima@gunma-u.ac.jp	Shuto, Satoshi/AAH-4998-2020; Im, Dong-Soon/AAH-9104-2020; Arisawa, Mitsuhiro/D-9098-2012	Shuto, Satoshi/0000-0001-7850-8064; Sato, Koichi/0000-0001-7694-4014; Nakakura, Takashi/0000-0003-1898-563X; IM, DONG-SOON/0000-0001-8054-8946; ARISAWA, Mitsuhiro/0000-0002-7937-670X	Japan Society for the Promotion of Science (JSPS) [23659029, 25670617]; National Research Foundation of Korea (NRF) [NRF-2011-0021158]; Joint research program of Institute for Molecular and Cellular Regulation, Gunma University [11025, 14017]; Ministry of Education, Science and Technology; ministry of Education, Culture, Sports, Science and Technology (MEXT)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Joint research program of Institute for Molecular and Cellular Regulation, Gunma University; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was supported by the following: Grant-in-Aid for Challenging Exploratory Research (23659029 and 25670617), Japan Society for the Promotion of Science (JSPS), http://www.jsps.go.jp/jgrantsinaid/03_keikaku/download.html, FO; Basic Science Research Program through the National Research Foundation of Korea (NRF) (NRF-2011-0021158), Ministry of Education, Science and Technology, http://www.nrf.re.kr/nrf_eng_cms/, DI; Joint research program of the Institute for Molecular and Cellular Regulation, Gunma University (11025), The ministry of Education, Culture, Sports, Science and Technology (MEXT), http://www.imcr.gunma-u.ac.jp/activity/activity3, HK; and Joint research program of the Institute for Molecular and Cellular Regulation, Gunma University (14017), The ministry of Education, Culture, Sports, Science and Technology (MEXT), http://www.imcr.gunma-u.ac.jp/activity/activity3, MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/712962; Aoki H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079985; Bernat V, 2014, ACS CHEM BIOL, V9, P2664, DOI 10.1021/cb500678c; Bhowmick N, 1998, ENDOCRINOLOGY, V139, P3185, DOI 10.1210/en.139.7.3185; Chen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027586; Dong LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061991; Engers DW, 2014, DRUG DISCOV TODAY TE, V10, pe269; Fukunaga S, 2006, LIFE SCI, V80, P17, DOI 10.1016/j.lfs.2006.08.022; Ichimonji I, 2010, AM J PHYSIOL-LUNG C, V299, pL567, DOI 10.1152/ajplung.00415.2009; Im DS, 2001, J CELL BIOL, V153, P429, DOI 10.1083/jcb.153.2.429; Jin Y, 2014, J NEUROCHEM, V129, P683, DOI 10.1111/jnc.12661; Justus CR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00354; Kabarowski JH, 2009, PROSTAG OTH LIPID M, V89, P73, DOI 10.1016/j.prostaglandins.2009.04.007; Kanazawa T, 2000, J CELL BIOL, V149, P943, DOI 10.1083/jcb.149.4.943; Kimura T, 2001, J BIOL CHEM, V276, P31780, DOI 10.1074/jbc.M104353200; Kimura T, 2010, J BIOL CHEM, V285, P4387, DOI 10.1074/jbc.M109.043869; Kotake M, 2014, CELL SIGNAL, V26, P2326, DOI 10.1016/j.cellsig.2014.07.010; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Li YD, 2014, PEDIATR NEUROL, V51, P600, DOI 10.1016/j.pediatrneurol.2014.08.003; Liu JP, 2010, AM J PHYSIOL-HEART C, V299, pH731, DOI 10.1152/ajpheart.00977.2009; Liu JP, 2010, PHARMACOL RES, V61, P499, DOI 10.1016/j.phrs.2010.02.013; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Matsuzaki S, 2011, BIOCHEM BIOPH RES CO, V413, P499, DOI 10.1016/j.bbrc.2011.08.087; Mogi C, 2005, J PHARMACOL SCI, V99, P160, DOI 10.1254/jphs.FP0050599; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; Navarro A, 1999, BRAIN RES, V816, P47, DOI 10.1016/S0006-8993(98)01062-2; Obinata H, 2009, PROSTAG OTH LIPID M, V89, P66, DOI 10.1016/j.prostaglandins.2008.11.002; Okajima F, 2013, CELL SIGNAL, V25, P2263, DOI 10.1016/j.cellsig.2013.07.022; Pfeiffer R, 1998, EXP CELL RES, V244, P327, DOI 10.1006/excr.1998.4159; Radu CG, 2005, P NATL ACAD SCI USA, V102, P1632, DOI 10.1073/pnas.0409415102; Roettger BF, 1997, MOL PHARMACOL, V51, P357; Saki M, 2004, International patent application, Patent No. [WO 2004/093912 A1, 2004093912, PCT/JP2004/005930, WO2004/093912 A1]; Seuwen K, 2006, J RECEPT SIG TRANSD, V26, P599, DOI 10.1080/10799890600932220; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Suzuki K, 1998, NEUROCHEM RES, V23, P251, DOI 10.1023/A:1022436928925; Taracido IC, 2009, United States patent application, Patent No. [12/468,706, 12468706]; Tobo M, 2007, CELL SIGNAL, V19, P1745, DOI 10.1016/j.cellsig.2007.03.009; Tomura H, 2005, J BIOL CHEM, V280, P34458, DOI 10.1074/jbc.M505287200; Tomura H, 2005, CELL SIGNAL, V17, P1466, DOI 10.1016/j.cellsig.2005.06.002; Tomura H, 2008, J BONE MINER RES, V23, P1129, DOI 10.1359/JBMR.080236; Voccoli V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.483; Wang JQ, 2004, J BIOL CHEM, V279, P45626, DOI 10.1074/jbc.M406966200; Willins DL, 1998, ANN NY ACAD SCI, V861, P121, DOI 10.1111/j.1749-6632.1998.tb10182.x; Xu Y, 2002, BBA-MOL CELL BIOL L, V1582, P81, DOI 10.1016/S1388-1981(02)00140-3	44	23	23	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129334	10.1371/journal.pone.0129334	http://dx.doi.org/10.1371/journal.pone.0129334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070068	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000066
J	Tang, XY; Li, RJ; Jing, QM; Liu, YF; Liu, P				Tang, Xiuying; Li, Runjun; Jing, Quanmin; Liu, Yingfeng; Liu, Peng			Efficacy and Safety of Intracoronary versus Intravenous Administration of Tirofiban during Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							GLYCOPROTEIN IIB/IIIA INHIBITORS; ELEVATION MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; ANGIOGRAPHIC ASSESSMENT; PLATELET REACTIVITY; PRIMARY ANGIOPLASTY; AMERICAN-COLLEGE; CLOPIDOGREL; REVASCULARIZATION; ASPIRIN	Background Percutaneous coronary intervention (PCI) is known as the most effective treatment for acute coronary syndrome (ACS). However, without proper therapy and patient management, stent thrombosis after PCI may lead to another myocardial infarction. In addition to aspirin and clopidogrel, tirofiban is often used as an antiplatelet therapy in patients with ACS. To date, there has been no comprehensive evaluation of the efficacy and safety of intracoronary (IC) tirofiban administration for ACS patients undergoing PCI compared with intravenous (IV) administration. Therefore, this meta-analysis was conducted to investigate the clinical efficiency and safety of IC versus intravenous (IV) tirofiban in ACS patients undergoing PCI. Methods We searched PubMed and Medline for randomized controlled trials (RCTs) comparing IC versus IV administration of tirofiban in ACS patients undergoing PCI. We evaluated the effects of tirofiban on thrombolysis in myocardial infarction (TIMI) grade 3 flow after PCI, TIMI myocardial perfusion grade 3 (TMP grade 3), left ventricular ejection fraction (LVEF), major adverse cardiovascular events (MACE), target vessel revascularization (TVR), death, reinfarction and adverse drug effects (specifically bleeding events). Results Seven trials involving 1,027 patients were included in this meta-analysis. IC administration of tirofiban significantly increased TIMI grade 3 flow (OR 2.11; 95% CI 1.02 to 4.37; P = 0.04) and TMP grade 3 (OR 2.67; 95% CI 1.09 to 6.49; P = 0.03, I-2 = 64%) while reducing MACE (OR 0.46, 95% CI: 0.28 to 0.75; P = 0.002) compared with IV administration of tirofiban. No significant differences were observed in the occurrence of TVR, death, reinfarction and the incidence of bleeding events between the two groups. Conclusions This meta-analysis supports the use of IC over IV administration of tirofiban in patients with ACS to improve TIMI flow, TMP flow and MACE. However, there was no statistically significant difference in the risk of bleeding complications between the two groups.	[Tang, Xiuying] First Hosp QinHuangDao, Dept Cardiol, Qinhuangdao, Hebei, Peoples R China; [Li, Runjun] First Hosp QinHuangDao, Dept Emergency Med, Qinhuangdao, Hebei, Peoples R China; [Jing, Quanmin] Gen Hosp Shenyang Mil Area Command, Dept Cardiol, Shenyang, Liaoning, Peoples R China; [Liu, Yingfeng; Liu, Peng] Southern Med Univ, Zhujiang Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Tang, XY (corresponding author), First Hosp QinHuangDao, Dept Cardiol, Qinhuangdao, Hebei, Peoples R China.	13472996700@163.com						Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bosch X, 2013, COCHRANE DB SYST REV, V11, pD2130; Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; Candemir B, 2012, J THROMB THROMBOLYS, V34, P65, DOI 10.1007/s11239-012-0685-y; De Luca G, 2008, HEART, V94, P1548, DOI 10.1136/hrt.2008.141648; De Luca G, 2005, JAMA-J AM MED ASSOC, V293, P1759, DOI 10.1001/jama.293.14.1759; Deibele AJ, 2010, CIRCULATION, V121, P784, DOI 10.1161/CIRCULATIONAHA.109.882746; Eitel I, 2011, CLIN RES CARDIOL, V100, P425, DOI 10.1007/s00392-010-0260-5; Erdim R, 2010, ANATOL J CARDIOL, V10, P340, DOI 10.5152/akd.2010.093; Fox KAA, 2004, CIRCULATION, V110, P1202, DOI 10.1161/01.CIR.0000140675.85342.1B; Friedland S, 2011, AM J CARDIOL, V108, P1244, DOI 10.1016/j.amjcard.2011.06.039; Fu G, 2012, J INTERV CARDIOL, V25, P223, DOI 10.1111/j.1540-8183.2011.00711.x; Henriques JPS, 2003, CIRCULATION, V107, P2115, DOI 10.1161/01.CIR.0000065221.06430.ED; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Huber K, 2010, EUR HEART J, V31, P1708, DOI 10.1093/eurheartj/ehq143; Iversen A, 2011, J INTERV CARDIOL, V24, P105, DOI 10.1111/j.1540-8183.2010.00616.x; Jeremias A, 2009, AM J MED, V122, P152, DOI 10.1016/j.amjmed.2008.07.027; Kafian S, 2015, PLATELETS, V26, P467, DOI 10.3109/09537104.2014.940304; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; Kirma C, 2012, CATHETER CARDIO INTE, V79, P59, DOI 10.1002/ccd.23109; Kovacic JC, 2014, J CARDIOVASC PHARM T, V19, P201, DOI 10.1177/1074248413510605; Lang SH, 2012, CURR MED RES OPIN, V28, P351, DOI 10.1185/03007995.2012.657299; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Mason PJ, 2005, J AM COLL CARDIOL, V46, P986, DOI 10.1016/j.jacc.2004.08.070; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; Nallamothu BK, 2014, J AM COLL CARDIOL, V63, P722, DOI 10.1016/j.jacc.2013.12.003; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Porto I, 2010, AM HEART J, V160, P1015, DOI 10.1016/j.ahj.2010.08.009; Price MJ, 2011, CIRCULATION, V124, P1132, DOI 10.1161/CIRCULATIONAHA.111.029165; Romagnoli E, 2007, J THROMB THROMBOLYS, V23, P57, DOI 10.1007/s11239-006-9000-0; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Schomig A, 2008, J AM COLL CARDIOL, V52, P894, DOI 10.1016/j.jacc.2008.05.051; Sharma S, 2006, J CARDIOVASC PHARM T, V11, P136, DOI 10.1177/1074248406288761; Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Srinivasan M, 2009, J INVASIVE CARDIOL, V21, P224; van't Hof AWJ, 2008, LANCET, V372, P537, DOI 10.1016/S0140-6736(08)61235-0; Wang YS, 2012, AM J CARDIOL, V109, P1124, DOI 10.1016/j.amjcard.2011.11.053; Wu TG, 2008, CIRC J, V72, P1605, DOI 10.1253/circj.CJ-08-0357; Xin-chun Yang, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P517; Yan HB, 2010, CHINESE MED J-PEKING, V123, P877, DOI 10.3760/cma.j.issn.0366-6999.2010.07.021; Zhu TQ, 2013, INT J CARDIOL, V165, P437, DOI 10.1016/j.ijcard.2011.08.082	43	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129718	10.1371/journal.pone.0129718	http://dx.doi.org/10.1371/journal.pone.0129718			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067296	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900074
J	Frank, KL; Vergidis, P; Brinkman, CL; Quaintance, KEG; Barnes, AMT; Mandrekar, JN; Patrick, MSB; Dunny, GM; Patel, R				Frank, Kristi L.; Vergidis, Paschalis; Brinkman, Cassandra L.; Quaintance, Kerryl E. Greenwood; Barnes, Aaron M. T.; Mandrekar, Jayawant N.; Patrick, M. Schlievert B.; Dunny, Gary M.; Patel, Robin			Evaluation of the Enterococcus faecalis Biofilm-Associated Virulence Factors AhrC and Eep in Rat Foreign Body Osteomyelitis and In Vitro Biofilm-Associated Antimicrobial Resistance	PLOS ONE			English	Article							PROSTHETIC JOINT INFECTION; GENETIC-DETERMINANTS; ENDOCARDITIS; PATHOGENESIS; EXPRESSION; ADHERENCE; PILI	Enterococcus faecalis can cause healthcare-associated biofilm infections, including those of orthopedic devices. Treatment of enterococcal prosthetic joint infection is difficult, in part, due to biofilm-associated antimicrobial resistance. We previously showed that the E. faecalis OG1RF genes ahrC and eep are in vitro biofilm determinants and virulence factors in animal models of endocarditis and catheter-associated urinary tract infection. In this study, we evaluated the role of these genes in a rat acute foreign body osteomyelitis model and in in vitro biofilm-associated antimicrobial resistance. Osteomyelitis was established for one week following the implantation of stainless steel orthopedic wires inoculated with E. faecalis strains OG1RF, delta ahrC, and Delta eep into the proximal tibiae of rats. The median bacterial loads recovered from bones and wires did not differ significantly between the strains at multiple inoculum concentrations. We hypothesize that factors present at the infection site that affect biofilm formation, such as the presence or absence of shear force, may account for the differences in attenuation in the various animal models we have used to study the Omega ahrC and Delta eep strains. No differences among the three strains were observed in the planktonic and biofilm antimicrobial susceptibilities to ampicillin, vancomycin, daptomycin, linezolid, and tetracycline. These findings suggest that neither ahrC nor eep directly contribute to E. faecalis biofilm-associated antimicrobial resistance. Notably, the experimental evidence that the biofilm attachment mutant Omega ahrC displays biofilm-associated antimicrobial resistance suggests that surface colonization alone is sufficient for E. faecalis cells to acquire the biofilm antimicrobial resistance phenotype.	[Frank, Kristi L.; Barnes, Aaron M. T.; Patrick, M. Schlievert B.; Dunny, Gary M.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Vergidis, Paschalis; Brinkman, Cassandra L.; Quaintance, Kerryl E. Greenwood; Patel, Robin] Mayo Clin, Div Clin Microbiol, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Mandrekar, Jayawant N.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Patel, Robin] Mayo Clin, Dept Internal Med, Div Infect Dis, Rochester, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic; Mayo Clinic	Patel, R (corresponding author), Mayo Clin, Div Clin Microbiol, Dept Lab Med & Pathol, Rochester, MN 55905 USA.	patel.robin@mayo.edu	Barnes, Aaron M. T./B-7009-2012	Barnes, Aaron M. T./0000-0002-7014-7556; Schlievert, Patrick/0000-0001-8314-9369	National Institutes of Health [R01 AI058134]; University of Minnesota Medical Scientist Training Program [T32 GM008244]; National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program [T32 AR56950]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR056950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Medical Scientist Training Program; National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [R01 AI058134]. AMTB received additional support from the University of Minnesota Medical Scientist Training Program [T32 GM008244]. CLB received support for this work from the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program [T32 AR56950]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An FY, 1999, J BACTERIOL, V181, P5915, DOI 10.1128/JB.181.19.5915-5921.1999; Arciola CR, 2008, BIOMATERIALS, V29, P580, DOI 10.1016/j.biomaterials.2007.10.008; Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031; Baldassarri L, 2006, INT J ARTIF ORGANS, V29, P402, DOI 10.1177/039139880602900410; Ballering KS, 2009, J BACTERIOL, V191, P2806, DOI 10.1128/JB.01688-08; Bourgogne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r110; Clinical and Laboratory Standards Institute, 2018, M07A10 CLSI, V11th, DOI DOI 10.1371/JOURNAL.PPAT.1009338; CLSI, 1999, M26A CLSI, V19; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; El Helou OC, 2008, CLIN INFECT DIS, V47, P903, DOI 10.1086/591536; Frank KL, 2007, ANTIMICROB AGENTS CH, V51, P888, DOI 10.1128/AAC.01052-06; Frank KL, 2013, INFECT IMMUN, V81, P1696, DOI 10.1128/IAI.01210-12; Frank KL, 2012, INFECT IMMUN, V80, P539, DOI 10.1128/IAI.05964-11; GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014; Kristich CJ, 2008, APPL ENVIRON MICROB, V74, P3377, DOI 10.1128/AEM.02665-07; Kristich CJ, 2007, PLASMID, V57, P131, DOI 10.1016/j.plasmid.2006.08.003; Leuck AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107282; Mah TF, 2012, FUTURE MICROBIOL, V7, P1061, DOI [10.2217/FMB.12.76, 10.2217/fmb.12.76]; Mohamed JA, 2004, INFECT IMMUN, V72, P3658, DOI 10.1128/IAI.72.6.3658-3663.2004; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Nallapareddy SR, 2011, INFECT IMMUN, V79, P2901, DOI 10.1128/IAI.00038-11; Paganelli FL, 2012, TRENDS MICROBIOL, V20, P40, DOI 10.1016/j.tim.2011.11.001; Yuste JR, 2014, INT J INFECT DIS, V27, P65, DOI 10.1016/j.ijid.2014.05.034; Rasouli MR, 2012, CLIN ORTHOP RELAT R, V470, P2708, DOI 10.1007/s11999-012-2374-8; Sandoe JAT, 2003, J MED MICROBIOL, V52, P547, DOI 10.1099/jmm.0.05201-0; Singh KV, 2007, J INFECT DIS, V195, P1671, DOI 10.1086/517524; Singh KV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000716; Souto R, 2008, ARCH ORAL BIOL, V53, P155, DOI 10.1016/j.archoralbio.2007.08.004; Thurlow LR, 2010, INFECT IMMUN, V78, P4936, DOI 10.1128/IAI.01118-09; Tornero E, 2014, CLIN MICROBIOL INFEC, V20, P1219, DOI 10.1111/1469-0691.12721; Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588; Vergidis P, 2011, ANTIMICROB AGENTS CH, V55, P1182, DOI 10.1128/AAC.00740-10	34	26	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130187	10.1371/journal.pone.0130187	http://dx.doi.org/10.1371/journal.pone.0130187			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076451	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900151
J	Gall, A; Fero, J; Mccoy, C; Claywell, BC; Sanchez, CA; Blount, PL; Li, XH; Vaughan, TL; Matsen, FA; Reid, BJ; Salama, NR				Gall, Alevtina; Fero, Jutta; Mccoy, Connor; Claywell, Brian C.; Sanchez, Carissa A.; Blount, Patricia L.; Li, Xiaohong; Vaughan, Thomas L.; Matsen, Frederick A.; Reid, Brian J.; Salama, Nina R.			Bacterial Composition of the Human Upper Gastrointestinal Tract Microbiome Is Dynamic and Associated with Genomic Instability in a Barrett's Esophagus Cohort	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; DISTAL ESOPHAGUS; MOLECULAR ANALYSIS; FECAL MICROBIOTA; GASTRIC ATROPHY; GUT MICROBIOTA; RISK; ADENOCARCINOMA; INFLAMMATION; PROGRESSION	Background The incidence of esophageal adenocarcinoma (EAC) has increased nearly five-fold over the last four decades in the United States. Barrett's esophagus, the replacement of the normal squamous epithelial lining with a mucus-secreting columnar epithelium, is the only known precursor to EAC. Like other parts of the gastrointestinal (GI) tract, the esophagus hosts a variety of bacteria and comparisons among published studies suggest bacterial communities in the stomach and esophagus differ. Chronic infection with Helicobacter pylori in the stomach has been inversely associated with development of EAC, but the mechanisms underlying this association remain unclear. Methodology The bacterial composition in the upper GI tract was characterized in a subset of participants (n=12) of the Seattle Barrett's Esophagus Research cohort using broad-range 16S PCR and pyrosequencing of biopsy and brush samples collected from squamous esophagus, Barrett's esophagus, stomach corpus and stomach antrum. Three of the individuals were sampled at two separate time points. Prevalence of H. pylori infection and subsequent development of aneuploidy (n=339) and EAC (n=433) was examined in a larger subset of this cohort. Results/Significance Within individuals, bacterial communities of the stomach and esophagus showed overlapping community membership. Despite closer proximity, the stomach antrum and corpus communities were less similar than the antrum and esophageal samples. Re-sampling of study participants revealed similar upper GI community membership in two of three cases. In this Barrett's esophagus cohort, Streptococcus and Prevotella species dominate the upper GI and the ratio of these two species is associated with waist-to-hip ratio and hiatal hernia length, two known EAC risk factors in Barrett's esophagus. H. pylori-positive individuals had a significantly decreased incidence of aneuploidy and a non-significant trend toward lower incidence of EAC.	[Gall, Alevtina] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA; [Gall, Alevtina; Fero, Jutta; Sanchez, Carissa A.; Li, Xiaohong; Reid, Brian J.; Salama, Nina R.] Fred Hutchinson Canc Res Ctr, Human Biol, Seattle, WA 98104 USA; [Mccoy, Connor; Claywell, Brian C.; Blount, Patricia L.; Li, Xiaohong; Vaughan, Thomas L.; Matsen, Frederick A.; Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Vaughan, Thomas L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Salama, Nina R.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Blount, Patricia L.; Reid, Brian J.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Mccoy, Connor; Claywell, Brian C.; Matsen, Frederick A.] Fred Hutchinson Canc Res Ctr, Program Computat Biol, Seattle, WA 98104 USA; [Reid, Brian J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Salama, NR (corresponding author), Fred Hutchinson Canc Res Ctr, Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.	nsalama@fhcrc.org	Salama, Nina Reda/AAG-2437-2019	Salama, Nina Reda/0000-0003-2762-1424; Gall, Alevtina/0000-0001-6386-7566	US National Institutes of Health [P30 CA015704, R01 CA179949, P01 CA 91955, R01 HG005966, K05 CA124911, R01 CA136725]; US National Science Foundation [1223057]; NATIONAL CANCER INSTITUTE [R01CA136725, P30CA015704, P01CA091955, K05CA124911, R01CA179949] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020069] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this work came from the US National Institutes of Health under award numbers P30 CA015704 (NRS), R01 CA179949 (BJR, TLV), P01 CA 91955 (BJR, TLV), R01 HG005966 (FAM), K05 CA124911 (TLV), R01 CA136725 (TLV), and the US National Science Foundation Award 1223057 (FAM).	Amir I, 2014, ENVIRON MICROBIOL, V16, P2905, DOI 10.1111/1462-2920.12285; Anaparthy R, 2013, CLIN GASTROENTEROL H, V11, P1430, DOI 10.1016/j.cgh.2013.05.007; Anderson LA, 2008, GUT, V57, P734, DOI 10.1136/gut.2007.132662; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Andrici J, 2013, J GASTROEN HEPATOL, V28, P415, DOI 10.1111/j.1440-1746.2012.07199.x; [Anonymous], 2014, R LANG ENV STAT COMP; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Brown LM, 2008, J NATL CANCER I, V100, P1184, DOI 10.1093/jnci/djn211; Chow WH, 1998, CANCER RES, V58, P588; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Corley DA, 2008, GUT, V57, P727, DOI 10.1136/gut.2007.132068; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; Evans SN, 2012, J R STAT SOC B, V74, P569, DOI 10.1111/j.1467-9868.2011.01018.x; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; FORMAN D, 1993, GUT, V34, P1672, DOI 10.1136/gut.34.12.1672; Gevers D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002779; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hardikar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052192; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Jones AD, 2003, J GASTROINTEST SURG, V7, P68, DOI 10.1016/S1091-255X(02)00129-4; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lao-Sirieix P, 2008, DIS ESOPHAGUS, V21, P529, DOI 10.1111/j.1442-2050.2007.00807.x; Leibowitz MS, 2013, CLIN CANCER RES, V19, P798, DOI 10.1158/1078-0432.CCR-12-1517; Levine DS, 2000, AM J GASTROENTEROL, V95, P1152; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063139; Liu N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-130; Martinez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069621; Matsen FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056859; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Maukonen J, 2008, J MED MICROBIOL, V57, P1560, DOI 10.1099/jmm.0.47352-0; NEEFS JM, 1993, NUCLEIC ACIDS RES, V21, P3025, DOI 10.1093/nar/21.13.3025; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Rabinovitch PS, 2001, AM J GASTROENTEROL, V96, P3071, DOI 10.1111/j.1572-0241.2001.05261.x; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Reid BJ, 2000, AM J GASTROENTEROL, V95, P1669, DOI 10.1111/j.1572-0241.2000.02196.x; REID BJ, 1992, GASTROENTEROLOGY, V102, P1212; Rex DK, 2003, GASTROENTEROLOGY, V125, P1670, DOI 10.1053/j.gastro.2003.09.030; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rudney JD, 2003, ARCH ORAL BIOL, V48, P475, DOI 10.1016/S0003-9969(03)00043-8; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1399, DOI 10.1016/j.cgh.2013.05.009; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; van Tongeren SP, 2005, APPL ENVIRON MICROB, V71, P6438, DOI 10.1128/AEM.71.10.6438-6442.2005; Waghray M, 2010, GASTROENTEROLOGY, V138, P562, DOI 10.1053/j.gastro.2009.10.043; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yang LY, 2009, GASTROENTEROLOGY, V137, P588, DOI 10.1053/j.gastro.2009.04.046	57	77	83	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129055	10.1371/journal.pone.0129055	http://dx.doi.org/10.1371/journal.pone.0129055			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076489	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900044
J	Raum, P; Lamparter, J; Ponto, KA; Peto, T; Hoehn, R; Schulz, A; Schneider, A; Wild, PS; Pfeiffer, N; Mirshahi, A				Raum, Philipp; Lamparter, Julia; Ponto, Katharina A.; Peto, Tunde; Hoehn, Rene; Schulz, Andreas; Schneider, Astrid; Wild, Philipp S.; Pfeiffer, Norbert; Mirshahi, Alireza			Prevalence and Cardiovascular Associations of Diabetic Retinopathy and Maculopathy: Results from the Gutenberg Health Study	PLOS ONE			English	Article							RISK-FACTORS; TYPE-2; EYE; RANIBIZUMAB; POPULATION; GLUCOSE; DISEASE; EDEMA	Objective Diabetic retinopathy (DR) is the leading cause of blindness in people of working age. The purpose of this paper is to report the prevalence and cardiovascular associations of diabetic retinopathy and maculopathy (DMac) in Germany. Research Design and Methods The Gutenberg Health Study (GHS) is a population-based study with 15,010 participants aged between 35 at 74 years from the city of Mainz and the district of Mainz-Bingen. We determined the weighted prevalence of DR and DMac by assessing fundus photographs of persons with diabetes from the GHS data base. Diabetes was defined as HbA1c >= 6.5%, known diagnosis diabetes mellitus or known diabetes medication. Furthermore, we analysed the association between DR and cardiovascular risk factors and diseases. Results Overall, 7.5% (1,124/15,010) of the GHS cohort had diabetes. Of these, 27.7% were unaware of their disease and thus were newly diagnosed by their participation in the GHS. The prevalence of DR and DMac was 21.7% and 2.3%, respectively among patients with diabetes. Vision-threatening disease was present in 5% of the diabetic cohort. In the multivariable analysis DR (all types) was associated with age (Odds Ratio [95% confidence interval]: 0.97 [0.955-0.992]; p = 0.006) arterial hypertension (1.90 [1.190-3.044]; p = 0.0072) and vision-threatening DR with obesity (3.29 [1.504-7.206]; p = 0.0029). DR (all stages) and vision-threatening DR were associated with duration of diabetes (1.09 [1.068-1.114]; p < 0.0001 and 1.18 [1.137-1.222]; p < 0.0001, respectively). Conclusions Our calculations suggest that more than a quarter-million persons have vision-threatening diabetic retinal disease in Germany. Prevalence of DR was lower in the GHS compared to East-Asian studies. Associations were found with age, arterial hypertension, obesity, and duration of diabetes mellitus.	[Raum, Philipp; Lamparter, Julia; Ponto, Katharina A.; Hoehn, Rene; Pfeiffer, Norbert; Mirshahi, Alireza] Univ Med Ctr, Dept Ophthalmol, Mainz, Germany; [Peto, Tunde] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England; [Peto, Tunde] UCL Inst Ophthalmol, London, England; [Schulz, Andreas; Schneider, Astrid] Univ Med Ctr, Biomed Stat, Mainz, Germany; [Ponto, Katharina A.; Wild, Philipp S.] Univ Med Ctr, CTH, Mainz, Germany; [Wild, Philipp S.] Univ Med Ctr, Dept Med 2, Mainz, Germany; [Wild, Philipp S.] Univ Med Ctr, German Ctr Heart & Circulat Syst Res DZHK, Mainz, Germany; [Mirshahi, Alireza] Dardenne Eye Hosp, Bonn, Germany	Johannes Gutenberg University of Mainz; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Mirshahi, A (corresponding author), Univ Med Ctr, Dept Ophthalmol, Mainz, Germany.	dr.mirshahi@gmail.com	Peto, Tunde/G-8812-2018; Ponto, Katharina/AAF-3890-2020; Pfeiffer, Norbert/AAO-7586-2020; Wild, Philipp S./M-2106-2019	Peto, Tunde/0000-0001-6265-0381; Hohn, Rene/0000-0003-2870-1469; Wild, Philipp/0000-0003-4413-9752	government of Rhineland-Palatinate ("Stiftung Rheinland-Pfalz fur Innovation") [AZ 961-386261/733]; research program "Wissen schafft Zukunft"; research program "Center for Translational Vascular Biology (CTVB)"; Center for Thrombosis and Haemostasis (CTH) of the Johannes Gutenberg-University of Mainz; Boehringer Ingelheim; PHILIPS Medical Systems; Novartis; Federal Ministry of Education and Research (BMBF) [01EO1003]	government of Rhineland-Palatinate ("Stiftung Rheinland-Pfalz fur Innovation"); research program "Wissen schafft Zukunft"; research program "Center for Translational Vascular Biology (CTVB)"; Center for Thrombosis and Haemostasis (CTH) of the Johannes Gutenberg-University of Mainz; Boehringer Ingelheim(Boehringer Ingelheim); PHILIPS Medical Systems; Novartis(Novartis); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The Gutenberg Health Study is funded through the government of Rhineland-Palatinate ("Stiftung Rheinland-Pfalz fur Innovation", contract AZ 961-386261/733), the research programs "Wissen schafft Zukunft" and "Center for Translational Vascular Biology (CTVB)" as well as the Center for Thrombosis and Haemostasis (CTH) of the Johannes Gutenberg-University of Mainz, and its contract with Boehringer Ingelheim, PHILIPS Medical Systems and Novartis including an unrestricted grant for the Gutenberg Health Study. Philipp Wild and Katharina Ponto are funded by the Federal Ministry of Education and Research (BMBF 01EO1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maskari Fatma, 2007, BMC Ophthalmol, V7, P11; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 1991, Ophthalmology, V98, P786; Bandello F, 2003, Semin Ophthalmol, V18, P251; Bertelsen G, 2013, ACTA OPHTHALMOL, V91, P716, DOI [10.1111/j.1755-3768.2012.2542.x, 10.1111/j.1755-3768.2012.02542.x]; Cheng YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101289; Cheung N, 2007, DIABETES CARE, V30, P1742, DOI 10.2337/dc07-0264; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Do DV, 2013, JAMA OPHTHALMOL, V131, P139, DOI 10.1001/2013.jamaophthalmol.91; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Fletcher Erica L, 2005, Clin Exp Optom, V88, P132; Furthauer J, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-47; Gardner T W, 2000, Diabetes Technol Ther, V2, P601; Hoffmann EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066158; Jorgensen ME, 2010, J CLIN ENDOCR METAB, V95, pE333, DOI 10.1210/jc.2010-0710; Lamparter J, 2014, J DIABETES COMPLICAT, V28, P482, DOI 10.1016/j.jdiacomp.2014.02.008; Lieth E, 2000, CLIN EXP OPHTHALMOL, V28, P3, DOI 10.1046/j.1442-9071.2000.00222.x; Lilly M, 2009, CAN FAM PHYSICIAN, V55, P363; Ly A, 2011, INVEST OPHTH VIS SCI, V52, P9316, DOI 10.1167/iovs.11-7879; Malkani S, 2011, AM J MED, V124, P395, DOI 10.1016/j.amjmed.2010.11.025; Matthaei S, 2009, EXP CLIN ENDOCR DIAB, V117, P522, DOI 10.1055/s-0029-1239559; Mirshahi A, 2013, OPHTHALMOLOGE, V110, P210, DOI 10.1007/s00347-012-2666-0; Mitchell P, 1998, OPHTHALMOLOGY, V105, P406, DOI 10.1016/S0161-6420(98)93019-6; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Rathmann W, 2012, ANN MED, V44, P170, DOI 10.3109/07853890.2010.531759; Rema M, 2005, INVEST OPHTH VIS SCI, V46, P2328, DOI 10.1167/iovs.05-0019; Sanford M, 2013, DRUGS, V73, P187, DOI 10.1007/s40265-013-0010-x; Sasaki M, 2014, INVEST OPHTH VIS SCI, V55, P1749, DOI 10.1167/iovs.13-13035; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; STOLK RP, 1995, DIABETES, V44, P11, DOI 10.2337/diabetes.44.1.11; Thomas BJ, 2013, CAN J OPHTHALMOL, V48, P22, DOI 10.1016/j.jcjo.2012.11.012; Tomic M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/818671; Vujosevic S, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/905058; Wang FH, 2009, OPHTHALMOLOGY, V116, P461, DOI 10.1016/j.ophtha.2008.10.003; Wild PS, 2012, BUNDESGESUNDHEITSBLA, V55, P824, DOI 10.1007/s00103-012-1502-7; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Xie XW, 2008, GRAEF ARCH CLIN EXP, V246, P1519, DOI 10.1007/s00417-008-0884-6; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111	39	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0127188	10.1371/journal.pone.0127188	http://dx.doi.org/10.1371/journal.pone.0127188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075604	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900010
J	Kim, YH; Chiu, CY; Bregant, J				Kim, Young-Hoon; Chiu, Chi-Yue; Bregant, Jessica			Unskilled and Don't Want to Be Aware of It: The Effect of Self-Relevance on the Unskilled and Unaware Phenomenon	PLOS ONE			English	Article							ENHANCEMENT; LEAD	Previous research found that poor performers tend to overestimate how well their performance compares to others'. This unskilled and unaware effect has been attributed to poor performers' lack of metacognitive ability to realize their ineptitude. We contend that the unskilled are motivated to ignore (be unaware of) their poor performance so that they can feel better about themselves. We tested this idea in an experiment in which we manipulated the perceived self-relevancy of the task to men and women after they had completed a visual pun task and before they estimated their performance on the task. As predicted, the unskilled and unaware effect was attenuated when the task was perceived to have low self-relevance.	[Kim, Young-Hoon] Yonsei Univ, Dept Psychol, Seoul 120749, South Korea; [Chiu, Chi-Yue] Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Bregant, Jessica] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	Yonsei University; Chinese University of Hong Kong; University of Chicago	Kim, YH (corresponding author), Yonsei Univ, Dept Psychol, Seoul 120749, South Korea.	younghoonkim@yonsei.ac.kr		Chiu, Chi Yue/0000-0002-3810-6666				Baumeister RF, 1998, HDB SOCIAL PSYCHOL, V4, P694; BROWN JD, 1986, SOC COGNITION, V4, P353, DOI 10.1521/soco.1986.4.4.353; Burson KA, 2006, J PERS SOC PSYCHOL, V90, P60, DOI 10.1037/0022-3514.90.1.60; Dunning D, 2003, CURR DIR PSYCHOL SCI, V12, P83, DOI 10.1111/1467-8721.01235; Ehrlinger J, 2003, J PERS SOC PSYCHOL, V84, P5, DOI 10.1037/0022-3514.84.1.5; Kim YH, 2011, EMOTION, V11, P1096, DOI 10.1037/a0025478; Kim YH, 2010, J PERS SOC PSYCHOL, V99, P395, DOI 10.1037/a0020555; Krueger J, 2002, J PERS SOC PSYCHOL, V82, P180, DOI 10.1037//0022-3514.82.2.180; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; SEDIKIDES C, 1993, J PERS SOC PSYCHOL, V65, P317, DOI 10.1037/0022-3514.65.2.317; Sedikides C., 2003, SAGE HDB SOCIAL PSYC, P110, DOI DOI 10.4135/9781848608221.N5; Taylor SE, 2003, J PERS SOC PSYCHOL, V85, P605, DOI 10.1037/0022-3514.85.4.605; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Tesser A, 2002, SELF AND MOTIVATION: EMERGING PSYCHOLOGICAL PERSPECTIVES, P3	14	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130309	10.1371/journal.pone.0130309	http://dx.doi.org/10.1371/journal.pone.0130309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26070150	gold, Green Submitted, Green Published			2022-12-27	WOS:000356327000155
J	Takatsuki, H; Satoh, K; Sano, K; Fuse, T; Nakagaki, T; Mori, T; Ishibashi, D; Mihara, B; Takao, M; Iwasaki, Y; Yoshida, M; Atarashi, R; Nishida, N				Takatsuki, Hanae; Satoh, Katsuya; Sano, Kazunori; Fuse, Takayuki; Nakagaki, Takehiro; Mori, Tsuyoshi; Ishibashi, Daisuke; Mihara, Ban; Takao, Masaki; Iwasaki, Yasushi; Yoshida, Mari; Atarashi, Ryuichiro; Nishida, Noriyuki			Rapid and Quantitative Assay of Amyloid-Seeding Activity in Human Brains Affected with Prion Diseases	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; TO-PERSON TRANSMISSION; MICE EXPRESSING HUMAN; BLOOD-TRANSFUSION; SPONGIFORM ENCEPHALOPATHY; PROTEIN; SUSCEPTIBILITY; CHIMPANZEES; CONVERSION; SCRAPIE	The infectious agents of the transmissible spongiform encephalopathies are composed of amyloidogenic prion protein, PrPSc. Real-time quaking-induced conversion can amplify very small amounts of PrPSc seeds in tissues/body fluids of patients or animals. Using this in vitro PrP-amyloid amplification assay, we quantitated the seeding activity of affected human brains. End-point assay using serially diluted brain homogenates of sporadic Creutzfeldt-Jakob disease patients demonstrated that 50% seeding dose (SD50) is reached approximately 10(10)/g brain (values varies 10(8.79-10.63)/g). A genetic case (GSS-P102L) yielded a similar level of seeding activity in an autopsy brain sample. The range of PrPSc concentrations in the samples, determined by dot-blot assay, was 0.6-5.4 mu g/g brain; therefore, we estimated that 1 SD50 unit was equivalent to 0.06-0.27 fg of PrPSc. The SD50 values of the affected brains dropped more than three orders of magnitude after autoclaving at 121 degrees C. This new method for quantitation of human prion activity provides a new way to reduce the risk of iatrogenic prion transmission.	[Takatsuki, Hanae; Satoh, Katsuya; Fuse, Takayuki; Nakagaki, Takehiro; Mori, Tsuyoshi; Ishibashi, Daisuke; Atarashi, Ryuichiro; Nishida, Noriyuki] Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Sano, Kazunori] Fukuoka Univ, Fac Pharmaceut Sci, Dept Physiol & Pharmacol, Fukuoka 81401, Japan; [Mihara, Ban; Takao, Masaki] Mihara Mem Hosp, Inst Brain & Blood Vessels, Dept Neurol, Isesaki, Japan; [Takao, Masaki] Saitama Med Univ, Dept Neurol, Int Med Ctr, Saitama, Japan; [Iwasaki, Yasushi; Yoshida, Mari] Aichi Med Univ, Inst Med Sci Aging, Dept Neuropathol, Nagakute, Aichi, Japan	Nagasaki University; Fukuoka University; Saitama Medical University; Aichi Medical University	Satoh, K (corresponding author), Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki 852, Japan.	satoh-prion@nagasaki-u.ac.jp		Nakagaki, Takehiro/0000-0003-1960-8326	Research Committee of Surveillance and Infection Control of Prion Disease; Research Committee of Prion Disease and Slow Virus Infection of the Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [24591268, 14507303, 23300127, 23790998]; Japan Society for the Promotion of Science; Research Committee on Surveillance and Infection Control of Prion Disease of the Ministry of Health, Labour and Welfare of Japan; Ministry of Health, Labour and Welfare of Japan; Takeda Science Foundation; Grants-in-Aid for Scientific Research [25461514] Funding Source: KAKEN	Research Committee of Surveillance and Infection Control of Prion Disease; Research Committee of Prion Disease and Slow Virus Infection of the Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Committee on Surveillance and Infection Control of Prion Disease of the Ministry of Health, Labour and Welfare of Japan; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid from the Research Committee of Surveillance and Infection Control of Prion Disease and from the Research Committee of Prion Disease and Slow Virus Infection of the Ministry of Health, Labour and Welfare of Japan. Dr. Satoh received research support from a Grant-in Aid for Scientific Research (C) (24591268) and Scientific Research (B) (Overseas Academic Research) (14507303) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Japan Society for the Promotion of Science. This work was supported by Grants-in-Aid from the Research Committee on Surveillance and Infection Control of Prion Disease of the Ministry of Health, Labour and Welfare of Japan. Dr. Atarashi received research support from a Grant-in-Aid for Scientific Research (B) (23300127) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant from the Ministry of Health, Labour and Welfare of Japan, as well as a grant from the Takeda Science Foundation. Dr. Sano received research support from a Grant-in-Aid for Young Scientific Researchers (B) (23790998) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; BERNOULLI C, 1977, LANCET, V1, P478; COLLINGE J, 1995, NATURE, V378, P779, DOI 10.1038/378779a0; DUFFY P, 1974, NEW ENGL J MED, V290, P692; GAJDUSEK DC, 1966, NATURE, V209, P794, DOI 10.1038/209794a0; GAJDUSEK DC, 1967, SCIENCE, V155, P212; GIBBS CJ, 1969, SCIENCE, V165, P1023, DOI 10.1126/science.165.3897.1023; GIBBS CJ, 1968, SCIENCE, V161, P388, DOI 10.1126/science.161.3839.388; GIBBS CJ, 1972, NATURE, V236, P73, DOI 10.1038/236073a0; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; KOCH TK, 1985, NEW ENGL J MED, V313, P731, DOI 10.1056/NEJM198509193131206; Korth C, 2003, P NATL ACAD SCI USA, V100, P4784, DOI 10.1073/pnas.2627989100; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Rubenstein R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066352; Shi S, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-44; TAGUCHI F, 1991, ARCH VIROL, V119, P297, DOI 10.1007/BF01310679; Taguchi Y, 2003, AM J PATHOL, V163, P2585, DOI 10.1016/S0002-9440(10)63613-9; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; TELLING GC, 1994, P NATL ACAD SCI USA, V91, P9936, DOI 10.1073/pnas.91.21.9936; THADANI V, 1988, J NEUROSURG, V69, P766, DOI 10.3171/jns.1988.69.5.0766; Vascellari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048969; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; WILL RG, 1982, J NEUROL NEUROSUR PS, V45, P235, DOI 10.1136/jnnp.45.3.235; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8	29	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0126930	10.1371/journal.pone.0126930	http://dx.doi.org/10.1371/journal.pone.0126930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070208	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000004
J	Cohen, AL; McMorrow, M; Walaza, S; Cohen, C; Tempia, S; Alexander-Scott, M; Widdowson, MA				Cohen, Adam L.; McMorrow, Meredith; Walaza, Sibongile; Cohen, Cheryl; Tempia, Stefano; Alexander-Scott, Marissa; Widdowson, Marc-Alain			Potential Impact of Co-Infections and Co-Morbidities Prevalent in Africa on Influenza Severity and Frequency: A Systematic Review	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; HUMAN-IMMUNODEFICIENCY-VIRUS; TIME-SERIES ANALYSIS; MENINGOCOCCAL DISEASE; IMMUNE-RESPONSE; SEASONAL INFLUENZA; PANDEMIC H1N1; SOUTH-AFRICA; PEDIATRIC-PATIENTS; YOUNG-CHILDREN	Infectious diseases and underlying medical conditions common to Africa may affect influenza frequency and severity. We conducted a systematic review of published studies on influenza and the following co-infections or co-morbidities that are prevalent in Africa: dengue, malaria, measles, meningococcus, Pneumocystis jirovecii pneumonia (PCP), hemoglobinopathies, and malnutrition. Articles were identified except for influenza and PCP. Very few studies were from Africa. Sickle cell disease, dengue, and measles co-infection were found to increase the severity of influenza disease, though this is based on few studies of dengue and measles and the measles study was of low quality. The frequency of influenza was increased among patients with sickle cell disease. Influenza infection increased the frequency of meningococcal disease. Studies on malaria and malnutrition found mixed results. Age-adjusted morbidity and mortality from influenza may be more common in Africa because infections and diseases common in the region lead to more severe outcomes and increase the influenza burden. However, gaps exist in our knowledge about these interactions.	[Cohen, Adam L.; McMorrow, Meredith; Tempia, Stefano; Widdowson, Marc-Alain] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30329 USA; [Cohen, Adam L.; Tempia, Stefano] Ctr Dis Control & Prevent South Africa, Influenza Program, Pretoria, South Africa; [Cohen, Adam L.; McMorrow, Meredith] US PHS, Rockville, MD USA; [Walaza, Sibongile; Cohen, Cheryl; Tempia, Stefano] Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Walaza, Sibongile; Cohen, Cheryl] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Walaza, Sibongile; Cohen, Cheryl] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Alexander-Scott, Marissa] NIOSH, Ctr Dis Control & Prevent, DART, Cincinnati, OH 45226 USA; [Alexander-Scott, Marissa] Univ Illinois, Springfield, IL USA	Centers for Disease Control & Prevention - USA; United States Public Health Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); University of Illinois System; University of Illinois Springfield	Cohen, AL (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30329 USA.	DVJ1@cdc.gov	McMorrow, Meredith/M-1274-2019	Cohen, Cheryl/0000-0003-0376-2302; McMorrow, Meredith/0000-0001-6363-4033	Centers for Disease Control and Prevention, Atlanta, Georgia, USA	Centers for Disease Control and Prevention, Atlanta, Georgia, USA(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work is supported by the Centers for Disease Control and Prevention, Atlanta, Georgia, USA.	ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; Allard R, 2012, INFLUENZA OTHER RESP, V6, P268, DOI 10.1111/j.1750-2659.2011.00297.x; Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515; Perez MA, 2010, PEDIATR INFECT DIS J, V29, P1052, DOI 10.1097/INF.0b013e3181e6c69b; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P94; BALLESTER OF, 1985, AM J HEMATOL, V20, P409, DOI 10.1002/ajh.2830200413; Bellei N.C.J., 2006, Braz J Infect Dis, V10, P269, DOI 10.1590/S1413-86702006000400011; Blau DM, 2011, EMERG INFECT DIS, V17, P2069, DOI 10.3201/eid1711.110429; Brundage JF, 2006, LANCET INFECT DIS, V6, P303, DOI 10.1016/S1473-3099(06)70466-2; Bundy DG, 2010, PEDIATRICS, V125, P234, DOI 10.1542/peds.2009-1465; CARTWRIGHT KAV, 1991, LANCET, V338, P554, DOI 10.1016/0140-6736(91)91112-8; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1016; Chadha MK, 2011, PROSTATE, V71, P368, DOI 10.1002/pros.21250; Chaiwarith Romanee, 2011, Journal of the Medical Association of Thailand, V94, P908; Chertow DS, 2013, JAMA-J AM MED ASSOC, V309, P275, DOI 10.1001/jama.2012.194139; Cohen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118884; Cohen C, 2013, EMERG INFECT DIS, V19, P1766, DOI 10.3201/eid1911.130546; Cohen C, 2012, CLIN INFECT DIS, V55, P996, DOI 10.1093/cid/cis549; Colonnello F, 1967, G Mal Infett Parassit, V19, P497; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Dominguez A, 2007, ANN EPIDEMIOL, V17, P654, DOI 10.1016/j.annepidem.2007.03.006; Duque J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-41; EICKHOFF TC, 1971, J INFECT DIS, V123, P519, DOI 10.1093/infdis/123.5.519; Esposito S, 2010, VACCINE, V28, P7825, DOI 10.1016/j.vaccine.2010.09.058; Fine AD, 2001, CLIN INFECT DIS, V32, P1784, DOI 10.1086/320747; Fulop T, 1999, J GERONTOL A-BIOL, V54, pM59, DOI 10.1093/gerona/54.2.M59; Gardner EM, 2000, MECH AGEING DEV, V117, P29, DOI 10.1016/S0047-6374(00)00134-2; Gentile A, 2011, ARCH ARGENT PEDIATR, V109, P198, DOI 10.1590/S0325-00752011000300003; George A, 2011, PEDIATR BLOOD CANCER, V57, P648, DOI 10.1002/pbc.23030; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Gilroy SA, 2011, SEMIN RESP CRIT CARE, V32, P775, DOI 10.1055/s-0031-1295725; Girodon F, 1999, ARCH INTERN MED, V159, P748, DOI 10.1001/archinte.159.7.748; Glezen WP, 2000, JAMA-J AM MED ASSOC, V283, P499, DOI 10.1001/jama.283.4.499; GLEZEN WP, 1983, AM J DIS CHILD, V137, P1095, DOI 10.1001/archpedi.1983.02140370055018; Gordon A, 2010, CLIN INFECT DIS, V50, P1462, DOI 10.1086/652647; Grohskopf LA, 2013, MMWR RECOMM REP, V62, P1; Gutierrez G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001394; Hambidge SJ, 2006, JAMA-J AM MED ASSOC, V296, P1990, DOI 10.1001/jama.296.16.1990; Hambidge SJ, 2012, PEDIATRICS, V129, pE54, DOI 10.1542/peds.2011-1294; Hambidge SJ, 2011, VACCINE, V29, P8179, DOI 10.1016/j.vaccine.2011.09.002; Hara M, 2005, VACCINE, V23, P1457, DOI 10.1016/j.vaccine.2004.09.022; HARRISON LH, 1991, ARCH INTERN MED, V151, P1005, DOI 10.1001/archinte.151.5.1005; Hui SL, 2006, VACCINE, V24, P5371, DOI 10.1016/j.vaccine.2006.04.032; Hussain Raheela, 2012, J Infect Public Health, V5, P199, DOI 10.1016/j.jiph.2011.12.005; Inusa B, 2010, BLOOD, V115, P2329, DOI 10.1182/blood-2009-12-260836; Jacobs JE, 2011, PEDIATR BLOOD CANCER, V56, P95, DOI 10.1002/pbc.22656; Jansen AGSC, 2008, EPIDEMIOL INFECT, V136, P1448, DOI 10.1017/S0950268807000271; Jensen ES, 2004, EUR J EPIDEMIOL, V19, P181, DOI 10.1023/B:EJEP.0000017659.80903.5f; Klugman KP, 2009, VACCINE, V27, pC9, DOI 10.1016/j.vaccine.2009.06.007; KRASINSKI K, 1987, AM J EPIDEMIOL, V125, P499, DOI 10.1093/oxfordjournals.aje.a114556; Kumar S, 2010, PEDIATR INFECT DIS J, V29, P591, DOI 10.1097/INF.0b013e3181d73e32; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; LAL H B, 1963, J Indian Med Assoc, V40, P113; Lera E, 2011, EUR J PEDIATR, V170, P371, DOI 10.1007/s00431-011-1399-4; Lin JC, 2001, ARCH INTERN MED, V161, P441, DOI 10.1001/archinte.161.3.441; Long CB, 2012, J PEDIATR-US, V160, P74, DOI 10.1016/j.jpeds.2011.06.045; Madhi SA, 2002, PEDIATR INFECT DIS J, V21, P291, DOI 10.1097/00006454-200204000-00007; Madhi SA, 2000, J PEDIATR-US, V137, P78, DOI 10.1067/mpd.2000.105350; Madhi SA, 2011, CLIN INFECT DIS, V52, P128, DOI 10.1093/cid/ciq004; Madhi Shabir A, 2008, Expert Rev Respir Med, V2, P663, DOI 10.1586/17476348.2.5.663; Makras P, 2001, CLIN INFECT DIS, V33, pE48, DOI 10.1086/322609; Mayer KH, 2011, CLIN INFECT DIS, V52, pS205, DOI 10.1093/cid/ciq043; Miranda-Choque Edwin, 2011, Rev. perú. med. exp. salud publica, V28, P610; MOORE PS, 1990, JAMA-J AM MED ASSOC, V264, P1271, DOI 10.1001/jama.264.10.1271; Moreno-Civantos A, 2000, Gac Sanit, V14, P422; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; Morrison C, 2011, EMERG INFECT DIS, V17, P87, DOI 10.3201/eid1701.091499; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Niang MN, 2010, J MED VIROL, V82, P866, DOI 10.1002/jmv.21665; Noymer A, 2011, VACCINE, V29, pB38, DOI 10.1016/j.vaccine.2011.02.053; Ope MO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020111; Paul M, 2008, STAT MED, V27, P6250, DOI 10.1002/sim.3440; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; Potter JM, 1999, AGE AGEING, V28, P141, DOI 10.1093/ageing/28.2.141; POZZETTO B, 1993, J MED VIROL, V41, P39, DOI 10.1002/jmv.1890410109; Provinciali M, 1998, AGE AGEING, V27, P715, DOI 10.1093/ageing/27.6.715; Purohit S, 2012, PEDIATR BLOOD CANCER, V59, P1280, DOI 10.1002/pbc.24206; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; REILLY S, 1991, LANCET, V338, P1143, DOI 10.1016/0140-6736(91)91999-B; Ribeiro A, 2010, 14TH INTERNATIONAL C; Rodriguez EL, 2010, EMERG INFECT DIS, V16, P882, DOI 10.3201/eid1605.091920; Rolleston H, 1919, BRIT MED J, V1919, P406, DOI 10.1136/bmj.1.3040.406-a; ROOTH IB, 1992, AM J TROP MED HYG, V47, P675, DOI 10.4269/ajtmh.1992.47.675; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Sagawa M, 2011, GERIATR GERONTOL INT, V11, P63, DOI 10.1111/j.1447-0594.2010.00641.x; SCHUBIGER G, 1986, SCHWEIZ MED WSCHR, V116, P1172; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; Souza AR, 2010, VACCINE, V28, P1117, DOI 10.1016/j.vaccine.2009.05.046; STEINBERG E, 1978, J PEDIATR-US, V92, P823, DOI 10.1016/S0022-3476(78)80166-8; Strouse JJ, 2010, BLOOD, V116, P3431, DOI 10.1182/blood-2010-05-282194; Tan D S, 1979, Med J Malaysia, V33, P355; The World Bank, 2012, COUNTRY AND LENDING; Thompson MG, 2012, J INFECT DIS, V206, P1674, DOI 10.1093/infdis/jis591; Tuite A, 2011, CANADIAN JOURNAL OF, V22, p19A; Tuite AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015493; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Waitumbi JN, 2010, AM J TROP MED HYG, V83, P1010, DOI 10.4269/ajtmh.2010.10-0174; Walaza S, 2013, EXCESS MORTALITY ASS; Walaza S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0746-x; Wells GA, THE NEWCASTLE OTTAWA; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2011, WORLD HEALTH STATIST; World Health Organization, CHILD HEALTH CHILD A; Yazdanbakhsh M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000182; YOUNG LS, 1972, NEW ENGL J MED, V287, P5, DOI 10.1056/NEJM197207062870102; Yousey-Hindes KM, 2011, AM J PUBLIC HEALTH, V101, P1785, DOI 10.2105/AJPH.2011.300224	108	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128580	10.1371/journal.pone.0128580	http://dx.doi.org/10.1371/journal.pone.0128580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068416	Green Submitted, Green Published, gold			2022-12-27	WOS:000356100900026
J	Herrmann, T; Mallow, J; Plaumann, M; Luchtmann, M; Stadler, J; Mylius, J; Brosch, M; Bernarding, J				Herrmann, Tim; Mallow, Johannes; Plaumann, Markus; Luchtmann, Michael; Stadler, Joerg; Mylius, Judith; Brosch, Michael; Bernarding, Johannes			The Travelling-Wave Primate System: A New Solution for Magnetic Resonance Imaging of Macaque Monkeys at 7 Tesla Ultra-High Field	PLOS ONE			English	Article							MRI; BRAIN; MOTION; FMRI; INHOMOGENEITY; COMBINATION; EXCITATION	Introduction Neuroimaging of macaques at ultra-high field (UHF) is usually conducted by combining a volume coil for transmit (Tx) and a phased array coil for receive (Rx) tightly enclosing the monkey's head. Good results have been achieved using vertical or horizontal magnets with implanted or near-surface coils. An alternative and less costly approach, the travelling-wave (TW) excitation concept, may offer more flexible experimental setups on human whole-body UHF magnetic resonance imaging (MRI) systems, which are now more widely available. Goal of the study was developing and validating the TW concept for in vivo primate MRI. Methods The TW Primate System (TWPS) uses the radio frequency shield of the gradient system of a human whole-body 7 T MRI system as a waveguide to propagate a circularly polarized B1 field represented by the TE11 mode. This mode is excited by a specifically designed 2-port patch antenna. For receive, a customized neuroimaging monkey head receive-only coil was designed. Field simulation was used for development and evaluation. Signal-to-noise ratio (SNR) was compared with data acquired with a conventional monkey volume head coil consisting of a homogeneous transmit coil and a 12-element receive coil. Results The TWPS offered good image homogeneity in the volume-of-interest Turbo spin echo images exhibited a high contrast, allowing a clear depiction of the cerebral anatomy. As a prerequisite for functional MRI, whole brain ultrafast echo planar images were successfully acquired. Conclusion The TWPS presents a promising new approach to fMRI of macaques for research groups with access to a horizontal UHF MRI system.	[Herrmann, Tim; Mallow, Johannes; Plaumann, Markus; Luchtmann, Michael; Bernarding, Johannes] OvG Univ, Dept Biometr & Med Informat, Magdeburg, Germany; [Stadler, Joerg; Mylius, Judith; Brosch, Michael] LIN, Magdeburg, Germany; [Brosch, Michael; Bernarding, Johannes] Ctr Behav Brain Sci, Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN)	Herrmann, T (corresponding author), OvG Univ, Dept Biometr & Med Informat, Magdeburg, Germany.	tim.herrmann@med.ovgu.de	Plaumann, Markus/F-5918-2013	Plaumann, Markus/0000-0002-6295-3320; Luchtmann, Michael/0000-0002-9947-9095; Brosch, Michael/0000-0003-3687-3754; Stadler, Jorg/0000-0003-4313-129X	Deutsche Forschungsgemeinschaft [SFB 779]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grant SFB 779, of Deutsche Forschungsgemeinschaft (www.dfg.de), to JMY and MB.	Alt S, 2012, MAGN RESON MED, V67, P1173, DOI 10.1002/mrm.23069; Brunner DO, 2011, MAGN RESON MED, V66, P290, DOI 10.1002/mrm.22817; Brunner DO, 2009, NATURE, V457, P994, DOI 10.1038/nature07752; Cho ZH, 2010, NEUROIMAGE, V49, P2134, DOI 10.1016/j.neuroimage.2009.11.002; Constantinides CD, 1997, MAGNET RESON MED, V38, P852, DOI 10.1002/mrm.1910380524; CST AG, 2014, CST MICROWAVE STUDIO; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; Dietrich O, 2008, MAGN RESON IMAGING, V26, P754, DOI 10.1016/j.mri.2008.02.001; Erni D, 2011, IEEE ENG MED BIO, P554; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Geschewski FH, 2013, MAGN RESON MED, V69, P1805, DOI 10.1002/mrm.24403; Goense JBM, 2008, NEUROIMAGE, V39, P1081, DOI 10.1016/j.neuroimage.2007.09.038; Hayes CE, 2009, NMR BIOMED, V22, P908, DOI 10.1002/nbm.1431; HENNIG J, 1988, J MAGN RESON, V78, P397, DOI 10.1016/0022-2364(88)90128-X; Hoffmann J, 2013, MAGN RESON MED, V69, P1494, DOI 10.1002/mrm.24367; IEC, 2010, MEDICAL ELECTRICAL E; Kagan I, 2010, P NATL ACAD SCI USA, V107, P7933, DOI 10.1073/pnas.1002825107; Keliris GA, 2007, NEUROIMAGE, V36, P550, DOI 10.1016/j.neuroimage.2007.02.057; KLOSE U, 1992, MED PHYS, V19, P1099, DOI 10.1118/1.596828; Kolster H, 2009, J NEUROSCI, V29, P7031, DOI 10.1523/JNEUROSCI.0518-09.2009; Maclaren J, 2013, MAGN RESON MED, V69, P621, DOI 10.1002/mrm.24314; Mallow J, 2013, MAGN RESON MATER PHY, V26, P389, DOI 10.1007/s10334-012-0358-z; MANSFIELD P, 1984, BRIT MED BULL, V40, P187, DOI 10.1093/oxfordjournals.bmb.a071970; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Orzada S, 2013, MAGN RESON MED, V70, P290, DOI 10.1002/mrm.24453; Orzada S, 2010, MAGN RESON MED, V64, P327, DOI 10.1002/mrm.22527; Orzada S, 2010, MED PHYS, V37, P2225, DOI 10.1118/1.3378478; Pan JW, 2012, MAGN RESON MED, V68, P1007, DOI 10.1002/mrm.24122; Pfeuffer J, 2004, MAGN RESON IMAGING, V22, P1343, DOI 10.1016/j.mri.2004.10.004; PURCELL EM, 1946, PHYS REV, V69, P37, DOI 10.1103/PhysRev.69.37; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Schulz J, 2014, NEUROIMAGE, V84, P124, DOI 10.1016/j.neuroimage.2013.08.006; Sengupta S, 2011, J MAGN RESON, V210, P218, DOI 10.1016/j.jmr.2011.03.007; Shajan G, 2012, NMR BIOMED, V25, P1170, DOI 10.1002/nbm.2786; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; Vaughan TT, 2009, MAGN RESON MED, V61, P244, DOI 10.1002/mrm.21751; Wolf S, 2013, MAGN RESON MED, V69, P1157, DOI 10.1002/mrm.24329; Zhang Y., 2011, APPL COMPUT INTELL S, V2011, P7, DOI DOI 10.5194/CP-7-801-2011	38	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129371	10.1371/journal.pone.0129371	http://dx.doi.org/10.1371/journal.pone.0129371			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066653	Green Published, gold			2022-12-27	WOS:000356100900052
J	Hsu, BY; Bae, YH; Mui, KL; Liu, SL; Assoian, RK				Hsu, Bernadette Y.; Bae, Yong Ho; Mui, Keeley L.; Liu, Shu-Lin; Assoian, Richard K.			Apolipoprotein E3 Inhibits Rho to Regulate the Mechanosensitive Expression of Cox2	PLOS ONE			English	Article							CELL-ADHESION; MECHANICAL-PROPERTIES; STIFFNESS; APOE; HDL; PROLIFERATION; ACTIVATION; MIGRATION; TISSUE	Apolipoprotein E3 (apoE3) is thought to protect against atherosclerosis by enhancing reverse cholesterol transport. However, apoE3 also has cholesterol-independent effects that contribute to its anti-atherogenic properties. These include altering extracellular matrix protein synthesis and inhibiting vascular smooth muscle cell proliferation. Both of these cholesterol-independent effects result from an apoE3-mediated induction of cyclooxygenase-2 (Cox2). Nevertheless, how apoE3 regulates Cox2 remains unknown. Here, we show that apoE3 inhibits the activation of Rho, which reduces the formation of actin stress fibers and focal adhesions and results in cellular softening. Inhibition of Rho-Rho kinase signaling or direct cellular softening recapitulates the effect of apoE3 on Cox2 expression while a constitutively active Rho mutant overrides the apoE3 effect on both intracellular stiffness and Cox2. Thus, our results describe a previously unidentified mechanism by which an atheroprotective apolipoprotein uses Rho to control cellular mechanics and Cox2.	[Hsu, Bernadette Y.; Bae, Yong Ho; Mui, Keeley L.; Liu, Shu-Lin; Assoian, Richard K.] Univ Penn, Inst Translat Med & Therapeut, Program Translat Biomech, Philadelphia, PA 19104 USA; [Hsu, Bernadette Y.; Bae, Yong Ho; Mui, Keeley L.; Liu, Shu-Lin; Assoian, Richard K.] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Bae, YH (corresponding author), Univ Penn, Inst Translat Med & Therapeut, Program Translat Biomech, Philadelphia, PA 19104 USA.	yob@mail.med.upenn.edu	Bae, Yong Ho/M-8427-2015	Bae, Yong Ho/0000-0002-1838-1652	NIH [HL062250, HL119346, R25CA101871]; American Heart Association; NATIONAL CANCER INSTITUTE [R25CA101871] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL062250, R01HL119346] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant HL062250 and HL119346. YHB was supported by a post-doctoral fellowship from the American Heart Association. KLM was supported by NIH training grant R25CA101871.	Ali K, 2008, ATHEROSCLEROSIS, V196, P201, DOI 10.1016/j.atherosclerosis.2007.03.038; Bae YH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004838; Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002; Cho T, 2008, J BIOL CHEM, V283, P30503, DOI 10.1074/jbc.M802648200; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Ishigami M, 2000, ARTERIOSCL THROM VAS, V20, P1020, DOI 10.1161/01.ATV.20.4.1020; Ishigami M, 1998, J BIOL CHEM, V273, P20156, DOI 10.1074/jbc.273.32.20156; Janmey PA, 2013, DIFFERENTIATION, V86, P112, DOI 10.1016/j.diff.2013.07.004; Klein EA, 2007, METHOD ENZYMOL, V426, P155, DOI 10.1016/S0076-6879(07)26008-2; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Kothapalli D, 2004, J CLIN INVEST, V113, P609, DOI 10.1172/JCI200419097; Kothapalli D, 2013, ATHEROSCLEROSIS, V227, P65, DOI 10.1016/j.atherosclerosis.2012.12.003; Kothapalli D, 2012, CELL REP, V2, P1259, DOI 10.1016/j.celrep.2012.09.018; Lamon-Fava S, 2014, CURR OPIN LIPIDOL, V25, P189, DOI 10.1097/MOL.0000000000000070; LEE RT, 1992, ARTERIOSCLER THROMB, V12, P1, DOI 10.1161/01.ATV.12.1.1; Mahley RW, 1999, CURR OPIN LIPIDOL, V10, P207, DOI 10.1097/00041433-199906000-00003; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Riches K, 2013, INT J BIOCHEM CELL B, V45, P1776, DOI 10.1016/j.biocel.2013.05.021; Rye K, 2006, J LIPID RES, V47, P1025, DOI 10.1194/jlr.M500525-JLR200; Schwartz MP, 2010, INTEGR BIOL-UK, V2, P32, DOI 10.1039/b912438a; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Thorngate FE, 2003, J LIPID RES, V44, P2331, DOI 10.1194/jlr.M300224-JLR200; Wakatsuki T, 2001, J CELL SCI, V114, P1025; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	29	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128974	10.1371/journal.pone.0128974	http://dx.doi.org/10.1371/journal.pone.0128974			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068461	gold, Green Submitted, Green Published			2022-12-27	WOS:000356100900037
J	Milani, M; Laranjeira, ABA; de Vasconcellos, JF; Brandalise, SR; Nowill, AE; Yunes, JA				Milani, Mateus; Albertoni Laranjeira, Angelo Brunelli; de Vasconcellos, Jaira Ferreira; Brandalise, Silvia Regina; Nowill, Alexandre Eduardo; Yunes, Jose Andres			Plasma Hsp90 Level as a Marker of Early Acute Lymphoblastic Leukemia Engraftment and Progression in Mice	PLOS ONE			English	Article							REGULATORY MECHANISM; DISEASE PROGRESSION; EXPRESSION; MODEL; HSP90-ALPHA; MALIGNANCY; GROWTH; CELLS	Current monitoring of acute lymphoblastic leukemia (ALL) in living mice is based on FACS analysis of blood hCD45+ cells. In this work, we evaluated the use of human IGFBP2, B2M or Hsp90 as soluble markers of leukemia. ELISA for B2M and IGFBP2 resulted in high background levels in healthy animals, precluding its use. Conversely, plasma levels of Hsp90 showed low background and linear correlation to FACS results. In another experiment, we compared Hsp90 levels with percentage of hCD45+ cells in blood, bone marrow, liver and spleen of animals weekly sacrificed. Hsp90 levels proved to be a superior method for the earlier detection of ALL engraftment and correlated linearly to ALL burden and progression in all compartments, even at minimal residual disease levels. Importantly, the Hsp90/hCD45+ ratio was not altered when animals were treated with dexamethasone or a PI3K inhibitor, indicating that chemotherapy does not directly interfere with leukemia production of Hsp90. In conclusion, plasma Hsp90 was validated as a soluble biomarker of ALL, useful for earlier detection of leukemia engraftment, monitoring leukemia kinetics at residual disease levels, and pre-clinical or mouse avatar evaluations of anti-leukemic drugs.	[Milani, Mateus; Albertoni Laranjeira, Angelo Brunelli; de Vasconcellos, Jaira Ferreira; Brandalise, Silvia Regina; Yunes, Jose Andres] Ctr Infantil Boldrini, Mol Biol Lab, Campinas, SP, Brazil; [Nowill, Alexandre Eduardo] Univ Estadual Campinas, FCM, CIPOI, Campinas, SP, Brazil; [Yunes, Jose Andres] Univ Estadual Campinas, FCM, Dept Med Genet, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Yunes, JA (corresponding author), Ctr Infantil Boldrini, Mol Biol Lab, Campinas, SP, Brazil.	andres@boldrini.org.br	Nowill, Alexandre Eduardo/I-9038-2012; Brunelli Albertoni Laranjeira, Angelo/H-3601-2016; Brandalise, Silvia Regina/ABG-9609-2021	Nowill, Alexandre Eduardo/0000-0003-0648-6913; Brunelli Albertoni Laranjeira, Angelo/0000-0002-6772-0956; Milani, Mateus/0000-0001-5004-3250; Yunes, Jose Andres/0000-0002-1316-3525; Ferreira de Vasconcellos, Jaira/0000-0001-5011-4493	Sao Paulo Research Foundation (FAPESP) [08/10034-1, 12/12802-1]; FAPESP; National Counsel of Technological and Scientific Development (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Sao Paulo Research Foundation (FAPESP) (08/10034-1 and 12/12802-1) to JAY. MM, ABAL and JFV received FAPESP fellowships. JAY received a fellowship from the National Counsel of Technological and Scientific Development (CNPq Productivity fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello F, 1996, BLOOD, V87, P4325, DOI 10.1182/blood.V87.10.4325.bloodjournal87104325; Barrott JJ, 2013, FEBS J, V280, P1381, DOI 10.1111/febs.12147; Bien Ewa, 2004, Wiad Lek, V57, P8; Campana D, 2012, CURR HEMATOL MALIG R, V7, P170, DOI 10.1007/s11899-012-0115-4; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cheng C. Yan, 2008, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V8, P1, DOI 10.2174/187152208783790778; Christoph S, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-10; Dickson PV, 2007, J PEDIATR SURG, V42, P1172, DOI 10.1016/j.jpedsurg.2007.02.027; GLEAVE ME, 1992, CANCER RES, V52, P1598; Hudson WA, 1998, LEUKEMIA, V12, P2029, DOI 10.1038/sj.leu.2401236; Inoue Y, 2007, EXP HEMATOL, V35, P407, DOI 10.1016/j.exphem.2006.11.006; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Juarez J, 2007, LEUKEMIA, V21, P1249, DOI 10.1038/sj.leu.2404684; Kato I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027042; Keating A, 2013, HIGH LEVEL ENGRAFTME, P2406; Lauten M, 2003, LEUKEMIA, V17, P1551, DOI 10.1038/sj.leu.2403027; Liem NLM, 2004, BLOOD, V103, P3905, DOI 10.1182/blood-2003-08-2911; Lock RB, 2002, BLOOD, V99, P4100, DOI 10.1182/blood.V99.11.4100; Malaney P, 2014, CANCER LETT, V344, P1, DOI 10.1016/j.canlet.2013.10.010; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Mohnike K., 1998, HAEMATOL BLOOD TRANS, V39, P375, DOI [10.1007/978-3-642-71960-8, DOI 10.1007/978-3-642-71960-8]; Silveira AB, 2015, ONCOTARGET; Song XM, 2010, J BIOL CHEM, V285, P40039, DOI 10.1074/jbc.M110.181941; Szymanska B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033894; Tissing WJE, 2005, LEUKEMIA, V19, P727, DOI 10.1038/sj.leu.2403681; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Xiao K, 1996, J Tongji Med Univ, V16, P212; YUFU Y, 1992, LEUKEMIA RES, V16, P597, DOI 10.1016/0145-2126(92)90008-U	28	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129298	10.1371/journal.pone.0129298	http://dx.doi.org/10.1371/journal.pone.0129298			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068922	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900048
J	Tebbens, RJD; Pallansch, MA; Wassilak, SGF; Cochi, SL; Thompson, KM				Tebbens, Radboud J. Duintjer; Pallansch, Mark A.; Wassilak, Steven G. F.; Cochi, Stephen L.; Thompson, Kimberly M.			Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria	PLOS ONE			English	Article							VACCINE-DERIVED POLIOVIRUS; POPULATION IMMUNITY; WILD POLIOVIRUS; PARALYTIC POLIOMYELITIS; ERADICATION; EPIDEMIOLOGY; CIRCULATION; STRATEGIES; EMERGENCE; OUTBREAK	Background Frequent supplemental immunization activities (SIAs) with the oral poliovirus vaccine (OPV) represent the primary strategy to interrupt poliovirus transmission in the last endemic areas. Materials and Methods Using a differential-equation based poliovirus transmission model tailored to high-risk areas in Nigeria, we perform one-way and multi-way sensitivity analyses to demonstrate the impact of different assumptions about routine immunization (RI) and the frequency and quality of SIAs on population immunity to transmission and persistence or emergence of circulating vaccine-derived polioviruses (cVDPVs) after OPV cessation. Results More trivalent OPV use remains critical to avoid serotype 2 cVDPVs. RI schedules with or without inactivated polio vaccine (IPV) could significantly improve population immunity if coverage increases well above current levels in under-vaccinated subpopulations. Similarly, the impact of SIAs on overall population immunity and cVDPV risks depends on their ability to reach under-vaccinated groups (i.e., SIA quality). Lower SIA coverage in the under-vaccinated subpopulation results in a higher frequency of SIAs needed to maintain high enough population immunity to avoid cVDPVs after OPV cessation. Conclusions National immunization program managers in northwest Nigeria should recognize the benefits of increasing RI and SIA quality. Sufficiently improving RI coverage and improving SIA quality will reduce the frequency of SIAs required to stop and prevent future poliovirus transmission. Better information about the incremental costs to identify and reach under-vaccinated children would help determine the optimal balance between spending to increase SIA and RI quality and spending to increase SIA frequency.	[Tebbens, Radboud J. Duintjer; Thompson, Kimberly M.] Kid Risk Inc, Orlando, FL 32832 USA; [Pallansch, Mark A.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Wassilak, Steven G. F.; Cochi, Stephen L.] Ctr Dis Control & Prevent, Global Immunizat Div, Ctr Global Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Tebbens, RJD (corresponding author), Kid Risk Inc, Orlando, FL 32832 USA.	rdt@kidrisk.org		Thompson, Kimberly/0000-0002-0849-9147	US Centers for Disease Control and Prevention [U66IP000519]; National Center for Immunization and Respiratory Diseases (NCIRD) [U66IP000519] Funding Source: NIH RePORTER	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	RJDT and KMT acknowledge support for this work from the US Centers for Disease Control and Prevention under Contract U66IP000519. The contents of this article are solely the responsibility of the authors and do not represent the official views of the US Centers for Disease Control and Prevention.	Anis E, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.38.20586; [Anonymous], 2001, Wkly Epidemiol Rec, V76, P95; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1393; Bahl S, 2014, MMWR-MORBID MORTAL W, V63, pCOVER1; Barau I, 2014, J INFECT DIS, V210, pS102, DOI 10.1093/infdis/jiu010; Burns CC, 2014, J INFECT DIS, V210, pS283, DOI 10.1093/infdis/jiu295; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P145; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Galindo M, 2007, NEW ENGL J MED, V356, P1536, DOI 10.1056/NEJMoa054960; Hird TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002599; HULL HF, 1994, LANCET, V343, P1331, DOI 10.1016/S0140-6736(94)92472-4; Jafari H, 2014, SCIENCE, V345, P922, DOI 10.1126/science.1255006; Jenkins HE, 2010, NEW ENGL J MED, V362, P2360, DOI 10.1056/NEJMoa0910074; Kalkowska DA, 2015, J INFECT DIS, V211, P1800, DOI 10.1093/infdis/jiu674; Kalkowska DA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0791-5; Kalkowska DA, 2014, J INFECT DIS, V210, pS398, DOI 10.1093/infdis/jit844; Kalkowska DA, 2014, J INFECT DIS, V210, pS412, DOI 10.1093/infdis/jit834; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2014, MMWR-MORBID MORTAL W, V63, P1031; Mach O, 2014, J INFECT DIS, V210, pS275, DOI 10.1093/infdis/jit454; Nathanson N, 2010, AM J EPIDEMIOL, V172, P1213, DOI 10.1093/aje/kwq320; National Population Commission of Nigeria, 2014, NIG DEM HLTH SURV 20; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Polio Global Eradication Initiative, 2013, POL ER ENDG STRAT PL; Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, 2013, WORLD POP PROSP 2012; Sabin AB, 1986, BMJ-BRIT MED J, V292, P513; Tebbens RJD, 2014, J INFECT DIS, V210, pS485, DOI 10.1093/infdis/jit838; Tebbens RJD, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-45; Tebbens RJD, 2013, RISK ANAL, V33, P680, DOI 10.1111/risa.12022; Tebbens RJD, 2013, RISK ANAL, V33, P544, DOI 10.1111/j.1539-6924.2012.01864.x; Tebbens RJD, 2013, RISK ANAL, V33, P703, DOI 10.1111/risa.12044; Tebbens RJD, 2013, RISK ANAL, V33, P606, DOI 10.1111/risa.12031; Thompson KM, 2008, AM J PUBLIC HEALTH, V98, P1322, DOI 10.2105/AJPH.2007.122192; Thompson KM, 2007, LANCET, V369, P1363, DOI 10.1016/S0140-6736(07)60532-7; Thompson KM, 2015, VACCINE, V33, P1568, DOI 10.1016/j.vaccine.2015.02.013; Thompson KM, 2014, LANCET, V384, P1480, DOI 10.1016/S0140-6736(14)60983-1; Thompson KM, 2014, EXPERT REV VACCINES, V13, P221, DOI 10.1586/14760584.2014.864563; Thompson KM, 2014, J INFECT DIS, V210, pS475, DOI 10.1093/infdis/jit845; Thompson KM, 2013, RISK ANAL, V33, P647, DOI 10.1111/j.1539-6924.2012.01891.x; Thompson KM, 2013, RISK ANAL, V33, P516, DOI 10.1111/risa.12019; Thompson KM, UNPUB; Wassilak S, 2011, J INFECT DIS, V203, P898, DOI 10.1093/infdis/jiq140; World Health Organization, 2015, GLOB POL ER IN CIRC; World Health Organization, 2015, GLOB POL ER IN LIST; World Health Organization, 2005, WHOPOL0502	45	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130123	10.1371/journal.pone.0130123	http://dx.doi.org/10.1371/journal.pone.0130123			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK3FB	26068928	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900100
J	Caziot, B; Backus, BT				Caziot, Baptiste; Backus, Benjamin T.			Stereoscopic Offset Makes Objects Easier to Recognize	PLOS ONE			English	Article							VISUAL-CORTEX; ATTENTION; VIEWPOINT; VIEWS; REPRESENTATIONS; PERCEPTION; STEREOPSIS; ADVANTAGE; DISPARITY; MOVEMENTS	Binocular vision is obviously useful for depth perception, but it might also enhance other components of visual processing, such as image segmentation. We used naturalistic images to determine whether giving an object a stereoscopic offset of 15-120 arcmin of crossed disparity relative to its background would make the object easier to recognize in briefly presented (33-133 ms), temporally masked displays. Disparity had a beneficial effect across a wide range of disparities and display durations. Most of this benefit occurred whether or not the stereoscopic contour agreed with the object's luminance contour. We attribute this benefit to an orienting of spatial attention that selected the object and its local background for enhanced 2D pattern processing. At longer display durations, contour agreement provided an additional benefit, and a separate experiment using random-dot stimuli confirmed that stereoscopic contours plausibly contributed to recognition at the longer display durations in our experiment. We conclude that in real-world situations binocular vision confers an advantage not only for depth perception, but also for recognizing objects from their luminance patterns and bounding contours.	[Caziot, Baptiste; Backus, Benjamin T.] SUNY Coll Optometry, Grad Ctr Vis Res, 33 W 42nd St, New York, NY 10036 USA; [Caziot, Baptiste; Backus, Benjamin T.] SUNY Eye Inst, New York, NY 10036 USA	State University of New York (SUNY) System; SUNY Optometry	Caziot, B (corresponding author), SUNY Coll Optometry, Grad Ctr Vis Res, 33 W 42nd St, New York, NY 10036 USA.	bcaziot@sunyopt.edu			National Institutes of Health [R01 EY013988]; NATIONAL EYE INSTITUTE [R01EY013988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grant R01 EY013988 to BTB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN GJ, 1993, PERCEPT PSYCHOPHYS, V53, P658, DOI 10.3758/BF03211742; ARMALY MF, 1969, ARCH OPHTHALMOL-CHIC, V81, P192; Backus BT, 2003, J VISION, V3, P737, DOI 10.1167/3.11.8; Bennett DJ, 2006, PERCEPT PSYCHOPHYS, V68, P1082, DOI 10.3758/BF03193711; BLAKEMORE C, 1970, J PHYSIOL-LONDON, V211, P599, DOI 10.1113/jphysiol.1970.sp009296; Bridges W, 1811, MAP CITY NEWYORK ISL; Burge J, 2014, J VISION, V14, DOI 10.1167/14.2.1; Burke D, 2005, VIS COGN, V12, P705, DOI 10.1080/13506280444000463; Burke D, 2007, VISION RES, V47, P2164, DOI 10.1016/j.visres.2007.04.018; Bushnell BN, 2011, J NEUROSCI, V31, P4012, DOI 10.1523/JNEUROSCI.4766-10.2011; Caziot B, 2015, J EXP PSYCH IN PRESS; de Gardelle V, 2014, PSYCHOL SCI, V25, P1286, DOI 10.1177/0956797614528956; Downing C. J., 1985, ATTENTION PERFORM, P171; Driver J, 2001, COGNITION, V80, P61, DOI 10.1016/S0010-0277(00)00151-7; Dunser A, 2008, OZCHI 2008 P; EDELMAN S, 1992, VISION RES, V32, P2385, DOI 10.1016/0042-6989(92)90102-O; ELLIOTT PB, 1964, SIGNAL DETECT RECOG, P651; ENRIGHT JT, 1991, VISION RES, V31, P1549, DOI 10.1016/0042-6989(91)90132-O; Finlayson NJ, 2013, J VISION, V13, DOI 10.1167/13.8.11; GAWRYSZEWSKI LD, 1987, NEUROPSYCHOLOGIA, V25, P19, DOI 10.1016/0028-3932(87)90040-6; Gegenfurtner KR, 2000, CURR BIOL, V10, P805, DOI 10.1016/S0960-9822(00)00563-7; Green DM, 1966, SIGNAL DETECTION THE; HACKER MJ, 1979, PERCEPT PSYCHOPHYS, V26, P168, DOI 10.3758/BF03208311; Howard I. P., 2002, SEEING DEPTH, V2; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; JULESZ B, 1960, AT&T TECH J, V39, P1125, DOI 10.1002/j.1538-7305.1960.tb03954.x; JULESZ B, 1978, PERCEPTION, V7, P315, DOI 10.1068/p070315; Julesz B., 2006, FDN CYCLOPEAN PERCEP; Julesz B., 1971, FDN CYCLOPEAN PERCEP; Kane D, 2014, J NEUROSCI, V34, P1397, DOI 10.1523/JNEUROSCI.1652-13.2014; Lee YL, 2011, J VISION, V11, DOI 10.1167/11.9.6; Liu CH, 2006, VIS COGN, V13, P51, DOI 10.1080/13506280500143391; Macmillan NA, 2005, DETECTION THEORY USE; NAKAYAMA K, 1986, NATURE, V320, P264, DOI 10.1038/320264a0; Norman JF, 2004, PSYCHOL SCI, V15, P565, DOI 10.1111/j.0956-7976.2004.00720.x; OGLE KN, 1953, J OPT SOC AM, V43, P906, DOI 10.1364/JOSA.43.000906; OGLE KN, 1956, J OPT SOC AM, V46, P269, DOI 10.1364/JOSA.46.000269; Ogle KN, 1962, EYE, P271; OToole AJ, 1997, PERCEPT PSYCHOPHYS, V59, P202, DOI 10.3758/BF03211889; Pierce CS., 1885, MEMOIRS NATL ACAD SC, V3, P73; Qiu FTT, 2005, NEURON, V47, P155, DOI 10.1016/j.neuron.2005.05.028; RICHARDS W, 1977, VISION RES, V17, P967, DOI 10.1016/0042-6989(77)90072-4; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; STEINMAN SB, 1987, PERCEPTION, V16, P389, DOI 10.1068/p160389; Tyler C.W., 1991, VISION VISUAL DYSFUN, P19; Valsecchi M, 2013, I-PERCEPTION, V4, P122, DOI 10.1068/i0587; von der Heydt R, 2000, VISION RES, V40, P1955, DOI 10.1016/S0042-6989(00)00044-4; Wardle SG, 2010, J VISION, V10, DOI 10.1167/10.14.38; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Wolfe JM, 1998, VISUAL SEARCH ATTENT	51	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129101	10.1371/journal.pone.0129101	http://dx.doi.org/10.1371/journal.pone.0129101			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9EB	26079788	gold, Green Submitted, Green Published			2022-12-27	WOS:000356542300013
J	Park, SH; Chen, WC; Durmus, N; Bleck, B; Reibman, J; Riemekasten, G; Grunig, G				Park, Sung-Hyun; Chen, Wen-Chi; Durmus, Nedim; Bleck, Bertram; Reibman, Joan; Riemekasten, Gabriela; Grunig, Gabriele			The Effects of Antigen-Specific IgG1 Antibody for the Pulmonary-Hypertension-Phenotype and B Cells for Inflammation in Mice Exposed to Antigen and Fine Particles from Air Pollution	PLOS ONE			English	Article							RESISTIN-LIKE-MOLECULE; INDUCED MITOGENIC FACTOR; SMOOTH-MUSCLE-CELLS; FC-GAMMA RECEPTOR; ARTERIAL-HYPERTENSION; MATRIX METALLOPROTEINASES; ANTIINFLAMMATORY ACTIVITY; SERUM CONCENTRATIONS; DENDRITIC CELLS; TISSUE	Air pollution is known to exacerbate chronic inflammatory conditions of the lungs including pulmonary hypertension, cardiovascular diseases and autoimmune diseases. Directly pathogenic antibodies bind pro-inflammatory cell receptors and cause or exacerbate inflammation. In contrast, anti-inflammatory antibody isotypes (e.g. mouse immunoglobulin G1, IgG1) bind inhibitory cell receptors and can inhibit inflammation. Our previous studies showed that co-exposure to antigen and urban ambient particulate matter (PM2.5) induced severe pulmonary arterial thickening and increased right ventricular systolic pressures in mice via T-cell produced cytokines, Interleukin (IL)-13 and IL-17A. The aim of the current study was to understand how B cell and antibody responses integrate into this T cell cytokine network for the pulmonary hypertension phenotype. Special focus was on antigen-specific IgG1 that is the predominant antibody in the experimental response to antigen and urban ambient PM2.5. Wild type and B cell-deficient mice were primed with antigen and then challenged with antigen and urban particulate matter and injected with antibodies as appropriate. Our data surprisingly showed that B cells were necessary for the development of increased right ventricular pressures and molecular changes in the right heart in response to sensitization and intranasal challenge with antigen and PM2.5. Further, our studies showed that both, the increase in right ventricular systolic pressure and right ventricular molecular changes were restored by reconstituting the B cell KO mice with antigen specific IgG1. In addition, our studies identified a critical, non-redundant role of B cells for the IL-17A-directed inflammation in response to exposure with antigen and PM2.5, which was not corrected with antigen-specific IgG1. In contrast, IL-13-directed inflammatory markers, as well as severe pulmonary arterial remodeling induced by challenge with antigen and PM2.5 were similar in B cell-deficient and wild type mice. Our studies have identified B cells and antigen specific IgG1 as potential therapeutic targets for pulmonary hypertension associated with immune dysfunction and environmental exposures.	[Park, Sung-Hyun; Chen, Wen-Chi; Durmus, Nedim; Reibman, Joan; Grunig, Gabriele] NYU, Langone Med Ctr, Dept Environm Med, Tuxedo Pk, NY 10987 USA; [Bleck, Bertram; Reibman, Joan; Grunig, Gabriele] NYU, Dept Med, Div Pulm Med, Langone Med Ctr, New York, NY 10016 USA; [Riemekasten, Gabriela] Med Univ Lubeck, Clin Rheumatol, D-23538 Lubeck, Germany	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; University of Lubeck	Grunig, G (corresponding author), NYU, Langone Med Ctr, Dept Environm Med, Tuxedo Pk, NY 10987 USA.	ggrunig1@earthlink.net	Riemekasten, Gabriela/B-5019-2017	Reibman, Joan/0000-0001-7878-1511	National Institutes of Health [1R21HL092370-01, 1R01 HL095764-01]; American Heart Association [0855943D]; Stony Wold - Herbert Fund, New York; Hacettepe University grant [014G602002]; Scientific and Technological Research Council of Turkey grant [1059B191401602]; NIEHS center grant [ES00260]; NCI Cancer center grant [5P30CA16087-33]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095764, R21HL092370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Stony Wold - Herbert Fund, New York; Hacettepe University grant(Hacettepe University); Scientific and Technological Research Council of Turkey grant(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NIEHS center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI Cancer center grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was funded in part by the National Institutes of Health 1R21HL092370-01 (GG), 1R01 HL095764-01 (GG); American Heart Association, Founders affiliate 0855943D, (GG); Stony Wold - Herbert Fund, New York (SHP); Hacettepe University grant 014G602002 (ND), Scientific and Technological Research Council of Turkey grant 1059B191401602 (ND); core support was by NIEHS center grant (ES00260) and NCI Cancer center grant (5P30CA16087-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini DJ, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-1; Arends SJ, 2013, CLIN EXP IMMUNOL, V174, P433, DOI 10.1111/cei.12166; Arends SJ, 2010, EUR RESPIR J, V35, P923, DOI 10.1183/09031936.00164209; Arends SJ, 2013, AUTOIMMUNITY, V46, P463, DOI 10.3109/08916934.2013.812080; Barst RJ, 2009, J AM COLL CARDIOL, V54, pS78, DOI 10.1016/j.jacc.2009.04.017; Baumann U, 2001, J IMMUNOL, V167, P1022, DOI 10.4049/jimmunol.167.2.1022; Becker MO, 2014, AM J RESP CRIT CARE, V190, P808, DOI 10.1164/rccm.201403-0442OC; Biasin V, 2014, J PATHOL, V233, P7, DOI 10.1002/path.4303; Bloomfield GS, 2012, GLOB HEART, V7, P249, DOI 10.1016/j.gheart.2012.06.015; Bogaard HJ, 2009, CIRCULATION, V120, P1951, DOI 10.1161/CIRCULATIONAHA.109.883843; Bussone G, 2012, ANN RHEUM DIS, V71, P596, DOI 10.1136/annrheumdis-2011-200195; Bussone G, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3336; Chaisson NF, 2013, CHEST, V144, P1346, DOI 10.1378/chest.12-2396; Chelladurai P, 2012, EUR RESPIR J, V40, P766, DOI 10.1183/09031936.00209911; Chen WC, 2013, JOVE-J VIS EXP, DOI 10.3791/50023; Colvin KL, 2013, AM J RESP CRIT CARE, V188, P1126, DOI 10.1164/rccm.201302-0403OC; Daley E, 2008, J EXP MED, V205, P361, DOI 10.1084/jem.20071008; Desai DD, 2007, J IMMUNOL, V178, P6217, DOI 10.4049/jimmunol.178.10.6217; Dib H, 2012, EUR RESPIR J, V39, P1405, DOI 10.1183/09031936.00181410; Esmaeil N, 2014, AM J CLIN EXP IMMUNO, V3, P20; Faquim-Mauro EL, 1999, J IMMUNOL, V163, P3572; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Ford JG, 2001, J IMMUNOL, V167, P1769, DOI 10.4049/jimmunol.167.3.1769; Fritz JS, 2013, CHEST, V143, P315, DOI 10.1378/chest.12-0270; Gerstmayer B, 2003, GENOMICS, V81, P588, DOI 10.1016/S0888-7543(03)00070-3; Gilmour MI, 2007, INHAL TOXICOL, V19, P7, DOI 10.1080/08958370701490379; Grunig G, 1997, J EXP MED, V185, P1089, DOI 10.1084/jem.185.6.1089; Grunig G, 2014, PULM CIRC, V4, P25, DOI 10.1086/674902; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Hoffman C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027629; Holguin F, 2014, AM J RESP CRIT CARE, V189, P1018, DOI 10.1164/rccm.201404-0613ED; HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628, DOI 10.1164/ajrccm.151.5.7735624; Ishikawa Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-42; Jin S, 2014, EXP DERMATOL, V23, P938, DOI 10.1111/exd.12563; Johnson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020828; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Kill A, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4457; Kim YM, 2011, AM J PATHOL, V179, P1560, DOI 10.1016/j.ajpath.2011.05.051; Kuroda E, 2011, IMMUNITY, V34, P514, DOI 10.1016/j.immuni.2011.03.019; Leary PJ, 2014, AM J RESP CRIT CARE, V189, P1093, DOI 10.1164/rccm.201312-2298OC; Lefrancais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111; Li FB, 2014, J IMMUNOL, V192, P3021, DOI 10.4049/jimmunol.1302934; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Makellar A, 1846, INVESTIGATION NATURE; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; Mayadas TN, 2009, CIRCULATION, V120, P2012, DOI 10.1161/CIRCULATIONAHA.108.771170; Medesan C, 1997, J IMMUNOL, V158, P2211; Michelakis ED, 2008, CIRCULATION, V118, P1486, DOI 10.1161/CIRCULATIONAHA.106.673988; Miller FW, 2012, J AUTOIMMUN, V39, P259, DOI 10.1016/j.jaut.2012.05.002; Mishra A, 2007, AM J PHYSIOL-LUNG C, V293, pL305, DOI 10.1152/ajplung.00147.2007; Morse JH, 2000, SCAND J IMMUNOL, V51, P607; Munitz A, 2009, J IMMUNOL, V182, P2357, DOI 10.4049/jimmunol.0803130; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Nimmerjahn F, 2007, J EXP MED, V204, P11, DOI 10.1084/jem.20061788; Oshiba A, 1996, J CLIN INVEST, V97, P1398, DOI 10.1172/JCI118560; Padilla J, 2005, J IMMUNOL, V174, P8097, DOI 10.4049/jimmunol.174.12.8097; Park K, 2012, J LEUKOCYTE BIOL, V91, P245, DOI 10.1189/jlb.0111020; Park SH, 2014, PULM CIRC, V4, P654, DOI 10.1086/678511; Park SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055180; Parks CG, 2014, INT J MOL SCI, V15, P14269, DOI 10.3390/ijms150814269; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; Polikepahad S, 2010, J BIOL CHEM, V285, P30139, DOI 10.1074/jbc.M110.145698; Rabinovitch M, 2014, CIRC RES, V115, P165, DOI 10.1161/CIRCRESAHA.113.301141; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Renigunta A, 2006, FEBS LETT, V580, P900, DOI 10.1016/j.febslet.2006.01.012; Riemekasten G, 2011, ANN RHEUM DIS, V70, P530, DOI 10.1136/ard.2010.135772; Said SI, 2010, EUR RESPIR J, V35, P730, DOI 10.1183/09031936.00097109; Sanchez O, 2006, CHEST, V130, P182, DOI 10.1378/chest.130.1.182; SCANO G, 1980, ARCH ENVIRON HEALTH, V35, P360; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Shojima N, 2005, DIABETOLOGIA, V48, P984, DOI 10.1007/s00125-005-1735-1; Su Q, 2007, FASEB J OFFICIAL PUB; Teng XW, 2003, CIRC RES, V92, P1065, DOI 10.1161/01.RES.0000073999.07698.33; Tuder RM, 2013, J AM COLL CARDIOL, V62, pD4, DOI 10.1016/j.jacc.2013.10.025; Ulrich S, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-20; WHO, 2000, SIL; Wright JL, 2007, AM J PHYSIOL-LUNG C, V292, pL125, DOI 10.1152/ajplung.00539.2005; Yamaji-Kegan K, 2014, AM J PHYSIOL-LUNG C, V306, pL1090, DOI 10.1152/ajplung.00279.2013; Zaidi SHE, 2002, CIRCULATION, V105, P516, DOI 10.1161/hc0402.102866	81	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129910	10.1371/journal.pone.0129910	http://dx.doi.org/10.1371/journal.pone.0129910			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079807	Green Published, Green Submitted, gold			2022-12-27	WOS:000356542300035
J	Ruiz, FM; Santillana, E; Spinola-Amilibia, M; Torreira, E; Culebras, E; Romero, A				Ruiz, Federico M.; Santillana, Elena; Spinola-Amilibia, Mercedes; Torreira, Eva; Culebras, Esther; Romero, Antonio			Crystal Structure of Hcp from Acinetobacter baumannii: A Component of the Type VI Secretion System	PLOS ONE			English	Article							SEDIMENTATION-VELOCITY; PROTEIN; ULTRACENTRIFUGATION; EXPRESSION; RESISTANT; LOCUS	The type VI secretion system (T6SS) is a bacterial macromolecular machine widely distributed in Gram-negative bacteria, which transports effector proteins into eukaryotic host cells or other bacteria. Membrane complexes and a central tubular structure, which resembles the tail of contractile bacteriophages, compose the T6SS. One of the proteins forming this tube is the hemolysin co-regulated protein (Hcp), which acts as virulence factor, as transporter of effectors and as a chaperone. In this study, we present the structure of Hcp from Acinetobacter baumannii, together with functional and oligomerization studies. The structure of this protein exhibits a tight beta barrel formed by two beta sheets and flanked at one side by a short a-helix. Six Hcp molecules associate to form a donut-shaped hexamer, as observed in both the crystal structure and solution. These results emphasize the importance of this oligomerization state in this family of proteins, despite the low similarity of sequence among them. The structure presented in this study is the first one for a protein forming part of a functional T6SS from A. baumannii. These results will help us to understand the mechanism and function of this secretion system in this opportunistic nosocomial pathogen.	[Ruiz, Federico M.; Santillana, Elena; Spinola-Amilibia, Mercedes; Torreira, Eva; Romero, Antonio] CSIC, Ctr Invest Biol, Dept Chem & Phys Biol, Madrid, Spain; [Culebras, Esther] Hosp Clin San Carlos, Dept Clin Microbiol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Clinico San Carlos	Ruiz, FM (corresponding author), CSIC, Ctr Invest Biol, Dept Chem & Phys Biol, Madrid, Spain.	fruiz@cib.csic.es; romero@cib.csic.es	Romero, Antonio/K-5754-2014; Culebras, ESTHER/AAA-3865-2019; Ruiz, Federico M./AAO-9600-2021	Romero, Antonio/0000-0002-6990-6973; Ruiz, Federico M./0000-0002-0385-7777; Culebras, Esther/0000-0001-7395-2684; Santillana Heras, Elena/0000-0002-6227-1725				Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Brunet YR, 2014, EMBO REP, V15, P315, DOI 10.1002/embr.201337936; Carruthers MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059388; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W., THE PYMOL MOLECULAR; Douzi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086918; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Filloux Alain, 2013, F1000Prime Rep, V5, P52, DOI 10.12703/P5-52; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Henry R, 2012, ANTIMICROB AGENTS CH, V56, P59, DOI 10.1128/AAC.05191-11; Ho BT, 2014, CELL HOST MICROBE, V15, P9, DOI 10.1016/j.chom.2013.11.008; Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Jobichen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012910; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741; Osipiuk Jerzy, 2011, Journal of Structural and Functional Genomics, V12, P21, DOI 10.1007/s10969-011-9107-1; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Silverman JM, 2013, MOL CELL, V51, P584, DOI 10.1016/j.molcel.2013.07.025; Vila J, 2008, EXPERT OPIN PHARMACO, V9, P587, DOI 10.1517/14656566.9.4.587; Weber BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055142; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zoued A, 2014, BBA-MOL CELL RES, V1843, P1664, DOI 10.1016/j.bbamcr.2014.03.018	40	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129691	10.1371/journal.pone.0129691	http://dx.doi.org/10.1371/journal.pone.0129691			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079269	Green Published, Green Submitted, gold			2022-12-27	WOS:000356542300030
J	Velsko, IM; Chukkapalli, SS; Rivera-Kweh, MF; Chen, H; Zheng, DH; Bhattacharyya, I; Gangula, PR; Lucas, AR; Kesavalu, L				Velsko, Irina M.; Chukkapalli, Sasanka S.; Rivera-Kweh, Mercedes. F.; Chen, Hao; Zheng, Donghang; Bhattacharyya, Indraneel; Gangula, Pandu R.; Lucas, Alexandra R.; Kesavalu, Lakshmyya			Fusobacterium nucleatum Alters Atherosclerosis Risk Factors and Enhances Inflammatory Markers with an Atheroprotective Immune Response in ApoE(null) Mice	PLOS ONE			English	Article							ALVEOLAR BONE-RESORPTION; SITU HYBRIDIZATION FISH; PERIODONTAL PATHOGENS; PORPHYROMONAS-GINGIVALIS; DIRECT VISUALIZATION; RAT MODEL; BACTERIA; INFECTION; IDENTIFICATION; LESIONS	The American Heart Association supports an association between periodontal disease (PD) and atherosclerotic vascular disease (ASVD) but does not as of yet support a causal relationship. Recently, we have shown that major periodontal pathogens Porphyromonas gingivalis and Treponema denticola are causally associated with acceleration of aortic atherosclerosis in ApoE(null) hyperlipidemic mice. The aim of this study was to determine if oral infection with another significant periodontal pathogen Fusobacterium nucleatum can accelerate aortic inflammation and atherosclerosis in the aortic artery of ApoEnull mice. ApoEnull mice (n = 23) were orally infected with F. nucleatum ATCC 49256 and euthanized at 12 and 24 weeks. Periodontal disease assessments including F. nucleatum oral colonization, gingival inflammation, immune response, intrabony defects, and alveolar bone resorption were evaluated. Systemic organs were evaluated for infection, aortic sections were examined for atherosclerosis, and inflammatory markers were measured. Chronic oral infection established F. nucleatum colonization in the oral cavity, induced significant humoral IgG (P=0.0001) and IgM (P=0.001) antibody response (12 and 24 weeks), and resulted in significant (P=0.0001) alveolar bone resorption and intrabony defects. F. nucleatum genomic DNA was detected in systemic organs (heart, aorta, liver, kidney, lung) indicating bacteremia. Aortic atherosclerotic plaque area was measured and showed a local inflammatory infiltrate revealed the presence of F4/80(+) macrophages and CD3(+) T cells. Vascular inflammation was detected by enhanced systemic cytokines (CD30L, IL-4, IL-12), oxidized LDL and serum amyloid A, as well as altered serum lipid profile (cholesterol, triglycerides, chylomicrons, VLDL, LDL, HDL), in infected mice and altered aortic gene expression in infected mice. Despite evidence for systemic infection in several organs and modulation of known atherosclerosis risk factors, aortic atherosclerotic lesions were significantly reduced after F. nucleatum infection suggesting a potential protective function for this member of the oral microbiota.	[Velsko, Irina M.; Chukkapalli, Sasanka S.; Rivera-Kweh, Mercedes. F.; Kesavalu, Lakshmyya] Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL 32611 USA; [Kesavalu, Lakshmyya] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Chen, Hao; Zheng, Donghang; Lucas, Alexandra R.] Univ Florida, Coll Med, Cardiovasc Med & Mol Genet & Microbiol, Gainesville, FL USA; [Bhattacharyya, Indraneel] Univ Florida, Coll Dent, Oral Diagnost Sci, Gainesville, FL USA; [Gangula, Pandu R.] CWHR Meharry Med Coll, Dept Oral Biol & Res, Nashville, TN USA; [Gangula, Pandu R.] CWHR Meharry Med Coll, Dept Physiol, Nashville, TN USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Meharry Medical College; Meharry Medical College	Kesavalu, L (corresponding author), Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL 32611 USA.	Kesavalu@dental.ufl.edu	Chukkapalli, sasanka/AAS-8080-2021		NIH National Institute for Dental and Craniofacial Research [R01DE020820]; NIH National Center for Research Resources [1U54RR026140-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020820] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007593] Funding Source: NIH RePORTER	NIH National Institute for Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by the NIH National Institute for Dental and Craniofacial Research (R01DE020820; Dr. Kesavalu) and the NIH National Center for Research Resources (1U54RR026140-01; Dr. Gangula).	Bahrani-Mougeot FK, 2008, J CLIN MICROBIOL, V46, P2129, DOI 10.1128/JCM.02004-07; Bainbridge B, 2010, INFECT IMMUN, V78, P4560, DOI 10.1128/IAI.00703-10; Bolstad AI, 1996, CLIN MICROBIOL REV, V9, P55, DOI 10.1128/CMR.9.1.55; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chukkapalli SS, 2014, INFECT IMMUN, V82, P1959, DOI 10.1128/IAI.01511-14; Ebersole JL, 1997, MICROB PATHOGENESIS, V23, P23, DOI 10.1006/mpat.1996.0129; Elkaim R, 2008, J PERIODONTAL RES, V43, P224, DOI 10.1111/j.1600-0765.2007.01018.x; Fardini Y, 2011, MOL MICROBIOL, V82, P1468, DOI 10.1111/j.1365-2958.2011.07905.x; Feingold KR, 2011, J LIPID RES, V52, P1, DOI 10.1194/jlr.E012138; Feuille F, 1996, INFECT IMMUN, V64, P2095, DOI 10.1128/IAI.64.6.2094-2100.1996; Fiehn NE, 2005, J PERIODONTOL, V76, P731, DOI 10.1902/jop.2005.76.5.731; Figuero E, 2011, J PERIODONTOL, V82, P1469, DOI 10.1902/jop.2011.100719; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Guo M, 2000, ORAL MICROBIOL IMMUN, V15, P119, DOI 10.1034/j.1399-302x.2000.150208.x; Han YW, 2013, J DENT RES, V92, P485, DOI 10.1177/0022034513487559; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Jewett A, 2000, INFECT IMMUN, V68, P1893, DOI 10.1128/IAI.68.4.1893-1898.2000; Kesavalu L, 2012, J DENT RES, V91, P255, DOI 10.1177/0022034511435101; Kesavalu L, 2007, INFECT IMMUN, V75, P1704, DOI 10.1128/IAI.00733-06; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kuo LE, 2007, PEPTIDES, V28, P435, DOI 10.1016/j.peptides.2006.08.035; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Lee HR, 2012, MOL ORAL MICROBIOL, V27, P109, DOI 10.1111/j.2041-1014.2011.00636.x; Lee JA, 2011, SEMIN THROMB HEMOST, V37, P395, DOI 10.1055/s-0031-1276589; Liu HQ, 2007, J IMMUNOL, V179, P2501, DOI 10.4049/jimmunol.179.4.2501; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; MANGAN DF, 1983, INFECT IMMUN, V40, P1104, DOI 10.1128/IAI.40.3.1104-1111.1983; Matthys KE, 1997, MEDIAT INFLAMM, V6, P3, DOI 10.1080/09629359791875; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Norata GD, 2011, CURR OPIN LIPIDOL, V22, P410, DOI 10.1097/MOL.0b013e32834adac3; Ott SJ, 2006, CIRCULATION, V113, P929, DOI 10.1161/CIRCULATIONAHA.105.579979; Renckens R, 2007, BLOOD, V109, P1593, DOI 10.1182/blood-2006-05-025197; Rivera MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057178; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Saito A, 2009, MICROB PATHOGENESIS, V47, P329, DOI 10.1016/j.micpath.2009.09.012; Settem RP, 2012, INFECT IMMUN, V80, P2436, DOI 10.1128/IAI.06276-11; Siegel SJ, 2014, CELL HOST MICROBE, V16, P55, DOI 10.1016/j.chom.2014.06.005; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Stein PS, 2012, ALZHEIMERS DEMENT, V8, P196, DOI 10.1016/j.jalz.2011.04.006; Sunde PT, 2003, MICROBIOL-SGM, V149, P1095, DOI 10.1099/mic.0.26077-0; Tateishi F, 2012, J CLIN PERIODONTOL, V39, P417, DOI 10.1111/j.1600-051X.2012.01855.x; Toussi DN, 2012, CLIN VACCINE IMMUNOL, V19, P1093, DOI 10.1128/CVI.00236-12; Velsko IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097811; Verma RK, 2010, ORAL DIS, V16, P686, DOI 10.1111/j.1601-0825.2010.01678.x; Zhang YM, 2008, CHINESE MED J-PEKING, V121, P1595, DOI 10.1097/00029330-200808020-00018	53	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129795	10.1371/journal.pone.0129795	http://dx.doi.org/10.1371/journal.pone.0129795			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079509	Green Published, gold, Green Submitted			2022-12-27	WOS:000356542300032
J	Baralla, A; Sotgiu, E; Deiana, M; Pasella, S; Pinna, S; Mannu, A; Canu, E; Sotgiu, G; Ganau, A; Zinellu, A; Sotgia, S; Carru, C; Deiana, L				Baralla, Angela; Sotgiu, Elisabetta; Deiana, Marta; Pasella, Sara; Pinna, Sara; Mannu, Andrea; Canu, Elisabetta; Sotgiu, Giovanni; Ganau, Antonello; Zinellu, Angelo; Sotgia, Salvatore; Carru, Ciriaco; Deiana, Luca			Plasma Clusterin and Lipid Profile: A Link with Aging and Cardiovascular Diseases in a Population with a Consistent Number of Centenarians	PLOS ONE			English	Article							BIOMARKER CLUSTERIN/APOLIPOPROTEIN-J; CORONARY-HEART-DISEASE; SERUM APOLIPOPROTEIN-J; HEALTHY CENTENARIANS; NUCLEAR CLUSTERIN; ADVANCED CANCER; SHOCK PROTEINS; CHOLESTEROL; GENE; ATHEROSCLEROSIS	The role of Clusterin in attenuation of inflammation and reverse cholesterol transfer makes this molecule a potential candidate as a marker for cancer, cardiovascular disease, diabetes mellitus, and metabolic syndrome. In elderly subjects cardiovascular diseases represent the primary cause of death and different clinical studies have shown a positive correlation of these diseases with changes in the lipid pattern. This work aimed at evaluating the relationship between circulating clusterin and the biochemical parameters that characterize the lipid profile of a Sardinian population divided into five age groups including centenarians; the high frequency in Sardinia of these long-lived individuals gave us the opportunity to extend the range of the age groups to be analyzed to older ages and to better evaluate the changes in the lipid balance during ageing and its relationship with clusterin concentration in plasma. Our results showed that Clusterin concentration values of the youngest group were more similar with the centenarian's group compared to the other age groups, and a positive correlation arises with LDL. Furthermore given the high prevalence of cardiovascular diseases in the population examined and the association of Clusterin with these pathologies we evaluated Clusterin concentration variation in two groups with or without cardiovascular diseases. In presence of cardiovascular disease, Clusterin is significantly related to the most atherogenic components of lipid profile (total cholesterol and LDL), especially in women, suggesting its potential role in modulating cardiovascular metabolic risk factors.	[Baralla, Angela; Sotgiu, Elisabetta; Pasella, Sara; Pinna, Sara; Mannu, Andrea; Canu, Elisabetta; Sotgiu, Giovanni; Zinellu, Angelo; Sotgia, Salvatore; Carru, Ciriaco; Deiana, Luca] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Deiana, Marta; Deiana, Luca] Assoc LIsola Centenari, Sassari, Italy; [Deiana, Marta; Ganau, Antonello] Univ Sassari, Dept Clin & Expt Med, Cardiol Unit, I-07100 Sassari, Italy	University of Sassari; University of Sassari	Deiana, L (corresponding author), Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.	proflucadeiana@gmail.com	Sotgiu, Giovanni/N-1032-2017; Carru, Ciriaco/AAI-9996-2021; Ganau, Antonello/D-6899-2012; Sotgia, Salvatore/T-6598-2019	Sotgiu, Giovanni/0000-0002-1600-4474; Zinellu, Angelo/0000-0002-8396-0968; Sotgiu, Elisabetta/0000-0001-8053-1247; Sotgia, Salvatore/0000-0002-3717-3437; Baralla, Angela/0000-0002-5022-0285; Carru, Ciriaco/0000-0002-6985-4907; GANAU, Antonello/0000-0002-7053-293X	Regione Autonoma della Sardegna [L.R.7/2007]; Fondazione Banco di Sardegna [Prot. 998/2007.0729, Prot. 906/2012-1046]	Regione Autonoma della Sardegna(Regione Sardegna); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna)	LD was funded by Regione Autonoma della Sardegna, grant number L.R.7/2007, http://www.regione.sardegna.it/. Funding provided to the institution Associazione L'Isola dei Centenari by Fondazione Banco di Sardegna, grant numbers Prot. 998/2007.0729, Prot. 906/2012-1046, http://www.fondazionebancodisardegna.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, EXECUTIVE SUMMARY 3, V285, P2486; Arai Yasumichi, 2004, J Atheroscler Thromb, V11, P246; Aronis KN, 2011, J CLIN ENDOCR METAB, V96, pE1871, DOI 10.1210/jc.2011-1555; Baggio G, 1998, FASEB J, V12, P433, DOI 10.1096/fasebj.12.6.433; Banfi C, 2009, PROTEOMICS, V9, P1344, DOI 10.1002/pmic.200800566; BERNS MAM, 1988, INT J EPIDEMIOL, V17, P789, DOI 10.1093/ije/17.4.789; Bettuzzi S, 2009, ADV CANCER RES, V105, P133, DOI 10.1016/S0065-230X(09)05008-8; BLATTER MC, 1993, EUR J BIOCHEM, V211, P871, DOI 10.1111/j.1432-1033.1993.tb17620.x; Caccamo AE, 2005, CELL DEATH DIFFER, V12, P101, DOI 10.1038/sj.cdd.4401491; Chi KN, 2008, CLIN CANCER RES, V14, P833, DOI 10.1158/1078-0432.CCR-07-1310; ChoiMiura NH, 1996, NEUROBIOL AGING, V17, P717; Deiana L, 2002, J AM GERIATR SOC, V50, P2098, DOI 10.1046/j.1532-5415.2002.50630.x; Deiana L, 1999, AGING CLIN EXP RES, V11, P142, DOI 10.1007/BF03399655; Franceschi C, 2003, BIOCHEM SOC T, V31, P457, DOI 10.1042/BST0310457; Gelissen IC, 1998, BIOCHEM J, V331, P231, DOI 10.1042/bj3310231; GILLUM RF, 1982, J CHRON DIS, V35, P635, DOI 10.1016/0021-9681(82)90015-7; Gobal Freij A, 2010, Ther Adv Cardiovasc Dis, V4, P375, DOI 10.1177/1753944710385048; Holliday R, 1998, ANN NY ACAD SCI, V854, P61, DOI 10.1111/j.1749-6632.1998.tb09892.x; Hui-Hui Liu J-JL, 2014, AGEING RES REV, V19, P43, DOI [10.1016/j.arr.2014.12.001, DOI 10.1016/J.ARR.2014.12.001]; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Zhao Dong, 2006, Legal Medicine, V8, P258, DOI 10.1016/j.legalmed.2006.05.004; Ishikawa Y, 1998, ARTERIOSCL THROM VAS, V18, P665, DOI 10.1161/01.ATV.18.4.665; Ishikawa Y, 2001, ATHEROSCLEROSIS, V156, P29, DOI 10.1016/S0021-9150(00)00610-9; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; JORDANSTARCK TC, 1994, J LIPID RES, V35, P194; Karlsson H, 2005, PROTEOMICS, V5, P551, DOI 10.1002/pmic.200300938; Kolovou G, 2011, CURR OPIN CARDIOL, V26, P348, DOI 10.1097/HCO.0b013e32834659d4; Kujiraoka T, 2006, J ATHEROSCLER THROMB, V13, P314, DOI 10.5551/jat.13.314; Lau KM, 2003, LAB INVEST, V83, P743, DOI 10.1097/01.LAB.0000069519.06988.24; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Mackness B, 1997, ARTERIOSCL THROM VAS, V17, P1233, DOI 10.1161/01.ATV.17.7.1233; Malaguarnera M, 1998, Eur Rev Med Pharmacol Sci, V2, P75; Martinez-Bujidos M, 2014, FASEB J; Michel D, 1997, BIOCHEM J, V328, P45, DOI 10.1042/bj3280045; Miwa Y, 2005, BIOCHEM BIOPH RES CO, V331, P1587, DOI 10.1016/j.bbrc.2005.04.069; Nago N, 2011, J EPIDEMIOL, V21, P67, DOI 10.2188/jea.JE20100065; Okamura T, 2003, J INTERN MED, V253, P169, DOI 10.1046/j.1365-2796.2003.01080.x; Patel NV, 2004, NEUROSCI LETT, V371, P199, DOI 10.1016/j.neulet.2004.08.076; Poulakou MV, 2008, ANGIOLOGY, V59, P137, DOI 10.1177/0003319707311722; Pucci S, 2004, ONCOGENE, V23, P2298, DOI 10.1038/sj.onc.1207404; Redondo M, 2000, AM J PATHOL, V157, P393, DOI 10.1016/S0002-9440(10)64552-X; Schwarz M, 2008, THROMB HAEMOSTASIS, V100, P110, DOI 10.1160/TH07-12-0737; Shannan B, 2006, CELL DEATH DIFFER, V13, P12, DOI 10.1038/sj.cdd.4401779; STUART WD, 1992, BIOCHEMISTRY-US, V31, P8552, DOI 10.1021/bi00151a024; Sun HY, 2010, CLIN CHIM ACTA, V411, P336, DOI 10.1016/j.cca.2009.11.023; Suzuki M, 2001, ASIA PAC J CLIN NUTR, V10, P165, DOI 10.1046/j.1440-6047.2001.00219.x; Trougakos IP, 2006, ANN NY ACAD SCI, V1067, P294, DOI 10.1196/annals.1354.039; Trougakos IP, 2006, FREE RADICAL RES, V40, P1324, DOI 10.1080/10715760600902310; Trougakos IP, 2002, EXP GERONTOL, V37, P1175, DOI 10.1016/S0531-5565(02)00139-0; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Walter M, 2009, ARTERIOSCL THROM VAS, V29, P1244, DOI 10.1161/ATVBAHA.108.181438; Won JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103351; WONG P, 1994, EUR J BIOCHEM, V221, P917, DOI 10.1111/j.1432-1033.1994.tb18807.x; Zoubeidi A, 2010, CLIN CANCER RES, V16, P1088, DOI 10.1158/1078-0432.CCR-09-2917	54	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128029	10.1371/journal.pone.0128029	http://dx.doi.org/10.1371/journal.pone.0128029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076476	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900017
J	Gebhardt, S; Oberholzer, L				Gebhardt, Stefan; Oberholzer, Leana			Elective Delivery at Term after a Previous Unexplained Intra-Uterine Fetal Death: Audit of Delivery Outcome at Tygerberg Hospital, South Africa	PLOS ONE			English	Article							LATE PRETERM; STILLBIRTH; RISK; POPULATION; SUBSEQUENT; RECURRENCE; PREGNANCY	Objectives To assess the delivery outcome in a pregnancy with a previous unexplained intra-uterine death by elective induction of labour at term. Methods An audit of the pregnancy outcome of all women within the catchment area with a current singleton pregnancy; and a previous unexplained or unexplored singleton fetal demise >= 24 weeks (or 500 grams birth weight if gestation unknown) after planned routine induction of labour at full term (39-40 weeks). Results During the audit period, 306 patients with a previous intra-uterine fetal death were referred for further management. Of these, 161 had a clear indication for earlier intervention and were excluded from the protocol. Of the remaining 145 patients, 9 met further exclusion criteria and there were 2 patients who defaulted. Forty-two of the remaining study patients (with no known previous medical problems) developed complications during their antenatal course that necessitated a change in clinical management and earlier (<39 weeks) delivery. Of the remaining 92 patients in the audit, 47 (51%) went into spontaneous labour before their induction date; all 92 women delivered without major complications. There were no intra-uterine deaths prior to induction. Conclusions Careful follow up at a high risk clinic identifies new or concealed maternal or fetal complications in 29% of patients with a previous intra-uterine death and no obvious maternal or fetal disease in the index pregnancy. When all risks are excluded and the pregnancy allowed to progress to full term (39-40 weeks) before an induction is offered, 50% will go into spontaneous labour.	[Gebhardt, Stefan] Univ Stellenbosch, Dept Obstet & Gynaecol, Cape Town, South Africa; Tygerberg Hosp, Cape Town, South Africa	Stellenbosch University; Tygerberg Hospital	Gebhardt, S (corresponding author), Univ Stellenbosch, Dept Obstet & Gynaecol, Cape Town, South Africa.	gsgeb@sun.ac.za		Gebhardt, Gabriel/0000-0001-8999-8193				Bhattacharya S, 2010, BJOG-INT J OBSTET GY, V117, P1243, DOI 10.1111/j.1471-0528.2010.02641.x; Black M, 2008, BJOG-INT J OBSTET GY, V115, P269, DOI 10.1111/j.1471-0528.2007.01562.x; Fretts RC, 2005, AM J OBSTET GYNECOL, V193, P1923, DOI 10.1016/j.ajog.2005.03.074; Getahun D, 2009, AM J OBSTET GYNECOL, V201, pe1, DOI DOI 10.1016/J.AJ0G.2009.06.071; Kramer MS, 2013, PAEDIATR PERINAT EP, V27, P7, DOI 10.1111/ppe.12031; Leunen K, 2003, J TROP PEDIATRICS, V49, P231, DOI 10.1093/tropej/49.4.231; Odendaal HJ, 2013, SAJOG-S AFR J OBSTET, V19, P67, DOI 10.7196/SAJOG.662; Pattinson RC., 2011, SAVING BABIES 2008 9, P29; Salihu HM, 2011, EARLY HUM DEV, V87, P641, DOI 10.1016/j.earlhumdev.2011.05.001; Sharma PP, 2007, PAEDIATR PERINAT EP, V21, P24, DOI 10.1111/j.1365-3016.2007.00834.x; Silver RM, 2011, SEMIN PERINATOL, V35, P302, DOI 10.1053/j.semperi.2011.05.006; Stock SJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2838	12	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130254	10.1371/journal.pone.0130254	http://dx.doi.org/10.1371/journal.pone.0130254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076349	gold, Green Published			2022-12-27	WOS:000356329900159
J	Liu, D; Su, LX; Han, GC; Yan, P; Xie, LX				Liu, Dan; Su, Longxiang; Han, Gencheng; Yan, Peng; Xie, Lixin			Prognostic Value of Procalcitonin in Adult Patients with Sepsis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CRITICALLY-ILL PATIENTS; C-REACTIVE PROTEIN; SEPTIC SHOCK; EMERGENCY-DEPARTMENT; HOSPITAL MORTALITY; DISEASE SEVERITY; DIAGNOSTIC-VALUE; PREDICTION; ADMISSION; PRESEPSIN	Procalcitonin (PCT) has been widely investigated for its prognostic value in septic patients. However, studies have produced conflicting results. The purpose of the present meta-analysis is to explore the diagnostic accuracy of a single PCT concentration and PCT non-clearance in predicting all-cause sepsis mortality. We searched PubMed, Embase, Web of Knowledge and the Cochrane Library. Articles written in English were included. A 2 x 2 contingency table was constructed based on all-cause mortality and PCT level or PCT nonclearance in septic patients. Two authors independently evaluated study eligibility and extracted data. The diagnostic value of PCT in predicting prognosis was determined using a bivariate meta-analysis model. We used the Q-test and I-2 index to test heterogeneity. Twenty-three studies with 3,994 patients were included. An elevated PCT level was associated with a higher risk of death. The pooled relative risk (RR) was 2.60 (95% confidence interval (CI), 2.05-3.30) using a random-effects model (I-2 = 63.5%). The overall area under the summary receiver operator characteristic (SROC) curve was 0.77 (95% CI, 0.73-0.80), with a sensitivity and specificity of 0.76 (95% CI, 0.67-0.82) and 0.64 (95% CI, 0.52-0.74), respectively. There was significant evidence of heterogeneity for the PCT testing time (P = 0.020). Initial PCT values were of limited prognostic value in patients with sepsis. PCT non-clearance was a prognostic factor of death in patients with sepsis. The pooled RR was 3.05 (95% CI, 2.35-3.95) using a fixed-effects model (I2 = 37.9%). The overall area under the SROC curve was 0.79 (95% CI, 0.75-0.83), with a sensitivity and specificity of 0.72 (95% CI, 0.58-0.82) and 0.77 (95% CI, 0.55-0.90), respectively. Elevated PCT concentrations and PCT non-clearance are strongly associated with all-cause mortality in septic patients. Further studies are needed to define the optimal cut-off point and the optimal definition of PCT non-clearance for accurate risk assessment.	[Liu, Dan; Yan, Peng; Xie, Lixin] Chinese Peoples Liberat Army Gen Hosp, Dept Pulm & Crit Care Med, Beijing 100853, Peoples R China; [Liu, Dan] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Liu, Dan] Tianjin Med Univ, Dept Resp Med, Gen Hosp, Tianjin 300070, Peoples R China; [Su, Longxiang] Peking Union Med Coll Hosp, Dept Crit Care Med, Peking Union Med Coll, Beijing 100005, Peoples R China; [Su, Longxiang] Chinese Acad Med Sci, Beijing 100005, Peoples R China; [Han, Gencheng] Inst Basic Med Sci, Immunol Lab, Beijing 100850, Peoples R China	Chinese People's Liberation Army General Hospital; Nankai University; Tianjin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College	Xie, LX (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Pulm & Crit Care Med, 28 Fuxing Rd, Beijing 100853, Peoples R China.	xielx@263.net	Su, Longxiang/I-6788-2019; Xie, li/HGE-6052-2022	Su, Longxiang/0000-0002-0942-2870; 				Adamik B, 2000, INTENS CARE MED, V26, P1259, DOI 10.1007/s001340000610; Akpinar S, 2014, J THORAC DIS, V6, P921, DOI 10.3978/j.issn.2072-1439.2014.06.42; Behnes M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0507-z; Bessiere F, 2013, INTENS CARE MED, V39, P1181, DOI 10.1007/s00134-013-2902-3; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Clec'h C, 2006, CRIT CARE MED, V34, P102, DOI 10.1097/01.CCM.0000195012.54682.F3; Cucherat M, 1997, COMPUT METH PROG BIO, V53, P187, DOI 10.1016/S0169-2607(97)00016-3; Czura CJ, 2011, MOL MED, V17, P2, DOI 10.2119/molmed.2010.00001.commentary; Dahaba AA, 2006, BRIT J ANAESTH, V97, P503, DOI 10.1093/bja/ael181; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Feng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038400; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; de Guadiana-Romualdo LMG, 2015, MED INTENSIVA, V39, P207, DOI 10.1016/j.medin.2014.04.005; Garnacho-Montero J, 2014, CRIT CARE, V18, DOI 10.1186/cc13908; Giamarellos-Bourboulis EJ, 2011, J HOSP INFECT, V77, P58, DOI 10.1016/j.jhin.2010.07.026; Grundler K, 2014, CRIT CARE, V18, DOI 10.1186/cc13724; Guan J, 2011, SHOCK, V36, P570, DOI 10.1097/SHK.0b013e31823533f9; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hillas G, 2010, EUR RESPIR J, V35, P805, DOI 10.1183/09031936.00051309; Huang DT, 2008, ANN EMERG MED, V52, P48, DOI 10.1016/j.annemergmed.2008.01.003; Iskander KN, 2013, PHYSIOL REV, V93, P1247, DOI 10.1152/physrev.00037.2012; Jain Saransh, 2014, BMC Res Notes, V7, P458, DOI 10.1186/1756-0500-7-458; Jensen JU, 2011, CRIT CARE MED, V39, P2048, DOI 10.1097/CCM.0b013e31821e8791; Karlsson S, 2010, CRIT CARE, V14, DOI 10.1186/cc9327; Kenzaka T, 2012, INT J GEN MED, V5, P483, DOI 10.2147/IJGM.S32758; Kiers ND, 2010, J CRIT CARE, V25, P563, DOI 10.1016/j.jcrc.2010.04.012; Kiguchi T, 2013, CRIT CARE MED, V41, P1443, DOI 10.1097/CCM.0b013e31827ca960; Kruger S, 2008, EUR RESPIR J, V31, P349, DOI 10.1183/09031936.00054507; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Li ZY, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/641039; Magrini L, 2013, EUR REV MED PHARMACO, V17, P133; Masson S, 2014, CRIT CARE, V18, DOI 10.1186/cc13183; Meng FS, 2009, CLIN BIOCHEM, V42, P1025, DOI 10.1016/j.clinbiochem.2009.03.012; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Nor MBM, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/819034; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Ruiz-Rodriguez JC, 2012, MED INTENSIVA, V36, P475, DOI [10.1016/j.medin.2011.11.024, 10.1016/j.medine.2012.10.003]; Sanders M, 2014, ENCYCL EARLY CHILD D, V21, P1; Savva A, 2011, J INFECTION, V63, P344, DOI 10.1016/j.jinf.2011.07.016; Schuetz P, 2013, CRIT CARE, V17, DOI 10.1186/cc12787; Suberviola B, 2013, INTENS CARE MED, V39, P1945, DOI 10.1007/s00134-013-3056-z; Suberviola B, 2012, MED INTENSIVA, V36, P177, DOI 10.1016/j.medin.2011.09.008; Tschaikowsky K, 2011, J CRIT CARE, V26, P54, DOI 10.1016/j.jcrc.2010.04.011; Ulla M, 2013, CRIT CARE, V17, DOI 10.1186/cc12847; Vassiliou AG, 2014, CYTOKINE, V69, P240, DOI 10.1016/j.cyto.2014.06.010; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Yaroustovsky M, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-8; Yin Q, 2013, THROMB RES, V132, P471, DOI 10.1016/j.thromres.2013.08.011; Zhang ZH, 2014, CRIT CARE MED, V42, P2118, DOI 10.1097/CCM.0000000000000405	52	76	88	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129450	10.1371/journal.pone.0129450	http://dx.doi.org/10.1371/journal.pone.0129450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076027	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900076
J	Mwalusepo, S; Tonnang, HEZ; Massawe, ES; Okuku, GO; Khadioli, N; Johansson, T; Calatayud, PA; Le Ru, BP				Mwalusepo, Sizah; Tonnang, Henri E. Z.; Massawe, Estomih S.; Okuku, Gerphas O.; Khadioli, Nancy; Johansson, Tino; Calatayud, Paul-Andre; Le Ru, Bruno Pierre			Predicting the Impact of Temperature Change on the Future Distribution of Maize Stem Borers and Their Natural Enemies along East African Mountain Gradients Using Phenology Models	PLOS ONE			English	Article							PARTELLUS SWINHOE LEPIDOPTERA; CLIMATE-CHANGE; BUSSEOLA-FUSCA; RANGE; BIODIVERSITY; IRRIGATION; CRAMBIDAE; EXPANSION; ABUNDANCE; SORGHUM	Lepidopteran stem borers are among the most important pests of maize in East Africa. The objective of the present study was to predict the impact of temperature change on the distribution and abundance of the crambid Chilo partellus, the noctuid Busseola fusca, and their larval parasitoids Cotesia flavipes and Cotesia sesamiae at local scale along Kilimanjaro and Taita Hills gradients in Tanzania and Kenya, respectively. Temperature-dependent phenology models of pests and parasitoids were used in a geographic information system for mapping. The three risk indices namely establishment, generation, and activity indices were computed using current temperature data record from local weather stations and future (i.e., 2055) climatic condition based on downscaled climate change data from the AFRICLIM database. The calculations were carried out using index interpolator, a sub-module of the Insect Life Cycle Modeling (ILCYM) software. Thin plate algorithm was used for interpolation of the indices. Our study confirmed that temperature was a key factor explaining the distribution of stem borers and their natural enemies but other climatic factors and factors related to the top-down regulation of pests by parasitoids (host-parasitoid synchrony) also played a role. Results based on temperature only indicated a worsening of stem borer impact on maize production along the two East African mountain gradients studied. This was attributed to three main changes occurring simultaneously: (1) range expansion of the lowland species C. partellus in areas above 1200 m.a.s.l.; (2) increase of the number of pest generations across all altitudes, thus by 2055 damage by both pests will increase in the most productive maize zones of both transects; (3) disruption of the geographical distribution of pests and their larval parasitoids will cause an improvement of biological control at altitude below 1200 m.a.s.l. and a deterioration above 1200 m.a.s.l. The predicted increase in pest activity will significantly increase maize yield losses in all agro-ecological zones across both transects but to a much greater extent in lower areas.	[Mwalusepo, Sizah; Tonnang, Henri E. Z.; Johansson, Tino; Calatayud, Paul-Andre; Le Ru, Bruno Pierre] Icipe African Insect Sci Food & Hlth, CHIESA Project, Nairobi, Kenya; [Mwalusepo, Sizah; Massawe, Estomih S.] Univ Dar Es Salaam, Dept Math, Dar Es Salaam, Tanzania; [Mwalusepo, Sizah] Dar Es Salaam Inst Technol, Dept Gen studies, Dar Es Salaam, Tanzania; [Okuku, Gerphas O.; Khadioli, Nancy] Icipe African Insect Sci Food & Hlth, NSBB Project, Nairobi, Kenya; [Calatayud, Paul-Andre; Le Ru, Bruno Pierre] CNRS, Lab Evolut Genomes Comportement & Ecol, EGCE, IRD,UMR 247, Gif Sur Yvette, France; [Calatayud, Paul-Andre; Le Ru, Bruno Pierre] Univ Paris 11, Orsay, France	International Centre of Insect Physiology & Ecology (ICIPE); University of Dar es Salaam; International Centre of Insect Physiology & Ecology (ICIPE); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Le Ru, BP (corresponding author), Icipe African Insect Sci Food & Hlth, CHIESA Project, Nairobi, Kenya.	bleru@icipe.org	LE RU, BRUNO/C-5862-2011; TONNANG, Henri/AAQ-2206-2021; Paul-André, Calatayud/K-3282-2019; Calatayud, Paul-andre/AAG-8117-2020; Le Ru, bruno/K-3480-2016	TONNANG, Henri/0000-0002-9424-9186; Calatayud, Paul-andre/0000-0002-9482-4646; Le Ru, bruno/0000-0002-4208-3727; Johansson, Tino Petri/0000-0002-2381-5144	Ministry for Foreign Affairs of Finland	Ministry for Foreign Affairs of Finland	This research was conducted under the Climate Change Impacts on Ecosystem Services and Food Security in Eastern Africa (CHIESA) project. CHIESA is funded by the Ministry for Foreign Affairs of Finland.	AATF (African Agricultural Technology Foundation), 2009, BAS STUD SMALLH FARM; ABRAHAM C C, 1972, Agricultural Research Journal of Kerala, V10, P141; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Banziger M, 2006, AGR WATER MANAGE, V80, P212, DOI 10.1016/j.agwat.2005.07.014; Bassler C, 2014, PLOS ONE, V8; Battisti A, 2006, GLOBAL CHANGE BIOL, V12, P662, DOI 10.1111/j.1365-2486.2006.01124.x; Boko M, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P433; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; CEPF (CRITICAL ECOSYSTEM PARTNERSHIP FUND), 2012, EC PROF E ARC MOUNT; Chabi-Olaye A, 2005, AGR ECOSYST ENVIRON, V108, P17, DOI 10.1016/j.agee.2004.12.004; Christy JR, 2009, J CLIMATE, V22, P3342, DOI 10.1175/2008JCLI2726.1; Coulson SJ, 2002, DIVERS DISTRIB, V8, P327, DOI 10.1046/j.1472-4642.2002.00157.x; De Groote H, 2004, P 7 E SO AFRICA REGI, P401; De Groote Hugo, 2002, Insect Science and its Application, V22, P89; Edenhofer O., 2014, CONTRIBUTION WORKING; Ellers J, 2002, ECOL ENTOMOL, V27, P279, DOI 10.1046/j.1365-2311.2002.00421.x; Fand BB, 2014, ECOL MODEL, V288, P62, DOI 10.1016/j.ecolmodel.2014.05.018; Farre I, 2006, AGR WATER MANAGE, V83, P135, DOI 10.1016/j.agwat.2005.11.001; Geurts K, 2014, B ENTOMOL RES, V104, P288, DOI 10.1017/S0007485313000722; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Harris K. M., 1992, ICRISAT Information Bulletin; Hartley Stephen, 2003, New Zealand Entomologist, V26, P91; Hassan RM, 1998, MAIZE TECHNOLOGY DEVELOPMENT AND TRANSFER, P43; HILBERT DW, 1983, ENVIRON ENTOMOL, V12, P1, DOI 10.1093/ee/12.1.1; Hodkinson ID, 1998, ARCTIC ALPINE RES, V30, P78, DOI 10.2307/1551747; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Jarvis A, 2012, TROP PLANT BIOL, V5, P9, DOI 10.1007/s12042-012-9096-7; Jepsen JU, 2008, J ANIM ECOL, V77, P257, DOI 10.1111/j.1365-2656.2007.01339.x; Kfir R, 1997, ANN ENTOMOL SOC AM, V90, P619, DOI 10.1093/aesa/90.5.619; Kfir R, 2002, ANNU REV ENTOMOL, V47, P701, DOI 10.1146/annurev.ento.47.091201.145254; Khadioli N, 2014, ANN APPL BIOL, V165, P373, DOI 10.1111/aab.12157; Khadioli N, 2014, B ENTOMOL RES, V104, P809, DOI 10.1017/S0007485314000601; Khadioli N, 2015, THESIS NAIROBI U NAI, P145; Tran JK, 2007, ECOL APPL, V17, P882, DOI 10.1890/06-0512; Kroschel J, 2013, AGR FOREST METEOROL, V170, P228, DOI 10.1016/j.agrformet.2012.06.017; Ladanyi M, 2010, APPL ECOL ENV RES, V8, P143, DOI 10.15666/aeer/0802_143151; Latimer AM, 2006, ECOL APPL, V16, P33, DOI 10.1890/04-0609; Levine RS, 2004, AM J TROP MED HYG, V70, P105, DOI 10.4269/ajtmh.2004.70.105; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Lyon B, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050337; Maeda EE, 2011, J ENVIRON MANAGE, V92, P982, DOI 10.1016/j.jenvman.2010.11.005; Maeda EE, 2010, AGR SYST, V103, P609, DOI 10.1016/j.agsy.2010.07.004; Mailafiya DM, 2010, BIOL CONTROL, V54, P1, DOI 10.1016/j.biocontrol.2009.11.008; Marts PJ, 2015, AFRICAN J ECOLOGY, V53, P103, DOI DOI 10.1111/AJE.12180; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Matsuo Y, 2006, FUNCT ECOL, V20, P300, DOI 10.1111/j.1365-2435.2006.01097.x; Menendez Rosa, 2007, Tijdschrift voor Entomologie, V150, P355; Mgoo VH, 2006, ANN SOC ENTOMOL FR, V42, P487, DOI 10.1080/00379271.2006.10697483; Niang I, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1199; Ong'amo GO, 2006, ANN SOC ENTOMOL FR, V42, P171, DOI 10.1080/00379271.2006.10700620; ONYANGO FO, 1994, ENTOMOL EXP APPL, V73, P139, DOI 10.1007/BF02383419; Overholt W.A., 2000, P52; OVERHOLT WA, 1994, B ENTOMOL RES, V84, P367, DOI 10.1017/S0007485300032491; Pachauri R.K, 2007, CONTRIBUTION WORKING, P104, DOI DOI 10.1017/CBO9780511546013; Peterson David L., 2012, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1; Platts PJ, 2008, ECOL MODEL, V218, P121, DOI 10.1016/j.ecolmodel.2008.06.028; Platts PJ, 2010, DIVERS DISTRIB, V16, P628, DOI 10.1111/j.1472-4642.2010.00668.x; Platts PJ, 2012, THESIS U YORK; Rasmann S, 2014, J ECOL, V102, P930, DOI 10.1111/1365-2745.12253; Regniere J, 2012, BIOL INVASIONS, V14, P1571, DOI 10.1007/s10530-010-9918-1; Rosenthal DM, 2012, TROP PLANT BIOL, V5, P30, DOI 10.1007/s12042-011-9086-1; Schellnhuber HJ, 2013, TURN HEAT CLIMATE EX, P1; SHARPE PJH, 1977, J THEOR BIOL, V64, P649, DOI 10.1016/0022-5193(77)90265-X; Sithole SZ, 1989, INT WORKSH SORGH STE; Smale M, 2001, 5659 WORLD BANK, P1; Sporleder M, 2008, ADV CROP RES, V10, P15; Sporleder M., 2013, ILCYM INSECT LIFE CY, P193; STINNER RE, 1974, CAN ENTOMOL, V106, P519, DOI 10.4039/Ent106519-5; Stoeckli S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035723; Tams W.H.T., 1932, ENTOMOLOGIST, V65, P124; Thornton PK, 2011, PHILOS T R SOC A, V369, P117, DOI 10.1098/rsta.2010.0246; Thornton PK, 2010, AGR SYST, V103, P73, DOI 10.1016/j.agsy.2009.09.003; UNEP, 2009, KEN ATL OUR CHANG EV; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; WAGNER TL, 1991, J AGR ENTOMOL, V8, P251; Waithaka M, 2013, E AFRICAN CLIMATE CH; Wale M, 2006, ANN SOC ENTOMOL FR, V42, P389, DOI 10.1080/00379271.2006.10697471; Ward NL, 2007, GLOBAL CHANGE BIOL, V13, P1605, DOI 10.1111/j.1365-2486.2007.01399.x; Williams A., 2011, CLIM DYNAM, P1, DOI [10.1007/s00382-010-0984-y, DOI 10.1007/S00382-010-0984-Y]; Zhou G, 2001, ECOL APPL, V11, P1554, DOI 10.2307/3060939	81	45	47	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130427	10.1371/journal.pone.0130427	http://dx.doi.org/10.1371/journal.pone.0130427			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075605	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900172
J	Sousa, JB; Vieira-Rocha, MS; Arribas, SM; Gonzalez, MC; Fresco, P; Diniz, C				Sousa, Joana Beatriz; Vieira-Rocha, Maria Sofia; Arribas, Silvia M.; Gonzalez, Maria Carmen; Fresco, Paula; Diniz, Carmen			Endothelial and Neuronal Nitric Oxide Activate Distinct Pathways on Sympathetic Neurotransmission in Rat Tail and Mesenteric Arteries	PLOS ONE			English	Article							EXTRACELLULAR ADENOSINE ACCUMULATION; HIPPOCAMPAL SYNAPTIC-TRANSMISSION; SPONTANEOUSLY HYPERTENSIVE-RATS; RECEPTOR-MEDIATED FACILITATION; H-3 NOREPINEPHRINE RELEASE; PROTEIN-KINASE-C; NORADRENALINE RELEASE; A(1)-ADENOSINE RECEPTORS; NERVE-STIMULATION; FOREBRAIN NEURONS	Nitric oxide (NO) seems to contribute to vascular homeostasis regulating neurotransmission. This work aimed at assessing the influence of NO from different sources and respective intracellular pathways on sympathetic neurotransmission, in two vascular beds. Electrically-evoked [H-3]-noradrenaline release was assessed in rat mesenteric and tail arteries in the presence of NO donors or endothelial/neuronal nitric oxide synthase (NOS) inhibitors. The influence of NO on adenosine-mediated effects was also studied using selective antagonists for adenosine receptors subtypes. Location of neuronal NOS (nNOS) was investigated by immunohistochemistry (with specific antibodies for nNOS and for Schwann cells) and Confocal Microscopy. Results indicated that: 1) in mesenteric arteries, noradrenaline release was reduced by NO donors and it was increased by nNOS inhibitors; the effect of NO donors was only abolished by the adenosine A(1) receptors antagonist; 2) in tail arteries, noradrenaline release was increased by NO donors and it was reduced by eNOS inhibitors; adenosine receptors antagonists were devoid of effect; 3) confocal microscopy showed nNOS staining in adventitial cells, some co-localized with Schwann cells. nNOS staining and its co-localization with Schwann cells were significantly lower in tail compared to mesenteric arteries. In conclusion, in mesenteric arteries, nNOS, mainly located in Schwann cells, seems to be the main source of NO influencing perivascular sympathetic neurotransmission with an inhibitory effect, mediated by adenosine A1 receptors activation. Instead, in tail arteries endothelial NO seems to play a more relevant role and has a facilitatory effect, independent of adenosine receptors activation.	[Sousa, Joana Beatriz; Vieira-Rocha, Maria Sofia; Fresco, Paula; Diniz, Carmen] Univ Porto, Fac Pharm, Dept Drug Sci, Pharmacol Lab, P-4100 Oporto, Portugal; [Sousa, Joana Beatriz; Vieira-Rocha, Maria Sofia; Diniz, Carmen] Univ Porto, LAQV REQUIMTE, Oporto, Portugal; [Arribas, Silvia M.; Gonzalez, Maria Carmen] Univ Autonoma Madrid, Fac Med, Dept Physiol, Madrid, Spain	Universidade do Porto; Universidade do Porto; Autonomous University of Madrid	Sousa, JB (corresponding author), Univ Porto, Fac Pharm, Dept Drug Sci, Pharmacol Lab, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	joanabeatrizsousa@gmail.com	, CDiniz/D-6293-2013; Sousa, Joana/N-4763-2019; Gonzalez-Garcia, M Carmen/AAE-9533-2019; Fresco, Paula/D-4845-2013	, CDiniz/0000-0003-4668-9360; Sousa, Joana/0000-0002-1744-7840; Gonzalez-Garcia, M Carmen/0000-0002-5522-0786; Fresco, Paula/0000-0001-6705-7798; Arribas, Silvia M/0000-0001-7103-6105	FEDER through Program of Operational Competitiveness Factors - COMPETE; National Funds through Foundation for Science and Technology (FCT) [PEst C/EQB/LA0006/2011]; FCT	FEDER through Program of Operational Competitiveness Factors - COMPETE; National Funds through Foundation for Science and Technology (FCT); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by FEDER through Program of Operational Competitiveness Factors - COMPETE and by National Funds through Foundation for Science and Technology (FCT): Grant No. PEst C/EQB/LA0006/2011. JBS was supported by PhD grant (SFRH/BD//2009) - FCT (URL: http://www.fct.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICKS K, 1994, MICROSC RES TECHNIQ, V29, P161, DOI 10.1002/jemt.1070290214; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Arrigoni E, 2006, EUR J NEUROSCI, V24, P2471, DOI 10.1111/j.1460-9568.2006.05124.x; Blanco-Rivero J, 2013, J HYPERTENS, V31, P916, DOI 10.1097/HJH.0b013e32835f749c; Blanco-Rivero J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053802; Boison D, 2013, PHARMACOL REV, V65, P906, DOI 10.1124/pr.112.006361; Bon CLM, 2001, NEUROPHARMACOLOGY, V40, P501, DOI 10.1016/S0028-3908(00)00193-3; Brassai A, 2002, NEUROCHEM INT, V41, P279, DOI 10.1016/S0197-0186(02)00012-8; Brorson JR, 1999, J NEUROSCI, V19, P147, DOI 10.1523/JNEUROSCI.19-01-00147.1999; Brown GC, 2003, MOL NEUROBIOL, V27, P325, DOI 10.1385/MN:27:3:325; BUTT E, 1993, NEUROCHEM RES, V18, P27, DOI 10.1007/BF00966920; Castro AF, 1998, AM J PHYSIOL-CELL PH, V275, pC113, DOI 10.1152/ajpcell.1998.275.1.C113; CHEN C, 1995, J PHYSIOL-LONDON, V482, P521, DOI 10.1113/jphysiol.1995.sp020537; del Campo L, 2009, J HYPERTENS, V27, P791, DOI 10.1097/HJH.0b013e32832531e6; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Diniz C, 2004, EUR J PHARMACOL, V504, P17, DOI 10.1016/j.ejphar.2004.09.048; Domek-Lopacinska K, 2005, J Physiol Pharmacol, V56 Suppl 2, P15; Domenico R, 2004, CURR PHARM DESIGN, V10, P1667, DOI 10.2174/1381612043384709; Fragata IR, 2006, EUR J PHARMACOL, V543, P32, DOI 10.1016/j.ejphar.2006.05.043; Fresco P, 2004, CARDIOVASC RES, V63, P739, DOI 10.1016/j.cardiores.2004.05.015; Fresco P, 2002, BRIT J PHARMACOL, V136, P230, DOI 10.1038/sj.bjp.0704686; Fresco P, 2007, NEUROCHEM INT, V51, P47, DOI 10.1016/j.neuint.2007.03.009; Gautier C, 2006, BIOCHEM BIOPH RES CO, V341, P816, DOI 10.1016/j.bbrc.2006.01.031; GONZALEZ C, 1990, CAN J PHYSIOL PHARM, V68, P104, DOI 10.1139/y90-016; Jo YH, 1999, NAT NEUROSCI, V2, P241, DOI 10.1038/6344; Johnson CD, 2010, ADV PHYSIOL EDUC, V34, P217, DOI 10.1152/advan.00070.2010; Kolo LL, 2004, AM J PHYSIOL-HEART C, V287, pH1842, DOI 10.1152/ajpheart.00013.2004; Kolo LL, 2004, AM J PHYSIOL-HEART C, V286, pH296, DOI 10.1152/ajpheart.00668.2003; Koyama T, 2010, HYPERTENS RES, V33, P485, DOI 10.1038/hr.2010.48; Li D, 2007, HYPERTENSION, V50, P69, DOI 10.1161/HYPERTENSIONAHA.107.088591; Lo WC, 1998, HYPERTENSION, V32, P1034, DOI 10.1161/01.HYP.32.6.1034; LONART G, 1995, J PHARMACOL EXP THER, V275, P7; LONART G, 1995, J PHARMACOL EXP THER, V275, P14; Lovatt D, 2012, P NATL ACAD SCI USA, V109, P6265, DOI 10.1073/pnas.1120997109; Lu Y, 2003, EUR J NEUROSCI, V17, P1213, DOI 10.1046/j.1460-9568.2003.02554.x; Macarthur H, 2011, ACTA PHYSIOL, V203, P37, DOI 10.1111/j.1748-1716.2010.02242.x; Martire M, 1998, EUR J PHARMACOL, V350, P345, DOI 10.1016/S0014-2999(98)00269-6; Michel T, 2010, PFLUG ARCH EUR J PHY, V459, P807, DOI 10.1007/s00424-009-0765-9; Mohan RM, 2000, CARDIOVASC RES, V47, P81, DOI 10.1016/S0008-6363(00)00057-2; Pankratov Y, 2007, J GEN PHYSIOL, V129, P257, DOI 10.1085/jgp.200609693; Pilz RB, 2005, FRONT BIOSCI-LANDMRK, V10, P1239, DOI 10.2741/1616; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Queiroz G, 2004, NEUROPHARMACOLOGY, V47, P216, DOI 10.1016/j.neuropharm.2004.03.015; Rocha-Pereira C, 2013, NEUROCHEM INT, V62, P399, DOI 10.1016/j.neuint.2013.02.010; Rocha-Pereira C, 2013, J PHARMACOL SCI, V122, P59, DOI 10.1254/jphs.12266FP; Rosenberg PA, 2000, J NEUROSCI, V20, P6294, DOI 10.1523/JNEUROSCI.20-16-06294.2000; SCHWARZ P, 1995, CIRC RES, V77, P841, DOI 10.1161/01.RES.77.4.841; Shinozuka K, 2002, JPN J PHARMACOL, V88, P19, DOI 10.1254/jjp.88.19; Sinclair CJD, 2001, BRIT J PHARMACOL, V134, P1037, DOI 10.1038/sj.bjp.0704349; Song MS, 2002, NEUROSCI LETT, V326, P41, DOI 10.1016/S0304-3940(02)00290-2; Sousa JB, 2015, NEUROCHEM INT, V80, P7, DOI 10.1016/j.neuint.2014.11.001; Sousa JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105540; Stegbauer J, 2008, AM J PHYSIOL-REG I, V294, pR421, DOI 10.1152/ajpregu.00481.2007; Talaia C, 2011, EUR J PHARMACOL, V652, P33, DOI 10.1016/j.ejphar.2010.10.075; Tripovic D, 2013, J PHYSIOL-LONDON, V591, P2867, DOI 10.1113/jphysiol.2012.250365; VAZDASILVA MJ, 1995, N-S ARCH PHARMACOL, V352, P640; VONKUGELGEN I, 1995, BRIT J PHARMACOL, V115, P247; Webb AJ, 2008, CIRC RES, V103, P957, DOI 10.1161/CIRCRESAHA.108.175810; WHITE TD, 1990, ANN NY ACAD SCI, V603, P287; Xavier FE, 2011, EUR J PHARMACOL, V654, P280, DOI 10.1016/j.ejphar.2011.01.007; Xu ZL, 2005, CARDIOVASC RES, V65, P803, DOI 10.1016/j.cardiores.2004.12.004; Yoshida M, 1998, EUR J PHARMACOL, V357, P213, DOI 10.1016/S0014-2999(98)00566-4; Yu M, 2002, J APPL PHYSIOL, V93, P1391, DOI 10.1152/japplphysiol.00247.2002	64	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129224	10.1371/journal.pone.0129224	http://dx.doi.org/10.1371/journal.pone.0129224			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075386	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900054
J	Sun, YC; Wu, SJ; Spence, I				Sun, Yuechuan; Wu, Sijing; Spence, Ian			The Commingled Division of Visual Attention	PLOS ONE			English	Article							INATTENTIONAL BLINDNESS; SELECTIVE LOOKING; SPATIAL ATTENTION; PERCEPTUAL LOAD; SYSTEM	Many critical activities require visual attention to be distributed simultaneously among distinct tasks where the attended foci are not spatially separated. In our two experiments, participants performed a large number of trials where both a primary task (enumeration of spots) and a secondary task (reporting the presence/absence or identity of a distinctive shape) required the division of visual attention. The spots and the shape were commingled spatially and the shape appeared unpredictably on a relatively small fraction of the trials. The secondary task stimulus (the shape) was reported in inverse proportion to the attentional load imposed by the primary task (enumeration of spots). When the shape did appear, performance on the primary task (enumeration) suffered relative to when the shape was absent; both speed and accuracy were compromised. When the secondary task required identification in addition to detection, reaction times increased by about 200 percent. These results are broadly compatible with biased competition models of perceptual processing. An important area of application, where the commingled division of visual attention is required, is the augmented reality head-up display (AR-HUD). This innovation has the potential to make operating vehicles safer but our data suggest that there are significant concerns regarding driver distraction.	[Sun, Yuechuan; Wu, Sijing; Spence, Ian] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada	University of Toronto	Spence, I (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada.	ian.spence@utoronto.ca	Spence, Ian/D-4334-2011	Spence, Ian/0000-0002-7382-8170	Natural Science and Engineering Research Council of Canada Discovery Grant [8351]	Natural Science and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	Natural Science and Engineering Research Council of Canada Discovery Grant #8351, http://www.nserc-crsng.gc.ca/, IS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves PRJA, 2013, 2013 IEEE INTELLIGENT VEHICLES SYMPOSIUM WORKSHOPS (IV WORKSHOPS), P1; Awh E, 2000, J EXP PSYCHOL HUMAN, V26, P834, DOI 10.1037/0096-1523.26.2.834; BECKLEN R, 1983, MEM COGNITION, V11, P601, DOI 10.3758/BF03198284; Bressan P, 2008, COGNITION, V106, P370, DOI 10.1016/j.cognition.2007.03.001; Cartwright-Finch U, 2007, COGNITION, V102, P321, DOI 10.1016/j.cognition.2006.01.002; Charissis V, 2009, LECT NOTES COMPUT SC, V5613, P683, DOI 10.1007/978-3-642-02583-9_74; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Duncan J, 2008, J EXP PSYCHOL GEN, V113, P501; Feng I, 2013, EXP PSYCHOL, V60, P149, DOI [10.1027/1618-3169/a000182, DOI 10.1027/1618-3169/A000182]; Franconeri SL, 2013, TRENDS COGN SCI, V17, P134, DOI 10.1016/j.tics.2013.01.010; Gabbard JL, 2014, P IEEE, V102, P124, DOI 10.1109/JPROC.2013.2294642; Jans B, 2010, PSYCHOL REV, V117, P637, DOI 10.1037/a0019082; Jevons W.S., 1871, NATURE, V3, P281, DOI [10.1038/003281a0, DOI 10.1038/003281A0]; Johnson N.L., 1992, BIOMETRICAL J, V36, P565, DOI [10.1002/bimj.4710360207, DOI 10.1002/BIMJ.4710360207]; Koivisto M, 2004, VISION RES, V44, P3211, DOI 10.1016/j.visres.2004.07.026; Koivisto M, 2008, PSYCHOL RES-PSYCH FO, V72, P39, DOI 10.1007/s00426-006-0072-4; Kramer AF, 1995, PSYCHOL SCI, V6, P381, DOI 10.1111/j.1467-9280.1995.tb00530.x; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lavie N, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0205; Leclercq V, 2012, VISION RES, V61, P70, DOI 10.1016/j.visres.2011.07.017; Mack A., 1998, INATTENTIONAL BLINDN; McCormick PA, 1998, J EXP PSYCHOL HUMAN, V24, P350, DOI 10.1037/0096-1523.24.1.350; Most SB, 2005, PSYCHOL REV, V112, P217, DOI 10.1037/0033-295X.112.1.217; NEISSER U, 1975, COGNITIVE PSYCHOL, V7, P480, DOI 10.1016/0010-0285(75)90019-5; Neisser U., 1979, PERCEPTION ITS DEV T, P201; Newby EA, 1998, PERCEPTION, V27, P1025, DOI 10.1068/p271025; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Park HS, 2013, ETRI J, V35, P1038, DOI 10.4218/etrij.13.2013.0041; Railo H, 2008, COGNITION, V107, P82, DOI 10.1016/j.cognition.2007.08.004; Redelmeier DA, 1997, NEW ENGL J MED, V336, P453, DOI 10.1056/NEJM199702133360701; Sathian K, 1999, J COGNITIVE NEUROSCI, V11, P36, DOI 10.1162/089892999563238; Schneider W., 2002, E PRIME VERSION 20 C; Scholl B. J., 2003, J VISION, V3; Shim WM, 2008, PSYCHON B REV, V15, P390, DOI 10.3758/PBR.15.2.390; Spence I, 2013, APPL COGNITIVE PSYCH, V27, P633, DOI 10.1002/acp.2943; Strayer D.L., 2013, MEASURING COGNITIVE; Swallow KM, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00274; Swallow KM, 2010, COGNITION, V115, P118, DOI 10.1016/j.cognition.2009.12.003; Tretten P., 2011, P HUMAN FACTORS ERGO, V55, P1914, DOI DOI 10.1177/1071181311551398; Vetter P, 2009, THESIS U COLL LONDON; Vetter P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003269; Weinberg G, 2011, P 6 INT DRIV S HUM F, P195; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y	44	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130611	10.1371/journal.pone.0130611	http://dx.doi.org/10.1371/journal.pone.0130611			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076144	Green Published, gold			2022-12-27	WOS:000356329900185
J	Thurber, KA; Dobbins, T; Kirk, M; Dance, P; Banwell, C				Thurber, Katherine A.; Dobbins, Timothy; Kirk, Martyn; Dance, Phyll; Banwell, Cathy			Early Life Predictors of Increased Body Mass Index among Indigenous Australian Children	PLOS ONE			English	Article							BIRTH-WEIGHT PERCENTILES; RISK; OBESITY; DISEASE; PREGNANCY	Aboriginal and Torres Strait Islander Australians are more likely than non-Indigenous Australians to be obese and experience chronic disease in adulthood-conditions linked to being overweight in childhood. Birthweight and prenatal exposures are associated with increased Body Mass Index (BMI) in other populations, but the relationship is unclear for Indigenous children. The Longitudinal Study of Indigenous Children is an ongoing cohort study of up to 1,759 children across Australia. We used a multilevel model to examine the association between children's birthweight and BMI z-score in 2011, at age 3-9 years, adjusted for sociodemographic and maternal factors. Complete data were available for 682 of the 1,264 children participating in the 2011 survey; we repeated the analyses in the full sample with BMI recorded (n=1,152) after multilevel multiple imputation. One in ten children were born large for gestational age, and 17% were born small for gestational age. Increasing birthweight predicted increasing BMI; a 1-unit increase in birthweight z-score was associated with a 0.22-unit (95% CI: 0.13, 0.31) increase in childhood BMI z-score. Maternal smoking during pregnancy was associated with a significant increase (0.25; 95% CI: 0.05, 0.45) in BMI z-score. The multiple imputation analysis indicated that our findings were not distorted by biases in the missing data. High birthweight may be a risk indicator for overweight and obesity among Indigenous children. National targets to reduce the incidence of low birthweight which measure progress by an increase in the population's average birthweight may be ignoring a significant health risk; both ends of the spectrum must be considered. Interventions to improve maternal health during pregnancy are the first step to decreasing the prevalence of high BMI among the next generation of Indigenous children.	[Thurber, Katherine A.; Dobbins, Timothy; Kirk, Martyn; Banwell, Cathy] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, Canberra, ACT, Australia; [Dance, Phyll] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Dance, Phyll] Australian Natl Univ, Natl Ctr Indigenous Studies, Canberra, ACT, Australia	Australian National University; Australian National University; Australian National University	Thurber, KA (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, Canberra, ACT, Australia.	katherine.thurber@anu.edu.au	Dobbins, Timothy A/I-5819-2013; Dobbins, Timothy/AAS-1422-2020	Dobbins, Timothy A/0000-0003-1841-9056; Dobbins, Timothy/0000-0003-1841-9056; Kirk, Martyn/0000-0001-5432-5984; Banwell, Cathy/0000-0001-6808-1052	Australian National University; Fulbright-Anne Wexler Master's Scholarship in Public Policy	Australian National University(Australian National University); Fulbright-Anne Wexler Master's Scholarship in Public Policy	This work was supported by the Australian National University and the Fulbright-Anne Wexler Master's Scholarship in Public Policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mamun A, 2006, AM J EPIDEMIOL, V164, P317, DOI 10.1093/aje/kwj209; Australian Bureau of Statistics, 2014, AB TORR STRAIT ISL B, DOI [10.1186/1471-2288-12-90, DOI 10.1186/1471-2288-12-90]; [Australian Bureau of Statistics Statistics ABo], 2013, LIF TABL AB TORR STR; Australian Bureau of Statistics, 2014, WEEKL PAYR JOBS WAG; Australian Institute of Health and Welfare, 2014, BIRTHW BAB BORN IND; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Bell LM, 2007, J CLIN ENDOCR METAB, V92, P517, DOI 10.1210/jc.2006-1714; Biddle N, 2009, RANKING REGIONS REVI; Blossner M, 2009, WHO ANTHROPLUS PERSO; Carpenter JR, 2011, J STAT SOFTW, V45, P1; Chamberlain C, 2014, AUST NZ J OBSTET GYN, V54, P433, DOI 10.1111/ajo.12213; Council of Australian Governments Reform Council, 2014, HEALTHC AUSTR 2012 1; de Onis M, 2010, INT J PEDIATR OBES, V5, P458, DOI 10.3109/17477161003615583; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P142, DOI 10.1017/S1368980011001315; Dobbins TA, 2012, MED J AUSTRALIA, V197, P291, DOI 10.5694/mja11.11331; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Hardy LL, 2014, MED J AUSTRALIA, V200, P667, DOI 10.5694/mja13.10614; Hewitt B, 2012, LONGITUDINAL STUDY I, P1; Hilder L, 2014, PERINATAL STAT SERIE, V30; Koupil I, 2008, INT J OBESITY, V32, P73, DOI 10.1038/sj.ijo.0803681; Lausten-Thomsen Ulrik, 2013, Eur J Pediatr, V172, P747, DOI 10.1007/s00431-013-1949-z; Ludwig DS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001521; Malcolm J, 2012, DIABETES-METAB RES, V28, P307, DOI 10.1002/dmrr.2275; McNamara BJ, 2012, INT J EPIDEMIOL, V41, P1661, DOI 10.1093/ije/dys190; Moller SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109184; Nohr EA, 2013, INT J EPIDEMIOL, V42, P1016, DOI 10.1093/ije/dyt102; Oldroyd J, 2011, EUR J PEDIATR, V170, P899, DOI 10.1007/s00431-010-1375-4; Passey ME, 2013, MED J AUSTRALIA, V199, P39, DOI 10.5694/mja12.11848; Pink B, 2011, AUSTR STAT GEOGRAPHY; Roberts CL, 1999, MED J AUSTRALIA, V170, P114, DOI 10.5694/j.1326-5377.1999.tb127678.x; Schellong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047776; Smylie Janet, 2010, Open Womens Health J, P7; Steering Committee for the Review of Government Service Provision, 2014, OV IND DIS KEY IND 2; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Thrift AP, 2014, MED J AUSTRALIA, V201, P592, DOI 10.5694/mja13.11170; Thurber K. A., 2014, Public Health Research & Practice, V25, pe2511407; Thurber KA, 2012, THESIS AUSTR NATL U; Thurber KA, 2014, INT J EPIDEMIOL; Vos T, 2009, INT J EPIDEMIOL, V38, P470, DOI 10.1093/ije/dyn240; Wicklow BA, 2015, BEST PRACT RES CL OB, V29, P43, DOI 10.1016/j.bpobgyn.2014.04.017; World Health Organization, WHO ANTHR VERS 3 2 2	42	11	12	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130039	10.1371/journal.pone.0130039	http://dx.doi.org/10.1371/journal.pone.0130039			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075400	gold, Green Published			2022-12-27	WOS:000356329900126
J	Tian, B; Harrison, R; Morton, J; Deb-Choudhury, S				Tian, Bin; Harrison, Roland; Morton, James; Deb-Choudhury, Santanu			Proteomic Analysis of Sauvignon Blanc Grape Skin, Pulp and Seed and Relative Quantification of Pathogenesis-Related Proteins	PLOS ONE			English	Article							HAZE FORMATION; WHITE WINES; BERRY; BENTONITE; SEQUENCE; IDENTIFICATION; CHITINASES; STRESS; GENOME; WELL	Thaumatin-like proteins (TLPs) and chitinases are the main constituents of so-called protein hazes which can form in finished white wine and which is a great concern of winemakers. These soluble pathogenesis-related (PR) proteins are extracted from grape berries. However, their distribution in different grape tissues is not well documented. In this study, proteins were first separately extracted from the skin, pulp and seed of Sauvignon Blanc grapes, followed by trypsin digestion and analysis by liquid chromatography-electrospray ionization- tandem mass spectrometry (LC-ESI-MS/MS). Proteins identified included 75 proteins from Sauvignon Blanc grape skin, 63 from grape pulp and 35 from grape seed, mostly functionally classified as associated with metabolism and energy. Some were present exclusively in specific grape tissues; for example, proteins involved in photosynthesis were only detected in grape skin and proteins found in alcoholic fermentation were only detected in grape pulp. Moreover, proteins identified in grape seed were less diverse than those identified in grape skin and pulp. TLPs and chitinases were identified in both Sauvignon Blanc grape skin and pulp, but not in the seed. To relatively quantify the PR proteins, the protein extracts of grape tissues were seperated by HPLC first and then analysed by SDS-PAGE. The results showed that the protein fractions eluted at 9.3 min and 19.2 min under the chromatographic conditions of this study confirmed that these corresponded to TLPs and chitinases seperately. Thus, the relative quantification of TLPs and chitinases in protein extracts was carried out by comparing the area of corresponding peaks against the area of a thamautin standard. The results presented in this study clearly demonstrated the distribution of haze-forming PR proteins in grape berries, and the relative quantification of TLPs and chitinases could be applied in fast tracking of changes in PR proteins during grape growth and determination of PR proteins in berries at harvest.	[Tian, Bin; Harrison, Roland; Morton, James] Lincoln Univ, Dept Wine Food & Mol Biosci, Canterbury 7647, New Zealand; [Deb-Choudhury, Santanu] Lincoln Res Ctr, AgRes, Canterbury 8140, New Zealand	Lincoln University - New Zealand; AgResearch - New Zealand	Tian, B (corresponding author), Lincoln Univ, Dept Wine Food & Mol Biosci, Canterbury 7647, New Zealand.	tianbin0201@gmail.com	Harrison, Roland/S-9718-2018; Tian, Bin/X-7123-2018; Morton, James/C-6149-2012	Harrison, Roland/0000-0001-5879-2221; Tian, Bin/0000-0002-2700-7945; Morton, James/0000-0001-9645-5568	New Zealand Winegrowers; Agresearch, Lincoln Research Centre	New Zealand Winegrowers; Agresearch, Lincoln Research Centre	This research was funded by the New Zealand Winegrowers. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The coauthor, Santanu Deb-choudhury, is employed by a commercial company Agresearch, Lincoln Research Centre. Agresearch, Lincoln Research Centre provided support in the form of salary for author SD-C, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	BLADE WH, 1988, AM J ENOL VITICULT, V39, P193; Colas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043681; DATTA SK, 1999, PATHOGENESIS RELATED; Deytieux C, 2007, J EXP BOT, V58, P1851, DOI 10.1093/jxb/erm049; Ferreira RB, 2001, TRENDS FOOD SCI TECH, V12, P230, DOI 10.1016/S0924-2244(01)00080-2; Giribaldi M, 2007, PROTEOMICS, V7, P3154, DOI 10.1002/pmic.200600974; Giribaldi M, 2010, J PROTEOMICS, V73, P1647, DOI 10.1016/j.jprot.2010.05.002; Grimplet J, 2009, PROTEOMICS, V9, P2503, DOI 10.1002/pmic.200800158; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jellouli N, 2008, J PLANT PHYSIOL, V165, P471, DOI 10.1016/j.jplph.2007.02.009; Lambri M, 2010, AM J ENOL VITICULT, V61, P225; Le Bourse D, 2011, ANAL BIOANAL CHEM, V401, P1541, DOI 10.1007/s00216-011-4912-8; Loon L. C. van, 1994, Plant Molecular Biology Reporter, V12, P245, DOI 10.1007/BF02668748; Marangon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113757; Marangon M, 2011, J AGR FOOD CHEM, V59, P733, DOI 10.1021/jf1038234; Marangon M, 2009, J AGR FOOD CHEM, V57, P4415, DOI 10.1021/jf9000742; Monteiro S, 2007, PHYTOCHEMISTRY, V68, P416, DOI 10.1016/j.phytochem.2006.11.014; Moser C., 2005, Functional & Integrative Genomics, V5, P208, DOI 10.1007/s10142-005-0143-4; Okuda T, 2006, FOOD SCI TECHNOL RES, V12, P131, DOI 10.3136/fstr.12.131; Peng ZK, 1997, J AGR FOOD CHEM, V45, P4639, DOI 10.1021/jf970194a; Pocock KF, 2006, AUST J GRAPE WINE R, V12, P212, DOI 10.1111/j.1755-0238.2006.tb00061.x; Pocock K. F., 1998, Australian Journal of Grape and Wine Research, V4, P23, DOI 10.1111/j.1755-0238.1998.tb00131.x; Pocock KF, 2000, J AGR FOOD CHEM, V48, P1637, DOI 10.1021/jf9905626; Robinson S. P., 2000, Australian Journal of Grape and Wine Research, V6, P175, DOI 10.1111/j.1755-0238.2000.tb00177.x; Robinson SP, 1997, PLANT PHYSIOL, V114, P771, DOI 10.1104/pp.114.3.771; Salazar FN, 2012, EUR FOOD RES TECHNOL, V234, P509, DOI 10.1007/s00217-012-1659-1; Sarry JE, 2004, PROTEOMICS, V4, P201, DOI 10.1002/pmic.200300499; Sauvage FX, 2010, FOOD CHEM, V118, P26, DOI 10.1016/j.foodchem.2009.02.080; Tattersall DB, 1997, PLANT PHYSIOL, V114, P759, DOI 10.1104/pp.114.3.759; Tattersall DB, 2001, MOLECULAR BIOLOGY & BIOTECHNOLOGY OF THE GRAPEVINE, P183; Tian B, 2015, AUST J GRAPE WINE R, V21, P417, DOI 10.1111/ajgw.12135; Van Sluyter SC, 2009, J AGR FOOD CHEM, V57, P11376, DOI 10.1021/jf902365r; VANLOON LC, 1970, VIROLOGY, V40, P199, DOI 10.1016/0042-6822(70)90395-8; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Vincent D, 2006, ELECTROPHORESIS, V27, P1853, DOI 10.1002/elps.200500698; Wang W, 2009, ACTA PHYSIOL PLANT, V31, P597, DOI 10.1007/s11738-008-0269-9; Waters EJ, 1996, J AGR FOOD CHEM, V44, P3, DOI 10.1021/jf9505584; Waters EJ, 1998, J AGR FOOD CHEM, V46, P4950, DOI 10.1021/jf980421o	38	6	8	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130132	10.1371/journal.pone.0130132	http://dx.doi.org/10.1371/journal.pone.0130132			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076362	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900141
J	Ikram, UZ; Malmusi, D; Juel, K; Rey, G; Kunst, AE				Ikram, Umar Z.; Malmusi, Davide; Juel, Knud; Rey, Gregoire; Kunst, Anton E.			Association between Integration Policies and Immigrants' Mortality: An Explorative Study across Three European Countries	PLOS ONE			English	Article							EDUCATIONAL INEQUALITIES; JIM-CROW; MIGRANTS; HEALTH; WESTERN; MEN; NETHERLANDS; POPULATIONS; MULTILEVEL; ARTIFACT	Background To integrate immigrants into their societies, European countries have adopted different types of policies, which may influence health through both material and psychosocial determinants. Recent studies have suggested poorer health outcomes for immigrants living in countries with poorly rated integration policies. Objective To analyse mortality differences of immigrants from the same country of origin living in countries with distinct integration policy contexts. Methods From the mortality dataset collected in the Migrant Ethnic Health Observatory (MEHO) project, we chose the Netherlands (linked data from 1996-2006), France (unlinked; 2005-2007) and Denmark (linked; 1992-2001) as representatives of the inclusive, assimilationist and exclusionist policy models, respectively, based on the Migrant Integration Policy Index. We calculated for each country sex-and age-standardized mortality rates for Turkish-, Moroccan- and local-born populations aged 20-69 years. Poisson regression was used to estimate the mortality rate ratios (MRRs) for cross-country and within-country comparisons. The analyses were further stratified by age group and cause of death. Results Compared with their peers in the Netherlands, Turkish-born immigrants had higher allcause mortality in Denmark (MRR men 1.92; 95% CI 1.74-2.13 and women 2.11; 1.80-2.47) but lower in France (men 0.64; 0.59-0.69 and women 0.58; 0.51-0.67). A similar pattern emerged for Moroccan-born immigrants. The relative differences between immigrants and the local-born population were also largest in Denmark and lowest in France (e.g., Turkishborn men MRR 1.52; 95% CI 1.38-1.67 and 0.62; 0.58-0.66, respectively). These patterns were consistent across all age groups, and more marked for cardiovascular diseases. Conclusions Although confounders and data comparability issues (e.g., French cross-sectional data) may affect the findings, this study suggests that different macro-level policy contexts may influence immigrants' mortality. Comparable mortality registration systems across Europe along with detailed socio-demographic information on immigrants may help to better assess this association.	[Ikram, Umar Z.; Kunst, Anton E.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [Malmusi, Davide] Agencia Salut Publ Barcelona IIB St Pau, Barcelona, Spain; [Malmusi, Davide] CIBER Epidemiol & Salud Publ, Barcelona, Spain; [Juel, Knud] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Rey, Gregoire] INSERM, CepiDc, F-94275 Le Kremlin Bicetre, France	University of Amsterdam; Academic Medical Center Amsterdam; Public Health Agency of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Southern Denmark; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ikram, UZ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	u.ikram@amc.uva.nl	Rey, Grégoire/AAD-8966-2019; Juel, Knud/C-8916-2013	Juel, Knud/0000-0002-4134-1173; Kunst, Anton/0000-0002-3313-5273; Rey, Gregoire/0000-0001-7291-9444	European Commission Directorate General for Health and Consumer Affairs (DG SANCO) [2005122]; 7th Framework Programme [278173]	European Commission Directorate General for Health and Consumer Affairs (DG SANCO); 7th Framework Programme(European Commission)	This work was funded by the following: 1. European Commission Directorate General for Health and Consumer Affairs (DG SANCO), grant number 2005122 (URL: http://ec.europa.eu/dgs/health_foodsafety/index_en.htm); 2. 7th Framework Programme, grant number 278173 (URL: http://ec.europa.eu/research/fp7/index_en.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadan-Unat N., 2011, TURKS EUROPE GUEST W; Akgunduz A., 2008, LABOUR MIGRATION TUR, P221; Becares Laia, 2012, Am J Public Health, V102, pe33, DOI 10.2105/AJPH.2012.300832; Bekouchi MH., 2010, MAROCAINS AILLEURS I, P263; Bhopal RS, 2012, EUR J PUBLIC HEALTH, V22, P353, DOI 10.1093/eurpub/ckr062; Bos V, 2004, INT J EPIDEMIOL, V33, P1112, DOI 10.1093/ije/dyh189; Boulogne R, 2012, SOC SCI MED, V74, P1213, DOI 10.1016/j.socscimed.2012.01.002; Castles S., 1995, J ETHN MIGR STUD, V21, P293, DOI DOI 10.1080/1369183X.1995.9976493; Danmarks Statistik, 2010, INDVANDRERE DANMARK; Darmon N, 2007, PUBLIC HEALTH NUTR, V4, P163; Favell Adrian., 2001, CITIZENSHIP TODAY GL, P349; FRA, 2009, EU MIDIS EUR UN MIN, DOI [10.2811/32815, DOI 10.2811/32815]; FREEMAN GP, 1995, INT MIGR REV, V29, P881, DOI 10.2307/2547729; Hadjar A, 2013, COMP SOCIOL, V12, P645, DOI 10.1163/15691330-12341279; Hollifield I.F., 1997, IMMIGRATION W SOC PR, P28; Huddleston T, 2011, MIGRANT INTEGRATION, VIII, P221; Huisman M, 2004, J EPIDEMIOL COMMUN H, V58, P468, DOI 10.1136/jech.2003.010496; Huisman M, 2005, LANCET, V365, P493, DOI 10.1016/S0140-6736(05)17867-2; Juel K, 2000, EUR J PUBLIC HEALTH, V10, P93, DOI 10.1093/eurpub/10.2.93; Khlat M, 2003, INT J EPIDEMIOL, V32, P1115, DOI 10.1093/ije/dyg308; Kibele E, 2008, EUR J EPIDEMIOL, V23, P389, DOI 10.1007/s10654-008-9247-1; Koopmans Ruud, 2000, CHALLENGING IMMIGRAT, P13; Krieger N, 2014, EPIDEMIOLOGY, V25, P494, DOI 10.1097/EDE.0000000000000104; Krieger N, 2013, AM J PUBLIC HEALTH, V103, P2234, DOI 10.2105/AJPH.2013.301350; Kunst AE, 1998, BMJ-BRIT MED J, V316, P1636, DOI 10.1136/bmj.316.7145.1636; Levecque K, 2015, ETHNIC HEALTH, V20, P49, DOI 10.1080/13557858.2014.883369; Liebig T., 2007, 10281132815 EUMIDIS, P80, DOI [10.1787/ 233783261534, DOI 10.1787/233783261534]; Malmusi D, 2015, EUR J PUBLIC HEALTH, V25, P293, DOI 10.1093/eurpub/cku156; Martinez O, 2015, J IMMIGR MINOR HEALT, V17, P947, DOI 10.1007/s10903-013-9968-4; Meuleman B, 2009, THESIS KU LEUVEN; Norredam M, 2015, EUR J PUBLIC HEALTH, V25, P84, DOI 10.1093/eurpub/cku138; Norredam M, 2014, TROP MED INT HEALTH, V19, P958, DOI 10.1111/tmi.12340; Norredam M, 2010, EUR J PUBLIC HEALTH, V20, P555, DOI 10.1093/eurpub/ckp195; OECD, 2012, OECD IND IMM INT 201, DOI [10.1787/9789264171534-en, DOI 10.1787/9789264171534-EN]; Rafnsson SB, 2013, EUR J PUBLIC HEALTH, V23, P594, DOI 10.1093/eurpub/ckt023; Schlueter E, 2013, SOC SCI RES, V42, P670, DOI 10.1016/j.ssresearch.2012.12.001; Scott AP, 2013, J EPIDEMIOL COMMUN H, V67, P743, DOI 10.1136/jech-2012-202265; Solar O, 2010, SOCIAL DETERMINATS H, V2; Spallek J, 2011, EMERG THEMES EPIDEMI, DOI [10.1186/1742-7622-8-7, DOI 10.1186/1742-7622-8-7]; Uitewaal PJM, 2004, PREV MED, V39, P1068, DOI 10.1016/j.ypmed.2004.04.009; Ujcic-Voortman JK, 2012, OBES REV, V13, P2, DOI 10.1111/j.1467-789X.2011.00932.x; van Oort FVA, 2005, J EPIDEMIOL COMMUN H, V59, P214, DOI 10.1136/jech.2003.016493; Villadsen SF, 2010, EUR J PUBLIC HEALTH, V20, P530, DOI 10.1093/eurpub/ckq004; Wallace M, 2014, SOC SCI MED, V120, P100, DOI 10.1016/j.socscimed.2014.08.032; Weitoft GR, 1999, INT J EPIDEMIOL, V28, P756, DOI 10.1093/ije/28.4.756; Weldon SA, 2006, AM J POLIT SCI, V50, P331, DOI 10.1111/j.1540-5907.2006.00187.x; Wimmer A., 2000, J INT MIGRATION INTE, V1, P177, DOI DOI 10.1007/S12134-000-1001-9	47	28	29	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129916	10.1371/journal.pone.0129916	http://dx.doi.org/10.1371/journal.pone.0129916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26067249	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000123
J	Kishimoto, Y; Yamamoto, S; Suzuki, K; Toyoda, H; Kano, M; Tsukada, H; Kirino, Y				Kishimoto, Yasushi; Yamamoto, Shigeyuki; Suzuki, Kazutaka; Toyoda, Haruyoshi; Kano, Masanobu; Tsukada, Hideo; Kirino, Yutaka			Implicit Memory in Monkeys: Development of a Delay Eyeblink Conditioning System with Parallel Electromyographic and High-Speed Video Measurements	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; EYELID RESPONSES; CEREBELLAR DEGENERATION; CONSCIOUS MONKEYS; BEHAVING RABBITS; MAMMALIAN BRAIN; MOUSE MODEL; TRACE; AWARENESS; RECEPTOR	Delay eyeblink conditioning, a cerebellum-dependent learning paradigm, has been applied to various mammalian species but not yet to monkeys. We therefore developed an accurate measuring system that we believe is the first system suitable for delay eyeblink conditioning in a monkey species (Macaca mulatta). Monkey eyeblinking was simultaneously monitored by orbicularis oculi electromyographic (OO-EMG) measurements and a high-speed camera-based tracking system built around a 1-kHz CMOS image sensor. A 1-kHz tone was the conditioned stimulus (CS), while an air puff (0.02 MPa) was the unconditioned stimulus. EMG analysis showed that the monkeys exhibited a conditioned response (CR) incidence of more than 60% of trials during the 5-day acquisition phase and an extinguished CR during the 2-day extinction phase. The camera system yielded similar results. Hence, we conclude that both methods are effective in evaluating monkey eyeblink conditioning. This system incorporating two different measuring principles enabled us to elucidate the relationship between the actual presence of eyelid closure and OO-EMG activity. An interesting finding permitted by the new system was that the monkeys frequently exhibited obvious CRs even when they produced visible facial signs of drowsiness or microsleep. Indeed, the probability of observing a CR in a given trial was not influenced by whether the monkeys closed their eyelids just before CS onset, suggesting that this memory could be expressed independently of wakefulness. This work presents a novel system for cognitive assessment in monkeys that will be useful for elucidating the neural mechanisms of implicit learning in nonhuman primates.	[Kishimoto, Yasushi; Kirino, Yutaka] Tokushima Bunri Univ, Dept Neurobiophys, Kagawa Sch Pharmaceut Sci, Sanuki, Kagawa, Japan; [Yamamoto, Shigeyuki; Suzuki, Kazutaka; Toyoda, Haruyoshi; Tsukada, Hideo] Hamamatsu Photon KK, Cent Res Lab, Hamakita Ku, Hamamatsu, Shizuoka, Japan; [Kano, Masanobu] Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Bunkyo Ku, Tokyo, Japan	Tokushima Bunri University; Hamamatsu Photonics; University of Tokyo	Kirino, Y (corresponding author), Tokushima Bunri Univ, Dept Neurobiophys, Kagawa Sch Pharmaceut Sci, Sanuki, Kagawa, Japan.	y-kirino@tokushima.bunri-u.ac.jp	Kishimoto, Yasushi/AAH-4923-2021	Kano, Masanobu/0000-0002-0725-3292; Kishimoto, Yasushi/0000-0002-4828-1249	Hamamatsu Photonics K.K.;  [21220006];  [90441592];  [20790084];  [24590068]	Hamamatsu Photonics K.K.; ; ; ; 	This study was supported by Grants-in-Aid for Scientific Research (21220006 and 90441592 to Y. Kishimoto, 20790084 to MK, and 24590068 to Y. Kirino). URL: http://www.jsps.go.jp/english/e-grants/. Hamamatsu Photonics K.K., provided support in the form of salaries for authors SY, KS, H. Toyoda, and H. Tsukada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adachi K, 2004, IEEJ T, V124, P776; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ANDREWS SJ, 1995, DEV PSYCHOBIOL, V28, P307, DOI 10.1002/dev.420280602; Attwell PJE, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0003.1999; Attwell PJE, 2002, NEURON, V34, P1011, DOI 10.1016/S0896-6273(02)00719-5; Carretero-Guillen A, 2015, CEREB CORTEX, V25, P1278, DOI 10.1093/cercor/bht321; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Clark RE, 1998, BEHAV NEUROSCI, V112, P1062, DOI 10.1037/0735-7044.112.5.1062; DAUM I, 1989, J NEUROL NEUROSUR PS, V52, P47, DOI 10.1136/jnnp.52.1.47; ESLINGER PJ, 1986, J NEUROSCI, V6, P3006; Gerwig M, 2008, EXP BRAIN RES, V187, P85, DOI 10.1007/s00221-008-1283-2; Gerwig M, 2005, J NEUROSCI, V25, P3919, DOI 10.1523/JNEUROSCI.0266-05.2005; Gruart A, 2008, NEUROBIOL DIS, V30, P439, DOI 10.1016/j.nbd.2008.03.001; GRUART A, 1995, J NEUROPHYSIOL, V74, P226, DOI 10.1152/jn.1995.74.1.226; Hesslow G, 1998, SCIENCE, V280, P1817; Hilgard ER, 1936, PSYCHOL MONOGR, V47, P186, DOI 10.1037/h0093413; Inoue K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039149; Ito M, 2002, ANN NY ACAD SCI, V978, P273, DOI 10.1111/j.1749-6632.2002.tb07574.x; KEIFER J, 1995, J NEUROSCI, V15, P5036; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; Kishimoto Y, 2006, J NEUROSCI, V26, P1562, DOI 10.1523/JNEUROSCI.4142-05.2006; Kishimoto Y, 2006, J NEUROSCI, V26, P8829, DOI 10.1523/JNEUROSCI.1236-06.2006; Kishimoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060627; Kishimoto Y, 2013, NEUROSCI LETT, V538, P15, DOI 10.1016/j.neulet.2013.01.025; Kishimoto Y, 2012, NEUROSCI LETT, V506, P155, DOI 10.1016/j.neulet.2011.10.071; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Koekkoek SKE, 2002, J NEUROPHYSIOL, V88, P2124, DOI 10.1152/jn.2002.88.4.2124; KRUPA DJ, 1993, SCIENCE, V260, P989, DOI 10.1126/science.8493536; Larner AJ, 1997, DEMENT GERIATR COGN, V8, P203, DOI 10.1159/000106632; Leal-Campanario R, 2013, J NEUROSCI, V33, P4378, DOI 10.1523/JNEUROSCI.5560-12.2013; Lisberger SG, 2009, NEUROSCIENCE, V162, P763, DOI 10.1016/j.neuroscience.2009.03.059; Lovibond PF, 2011, BIOL PSYCHOL, V87, P393, DOI 10.1016/j.biopsycho.2011.05.002; Malla AM, 2010, IEEE ENG MED BIO, P6741, DOI 10.1109/IEMBS.2010.5626013; Manns JR, 2001, COGN AFFECT BEHAV NE, V1, P192, DOI 10.3758/CABN.1.2.192; Marquis DG, 1937, BRAIN, V60, P1, DOI 10.1093/brain/60.1.1; Mauk MD, 1997, NEURON, V18, P343, DOI 10.1016/S0896-6273(00)81235-0; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; Miyata M, 2011, J NEUROSCI, V31, P6067, DOI 10.1523/JNEUROSCI.5651-10.2011; Nakamura Yoshiko, 2008, Nippon Ganka Gakkai Zasshi, V112, P1059; PENNYPACKER HS, 1966, J EXP ANAL BEHAV, V9, P601, DOI 10.1901/jeab.1966.9-601; Sanchez-Campusano R, 2007, J NEUROSCI, V27, P6620, DOI 10.1523/JNEUROSCI.0488-07.2007; Sanchez-Campusano R, 2009, J NEUROSCI, V29, P10750, DOI 10.1523/JNEUROSCI.2178-09.2009; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Skosnik PD, 2008, NEUROPSYCHOPHARMACOL, V33, P1432, DOI 10.1038/sj.npp.1301506; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Sugiyama Y, 2005, IEEE J SOLID-ST CIRC, V40, P2816, DOI 10.1109/JSSC.2005.858475; Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007; TAKECHI H, 1994, NEUROSCI LETT, V182, P279, DOI 10.1016/0304-3940(94)90816-8; Takumi M, 2002, P IAPR WORK MACH VIS, V8-37, P384; Thompson RF, 1996, P NATL ACAD SCI USA, V93, P13438, DOI 10.1073/pnas.93.24.13438; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; THOMPSON RF, 1997, CEREBELLUM COGNITION, P152; TOPKA H, 1993, BRAIN, V116, P961, DOI 10.1093/brain/116.4.961; Woodruff- Pak DS, 2000, EYEBLINK CLASSICAL C, VII; Woodruff-Pak DS, 2000, EYEBLINK CLASSICAL C, VI; WoodruffPak DS, 1996, NEUROBIOL AGING, V17, P397, DOI 10.1016/0197-4580(96)00022-X; Yamamoto S, 2013, NEUROPSYCHOPHARMACOL, V38, P2666, DOI 10.1038/npp.2013.176; Yamamoto S, 2011, NEUROPSYCHOPHARMACOL, V36, P1455, DOI 10.1038/npp.2011.31; Yeo CH, 1998, TRENDS COGN SCI, V2, P322, DOI 10.1016/S1364-6613(98)01219-4	59	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129828	10.1371/journal.pone.0129828	http://dx.doi.org/10.1371/journal.pone.0129828			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068663	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000112
J	Lu, Q; Lv, WW; Tian, J; Zhang, LJ; Zhu, BP				Lu, Qiang; Lv, Weiwei; Tian, Jiang; Zhang, Lijie; Zhu, Baoping			Risk Factors for Non-Occupational Carbon Monoxide Poisoning: Anshan Prefecture, Liaoning Province, China, 2011-2012	PLOS ONE			English	Article							EXPOSURE	Background Carbon monoxide (CO) poisoning can be fatal but is preventable. From October 2010 to February 2011, Anshan Prefecture reported 57 cases of non-occupational CO poisoning in District A, with two deaths. We conducted an investigation to identify risk factors and recommend preventive measures. Methods We defined a possible case of non-occupational CO poisoning as onset of at least two of the following symptoms: fatigue, headache, dizziness, nausea, vomiting, cyanosis, loss of consciousness, coma, and shock from October 1, 2010, to February 28, 2011, in a resident of Anshan Prefecture with non-occupational exposure to CO poisoning. We defined a probable case as onset of at least one of the following symptoms: cyanosis, loss of consciousness, coma and shock, plus at least one of the following symptoms: fatigue, headache, dizziness, nausea, vomiting, among possible cases. A confirmed CO poisoning case was a possible case or probable case plus hemoglobin (Hb) CO higher than 10%. We searched for cases by reviewing medical records and records of hyperbaric oxygen tank usage. In a case-control investigation, we compared home heating practices of 30 case-persons and 120 control-persons who were individually matched to each case by neighborhood. Results Overall, 56% (39/70) of case-patients' households burned coal for home-heating. In the case-control investigation, 40% (12/30) of case-persons' households compared with 5.8% (7/120) of control-persons' households placed stoves in bedrooms (Mantel-Haenszel odds ratio [ORM-H] = 11, 95% confidence interval [CI] = 3.0-41); 53% (16/30) of case-patients' households and 33% (40/120) of control-patients' households did not extinguish the fire before sleeping (ORM-H = 3.6, 95% CI = 1.1-12); 13% (4/30) of case-patients' households and 3% (4/120) of control-patients' households had not installed the ventilation pipe vertically (ORM-H = 7.3, 95% CI = 1.0-56). Overall, 77% (23/30) of case-patients' households and 39% (47/120) of control-patients' households had at least one of those three risk factors (ORM-H = 10, 95% CI = 2.5-40; population attributable risk percentage: 78%). Conclusions Dangerous practices with coal-burning stoves inside the home accounted for the majority of CO poisoning incidents. Community health centers should provide instruction to and supervision of residents on proper installation and use of home heating stoves as well as inspection of installation.	[Lu, Qiang] Peking Union Med Coll Hosp, Dept Neurol, Beijing, Peoples R China; [Lv, Weiwei] Anshan Prefecture Ctr Dis Control & Prevent, Dept Infect Dis Control, Liaoning, Peoples R China; [Lv, Weiwei; Tian, Jiang] Liaoning Ctr Dis Control & Prevent, Dept Infect Dis Control, Shenyang, Peoples R China; [Tian, Jiang; Zhang, Lijie; Zhu, Baoping] Chinese Ctr Dis Control & Prevent, Field Epidemiol Training Program, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Center for Disease Control & Prevention	Zhang, LJ (corresponding author), Chinese Ctr Dis Control & Prevent, Field Epidemiol Training Program, Beijing, Peoples R China.	cfetpzlj@126.com		Zhu, Baoping/0000-0003-0065-0153				Amitai Y, 1998, ARCH NEUROL-CHICAGO, V55, P845, DOI 10.1001/archneur.55.6.845; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P765; Chen XH, 2008, OCCUP HLTH, V24, P498; Ernst A, 1998, NEW ENGL J MED, V339, P1603, DOI 10.1056/NEJM199811263392206; Karapirli M, 2013, J FORENSIC LEG MED, V20, P95, DOI 10.1016/j.jflm.2012.04.031; Li C, 2008, PUBLIC HLTH REPORTS, V125, P605; McCracken JP, 2007, ENVIRON HEALTH PERSP, V115, P996, DOI 10.1289/ehp.9888; Miquel P., 2008, DICT EPIDEMIOLOGY; Smith K.R., 2004, COMP QUANTIFICATION, V18, P1435	9	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129121	10.1371/journal.pone.0129121	http://dx.doi.org/10.1371/journal.pone.0129121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070201	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000049
J	Nowack, N; Wittsiepe, J; Kasper-Sonnenberg, M; Wilhelm, M; Scholmerich, A				Nowack, Nikola; Wittsiepe, Juergen; Kasper-Sonnenberg, Monika; Wilhelm, Michael; Schoelmerich, Axel			Influence of Low-Level Prenatal Exposure to PCDD/Fs and PCBs on Empathizing, Systemizing and Autistic Traits: Results from the Duisburg Birth Cohort Study	PLOS ONE			English	Article							POLYCHLORINATED-BIPHENYLS PCBS; ENDOCRINE-DISRUPTING CHEMICALS; PERSISTENT ORGANIC POLLUTANTS; SOCIAL RESPONSIVENESS SCALE; HAZARDOUS AIR-POLLUTANTS; HIGH-FUNCTIONING AUTISM; 4TH DIGIT RATIO; FETAL TESTOSTERONE; SPECTRUM DISORDERS; GENE-EXPRESSION	Background Polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs) and polychlorinated biphenyls (PCBs) are assumed to act as endocrine disruptor chemicals. Prenatal exposure to these pollutants might influence fetal steroid hormone levels, which are thought to be related to sex-typical development and autistic traits. Objectives We examined associations of prenatal levels of PCDD/Fs and PCBs with autism traits and sex-typical behaviour in childhood. Methods We measured levels of PCDD/Fs and PCBs in maternal blood samples during pregnancy using gas chromatography/high-resolution mass spectrometry. Sex-typical behaviour was assessed at 9 years of age (n = 96) and autistic traits at 10 years of age using the Social Responsiveness Scale (SRS; n = 100). Multiple regression analyses were conducted to estimate the associations between prenatal exposure and outcome variables. Results Blood concentrations (WHO2005-TEq) of Sigma PCDD/Fs ranged from 2.93-46.45 pg/g (lipid base) (median = 12.91 pg/g (lipid base)) and concentrations of Sigma PCBs were in the range of 1.24-25.47 pg/g (lipid base) (median = 6.85 pg/g (lipid base)) which is within the range of German background exposure. We found significant negative associations between PCDD/F levels in maternal blood and SRS scores in the whole group (beta = -6.66, p < .05), in girls (beta = -10.98, p < .05) and, in one SRS subscale, in boys (beta = -6.86, p < .05). For PCB levels, associations with one SRS subscale were significant for the whole study group as were associations with two subscales in girls. We did not find significant associations between PCDD/F or PCB levels and sex-typical behaviour for either sex. Conclusions In an earlier part of this study, prenatal exposure to PCDD/Fs and PCBs was found to be associated with lower testosterone levels, therefore, our findings are consistent with the idea that autism spectrum conditions are related to fetal androgen levels. Several possible mechanisms, through which PCDD/Fs and PCBs might influence autistic behaviour, are discussed.	[Nowack, Nikola; Schoelmerich, Axel] Ruhr Univ Bochum, Dept Dev Psychol, D-44801 Bochum, Germany; [Wittsiepe, Juergen; Kasper-Sonnenberg, Monika; Wilhelm, Michael] Ruhr Univ Bochum, Dept Hyg Social & Environm Med, D-44801 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Nowack, N (corresponding author), Ruhr Univ Bochum, Dept Dev Psychol, Univ Str 150, D-44801 Bochum, Germany.	Nikola.Nowack@rub.de	Kasper-Sonnenberg, Monika/AAH-2769-2021; Schoelmerich, Axel/C-9039-2009	Kasper-Sonnenberg, Monika/0000-0002-9435-1391; Schoelmerich, Axel/0000-0002-9844-3920; Schoelmerich, Axel/0000-0002-2597-3365	NorthRhine-Westphalia State Environment Agency; German Federal Environment Agency [3708 61 201 3]	NorthRhine-Westphalia State Environment Agency; German Federal Environment Agency	The study was initiated and financially supported by the NorthRhine-Westphalia State Environment Agency (http://www.lanuv.nrw.de/englisch/home.htm). The follow-up was funded by the German Federal Environment Agency (3708 61 201 3; http://www.umweltbundesamt.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salman F, 2012, TOXICOL APPL PHARM, V263, P7, DOI 10.1016/j.taap.2012.05.016; American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Asperger H, 1944, ARCH PSYCHIAT NERVEN, V117, P76, DOI 10.1007/BF01837709; Auyeung B, 2006, EUR J ENDOCRINOL, V155, pS123, DOI 10.1530/eje.1.02260; Auyeung B, 2012, ARCH SEX BEHAV, V41, P571, DOI 10.1007/s10508-011-9864-8; Auyeung B, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-11; Auyeung B, 2009, J AUTISM DEV DISORD, V39, P1509, DOI 10.1007/s10803-009-0772-x; Auyeung B, 2009, PSYCHOL SCI, V20, P144, DOI 10.1111/j.1467-9280.2009.02279.x; Auyeung B, 2009, BRIT J PSYCHOL, V100, P1, DOI 10.1348/000712608X311731; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2015, MOL PSYCHIATR, V20, P369, DOI 10.1038/mp.2014.48; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Becerra TA, 2013, ENVIRON HEALTH PERSP, V121, P380, DOI 10.1289/ehp.1205827; Berghuis SA, 2013, NEUROTOXICOLOGY, V38, P124, DOI 10.1016/j.neuro.2013.07.003; Bjork C, 2013, REPROD TOXICOL, V35, P144, DOI 10.1016/j.reprotox.2012.10.010; Bjork C, 2011, REPROD TOXICOL, V32, P293, DOI 10.1016/j.reprotox.2011.06.075; Bolte S, 2008, AUTISM RES, V1, P354, DOI 10.1002/aur.49; Bolte S., 2008, SKALA ERFASSUNG SOZI; Bolte S, 2011, J AUTISM DEV DISORD, V41, P66, DOI 10.1007/s10803-010-1024-9; Bonefeld-Jorgensen EC, 2001, TOXICOLOGY, V158, P141, DOI 10.1016/S0300-483X(00)00368-1; Braun JM, 2014, ENVIRON HEALTH PERSP, V122, P513, DOI 10.1289/ehp.1307261; BREEDLOVE SM, 1992, J NEUROSCI, V12, P4133; Brouwer A, 1999, ENVIRON HEALTH PERSP, V107, P639, DOI 10.2307/3434557; Cao YG, 2008, INT J HYG ENVIR HEAL, V211, P30, DOI 10.1016/j.ijheh.2007.04.005; Center for Disease Control and Prevention, 2014, AUT SPECTR DIS ASD D; Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Chapman E, 2006, SOC NEUROSCI-UK, V1, P135, DOI 10.1080/17470910600992239; Charman T, 2007, BRIT J PSYCHIAT, V191, P554, DOI 10.1192/bjp.bp.107.040196; Cheslack-Postava K, 2013, NEUROTOXICOL TERATOL, V38, P1, DOI 10.1016/j.ntt.2013.04.001; Chung YW, 2001, PHYSIOL BEHAV, V74, P363, DOI 10.1016/S0031-9384(01)00579-0; Cohen-Bendahan CCC, 2005, NEUROSCI BIOBEHAV R, V29, P353, DOI 10.1016/j.neubiorev.2004.11.004; Colciago A, 2006, REPROD TOXICOL, V22, P738, DOI 10.1016/j.reprotox.2006.07.002; Constantino J. N., 2005, SOCIAL RESPONSIVENES; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Constantino JN., 2002, SOCIAL RESPONSIVENES; Constantino JN, 2007, J AM ACAD CHILD PSY, V46, P1668, DOI 10.1097/chi.0b013e318157cb23; Faass O, 2013, GEN COMP ENDOCR, V188, P232, DOI 10.1016/j.ygcen.2013.04.008; Fatemi SH, 2012, CEREBELLUM, V11, P777, DOI 10.1007/s12311-012-0355-9; Goncharov A, 2009, ENVIRON HEALTH PERSP, V117, P1454, DOI 10.1289/ehp.0800134; Gorski R A, 1985, J Anim Sci, V61 Suppl 3, P38; Hagmar L, 2003, THYROID, V13, P1021, DOI 10.1089/105072503770867192; HAMPSON E, 1995, J PSYCHIATR NEUROSCI, V20, P397; Hedges VL, 2012, FRONT NEUROENDOCRIN, V33, P403, DOI 10.1016/j.yfrne.2012.08.005; Henningsson S, 2009, PSYCHONEUROENDOCRINO, V34, P752, DOI 10.1016/j.psyneuen.2008.12.007; Hertz-Picciotto I, 2009, EPIDEMIOLOGY, V20, P84, DOI 10.1097/EDE.0b013e3181902d15; HINES M, 1985, J NEUROSCI, V5, P40; Hu VW, 2012, NEUROTOXICOLOGY, V33, P1434, DOI 10.1016/j.neuro.2012.07.009; Hu VW, 2009, AUTISM RES, V2, P78, DOI 10.1002/aur.73; JACOBSON CD, 1981, J NEUROSCI, V1, P1142; Jolliffe T, 1997, J CHILD PSYCHOL PSYC, V38, P527, DOI 10.1111/j.1469-7610.1997.tb01539.x; Kajta M, 2009, NEUROSCIENCE, V158, P811, DOI 10.1016/j.neuroscience.2008.10.045; Kalkbrenner AE, 2014, CURR PROB PEDIATR AD, V44, P1, DOI [10.1016/j.cppeds.2013.10.008, DOI 10.1016/J.CPPEDS.2013.10.008]; Kalkbrenner AE, 2010, EPIDEMIOLOGY, V21, P631, DOI 10.1097/EDE.0b013e3181e65d76; Kerdivel G, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/501851; Kester MHA, 2000, ENDOCRINOLOGY, V141, P1897, DOI 10.1210/en.141.5.1897; Kester MHA, 2002, J CLIN ENDOCR METAB, V87, P1142, DOI 10.1210/jc.87.3.1142; Kim SM, 2010, PSYCHIAT INVEST, V7, P122, DOI 10.4306/pi.2010.7.2.122; Kimura D, 1996, CURR OPIN NEUROBIOL, V6, P259, DOI 10.1016/S0959-4388(96)80081-X; Kimura-Kuroda J, 2007, CHEMOSPHERE, V67, pS412, DOI 10.1016/j.chemosphere.2006.05.137; Klinge CM, 2000, ARCH BIOCHEM BIOPHYS, V373, P163, DOI 10.1006/abbi.1999.1552; Knickmeyer R, 2006, HORM BEHAV, V49, P282, DOI 10.1016/j.yhbeh.2005.08.010; Knickmeyer R, 2005, J CHILD PSYCHOL PSYC, V46, P198, DOI 10.1111/j.1469-7610.2004.00349.x; Knickmeyer RC, 2006, J CHILD NEUROL, V21, P825, DOI 10.1177/08830738060210101601; Landrigan PJ, 2001, MOL GENET METAB, V73, P11, DOI 10.1006/mgme.2001.3177; Larsson M, 2009, NEUROTOXICOLOGY, V30, P822, DOI 10.1016/j.neuro.2009.01.011; Lenz KM, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00026; Lutchmaya S, 2002, INFANT BEHAV DEV, V25, P327, DOI 10.1016/S0163-6383(02)00094-2; Lutchmaya S, 2002, INFANT BEHAV DEV, V24, P418; Manning JT, 2003, EVOL HUM BEHAV, V24, P399, DOI 10.1016/S1090-5138(03)00052-7; Manning JT, 2001, DEV MED CHILD NEUROL, V43, P160, DOI 10.1017/S0012162201000317; Meeker JD, 2010, SYST BIOL REPROD MED, V56, P122, DOI 10.3109/19396360903443658; Miodovnik A, 2011, NEUROTOXICOLOGY, V32, P261, DOI 10.1016/j.neuro.2010.12.009; Mitchell MM, 2012, ENVIRON MOL MUTAGEN, V53, P589, DOI 10.1002/em.21722; Morris JA, 2005, J COMP NEUROL, V487, P217, DOI 10.1002/cne.20558; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Murray MJ, 2011, J AUTISM DEV DISORD, V41, P1586, DOI 10.1007/s10803-011-1178-0; Nakagami A, 2011, DEV PSYCHOBIOL, V53, P79, DOI 10.1002/dev.20493; Negishi T, 2006, TOXICOL LETT, V160, P233, DOI 10.1016/j.toxlet.2005.07.008; Neugebauer J, 2015, INT J HYG ENVIR HEAL, V218, P153, DOI 10.1016/j.ijheh.2014.09.005; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Nishijo M, 2014, MOL PSYCHIATR, V19, P1220, DOI 10.1038/mp.2014.18; Otake Takamitsu, 2006, Environmental Health and Preventive Medicine, V11, P65, DOI 10.1007/BF02898144; Portigal CL, 2002, TOXICOL APPL PHARM, V179, P185, DOI 10.1006/taap.2002.9371; Rennert A, 2012, J TOXICOL ENV HEAL A, V75, P1232, DOI 10.1080/15287394.2012.709375; Roberts AL, 2013, ENVIRON HEALTH PERSP, V121, P978, DOI 10.1289/ehp.1206187; Roberts EM, 2007, ENVIRON HEALTH PERSP, V115, P1482, DOI 10.1289/ehp.10168; Roze E, 2009, ENVIRON HEALTH PERSP, V117, P1953, DOI 10.1289/ehp.0901015; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-39; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-14; Sarachana T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017116; SCHANTZ SL, 1995, FUND APPL TOXICOL, V26, P117, DOI 10.1006/faat.1995.1081; Schantz SL, 1996, NEUROTOXICOL TERATOL, V18, P305; SCHANTZ SL, 1992, NEUROTOXICOL TERATOL, V14, P433, DOI 10.1016/0892-0362(92)90054-E; Scholmerich A., 2011, EMPATHY SYSTEMIZING; STEIN SA, 1991, ADV EXP MED BIOL, V299, P47; Sutcliffe JS, 2008, SCIENCE, V321, P208, DOI 10.1126/science.1160555; Swan SH., 2008, ENCY ECOLOGY, P1265, DOI DOI 10.1016/B978-008045405-4.00245-7; Tewes U., 2006, WECHSLER INTELLIGENZ; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Volk HE, 2013, JAMA PSYCHIAT, V70, P71, DOI 10.1001/jamapsychiatry.2013.266; Volk HE, 2011, ENVIRON HEALTH PERSP, V119, P873, DOI 10.1289/ehp.1002835; Vreugdenhil HJI, 2002, ENVIRON HEALTH PERSP, V110, pA593, DOI 10.1289/ehp.021100593; Wallen K, 1996, HORM BEHAV, V30, P364, DOI 10.1006/hbeh.1996.0042; Wang XQ, 2002, PHYSIOL BEHAV, V75, P689, DOI 10.1016/S0031-9384(02)00673-X; Warner J, 2012, SCI TOTAL ENVIRON, V414, P81, DOI 10.1016/j.scitotenv.2011.10.044; Wilhelm M, 2008, MUTAT RES-REV MUTAT, V659, P83, DOI 10.1016/j.mrrev.2007.11.002; Windham GC, 2006, ENVIRON HEALTH PERSP, V114, P1438, DOI 10.1289/ehp.9120; Winneke G, 2002, TOXICOLOGY, V181, P161, DOI 10.1016/S0300-483X(02)00274-3; Winneke G, 2014, ENVIRON HEALTH PERSP, V122, P292, DOI 10.1289/ehp.1306533; Wittsiepe J, 2000, CHEMOSPHERE, V40, P1103, DOI 10.1016/S0045-6535(99)00359-8; Wittsiepe J, 2007, CHEMOSPHERE, V67, pS286, DOI 10.1016/j.chemosphere.2006.05.118; Wright DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031661; Wu MV, 2011, CURR OPIN NEUROBIOL, V21, P116, DOI 10.1016/j.conb.2010.09.014; Zoeller RT, 2012, ENDOCRINOLOGY, V153, P4097, DOI 10.1210/en.2012-1422	119	43	44	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129906	10.1371/journal.pone.0129906	http://dx.doi.org/10.1371/journal.pone.0129906			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066795	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000122
J	Owen-Smith, N; Martin, J				Owen-Smith, Norman; Martin, Jodie			Identifying Space Use at Foraging Arena Scale within the Home Ranges of Large Herbivores	PLOS ONE			English	Article							ANIMAL MOVEMENT; SABLE ANTELOPE; ECOLOGY; HABITAT; MODELS; MECHANISMS; RESOURCES; RESPONSES; MEMORY; STATES	An intermediate spatiotemporal scale of food procurement by large herbivores is evident within annual or seasonal home ranges. It takes the form of settlement periods spanning several days or weeks during which foraging activity is confined to spatially discrete foraging arenas, separated by roaming interludes. Extended by areas occupied for other activities, these foraging arenas contribute towards generating the home range structure. We delineated and compared the foraging arenas exploited by two African large herbivores, sable antelope (a ruminant) and plains zebra (a non-ruminant), using GPS-derived movement data. We developed a novel approach to specifically delineate foraging arenas based on local change points in distance relative to adjoining clusters of locations, and compared its output with modifications of two published methods developed for home range estimation and residence time estimation respectively. We compared how these herbivore species responded to seasonal variation in food resources and how they differed in their spatial patterns of resource utilization. Sable antelope herds tended to concentrate their space use locally, while zebra herds moved more opportunistically over a wider set of foraging arenas. The amalgamated extent of the foraging arenas exploited by sable herds amounted to 1230 km(2), compared with 22-100 km(2) for the zebra herds. Half-day displacement distances differed between settlement periods and roaming interludes, and zebra herds generally shifted further over 12h than sable herds. Foraging arenas of sable herds tended to be smaller than those of zebra, and were occupied for period twice as long, and hence exploited more intensively in days spent per unit area than the foraging arenas of zebra. For sable both the intensity of utilization of foraging arenas and proportion of days spent in foraging arenas relative to roaming interludes declined as food resources diminished seasonally, while zebra showed no seasonal variation in these metrics. Identifying patterns of space use at foraging arena scale helps reveal mechanisms generating the home range extent, and in turn the local population density. Thereby it helps forge links between behavioural ecology, movement ecology and population ecology.	[Owen-Smith, Norman; Martin, Jodie] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Ctr African Ecol, ZA-2050 Johannesburg, South Africa	University of Witwatersrand	Owen-Smith, N (corresponding author), Univ Witwatersrand, Sch Anim Plant & Environm Sci, Ctr African Ecol, ZA-2050 Johannesburg, South Africa.	norman.owen-smith@wits.ac.za	Owen-Smith, Norman/ABI-5113-2020	Owen-Smith, Norman/0000-0001-8429-1201	South African Foundation for Research Development	South African Foundation for Research Development	This work was supported by the South African Foundation for Research Development funds for original placement of GPS collars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens RNM, 2012, FISH FISH, V13, P41, DOI 10.1111/j.1467-2979.2011.00432.x; [Anonymous], FORAGING THEORY; Avgar T, 2013, ECOL MODEL, V251, P158, DOI 10.1016/j.ecolmodel.2012.12.002; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Benhamou S, 2013, ECOLOGY LETT; Benhamou S, 2012, ECOL MODEL, V227, P112, DOI 10.1016/j.ecolmodel.2011.12.015; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014592; Beyer HL, 2013, METHODS ECOL EVOL, V4, P433, DOI 10.1111/2041-210X.12026; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Borger L, 2006, AM NAT, V168, P471, DOI 10.1086/507883; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Cain JW, 2012, J ZOOL, V286, P58, DOI 10.1111/j.1469-7998.2011.00848.x; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; CARR GM, 1986, ANIM BEHAV, V34, P1540, DOI 10.1016/S0003-3472(86)80223-8; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chirima GJ, 2013, ECOGRAPHY, V36, P68, DOI 10.1111/j.1600-0587.2012.07333.x; Cornelis D, 2011, J MAMMAL, V92, P1287, DOI 10.1644/10-MAMM-A-397.1; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fieberg J, 2012, J MAMMAL, V93, P890, DOI 10.1644/11-MAMM-S-172.1; Gautestad AO, 2013, J ANIM ECOL, V82, P572, DOI 10.1111/1365-2656.12027; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; JEWELL P. A., 1966, SYMP ZOOL SOC LONDON, V18, P85; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Lavielle M, 2005, SIGNAL PROCESS, V85, P1501, DOI 10.1016/j.sigpro.2005.01.012; Lyons AJ, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-2; Macandza VA, 2012, J ZOOL, V287, P175, DOI 10.1111/j.1469-7998.2012.00900.x; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Moorcroft PR, 2008, ECOLOGY, V89, P1112, DOI 10.1890/06-1985.1; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Owen-Smith N, 2014, J ZOOL, V293, P181, DOI 10.1111/jzo.12132; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Owen-Smith N, ECOSPHERE IN PRESS; Owen-Smith N, 2013, WILDLIFE RES, V40, P232, DOI 10.1071/WR13024; Owen-Smith N, 2012, WILDLIFE RES, V39, P452, DOI 10.1071/WR12062; Owen-Smith RN., 2002, ADAPTIVE HERBIVORE E, VStudent; OWENSMITH N, 1994, ECOLOGY, V75, P1050, DOI 10.2307/1939429; Powell RA, 2000, METH C CONS, P65; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; SENFT RL, 1987, BIOSCIENCE, V37, P789, DOI 10.2307/1310545; Spencer WD, 2012, J MAMMAL, V93, P929, DOI 10.1644/12-MAMM-S-061.1; SYSTAT Software Inc, 2004, YSTAT 11; Van Moorter B, 2009, OIKOS, V118, P641, DOI 10.1111/j.1600-0706.2008.17003.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	47	19	19	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128821	10.1371/journal.pone.0128821	http://dx.doi.org/10.1371/journal.pone.0128821			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066834	Green Submitted, gold, Green Published			2022-12-27	WOS:000356100900031
J	Al-Safadi, S; Branchaud, M; Rutherford, S; Amir, S				Al-Safadi, Sherin; Branchaud, Marie; Rutherford, Spencer; Amir, Shimon			Glucocorticoids and Stress-Induced Changes in the Expression of PERIOD1 in the Rat Forebrain	PLOS ONE			English	Article							DORSOMEDIAL HYPOTHALAMIC NUCLEUS; PERIPHERAL CIRCADIAN CLOCKS; CENTRAL EXTENDED AMYGDALA; STRIA TERMINALIS; BED NUCLEUS; GENE-EXPRESSION; OVAL NUCLEUS; PARAVENTRICULAR NUCLEUS; DIURNAL RHYTHMS; PROTEIN	The secretion of glucocorticoids in mammals is under circadian control, but glucocorticoids themselves are also implicated in modulating circadian clock gene expression. We have shown that the expression of the circadian clock protein PER1 in the forebrain is modulated by stress, and that this effect is associated with changes in plasma corticosterone levels, suggesting a possible role for glucocorticoids in the mediation of stress-induced changes in the expression of PER1 in the brain. To study this, we assessed the effects of adrenalectomy and of pretreatment with the glucocorticoid receptor antagonist, mifepristone, on the expression of PER1 in select limbic and hypothalamic regions following acute exposure to a neurogenic stressor, restraint, or a systemic stressor, 2-Deoxy-D-glucose (2DG) in rats. Acute restraint suppressed PER1 expression in the oval nucleus of the bed nucleus of the stria terminalis (BNSTov) and the central nucleus of the amygdala (CEAl), whereas 2DG increased PER1 in both regions. Both stressors increased PER1 expression in the paraventricular (PVN) and dorsomedial (DMH) nuclei of the hypothalamus, and the piriform cortex (Pi). Adrenalectomy and pretreatment with mifepristone reversed the effects of both stressors on PER1 expression in the BNSTov and CEAl, and blocked their effects in the DMH. In contrast, both treatments enhanced the effects of restraint and 2DG on PER1 levels in the PVN. Stress-induced PER1 expression in the Pi was unaffected by either treatment. PER1 expression in the suprachiasmatic nucleus, the master circadian clock, was not altered by either exposure to stress or by the glucocorticoid manipulations. Together, the results demonstrate a key role for glucocorticoid signaling in stress-induced changes in PER1 expression in the brain.	[Al-Safadi, Sherin; Amir, Shimon] Concordia Univ, Dept Biol, Montreal, PQ H4B 1R6, Canada; [Al-Safadi, Sherin; Branchaud, Marie; Rutherford, Spencer; Amir, Shimon] Concordia Univ, Ctr Studies Behav Neurobiol, Dept Psychol, Montreal, PQ H4B 1R6, Canada	Concordia University - Canada; Concordia University - Canada	Amir, S (corresponding author), Concordia Univ, Dept Biol, SP-375-07,7141 Sherbrooke St West, Montreal, PQ H4B 1R6, Canada.	shimon.amir@concordia.ca	Rutherford, Spencer/GPS-9422-2022; Amir, Shimon/AAE-4635-2022		Natural Sciences and Engineering Research Council of Canada (NSERC); les Fonds de la recherche en sante Quebec (FRSQ); Concordia University Research Chair Program	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); les Fonds de la recherche en sante Quebec (FRSQ); Concordia University Research Chair Program	This study was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC), les Fonds de la recherche en sante Quebec (FRSQ) and the Concordia University Research Chair Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2000, GENE DEV, V14, P645; Akhisaroglu M, 2004, PHARMACOL BIOCHEM BE, V79, P37, DOI 10.1016/j.pbb.2004.06.014; Al-Safadi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111166; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Amir S, 2004, J NEUROSCI, V24, P781, DOI 10.1523/JNEUROSCI.4488-03.2004; Amir S, 2006, NEUROSCI LETT, V407, P254, DOI 10.1016/j.neulet.2006.08.057; Anisman H, 2001, BEHAV NEUROSCI, V115, P443, DOI 10.1037/0735-7044.115.2.443; Bailey TW, 2001, AM J PHYSIOL-REG I, V280, pR8, DOI 10.1152/ajpregu.2001.280.1.R8; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Chen YZ, 2001, NEWS PHYSIOL SCI, V16, P292; Davis M, 1999, ANN NY ACAD SCI, V877, P281, DOI 10.1111/j.1749-6632.1999.tb09273.x; Day HEW, 2005, EUR J NEUROSCI, V21, P441, DOI 10.1111/j.1460-9568.2005.03865.x; Di S, 2003, J NEUROSCI, V23, P4850; Dickmeis T, 2013, MOL CELL ENDOCRINOL, V380, P2, DOI 10.1016/j.mce.2013.05.012; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; Dong L, 2011, AM J PSYCHIAT, V168, P1090, DOI 10.1176/appi.ajp.2011.10111579; Fuchs E, 2003, PHYSIOL BEHAV, V79, P417, DOI 10.1016/S0031-9384(03)00161-6; Gery S, 2007, CLIN CANCER RES, V13, P1399, DOI 10.1158/1078-0432.CCR-06-1730; HONKANIEMI J, 1992, NEUROENDOCRINOLOGY, V55, P451, DOI 10.1159/000126156; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; Keim SR, 1996, BRAIN RES, V739, P46, DOI 10.1016/S0006-8993(96)00810-4; Koresh O, 2012, EUR NEUROPSYCHOPHARM, V22, P205, DOI 10.1016/j.euroneuro.2011.07.012; Kozicz T, 2002, EUR J NEUROSCI, V16, P823, DOI 10.1046/j.1460-9568.2002.02129.x; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Li HY, 1998, J COMP NEUROL, V393, P244; Meerlo P, 2002, STRESS, V5, P15, DOI 10.1080/102538902900012323; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Nader N, 2010, TRENDS ENDOCRIN MET, V21, P277, DOI 10.1016/j.tem.2009.12.011; O'Callaghan EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047087; Paladino N, 2010, J NEUROIMMUNOL, V225, P62, DOI 10.1016/j.jneuroim.2010.04.015; Pantazopoulos H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020658; POMPEI P, 1995, MOL BRAIN RES, V33, P209, DOI 10.1016/0169-328X(95)00115-9; Segall LA, 2006, NEUROSCIENCE, V140, P753, DOI 10.1016/j.neuroscience.2006.03.037; Segall LA, 2009, NEUROSCI LETT, V457, P58, DOI 10.1016/j.neulet.2009.03.083; Segall LA, 2010, J MOL NEUROSCI, V42, P168, DOI 10.1007/s12031-010-9341-1; Segall LA, 2010, J MOL NEUROSCI, V42, P176, DOI 10.1007/s12031-010-9375-4; Spencer S, 2013, EUR J NEUROSCI, V37, P242, DOI 10.1111/ejn.12010; Strehl C, 2011, ARTHRITIS RHEUM-US, V63, P3779, DOI 10.1002/art.30637; Takahashi S, 2001, ENDOCRINOLOGY, V142, P4910, DOI 10.1210/en.142.11.4910; Tasker JG, 2006, ENDOCRINOLOGY, V147, P5549, DOI 10.1210/en.2006-0981; Tasker JG, 2005, INTEGR COMP BIOL, V45, P665, DOI 10.1093/icb/45.4.665; Vernocchi S, 2013, MOL CELL PROTEOMICS, V12, P1764, DOI 10.1074/mcp.M112.022947; Verwey M, 2009, EUR J NEUROSCI, V29, P2217, DOI 10.1111/j.1460-9568.2009.06766.x; Weibel L, 2002, J BIOL RHYTHM, V17, P438, DOI 10.1177/074873002237138; Weiser MJ, 2011, J NEUROENDOCRINOL, V23, P1231, DOI 10.1111/j.1365-2826.2011.02217.x; Wong CCP, 2012, J NEURAL TRANSM, V119, P1111, DOI 10.1007/s00702-012-0829-4; Yamamoto T, 2005, J BIOL CHEM, V280, P42036, DOI 10.1074/jbc.M509600200; Yang XM, 2009, CHRONOBIOL INT, V26, P1323, DOI 10.3109/07420520903431301; Zalachoras I, 2013, P NATL ACAD SCI USA, V110, P7910, DOI 10.1073/pnas.1219411110; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016212	51	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130085	10.1371/journal.pone.0130085	http://dx.doi.org/10.1371/journal.pone.0130085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075608	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000356329900136
J	Ambrosio, JR; Valverde-Islas, L; Nava-Castro, KE; Palacios-Arreola, MI; Ostoa-Saloma, P; Reynoso-Ducoing, O; Escobedo, G; Ruiz-Rosado, A; Dominguez-Ramirez, L; Morales-Montor, J				Ambrosio, Javier R.; Valverde-Islas, Laura; Nava-Castro, Karen E.; Isabel Palacios-Arreola, M.; Ostoa-Saloma, Pedro; Reynoso-Ducoing, Olivia; Escobedo, Galileo; Ruiz-Rosado, Azucena; Dominguez-Ramirez, Lenin; Morales-Montor, Jorge			Androgens Exert a Cysticidal Effect upon Taenia crassiceps by Disrupting Flame Cell Morphology and Function	PLOS ONE			English	Article							HOST-PARASITE RELATIONSHIP; MURINE CYSTICERCOSIS; SEX-HORMONES; ALBINO MICE; PROGESTERONE; INFECTIONS; GROWTH; SOLIUM; CESTODA; GONADECTOMY	The effects of testosterone (T-4) and dihydrotestosterone (DHT) on the survival of the helminth cestode parasite Taenia crassiceps, as well as their effects on actin, tubulin and myosin expression and their assembly into the excretory system of flame cells are described in this paper. In vitro evaluations on parasite viability, flow cytometry, confocal microscopy, video-microscopy of live flame cells, and docking experiments of androgens interacting with actin, tubulin, and myosin were conducted. Our results show that T-4 and DHT reduce T. crassiceps viability in a dose-and time-dependent fashion, reaching 90% of mortality at the highest dose used (40 ng/ml) and time exposed (10 days) in culture. Androgen treatment does not induce differences in the specific expression pattern of actin, tubulin, and myosin isoforms as compared with control parasites. Confocal microscopy demonstrated a strong disruption of the parasite tegument, with reduced assembly, shape, and motion of flame cells. Docking experiments show that androgens are capable of affecting parasite survival and flame cell morphology by directly interacting with actin, tubulin and myosin without altering their protein expression pattern. We show that both T-4 and DHT are able to bind actin, tubulin, and myosin affecting their assembly and causing parasite intoxication due to impairment of flame cell function. Live flame cell video microscopy showing a reduced motion as well changes in the shape of flame cells are also shown. In summary, T-4 and DHT directly act on T. crassiceps cysticerci through altering parasite survival as well as the assembly and function of flame cells.	[Ambrosio, Javier R.; Valverde-Islas, Laura; Reynoso-Ducoing, Olivia] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico; [Nava-Castro, Karen E.] Univ Nacl Autonoma Mexico, Ctr Ciencias Atmosfera, Dept Ciencias Ambientales, Mexico City 04510, DF, Mexico; [Isabel Palacios-Arreola, M.; Ostoa-Saloma, Pedro; Ruiz-Rosado, Azucena; Morales-Montor, Jorge] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico; [Escobedo, Galileo] Univ Nacl Autonoma Mexico, Fac Med, Unidad Med Expt, Mexico City 04510, DF, Mexico; [Ruiz-Rosado, Azucena] McGill Univ, Div Expt Med, Montreal, PQ, Canada; [Ruiz-Rosado, Azucena] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Segar Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Dominguez-Ramirez, Lenin] Univ Amer Puebla, Escuela Ciencias, Dept Ciencias Quim Biol, Santa Catarina Martir Ch, Puebla, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; McGill University; Lady Davis Institute; McGill University; Universidad Americas Puebla (UDLAP)	Morales-Montor, J (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico.	jmontor66@biomedicas.unam.mx	Montor, Jorge/B-1224-2012; Dominguez-Ramirez, Lenin/AAG-9864-2020; Ambrosio, Javier R/A-6099-2008; Nava-Castro, Karen E/V-4161-2018; Ostoa-Saloma, Pedro/V-3226-2019	Montor, Jorge/0000-0002-9461-610X; Dominguez-Ramirez, Lenin/0000-0002-3483-4658; Ambrosio, Javier R/0000-0001-7441-0609; Nava-Castro, Karen E/0000-0003-2223-6703; Palacios-Arreola, Margarita Isabel/0000-0001-8882-7544; Ostoa-Saloma, Pedro/0000-0003-2066-8019	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) from Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico (U.N.A.M.) [IN-216213, IN-201510]; Programa de Fondos Sectoriales CB-SEP, Consejo Nacional de Ciencia y Tecnologia (CONACyT) [176803]; CONACyT [151747]; Pew Latin American Fellows Program in the Biomedical Sciences; CONACyT	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) from Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico (U.N.A.M.); Programa de Fondos Sectoriales CB-SEP, Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Pew Latin American Fellows Program in the Biomedical Sciences; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants # IN-216213 and # IN-201510 to Javier Ambrosio, obtained from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) from Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico (U.N.A.M.), and Grant 176803, from Programa de Fondos Sectoriales CB-SEP, Consejo Nacional de Ciencia y Tecnologia (CONACyT) to Jorge Morales Montor, and Grant 151747 to Pedro Ostoa-Saloma, also from CONACyT. Lenin Dominguez-Ramirez was in part funded by the Pew Latin American Fellows Program in the Biomedical Sciences. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Karen Nava-Castro has a postdoctoral fellowship from CONACyT. M. Isabel Palacios-Arreola is a PhD student at Programa de Doctorado en Ciencias Biomedicas, UNAM, and has a scholarship from CONACyT.	Alvarez LI, 2007, TRENDS PARASITOL, V23, P97, DOI 10.1016/j.pt.2007.01.003; Ambrosio JR, 2014, INT J PARASITOL, V44, P687, DOI 10.1016/j.ijpara.2014.04.004; Barnes D, 1987, ZOOLOGIA INVERTEBRAD, P179; BHAI I, 1982, INT J PARASITOL, V12, P589, DOI 10.1016/0020-7519(82)90057-1; Bottasso O, 2009, NEUROIMMUNOMODULAT, V16, P65, DOI 10.1159/000180260; Chen LF, 2002, J STRUCT BIOL, V138, P92, DOI 10.1016/S1047-8477(02)00013-8; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coil W.H., 1991, P211; Cruz-Rivera M, 2006, CELL BIOL INT, V30, P598, DOI 10.1016/j.cellbi.2006.02.010; CULBRETH KL, 1972, EXP PARASITOL, V32, P272, DOI 10.1016/0014-4894(72)90034-3; de Forges H, 2012, INT J BIOCHEM CELL B, V44, P266, DOI 10.1016/j.biocel.2011.11.009; DOBSON C, 1961, PARASITOLOGY, V51, P499, DOI 10.1017/S0031182000070748; DORAIS FJ, 1969, EXP PARASITOL, V25, P395, DOI 10.1016/0014-4894(69)90086-1; Durrant JD, 2011, J CHEM INF MODEL, V51, P2897, DOI 10.1021/ci2003889; Escobedo G, 2005, TRENDS PARASITOL, V21, P588, DOI 10.1016/j.pt.2005.09.013; Escobedo G, 2004, J PARASITOL, V90, P1235, DOI 10.1645/GE-297R; Escobedo G, 2011, INT J BIOL SCI, V7, P1443, DOI 10.7150/ijbs.7.1443; Escobedo G, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/591079; FRAYHA GJ, 1971, EXP PARASITOL, V29, P255, DOI 10.1016/0014-4894(71)90032-4; Ibarra-Coronado EG, 2011, STEROIDS, V76, P1149, DOI 10.1016/j.steroids.2011.05.003; Hernandez-Bello R, 2010, PARASITE IMMUNOL, V32, P633, DOI 10.1111/j.1365-3024.2010.01232.x; Hernandez-Bello R, 2012, MINIREVIEWS MED CHEM; Hernandez-Bello R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/625380; Kumar D, 2003, PARASITOLOGY, V127, P457, DOI 10.1017/S0031182003003925; LARRALDE C, 1995, J STEROID BIOCHEM, V52, P575, DOI 10.1016/0960-0760(95)00062-5; MOCK BA, 1988, INFECT IMMUN, V56, P3316, DOI 10.1128/IAI.56.12.3316-3319.1988; Morales-Montor J, 2008, CURR TOP MED CHEM, V8, P400, DOI 10.2174/156802608783790866; Morales-Montor J, 2002, EXP PARASITOL, V100, P209, DOI 10.1016/S0014-4894(02)00028-0; Nava-Castro K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/257060; NOVAK M, 1975, INT J PARASITOL, V5, P269, DOI 10.1016/0020-7519(75)90072-7; Palomares F, 2006, J ANTIMICROB CHEMOTH, V57, P482, DOI 10.1093/jac/dki484; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Ricardo PU, 2012, EXP PARASITOL, V130, P32, DOI 10.1016/j.exppara.2011.10.002; ROHDE K, 1992, INT J PARASITOL, V22, P443, DOI 10.1016/0020-7519(92)90145-B; Sciutto E, 2011, PARASITE IMMUNOL, V33, P79, DOI 10.1111/j.1365-3024.2010.01257.x; SCIUTTO E, 1990, PARASITE IMMUNOL, V12, P687, DOI 10.1111/j.1365-3024.1990.tb00997.x; SOLOMON GB, 1966, EXP PARASITOL, V18, P374, DOI 10.1016/0014-4894(66)90039-7; Tsai IJ, 2013, NATURE, V496, P57, DOI 10.1038/nature12031; Valverde-Islas LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014754; Vargas-Villavicencio JA, 2006, PARASITE IMMUNOL, V28, P667, DOI 10.1111/j.1365-3024.2006.00906.x; Vargas-Villavicencio JA, 2005, MICROBES INFECT, V7, P485, DOI 10.1016/j.micinf.2004.12.015; VOGE M, 1963, J PARASITOL, V49, P85, DOI 10.2307/3275681; Yang LJ, 2006, J PHYS CHEM B, V110, P13166, DOI 10.1021/jp060163v	43	7	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0127928	10.1371/journal.pone.0127928	http://dx.doi.org/10.1371/journal.pone.0127928			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076446	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900016
J	Calderon, MJ; Ploegman, AG; Bailey, B; Jung, DO; Navratil, AM; Ellsworth, BS				Calderon, Michael J.; Ploegman, Adam G.; Bailey, Brock; Jung, Deborah O.; Navratil, Amy M.; Ellsworth, Buffy S.			Loss of Foxm1 Results in Reduced Somatotrope Cell Number during Mouse Embryogenesis	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; GENE-EXPRESSION; PITUITARY ORGANOGENESIS; GLUCOSE-HOMEOSTASIS; BETA-CATENIN; CYCLE EXIT; MICE; FOXL2; PROLIFERATION; PROTEIN	FOXM1, a member of the forkhead box transcription factor family, plays a key role in cell cycling progression by regulating the expression of critical G1/S and G2/M phase transition genes. In vivo studies reveal that Foxm1 null mice have a 91% lethality rate at e18.5 due to significant cardiovascular and hepatic hypoplasia. Thus, FOXM1 has emerged as a key protein regulating mitotic division and cell proliferation necessary for embryogenesis. In the current study, we assess the requirement for Foxm1 in the developing pituitary gland. We find that Foxm1 is expressed in the pituitary at embryonic days 10.5-e18.5 and localizes with markers for active cell proliferation (BrdU). Interestingly, direct analysis of Foxm1 null mice at various embryonic ages, reveals no difference in gross pituitary morphology or cell proliferation. We do observe a downward trend in overall pituitary cell number and a small reduction in pituitary size in e18.5 embryos suggesting there may be subtle changes in pituitary proliferation not detected with our proliferation makers. Consistent with this, Foxm1 null mice have reductions in both the somatotrope and gonadotrope cell populations.	[Calderon, Michael J.; Ploegman, Adam G.; Bailey, Brock; Jung, Deborah O.; Ellsworth, Buffy S.] So Illinois Univ, Dept Physiol, Carbondale, IL 62901 USA; [Navratil, Amy M.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA	Southern Illinois University System; Southern Illinois University; University of Wyoming	Ellsworth, BS (corresponding author), So Illinois Univ, Dept Physiol, Carbondale, IL 62901 USA.	bellsworth@siumed.edu		Jung, Deborah/0000-0002-8307-8772	Southern Illinois School of Medicine Central Research Committee; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R15HD063469-01]; National Center for Research Resources [P20RR016474]; National Institute of General Medical Sciences from the National Institutes of Health [P20GM103432]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD063469] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103432] Funding Source: NIH RePORTER	Southern Illinois School of Medicine Central Research Committee; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from Southern Illinois School of Medicine Central Research Committee (B. S. E) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R15HD063469-01, B. S. E.), the National Center for Research Resources (P20RR016474, A. M. N.) and the National Institute of General Medical Sciences (P20GM103432, A. M. N.) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arriola DJ, 2012, J BIOL CHEM, V287, P33424, DOI 10.1074/jbc.M112.362103; Bilodeau S, 2009, MOL CELL BIOL, V29, P1895, DOI 10.1128/MCB.01885-08; Brannick KE, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100636; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calvisi DF, 2009, GUT, V58, P679, DOI 10.1136/gut.2008.152652; Carninci P, 2003, GENOME RES, V13, P1273, DOI 10.1101/gr.1119703; Cheung CC, 2007, PITUITARY, V10, P335, DOI 10.1007/s11102-007-0051-9; Coss D, 2010, TRENDS ENDOCRIN MET, V21, P562, DOI 10.1016/j.tem.2010.05.006; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Davis SW, 2010, MOL CELL ENDOCRINOL, V323, P4, DOI 10.1016/j.mce.2009.12.012; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; GODFREY VL, 1991, P NATL ACAD SCI USA, V88, P5528, DOI 10.1073/pnas.88.13.5528; Gumbel JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052156; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; JAPON MA, 1994, J HISTOCHEM CYTOCHEM, V42, P1117, DOI 10.1177/42.8.8027530; Jung DO, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094904; Justice NJ, 2011, MOL ENDOCRINOL, V25, P1404, DOI 10.1210/me.2011-0093; Kim IM, 2005, J BIOL CHEM, V280, P22278, DOI 10.1074/jbc.M500936200; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Lamba P, 2009, MOL ENDOCRINOL, V23, P1001, DOI 10.1210/me.2008-0324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyon MF, 1986, MOUSE NEWS LETT, V74, P93; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Mirzayans F, 2000, EUR J HUM GENET, V8, P71, DOI 10.1038/sj.ejhg.5200354; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Nishimura DY, 2001, AM J HUM GENET, V68, P364, DOI 10.1086/318183; Norquay LD, 2006, MOL ENDOCRINOL, V20, P598, DOI 10.1210/me.2005-0221; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Ramakrishna S, 2007, DEV DYNAM, V236, P1000, DOI 10.1002/dvdy.21113; Salisbury TB, 2008, MOL ENDOCRINOL, V22, P1295, DOI 10.1210/me.2007-0515; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen W, 2001, J BIOL CHEM, V276, P42812, DOI 10.1074/jbc.M106344200; Shih DQ, 1999, P NATL ACAD SCI USA, V96, P10152, DOI 10.1073/pnas.96.18.10152; Tran S, 2013, MOL ENDOCRINOL, V27, P407, DOI 10.1210/me.2012-1286; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Waite E, 2010, ENDOCRINOLOGY, V151, P234, DOI 10.1210/en.2009-0539; Wierstra I, 2013, ADV CANCER RES, V118, P97, DOI 10.1016/B978-0-12-407173-5.00004-2; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006	47	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128942	10.1371/journal.pone.0128942	http://dx.doi.org/10.1371/journal.pone.0128942			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075743	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900038
J	Jeronimus, BF; Stavrakakis, N; Veenstra, R; Oldehinkel, AJ				Jeronimus, Bertus F.; Stavrakakis, Nikolaos; Veenstra, Rene; Oldehinkel, Albertine J.			Relative Age Effects in Dutch Adolescents: Concurrent and Prospective Analyses	PLOS ONE			English	Article							INDIVIDUAL-LIVES SURVEY; SELF-ESTEEM; INTERNATIONAL EVIDENCE; ANXIETY PROBLEMS; YOUNG ADULTHOOD; BIRTH; CHILDREN; OUTCOMES; DEPRESSION; SCHOOL	The literature on relative age position effects is rather inconsistent. In this study we examined intra-classroom age position (or relative age) effects on Dutch adolescents' school progress and performance (as rated by teachers), physical development, temperamental development (fear and frustration), and depressive symptoms, all adjusted for age at the time of measurement. Data were derived from three waves of Tracking Adolescents' Individuals Lives Survey (TRAILS) of 2230 Dutch adolescents (baseline mean age 11.1, SD = 0.6, 51% girls). Albeit relative age predicted school progress (grade retention ORs = 0.83 for each month, skipped grade OR = 1.47, both p<.001), our key observation is the absence of substantial developmental differences as a result of relative age position in Dutch adolescents with a normative school trajectory, in contrast to most literature. For adolescents who had repeated a grade inverse relative age effects were observed, in terms of physical development and school performance, as well as on depressive symptoms, favoring the relatively young. Cross-cultural differences in relative age effect may be partly explained by the decision threshold for grade retention.	[Jeronimus, Bertus F.; Stavrakakis, Nikolaos; Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Veenstra, Rene] Univ Groningen, Dept Sociol, Groningen, Netherlands; [Veenstra, Rene] Univ Groningen, Interuniv Ctr Social Sci Theory & Methodol ICS, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Jeronimus, BF (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	B.F.Jeronimus@umcg.nl	Jeronimus, Bertus F/AAC-2877-2020; Veenstra, René/G-6696-2011	Veenstra, René/0000-0001-6686-6307; Jeronimus, Bertus/0000-0003-2826-4537	Alzheimer Forschung Initiative e.V. (AFI) [05825]; AiF/IGF grant of the Bundesministerium fur Wirtschaft [15727 N/1]; Ernst Schering Foundation; Massachusetts Alzheimer Disease Research Center (MADRC) (National Institute on Aging (NIA) grant [P50 AG005134]; NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER	Alzheimer Forschung Initiative e.V. (AFI); AiF/IGF grant of the Bundesministerium fur Wirtschaft; Ernst Schering Foundation; Massachusetts Alzheimer Disease Research Center (MADRC) (National Institute on Aging (NIA) grant; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants to C. A. F. v. A from the Alzheimer Forschung Initiative e.V. (AFI) (grant number 05825), from an AiF/IGF grant (grant number 15727 N/1) of the Bundesministerium fur Wirtschaft, a Doctoral Fellowship to A. W. from the Ernst Schering Foundation, and from the Massachusetts Alzheimer Disease Research Center (MADRC) (National Institute on Aging (NIA) grant award number P50 AG005134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela JRZ, 2012, J CLIN CHILD ADOLESC, V41, P391, DOI 10.1080/15374416.2012.654463; Achenbach TM, 2003, J CLIN CHILD ADOLESC, V32, P328, DOI 10.1207/S15374424JCCP3203_02; Achenbach TM, 2003, MANUAL ASEBA ADULT F; Allen J., 2008, J SOCIO-ECON, V37, P343; Beam CR, 2013, DEV PSYCHOPATHOL, V25, P7, DOI 10.1017/S0954579412000867; Bedard K, 2006, Q J ECON, V121, P1437, DOI 10.1162/qjec.121.4.1437; BELL JF, 1990, OXFORD REV EDUC, V16, P67, DOI 10.1080/0305498900160106; Bobak M, 2001, HUM REPROD, V16, P1512, DOI 10.1093/humrep/16.7.1512; Borenstein M, 2009, INTRO META ANAL; Boyce WT, 2012, P NATL ACAD SCI USA, V109, P17168, DOI 10.1073/pnas.1201730109; Buckles KS, 2013, REV ECON STAT, V95, P711, DOI 10.1162/REST_a_00314; Cascio E, 2007, NBER WORKING PAPER N; Caspi A., 2006, HDB CHILD PSYCHOL, V3, P300, DOI DOI 10.1002/9780470147658.CHPSY0306; Collins WA, 2009, ANNU REV PSYCHOL, V60, P631, DOI 10.1146/annurev.psych.60.110707.163459; Cyranowski JM, 2000, ARCH GEN PSYCHIAT, V57, P21, DOI 10.1001/archpsyc.57.1.21; Dalton B, 2012, COMP EDUC REV, V56, P125, DOI 10.1086/660745; de Winter AF, 2005, EUR J EPIDEMIOL, V20, P173, DOI 10.1007/s10654-004-4948-6; Deardorff J, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-27; Denessen EJPG, 2010, J EDUC RES, V4; Dhuey E, 2008, ECON EDUC REV, V27, P173, DOI 10.1016/j.econedurev.2006.08.005; Dijkstra JK, 2013, DEV PSYCHOL, V49, P1242, DOI 10.1037/a0030098; Doornbos K, 1971, THESIS RIJKSUNIVERSI; Eaves L, 2004, TWIN RES, V7, P471, DOI 10.1375/1369052042335278; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fenzel L, 1992, J EARLY ADOLESC, V12, P253, DOI DOI 10.1177/0272431692012003002; Ferdinand RF, 2008, J ANXIETY DISORD, V22, P126, DOI 10.1016/j.janxdis.2007.01.008; Flynn J. R., 2009, WHAT IS INT BEYOND; Fraley RC, 2002, PERS SOC PSYCHOL REV, V6, P123, DOI 10.1207/S15327957PSPR0602_03; Gladwell Malcolm, 2008, OUTLIERS; GLEDHILL J, 2002, RES EDUC, V68, P41, DOI DOI 10.7227/RIE.68.4; Goodman R, 2003, BMJ-BRIT MED J, V327, P472, DOI 10.1136/bmj.327.7413.472; Graue ME, 2000, AM EDUC RES J, V37, P509, DOI 10.3102/00028312037002509; Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128; Harris J. R., 2009, NURTURE ASSUMPTION W; HARRIS JR, 1995, PSYCHOL REV, V102, P458, DOI 10.1037/0033-295X.102.3.458; HARTMAN CA, 2000, DUTCH TRANSLATION EA; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Huisman M, 2008, INT J EPIDEMIOL, V37, P1227, DOI 10.1093/ije/dym273; Hutchison D, 2013, BRIT ED RES ASS C SE; Janssens KAM, 2011, PEDIATRICS, V128, P553, DOI 10.1542/peds.2010-2364; Jeronimus BF, 2014, J PERS SOC PSYCHOL, V107, P751, DOI 10.1037/a0037009; Koenig MA, 2011, CHILD DEV, V82, P1634, DOI 10.1111/j.1467-8624.2011.01618.x; Laceulle OM, 2015, EUR J PERSONALITY, V29, P125, DOI 10.1002/per.1989; Laurence Stephen, 2006, INNATE MIND CULTURE, V2; Lawlor DA, 2006, BRIT J EDUC PSYCHOL, V76, P481, DOI 10.1348/000709905X49700; Li X, 2012, INVEST OPHTH VIS SCI, V53, P3082, DOI 10.1167/iovs.12-9967; Martin R., 2013, WE DO IT EVOLUTION F; Martin RP, 2004, J LEARN DISABIL-US, V37, P307, DOI 10.1177/00222194040370040301; McDonald G., 2001, COMPARE, V31, P381; Morrow RL, 2012, CAN MED ASSOC J, V184, P755, DOI 10.1503/cmaj.111619; Muhlenweg AM, 2010, ECON LETT, V109, P157, DOI 10.1016/j.econlet.2010.08.032; Musch J, 2001, DEV REV, V21, P147, DOI 10.1006/drev.2000.0516; NEWCOMB AF, 1993, PSYCHOL BULL, V113, P99, DOI 10.1037/0033-2909.113.1.99; Neyer FJ, 2014, J PERS, V82, P539, DOI 10.1111/jopy.12063; Oldehinkel AJ, 1999, PSYCHOL MED, V29, P655, DOI 10.1017/S0033291799008454; Oldehinkel AJ, 2004, DEV PSYCHOPATHOL, V16, P421, DOI 10.1017/S0954579404044591; Oldehinkel AJ, 2007, J ABNORM CHILD PSYCH, V35, P417, DOI 10.1007/s10802-007-9100-0; Ormel J, 2012, J AM ACAD CHILD PSY, V51, P1020, DOI 10.1016/j.jaac.2012.08.004; Orth U, 2008, J PERS SOC PSYCHOL, V95, P695, DOI 10.1037/0022-3514.95.3.695; Persico N, 2004, NATL BUREAU EC RES W, V10522; Peterson RA, 2005, J APPL PSYCHOL, V90, P175, DOI 10.1037/0021-9010.90.1.175; Pierson K, 2014, J SPORT SCI, V32, P776, DOI 10.1080/02640414.2013.855804; Putnam SP., 2001, ADV RES TEMPERAMENT, P165; Rothbart M.K., 2011, BECOMING WHO WE ARE; Rothbart MK, 2000, J PERS SOC PSYCHOL, V78, P122, DOI 10.1037/0022-3514.78.1.122; Sandercock GRH, 2013, J STRENGTH COND RES, V27, P3293, DOI 10.1519/JSC.0b013e318291b28d; Shirtcliff EA, 2009, CHILD DEV, V80, P327, DOI 10.1111/j.1467-8624.2009.01263.x; Sukhnandan L., 1998, STREAMING SETTING GR; Thompson AH, 2004, EDUC RES-UK, V46, P313, DOI 10.1080/0013188042000277368; Thompson AH, 1999, CAN J PSYCHIAT, V44, P82, DOI 10.1177/070674379904400111; van Lang NDJ, 2005, BEHAV RES THER, V43, P1485, DOI 10.1016/j.brat.2004.11.005; Verachtert P, 2010, OXFORD REV EDUC, V36, P285, DOI 10.1080/03054981003629896; Wu W, 2010, J EDUC PSYCHOL, V102, P135, DOI 10.1037/a0016664	73	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128856	10.1371/journal.pone.0128856	http://dx.doi.org/10.1371/journal.pone.0128856			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076384	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900033
J	Li, LT; Dong, JB; Wang, XH; Guo, HM; Wang, HJ; Zhao, J; Qiu, YL; Abuduxikuer, K; Wang, JS				Li, Liting; Dong, Jibin; Wang, Xiaohong; Guo, Hongmei; Wang, Huijun; Zhao, Jing; Qiu, Yiling; Abuduxikuer, Kuerbanjiang; Wang, Jianshe			JAG1 Mutation Spectrum and Origin in Chinese Children with Clinical Features of Alagille Syndrome	PLOS ONE			English	Article							GENE; FAMILIES	Alagille syndrome is an autosomal dominant disorder that results from defects in the Notch signaling pathway, which is most frequently due to JAG1 mutations. This study investigated the rate, spectrum, and origin of JAG1 mutations in 91 Chinese children presenting with at least two clinical features of Alagille syndrome (cholestasis, heart murmur, skeletal abnormalities, ocular abnormalities, characteristic facial features, and renal abnormalities). Direct sequencing and/or multiplex-ligation-dependent probe amplification were performed in these patients, and segregation analysis was performed using samples available from the parents. JAG1 disease-causing mutations were detected in 70/91 (76.9%) patients, including 29/70 (41.4%) small deletions, 6/70 (8.6%) small insertions, 16/70 (22.9%) nonsense mutations, 8/70 (11.4%) splice-site mutations, 6/70 (9.4%) missense mutations, and 5/70 (7.1%) gross deletions. Of the mutations detected, 45/62 (72.6%) were novel, and almost all were unique, with the exception of c.439C>T, c.439+1G>A, c.703C>T, c.1382_1383delAC, c.2698C>T, and c.2990C>A, which were detected in two cases each; three cases exhibited entire gene deletions. A majority (69.2%) of the point and frameshift mutations could be detected by the sequencing of eleven exons (exons 3, 5, 6, 11, 14, 16, 18, 21, and 23-25). The mutation detection rate was 50.0% (10/20) in atypical cases that only presented with two or three clinical features of Alagille syndrome. Segregation analysis revealed that 81.1% (30/37) of these mutations were de novo. In conclusion, JAG1 mutations are present in the majority of Chinese pediatric patients with clinical features of Alagille syndrome, and the mutations concentrate on different exons from other reports. Genetic study is important for the diagnosis of atypical Alagille syndrome in Chinese patients.	[Li, Liting; Wang, Xiaohong; Zhao, Jing; Qiu, Yiling; Abuduxikuer, Kuerbanjiang; Wang, Jianshe] Fudan Univ, Childrens Hosp, Ctr Pediat Liver Dis, Shanghai 200433, Peoples R China; [Dong, Jibin] Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China; [Guo, Hongmei] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Wang, Huijun] Fudan Univ, Translat Med Res Ctr Children Dev & Dis, Shanghai Key Lab Birth Defect, Mol Genet Diag Ctr,Pediat Res Inst,Childrens Hosp, Shanghai 200433, Peoples R China; [Wang, Jianshe] Fudan Univ, Jinshan Hosp, Dept Pediat, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Nanjing Medical University; Fudan University; Fudan University	Wang, JS (corresponding author), Fudan Univ, Childrens Hosp, Ctr Pediat Liver Dis, Shanghai 200433, Peoples R China.	jshwang@shmu.edu.cn	wang, xiao/HGB-7081-2022; Abuduxikuer, Kuerbanjiang/T-6521-2019; wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022; wang, Jian-She/F-1154-2011	wang, xiao/0000-0002-4088-3341; Abuduxikuer, Kuerbanjiang/0000-0003-0298-3269; wang, jianshe/0000-0003-0823-586X	National Natural Science Foundation of China [81070281, 81361128006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research work was supported by the National Natural Science Foundation of China (No. 81070281 and No. 81361128006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAGILLE D, 1987, J PEDIATR-US, V110, P195, DOI 10.1016/S0022-3476(87)80153-1; Crosnier C, 1999, GASTROENTEROLOGY, V116, P1141, DOI 10.1016/S0016-5085(99)70017-X; Crosnier C, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<72::AID-HUMU11>3.0.CO;2-U; DANKS DM, 1977, ARCH DIS CHILD, V52, P360, DOI 10.1136/adc.52.5.360; Giannakudis J, 2001, EUR J HUM GENET, V9, P209, DOI 10.1038/sj.ejhg.5200613; Guegan K, 2012, CLIN GENET, V82, P33, DOI 10.1111/j.1399-0004.2011.01749.x; Heritage ML, 2000, HUM MUTAT, V16, P408, DOI 10.1002/1098-1004(200011)16:5<408::AID-HUMU5>3.0.CO;2-9; Jurkiewicz D, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9313; Kamath BM, 2007, LIVER DISEASE IN CHILDREN, 3RD EDITION, P326, DOI 10.1017/CBO9780511547409.017; Krantz ID, 1998, AM J HUM GENET, V62, P1361, DOI 10.1086/301875; Onouchi Y, 1999, J HUM GENET, V44, P235, DOI 10.1007/s100380050150; Pilia G, 1999, HUM MUTAT, V14, P394, DOI 10.1002/(SICI)1098-1004(199911)14:5<394::AID-HUMU5>3.0.CO;2-1; Ropke Albrecht, 2003, Hum Mutat, V21, P100, DOI 10.1002/humu.9102; Spinner NB, 2001, HUM MUTAT, V17, P18, DOI 10.1002/1098-1004(2001)17:1<18::AID-HUMU3>3.0.CO;2-T; Turnpenny PD, 2012, EUR J HUM GENET, V20, P251, DOI 10.1038/ejhg.2011.181; Wang HL, 2012, GENE, V499, P191, DOI 10.1016/j.gene.2012.02.038; Warthen DM, 2006, HUM MUTAT, V27, P436, DOI 10.1002/humu.20310	17	19	32	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130355	10.1371/journal.pone.0130355	http://dx.doi.org/10.1371/journal.pone.0130355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076142	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900167
J	Lourenco, S; Carnide, F; Benavides, FG; Lucas, R				Lourenco, Sara; Carnide, Filomena; Benavides, Fernando G.; Lucas, Raquel			Psychosocial Work Environment and Musculoskeletal Symptoms among 21-Year-Old Workers: A Population-Based Investigation (2011-2013)	PLOS ONE			English	Article							LOW-BACK-PAIN; SOCIAL SUPPORT; JOB STRAIN; HEART-DISEASE; RISK-FACTORS; HEALTH; ONSET; METAANALYSIS; PREDICTORS; DISORDERS	Background The current labour market is becoming more flexible and informal, with job insecurity selectively affecting young workers. However, the role of these increasing adverse psychosocial working conditions on health outcomes remains little known among newly employed workers. Objective To estimate the associations between psychosocial work environment and musculoskeletal outcomes (widespread pain syndrome features and regional pain) in a population-based sample of young workers. Methods Cross-sectional data from workers aged 21 years were collected during the third wave of the EPITeen cohort study (2011-2013; n=650). The Job Content Questionnaire was used to characterize the psychosocial work environment according to the demand-control-support model. Data on pain and non-pain dimensions of the widespread pain syndrome (Fibromyalgia Survey Questionnaire) as well as on regional musculoskeletal pain (Nordic Musculoskeletal Questionnaire) were also collected. Crude and adjusted odds ratios (OR) with 95% confidence intervals (95% CI) were computed using logistic regression and all estimates were adjusted for sex, education and occupational biomechanical demands. Results Job insecurity was significantly associated to the non-pain dimension of the widespread pain syndrome (adjusted OR [95% CI]=1.51 [1.08, 2.12]). Young workers with strain jobs were significantly more likely to report high levels of non-pain symptoms when compared with those with no-strain jobs and this effect was even stronger when social support was added to the main exposure: workers with strain jobs and low social support had twice the odds of reporting high levels of non-pain features than those with high strain but high social support jobs (adjusted OR=1.86, 95% CI: 1.04, 3.31). These significant associations were not observed when widespread pain or multisite regional pain were the outcomes. Conclusion In the beginning of professional life, high strain jobs were associated to non-pain complaints, especially when the work environment provided also low social support.	[Lourenco, Sara; Lucas, Raquel] Univ Porto, Inst Publ Hlth, EPIUnit, P-4100 Oporto, Portugal; [Carnide, Filomena] Univ Lisbon, Fac Human Kinet, Cruz Quebrada Dafundo, Portugal; [Benavides, Fernando G.] Pompeu Fabra Univ, Res Ctr Occupat Hlth, Barcelona, Spain; [Lucas, Raquel] Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med & Publ Hlth, P-4100 Oporto, Portugal	Universidade do Porto; Universidade de Lisboa; Pompeu Fabra University; Universidade do Porto	Lourenco, S (corresponding author), Univ Porto, Inst Publ Hlth, EPIUnit, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	slourenco@med.up.pt	Carnide, Filomena/K-5603-2013	Carnide, Filomena/0000-0002-0580-8637; Lucas, Raquel/0000-0002-4408-8134	Portuguese Foundation for Science and Technology (FCT) [FCOMP-01-0124-FEDER-015750, FCT - PTDC/SAU-EPI/115254/2009, SFRH/BD/77965/2011]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This study was supported by the Portuguese Foundation for Science and Technology (FCT, references: FCOMP-01-0124-FEDER-015750, FCT - PTDC/SAU-EPI/115254/2009). Sara Lourenco gratefully acknowledges a doctoral grant from the Portuguese Foundation for Science and Technology (FCT; reference SFRH/BD/77965/2011). The funder (FCT) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AhlbergHulten GK, 1995, SCAND J WORK ENV HEA, V21, P435, DOI 10.5271/sjweh.59; Alves L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037158; Alves Márcia Guimarães de Mello, 2013, Rev. bras. epidemiol., V16, P125, DOI 10.1590/S1415-790X2013000100012; [Anonymous], 2014, GLOB EMPL TRENDS 201; [Anonymous], 2013, IMP CRIS WORK COND E; Astell-Burt T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056674; Barbe MF, 2006, BRAIN BEHAV IMMUN, V20, P423, DOI 10.1016/j.bbi.2006.03.001; da Costa BR, 2010, AM J IND MED, V53, P285, DOI 10.1002/ajim.20750; Descatha A, 2012, SCAND J WORK ENV HEA, V38, P568, DOI 10.5271/sjweh.3300; Eriksen W, 2004, OCCUP ENVIRON MED, V61, P398, DOI 10.1136/oem.2003.008482; Eurofound and EU-OSHA, 2014, PSYCH RISKS EUR PREV; European Commission, 2012, NEW SKILLS JOBS EUR; Ferguson E, 2006, J PSYCHOSOM RES, V60, P45, DOI 10.1016/j.jpsychores.2005.06.076; Fingerhut Marilyn, 2006, Med Lav, V97, P313; GANSTER DC, 1986, J APPL PSYCHOL, V71, P102, DOI 10.1037/0021-9010.71.1.102; Hauser W, 2009, J RHEUMATOL, V36, P2806, DOI 10.3899/jrheum.090579; Harkness EF, 2004, ARTHRITIS RHEUM-US, V50, P1655, DOI 10.1002/art.20258; Hartvigsen J, 2004, OCCUP ENVIRON MED, V61; Hoozemans MJM, 2014, OCCUP ENVIRON MED, V71, P788, DOI 10.1136/oemed-2013-101837; International Labour Office, 2012, ISCO88 INT LAB OFF; International Labour Organisation, 2013, PROT WORKPL SAF HLTH; JOHNSON JV, 1988, AM J PUBLIC HEALTH, V78, P1336, DOI 10.2105/AJPH.78.10.1336; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kerr MS, 2001, AM J PUBLIC HEALTH, V91, P1069, DOI 10.2105/AJPH.91.7.1069; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Lang J, 2012, SOC SCI MED, V75, P1163, DOI 10.1016/j.socscimed.2012.04.015; Lariviere M, 2007, CLIN J PAIN, V23, P506, DOI 10.1097/AJP.0b013e31806a23e8; Lourenco S, 2015, SCAND J WOR IN PRESS; Lourenco S, 2015, RHEUMATOLOG IN PRESS; McBeth J, 2001, ARTHRITIS RHEUM, V44, P940, DOI 10.1002/1529-0131(200104)44:4<940::AID-ANR151>3.0.CO;2-S; Nahit ES, 2003, ANN RHEUM DIS, V62, P755, DOI 10.1136/ard.62.8.755; Nahit ES, 2001, OCCUP ENVIRON MED, V58, P374, DOI 10.1136/oem.58.6.374; Nahit ES, 2001, J RHEUMATOL, V28, P1378; National Research Council, 2001, MUSC DIS WORKPL LOW; Organisation for Economic Co-operation and Development, 2012, LAB FORC STAT SEX AG; Otobe N., 2011, GLOBAL EC CRISIS GEN; Park KO, 2004, AM J HEALTH BEHAV, V28, P444; Pulvers K, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0330-2; Punnett L, 2004, J ELECTROMYOGR KINES, V14, P13, DOI 10.1016/j.jelekin.2003.09.015; Ramos E, 2007, ACTA PAEDIATR, V96, P281, DOI 10.1111/j.1651-2227.2007.00107.x; Roquelaure Y, 2012, OCCUP MED-OXFORD, V62, P514, DOI 10.1093/occmed/kqs004; Rugulies R, 2008, J EPIDEMIOL COMMUN H, V62, P245, DOI 10.1136/jech.2006.059113; Sanderson K, 2006, CAN J PSYCHIAT, V51, P63, DOI 10.1177/070674370605100202; Soderberg M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1102; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; Tennant C, 2001, J PSYCHOSOM RES, V51, P697, DOI 10.1016/S0022-3999(01)00255-0; Waddell G., 2006, IS WORK GOOD YOUR HL; Wilson HD, 2009, ARTHRIT RHEUM-ARTHR, V61, P527, DOI 10.1002/art.24163; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594	51	5	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130010	10.1371/journal.pone.0130010	http://dx.doi.org/10.1371/journal.pone.0130010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076365	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900123
J	Vannini, C; Volpi, M; Lardicci, C				Vannini, Claudia; Volpi, Marta; Lardicci, Claudio			A Multi Size-Level Assessment of Benthic Marine Communities in a Coastal Environment: Are They Different Sides of the Same Coin?	PLOS ONE			English	Article							SUBUNIT RIBOSOMAL-RNA; BODY-SIZE; ECOLOGICAL HEALTH; ORGANISM SIZE; BACTERIA; INDICATORS; MACROFAUNA; DIVERSITY; MEIOFAUNA	Organism body size has been demonstrated to be a discriminating element in shaping the response of living beings to environmental factors, thus playing a fundamental role in community structuring. Despite the importance of studies elucidating relations among communities of different size levels in ecosystems, the attempts that have been made in this sense are still very scarce and a reliable approach for these research still has to be defined. We characterized the benthic communities of bacteria, microbial eukaryotes, meiofauna and macrofauna in a coastal environment, encompassing a 10000-fold gradient in body size, testing and discussing a mixed approach of molecular fingerprinting for microbes and morphological observations for meio-and macrofauna. We found no correlation among structures of the different size-level communities: this suggests that community composition at one size-level could have no (or very low) influence on the community composition at other size-levels. Moreover, each community responds in a different way to the environmental parameters and with a degree of sensitivity which seems to increase with organism size. Therefore, our data indicate that the characterization of all the different size levels is clearly a necessity in order to study the dynamics really acting in a system.	[Vannini, Claudia; Volpi, Marta; Lardicci, Claudio] Univ Pisa, Dept Biol, Pisa, Italy; [Volpi, Marta] Univ Aarhus, Ctr Geomicrobiol, Inst Bioscience, Aarhus, Denmark	University of Pisa; Aarhus University	Vannini, C (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	claudia.vannini@unipi.it	lardicci, claudio/K-8698-2018	LARDICCI, CLAUDIO/0000-0001-5356-7914	University of Pisa	University of Pisa	This work was funded by University of Pisa, Lardicci 308-60% 2012 and Vannini 565-60% 2012. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfuso G, 2011, GEOMORPHOLOGY, V129, P204, DOI 10.1016/j.geomorph.2011.01.023; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Bernhard AE, 2000, APPL ENVIRON MICROB, V66, P1587, DOI 10.1128/AEM.66.4.1587-1594.2000; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; Case T., 1986, COMMUNITY ECOL, P98; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Danovaro R, 1996, MAR BIOL, V127, P1, DOI 10.1007/BF00993638; Doi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069594; Farjalla VF, 2012, ECOLOGY, V93, P1752, DOI 10.1890/11-1144.1; Fierer N, 2011, ECOLOGY, V92, P797, DOI 10.1890/10-1170.1; Gorley C.K., 2006, GETTING STARTED PRIM; Heino J, 2011, FRESHWATER BIOL, V56, P1703, DOI 10.1111/j.1365-2427.2011.02610.x; Hyland J, 2005, MAR ECOL PROG SER, V295, P91, DOI 10.3354/meps295091; Lear G, 2009, FRESHWATER BIOL, V54, P1532, DOI 10.1111/j.1365-2427.2009.02190.x; Lear G, 2011, AQUAT ECOL, V45, P517, DOI 10.1007/s10452-011-9372-x; Longmuir A, 2007, ECOLOGY, V88, P1663, DOI 10.1890/06-1448.1; Mellin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020141; Meng XF, 2012, RES MICROBIOL, V163, P349, DOI 10.1016/j.resmic.2012.03.005; Papageorgiou N, 2007, HELGOLAND MAR RES, V61, P31, DOI 10.1007/s10152-006-0051-6; Pusceddu A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091056; Shurin JB, 2009, OECOLOGIA, V159, P151, DOI 10.1007/s00442-008-1174-z; Soininen J, 2013, ECOLOGY, V94, P660, DOI 10.1890/12-0777.1; Somboonna N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S29; Suzuki M, 1998, APPL ENVIRON MICROB, V64, P4522; Tataranni M, 2010, ENVIRON POLLUT, V158, P26, DOI 10.1016/j.envpol.2009.08.020; Van de Peer Y, 1998, NUCLEIC ACIDS RES, V26, P179, DOI 10.1093/nar/26.1.179; Velghe K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057019; Warwick RM, 2001, OCEANOGR MAR BIOL, V39, P207; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; Wieltschnig C, 2008, MICROB ECOL, V56, P1, DOI 10.1007/s00248-007-9318-y; Wish M., 1978, MULTIDIMENSIONAL SCA; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Woodward G, 2002, J ANIM ECOL, V71, P1063, DOI 10.1046/j.1365-2656.2002.00669.x; Wuyts J, 2000, NUCLEIC ACIDS RES, V28, P4698, DOI 10.1093/nar/28.23.4698; [No title captured]	36	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129942	10.1371/journal.pone.0129942	http://dx.doi.org/10.1371/journal.pone.0129942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075405	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900117
J	Yang, J; Liu, XX; Ai, DN; Fan, JF; Zheng, YJ; Li, F; Huo, L; Wang, YT				Yang, Jian; Liu, Xinxin; Ai, Danni; Fan, Jingfan; Zheng, Youjing; Li, Fang; Huo, Li; Wang, Yongtian			PET Index of Bone Glucose Metabolism (PIBGM) Classification of PET/CT Data for Fever of Unknown Origin Diagnosis	PLOS ONE			English	Article							STANDARDIZED UPTAKE VALUES; PROSTATE-CANCER; ACTIVE CONTOURS; NORMAL-TISSUES; SCAN INDEX; FDG-PET; F-18-FDG; CT; SEGMENTATION; SPECIFICITY	Objectives Fever of unknown origin (FUO) remains a challenge in clinical practice. Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is helpful in diagnosing the etiology of FUO. This paper aims to develop a completely automatic classification method based on PET/CT data for the computer-assisted diagnosis of FUO. Methods We retrospectively analyzed the FDG PET/CT scan of 175 FUO patients, 79 males and 96 females. The final diagnosis of all FUO patients was achieved through pathology or clinical evaluation, including 108 normal patients and 67 FUO patients. CT anatomic information was used to acquire bone functional information from PET images. The skeletal system of FUO patients was classified by analyzing the standardized uptake value (SUV) and the PET index of bone glucose metabolism (PIBGM). The SUV distributions in the bone marrow and the bone cortex were also studied in detail. Results The SUV and PIBGM of the bone marrow only slightly differed between the FUO patients and normal people, whereas the SUV of whole bone structures and the PIBGM of the bone cortex significantly differed between the normal people and FUO patients. The method detected 43 patients from 67 FUO patients, with sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 64.18%, 95%, 93.48%, 72.73%, and 83.33%, respectively. Conclusion The experimental results demonstrate that the study can achieve automatic classification of FUO patients by the proposed novel biomarker of PIBGM, which has the potential to be utilized in clinical practice.	[Yang, Jian; Liu, Xinxin; Ai, Danni; Fan, Jingfan; Wang, Yongtian] Beijing Inst Technol, Sch Opt & Elect, Beijing Engn Res Ctr Mixed Real & Adv Display, Beijing 100081, Peoples R China; [Zheng, Youjing; Li, Fang; Huo, Li] Beijing Union Med Coll Hosp, PET Ctr, Dept Nucl Med, Beijing 100032, Peoples R China	Beijing Institute of Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Huo, L (corresponding author), Beijing Union Med Coll Hosp, PET Ctr, Dept Nucl Med, Beijing 100032, Peoples R China.	huoli@pumch.cn	Fan, Jingfan/AAT-3761-2020	Fan, Jingfan/0000-0003-4857-6490	National Basic Research Program of China [2013CB328806]; Key Projects in the National Science and Technology Pillar Program [2013BAI01B01]; National Hi-Tech Research and Development Program [2013AA013703]; National Natural Science Foundation of China [81071188]	National Basic Research Program of China(National Basic Research Program of China); Key Projects in the National Science and Technology Pillar Program; National Hi-Tech Research and Development Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2013CB328806), the Key Projects in the National Science and Technology Pillar Program (2013BAI01B01), the National Hi-Tech Research and Development Program (2013AA013703) and the National Natural Science Foundation of China (81071188).	Arnow PM, 1997, LANCET, V350, P575, DOI 10.1016/S0140-6736(97)07061-X; Nakayo EMB, 2012, REV ESP MED NUCL IMA, V31, P178, DOI 10.1016/j.remn.2011.08.007; Bleeker-Rovers CP, 2007, MEDICINE, V86, P26, DOI 10.1097/md.0b013e31802fe858; Blokhuis GJ, 2014, EUR J NUCL MED MOL I, V41, P1916, DOI 10.1007/s00259-014-2801-z; Brenner H, 1997, STAT MED, V16, P981, DOI 10.1002/(SICI)1097-0258(19970515)16:9<981::AID-SIM510>3.0.CO;2-N; Buysschaert Ian, 2004, Eur J Intern Med, V15, P151, DOI 10.1016/j.ejim.2004.01.018; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Crouzet J, 2012, EUR J CLIN MICROBIOL, V31, P1727, DOI 10.1007/s10096-011-1440-6; Dennis ER, 2012, J CLIN ONCOL, V30, P519, DOI 10.1200/JCO.2011.36.5791; Dong MJ, 2011, EUR J RADIOL, V80, P834, DOI 10.1016/j.ejrad.2010.11.018; Durack D T, 1991, Curr Clin Top Infect Dis, V11, P35; Ferda J, 2010, EUR J RADIOL, V73, P518, DOI 10.1016/j.ejrad.2008.12.014; Imbriaco M, 1998, CLIN CANCER RES, V4, P1765; Kaboteh R, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-9; Kaim AH, 2002, RADIOLOGY, V223, P446, DOI 10.1148/radiol.2232010914; Kang Y, 2003, IEEE T MED IMAGING, V22, P586, DOI 10.1109/TMI.2003.812265; Keidar Z, 2008, J NUCL MED, V49, P1980, DOI 10.2967/jnumed.108.054692; Kim YJ, 2012, INTERN MED J, V42, P834, DOI 10.1111/j.1445-5994.2012.02828.x; Kouijzer IJE, 2013, SEMIN NUCL MED, V43, P333, DOI 10.1053/j.semnuclmed.2013.04.005; Kubota K, 2011, ANN NUCL MED, V25, P355, DOI 10.1007/s12149-011-0470-6; Kucukardali Y, 2008, INT J INFECT DIS, V12, P71, DOI 10.1016/j.ijid.2007.04.013; Meller J, 2000, EUR J NUCL MED, V27, P1617, DOI 10.1007/s002590000341; Paquet N, 2004, J NUCL MED, V45, P784; Pedersen TI, 2012, SCAND J INFECT DIS, V44, P18, DOI 10.3109/00365548.2011.603741; PETERSDORF R, 1961, MEDICINE, V40, P1, DOI 10.1097/00005792-196102000-00001; Seshadri N, 2012, J INFECTION, V65, P71, DOI 10.1016/j.jinf.2012.02.008; Sheng JF, 2011, EUR J INTERN MED, V22, P112, DOI 10.1016/j.ejim.2010.09.015; Truc PTH, 2010, J DIGIT IMAGING, V23, P793, DOI 10.1007/s10278-009-9210-z; van Stralen KJ, 2009, KIDNEY INT, V75, P1257, DOI 10.1038/ki.2009.92; YAMADA S, 1995, J NUCL MED, V36, P1301; ZASADNY K, 1992, RADIOLOGY, V185, P186	31	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130173	10.1371/journal.pone.030173	http://dx.doi.org/10.1371/journal.pone.030173			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076139				2022-12-27	WOS:000356329900149
J	Germine, L; Dunn, EC; McLaughlin, KA; Smoller, JW				Germine, Laura; Dunn, Erin C.; McLaughlin, Katie A.; Smoller, Jordan W.			Childhood Adversity Is Associated with Adult Theory of Mind and Social Affiliation, but Not Face Processing	PLOS ONE			English	Article							EARLY EXPERIENCE; EMOTION; RECOGNITION; HEALTH; WORLD; PSYCHOPATHOLOGY; MALTREATMENT; DISORDERS; ANHEDONIA; CHILDREN	People vary substantially in their ability to acquire and maintain social ties. Here, we use a combined epidemiological and individual differences approach to understand the childhood roots of adult social cognitive functioning. We assessed exposure to 25 forms of traumatic childhood experiences in over 5000 adults, along with measures of face discrimination, face memory, theory of mind, social motivation, and social support. Retrospectively-reported experiences of parental maltreatment in childhood (particularly physical abuse) were the most broadly and robustly associated with adult variations in theory of mind, social motivation, and social support. Adult variations in face discrimination and face memory, on the other hand, were not significantly associated with exposure to childhood adversity. Our findings indicate domains of social cognition that may be particularly vulnerable to the effects of adverse childhood environments, and suggest mechanisms whereby environmental factors might influence the development of social abilities.	[Germine, Laura; Dunn, Erin C.; Smoller, Jordan W.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Germine, Laura; Dunn, Erin C.; Smoller, Jordan W.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Germine, Laura; Dunn, Erin C.; Smoller, Jordan W.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Germine, Laura] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [McLaughlin, Katie A.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; University of Washington; University of Washington Seattle	Germine, L (corresponding author), Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA.	lgermine@gmail.com	Dunn, Erin C./AFM-9511-2022	Dunn, Erin C./0000-0003-1413-3229; Germine, Laura/0000-0001-8690-8412	US National Institute of Mental Health [K24 MH094614, T32MH016259, F32MH102971]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH092526, F32MH102971, K24MH094614, T32MH016259] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by US National Institute of Mental Health grants to JWS (K24 MH094614) and to LG (T32MH016259 and F32MH102971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Chambers JM, 1992, STAT MODELS S; CHAPMAN LJ, 1980, SCHIZOPHRENIA BULL, V6, P476, DOI 10.1093/schbul/6.3.476; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Duchaine BC, 2006, CURR OPIN NEUROBIOL, V16, P166, DOI 10.1016/j.conb.2006.03.003; Duchaine B, 2009, NEUROPSYCHOLOGIA, V47, P2029, DOI 10.1016/j.neuropsychologia.2009.03.011; Dunn EC, 2013, DEPRESS ANXIETY, V30, P955, DOI 10.1002/da.22102; EKMAN P, 1976, ENVIRON PSYCH NONVER, V1, P56, DOI 10.1007/BF01115465; Farah MJ, 2006, BRAIN RES, V1110, P166, DOI 10.1016/j.brainres.2006.06.072; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fisher H. L., 2014, SCHIZOPHR B; Garrido L, 2009, BRAIN, V132, P3443, DOI 10.1093/brain/awp271; Germine LT, 2011, PSYCHOL MED, V41, P937, DOI 10.1017/S0033291710001571; Germine L, 2012, PSYCHON B REV, V19, P847, DOI 10.3758/s13423-012-0296-9; Germine LT, 2011, NEUROIMAGE, V58, P935, DOI 10.1016/j.neuroimage.2011.06.059; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2010, BRIT J PSYCHIAT, V197, P378, DOI 10.1192/bjp.bp.110.080499; Kwapil TR, 1998, J ABNORM PSYCHOL, V107, P558, DOI 10.1037/0021-843X.107.4.558; Leppanen JM, 2009, NAT REV NEUROSCI, V10, P37, DOI 10.1038/nrn2554; McLaughlin KA, 2010, PSYCHOL MED, V40, P847, DOI 10.1017/S0033291709991115; McLaughlin KA, 2012, J CHILD PSYCHOL PSYC, V53, P46, DOI 10.1111/j.1469-7610.2011.02437.x; Miller G, 2009, ANNU REV PSYCHOL, V60, P501, DOI 10.1146/annurev.psych.60.110707.163551; Moulson MC, 2009, CHILD DEV, V80, P1039, DOI 10.1111/j.1467-8624.2009.01315.x; Moulson MC, 2009, DEV PSYCHOL, V45, P17, DOI 10.1037/a0014035; Nelson CA, 2007, SCIENCE, V318, P1937, DOI 10.1126/science.1143921; Ochsner KN, 2008, BIOL PSYCHIAT, V64, P48, DOI 10.1016/j.biopsych.2008.04.024; Pitcher D, 2008, J NEUROSCI, V28, P8929, DOI 10.1523/JNEUROSCI.1450-08.2008; Pollak SD, 2002, P NATL ACAD SCI USA, V99, P9072, DOI 10.1073/pnas.142165999; Pollak SD, 2000, DEV PSYCHOL, V36, P679, DOI 10.1037//0012-1649.36.5.679; Pollak SD, 2008, CURR DIR PSYCHOL SCI, V17, P370, DOI 10.1111/j.1467-8721.2008.00608.x; Revelle William, 2020, CRAN; Scott KM, 2012, BRIT J PSYCHIAT, V200, P469, DOI 10.1192/bjp.bp.111.103267; Skelly LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040371; Straus MA, 1979, MEASURING INTRAFAMIL, P75; Wilmer JB, 2012, COGN NEUROPSYCHOL, V29, P360, DOI 10.1080/02643294.2012.753433; Wilmer JB, 2010, P NATL ACAD SCI USA, V107, P5238, DOI 10.1073/pnas.0913053107; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	41	73	73	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129612	10.1371/journal.pone.0129612	http://dx.doi.org/10.1371/journal.pone.0129612			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26068107	Green Published, gold			2022-12-27	WOS:000356327000095
J	Jamal, S; Goyal, S; Shanker, A; Grover, A				Jamal, Salma; Goyal, Sukriti; Shanker, Asheesh; Grover, Abhinav			Checking the STEP-Associated Trafficking and Internalization of Glutamate Receptors for Reduced Cognitive Deficits: A Machine Learning Approach-Based Cheminformatics Study and Its Application for Drug Repurposing	PLOS ONE			English	Article							ACCURATE DOCKING; FORCE-FIELD; CLASSIFICATION; PROTEIN; PREDICTION; MODELS; LIGAND; GLIDE	Background Alzheimer's disease, a lethal neurodegenerative disorder that leads to progressive memory loss, is the most common form of dementia. Owing to the complexity of the disease, its root cause still remains unclear. The existing anti-Alzheimer's drugs are unable to cure the disease while the current therapeutic options have provided only limited help in restoring moderate memory and remain ineffective at restricting the disease's progression. The striatal-enriched protein tyrosine phosphatase (STEP) has been shown to be involved in the internalization of the receptor, N-methyl D-aspartate (NMDR) and thus is associated with the disease. The present study was performed using machine learning algorithms, docking protocol and molecular dynamics (MD) simulations to develop STEP inhibitors, which could be novel anti-Alzheimer's molecules. Methods The present study deals with the generation of computational predictive models based on chemical descriptors of compounds using machine learning approaches followed by substructure fragment analysis. To perform this analysis, the 2D molecular descriptors were generated and machine learning algorithms (Naive Bayes, Random Forest and Sequential Minimization Optimization) were utilized. The binding mechanisms and the molecular interactions between the predicted active compounds and the target protein were modelled using docking methods. Further, the stability of the protein-ligand complex was evaluated using MD simulation studies. The substructure fragment analysis was performed using Substructure fingerprint (SubFp), which was further explored using a predefined dictionary. Results The present study demonstrates that the computational methodology used can be employed to examine the biological activities of small molecules and prioritize them for experimental screening. Large unscreened chemical libraries can be screened to identify potential novel hits and accelerate the drug discovery process. Additionally, the chemical libraries can be searched for significant substructure patterns as reported in the present study, thus possibly contributing to the activity of these molecules.	[Jamal, Salma; Goyal, Sukriti; Shanker, Asheesh] Banasthali Univ, Dept Biosci & Biotechnol, Tonk, Rajasthan, India; [Grover, Abhinav] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India	Banasthali Vidyapith; Jawaharlal Nehru University, New Delhi	Grover, A (corresponding author), Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India.	abhinavgr@gmail.com			Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	AG is thankful to Department of Science and Technology, Government of India for the financial support.	Alzheimer's Association, 2013, ALZH DIS FACTS FIG S; Ambure P, 2014, EXPERT OPIN DRUG DIS, V9, P697, DOI 10.1517/17460441.2014.909404; Anderson C, 2011, LANCET NEUROL, V10, P43, DOI 10.1016/S1474-4422(10)70250-7; [Anonymous], LIGPREP V 2 3; Appleby BS, 2013, DEMENT GERIATR COGN, V35, P1, DOI 10.1159/000345791; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernardi A, 2012, INT J NANOMED, V7, P4927, DOI 10.2147/IJN.S35333; Bouckaert RR, 2010, J MACH LEARN RES, V11, P2533; Breiman L., 2001, MACH LEARN, V45, P5; Cheng FX, 2011, J CHEM INF MODEL, V51, P996, DOI 10.1021/ci200028n; Corbett A, 2013, PHARMACEUTICALS, V6, P1304, DOI 10.3390/ph6101304; Corbett A, 2012, NAT REV DRUG DISCOV, V11, P833, DOI 10.1038/nrd3869; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Coskuner O, 2014, J ALZHEIMERS DIS, V41, P561, DOI 10.3233/JAD-132300; Das UN, 2008, PROSTAGLANDINS LEUKO, P78111; Desmond, 2013, SCHRODINGER DESMOND; Dong N, 2005, ACTA PHARMACOL SIN, V26, P107, DOI 10.1111/j.1745-7254.2005.00014.x; Fiandaca MS, 2014, ALZHEIMERS DEMENT, V10, pS196, DOI 10.1016/j.jalz.2014.04.015; Ford AH, 2010, NEUROLOGY, V75, P1540, DOI 10.1212/WNL.0b013e3181f962c4; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hann M, 1999, J CHEM INF COMP SCI, V39, P897, DOI 10.1021/ci990423o; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hubsher G, 2012, NEUROLOGY, V78, P1096, DOI 10.1212/WNL.0b013e31824e8f0d; Huth JR, 2005, J AM CHEM SOC, V127, P217, DOI 10.1021/ja0455547; Jaturapatporn D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006378.pub2; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Klepsch F, 2014, J CHEM INF MODEL, V54, P218, DOI 10.1021/ci400289j; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Koutsoukas A, 2013, J CHEM INF MODEL, V53, P1957, DOI 10.1021/ci300435j; Li H, 2006, J MOL GRAPH MODEL, V25, P313, DOI 10.1016/j.jmgm.2006.01.007; Li QY, 2008, MOL PHARMACEUT, V5, P117, DOI 10.1021/mp700124e; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; Liu KJ, 2005, J CHEM INF MODEL, V45, P515, DOI 10.1021/ci049847v; Lv W, 2010, EUR J MED CHEM, V45, P1167, DOI 10.1016/j.ejmech.2009.12.038; McCarren P, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-51; Meng XB, 2014, TOXICOL APPL PHARM, V279, P63, DOI 10.1016/j.taap.2014.03.026; Mogi M, 2008, BIOCHEM BIOPH RES CO, V375, P446, DOI 10.1016/j.bbrc.2008.08.032; Periwal Vinita, 2012, BMC Pharmacology, V12, P1, DOI 10.1186/1471-2210-12-1; Periwal Vinita, 2011, BMC Res Notes, V4, P504, DOI 10.1186/1756-0500-4-504; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schierz AC, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-21; Schrodinger L., 2011, SCHRODINGER SOFTWARE; Singla D, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-49; Sun HM, 2012, J CHEM INF MODEL, V52, P1798, DOI 10.1021/ci3001875; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Thatcher GRJ, 2004, J ALZHEIMERS DIS, V6, pS75; Venkitaramani DV, 2009, SYNAPSE, V63, P69, DOI 10.1002/syn.20608; Wang J, 2007, J CLIN INVEST, V117, P3393, DOI 10.1172/JCI31547; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wimo A, 2013, WORLD ALZHEIMER REPO; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Yiannopoulou KG, 2013, THER ADV NEUROL DISO, V6, P19, DOI 10.1177/1756285612461679; Yongfang Z, 2010, P NATL ACAD SCI USA, V10744; Yutaka F, 2013, BIOINFORMATION, V92; Zhang Y, 2008, J NEUROSCI, V28, P10561, DOI 10.1523/JNEUROSCI.2666-08.2008	61	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129370	10.1371/journal.pone.0129370	http://dx.doi.org/10.1371/journal.pone.0129370			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066505	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000068
J	Miyamoto, Y; Baba, Y; Sakamoto, Y; Ohuchi, M; Tokunaga, R; Kurashige, J; Hiyoshi, Y; Iwagami, S; Yoshida, N; Watanabe, M; Baba, H				Miyamoto, Yuji; Baba, Yoshifumi; Sakamoto, Yasuo; Ohuchi, Mayuko; Tokunaga, Ryuma; Kurashige, Junji; Hiyoshi, Yukiharu; Iwagami, Shiro; Yoshida, Naoya; Watanabe, Masayuki; Baba, Hideo			Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer	PLOS ONE			English	Article							BODY-COMPOSITION; CLINICAL-IMPLICATIONS; HEPATIC RESECTION; SARCOPENIA; DETERMINANT; MORTALITY; SURVIVAL; TOXICITY; OUTCOMES	Background Skeletal muscle depletion (sarcopenia) is closely associated with limited physical ability and high mortality. This study evaluated the prognostic significance of skeletal muscle status before and after chemotherapy in patients with unresectable colorectal cancer (CRC). Methods We conducted a retrospective analysis of 215 consecutive patients with unresectable CRC who underwent systemic chemotherapy. Skeletal muscle cross-sectional area was measured by computed tomography. We evaluated the prognostic value of skeletal muscle mass before chemotherapy and the rate of skeletal muscle change in cross-sectional area after chemotherapy. Results One-hundred-eighty-two patients met our inclusion criteria. There were no significant differences in progression-free survival (PFS) or overall survival (OS) associated with skeletal muscle mass before chemotherapy. However, 22 patients with skeletal muscle loss (>5%) after chemotherapy showed significantly shorter PFS and OS compared with those without skeletal muscle loss (PFS, log-rank p = 0.029; OS, log-rank p = 0.009). Multivariate Cox regression analysis revealed that skeletal muscle loss after chemotherapy (hazard ratio, 2.079; 95% confidence interval, 1.194-3.619; p = 0.010) was independently associated with OS. Conclusions Skeletal muscle loss after chemotherapy was an independent, negative prognostic factor in unresectable CRC.	[Miyamoto, Yuji; Baba, Yoshifumi; Sakamoto, Yasuo; Ohuchi, Mayuko; Tokunaga, Ryuma; Kurashige, Junji; Hiyoshi, Yukiharu; Iwagami, Shiro; Yoshida, Naoya; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan; [Watanabe, Masayuki] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan	Kumamoto University; Japanese Foundation for Cancer Research	Baba, H (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan.	hdobaba@kumamoto-u.ac.jp		Miyamoto, Yuji/0000-0003-3948-5044	Japan Society for the Promotion of Science (JSPS) [26462020]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (C), grant number 26462020.	Antoun S, 2013, CURR OPIN SUPPORT PA, V7, P383, DOI 10.1097/SPC.0000000000000011; Barret M, 2014, NUTR CANCER, V66, P583, DOI 10.1080/01635581.2014.894103; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Collins J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003697; Dodson S, 2011, ANNU REV MED, V62, P265, DOI 10.1146/annurev-med-061509-131248; Hasselager R, 2014, LANGENBECK ARCH SURG, V399, P287, DOI 10.1007/s00423-014-1174-x; Iritani S, J GASTROENTEROL, DOI [10.1007/s00535-014-0964-92014, DOI 10.1007/S00535-014-0964-92014]; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Kovarik M, 2014, LUNG CANCER, V84, P1, DOI 10.1016/j.lungcan.2014.01.020; Lieffers JR, 2012, BRIT J CANCER, V107, P931, DOI 10.1038/bjc.2012.350; Matsuda A, 2014, JPN J CLIN ONCOL, V44, P388, DOI 10.1093/jjco/hyu003; Meulenbeld HJ, 2008, ANN ONCOL, V19, P1600, DOI 10.1093/annonc/mdn176; Peng PD, 2011, HPB, V13, P439, DOI 10.1111/j.1477-2574.2011.00301.x; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Prado CMM, 2007, CLIN CANCER RES, V13, P3264, DOI 10.1158/1078-0432.CCR-06-3067; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Sabel MS, 2011, ANN SURG ONCOL, V18, P3579, DOI 10.1245/s10434-011-1976-9; SEGAL MR, 1988, BIOMETRICS, V44, P35, DOI 10.2307/2531894; Stene GB, 2014, ACTA ONCOL, P1; Tan BHL, 2009, CLIN CANCER RES, V15, P6973, DOI 10.1158/1078-0432.CCR-09-1525; van Vledder MG, 2012, BRIT J SURG, V99, P550, DOI 10.1002/bjs.7823; Voron T, 2015, ANN SURG, V261, P1173, DOI 10.1097/SLA.0000000000000743; Yip C, 2014, EUR RADIOL, V24, P998, DOI 10.1007/s00330-014-3110-4	23	97	97	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129742	10.1371/journal.pone.0129742	http://dx.doi.org/10.1371/journal.pone.0129742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069972	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000103
J	Young, HML; Hudson, N; Clarke, AL; Dungey, M; Feehally, J; Burton, JO; Smith, AC				Young, Hannah M. L.; Hudson, Nicky; Clarke, Amy L.; Dungey, Maurice; Feehally, John; Burton, James O.; Smith, Alice C.			Patient and Staff Perceptions of Intradialytic Exercise before and after Implementation: A Qualitative Study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; BEHAVIOR-CHANGE; KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; PHYSICAL FUNCTION; SELF-MANAGEMENT; CARE; PARTICIPATION; FRAMEWORK; INTERVENTIONS	Introduction Despite guidance and evidence for the beneficial effects of intradialytic exercise (IDE), such programmes are rarely adopted within practice and little is known about how they may best be sustained. The Theoretical Domains Framework (TDF) was used to guide the understanding of the barriers and facilitators to initial and ongoing IDE participation and to understand how these are influential at each stage. Materials and Methods Focus groups explored patient (n=24) and staff (n=9) perceptions of IDE prior to the introduction of a programme and, six months later, face to face semi-structured interviews captured exercising patients (n=11) and staffs' (n=8) actual experiences. Data were collected at private and NHS haemodialysis units within the UK. All data were audio-recorded, translated where necessary, transcribed verbatim and subject to framework analysis. Results IDE initiation can be facilitated by addressing the pre-existing beliefs about IDE through the influence of peers (for patients) and training (for staff). Participation was sustained through the observation of positive outcomes and through social influences such as teamwork and collaboration. Despite this, environment and resource limitations remained the greatest barrier perceived by both groups. Conclusions Novel methods of staff training and patient education should enhance engagement. Programmes that clearly highlight the benefits of IDE should be more successful in the longer term. The barrier of staff workload needs to be addressed through specific guidance that includes recommendations on staffing levels, roles, training and skill mix.	[Young, Hannah M. L.; Clarke, Amy L.; Dungey, Maurice; Burton, James O.; Smith, Alice C.] Leicester Gen Hosp, Acad Unit, Leicester Kidney Exercise Team, Leicester LE5 4PW, Leics, England; [Hudson, Nicky] De Montfort Univ, Sch Appl Social Sci, Leicester LE1 9BH, Leics, England; [Clarke, Amy L.; Smith, Alice C.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Dungey, Maurice] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Feehally, John] Univ Hosp Leicester NHS Trusts, Leicester Gen Hosp, John Walls Renal Unit, Leicester, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; De Montfort University; University of Leicester; Loughborough University; University Hospitals of Leicester NHS Trust; Leicester General Hospital	Young, HML (corresponding author), Leicester Gen Hosp, Acad Unit, Leicester Kidney Exercise Team, Gwendolen Rd, Leicester LE5 4PW, Leics, England.	hannah.young@uhl-tr.nhs.uk	Burton, James O/AAQ-7361-2021	Burton, James O/0000-0003-1176-7592; Dungey, Maurice/0000-0003-0762-1726; young, hannah/0000-0002-4249-9060; Hudson, Nicky/0000-0003-4091-1493	National Institute for Health Research (NIHR) Diet, Lifestyle & Physical Activity Biomedical Research Unit based at University Hospital of Leicester; National Institute for Health Research (NIHR) Diet, Lifestyle & Physical Activity Biomedical Research Unit based at University Hospital of Loughborough University; British Renal Society/ British Kidney Patient Association Research Grant; British Renal Society Research Grant; Leicester Kidney Care	National Institute for Health Research (NIHR) Diet, Lifestyle & Physical Activity Biomedical Research Unit based at University Hospital of Leicester; National Institute for Health Research (NIHR) Diet, Lifestyle & Physical Activity Biomedical Research Unit based at University Hospital of Loughborough University; British Renal Society/ British Kidney Patient Association Research Grant; British Renal Society Research Grant; Leicester Kidney Care	This research was supported by the National Institute for Health Research (NIHR) Diet, Lifestyle & Physical Activity Biomedical Research Unit based at University Hospitals of Leicester and Loughborough University. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. ACS, NH and JOB received grants from British Renal Society/ British Kidney Patient Association Research Grant 2010, the British Renal Society Research Grant 2011 and the Leicester Kidney Care Appeal during the conduct of the study. http://www.britishrenal.org/Home.aspx. http://www.britishkidney-pa.co.uk/. http://www.leicestershospitals.nhs.uk/aboutus/departmentsservices/kidney-services/kidney-care-appeal/ Outside the submitted work Reck United Kingdom (manufacturers of the exercise bike used during the implementation phase) funded HMLY, MD, and JOB to attend the 2012 BMJ Awards. http://www.motomed.com/. The other authors declare that they have no relevant financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; [Anonymous], 2004, ENGL NAT SERV FRAM 1; [Anonymous], 2014, ENGL CHRON KIDN DIS; Aschner P, 2007, INT J CLIN PRACT, V61, P22, DOI 10.1111/j.1742-1241.2007.01606.x; Bennett PN, 2010, SEMIN DIALYSIS, V23, P62, DOI 10.1111/j.1525-139X.2009.00652.x; Bryman A., 2012, SOCIAL RES METHODS, DOI DOI 10.1007/978-1-349-21149-4_10; Cade JE, 2009, DIABETIC MED, V26, P1048, DOI 10.1111/j.1464-5491.2009.02808.x; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Delgado C, 2012, NEPHROL DIAL TRANSPL, V27, P1152, DOI 10.1093/ndt/gfr404; Dennis CL, 2003, INT J NURS STUD, V40, P321, DOI 10.1016/S0020-7489(02)00092-5; DOH, 2005, STRUCT PAT ED DIAB R; Doody O, 2013, BR J NURS, V22, P171; Forgeron S, 2001, CANNT J, V11, P19; Francis JJ, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-35; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Funnell MM, 2010, FAM PRACT, V27, pI17, DOI 10.1093/fampra/cmp027; Goodman Eric D, 2004, Nephrol Nurs J, V31, P23; Greenwood SA, 2014, NEPHRON CLIN PRACT, V128, P61, DOI [10.1159/000363297, DOI 10.1159/000363297]; Hancock C, 2011, PRI HLTH CARE, V21, P24; Heiwe S, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-68; Heiwe S, 2014, AM J KIDNEY DIS, V64, P383, DOI 10.1053/j.ajkd.2014.03.020; Hughes J, 2009, HEALTH EXPECT, V12, P396, DOI 10.1111/j.1369-7625.2009.00568.x; Idier L, 2011, INT J NURS STUD, V48, P1570, DOI 10.1016/j.ijnurstu.2011.08.006; Jain N, 2008, J REN CARE, V34, P173, DOI 10.1111/j.1755-6686.2008.00037.x; Jain Neerja, 2008, Br J Community Nurs, V13, P166; Johansen KL, 2003, AM J KIDNEY DIS, V41, P171, DOI 10.1053/ajkd.2003.50001; Gagliardino JJ, 2013, DIABETES-METAB RES, V29, P152, DOI 10.1002/dmrr.2368; K/DOQI Workgroup, 2005, AM J KIDNEY DIS S, V45, pS16; Karmiel J C, 1999, J Ren Nutr, V9, P214, DOI 10.1016/S1051-2276(99)90037-7; Kitson AL, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-1; Kolewaski Carrie D, 2005, CANNT J, V15, P22; Konstantinidou E, 2002, J REHABIL MED, V34, P40, DOI 10.1080/165019702317242695; Kontos PC, 2007, INT UROL NEPHROL, V39, P1303, DOI 10.1007/s11255-007-9265-z; Kosmadakis GC, 2010, NEPHRON CLIN PRACT, V115, pE7, DOI 10.1159/000286344; Koufaki P, 2009, ADV CHRONIC KIDNEY D, V16, P410, DOI 10.1053/j.ackd.2009.08.010; Lingerfelt KL, 2011, NEPHROL NURS J, V38, P483; Ma Sunny, 2012, CANNT J, V22, P26; Mason J, 2008, AM J KIDNEY DIS, V51, P933, DOI 10.1053/j.ajkd.2008.01.024; McPherson Sandra L, 2004, Nurs Forum, V39, P5; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Morse J. M., 2002, INT J QUAL METHODS, P13, DOI 10.1177/160940690200100202; Oh-Park M, 2002, AM J PHYS MED REHAB, V81, P814, DOI 10.1097/00002060-200211000-00003; Painter Patricia, 2005, Hemodial Int, V9, P218, DOI 10.1111/j.1492-7535.2005.01136.x; Painter Patricia, 2004, Nephrol Nurs J, V31, P67; Painter P, 2014, AM J KIDNEY DIS, V64, P425, DOI 10.1053/j.ajkd.2014.01.433; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Penn L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002949; Plummer-D'Amato P, 2008, INT J THER REHABIL, V15, P69, DOI 10.12968/ijtr.2008.15.2.28189; Pope C., 2009, QUALITATIVE RES HLTH, P1; Sheng KX, 2014, AM J NEPHROL, V40, P478, DOI 10.1159/000368722; Sietsema KE, 2004, KIDNEY INT, V65, P719, DOI 10.1111/j.1523-1755.2004.00411.x; Sinclair P, 2011, J REN CARE, V37, P108, DOI 10.1111/j.1755-6686.2011.00217.x; Smart N, 2011, NEPHROLOGY, V16, P626, DOI 10.1111/j.1440-1797.2011.01471.x; Smith AC, 2012, J REN CARE, V38, P52, DOI 10.1111/j.1755-6686.2012.00279.x; Smith Joanna, 2011, Nurse Res, V18, P52; Tavallaii SA, 2009, EUR J INTERN MED, V20, P411, DOI 10.1016/j.ejim.2009.03.007; Tobita I, 2009, J RENAL CARE, V35, P48, DOI 10.1111/j.1755-6686.2009.00079.x; Wilund KR, 2010, NEPHROL DIAL TRANSPL, V25, P2695, DOI 10.1093/ndt/gfq106	59	33	33	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128995	10.1371/journal.pone.0128995	http://dx.doi.org/10.1371/journal.pone.0128995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26068875	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000037
J	Zhang, HJ; Wang, RQ; Wang, X; Du, N; Ge, XL; Du, YD; Liu, J				Zhang, Haijie; Wang, Renqing; Wang, Xiao; Du, Ning; Ge, Xiuli; Du, Yuanda; Liu, Jian			Recurrent Water Level Fluctuation Alleviates the Effects of Submergence Stress on the Invasive Riparian Plant Alternanthera philoxeroides	PLOS ONE			English	Article							2 WETLAND PLANTS; PHENOTYPIC PLASTICITY; DE-SUBMERGENCE; QUIESCENCE STRATEGIES; BIOMASS ALLOCATION; RESOURCE PULSES; ALLIGATOR WEED; RESPONSES; GROWTH; SURVIVAL	Recurrent water level fluctuation and submergence of plants are common in riparian zones. Our study objectives were to test the independent and interactive effects of submergence level and fluctuation frequency on a globally important riparian invasive plant, Alternanthera philoxeroides. To this end, we conducted a greenhouse experiment, in which ramets of the plants, obtained from a wetland in China, were treated with four fluctuation frequencies (0, 3, 6, and 12 cycles over a 96-day experimental period) under three water levels (0, 10, and 30 cm). We found that effects of fluctuation frequency were non-significant, negative, and positive under water levels of 0, 10 and 30 cm, respectively. As fluctuation frequency increased, the effects of increasing water level decreased significantly. When water levels were high, A. philoxeroides allocated greater biomass to shoot production probably in order to elongate and escape from submergence. However, as fluctuation frequency increased, biomass investment in roots and leaves also increased, probably in order to maximize nutrient absorption and photosynthesis, respectively. These results suggest that water level fluctuation may alleviate the effects of submergence on A. philoxeroides. In addition, A. philoxeroides showed significant phenotypic plasticity, adjusting its functional traits, such as number of nodes and leaves per stem, as well as stem diameter and pith cavity diameter, according to recurrent water level fluctuation. We conclude that A. philoxeroides may perform better in shallow water zones under conditions of disturbance that include recurrent water level fluctuation. This ability to adapt to disturbance likely promotes its growth and invasion in disturbed habitats.	[Zhang, Haijie; Wang, Renqing; Du, Yuanda; Liu, Jian] Shandong Univ, Inst Environm Res, Jinan 250100, Peoples R China; [Wang, Renqing; Wang, Xiao; Du, Ning] Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China; [Wang, Renqing; Wang, Xiao; Du, Ning] Shandong Univ, Shandong Prov Engn & Technol Res Ctr Vegetat Ecol, Jinan 250100, Peoples R China; [Ge, Xiuli] Qilu Univ Technol, Sch Environm Sci & Engn, Jinan, Peoples R China	Shandong University; Shandong University; Shandong University; Qilu University of Technology	Liu, J (corresponding author), Shandong Univ, Inst Environm Res, Jinan 250100, Peoples R China.	ecology@sdu.edu.cn	Liu, Jian/AAG-9184-2019; Liu, Jian/T-1760-2017	Liu, Jian/0000-0003-1920-2641; Liu, Jian/0000-0003-1920-2641	National Natural Science Foundation of China [31200426, 31400356]; National Water Special Project [2012ZX07203-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Water Special Project	This study was financially supported by "National Natural Science Foundation of China" (No. 31200426, 31400356) and "National Water Special Project" (No. 2012ZX07203-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumberger T, 2012, AQUAT BOT, V102, P65, DOI 10.1016/j.aquabot.2012.05.003; Benschop JJ, 2005, PLANT J, V44, P756, DOI 10.1111/j.1365-313X.2005.02563.x; Callieri C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109526; Castillo JM, 2005, ESTUARIES, V28, P761, DOI 10.1007/BF02732913; Chen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081456; Colmer TD, 2009, FUNCT PLANT BIOL, V36, P665, DOI 10.1071/FP09144; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Deegan BM, 2007, AQUAT BOT, V86, P309, DOI 10.1016/j.aquabot.2006.11.006; Drenovsky RE, 2012, ANN BOT-LONDON, V110, P141, DOI 10.1093/aob/mcs100; Evtimova VV, 2014, J APPL ECOL, V51, P1282, DOI 10.1111/1365-2664.12297; Gao J, 2012, AQUAT BIOL, V17, P295, DOI [10.3354/ab00484, DOI 10.3354/AB00484]; Geng YP, 2007, BIOL INVASIONS, V9, P245, DOI 10.1007/s10530-006-9029-1; Geng YP, 2006, ACTA OECOL, V30, P380, DOI 10.1016/j.actao.2006.07.002; Holt RD, 2008, ECOLOGY, V89, P671, DOI 10.1890/07-0348.1; JULIEN MH, 1995, J AQUAT PLANT MANAGE, V33, P55; Kawano N, 2009, ANN BOT-LONDON, V103, P161, DOI 10.1093/aob/mcn171; Licausi F, 2011, NATURE, V479, P419, DOI 10.1038/nature10536; Lin JinCheng, 2004, Acta Agriculturae Shanghai, V20, P96; Lorbiecke R, 1999, PLANT PHYSIOL, V119, P21, DOI 10.1104/pp.119.1.21; Luo FL, 2014, ANN BOT-LONDON, V113, P1265, DOI 10.1093/aob/mcu057; Luo FL, 2012, J PLANT PHYSIOL, V169, P1680, DOI 10.1016/j.jplph.2012.06.015; Luo FL, 2011, ANN BOT-LONDON, V107, P49, DOI 10.1093/aob/mcq212; Luo FL, 2009, ANN BOT-LONDON, V104, P1435, DOI 10.1093/aob/mcp257; Miao SL, 2009, AM NAT, V173, P113, DOI 10.1086/593307; MIAO SL, 1990, ECOLOGY, V71, P2166, DOI 10.2307/1938630; Paillisson JM, 2011, ECOL ENG, V37, P241, DOI 10.1016/j.ecoleng.2010.11.017; Parolin P, 2001, OECOLOGIA, V128, P326, DOI 10.1007/s004420100660; Polacik KA, 2013, ENVIRON EXP BOT, V89, P19, DOI 10.1016/j.envexpbot.2012.12.005; Rich SM, 2012, ANN BOT-LONDON, V110, P405, DOI 10.1093/aob/mcs051; Sauter M, 2013, CURR OPIN PLANT BIOL, V16, P282, DOI 10.1016/j.pbi.2013.03.013; SCHAT H, 1984, OECOLOGIA, V62, P279, DOI 10.1007/BF00379027; Smith RGB, 2007, PLANT ECOL, V188, P103, DOI 10.1007/s11258-006-9151-2; Tao Y, 2009, J PLANT BIOL, V52, P403, DOI 10.1007/s12374-009-9051-9; Voesenek LACJ, 2013, CURR OPIN PLANT BIOL, V16, P647, DOI 10.1016/j.pbi.2013.06.008; Voesenek LACJ, 2006, NEW PHYTOL, V170, P213, DOI 10.1111/j.1469-8137.2006.01692.x; Voesenek LACJ, 2003, ANN BOT-LONDON, V91, P205, DOI 10.1093/aob/mcf116; Vretare V, 2001, AQUAT BOT, V69, P127, DOI 10.1016/S0304-3770(01)00134-6; Wang Hai-Feng, 2008, Wuhan Zhiwuxue Yanjiu, V26, P147; Wei H, 2014, J FRESHWATER ECOL, V29, P101, DOI 10.1080/02705060.2013.833142; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; You WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097246; Yu LF, 2009, FUND APPL LIMNOL, V174, P295, DOI 10.1127/1863-9135/2009/0174-0295; Zhang XK, 2013, J PLANT ECOL, V6, P64, DOI 10.1093/jpe/rts009; Zhu GR, 2012, HYDROBIOLOGIA, V696, P77, DOI 10.1007/s10750-012-1185-y	44	5	5	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129549	10.1371/journal.pone.0129549	http://dx.doi.org/10.1371/journal.pone.0129549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066509	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000088
J	DuVall, JA; Borba, JC; Shafagati, N; Luzader, D; Shukla, N; Li, JY; Kehn-Hall, K; Kendall, MM; Feldman, SH; Landers, JP				DuVall, Jacquelyn A.; Borba, Juliane C.; Shafagati, Nazly; Luzader, Deborah; Shukla, Nishant; Li, Jingyi; Kehn-Hall, Kylene; Kendall, Melissa M.; Feldman, Sanford H.; Landers, James P.			Optical Imaging of Paramagnetic Bead-DNA Aggregation Inhibition Allows for Low Copy Number Detection of Infectious Pathogens	PLOS ONE			English	Article							RAPID DETECTION; BIOLOGICAL SAMPLES; PURIFICATION; VIRUS; EXTRACTION; EXPRESSION; ADHERENCE; PROTEIN; CELLS	DNA-paramagnetic silica bead aggregation in a rotating magnetic field facilitates the quantification of DNA with femtogram sensitivity, but yields no sequence-specific information. Here we provide an original description of aggregation inhibition for the detection of DNA and RNA in a sequence-specific manner following loop-mediated isothermal amplification (LAMP). The fragments generated via LAMP fail to induce chaotrope-mediated bead aggregation; however, due to their ability to passivate the bead surface, they effectively inhibit bead aggregation by longer 'trigger' DNA. We demonstrate the utility of aggregation inhibition as a method for the detection of bacterial and viral pathogens with sensitivity that approaches single copies of the target. We successfully use this methodology for the detection of notable food-borne pathogens Escherichia coli O157:H7 and Salmonella enterica, as well as Rift Valley fever virus, a weaponizable virus of national security concern. We also show the concentration dependence of aggregation inhibition, suggesting the potential for quantification of target nucleic acid in clinical and environmental samples. Lastly, we demonstrate the ability to rapidly detect infectious pathogens by utilizing a cell phone and custom-written application (App), making this novel detection modality fully portable for point-of-care use.	[DuVall, Jacquelyn A.; Borba, Juliane C.; Li, Jingyi; Landers, James P.] Univ Virginia, Dept Chem, Charlottesville, VA 22903 USA; [Shafagati, Nazly; Kehn-Hall, Kylene] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA; [Luzader, Deborah; Kendall, Melissa M.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA; [Shukla, Nishant] Univ Virginia, Dept Comp Sci, Charlottesville, VA 22903 USA; [Feldman, Sanford H.] Univ Virginia, Ctr Comparat Med, Charlottesville, VA USA; [Landers, James P.] Univ Virginia, Dept Mech Engn, Charlottesville, VA USA; [Landers, James P.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	University of Virginia; George Mason University; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Landers, JP (corresponding author), Univ Virginia, Dept Chem, Charlottesville, VA 22903 USA.	jpl5e@virginia.edu	Kehn-Hall, Kylene/I-5752-2013; Feldman, Sanford/AAH-7070-2021	Luzader, Deborah/0000-0002-7453-406X; Kehn-Hall, Kylene/0000-0001-8036-7213				Bienvenue JM, 2006, J FORENSIC SCI, V51, P266, DOI 10.1111/j.1556-4029.2006.00054.x; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Breadmore MC, 2003, ANAL CHEM, V75, P1880, DOI 10.1021/ac0204855; California Food Emergency Response Team, 2007, INVESTIGATION OF AN; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Chen SY, 2011, APPL ENVIRON MICROB, V77, P4008, DOI 10.1128/AEM.00354-11; GRIFFIN PM, 1988, ANN INTERN MED, V109, P705, DOI 10.7326/0003-4819-109-9-705; Hagan KA, 2008, ANAL CHEM, V80, P8453, DOI 10.1021/ac8011945; Ikegami T, 2009, VACCINE, V27, pD69, DOI 10.1016/j.vaccine.2009.07.046; Kiilerich-Pedersen K, 2013, BIOSENS BIOELECTRON, V49, P374, DOI 10.1016/j.bios.2013.05.046; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lazcka O, 2007, BIOSENS BIOELECTRON, V22, P1205, DOI 10.1016/j.bios.2006.06.036; Le Roux CA, 2009, J CLIN MICROBIOL, V47, P645, DOI 10.1128/JCM.01412-08; Leland DS, 2007, CLIN MICROBIOL REV, V20, P49, DOI 10.1128/CMR.00002-06; Leslie DC, 2012, J AM CHEM SOC, V134, P5689, DOI 10.1021/ja300839n; Li JY, 2013, ANAL CHEM, V85, P11233, DOI 10.1021/ac401402h; Luisi PL, 2010, MINIMAL CELL BIOPHYS, P65; Lundberg L, 2013, ANTIVIR RES, V100, P662, DOI 10.1016/j.antiviral.2013.10.004; Mohawk KL, 2010, MICROB PATHOGENESIS, V48, P131, DOI 10.1016/j.micpath.2010.01.003; Narayanan A, 2011, EXPERT OPIN INV DRUG, V20, P239, DOI 10.1517/13543784.2011.547852; NATARO JP, 1994, J BACTERIOL, V176, P4691, DOI 10.1128/JB.176.15.4691-4699.1994; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Shafagati N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002296; Szretter K, 2005, CURR PROTOC MICROBIO; Tian HJ, 2000, ANAL BIOCHEM, V283, P175, DOI 10.1006/abio.2000.4577; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615; Wang F, 2012, J CLIN MICROBIOL, V50, P91, DOI 10.1128/JCM.05612-11; WELLS JG, 1983, J CLIN MICROBIOL, V18, P512, DOI 10.1128/JCM.18.3.512-520.1983; WU SX, 1991, ACTA PAEDIATR SCAND, V80, P1019; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; Yao ZY, 2013, APPL ENVIRON MICROB, V79, P1755, DOI 10.1128/AEM.03605-12; Zhao XH, 2010, MOL BIOL REP, V37, P2183, DOI 10.1007/s11033-009-9700-6	35	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129830	10.1371/journal.pone.0129830	http://dx.doi.org/10.1371/journal.pone.0129830			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068926	Green Submitted, gold, Green Published			2022-12-27	WOS:000356100900082
J	Huan, YJ; Wu, ZF; Zhang, JG; Zhu, J; Liu, ZH; Song, XX				Huan, Yanjun; Wu, Zhanfeng; Zhang, Jiguang; Zhu, Jiang; Liu, Zhonghua; Song, Xuexiong			Epigenetic Modification Agents Improve Gene-Specific Methylation Reprogramming in Porcine Cloned Embryos	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; DNA METHYLATION; BOVINE EMBRYOS; SOMATIC-CELLS; MOUSE EMBRYOS; EXPRESSION; CLONING; 5-HYDROXYMETHYLCYTOSINE; 5-AZA-2'-DEOXYCYTIDINE; EMBRYOGENESIS	Incomplete DNA methylation reprogramming in cloned embryos leads to poor cloning efficiency. Epigenetic modification agents can improve genomic methylation reprogramming and the development of cloned embryos, however, the effect of epigenetic modification agents on gene-specific methylation reprogramming remains poorly studied. Here, we investigated DNA methylation reprogramming of pluripotency (Oct4) and tissue specific (Thy1) genes during early embryo development in pigs. In this study, we found that compared with in vitro fertilized counterparts, cloned embryos displayed the disrupted patterns of Oct4 demethylation and Thy1 remethylation. When 5-aza-2'-deoxycytidine (5-aza-dC) or trichostatin A (TSA) enhanced the development of cloned embryos, the transcripts of DNA methyltransferases (Dnmt1 and Dnmt3a), histone acetyltransferase 1 (Hat1) and histone deacetylase 1 (Hdac1) and the methylation and expression patterns of Oct4 and Thy1 became similar to those detected in in vitro fertilized counterparts. Further studies showed that Dnmt1 knockdown in cloned embryos enhanced the methylation reprogramming of Oct4 and Thy1 and promoted the activation of Oct4 and the silence of Thy1. In conclusion, our results demonstrated that cloned embryos displayed incomplete gene-specific methylation reprogramming and disrupted expression patterns of pluripotency and tissue specific genes, and epigenetic modification agents improved gene-specific methylation reprogramming and expression pattern by regulating epigenetic modification related genes. This work would have important implications in improving cloning efficiency.	[Huan, Yanjun; Song, Xuexiong] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao, Shandong, Peoples R China; [Wu, Zhanfeng; Zhang, Jiguang] Shouguang City Hosp Chinese Med, Weifang, Shandong, Peoples R China; [Zhu, Jiang; Liu, Zhonghua] Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang Pr, Peoples R China	Qingdao Agricultural University; Northeast Agricultural University - China	Liu, ZH (corresponding author), Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang Pr, Peoples R China.	liu086@126.com; sxx1959@163.com	Liu, Zhonghua/AAO-3590-2021; Liu, Zhunghua/F-2485-2010	Liu, Zhonghua/0000-0002-9199-6493; Liu, Zhunghua/0000-0002-9199-6493; , Yanjun/0000-0001-7334-4582	Genetically Modified Organisms Breeding Major Projects [2009ZX08006-007B]; China Postdoctoral Science Foundation [2014M551943]; special foundation of Postdoctoral Innovation Project in Shandong Province of China [201402044]	Genetically Modified Organisms Breeding Major Projects; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); special foundation of Postdoctoral Innovation Project in Shandong Province of China	Genetically Modified Organisms Breeding Major Projects (2009ZX08006-007B) to XXS, http://www.moa.gov.cn/; China Postdoctoral Science Foundation (2014M551943) to YJH, http://bg.chinapostdoctor.org.cn/; the special foundation of Postdoctoral Innovation Project in Shandong Province of China (201402044) to YJH, http://www.sdhrss.gov.cn/cm/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Chen Hong Ping, 2015, Critical Reviews in Oncogenesis, V20, P35; Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286; Deng Dajun, 2014, Yichuan, V36, P403, DOI 10.3724/SP.J.1005.2014.0403; Ding X, 2008, THERIOGENOLOGY, V70, P622, DOI 10.1016/j.theriogenology.2008.04.042; Esch D, 2013, NAT CELL BIOL ADV ON; Huan YJ, 2014, J REPROD DEVELOP, V60, P377, DOI 10.1262/jrd.2014-062; Huan YJ, 2013, J REPROD DEVELOP, V59, P442, DOI 10.1262/jrd.2013-026; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Ji Huili, 2014, Yichuan, V36, P1211, DOI 10.3724/SP.J.1005.2014.1211; Kong Qing-Ran, 2011, Yichuan, V33, P749, DOI 10.3724/SP.J.1005.2011.00749; Lee KiHo, 2013, Animal Frontiers, V3, P56, DOI 10.2527/af.2013-0034; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Long CR, 2014, MOL REPROD DEV, V81, P183, DOI 10.1002/mrd.22271; Ma PP, 2008, DEV BIOL, V319, P110, DOI 10.1016/j.ydbio.2008.04.011; Messerschmidt DM, 2014, GENE DEV, V28, P812, DOI 10.1101/gad.234294.113; Miyamoto K, 2009, BIOL REPROD, V80, P935, DOI 10.1095/biolreprod.108.073676; Mizutani E, 2015, METHODS MOL BIOL, V1222, P101, DOI 10.1007/978-1-4939-1594-1_8; Niemann H, 2008, REPRODUCTION, V135, P151, DOI 10.1530/REP-07-0397; Niemann H, 2010, CELL REPROGRAM, V12, P33, DOI 10.1089/cell.2009.0063; Peat JR, 2012, NAT GENET, V44, P965, DOI 10.1038/ng.2393; Rodriguez-Osorio N, 2012, THERIOGENOLOGY, V78, P1869, DOI 10.1016/j.theriogenology.2012.05.030; Tamada H, 2004, CYTOGENET GENOME RES, V105, P285, DOI 10.1159/000078200; Wang YS, 2011, CELL REPROGRAM, V13, P297, DOI 10.1089/cell.2010.0098; Wei YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020154; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Xu WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064705; Yamanaka K, 2011, J REPROD DEVELOP, V57, P393, DOI 10.1262/jrd.10-181A; Yin LJ, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-26; Zhao JG, 2010, CELL TISSUE RES, V341, P13, DOI 10.1007/s00441-010-1000-x; Zhao MT, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104471	33	24	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129803	10.1371/journal.pone.0129803	http://dx.doi.org/10.1371/journal.pone.0129803			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068219	gold, Green Published, Green Submitted			2022-12-27	WOS:000356100900079
J	Stein, C; Makarewicz, O; Bohnert, JA; Pfeifer, Y; Kesselmeier, M; Hagel, S; Pletz, MW				Stein, Claudia; Makarewicz, Oliwia; Bohnert, Juergen A.; Pfeifer, Yvonne; Kesselmeier, Miriam; Hagel, Stefan; Pletz, Mathias W.			Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia Isolates	PLOS ONE			English	Article							BETA-LACTAMASE PRODUCTION; COMBINATION THERAPY; ERTAPENEM-RESISTANT; PORIN; DERIVATIVES; MORTALITY; IMPACT; SPREAD	The spread of carbapenem-non-susceptible Klebsiella pneumoniae strains bearing different resistance determinants is a rising problem worldwide. Especially infections with KPC (Klebsiella pneumoniae carbapenemase) - producers are associated with high mortality rates due to limited treatment options. Recent clinical studies of KPC-blood stream infections revealed that colistin-based combination therapy with a carbapenem and/or tigecycline was associated with significantly decreased mortality rates when compared to colistin monotherapy. However, it remains unclear if these observations can be transferred to K. pneumoniae harboring other mechanisms of carbapenem resistance. A three-dimensional synergy analysis was performed to evaluate the benefits of a triple combination with meropenem, tigecycline and colistin against 20 K. pneumoniae isolates harboring different beta-lactamases. To examine the mechanism behind the clinically observed synergistic effect, efflux properties and outer membrane porin (Omp) genes (ompK35 and ompK36) were also analyzed. Synergism was found for colistin-based double combinations for strains exhibiting high minimal inhibition concentrations against all of the three antibiotics. Adding a third antibiotic did not result in further increased synergistic effect in these strains. Antagonism did not occur. These results support the idea that colistin-based double combinations might be sufficient and the most effective combination partner for colistin should be chosen according to its MIC.	[Stein, Claudia; Makarewicz, Oliwia; Hagel, Stefan; Pletz, Mathias W.] Jena Univ Hosp, Ctr Infect Dis & Infect Control, D-07747 Jena, Germany; [Bohnert, Juergen A.] Jena Univ Hosp, Inst Med Microbiol, D-07747 Jena, Germany; [Pfeifer, Yvonne] Robert Koch Inst, Nosocomial Pathogens & Antibiot Resistance, D-8855 Wernigerode, Germany; [Kesselmeier, Miriam] Jena Univ Hosp, Ctr Sepsis Control & Care, Clin Epidemiol Integrated Res & Treatment Ctr, D-07747 Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Robert Koch Institute; Friedrich Schiller University of Jena	Stein, C (corresponding author), Jena Univ Hosp, Ctr Infect Dis & Infect Control, D-07747 Jena, Germany.	Claudia.Stein@med.uni-jena.de	Kesselmeier, Miriam/G-5546-2016; Pletz, Mathias Wilhelm/H-9782-2019; Hagel, Stefan/AAE-1174-2022	Kesselmeier, Miriam/0000-0001-6462-2579; Pletz, Mathias Wilhelm/0000-0001-8157-2753; Hagel, Stefan/0000-0003-2999-6131; Makarewicz, Oliwia/0000-0002-4404-1862	German Ministry of Education and Research [01KI1204, 01EO1002]; ARGUS-Stiftung	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); ARGUS-Stiftung	This work was supported by grants from the German Ministry of Education and Research (grant numbers 01KI1204 and 01EO1002) and from ARGUS-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI S, 1995, INFECT IMMUN, V63, P903; Bauer G, 2004, J ANTIMICROB CHEMOTH, V53, P592, DOI 10.1093/jac/dkh125; Betts JW, 2014, ANTIMICROB AGENTS CH, V58, P3541, DOI 10.1128/AAC.02449-14; Bohnert JA, 2010, ANTIMICROB AGENTS CH, V54, P3770, DOI 10.1128/AAC.00620-10; Borer A, 2009, INFECT CONT HOSP EP, V30, P972, DOI 10.1086/605922; CHEN CCH, 1972, ANTIMICROB AGENTS CH, V22, P331, DOI 10.1128/AAC.2.5.331; Clancy CJ, 2013, ANTIMICROB AGENTS CH, V57, P5258, DOI 10.1128/AAC.01069-13; Daikos GL, 2014, ANTIMICROB AGENTS CH, V58, P2322, DOI 10.1128/AAC.02166-13; den Hollander JG, 1998, ANTIMICROB AGENTS CH, V42, P744, DOI 10.1128/AAC.42.4.744; Doern GV, 2011, J CLIN MICROBIOL, V49, P3109, DOI 10.1128/JCM.00580-11; Domenech-Sanchez A, 2003, ANTIMICROB AGENTS CH, V47, P3332, DOI 10.1128/AAC.47.10.3332-3335.2003; European Centre for Disease Prevention and Control (ECDC), 2013, ANNUAL EPIDEMIOLOGIC; Garcia-Fernandez A, 2010, ANTIMICROB AGENTS CH, V54, P4178, DOI 10.1128/AAC.01301-09; Garcia-Sureda L, 2011, ANTIMICROB AGENTS CH, V55, P1803, DOI 10.1128/AAC.01441-10; Gerasimenko D. V., 2004, Prikladnaya Biokhimiya i Mikrobiologiya, V40, P301; Grill MF, 2011, BRIT J CLIN PHARMACO, V72, P381, DOI 10.1111/j.1365-2125.2011.03991.x; Handzlik J, 2013, BIOORGAN MED CHEM, V21, P135, DOI 10.1016/j.bmc.2012.10.053; Handzlik J, 2012, BIOORGAN MED CHEM, V20, P4245, DOI 10.1016/j.bmc.2012.05.064; Hong JH, 2013, ANTIMICROB AGENTS CH, V57, P2147, DOI 10.1128/AAC.02411-12; Kaczmarek FM, 2006, ANTIMICROB AGENTS CH, V50, P3396, DOI 10.1128/AAC.00285-06; Lee CH, 2007, J ANTIMICROB CHEMOTH, V60, P410, DOI 10.1093/jac/dkm215; Martinez-Martinez L, 2008, CLIN MICROBIOL INFEC, V14, P82, DOI 10.1111/j.1469-0691.2007.01860.x; NIKAIDO H, 1994, J BIOL CHEM, V269, P3905; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Novais A, 2012, EUR J CLIN MICROBIOL, V31, P3057, DOI 10.1007/s10096-012-1665-z; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Paul M, 2014, J ANTIMICROB CHEMOTH, V69, P2305, DOI 10.1093/jac/dku168; Plachouras D, 2009, ANTIMICROB AGENTS CH, V53, P3430, DOI 10.1128/AAC.01361-08; Poulou A, 2013, J CLIN MICROBIOL, V51, P3176, DOI 10.1128/JCM.01244-13; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Qureshi ZA, 2012, ANTIMICROB AGENTS CH, V56, P2108, DOI 10.1128/AAC.06268-11; Tsai YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079640; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; Wang XD, 2009, J MED MICROBIOL, V58, P1196, DOI 10.1099/jmm.0.008094-0; Watkins RR, 2015, EXPERT REV ANTI-INFE, V13, P405, DOI 10.1586/14787210.2015.1018825; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001	36	53	56	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0126479	10.1371/journal.pone.0126479	http://dx.doi.org/10.1371/journal.pone.0126479			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067824	gold, Green Published			2022-12-27	WOS:000356100900009
J	Cui, XJ; McAllister, R; Boregowda, R; Sohn, JA; Ledesma, FC; Caldecott, KW; Seeger, C; Hu, JM				Cui, Xiuji; McAllister, Rebecca; Boregowda, Rajeev; Sohn, Ji A.; Cortes Ledesma, Felipe; Caldecott, Keith W.; Seeger, Christoph; Hu, Jianming			Does Tyrosyl DNA Phosphodiesterase-2 Play a Role in Hepatitis B Virus Genome Repair?	PLOS ONE			English	Article							CLOSED CIRCULAR DNA; HEPADNAVIRUS REVERSE-TRANSCRIPTASE; ENVELOPE PROTEINS; COVALENT COMPLEXES; VIRAL-DNA; IN-VITRO; CELLS; TDP2; REPLICATION; POLYMERASE	Hepatitis B virus (HBV) replication and persistence are sustained by a nuclear episome, the covalently closed circular (CCC) DNA, which serves as the transcriptional template for all viral RNAs. CCC DNA is converted from a relaxed circular (RC) DNA in the virion early during infection as well as from RC DNA in intracellular progeny nucleocapsids via an intracellular amplification pathway. Current antiviral therapies suppress viral replication but cannot eliminate CCC DNA. Thus, persistence of CCC DNA remains an obstacle toward curing chronic HBV infection. Unfortunately, very little is known about how CCC DNA is formed. CCC DNA formation requires removal of the virally encoded reverse transcriptase (RT) protein from the 5' end of the minus strand of RC DNA. Tyrosyl DNA phosphodiesterase-2 (Tdp2) was recently identified as the enzyme responsible for cleavage of tyrosyl-5' DNA linkages formed between topoisomerase II and cellular DNA. Because the RT-DNA linkage is also a 5' DNA-phosphotyrosyl bond, it has been hypothesized that Tdp2 might be one of several elusive host factors required for CCC DNA formation. Therefore, we examined the role of Tdp2 in RC DNA deproteination and CCC DNA formation. We demonstrated Tdp2 can cleave the tyrosyl-minus strand DNA linkage using authentic HBV RC DNA isolated from nucleocapsids and using RT covalently linked to short minus strand DNA produced in vitro. On the other hand, our results showed that Tdp2 gene knockout did not block CCC DNA formation during HBV infection of permissive human hepatoma cells and did not prevent intracellular amplification of duck hepatitis B virus CCC DNA. These results indicate that although Tdp2 can remove the RT covalently linked to the 5' end of the HBV minus strand DNA in vitro, this protein might not be required for CCC DNA formation in vivo.	[Cui, Xiuji; McAllister, Rebecca; Boregowda, Rajeev; Hu, Jianming] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; [Sohn, Ji A.; Seeger, Christoph] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Cortes Ledesma, Felipe] CSIC, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville 41092, Spain; [Caldecott, Keith W.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Fox Chase Cancer Center; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); University of Sussex	Hu, JM (corresponding author), Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA.	juh13@psu.edu	Ledesma, Felipe Cortés/F-4803-2014; Caldecott, Keith/S-4245-2019	Ledesma, Felipe Cortés/0000-0002-0440-6783; Caldecott, Keith/0000-0003-4255-9016	National Institutes of Health [R01 AI074982, R21 AI101558, T32 CA060395]; NATIONAL CANCER INSTITUTE [T32CA060395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074982, R21AI119433, R21AI101558] Funding Source: NIH RePORTER; Cancer Research UK [16771] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Research UK(Cancer Research UK)	Funding for this work came from the National Institutes of Health, http://www.nih.gov, R01 AI074982 to JH, R21 AI101558 to CS, and T32 CA060395 to RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boregowda RK, 2011, J VIROL, V85, P7754, DOI 10.1128/JVI.00483-11; Gao R, 2014, J BIOL CHEM, V289, P17960, DOI 10.1074/jbc.M114.565374; Gao WF, 2007, J VIROL, V81, P6164, DOI 10.1128/JVI.02721-06; Guo H, 2007, J VIROL, V81, P12472, DOI 10.1128/JVI.01123-07; Hantz O, 2009, J GEN VIROL, V90, P127, DOI 10.1099/vir.0.004861-0; Hu J, 2015, COLD SPRING HARB PER; Jones SA, 2013, J VIROL, V87, P2563, DOI 10.1128/JVI.02786-12; Jones SA, 2012, J VIROL, V86, P5134, DOI 10.1128/JVI.07137-11; Kock J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001082; Koniger C, 2014, P NATL ACAD SCI USA, V111, pE4244, DOI 10.1073/pnas.1409986111; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Lentz TB, 2011, J VIROL, V85, P11916, DOI 10.1128/JVI.05373-11; Lin CP, 2009, J BIOL CHEM, V284, P28084, DOI 10.1074/jbc.M109.030601; Lin L, 2008, J VIROL, V82, P2305, DOI 10.1128/JVI.02147-07; Litwin S, 2005, J CLIN VIROL, V34, pS96, DOI 10.1016/S1386-6532(05)80018-6; Nguyen DH, 2007, J VIROL, V81, P4465, DOI 10.1128/JVI.02510-06; Ning XJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002255; Pommier Y, 2014, DNA REPAIR, V19, P114, DOI 10.1016/j.dnarep.2014.03.020; Raney AK, 2001, J VIROL, V75, P2900, DOI 10.1128/JVI.75.6.2900-2911.2001; Schellenberg MJ, 2012, NAT STRUCT MOL BIOL, V19, P1363, DOI 10.1038/nsmb.2418; Seeger C., 2013, FIELDS VIROLOGY, P2185; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; Shi K, 2012, NAT STRUCT MOL BIOL, V19, P1372, DOI 10.1038/nsmb.2423; Sohn JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008093; SUMMERS J, 1990, J VIROL, V64, P2819, DOI 10.1128/JVI.64.6.2819-2824.1990; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; SUMMERS J, 1991, J VIROL, V65, P1310, DOI 10.1128/JVI.65.3.1310-1317.1991; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1; WANG GH, 1992, CELL, V71, P663, DOI 10.1016/0092-8674(92)90599-8; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang XT, 2003, J VIROL, V77, P4471, DOI 10.1128/JVI.77.8.4471-4480.2003; WEBER M, 1994, J VIROL, V68, P2994, DOI 10.1128/JVI.68.5.2994-2999.1994; WU TT, 1990, VIROLOGY, V175, P255, DOI 10.1016/0042-6822(90)90206-7; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Zeng ZH, 2011, J BIOL CHEM, V286, P403, DOI 10.1074/jbc.M110.181016; Zhang AL, 2006, J BIOL CHEM, V281, P35997, DOI 10.1074/jbc.M604149200; Zhang YZ, 2003, P NATL ACAD SCI USA, V100, P12372, DOI 10.1073/pnas.2033898100; ZOULIM F, 1994, J VIROL, V68, P6, DOI 10.1128/JVI.68.1.6-13.1994	41	59	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0128401	10.1371/journal.pone.0128401	http://dx.doi.org/10.1371/journal.pone.0128401			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079492	Green Published, gold			2022-12-27	WOS:000356542300010
J	Matsumoto-Takahashi, ELA; Tongol-Rivera, P; Villacorte, EA; Angluben, RU; Jimba, M; Kano, S				Matsumoto-Takahashi, Emilie Louise Akiko; Tongol-Rivera, Pilarita; Villacorte, Elena A.; Angluben, Ray U.; Jimba, Masamine; Kano, Shigeyuki			Patient Knowledge on Malaria Symptoms Is a Key to Promoting Universal Access of Patients to Effective Malaria Treatment in Palawan, the Philippines	PLOS ONE			English	Article							AWARENESS-RAISING ACTIVITIES; COMMUNITY-HEALTH WORKERS; RURAL BURKINA-FASO; SEEKING BEHAVIOR; DRUG-RESISTANCE; PREVENTION; MORTALITY; ILLNESS	Introduction Palawan, where health care facilities are still limited, is one of the most malaria endemic provinces in the Philippines. Since 1999, microscopists (community health workers) have been trained in malaria diagnosis and feasibility of early diagnosis and treatments have been enhanced throughout the province. To accelerate the universal access of malaria patients to diagnostic testing in Palawan, positive health seeking behavior should be encouraged when malaria infection is suspected. Methods In this cross-sectional study, structured interviews were carried out with residents (N = 218) of 20 remote malaria-endemic villages throughout Palawan with a history of suspected malaria from January to February in 2012. Structural equation modeling (SEM) was conducted to determine factors associated with appropriate treatment, which included: (1) socio-demo-graphic characteristics; (2) proximity to a health facility; (3) health seeking behavior; (4) knowledge on malaria; (5) participation in community awareness-raising activities. Results Three factors independently associated with appropriate treatment were identified by SEM (CMIN = 10.5, df = 11, CFI = 1.000, RMSEA = .000): "living near microscopist" (p < 0.001), "not living near private pharmacy" (p < 0.01), and "having severe symptoms" (p < 0.01). "Severe symptoms" were positively correlated with more "knowledge on malaria symptoms" (p < 0.001). This knowledge was significantly increased by attending "community awareness-raising activities by microscopists" (p < 0.001). Conclusions In the resource-limited settings, microscopists played a significant role in providing appropriate treatment to all participants with severe malaria symptoms. However, it was considered that knowledge on malaria symptoms made participants more aware of their symptoms, and further progressed self-triage. Strengthening this recognition sensitivity and making residents aware of nearby microscopists may be the keys to accelerating universal access to effective malaria treatment in Palawan.	[Matsumoto-Takahashi, Emilie Louise Akiko; Kano, Shigeyuki] Natl Ctr Global Hlth & Med, Res Inst, Dept Trop Med & Malaria, Tokyo, Japan; [Matsumoto-Takahashi, Emilie Louise Akiko; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan; [Tongol-Rivera, Pilarita; Villacorte, Elena A.] Univ Philippines, Coll Publ Hlth, Dept Parasitol, Manila, Philippines; [Angluben, Ray U.] Kilusan Ligtas Malaria Pilipinas Shell Fdn Inc, SPS Govt Ctr, Palawan City, Philippines	National Center for Global Health & Medicine - Japan; University of Tokyo; University of the Philippines System; University of the Philippines Manila	Kano, S (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Trop Med & Malaria, Tokyo, Japan.	kano@ri.ncgm.go.jp	Jimba, Masamine/AAF-5630-2020	Kano, Shigeyuki/0000-0001-9050-4955	Japanese Ministry of Health, Labour and Welfare [H21-Chikyukibo-Ippan-006]; National Center for Global Health and Medicine [25A-2]	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	The present study was supported by a grant from the Japanese Ministry of Health, Labour and Welfare (http://www.mhlw.go.jp) (grant number: H21-Chikyukibo-Ippan-006) and by a Grant from the National Center for Global Health and Medicine ( http://www.ncgm.go.jp/) (grant number: 25A-2). SK received both funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Abubakar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071998; Ahorlu CK, 1997, TROP MED INT HEALTH, V2, P488, DOI 10.1046/j.1365-3156.1997.d01-298.x; Akogun OB, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-13; Almuzaini T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002923; Angluben R. U., 2008, Tropical Medicine and Health, V36, P45, DOI 10.2149/tmh.36.45; [Anonymous], PROV HLTH REP 2005; [Anonymous], PROV HLTH REP 1995; [Anonymous], POP PHIL CENS YEARS; [Anonymous], PROV HLTH REP 2000; Beiersmann C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-106; Chibwana AI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-219; Delacollette C, 1996, B WORLD HEALTH ORGAN, V74, P423; Deressa W, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-259; Feyisetan B J, 1997, Health Transit Rev, V7, P221; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hazel E, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001384, 10.1371/journal.pmed.1001416]; Hwang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011692; Kelesidis T, 2007, J ANTIMICROB CHEMOTH, V60, P214, DOI 10.1093/jac/dkm109; Makemba AM, 1996, TROP MED INT HEALTH, V1, P305; Matsumoto-Takahashi ELA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-384; Matsumoto-Takahashi ELA, 2014, PARASITOL INT, V63, P519, DOI 10.1016/j.parint.2014.01.008; Mita T, 2012, JPN J INFECT DIS, V65, P465, DOI 10.7883/yoken.65.465; Mubi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019753; Muller O, 2003, TROP MED INT HEALTH, V8, P290, DOI 10.1046/j.1365-3156.2003.01030.x; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Mwangome M, 2010, J HEALTH POPUL NUTR, V28, P167; Ndiaye Y, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-240; Parija SC, 2011, INDIAN J MED MICROBI, V29, P243, DOI 10.4103/0255-0857.83906; Provincial Health Office of Palawan, 2010, PROV HLTH REP 2010; Provincial Health Office of Palawan, 2012, PROV HLTH REP 2012; Santos G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059968; Satterfield D., 2002, HEALTH PROMOT PRACT, V3, P166, DOI [10.1177/152483990200300212, DOI 10.1177/152483990200300212]; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Sumba PO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-245; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Yasuoka J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-109	37	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0127858	10.1371/journal.pone.0127858	http://dx.doi.org/10.1371/journal.pone.0127858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079135	Green Published, Green Submitted, gold			2022-12-27	WOS:000356542300007
J	Wang, YL; Jiang, B; Yin, FF; Shi, HQ; Xu, XD; Zheng, SS; Wu, S; Hou, SC				Wang, You-Lin; Jiang, Bo; Yin, Fu-Fen; Shi, Hao-Qing; Xu, Xiao-Dong; Zheng, Shuai-Shuai; Wu, Shuai; Hou, Si-Chuan			Perioperative Blood Transfusion Promotes Worse Outcomes of Bladder Cancer after Radical Cystectomy: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; RECURRENCE; SURVIVAL; IMPACT; PROGNOSIS; COMPLICATIONS; MORTALITY; RESECTION; SURGERY	Background Multiple studies have investigated the effect of perioperative blood transfusion (PBT) for patients with radical cystectomy (RC), but the results have been inconsistent. We conducted a systematic review and meta-analysis to investigate the relationship between PBT and the clinical outcomes of RC patients. Methods We searched MEDLINE, EMBASE, the Cochrane library and BIOSIS previews to identify relevant literature for studies that focused on the relationship of PBT and outcomes of patients undergoing RC. A fixed or random effects model was used in this meta-analysis to calculate the pooled hazard ratio (HR) with 95% confidence intervals (CIs). Results A total of 7080 patients in 6 studies matched the selection criteria. Aggregation of the data suggested that PBT in patients who underwent RC correlated with increased all-cause mortality, cancer-specific mortality and cancer recurrence. The combined HRs were 1.19 (n = 6 studies, 95% CI: 1.11-1.27, Z = 4.71, P<0.00001), 1.17 (n = 4 studies, 95% CI: 1.06-1.30, Z = 3.06, P = 0.002), 1.14 (n = 3 studies, 95% CI: 1.03-1.27, Z = 2.50, P = 0.01), respectively. The all-cause mortality associated with PBT did not vary by the characteristics of the study, including number of study participants, follow-up period and the median blood transfusion ratio of the study. Conclusion Our data showed that PBT significantly increased the risks of all-cause mortality, cancer-specific mortality and cancer recurrence in patients undergoing RC for bladder cancer.	[Wang, You-Lin; Jiang, Bo; Zheng, Shuai-Shuai; Wu, Shuai; Hou, Si-Chuan] Qingdao Univ, Qingdao Municipal Hosp, Sch Med, Dept Urol, Qingdao 266071, Peoples R China; [Hou, Si-Chuan] Dalian Med Univ, Qingdao Municipal Hosp, Dept Urol, Dalian, Peoples R China; [Yin, Fu-Fen] Qingdao Univ, Affiliate Hosp, Dept Obstet & Gynecol, Qingdao 266071, Peoples R China; [Shi, Hao-Qing; Xu, Xiao-Dong] Qingdao Univ, Affiliate Hosp, Dept Urol, Qingdao 266071, Peoples R China	Qingdao Municipal Hospital; Qingdao University; Dalian Medical University; Qingdao University; Qingdao University	Wu, S (corresponding author), Qingdao Univ, Qingdao Municipal Hosp, Sch Med, Dept Urol, Qingdao 266071, Peoples R China.	wushuai_78@163.com; drhousichuan@sina.com	wang, youlin/GRS-4916-2022		National Natural Science Foundation of China [81301968]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81301968).	Abel EJ, 2014, EUROPEAN UROLOGY; BLAJCHMAN MA, 1995, IMMUNOL INVEST, V24, P311, DOI 10.3109/08820139509062781; BLUMBERG N, 1994, ARCH PATHOL LAB MED, V118, P371; Boehm K, 2014, WORLD J UROL, P1; CARSON JL, 1988, LANCET, V1, P727; Chang SS, 2001, J UROLOGY, V166, P2151, DOI 10.1016/S0022-5347(05)65524-3; Douglas T, 1995, TECHNIQUES UROLOGY, V2, P73; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fan ST, 1999, ARCH SURG-CHICAGO, V134, P1124, DOI 10.1001/archsurg.134.10.1124; Ghio M, 1999, BLOOD, V93, P1770, DOI 10.1182/blood.V93.5.1770.405a14_1770_1777; Gierth M, 2014, WORLD J UROL, P1; GOODARZI MO, 1995, TRANSFUSION, V35, P145, DOI 10.1046/j.1537-2995.1995.35295125737.x; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOUBIERS JGA, 1994, LANCET, V344, P573, DOI 10.1016/S0140-6736(94)91965-8; JAHNSON S, 1994, BRIT J UROL, V74, P779, DOI 10.1111/j.1464-410X.1994.tb07125.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KAPLAN J, 1984, BLOOD, V64, P308; Katz SC, 2009, ANN SURG, V249, P617, DOI 10.1097/SLA.0b013e31819ed22f; Kluth LA, 2014, BJU INT, V113, P393, DOI 10.1111/bju.12439; Kwon AH, 2001, CANCER-AM CANCER SOC, V91, P771; Law WL, 2007, ANN SURG ONCOL, V14, P2559, DOI 10.1245/s10434-007-9434-4; Linder BJ, 2013, EUR UROL, V63, P839, DOI 10.1016/j.eururo.2013.01.004; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064261; Morgan TM, 2013, UR ONC SEM OR INV; Murthy BL, 2007, BRIT J CANCER, V97, P1211, DOI 10.1038/sj.bjc.6604004; Nosotti M, 2003, CHEST, V124, P102, DOI 10.1378/chest.124.1.102; Rzyman W, 2003, J THORAC CARDIOV SUR, V126, P755, DOI 10.1016/S0022-5223(03)00217-4; Sadeghi N, 2012, CAN J UROL, V19, P6443; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Suer E, 2014, INT UROL NEPHROL, V46, P1521, DOI 10.1007/s11255-014-0698-x; Sugita S, 2008, EJSO-EUR J SURG ONC, V34, P339, DOI 10.1016/j.ejso.2007.02.010; Vamvakas EC, 2000, BEST PRACT RES CL HA, V13, P533, DOI 10.1053/beha.2000.0098; Vamvakas EC, 2007, BLOOD REV, V21, P327, DOI 10.1016/j.blre.2007.07.003; Ydy LRA, 2007, WORLD J SURG, V31, P2044, DOI 10.1007/s00268-007-9159-3	34	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0130122	10.1371/journal.pone.0130122	http://dx.doi.org/10.1371/journal.pone.0130122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080092	gold, Green Published, Green Submitted			2022-12-27	WOS:000356542300039
J	Borek, WE; Zou, J; Rappsilber, J; Sawin, KE				Borek, Weronika E.; Zou, Juan; Rappsilber, Juri; Sawin, Kenneth E.			Deletion of Genes Encoding Arginase Improves Use of "Heavy" Isotope-Labeled Arginine for Mass Spectrometry in Fission Yeast	PLOS ONE			English	Article							CELL-CULTURE SILAC; AMINO-ACIDS; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; QUANTITATIVE PROTEOMICS; AMMONIA ASSIMILATION; METABOLISM; MECHANISMS; CONVERSION; COMPLEXES	The use of "heavy" isotope-labeled arginine for stable isotope labeling by amino acids in cell culture (SILAC) mass spectrometry in the fission yeast Schizosaccharomyces pombe is hindered by the fact that under normal conditions, arginine is extensively catabolized in vivo, resulting in the appearance of "heavy"-isotope label in several other amino acids, most notably proline, but also glutamate, glutamine and lysine. This "arginine conversion problem" significantly impairs quantification of mass spectra. Previously, we developed a method to prevent arginine conversion in fission yeast SILAC, based on deletion of genes involved in arginine catabolism. Here we show that although this method is indeed successful when C-13(6)-arginine (Arg-6) is used for labeling, it is less successful when C-13(6) N-15(4)-arginine (Arg-10), a theoretically preferable label, is used. In particular, we find that with this method, "heavy"-isotope label derived from Arg-10 is observed in amino acids other than arginine, indicating metabolic conversion of Arg-10. Arg-10 conversion, which severely complicates both MS and MS/MS analysis, is further confirmed by the presence of C-13(5) N-15(2)-arginine (Arg-7) in arginine-containing peptides from Arg-10-labeled cells. We describe how all of the problems associated with the use of Arg-10 can be overcome by a simple modification of our original method. We show that simultaneous deletion of the fission yeast arginase genes car1+ and aru1+ prevents virtually all of the arginine conversion that would otherwise result from the use of Arg-10. This solution should enable a wider use of heavy isotopelabeled amino acids in fission yeast SILAC.	[Borek, Weronika E.; Zou, Juan; Rappsilber, Juri; Sawin, Kenneth E.] Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Rappsilber, Juri] Tech Univ Berlin, Dept Bioanalyt, Inst Biotechnol, Berlin, Germany	University of Edinburgh; Technical University of Berlin	Rappsilber, J (corresponding author), Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	juri.rappsilber@ed.ac.uk; ken.sawin@ed.ac.uk	Rappsilber, Juri/ABF-3328-2020; Rappsilber, Juri/B-7265-2015	Rappsilber, Juri/0000-0001-5999-1310; Sawin, Kenneth/0000-0002-2607-2219; Zou, Juan/0000-0003-2594-6217	Wellcome Trust [094517, 092076]; Wellcome Trust Senior Research Fellowship [103139, 091020]; Cancer Research UK [C20060/A10789]	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Senior Research Fellowship(Wellcome Trust); Cancer Research UK(Cancer Research UK)	This work was supported by a Wellcome Trust grant [094517] to KES and Wellcome Trust Senior Research Fellowship [103139] and instrument grant [091020] to JR (www.wellcome.ac.uk). WEB was supported by a PhD Studentship [C20060/A10789] from Cancer Research UK (http://www.cancerresearchuk.org). The Wellcome Trust Centre for Cell Biology is supported by core funding from the Wellcome Trust [092076]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Bicho CC, 2010, MOL CELL PROTEOMICS, V9, P1567, DOI 10.1074/mcp.M110.000208; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Blagoev B, 2006, METHODS, V40, P243, DOI 10.1016/j.ymeth.2006.08.001; Carpy A, 2015, MOL CELL PROTEOMICS, V14, P243, DOI 10.1074/mcp.O114.045302; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DAVIS RH, 1986, MICROBIOL REV, V50, P280, DOI 10.1128/MMBR.50.3.280-313.1986; Eitinger T, 2000, J BIOL CHEM, V275, P18029, DOI 10.1074/jbc.M001978200; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Gopinath RK, 2014, GENOME BIOL EVOL, V6, P2851, DOI 10.1093/gbe/evu226; Gunaratne J, 2013, MOL CELL PROTEOMICS, V12, P1741, DOI 10.1074/mcp.M112.023754; Harigaya Y, 2007, CHROMOSOME RES, V15, P523, DOI 10.1007/s10577-007-1151-0; Hauf S, 2013, BIOCHEM SOC T, V41, P1755, DOI 10.1042/BST20130240; Hilger M, 2012, J PROTEOME RES, V11, P982, DOI 10.1021/pr200740a; Janson ME, 2005, J CELL BIOL, V169, P297, DOI 10.1083/jcb.200410119; JOHNSON B, 1974, J GEN MICROBIOL, V85, P169, DOI 10.1099/00221287-85-1-169; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Larance M, 2011, NAT METHODS, V8, P849, DOI [10.1038/NMETH.1679, 10.1038/nmeth.1679]; Maaheimo H, 2001, EUR J BIOCHEM, V268, P2464, DOI 10.1046/j.1432-1327.2001.02126.x; Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Olsson I, 2011, CURR GENET, V57, P1, DOI 10.1007/s00294-010-0327-x; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2003, J PROTEOME RES, V2, P173, DOI 10.1021/pr0255708; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Otsubo Y, 2008, CRIT REV BIOCHEM MOL, V43, P277, DOI [10.1080/10409230802254911, 10.1080/10409230802254911 ]; PERYSINAKIS A, 1995, CURR MICROBIOL, V30, P367, DOI 10.1007/BF00369864; Piel M, 2009, CURR BIOL, V19, pR823, DOI 10.1016/j.cub.2009.08.012; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Samejima I, 2005, MOL BIOL CELL, V16, P3040, DOI 10.1091/mbc.e04-11-1003; Sanso M, 2013, BIOCHEM SOC T, V41, P1660, DOI 10.1042/BST20130238; VANANDEL JG, 1977, ARCH MICROBIOL, V111, P265, DOI 10.1007/BF00549365; Venkatram S, 2005, MOL BIOL CELL, V16, P3052, DOI 10.1091/mbc.E04-12-1043	35	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129548	10.1371/journal.pone.0129548	http://dx.doi.org/10.1371/journal.pone.0129548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075619	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900082
J	Faddeeva, A; Studer, RA; Kraaijeveld, K; Sie, D; Ylstra, B; Marien, J; op den Camp, HJM; Datema, E; den Dunnen, JT; van Straalen, NM; Roelofs, D				Faddeeva, A.; Studer, R. A.; Kraaijeveld, K.; Sie, D.; Ylstra, B.; Marien, J.; op den Camp, H. J. M.; Datema, E.; den Dunnen, J. T.; van Straalen, N. M.; Roelofs, D.			Collembolan Transcriptomes Highlight Molecular Evolution of Hexapods and Provide Clues on the Adaptation to Terrestrial Life	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; HEAVY-METAL TOLERANCE; ORCHESELLA-CINCTA; PANCRUSTACEAN PHYLOGENY; SEQUENCE ALIGNMENT; GENOME SEQUENCE; SODIUM-CHANNEL; SOIL ARTHROPOD; INSECT GENOMES; GENES	Background Collembola (springtails) represent a soil-living lineage of hexapods in between insects and crustaceans. Consequently, their genomes may hold key information on the early processes leading to evolution of Hexapoda from a crustacean ancestor. Method We assembled and annotated transcriptomes of the Collembola Folsomia candida and Orchesella cincta, and performed comparative analysis with protein-coding gene sequences of three crustaceans and three insects to identify adaptive signatures associated with the evolution of hexapods within the pancrustacean clade. Results Assembly of the springtail transcriptomes resulted in 37,730 transcripts with predicted open reading frames for Folsomia candida and 32,154 for Orchesella cincta, of which 34.2% were functionally annotated for Folsomia candida and 38.4% for Orchesella cincta. Subsequently, we predicted orthologous clusters among eight species and applied the branch-site test to detect episodic positive selection in the Hexapoda and Collembola lineages. A subset of 250 genes showed significant positive selection along the Hexapoda branch and 57 in the Collembola lineage. Gene Ontology categories enriched in these genes include metabolism, stress response (i.e. DNA repair, immune response), ion transport, ATP metabolism, regulation and development- related processes (i.e. eye development, neurological development). Conclusions We suggest that the identified gene families represent processes that have played a key role in the divergence of hexapods within the pancrustacean clade that eventually evolved into the most species-rich group of all animals, the hexapods. Furthermore, some adaptive signatures in collembolans may provide valuable clues to understand evolution of hexapods on land.	[Faddeeva, A.; Kraaijeveld, K.; Marien, J.; van Straalen, N. M.; Roelofs, D.] Vrije Univ Amsterdam, Dept Ecol Sci, Amsterdam, Netherlands; [Studer, R. A.] EMBL European Bioinformat Inst, Cambridge, England; [Sie, D.; Ylstra, B.] Vrije Univ Amsterdam Med Ctr, Microarray Facil, Amsterdam, Netherlands; [op den Camp, H. J. M.] Radboud Univ Nijmegen, Dept Microbiol, NL-6525 ED Nijmegen, Netherlands; [Datema, E.] Keygene NV, Wageningen, Netherlands; [den Dunnen, J. T.] Leiden Univ, Med Ctr, Leiden Genome Technol Ctr, Human & Clin Genet, Leiden, Netherlands	Vrije Universiteit Amsterdam; European Molecular Biology Laboratory (EMBL); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen; Keygene N.V.; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Faddeeva, A (corresponding author), Vrije Univ Amsterdam, Dept Ecol Sci, Amsterdam, Netherlands.	ann.faddeeva@gmail.com	dunnen, johan den/ABH-4228-2020; Camp, Huub J.M. Op den/F-5114-2011; Ylstra, Bauke/D-2906-2012	dunnen, johan den/0000-0002-6304-1710; Camp, Huub J.M. Op den/0000-0003-1990-9030; Ylstra, Bauke/0000-0001-9479-3010; Marien, Janine/0000-0001-7600-5594; Roelofs, Dick/0000-0003-3954-3590; Studer, Romain A/0000-0003-0687-9848; Sie, Daoud/0000-0001-6762-2582	Dutch Biotechnology based Ecologically Balanced Sustainable Industrial Consortium (BE-BASIC) [F08.001.03]; European Union FP7 large scale intergration Project 'Sustainable Nanotechnologies (SUN)' [604305]; Keygene NV	Dutch Biotechnology based Ecologically Balanced Sustainable Industrial Consortium (BE-BASIC); European Union FP7 large scale intergration Project 'Sustainable Nanotechnologies (SUN)'; Keygene NV(Keygene N.V.)	This research was supported by a grant from the Dutch Biotechnology based Ecologically Balanced Sustainable Industrial Consortium (BE-BASIC), grant number F08.001.03, http://www.bebasic.org. In addition, D. Roelofs is supported by the European Union FP7 large scale intergration Project 'Sustainable Nanotechnologies (SUN)', Grant number 604305. Keygene NV provided support in the form of salaries for E. Datema, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	1KITE Consortium, 1KITE 1K INS TRANSCR; Alexa A, 2006, TOPGO ENV ANAL GENE; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews S, FASTQC QUALITY CONTR; [Anonymous], 2012, UNIVEC UNIVEC CORE D; [Anonymous], 2013, UPDATED GENE OMES MR; Areal H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-368; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cook CE, 2005, P ROY SOC B-BIOL SCI, V272, P1295, DOI 10.1098/rspb.2004.3042; D'Haese CA, 2002, P ROY SOC B-BIOL SCI, V269, P1143, DOI 10.1098/rspb.2002.1981; Dabney A., QVALUE Q VALUE ESTIM; Dell'Ampio E, 2014, MOL BIOL EVOL, V31, P239, DOI 10.1093/molbev/mst196; EISENBEIS G, 1982, J INSECT PHYSIOL, V28, P11, DOI 10.1016/0022-1910(82)90017-8; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Forster F, 2012, BIOINFORM BIOL INSIG, V6, P69, DOI 10.4137/BBI.S9150; Fountain MT, 2005, ANNU REV ENTOMOL, V50, P201, DOI 10.1146/annurev.ento.50.071803.130331; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Ge RL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2860; Gharib WH, 2013, MOL BIOL EVOL, V30, P1675, DOI 10.1093/molbev/mst062; Gibson AK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-135; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Holloway AK, 2007, PLOS GENET, V3, P2007, DOI 10.1371/journal.pgen.0030187; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Konopova B, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-2; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Marquis O, 2009, AQUAT TOXICOL, V95, P152, DOI 10.1016/j.aquatox.2009.09.001; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Montoya-Burgos JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024800; Nickerl J, 2013, ZOOMORPHOLOGY, V132, P183, DOI 10.1007/s00435-012-0181-0; Nota B, 2008, ENVIRON SCI TECHNOL, V42, P8152, DOI 10.1021/es801472r; Nota B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-236; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oakley TH, 2013, MOL BIOL EVOL, V30, P215, DOI 10.1093/molbev/mss216; Oliver TA, 2010, GENOME BIOL EVOL, V2, P800, DOI 10.1093/gbe/evq063; Ometto L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-7; Organisation for Economic Co-operation and Development OECD, 2009, TEST 232 COLL REPR T; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; PONGE JF, 1991, GEODERMA, V49, P33, DOI 10.1016/0016-7061(91)90090-G; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Pruitt K, 2013, NCBI HDB; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rands CM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-95; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Roelofs D, 2007, INSECT BIOCHEM MOLEC, V37, P287, DOI 10.1016/j.ibmb.2006.11.013; Roelofs D, 2013, MOL BIOL EVOL, V30, P541, DOI 10.1093/molbev/mss269; Roelofs D, 2009, MOL ECOL, V18, P3227, DOI 10.1111/j.1365-294X.2009.04261.x; Rota-Stabelli O, 2013, CURR BIOL, V23, P392, DOI 10.1016/j.cub.2013.01.026; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Savard J, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-7; Schauvliege R, 2007, J CELL MOL MED, V11, P453, DOI 10.1111/j.1582-4934.2007.00040.x; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Simola DF, 2013, GENOME RES, V23, P1235, DOI 10.1101/gr.155408.113; Studer RA, 2008, GENOME RES, V18, P1393, DOI 10.1101/gr.076992.108; Studer RA, 2011, PHYSIOL GENOMICS, V43, P844, DOI 10.1152/physiolgenomics.00002.2011; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Sweder K., 2002, Journal of Biomedicine & Biotechnology, V2, P94, DOI 10.1155/S1110724302205033; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; The International Organization for Standardization (ISO), 1999, GUID 11267 SOIL QUAL; Timmermans MJTN, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-83; Timmermans MJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-341; Van Straalen N.M., 2011, INTRO ECOLOGICAL GEN; VERHOEF HA, 1983, PEDOBIOLOGIA, V25, P3; von Reumont BM, 2012, MOL BIOL EVOL, V29, P1031, DOI 10.1093/molbev/msr270; Wissler L, 2013, GENOME BIOL EVOL, V5, P439, DOI 10.1093/gbe/evt009; Wissler L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-8; Yamada T, 2011, NUCLEIC ACIDS RES, V39, pW412, DOI 10.1093/nar/gkr313; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Yang ZH, 2009, P NATL ACAD SCI USA, V106, pE95, DOI 10.1073/pnas.0904550106; Yim HS, 2014, NAT GENET, V46, P88, DOI 10.1038/ng.2835; Zakon HH, 2006, P NATL ACAD SCI USA, V103, P3675, DOI 10.1073/pnas.0600160103; Zhang JZ, 2006, NAT GENET, V38, P819, DOI 10.1038/ng1812; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031; Zhulidov PA, 2005, RUSS J BIOORG CHEM+, V31, P170, DOI 10.1007/s11171-005-0023-7	96	19	19	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130600	10.1371/journal.pone.0130600	http://dx.doi.org/10.1371/journal.pone.0130600			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075903	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900183
J	Jiang, LB; Ma, YF; Zhao, CW; Shen, WF; Feng, X; Xu, YA; Zhang, M				Jiang, Libing; Ma, Yuefeng; Zhao, Changwei; Shen, Weifeng; Feng, Xia; Xu, Yongan; Zhang, Mao			Role of Transthoracic Lung Ultrasonography in the Diagnosis of Pulmonary Embolism: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							EMERGENCY-DEPARTMENT PATIENTS; SPIRAL CT; ENDOBRONCHIAL ULTRASOUND; COMPUTED-TOMOGRAPHY; CHEST SONOGRAPHY; MULTICENTER; ANGIOGRAPHY; INFARCTION; ACCURACY; PLEURA	Background Pulmonary embolism (PE) is a potentially life-threatening condition. Although computed tomography pulmonary angiography (CTPA) is the reference standard for diagnosis, its early diagnosis remains a challenge, and the concerns about the radiation exposures further limit the general use of CTPA. The primary aim of this meta-analysis was to evaluate the overall diagnostic accuracy of transthoracic lung ultrasound (TLS) in the diagnosis of PE. Methods PubMed, Web of science, OvidSP, ProQuest, EBSCO, Cochrane Library and Clinicaltrial. gov were searched systematically. The quality of included studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 tool. The sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR) and hierarchical summary receiver operating characteristic (HSROC) curves were used to examine the TS performance. The Bayes analysis was used to calculate the post-test probability of PE. Publication bias was assessed with Deeks funnel plot. Results The results indicated that the sensitivity, specificity, PLR and NLR were 0.85 (95% confidence interval (CI), 0.78 to 0.90), and 0.83 (95% CI, 0.73 to 0.90). And the DOR and HSROC were 28.82 (95% CI, 17.60 to 47.21), 0.91(95% CI, 0.88, 0.93). Conclusions The present meta-analysis suggested that transthoracic lung ultrasonography is helpful in diagnosing pulmonary embolism. Although the application of transthoracic lung ultrasound may change some patients' diagnostic processes, it is inappropriate to generally use transthoracic ultrasonography in diagnosing pulmonary embolism currently.	[Jiang, Libing; Ma, Yuefeng; Zhao, Changwei; Shen, Weifeng; Xu, Yongan; Zhang, Mao] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Emergency Med, Hangzhou 310027, Zhejiang, Peoples R China; [Jiang, Libing; Ma, Yuefeng; Zhao, Changwei; Shen, Weifeng; Xu, Yongan; Zhang, Mao] Zhejiang Univ, Inst Emergency Med, Hangzhou 310027, Zhejiang, Peoples R China; [Jiang, Libing; Ma, Yuefeng; Feng, Xia; Zhang, Mao] China Emergency & Crit Care Evidence Based Grp, Hangzhou, Zhejiang, Peoples R China; [Feng, Xia] Third Peoples Hosp Hangzhou, Dept Respirat, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhang, M (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Emergency Med, Hangzhou 310027, Zhejiang, Peoples R China.	zmhzjzk@163.com	ma, yue/GXE-9897-2022					Aumiller J, 2009, RESPIRATION, V77, P298, DOI 10.1159/000183197; Casoni GL, 2008, EUR RESPIR J, V32, P1416, DOI 10.1183/09031936.00075208; Comert SS, 2013, ANN THORAC MED, V8, P99, DOI 10.4103/1817-1737.109822; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Douma RA, 2010, NAT REV CARDIOL, V7, P585, DOI 10.1038/nrcardio.2010.106; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Hellmich M, 2005, METHOD INFORM MED, V44, P124; Henzler T, 2012, J THORAC IMAG, V27, P304, DOI 10.1097/RTI.0b013e31825da2bc; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Horlander KR, 2003, ARCH INTERN MED, V163, P1711, DOI 10.1001/archinte.163.14.1711; Joyner C R Jr, 1966, Trans Assoc Am Physicians, V79, P262; Kline JA, 2004, J THROMB HAEMOST, V2, P1247, DOI 10.1111/j.1538-7836.2004.00790.x; Kline JA, 2014, CIRC-CARDIOVASC IMAG, V7, P66, DOI 10.1161/CIRCIMAGING.113.001080; Koenig S, 2014, CHEST, V145, P818, DOI 10.1378/chest.13-0797; KROSCHEL U, 1991, ULTRASCHALL MED, V12, P263, DOI 10.1055/s-2007-1005941; Lechleitner P, 2002, ULTRASCHALL MED, V23, P373, DOI 10.1055/s-2002-36173; Lechleitner P, 1998, ULTRASCHALL MED, V19, P78, DOI 10.1055/s-2007-1000465; Macaskill P, 2004, J CLIN EPIDEMIOL, V57, P925, DOI 10.1016/j.jclinepi.2003.12.019; Mathis G, 2005, CHEST, V128, P1531, DOI 10.1378/chest.128.3.1531; MATHIS G, 1990, ULTRASCHALL MED, V11, P281, DOI 10.1055/s-2007-1011576; MATHIS G, 1993, EUR J RADIOL, V17, P170, DOI 10.1016/0720-048X(93)90098-8; MATHIS G, 1993, EUR HEART J, V14, P804, DOI 10.1093/eurheartj/14.6.804; Mathis G, 1999, ULTRASCHALL MED, V20, P54, DOI 10.1055/s-1999-14234; MILLER LD, 1967, ANN SURG, V166, P381, DOI 10.1097/00000658-196709000-00006; Mittadodla PS, 2013, J COMMUNITY HOSP INT, V17, P3; Mohn K, 2003, J ULTRAS MED, V22, P673, DOI 10.7863/jum.2003.22.7.673; Nazerian P, 2014, CHEST, V145, P950, DOI 10.1378/chest.13-1087; Niemann T, 2009, ULTRASCHALL MED, V30, P150, DOI 10.1055/s-2008-1027856; Perrier A, 2004, AM J MED, V116, P291, DOI 10.1016/j.amjmed.2003.09.041; Pfeil A, 2010, LUNG, V188, P43, DOI 10.1007/s00408-009-9195-x; Pruszczyk P, 1997, CHEST, V112, P722, DOI 10.1378/chest.112.3.722; Raymakers AJN, 2014, J THORAC IMAG, V29, P209, DOI 10.1097/RTI.0b013e3182999e41; Reissig A, 2004, EUR J RADIOL, V49, P250, DOI 10.1016/S0720-048X(03)00141-4; Reissig A, 2003, RESPIRATION, V70, P441, DOI 10.1159/000074195; Reissig A, 2001, CHEST, V120, P1977, DOI 10.1378/chest.120.6.1977; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Righini M, 2008, LANCET, V371, P1343, DOI 10.1016/S0140-6736(08)60594-2; Roy PM, 2005, BMJ-BRIT MED J, V331, P259, DOI 10.1136/bmj.331.7511.259; Senturk A, 2013, ARCH BRONCONEUMOL, V49, P268, DOI 10.1016/j.arbres.2012.08.006; Shah AA, 1999, RADIOLOGY, V211, P147, DOI 10.1148/radiology.211.1.r99ap03147; Simon M., 1973, PULMONARY THROMBOEMB; Squizzato A, 2013, J THROMB HAEMOST, V11, P1269, DOI 10.1111/jth.12232; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Stein PD, 2010, ANN INTERN MED, V152, P434, DOI 10.7326/0003-4819-152-7-201004060-00008; STEIN PD, 1995, CHEST, V108, P978, DOI 10.1378/chest.108.4.978; Tapson VF, 2008, NEW ENGL J MED, V358, P1037, DOI 10.1056/NEJMra072753; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Zarogoulidis P, 2015, J THORAC DIS, V7, pS73, DOI 10.3978/j.issn.2072-1439.2015.01.44	50	19	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129909	10.1371/journal.pone.0129909	http://dx.doi.org/10.1371/journal.pone.0129909			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076021	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900112
J	Juan, CK; Chen, HJ; Shen, JL; Kao, CH				Juan, Chao-Kuei; Chen, Hsuan-Ju; Shen, Jui-Lung; Kao, Chia-Hung			Lichen Simplex Chronicus Associated With Erectile Dysfunction: A Population-Based Retrospective Cohort Study	PLOS ONE			English	Article							SEXUAL DYSFUNCTION; PREVALENCE; DISEASE; HYPERTENSION; DEPRESSION; ANXIETY; RISK; MEN	Background An association between lichen simplex chronicus (LSC) and sexual dysfunction was explored. However, no data are available from investigations into the relationship between erectile dysfunction (ED) and LSC. Objectives This retrospective population-based cohort study aimed to clarify the risk of ED associated with LSC. Methods By using the Taiwan National Health Insurance Research dataset, we identified 5611 male patients who had been newly diagnosed with LSC from 2000 to 2004. The date of diagnosis was identified as the index date. LSC patients with incomplete demographic information or with a history of ED before the index date were excluded. In total, 22444 age-matched patients without LSC were randomly selected as the non-LSC group based on a 1: 4 ratio. Subsequence occurrence of ED was measured until 2011. The association between LSC and the risk of developing ED was estimated using Cox proportional hazard regression model. Results After adjusting for age and comorbidities, patients with LSC had a 1.74-fold greater risk of developing ED compared with those without LSC (95% confidence interval= 1.44-2.10). LSC patients with comorbidities including diabetes, hyperlipidemia, hypertension, cardiovascular disease, peripheral arterial disease, chronic obstructive pulmonary disease, chronic kidney disease, depression, and anxiety were at a higher risk of ED compared with the non-LSC patients without comorbidities. Conclusions LSC confers a greater risk in the development of ED. Physicians should be aware of the potential of ED occurrence in LSC patients.	[Juan, Chao-Kuei; Shen, Jui-Lung] Taichung Vet Gen Hosp, Dept Dermatol, Taichung, Taiwan; [Chen, Hsuan-Ju] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chen, Hsuan-Ju] China Med Univ, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.	d10040@mail.cmuh.org.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039-006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo Kiyo Aoshima Memorial Funds, Japan; Health, and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence, Taiwan [MOHW104-TDU-B212-124-002]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo Kiyo Aoshima Memorial Funds, Japan; Health, and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002); China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM104010092); NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039-006); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and Health, and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (MOHW104-TDU-B212-124-002, Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	An JG, 2013, INT J MED SCI, V10, P593, DOI 10.7150/ijms.5624; [Anonymous], 1993, Int J Impot Res, V5, P181; Araujo AB, 1998, PSYCHOSOM MED, V60, P458, DOI 10.1097/00006842-199807000-00011; Aversa A, 2008, INT J IMPOT RES, V20, P566, DOI 10.1038/ijir.2008.43; Ayyar K S, 1986, Indian J Psychiatry, V28, P155; Bhatia M S, 1996, J Indian Med Assoc, V94, P445; Burgin S, 2012, FITZPATRICKS DERMATO, P182; Cheng JYW, 2007, INT J IMPOT RES, V19, P229, DOI 10.1038/sj.ijir.3901517; Ermertcan AT, 2011, J ANDROL, V32, P165, DOI 10.2164/jandrol.110.010959; HALE VE, 1990, ARCH SEX BEHAV, V19, P569, DOI 10.1007/BF01542466; Javaroni V, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/627278; Kahraman H, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-66; Kennedy SH, 1999, J AFFECT DISORDERS, V56, P201, DOI 10.1016/S0165-0327(99)00050-6; Konuk N, 2007, GEN HOSP PSYCHIAT, V29, P232, DOI 10.1016/j.genhosppsych.2007.01.006; Koseoglu N, 2005, J UROLOGY, V174, P249, DOI 10.1097/01.ju.0000163259.33846.74; Lewis RW, 2010, J SEX MED, V7, P1598, DOI 10.1111/j.1743-6109.2010.01778.x; Ley HL, 2013, CLIN DERMATOL, V31, P31, DOI 10.1016/j.clindermatol.2011.11.004; Liao YH, 2014, BRIT J DERMATOL, V170, P890, DOI 10.1111/bjd.12811; Lotti T, 2008, DERMATOL THER, V21, P42, DOI 10.1111/j.1529-8019.2008.00168.x; Malavige LS, 2009, J SEX MED, V6, P1232, DOI 10.1111/j.1743-6109.2008.01168.x; Meller SM, 2013, J INVASIVE CARDIOL, V25, P313; Mercan S, 2008, J SEX MARITAL THER, V34, P160, DOI 10.1080/00926230701267951; Mittawae B, 2006, UROLOGY, V67, P575, DOI 10.1016/j.urology.2005.09.040; Navaneethan SD, 2010, AM J KIDNEY DIS, V56, P670, DOI 10.1053/j.ajkd.2010.06.016; Niemeier V, 1997, HAUTARZT, V48, P629, DOI 10.1007/s001050050635; Polonsky TS, 2009, ATHEROSCLEROSIS, V207, P440, DOI 10.1016/j.atherosclerosis.2009.05.005; Quek KF, 2008, J SEX MED, V5, P70, DOI 10.1111/j.1743-6109.2006.00423.x; Ryu JK, 2009, J SEX MED, V6, P1893, DOI 10.1111/j.1743-6109.2009.01275.x; Seftel AD, 2004, J UROLOGY, V171, P2341, DOI 10.1097/01.ju.0000125198.32936.38; Shamloul R, 2013, LANCET, V381, P153, DOI 10.1016/S0140-6736(12)60520-0; van Dorssen I E, 1992, Ned Tijdschr Geneeskd, V136, P2175	31	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128869	10.1371/journal.pone.0128869	http://dx.doi.org/10.1371/journal.pone.0128869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076496	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900035
J	Lin, WL; Guu, SY; Tsai, CC; Prakash, E; Viswaraman, M; Chen, HB; Chang, CF				Lin, Wei-Ling; Guu, Shih-Yun; Tsai, Chan-Chuan; Prakash, Ekambaranellore; Viswaraman, Mohan; Chen, Hsing-Bao; Chang, Chuan-Fa			Derivation of Cinnamon Blocks Leukocyte Attachment by Interacting with Sialosides	PLOS ONE			English	Article							P-SELECTIN; WATER EXTRACT; SIALIC-ACID; IN-VIVO; INFLUENZA-VIRUSES; BLOOD-GLUCOSE; INFLAMMATION; INHIBITOR; RECEPTOR; BINDING	Molecules derived from cinnamon have demonstrated diverse pharmacological activities against infectious pathogens, diabetes and inflammatory diseases. This study aims to evaluate the effect of the cinnamon-derived molecule IND02 on the adhesion of leukocytes to host cells. The anti-inflammatory ability of IND02, a pentameric procyanidin type A polyphenol polymer isolated from cinnamon alcohol extract, was examined. Pretreatment with IND02 significantly reduced the attachment of THP-1 cells or neutrophils to TNF-alpha-activated HUVECs or E-selectin/ICAM-1, respectively. IND02 also reduced the binding of E-, L- and P-selectins with sialosides. Furthermore, IND02 could agglutinate human red blood cells (RBC), and the agglutination could be disrupted by sialylated glycoprotein. Our findings demonstrate that IND02, a cinnamon-derived compound, can interact with sialosides and block the binding of selectins and leukocytes with sialic acids.	[Guu, Shih-Yun; Chang, Chuan-Fa] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Lin, Wei-Ling] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Coll Med, Tainan 70101, Taiwan; [Tsai, Chan-Chuan] Pingtung Christian Hosp, Dept Pathol, Pingtung 900, Taiwan; [Prakash, Ekambaranellore; Viswaraman, Mohan] Ind Biotech Private Ltd, Pune 411048, Maharashtra, India; [Chen, Hsing-Bao] E DA Hosp, Dept Surg, Div Colorectal Surg, Kaohsiung 82445, Taiwan; [Chang, Chuan-Fa] Natl Cheng Kung Univ, Coll Med, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Chang, Chuan-Fa] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; E-Da Hospital; National Cheng Kung University; National Cheng Kung University	Chang, CF (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan.	affa@mail.ncku.edu.tw	Lin, Wei-Ling/GQP-6706-2022; Chang, Chuan-Fa/F-8660-2011; Lin, Wei-Ling/AAH-2429-2019	Chang, Chuan-Fa/0000-0003-2404-1248; Ekambaranellore, Prakash/0000-0003-3128-9524	Center of Infectious Disease and Signaling Research of NCKU; Ministry of Science and Technology of Taiwan [NSC 102-2321-B-006-006]; Indus Biotech Private Limited	Center of Infectious Disease and Signaling Research of NCKU; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Indus Biotech Private Limited	This work was supported by the Center of Infectious Disease and Signaling Research of NCKU and the Ministry of Science and Technology of Taiwan (NSC 102-2321-B-006-006, http://www.most.gov.tw/). Indus Biotech Private Limited provided support in the form of salaries for authors Ekambaranellore Prakash and Mohan Viswaraman, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	AYMARD M, 1982, J BIOL STAND, V10, P125, DOI 10.1016/S0092-1157(82)80035-8; Beauharnois ME, 2005, BIOCHEMISTRY-US, V44, P9507, DOI 10.1021/bi0507130; Bedard PW, 2010, EXPERT OPIN THER PAT, V20, P781, DOI 10.1517/13543771003767468; Bendas Gerd, 2012, Int J Cell Biol, V2012, P676731, DOI 10.1155/2012/676731; Cao HP, 2010, PHYTOMEDICINE, V17, P1027, DOI 10.1016/j.phymed.2010.03.023; Carvalho ACS, 2014, PANCREAS, V43, P82, DOI 10.1097/MPA.0b013e3182a63b9d; Chang CF, 2011, GLYCOBIOLOGY, V21, P895, DOI 10.1093/glycob/cwr021; Chu A, 1999, J IMMUNOL, V163, P5086; CUMMING DA, 1989, BIOCHEMISTRY-US, V28, P6500, DOI 10.1021/bi00441a051; Endemann G, 1997, J IMMUNOL, V158, P4879; Etzioni A, 1993, Immunodeficiency, V4, P307; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; Geng JG, 2004, CURR MED CHEM, V11, P2153, DOI 10.2174/0929867043364720; Hagenlocher Y, 2013, ALLERGY, V68, P490, DOI 10.1111/all.12122; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Hong JW, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-237; Ito T, 1997, VIROLOGY, V227, P493, DOI 10.1006/viro.1996.8323; Japp AG, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.006007; Jiao LH, 2013, FOOD CHEM TOXICOL, V56, P398, DOI 10.1016/j.fct.2013.02.049; Kandhare AD, 2013, BIOMED AGING PATHOL, V3, P23; Kim SH, 2006, J ETHNOPHARMACOL, V104, P119, DOI 10.1016/j.jep.2005.08.059; Kleinhans H, 2009, HISTOL HISTOPATHOL, V24, P551, DOI 10.14670/HH-24.551; Koppikar SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-210; Kurosawa S, 2000, J IMMUNOL, V165, P4697, DOI 10.4049/jimmunol.165.8.4697; Kwon HK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-392; Kwon HK, 2009, CANCER LETT, V278, P174, DOI 10.1016/j.canlet.2009.01.015; Lee BJ, 2011, IMMUNOPHARM IMMUNOT, V33, P714, DOI 10.3109/08923973.2011.564185; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Lowe JB, 2002, IMMUNOL REV, V186, P19, DOI 10.1034/j.1600-065X.2002.18603.x; Lu JM, 2010, CARCINOGENESIS, V31, P481, DOI 10.1093/carcin/bgp292; Lu T, 2012, NUTR RES, V32, P408, DOI 10.1016/j.nutres.2012.05.003; MARTENS CL, 1995, J BIOL CHEM, V270, P21129, DOI 10.1074/jbc.270.36.21129; Mau JL, 2001, J AGR FOOD CHEM, V49, P183, DOI 10.1021/jf000263c; Morokutti A, 2013, J CLIN VIROL, V56, P323, DOI 10.1016/j.jcv.2012.12.002; Myers DD, 2006, J VASC SURG, V44, P625, DOI 10.1016/j.jvs.2006.05.021; Papp I, 2008, CHEM COMMUN, P5851, DOI 10.1039/b813414f; Park IY, 1998, TRANSPLANT P, V30, P2927, DOI 10.1016/S0041-1345(98)00872-0; Pavlovic D, 2002, J IMMUNOL METHODS, V264, P53, DOI 10.1016/S0022-1759(02)00079-0; Qin BL, 2003, DIABETES RES CLIN PR, V62, P139, DOI 10.1016/S0168-8227(03)00173-6; Rathi Badal, 2013, Sci Pharm, V81, P567, DOI 10.3797/scipharm.1301-16; Rosenkranz AR, 1999, J CLIN INVEST, V103, P649, DOI 10.1172/JCI5183; Sartorius T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092358; Schon Michael P, 2005, Ther Clin Risk Manag, V1, P201; Shamay Y, 2009, J MED CHEM, V52, P5906, DOI 10.1021/jm900308r; Shan B, 2007, J AGR FOOD CHEM, V55, P5484, DOI 10.1021/jf070424d; Shen Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095786, 10.1371/journal.pone.0087894]; Shihabudeen HMS, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-46; Sperandio M, 2006, FEBS J, V273, P4377, DOI 10.1111/j.1742-4658.2006.05437.x; Stevenson JL, 2007, THROMB RES, V120, pS107, DOI 10.1016/S0049-3848(07)70138-X; Vetal S, 2013, FOOD SCI HUM WELL, V2, P59, DOI [10.1016/j.fshw.2013.03.003, DOI 10.1016/J.FSHW.2013.03.003]; Watz H, 2013, PULM PHARMACOL THER, V26, P265, DOI 10.1016/j.pupt.2012.12.003; Woodhall T, 2005, ORG BIOMOL CHEM, V3, P1795, DOI 10.1039/b501503k; Wynn TA, 2004, HEPATOLOGY, V39, P676, DOI 10.1002/hep.20102	53	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130389	10.1371/journal.pone.0130389	http://dx.doi.org/10.1371/journal.pone.0130389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076445	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900169
J	Qu, JL; Qu, XJ; Li, Z; Zhang, JD; Liu, J; Teng, YE; Jin, B; Zhao, MF; Yu, P; Shi, J; Fu, LY; Wang, ZN; Liu, YP				Qu, Jing-lei; Qu, Xiu-juan; Li, Zhi; Zhang, Jing-dong; Liu, Jing; Teng, Yue-e; Jin, Bo; Zhao, Ming-fang; Yu, Ping; Shi, Jing; Fu, Ling-yu; Wang, Zhen-ning; Liu, Yun-peng			Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer	PLOS ONE			English	Article							PREOPERATIVE NEUTROPHIL-LYMPHOCYTE; LONG-TERM OUTCOMES; STAGE; CHEMOTHERAPY; RESECTION; RATIO; RECURRENCE; SURGERY; TRIAL; INDEX	Prognostic models are generally used to predict gastric cancer outcomes. However, no model combining patient-, tumor- and host-related factors has been established to predict outcomes after radical gastrectomy, especially outcomes of patients without nodal involvement. The aim of this study was to develop a prognostic model based on the systemic inflammatory response and clinicopathological factors of resectable gastric cancer and determine whether the model can improve prognostic accuracy in node-negative patients. We reviewed the clinical, laboratory, histopathological and survival data of 1397 patients who underwent radical gastrectomy between 2007 and 2013. Patients were split into development and validation sets of 1123 and 274 patients, respectively. Among all 1397 patients, 545 had node-negative gastric cancer; 440 were included in the development set, 105 were included in the validation set. A prognostic model was constructed from the development set. The scoring system was based on hazard ratios in a Cox proportional hazard model. In the multivariate analysis, age, tumor size, Lauren type, depth of invasion, lymph node metastasis, and the neutrophil-lymphocyte ratio were independent prognostic indicators of overall survival. A prognostic model was then established based on the significant factors. Patients were categorized into five groups according to their scores. The 3-year survival rates for the low-to high-risk groups were 98.9%, 92.8%, 82.4%, 58.4%, and 36.9%, respectively (P < 0.001). The prognostic model clearly discriminated patients with stage pT1-4N0M0 tumor into four risk groups with significant differences in the 3-year survival rates (P < 0.001). Compared with the pathological T stage, the model improved the predictive accuracy of the 3-year survival rate by 5% for node-negative patients. The prognostic scores also stratified the patients with stage pT4aN0M0 tumor into significantly different risk groups (P = 0.004). Furthermore, the predictive value of this model was validated in an independent set of 274 patients. This model, which included the systemic inflammatory markers and clinicopathological factors, is more effective in predicting the prognosis of node-negative gastric cancer than traditional staging systems. Patients in the high-risk group might be good candidates for adjuvant chemotherapy.	[Qu, Jing-lei; Qu, Xiu-juan; Li, Zhi; Zhang, Jing-dong; Liu, Jing; Teng, Yue-e; Jin, Bo; Zhao, Ming-fang; Yu, Ping; Shi, Jing; Liu, Yun-peng] China Med Univ, Hosp 1, Dept Med Oncol, Shenyang 110001, Liaoning, Peoples R China; [Fu, Ling-yu] China Med Univ, Hosp 1, Dept Clin Epidemiol & Evidence Based Med, Shenyang 110001, Liaoning, Peoples R China; [Wang, Zhen-ning] China Med Univ, Hosp 1, Dept Surg Oncol, Shenyang 110001, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University	Qu, JL (corresponding author), China Med Univ, Hosp 1, Dept Med Oncol, Shenyang 110001, Liaoning, Peoples R China.	qujinglei@hotmail.com; qu_xiujuan@hotmail.com; cmuliuyunpeng@hotmail.com	Gao, Peng/B-8031-2013; wang, zhen ning/E-1878-2011; Zhang, Jing/GWZ-7332-2022; Li, Zhi/ABE-5902-2022	wang, zhen ning/0000-0003-0557-3097; Li, Zhi/0000-0002-6437-0348	National Natural Science Foundation of China [81372547, 81372485, 81172369]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2013ZX09303002]; Science and Technology Plan Project of Liaoning Province [2014225013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of the Ministry of Science and Technology of China; Science and Technology Plan Project of Liaoning Province	This study was supported by the National Natural Science Foundation of China (No. 81372547, No. 81372485, No. 81172369), National Science and Technology Major Project of the Ministry of Science and Technology of China (No. 2013ZX09303002), and Science and Technology Plan Project of Liaoning Province (No. 2014225013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Bentrem D, 2007, ANN SURG ONCOL, V14, P1853, DOI 10.1245/s10434-006-9037-5; Chou HH, 2013, AM J SURG, V205, P623, DOI 10.1016/j.amjsurg.2012.04.014; Costa MLV, 2006, ANN SURG ONCOL, V13, P843, DOI 10.1245/ASO.2006.05.040; Di Maio M, 2010, EUR J CANCER, V46, P735, DOI 10.1016/j.ejca.2009.12.013; Diaz-Nieto R, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008415.pub2; Du CY, 2011, J GASTROINTEST SURG, V15, P2153, DOI 10.1007/s11605-011-1684-6; Edge SB, 2009, AM JOINT COMMITTEE C, DOI [10.1245/s10434-009-0530-5, DOI 10.1245/S10434-009-0530-5]; Jeong JY, 2012, J GASTRIC CANCER, V12, P210, DOI 10.5230/jgc.2012.12.4.210; Jiang N, 2014, BIOMARKERS, V19, P444, DOI 10.3109/1354750X.2014.926567; Jiang X, 2012, BRIT J CANCER, V107, P275, DOI 10.1038/bjc.2012.262; Kanagavel D, 2010, ANN ONCOL, V21, P1779, DOI 10.1093/annonc/mdq032; Koo DH, 2011, CANCER CHEMOTH PHARM, V68, P913, DOI 10.1007/s00280-011-1561-8; Lee JH, 2015, WORLD J SURG, V39, P732, DOI 10.1007/s00268-014-2846-y; Li XB, 2014, HEPATO-GASTROENTEROL, V61, P535, DOI 10.5754/hge13684; Marrelli D, 2005, ANN SURG, V241, P247, DOI 10.1097/01.sla.0000152019.14741.97; Migita K, 2013, ANN SURG ONCOL, V20, P2647, DOI 10.1245/s10434-013-2926-5; Mohri Y, 2010, WORLD J SURG, V34, P285, DOI 10.1007/s00268-009-0302-1; Paramanathan A, 2014, SURG ONCOL, V23, P31, DOI 10.1016/j.suronc.2013.12.001; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Shimada H, 2010, GASTRIC CANCER, V13, P170, DOI 10.1007/s10120-010-0554-3; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434; Wang DS, 2012, TUMOR BIOL, V33, P749, DOI 10.1007/s13277-011-0285-z; Xu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101061; Yamashita H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-147	26	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128540	10.1371/journal.pone.0128540	http://dx.doi.org/10.1371/journal.pone.0128540			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075713	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900020
J	Tsujimoto, N; Saraya, T; Light, RW; Tsukahara, Y; Koide, T; Kurai, D; Ishii, H; Kimura, H; Goto, H; Takizawa, H				Tsujimoto, Naoki; Saraya, Takeshi; Light, Richard W.; Tsukahara, Yayoi; Koide, Takashi; Kurai, Daisuke; Ishii, Haruyuki; Kimura, Hirokazu; Goto, Hajime; Takizawa, Hajime			A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT	PLOS ONE			English	Article							EMPYEMA; MANAGEMENT; INFECTION	Background Pleural separation, the "split pleura" sign, has been reported in patients with empyema. However, the diagnostic yield of the split pleura sign for complicated parapneumonic effusion (CPPE)/empyema and its utility for differentiating CPPE/empyema from parapneumonic effusion (PPE) remains unclear. This differentiation is important because CPPE/empyema patients need thoracic drainage. In this regard, the aim of this study was to develop a simple method to distinguish CPPE/empyema from PPE using computed tomography (CT) focusing on the split pleura sign, fluid attenuation values (HU: Hounsfield units), and amount of fluid collection measured on thoracic CT prior to diagnostic thoracentesis. Methods A total of 83 consecutive patients who underwent chest CT and were diagnosed with CPPE (n=18)/empyema (n=18) or PPE (n=47) based on the diagnostic thoracentesis were retrospectively analyzed. Results On univariate analysis, the split pleura sign (odds ratio (OR), 12.1; p<0.001), total amount of pleural effusion (>= 30 mm) (OR, 6.13; p<0.001), HU value >= 10 (OR, 5.94; p=0.001), and the presence of septum (OR, 6.43; p=0.018), atelectasis (OR, 6.83; p=0.002), or air (OR, 9.90; p=0.002) in pleural fluid were significantly higher in the CPPE/empyema group than in the PPE group. On multivariate analysis, only the split pleura sign (hazard ratio (HR), 6.70; 95% confidence interval (CI), 1.91-23.5; p=0.003) and total amount of pleural effusion (>= 30 mm) on thoracic CT (HR, 7.48; 95% CI, 1.76-31.8; p=0.006) were risk factors for empyema. Sensitivity, specificity, positive predictive value, and negative predictive value of the presence of both split pleura sign and total amount of pleural effusion (>= 30 mm) on thoracic CT for CPPE/empyema were 79.4%, 80.9%, 75%, and 84.4%, respectively, with an area under the curve of 0.801 on receiver operating characteristic curve analysis. Conclusion This study showed a high diagnostic yield of the split pleura sign and total amount of pleural fluid (>= 30 mm) on thoracic CT that is useful and simple for discriminating between CPPE/empyema and PPE prior to diagnostic thoracentesis.	[Tsujimoto, Naoki; Saraya, Takeshi; Koide, Takashi; Kurai, Daisuke; Ishii, Haruyuki; Goto, Hajime; Takizawa, Hajime] Kyorin Univ, Sch Med, Dept Resp Med, Tokyo, Japan; [Light, Richard W.] Vanderbilt Univ, Med Ctr, Div Allergy Pulm Crit Care, Nashville, TN USA; [Tsukahara, Yayoi] Kyorin Univ, Sch Med, Dept Radiol, Tokyo, Japan; [Kimura, Hirokazu] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan	Kyorin University; Vanderbilt University; Kyorin University; National Institute of Infectious Diseases (NIID)	Saraya, T (corresponding author), Kyorin Univ, Sch Med, Dept Resp Med, Tokyo, Japan.	sara@yd5.so-net.ne.jp		Saraya, Takeshi/0000-0003-0502-8128; Kurai, Daisuke/0000-0001-9492-8798				ALFAGEME I, 1993, CHEST, V103, P839, DOI 10.1378/chest.103.3.839; Algin O, 2011, DIAGN INTERV RADIOL, V17, P18, DOI 10.4261/1305-3825.DIR.2901-09.1; Colicc GL, 2000, CHEST, V118, P1158, DOI 10.1378/chest.118.4.1158; Collins J, 2001, RADIOL CLIN N AM, V39, P1115, DOI 10.1016/S0033-8389(05)70334-1; Davies CWH, 1999, AM J RESP CRIT CARE, V160, P1682, DOI 10.1164/ajrccm.160.5.9903002; Ferguson AD, 1996, QJM-MON J ASSOC PHYS, V89, P285; Kraus Guenther J, 2007, Radiology, V243, P297, DOI 10.1148/radiol.2431041658; Light RW, 2002, NEW ENGL J MED, V346, P1971, DOI 10.1056/NEJMcp010731; Maskell NA, 2005, NEW ENGL J MED, V352, P865, DOI 10.1056/NEJMoa042473; Narayanaswamy S, 2007, CLIN RADIOL, V62, P233, DOI 10.1016/j.crad.2006.10.007; Rovina N, 2013, CYTOKINE, V63, P166, DOI 10.1016/j.cyto.2013.04.017; SMITH JA, 1991, ANN THORAC SURG, V51, P39, DOI 10.1016/0003-4975(91)90443-T; STARK DD, 1983, AM J ROENTGENOL, V141, P163, DOI 10.2214/ajr.141.1.163; Wang PS, 2002, LUNG, V180, P25, DOI 10.1007/s004080000078; Yudin A, 2014, METAPHORICAL SIGNS I, P5	15	27	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130141	10.1371/journal.pone.0130141	http://dx.doi.org/10.1371/journal.pone.0130141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076488	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900143
J	Zhang, B; Liang, L; Chen, WB; Liang, CH; Zhang, SX				Zhang, Bin; Liang, Long; Chen, Wenbo; Liang, Changhong; Zhang, Shuixing			An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis	PLOS ONE			English	Article							RESONANCE-IMAGING CONTRAST; RENAL-FAILURE; CASE SERIES; DISEASE; RISK; GADODIAMIDE; MRI; PREVALENCE; EXPOSURE; DIALYSIS	Background Nephrogenic systemic fibrosis (NSF) is a rare but serious disorder disease affecting patients with advanced renal disease. Although multiple studies have indicated an association between gadolinium-based contrast agents (GBCAs) and NSF, some studies published after 2007 found no association. We therefore performed a meta-analysis to evaluate the association and analyze related (co) factors. Methods Studies for analysis were identified by searching PubMed, Embase, and the Cochrane Central Register of Controlled Trials through December 2014. Pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated using the fixed-effects model. Statistical heterogeneity was assessed by Q statistics and the I-2 test. Publication bias was evaluated using Begg's test, Egger's test, funnel plot, and classic fail-safe N. Study quality was assessed using the Newcastle-Ottawa Scale. We also conducted sensitivity analyses, subgroup analyses and a cumulative meta-analysis. All statistical analyses were performed using Comprehensive Meta-Analysis 2.0. Results A total of 14 studies (6,398 patients) met the inclusion criteria, but 3 were excluded since they reported no NSF events. Meta-analysis of controlled trials indicated a significant association between GBCAs and NSF development (OR = 16.504; 95% CI: 7.455-36.533; P < 0.001) and between gadodiamide and NSF (OR = 20.037; 95% CI: 3.725-107.784; P < 0.001). No statistical heterogeneity was observed across studies (P = 0.819, I-2 = 0%; P = 0.874, I-2 = 0%, respectively). Cumulative analysis demonstrated that the pooled ORs for association between GBCAs and NSF decreased post-2007 compared to pre-2007 (OR = 26.708; 95% CI: 10.273-69.436; P<0.001). Conclusions Although this updated meta-analysis found a significant association between GBCAs and the incidence of NSF in patients with advanced renal disease, the association decreased after 2007. More studies, especially randomized controlled trials, are warranted to examine the potential association between GBCAs other than gadodiamide and NSF.	[Zhang, Bin; Liang, Long; Chen, Wenbo; Liang, Changhong; Zhang, Shuixing] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Zhang, Bin; Liang, Long] Southern Med Univ, Grad Coll, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China	Zhang, SX (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China.	shui7515@hotmail.com	Zhang, Bin/AAH-4560-2019; Zhang, Bin/M-3689-2014; Liang, Chang Hong/L-1885-2016	Zhang, Bin/0000-0002-6286-6227; Zhang, Bin/0000-0001-7313-9300; 	National Scientific Foundation of China [81171329]; Guangdong Science Foundation [S2011010000790]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science Foundation	This study was supported by grants from National Scientific Foundation of China (No: 81171329) and Guangdong Science Foundation (No: S2011010000790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abujudeh HH, 2009, RADIOLOGY, V253, P81, DOI 10.1148/radiol.2531082160; Agarwal R, 2009, NEPHROL DIAL TRANSPL, V24, P856, DOI 10.1093/ndt/gfn593; Altman DG, 2001, SYSTEMATIC REV HLTH; Amet S, 2014, INVEST RADIOL, V49, P109, DOI 10.1097/RLI.0000000000000000; Becker S, 2012, NEPHRON CLIN PRACT, V121, pC91, DOI 10.1159/000345150; Besheli LD, 2014, CLIN RADIOL, V69, P661, DOI 10.1016/j.crad.2014.01.003; Bhave G, 2008, J UROLOGY, V180, P830, DOI 10.1016/j.juro.2008.05.005; Broome DR, 2008, EUR J RADIOL, V66, P230, DOI 10.1016/j.ejrad.2008.02.011; Broome DR, 2007, AM J ROENTGENOL, V188, P586, DOI 10.2214/AJR.06.1094; Caccetta T, 2008, AUSTRALAS J DERMATOL, V49, P48, DOI 10.1111/j.1440-0960.2007.00426.x; Chao CC, 2008, J FORMOS MED ASSOC, V107, P270, DOI 10.1016/S0929-6646(08)60147-3; Cheng S., 2007, Morbidity and Mortality Weekly Report, V56, P137; Collidge TA, 2007, RADIOLOGY, V245, P168, DOI 10.1148/radiol.2451070353; de Campos ROP, 2011, AM J ROENTGENOL, V196, P545, DOI 10.2214/AJR.10.4500; Deo A, 2007, CLIN J AM SOC NEPHRO, V2, P264, DOI 10.2215/CJN.03921106; Deray G, 2013, EUR RADIOL, V23, P1250, DOI 10.1007/s00330-012-2705-x; Edward M, 2010, RADIOLOGY, V256, P735, DOI 10.1148/radiol.10091131; Elmholdt TR, 2011, BRIT J DERMATOL, V165, P828, DOI 10.1111/j.1365-2133.2011.10465.x; Grebe SO, 2008, CLIN EXP NEPHROL, V12, P403, DOI 10.1007/s10157-008-0063-4; Grobner T, 2008, SEMIN DIALYSIS, V21, P135, DOI 10.1111/j.1525-139X.2007.00406.x; Heinz-Peer G, 2010, EUR J RADIOL, V76, P129, DOI 10.1016/j.ejrad.2009.06.028; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; High WA, 2007, J AM ACAD DERMATOL, V56, P21, DOI 10.1016/j.jaad.2006.10.047; Hoppe H, 2010, EUR RADIOL, V20, P595, DOI 10.1007/s00330-009-1586-0; Introcaso CE, 2007, INT J DERMATOL, V46, P447, DOI 10.1111/j.1365-4632.2007.03301.x; Ishiguchi Tsuneo, 2010, Drugs R D, V10, P133, DOI 10.2165/11539140-000000000-00000; Janus N, 2010, EUR J RADIOL, V73, P357, DOI 10.1016/j.ejrad.2008.11.021; Kallen A, 2008, AM J KIDNEY DIS, V51, P966, DOI 10.1053/j.ajkd.2007.12.036; Kielstein JT, 2010, INTERNIST, V51, P39, DOI 10.1007/s00108-009-2408-9; Kim KH, 2010, AM J KIDNEY DIS, V56, P458, DOI 10.1053/j.ajkd.2010.03.027; Kitajima K, 2012, INT J UROL, V19, P806, DOI 10.1111/j.1442-2042.2012.03042.x; Marckmann P, 2006, J AM SOC NEPHROL, V17, P2359, DOI 10.1681/ASN.2006060601; Martin DR, 2010, J MAGN RESON IMAGING, V31, P440, DOI 10.1002/jmri.22024; Moher David, 2009, Open Med, V3, pe123; Moreno-Romero JA, 2007, BRIT J DERMATOL, V157, P783, DOI 10.1111/j.1365-2133.2007.08067.x; Nacif MS, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-18; Ng YY, 2007, AM J ROENTGENOL, V188, pW582, DOI 10.2214/AJR.07.0047; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Othersen JB, 2007, NEPHROL DIAL TRANSPL, V22, P3179, DOI 10.1093/ndt/gfm584; Penfield JG, 2008, SEMIN DIALYSIS, V21, P129, DOI 10.1111/j.1525-139X.2007.00408.x; Reiter T, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-31; Rydahl C, 2008, INVEST RADIOL, V43, P141, DOI 10.1097/RLI.0b013e31815a3407; Todd DJ, 2007, ARTHRITIS RHEUM, V56, P3433, DOI 10.1002/art.22925; Wang YB, 2011, RADIOLOGY, V260, P105, DOI 10.1148/radiol.11102340; Wiginton CD, 2008, AM J ROENTGENOL, V190, P1060, DOI 10.2214/AJR.07.2822; Yang L, 2012, RADIOLOGY, V265, P248, DOI 10.1148/radiol.12112783; Zou ZT, 2011, JACC-CARDIOVASC IMAG, V4, P1206, DOI 10.1016/j.jcmg.2011.08.013; Zou ZT, 2009, J MAGN RESON IMAGING, V30, P1309, DOI 10.1002/jmri.21769	48	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129720	10.1371/journal.pone.0129720	http://dx.doi.org/10.1371/journal.pone.0129720			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076348	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900096
J	Huh, Y; Cho, J				Huh, Yeowool; Cho, Jeiwon			Changes in Activity of the Same Thalamic Neurons to Repeated Nociception in Behaving Mice	PLOS ONE			English	Article							SPINAL-CORD-INJURY; ECCENTRIC EXERCISE; THALAMOCORTICAL DYSRHYTHMIA; REPEATED BOUTS; MUSCLE DAMAGE; FORMALIN TEST; CENTRAL PAIN; STIMULATION; RAT; INHIBITION	The sensory thalamus has been reported to play a key role in central pain sensory modulation and processing, but its response to repeated nociception at thalamic level is not well known. Current study investigated thalamic response to repeated nociception by recording and comparing the activity of the same thalamic neuron during the 1st and 2nd formalin injection induced nociception, with a week interval between injections, in awake and behaving mice. Behaviorally, the 2nd injection induced greater nociceptive responses than the 1st. Thalamic activity mirrored these behavioral changes with greater firing rate during the 2nd injection. Analysis of tonic and burst firing, characteristic firing pattern of thalamic neurons, revealed that tonic firing activity was potentiated while burst firing activity was not significantly changed by the 2nd injection relative to the 1st. Likewise, burst firing property changes, which has been consistently associated with different phases of nociception, were not induced by the 2nd injection. Overall, data suggest that repeated nociception potentiated responsiveness of thalamic neurons and confirmed that tonic firing transmits nociceptive signals.	[Huh, Yeowool; Cho, Jeiwon] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea; [Cho, Jeiwon] Univ Sci & Technol, Neurosci, Taejon, South Korea	Korea Institute of Science & Technology (KIST)	Cho, J (corresponding author), Korea Inst Sci & Technol, Ctr Neural Sci, L7313 Hawolgok Dong, Seoul, South Korea.	jeiwon@kist.re.kr			National Research Foundation of Korea (NRF) - Korean government (MSIP) [2012R1A2A2A02011838]; Korea Institute of Science and Technology Intramural Fund [2E25210]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Korea Institute of Science and Technology Intramural Fund	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. 2012R1A2A2A02011838) and Korea Institute of Science and Technology Intramural Fund (2E25210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; Dessem D, 2011, PAIN RES TREAT, V2011, DOI 10.1155/2011/647967; Dostrovsky J O, 2000, Prog Brain Res, V129, P245; DOSTROVSKY JO, 1990, PAIN, V40, P93, DOI 10.1016/0304-3959(90)91056-O; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Fuggetta G, 2013, EXP NEUROL, V245, P87, DOI 10.1016/j.expneurol.2012.10.010; Gerke MB, 2003, NEUROSCIENCE, V117, P715, DOI 10.1016/S0306-4522(02)00961-2; GUILBAUD G, 1980, PAIN, V8, P303, DOI 10.1016/0304-3959(80)90076-7; Hains BC, 2006, J NEUROPHYSIOL, V95, P3343, DOI 10.1152/jn.01009.2005; Henry JL, 1999, PAIN, V82, P57, DOI 10.1016/S0304-3959(99)00033-0; HIRAYAMA T, 1989, STEREOT FUNCT NEUROS, V52, P120, DOI 10.1159/000099492; Huh Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067655; Huh Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030699; Jones E.G., 2007, THALAMUS, VVolume 1, P575; Jones EG, 2010, PAIN, V150, P4, DOI 10.1016/j.pain.2010.03.022; Kolhekar R, 1997, PAIN, V71, P31, DOI 10.1016/S0304-3959(97)03334-4; Le Bars D, 2001, PHARMACOL REV, V53, P597; Lee JI, 2005, J NEUROPHYSIOL, V94, P1676, DOI 10.1152/jn.00343.2005; LENZ FA, 1995, NAT MED, V1, P910, DOI 10.1038/nm0995-910; LENZ FA, 1991, ADV PAIN RES THER, V19, P141; LENZ FA, 1989, BRAIN RES, V496, P357, DOI 10.1016/0006-8993(89)91088-3; Li K, 2010, J PAIN, V11, P1056, DOI 10.1016/j.jpain.2010.01.268; Light, 2010, TRANSLATIONAL PAIN R; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; MAFFEI L, 1965, SCIENCE, V149, P563, DOI 10.1126/science.149.3683.563; MCCORMICK DA, 1990, NEUROSCIENCE, V39, P103, DOI 10.1016/0306-4522(90)90225-S; McHugh MP, 2003, SCAND J MED SCI SPOR, V13, P88, DOI 10.1034/j.1600-0838.2003.02477.x; NOSAKA K, 1995, MED SCI SPORT EXER, V27, P1263; PESCHANSKI M, 1980, BRAIN RES, V197, P401, DOI 10.1016/0006-8993(80)91125-7; Pizza FX, 1996, J APPL PHYSIOL, V80, P47, DOI 10.1152/jappl.1996.80.1.47; Radhakrishnan V, 1999, PAIN, V80, P567, DOI 10.1016/S0304-3959(98)00248-6; Rengachary J, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00029, 10.3389/fnhum.2011.00069]; SACCO P, 1992, EXP PHYSIOL, V77, P757, DOI 10.1113/expphysiol.1992.sp003642; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588	38	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129395	10.1371/journal.pone.0129395	http://dx.doi.org/10.1371/journal.pone.0129395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070157	Green Submitted, gold, Green Published			2022-12-27	WOS:000356327000072
J	Nussbaumer-Ochsner, Y; Stolk, J; da Silva, LFF; van Schadewijk, A; de Jeu, RC; Prins, FA; Mauad, T; Rabe, KF; Hiemstra, PS				Nussbaumer-Ochsner, Yvonne; Stolk, Jan; Ferraz da Silva, Luiz F.; van Schadewijk, Annemarie; de Jeu, Ronald C.; Prins, Frans A.; Mauad, Thais; Rabe, Klaus F.; Hiemstra, Pieter S.			Association of Lung Inflammatory Cells with Small Airways Function and Exhaled Breath Markers in Smokers - Is There a Specific Role for Mast Cells?	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; COPD; EXPRESSION; ASTHMA; IL-17A; AIR; STANDARDIZATION; VOLUMES; TISSUE; TRIAL	Background Smoking is associated with a mixed inflammatory infiltrate in the airways. We evaluated whether airway inflammation in smokers is related to lung function parameters and inflammatory markers in exhaled breath. Methods Thirty-seven smokers undergoing lung resection for primary lung cancer were assessed pre-operatively by lung function testing including single-breath-nitrogen washout test (sb-N2- test), measurement of fractional exhaled nitric oxide (FeNO) and pH/8-isoprostane in exhaled breath condensate (EBC). Lung tissue sections containing cancer-free large (LA) and small airways (SA) were stained for inflammatory cells. Mucosal (MCT) respectively connective tissue mast cells (MCTC) and interleukin-17A (IL-17A) expression by mast cells was analysed using a double-staining protocol. Results The median number of neutrophils, macrophages and mast cells infiltrating the lamina propria and adventitia of SA was higher than in LA. Both MCTC and MCT were higher in the lamina propria of SA compared to LA (MCTC: 49 vs. 27.4 cells/mm(2); MCT: 162.5 vs. 35.4 cells/mm(2); P<0.005 for both instances). IL-17A expression was predominantly detected in MCTC of LA. Significant correlations were found for the slope of phase III % pred. of the sb-N2-test (r(s)=-0.39), for the FEV1% pred. (r(s)=0.37) and for FEV1/FVC ratio (r(s)=0.38) with MCT in SA (P<0.05 for all instances). 8-isoprostane concentration correlated with the mast cells in the SA (r(s)=0.44), there was no correlation for pH or FeNO with cellular distribution in SA. Conclusions Neutrophils, macrophages and mast cells are more prominent in the SA indicating that these cells are involved in the development of small airway dysfunction in smokers. Among these cell types, the best correlation was found for mast cells with lung function parameters and inflammatory markers in exhaled breath. Furthermore, the observed predominant expression of IL-17A in mast cells warrants further investigation to elucidate their role in smoking-induced lung injury, despite the lack of correlation with lung function and exhaled breath parameters.	[Nussbaumer-Ochsner, Yvonne; Stolk, Jan; van Schadewijk, Annemarie; de Jeu, Ronald C.; Rabe, Klaus F.; Hiemstra, Pieter S.] Leiden Univ, Med Ctr LUMC, Dept Pulmonol, Leiden, Netherlands; [Ferraz da Silva, Luiz F.; Mauad, Thais] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil; [Prins, Frans A.] Leiden Univ, Dept Pathol, Med Ctr LUMC, Leiden, Netherlands; [Rabe, Klaus F.] Grosshansdorf Hosp, Ctr Pneumol & Thorac Surg, Grosshansdorf, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universidade de Sao Paulo; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Grosshansdorf Hospital	Nussbaumer-Ochsner, Y (corresponding author), Leiden Univ, Med Ctr LUMC, Dept Pulmonol, Leiden, Netherlands.	yvonne.nussbaumer@hispeed.ch	/V-8478-2019; Hiemstra, Pieter S/K-8587-2018; Silva, Luiz/D-2760-2012; Rabe, Klaus F./AAW-6296-2021	Hiemstra, Pieter S/0000-0002-0238-5982; Silva, Luiz/0000-0002-0181-6357; Rabe, Klaus F./0000-0002-7020-1401	Swiss National Science Foundation [PBZHP3-131017]; CNP (Brazilian National Research Council)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CNP (Brazilian National Research Council)	Yvonne Nussbaumer-Ochsner was funded by a grant from the Swiss National Science Foundation (PBZHP3-131017). Thais Mauad is funded by CNP (Brazilian National Research Council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson CK, 2010, AM J RESP CRIT CARE, V181, P206, DOI 10.1164/rccm.200906-0932OC; Battaglia S, 2005, THORAX, V60, P639, DOI 10.1136/thx.2004.035279; Battaglia S, 2007, J CLIN PATHOL, V60, P907, DOI 10.1136/jcp.2006.037002; Borrill Zoe L, 2008, Int J Chron Obstruct Pulmon Dis, V3, P171; BUIST AS, 1973, AM REV RESPIR DIS, V107, P744; Chang Y, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0145-7; Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; COSIO M, 1978, NEW ENGL J MED, V298, P1277, DOI 10.1056/NEJM197806082982303; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Ekberg-Jansson A, 2005, RESP MED, V99, P75, DOI 10.1016/j.rmed.2004.05.013; Eustace A, 2010, CHEST; Eustace A, 2011, CHEST, V139, P1089, DOI 10.1378/chest.10-0779; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2015, GLOB STRAT DIAGN MAN; Gosman MM, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-64; Grashoff WFH, 1997, AM J PATHOL, V151, P1785; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Inonu H, 2012, RESP CARE, V57, P413, DOI 10.4187/respcare.01302; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; Koczulla R, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-78; Lapperre TS, 2007, CHEST, V131, P53, DOI 10.1378/chest.06-0796; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Noordenbos T, 2012, ARTHRITIS RHEUM-US, V64, P99, DOI 10.1002/art.33396; Rahman Irfan, 2005, Treat Respir Med, V4, P175, DOI 10.2165/00151829-200504030-00003; Saetta M, 1999, AM J RESP CRIT CARE, V160, pS17, DOI 10.1164/ajrccm.160.supplement_1.6; Shaw DE, 2007, AM J RESP CRIT CARE, V176, P231, DOI 10.1164/rccm.200610-1427OC; Shen N, 2011, INHAL TOXICOL, V23, P212, DOI 10.3109/08958378.2011.559603; Suurmond J, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3466; van der Loos CM, 2008, J HISTOCHEM CYTOCHEM, V56, P313, DOI 10.1369/jhc.2007.950170; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Xiong WN, 2007, J HUAZHONG U SCI-MED, V27, P498, DOI 10.1007/s11596-007-0505-3; Zhang JQ, 2013, INT IMMUNOPHARMACOL, V15, P58, DOI 10.1016/j.intimp.2012.10.018; Zhang L, 2013, COPD, V10, P459, DOI 10.3109/15412555.2013.770456	34	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129426	10.1371/journal.pone.0129426	http://dx.doi.org/10.1371/journal.pone.0129426			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069967	gold, Green Submitted, Green Published			2022-12-27	WOS:000356327000074
J	Scolforo, HF; Scolforo, JRS; Mello, CR; Mello, JM; Ferraz, AC				Scolforo, Henrique Ferraco; Soares Scolforo, Jose Roberto; Mello, Carlos Rogerio; Mello, Jose Marcio; Ferraz Filho, Antonio Carlos			Spatial Distribution of Aboveground Carbon Stock of the Arboreal Vegetation in Brazilian Biomes of Savanna, Atlantic Forest and Semi-Arid Woodland	PLOS ONE			English	Article							RAINFALL EROSIVITY; VARIABILITY; EQUATIONS; BIOMASS	The objective of this study was to map the spatial distribution of aboveground carbon stock (using Regression-kriging) of arboreal plants in the Atlantic Forest, Semi-arid woodland, and Savanna Biomes in Minas Gerais State, southeastern Brazil. The database used in this study was obtained from 163 forest fragments, totaling 4,146 plots of 1,000 m(2) distributed in these Biomes. A geographical model for carbon stock estimation was parameterized as a function of Biome, latitude and altitude. This model was applied over the samples and the residuals generated were mapped based on geostatistical procedures, selecting the exponential semivariogram theoretical model for conducting ordinary Kriging. The aboveground carbon stock was found to have a greater concentration in the north of the State, where the largest contingent of native vegetation is located, mainly the Savanna Biome, with Wooded Savanna and Shrub Savanna phytophysiognomes. The largest weighted averages of carbon stock per hectare were found in the south-center region (48.6 Mg/ha) and in the southern part of the eastern region (48.4 Mg/ha) of Minas Gerais State, due to the greatest predominance of Atlantic Forest Biome forest fragments. The smallest weighted averages per hectare were found in the central (21.2 Mg/ha), northern (20.4 Mg/ha), and northwestern (20.7 Mg/ha) regions of Minas Gerais State, where Savanna Biome fragments are predominant, in the phytophysiognomes Wooded Savanna and Shrub Savanna.	[Scolforo, Henrique Ferraco] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Soares Scolforo, Jose Roberto; Mello, Jose Marcio; Ferraz Filho, Antonio Carlos] Univ Fed Lavras, Dept Forest Sci, Lavras, MG, Brazil; [Mello, Carlos Rogerio] Univ Fed Lavras, Dept Engn, Lavras, MG, Brazil	University of North Carolina; North Carolina State University; Universidade Federal de Lavras; Universidade Federal de Lavras	Scolforo, JRS (corresponding author), Univ Fed Lavras, Dept Forest Sci, Lavras, MG, Brazil.	jscolforo@dcf.ufla.br	SCOLFORO, JOSE/GLV-1991-2022; DE MELLO, JOSÉ MARCIO/S-9935-2019; Mello, Carlos/G-5821-2012; Filho, Antonio Ferraz/D-7283-2016	SCOLFORO, JOSE/0000-0002-5888-6751; Mello, Carlos/0000-0002-6033-5342; Filho, Antonio Ferraz/0000-0001-9178-918X; Mello, Jose Marcio de/0000-0002-0522-5060	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Instituto Estadual de Florestas (IEF)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Instituto Estadual de Florestas (IEF)	The authors are grateful to the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), and the Instituto Estadual de Florestas (IEF) for supporting this work. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105519; Black J.T, 1992, MULTIVARIATE DATA AN; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; Carvalho L.D., 2008, ZONEAMENTO ECOLOGICO, P89; Curi N., 1992, Informe Agropecuario (Belo Horizonte), V16, P5; de Mello CR, 2012, CIENC AGROTEC, V36, P53, DOI 10.1590/S1413-70542012000100007; de Rezende MG, 2013, BIOTA NEOTROP, V13, P201, DOI 10.1590/S1676-06032013000400019; Environmental systems research institute, 2010, GEOST AN; FERREIRA DF, 2008, ESTATISTICA MULTIVAR; Gomes Ana Paula de Souza, 2006, Acta Bot. Bras., V20, P37; Gomide L. R., 2005, Cerne, V11, P376; Hengl T, 2007, COMPUT GEOSCI-UK, V33, P1301, DOI 10.1016/j.cageo.2007.05.001; HERSHEY RR, 1996, SPATIAL ACCURACY ASS, P73; Instituto Brasileiro de Geografia e Estatistica, 2010, BRAS PROD INT BRUT P; Journel A. G., 1978, MINING GEOSTATISTICS; KAUFFMAN JB, 1994, J ECOL, V82, P519, DOI 10.2307/2261261; LEITAO-FILHO H.F., 1994, AN ACAD BRAS CIENC, V66, P91; Galeana-Pizana JM, 2014, INT J APPL EARTH OBS, V30, P179, DOI 10.1016/j.jag.2014.02.005; Mello CR, 2013, GEODERMA, V202, P88, DOI 10.1016/j.geoderma.2013.03.009; Mello Carlos R. de, 2009, Rev. bras. eng. agríc. ambient., V13, P68, DOI 10.1590/S1415-43662009000100010; Menezes MD, 2011, THESIS FEDERAL U LAV; Meusburger K, 2012, HYDROL EARTH SYST SC, V16, P167, DOI 10.5194/hess-16-167-2012; Miller J, 2007, ECOL MODEL, V202, P225, DOI 10.1016/j.ecolmodel.2006.12.012; Morais VA, 2013, CERNE, V19, P237, DOI 10.1590/S0104-77602013000200007; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Oliveira MBL., 2006, REV BRAS METEOROL, V21, P378; OLIVEIRA-FILHO A. T, 2008, INVENTARIO FLORESTAL; Previtali FS, 2013, REDD REV ESPACO DIAL, V7, P1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reboita Michelle Simões, 2010, Rev. bras. meteorol., V25, P185, DOI 10.1590/S0102-77862010000200004; Rezende A. V., 2006, Scientia Forestalis, P65; Ribeiro P.J, 2001, R NEWS, V1, P14, DOI DOI 10.1159/000323281; Rodrigues GSSC, 2011, REV GEOGRAFICA AM CE, V2, P1; Rufini AL, 2010, CERNE, V16, P1, DOI 10.1590/S0104-77602010000100001; Yamamoto JK, 2013, GEOESTATISTICA CONCE	35	37	38	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128781	10.1371/journal.pone.0128781	http://dx.doi.org/10.1371/journal.pone.0128781			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066508	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000029
J	Soons, J; Genbrugge, A; Podos, J; Adriaens, D; Aerts, P; Dirckx, J; Herrel, A				Soons, Joris; Genbrugge, Annelies; Podos, Jeffrey; Adriaens, Dominique; Aerts, Peter; Dirckx, Joris; Herrel, Anthony			Is Beak Morphology in Darwin's Finches Tuned to Loading Demands?	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; BITE FORCE; MECHANICAL FUNCTION; APPARENT DENSITY; CANCELLOUS BONE; GEOSPIZA-FORTIS; BIRD BEAKS; EVOLUTION; SHAPE; PERFORMANCE	One of nature's premier illustrations of adaptive evolution concerns the tight correspondence in birds between beak morphology and feeding behavior. In seed-crushing birds, beaks have been suggested to evolve at least in part to avoid fracture. Yet, we know little about mechanical relationships between beak shape, stress dissipation, and fracture avoidance. This study tests these relationships for Darwin's finches, a clade of birds renowned for their diversity in beak form and function. We obtained anatomical data from micro-CT scans and dissections, which in turn informed the construction of finite element models of the bony beak and rhamphotheca. Our models offer two new insights. First, engineering safety factors are found to range between 1 and 2.5 under natural loading conditions, with the lowest safety factors being observed in species with the highest bite forces. Second, size-scaled finite element (FE) models reveal a correspondence between inferred beak loading profiles and observed feeding strategies (e.g. edge-crushing versus tip-biting), with safety factors decreasing for base-crushers biting at the beak tip. Additionally, we identify significant correlations between safety factors, keratin thickness at bite locations, and beak aspect ratio (depth versus length). These lines of evidence together suggest that beak shape indeed evolves to resist feeding forces.	[Soons, Joris; Genbrugge, Annelies; Dirckx, Joris] Univ Antwerp, Lab Biomed Phys, B-2020 Antwerp, Belgium; [Genbrugge, Annelies; Adriaens, Dominique] Univ Ghent, Evolutionary Morphol Vertebrates, B-9000 Ghent, Belgium; [Podos, Jeffrey] Univ Massachusetts, Dept Biol, Morrill Sci Ctr 221, Amherst, MA 01003 USA; [Aerts, Peter; Herrel, Anthony] Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium; [Aerts, Peter] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium; [Herrel, Anthony] Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, F-75231 Paris 5, France	University of Antwerp; Ghent University; University of Massachusetts System; University of Massachusetts Amherst; University of Antwerp; Ghent University; Museum National d'Histoire Naturelle (MNHN)	Soons, J (corresponding author), Univ Antwerp, Lab Biomed Phys, Groenenborgerlaan 171, B-2020 Antwerp, Belgium.	joris.soons@ua.ac.be	Adriaens, Dominique/G-1587-2010; Podos, Jeff/I-3843-2019; Herrel, Anthony/C-3712-2013	Adriaens, Dominique/0000-0003-3610-2773; Herrel, Anthony/0000-0003-0991-4434; Podos, Jeffrey/0000-0002-2546-7999; Aerts, Peter/0000-0002-6867-5421	National Science Foundation under NSF [ECS-0335765]; Research Foundation - Flanders (FWO); University of Antwerp; NSF [IBN-0347291]	National Science Foundation under NSF(National Science Foundation (NSF)); Research Foundation - Flanders (FWO)(FWO); University of Antwerp; NSF(National Science Foundation (NSF))	This work was performed in part at the Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by the National Science Foundation under NSF award no. ECS-0335765. CNS is part of the Faculty of Arts and Sciences at Harvard University. Financial support to this project was provided by the Research Foundation - Flanders (FWO) to JS, an interdisciplinary research grant of the special research fund of the University of Antwerp to PA, JD, AH, a PHC Tournesol project to AH, AG and DA, and JP was supported by NSF grant IBN-0347291. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthaume MA, 2012, J THEOR BIOL, V300, P242, DOI 10.1016/j.jtbi.2012.01.031; BOAG PT, 1981, SCIENCE, V214, P82, DOI 10.1126/science.214.4516.82; BOCK WJ, 1964, J MORPHOL, V114, P1, DOI 10.1002/jmor.1051140102; Bout RG, 2002, VERTEBRATE BIOMECHAN, VII, P49; Bowman R.I., 1961, MORPHOLOGICAL DIFFER; Campas O, 2010, P NATL ACAD SCI USA, V107, P3356, DOI 10.1073/pnas.0911575107; CARTER DR, 1976, SCIENCE, V194, P1174, DOI 10.1126/science.996549; Chou SF, 2012, MAT SCI ENG A-STRUCT, V557, P36, DOI 10.1016/j.msea.2012.05.111; Currey JD., 2006, BONES STRUCTURE MECH; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Farren L, 2004, J EXP BIOL, V207, P735, DOI 10.1242/jeb.00814; Fitton LC, 2015, ANAT REC, V298, P107, DOI 10.1002/ar.23075; Ford CM, 1996, J BIOMECH, V29, P1309, DOI 10.1016/0021-9290(96)00062-0; Foster DJ, 2008, J EVOLUTION BIOL, V21, P263, DOI 10.1111/j.1420-9101.2007.01449.x; Fyhrie DP, 2000, BONE, V26, P169, DOI 10.1016/S8756-3282(99)00246-X; Genbrugge A, 2012, J ANAT, V221, P383, DOI 10.1111/j.1469-7580.2012.01561.x; Genbrugge A, 2011, J ANAT, V219, P676, DOI 10.1111/j.1469-7580.2011.01437.x; Genbrugge A, 2011, J ANAT, V219, P115, DOI 10.1111/j.1469-7580.2011.01388.x; Grant P.R., 1999, RECOGNITION STATES L, V2; Grant P. R., 2008, WHY SPECIES MULTIPLY; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; GRANT PR, 1981, PROC R SOC SER B-BIO, V212, P403, DOI 10.1098/rspb.1981.0046; Herrel A, 2005, FUNCT ECOL, V19, P43, DOI 10.1111/j.0269-8463.2005.00923.x; Herrel A, 2005, J EVOLUTION BIOL, V18, P669, DOI 10.1111/j.1420-9101.2004.00857.x; Herrel A, 2010, EMU, V110, P39, DOI 10.1071/MU09034; Herrel A, 2009, FUNCT ECOL, V23, P119, DOI 10.1111/j.1365-2435.2008.01494.x; Kupczik K, 2007, J ANAT, V210, P41, DOI 10.1111/j.1469-7580.2006.00662.x; Lack D., 1947, DARWINS FINCHES; Li BW, 2010, J EXP BIOL, V213, P479, DOI 10.1242/jeb.035428; Loeb G. E., 1986, ELECTROMYOGRAPHY EXP; MAAS S, 2008, FEBIO FINITE ELEMENT; MENDEZ J, 1960, METABOLISM, V9, P184; Nigg B., 2007, BIOMECHANICS MUSCULO; Nuijens FW, 1997, J MORPHOL, V232, P1, DOI 10.1002/(SICI)1097-4687(199704)232:1<1::AID-JMOR1>3.0.CO;2-G; Panagiotopoulou O, 2011, J ANAT, V218, P75, DOI 10.1111/j.1469-7580.2010.01257.x; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; RICE JC, 1988, J BIOMECH, V21, P155, DOI 10.1016/0021-9290(88)90008-5; Richmond BG, 2005, ANAT REC PART A, V283A, P259, DOI 10.1002/ar.a.20169; Ross CF, 2005, ANAT REC PART A, V283A, P253, DOI 10.1002/ar.a.20177; Si H, 2006, TETGEN QUALITY TETRA; Soons J, 2012, J R SOC INTERFACE, V9, P1787, DOI 10.1098/rsif.2011.0910; Soons J, 2012, J R SOC INTERFACE, V9, P1381, DOI 10.1098/rsif.2011.0667; Soons J, 2010, PHILOS T R SOC B, V365, P1093, DOI 10.1098/rstb.2009.0280; Temeles EJ, 2003, SCIENCE, V300, P630, DOI 10.1126/science.1080003; Temeles EJ, 2009, ECOLOGY, V90, P1147, DOI 10.1890/08-0695.1; van der Meij MAA, 2004, J EXP BIOL, V207, P2745, DOI 10.1242/jeb.01091; van der Meij MAA, 2008, J EXP BIOL, V211, P1668, DOI 10.1242/jeb.015289; Vogel S., 2003, COMP BIOMECHANICS LI; Yamada H., 1970, STRENGTH BIOL MAT	49	36	36	3	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129479	10.1371/journal.pone.0129479	http://dx.doi.org/10.1371/journal.pone.0129479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068929	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000082
J	Deng, WW; Clausen, J; Boden, S; Oliver, SN; Casao, MC; Ford, B; Anderssen, RS; Trevaskis, B				Deng, Weiwei; Clausen, Jenni; Boden, Scott; Oliver, Sandra N.; Casao, M. Cristina; Ford, Brett; Anderssen, Robert S.; Trevaskis, Ben			Dawn and Dusk Set States of the Circadian Oscillator in Sprouting Barley (Hordeum vulgare) Seedlings	PLOS ONE			English	Article							FLOWERING-TIME GENES; ARABIDOPSIS-THALIANA; CLOCK; PROTEIN; EXPRESSION; RHYTHMS; LIGHT; GIGANTEA; VERNALIZATION; ADAPTATION	The plant circadian clock is an internal timekeeper that coordinates biological processes with daily changes in the external environment. The transcript levels of clock genes, which oscillate to control circadian outputs, were examined during early seedling development in barley (Hordeum vulgare), a model for temperate cereal crops. Oscillations of clock gene transcript levels do not occur in barley seedlings grown in darkness or constant light but were observed with day-night cycles. A dark-to-light transition influenced transcript levels of some clock genes but triggered only weak oscillations of gene expression, whereas a light-to-dark transition triggered robust oscillations. Single light pulses of 6, 12 or 18 hours induced robust oscillations. The light-to-dark transition was the primary determinant of the timing of subsequent peaks of clock gene expression. After the light-to-dark transition the timing of peak transcript levels of clock gene also varied depending on the length of the preceding light pulse. Thus, a single photoperiod can trigger initiation of photoperiod-dependent circadian rhythms in barley seedlings. Photoperiod-specific rhythms of clock gene expression were observed in two week old barley plants. Changing the timing of dusk altered clock gene expression patterns within a single day, showing that alteration of circadian oscillator behaviour is amongst the most rapid molecular responses to changing photoperiod in barley. A barley EARLY FLOWERING3 mutant, which exhibits rapid photoperiod-insensitive flowering behaviour, does not establish clock rhythms in response to a single photoperiod. The data presented show that dawn and dusk cues are important signals for setting the state of the circadian oscillator during early development of barley and that the circadian oscillator of barley exhibits photoperiod-dependent oscillation states.	[Deng, Weiwei; Clausen, Jenni; Boden, Scott; Oliver, Sandra N.; Ford, Brett; Trevaskis, Ben] CSIRO, Agr, Canberra, ACT 2601, Australia; [Casao, M. Cristina] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [Anderssen, Robert S.] CSIRO, Digital Prod, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Max Planck Society; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Trevaskis, B (corresponding author), CSIRO, Agr, GPO Box 1600, Canberra, ACT 2601, Australia.	Ben.Trevaskis@csiro.au	Boden, Scott/ABC-6639-2020; Boden, Scott/H-8857-2015; Trevaskis, Ben/B-5350-2011; Ford, Brett/C-3285-2014	Boden, Scott/0000-0001-5297-4067; Trevaskis, Ben/0000-0001-7277-4994; Ford, Brett/0000-0002-7467-0950	vacation scholarship from the Commonwealth Scientific and Industrial Organisation	vacation scholarship from the Commonwealth Scientific and Industrial Organisation	JC was supported by a vacation scholarship from the Commonwealth Scientific and Industrial Organisation http://www.csiro.au/Portals/Careers/Work-experience-and-scholarships/Vacationscholarships/About-vacation-scholarship-scheme.aspx.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Barak S, 2000, TRENDS PLANT SCI, V5, P517, DOI 10.1016/S1360-1385(00)01785-4; Barrero JM, 2009, PLANT PHYSIOL, V150, P1006, DOI 10.1104/pp.109.137901; Campoli C, 2013, NEW PHYTOL, V199, P1045, DOI 10.1111/nph.12346; Campoli C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-97; Campoli C, 2012, PLANT J, V69, P868, DOI 10.1111/j.1365-313X.2011.04839.x; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Corbesier L, 2005, PLANT CELL ENVIRON, V28, P54, DOI 10.1111/j.1365-3040.2005.01283.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Dalchau N, 2011, P NATL ACAD SCI USA, V108, P5104, DOI 10.1073/pnas.1015452108; Dixon LE, 2014, NEW PHYTOL, V203, P568, DOI 10.1111/nph.12853; Doyle MR, 2002, NATURE, V58, P386; Dunford RP, 2005, THEOR APPL GENET, V110, P925, DOI 10.1007/s00122-004-1912-5; Edwards KD, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.81; Faure S, 2012, P NATL ACAD SCI USA, V109, P8328, DOI 10.1073/pnas.1120496109; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Gendron JM, 2012, P NATL ACAD SCI USA, V109, P3167, DOI 10.1073/pnas.1200355109; Haydon MJ, 2013, NATURE, V502, P689, DOI 10.1038/nature12603; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; Herrero E, 2012, PLANT CELL, V24, P428, DOI 10.1105/tpc.111.093807; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Kaczorowski KA, 2003, PLANT CELL, V15, P2654, DOI 10.1105/tpc.015065; Karayekov E, 2013, PLANT CELL, V25, P2892, DOI 10.1105/tpc.113.114306; Kikis EA, 2005, PLANT J, V44, P300, DOI 10.1111/j.1365-313X.2005.02531.x; Makino S, 2001, PLANT CELL PHYSIOL, V42, P334, DOI 10.1093/pcp/pce036; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; McClung CR, 2001, ANNU REV PLANT PHYS, V52, P139, DOI 10.1146/annurev.arplant.52.1.139; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; Millar AJ, 2003, J EXP BIOL, V55, P227; Murakami M, 2007, PLANT CELL PHYSIOL, V48, P110, DOI 10.1093/pcp/pcl043; Nagel DH, 2012, CURR BIOL, V22, pR648, DOI 10.1016/j.cub.2012.07.025; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Pokhilko A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.6; Salome PA, 2008, PLANT PHYSIOL, V147, P1110, DOI 10.1104/pp.108.117622; Sasani S, 2009, J EXP BOT, V60, P2169, DOI 10.1093/jxb/erp098; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Somers DE, 1998, DEVELOPMENT, V125, P485; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Trevaskis B, 2006, PLANT PHYSIOL, V140, P1397, DOI 10.1104/pp.105.073486; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Yakir E, 2011, PLANT J, V68, P520, DOI 10.1111/j.1365-313X.2011.04707.x; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Zakhrabekova S, 2012, P NATL ACAD SCI USA, V109, P4326, DOI 10.1073/pnas.1113009109; Zhong HH, 1998, PLANT CELL, V10, P2005, DOI 10.1105/tpc.10.12.2005	49	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129781	10.1371/journal.pone.0129781	http://dx.doi.org/10.1371/journal.pone.0129781			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068005	gold, Green Published			2022-12-27	WOS:000356100900078
J	Ou, Q; Chen, YC; Zhuo, SQ; Tian, XT; He, CH; Lu, XL; Gao, XL				Ou, Qiong; Chen, Yong-Chi; Zhuo, Sheng-Qing; Tian, Xiang-Ting; He, Chun-Huan; Lu, Xi-Lin; Gao, Xing-Lin			Continuous Positive Airway Pressure Treatment Reduces Mortality in Elderly Patients with Moderate to Severe Obstructive Severe Sleep Apnea: A Cohort Study	PLOS ONE			English	Article							RISK-FACTOR; ASSOCIATION; HYPERTENSION; STROKE	Obstructive sleep apnea (OSA) is much more prevalent in older people than in middle-aged or young populations, and has been associated with cardiovascular disease. Continuous positive airway pressure (CPAP) is the first-line therapy for OSA, but its long-term clinical benefit in the elderly is unclear. Here, we carried out a prospective cohort study to explore the survival rate and incidence of cardiovascular events in elderly patients with moderate to severe OSA who did or did not receive CPAP treatment. The study included 130 patients (104 male, 26 female; mean age: 77.8 +/- 6.2 years) who were followed up for a mean of 5 +/- 2.54 years (range, 1-8 years). Thirty-six patients received CPAP and 88 had no CPAP. The results showed that mortality in the untreated group (21.6%) was significantly higher than in the CPAP group (5.6%). Kaplan-Meier survival analysis showed that the survival rate in the CPAP group was 94.4%, which was markedly higher than the rate of 78.4% in the untreated group. The incidence of cardiovascular events was 13.9% in the CPAP group and 55.7% in the untreated group. The present study provides evidence that CPAP can reduce mortality in older patients with moderate to severe OSA, and lead to a good long-term prognosis. The study also indicates that death in older OSA patients is associated with cardiovascular disease and diabetes.	[Ou, Qiong; Gao, Xing-Lin] Guangdong Acad Med Sci, Guangdong Prov Inst Geriatr, Guangdong Gen Hosp, Sleep Ctr,Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Chen, Yong-Chi; Zhuo, Sheng-Qing; Tian, Xiang-Ting; He, Chun-Huan] Guangdong Acad Med Sci, Guangdong Prov Inst Geriatr, Dept Cardiol, Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China; [Lu, Xi-Lin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Sun Yat Sen University	Gao, XL (corresponding author), Guangdong Acad Med Sci, Guangdong Prov Inst Geriatr, Guangdong Gen Hosp, Sleep Ctr,Dept Resp Med, Guangzhou, Guangdong, Peoples R China.	xinglingao@hotmail.com			National Key Clinical Department, National Key Discipline [Y3016]; Guangdong Key Laboratory For Diagnosis and Treatment of Major Neurological Diseases [2010A060801005]; Guangdong Technological grant [2008B030301188, 2012B031800107]; Guangdong Department of Science & Technology Translational Medicine Center [2011A080300002]	National Key Clinical Department, National Key Discipline; Guangdong Key Laboratory For Diagnosis and Treatment of Major Neurological Diseases; Guangdong Technological grant; Guangdong Department of Science & Technology Translational Medicine Center	This study was supported by grants from the National Key Clinical Department, National Key Discipline (No. Y3016), Guangdong Key Laboratory For Diagnosis and Treatment of Major Neurological Diseases(No. 2010A060801005), Guangdong Technological grant (No. 2008B030301188, 2012B031800107), and Guangdong Department of Science & Technology Translational Medicine Center grant (No. 2011A080300002).	AncoliIsrael S, 1996, SLEEP, V19, P277, DOI 10.1093/sleep/19.4.277; Arzt M, 2005, AM J RESP CRIT CARE, V172, P1447, DOI 10.1164/rccm.200505-702OC; BLIWISE DL, 1988, AM J PUBLIC HEALTH, V78, P544, DOI 10.2105/AJPH.78.5.544; Campos-Rodriguez F, 2005, CHEST, V128, P624, DOI 10.1378/chest.128.2.624; Caples SM, 2005, ANN INTERN MED, V142, P187, DOI 10.7326/0003-4819-142-3-200502010-00010; Doherty LS, 2005, CHEST, V127, P2076, DOI 10.1378/chest.127.6.2076; Endeshaw Y, 2006, J AM GERIATR SOC, V54, P1740, DOI 10.1111/j.1532-5415.2006.00924.x; Groth M, 2005, CLIN GERIATR MED, V21, P701, DOI 10.1016/j.cger.2005.06.009; Lavie P, 2009, J SLEEP RES, V18, P397, DOI 10.1111/j.1365-2869.2009.00754.x; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Lopez-Jimenez F, 2008, CHEST, V133, P793, DOI 10.1378/chest.07-0800; Maekawa M, 2000, Nihon Rinsho, V58, P1702; Martinez-Garcia AA, 2005, CHEST, V128, P2123, DOI 10.1378/chest.128.4.2123; McMahon Joseph P, 2003, WMJ, V102, P36; Mehra R, 2006, AM J RESP CRIT CARE, V173, P910, DOI 10.1164/rccm.200509-1442OC; Munoz R, 2006, STROKE, V37, P2317, DOI 10.1161/01.STR.0000236560.15735.0f; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Norman D, 2008, CLIN GERIATR MED, V24, P151, DOI 10.1016/j.cger.2007.08.006; Ohayon MM, 2000, J PSYCHOSOM RES, V48, P593, DOI 10.1016/S0022-3999(00)00142-2; Parish JM, 2004, MAYO CLIN PROC, V79, P1036, DOI 10.4065/79.8.1036; Robinson GV, 2004, THORAX, V59, P777, DOI 10.1136/thx.2003.018739; Sforza E, 2004, EUR RESPIR J, V24, P279, DOI 10.1183/09031936.04.00091903; Silverberg D S, 2001, Curr Hypertens Rep, V3, P209, DOI 10.1007/s11906-001-0040-8; Skinner MA, 2005, CHEST, V127, P66, DOI 10.1378/chest.127.1.66; Thurnheer R, 2007, SWISS MED WKLY, V137, P217; Weaver TE, 2007, SLEEP MED REV, V11, P99, DOI 10.1016/j.smrv.2006.08.001; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 2000, SLEEP, V23, pS122	29	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0127775	10.1371/journal.pone.0127775	http://dx.doi.org/10.1371/journal.pone.0127775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK3FB	26068440	gold, Green Submitted, Green Published			2022-12-27	WOS:000356100900012
J	Park, J; Lai, LX; Samuel, MS; Wax, D; Prather, RS; Tian, XC				Park, Joonghoon; Lai, Liangxue; Samuel, Melissa S.; Wax, David; Prather, Randall S.; Tian, Xiuchun			Disruption of Mitochondrion-To-Nucleus Interaction in Deceased Cloned Piglets	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; DNA; HETEROPLASMY; CELLS; FETAL; OOCYTES; FETUSES; GENOME; KIDNEY; BRAIN	Most animals produced by somatic cell nuclear transfer (SCNT) are heteroplasmic for mitochondrial DNA (mtDNA). Oxidative phosphorylation (OXPHOS) in clones therefore requires the coordinated expression of genes encoded by the nuclear DNA and the two sources of mitochondria. Such interaction is rarely studied because most clones are generated using slaughterhouse oocytes of unrecorded origin. Here we traced the maternal lineages of seven diseased and five one-month-old live cloned piglets by sequencing their mtDNA. Additionally by using a 13K oligonucleotide microarray, we compared the expression profiles of nuclear and mtDNA-encoded genes that are involved in mitochondrial functions and regulation between the cloned groups and their age-matched controls (n=5 per group). We found that the oocytes used to generate the cloned piglets were of either the Large White or Duroc background, and oocyte genetic background was not related to the clones' survival. Expression profiles of mtDNA-encoded genes in clones and controls showed intermixed clustering patterns without treatment or maternal lineage-dependency. In contrast, clones and controls clustered separately for their global and nuclear DNA-encoded mitochondrial genes in the lungs for both the deceased and live groups. Functional annotation of differentially expressed genes encoded by both nuclear and mtDNA revealed abnormal gene expression in the mitochondrial OXPHOS pathway in deceased clones. Among the nine differentially expressed genes of the OXPHOS pathway, seven were down-regulated in deceased clones compared to controls, suggesting deficiencies in mitochondrial functions. Together, these data demonstrate that the coordination of expression of mitochondrial genes encoded by nuclear and mtDNA is disrupted in the lung of diseased clones.	[Park, Joonghoon; Tian, Xiuchun] Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA; [Park, Joonghoon; Tian, Xiuchun] Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA; [Lai, Liangxue; Samuel, Melissa S.; Wax, David; Prather, Randall S.] Univ Missouri, Dept Anim Sci, Columbia, MO 65211 USA	University of Connecticut; University of Connecticut; University of Missouri System; University of Missouri Columbia	Tian, XC (corresponding author), Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA.	xiuchun.tian@uconn.edu		Prather, Randall/0000-0002-6012-4035	USDA Regional Research Project [W2171]; USDA-ARS [58-1265-0-040]	USDA Regional Research Project; USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The work received the following grant support: USDA Regional Research Project W2171 and USDA-ARS contract 58-1265-0-040.	Acton BM, 2007, BIOL REPROD, V77, P569, DOI 10.1095/biolreprod.107.060806; Bruggerhoff K, 2002, BIOL REPROD, V66, P367, DOI 10.1095/biolreprod66.2.367; Burgstaller JP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-141; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Carroll JA, 2005, DOMEST ANIM ENDOCRIN, V29, P564, DOI 10.1016/j.domaniend.2005.03.009; Chen JQ, 2007, MOL REPROD DEV, V74, P568, DOI 10.1002/mrd.20647; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cotter D, 2004, NUCLEIC ACIDS RES, V32, pD463, DOI 10.1093/nar/gkh048; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dietrich JB, 2004, ANN NY ACAD SCI, V1025, P345, DOI 10.1196/annals.1316.042; Dmitrenka V, 2005, CANCER LETT, V218, P99, DOI 10.1016/j.canlet.2004.07.001; Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0; Hiendleder S, 1999, MOL REPROD DEV, V54, P24, DOI 10.1002/(SICI)1098-2795(199909)54:1&lt;24::AID-MRD4&gt;3.0.CO;2-S; Hiendleder S, 2004, BIOL REPROD, V70, P1196, DOI 10.1095/biolreprod.103.023028; Hiendleder S, 2003, BIOL REPROD, V68, P159, DOI 10.1095/biolreprod.102.008201; Hsieh SY, 2006, PROTEOMICS, V6, P5322, DOI 10.1002/pmic.200500541; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jiao F, 2007, MOL REPROD DEV, V74, P1278, DOI 10.1002/mrd.20698; Kim KI, 2002, ANIM GENET, V33, P19, DOI 10.1046/j.1365-2052.2002.00784.x; Kishigami S, 2008, EXP CELL RES, V314, P1945, DOI 10.1016/j.yexcr.2008.01.027; Kulawiec M, 2006, CANCER BIOL THER, V5, P967, DOI 10.4161/cbt.5.8.2880; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lan GC, 2006, MOL REPROD DEV, V73, P834, DOI 10.1002/mrd.20443; LATHAM KE, 1994, DEVELOPMENT, V120, P3419; Lee JH, 2010, CELL REPROGRAM, V12, P347, DOI 10.1089/cell.2009.0096; Li HS, 2001, PHYSIOL GENOMICS, V6, P91, DOI 10.1152/physiolgenomics.2001.6.2.91; Li Y, 2007, J BIOL CHEM; McKenzie M, 2000, J BIOL CHEM, V275, P31514, DOI 10.1074/jbc.M004070200; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Ogonuki N, 2002, NAT GENET, V30, P253, DOI 10.1038/ng841; OHTA S, 1988, J BIOL CHEM, V263, P11257; Park J, 2010, ALTERED GENE E UNPUB, DOI [10.1089/cell.2010.0004, DOI 10.1089/CELL.2010.0004]; Park J, 2011, CELL REPROGRAM, V13, P215, DOI 10.1089/cell.2010.0088; Park J, 2010, CELL REPROGRAM, V12, P589, DOI 10.1089/cell.2010.0004; Piruat JI, 2005, J BIOL CHEM, V280, P42676, DOI 10.1074/jbc.M507044200; Powell AM, 2004, BIOL REPROD, V71, P210, DOI 10.1095/biolreprod.104.027193; Tagliaro C. H., 1999, Ciencia Rural, V29, P319, DOI 10.1590/S0103-84781999000200022; Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200; Urakawa M, 2004, THERIOGENOLOGY, V62, P714, DOI 10.1016/j.theriogenology.2003.11.024; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003; YAN WL, 1994, GENOMICS, V24, P375, DOI 10.1006/geno.1994.1631; Yan ZH, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-31; Zhao SH, 2005, GENOMICS, V86, P618, DOI 10.1016/j.ygeno.2005.08.001	45	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129378	10.1371/journal.pone.0129378	http://dx.doi.org/10.1371/journal.pone.0129378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067091	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900053
J	Rodriguez, C; Soulie, C; Marcelin, AG; Calvez, V; Descamps, D; Charpentier, C; Flandre, P; Recordon-Pinson, P; Bellecave, P; Pawlotsky, JM; Masquelier, B				Rodriguez, Christophe; Soulie, Cathia; Marcelin, Anne-Genevieve; Calvez, Vincent; Descamps, Diane; Charpentier, Charlotte; Flandre, Philippe; Recordon-Pinson, Patricia; Bellecave, Pantxika; Pawlotsky, Jean-Michel; Masquelier, Bernard		ANRS AC11 Study Grp	HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc	PLOS ONE			English	Article							ROC CURVES; TROPISM; ASSAY; CCR5; PREDICTION	Background Maraviroc is an HIV entry inhibitor that alters the conformation of CCR5 and is poorly efficient in patients infected by viruses that use CXCR4 as an entry coreceptor. The goal of this study was to assess the capacity of ultra-deep pyrosequencing (UDPS) and different data analysis approaches to characterize HIV tropism at baseline and predict the therapeutic outcome on maraviroc treatment. Methods 113 patients with detectable HIV-1 RNA on HAART were treated with maraviroc. The virological response was assessed at months 1, 3 and 6. The sequence of the HIV V3 loop was determined at baseline and prediction of maraviroc response by different software and interpretation algorithms was analyzed. Results UDPS followed by analysis with the Pyrotrop software or geno2pheno algorithm provided better prediction of the response to maraviroc than Sanger sequencing. We also found that the H34Y/S substitution in the V3 loop was the strongest individual predictor of maraviroc response, stronger than substitutions at positions 11 or 25 classically used in interpretation algorithms. Conclusions UDPS is a powerful tool that can be used with confidence to predict maraviroc response in HIV-1-infected patients. Improvement of the predictive value of interpretation algorithms is possible and our results suggest that adding the H34S/Y substitution would substantially improve the performance of the 11/25/charge rule.	[Rodriguez, Christophe; Pawlotsky, Jean-Michel] Univ Paris Est, Henri Mondor Hosp, Natl Reference Ctr Viral Hepatitis B C & Delta, Dept Virol, Creteil, France; [Rodriguez, Christophe; Pawlotsky, Jean-Michel] INSERM U955, Creteil, France; [Soulie, Cathia; Marcelin, Anne-Genevieve; Calvez, Vincent] Hop La Pitie Salpetriere, Dept Virol, Paris, France; [Descamps, Diane; Charpentier, Charlotte] HUPNVS, Bichat Claude Bernard Hosp, Dept Virol, Paris, France; [Flandre, Philippe] INSERM U943 UPMC, UMR S 943, Paris, France; [Recordon-Pinson, Patricia; Bellecave, Pantxika; Masquelier, Bernard] Univ Bordeaux, Univ Hosp Bordeaux, Dept Virol, Bordeaux, France; [Recordon-Pinson, Patricia; Bellecave, Pantxika; Masquelier, Bernard] Univ Bordeaux, UMR5234, Bordeaux, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Pawlotsky, JM (corresponding author), Univ Paris Est, Henri Mondor Hosp, Natl Reference Ctr Viral Hepatitis B C & Delta, Dept Virol, Creteil, France.	jean.michel.pawlotsky@hmn.aphp.fr	André, Patrice/M-8139-2014; rodriguez, christophe/B-8024-2012; SOULIE, CATHIA/AIF-3965-2022; Pawlotsky, Jean-Michel/R-8159-2018; Flandre, Philippe/N-6314-2017; de ROUGEMONT, Alexis/M-1090-2016; Rogez, Sylvie/O-8891-2016; Charpentier, Charlotte/C-3579-2019; chaillon, antoine/GNH-1623-2022; Recordon-Pinson, Patricia/AAV-1295-2021; Chaillon, Antoine/GNH-6121-2022; Marcelin, Anne-Genevieve/D-8272-2014	André, Patrice/0000-0002-5834-7395; rodriguez, christophe/0000-0001-8128-4030; Flandre, Philippe/0000-0002-2612-3522; de ROUGEMONT, Alexis/0000-0002-3084-9414; Rogez, Sylvie/0000-0002-4092-7164; Recordon-Pinson, Patricia/0000-0001-6002-0941; Marcelin, Anne-Genevieve/0000-0003-4808-8999; Fafi-Kremer, Samira/0000-0003-3886-7833; VABRET, Astrid/0000-0002-8940-7645; Pawlotsky, Jean-Michel/0000-0003-0745-7559; Trabaud, Mary-Anne/0000-0001-8614-1071; PLANTIER, Jean-Christophe/0000-0001-6417-4083; Raymond, Stephanie/0000-0002-3780-5844; BOURLET, Thomas/0000-0002-9226-1149	project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" within the 7th Framework Program of the European Community (FP7); National Agency for Research on AIDS and Viral Hepatitis (ANRS); ANRS	project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" within the 7th Framework Program of the European Community (FP7); National Agency for Research on AIDS and Viral Hepatitis (ANRS)(French National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR))	This research has been funded as part of the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" within the 7th Framework Program of the European Community (FP7) and by the National Agency for Research on AIDS and Viral Hepatitis (ANRS). C.R. is the recipient of a pre-doctoral fellowship from ANRS.	Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Bandos AI, 2005, STAT MED, V24, P2873, DOI 10.1002/sim.2149; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Chen MJ, 2013, BIOINFORMATICS, V29, P451, DOI 10.1093/bioinformatics/btt002; Daumer M, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-30; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Delobel P, 2007, J CLIN MICROBIOL, V45, P1572, DOI 10.1128/JCM.02090-06; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Gibson RM, 2014, ANTIMICROB AGENTS CH, V58, P2167, DOI 10.1128/AAC.02710-13; Kagan RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046334; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Poveda E, 2012, AIDS REV, V14, P208; R Core Team, 2018, R LANG ENV STAT COMP; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Recordon-Pinson P, 2010, ANTIMICROB AGENTS CH, V54, P3335, DOI 10.1128/AAC.00148-10; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rodriguez C, 2013, HEPATOLOGY, V58, P890, DOI 10.1002/hep.26383; Rose JD, 2009, CURR OPIN HIV AIDS, V4, P136, DOI 10.1097/COH.0b013e328322f973; Saliou A, 2011, ANTIMICROB AGENTS CH, V55, P2831, DOI 10.1128/AAC.00091-11; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Swenson LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/infdis/jiq030; Vandekerckhove L, 2011, J ANTIMICROB CHEMOTH, V66, P265, DOI 10.1093/jac/dkq458; Westby M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06	24	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0127816	10.1371/journal.pone.0127816	http://dx.doi.org/10.1371/journal.pone.0127816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068869	Green Submitted, Green Published, gold			2022-12-27	WOS:000356100900013
J	Shen, TC; Lin, CL; Wei, CC; Chen, CH; Tu, CY; Hsia, TC; Shih, CM; Hsu, WH; Sung, FC; Kao, CH				Shen, Te-Chun; Lin, Cheng-Li; Wei, Chang-Ching; Chen, Chia-Hung; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei; Sung, Fung-Chang; Kao, Chia-Hung			Risk of Obstructive Sleep Apnea in Adult Patients with Asthma: A Population-Based Cohort Study in Taiwan	PLOS ONE			English	Article							UPPER AIRWAY; ASSOCIATION; SYMPTOMS; RHINITIS; COMMON; AWAKE	Background There are several publications reported that obstructive sleep apnea (OSA) was associated with asthma. However, large-scaled, population-based cohort study has been limited. We aimed to examine the risk of OSA among adult patients with asthma in an Asian population. Methods We conducted a retrospective cohort study using data from the National Health Insurance (NHI) of Taiwan. The asthma cohort included 38,840 newly diagnosed patients between 2000 and 2010. The date of diagnosis was defined as the index date. Each patient was randomly matched with four people without asthma according to gender, age, and the index year as the comparison cohort. The occurrence of OSA was followed up until the end of 2011. The risk of OSA was estimated using the Cox proportional hazard model after adjusting for gender, age, and comorbidities. Results The overall incidence of OSA was 2.51-fold greater in the asthma cohort than in the comparison cohort (12.1 versus 4.84 per 1000 person-years). Compared to non-asthma subjects, the adjusted hazard ratio (aHR) of OSA increased to 1.78 for asthma patients with one or less annual emergency room (ER) visit, and 23.8 for those who visited ER more than once per year. In addition, aHR in patients with inhaled steroid treatment compared to those without steroid treatment was 1.33 (95% CI = 1.01-1.76). Conclusion Patients with asthma have a significantly higher risk of developing OSA than the general population. The results suggest that the risk of OSA is proportional to asthma control and patients with inhaled steroid treatment have a higher risk for OSA than those without steroid treatment.	[Shen, Te-Chun; Wei, Chang-Ching; Sung, Fung-Chang; Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Shen, Te-Chun; Chen, Chia-Hung; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei] China Med Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Taichung, Taiwan; [Lin, Cheng-Li; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wei, Chang-Ching] China Med Univ Hosp, Div Nephrol, Dept Pediat, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.	d10040@mail.cmuh.org.tw		Shen, Te-Chun/0000-0002-9427-1068	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This work was supported by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 2014, GLOB STRAT ASTHM MAN; Boulet LP, 2009, EUR RESPIR J, V33, P897, DOI 10.1183/09031936.00121308; Braido F, 2014, RESP CARE, V59, P1851, DOI 10.4187/respcare.03084; Byun MK, 2013, YONSEI MED J, V54, P942, DOI 10.3349/ymj.2013.54.4.942; Chen YL, 2014, J CLIN ENDOCR METAB, V99, P2441, DOI 10.1210/jc.2014-1718; Chung WS, 2014, EUR J INTERN MED, V25, P941, DOI 10.1016/j.ejim.2014.10.023; Chung WS, 2014, EUR J CLIN INVEST, V44, P1025, DOI 10.1111/eci.12336; Ciftci TU, 2005, RESP MED, V99, P529, DOI 10.1016/j.rmed.2004.10.011; Cruz AA, 2007, ALLERGY, V62, P1, DOI 10.1111/j.1398-9995.2007.01551.x; Ekici A, 2005, CHEST, V128, P3358, DOI 10.1378/chest.128.5.3358; FITZPATRICK MF, 1993, EUR RESPIR J, V6, P531; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Goodwin RD, 2003, ARCH GEN PSYCHIAT, V60, P1125, DOI 10.1001/archpsyc.60.11.1125; GUILLEMINAULT C, 1988, EUR RESPIR J, V1, P902; Janson C, 1996, EUR RESPIR J, V9, P2132, DOI 10.1183/09031936.96.09102132; Kang JH, 2012, UROLOGY, V79, P340, DOI 10.1016/j.urology.2011.08.040; Larsson LG, 2001, RESP MED, V95, P423, DOI 10.1053/rmed.2001.1054; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Prasad B, 2014, SLEEP MED REV, V18, P165, DOI 10.1016/j.smrv.2013.04.004; Puthalapattu S, 2014, J INVEST MED, V62, P665, DOI 10.2310/JIM.0000000000000065; Reid MB, 2002, AM J RESP CRIT CARE, V166, P479, DOI 10.1164/rccm.2202005; Salles C, 2013, J BRAS PNEUMOL, V39, P604, DOI 10.1590/S1806-37132013000500011; SCHWAB RJ, 1993, AM REV RESPIR DIS, V148, P1385, DOI 10.1164/ajrccm/148.5.1385; SHIPLEY JE, 1992, SLEEP, V15, P514, DOI 10.1093/sleep/15.6.514; Teodorescu M, 2015, JAMA-J AM MED ASSOC, V313, P156, DOI 10.1001/jama.2014.17822; Teodorescu M, 2014, J CLIN SLEEP MED, V10, P183, DOI 10.5664/jcsm.3450; Teodorescu Mihaela, 2013, Sleep Disord, V2013, P251567, DOI 10.1155/2013/251567; Tishler PV, 2003, JAMA-J AM MED ASSOC, V289, P2230, DOI 10.1001/jama.289.17.2230; Weiss JW, 1999, PROG CARDIOVASC DIS, V41, P367, DOI 10.1053/pcad.1999.0410367; Rabelo FAW, 2013, BRAZ J OTORHINOLAR, V79, P100, DOI 10.5935/1808-8694.20130017; Yamasaki A, 2014, INT J GEN MED, V7, P505, DOI 10.2147/IJGM.S72713; Yigla M, 2003, J ASTHMA, V40, P865, DOI 10.1081/JAS-120023577; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080	33	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128461	10.1371/journal.pone.0128461	http://dx.doi.org/10.1371/journal.pone.0128461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067280	gold, Green Published, Green Submitted			2022-12-27	WOS:000356100900022
J	Hahn, C; Weiss, SJ; Stojanovski, S; Bachmann, L				Hahn, Christoph; Weiss, Steven J.; Stojanovski, Stojmir; Bachmann, Lutz			Co-Speciation of the Ectoparasite Gyrodactylus teuchis (Monogenea, Platyhelminthes) and Its Salmonid Hosts	PLOS ONE			English	Article							MITOCHONDRIAL CONTROL REGION; BROWN TROUT POPULATIONS; ATLANTIC SALMON; THYMALLI PLATYHELMINTHES; MOLECULAR PHYLOGENY; MAXIMUM-LIKELIHOOD; TRUTTA; PARASITES; SALARIS; FISH	Co-speciation is a fundamental concept of evolutionary biology and intuitively appealing, yet in practice hard to demonstrate as it is often blurred by other evolutionary processes. We investigate the phylogeographic history of the monogenean ectoparasites Gyrodactylus teuchis and G. truttae on European salmonids of the genus Salmo. Mitochondrial cytochrome oxidase subunit 1 and the nuclear ribosomal internal transcribed spacer 2 were sequenced for 189 Gyrodactylus individuals collected from 50 localities, distributed across most major European river systems, from the Iberian-to the Balkan Peninsula. Despite both anthropogenic and naturally caused admixture of the principal host lineages among major river basins, co-phylogenetic analyses revealed significant global congruence for host and parasite phylogenies, providing firm support for co-speciation of G. teuchis and its salmonid hosts brown trout (S. trutta) and Atlantic salmon (S. salar). The major split within G. teuchis, coinciding with the initial divergence of the hosts was dated to similar to 1.5 My BP, using a Bayesian framework based on an indirect calibration point obtained from the host phylogeny. The presence of G. teuchis in Europe thus predates some of the major Pleistocene glaciations. In contrast, G. truttae exhibited remarkably low intraspecific genetic diversity. Given the direct life cycle and potentially high transmission potential of gyrodactylids, this finding is interpreted as indication for a recent emergence (<60 ky BP) of G. truttae via a host-switch. Our study thus suggests that instances of two fundamentally different mechanisms of speciation (co-speciation vs. host-switching) may have occurred on the same hosts in Europe within a time span of less than 1.5 My in two gyrodactylid ectoparasite species.	[Hahn, Christoph; Bachmann, Lutz] Univ Oslo, Nat Hist Museum, N-0318 Oslo, Norway; [Hahn, Christoph] Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Weiss, Steven J.] Karl Franzens Univ Graz, Inst Zool, A-8010 Graz, Austria; [Stojanovski, Stojmir] Inst Hydrobiol, Dept Fish Parasitol, Ohrid 6000, North Macedonia	University of Oslo; University of Hull; University of Graz	Hahn, C (corresponding author), Univ Oslo, Nat Hist Museum, N-0318 Oslo, Norway.	c.hahn@hull.ac.uk	Weiss, Steven J/L-6016-2015	Weiss, Steven J/0000-0002-4734-5984; Hahn, Christoph/0000-0003-4265-4793	Natural History Museum, University of Oslo	Natural History Museum, University of Oslo	The study was financed exclusively by the Natural History Museum, University of Oslo, in the form of a PhD fellowship including material costs to CH.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2014, TRACER V1 6; Balbuena JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061048; Bakke TA, 2007, ADV PARASIT, V64, P161, DOI 10.1016/S0065-308X(06)64003-7; Bakke TA, 2002, INT J PARASITOL, V32, P281, DOI 10.1016/S0020-7519(01)00331-9; Bakke TA, 1999, PARASITOLOGY, V119, P467, DOI 10.1017/S0031182099004990; Bernatchez L, 2001, EVOLUTION, V55, P351, DOI 10.1111/j.0014-3820.2001.tb01300.x; Bouza C, 2008, CONSERV GENET, V9, P917, DOI 10.1007/s10592-007-9398-8; Cable J, 2005, SYST PARASITOL, V60, P159, DOI 10.1007/s11230-004-6348-4; Cable J, 2002, INT J PARASITOL, V32, P255, DOI 10.1016/S0020-7519(01)00330-7; COHEN J, 1977, REPRODUCTION; Cortey M, 2004, MOL PHYLOGENET EVOL, V33, P831, DOI 10.1016/j.ympev.2004.08.012; Cortey M, 2002, J FISH BIOL, V60, P1058, DOI 10.1111/j.1095-8649.2002.tb02429.x; Cortey M, 2009, BIOL J LINN SOC, V97, P904, DOI 10.1111/j.1095-8312.2009.01220.x; Crete-Lafreniere A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046662; Cunningham CO, 2001, SYST PARASITOL, V48, P141, DOI 10.1023/A:1006407428666; Darwin C., 1877, VARIOUS CONTRIVANCES; de Vienne DM, 2013, NEW PHYTOL, V198, P347, DOI 10.1111/nph.12150; Descroix A, 2009, ECOL FRESHW FISH, V18, P282, DOI 10.1111/j.1600-0633.2008.00345.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duftner N, 2003, J FISH BIOL, V62, P427, DOI 10.1046/j.1095-8649.2003.00038.x; Eichler W., 1948, ANN MAG NAT HIST, V1, P588, DOI DOI 10.1080/00222934808653932; Fahrenholz H, 1913, ZOOL ANZ, V41, P371; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Fromm B, 2014, INT J PARASITOL, V44, P787, DOI 10.1016/j.ijpara.2014.05.010; Gilmore SR, 2010, J FISH DIS, V33, P461, DOI 10.1111/j.1365-2761.2010.01154.x; Hahn C, 2011, PARASITOL INT, V60, P480, DOI 10.1016/j.parint.2011.08.016; Hansen H, 2007, TRENDS PARASITOL, V23, P363, DOI 10.1016/j.pt.2007.06.007; Hansen H, 2007, PARASITOL RES, V100, P1389, DOI 10.1007/s00436-006-0423-5; Harris PD, 2004, SYST PARASITOL, V59, P1, DOI 10.1023/B:SYPA.0000038447.52015.e4; Huyse T, 2005, SYST BIOL, V54, P710, DOI 10.1080/10635150500221036; Johnson KP, 2003, SYST BIOL, V52, P37, DOI 10.1080/10635150390132704; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kellogg VL, 1913, AM NAT, V47, P129, DOI 10.1086/279337; Lautraite A, 1999, B FR PECHE PISCIC, P305, DOI 10.1051/kmae:1999001; Legendre P, 2002, SYST BIOL, V51, P217, DOI 10.1080/10635150252899734; Lerceteau-Kohler E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-176; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Martinez JL, 2001, FRESHWATER BIOL, V46, P835, DOI 10.1046/j.1365-2427.2001.00711.x; Matejusova I, 2001, INT J PARASITOL, V31, P738, DOI 10.1016/S0020-7519(01)00176-X; Meinila M, 2004, INT J PARASITOL, V34, P515, DOI 10.1016/j.ijpara.2003.12.002; Nylander JAA., 2004, BIOINFORMATICS; Page RDM, 1996, INT J PARASITOL, V26, P213, DOI 10.1016/0020-7519(95)00115-8; Page RDM, 1998, TRENDS ECOL EVOL, V13, P356, DOI 10.1016/S0169-5347(98)01438-4; Poinar G, 2003, INVERTEBR BIOL, V122, P308, DOI 10.1111/j.1744-7410.2003.tb00095.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saura M, 2008, J FISH BIOL, V72, P1223, DOI 10.1111/j.1095-8649.2007.01782.x; Schenekar T, 2014, CONSERVATION GENETIC; Shedko S V, 2013, Genetika, V49, P718; Simkova A, 2004, EVOLUTION, V58, P1001, DOI 10.1111/j.0014-3820.2004.tb00434.x; Snoj A, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-22; Soleng A, 2001, INT J PARASITOL, V31, P793, DOI 10.1016/S0020-7519(01)00188-6; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Susnik S, 2007, MOL PHYLOGENET EVOL, V44, P63, DOI 10.1016/j.ympev.2006.08.021; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vignon M, 2011, SYST PARASITOL, V79, P161, DOI 10.1007/s11230-011-9303-1; Weiss S, 2001, MOL ECOL, V10, P1241, DOI 10.1046/j.1365-294X.2001.01261.x; Willett CS, 2012, J MOL EVOL, V74, P310, DOI 10.1007/s00239-012-9508-1; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Yip KY, 2008, BIOINFORMATICS, V24, P290, DOI 10.1093/bioinformatics/btm584; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zietara MS, 2002, EVOLUTION, V56, P2445, DOI 10.1111/j.0014-3820.2002.tb00170.x	64	17	18	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0127340	10.1371/journal.pone.0127340	http://dx.doi.org/10.1371/journal.pone.0127340			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080029	Green Published, gold, Green Submitted			2022-12-27	WOS:000356542300004
J	Bullard, KM; Gullberg, RC; Soltani, E; Steel, JJ; Geiss, BJ; Keenan, SM				Bullard, Kristen M.; Gullberg, Rebekah C.; Soltani, Elnaz; Steel, J. Jordan; Geiss, Brian J.; Keenan, Susan M.			Murine Efficacy and Pharmacokinetic Evaluation of the Flaviviral NS5 Capping Enzyme 2-Thioxothiazolidin-4-One Inhibitor BG-323	PLOS ONE			English	Article							WEST-NILE-VIRUS; 3-DIMENSIONAL STRUCTURE; METABOLIC STABILITY; RNA CAP; METHYLTRANSFERASE; DRUGS; GUANYLYLTRANSFERASE; METHYLATIONS; ANTAGONIST; BINDING	Arthropod-borne flavivirus infection continues to cause significant morbidity and mortality worldwide. Identification of drug targets and novel antiflaviviral compounds to treat these diseases has become a global health imperative. A previous screen of 235,456 commercially available small molecules identified the 2-thioxothiazolidin-4-one family of compounds as inhibitors of the flaviviral NS5 capping enzyme, a promising target for antiviral drug development. Rational drug design methodologies enabled identification of lead compound BG-323 from this series. We have shown previously that BG-323 potently inhibits NS5 capping enzyme activity, displays antiviral effects in dengue virus replicon assays and inhibits growth of West Nile and yellow fever viruses with low cytotoxicity in vitro. In this study we further characterized BG-323's antiviral activity in vitro and in vivo. We found that BG-323 was able to reduce replication of WNV (NY99) and Powassan viruses in culture, and we were unable to force resistance into WNV (Kunjin) in long-term culture experiments. We then evaluated the antiviral activity of BG-323 in a murine model. Mice were challenged with WNV NY99 and administered BG-323 or mock by IP inoculation immediately post challenge and twice daily thereafter. Mice were bled and viremia was quantified on day three. No significant differences in viremia were observed between BG-323-treated and control groups and clinical scores indicated both BG-323-treated and control mice developed signs of illness on approximately the same day post challenge. To determine whether differences in in vitro and in vivo efficacy were due to unfavorable pharmacokinetic properties of BG-323, we conducted a pharmacokinetic evaluation of this small molecule. Insights from pharmacokinetic studies indicate that BG-323 is cell permeable, has a low efflux ratio and does not significantly inhibit two common cytochrome P450 (CYP P450) isoforms thus suggesting this molecule may be less likely to cause adverse drug interactions. However, the T-1/2 of BG-323 was suboptimal and the percent of drug bound to plasma binding proteins was high. Future studies with BG-323 will be aimed at increasing the T-1/2 and determining strategies for mitigating the effects of high plasma protein binding, which likely contribute to low in vivo efficacy.	[Bullard, Kristen M.; Keenan, Susan M.] Univ Colorado, Sch Biol Sci, Greeley, CO USA; [Gullberg, Rebekah C.; Soltani, Elnaz; Steel, J. Jordan; Geiss, Brian J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Geiss, Brian J.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	University of Colorado System; Colorado State University; Colorado State University	Geiss, BJ (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Brian.Geiss@colostate.edu; Susan.Keenan@unco.edu	Geiss, Brian/J-3021-2017	Geiss, Brian/0000-0001-8180-5772; Steel, James Jordan/0000-0002-1256-2639	Rocky Mountain Regional Center for Excellence (RMRCE) (NIH/NIAID) [U54 AI065357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114675, U54AI065357] Funding Source: NIH RePORTER	Rocky Mountain Regional Center for Excellence (RMRCE) (NIH/NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the Rocky Mountain Regional Center for Excellence (RMRCE) (NIH/NIAID U54 AI065357).	[Anonymous], 2014, VECT BORN DIS; Benarroch D, 2004, J BIOL CHEM, V279, P35638, DOI 10.1074/jbc.M400460200; Brinton MA, 2002, ANNU REV MICROBIOL, V56, P371, DOI 10.1146/annurev.micro.56.012302.160654; Di L, 2008, DRUG LIKE PROPERTIES; Doherty AJ, 1997, ACTA CRYSTALLOGR D, V53, P482, DOI 10.1107/S090744499700231X; Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07; Dong HP, 2008, VIROLOGY, V377, P1, DOI 10.1016/j.virol.2008.04.026; Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Fessey R.E., 2006, PHARMACOKINETIC PROF, P119; Geiss BJ, 2011, J BIOMOL SCREEN, V16, P852, DOI 10.1177/1087057111412183; Geiss BJ, 2009, FUTURE MED CHEM, V1, P327, DOI 10.4155/FMC.09.27; Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058; Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018; Hanley KA, 2002, J VIROL, V76, P525, DOI 10.1128/JVI.76.2.525-531.2002; Heinz FX, 2000, VIRUS TAXONOMY; Hester JB, 2001, J MED CHEM, V44, P1099, DOI 10.1021/jm0004289; Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709; Khromykh AA, 1998, J VIROL, V72, P7270, DOI 10.1128/JVI.72.9.7270-7279.1998; Kratochwil NA, 2002, BIOCHEM PHARMACOL, V64, P1355, DOI 10.1016/S0006-2952(02)01074-2; Lakkakula JR, 2014, NANOMEDICINE-UK, V9, P877, DOI [10.2217/NNM.14.41, 10.2217/nnm.14.41]; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lindenbach B.D., 2007, FIELDS VIROLOGY; MacKenzie AR, 2002, J MED CHEM, V45, P5365, DOI 10.1021/jm0209331; MANOURY PM, 1987, J MED CHEM, V30, P1003, DOI 10.1021/jm00389a008; Mitchell LA, 2013, INT IMMUNOPHARMACOL, V15, P357, DOI 10.1016/j.intimp.2012.11.016; Peglion JL, 2002, J MED CHEM, V45, P165, DOI 10.1021/jm010975+; Plobeck N, 2000, J MED CHEM, V43, P3878, DOI 10.1021/jm000228x; Pouton CW, 2006, EUR J PHARM SCI, V29, P278, DOI 10.1016/j.ejps.2006.04.016; Pouton CW, 2000, EUR J PHARM SCI, V11, pS93, DOI 10.1016/S0928-0987(00)00167-6; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707; Stahla-Beek HJ, 2012, J VIROL, V86, P8730, DOI 10.1128/JVI.00384-12; STEHLE T, 1990, J MOL BIOL, V211, P249, DOI 10.1016/0022-2836(90)90024-G; Sweetana S, 1996, PDA J Pharm Sci Technol, V50, P330; Tandon M, 2004, BIOORG MED CHEM LETT, V14, P1709, DOI 10.1016/j.bmcl.2004.01.045; Teramoto T, 2014, J BIOL CHEM; Thompson TB, 1999, BIOCHEMISTRY-US, V38, P12995, DOI 10.1021/bi990910x; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	39	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130083	10.1371/journal.pone.0130083	http://dx.doi.org/10.1371/journal.pone.0130083			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075394	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900135
J	Fu, YH; Xu, ZZ; Lu, ZJ; Zhao, S; Mathews, DH				Fu, Yinghan; Xu, Zhenjiang Zech; Lu, Zhi J.; Zhao, Shan; Mathews, David H.			Discovery of Novel ncRNA Sequences in Multiple Genome Alignments on the Basis of Conserved and Stable Secondary Structures	PLOS ONE			English	Article							NONCODING RNA GENES; STRUCTURE PREDICTION; ALGORITHM; MODEL; CONSTRAINTS; PARAMETERS; STABILITY; THOUSANDS; DATABASE; BROWSER	Recently, non-coding RNAs (ncRNAs) have been discovered with novel functions, and it has been appreciated that there is pervasive transcription of genomes. Moreover, many novel ncRNAs are not conserved on the primary sequence level. Therefore, de novo computational ncRNA detection that is accurate and efficient is desirable. The purpose of this study is to develop a ncRNA detection method based on conservation of structure in more than two genomes. A new method called Multifind, using Multilign, was developed. Multilign predicts the common secondary structure for multiple input sequences. Multifind then uses measures of structure conservation to estimate the probability that the input sequences are a conserved ncRNA using a classification support vector machine. Multilign is based on Dynalign, which folds and aligns two sequences simultaneously using a scoring scheme that does not include sequence identity; its structure prediction quality is therefore not affected by input sequence diversity. Additionally, ensemble defect was introduced to Multifind as an additional discriminating feature that quantifies the compactness of the folding space for a sequence. Benchmarks showed Multifind performs better than RNAz and LocARNATE+RNAz, a method that uses RNAz on structure alignments generated by LocARNATE, on testing sequences extracted from the Rfam database. For de novo ncRNA discovery in three genomes, Multifind and LocARNATE+RNAz had an advantage over RNAz in low similarity regions of genome alignments. Additionally, Multifind and LocARNATE+RNAz found different subsets of known ncRNA sequences, suggesting the two approaches are complementary.	[Fu, Yinghan; Xu, Zhenjiang Zech; Zhao, Shan; Mathews, David H.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Fu, Yinghan; Xu, Zhenjiang Zech; Zhao, Shan; Mathews, David H.] Univ Rochester, Med Ctr, Ctr RNA Biol, Rochester, NY 14642 USA; [Lu, Zhi J.] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Mathews, David H.] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; Tsinghua University; University of Rochester	Mathews, DH (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA.	David_Mathews@urmc.rochester.edu	Xu, Zhenjiang Zech/F-6493-2012	Xu, Zhenjiang Zech/0000-0003-1080-024X	United States National Institutes of Health [R01GM076485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076485] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Grant funding was provided by the United States National Institutes of Health, R01GM076485 to DHM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chan CY, 2008, J MATH BIOL, V56, P93, DOI 10.1007/s00285-007-0129-z; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Fouts DE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000141; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gardner Paul P, 2011, Nucleic Acids Res, V39, pD141, DOI 10.1093/nar/gkq1129; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gruber AR, 2010, BIOCOMPUT-PAC SYM, P69; Gruber AR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-122; Harmanci AO, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-130; Holt KE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-36; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lu ZJ, 2009, RNA, V15, P1805, DOI 10.1261/rna.1643609; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 2002, J MOL BIOL, V317, P191, DOI 10.1006/jmbi.2001.5351; Mathews DH, 2002, BIOCHEMISTRY-US, V41, P869, DOI 10.1021/bi011441d; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Torarinsson E, 2008, GENOME RES, V18, P242, DOI 10.1101/gr.6887408; Torarinsson E, 2006, GENOME RES, V16, P885, DOI 10.1101/gr.5226606; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Vockenhuber MP, 2011, RNA BIOL, V8, P468, DOI 10.4161/rna.8.3.14421; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Washietl S, 2007, GENOME RES, V17, P852, DOI 10.1101/gr.5650707; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Xu ZJ, 2011, BIOINFORMATICS, V27, P626, DOI 10.1093/bioinformatics/btq726; Yao ZZ, 2006, BIOINFORMATICS, V22, P445, DOI 10.1093/bioinformatics/btk008; Zadeh JN, 2011, J COMPUT CHEM, V32, P439, DOI 10.1002/jcc.21633	45	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130200	10.1371/journal.pone.0130200	http://dx.doi.org/10.1371/journal.pone.0130200			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075601	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900154
J	Kano, F; Hirata, S; Call, J				Kano, Fumihiro; Hirata, Satoshi; Call, Josep			Social Attention in the Two Species of Pan: Bonobos Make More Eye Contact than Chimpanzees	PLOS ONE			English	Article							TOOL USE; GAZE; HUMANS; FACE; TROGLODYTES; FIXATION; PATTERNS; CONSPECIFICS; PRIMATES; INFANTS	Humans' two closest primate living relatives, bonobos and chimpanzees, differ behaviorally, cognitively, and emotionally in several ways despite their general similarities. While bonobos show more affiliative behaviors towards conspecifics, chimpanzees display more overt and severe aggression against conspecifics. From a cognitive standpoint, bonobos perform better in social coordination, gaze-following and food-related cooperation, while chimpanzees excel in tasks requiring extractive foraging skills. We hypothesized that attention and motivation play an important role in shaping the species differences in behavior, cognition, and emotion. Thus, we predicted that bonobos would pay more attention to the other individuals' face and eyes, as those are related to social affiliation and social coordination, while chimpanzees would pay more attention to the action target objects, as they are related to foraging. Using eye-tracking we examined the bonobos' and chimpanzees' spontaneous scanning of pictures that included eyes, mouth, face, genitals, and action target objects of conspecifics. Although bonobos and chimpanzees viewed those elements overall similarly, bonobos viewed the face and eyes longer than chimpanzees, whereas chimpanzees viewed the other elements, the mouth, action target objects and genitals, longer than bonobos. In a discriminant analysis, the individual variation in viewing patterns robustly predicted the species of individuals, thus clearly demonstrating species-specific viewing patterns. We suggest that such attentional and motivational differences between bonobos and chimpanzees could have partly contributed to shaping the species-specific behaviors, cognition, and emotion of these species, even in a relatively short period of evolutionary time.	[Hirata, Satoshi] Kyoto Univ, Wildlife Res Ctr, Kumamoto Sanctuary, Kumamoto 990, Japan; [Kano, Fumihiro] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Kano, Fumihiro; Call, Josep] Max Planck Inst Evolutionare Anthropol, Dept Dev & Comparat Psychol, D-04103 Leipzig, Germany; [Kano, Fumihiro] Japan Soc Promot Sci, Tokyo, Japan; [Call, Josep] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	Kyoto University; Kyoto University; Max Planck Society; Japan Society for the Promotion of Science; University of St Andrews	Kano, F (corresponding author), Kyoto Univ, Wildlife Res Ctr, Kumamoto Sanctuary, Kumamoto 990, Japan.	fkanou@gmail.com		Call Balaguer, Josep/0000-0002-8597-8336; Kano, Fumihiro/0000-0003-4534-6630	JSPS [26885040, 26245069]; MEXT [24000001]; MEXT-PRI-Human Evolution;  [JSPS-LGP-U04]; Grants-in-Aid for Scientific Research [26245069] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-PRI-Human Evolution; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was conducted in part under FK's post-doc program; the Japan Society for Promotion of Science (JSPS) for study abroad. FK and SH respectively received JSPS KAKENHI Grant Number 26885040 and 26245069 URL: http://www.jsps.go.jp/english/. This study was in part funded by JSPS KAKENHI Grant Number 26885040 and 26245069, MEXT KAKENHI Grant Number 24000001, JSPS-LGP-U04, JSPS core-to-core type A CCSN, and MEXT-PRI-Human Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ARGYLE M, 1965, SOCIOMETRY, V28, P289, DOI 10.2307/2786027; Bard KA, 2005, DEV PSYCHOL, V41, P616, DOI 10.1037/0012-1649.41.4.616; Baron-Cohen S, 2009, ANN NY ACAD SCI, V1156, P68, DOI 10.1111/j.1749-6632.2009.04467.x; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Conty L, 2006, SPATIAL VISION, V19, P529, DOI 10.1163/156856806779194026; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; de Waal F.B.M., 1990, PEACEMAKING PRIMATES; de Waal FB., 1990, SOCIOSEXUAL BEHAV US, P378; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Ebitz RB, 2013, P NATL ACAD SCI USA, V110, P11630, DOI 10.1073/pnas.1305230110; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Ferrari PF, 2009, CURR BIOL, V19, P1768, DOI 10.1016/j.cub.2009.08.055; Fletcher-Watson S, 2008, PERCEPTION, V37, P571, DOI 10.1068/p5705; Furuichi T, 2011, EVOL ANTHROPOL, V20, P131, DOI 10.1002/evan.20308; Gomez Juan Carlos, 1996, P131; Gothard KM, 2004, ANIM COGN, V7, P25, DOI 10.1007/s10071-003-0179-6; Gruber T, 2010, ANIM BEHAV, V80, P1023, DOI 10.1016/j.anbehav.2010.09.005; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; Guo K, 2003, EXP BRAIN RES, V150, P363, DOI 10.1007/s00221-003-1429-1; Guo K, 2007, EXP BRAIN RES, V181, P673, DOI 10.1007/s00221-007-1038-5; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; Hare B, 2000, ANIM BEHAV, V59, P771, DOI 10.1006/anbe.1999.1377; Hare B, 2007, CURR BIOL, V17, P619, DOI 10.1016/j.cub.2007.02.040; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; Herrmann E, 2011, DEVELOPMENTAL SCI, V14, P1393, DOI 10.1111/j.1467-7687.2011.01082.x; Herrmann E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012438; Hershler O, 2005, VISION RES, V45, P1707, DOI 10.1016/j.visres.2004.12.021; Hirata S, 2010, ANIM COGN, V13, P679, DOI 10.1007/s10071-010-0316-y; Hohmann G, 2003, CURR ANTHROPOL, V44, P563, DOI 10.1086/377649; Jones W, 2013, NATURE, V504, P427, DOI 10.1038/nature12715; JORDAN C, 1982, J HUM EVOL, V11, P36; Kano F, 2014, ANIM BEHAV, V91, P137, DOI 10.1016/j.anbehav.2014.03.011; Kano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059785; Kano F, 2012, J COMP PSYCHOL, V126, P388, DOI 10.1037/a0029615; Kano F, 2011, VISION RES, V51, P2348, DOI 10.1016/j.visres.2011.09.006; Kano F, 2010, ANIM BEHAV, V79, P227, DOI 10.1016/j.anbehav.2009.11.003; Kano T., 1982, Primates, V23, P453, DOI 10.1007/BF02381327; Kawashima R, 1999, BRAIN, V122, P779, DOI 10.1093/brain/122.4.779; KEATING CF, 1982, PERCEPTION, V11, P211, DOI 10.1068/p110211; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Koops K, CHIMPANZEES IN PRESS; Lutchmaya S, 2002, INFANT BEHAV DEV, V25, P327, DOI 10.1016/S0163-6383(02)00094-2; MacLean EL, 2014, BEHAVIOUR IN PRESS; Matsuzawa T., 2006, COGNITIVE DEV CHIMPA; McIntyre MH, 2009, J HUM EVOL, V56, P361, DOI 10.1016/j.jhevol.2008.12.004; Mosher CP, 2014, CURR BIOL, V24, P2459, DOI 10.1016/j.cub.2014.08.063; Myowa-Yamakoshi M, 2003, COGNITION, V89, pB53, DOI 10.1016/S0010-0277(03)00071-4; Myowa-Yamakoshi M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1695; Nagasawa M, 2015, SCIENCE, V348, P333, DOI 10.1126/science.1261022; Oliva JL, 2015, ANIM COGN, V18, P767, DOI 10.1007/s10071-015-0843-7; Palagi E, 2006, AM J PHYS ANTHROPOL, V129, P418, DOI 10.1002/ajpa.20289; Rilling JK, 2012, SOC COGN AFFECT NEUR, V7, P369, DOI 10.1093/scan/nsr017; Rosati AG, 2007, CURR BIOL, V17, P1663, DOI 10.1016/j.cub.2007.08.033; Rosati AG, 2012, DEVELOPMENTAL SCI, V15, P840, DOI 10.1111/j.1467-7687.2012.01182.x; Ruiz A, 2009, ANIM COGN, V12, P427, DOI 10.1007/s10071-008-0202-z; Schick KD, 1999, J ARCHAEOL SCI, V26, P821, DOI 10.1006/jasc.1998.0350; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Staes N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113364; Takeshita H, 1996, PRIMATES, V37, P423, DOI 10.1007/BF02381377; Tan JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051922; THOMSEN CE, 1974, ANIM BEHAV, V22, P144, DOI 10.1016/S0003-3472(74)80063-1; Tomonaga M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009131; van de Waal E, 2010, P ROY SOC B-BIOL SCI, V277, P2105, DOI 10.1098/rspb.2009.2260; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wilson ML, 2014, NATURE, V513, P414, DOI 10.1038/nature13727; YAMAGIWA J, 1992, PRIMATES, V33, P523, DOI 10.1007/BF02381153	68	55	56	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129684	10.1371/journal.pone.0129684	http://dx.doi.org/10.1371/journal.pone.0129684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26075710	gold, Green Published			2022-12-27	WOS:000356329900092
J	Khandaker, MU; Asaduzzaman, K; Nawi, SM; Usman, AR; Amin, YM; Daar, E; Bradley, DA; Ahmed, H; Okhunov, AA				Khandaker, M. U.; Asaduzzaman, Kh; Nawi, S. M.; Usman, A. R.; Amin, Y. M.; Daar, E.; Bradley, D. A.; Ahmed, H.; Okhunov, A. A.			Assessment of Radiation and Heavy Metals Risk due to the Dietary Intake of Marine Fishes (Rastrelliger kanagurta) from the Straits of Malacca	PLOS ONE			English	Article							NATURAL RADIOACTIVITY; BLACK-SEA; RADIONUCLIDE; ORGANISMS; AREA; BAY; CARCINOGENICITY; EXPOSURE; RA-226; PO-210	The environment of the Straits of Malacca receives pollution as a result of various industrial and anthropogenic sources, making systematic studies crucial in determining the prevailing water quality. Present study concerns concentrations of natural radionuclides and heavy metals in marine fish (Rastrelliger kanagurta) collected from the Straits of Malacca, since aquatic stock form an important source of the daily diet of the surrouding populace. Assessment was made of the concentrations of key indicator radionuclides (Ra-226, Th-232, K-40) and heavy metals (As, Mn, Fe, Cr, Ni, Zn, Cu, Co, Sr, Al, Hg and Pb) together with various radiation indices linked to the consumption of seafish. The annual effective dose for all detected radionuclides for all study locations has been found to be within UNSCEAR acceptable limits as has the associated life-time cancer risk. The overall contamination of the sampled fish from heavy metals was also found to be within limits of tolerance.	[Khandaker, M. U.; Asaduzzaman, Kh; Nawi, S. M.; Usman, A. R.; Amin, Y. M.; Bradley, D. A.] Univ Malaya, Dept Phys, Fac Sci, Kuala Lumpur 50603, Malaysia; [Daar, E.; Bradley, D. A.] Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England; [Daar, E.] Univ Jordan, Dept Phys, Fac Sci, Amman 11942, Jordan; [Ahmed, H.] Jazan Univ, Dept Phys, Fac Sci, Gizan 22822, Saudi Arabia; [Okhunov, A. A.] Int Islamic Univ Malaya, Dept Engn Sci, Kuala Lumpur 50728, Malaysia	Universiti Malaya; University of Surrey; University of Jordan; Jazan University	Khandaker, MU (corresponding author), Univ Malaya, Dept Phys, Fac Sci, Kuala Lumpur 50603, Malaysia.	mu_khandaker@um.edu.my	MOHD AMIN, YUSOFF/B-5339-2010; Khandaker, Mayeen Uddin/F-5376-2011; Khandoker, Asaduzzaman/J-9209-2013; Okhunov, Abdurahim/AAZ-5609-2020	Khandaker, Mayeen Uddin/0000-0003-3772-294X; Khandoker, Asaduzzaman/0000-0003-2420-6743; Usman, Ahmed Rufai/0000-0002-4469-7335	University of Malaya [RP006D-13AFR, UM.C/HIR/MOHE/SC/33]	University of Malaya(Universiti Malaya)	This work was supported by University of Malaya Research Grant: RP006D-13AFR and UM.C/HIR/MOHE/SC/33; fund receiver: MUK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasisiar F., 2004, J RADIAT RES, V2, P35; Alam L, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-43; ALAM MN, 1995, APPL RADIAT ISOTOPES, V46, P363, DOI 10.1016/0969-8043(95)00013-4; Alina M., 2012, International Food Research Journal, V19, P135; Amin YM, 2013, RADIAT PROT DOSIM, V156, P475, DOI 10.1093/rpd/nct097; Amin YM, 2013, APPL RADIAT ISOTOPES, V80, P109, DOI 10.1016/j.apradiso.2013.06.014; [Anonymous], 1996, SAF SER INT AT EN AG, V115; Antoine JMR, 2012, J FOOD COMPOS ANAL, V26, P111, DOI 10.1016/j.jfca.2012.01.003; Ariffin NAN, 2011, J ANAL SCI METH INST, V1, P1; Arogunjo AM, 2009, J ENVIRON RADIOACTIV, V100, P232, DOI 10.1016/j.jenvrad.2008.12.004; Asaduzzaman K, 2015, ANN NUCL ENERGY, V76, P85, DOI 10.1016/j.anucene.2014.09.036; Asaduzzaman K, 2014, J ENVIRON RADIOACTIV, V135, P120, DOI 10.1016/j.jenvrad.2014.04.009; Awudu AR, 2012, J RADIOANAL NUCL CH, V291, P635, DOI 10.1007/s10967-011-1444-9; Aydin D, 2015, FOOD ADDIT CONTAM B, V8, P25, DOI 10.1080/19393210.2014.949873; BLAYLOCK BG, 1982, NUCL SAFETY, V23, P427; Bogatov S., 2009, RADIOPROTECTION, V44, P159; Bose-O'Reilly S, 2010, CURR PROB PEDIATR AD, V40, P186, DOI 10.1016/j.cppeds.2010.07.002; Carvalho FP, 2011, ICES J MAR SCI, V68, P333, DOI 10.1093/icesjms/fsq088; Choi MS, 2008, J ENVIRON RADIOACTIV, V99, P1319, DOI 10.1016/j.jenvrad.2008.04.003; Connan O, 2007, J ENVIRON RADIOACTIV, V97, P168, DOI 10.1016/j.jenvrad.2007.04.004; De Boeck M, 2003, MUTAT RES-FUND MOL M, V533, P135, DOI 10.1016/j.mrfmmm.2003.07.012; FAO, 2001, JOINT FAO WHO EXP CO; Fishbein L, 1987, GENOTOXIC CARCINOGEN, P339; Fraizier A, 1976, IAEASM19918, P679; Freeman DB, 2004, STRAITS MALACCA GATE, P528; Gerber GB, 2002, CRIT REV ONCOL HEMAT, V42, P25, DOI 10.1016/S1040-8428(01)00178-0; Ghose S, 2000, RADIAT PROT DOSIM, V87, P287, DOI 10.1093/oxfordjournals.rpd.a033010; Gorur FK, 2012, CHEMOSPHERE, V87, P356, DOI 10.1016/j.chemosphere.2011.12.022; GUARY JC, 1977, HEALTH PHYS, V32, P21, DOI 10.1097/00004032-197701000-00003; Health Canada, 2007, HUM HLTH RISK ASS ME; Hvistendahl M., 2007, COAL ASH IS MORE RAD; Hyde, 1960, RADIOCHEMISTRY THORI; IAEA (International Atomic Energy Agency), 1995, IAEATECDOC838; ICRP, 1994, ICRP PUBL, V67; Kalay Mustafa, 2000, Turkish Journal of Zoology, V24, P429; Khan MF, 2011, MAR POLLUT BULL, V62, P399, DOI 10.1016/j.marpolbul.2010.12.016; Khan MF, 2011, TOXICOL ENVIRON CHEM, V93, P549, DOI 10.1080/02772248.2010.548118; Khandaker MU, 2015, RADIAT PROT DOSIM, V167, P196, DOI 10.1093/rpd/ncv243; Khandaker MU, 2012, RADIAT PROT DOSIM, V152, P33, DOI 10.1093/rpd/ncs145; Khandaker MU, 2013, RADIAT PHYS CHEM, V88, P1, DOI 10.1016/j.radphyschem.2013.02.034; Makon T.B., 2011, WORLD J NUCL SCI TEC, V1, P37, DOI [DOI 10.4236/WJNST.2011.12007, 10.4236/wjnst.2011.12007]; Mir-Marques A, 2012, J FOOD COMPOS ANAL, V27, P160, DOI 10.1016/j.jfca.2012.06.006; Patra A.C., 2013, RADIAT PROT DOSIM, P1; Pentreath RJ, 1980, P INT S IMP RAD REL, P241; Real A, 2004, J RADIOL PROT, V24, pA123, DOI 10.1088/0952-4746/24/4A/008; Rojas E, 1999, MUTAT RES-GEN TOX EN, V443, P157, DOI 10.1016/S1383-5742(99)00018-6; Roychowdhury T, 2003, SCI TOTAL ENVIRON, V308, P15, DOI 10.1016/S0048-9697(02)00612-5; Stern AH, 2010, ENVIRON RES, V110, P798, DOI 10.1016/j.envres.2010.08.002; Topcuoglu S, 2002, ENVIRON INT, V27, P521, DOI 10.1016/S0160-4120(01)00099-X; Turkmen A, 2005, FOOD CHEM, V91, P167, DOI 10.1016/j.foodchem.2004.08.008; Tuzen M, 2009, FOOD CHEM TOXICOL, V47, P1785, DOI 10.1016/j.fct.2009.04.029; UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation), 1982, ION RAD SOURC BIOL E; UNSCEAR (United Nations Scientific Committee on the effects of Atomic Radiation), 2000, EXP NAT RAD SOURC, P140; UNSCEAR (United Nations Scientific Committee on the effects of Atomic Radiation) Sources and effects of Ionizing radiation, 2008, SOURC EFF LON RAD EX; USEPA, 1999, 13 USEPA; Usero J, 2004, ENVIRON INT, V29, P949, DOI 10.1016/S0160-4120(03)00061-8; VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001; WHO, 1996, CHEM ASP; Zhuang P, 2009, SCI TOTAL ENVIRON, V407, P1551, DOI 10.1016/j.scitotenv.2008.10.061	59	28	29	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128790	10.1371/journal.pone.0128790	http://dx.doi.org/10.1371/journal.pone.0128790			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075909	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900030
J	Kiebala, M; Singh, MV; Piepenbrink, MS; Qiu, X; Kobie, JJ; Maggirwar, SB				Kiebala, Michelle; Singh, Meera V.; Piepenbrink, Michael S.; Qiu, Xing; Kobie, James J.; Maggirwar, Sanjay B.			Platelet Activation in Human Immunodeficiency Virus Type-1 Patients Is Not Altered with Cocaine Abuse	PLOS ONE			English	Article							NF-KAPPA-B; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; CARDIOVASCULAR-DISEASE; CIRCULATING PLATELET; MONOCYTE COMPLEXES; RELEASE; INFLAMMATION; DECLINE; PROTEIN	Recent work has indicated that platelets, which are anucleate blood cells, significantly contribute to inflammatory disorders. Importantly, platelets also likely contribute to various inflammatory secondary disorders that are increasingly associated with Human Immunodeficiency Virus Type-1 (HIV) infection including neurological impairments and cardiovascular complications. Indeed, HIV infection is often associated with increased levels of platelet activators. Additionally, cocaine, a drug commonly abused by HIV-infected individuals, leads to increased platelet activation in humans. Considering that orchestrated signaling mechanisms are essential for platelet activation, and that nuclear factor-kappa B (NF-kappa B) inhibitors can alter platelet function, the role of NF-kappa B signaling in platelet activation during HIV infection warrants further investigation. Here we tested the hypothesis that inhibitory kappa B kinase complex (IKK) activation would be central for platelet activation induced by HIV and cocaine. Whole blood from HIV-positive and HIV-negative individuals, with or without cocaine abuse was used to assess platelet activation via flow cytometry whereas IKK activation was analyzed by performing immunoblotting and in vitro kinase assays. We demonstrate that increased platelet activation in HIV patients, as measured by CD62P expression, is not altered with reported cocaine use. Furthermore, cocaine and HIV do not activate platelets in whole blood when treated ex vivo. Finally, HIV-induced platelet activation does not involve the NF-kappa B signaling intermediate, IKK beta. Platelet activation in HIV patients is not altered with cocaine abuse. These results support the notion that non-IKK targeting approaches will be better suited for the treatment of HIV-associated inflammatory disorders.	[Kiebala, Michelle; Singh, Meera V.; Maggirwar, Sanjay B.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Piepenbrink, Michael S.; Kobie, James J.] Univ Rochester, Sch Med & Dent, Div Infect Dis, Rochester, NY 14642 USA; [Qiu, Xing] Univ Rochester, Sch Med & Dent, Dept Biostat & Computat Biol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Kiebala, M (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	Michelle_Kiebala@urmc.rochester.edu	Piepenbrink, Michael/GPK-5944-2022		National Institutes of Health, USA [R03 DA035086, R01 NS054578, R01 NS066801]; University of Rochester Center for AIDS Research [P30AI078498]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI078498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054578, R01NS066801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA035086] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institutes of Health, USA (R03 DA035086 to MK; R01 NS054578 and R01 NS066801 to SBM). It was also supported in part by pilot funds to JK from the University of Rochester Center for AIDS Research grant P30AI078498 (National Institutes of Health/National Institute of Allergy and Infectious Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso L, 2007, AM J CARDIOL, V100, P1040, DOI 10.1016/j.amjcard.2007.04.049; Auerbach DJ, 2012, P NATL ACAD SCI USA, V109, P9569, DOI 10.1073/pnas.1207314109; Buch S, 2011, J NEUROIMMUNE PHARM, V6, P503, DOI 10.1007/s11481-011-9297-0; Callahan KP, 2001, SWISS MED WKLY, V131, P487; Chaipan C, 2006, J VIROL, V80, P8951, DOI 10.1128/JVI.00136-06; Clark KH, 2013, NEUROTOX RES, V23, P174, DOI 10.1007/s12640-012-9334-7; Cognasse F, 2009, AIDS, V23, P2057, DOI 10.1097/QAD.0b013e328330da65; Corrales-Medina VF, 2010, JAIDS-J ACQ IMM DEF, V54, P217, DOI 10.1097/QAI.0b013e3181c8f4c9; Coulon L, 2003, FREE RADICAL BIO MED, V35, P616, DOI 10.1016/S0891-5849(03)00386-1; Davidson DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059950; Davidson DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051793; Evans SM, 1996, J PHARMACOL EXP THER, V279, P1345; Frankhauser P, 2006, NEUROSCI LETT, V399, P197, DOI 10.1016/j.neulet.2006.01.062; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; GELBARD HA, 1994, J VIROL, V68, P4628, DOI 10.1128/JVI.68.7.4628-4635.1994; Gresele P, 2012, THROMB RES, V129, P301, DOI 10.1016/j.thromres.2011.11.022; Hachem A, 2012, BIOCHEM BIOPH RES CO, V425, P58, DOI 10.1016/j.bbrc.2012.07.049; Hanai Y, 2009, LIFE SCI, V85, P386, DOI 10.1016/j.lfs.2009.07.003; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heesch CM, 2000, HEART, V83, P688, DOI 10.1136/heart.83.6.688; Holme PA, 1998, FASEB J, V12, P79, DOI 10.1096/fasebj.12.1.79; Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x; Johnson TP, 2013, P NATL ACAD SCI USA, V110, P13588, DOI 10.1073/pnas.1308673110; Karim ZA, 2013, BLOOD, V121, P4567, DOI 10.1182/blood-2012-11-470468; Kiebala M, 2014, EXP HEMATOL; Kiebala M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018633; Klinkenberg WD, 2004, AIDS CARE, V16, pS22, DOI 10.1080/09540120412331315303; KUGELMASS AD, 1993, CIRCULATION, V88, P876, DOI 10.1161/01.CIR.88.3.876; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Liu FQ, 2002, THROMB RES, V106, P199, DOI 10.1016/S0049-3848(02)00130-5; Malaver E, 2009, J THROMB HAEMOST, V7, P1333, DOI 10.1111/j.1538-7836.2009.03492.x; Maraj S, 2010, CLIN CARDIOL, V33, P264, DOI 10.1002/clc.20746; Mediouni Sonia, 2012, Infectious Disorders - Drug Targets, V12, P81; Mosunjac MI, 2008, AM J FOREN MED PATH, V29, P9, DOI 10.1097/PAF.0b013e318165152f; O'Brien JJ, 2008, BLOOD, V112, P4051, DOI 10.1182/blood-2008-05-158535; O'Dea E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000216; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Ombrello C, 2010, J CARDIOVASC TRANSL, V3, P538, DOI 10.1007/s12265-010-9213-7; Palella FJ, 2011, CURR OPIN HIV AIDS, V6, P266, DOI 10.1097/COH.0b013e328347876c; Panicot-Dubois L, 2007, J CLIN INVEST, V117, P3708, DOI 10.1172/JCI32655; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Ragin AB, 2011, J NEUROVIROL, V17, P487, DOI 10.1007/s13365-011-0053-2; Ricci A, 2001, N-S ARCH PHARMACOL, V363, P376, DOI 10.1007/s002100000339; RINDER HM, 1994, CIRCULATION, V90, P1162, DOI 10.1161/01.CIR.90.3.1162; Rondina MT, 2013, CIRC RES, V112, P1506, DOI 10.1161/CIRCRESAHA.113.300512; Rozmyslowicz T, 2003, AIDS, V17, P33, DOI 10.1097/00002030-200301030-00006; Rumbaugh Jeffrey A, 2008, Futur HIV Ther, V2, P271, DOI 10.2217/17469600.2.3.271; Sahler J, 2011, THROMB RES, V127, P426, DOI 10.1016/j.thromres.2010.12.013; Satchell CS, 2010, AIDS, V24, P649, DOI 10.1097/QAD.0b013e328336098c; Singh MV, 2014, J IMMUNOL, V192, P4674, DOI 10.4049/jimmunol.1302318; Singh MV, 2012, J VIROL METHODS, V181, P170, DOI 10.1016/j.jviromet.2012.02.005; Spinelli SL, 2010, ARTERIOSCL THROM VAS, V30, P591, DOI 10.1161/ATVBAHA.109.197343; Sui Z, 2007, J IMMUNOL, V178, P3226, DOI 10.4049/jimmunol.178.5.3226; Torre D, 2008, CURR HIV RES, V6, P411, DOI 10.2174/157016208785861140; Tsegaye TS, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-48; Wachtman LM, 2006, J NEUROVIROL, V12, P25, DOI 10.1080/13550280500516484; Wachtman LM, 2007, ARCH NEUROL-CHICAGO, V64, P1264, DOI 10.1001/archneur.64.9.1264; Wang J, 2011, J THROMB HAEMOST, V9, P562, DOI 10.1111/j.1538-7836.2010.04168.x; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Ziu E, 2014, SCI REP-UK, V4, DOI 10.1038/srep05945	60	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130061	10.1371/journal.pone.0130061	http://dx.doi.org/10.1371/journal.pone.0130061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076359	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900132
J	Lokody, IB; Francis, JC; Gardiner, JR; Erler, JT; Swain, A				Lokody, Isabel B.; Francis, Jeffrey C.; Gardiner, Jennifer R.; Erler, Janine T.; Swain, Amanda			Pten Regulates Epithelial Cytodifferentiation during Prostate Development	PLOS ONE			English	Article							STEM-CELL; MURINE; LEADS; MORPHOGENESIS; NKX3.1; BASAL; SUBPOPULATION; INACTIVATION; HYPERPLASIA; ACTIVATION	Gene expression and functional studies have indicated that the molecular programmes involved in prostate development are also active in prostate cancer. PTEN has been implicated in human prostate cancer and is frequently mutated in this disease. Here, using the Nkx3.1: Cre mouse strain and a genetic deletion approach, we investigate the role of Pten specifically in the developing mouse prostate epithelia. In contrast to its role in other developing organs, this gene is dispensable for the initial developmental processes such as budding and branching. However, as cytodifferentiation progresses, abnormal luminal cells fill the ductal lumens together with augmented epithelial proliferation. This phenotype resembles the hyperplasia seen in postnatal Pten deletion models that develop neoplasia at later stages. Consistent with this, gene expression analysis showed a number of genes affected that are shared with Pten mutant prostate cancer models, including a decrease in androgen receptor regulated genes. In depth analysis of the phenotype of these mice during development revealed that loss of Pten leads to the precocious differentiation of epithelial cells towards a luminal cell fate. This study provides novel insight into the role of Pten in prostate development as part of the process of coordinating the differentiation and proliferation of cell types in time and space to form a functional organ.	[Lokody, Isabel B.; Francis, Jeffrey C.; Gardiner, Jennifer R.; Erler, Janine T.; Swain, Amanda] Inst Canc Res, Div Canc Biol, London SW3 6JB, England; [Erler, Janine T.] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Copenhagen	Swain, A (corresponding author), Inst Canc Res, Div Canc Biol, 237 Fulham Rd, London SW3 6JB, England.	amanda.swain@icr.ac.uk		Francis, Jeff/0000-0001-6646-5749; Swain, Amanda/0000-0001-8666-1608; Erler, Janine/0000-0001-8675-6527	Institute of Cancer Research; Novo Nordisk Fonden [NNF12OC1015992] Funding Source: researchfish	Institute of Cancer Research; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Institute of Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; Dahia PLM, 2000, ENDOCR-RELAT CANCER, V7, P115, DOI 10.1677/erc.0.0070115; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; DONJACOUR AA, 1993, ENDOCRINOLOGY, V132, P2342, DOI 10.1210/en.132.6.2342; Francis JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003180; Gardiner JR, 2012, DEVELOPMENT, V139, P3456, DOI 10.1242/dev.079400; Ghosh S, 2011, DEV BIOL, V360, P329, DOI 10.1016/j.ydbio.2011.09.027; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Higano CS, 2013, ONCOTARGETS THER, V6, P785, DOI 10.2147/OTT.S33077; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P2884, DOI 10.1073/pnas.042688999; Koltai T, 2014, ONCOTARGETS THER, V7, P447, DOI 10.2147/OTT.S58622; Korsten H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005662; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; LEONG KG, 2008, NATURE; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Li G, 2002, DEVELOPMENT, V129, P4159; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Pritchard C, 2009, CANCER RES, V69, P1739, DOI 10.1158/0008-5472.CAN-07-6817; Schaeffer EM, 2008, ONCOGENE, V27, P7180, DOI 10.1038/onc.2008.327; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stoyanova T, 2012, GENE DEV, V26, P2271, DOI 10.1101/gad.196451.112; SUGIMURA Y, 1986, BIOL REPROD, V34, P985, DOI 10.1095/biolreprod34.5.985; Suzuki A, 2003, CANCER RES, V63, P674; Suzuki H, 1998, CANCER RES, V58, P204; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thomsen MK, 2008, DEV BIOL, V316, P302, DOI 10.1016/j.ydbio.2008.01.030; Thomson AA, 2006, DIFFERENTIATION, V74, P382, DOI 10.1111/j.1432-0436.2006.00101.x; Trerotola M, 2013, ONCOGENE, V32, P222, DOI 10.1038/onc.2012.36; Van de Sande T, 2005, J PATHOL, V206, P214, DOI 10.1002/path.1760; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang YZ, 2001, DIFFERENTIATION, V68, P270, DOI 10.1046/j.1432-0436.2001.680414.x; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019	42	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129470	10.1371/journal.pone.0129470	http://dx.doi.org/10.1371/journal.pone.0129470			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076167	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900077
J	Romkema, S; Bongers, RM; van der Sluis, CK				Romkema, Sietske; Bongers, Raoul M.; van der Sluis, Corry K.			Influence of Inter-Training Intervals on Intermanual Transfer Effects in Upper-Limb Prosthesis Training: A Randomized Pre-Posttest Study	PLOS ONE			English	Article							DISTRIBUTED PRACTICE; BILATERAL TRANSFER; SKILL; PERFORMANCE; ACQUISITION; HANDS; TASK; COMPONENTS; SIMULATOR; RECALL	Improvement in prosthetic training using intermanual transfer (the transfer of motor skills from the trained, "unaffected" hand to the untrained, "affected" hand) has been shown in previous studies. The aim of this study is to determine the influence of the inter-training interval on the magnitude of the intermanual transfer effects. This was done using a mechanistic, randomized, single-blinded pretest-posttest design. Sixty-four able-bodied, righthanded participants were randomly assigned to the Short and Long Interval Training Groups and the Short and Long Interval Control Groups. The Short and Long Interval Training Groups used a prosthesis simulator in their training program. The Short and Long Interval Control Groups executed a sham training program, that is, a dummy training program in which the same muscles were trained as with the prosthesis simulator. The Short Interval Training Group and the Short Interval Control Groups trained on consecutive days, while the Long Interval Training Group and Long Interval Control Group trained twice a week. To determine the improvement in skills, a test was administered before, immediately after, and at two points in time after the training. Training was performed with the "unaffected" arm; tests were performed with the "affected" arm. The outcome measurements were: the movement time (the time from the beginning of the movement until completion of the task); the duration of maximum hand opening, (the opening of the prosthetic hand while grasping an object); and the grip-force control (the error from the required grip-force during a tracking task). Intermanual transfer was found in movement times, but not in hand opening or gripforce control. The length of the inter-training interval did not affect the magnitude of intermanual transfer effects. No difference in the intermanual transfer effect in upper-limb prosthesis training was found for training on a daily basis as compared to training twice a week.	[Romkema, Sietske; van der Sluis, Corry K.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands; [Bongers, Raoul M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands	University of Groningen; University of Groningen	Romkema, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands.	s.romkema@umcg.nl	Bongers, Raoul/C-1094-2012	Bongers, Raoul/0000-0002-3518-7464	Fonds NutsOhra [1103-029]; Revalidatiefonds [R2011147]; Stichting Beatrixoord [210.130]; OIM Stichting [1103]	Fonds NutsOhra; Revalidatiefonds; Stichting Beatrixoord; OIM Stichting	This study was supported by Fonds NutsOhra [grant number 1103-029]; http://www.revalidatiefonds.nl/ Revalidatiefonds [grant number R2011147]; Stichting Beatrixoord [grant number 210.130]; and OIM Stichting [grant number 1103]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins D, 1992, ATLAS OF LIMB PROSTH; Bongers RM, 2012, HUM MOVEMENT SCI, V31, P487, DOI 10.1016/j.humov.2011.07.014; Bonzano L, 2011, HUM BRAIN MAPP, V32, P218, DOI 10.1002/hbm.21011; Bouwsema H, 2008, ARCH PHYS MED REHAB, V89, P1759, DOI 10.1016/j.apmr.2007.12.046; Bouwsema H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098301; Bouwsema H, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-16; Bouwsema H, 2012, J REHABIL RES DEV, V49, P1331, DOI 10.1682/JRRD.2011.09.0179; Bouwsema H, 2010, ARCH PHYS MED REHAB, V91, P1442, DOI 10.1016/j.apmr.2010.06.025; CARRON AV, 1969, RES QUART, V40, P481, DOI 10.1080/10671188.1969.10614866; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Cepeda NJ, 2009, EXP PSYCHOL, V56, P236, DOI 10.1027/1618-3169.56.4.236; Di Pino G, 2009, PROG NEUROBIOL, V88, P114, DOI 10.1016/j.pneurobio.2009.03.001; Donovan JJ, 1999, J APPL PSYCHOL, V84, P795, DOI 10.1037/0021-9010.84.5.795; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gaine WJ, 1997, J HAND SURG-BRIT EUR, V22B, P73, DOI 10.1016/S0266-7681(97)80023-X; HALSBAND U, 1992, NEUROREPORT, V3, P397, DOI 10.1097/00001756-199205000-00005; HICKS RE, 1983, AM J PSYCHOL, V96, P223, DOI 10.2307/1422813; IMAMIZU H, 1995, J EXP PSYCHOL HUMAN, V21, P719, DOI 10.1037/0096-1523.21.4.719; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kornmeier J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00203; Kumar S, 2005, LATERALITY, V10, P337, DOI 10.1080/13576500442000120; LASZLO JI, 1970, J MOTOR BEHAV, V2, P261, DOI 10.1080/00222895.1970.10734884; Lee M, 2010, J PHYSIOL-LONDON, V588, P201, DOI 10.1113/jphysiol.2009.183855; LEE TD, 1988, RES Q EXERCISE SPORT, V59, P277, DOI 10.1080/02701367.1988.10609373; Light CM, 2002, ARCH PHYS MED REHAB, V83, P776, DOI 10.1053/apmr.2002.32737; Malone J M, 1984, J Rehabil Res Dev, V21, P33; Mitchell EL, 2011, AM J SURG, V201, P31, DOI 10.1016/j.amjsurg.2010.07.040; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Panzer S, 2014, EXP AGING RES, V40, P107, DOI 10.1080/0361073X.2014.857566; Park JH, 2002, J MOTOR BEHAV, V34, P253, DOI 10.1080/00222890209601944; PARLOW SE, 1989, BRAIN COGNITION, V11, P98, DOI 10.1016/0278-2626(89)90008-0; PARLOW SE, 1991, BEHAV BRAIN RES, V46, P1, DOI 10.1016/S0166-4328(05)80091-9; Romkema S, 2015, PHYS THER; Romkema S, 2013, PHYS THER, V93, P22, DOI 10.2522/ptj.20120058; Savion-Lemieux T, 2005, EXP BRAIN RES, V161, P423, DOI 10.1007/s00221-004-2085-9; Schulze K, 2002, CORTEX, V38, P805, DOI 10.1016/S0010-9452(08)70047-9; Senff O, 2011, LATERALITY, V16, P227, DOI 10.1080/13576500903549414; Siengsukon CF, 2009, PHYS THER, V89, P370, DOI 10.2522/ptj.20080310; Smurr LM, 2008, J HAND THER, V21, P160, DOI 10.1197/j.jht.2007.09.006; Takeuchi N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/823285; Teixeira LA, 2000, BRAIN COGNITION, V44, P455, DOI 10.1006/brcg.1999.1205; Thakur RC, 1977, J PSYCHOL RES, V21, P135; Toppino TC, 2002, J EXP PSYCHOL LEARN, V28, P437, DOI 10.1037//0278-7393.28.3.437; Uehara I, 1998, PERCEPT MOTOR SKILL, V87, P1427, DOI 10.2466/pms.1998.87.3f.1427; van Mier HI, 2006, NEUROPSYCHOLOGIA, V44, P939, DOI 10.1016/j.neuropsychologia.2005.08.010; VANLUNTEREN A, 1983, PROSTHET ORTHOT INT, V7, P141; Weeks DL, 2003, ARCH PHYS MED REHAB, V84, P437, DOI 10.1053/apmr.2003.50014	48	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128747	10.1371/journal.pone.0128747	http://dx.doi.org/10.1371/journal.pone.0128747			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26075396	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900027
J	Schou, MF; Loeschcke, V; Kristensen, TN				Schou, Mads Fristrup; Loeschcke, Volker; Kristensen, Torsten Nygaard			Strong Costs and Benefits of Winter Acclimatization in Drosophila melanogaster	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; DEVELOPMENTAL TEMPERATURE; COLD-ACCLIMATION; THERMAL LIMITS; CLIMATE-CHANGE; EVOLUTIONARY; TOLERANCE; RESISTANCE; FIELD; EXTREMES	Studies on thermal acclimation in insects are often performed on animals acclimated in the laboratory under conditions that are not ecologically relevant. Costs and benefits of acclimation responses under such conditions may not reflect costs and benefits in natural populations subjected to daily and seasonal temperature fluctuations. Here we estimated costs and benefits in thermal tolerance limits in relation to winter acclimatization of Drosophila melanogaster. We sampled flies from a natural habitat during winter in Denmark (field flies) and compared heat and cold tolerance of these to that of flies collected from the same natural population, but acclimated to 25 degrees C or 13 degrees C in the laboratory (laboratory flies). We further obtained thermal performance curves for egg-to-adult viability of field and laboratory (25 degrees C) flies, to estimate possible cross-generational effects of acclimation. We found much higher cold tolerance and a lowered heat tolerance in field flies compared to laboratory flies reared at 25 degrees C. Flies reared in the laboratory at 13 degrees C exhibited the same thermal cost-benefit relations as the winter acclimatized flies. We also found a cost of winter acclimatization in terms of decreased egg-to-adult viability at high temperatures of eggs laid by winter acclimatized flies. Based on our findings we suggest that winter acclimatization in nature can induce strong benefits in terms of increased cold tolerance. These benefits can be reproduced in the laboratory under ecologically relevant rearing and testing conditions, and should be incorporated in species distribution modelling. Winter acclimatization also leads to decreased heat tolerance. This may create a mismatch between acclimation responses and the thermal environment, e.g. if temperatures suddenly increase during spring, under current and expected more variable future climatic conditions.	[Schou, Mads Fristrup; Loeschcke, Volker] Aarhus Univ, Dept Biosci, Aarhus C, Denmark; [Kristensen, Torsten Nygaard] Aalborg Univ, Dept Chem & Biosci, Aalborg, Denmark	Aarhus University; Aalborg University	Schou, MF (corresponding author), Aarhus Univ, Dept Biosci, Aarhus C, Denmark.	mads.schou@biology.au.dk	Schou, Mads Fristrup/J-2148-2014; Loeschcke, Volker/J-2527-2013; Kristensen, Torsten N/C-5031-2015	Schou, Mads Fristrup/0000-0001-5521-5269; Loeschcke, Volker/0000-0003-1450-0754; Kristensen, Torsten N/0000-0001-6204-8753				Andersen JL, 2015, FUNCT ECOL, V29, P55, DOI 10.1111/1365-2435.12310; Angilletta MJ, 2002, J THERM BIOL, V27, P199, DOI 10.1016/S0306-4565(01)00084-5; Bale JS, 2010, J EXP BIOL, V213, P980, DOI 10.1242/jeb.037911; Bergland AO, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004775; Bouletreau-Merle J, 2002, EVOL ECOL, V16, P309, DOI 10.1023/A:1020216230976; Chidawanyika F, 2011, EVOL APPL, V4, P534, DOI 10.1111/j.1752-4571.2010.00168.x; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Chown SL, 2010, CLIM RES, V43, P3, DOI 10.3354/cr00879; Chown SL, 2009, FUNCT ECOL, V23, P133, DOI 10.1111/j.1365-2435.2008.01481.x; Clusella-Trullas S, 2011, AM NAT, V177, P738, DOI 10.1086/660021; David J. R., 1983, GENET BIOL DROSOPHIL, P107; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Diamond SE, 2012, GLOBAL CHANGE BIOL, V18, P448, DOI 10.1111/j.1365-2486.2011.02542.x; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Ferrer A, 2013, J EVOLUTION BIOL, V26, P2321, DOI 10.1111/jeb.12218; Fuller A, 2010, PHYSIOL BIOCHEM ZOOL, V83, P713, DOI 10.1086/652242; Gibert P, 2001, PHYSIOL BIOCHEM ZOOL, V74, P429, DOI 10.1086/320429; Gilchrist GW, 2001, EVOLUTION, V55, P209, DOI 10.1111/j.0014-3820.2001.tb01287.x; Goto SG, 1998, J INSECT PHYSIOL, V44, P1009, DOI 10.1016/S0022-1910(97)00143-1; Harshman LG, 2000, TRENDS ECOL EVOL, V15, P32, DOI 10.1016/S0169-5347(99)01756-5; Hijmans R.J., 2014, RASTER GEOGRAPHIC DA, V2, P15; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann AA, 2010, J EXP BIOL, V213, P870, DOI 10.1242/jeb.037630; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; Huey RB, 1999, AM ZOOL, V39, P323; IZQUIERDO JI, 1991, ENTOMOL EXP APPL, V59, P51, DOI 10.1007/BF00187965; Jeffs CT, 2014, ENTOMOL EXP APPL, V150, P240, DOI 10.1111/eea.12160; Kellermann V, 2012, EVOLUTION, V66, P3377, DOI 10.1111/j.1558-5646.2012.01685.x; Kellermann V, 2009, SCIENCE, V325, P1244, DOI 10.1126/science.1175443; Kelly VE, 2012, PARKINSONS DIS-US, V2012, DOI [10.1155/2012/918719, 10.1073/pnas.1207553109]; Kelty JD, 2001, J EXP BIOL, V204, P1659; Kelty J, 2007, PHYSIOL ENTOMOL, V32, P343, DOI 10.1111/j.1365-3032.2007.00584.x; Kristensen TN, 2008, P NATL ACAD SCI USA, V105, P216, DOI 10.1073/pnas.0708074105; LEE RE, 1987, SCIENCE, V238, P1415, DOI 10.1126/science.238.4832.1415; LEVINS R, 1969, AM NAT, V103, P483, DOI 10.1086/282616; Loeschcke V, 2007, AM NAT, V169, P175, DOI 10.1086/510632; MacMillan HA, 2012, P NATL ACAD SCI USA, V109, P20750, DOI 10.1073/pnas.1212788109; MacMillan HA, 2011, J INSECT PHYSIOL, V57, P12, DOI 10.1016/j.jinsphys.2010.10.004; Mitchell KA, 2010, FUNCT ECOL, V24, P694, DOI 10.1111/j.1365-2435.2009.01666.x; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; Overgaard J, 2014, GLOBAL CHANGE BIOL, V20, P1738, DOI 10.1111/gcb.12521; Overgaard J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032758; Overgaard J, 2011, J THERM BIOL, V36, P409, DOI 10.1016/j.jtherbio.2011.07.005; R Core Team, 2021, R LANGUAGE ENV STAT; Rako L, 2006, J INSECT PHYSIOL, V52, P94, DOI 10.1016/j.jinsphys.2005.09.007; SAUNDERS DS, 1989, P NATL ACAD SCI USA, V86, P3748, DOI 10.1073/pnas.86.10.3748; Schiffer M, 2013, J EXP BIOL, V216, P3790, DOI 10.1242/jeb.085126; Schou MF, 2013, FLY, V7, DOI 10.4161/fly.22758; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sorensen JG, 2015, J INSECT PHYSIOL, V77, P9, DOI 10.1016/j.jinsphys.2015.03.014; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Tatar M, 2001, AM NAT, V158, P248, DOI 10.1086/321320; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283; Tobler R, 2014, MOL BIOL EVOL, V31, P364, DOI 10.1093/molbev/mst205; Vesala L, 2011, J INSECT PHYSIOL, V57, P46, DOI 10.1016/j.jinsphys.2010.09.007; ZACHARIASSEN KE, 1985, PHYSIOL REV, V65, P799, DOI 10.1152/physrev.1985.65.4.799; Zuur Alain F., 2009, P1	60	37	38	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130307	10.1371/journal.pone.0130307	http://dx.doi.org/10.1371/journal.pone.0130307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075607	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900163
J	Demant, KM; Vinberg, M; Kessing, LV; Miskowiak, KW				Demant, Kirsa M.; Vinberg, Maj; Kessing, Lars V.; Miskowiak, Kamilla W.			Effects of Short-Term Cognitive Remediation on Cognitive Dysfunction in Partially or Fully Remitted Individuals with Bipolar Disorder: Results of a Randomised Controlled Trial	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; QUALITY-OF-LIFE; EUTHYMIC PATIENTS; RATING-SCALE; I DISORDER; SCHIZOPHRENIA; IMPAIRMENT; DEFICITS; METAANALYSIS; ASSOCIATION	Introduction Cognitive dysfunction is common in bipolar disorder (BD) but is not sufficiently addressed by current treatments. Cognitive remediation (CR) may improve cognitive function in schizophrenia but no randomised controlled trial has investigated this intervention in BD. The present study aimed to investigate the effects of CR on persistent cognitive dysfunction in BD. Method Patients with BD in partial remission with cognitive complaints were randomised to 12 weeks group-based CR (n=23) or standard treatment (ST) (n=23). Outcomes were improved verbal memory (primary), sustained attention, executive and psychosocial function (secondary) and additional measures of cognitive and psychosocial function (tertiary). Participants were assessed at baseline and weeks 12 and 26. Results Of the 46 randomised participants five dropped out and one was excluded after baseline. CR (n=18) had no effect on primary or secondary measures of cognitive or psychosocial function compared with ST (n=22). However, CR improved subjective sharpness at week 12, and quality of life and verbal fluency at week 26 follow-up (tertiary outcomes). Although the trial turned out to have suboptimal statistical power for the primary outcome analysis, calculation of the 95% confidence interval showed that it was highly unlikely that an increase in sample size would have rendered any beneficial effects of CR vs. ST on the verbal memory. Conclusions Short-term group-based CR did not seem to improve overall cognitive or psychosocial function in individuals with BD in full or partial remission. The present findings suggest that that longer-term, more intensive and individualised CR may be necessary to improve cognition in BD.	[Demant, Kirsa M.; Vinberg, Maj; Kessing, Lars V.; Miskowiak, Kamilla W.] Copenhagen Univ Hosp, Rigshosp, Psychiat Ctr Copenhagen, Copenhagen Affect Disorder Clin, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Miskowiak, KW (corresponding author), Copenhagen Univ Hosp, Rigshosp, Psychiat Ctr Copenhagen, Copenhagen Affect Disorder Clin, Copenhagen, Denmark.	kamilla.woznica.miskowiak@regionh.dk	Vinberg/ABC-7493-2021	Vinberg/0000-0002-5982-1335; Kessing, Lars/0000-0001-9377-9436; Miskowiak, Kamilla/0000-0003-2572-1384	TRYG foundation [7-09-0159]	TRYG foundation	The study was funded by the TRYG foundation (grant number 7-09-0159), received by KWM. The funding source had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	[Anonymous], 1998, RBANS MANUAL REPEATA; Army Individual Test Battery, 1944, MAN DIR SCOR; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Bozikas VP, 2006, J AFFECT DISORDERS, V91, P53, DOI 10.1016/j.jad.2005.11.013; Brissos S, 2008, PSYCHIAT RES, V160, P55, DOI 10.1016/j.psychres.2007.04.010; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Burdick KE, 2012, J CLIN PSYCHIAT, V73, P103, DOI 10.4088/JCP.11m07299; Burdick KE, 2011, NEUROPSYCHOPHARMACOL, V36, P1587, DOI 10.1038/npp.2011.36; Burdick KE, 2006, J NERV MENT DIS, V194, P255, DOI 10.1097/01.nmd.0000207360.70337.7e; Burdick KE, 2014, PSYCHOL MED; Chamberlain Samuel R, 2006, Curr Psychiatry Rep, V8, P458, DOI 10.1007/s11920-006-0051-x; Chamberlain Samuel R, 2004, Curr Psychiatry Rep, V6, P451; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; d'Amato T, 2011, SCHIZOPHR RES, V125, P284, DOI 10.1016/j.schres.2010.10.023; Deckersbach T, 2010, CNS NEUROSCI THER, V16, P298, DOI 10.1111/j.1755-5949.2009.00110.x; Demant KM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-378; Depp CA, 2012, BIPOLAR DISORD, V14, P217, DOI 10.1111/j.1399-5618.2012.01011.x; Donohoe G, 2012, BIPOLAR DISORD, V14, P743, DOI 10.1111/bdi.12011; Elgamal S, 2007, PSYCHOL MED, V37, P1229, DOI 10.1017/S0033291707001110; Fava M, 2006, J CLIN PSYCHIAT, V67, P1754, DOI 10.4088/JCP.v67n1113; Getz GE, 2003, J INT NEUROPSYCH SOC, V9, P623, DOI 10.1017/S1355617703940021; Goldberg JF, 2009, BIPOLAR DISORD, V11, P123, DOI 10.1111/j.1399-5618.2009.00716.x; Grynszpan O, 2011, PSYCHOL MED, V41, P163, DOI 10.1017/S0033291710000607; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Jaeger J, 2006, PSYCHIAT RES, V145, P39, DOI 10.1016/j.psychres.2005.11.011; Jorgensen K, 2012, DANSKE NORMER TIL NE; Kessing LV, 2013, BRIT J PSYCHIAT, V202, P212, DOI 10.1192/bjp.bp.112.113548; Kessing LV, 1998, PSYCHOL MED, V28, P1027, DOI 10.1017/S0033291798006862; Lewandowski KE, 2011, PSYCHOL MED, V41, P225, DOI 10.1017/S0033291710001042; Macartney-Filgate M S, 1988, Arch Clin Neuropsychol, V3, P121, DOI 10.1016/0887-6177(88)90057-1; Martinez-Aran A, 2004, AM J PSYCHIAT, V161, P262, DOI 10.1176/appi.ajp.161.2.262; Martinez-Aran A, 2000, PSYCHOTHER PSYCHOSOM, V69, P2, DOI 10.1159/000012361; Martino DJ, 2008, J AFFECT DISORDERS, V109, P149, DOI 10.1016/j.jad.2007.12.232; McGurk SR, 2009, SCHIZOPHRENIA BULL, V35, P319, DOI 10.1093/schbul/sbn182; McIntyre RS, 2012, BIPOLAR DISORD, V14, P697, DOI 10.1111/bdi.12006; Miskowiak KW, 2014, J CLIN PSYC IN PRESS; Mundt JC, 2002, BRIT J PSYCHIAT, V180, P461, DOI 10.1192/bjp.180.5.461; Naismith SL, 2010, J AFFECT DISORDERS, V121, P258, DOI 10.1016/j.jad.2009.06.028; Rey A, 1964, LEXAMEN CLINIQUE PSY; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Robinson LJ, 2006, BIPOLAR DISORD, V8, P103, DOI 10.1111/j.1399-5618.2006.00277.x; Robinson LJ, 2006, J AFFECT DISORDERS, V93, P105, DOI 10.1016/j.jad.2006.02.016; Rosa Adriane R, 2007, Clin Pract Epidemiol Ment Health, V3, P5, DOI 10.1186/1745-0179-3-5; Smith DJ, 2006, BIPOLAR DISORD, V8, P40, DOI 10.1111/j.1399-5618.2006.00275.x; Strauss E, 2006, COMPENDIUM NEUROPSYC; Svendsen AM, 2012, NORD J PSYCHIAT, V66, P248, DOI 10.3109/08039488.2011.626870; Torrent C, 2013, AM J PSYCHIAT, V170, P852, DOI 10.1176/appi.ajp.2012.12070971; Torrent Carla, 2012, J Clin Psychiatry, V73, pe899, DOI 10.4088/JCP.11m07471; Wechsler D., 1997, WECHSLER ADULT INTEL; West B. T., 2007, LINEAR MIXED MODELS; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Wykes T, 2011, AM J PSYCHIAT, V168, P472, DOI 10.1176/appi.ajp.2010.10060855; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	56	55	55	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0127955	10.1371/journal.pone.0127955	http://dx.doi.org/10.1371/journal.pone.0127955			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26070195	gold, Green Submitted, Green Published			2022-12-27	WOS:000356327000013
J	Fei, DL; Zhang, HC; Diao, QY; Jiang, LL; Wang, Q; Zhong, Y; Fan, ZB; Ma, MX				Fei, Dongliang; Zhang, Haochun; Diao, Qingyun; Jiang, Lili; Wang, Qiang; Zhong, Yi; Fan, Zhaobin; Ma, Mingxiao			Codon Optimization, Expression in Escherichia coli, and Immunogenicity of Recombinant Chinese Sacbrood Virus (CSBV) Structural Proteins VP1, VP2, and VP3	PLOS ONE			English	Article							HONEY-BEE; TOXOPLASMA-GONDII; GENE-EXPRESSION; MECHANISMS; PROTEOMICS; SEQUENCE; IMMUNITY	Chinese sacbrood virus (CSBV) is a small RNA virus family belonging to the genus Iflavirus that causes larval death, and even the collapse of entire bee colonies. The virus particle is spherical, non-enveloped, and its viral capsid is composed of four proteins, although the functions of the structural proteins are unclear. In this study, we used codon recoding to express the recombinant proteins VP1, VP2, and VP3 in Escherichia coli. SDS-PAGE analysis and Western blotting revealed that the target genes were expressed at high levels. Mice were then immunized with the purified, recombinant proteins, and antibody levels and lymphocyte proliferation were analyzed by ELISA and the MTT assay, respectively. The results show that the recombinant proteins induced high antibody levels and promoted lymphocyte proliferation. Polyclonal antibodies directed against these proteins will aid future studies of the molecular pathogenesis of CSBV.	[Fei, Dongliang; Zhang, Haochun; Jiang, Lili; Zhong, Yi; Fan, Zhaobin; Ma, Mingxiao] Liaoning Med Univ, Anim Husb & Vet Inst, Jinzhou, Peoples R China; [Diao, Qingyun] Chinese Acad Agr Sci, Honeybee Res Inst, Beijing 100193, Peoples R China; [Wang, Qiang] Liaoning Water Conservancy Vocat Coll, Shenyang, Peoples R China	Jinzhou Medical University; Chinese Academy of Agricultural Sciences	Ma, MX (corresponding author), Liaoning Med Univ, Anim Husb & Vet Inst, Jinzhou, Peoples R China.	371751697@qq.com	?, ?/AAU-8474-2021		National Natural Science Foundation of China [31372435]; Science and Technology Department of Liaoning Province [2014022047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Liaoning Province	This work was supported by grants from the National Natural Science Foundation of China (No. 31372435) and the Science and Technology Department of Liaoning Province (No. 2014022047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HX, 2012, J INVERTEBR PATHOL, V109, P160, DOI 10.1016/j.jip.2011.10.006; Bailey L, 1976, Adv Virus Res, V20, P271, DOI 10.1016/S0065-3527(08)60507-2; BAILEY L, 1964, VIROLOGY, V23, P425, DOI 10.1016/0042-6822(64)90266-1; Bhakta Gajadhar, 2014, Results Immunol, V4, P46, DOI 10.1016/j.rinim.2014.04.001; Bull JC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003083; Choe SE, 2012, VIROLOGY, V432, P155, DOI 10.1016/j.virol.2012.06.008; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Feng JX, 1998, J ELECT MICROS, V17, P387; Feng M, 2013, J PROTEOMICS, V87, P1, DOI 10.1016/j.jprot.2013.05.021; Fernandez-Sainz IJ, 2014, VIROLOGY, V456, P121, DOI 10.1016/j.virol.2014.03.005; Freiberg M, 2012, GENET MOL RES, V11, P3310, DOI 10.4238/2012.September.12.14; Gao JP, 2013, J VET SCI, V14, P441, DOI 10.4142/jvs.2013.14.4.441; Ghosh RC, 1999, J GEN VIROL, V80, P1541, DOI 10.1099/0022-1317-80-6-1541; Han B, 2013, J PROTEOME RES, V12, P1881, DOI 10.1021/pr301226d; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Hussmann KL, 2014, J GEN VIROL, V95, P1991, DOI 10.1099/vir.0.065474-0; Laguia-Becher M, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-52; Liu XJ, 2010, CURR MICROBIOL, V61, P422, DOI 10.1007/s00284-010-9633-2; Liu YS, 2013, APPL MICROBIOL BIOT, V97, P10349, DOI 10.1007/s00253-013-5264-4; Ma Ming-xiao, 2010, Chinese Journal of Biologicals, V23, P425; Ma MX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052670; Ma MX, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/409386; Menzella HG, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-15; Nguyen NTB, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00076-12; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sun XJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-429; Wang Q, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/732017; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Xia XC, 2014, ARCH VIROL, V159, P3435, DOI 10.1007/s00705-014-2183-3; Xie ZH, 2011, J APIC SCI, V55, P77; Xu ShuFa, 2011, Journal of Shanghai Jiaotong University - Agricultural Science, V29, P44; Yan Xun, 2008, Chinese Bulletin of Entomology, V45, P483; Zorina V. N., 2013, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P111; Zylicz-Stachula A, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-7	35	13	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128486	10.1371/journal.pone.0128486	http://dx.doi.org/10.1371/journal.pone.0128486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067659	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000018
J	Ku, EJ; Jung, KY; Kim, YJ; Kim, KM; Moon, JH; Choi, SH; Cho, YM; Park, KS; Jang, HC; Lim, S; Ahren, B				Ku, Eu Jeong; Jung, Kyong Yeon; Kim, Yoon Ji; Kim, Kyoung Min; Moon, Jae Hoon; Choi, Sung Hee; Cho, Young Min; Park, Kyong Soo; Jang, Hak Chul; Lim, Soo; Ahren, Bo			Four-Year Durability of Initial Combination Therapy with Sitagliptin and Metformin in Patients with Type 2 Diabetes in Clinical Practice; COSMIC Study	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITOR; GLUCOSE-LOWERING EFFICACY; BETA-CELL FUNCTION; GLYCEMIC CONTROL; DOUBLE-BLIND; PLUS METFORMIN; SAFETY; MONOTHERAPY; SULFONYLUREA; VILDAGLIPTIN	Objectives We investigated the efficacy of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes for 4 years in clinical practice. Methods Between 2009 and 2010, we reviewed 1,178 patients with type 2 diabetes (HbA(1c)>= 7.5% or 58 mmol/mol) prescribed initial combination therapy with sitagliptin and metformin. After excluding 288 patients without a second follow-up, 890 individuals (age, 58.0 +/- 12.5 years; BMI, 25.4 +/- 3.5 kg/m(2); HbA(1c), 8.6 +/- 1.1%) were followed up with every 3-6 months for 4 years. Homeostasis model assessments for insulin resistance and beta-cell function (HOMA-beta) were recorded at baseline. The response criterion was HbA(1c) reduction by >= 0.8% from baseline or attainment of the target HbA(1c) (<= 7.0% or 53 mmol/mol). At the end of every year of treatment, changes in HbA(1c) from the baseline were assessed. Results After 1 year, 72.2% of patients with initial combination therapy had responded, defined as HbA(1c) reduction >= 0.8% or attainment of the target HbA(1c)<= 7.0%. After 4 years, 35.4% of the patients still showed a response, with an HbA(1c) level of 7.0 +/- 0.9%. A high HbA(1c) level at baseline was the most significant independent predictor of the long-term response (P<0.001). In addition, low HOMA-beta was a significant predictor of a greater reduction in HbA(1c). This treatment was generally well tolerated over the 4-year follow-up period, without any serious adverse events. Conclusions This real-world follow-up study shows a persistent glucose-reducing effect of initial combination therapy with sitagliptin and metformin for up to 4 years.	[Ku, Eu Jeong; Jung, Kyong Yeon; Kim, Yoon Ji; Kim, Kyoung Min; Moon, Jae Hoon; Choi, Sung Hee; Cho, Young Min; Park, Kyong Soo; Jang, Hak Chul; Lim, Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Jung, Kyong Yeon; Kim, Yoon Ji; Kim, Kyoung Min; Moon, Jae Hoon; Choi, Sung Hee; Jang, Hak Chul; Lim, Soo] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; [Ku, Eu Jeong] Chungbuk Natl Univ Hosp, Dept Internal Med, Cheongju, South Korea; [Ahren, Bo] Lund Univ, Dept Clin Sci, Lund, Sweden	Seoul National University (SNU); Seoul National University (SNU); Chungbuk National University; Chungbuk National University Hospital; Lund University	Lim, S (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	limsoo@snu.ac.kr	Lim, Soo/AAU-8107-2020; Park, Kyong Soo/C-2265-2008	Lim, Soo/0000-0002-4137-1671; Park, Kyong Soo/0000-0003-3597-342X; Ku, Eu Jeong/0000-0001-5533-4989; Kim, Kyoung Min/0000-0001-8150-0266; CHOI, SUNG HEE/0000-0003-0740-8116	Novartis A/S; GlaxoSmithKline; Merck; Sanofi; Boehringer Ingelheim; Bristol-Myers Squibb/AstraZeneca; Takeda; Novo Nordisk; MSD; Lilly; Novartis; AstraZeneca	Novartis A/S; GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Sanofi; Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb/AstraZeneca(Bristol-Myers SquibbAstraZeneca); Takeda(Takeda Pharmaceutical Company Ltd); Novo Nordisk(Novo Nordisk); MSD; Lilly(Eli Lilly); Novartis(Novartis); AstraZeneca(AstraZeneca)	B.A. has consulted for and/or received lecture fees from Novartis A/S, GlaxoSmithKline, Merck, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb/AstraZeneca, Takeda, and Novo Nordisk. Y.M.C. received a lecture fee or consultation fee from MSD, Lilly, Novartis, AstraZeneca, and Boehringer Ingelheim. Other authors have no conflicts of interests to disclose. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Ahren B, 2007, DIABETES CARE, V30, P1344, DOI 10.2337/dc07-0233; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Bloomgarden ZT, 2006, DIABETES CARE, V29, P2137, DOI 10.2337/dc06-1120; Charbonnel B, 2006, DIABETES CARE, V29, P2638, DOI 10.2337/dc06-0706; Cho YM, 2011, DIABETOLOGIA, V54, P219, DOI 10.1007/s00125-010-1986-3; Chwieduk CM, 2011, DRUGS, V71, P349, DOI 10.2165/11206060-000000000-00000; Deacon CF, 2011, DIABETES OBES METAB, V13, P7, DOI 10.1111/j.1463-1326.2010.01306.x; Del Prato S, 2014, DIABETIC MED, V31, P1178, DOI 10.1111/dme.12508; Derosa G, 2012, DIABETES RES CLIN PR, V98, P51, DOI 10.1016/j.diabres.2012.05.022; Gitt AK, 2013, INT J CLIN PRACT, V67, P1005, DOI 10.1111/ijcp.12179; Goldstein BJ, 2007, DIABETES CARE, V30, P1979, DOI 10.2337/dc07-0627; Haak T, 2013, INT J CLIN PRACT, V67, P1283, DOI 10.1111/ijcp.12308; Henry RR, 2014, DIABETES OBES METAB, V16, P223, DOI 10.1111/dom.12194; Herman GA, 2007, CLIN PHARMACOL THER, V81, P761, DOI 10.1038/sj.clpt.6100167; Inzucchi SE, 2002, JAMA-J AM MED ASSOC, V287, P360, DOI 10.1001/jama.287.3.360; Jermendy G, 2012, MED SCI MONITOR, V18, pCR72, DOI 10.12659/MSM.882459; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kim YG, 2013, DIABETOLOGIA, V56, P696, DOI 10.1007/s00125-012-2827-3; Korean Diabetes Association, 2013, DIAB FACT SHEET KOR; Korean Diabetes Association, 2007, TREATMENT GUIDELINE; Koro CE, 2004, DIABETES CARE, V27, P17, DOI 10.2337/diacare.27.1.17; Lee YK, 2013, DIABETES METAB J, V37, P465, DOI 10.4093/dmj.2013.37.6.465; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lim S, 2012, CLIN ENDOCRINOL, V77, P215, DOI 10.1111/j.1365-2265.2011.04240.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nauck MA, 2007, DIABETES OBES METAB, V9, P194, DOI 10.1111/j.1463-1326.2006.00704.x; Neumiller JJ, 2010, PHARMACOTHERAPY, V30, P463, DOI 10.1592/phco.30.5.463; Omar BA, 2013, DIABETOLOGIA, V56, P1752, DOI 10.1007/s00125-013-2927-8; Pratley RE, 2014, DIABETES OBES METAB, V16, P613, DOI 10.1111/dom.12258; Raz I, 2006, DIABETOLOGIA, V49, P2564, DOI 10.1007/s00125-006-0416-z; Ristic S, 2007, DIABETES OBES METAB, V9, P506, DOI 10.1111/j.1463-1326.2006.00632.x; Scott R, 2007, INT J CLIN PRACT, V61, P171, DOI 10.1111/j.1742-1241.2006.01246.x; Seck T, 2010, INT J CLIN PRACT, V64, P562, DOI 10.1111/j.1742-1241.2010.02353.x; Sherifali D, 2010, DIABETES CARE, V33, P1859, DOI 10.2337/dc09-1727; St Onge Erin L, 2012, P T, V37, P699; Valensi P, 2014, P 74 SCI SESS SAN FR; Williams-Herman D, 2010, DIABETES OBES METAB, V12, P442, DOI 10.1111/j.1463-1326.2010.01204.x	37	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129477	10.1371/journal.pone.0129477	http://dx.doi.org/10.1371/journal.pone.0129477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068661	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000080
J	Yousaf, M; Ghaffar, T; Qamar, S				Yousaf, Muhammad; Ghaffar, Tayabia; Qamar, Shamsul			Application of Central Upwind Scheme for Solving Special Relativistic Hydrodynamic Equations	PLOS ONE			English	Article							KINETIC SCHEMES; DISSIPATION; FLOWS	The accurate modeling of various features in high energy astrophysical scenarios requires the solution of the Einstein equations together with those of special relativistic hydrodynamics (SRHD). Such models are more complicated than the non-relativistic ones due to the nonlinear relations between the conserved and state variables. A high-resolution shock-capturing central upwind scheme is implemented to solve the given set of equations. The proposed technique uses the precise information of local propagation speeds to avoid the excessive numerical diffusion. The second order accuracy of the scheme is obtained with the use of MUSCL-type initial reconstruction and Runge-Kutta time stepping method. After a discussion of the equations solved and of the techniques employed, a series of one and two-dimensional test problems are carried out. To validate the method and assess its accuracy, the staggered central and the kinetic flux-vector splitting schemes are also applied to the same model. The scheme is robust and efficient. Its results are comparable to those obtained from the sophisticated algorithms, even in the case of highly relativistic two-dimensional test problems.	[Yousaf, Muhammad; Qamar, Shamsul] COMSATS Inst Informat Technol, Dept Math, Islamabad, Pakistan; [Ghaffar, Tayabia] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan	COMSATS University Islamabad (CUI); Quaid I Azam University	Yousaf, M (corresponding author), COMSATS Inst Informat Technol, Dept Math, Pk Rd, Islamabad, Pakistan.	myousaf@comsats.edu.pk						Aloy MA, 1999, ASTROPHYS J SUPPL S, V122, P151, DOI 10.1086/313214; Balbas J, 2009, ESAIM-MATH MODEL NUM, V43, P333, DOI 10.1051/m2an:2008050; Bryson S, 2005, IMA J NUMER ANAL, V25, P113, DOI 10.1093/imanum/drh015; Csernai L. P., 1994, INTRO RELATIVISTIC H; Donat R, 1996, J COMPUT PHYS, V125, P42, DOI 10.1006/jcph.1996.0078; Kunik M, 2004, SIAM J SCI COMPUT, V26, P196, DOI 10.1137/S1064827503422208; Kunik M, 2004, NUMER MATH, V97, P159, DOI 10.1007/s00211-003-0510-9; Kunik M, 2003, J COMPUT PHYS, V187, P572, DOI 10.1016/S0021-9991(03)00125-6; Kurganov A, 2000, J COMPUT PHYS, V160, P241, DOI 10.1006/jcph.2000.6459; Kurganov A, 2007, COMMUN COMPUT PHYS, V2, P141; Kurganov A, 2009, SIAM J SCI COMPUT, V31, P1742, DOI 10.1137/080719091; Marti J.M, 1999, LIVING REV RELATIV, V2, P1; Marti JM, 1996, J COMPUT PHYS, V123, P1, DOI 10.1006/jcph.1996.0001; MARTI JM, 1995, ASTROPHYS J, V448, pL105, DOI 10.1086/309606; NESSYAHU H, 1990, J COMPUT PHYS, V87, P408, DOI 10.1016/0021-9991(90)90260-8; PIRAN T, 1993, MON NOT R ASTRON SOC, V263, P861, DOI 10.1093/mnras/263.4.861; Qamar S, 2013, COMPUT MATH APPL, V65, P1220, DOI 10.1016/j.camwa.2013.02.021; Qamar S, 2012, J COMPUT PHYS, V231, P3928, DOI 10.1016/j.jcp.2012.01.039; Qamar S, 2011, COMPUT PHYS COMMUN, V182, P994, DOI 10.1016/j.cpc.2010.12.044; Qamar S, 2005, INT J COMP METH-SING, V2, P49, DOI 10.1142/S0219876205000338; SCHNEIDER V, 1993, J COMPUT PHYS, V105, P92, DOI 10.1006/jcph.1993.1056; Tang HZ, 2000, COMPUT FLUIDS, V29, P917, DOI 10.1016/S0045-7930(99)00042-0; Van Dyke, 1982, ALBUM FLUID MOTION; Yang JY, 1997, J COMPUT PHYS, V136, P19, DOI 10.1006/jcph.1997.5767	27	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128698	10.1371/journal.pone.0128698	http://dx.doi.org/10.1371/journal.pone.0128698			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070067	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000024
J	Eriani, G; Karam, J; Jacinto, J; Richard, EM; Geslain, R				Eriani, Gilbert; Karam, Joseph; Jacinto, Jomel; Richard, Erin Morris; Geslain, Renaud			MIST, a Novel Approach to Reveal Hidden Substrate Specificity in Aminoacyl-tRNA Synthetases	PLOS ONE			English	Article							GENETIC-CODE; RECOGNITION SETS; YEAST; IDENTITY; ENZYME; ACTIVATION; EXPRESSION; SEQUENCE; ACCEPTOR; KINASE	Aminoacyl-tRNA synthetases (AARSs) constitute a family of RNA-binding proteins, that participate in the translation of the genetic code, by covalently linking amino acids to appropriate tRNAs. Due to their fundamental importance for cell life, AARSs are likely to be one of the most ancient families of enzymes and have therefore been characterized extensively. Paradoxically, little is known about their capacity to discriminate tRNAs mainly because of the practical challenges that represent precise and systematic tRNA identification. This work describes a new technical and conceptual approach named MIST (Microarray Identification of Shifted tRNAs) designed to study the formation of tRNA/AARS complexes independently from the aminoacylation reaction. MIST combines electrophoretic mobility shift assays with microarray analyses. Although MIST is a non-cellular assay, it fully integrates the notion of tRNA competition. In this study we focus on yeast cytoplasmic Arginyl-tRNA synthetase (yArgRS) and investigate in depth its ability to discriminate cellular tRNAs. We report that yArgRS in submicromolar concentrations binds cognate and non-cognate tRNAs with a wide range of apparent affinities. In particular, we demonstrate that yArgRS binds preferentially to type II tRNAs but does not support their misaminoacylation. Our results reveal important new trends in tRNA/AARS complex formation and potential deep physiological implications.	[Eriani, Gilbert] Univ Strasbourg, Architecture & React ARN, CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; [Karam, Joseph; Jacinto, Jomel; Richard, Erin Morris; Geslain, Renaud] Coll Charleston, Dept Biol, Lab tRNA Biol, Charleston, SC 29424 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; College of Charleston	Geslain, R (corresponding author), Coll Charleston, Dept Biol, Lab tRNA Biol, Charleston, SC 29424 USA.	geslainr@cofc.edu		Karam, Joseph/0000-0002-4536-7362; Eriani, Gilbert/0000-0002-8518-4675	Research and Development, College of Charleston; Centre National de la Recherche Scientifique [ANR11SVSE8-025-01]	Research and Development, College of Charleston; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This study was supported in party by Research and Development, College of Charleston (to RG) and by ANR11SVSE8-025-01, Centre National de la Recherche Scientifique (to GE).	Bezerra AR, 2013, P NATL ACAD SCI USA, V110, P11079, DOI 10.1073/pnas.1302094110; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Copela LA, 2006, RNA, V12, P644, DOI 10.1261/rna.2307206; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; Cusack S., 1990, NATURE, V347, P347; de Pouplana LR, 2001, CELL, V104, P191, DOI 10.1016/S0092-8674(01)00204-5; Delagoutte B, 2000, EMBO J, V19, P5599, DOI 10.1093/emboj/19.21.5599; Dittmar KA, 2004, J MOL BIOL, V337, P31, DOI 10.1016/j.jmb.2004.01.024; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; EBEL JP, 1973, BIOCHIMIE, V55, P547, DOI 10.1016/S0300-9084(73)80415-8; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fender A, 2004, NUCLEIC ACIDS RES, V32, P5076, DOI 10.1093/nar/gkh843; Frugier M, 2005, EMBO REP, V6, P860, DOI 10.1038/sj.embor.7400481; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Galburt EA, 2002, STRUCTURE, V10, P1249, DOI 10.1016/S0969-2126(02)00835-3; GANGLOFF J, 1976, EUR J BIOCHEM, V65, P177, DOI 10.1111/j.1432-1033.1976.tb10403.x; Geslain R, 2003, NUCLEIC ACIDS RES, V31, P4729, DOI 10.1093/nar/gkg685; Geslain R, 2006, J BIOL CHEM, V281, P38217, DOI 10.1074/jbc.M607862200; Geslain R, 2010, J MOL BIOL, V396, P821, DOI 10.1016/j.jmb.2009.12.018; Godinic-Mikulcic V, 2014, NUCLEIC ACIDS RES, V42, P5191, DOI 10.1093/nar/gku164; Godinic-Mikulcic V, 2011, J BIOL CHEM, V286, P3396, DOI 10.1074/jbc.M110.168526; Goodenbour JM, 2006, NUCLEIC ACIDS RES, V34, P6137, DOI 10.1093/nar/gkl725; Hopper AK, 2013, GENETICS, V194, P43, DOI 10.1534/genetics.112.147470; Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; Krishnakumar R, 2013, CHEMBIOCHEM, V14, P1967, DOI 10.1002/cbic.201300444; Li L, 2011, P NATL ACAD SCI USA, V108, P9378, DOI 10.1073/pnas.1016460108; MCCLAIN WH, 1993, J MOL BIOL, V234, P257, DOI 10.1006/jmbi.1993.1582; MEHLER AH, 1967, J BIOL CHEM, V242, P5495; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Pavon-Eternod M, 2010, RNA, V16, P267, DOI 10.1261/rna.1928110; Pavon-Eternod M, 2009, NUCLEIC ACIDS RES, V37, P7268, DOI 10.1093/nar/gkp787; Roy H, 2003, P NATL ACAD SCI USA, V100, P9837, DOI 10.1073/pnas.1632156100; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; Sissler M, 1996, EMBO J, V15, P5069, DOI 10.1002/j.1460-2075.1996.tb00887.x; Sissler M, 1997, NUCLEIC ACIDS RES, V25, P4899, DOI 10.1093/nar/25.24.4899; Tocchini-Valentini G, 2000, J MOL BIOL, V298, P779, DOI 10.1006/jmbi.2000.3694; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Zaborske JM, 2009, J BIOL CHEM, V284, P25254, DOI 10.1074/jbc.M109.000877	40	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130042	10.1371/journal.pone.0130042	http://dx.doi.org/10.1371/journal.pone.0130042			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067673	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900096
J	Chen, XH; Du, H; Liu, BJ; Zou, L; Chen, W; Yang, Y; Zhu, Y; Gong, YJ; Tian, JB; Li, F; Zhong, S				Chen, Xiaohua; Du, Hua; Liu, Binjian; Zou, Li; Chen, Wei; Yang, Yang; Zhu, Ying; Gong, Yajie; Tian, Jianbo; Li, Feng; Zhong, Shan			The Associations between RNA Splicing Complex Gene SF3A1 Polymorphisms and Colorectal Cancer Risk in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; LUNG-CANCER; COLON; METAANALYSIS; SCAN; VARIANTS; PATHWAY; BLADDER; SITES	Background Aberrant alternative splicing included alterations in components of the mRNA splicing machinery often occurred in colon cancer. However, the role of SF3A1, one key component of the mRNA splicing machinery, on colorectal cancer (CRC) risk was still not elucidated. Method and Findings We performed a hospital-based case-control study containing 801 CRC patients and 817 cancer-free controls to examine the association between SF3A1 polymorphisms and CRC risk in a Chinese population. Four candidate SNPs (rs10376, rs5753073, rs2839998 and rs2074733) were selected based on bioinformatics analysis and previous findings. The results showed no significant associations between these SNPs and CRC risk (P > 0.05). Besides, the stratified analysis based on the smoking and alcohol use status obtained no statistically significant results. Conclusion Our study was the first one to investigate the association between SF3A1 polymorphisms and CRC risk. The results suggested these four SNPs in SF3A1 were not associated with CRC risk in a Chinese population, however, further more studies are needed to confirm our findings.	[Chen, Xiaohua; Li, Feng; Zhong, Shan] Wuhan Univ, Sch Basic Med Sci, Dept Med Genet, Wuhan 430071, Peoples R China; [Chen, Xiaohua; Du, Hua; Liu, Binjian] 161 Hosp PLA, Dept Lab Med, Wuhan 430010, Peoples R China; [Zou, Li; Chen, Wei; Yang, Yang; Zhu, Ying; Gong, Yajie; Tian, Jianbo] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Zhong, Shan] Hubei Prov Key Lab Developmentally Originated Dis, Wuhan 430071, Peoples R China	Wuhan University; Huazhong University of Science & Technology	Zhong, S (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Med Genet, Wuhan 430071, Peoples R China.	zhongshan@whu.edu.cn			National Natural Science Foundation of China [31172395]; Key Technologies Research and Development Program of China [2013BAI12B01-3]; Health and Family Planning Commission of Hubei Province of China [WJ-2015MB039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technologies Research and Development Program of China(National Key Technology R&D Program); Health and Family Planning Commission of Hubei Province of China	This work was supported by the National Natural Science Foundation of China (Grant No. 31172395), the Key Technologies Research and Development Program of China (Grant No. 2013BAI12B01-3) and the Health and Family Planning Commission of Hubei Province of China (Grant No. WJ-2015MB039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AS, 2014, GENE DEV, V28, P1068, DOI 10.1101/gad.237206.113; Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Bisognin A, 2014, MOL ONCOL, V8, P129, DOI 10.1016/j.molonc.2013.10.004; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Chen KX, 2008, CARCINOGENESIS, V29, P1306, DOI 10.1093/carcin/bgn116; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Mojica W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-5; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Padgett RA, 2012, TRENDS GENET, V28, P147, DOI 10.1016/j.tig.2012.01.001; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Pal S, 2012, PHARMACOL THERAPEUT, V136, P283, DOI 10.1016/j.pharmthera.2012.08.005; Pennisi E, 2011, SCIENCE, V332, P1031, DOI 10.1126/science.332.6033.1031; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; Thorsen K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002998; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Yao LJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6114; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhang B, 2014, INT J CANCER, V135, P948, DOI 10.1002/ijc.28733; Zhang B, 2014, NAT GENET, V46, P533, DOI 10.1038/ng.2985; Zhong R, 2013, MOL CARCINOGEN, V52, P118, DOI 10.1002/mc.22043; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395; Zhu BB, 2015, MOL CARCINOGEN, V54, P761, DOI 10.1002/mc.22140; Zhu BB, 2014, CLIN GASTROENTEROL H, V12, P1991, DOI 10.1016/j.cgh.2014.03.019	45	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0130377	10.1371/journal.pone.0130377	http://dx.doi.org/10.1371/journal.pone.0130377			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079486	Green Published, gold, Green Submitted			2022-12-27	WOS:000356542300043
J	Daniels, K; Sanders, D; Daviaud, E; Doherty, T				Daniels, Karen; Sanders, David; Daviaud, Emmanuelle; Doherty, Tanya			Valuing and Sustaining (or Not) the Ability of Volunteer Community Health Workers to Deliver Integrated Community Case Management in Northern Ghana: A Qualitative Study	PLOS ONE			English	Article							CHILD SURVIVAL; INCOME COUNTRIES; SCALING-UP; SERVICES; PROGRAM; PERCEPTIONS; MALARIA; AFRICA; MIDDLE; CARE	Background Within the integrated community case management of childhood illnesses (iCCM) programme, the traditional health promotion and prevention role of community health workers (CHWs) has been expanded to treatment. Understanding both the impact and the implementation experience of this expanded role are important. In evaluating UNICEF's implementation of iCCM, this qualitative case study explores the implementation experience in Ghana. Methods and Findings Data were collected through a rapid appraisal using focus groups and individual interviews during a field visit in May 2013 to Accra and the Northern Region of Ghana. We sought to understand the experience of iCCM from the perspective of locally based UNICEF staff, their partners, researchers, Ghana health services management staff, CHWs and their supervisors, nurses in health facilities and mothers receiving the service. Our analysis of the findings showed that there is an appreciation both by mothers and by facility level staff for the contribution of CHWs. Appreciation was expressed for the localisation of the treatment of childhood illness, thus saving mothers from the effort and expense of having to seek treatment outside of the village. Despite an overall expression of value for the expanded role of CHWs, we also found that there were problems in supporting and sustaining their efforts. The data showed concern around CHWs being unpaid, poorly supervised, regularly out of stock, lacking in essential equipment and remaining outside the formal health system. Conclusions Expanding the roles of CHWs is important and can be valuable, but contextual and health system factors threaten the sustainability of iCCM in Ghana. In this and other implementation sites, policymakers and key donors need to take into account historical lessons from the CHW literature, while exploring innovative and sustainable mechanisms to secure the programme as part of a government owned and government led strategy.	[Daniels, Karen; Daviaud, Emmanuelle; Doherty, Tanya] South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa; [Sanders, David; Doherty, Tanya] Univ Western Cape, Sch Publ Hlth, ZA-7535 Bellville, South Africa; [Sanders, David] Univ Cape Town, Fac Hlth Sci, Sch Child & Adolescent Hlth, ZA-7700 Rondebosch, South Africa	South African Medical Research Council; University of the Western Cape; University of Cape Town	Daniels, K (corresponding author), South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa.	karen.daniels@mrc.ac.za	Daniels, Karen/AAY-8659-2020	Daniels, Karen/0000-0002-4345-5406	Department of Foreign Affairs, Trade and Development Canada (DFATD); NRF	Department of Foreign Affairs, Trade and Development Canada (DFATD); NRF	The Department of Foreign Affairs, Trade and Development Canada (DFATD) funded the study through a grant to UNICEF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. UNICEF, who commissioned the study to the South African Medical Research Council (SAMRC), provided technical support to protocol development, and development of the interview guides. They also reviewed the manuscript drafts. All decisions regarding manuscript content and the decision to submit for publication where made by the authors. KD, EM and TD are salaried employees of the SAMRC. DS was paid by the SAMRC as a consultant on this study and he is also employed part- time at the University of the Western Cape. TD and DS are National Research Foundation (NRF) rated scholars. As such, they (TD and DS) receive generalised financial support from the NRF, but the NRF has played no direct role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyepong IA, 2008, HEALTH POLICY PLANN, V23, P150, DOI 10.1093/heapol/czn002; Ankrah OE, 2013, HLTH POLICY PLAN, DOI [10.1093/heapol/czt013, DOI 10.1093/HEAP0L/CZT013]; Atun R, 2011, JAIDS-J ACQ IMM DEF, V57, pS72, DOI 10.1097/QAI.0b013e318221842a; Baum F. E., 2007, SOC MED, V2, P34; Bennett S, 2014, TROP MED INT HEALTH, V19, P872, DOI 10.1111/tmi.12319; Bhattacharyya K, 2001, COMMUNITY HLTH WORKE; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; Bryce J, 2010, LANCET, V375, P572, DOI 10.1016/S0140-6736(09)62060-2; Chinbuah AM, 2006, TROP MED INT HEALTH, V11, P1003, DOI 10.1111/j.1365-3156.2006.01654.x; Colvin C, 2012, INITIA IN PRESS 0712; Dil Y, 2012, J COMMUN HEALTH, V37, P1192, DOI 10.1007/s10900-012-9569-5; Doherty T, 2014, REPORT SUMMATIVE EXT; Dovlo Delanyo, 2004, Hum Resour Health, V2, P7, DOI 10.1186/1478-4491-2-7; Fereday J., 2006, INT J QUAL METH, V5, P80, DOI [DOI 10.1177/160940690600500107, 10.1177/160940690600500107]; George A, 2012, AM J TROP MED HYG, V87, P85, DOI 10.4269/ajtmh.2012.11-0757; GILSON L, 1989, Journal of Public Health Policy, V10, P518, DOI 10.2307/3342522; Glenton C, 2010, SOC SCI MED, V70, P1920, DOI 10.1016/j.socscimed.2010.02.034; Global Health Workforce Alliance (GHWA): Task Force on Scaling Up Education and Training for Health Workers, 2008, TASK FORC SCAL ED TR, DOI [10.1016/S0140-6736(08)60309-8, DOI 10.1016/S0140-6736(08)60309-8]; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Green J., 2018, QUALITATIVE METHODS, VFourth; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hill Z, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24085; Jimba M, 2010, 1 GLOB S HLTH SYST R; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kok MC, 2015, HEALTH POLICY PLANN, V30, P1207, DOI 10.1093/heapol/czu126; Kvale S, 1996, INTERVIEWS INTRO QUA; Lehmann U, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-49; Lewin S, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004015.pub2, DOI 10.1002/14651858.CD004015.PUB2]; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McGorman L, 2012, AM J TROP MED HYG, V87, P69, DOI 10.4269/ajtmh.2012.11-0758; McPake B, 2008, LANCET, V372, P870, DOI 10.1016/S0140-6736(08)61375-6; Mugeni C, 2011, DRAFT BACKGROUND PAP; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; OforiAdjei D, 1996, SOC SCI MED, V42, P1169, DOI 10.1016/0277-9536(95)00389-4; Pallas SW, 2015, B WORLD HEALTH ORGAN, V93, P11, DOI 10.2471/BLT.14.141614; Pallas SW, 2013, AM J PUBLIC HEALTH, V103, pE74, DOI 10.2105/AJPH.2012.301102; People's Health Movement Medact Health Action International Medicos International Third World Network, 2011, GLOBAL HLTH WATCH, V3; Perry HB, 2014, ANNU REV PUBL HEALTH, V35, P399, DOI 10.1146/annurev-publhealth-032013-182354; Phillips JF, 2006, B WORLD HEALTH ORGAN, V84, P949, DOI 10.2471/BLT.06.030064; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; South African Medical Research Council University of the Western Cape and Save the Children, 2014, REP SUMM EXT EV CAT; Strachan DL, 2012, AM J TROP MED HYG, V87, P111, DOI 10.4269/ajtmh.2012.12-0030; UNICEF, 2013, CAT IN SUPP IN UNPUB; UNICEF, 2012, UNICEF ANN PROGR REP; UNICEF Ghana GHS NHRC and LSTM, 2013, INTERVENTIONS; USAID Center for Development Information and Evaluation, 1996, US RAP APPR METH PER; Vondal P., 2010, USING RAPID APPRAISA; World Health Organisation, 2007, WHOHSS0901; World Health Organisation: Health Systems and Services (HSS) Cluster, 2009, HLTH SYST SERV ANN R; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	51	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0126322	10.1371/journal.pone.0126322	http://dx.doi.org/10.1371/journal.pone.0126322			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9EB	26079713	Green Published, gold, Green Submitted			2022-12-27	WOS:000356542300001
J	Besser, S; Sicker, M; Marx, G; Winkler, U; Eulenburg, V; Hulsmann, S; Hirrlinger, J				Besser, Stefanie; Sicker, Marit; Marx, Grit; Winkler, Ulrike; Eulenburg, Volker; Huelsmann, Swen; Hirrlinger, Johannes			A Transgenic Mouse Line Expressing the Red Fluorescent Protein tdTomato in GABAergic Neurons	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; GAMMA-AMINOBUTYRIC-ACID; MESSENGER-RNAS; 2 FORMS; COMPARATIVE LOCALIZATION; GLYCINERGIC NEURONS; ADULT NEUROGENESIS; CELL-PROLIFERATION; SUBEPENDYMAL LAYER; MICE LACKING	GABAergic inhibitory neurons are a large population of neurons in the central nervous system (CNS) of mammals and crucially contribute to the function of the circuitry of the brain. To identify specific cell types and investigate their functions labelling of cell populations by transgenic expression of fluorescent proteins is a powerful approach. While a number of mouse lines expressing the green fluorescent protein (GFP) in different subpopulations of GABAergic cells are available, GFP expressing mouse lines are not suitable for either crossbreeding to other mouse lines expressing GFP in other cell types or for Ca2+-imaging using the superior green Ca2+-indicator dyes. Therefore, we have generated a novel transgenic mouse line expressing the red fluorescent protein tdTomato in GABAergic neurons using a bacterial artificial chromosome based strategy and inserting the tdTomato open reading frame at the start codon within exon 1 of the GAD2 gene encoding glutamic acid decarboxylase 65 (GAD65). TdTomato expression was observed in all expected brain regions; however, the fluorescence intensity was highest in the olfactory bulb and the striatum. Robust expression was also observed in cortical and hippocampal neurons, Purkinje cells in the cerebellum, amacrine cells in the retina as well as in cells migrating along the rostral migratory stream. In cortex, hippocampus, olfactory bulb and brainstem, 80% to 90% of neurons expressing endogenous GAD65 also expressed the fluorescent protein. Moreover, almost all tdTomato-expressing cells coexpressed GAD65, indicating that indeed only GABAergic neurons are labelled by tdTomato expression. This mouse line with its unique spectral properties for labelling GABAergic neurons will therefore be a valuable new tool for research addressing this fascinating cell type.	[Besser, Stefanie; Sicker, Marit; Marx, Grit; Hirrlinger, Johannes] Univ Leipzig, Carl Ludwig Inst Physiol, D-04109 Leipzig, Germany; [Eulenburg, Volker] Univ Erlangen Nurnberg, Inst Biochem & Mol Med, D-91054 Erlangen, Germany; [Huelsmann, Swen] Univ Hosp Gottingen, Anesthesiol Clin, Lab Expt Neuroanesthesiol, Gottingen, Germany; [Huelsmann, Swen] Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, Gottingen, Germany; [Hirrlinger, Johannes] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany	Leipzig University; University of Erlangen Nuremberg; University of Gottingen; Max Planck Society	Hirrlinger, J (corresponding author), Univ Leipzig, Carl Ludwig Inst Physiol, D-04109 Leipzig, Germany.	johannnes.hirrlinger@medizin.uni-leipzig.de	Hülsmann, Swen/F-7169-2010; Hirrlinger, Johannes/F-5984-2010; Eulenburg, Volker/B-7263-2013	Hülsmann, Swen/0000-0001-5042-8724; Eulenburg, Volker/0000-0002-4878-5746	"Deutsche Forschungsgemeinschaft" (DFG) [HI1414/2-1, HU797/7-1]	"Deutsche Forschungsgemeinschaft" (DFG)(German Research Foundation (DFG))	The work was supported by the "Deutsche Forschungsgemeinschaft" (DFG; www.dfg.de), grants to JH (HI1414/2-1) and SH (HU797/7-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen K, 2015, CURR OPIN NEUROBIOL, V31, P81, DOI 10.1016/j.conb.2014.08.016; ALTMAN J, 1963, ANAT REC, V145, P573, DOI 10.1002/ar.1091450409; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Balasubramanian Revathi, 2014, Curr Ophthalmol Rep, V2, P100; BLAKEMORE WF, 1972, J NEUROCYTOL, V1, P69, DOI 10.1007/BF01098647; Botcher NA, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00104; BRECHA NC, 1991, CELL MOL NEUROBIOL, V11, P497, DOI 10.1007/BF00734812; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; Caputi A, 2013, CURR OPIN NEUROBIOL, V23, P179, DOI 10.1016/j.conb.2013.01.021; Connaughton VP, 1999, VISUAL NEUROSCI, V16, P483, DOI 10.1017/S0952523899163090; CROOKS J, 1992, J COMP NEUROL, V315, P287, DOI 10.1002/cne.903150305; De Marchis S, 2004, EUR J NEUROSCI, V20, P1307, DOI 10.1111/j.1460-9568.2004.03584.x; DeFelipe J, 2002, PROG BRAIN RES, V136, P215; Deniz S, 2011, J NEUROCHEM, V116, P350, DOI 10.1111/j.1471-4159.2010.07114.x; Dkhissi O, 2001, BRAIN RES, V919, P242, DOI 10.1016/S0006-8993(01)03022-0; Dumoulin A, 2001, J NEUROSCI, V21, P6045, DOI 10.1523/JNEUROSCI.21-16-06045.2001; Dupuy ST, 1996, J NEUROSCI, V16, P6919; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; ESCLAPEZ M, 1993, J COMP NEUROL, V331, P339, DOI 10.1002/cne.903310305; FELDBLUM S, 1993, J NEUROSCI RES, V34, P689, DOI 10.1002/jnr.490340612; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fujita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086679; Fukuda T, 1997, BRAIN RES, V764, P237, DOI 10.1016/S0006-8993(97)00683-5; Gelman D.M., 2012, JASPERS BASIC MECH E; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Ishibashi H, 2013, J PHYSIOL-LONDON, V591, P3821, DOI 10.1113/jphysiol.2012.250647; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kao YH, 2006, VISUAL NEUROSCI, V23, P931, DOI 10.1017/S0952523806230293; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; KATAROVA Z, 1990, EUR J NEUROSCI, V2, P190, DOI 10.1111/j.1460-9568.1990.tb00412.x; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; KOBAYASHI Y, 1987, J NEUROSCI, V7, P2768; KOSAKA T, 1987, BRAIN RES, V419, P119, DOI 10.1016/0006-8993(87)90575-0; Liu YQ, 2014, NEUROSCI BULL, V30, P985, DOI 10.1007/s12264-014-1478-4; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; Lovett-Barron M, 2014, CURR OPIN NEUROBIOL, V26, P27, DOI 10.1016/j.conb.2013.11.002; Lu T, 2008, NEURON, V57, P524, DOI 10.1016/j.neuron.2007.12.010; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MARTIN DL, 1991, J NEUROSCI, V11, P2725; MARTIN DL, 1991, NEUROCHEM RES, V16, P243, DOI 10.1007/BF00966087; Masland RH, 2012, VISUAL NEUROSCI, V29, P3, DOI 10.1017/S0952523811000344; MCDERMOTT KWG, 1990, DEV BRAIN RES, V57, P269, DOI 10.1016/0165-3806(90)90053-2; Meyer AH, 2002, J NEUROSCI, V22, P7055; Millen KJ, 1995, DEVELOPMENT, V121, P3935; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Namba K, 2011, J COMP NEUROL, V519, P2594, DOI 10.1002/cne.22640; Nolte C, 2001, GLIA, V33, P72; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Plachez C, 2012, J MOL HISTOL, V43, P215, DOI 10.1007/s10735-012-9394-2; PRIVAT A, 1972, J COMP NEUROL, V146, P277, DOI 10.1002/cne.901460302; Rahman J, 2013, EUR J NEUROSCI, V37, P1229, DOI 10.1111/ejn.12136; Roux L, 2015, NEUROPHARMACOLOGY, V88, P10, DOI 10.1016/j.neuropharm.2014.09.011; Sakamoto M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00121; Schnell C, 2015, BRAIN STRUCT FUNCT, V220, P193, DOI 10.1007/s00429-013-0645-0; Stephan Heckers, 2014, SCHIZOPHR RES; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Trudeau LE, 2007, MOL INTERV, V7, P138, DOI 10.1124/mi.7.3.5; VARDI N, 1995, J COMP NEUROL, V351, P374, DOI 10.1002/cne.903510305; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349; Zhang Z, 2011, NAT MED, V17, P1448, DOI 10.1038/nm.2442	69	21	21	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129934	10.1371/journal.pone.0129934	http://dx.doi.org/10.1371/journal.pone.0129934			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076353	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900114
J	Fan, XH; Hughes, BG; Ali, MAM; Cho, WJ; Lopez, W; Schulz, R				Fan, Xiaohu; Hughes, Bryan G.; Ali, Mohammad A. M.; Cho, Woo Jung; Lopez, Waleska; Schulz, Richard			Dynamic Alterations to alpha-Actinin Accompanying Sarcomere Disassembly and Reassembly during Cardiomyocyte Mitosis	PLOS ONE			English	Article							BINUCLEATED CARDIAC MYOCYTES; MATRIX METALLOPROTEINASE-2; CELL-CYCLE; IMMUNOELECTRON MICROSCOPY; MAMMALIAN CARDIOMYOCYTES; PHOSPHORYLATION SITES; PROTEIN PHOSPHATASES; HEART REGENERATION; REPERFUSION INJURY; MYOCARDIAL INJURY	Although mammals are thought to lose their capacity to regenerate heart muscle shortly after birth, embryonic and neonatal cardiomyocytes in mammals are hyperplastic. During proliferation these cells need to selectively disassemble their myofibrils for successful cytokinesis. The mechanism of sarcomere disassembly is, however, not understood. To study this, we performed a series of immunofluorescence studies of multiple sarcomeric proteins in proliferating neonatal rat ventricular myocytes and correlated these observations with biochemical changes at different cell cycle stages. During myocyte mitosis, alpha-actinin and titin were disassembled as early as prometaphase. alpha-actinin (representing the sarcomeric Z-disk) disassembly precedes that of titin (M-line), suggesting that titin disassembly occurs secondary to the collapse of the Z-disk. Sarcomere disassembly was concurrent with the dissolution of the nuclear envelope. Inhibitors of several intracellular proteases could not block the disassembly of alpha-actinin or titin. There was a dramatic increase in both cytosolic (soluble) and sarcomeric alpha-actinin during mitosis, and cytosolic alpha-actinin exhibited decreased phosphorylation compared to sarcomeric alpha-actinin. Inhibition of cyclin-dependent kinase 1 (CDK1) induced the quick reassembly of the sarcomere. Sarcomere dis- and re-assembly in cardiomyocyte mitosis is CDK1-dependent and features dynamic differential post-translational modifications of sarcomeric and cytosolic alpha-actinin.	[Fan, Xiaohu; Hughes, Bryan G.; Ali, Mohammad A. M.; Lopez, Waleska; Schulz, Richard] Univ Alberta, Fac Med & Dent, Dept Pediat, Edmonton, AB, Canada; [Fan, Xiaohu; Hughes, Bryan G.; Ali, Mohammad A. M.; Lopez, Waleska; Schulz, Richard] Univ Alberta, Fac Med & Dent, Dept Pharmacol, Edmonton, AB, Canada; [Fan, Xiaohu; Hughes, Bryan G.; Ali, Mohammad A. M.; Lopez, Waleska; Schulz, Richard] Univ Alberta, Fac Med & Dent, Cardiovasc Res Ctr, Edmonton, AB, Canada; [Fan, Xiaohu; Hughes, Bryan G.; Ali, Mohammad A. M.; Lopez, Waleska; Schulz, Richard] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Cho, Woo Jung] Univ Alberta, Fac Med & Dent, Dept Med Microbiol & Immunol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Schulz, R (corresponding author), Univ Alberta, Fac Med & Dent, Dept Pediat, Edmonton, AB, Canada.	Richard.schulz@ualberta.ca	Hughes, Bryan/L-4964-2017	Hughes, Bryan/0000-0002-2718-3818; Ali, Mohammad/0000-0002-6404-4198	Canadian Institutes of Health Research [MOP-66953]; Alberta Innovates - Health Solutions	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates - Health Solutions	This work was supported by the Canadian Institutes of Health Research (MOP-66953). MAM received a trainee award from Alberta Innovates - Health Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja P, 2004, J CELL SCI, V117, P3295, DOI 10.1242/jcs.01159; Ali MAM, 2012, J CELL PHYSIOL, V227, P3397, DOI 10.1002/jcp.24040; Ali MAM, 2012, BIOCHEM BIOPH RES CO, V423, P1, DOI 10.1016/j.bbrc.2012.05.005; Ali MAM, 2010, CIRCULATION, V122, P2039, DOI 10.1161/CIRCULATIONAHA.109.930222; Atkinson RA, 2000, BIOCHEMISTRY-US, V39, P5255, DOI 10.1021/bi991891u; Barr FA, 2011, J CELL SCI, V124, P2323, DOI 10.1242/jcs.087106; Barta J, 2005, MOL CELL BIOCHEM, V278, P1, DOI 10.1007/s11010-005-1370-7; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Chen F, 2007, CURR BIOL, V17, P293, DOI 10.1016/j.cub.2007.01.068; Ellis JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021169; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Engel FB, 2006, J MOL CELL CARDIOL, V41, P601, DOI 10.1016/j.yjmcc.2006.06.012; Fisher D, 2012, J CELL SCI, V125, P4703, DOI 10.1242/jcs.106351; Fukuda N, 2008, J PHYSIOL SCI, V58, P151, DOI 10.2170/physiolsci.RV005408; FURST DO, 1988, J CELL BIOL, V106, P1563, DOI 10.1083/jcb.106.5.1563; Gao JJ, 2010, MOL CELL PROTEOMICS, V9, P2586, DOI 10.1074/mcp.M110.001388; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Gupta V, 2012, FASEB J, V26, P1892, DOI 10.1096/fj.11-194548; Hernandez-Verdun D, 2011, NUCLEUS-PHILA, V2, P189, DOI 10.4161/nucl.2.3.16246; Horn H, 2014, NAT METHODS, V11, P603, DOI 10.1038/nmeth.2968; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kandasamy AD, 2009, CARDIOVASC RES, V83, P698, DOI 10.1093/cvr/cvp175; Kwan JA, 2004, FASEB J, V18, P690, DOI 10.1096/fj.02-1202fje; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Li FQ, 1997, J MOL CELL CARDIOL, V29, P1541, DOI 10.1006/jmcc.1997.0381; Li FQ, 1997, J MOL CELL CARDIOL, V29, P1553, DOI 10.1006/jmcc.1997.0403; Linke WA, 2010, CIRCULATION, V122, P2002, DOI 10.1161/CIRCULATIONAHA.110.985317; Luther PK, 2009, J MUSCLE RES CELL M, V30, P171, DOI 10.1007/s10974-009-9189-6; O'Donovan DS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.208; Obermann WMJ, 1996, J CELL BIOL, V134, P1441, DOI 10.1083/jcb.134.6.1441; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Porter Lisa A, 2003, Prog Cell Cycle Res, V5, P335; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Rossello A, 2004, BIOORGAN MED CHEM, V12, P2441, DOI 10.1016/j.bmc.2004.01.047; Sanger JW, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/858606; Sawicki G, 2005, CIRCULATION, V112, P544, DOI 10.1161/CIRCULATIONAHA.104.531616; Schoenwolf GC, 1995, CELL MOL BIOL RES, V41, P233; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Soonpaa MH, 1997, J CLIN INVEST, V99, P2644, DOI 10.1172/JCI119453; Srivastava D, 1997, TRENDS CELL BIOL, V7, P447, DOI 10.1016/S0962-8924(97)01150-1; Sung MM, 2007, J MOL CELL CARDIOL, V43, P429, DOI 10.1016/j.yjmcc.2007.07.055; Trost B, 2011, BIOINFORMATICS, V27, P2927, DOI 10.1093/bioinformatics/btr525; van Amerongen MJ, 2008, J CELL MOL MED, V12, P2233, DOI 10.1111/j.1582-4934.2008.00439.x; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Viappiani S, 2009, BIOCHEM PHARMACOL, V77, P826, DOI 10.1016/j.bcp.2008.11.004; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wang WJ, 2002, CIRCULATION, V106, P1543, DOI 10.1161/01.CIR.0000028818.33488.7B; Wang WJ, 2002, CARDIOVASC RES, V53, P165, DOI 10.1016/S0008-6363(01)00445-X; Zhang ZY, 2006, J BIOL CHEM, V281, P1746, DOI 10.1074/jbc.M509590200	53	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129176	10.1371/journal.pone.0129176	http://dx.doi.org/10.1371/journal.pone.0129176			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076379	Green Submitted, gold, Green Published			2022-12-27	WOS:000356329900051
J	Hayashi, T; Yao, SY; Crain, B; Promessi, VJ; Shyu, L; Sheng, C; Kang, M; Cottam, HB; Carson, DA; Corr, M				Hayashi, Tomoko; Yao, Shiyin; Crain, Brian; Promessi, Victor J.; Shyu, Luke; Sheng, Caroline; Kang, McNancy; Cottam, Howard B.; Carson, Dennis A.; Corr, Maripat			Induction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 Diabetes	PLOS ONE			English	Article							INNATE IMMUNITY; T-CELLS; CD127 EXPRESSION; NOD MICE; ACTIVATION; PREVENTION; AUTOIMMUNITY; STIMULATION; VITAMIN-D-3; INHIBITION	Autoimmune diabetes mellitus (DM) results from the destruction of pancreatic islet cells by activated T lymphocytes, which have been primed by activated dendritic cells (DC). Individualized therapy with ex vivo DC manipulation and reinfusion has been proposed as a treatment for DM, but this treatment is limited by cost, and requires specialized facilities. A means of in situ modulation of the DC phenotype in the host would be more accessible. Here we report a novel innate immune modulator, 1Z1, generated by conjugating a TLR7 ligand to six units of polyethylene glycol (PEG), which skews DC phenotype in vivo. 1Z1 was less potent in inducing cytokine production by DC than the parent ligand in vitro and in vivo. In addition, this drug only modestly increased DC surface expression of activation markers such as MHC class II, CD80, and CD86; however, the expression of negative regulatory molecules, such as programmed death ligand 1 (PD-L1), and interleukin-1 receptor-associated kinase M (IRAK-M) were markedly increased. In vivo transfer of 1Z1 treated DC into prediabetic NOD mice delayed pancreatic insulitis. Daily administration of 1Z1 effectively prevented the clinical onset of hyperglycemia and reduced histologic islet inflammation. Daily treatment with 1Z1 increased PD-L1 expression in the CD11c(+) population in peri-pancreatic lymph nodes; however, it did not induce an increase in regulatory T cells. Pharmaceutical modulation of DC maturation and function in situ, thus represents an opportunity to treat autoimmune disease.	[Hayashi, Tomoko; Yao, Shiyin; Crain, Brian; Promessi, Victor J.; Shyu, Luke; Sheng, Caroline; Kang, McNancy; Cottam, Howard B.; Carson, Dennis A.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Corr, Maripat] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Corr, M (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mcorr@ucsd.edu			Juvenile Diabetes Research Foundation [5-2011-212]; Telormedix SA (Bioggio, Switzerland); NIAMS [R21 AR062236-02]; Innovative Research Grant from the Rheumatology Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR062236] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Telormedix SA (Bioggio, Switzerland); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Innovative Research Grant from the Rheumatology Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This project was supported in part by research grants from Juvenile Diabetes Research Foundation (5-2011-212, http://jdrf.org)(DAC), Telormedix SA (Bioggio, Switzerland, http://www.telormedix.com) (TH), R21 AR062236-02 from NIAMS (http://www.niams.nih.gov) and an Innovative Research Grant from the Rheumatology Research Foundation (http://www.rheumatology.org) (MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2003, ANN NY ACAD SCI, V987, P258, DOI 10.1111/j.1749-6632.2003.tb06057.x; Arora M, 2011, INT IMMUNOPHARMACOL, V11, P827, DOI 10.1016/j.intimp.2011.01.034; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Tabarrozzi AEB, 2013, CLIN EXP IMMUNOL, V171, P135, DOI 10.1111/cei.12019; Barrat FJ, 2008, IMMUNOL REV, V223, P271, DOI 10.1111/j.1600-065X.2008.00630.x; Bluestone JA, 2007, NAT REV IMMUNOL, V7, P650, DOI 10.1038/nri2137; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Chan M, 2011, BIOCONJUGATE CHEM, V22, P445, DOI 10.1021/bc1004813; Chan M, 2009, BIOCONJUGATE CHEM, V20, P1194, DOI 10.1021/bc900054q; Cole TS, 2012, IMMUNOL LETT, V144, P49, DOI 10.1016/j.imlet.2012.03.006; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; Diana J, 2011, DISCOV MED, V11, P513; Farias AS, 2013, CNS NEUROSCI THER, V19, P269, DOI 10.1111/cns.12071; Feili-Hariri M, 2002, EUR J IMMUNOL, V32, P2021, DOI 10.1002/1521-4141(200207)32:7<2021::AID-IMMU2021>3.0.CO;2-J; Feili-Hariri M, 1999, DIABETES, V48, P2300, DOI 10.2337/diabetes.48.12.2300; Filippi CM, 2011, EUR J IMMUNOL, V41, P1399, DOI 10.1002/eji.200939841; Garate D, 2013, ARTHRITIS RHEUM-US, V65, P120, DOI 10.1002/art.37702; Giannoukakis N, 2012, IMMUNOTHERAPY-UK, V4, P1063, DOI [10.2217/IMT.12.76, 10.2217/imt.12.76]; Grieco FA, 2011, SEMIN IMMUNOPATHOL, V33, P57, DOI 10.1007/s00281-010-0206-z; Hayashi T, 2004, J CLIN INVEST, V114, P270, DOI 10.1172/JCI200421275; Hayashi T, 2008, AM J PHYSIOL-REG I, V295, pR123, DOI 10.1152/ajpregu.00527.2007; Hayashi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045860; Hayashi T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/262394; Hayashi T, 2009, P NATL ACAD SCI USA, V106, P2764, DOI 10.1073/pnas.0813037106; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Jaen O, 2009, IMMUNOLOGY, V126, P35, DOI 10.1111/j.1365-2567.2008.02875.x; Karumuthil-Melethil S, 2008, J IMMUNOL, V181, P8323, DOI 10.4049/jimmunol.181.12.8323; Kim DH, 2012, DIABETOLOGIA, V55, P3308, DOI 10.1007/s00125-012-2723-x; Kim DH, 2011, J IMMUNOL, V187, P5211, DOI 10.4049/jimmunol.1001388; Kim HS, 2009, CURR MOL MED, V9, P30, DOI 10.2174/156652409787314471; Kurimoto A, 2004, BIOORGAN MED CHEM, V12, P1091, DOI 10.1016/j.bmc.2003.12.008; Lan YY, 2006, J IMMUNOL, V177, P5868, DOI 10.4049/jimmunol.177.9.5868; Lee J, 2006, P NATL ACAD SCI USA, V103, P1828, DOI 10.1073/pnas.0510801103; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Leiter Edward H, 2001, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1509s24; Lewkowicz P, 2006, J IMMUNOL, V177, P7155, DOI 10.4049/jimmunol.177.10.7155; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lo J, 2006, AUTOIMMUN REV, V5, P419, DOI 10.1016/j.autrev.2005.12.001; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Ma LL, 2003, DIABETES, V52, P1976, DOI 10.2337/diabetes.52.8.1976; Mackern-Oberti JP, 2014, INT J MOL SCI, V15, P16381, DOI 10.3390/ijms150916381; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Marin-Gallen S, 2010, CLIN EXP IMMUNOL, V160, P207, DOI 10.1111/j.1365-2249.2009.04082.x; Mbongue J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/857143; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Mukherjee G, 2010, CLIN EXP IMMUNOL, V161, P197, DOI 10.1111/j.1365-2249.2010.04157.x; Orabona C, 2006, BLOOD, V107, P2846, DOI 10.1182/blood-2005-10-4077; Phillips B, 2011, CLIN DEV IMMUNOL, P1, DOI 10.1155/2011/432016; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Salazar L, 2007, EUR CYTOKINE NETW, V18, P78, DOI 10.1684/ecn.2007.0089; Sathish JG, 2013, NAT REV DRUG DISCOV, V12, P306, DOI 10.1038/nrd3974; Shiu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066914; Simonetta F, 2010, EUR J IMMUNOL, V40, P2528, DOI 10.1002/eji.201040531; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; TOCHINO Y, 1988, CRIT REV IMMUNOL, V8, P49; Torres-Aguilar H, 2010, AUTOIMMUN REV, V10, P8, DOI 10.1016/j.autrev.2010.07.015; Torres-Aguilar H, 2010, J IMMUNOL, V184, P1765, DOI 10.4049/jimmunol.0902133; Unger WWJ, 2009, EUR J IMMUNOL, V39, P3147, DOI 10.1002/eji.200839103; Zipris D, 2008, CURR OPIN ENDOCRINOL, V15, P326, DOI 10.1097/MED.0b013e3283073a46	59	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129867	10.1371/journal.pone.0129867	http://dx.doi.org/10.1371/journal.pone.0129867			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076454	Green Submitted, gold, Green Published			2022-12-27	WOS:000356329900106
J	Suarez, MH; Dopazo, GA; Lopez, DL; Espinosa, F				Hernandez Suarez, Marcos; Astray Dopazo, Gonzalo; Larios Lopez, Dina; Espinosa, Francisco			Identification of Relevant Phytochemical Constituents for Characterization and Authentication of Tomatoes by General Linear Model Linked to Automatic Interaction Detection (GLM-AID) and Artificial Neural Network Models (ANNs)	PLOS ONE			English	Article							ANTIOXIDANT CONTENT; SEASONAL-VARIATIONS; QUALITY; PREDICTION; CLASSIFICATION; TEMPERATURE; SYSTEMS; ACID	There are a large number of tomato cultivars with a wide range of morphological, chemical, nutritional and sensorial characteristics. Many factors are known to affect the nutrient content of tomato cultivars. A complete understanding of the effect of these factors would require an exhaustive experimental design, multidisciplinary scientific approach and a suitable statistical method. Some multivariate analytical techniques such as Principal Component Analysis (PCA) or Factor Analysis (FA) have been widely applied in order to search for patterns in the behaviour and reduce the dimensionality of a data set by a new set of uncorrelated latent variables. However, in some cases it is not useful to replace the original variables with these latent variables. In this study, Automatic Interaction Detection (AID) algorithm and Artificial Neural Network (ANN) models were applied as alternative to the PCA, AF and other multivariate analytical techniques in order to identify the relevant phytochemical constituents for characterization and authentication of tomatoes. To prove the feasibility of AID algorithm and ANN models to achieve the purpose of this study, both methods were applied on a data set with twenty five chemical parameters analysed on 167 tomato samples from Tenerife (Spain). Each tomato sample was defined by three factors: cultivar, agricultural practice and harvest date. General Linear Model linked to AID (GLM-AID) tree-structured was organized into 3 levels according to the number of factors. p-Coumaric acid was the compound the allowed to distinguish the tomato samples according to the day of harvest. More than one chemical parameter was necessary to distinguish among different agricultural practices and among the tomato cultivars. Several ANN models, with 25 and 10 input variables, for the prediction of cultivar, agricultural practice and harvest date, were developed. Finally, the models with 10 input variables were chosen with fit's goodness between 44 and 100%. The lowest fits were for the cultivar classification, this low percentage suggests that other kind of chemical parameter should be used to identify tomato cultivars.	[Hernandez Suarez, Marcos] Aula Dei Sci Technol Pk Fdn, Zaragoza, Spain; [Astray Dopazo, Gonzalo; Larios Lopez, Dina] Ohio Univ, Coll Arts & Sci, Dept Geol Sci, Athens, OH 45701 USA; [Astray Dopazo, Gonzalo] Univ Vigo, Fac Sci, Dept Phys Chem, Orense, Spain; [Espinosa, Francisco] Univ Extremadura, Fac Sci, Dept Plant Physiol Ecol & Earth Sci, Badajoz, Spain	University System of Ohio; Ohio University; Universidade de Vigo; Universidad de Extremadura	Espinosa, F (corresponding author), Univ Extremadura, Fac Sci, Dept Plant Physiol Ecol & Earth Sci, Badajoz, Spain.	espinosa@unex.es	Espinosa, Francisco/I-8205-2018	Espinosa, Francisco/0000-0002-6467-0359; Lopez, Dina/0000-0003-2680-5862; Astray, Gonzalo/0000-0002-0890-1191	Xunta de Galicia, Conselleria de Cultura, Educacion e Ordenacion Universitaria [P.P.0000 421S 140.08]; regional Government of Extremadura [GR10084]	Xunta de Galicia, Conselleria de Cultura, Educacion e Ordenacion Universitaria(Xunta de Galicia); regional Government of Extremadura	GAD thanks Xunta de Galicia, Conselleria de Cultura, Educacion e Ordenacion Universitaria, for the Postdoctoral grant (Plan I2C), P.P.0000 421S 140.08, and FE thanks the regional Government of Extremadura by the support to the research Group FBCMP (GR10084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; AOAC, 1990, OFFICIAL METHODS ANA; Araujo P, 2011, J ENVIRON MONITOR, V13, P35, DOI 10.1039/c0em00478b; Arvanitoyannis IS, 2007, CRIT REV FOOD SCI, V47, P675, DOI 10.1080/10408390600948568; Bilgili M, 2007, RENEW ENERG, V32, P2350, DOI 10.1016/j.renene.2006.12.001; Biswas MK, 2011, SCI HORTIC-AMSTERDAM, V129, P798, DOI 10.1016/j.scienta.2011.06.015; Canene-Adams K, 2005, J NUTR, V135, P1226, DOI 10.1093/jn/135.5.1226; Cebolla-Cornejo J, 2011, J AGR FOOD CHEM, V59, P2440, DOI 10.1021/jf1045427; Chuang Y H, 1967, Comput Biomed Res, V1, P173; Claye SS, 1996, FOOD CHEM, V57, P305, DOI 10.1016/0308-8146(95)00250-2; Fanasca S, 2006, J AGR FOOD CHEM, V54, P4319, DOI 10.1021/jf0602572; GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.1093/biomet/58.3.453; Galindo Villardon M.P., 1986, QUESTIIO, V10, P13; Gautier H, 2008, J AGR FOOD CHEM, V56, P1241, DOI 10.1021/jf072196t; Grattan SR, 1999, SCI HORTIC-AMSTERDAM, V78, P127, DOI 10.1016/S0304-4238(98)00192-7; Gundersen V, 2001, J AGR FOOD CHEM, V49, P3808, DOI 10.1021/jf0103774; Hernandez M, 2014, J PLANT NUTR SOIL SC, V177, P443, DOI 10.1002/jpln.201200642; Hernandez Suarez M, 2013, TOMATOES CULTIVATION, P191; HUNT KJ, 1992, AUTOMATICA, V28, P1083, DOI 10.1016/0005-1098(92)90053-I; KLEINFELD D, 1986, P NATL ACAD SCI USA, V83, P9469, DOI 10.1073/pnas.83.24.9469; Lamia K, 2010, SCI HORTIC-AMSTERDAM, V127, P54, DOI 10.1016/j.scienta.2010.09.012; Larcher W, 2003, PHYSL PLANT ECOLOGY, pChapter 6; Leonardi C, 2000, J AGR FOOD CHEM, V48, P4723, DOI 10.1021/jf000225t; Loh WY, 1997, STAT SINICA, V7, P815; Lutsenko EA, 2004, MOL CELL BIOL, V24, P3150, DOI 10.1128/MCB.24.8.3150-3156.2004; Max JFJ, 2009, SCI HORTIC-AMSTERDAM, V122, P179, DOI 10.1016/j.scienta.2009.05.007; Moldes OA, 2013, TENSIDE SURFACT DET, V50, P360, DOI 10.3139/113.110268; MORGAN JN, 1963, J AM STAT ASSOC, V58, P415, DOI 10.2307/2283276; Raffo A, 2006, J FOOD COMPOS ANAL, V19, P11, DOI 10.1016/j.jfca.2005.02.003; Galdon BR, 2010, J AGR FOOD CHEM, V58, P11435, DOI 10.1021/jf102014j; Rosales MA, 2006, J SCI FOOD AGR, V86, P1545, DOI 10.1002/jsfa.2546; Santesmases Mestre M, 2009, DYANE VERSION 4 DISE; Slimestad R, 2005, J AGR FOOD CHEM, V53, P3114, DOI 10.1021/jf047864e; Sutariya V., 2013, OPEN BIOINFORM J, V7, P49, DOI [DOI 10.2174/1875036201307010049, 10.2174/1875036201307010049]; Tedeschi P, 2011, J FOOD COMPOS ANAL, V24, P131, DOI 10.1016/j.jfca.2010.06.008; Thybo AK, 2006, LWT-FOOD SCI TECHNOL, V39, P835, DOI 10.1016/j.lwt.2005.09.010; Yin HB, 2002, TRANSPORT RES C-EMER, V10, P85, DOI 10.1016/S0968-090X(01)00004-3; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P225, DOI 10.1016/B978-0-12-386903-6.00009-5; Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7; Zhang YD, 2009, EXPERT SYST APPL, V36, P8849, DOI 10.1016/j.eswa.2008.11.028	40	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128566	10.1371/journal.pone.0128566	http://dx.doi.org/10.1371/journal.pone.0128566			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075889	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900021
J	Jabbour, G; Iancu, HD; Paulin, A; Lavoie, JM; Lemoine-Morel, S; Zouhal, H				Jabbour, Georges; Iancu, Horia-Daniel; Paulin, Anne; Lavoie, Jean-Marc; Lemoine-Morel, Sophie; Zouhal, Hassane			Effects of Acute Supramaximal Cycle Exercise on Plasma FFA Concentration in Obese Adolescent Boys	PLOS ONE			English	Article							ACCUMULATED OXYGEN DEFICIT; OXIDATION; METABOLISM; LIPOLYSIS; CHILDREN; INSULIN; SPRINT; GENDER; POWER	Aims The aims of the present study are 1) to evaluate the free fatty acid (FFA) profile and 2) to determine the relative anaerobic and aerobic contributions to total energy consumption during repeated supramaximal cycling bouts (SCE) in adolescent boys with different body weight statuses. Materials and Methods Normal-weight (NW), overweight (OW), and obese (OB) adolescent boys (n = 15 per group) completed a SCE sessions consisted of 6 x 6s maximal sprints with 2 min of passive rest between each repetition. Plasma FFA levels were determined at rest, immediately after a 10 min warm-up, and immediately at the end of SCE. The anaerobic and aerobic contributions (%) were measured via repeated SCE bouts. Insulin resistance was calculated using the homoeostatic model assessment (HOMA-IR) index. Results The FFA concentrations measured immediately after SCE were higher in the OB group than in the OW and NW (p<0.01 and p<0.01, respectively) groups. Moreover, the anaerobic contributions to SCE were significantly lower in obese adolescents (p<0.01) and decreased significantly during the 2nd, 3rd and 4th repetitions. The FFA levels were significantly associated with the HOMA-IR index and aerobic contribution among adolescent boys (r=0.83 and r=0.91, respectively, p<0.01). Conclusion In contrast to the NW and OW groups, there is an increase in lipid mobilization and sift to aerobic energy metabolism during SCE in the OB group.	[Jabbour, Georges; Iancu, Horia-Daniel; Paulin, Anne] Univ Moncton, Fac Hlth Sci & Community Serv, Sch Kinesiol & Leisure, Moncton, NB E1A 3E9, Canada; [Lavoie, Jean-Marc] Univ Montreal, Dept Kinesiol, Montreal, PQ H3C 3J7, Canada; [Lemoine-Morel, Sophie; Zouhal, Hassane] Univ Rennes 2, ENS Cachan, Movement Sport & Hlth Sci Lab, F-35043 Rennes, France	University of Moncton; Universite de Montreal; UDICE-French Research Universities; Universite Paris Saclay; Universite Rennes 2	Jabbour, G (corresponding author), Univ Moncton, Fac Hlth Sci & Community Serv, Sch Kinesiol & Leisure, Moncton, NB E1A 3E9, Canada.	georgesjabbour1980@hotmail.com	ZOUHAL, Hassane/AAE-6877-2021; Jabbour, Georges/P-1393-2019	ZOUHAL, Hassane/0000-0001-6743-6464; Jabbour, Georges/0000-0003-4758-8772	Faculty of Superior Studies and Research; Leadership Institute of the Ecole de kinesiologie et de Loisir of the Universte de Moncton	Faculty of Superior Studies and Research; Leadership Institute of the Ecole de kinesiologie et de Loisir of the Universte de Moncton	This work was funded by the Faculty of Superior Studies and Research and the Leadership Institute of the Ecole de kinesiologie et de Loisir of the Universte de Moncton (to GJ).	BLIMKIE CJR, 1990, EUR J APPL PHYSIOL, V61, P313, DOI 10.1007/BF00357619; Bogdanis GC, 1996, J APPL PHYSIOL, V80, P876, DOI 10.1152/jappl.1996.80.3.876; CAMPBELL PJ, 1992, AM J PHYSIOL, V263, pE1063; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; DANNUNZIO G, 2004, QUAD PEDIAT, V3, P44; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Duche P, 2002, MED SCI SPORT EXER, V34, P2072, DOI 10.1249/01.MSS.0000039305.73223.2E; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Fox E.L., 1974, INTERVAL TRAINING CO; GASTIN PB, 1995, MED SCI SPORT EXER, V27, P255; Greenhaff PL, 2002, BIOCHEM SOC T, V30, P275, DOI 10.1042/BST0300275; GUSTAFSON AB, 1990, METABOLISM, V39, P410, DOI 10.1016/0026-0495(90)90257-D; Horowitz JF, 2000, AM J CLIN NUTR, V72, p558S, DOI 10.1093/ajcn/72.2.558S; JENSEN MD, 1987, J CLIN INVEST, V79, P207, DOI 10.1172/JCI112785; Jensen MD, 1997, ANNU REV NUTR, V17, P127, DOI 10.1146/annurev.nutr.17.1.127; Lanzi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088707; Lazzer S, 2007, CLIN ENDOCRINOL, V67, P582, DOI 10.1111/j.1365-2265.2007.02929.x; Marker JC, 1996, AM J PHYSIOL, V260, P705; MARTIN ML, 1991, J CLIN INVEST, V88, P609, DOI 10.1172/JCI115345; McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232; Nevill ME, 1996, EUR J APPL PHYSIOL, V72, P460, DOI 10.1007/BF00242276; Perez-Martin A, 2001, DIABETES METAB, V27, P466; Ramsbottom R, 1994, J SPORT SCI, V12, P447, DOI 10.1080/02640419408732194; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Romijn JA, 1995, J APPL PHYSIOL, V79, P1939, DOI 10.1152/jappl.1995.79.6.1939; Sartorio A, 2006, J ENDOCRINOL INVEST, V29, P48, DOI 10.1007/BF03349176; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Spiro SG, 1997, BR J DIS CHEST, V71, P145; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Trapp EG, 2008, INT J OBESITY, V32, P684, DOI 10.1038/sj.ijo.0803781; VANBEAUMONT W, 1972, J APPL PHYSIOL, V32, P712, DOI 10.1152/jappl.1972.32.5.712; Vandewalle H.P., 1988, SCI MOV, V4, P38; Whyte LJ, 2010, METABOLISM, V59, P1421, DOI 10.1016/j.metabol.2010.01.002	33	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129654	10.1371/journal.pone.0129654	http://dx.doi.org/10.1371/journal.pone.0129654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076464	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900088
J	Jia, FJ; Wan, XM; Zhu, W; Sun, D; Zheng, CC; Liu, P; Huang, JG				Jia, Fengjuan; Wan, Xiaomin; Zhu, Wei; Sun, Dan; Zheng, Chengchao; Liu, Pei; Huang, Jinguang			Overexpression of Mitochondrial Phosphate Transporter 3 Severely Hampers Plant Development through Regulating Mitochondrial Function in Arabidopsis	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; OXIDATIVE STRESS; TRANSPORTER; EXPRESSION; POLLEN; PROTEIN; GROWTH; IDENTIFICATION; ACCUMULATION; RESPIRATION	Mitochondria are abundant and important organelles present in nearly all eukaryotic cells, which maintain metabolic communication with the cytosol through mitochondrial carriers. The mitochondrial membrane localized phosphate transporter (MPT) plays vital roles in diverse development and signaling processes, especially the ATP biosynthesis. Among the three MPT genes in Arabidopsis genome, AtMPT3 was proven to be a major member, and its overexpression gave rise to multiple developmental defects including curly leaves with deep color, dwarfed stature, and reduced fertility. Transcript profiles revealed that genes involved in plant metabolism, cellular redox homeostasis, alternative respiration pathway, and leaf and flower development were obviously altered in AtMPT3 overexpression (OEMPT3) plants. Moreover, OEMPT3 plants also accumulated higher ATP content, faster respiration rate and more reactive oxygen species (ROS) than wild type plants. Overall, our studies showed that AtMPT3 was indispensable for Arabidopsis normal growth and development, and provided new sights to investigate its possible regulation mechanisms.	[Jia, Fengjuan; Wan, Xiaomin; Zhu, Wei; Sun, Dan; Zheng, Chengchao; Huang, Jinguang] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Liu, Pei] Shandong Agr Univ, Coll Food Sci & Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Liu, P (corresponding author), Shandong Agr Univ, Coll Food Sci & Engn, Tai An, Shandong, Peoples R China.	liupei83224@sdau.edu.cn; jghuang@sdau.edu.cn			National Natural Science Foundation in China [31370305, 31000121]	National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation (Grant No. 31370305, 31000121) in China.	ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bartoli CG, 2006, J EXP BOT, V57, P1621, DOI 10.1093/jxb/erl005; Busi MV, 2006, PLANT J, V48, P873, DOI 10.1111/j.1365-313X.2006.02923.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DEIKMAN J, 1995, PLANT PHYSIOL, V108, P47, DOI 10.1104/pp.108.1.47; Gomez-Casati DF, 2002, FEBS LETT, V532, P70, DOI 10.1016/S0014-5793(02)03631-1; Gray MW, 2001, GENOME BIOL, V2; Hamel P, 2004, MOL MICROBIOL, V51, P307, DOI 10.1046/j.1365-2958.2003.03810.x; Huang X, 2008, PLANTA, V228, P545, DOI 10.1007/s00425-008-0757-6; Juszczuk IM, 2003, ACTA BIOCHIM POL, V50, P1257; Kawai-Yamada M, 2004, PLANT CELL, V16, P21, DOI 10.1105/tpc.014613; Kaya H, 2014, PLANT CELL, V26, P1069, DOI 10.1105/tpc.113.120642; Kiiskinen M, 1997, PLANT MOL BIOL, V35, P271, DOI 10.1023/A:1005868715571; Li LG, 2008, MOL PLANT, V1, P675, DOI 10.1093/mp/ssn031; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Lohse M, 2010, PLANT PHYSIOL, V153, P642, DOI 10.1104/pp.109.152553; Marechal A, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-42; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; McInnis SM, 2006, NEW PHYTOL, V172, P221, DOI 10.1111/j.1469-8137.2006.01875.x; Meyer EH, 2009, PLANT PHYSIOL, V151, P603, DOI 10.1104/pp.109.141770; Millar AH, 2003, PLANT PHYSIOL, V131, P443, DOI 10.1104/pp.009985; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakamori K, 2002, PLANT CELL PHYSIOL, V43, P1250, DOI 10.1093/pcp/pcf141; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; Ozgur R, 2014, J EXP BOT, V65, P1377, DOI 10.1093/jxb/eru034; Palmieri F, 1996, BBA-BIOENERGETICS, V1275, P127, DOI 10.1016/0005-2728(96)00062-X; Palmieri F, 2009, J BIOL CHEM, V284, P31249, DOI 10.1074/jbc.M109.041830; Palmieri L, 2008, PLANT PHYSIOL, V148, P1797, DOI 10.1104/pp.108.130310; Peterhansel C, 1997, PLANT CELL, V9, P1397, DOI 10.1105/tpc.9.8.1397; Picault N, 2004, TRENDS PLANT SCI, V9, P138, DOI 10.1016/j.tplants.2004.01.007; Picault N, 2002, J BIOL CHEM, V277, P24204, DOI 10.1074/jbc.M202702200; Potocky M, 2007, NEW PHYTOL, V174, P742, DOI 10.1111/j.1469-8137.2007.02042.x; SARASTE M, 1982, FEBS LETT, V144, P250, DOI 10.1016/0014-5793(82)80648-0; Smith AMO, 2004, J BIOL CHEM, V279, P51944, DOI 10.1074/jbc.M408920200; Takabatake R, 1999, PLANT MOL BIOL, V40, P479, DOI 10.1023/A:1006285009435; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tomaz T, 2010, PLANT PHYSIOL, V154, P1143, DOI 10.1104/pp.110.161612; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1211, DOI 10.1111/j.1365-3040.2009.01978.x; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; Yaeno T, 2004, PLANT J, V40, P931, DOI 10.1111/j.1365-313X.2004.02260.x; Yuan H, 2012, PLANT J, V70, P432, DOI 10.1111/j.1365-313X.2011.04883.x; Zhou HP, 2012, PLANT CELL, V24, P5106, DOI 10.1105/tpc.112.106393; Zhu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043530	45	28	29	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129717	10.1371/journal.pone.0129717	http://dx.doi.org/10.1371/journal.pone.0129717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076137	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900095
J	Lin, CP; Ko, CY; Kuo, CI; Liu, MS; Schafleitner, R; Chen, LFO				Lin, Ching-Ping; Ko, Chia-Yun; Kuo, Ching-I; Liu, Mao-Sen; Schafleitner, Roland; Chen, Long-Fang Oliver			Transcriptional Slippage and RNA Editing Increase the Diversity of Transcripts in Chloroplasts: Insight from Deep Sequencing of Vigna radiata Genome and Transcriptome	PLOS ONE			English	Article							GENE-EXPRESSION; ORGANELLAR GENOMES; PLASTID ANCESTOR; EVOLUTION; ORGANIZATION; PROTEIN; MAIZE; DNA; DIVERSIFICATION; CONSERVATION	We performed deep sequencing of the nuclear and organellar genomes of three mungbean genotypes: Vigna radiata ssp. sublobata TC1966, V. radiata var. radiata NM92 and the recombinant inbred line RIL59 derived from a cross between TC1966 and NM92. Moreover, we performed deep sequencing of the RIL59 transcriptome to investigate transcript variability. The mungbean chloroplast genome has a quadripartite structure including a pair of inverted repeats separated by two single copy regions. A total of 213 simple sequence repeats were identified in the chloroplast genomes of NM92 and RIL59; 78 single nucleotide variants and nine indels were discovered in comparing the chloroplast genomes of TC1966 and NM92. Analysis of the mungbean chloroplast transcriptome revealed mRNAs that were affected by transcriptional slippage and RNA editing. Transcriptional slippage frequency was positively correlated with the length of simple sequence repeats of the mungbean chloroplast genome (R-2=0.9911). In total, 41 C-to-U editing sites were found in 23 chloroplast genes and in one intergenic spacer. No editing site that swapped U to C was found. A combination of bioinformatics and experimental methods revealed that the plastid-encoded RNA polymerase-transcribed genes psbF and ndhA are affected by transcriptional slippage in mungbean and in main lineages of land plants, including three dicots (Glycine max, Brassica rapa, and Nicotiana tabacum), two monocots (Oryza sativa and Zea mays), two gymnosperms (Pinus taeda and Ginkgo biloba) and one moss (Physcomitrella patens). Transcript analysis of the rps2 gene showed that transcriptional slippage could affect transcripts at single sequence repeat regions with poly-A runs. It showed that transcriptional slippage together with incomplete RNA editing may cause sequence diversity of transcripts in chloroplasts of land plants.	[Lin, Ching-Ping; Ko, Chia-Yun; Kuo, Ching-I; Liu, Mao-Sen; Chen, Long-Fang Oliver] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan; [Lin, Ching-Ping] Univ Taipei, Dept Earth & Life Sci, Taipei 10048, Taiwan; [Schafleitner, Roland] AVRDC World Vegetable Ctr, Tainan 74199, Taiwan	Academia Sinica - Taiwan; University of Taipei	Chen, LFO (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan.	ochenlf@gate.sinica.edu.tw		Schafleitner, Roland/0000-0003-3637-7603	Innovative Translational Agricultural Research Program Academia Sinica Taiwan [2014CP04]	Innovative Translational Agricultural Research Program Academia Sinica Taiwan	This work was supported by the Innovative Translational Agricultural Research Program (Project #2014CP04) Academia Sinica Taiwan (http://itar.programs.sinica.edu.tw/index.php) to LFOC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Baranov PV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r25; Barkan A, 2011, PLANT PHYSIOL, V155, P1520, DOI 10.1104/pp.110.171231; Bentolila S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003584; BOCK R, 1993, MOL GEN GENET, V240, P238, DOI 10.1007/BF00277062; Borner T, 2014, ADVAN PL BIO, V5, P3, DOI 10.1007/978-1-4939-1136-3_1; Chang S, 1999, PLANT MOL BIOL REP, V11, P113; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Clarke LA, 2001, J CLIN PATHOL-MOL PA, V54, P351, DOI 10.1136/mp.54.5.351; Corneille S, 2000, MOL GEN GENET, V264, P419, DOI 10.1007/s004380000295; Deusch O, 2008, MOL BIOL EVOL, V25, P748, DOI 10.1093/molbev/msn022; FALVEY AK, 1976, NUCLEIC ACIDS RES, V3, P79, DOI 10.1093/nar/3.1.79; Freyer R, 1997, P NATL ACAD SCI USA, V94, P6285, DOI 10.1073/pnas.94.12.6285; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Gray MW, 1999, CURR OPIN GENET DEV, V9, P678, DOI 10.1016/S0959-437X(99)00030-1; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; Guo WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117075; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; HOCH B, 1991, NATURE, V353, P178, DOI 10.1038/353178a0; Inada M, 2004, PLANT CELL PHYSIOL, V45, P1615, DOI 10.1093/pcp/pch191; Jiang Y, 2012, GENET MOL RES, V11, P987, DOI 10.4238/2012.April.19.4; Kahlau S, 2006, J MOL EVOL, V63, P194, DOI 10.1007/s00239-005-0254-5; Kang YJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6443; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kleine T, 2009, ANNU REV PLANT BIOL, V60, P115, DOI 10.1146/annurev.arplant.043008.092119; Knoop V, 2011, CELL MOL LIFE SCI, V68, P567, DOI 10.1007/s00018-010-0538-9; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin CP, 2010, GENOME BIOL EVOL, V2, P504, DOI 10.1093/gbe/evq036; Maier RM, 1996, PLANT MOL BIOL, V32, P343, DOI 10.1007/BF00039390; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; MOR TS, 1995, MOL GEN GENET, V246, P600, DOI 10.1007/BF00298966; NECKERMANN K, 1994, GENE, V146, P177, DOI 10.1016/0378-1119(94)90290-9; de Alda JAGO, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5937; PALMER JD, 1985, ANNU REV GENET, V19, P325, DOI 10.1146/annurev.ge.19.120185.001545; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruwe H, 2013, FEBS LETT, V587, P1429, DOI 10.1016/j.febslet.2013.03.022; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Smith DR, 2011, GENOME BIOL EVOL, V3, P743, DOI [10.1093/gbe/evr001, 10.1093/gbe/evr068]; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Tamas I, 2008, P NATL ACAD SCI USA, V105, P14934, DOI 10.1073/pnas.0806554105; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; WAGNER LA, 1990, NUCLEIC ACIDS RES, V18, P3529, DOI 10.1093/nar/18.12.3529; Wakasugi T, 1996, P NATL ACAD SCI USA, V93, P8766, DOI 10.1073/pnas.93.16.8766; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yagi Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00061; Zhang Q, 2003, PLANT CELL PHYSIOL, V44, P941, DOI 10.1093/pcp/pcg121	54	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129396	10.1371/journal.pone.0129396	http://dx.doi.org/10.1371/journal.pone.0129396			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076132	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900068
J	Nichols, BS; Schindler, CE; Brown, JQ; Wilke, LG; Mulvey, CS; Krieger, MS; Gallagher, J; Geradts, J; Greenup, RA; Von Windheim, JA; Ramanujam, N				Nichols, Brandon S.; Schindler, Christine E.; Brown, Jonathon Q.; Wilke, Lee G.; Mulvey, Christine S.; Krieger, Marlee S.; Gallagher, Jennifer; Geradts, Joseph; Greenup, Rachel A.; Von Windheim, Jesko A.; Ramanujam, Nirmala			A Quantitative Diffuse Reflectance Imaging (QDRI) System for Comprehensive Surveillance of the Morphological Landscape in Breast Tumor Margins	PLOS ONE			English	Article							TISSUE OPTICAL-PROPERTIES; IN-VIVO; MONTE-CARLO; CONSERVING SURGERY; RADIATION-THERAPY; POSITIVE MARGINS; SURGICAL MARGINS; LOCAL RECURRENCE; INVERSE MODEL; STAGE-I	In an ongoing effort to address the clear clinical unmet needs surrounding breast conserving surgery (BCS), our group has developed a next-generation multiplexed optical-fiber-based tool to assess breast tumor margin status during initial surgeries. Specifically detailed in this work is the performance and clinical validation of a research-grade intra-operative tool for margin assessment based on diffuse optical spectroscopy. Previous work published by our group has illustrated the proof-of-concept generations of this device; here we incorporate a highly optimized quantitative diffuse reflectance imaging (QDRI) system utilizing a widefield (imaging area = 17cm(2)) 49-channel multiplexed fiber optic probe, a custom raster-scanning imaging platform, a custom dual-channel white LED source, and an astronomy grade imaging CCD and spectrograph. The system signal to noise ratio (SNR) was found to be greater than 40dB for all channels. Optical property estimation error was found to be less than 10%, on average, over a wide range of absorption (mu(a) = 0-8.9cm(-1)) and scattering (mu(s)' = 7.0-9.7cm(-1)) coefficients. Very low inter-channel and CCD crosstalk was observed (2% max) when used on turbid media (including breast tissue). A raster-scanning mechanism was developed to achieve sub-pixel resolution and was found to be optimally performed at an upsample factor of 8, affording 0.75mm spatially resolved diffuse reflectance images (lambda = 450-600nm) of an entire margin (area = 17cm(2)) in 13.8 minutes (1.23cm(2)/min). Moreover, controlled pressure application at the probe-tissue interface afforded by the imaging platform reduces repeated scan variability, providing <1% variation across repeated scans of clinical specimens. We demonstrate the clinical utility of this device through a pilot 20-patient study of high-resolution optical parameter maps of the ratio of the beta-carotene concentration to the reduced scattering coefficient. An empirical cumulative distribution function (eCDF) analysis is used to reduce optical property maps to quantitative distributions representing the morphological landscape of breast tumor margins. The optimizations presented in this work provide an avenue to rapidly survey large tissue areas on intra-operative time scales with improved sensitivity to regions of focal disease that may otherwise be overlooked.	[Nichols, Brandon S.; Schindler, Christine E.; Mulvey, Christine S.; Krieger, Marlee S.; Ramanujam, Nirmala] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Geradts, Joseph] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Gallagher, Jennifer; Greenup, Rachel A.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Wilke, Lee G.] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA; [Brown, Jonathon Q.; Krieger, Marlee S.; Von Windheim, Jesko A.; Ramanujam, Nirmala] Zenalux Biomed, Res Triangle Pk, NC USA; [Brown, Jonathon Q.] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA; [Von Windheim, Jesko A.] Duke Univ, Div Environm Sci & Policy, Durham, NC USA	Duke University; Duke University; Duke University; University of Wisconsin System; University of Wisconsin Madison; Tulane University; Duke University	Nichols, BS (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	brandon.nichols@duke.edu	Ramanujam, Nimmi/AAA-7575-2021	Ramanujam, Nimmi/0000-0001-7319-8415; Nichols, Brandon/0000-0002-9561-1802	Department of Defense (DOD) [W81XWH-09-1-0410]; Small Business Technology Transfer (STTR) phase II [2R42CA128160-02]; Zenalux, Inc.; NATIONAL CANCER INSTITUTE [R42CA128160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011574] Funding Source: NIH RePORTER	Department of Defense (DOD)(United States Department of Defense); Small Business Technology Transfer (STTR) phase II; Zenalux, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This project was supported by the Department of Defense (DOD) (http://www.defense.gov/) Grant Number W81XWH-09-1-0410 and by the Small Business Technology Transfer (STTR) (http://www.sbir.gov) phase II Grant Number 2R42CA128160-02 "Fast Spectral Imaging Device For Tumor Margin Mapping" awarded to Zenalux, Inc. and Duke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Zenalux, Inc. provided support in the form of salaries for authors JQB, MSK, JAvW, and NR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amelink A, 2008, ORAL ONCOL, V44, P65, DOI 10.1016/j.oraloncology.2006.12.011; Amelink A, 2005, J PHOTOCH PHOTOBIO B, V79, P243, DOI 10.1016/j.jphotobiol.2005.01.006; Arifler D, 2005, APPL OPTICS, V44, P4291, DOI 10.1364/AO.44.004291; Badizadegan K, 2004, FARADAY DISCUSS, V126, P265, DOI 10.1039/b305410a; Bender JE, 2009, OPT EXPRESS, V17, P23396, DOI 10.1364/OE.17.023396; Bender JE, 2009, IEEE T BIO-MED ENG, V56, P960, DOI 10.1109/TBME.2008.2005994; Bigio IJ, 2004, CANCER BIOL THER, V3, P259, DOI 10.4161/cbt.3.3.694; Brown JQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069906; Brown JQ, 2010, IEEE J SEL TOP QUANT, V16, P530, DOI 10.1109/JSTQE.2009.2033257; Brown JQ, 2009, CURR OPIN BIOTECH, V20, P119, DOI 10.1016/j.copbio.2009.02.004; Brown JQ, 2009, CANCER RES, V69, P2919, DOI 10.1158/0008-5472.CAN-08-3370; Bydlon TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051418; Bydlon TM, 2010, OPT EXPRESS, V18, P8058, DOI 10.1364/OE.18.008058; Chang VTC, 2009, NEOPLASIA, V11, P325, DOI 10.1593/neo.81386; Elkhuizen PHM, 1998, INT J RADIAT ONCOL, V40, P859, DOI 10.1016/S0360-3016(97)00917-6; Graham RA, 2002, AM J SURG, V184, P89, DOI 10.1016/S0002-9610(02)00902-9; Houssami N, 2014, ANN SURG ONCOL, V21, P717, DOI 10.1245/s10434-014-3480-5; Huston TL, 2006, AM J SURG, V192, P509, DOI 10.1016/j.amjsurg.2006.06.021; Jacobs L, 2008, ANN SURG ONCOL, V15, P1271, DOI 10.1245/s10434-007-9766-0; Kanick SC, 2014, BIOMED OPT EXPRESS, V5, P3376, DOI 10.1364/BOE.5.003376; Keller MD, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3600708; Kennedy S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2770; Kunos C, 2006, BREAST J, V12, P28, DOI 10.1111/j.1075-122X.2006.00181.x; Laughney AM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3455; Laughney AM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.036012; LAZOVICH D, 1991, JAMA-J AM MED ASSOC, V266, P3433, DOI 10.1001/jama.266.24.3433; Lim L, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.11.117003; Lin WC, 2000, J BIOMED OPT, V5, P214, DOI 10.1117/1.429989; Liu Q, 2011, WORLD J CLIN ONCOL, V2, P50, DOI 10.5306/wjco.v2.i1.50; Lue N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030887; Marin NM, 2005, GYNECOL ONCOL, V99, pS116, DOI 10.1016/j.ygyno.2005.07.054; Maxim PG, 2005, TECHNOL CANCER RES T, V4, P227, DOI 10.1177/153303460500400301; Mendez JE, 2006, AM J SURG, V192, P538, DOI 10.1016/j.amjsurg.2006.06.009; Mirabal YN, 2002, J BIOMED OPT, V7, P587, DOI 10.1117/1.1502675; Morrow M, 2001, J CLIN ONCOL, V19, P2254, DOI 10.1200/JCO.2001.19.8.2254; Muller MG, 2003, CANCER-AM CANCER SOC, V97, P1681, DOI 10.1002/cncr.11255; Nguyen FT, 2009, CANCER RES, V69, P8790, DOI 10.1158/0008-5472.CAN-08-4340; Nichols BS, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.057001; Nieman LT, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907450; Nold RJ, 2000, AM J SURG, V180, P413, DOI 10.1016/S0002-9610(00)00501-8; Palmer GM, 2006, APPL OPTICS, V45, P1072, DOI 10.1364/AO.45.001072; Palmer GM, 2006, APPL OPTICS, V45, P1062, DOI 10.1364/AO.45.001062; Palmer GM, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907161; Park CC, 2000, J CLIN ONCOL, V18, P1668, DOI 10.1200/JCO.2000.18.8.1668; Sanchez C, 2010, AM SURGEON, V76, P331; Schwarz RA, 2008, APPL OPTICS, V47, P825, DOI 10.1364/AO.47.000825; Sharwani A, 2006, ORAL ONCOL, V42, P343, DOI 10.1016/j.oraloncology.2005.08.008; Skala MC, 2007, OPT EXPRESS, V15, P7863, DOI 10.1364/OE.15.007863; Sunar U, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2397548; Utzinger U, 2001, LASER SURG MED, V28, P56, DOI 10.1002/1096-9101(2001)28:1<56::AID-LSM1017>3.0.CO;2-L; Wang HW, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1854679; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; Wilke LG, 2014, JAMA SURG, V149, P1296, DOI 10.1001/jamasurg.2014.926; Wilke LG, 2009, AM J SURG, V198, P566, DOI 10.1016/j.amjsurg.2009.06.018; Zhu CF, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1897398; Zhu CF, 2006, LASER SURG MED, V38, P714, DOI 10.1002/lsm.20356; Zonios G, 1999, APPL OPTICS, V38, P6628, DOI 10.1364/AO.38.006628	57	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0127525	10.1371/journal.pone.0127525	http://dx.doi.org/10.1371/journal.pone.0127525			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076123	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900014
J	da Luz, JMR; Paes, SA; Ribeiro, KVG; Mendes, IR; Kasuya, MCM				Rodrigues da Luz, Jose Maria; Paes, Sirlaine Albino; Goncalves Ribeiro, Karla Veloso; Mendes, Igor Rodrigues; Megumi Kasuya, Maria Catarina			Degradation of Green Polyethylene by Pleurotus ostreatus	PLOS ONE			English	Article							BIODEGRADATION; LACCASE; ENZYME; POLYMERS; LDPE	We studied the biodegradation of green polyethylene (GP) by Pleurotus ostreatus. The GP was developed from renewable raw materials to help to reduce the emissions of greenhouse gases. However, little information regarding the biodegradation of GP discarded in the environment is available. P. ostreatus is a lignocellulolytic fungus that has been used in bioremediation processes for agroindustrial residues, pollutants, and recalcitrant compounds. Recently, we showed the potential of this fungus to degrade oxo-biodegradable polyethylene. GP plastic bags were exposed to sunlight for up to 120 days to induce the initial photodegradation of the polymers. After this period, no cracks, pits, or new functional groups in the structure of GP were observed. Fragments of these bags were used as the substrate for the growth of P. ostreatus. After 30 d of incubation, physical and chemical alterations in the structure of GP were observed. We conclude that the exposure of GP to sunlight and its subsequent incubation in the presence of P. ostreatus can decrease the half-life of GP and facilitate the mineralization of these polymers.	[Rodrigues da Luz, Jose Maria; Paes, Sirlaine Albino; Goncalves Ribeiro, Karla Veloso; Mendes, Igor Rodrigues; Megumi Kasuya, Maria Catarina] Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil	Universidade Federal de Vicosa	Kasuya, MCM (corresponding author), Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil.	mkasuya@ufv.br	Kasuya, Maria Catarina Megumi/E-1123-2013; da Luz, José Maria/B-2276-2018	Kasuya, Maria Catarina Megumi/0000-0002-9539-9370; da Luz, José Maria/0000-0001-9826-7982	Brazilian Financial Agency: CAPES; Brazilian Financial Agency: CNPq; Brazilian Financial Agency: FAPEMIG	Brazilian Financial Agency: CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Financial Agency: CNPq; Brazilian Financial Agency: FAPEMIG	This research was supported by the Brazilian Financial Agencies: CAPES, CNPq, and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts JF, 2009, INT J FOOD MICROBIOL, V135, P47, DOI 10.1016/j.ijfoodmicro.2009.07.022; Arutchelvi J, 2008, INDIAN J BIOTECHNOL, V7, P9; Bonhomme S, 2003, POLYM DEGRAD STABIL, V81, P441, DOI 10.1016/S0141-3910(03)00129-0; Braskem, 2013, GREEN POL BIOP INN T; Cavallazzi JRP, 2004, J FOOD AGRIC ENVIRON, V2, P291; Chiellini E, 2007, POLYM DEGRAD STABIL, V92, P1378, DOI 10.1016/j.polymdegradstab.2007.03.007; Cohen R, 2002, APPL MICROBIOL BIOT, V58, P582, DOI 10.1007/s00253-002-0930-y; Contat-Rodrigo L, 2002, J APPL POLYM SCI, V83, P1683, DOI 10.1002/app.10087; El-Sharkawi H., 2012, ISRN SOIL SCI, V7, DOI [10.5402/2012/310727, DOI 10.5402/2012/310727]; Gross RA, 2002, SCIENCE, V297, P803, DOI 10.1126/science.297.5582.803; Grube Martin, 2009, Fungal Biology Reviews, V23, P72, DOI 10.1016/j.fbr.2009.10.001; HEINEMEYER O, 1989, PLANT SOIL, V116, P191, DOI 10.1007/BF02214547; KASUYA MCM, 2012, FEEDSTOCKS PRODUCTIO, V1, P487; Koutny M, 2006, POLYM DEGRAD STABIL, V91, P1495, DOI 10.1016/j.polymdegradstab.2005.10.007; Li KT, 2012, J APPL POLYM SCI, V123, P1169, DOI 10.1002/app.34579; Luz JMR, 2013, PLOS ONE, V8, P8, DOI DOI 10.1371/J0URNAL.P0NE.0069386.G003; Majcherczyk A, 1998, ENZYME MICROB TECH, V22, P335, DOI 10.1016/S0141-0229(97)00199-3; Nunes M. D., 2012, Journal of Food Research, V1, P113; Nyanhongo GS, 2006, ENZYME MICROB TECH, V39, P1197, DOI 10.1016/j.enzmictec.2006.03.004; Ohtake Y, 1998, POLYM DEGRAD STABIL, V60, P79, DOI 10.1016/S0141-3910(97)00032-3; Ojeda TFM, 2009, POLYM DEGRAD STABIL, V94, P965, DOI 10.1016/j.polymdegradstab.2009.03.011; da Luz JMR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107438; da Luz JMR, 2012, BRAZ J MICROBIOL, V43, P1508, DOI [10.1590/S1517-83822012000400035, 10.1590/S1517-838220120004000035]; da Luz JMR, 2013, LWT-FOOD SCI TECHNOL, V50, P575, DOI 10.1016/j.lwt.2012.08.006; Perez SR, 2008, BIODEGRADATION, V19, P519, DOI 10.1007/s10532-007-9157-z; Roldan-Carrillo T, 2003, BIORESOURCE TECHNOL, V86, P1, DOI 10.1016/S0960-8524(02)00142-6; Sanchez C, 2009, BIOTECHNOL ADV, V27, P185, DOI 10.1016/j.biotechadv.2008.11.001; Santo M, 2013, INT BIODETER BIODEGR, V84, P204, DOI 10.1016/j.ibiod.2012.03.001; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Shimao M, 2001, CURR OPIN BIOTECH, V12, P242, DOI 10.1016/S0958-1669(00)00206-8; Sivan A, 2011, CURR OPIN BIOTECH, V22, P422, DOI 10.1016/j.copbio.2011.01.013; Sudhakar M, 2008, INT BIODETER BIODEGR, V61, P203, DOI 10.1016/j.ibiod.2007.07.011; Yara R, 2006, J MICROBIOL, V44, P263	33	17	17	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0126047	10.1371/journal.pone.0126047	http://dx.doi.org/10.1371/journal.pone.0126047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076188	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900005
J	Tasev, D; van Wijhe, MH; Weijers, EM; van Hinsbergh, VWM; Koolwijk, P				Tasev, Dimitar; van Wijhe, Michiel H.; Weijers, Ester M.; van Hinsbergh, Victor W. M.; Koolwijk, Pieter			Long-Term Expansion in Platelet Lysate Increases Growth of Peripheral Blood-Derived Endothelial-Colony Forming Cells and Their Growth Factor-Induced Sprouting Capacity	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; NECROSIS-FACTOR-ALPHA; EX-VIVO EXPANSION; FETAL CALF SERUM; PROGENITOR CELLS; IN-VITRO; CORD BLOOD; CIRCULATING PROGENITORS; PLASMINOGEN-ACTIVATOR; ANGIOGENIC PROPERTIES	Introduction Efficient implementation of peripheral blood-derived endothelial-colony cells (PB-ECFCs) as a therapeutical tool requires isolation and generation of a sufficient number of cells in ex vivo conditions devoid of animal-derived products. At present, little is known how the isolation and expansion procedure in xenogeneic-free conditions affects the therapeutical capacity of PB-ECFCs. Results The findings presented in this study indicate that human platelet lysate (PL) as a serum substitute yields twice more colonies per mL blood compared to the conventional isolation with fetal bovine serum (FBS). Isolated ECFCs displayed a higher proliferative ability in PL supplemented medium than cells in FBS medium during 30 days expansion. The cells at 18 cumulative population doubling levels (CPDL) retained their proliferative capacity, showed higher sprouting ability in fibrin matrices upon stimulation with FGF-2 and VEGF-A than the cells at 6 CPDL, and displayed low beta-galactosidase activity. The increased sprouting of PBECFCs at 18 CPDL was accompanied by an intrinsic activation of the uPA/uPAR fibrinolytic system. Induced deficiency of uPA (urokinase-type plasminogen activator) or uPAR (uPA receptor) by siRNA technology completely abolished the angiogenic ability of PB-ECFCs in fibrin matrices. During the serial expansion, the gene induction of the markers associated with inflammatory activation such as VCAM-1 and ICAM-1 did not occur or only to limited extent. While further propagation up to 31 CPDL proceeded at a comparable rate, a marked upregulation of inflammatory markers occurred in all donors accompanied by a further increase of uPA/uPAR gene induction. The observed induction of inflammatory genes at later stages of long-term propagation of PB-ECFCs underpins the necessity to determine the right time-point for harvesting of sufficient number of cells with preserved therapeutical potential. Conclusion The presented isolation method and subsequent cell expansion in platelet lysate supplemented culture medium permits suitable large-scale propagation of PB-ECFC. For optimal use of PB-ECFCs in clinical settings, our data suggest that 15-20 CPDL is the most adequate maturation stage.	[Tasev, Dimitar; van Wijhe, Michiel H.; Weijers, Ester M.; van Hinsbergh, Victor W. M.; Koolwijk, Pieter] Vrije Univ Amsterdam, Med Ctr, ICaR VU, Dept Physiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Koolwijk, P (corresponding author), Vrije Univ Amsterdam, Med Ctr, ICaR VU, Dept Physiol, Amsterdam, Netherlands.	p.koolwijk@vumc.nl		Tasev, Dimitar/0000-0002-2185-9899	Netherlands Initiative for Regenerative Medicine (NIRM) [NIRM WP1.6]	Netherlands Initiative for Regenerative Medicine (NIRM)	The project (NIRM WP1.6) was financially supported by a grant from the Netherlands Initiative for Regenerative Medicine (NIRM).	Allen JB, 2010, STEM CELLS, V28, P318, DOI 10.1002/stem.275; Basire A, 2006, THROMB HAEMOSTASIS, V95, P678, DOI 10.1160/TH05-07-0511; Bompais H, 2004, BLOOD, V103, P2577, DOI 10.1182/blood-2003-08-2770; Carrell RW, 1996, BIOL CHEM H-S, V377, P1; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chen XF, 2010, TISSUE ENG PT A, V16, P585, DOI [10.1089/ten.tea.2009.0491, 10.1089/ten.TEA.2009.0491]; Corselli M, 2008, EXP HEMATOL, V36, P340, DOI 10.1016/j.exphem.2007.10.008; Crespo-Diaz R, 2011, CELL TRANSPLANT, V20, P797, DOI 10.3727/096368910X543376; de Korte D, 2006, TRANSFUSION, V46, P476, DOI 10.1111/j.1537-2995.2006.00746.x; Do Kang S, 2013, ANN BIOMED ENG, V41, P2181, DOI 10.1007/s10439-013-0807-5; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; Gluckman E, 2009, BONE MARROW TRANSPL, V44, P621, DOI 10.1038/bmt.2009.280; Hofbauer P, 2014, CYTOTHERAPY, V16, P1238, DOI 10.1016/j.jcyt.2014.04.009; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kilian O, 2004, EUR J MED RES, V9, P337; Koolwijk P, 1996, J CELL BIOL, V132, P1177, DOI 10.1083/jcb.132.6.1177; Krilleke D, 2009, BIOCHEM SOC T, V37, P1201, DOI 10.1042/BST0371201; Mackensen A, 2000, CANCER IMMUNOL IMMUN, V49, P152, DOI 10.1007/s002620050614; Mauge L, 2014, CYTOTHERAPY, V16, P213, DOI 10.1016/j.jcyt.2013.09.007; Medina RJ, 2013, STEM CELLS, V31, P1657, DOI 10.1002/stem.1414; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Nimura A, 2008, ARTHRITIS RHEUM, V58, P501, DOI 10.1002/art.23219; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Reinisch A, 2009, BLOOD, V113, P6716, DOI 10.1182/blood-2008-09-181362; Sahota PS, 2003, WOUND REPAIR REGEN, V11, P275, DOI 10.1046/j.1524-475X.2003.11407.x; Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x; Shumiya T, 2010, CIRC J, V74, P1006, DOI 10.1253/circj.CJ-09-0584; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Smadja DM, 2007, J CELL MOL MED, V11, P1149, DOI 10.1111/j.1582-4934.2007.00090.x; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; Supp DM, 2002, FASEB J, V16, DOI 10.1096/fj.01-0868com; Tuschong L, 2002, HUM GENE THER, V13, P1605, DOI 10.1089/10430340260201699; Van Beem RT, 2009, J THROMB HAEMOST, V7, P217, DOI 10.1111/j.1538-7836.2008.03192.x; VANHINSBERGH VWM, 1987, ARTERIOSCLEROSIS, V7, P389, DOI 10.1161/01.ATV.7.4.389; VANHINSBERGH VWM, 1994, BLOOD, V84, P2984; VANHINSBERGH VWM, 1990, BLOOD, V75, P1991; Wang CH, 2011, AM J PHYSIOL-REG I, V300, pR586, DOI 10.1152/ajpregu.00450.2010; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zhang YM, 2009, FASEB J, V23, P1358, DOI 10.1096/fj.08-110296	41	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129935	10.1371/journal.pone.0129935	http://dx.doi.org/10.1371/journal.pone.0129935			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076450	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900115
J	Walaza, S; Cohen, C; Nanoo, A; Cohen, AL; McAnerney, J; von Mollendorf, C; Moyes, J; Tempia, S				Walaza, Sibongile; Cohen, Cheryl; Nanoo, Ananta; Cohen, Adam L.; McAnerney, Johanna; von Mollendorf, Claire; Moyes, Jocelyn; Tempia, Stefano			Excess Mortality Associated with Influenza among Tuberculosis Deaths in South Africa, 1999-2009	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; UNITED-STATES; HIV; INFECTION; AGE; COHORT	Background Published data on the interaction between influenza and pulmonary tuberculosis (PTB) are limited. We aimed to estimate the influenza-associated mortality among individuals with PTB in South Africa from 1999-2009. Methods We modelled the excess influenza-associated mortality by applying Poisson regression models to monthly PTB and non-tuberculosis respiratory deaths, using laboratory-confirmed influenza as a covariate. Results PTB deaths increased each winter, coinciding with influenza virus circulation. Among individuals of any age, mean annual influenza-associated PTB mortality rate was 164/100,000 person-years (n = 439). The rate of non-tuberculosis respiratory deaths was 27/100,000 (n = 1125) for HIV-infected and 5/100,000 (n = 2367) for HIV-uninfected individuals of all ages. Among individuals aged <65 years, influenza-associated PTB mortality risk was elevated compared to influenza-associated non-tuberculosis respiratory deaths in HIV-infected (relative risk (RR): 5.2; 95% CI: 4.6-5.9) and HIV-uninfected individuals (RR: 61.0; CI: 41.4-91.0). Among individuals aged >= 65 years, influenza-associated PTB mortality risk was elevated compared to influenza-associated non-tuberculosis respiratory deaths in HIV-uninfected individuals (RR: 13.0; 95% CI: 12.0-14.0). Conclusion We observed an increased risk of influenza-associated mortality in persons with PTB compared to non-tuberculosis respiratory deaths. If confirmed in other settings, our findings may support recommendations for active inclusion of patients with TB for influenza vaccination and empiric influenza anti-viral treatment of patients with TB during influenza epidemics.	[Walaza, Sibongile; Cohen, Cheryl; Nanoo, Ananta; McAnerney, Johanna; von Mollendorf, Claire; Moyes, Jocelyn; Tempia, Stefano] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Cohen, Adam L.; Tempia, Stefano] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Cohen, Adam L.; Tempia, Stefano] Ctr Dis Control & Prevent, Influenza Div, Pretoria, South Africa; [Walaza, Sibongile; Cohen, Cheryl; von Mollendorf, Claire; Moyes, Jocelyn] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); Centers for Disease Control & Prevention - USA; University of Witwatersrand	Walaza, S (corresponding author), Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa.	sibongilew@nicd.ac.za; stefanot@nicd.ac.za	Moyes, Jocelyn/AAF-7882-2019	Cohen, Cheryl/0000-0003-0376-2302				Actuarial Society of South Africa A, 2013, AIDS DEM MOD; Archer B, 2009, EURO SURVEILL, V14; Brundage JF, 2006, LANCET INFECT DIS, V6, P303, DOI 10.1016/S1473-3099(06)70466-2; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Cohen C, 2013, EMERG INFECT DIS, V19, P1766, DOI 10.3201/eid1911.130546; Cohen C, 2010, CLIN INFECT DIS, V51, P1362, DOI 10.1086/657314; Darikwa TB, 2011, LEVEL TRENDS CHILD M, P159; Florido M, 2013, J IMMUNOL, V191, P302, DOI 10.4049/jimmunol.1202824; Glezen WP, 2003, JAMA-J AM MED ASSOC, V289, P2500, DOI 10.1001/jama.289.19.2500-a; Goldstein E, 2012, EPIDEMIOLOGY, V23, P829, DOI 10.1097/EDE.0b013e31826c2dda; Groenewald P, 2005, AIDS, V19, P744, DOI 10.1097/01.aids.0000166105.74756.62; *HLTH NDO, 2011, NAT STRAT PLAN HIV S; Johnson LF, 2012, S AFR J HIV MED, P22; McAnerney JM, 2012, J INFECT DIS, V206, pS153, DOI 10.1093/infdis/jis575; Nannan N, 2012, UNDER 5 MORTALITY ST; Nanoo A, 2013, 44 WORLD C LUNG HLTH, pS369; Noymer A, 2000, POPUL DEV REV, V26, P565, DOI 10.1111/j.1728-4457.2000.00565.x; Noymer A, 2011, VACCINE, V29, pB38, DOI 10.1016/j.vaccine.2011.02.053; Noymer A, 2009, SOC SCI MED, V68, P1599, DOI 10.1016/j.socscimed.2009.02.021; Nunes B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020661; Oei W, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/124861; Roth S, 2012, OTHER RESP VIRUSES; Simonsen L, 2003, JAMA-J AM MED ASSOC, V289, P2499, DOI 10.1001/jama.289.19.2499-b; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Statistics South Africa, 2013, MORT CAUS DEATH S AF; Statistics South Africa, 2012, LEVELS AND TRENDS OF; Tempia S, 2015, EMERG INFECT DIS, V21, P600, DOI 10.3201/eid2104.141033; Tempia S, 2014, CLIN INFECT DIS, V58, P1241, DOI 10.1093/cid/ciu095; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Walaza S, 2015, INFLUENZA; Walaza S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0746-x; WHO, 2014, SEAS INFL; WHO, 2011, WHO GLOBAL TUBERCULO; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315; Word Health Organization, GLOB TUB REP 2012; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	37	23	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129173	10.1371/journal.pone.0129173	http://dx.doi.org/10.1371/journal.pone.0129173			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076197	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900050
J	Aminoff, EM; Tarr, MJ				Aminoff, Elissa M.; Tarr, Michael J.			Associative Processing Is Inherent in Scene Perception	PLOS ONE			English	Article							PARAHIPPOCAMPAL PLACE AREA; VISUAL SCENES; CORTEX; REPRESENTATION; OBJECT; BRAIN; ROLES	How are complex visual entities such as scenes represented in the human brain? More concretely, along what visual and semantic dimensions are scenes encoded in memory? One hypothesis is that global spatial properties provide a basis for categorizing the neural response patterns arising from scenes. In contrast, non-spatial properties, such as single objects, also account for variance in neural responses. The list of critical scene dimensions has continued to grow-sometimes in a contradictory manner-coming to encompass properties such as geometric layout, big/small, crowded/sparse, and three-dimensionality. We demonstrate that these dimensions may be better understood within the more general framework of associative properties. That is, across both the perceptual and semantic domains, features of scene representations are related to one another through learned associations. Critically, the components of such associations are consistent with the dimensions that are typically invoked to account for scene understanding and its neural bases. Using fMRI, we show that non-scene stimuli displaying novel associations across identities or locations recruit putatively scene-selective regions of the human brain (the parahippocampal/lingual region, the retrosplenial complex, and the transverse occipital sulcus/occipital place area). Moreover, we find that the voxel-wise neural patterns arising from these associations are significantly correlated with the neural patterns arising from everyday scenes providing critical evidence whether the same encoding principals underlie both types of processing. These neuroimaging results provide evidence for the hypothesis that the neural representation of scenes is better understood within the broader theoretical framework of associative processing. In addition, the results demonstrate a division of labor that arises across scene-selective regions when processing associations and scenes providing better understanding of the functional roles of each region within the cortical network that mediates scene processing.	[Aminoff, Elissa M.; Tarr, Michael J.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Aminoff, Elissa M.; Tarr, Michael J.] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Aminoff, EM (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	eaminoff@cmu.edu	Aminoff, Elissa/AAF-7718-2019	Aminoff, Elissa/0000-0002-6455-8930	Office of Naval Research MURI [N000141010934]; National Science Foundation [1439237]	Office of Naval Research MURI(MURIOffice of Naval Research); National Science Foundation(National Science Foundation (NSF))	This research was supported by the Office of Naval Research MURI contract N000141010934 (to E.A. & M.T.) and by the National Science Foundation 1439237 (to E.A. & M.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Aminoff E, 2007, CEREB CORTEX, V17, P1493, DOI 10.1093/cercor/bhl078; Aminoff E, 2008, J COGNITIVE NEUROSCI, V20, P2226, DOI 10.1162/jocn.2008.20156; Aminoff EM, 2013, TRENDS COGN SCI, V17, P379, DOI 10.1016/j.tics.2013.06.009; Baldassano C, 2013, NEUROIMAGE, V75, P228, DOI 10.1016/j.neuroimage.2013.02.073; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Bar M, 2008, J NEUROSCI, V28, P8539, DOI 10.1523/JNEUROSCI.0987-08.2008; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Bettencourt KC, 2013, J COGNITIVE NEUROSCI, V16, P1, DOI [10.1016/j.neuron.2012.04.036, DOI 10.1016/J.NEURON.2012.04.036]; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Diedrichsen J, 2005, NEUROIMAGE, V27, P624, DOI 10.1016/j.neuroimage.2005.04.039; Dilks DD, 2013, J NEUROSCI, V33, P1331, DOI 10.1523/JNEUROSCI.4081-12.2013; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Epstein RA, 2007, CEREB CORTEX, V17, P1680, DOI 10.1093/cercor/bhl079; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Greene MR, 2009, COGNITIVE PSYCHOL, V58, P137, DOI 10.1016/j.cogpsych.2008.06.001; Harel A, 2013, CEREB CORTEX, V23, P947, DOI 10.1093/cercor/bhs091; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Janzen G, 2004, NAT NEUROSCI, V7, P673, DOI 10.1038/nn1257; Kravitz DJ, 2011, J NEUROSCI, V31, P7322, DOI 10.1523/JNEUROSCI.4588-10.2011; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Linsley D, 2015, CEREB CORTEX, V25, P2267, DOI 10.1093/cercor/bhu034; Litman L, 2009, HIPPOCAMPUS, V19, P308, DOI 10.1002/hipo.20515; MacEvoy SP, 2007, J NEUROPHYSIOL, V98, P2089, DOI 10.1152/jn.00438.2007; Maguire EA, 2001, SCAND J PSYCHOL, V42, P225, DOI 10.1111/1467-9450.00233; Megevand P, 2014, J NEUROSCI, V34, P5399, DOI 10.1523/JNEUROSCI.5202-13.2014; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Mullally SL, 2011, J NEUROSCI, V31, P7441, DOI 10.1523/JNEUROSCI.0267-11.2011; Nasr S, 2011, J NEUROSCI, V31, P13771, DOI 10.1523/JNEUROSCI.2792-11.2011; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; Park S, 2015, CEREB CORTEX, V25, P1792, DOI 10.1093/cercor/bht418; Park S, 2011, J NEUROSCI, V31, P1333, DOI 10.1523/JNEUROSCI.3885-10.2011; Park S, 2009, NEUROIMAGE, V47, P1747, DOI 10.1016/j.neuroimage.2009.04.058; Reber PJ, 2002, HIPPOCAMPUS, V12, P363, DOI 10.1002/hipo.10018; Remy F, 2014, BRAIN COGNITION, V84, P34, DOI 10.1016/j.bandc.2013.10.008; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Stansbury DE, 2013, NEURON, V79, P1025, DOI 10.1016/j.neuron.2013.06.034; Staresina BP, 2010, J NEUROSCI, V30, P9890, DOI 10.1523/JNEUROSCI.0826-10.2010; Stevens WD, 2012, CEREB CORTEX, V22, P1935, DOI 10.1093/cercor/bhr273; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Walther DB, 2011, P NATL ACAD SCI USA, V108, P9661, DOI 10.1073/pnas.1015666108; Watson DM, 2014, NEUROIMAGE, V99, P402, DOI 10.1016/j.neuroimage.2014.05.045	50	22	23	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128840	10.1371/journal.pone.0128840	http://dx.doi.org/10.1371/journal.pone.0128840			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26070142	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000031
J	Andersen, MN; Olsen, AMS; Madsen, JC; Faber, J; Torp-Pedersen, C; Gislason, GH; Selmer, C				Andersen, Mette Nygaard; Olsen, Anne-Marie Schjerning; Madsen, Jesper Clausager; Faber, Jens; Torp-Pedersen, Christian; Gislason, Gunnar Hilmar; Selmer, Christian			Levothyroxine Substitution in Patients with Subclinical Hypothyroidism and the Risk of Myocardial Infarction and Mortality	PLOS ONE			English	Article							AMERICAN THYROID ASSOCIATION; ISCHEMIC-HEART-DISEASE; ALL-CAUSE MORTALITY; L-THYROXINE; SUBDINICAL HYPOTHYROIDISM; CARDIOVASCULAR RISK; DOUBLE-BLIND; GUIDELINES; THERAPY; HYPERTHYROIDISM	Background Subclinical hypothyroidism is associated with a number of cardiovascular risk factors, yet only limited data exist on long-term outcome of levothyroxine treatment of this condition with respect to hard end-points. The aim of this retrospective cohort study was to determine effects of levothyroxine treatment on myocardial infarction (MI), cardiovascular death and all-cause mortality, in patients with subclinical hypothyroidism. Methods and Results Primary care patients aged 18 years and older that underwent thyroid function tests between 2000 and 2009 were enrolled. Participants were identified by individual-level linkage of nationwide registers. Patients with subclinical hypothyroidism at baseline were included in the study. Exclusion criteria included a history of thyroid disease, related medication or medication affecting thyroid function. The total cohort comprised 628,953 patients of which 12,212 (1.9%) had subclinical hypothyroidism (mean age 55.2 [SD +/- 18.8] years; 79.8% female). Within the first six months 2,483 (20.3%) patients claimed a prescription for levothyroxine. During a median follow-up of 5.0 (IQR: 5.2) years, 358 MI's and 1,566 (12.8%) deaths were observed. Out of these, 766 of the deaths were cardiovascular related. No beneficial effects were found in levothyroxine treated patients on MI (IRR 1.08 [95% CI: 0.81 to 1.44]), cardiovascular death (IRR 1.02 [95% CI: 0.83 to 1.25]) or all-cause mortality (IRR 1.03 [95% CI: 0.90 to 1.19]), except in patients under the age of 65 years (IRR 0.63 [95% CI: 0.40 to 0.99]). Conclusion Levothyroxine substitution in subclinical hypothyroid patients does not indicate an association with lower mortality or decreased risk of MI.	[Andersen, Mette Nygaard; Olsen, Anne-Marie Schjerning; Gislason, Gunnar Hilmar] Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Madsen, Jesper Clausager] Elect Lab Capital Reg, Copenhagen, Denmark; [Faber, Jens] Herlev Univ Hosp, Dept Endocrinol, DK-2730 Herlev, Denmark; [Faber, Jens; Gislason, Gunnar Hilmar] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Torp-Pedersen, Christian] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Gislason, Gunnar Hilmar] Danish Heart Fdn, Copenhagen, Denmark; [Gislason, Gunnar Hilmar] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Selmer, Christian] Amager Univ Hosp, Dept Internal Med, Amager, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Aalborg University; University of Southern Denmark	Andersen, MN (corresponding author), Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark.	mette.nygaard.andersen@gmail.com	Selmer, Christian/H-3314-2019; Gislason, Gunnar/B-7561-2009	Selmer, Christian/0000-0002-0534-3163; Gislason, Gunnar/0000-0002-0548-402X	Lundbeck Foundation; Agnes and Knut Morks Foundation; Novo Nordisk Fonden [NNF12OC1015957] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Agnes and Knut Morks Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was funded with a 1-year scholarship for MNA by The Lundbeck Foundation. The Lundbeck Foundation had no influence in the study design or manuscript writing process nor have they seen the results or final manuscript. The Music publishers Agnes and Knut Morks Foundation funded the work with a travel grant for MNA with the aim to participate in the conference of Endocrine Society in Chicago, Illinois, June 2014.	Appelhof BC, 2005, J CLIN ENDOCR METAB, V90, P2666, DOI 10.1210/jc.2004-2111; Baadsgaard M, 2011, SCAND J PUBLIC HEALT, V39, P103, DOI 10.1177/1403494811405098; BIONDI B, 1993, J CLIN ENDOCR METAB, V77, P334, DOI 10.1210/jc.77.2.334; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; Cohen-Lehman J, 2010, NAT REV ENDOCRINOL, V6, P34, DOI 10.1038/nrendo.2009.225; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; COOPER DS, 1984, ANN INTERN MED, V101, P18, DOI 10.7326/0003-4819-101-1-18; Danese Mark D., 2000, Journal of Clinical Endocrinology and Metabolism, V85, P2993, DOI 10.1210/jc.85.9.2993; Duntas LH, 2001, THYROID, V11, P361, DOI 10.1089/10507250152039091; EVERED DC, 1973, BRIT MED J, V1, P657, DOI 10.1136/bmj.1.5854.657; FABER J, 1994, EUR J ENDOCRINOL, V130, P350, DOI 10.1530/eje.0.1300350; Fosbol EL, 2008, PHARMACOEPIDEM DR S, V17, P822, DOI 10.1002/pds.1592; Fox CS, 2008, ARCH INTERN MED, V168, P587, DOI 10.1001/archinte.168.6.587; Garber JR, 2012, ENDOCR PRACT, V18, P989, DOI 10.4158/EP12280.GL; Gharib H, 2005, J CLIN ENDOCR METAB, V90, P581, DOI 10.1210/jc.2004-1231; Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Hak AE, 2000, ANN INTERN MED, V132, P270, DOI 10.7326/0003-4819-132-4-200002150-00004; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Huber G, 2002, J CLIN ENDOCR METAB, V87, P3221, DOI 10.1210/jc.87.7.3221; Imaizumi M, 2004, J CLIN ENDOCR METAB, V89, P3365, DOI 10.1210/jc.2003-031089; Jonklaas J, 2014, THYROID, V24, P1670, DOI 10.1089/thy.2014.0028; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knudsen N, 2005, J CLIN ENDOCR METAB, V90, P4019, DOI 10.1210/jc.2004-2225; KUNG AWC, 1995, CLIN ENDOCRINOL, V43, P445, DOI 10.1111/j.1365-2265.1995.tb02616.x; Lazarus JH, 2009, BEST PRACT RES CL EN, V23, P723, DOI 10.1016/j.beem.2009.06.002; Liu D, 2010, J HUM HYPERTENS, V24, P134, DOI 10.1038/jhh.2009.44; Luboshitzky R, 2002, THYROID, V12, P421, DOI 10.1089/105072502760043512; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Maratou E, 2009, EUR J ENDOCRINOL, V160, P785, DOI 10.1530/EJE-08-0797; Nuttall M, 2006, J CLIN EPIDEMIOL, V59, P265, DOI 10.1016/j.jclinepi.2005.07.015; Nyrnes A, 2006, INT J OBESITY, V30, P100, DOI 10.1038/sj.ijo.0803112; Owen PJD, 2003, TRENDS ENDOCRIN MET, V14, P257, DOI 10.1016/S1043-2760(03)00108-5; PARLE JV, 1993, BRIT J GEN PRACT, V43, P107; Pearce SHS, 2013, EUR THYROID J, V2, P215, DOI 10.1159/000356507; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Razvi S, 2007, J CLIN ENDOCR METAB, V92, P1715, DOI 10.1210/jc.2006-1869; Razvi S, 2012, ARCH INTERN MED, V172, P811, DOI 10.1001/archinternmed.2012.1159; Razvi S, 2010, J CLIN ENDOCR METAB, V95, P1734, DOI 10.1210/jc.2009-1749; Rodondi N, 2005, ARCH INTERN MED, V165, P2460, DOI 10.1001/archinte.165.21.2460; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; Ross DS, 2001, ENDOCRIN METAB CLIN, V30, P245, DOI 10.1016/S0889-8529(05)70186-9; ROSS DS, 1987, AM J MED, V82, P1167, DOI 10.1016/0002-9343(87)90219-1; Selmer C, 2014, J CLIN ENDOCR METAB, V99, P2372, DOI 10.1210/jc.2013-4184; Singh S, 2008, INT J CARDIOL, V125, P41, DOI 10.1016/j.ijcard.2007.02.027; Somwaru LL, 2012, J CLIN ENDOCR METAB, V97, P1962, DOI 10.1210/jc.2011-3047; Stott DJ, 2014, EUR THYROID J, V3, P137, DOI 10.1159/000360621; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Tanis BC, 1996, CLIN ENDOCRINOL, V44, P643, DOI 10.1046/j.1365-2265.1996.739560.x; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Vanderpump M, 2003, TRENDS ENDOCRIN MET, V14, P262, DOI 10.1016/S1043-2760(03)00103-6; Villar HCCE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003419.pub2; Walsh JP, 2005, ARCH INTERN MED, V165, P2467, DOI 10.1001/archinte.165.21.2467	56	36	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129793	10.1371/journal.pone.0129793	http://dx.doi.org/10.1371/journal.pone.0129793			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069971	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000107
J	Fukushima, A; Nakamura, M; Suzuki, H; Saito, K; Yamazaki, M				Fukushima, Atsushi; Nakamura, Michimi; Suzuki, Hideyuki; Saito, Kazuki; Yamazaki, Mami			High-Throughput Sequencing and De Novo Assembly of Red and Green Forms of the Perilla frutescens var. crispa Transcriptome	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; FLAVONOID BIOSYNTHETIC-PATHWAY; CHEMO-VARIETAL FORMS; RNA-SEQ DATA; ANTHOCYANIN BIOSYNTHESIS; GENE-EXPRESSION; FUNCTIONAL EXPRESSION; ARABIDOPSIS-THALIANA; REFERENCE GENOME; BIOCONDUCTOR PACKAGE	Perilla frutescens var. crispa (Labiatae) has two chemo-varietal forms, i.e. red and green forms of perilla, that differ in the production of anthocyanins. To facilitate molecular biological and biochemical studies in perilla-specialized metabolism we used Illumina RNA-sequencing technology in our comprehensive comparison of the transcriptome map of the leaves of red and green forms of perilla. Sequencing generated over 1.2 billion short reads with an average length of 101 nt. De novo transcriptome assembly yielded 47,788 and 47,840 unigenes in the red and green forms of perilla plants, respectively. Comparison of the assembled unigenes and existing perilla cDNA sequences showed highly reliable alignment. All unigenes were annotated with gene ontology (GO) and Enzyme Commission numbers and entered into the Kyoto Encyclopedia of Genes and Genomes. We identified 68 differentially expressed genes (DEGs) in red and green forms of perilla. GO enrichment analysis of the DEGs showed that genes involved in the anthocyanin metabolic process were enriched. Differential expression analysis revealed that the transcript level of anthocyanin biosynthetic unigenes encoding flavonoid 3'-hydroxylase, dihydroflavonol 4-reductase, and anthocyanidin synthase was significantly higher in red perilla, while the transcript level of unigenes encoding limonene synthase was significantly higher in green perilla. Our data serve as a basis for future research on perilla bio-engineering and provide a shortcut for the characterization of new functional genes in P. frutescens.	[Fukushima, Atsushi; Saito, Kazuki] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan; [Nakamura, Michimi; Saito, Kazuki; Yamazaki, Mami] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Chiba 2638522, Japan; [Suzuki, Hideyuki] Kazusa DNA Res Inst, Kisarazu, Chiba 2920818, Japan	RIKEN; Chiba University; Kazusa DNA Research Institute	Fukushima, A (corresponding author), RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan.	atsushi.fukushima@riken.jp; mamiy@faculty.chiba-u.jp	Saito, Kazuki/D-2670-2009; Yamazaki, Mami/A-9050-2010; Suzuki, Hideyuki/J-7571-2016; Fukushima, Atsushi/C-9279-2017	Saito, Kazuki/0000-0001-6310-5342; Yamazaki, Mami/0000-0001-6157-5287; Fukushima, Atsushi/0000-0001-9015-1694	Health Labour Sciences Research Grant from The Ministry of Health Labour and Welfare; JSPS [24390030]	Health Labour Sciences Research Grant from The Ministry of Health Labour and Welfare; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported, in part, by Health Labour Sciences Research Grant from The Ministry of Health Labour and Welfare, and JSPS KAKENHI Grant Number 24390030. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Carey CC, 2004, PLANT CELL, V16, P450, DOI 10.1105/tpc.018796; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Devic M, 1999, PLANT J, V19, P387, DOI 10.1046/j.1365-313X.1999.00529.x; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Fukushima A, 2014, J EXP BOT, V65, P5619, DOI 10.1093/jxb/eru322; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gong L, 2013, P NATL ACAD SCI USA, V110, P20320, DOI 10.1073/pnas.1319681110; Gong ZZ, 1999, MOL GEN GENET, V262, P65, DOI 10.1007/PL00008639; Gong ZZ, 1999, PLANT MOL BIOL, V41, P33, DOI 10.1023/A:1006237529040; Gong ZZ, 1997, PLANT MOL BIOL, V35, P915, DOI 10.1023/A:1005959203396; Gongora-Castillo E, 2013, NAT PROD REP, V30, P490, DOI 10.1039/c3np20099j; Gongora-Castillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052506; Goto N, 2010, BIOINFORMATICS, V26, P2617, DOI 10.1093/bioinformatics/btq475; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GROTEWOLD E, 1994, CELL, V76, P543, DOI 10.1016/0092-8674(94)90117-1; Hancock JM, 1996, NAT GENET, V14, P14, DOI 10.1038/ng0996-14; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kitada C, 2001, PLANT CELL PHYSIOL, V42, P1338, DOI 10.1093/pcp/pce169; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; KONDO T, 1989, AGR BIOL CHEM TOKYO, V53, P797; Kosuge T, 2014, NUCLEIC ACIDS RES, V42, pD44, DOI 10.1093/nar/gkt1066; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SC, 2014, J PLANT BIOL, V57, P312, DOI 10.1007/s12374-014-0263-2; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Loza-Tavera H, 1999, ADV EXP MED BIOL, V464, P49; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Matsuda F, 2012, PLANT J, V70, P624, DOI 10.1111/j.1365-313X.2012.04903.x; Mau CJD, 2010, PHYTOCHEMISTRY, V71, P373, DOI 10.1016/j.phytochem.2009.12.002; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Pages H, 2009, BIOSTRINGS STRING OB; Procissi A, 1997, PLANT CELL, V9, P1547, DOI 10.1105/tpc.9.9.1547; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saito K, 1999, PLANT J, V17, P181, DOI 10.1046/j.1365-313X.1999.00365.x; Saito K, 2002, NEW PHYTOL, V155, P9, DOI 10.1046/j.1469-8137.2002.00440.x; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Schoenbohm C, 2000, BIOL CHEM, V381, P749, DOI 10.1515/BC.2000.095; Shin J, 2007, PLANT J, V49, P981, DOI 10.1111/j.1365-313X.2006.03021.x; SHIRLEY BW, 1992, PLANT CELL, V4, P333, DOI 10.1105/tpc.4.3.333; Sompornpailin K, 2002, PLANT MOL BIOL, V50, P485, DOI 10.1023/A:1019850921627; Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219; Suzuki H, 2003, BIOCHEMISTRY-US, V42, P1764, DOI 10.1021/bi020618g; Tabanca N, 2015, IND CROP PROD, V65, P36, DOI 10.1016/j.indcrop.2014.11.043; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Tong W, 2015, GENE, V559, P155, DOI 10.1016/j.gene.2015.01.028; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Yamazaki M, 1999, J BIOL CHEM, V274, P7405, DOI 10.1074/jbc.274.11.7405; Yamazaki M, 2003, PHYTOCHEMISTRY, V62, P987, DOI 10.1016/S0031-9422(02)00721-5; Yamazaki M, 2002, CELL MOL LIFE SCI, V59, P1246, DOI 10.1007/s00018-002-8503-x; Yamazaki M, 2008, FEBS J, V275, P3494, DOI 10.1111/j.1742-4658.2008.06496.x; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040; Yonekura-Sakakibara K, 2014, PLANT J, V79, P769, DOI 10.1111/tpj.12580; Yonekura-Sakakibara K, 2012, PLANT J, V69, P154, DOI 10.1111/j.1365-313X.2011.04779.x; Yuba A, 1996, ARCH BIOCHEM BIOPHYS, V332, P280, DOI 10.1006/abbi.1996.0343	65	32	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129154	10.1371/journal.pone.0129154	http://dx.doi.org/10.1371/journal.pone.0129154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070213	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000053
J	Lee, CY; Thompson, GR; Hastey, CJ; Hodge, GC; Lunetta, JM; Pappagianis, D; Heinrich, V				Lee, Cheng-Yuk; Thompson, George R., III; Hastey, Christine J.; Hodge, Gregory C.; Lunetta, Jennine M.; Pappagianis, Demosthenes; Heinrich, Volkmar			Coccidioides Endospores and Spherules Draw Strong Chemotactic, Adhesive, and Phagocytic Responses by Individual Human Neutrophils	PLOS ONE			English	Article							ASPERGILLUS-FUMIGATUS; DENDRITIC CELLS; IN-VITRO; IMMITIS; MORPHOGENESIS; MACROPHAGES; MECHANICS; VIRULENCE; CAPSULE; ANTIGEN	Coccidioides spp. are dimorphic pathogenic fungi whose parasitic forms cause coccidioidomycosis (Valley fever) in mammalian hosts. We use an innovative interdisciplinary approach to analyze one-on-one encounters between human neutrophils and two forms of Coccidioides posadasii. To examine the mechanisms by which the innate immune system coordinates different stages of the host response to fungal pathogens, we dissect the immune-cell response into chemotaxis, adhesion, and phagocytosis. Our single-cell technique reveals a surprisingly strong response by initially quiescent neutrophils to close encounters with C. posadasii, both from a distance (by complement-mediated chemotaxis) as well as upon contact (by serum-dependent adhesion and phagocytosis). This response closely resembles neutrophil interactions with Candida albicans and zymosan particles, and is significantly stronger than the neutrophil responses to Cryptococcus neoformans, Aspergillus fumigatus, and Rhizopus oryzae under identical conditions. The vigorous in vitro neutrophil response suggests that C. posadasii evades in vivo recognition by neutrophils through suppression of long-range mobilization and recruitment of the immune cells. This observation elucidates an important paradigm of the recognition of microbes, i.e., that intact immunotaxis comprises an intricate spatiotemporal hierarchy of distinct chemotactic processes. Moreover, in contrast to earlier reports, human neutrophils exhibit vigorous chemotaxis toward, and frustrated phagocytosis of, the large spherules of C. posadasii under physiological-like conditions. Finally, neutrophils from healthy donors and patients with chronic coccidioidomycosis display subtle differences in their responses to antibodycoated beads, even though the patient cells appear to interact normally with C. posadasii endospores.	[Lee, Cheng-Yuk; Hastey, Christine J.; Heinrich, Volkmar] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Thompson, George R., III; Hodge, Gregory C.; Lunetta, Jennine M.; Pappagianis, Demosthenes] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Thompson, George R., III] Univ Calif Davis, Med Ctr, Dept Internal Med, Div Infect Dis, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Heinrich, V (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	vheinrich@ucdavis.edu	Heinrich, Volkmar/D-1169-2009	Heinrich, Volkmar/0000-0002-4932-5012; Lunetta, Jennine/0000-0002-7821-0257	National Institutes of Health, USA [R01 AI072391]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072391, R43AI051202] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health, USA, grant R01 AI072391 (VH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P105; BEAMAN L, 1981, INFECT IMMUN, V34, P347, DOI 10.1128/IAI.34.2.347-353.1981; BEAMAN L, 1980, INFECT IMMUN, V29, P1200; BEAMAN L, 1980, INFECT IMMUN, V28, P594; Behnsen J, 2007, PLOS PATHOG, V3, P138, DOI 10.1371/journal.ppat.0030013; Bonnett CR, 2006, INFECT IMMUN, V74, P6528, DOI 10.1128/IAI.00909-06; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brown GD, 2012, SCIENCE, V336, P647, DOI 10.1126/science.1222236; Brown Jennifer, 2013, Clin Epidemiol, V5, P185, DOI 10.2147/CLEP.S34434; Chosewood LC, 2009, BIOSAFETY MICROBIOLO; CONVERSE JL, 1959, J BACTERIOL, V78, P231, DOI 10.1128/JB.78.2.231-239.1959; Cox RA, 2004, CLIN MICROBIOL REV, V17, P804, DOI 10.1128/CMR.17.4.804-839.2004; Del Poeta M, 2004, EUKARYOT CELL, V3, P1067, DOI 10.1128/EC.3.5.1067-1075.2004; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; DRUTZ DJ, 1983, J INFECT DIS, V147, P372, DOI 10.1093/infdis/147.3.372; Ecker EE, 1943, J IMMUNOL, V47, P181; EINSTEIN HE, 1993, CLIN INFECT DIS, V16, P349, DOI 10.1093/clind/16.3.349; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; FREY CL, 1986, J INFECT DIS, V153, P933, DOI 10.1093/infdis/153.5.933; Galgiani JN, 2005, CLIN INFECT DIS, V41, P1217, DOI 10.1086/496991; GALGIANI JN, 1986, J INFECT DIS, V153, P217, DOI 10.1093/infdis/153.2.217; GALGIANI JN, 1982, J INFECT DIS, V146, P56, DOI 10.1093/infdis/146.1.56; GALGIANI JN, 1978, INFECT IMMUN, V21, P862, DOI 10.1128/IAI.21.3.862-865.1978; Graupmann-Kuzma A, 2008, J AM ANIM HOSP ASSOC, V44, P226, DOI 10.5326/0440226; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; HED J, 1982, IMMUNOLOGY, V45, P727; Heinrich V, 2005, LANGMUIR, V21, P1962, DOI 10.1021/la047801q; Heinrich V, 2011, J CELL SCI, V124, P3041, DOI 10.1242/jcs.086413; Herant M, 2005, J CELL SCI, V118, P1789, DOI 10.1242/jcs.02275; Herant M, 2006, J CELL SCI, V119, P1903, DOI 10.1242/jcs.02876; Herant M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001068; Hung CY, 2001, INFECT IMMUN, V69, P2211, DOI 10.1128/IAI.69.4.2211-2222.2001; HUPPERT M, 1982, MYCOPATHOLOGIA, V78, P107, DOI 10.1007/BF00442634; Jimenez-A MD, 2008, GENES IMMUN, V9, P338, DOI 10.1038/gene.2008.23; Kirkland TN, 1996, EMERG INFECT DIS, V2, P192, DOI 10.3201/eid0203.960305; Kolivras KN, 2003, INT J BIOMETEOROL, V47, P87, DOI 10.1007/s00484-002-0155-x; KOZEL TR, 1988, REV INFECT DIS, V10, pS436; KOZEL TR, 1987, CLIN EXP IMMUNOL, V70, P238; Kupferschmidt K, 2012, SCIENCE, V337, P636, DOI 10.1126/science.337.6095.636; Lam J, 2009, BIOPHYS J, V96, P248, DOI 10.1529/biophysj.108.139154; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lee CY, 2011, J CELL SCI, V124, P1106, DOI 10.1242/jcs.078592; Mankovich AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054735; Marsden-Haug N, 2013, CLIN INFECT DIS, V56, P847, DOI 10.1093/cid/cis1028; McDonald JU, 2011, FASEB J, V25, P1972, DOI 10.1096/fj.10-178517; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller MB, 2004, J CLIN MICROBIOL, V42, P2347, DOI 10.1128/JCM.42.5.2347-2349.2004; Mirbod-Donovan F, 2006, INFECT IMMUN, V74, P504, DOI 10.1128/IAI.74.1.504-515.2006; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241; O'Meara TR, 2012, CLIN MICROBIOL REV, V25, P387, DOI 10.1128/CMR.00001-12; Pillemer L, 1941, J BIOL CHEM, V137, P139; PONTOW SE, 1992, INT REV CYTOL, V137B, P221; RAAB SS, 1993, AM J CLIN PATHOL, V99, P582, DOI 10.1093/ajcp/99.5.582; Richards JO, 2002, J IMMUNOL, V169, P2020, DOI 10.4049/jimmunol.169.4.2020; Richards JO, 2001, J INFECT DIS, V184, P1220, DOI 10.1086/323664; SEGAL GP, 1985, J INFECT DIS, V151, P890, DOI 10.1093/infdis/151.5.890; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shevchenko MA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-78; Shubitz LE, 2007, ANN NY ACAD SCI, V1111, P395, DOI 10.1196/annals.1406.007; SUN SH, 1976, SABOURAUDIA, V14, P185; Sunenshine RH, 2007, ANN NY ACAD SCI, V1111, P96, DOI 10.1196/annals.1406.045; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Thompson GR, 2011, SEMIN RESP CRIT CARE, V32, P754, DOI 10.1055/s-0031-1295723; Thompson GR, 2011, CLIN INFECT DIS, V53, pE20, DOI 10.1093/cid/cir466; Tsang CA, 2013, MMWR-MORBID MORTAL W, V62, P217; van Bruggen R, 2009, MOL IMMUNOL, V47, P575, DOI 10.1016/j.molimm.2009.09.018; Viriyakosol S, 2005, INFECT IMMUN, V73, P1553, DOI 10.1128/IAI.73.3.1553-1560.2005; Voelz K, 2010, EUKARYOT CELL, V9, P835, DOI 10.1128/EC.00039-10; Wangdi T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004306	71	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129522	10.1371/journal.pone.0129522	http://dx.doi.org/10.1371/journal.pone.0129522			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070210	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000085
J	Van Lancker, V; Baeye, M				Van Lancker, Vera; Baeye, Matthias			Wave Glider Monitoring of Sediment Transport and Dredge Plumes in a Shallow Marine Sandbank Environment	PLOS ONE			English	Article							SUSPENDED PARTICULATE MATTER; SOUTHERN NORTH-SEA; ZOOPLANKTON; VARIABILITY; EVOLUTION; INTEGRITY; VELOCITY; FLOOR; BAY	As human pressure on the marine environment increases, safeguarding healthy and productive seas increasingly necessitates integrated, time-and cost-effective environmental monitoring. Employment of a Wave Glider proved very useful for the study of sediment transport in a shallow sandbank area in the Belgian part of the North Sea. During 22 days, data on surface and water-column currents and turbidity were recorded along 39 loops around an aggregate-extraction site. Correlation with wave and tidal-amplitude data allowed the quantification of current-and wave-induced advection and resuspension, important background information to assess dredging impacts. Important anomalies in suspended particulate matter concentrations in the water column suggested dredging-induced overflow of sediments in the near field (i.e., dynamic plume), and settling of finer-grained material in the far field (i.e., passive plume). Capturing the latter is a successful outcome to this experiment, since the location of dispersion and settling of a passive plume is highly dependent on the ruling hydro-meteorological conditions and thus difficult to predict. Deposition of the observed sediment plumes may cause habitat changes in the long-term.	[Van Lancker, Vera; Baeye, Matthias] Royal Belgian Inst Nat Sci, Operat Directorate Nat Environm, Brussels, Belgium	Royal Belgian Institute of Natural Sciences	Van Lancker, V (corresponding author), Royal Belgian Inst Nat Sci, Operat Directorate Nat Environm, Brussels, Belgium.	vera.vanlancker@naturalsciences.be	Van Lancker, Vera/AAY-2555-2020; Van Lancker, Vera/ABA-8526-2020	Van Lancker, Vera/0000-0002-8088-9713	project MOZ4 (Flemish Authorities, Agency Maritime Services and Coast, Coast) [211.177]; Belgian Science Policy [BR/121/A2/TILES]; ZAGRI	project MOZ4 (Flemish Authorities, Agency Maritime Services and Coast, Coast); Belgian Science Policy(Belgian Federal Science Policy Office); ZAGRI	Liquid Robotics (www.liquidr.com) provided the platform and sensors to conduct the experiment. This involvement does not alter our adherence to PLOS ONE policies on sharing data and materials. The study design relates to the project MOZ4 (Flemish Authorities, Agency Maritime Services and Coast, Coast, contract 211.177). Data collection and analysis were supported by the ZAGRI contract, a continuous monitoring programme, paid from the revenues of marine aggregate extraction activities. The paper contributes also to the Brain-be project TILES (Transnational and Integrated Long-term marine Exploitation Strategies), subsidised by Belgian Science Policy under contract BR/121/A2/TILES (grant VVL).	Binot J, 2007, EUROPEAN OCEAN RES F, P62; Black KS, 2001, CONT SHELF RES, V21, P859, DOI 10.1016/S0278-4343(00)00116-3; Borja A, 2008, MAR POLLUT BULL, V56, P1519, DOI 10.1016/j.marpolbul.2008.07.005; Borja A, 2010, MAR POLLUT BULL, V60, P2175, DOI 10.1016/j.marpolbul.2010.09.026; Brown CJ, 2009, APPL ACOUST, V70, P1242, DOI 10.1016/j.apacoust.2008.08.004; Cacchione DA, 2006, CONT SHELF RES, V26, P2319, DOI 10.1016/j.csr.2006.07.027; Chen ZQ, 2007, REMOTE SENS ENVIRON, V109, P207, DOI 10.1016/j.rse.2006.12.019; Daniel T, 2011, OCEAN DYNAM, V61, P1509, DOI 10.1007/s10236-011-0408-5; de Jonge VN, 2006, MAR POLLUT BULL, V53, P5, DOI 10.1016/j.marpolbul.2005.11.026; Degrendele K, 2010, J COASTAL RES, P77, DOI 10.2112/SI51-007.1; Deines K. L., 1999, 6 WORK C CURR MEAS, VI, P249, DOI DOI 10.1109/CCM.1999.755249; Duclos PA, 2013, J COASTAL RES, V29, P25, DOI 10.2112/JCOASTRES-D-12-00148.1; Favali P, 2006, ANN GEOPHYS-ITALY, V49, P515; Ferri G, 2015, IEEE J OCEANIC ENG, V40, P710, DOI 10.1109/JOE.2014.2359361; Fettweis M, 2008, ESTUAR COAST SHELF S, V78, P426, DOI 10.1016/j.ecss.2008.01.007; Fettweis M, 2007, CONT SHELF RES, V27, P1568, DOI 10.1016/j.csr.2007.01.017; Fettweis MP, 2011, OCEAN DYNAM, V61, P157, DOI 10.1007/s10236-010-0310-6; Fong DA, 2006, LIMNOL OCEANOGR-METH, V4, P58, DOI 10.4319/lom.2006.4.58; Foster SD, 2014, METHODS ECOL EVOL, V5, P287, DOI 10.1111/2041-210X.12156; Gartner JW, 2004, MAR GEOL, V211, P169, DOI 10.1016/j.margeo.2004.07.001; Giardino A, 2010, J COASTAL RES, P127, DOI 10.2112/SI51-012.1; Goff JA, 2005, CONT SHELF RES, V25, P461, DOI 10.1016/j.csr.2004.09.019; Guerrero M, 2012, FLOW MEAS INSTRUM, V23, P40, DOI 10.1016/j.flowmeasinst.2011.10.003; Haelters J, 2007, DESIGNATION MARINE P, P46; Harris PT, 2012, GEOHAB ATLAS SEAFLOO; Hitchcock DR, 2004, J COASTAL RES, V20, P101, DOI 10.2112/1551-5036(2004)20[101:PIOMAD]2.0.CO;2; Hull T., 2013, WAVE GLIDER TRIAL, P18; Jiang SN, 2007, DEEP-SEA RES PT I, V54, P608, DOI 10.1016/j.dsr.2006.12.011; Liquid Robotics Inc, 2010, WAV GLID MOD 08 US M, P190; Lorke A, 2004, FRESHWATER BIOL, V49, P1280, DOI 10.1111/j.1365-2427.2004.01267.x; Luyten PJ, 2011, MUMM COUPLED HYDRODY, P1177; Manley J.E., 2008, OCEANS 2008, P1, DOI DOI 10.1109/OCEANS.2008.5152052; Miles T, 2013, CONT SHELF RES, V63, pS36, DOI 10.1016/j.csr.2012.08.006; Monna S, 2014, J MARINE SYST, V130, P12, DOI 10.1016/j.jmarsys.2013.09.010; Munday E, 2014, 144 ANN M AM FISH SO; Newell RC, 1999, MAR POLLUT BULL, V38, P809, DOI 10.1016/S0025-326X(99)00045-4; Palinkas CM, 2010, MAR GEOL, V274, P151, DOI 10.1016/j.margeo.2010.03.012; Petersen W, 2014, J MARINE SYST, V140, P4, DOI 10.1016/j.jmarsys.2014.07.003; Piterbarg L, 2014, J MARINE SYST, V129, P381, DOI 10.1016/j.jmarsys.2013.08.003; Rice J, 2012, ECOL INDIC, V12, P174, DOI 10.1016/j.ecolind.2011.03.021; Rochelle-Newall E, 2014, ENVIRON MONIT ASSESS, V186, P589, DOI 10.1007/s10661-013-3401-2; Smith SJ, 2011, CONT SHELF RES, V31, pS50, DOI 10.1016/j.csr.2010.04.002; Spearman J, 2011, TERRA AQUA, V125, P14; Sternberg RW, 1999, J SEA RES, V41, P55, DOI 10.1016/S1385-1101(98)00037-9; Sternberg RW, 2001, CONT SHELF RES, V21, P509, DOI 10.1016/S0278-4343(00)00103-5; Tallis H, 2010, MAR POLICY, V34, P340, DOI 10.1016/j.marpol.2009.08.003; Thorne PD, 2002, CONT SHELF RES, V22, P603, DOI 10.1016/S0278-4343(01)00101-7; Van den Branden R, 2013, AUTOMATISCHE REGISTR; van Haren H, 2009, CONT SHELF RES, V29, P1809, DOI 10.1016/j.csr.2009.06.002; Van Lancker V, 2014, MONITORING IMPACT EX; Van Lancker V, 2015, MONITORING IMPACT EX, P74; Van Lancker V, 2012, ELSEV INSIGHT, P251, DOI 10.1016/B978-0-12-385140-6.00014-1; Vanhellemont Q., 2011, P COASTGIS 2011 C HE, P5; Vera RMV, 2010, J COASTAL RES, P151, DOI 10.2112/SI51-014.1; Villareal TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092280; Vincent CE, 1998, MAR GEOL, V150, P113, DOI 10.1016/S0025-3227(98)00048-6; Williams JJ, 1998, CONT SHELF RES, V18, P1215, DOI 10.1016/S0278-4343(98)00041-7; Wood J.D., 2007, OCEANS, P1, DOI DOI 10.1109/OCEANS.2007.4449165; Wynn RB, 2014, MAR GEOL, V352, P451, DOI 10.1016/j.margeo.2014.03.012	59	17	17	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128948	10.1371/journal.pone.0128948	http://dx.doi.org/10.1371/journal.pone.0128948			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070156	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000035
J	Wang, R; Wang, H; Zhao, CL; Hu, J; Jiang, YY; Tong, YJ; Liu, T; Huang, R; Wang, XY				Wang, Rui; Wang, He; Zhao, Chenglin; Hu, Juan; Jiang, Yuanyuan; Tong, Yanjun; Liu, Ting; Huang, Rong; Wang, Xiaoying			Evaluation of Multiparametric Magnetic Resonance Imaging in Detection and Prediction of Prostate Cancer	PLOS ONE			English	Article							ACTIVE SURVEILLANCE; MRI; DIAGNOSIS; MORTALITY; BIOPSY; RISK; PSA	Background Although European Society of Urogenital Radiology proposed the potential of multiparametric magnetic resonance imaging (MP-MRI) as a tool in the diagnostic pathway for prostate cancer (PCa) and published a unified scoring system named Prostate Imaging Reporting and Data System (PI-RADS version 1), these still need to be validated by real-life studies. Objective To evaluate the role of MP-MRI in detection and prediction of PCa. Methods Patients with clinical suspicion of PCa who underwent prebiopsy MP-MRI from 2002 to 2009 were recruited. MP-MRI results were retrospectively assigned as overall scores using PI-RADS by two radiologists. Patients were followed and the end point was the diagnosis of PCa. Receiver operating characteristics (ROC) curve was performed to test diagnostic efficacy of MP-MRI, under results of biopsy within three months. The cox proportional hazards model was used to identify independent variables for the detection of PCa. Results Finally, 1113 of the 1806 enrolled patients were included for analysis. The median follow-up was 56.0 months (1-137 mo). For 582 patients biopsied within three months, area under the curve for the detection of PCa with MP-MRI was 0.88 (95% confidence interval [CI], 0.75-1.00) in group of baseline prostate specific antigen (PSA) 0.01-4.00 ng/ml (n = 31), 0.90 (95% CI, 0.84-0.95) in PSA 4.01-10.00 ng/ml (n = 142), and 0.91 (95% CI, 0.87-0.94) in PSA > 10.00 ng/ml (n = 409), respectively. In the cox model adjusted for age and baseline PSA level, for the detection rate of PCa, compared with PI-RADS 1-2 (reference), the hazard ratio was 6.43 (95% CI, 4.29-9.65) for PI-RADS 3, 18.58 (95% CI, 13.36-25.84) for PIRADS 4-5 (p < 0.001). Conclusions Prebiopsy MP-MRI with PI-RADS is demonstrated as a valuable diagnostic and predictive tool for PCa.	[Wang, Rui; Wang, He; Zhao, Chenglin; Jiang, Yuanyuan; Wang, Xiaoying] Peking Univ, Hosp 1, Dept Radiol, Beijing 100871, Peoples R China; [Hu, Juan] Kunming Med Univ, Affiliated Hosp 1, Dept Radiol, Yunnan, Peoples R China; [Tong, Yanjun] Aerosp Cent Hosp, Dept Radiol, Beijing, Peoples R China; [Liu, Ting] Dongzhimen Hosp, Dept Radiol, Beijing, Peoples R China; [Huang, Rong] Peking Univ, Dept Radiol, Shenzhen Hosp, Shenzhen, Guangdong, Peoples R China	Peking University; Kunming Medical University; Beijing University of Chinese Medicine; Peking University	Wang, XY (corresponding author), Peking Univ, Hosp 1, Dept Radiol, Beijing 100871, Peoples R China.	cjr.wangxiaoying@vip.163.com	jiang, anyi/GPT-0379-2022					Abd-Alazeez M, 2014, PROSTATE CANCER P D, V17, P40, DOI 10.1038/pcan.2013.43; American College of Radiology, MR PROST IM REP DAT; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Dickinson L, 2011, EUR UROL, V59, P477, DOI 10.1016/j.eururo.2010.12.009; Fradet V, 2010, RADIOLOGY, V256, P176, DOI 10.1148/radiol.10091147; Hamoen EH, 2014, EUR UROL IN PRESS; Heidenreich A, 2014, EUR UROL, V65, P124, DOI 10.1016/j.eururo.2013.09.046; Heidenreich A, 2011, EUR UROL, V59, P495, DOI 10.1016/j.eururo.2011.01.013; Heijmink SWTPJ, 2011, ACTA ONCOL, V50, P25, DOI 10.3109/0284186X.2010.578369; Hoeks CMA, 2011, RADIOLOGY, V261, P46, DOI 10.1148/radiol.11091822; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Junker D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/252939; Kirkham APS, 2006, EUR UROL, V50, P1163, DOI 10.1016/j.eururo.2006.06.025; Komai Y, 2013, J UROLOGY, V190, P867, DOI 10.1016/j.juro.2013.03.078; Lucarelli G, 2012, PROSTATE, V72, P1611, DOI 10.1002/pros.22514; Miller K, 2007, EUR UROL SUPPL, V6, P327, DOI 10.1016/j.eursup.2006.12.001; Orsted DD, 2012, EUR UROL, V61, P865, DOI 10.1016/j.eururo.2011.11.007; Portalez D, 2010, EUR RADIOL, V20, P2781, DOI 10.1007/s00330-010-1868-6; Rais-Bahrami S, 2013, J UROLOGY, V190, P1721, DOI 10.1016/j.juro.2013.05.052; Rosenkrantz Andrew B, 2013, Radiology, V269, P482, DOI 10.1148/radiol.13122233; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Tanimoto A, 2007, J MAGN RESON IMAGING, V25, P146, DOI 10.1002/jmri.20793; Thompson JE, 2014, J UROLOGY, V192, P67, DOI 10.1016/j.juro.2014.01.014; Vargas HA, 2012, J UROLOGY, V188, P1732, DOI 10.1016/j.juro.2012.07.024; Villers A, 2009, CURR OPIN UROL, V19, P274, DOI 10.1097/MOU.0b013e328329a2ed	26	10	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130207	10.1371/journal.pone.0130207	http://dx.doi.org/10.1371/journal.pone.0130207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067423	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000150
J	Xiao, M; Wang, J; Lin, ZT; Lu, Y; Li, ZM; White, SW; Miller, DD; Li, W				Xiao, Min; Wang, Jin; Lin, Zongtao; Lu, Yan; Li, Zhenmei; White, Stephen W.; Miller, Duane D.; Li, Wei			Design, Synthesis and Structure-Activity Relationship Studies of Novel Survivin Inhibitors with Potent Anti-Proliferative Properties	PLOS ONE			English	Article							TARGET STABILITY DARTS; P-GLYCOPROTEIN; TUBULIN POLYMERIZATION; MULTIDRUG-RESISTANCE; CANCER CELLS; EXPRESSION; APOPTOSIS; ANGIOGENESIS; DISCOVERY; IDENTIFICATION	The anti-apoptotic protein survivin is highly expressed in most human cancer cells, but has very low expression in normal differentiated cells. Thus survivin is considered as an attractive cancer drug target. Herein we report the design and synthesis of a series of novel survivin inhibitors based on the oxyquinoline scaffold from our recently identified hit compound UC-112. These new analogs were tested against a panel of cancer cell lines including one with multidrug-resistant phenotype. Eight of these new UC-112 analogs showed IC50 values in the nanomole range in anti-proliferative assays. The best three compounds among them along with UC-112 were submitted for NCI-60 cancer cell line screening. The results indicated that structural modification from UC-112 to our best compound 4g has improved activity by four folds (2.2 mu M for UC-112 vs. 0.5 mu M for 4g, average GI(50) values over all cancer cell lines in the NCI-60 panel). Western blot analyses demonstrated the new compounds maintained high selectivity for survivin inhibition over other members in the inhibition of apoptosis protein family. When tested in an A375 human melanoma xenograft model, the most active compound 4g effectively suppressed tumor growth and strongly induced cancer cell apoptosis in tumor tissues. This novel scaffold is promising for the development of selective survivin inhibitors as potential anticancer agents.	[Xiao, Min; Wang, Jin; Lin, Zongtao; Lu, Yan; Miller, Duane D.; Li, Wei] Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Li, Zhenmei; White, Stephen W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Li, W (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Memphis, TN 38163 USA.	wli@uthsc.edu	Lin, Zongtao/GYU-9038-2022; Lin, Zongtao/J-3854-2019; White, Stephen W/N-8164-2018	Lin, Zongtao/0000-0002-6017-338X; Wang, Jin/0000-0001-5420-5704; Li, Wei/0000-0002-9522-4474	NIH [R01CA148706, 1S10OD010678-01, 1S10RR026377-01]; Center for Integrative and Translational Genomics; Molecular Resource Center at the University of Tennessee; University of Tennessee Research Foundation; University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE [R01CA148706] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026377] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010678] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Integrative and Translational Genomics; Molecular Resource Center at the University of Tennessee; University of Tennessee Research Foundation; University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is partially supported by NIH grants R01CA148706, 1S10OD010678-01, 1S10RR026377-01, and a pilot grant from the Center for Integrative and Translational Genomics and the Molecular Resource Center at the University of Tennessee. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors thank the University of Tennessee Research Foundation for providing funds to send compound 4g to Eurofins Panlabs for profiling its drug-like properties. Jin Wang acknowledges the support of the Alma and Hal Reagan Fellowship from University of Tennessee Health Science Center. The authors thank Mr. Zongtao Lin for performing the HRMS characterization for all final compounds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Chen JJ, 2012, J MED CHEM, V55, P7285, DOI 10.1021/jm300564b; Conway EM, 2003, AM J PATHOL, V163, P935, DOI 10.1016/S0002-9440(10)63453-0; Derry MM, 2014, CURR CANCER DRUG TAR, V14, P323, DOI 10.2174/1568009614666140411101942; Dong XW, 2009, CANCER RES, V69, P3918, DOI 10.1158/0008-5472.CAN-08-2747; Farruggia G, 2010, J ORG CHEM, V75, P6275, DOI 10.1021/jo101173t; Giodini A, 2002, CANCER RES, V62, P2462; Grossman D, 2001, J CLIN INVEST, V108, P991, DOI 10.1172/JCI200113345; Himmi B, 2008, J HETEROCYCLIC CHEM, V45, P1023, DOI 10.1002/jhet.5570450411; Iwai M, 2011, DRUG METAB DISPOS, V39, P2314, DOI 10.1124/dmd.111.040733; Kawasaki H, 2001, CANCER, V91, P2026, DOI 10.1002/1097-0142(20010601)91:11<2026::AID-CNCR1228>3.0.CO;2-E; Leonessa F, 1996, BRIT J CANCER, V73, P154, DOI 10.1038/bjc.1996.29; Lomenick Brett, 2011, Curr Protoc Chem Biol, V3, P163; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Lu Y, 2014, J MED CHEM, V57, P7355, DOI 10.1021/jm500764v; Nomura T, 2005, ONCOL REP, V14, P993; O'Connor DS, 2000, AM J PATHOL, V156, P393, DOI 10.1016/S0002-9440(10)64742-6; Pai MY, 2015, METHODS MOL BIOL, V1263, P287, DOI 10.1007/978-1-4939-2269-7_22; Pennati M, 2007, CARCINOGENESIS, V28, P1133, DOI 10.1093/carcin/bgm047; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Sangthong S, 2013, BIOORG MED CHEM LETT, V23, P6156, DOI 10.1016/j.bmcl.2013.09.004; Satoh K, 2001, CANCER, V92, P271, DOI 10.1002/1097-0142(20010715)92:2<271::AID-CNCR1319>3.0.CO;2-0; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Tamm I, 1998, CANCER RES, V58, P5315; Tirro E, 2006, CANCER RES, V66, P4263, DOI 10.1158/0008-5472.CAN-05-3248; Tsutsui S, 2006, BREAST CANCER RES TR, V98, P261, DOI 10.1007/s10549-005-9157-9; Tu SP, 2003, CANCER RES, V63, P7724; Uchiyama-Kokubu N, 2001, ANTI-CANCER DRUG, V12, P769, DOI 10.1097/00001813-200110000-00009; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Wang J, 2014, J PHARMACOL EXP THER, V349, P319, DOI 10.1124/jpet.113.212019; Wang Z, 2012, PHARM RES-DORDR, V29, P3040, DOI 10.1007/s11095-012-0726-4; Xiao M, 2013, J MED CHEM, V56, P3318, DOI 10.1021/jm4001117; Yang Y, 2011, J COLLOID INTERF SCI, V362, P157, DOI 10.1016/j.jcis.2011.06.008; Zhang SH, 2003, J PHARMACOL EXP THER, V304, P1258, DOI 10.1124/jpet.102.044412	36	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129807	10.1371/journal.pone.0129807	http://dx.doi.org/10.1371/journal.pone.0129807			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070194	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000110
J	Zou, H; Liu, XZ; Han, T; Hu, D; Wang, Y; Yuan, Y; Gu, JH; Bian, JC; Zhu, JQ; Liu, ZP				Zou, Hui; Liu, Xuezhong; Han, Tao; Hu, Di; Wang, Yi; Yuan, Yan; Gu, Jianhong; Bian, Jianchun; Zhu, Jiaqiao; Liu, Zong-ping			Salidroside Protects against Cadmium-Induced Hepatotoxicity in Rats via GJIC and MAPK Pathways	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; H2O2-INDUCED INHIBITION; GAP-JUNCTION; CELL-DEATH; APOPTOSIS; LIVER; CONNEXINS; CHANNELS; KINASE; DAMAGE	It is known that cadmium (Cd) induces cytotoxicity in hepatocytes; however, the underlying mechanism is unclear. Here, we studied the molecular mechanisms of Cd-induced hepatotoxicity in rat liver cells (BRL 3A) and in vivo. We observed that Cd treatment was associated with a time-and concentration-dependent decrease in the cell index (CI) of BRL 3A cells and cellular organelle ultrastructure injury in the rat liver. Meanwhile, Cd treatment resulted in the inhibition of gap junction intercellular communication (GJIC) and activation of mitogen-activated protein kinase (MAPK) pathways. Gap junction blocker 18-beta-glycyrrhetinic acid (GA), administered in combination with Cd, exacerbated cytotoxic injury in BRL 3A cells; however, GA had a protective effect on healthy cells co-cultured with Cd-exposed cells in a co-culture system. Cd-induced cytotoxic injury could be attenuated by co-treatment with an extracellular signal-regulated kinase (ERK) inhibitor (U0126) and a p38 inhibitor (SB202190) but was not affected by co-treatment with a c-Jun N-terminal kinase (JNK) inhibitor (SP600125). These results indicate that ERK and p38 play critical roles in Cd-induced hepatotoxicity and mediate the function of gap junctions. Moreover, MAPKs induce changes in GJIC by controlling connexin gene expression, while GJIC has little effect on the Cd-induced activation of MAPK pathways. Collectively, our study has identified a possible mechanistic pathway of Cd-induced hepatotoxicity in vitro and in vivo, and identified the participation of GJIC and MAPK-mediated pathways in Cd-induced hepatotoxicity. Furthermore, we have shown that salidroside may be a functional chemopreventative agent that ameliorates the negative effects of Cd via GJIC and MAPK pathways.	[Zhu, Jiaqiao] Yangzhou Univ, Coll Vet Med, Yangzhou 225009, Jiangsu, Peoples R China; Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Yangzhou University	Zhu, JQ (corresponding author), Yangzhou Univ, Coll Vet Med, Yangzhou 225009, Jiangsu, Peoples R China.	jqzhu1998@163.com; liuzongping@yzu.edu.cn		YUAN, YAN/0000-0002-1658-5328	National Natural Science Foundation of China [31101866, 31172373, 31302058]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No. 31101866 to Yan Yuan; No. 31172373 to Zong-ping Liu; No. 31302058 to Yi Wang) (http://www.nsfc.gov.cn/Portal0/default152.htm) and a project Funded by Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (http://jsycw.ec.js.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucherie S, 2013, BIOL CELL, V105, P561, DOI 10.1111/boc.201200092; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen L, 2008, J NEUROCHEM, V105, P251, DOI 10.1111/j.1471-4159.2007.05133.x; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045763; Decrock E, 2009, CELL DEATH DIFFER, V16, P151, DOI 10.1038/cdd.2008.138; DUDLEY RE, 1984, TOXICOL APPL PHARM, V76, P150, DOI 10.1016/0041-008X(84)90038-3; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Gong G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105944; Guo S, 2014, TOXICOL LETT, V229, P150, DOI 10.1016/j.toxlet.2014.05.026; Hu WY, 2002, TOXICOL SCI, V68, P429, DOI 10.1093/toxsci/68.2.429; Hu XL, 2010, CELL BIOL TOXICOL, V26, P499, DOI 10.1007/s10565-010-9159-1; Hwang JW, 2005, J AGR FOOD CHEM, V53, P8205, DOI 10.1021/jf051747h; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jeong SH, 2000, TOXICOL SCI, V57, P156, DOI 10.1093/toxsci/57.1.156; Jiang CY, 2014, BIOL TRACE ELEM RES, V158, P249, DOI 10.1007/s12011-014-9918-6; Kameritsch P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.105; Keogh RJ, 2010, PLACENTA, V31, P347, DOI 10.1016/j.placenta.2010.02.008; Kim JS, 2009, FOOD CHEM TOXICOL, V47, P404, DOI 10.1016/j.fct.2008.11.038; Klaassen CD, 2009, TOXICOL APPL PHARM, V238, P215, DOI 10.1016/j.taap.2009.03.026; Levin M, 2007, PROG BIOPHYS MOL BIO, V94, P186, DOI 10.1016/j.pbiomolbio.2007.03.005; Li XF, 2011, BRAIN RES, V1382, P9, DOI 10.1016/j.brainres.2011.01.015; Mao GX, 2010, BIOMED ENVIRON SCI, V23, P161, DOI 10.1016/S0895-3988(10)60047-5; MATESIC DF, 1994, MOL CARCINOGEN, V10, P226, DOI 10.1002/mc.2940100407; Rockwell P, 2004, CELL SIGNAL, V16, P343, DOI 10.1016/j.cellsig.2003.08.006; Ruch RJ, 2001, J CELL BIOCHEM, V83, P163, DOI 10.1002/jcb.1227; Rummel AM, 1999, TOXICOL SCI, V49, P232, DOI 10.1093/toxsci/49.2.232; Spray D, 1993, PROG LIVER DIS, V12, P1; Tan CB, 2009, BIOL PHARM BULL, V32, P1359, DOI 10.1248/bpb.32.1359; Tang YB, 2014, BRIT J PHARMACOL, V171, P2440, DOI 10.1111/bph.12611; Thevenod F, 2009, TOXICOL APPL PHARM, V238, P221, DOI 10.1016/j.taap.2009.01.013; Trosko J, 1990, IN VITRO TOXICOL, V3, P9; Trosko JE, 2011, J CELL COMMUN SIGNAL, V5, P53, DOI 10.1007/s12079-010-0108-9; Trosko James E., 1998, Frontiers in Bioscience, V3, pD208; TROSKO JE, 1993, LIFE SCI, V53, P1, DOI 10.1016/0024-3205(93)90606-4; Trosko JE, 1989, CELL CELL COMMUNICAT, P111; Upham BL, 1997, CARCINOGENESIS, V18, P37, DOI 10.1093/carcin/18.1.37; Upham BL, 2009, ANTIOXID REDOX SIGN, V11, P297, DOI 10.1089/ars.2008.2146; Vinken M, 2006, CELL SIGNAL, V18, P592, DOI 10.1016/j.cellsig.2005.08.012; Vinken M, 2008, HEPATOLOGY, V47, P1077, DOI 10.1002/hep.22049; Vinken M, 2011, BBA-REV CANCER, V1815, P13, DOI 10.1016/j.bbcan.2010.08.004; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wang JC, 2014, BIOL TRACE ELEM RES, V161, P180, DOI 10.1007/s12011-014-0105-6; Wang J, 2014, ONCOL LETT, V7, P1159, DOI 10.3892/ol.2014.1863; Wilson MR, 2000, EXP CELL RES, V254, P257, DOI 10.1006/excr.1999.4771; Wu YL, 2008, BIOL PHARM BULL, V31, P1523, DOI 10.1248/bpb.31.1523; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s; Xu BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019052; Xu J, 2003, J BIOCHEM MOL TOXIC, V17, P67, DOI 10.1002/jbt.10062; Zhang YR, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/516051; Zheng KL, 2014, BIOCHEM BIOPH RES CO, V451, P79, DOI 10.1016/j.bbrc.2014.07.072; Zhong XY, 2014, BIOL PHARM BULL, V37, P1199, DOI 10.1248/bpb.b14-00100; Zhou JZ, 2014, FEBS LETT, V588, P1186, DOI 10.1016/j.febslet.2014.01.001; Zhu Y, 2011, DNA CELL BIOL, V30, P809, DOI 10.1089/dna.2010.1183	53	27	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129788	10.1371/journal.pone.0129788	http://dx.doi.org/10.1371/journal.pone.0129788			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070151	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000105
J	Dong, J; Lu, M; Lu, T; Liang, BB; Xu, JK; Zhou, J; Lv, HJ; Qin, J; Cai, X; Huang, SH; Li, HP; Wang, D; He, XJ				Dong, Jun; Lu, Meng; Lu, Teng; Liang, Baobao; Xu, Junkui; Zhou, Jun; Lv, Hongjun; Qin, Jie; Cai, Xuan; Huang, Sihua; Li, Haopeng; Wang, Dong; He, Xijing			Meta-Analysis Comparing Zero-Profile Spacer and Anterior Plate in Anterior Cervical Fusion	PLOS ONE			English	Article							INTERBODY FUSION; ANCHORED SPACER; SPINE SURGERY; DISKECTOMY; DYSPHAGIA; DEVICE; OUTCOMES; IMPLANT; DESIGN	Background Anterior plate fusion is an effective procedure for the treatment of cervical spinal diseases but is accompanied by a high incidence of postoperative dysphagia. A zero profile (Zero-P) spacer is increasingly being used to reduce postoperative dysphagia and other potential complications associated with surgical intervention. Studies comparing the Zero-P spacer and anterior plate have reported conflicting results. Methodology A meta-analysis was conducted to compare the safety, efficacy, radiological outcomes and complications associated with the use of a Zero-P spacer versus an anterior plate in anterior cervical spine fusion for the treatment of cervical spinal disease. We comprehensively searched PubMed, Embase, the Cochrane Library and other databases and performed a meta-analysis of all randomized controlled trials (RCTs) and prospective or retrospective comparative studies assessing the two techniques. Results Ten studies enrolling 719 cervical spondylosis patients were included. The pooled data showed significant differences in the operation time [SMD = -0.58 (95% CI = -0.77 to 0.40, p < 0.01)] and blood loss [SMD = -0.40, 95% CI (-0.59 to -0.21), p < 0.01] between the two groups. Compared to the anterior plate group, the Zero-P group exhibited a significantly improved JOA score and reduced NDI and VAS. However, anterior plate fusion had greater postoperative segmental and cervical Cobb's angles than the Zero-P group at the last follow-up. The fusion rate in the two groups was similar. More importantly, the Zero-P group had a lower incidence of earlier and later postoperative dysphagia. Conclusions Compared to anterior plate fusion, Zero-P is a safer and effective procedure, with a similar fusion rate and lower incidence of earlier and later postoperative dysphagia. However, the results of this meta-analysis should be accepted with caution due to the limitations of the study. Further evaluation and large-sample RCTs are required to confirm and update the results of this study.	[Dong, Jun; Lu, Meng; Lu, Teng; Qin, Jie; Cai, Xuan; Huang, Sihua; Li, Haopeng; Wang, Dong; He, Xijing] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Orthopaed, Xian 710004, Shaanxi Provinc, Peoples R China; [Liang, Baobao] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Plast Surg, Xian 710004, Shaanxi Provinc, Peoples R China; [Xu, Junkui] Xi An Jiao Tong Univ, Xian Honghui Hosp, Dept Orthopaed, Xian 710054, Shaanxi Provinc, Peoples R China; [Zhou, Jun] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Dermatol, Xian 710004, Shaanxi Provinc, Peoples R China; [Lv, Hongjun] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Endocrinol, Xian 710061, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Wang, D (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Orthopaed, Xian 710004, Shaanxi Provinc, Peoples R China.	lengyuewuying@gmail.com; xijingh@sina.cn	He, Xijing/AAE-7424-2021; Li, Hao/GPS-9834-2022	He, Xijing/0000-0002-0465-5376; 	PhD Programs Foundation of Ministry of Education of China [20120201130009]	PhD Programs Foundation of Ministry of Education of China(Ministry of Education, China)	PhD Programs Foundation of Ministry of Education of China (No.: 20120201130009) was received in support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KK, 2013, GLOB SPINE J, V3, P273, DOI 10.1055/s-0033-1354253; Bazaz R, 2002, SPINE, V27, P2453, DOI 10.1097/00007632-200211150-00007; Buerba RA, 2014, SPINE, V39, P2062, DOI 10.1097/BRS.0000000000000606; CHALMERS TC, 1981, CONTROL CLIN TRIALS, V2, P31, DOI 10.1016/0197-2456(81)90056-8; Chen CJ, 2013, J NEUROSURG-SPINE, V19, P279, DOI 10.3171/2013.6.SPINE121134; Ghogawala Z, 2014, NEUROSURGERY, V75, P334, DOI 10.1227/NEU.0000000000000479; Hofstetter CP, 2015, J SPINAL DISORD TECH, V28, pE284, DOI 10.1097/BSD.0b013e31828873ed; Kaiser MG, 2002, NEUROSURGERY, V50, P229, DOI 10.1097/00006123-200202000-00001; Karikari IO, 2014, J SPINAL DISORD TECH, V27, P1, DOI 10.1097/BSD.0b013e31825bd26d; Kepler CK, 2012, SPINE J, V12, P639, DOI 10.1016/j.spinee.2012.03.024; Khaki F, 2013, SPINE, V38, pE528, DOI 10.1097/BRS.0b013e31828a2992; Lee MJ, 2005, J SPINAL DISORD TECH, V18, P406, DOI 10.1097/01.bsd.0000177211.44960.71; Li YB, 2015, J SPINAL DISORD TECH, V28, P398, DOI 10.1097/BSD.0000000000000032; Miao JH, 2013, J SPINAL DISORD TECH, V26, pE193, DOI 10.1097/BSD.0b013e31827a2812; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nemoto Osamu, 2015, Eur J Orthop Surg Traumatol, V25 Suppl 1, pS127, DOI 10.1007/s00590-014-1547-4; Park Y, 2010, SPINE J, V10, P193, DOI 10.1016/j.spinee.2009.09.006; Qi M, 2013, BONE JOINT J, V95B, P543, DOI 10.1302/0301-620X.95B4.30992; Rihn JA, 2011, CLIN ORTHOP RELAT R, V469, P658, DOI 10.1007/s11999-010-1731-8; Riley LH, 2010, SPINE, V35, pS76, DOI 10.1097/BRS.0b013e3181d81a96; Schollhorn B, 2013, VET SURG, V42, P825, DOI 10.1111/j.1532-950X.2013.12044.x; Scholz M, 2009, SPINE, V34, P156, DOI 10.1097/BRS.0b013e31818ff9c4; Shin Jae Sik, 2014, Korean J Spine, V11, P169, DOI 10.14245/kjs.2014.11.3.169; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; SMITH GW, 1958, J BONE JOINT SURG AM, V40, P607, DOI 10.2106/00004623-195840030-00009; Vanek P, 2013, SPINE, V38, pE792, DOI 10.1097/BRS.0b013e3182913400; Wang ZD, 2014, J CLIN NEUROSCI, V21, P462, DOI 10.1016/j.jocn.2013.05.019; Wang ZW, 2015, EUR SPINE J, V24, P148, DOI 10.1007/s00586-014-3628-9; Yang LL, 2012, ORTHOPEDICS, V35, pE1503, DOI 10.3928/01477447-20120919-20	29	26	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130223	10.1371/journal.pone.0130223	http://dx.doi.org/10.1371/journal.pone.0130223			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067917	Green Submitted, gold, Green Published			2022-12-27	WOS:000356100900105
J	Kim, J; Chung, YG; Park, JY; Chung, SC; Wallraven, C; Bulthoff, HH; Kim, SP				Kim, Junsuk; Chung, Yoon Gi; Park, Jang-Yeon; Chung, Soon-Cheol; Wallraven, Christian; Buelthoff, Heinrich H.; Kim, Sung-Phil			Decoding Accuracy in Supplementary Motor Cortex Correlates with Perceptual Sensitivity to Tactile Roughness	PLOS ONE			English	Article							NEURAL CODES; TEXTURE-DISCRIMINATION; NEURONAL-ACTIVITY; DECISION-MAKING; PREMOTOR CORTEX; BRAIN; AREA; PATTERNS; PARIETAL; FMRI	Perceptual sensitivity to tactile roughness varies across individuals for the same degree of roughness. A number of neurophysiological studies have investigated the neural substrates of tactile roughness perception, but the neural processing underlying the strong individual differences in perceptual roughness sensitivity remains unknown. In this study, we explored the human brain activation patterns associated with the behavioral discriminability of surface texture roughness using functional magnetic resonance imaging (fMRI). First, a whole-brain searchlight multi-voxel pattern analysis (MVPA) was used to find brain regions from which we could decode roughness information. The searchlight MVPA revealed four brain regions showing significant decoding results: the supplementary motor area (SMA), contralateral postcentral gyrus (S1), and superior portion of the bilateral temporal pole (STP). Next, we evaluated the behavioral roughness discrimination sensitivity of each individual using the just-noticeable difference (JND) and correlated this with the decoding accuracy in each of the four regions. We found that only the SMA showed a significant correlation between neuronal decoding accuracy and JND across individuals; Participants with a smaller JND (i.e., better discrimination ability) exhibited higher decoding accuracy from their voxel response patterns in the SMA. Our findings suggest that multivariate voxel response patterns presented in the SMA represent individual perceptual sensitivity to tactile roughness and people with greater perceptual sensitivity to tactile roughness are likely to have more distinct neural representations of different roughness levels in their SMA.	[Kim, Junsuk; Wallraven, Christian; Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Chung, Yoon Gi; Park, Jang-Yeon] Sungkyunkwan Univ, IBS Ctr Neurosci Imaging Res, Suwon, South Korea; [Park, Jang-Yeon] Sungkyunkwan Univ, Dept Global Biomed Engn, Suwon, South Korea; [Chung, Soon-Cheol] Konkuk Univ, Sch Biomed Engn, Chungju, South Korea; [Buelthoff, Heinrich H.] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, D-72076 Tubingen, Germany; [Kim, Sung-Phil] Ulsan Natl Inst Sci & Technol, Dept Human & Syst Engn, Ulsan, South Korea	Korea University; Institute for Basic Science - Korea (IBS); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Konkuk University; Max Planck Society; Ulsan National Institute of Science & Technology (UNIST)	Kim, SP (corresponding author), Ulsan Natl Inst Sci & Technol, Dept Human & Syst Engn, Ulsan, South Korea.	heinrich.buelthoff@tuebingen.mpg.de; spkim@unist.ac.kr	Kim, Junsuk/L-1495-2017; Bülthoff, Heinrich/AAC-8818-2019; Bülthoff, Heinrich H/J-6579-2012	Kim, Junsuk/0000-0002-7252-3420; Bülthoff, Heinrich H/0000-0003-2568-0607; Wallraven, Christian/0000-0002-2604-9115	Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [NRF-2011-0027921]; Brain Korea 21 Plus Program through the National Research Foundation of Korea - Ministry of Education	Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning; Brain Korea 21 Plus Program through the National Research Foundation of Korea - Ministry of Education	This research was supported by the Pioneer Research Center Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (NRF-2011-0027921) and by the Brain Korea 21 Plus Program through the National Research Foundation of Korea funded by the Ministry of Education.	Arabzadeh E, 2006, J NEUROSCI, V26, P9216, DOI 10.1523/JNEUROSCI.1491-06.2006; Boecker H, 1995, HUM BRAIN MAPP, V3, P236, DOI 10.1002/hbm.460030307; BURTON H, 1994, CAN J PHYSIOL PHARM, V72, P546, DOI 10.1139/y94-079; Burton H, 1997, CEREB CORTEX, V7, P3, DOI 10.1093/cercor/7.1.3; Carey LM, 2008, NEUROIMAGE, V39, P40, DOI 10.1016/j.neuroimage.2007.08.026; Chen XM, 2010, J NEUROSCI, V30, P14657, DOI 10.1523/JNEUROSCI.2669-10.2010; CONNOR CE, 1990, J NEUROSCI, V10, P3823, DOI 10.1523/JNEUROSCI.10-12-03823.1990; Fruend I, 2011, J VISION, V11, DOI 10.1167/11.6.16; GESCHEIDER GA, 1990, J ACOUST SOC AM, V87, P330, DOI 10.1121/1.399300; Gescheider GA, 1997, PSYCHOPHYSICS FUNDAM; Grant AC, 2005, EPILEPSIA, V46, P534, DOI 10.1111/j.0013-9580.2005.54604.x; HALSBAND U, 1994, NEUROSCI RES, V20, P149, DOI 10.1016/0168-0102(94)90032-9; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Harada T, 2004, J NEUROSCI, V24, P7524, DOI 10.1523/JNEUROSCI.1395-04.2004; Hartmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003831; Haxby JV, 2012, NEUROIMAGE, V62, P852, DOI 10.1016/j.neuroimage.2012.03.016; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Hebart MN, 2012, NEUROIMAGE, V63, P1393, DOI 10.1016/j.neuroimage.2012.08.027; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P1534, DOI 10.3758/BF03212154; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHNSON KO, 1992, ANNU REV NEUROSCI, V15, P227, DOI 10.1146/annurev.ne.15.030192.001303; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kitada R, 2005, NEUROIMAGE, V25, P90, DOI 10.1016/j.neuroimage.2004.11.026; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; LEDERMAN SJ, 1982, PERCEPT PSYCHOPHYS, V32, P109, DOI 10.3758/BF03204270; Liang M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2979; Libouton X, 2010, BEHAV BRAIN RES, V208, P473, DOI 10.1016/j.bbr.2009.12.017; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; Macar F, 1999, EXP BRAIN RES, V125, P271, DOI 10.1007/s002210050683; Macar Francoise, 2006, Cogn Process, V7, P89, DOI 10.1007/s10339-005-0025-7; Meftah E, 2000, EXP BRAIN RES, V132, P351, DOI 10.1007/s002210000348; Mita A, 2009, NAT NEUROSCI, V12, P502, DOI 10.1038/nn.2272; Miyaoka T, 1999, J ACOUST SOC AM, V105, P2485, DOI 10.1121/1.426852; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Oosterhof NN, 2010, J NEUROPHYSIOL, V104, P1077, DOI 10.1152/jn.00326.2010; OSULLIVAN BT, 1994, EUR J NEUROSCI, V6, P137, DOI 10.1111/j.1460-9568.1994.tb00255.x; Peelen MV, 2010, J NEUROSCI, V30, P10127, DOI 10.1523/JNEUROSCI.2161-10.2010; Pleger B, 2006, J NEUROSCI, V26, P12596, DOI 10.1523/JNEUROSCI.4275-06.2006; Ro T, 2013, CEREB CORTEX, V23, P1724, DOI 10.1093/cercor/bhs166; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Ross HE, 1996, EH WEBER TACTILE SEN, DOI [10.1016/j.neulet.2007.12.054, DOI 10.1016/J.NEULET.2007.12.054]; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Schurmann M, 2006, NEUROIMAGE, V30, P1325, DOI 10.1016/j.neuroimage.2005.11.020; Servos P, 2001, COGNITIVE BRAIN RES, V12, P307, DOI 10.1016/S0926-6410(01)00041-6; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Simoes-Franklin C, 2011, HUM BRAIN MAPP, V32, P1067, DOI 10.1002/hbm.21091; STEVENS SS, 1962, J EXP PSYCHOL, V64, P489, DOI 10.1037/h0042621; TANJI J, 1994, NEUROSCI RES, V19, P251, DOI 10.1016/0168-0102(94)90038-8; TAYLOR MM, 1975, PERCEPT PSYCHOPHYS, V17, P23, DOI 10.3758/BF03203993; Verrillo RT, 1999, SOMATOSENS MOT RES, V16, P352; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; WOODWARD KL, 1993, SOMATOSENS MOT RES, V10, P63, DOI 10.3109/08990229309028824	54	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129777	10.1371/journal.pone.0129777	http://dx.doi.org/10.1371/journal.pone.0129777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067832	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900077
J	Lang, FF; Qin, ZY; Li, F; Zhang, HL; Fang, ZH; Hao, EK				Lang, Fangfang; Qin, Zhaoyang; Li, Fang; Zhang, Huilin; Fang, Zhenghui; Hao, Enkui			Apoptotic Cell Death Induced by Resveratrol Is Partially Mediated by the Autophagy Pathway in Human Ovarian Cancer Cells	PLOS ONE			English	Article							DOUBLE-EDGED-SWORD; OXIDATIVE STRESS; ERK; CARCINOMA; INDUCTION; MECHANISM; DISEASE; ACID	Resveratrol (trans-3,4,5'-trihydroxystilbene) is an active compound in food, such as red grapes, peanuts, and berries. Resveratrol exhibits an anticancer effect on various human cancer cells. However, the mechanism of resveratrol-induced anti-cancer effect at the molecular level remains to be elucidated. In this study, the mechanism underlying the anti-cancer effect of resveratrol in human ovarian cancer cells (OVCAR-3 and Caov-3) was investigated using various molecular biology techniques, such as flow cytometry, western blotting, and RNA interference, with a major focus on the potential role of autophagy in resveratrol-induced apoptotic cell death. We demonstrated that resveratrol induced reactive oxygen species (ROS) generation, which triggers autophagy and subsequent apoptotic cell death. Resveratrol induced ATG5 expression and promoted LC3 cleavage. The apoptotic cell death induced by resveratrol was attenuated by both pharmacological and genetic inhibition of autophagy. The autophagy inhibitor chloroquine, which functions at the late stage of autophagy, significantly reduced resveratrol-induced cell death and caspase 3 activity in human ovarian cancer cells. We also demonstrated that targeting ATG5 by siRNA also suppressed resveratrol-induced apoptotic cell death. Thus, we concluded that a common pathway between autophagy and apoptosis exists in resveratrol-induced cell death in OVCAR-3 human ovarian cancer cells.	[Hao, Enkui] Shandong Univ, Qianfoshan Hosp, Dept Cardiol, Jinan 250100, Peoples R China; [Lang, Fangfang; Fang, Zhenghui] Shandong Univ, Jinan Cent Hosp, Dept Obstet & Gynecol, Jinan 250100, Peoples R China; [Qin, Zhaoyang] Rizhao Peoples Hosp, Dept Gen Surg, Rizhao, Peoples R China; [Li, Fang] Shandong Univ, Jinan Cent Hosp, Dept Hlth, Jinan 250100, Peoples R China; [Zhang, Huilin] Shandong Univ, Jinan Cent Hosp, Cent Lab, Jinan 250100, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Hao, EK (corresponding author), Shandong Univ, Qianfoshan Hosp, Dept Cardiol, Jinan 250100, Peoples R China.	haoenkui@sdu.edu.cn			promotive research fund for young and middle-aged scientists of Shandong Province [07-21]	promotive research fund for young and middle-aged scientists of Shandong Province	This study was supported by the promotive research fund for young and middle-aged scientists of Shandong Province (Grant No. 07-21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Fernandez V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056881; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; Davis M, 2014, GYNECOL ONCOL, V132, P760, DOI 10.1016/j.ygyno.2014.01.012; Delmas D, 2006, CURR DRUG TARGETS, V7, P423, DOI 10.2174/138945006776359331; Delmas D, 2011, CURR MED CHEM, V18, P1100, DOI 10.2174/092986711795029708; Duan WJ, 2013, MOL NUTR FOOD RES, V57, P1145, DOI 10.1002/mnfr.201200662; Juan ME, 2008, J AGR FOOD CHEM, V56, P4813, DOI 10.1021/jf800175a; Gupta SC, 2013, J BIOL CHEM, V288, P32343, DOI 10.1074/jbc.M113.455188; Hao EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069452; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Kimura T, 2013, CANCER RES, V73, P3, DOI 10.1158/0008-5472.CAN-12-2464; Kubisch J, 2013, SEMIN CANCER BIOL, V23, P252, DOI 10.1016/j.semcancer.2013.06.009; Lamy L, 2013, CANCER CELL, V23, P435, DOI 10.1016/j.ccr.2013.02.017; Le Corre L, 2005, MOL NUTR FOOD RES, V49, P462, DOI 10.1002/mnfr.200400094; Li L, 2012, FREE RADICAL BIO MED, V53, P1399, DOI 10.1016/j.freeradbiomed.2012.07.011; Lin HY, 2013, J CELL BIOCHEM, V114, P1940, DOI 10.1002/jcb.24539; Malik SA, 2011, ONCOGENE, V30, P3918, DOI 10.1038/onc.2011.104; Malik SA, 2011, AUTOPHAGY, V7, P914, DOI 10.4161/auto.7.8.15785; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Martinet W, 2009, CLIN SCI, V116, P697, DOI 10.1042/CS20080508; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Mukhopadhyay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015705; Puissant A, 2008, FASEB J, V22, P1894, DOI 10.1096/fj.07-101394; Puissant A, 2010, AUTOPHAGY, V6, P655, DOI 10.4161/auto.6.5.12126; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Santos Juliana A, 2013, Recent Pat Food Nutr Agric, V5, P144, DOI 10.2174/18761429113059990001; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Tan BJ, 2013, INT J ONCOL, V42, P1605, DOI 10.3892/ijo.2013.1843; Tang QS, 2013, CANCER LETT, V336, P325, DOI 10.1016/j.canlet.2013.03.023; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tyagi A, 2005, CARCINOGENESIS, V26, P1978, DOI 10.1093/carcin/bgi165; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881; Vergara D, 2012, MOL BIOSYST, V8, P1078, DOI 10.1039/c2mb05486h; Wenzel U, 2005, APOPTOSIS, V10, P359, DOI 10.1007/s10495-005-0810-x; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996; Wu Zhaoju, 2010, Genes Cancer, V1, P40, DOI 10.1177/1947601909358324; Zhang YB, 2014, MOL PHARMACEUT, V11, P1282, DOI 10.1021/mp400749f	39	77	80	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129196	10.1371/journal.pone.0129196	http://dx.doi.org/10.1371/journal.pone.0129196			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067645	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900045
J	Leonards, U; Fennell, JG; Oliva, G; Drake, A; Redmill, DW				Leonards, Ute; Fennell, John G.; Oliva, Gaby; Drake, Alex; Redmill, David W.			Treacherous Pavements: Paving Slab Patterns Modify Intended Walking Directions	PLOS ONE			English	Article							OPTIC FLOW; MOTION; STATISTICS; PERCEPTION; TASK	Current understanding in locomotion research is that, for humans, navigating natural environments relies heavily on visual input; in contrast, walking on even ground in man-made obstacle and hazard-free environments is so highly automated that visual information derived from floor patterns should not affect locomotion and in particular have no impact on the direction of travel. The vision literature on motion perception would suggest otherwise; specifically that oblique floor patterns may induce substantial veering away from the intended direction of travel due to the so-called aperture problem. Here, we tested these contrasting predictions by letting participants walk over commonly encountered floor patterns (paving slabs) and investigating participants' ability to walk "straight ahead" for different pattern orientations. We show that, depending on pattern orientation, participants veered considerably over the measured travel distance (up to 8% across trials), in line with predictions derived from the literature on motion perception. We argue that these findings are important to the study of locomotion, and, if also observed in real world environments, might have implications for architectural design.	[Leonards, Ute; Fennell, John G.; Oliva, Gaby; Drake, Alex; Redmill, David W.] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England	University of Bristol	Leonards, U (corresponding author), Univ Bristol, Sch Expt Psychol, Bristol, Avon, England.	ute.leonards@bristol.ac.uk	Fennell, John G/V-5947-2018	Fennell, John G/0000-0003-2991-3391; Leonards, Ute/0000-0001-6143-7466; Drake, Alexander/0000-0002-9462-6287	Wellcome Trust [WT089367AIA]; BRACE Charity (Bristol Research into Alzheimer's and Care of the Elderly)	Wellcome Trust(Wellcome TrustEuropean Commission); BRACE Charity (Bristol Research into Alzheimer's and Care of the Elderly)	This work was supported by an equipment grant from the Wellcome Trust (WT089367AIA) to set up the laboratory, and a grant awarded to UL from the BRACE Charity (Bristol Research into Alzheimer's and Care of the Elderly; http://www.alzheimers-brace.org), as a basis for further work examining the impact of the visual environment on falls risk in older people. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; Alais D, 1997, VISION RES, V37, P143, DOI 10.1016/0042-6989(95)00320-7; BRESSAN P, 1995, PERCEPTION, V24, P1165, DOI 10.1068/p241165; Calow D, 2007, NETWORK-COMP NEURAL, V18, P343, DOI 10.1080/09548980701642277; GIBSON EJ, 1979, PERCEPTION, V8, P609, DOI 10.1068/p080609; GIBSON JJ, 1958, BRIT J PSYCHOL, V49, P182, DOI 10.1111/j.2044-8295.1958.tb00656.x; Guertin PA, 2009, BRAIN RES REV, V62, P45, DOI 10.1016/j.brainresrev.2009.08.002; Kim B, 2010, J NEUROSCI, V30, P2340, DOI 10.1523/JNEUROSCI.1730-09.2010; Logan D, 2010, EXP BRAIN RES, V206, P337, DOI 10.1007/s00221-010-2414-0; Roth S, 2007, INT J COMPUT VISION, V74, P33, DOI 10.1007/s11263-006-0016-x; Salinas E, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00085; Shankar S, 2011, J NEUROSCI, V31, P8406, DOI 10.1523/JNEUROSCI.1419-11.2011; Wann JP, 2000, VISION RES, V40, P2533, DOI 10.1016/S0042-6989(00)00115-2; Warren PA, 2009, CURR BIOL, V19, P1555, DOI 10.1016/j.cub.2009.07.057; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; WHO global report on falls prevention in older age, 2007, 2007 WHO TECHN M FAL; Wuerger S, 1996, PERCEPTION, V25, P1317, DOI 10.1068/p251317	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130034	10.1371/journal.pone.0130034	http://dx.doi.org/10.1371/journal.pone.0130034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067491	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900095
J	Li, R; Zhou, H; Wei, W; Wang, C; Sun, YC; Gao, P				Li, Rui; Zhou, Hui; Wei, Wei; Wang, Chen; Sun, Ying Chun; Gao, Ping			Effects of Mechanical and Chemical Pretreatments of Zirconia or Fiber Posts on Resin Cement Bonding	PLOS ONE			English	Article							SURFACE TREATMENTS; SILANE SYSTEM; STRENGTH; COMPOSITE; ADHESION; MICROTENSILE; TITANIUM	The bonding strength between resin cement and posts is important for post and core restorations. An important method of improving the bonding strength is the use of various surface pretreatments of the post. In this study, the surfaces of zirconia (fiber) posts were treated by mechanical and/or chemical methods such as sandblasting and silanization. The bonding strength between the zirconia (fiber) post and the resin cement was measured by a push-out method after thermocycling based on the adhesion to Panavia F 2.0 resin cement. The zirconia and fiber posts exhibited different bonding strengths after sandblasting and/or silanization because of the different strengths and chemical structures. The zirconia post showed a high bonding strength of up to 17.1 MPa after a combined treatment of sandblasting and silanization because of the rough surface and covalent bonds at the interface. This effect was also enhanced by using 1,2-bis(trimethoxysilyl)ethane for the formation of a flexible layer at the interface. In contrast, a high bonding strength of 13.9 MPa was obtained for the fiber post treated by silane agents because the sandblasting treatment resulted in damage to the fiber post, as observed by scanning electron microscopy. The results indicated that the improvement in the bonding strength between the post and the resin cement could be controlled by different chemical and/or mechanical treatments. Enhanced bonding strength depended on covalent bonding and the surface roughness. A zirconia post with high bonding strength could potentially be used for the restoration of teeth in the future.	[Li, Rui; Zhou, Hui; Wei, Wei; Wang, Chen; Sun, Ying Chun; Gao, Ping] Tianjin Med Univ, Stomatol Hosp, Dept Prosthodont, Tianjin, Peoples R China	Tianjin Medical University	Gao, P (corresponding author), Tianjin Med Univ, Stomatol Hosp, Dept Prosthodont, Tianjin, Peoples R China.	kqxiufulirui@tijmu.edu.cn			Natural Science Foundation of Tianjin, China [12JCYBJC31300]	Natural Science Foundation of Tianjin, China(Natural Science Foundation of Tianjin)	This study is financially supported by Natural Science Foundation of Tianjin, China (12JCYBJC31300).	Aboushelib MN, 2013, J PROSTHODONT, V22, P190, DOI 10.1111/j.1532-849X.2012.00920.x; Almufleh BS, 2014, J PROSTHET DENT, V112, P957, DOI 10.1016/j.prosdent.2014.04.022; [Anonymous], 2015, TECHN BROCH; Bitter K, 2007, AM J DENT, V20, P353; Blatz MB, 2003, J PROSTHET DENT, V89, P268, DOI 10.1067/mpr.2003.50; Borges GA, 2003, J PROSTHET DENT, V89, P479, DOI 10.1016/S0022-3913(02)52704-9; Bottino MA, 2005, INT J PROSTHODONT, V18, P60; Chen D, 2014, J PROSTHET DENT, V112, P1406, DOI 10.1016/j.prosdent.2014.05.017; Chevalier J, 2004, BIOMATERIALS, V25, P5539, DOI 10.1016/j.biomaterials.2004.01.002; D'Arcangelo C, 2007, J ENDODONT, V33, P264, DOI 10.1016/j.joen.2006.10.015; Edwin P., 1991, SILANE COUPLING AGEN, V2nd ed., P31, DOI [10.1007/978-1-4899-2070-6_2, DOI 10.1007/978-1-4899-2070-6_2]; Elsaka SE, 2013, DENT MATER, V27, P165; Fazi G, 2012, AM J DENT, V25, P73; Ferrari M, 2007, AM J DENT, V20, P287; Goracci C, 2004, EUR J ORAL SCI, V112, P353, DOI 10.1111/j.1600-0722.2004.00146.x; Goracci C, 2005, DENT MATER, V21, P437, DOI 10.1016/j.dental.2004.07.012; Inokoshi M, 2013, J DENT, V41, P170, DOI 10.1016/j.jdent.2012.10.017; Kilicarslan MA, 2004, J PROSTHET DENT, V92, P365, DOI 10.1016/j.prosdent.2004.07.001; Li R, 2010, J ORAL REHABIL, V37, P560, DOI 10.1111/j.1365-2842.2010.02060.x; Li R, 2014, BIO-MED MATER ENG, V24, P2117, DOI 10.3233/BME-141022; Liu D, 2015, J MECH BEHAV BIOMED, V46, P23, DOI 10.1016/j.jmbbm.2015.02.015; Malferrari S, 2003, INT J PROSTHODONT, V16, P39; Manicardi CA, 2011, J ENDODONT, V37, P531, DOI 10.1016/j.joen.2010.12.009; Matinlinna JP, 2006, J DENT, V34, P740, DOI 10.1016/j.jdent.2006.01.008; Matinlinna JP, 2004, INT J PROSTHODONT, V17, P155; Matinlinna J, 2008, ACTA ODONTOL SCAND, V66, P250, DOI 10.1080/00016350802247131; Matinlinna JP, 2006, DENT MATER, V22, P824, DOI 10.1016/j.dental.2005.11.035; Matinlinna JP, 2010, SILICON-NETH, V2, P79, DOI 10.1007/s12633-010-9039-6; Matinlinna JP, 2011, J ADHES SCI TECHNOL, V25, P179, DOI 10.1163/016942410X503302; Mazzitelli C, 2008, J DENT RES, V87, P186, DOI 10.1177/154405910808700204; Patierno JM, 1996, ENDOD DENT TRAUMATOL, V12, P227; ROYDHOUSE RH, 1970, J DENT RES, V49, P131, DOI 10.1177/00220345700490010501; Sahafi A, 2003, J ADHES DENT, V5, P153; Samimi P, 2014, OPER DENT, V39, pE217, DOI 10.2341/11-486-L; Soejima H, 2013, DENT MATER J, V32, P659, DOI 10.4012/dmj.2013-078; Yun JY, 2010, DENT MATER, V26, P650, DOI 10.1016/j.dental.2010.03.008; Zicari F, 2012, DENT MATER, V28, P287, DOI 10.1016/j.dental.2011.11.003	37	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129690	10.1371/journal.pone.0129690	http://dx.doi.org/10.1371/journal.pone.0129690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066349	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900071
J	Raja, MAG; Katas, H; Wen, TJ				Raja, Maria Abdul Ghafoor; Katas, Haliza; Wen, Thum Jing			Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers	PLOS ONE			English	Article							GENE DELIVERY; MECHANISM; VECTORS	Chitosan (CS) nanoparticles have been extensively studied for siRNA delivery; however, their stability and efficacy are highly dependent on the types of cross-linker used. To address this issue, three common cross-linkers; tripolyphosphate (TPP), dextran sulphate (DS) and poly-D-glutamic acid (PGA) were used to prepare siRNA loaded CS-TPP/DS/PGA nanoparticles by ionic gelation method. The resulting nanoparticles were compared with regard to their physicochemical properties including particle size, zeta potential, morphology, binding and encapsulation efficiencies. Among all the formulations prepared with different cross linkers, CS-TPP-siRNA had the smallest particle size (ranged from 127 +/- 9.7 to 455 +/- 12.9 nm) with zeta potential ranged from +25.1 +/- 1.5 to +39.4 +/- 0.5 mV, and high entrapment (>95%) and binding efficiencies. Similarly, CS-TPP nanoparticles showed better siRNA protection during storage at 4 degrees C and as determined by serum protection assay. TEM micrographs revealed the assorted morphology of CS-TPP-siRNA nanoparticles in contrast to irregular morphology displayed by CS-DS-siRNA and CS-PGA-siRNA nanoparticles. All siRNA loaded CS-TPP/DS/PGA nanoparticles showed initial burst release followed by sustained release of siRNA. Moreover, all the formulations showed low and concentration-dependent cytotoxicity with human colorectal cancer cells (DLD-1), in vitro. The cellular uptake studies with CS-TPP-siRNA nanoparticles showed successful delivery of siRNA within cytoplasm of DLD-1 cells. The results demonstrate that ionically cross-linked CS-TPP nanoparticles are biocompatible non-viral gene delivery system and generate a solid ground for further optimization studies, for example with regard to steric stabilization and targeting.	[Raja, Maria Abdul Ghafoor; Katas, Haliza; Wen, Thum Jing] Univ Kebangsaan Malaysia, Ctr Drug Delivery Res, Fac Pharm, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia	Katas, H (corresponding author), Univ Kebangsaan Malaysia, Ctr Drug Delivery Res, Fac Pharm, Kuala Lumpur, Malaysia.	haliz12@hotmail.com	KATAS, HALIZA/I-6417-2016	KATAS, HALIZA/0000-0001-7249-1628	Ministry of Higher Education Exploratory Research Grant [ERGS/1/2011/SKK/UKM/02/11]	Ministry of Higher Education Exploratory Research Grant	This work was supported by the Ministry of Higher Education Exploratory Research Grant Scheme ERGS/1/2011/SKK/UKM/02/11 to HK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2007, J CLIN INVEST, V117, P3623, DOI 10.1172/JCI33494; Al-Qadi S, 2011, CARBOHYD POLYM, V86, P25, DOI 10.1016/j.carbpol.2011.03.022; Anitha A, 2011, CARBOHYD POLYM, V84, P1158, DOI 10.1016/j.carbpol.2011.01.005; Avadi MR, 2010, NANOMED-NANOTECHNOL, V6, P58, DOI 10.1016/j.nano.2009.04.007; Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015; Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4; Csaba N, 2009, INT J PHARMACEUT, V382, P205, DOI 10.1016/j.ijpharm.2009.07.028; Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Dudhani AR, 2010, CARBOHYD POLYM, V81, P243, DOI 10.1016/j.carbpol.2010.02.026; Fan W, 2012, COLLOID SURFACE B, V90, P21, DOI 10.1016/j.colsurfb.2011.09.042; FELGNER JH, 1994, J BIOL CHEM, V269, P2550; Ge CC, 2011, P NATL ACAD SCI USA, V108, P16968, DOI 10.1073/pnas.1105270108; Germershaus O, 2008, J CONTROL RELEASE, V125, P145, DOI 10.1016/j.jconrel.2007.10.013; Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002; Hickerson RP, 2008, OLIGONUCLEOTIDES, V18, P345, DOI 10.1089/oli.2008.0149; Hu WB, 2011, ACS NANO, V5, P3693, DOI 10.1021/nn200021j; Illum L, 1998, PHARM RES-DORDR, V15, P1326; Katas H, 2006, J CONTROL RELEASE, V115, P216, DOI 10.1016/j.jconrel.2006.07.021; Kim SH, 2006, BIOCONJUGATE CHEM, V17, P241, DOI 10.1021/bc050289f; Kirchhoff F, 2008, CELL, V134, P566, DOI 10.1016/j.cell.2008.08.004; Kleemann E, 2005, J CONTROL RELEASE, V109, P299, DOI 10.1016/j.jconrel.2005.09.036; Ko JA, 2002, INT J PHARMACEUT, V249, P165, DOI 10.1016/S0378-5173(02)00487-8; Li SD, 2007, J CONTROL RELEASE, V123, P181, DOI 10.1016/j.jconrel.2007.09.004; Lin YH, 2005, BIOMACROMOLECULES, V6, P1104, DOI 10.1021/bm049312a; Liu F, 2002, J CONTROL RELEASE, V78, P259, DOI 10.1016/S0168-3659(01)00494-1; Liu ZH, 2008, ADV DRUG DELIVER REV, V60, P1650, DOI 10.1016/j.addr.2008.09.001; Lundstrom K, 2003, TRENDS BIOTECHNOL, V21, P117, DOI 10.1016/S0167-7799(02)00042-2; Malmo J, 2011, BIOMACROMOLECULES, V12, P721, DOI 10.1021/bm1013525; Papadimitriou SA, 2012, INT J PHARMACEUT, V430, P318, DOI 10.1016/j.ijpharm.2012.04.004; Piao LZ, 2013, NANOMED-NANOTECHNOL, V9, P122, DOI 10.1016/j.nano.2012.03.008; Raja MAG, 2013, J NANOMATER, V2013, DOI 10.1155/2013/653892; Rampino A, 2013, INT J PHARMACEUT, V455, P219, DOI 10.1016/j.ijpharm.2013.07.034; Rodrigues S, 2012, CARBOHYD POLYM, V89, P282, DOI 10.1016/j.carbpol.2012.03.010; Savic R, 2003, SCIENCE, V300, P615, DOI 10.1126/science.1078192; Shim MS, 2010, FEBS J, V277, P4814, DOI 10.1111/j.1742-4658.2010.07904.x; Strand SP, 2008, BIOMACROMOLECULES, V9, P3268, DOI 10.1021/bm800832u; Tsai ML, 2011, CARBOHYD POLYM, V84, P756, DOI 10.1016/j.carbpol.2010.04.040; Tsao CT, 2011, CARBOHYD POLYM, V84, P812, DOI 10.1016/j.carbpol.2010.04.034; Vandenberg GW, 2001, J CONTROL RELEASE, V77, P297, DOI 10.1016/S0168-3659(01)00517-X	40	64	66	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128963	10.1371/journal.pone.0128963	http://dx.doi.org/10.1371/journal.pone.0128963			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068222	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900036
J	Wandu, WS; Tan, CY; Ogbeifun, O; Vistica, BP; Shi, GP; Hinshaw, SJH; Xie, C; Chen, X; Klinman, DM; Cai, HB; Gery, I				Wandu, Wambui S.; Tan, Cuiyan; Ogbeifun, Osato; Vistica, Barbara P.; Shi, Guangpu; Hinshaw, Samuel J. H.; Xie, Chengsong; Chen, Xi; Klinman, Dennis M.; Cai, Huaibin; Gery, Igal			Leucine-Rich Repeat Kinase 2 (Lrrk2) Deficiency Diminishes the Development of Experimental Autoimmune Uveitis (EAU) and the Adaptive Immune Response	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SUSCEPTIBILITY LOCI; CROHNS-DISEASE; T-CELLS; TH17; INNATE	Background Mutations in LRRK2 are related to certain forms of Parkinson's disease and, possibly, to the pathogenesis of Crohn's disease. In both these diseases inflammatory processes participate in the pathogenic process. LRRK2 is expressed in lymphoid cells and, interestingly, Lrrk2 (-/-) mice were reported to develop more severe experimental colitis than their wild type (WT) controls. Here, we examined the possible involvement of LRRK2 in the pathogenesis of experimental autoimmune uveitis (EAU), an animal model for human uveitis, by testing Lrrk2 (-/-) mice for their capacity to develop this experimental eye disease and related immune responses. Methods Lrrk2 (-/-) mice and their WT controls (C57Bl/6) were immunized with interphotoreceptor retinoid-binding protein (IRBP) and compared for their development of EAU, delayed type hypersensitivity (DTH) by skin tests, production of cytokines in culture, and expression of interferon (IFN)-gamma, interleukin (IL)-17 and FoxP3 by spleen cells, using flow cytometry. Peritoneal macrophages were examined for their production of cytokines/chemokines in culture following stimulation with LPS or the oligodeoxynucleotide CpG. The Lrrk2 (-/-) and WT mice were also compared for their response to bovine serum albumin (BSA). Results The Lrrk2 (-/-) mice developed lower levels of EAU, DTH responses and cytokine production by lymphocytes than did their WT controls. Intracellular expression of IFN-gamma and IL-17, by spleen cells, and secretion of cytokines/chemokines by activated peritoneal macrophages of Lrrk2 (-/-) mice trended toward diminished levels, although variabilities were noted. The expression levels of FoxP3 by Lrrk2 (-/-) spleen cells, however, were similar to those seen in WT controls. Consistent with their low response to IRBP, Lrrk2 (-/-) mice responded to BSA less vigorously than their WT controls. Conclusions Lrrk2 deficiency in mice diminished the development of EAU and the related adaptive immune responses to IRBP as compared to the WT controls.	[Wandu, Wambui S.; Tan, Cuiyan; Ogbeifun, Osato; Vistica, Barbara P.; Shi, Guangpu; Hinshaw, Samuel J. H.; Gery, Igal] NEI, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Xie, Chengsong; Chen, Xi; Cai, Huaibin] NIA, Neurogenet Lab, NIH, Transgen Sect, Bethesda, MD 20892 USA; [Klinman, Dennis M.] NCI, NIH, Canc & Inflammat Program, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gery, I (corresponding author), NEI, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	geryi@nei.nih.gov	Cai, Huaibin/H-3359-2013	Cai, Huaibin/0000-0002-8596-6108	National Eye Institute; National Institute on Aging, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010853] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000945, ZIAAG000944, ZIAAG000943] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by intramural funding by National Eye Institute (IG) and National Institute on Aging (HC), National Institutes of Health. The National Eye Institute and National Institute on Aging had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; Cox CA, 2008, J IMMUNOL, V180, P7414, DOI 10.4049/jimmunol.180.11.7414; Dachsel JC, 2010, ARCH NEUROL-CHICAGO, V67, P542, DOI 10.1001/archneurol.2010.79; Dzamko N, 2012, BIOCHEM SOC T, V40, P1134, DOI 10.1042/BST20120119; Dzamko N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039132; Forrester JV, 2013, INT REV IMMUNOL, V32, P76, DOI 10.3109/08830185.2012.747524; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Geremia A, 2014, AUTOIMMUN REV, V13, P3, DOI 10.1016/j.autrev.2013.06.004; Hakimi M, 2011, J NEURAL TRANSM, V118, P795, DOI 10.1007/s00702-011-0653-2; Hold GL, 2014, WORLD J GASTROENTERO, V20, P1192, DOI 10.3748/wjg.v20.i5.1192; Kaser A, 2009, SEMIN IMMUNOL, V21, P156, DOI 10.1016/j.smim.2009.01.001; Kim B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034693; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Ness D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066164; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Nussenblatt RB, 1996, J AUTOIMMUN, V9, P575, DOI 10.1006/jaut.1996.0077; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Russo I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-52; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schapansky J, 2014, NEUROSCIENCE, DOI [10.1016/j.neuroscience.2014.09.049, DOI 10.1016/J.NEUR0SCIENCE.2014.09.049]; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shi GP, 2013, J IMMUNOL, V191, P415, DOI 10.4049/jimmunol.1201732; Siegmund B, 2010, IMMUNITY, V32, P300, DOI 10.1016/j.immuni.2010.03.010; Sutton CE, 2012, EUR J IMMUNOL, V42, P2221, DOI 10.1002/eji.201242569; Thevenet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021519; Umeno J, 2011, INFLAMM BOWEL DIS, V17, P2407, DOI 10.1002/ibd.21651; Vistica BP, 2012, MOL VIS, V18, P1858	30	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128906	10.1371/journal.pone.0128906	http://dx.doi.org/10.1371/journal.pone.0128906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067490	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900033
J	Breckel, TPK; Giessing, C; Gieseler, A; Querbach, S; Reuter, M; Thiel, CM				Breckel, Thomas P. K.; Giessing, Carsten; Gieseler, Anja; Querbach, Sarah; Reuter, Martin; Thiel, Christiane M.			Nicotinergic Modulation of Attention-Related Neural Activity Differentiates Polymorphisms of DRD2 and CHRNA4 Receptor Genes	PLOS ONE			English	Article							C957T POLYMORPHISM; VISUOSPATIAL ATTENTION; ACETYLCHOLINE-RECEPTORS; INDIVIDUAL-DIFFERENCES; PERFORMANCE; AVAILABILITY; ADDICTION; NETWORKS; AREAS	Cognitive and neuronal effects of nicotine show high interindividual variability. Recent findings indicate that genetic variations that affect the cholinergic and dopaminergic neurotransmitter system impact performance in cognitive tasks and effects of nicotine. The current pharmacogenetic functional magnetic resonance imaging (fMRI) study aimed to investigate epistasis effects of CHRNA4/DRD2 variations on behavioural and neural correlates of visuospatial attention after nicotine challenge using a data driven partial least squares discriminant analysis (PLS-DA) approach. Fifty young healthy non-smokers were genotyped for CHRNA4 (rs1044396) and DRD2 (rs6277). They received either 7mg transdermal nicotine or a matched placebo in a double blind within subject design prior to performing a cued target detection task with valid and invalid trials. On behavioural level, the strongest benefits of nicotine in invalid trials were observed in participants carrying both, the DRD2 T-and CHRNA4 C+ variant. Neurally, we were able to demonstrate that different DRD2/CHRNA4 groups can be decoded from the pattern of brain activity in invalid trials under nicotine. Neural substrates of interindividual variability were found in a network of attention-related brain regions comprising the pulvinar, the striatum, the middle and superior frontal gyri, the insula, the left precuneus, and the right middle temporal gyrus. Our findings suggest that polymorphisms in the CHRNA4 and DRD2 genes are a relevant source of individual variability in pharmacological studies with nicotine.	[Breckel, Thomas P. K.; Giessing, Carsten; Gieseler, Anja; Querbach, Sarah; Thiel, Christiane M.] Carl von Ossietzky Univ Oldenburg, European Med Sch, Dept Psychol, Biol Psychol, D-26111 Oldenburg, Germany; [Breckel, Thomas P. K.; Thiel, Christiane M.] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany; [Reuter, Martin] Univ Bonn, Dept Psychol, Personal & Biol Psychol, Bonn, Germany; [Thiel, Christiane M.] Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, D-26111 Oldenburg, Germany; [Reuter, Martin] Univ Bonn, Ctr Econ Neurosci CENs, Neurogenet Lab, Bonn, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; University of Bonn; Carl von Ossietzky Universitat Oldenburg; University of Bonn	Thiel, CM (corresponding author), Carl von Ossietzky Univ Oldenburg, European Med Sch, Dept Psychol, Biol Psychol, D-26111 Oldenburg, Germany.	chritiane.thiel@uni-oldenburg.de		, Christiane/0000-0003-4788-4301	German Research Foundation DFG [TH766/6-1]	German Research Foundation DFG(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation DFG TH766/6-1.	Abdi Herve, 2013, Methods Mol Biol, V930, P549, DOI 10.1007/978-1-62703-059-5_23; Ahrens S, 2015, PSYCHOPHARMACOLOGY, V232, P2323, DOI 10.1007/s00213-015-3869-2; Behler O, 2015, PSYCHOPHARMACOLOGY, V232, P1269, DOI 10.1007/s00213-014-3761-5; BOND A, 1974, BRIT J MED PSYCHOL, V47, P211, DOI 10.1111/j.2044-8341.1974.tb02285.x; Caplan JB, 2007, CEREB CORTEX, V17, P1650, DOI 10.1093/cercor/bhl076; Colzato LS, 2010, NEUROSCIENCE, V170, P782, DOI 10.1016/j.neuroscience.2010.07.050; Cook R. D., 1982, RESIDUALS AND INFLUE; DEJONG S, 1993, CHEMOMETR INTELL LAB, V18, P251, DOI 10.1016/0169-7439(93)85002-X; Di Giorgio A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095997; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Espeseth T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014407; Evans S, 2013, J PSYCHOPHARMACOL, V27, P1007, DOI 10.1177/0269881113499828; Exley R, 2008, BRIT J PHARMACOL, V153, pS283, DOI 10.1038/sj.bjp.0707510; Feng Y, 2004, AM J HUM GENET, V75, P112, DOI 10.1086/422194; Giessing C, 2012, NEUROIMAGE, V59, P831, DOI 10.1016/j.neuroimage.2011.07.061; Gosselin R, 2010, CHEMOMETR INTELL LAB, V100, P12, DOI 10.1016/j.chemolab.2009.09.005; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Greenwood PM, 2012, NEUROSCI BIOBEHAV R, V36, P1331, DOI 10.1016/j.neubiorev.2012.02.010; Greenwood PM, 2005, J COGNITIVE NEUROSCI, V17, P1611, DOI 10.1162/089892905774597281; Hahn B, 2007, J NEUROSCI, V27, P3477, DOI 10.1523/JNEUROSCI.5129-06.2007; Hahn B, 2009, CEREB CORTEX, V19, P1990, DOI 10.1093/cercor/bhn226; Hammersley JJ, 2013, PHARMACOL BIOCHEM BE, V105, P199, DOI 10.1016/j.pbb.2013.02.017; Heishman SJ, 2010, PSYCHOPHARMACOLOGY, V210, P453, DOI 10.1007/s00213-010-1848-1; Herman AI, 2014, PHARMACOGENOMICS, V15, P221, DOI 10.2217/pgs.13.246; Herman AI, 2010, ADDICT BIOL, V15, P250, DOI 10.1111/j.1369-1600.2010.00213.x; Hirvonen M, 2004, MOL PSYCHIATR, V9, P1060, DOI 10.1038/sj.mp.4001561; Hirvonen MM, 2009, SYNAPSE, V63, P907, DOI 10.1002/syn.20672; Hirvonen MM, 2009, PROG NEURO-PSYCHOPH, V33, P630, DOI 10.1016/j.pnpbp.2009.02.021; Jacobsen LK, 2006, PSYCHOPHARMACOLOGY, V188, P530, DOI 10.1007/s00213-006-0469-1; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Lee MR, 2013, GENES BRAIN BEHAV, V12, P554, DOI 10.1111/gbb.12027; Markett S, 2014, NEUROSCI LETT, V566, P216, DOI 10.1016/j.neulet.2014.02.052; Markett S, 2013, NEUROIMAGE, V64, P167, DOI 10.1016/j.neuroimage.2012.08.059; Markett S, 2011, EMOTION, V11, P450, DOI 10.1037/a0021784; Markett SA, 2010, J COGNITIVE NEUROSCI, V22, P1944, DOI 10.1162/jocn.2009.21354; Mehmood T, 2012, CHEMOMETR INTELL LAB, V118, P62, DOI 10.1016/j.chemolab.2012.07.010; Newhouse PA, 2004, CURR OPIN PHARMACOL, V4, P36, DOI 10.1016/j.coph.2003.11.001; NISELL M, 1994, SYNAPSE, V16, P36, DOI 10.1002/syn.890160105; Parasuraman R, 2005, PSYCHOL SCI, V16, P200, DOI 10.1111/j.0956-7976.2005.00804.x; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Qu HN, 2010, PATTERN RECOGN, V43, P3448, DOI 10.1016/j.patcog.2010.05.002; Rodriguez-Jimenez R, 2006, NEUROPSYCHOBIOLOGY, V54, P166, DOI 10.1159/000098652; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; Shulman GL, 2009, J NEUROSCI, V29, P4392, DOI 10.1523/JNEUROSCI.5609-08.2009; Smolka MN, 2004, PSYCHOPHARMACOLOGY, V175, P374, DOI 10.1007/s00213-004-1824-8; Strumpf H, 2013, HUM BRAIN MAPP, V34, P1115, DOI 10.1002/hbm.21496; Thiel CM, 2008, NEUROSCIENCE, V152, P381, DOI 10.1016/j.neuroscience.2007.10.061; Thiel CM, 2005, NEUROPSYCHOPHARMACOL, V30, P810, DOI 10.1038/sj.npp.1300633; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; VANDERVOET H, 1994, CHEMOMETR INTELL LAB, V25, P313, DOI 10.1016/0169-7439(94)85050-X; Vossel S, 2008, NEUROPSYCHOPHARMACOL, V33, P731, DOI 10.1038/sj.npp.1301469; Vossel S, 2011, J PSYCHOPHARMACOL, V25, P1485, DOI 10.1177/0269881110391830; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052; Wong DF, 2013, J NUCL MED, V54, P1308, DOI 10.2967/jnumed.112.108001; Xu HY, 2007, SCHIZOPHR RES, V90, P104, DOI 10.1016/j.schres.2006.10.001	56	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0126460	10.1371/journal.pone.0126460	http://dx.doi.org/10.1371/journal.pone.0126460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079805	Green Published, gold, Green Submitted			2022-12-27	WOS:000356542300002
J	Chakrabarti, L; Morgan, C; Sandler, AD				Chakrabarti, Lina; Morgan, Clifford; Sandler, Anthony D.			Combination of Id2 Knockdown Whole Tumor Cells and Checkpoint Blockade: A Potent Vaccine Strategy in a Mouse Neuroblastoma Model	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; OPSOCLONUS-MYOCLONUS; T-CELLS; FAVORABLE PROGNOSIS; ANTITUMOR IMMUNITY; PHASE-II; CANCER; IMMUNOTHERAPY; CHILDREN; CTLA-4	Tumor vaccines have held much promise, but to date have demonstrated little clinical success. This lack of success is conceivably due to poor tumor antigen presentation combined with immuno-suppressive mechanisms exploited by the tumor itself. Knock down of Inhibitor of differentiation protein 2 (Id2-kd) in mouse neuroblastoma whole tumor cells rendered these cells immunogenic. Id2-kd neuroblastoma (Neuro2a) cells (Id2-kd N2a) failed to grow in most immune competent mice and these mice subsequently developed immunity against further wild-type Neuro2a tumor cell challenge. Id2-kd N2a cells grew aggressively in immune-compromised hosts, thereby establishing the immunogenicity of these cells. Therapeutic vaccination with Id2-kd N2a cells alone suppressed tumor growth even in established neuroblastoma tumors and when used in combination with immune checkpoint blockade eradicated large established tumors. Mechanistically, immune cell depletion studies demonstrated that while CD8+ T cells are critical for antitumor immunity, CD4+ T cells are also required to induce a sustained long-lasting helper effect. An increase in number of CD8+ T-cells and enhanced production of interferon gamma (IFN gamma) was observed in tumor antigen stimulated splenocytes of vaccinated mice. More importantly, a massive influx of cytotoxic CD8+ T-cells infiltrated the shrinking tumor following combined immunotherapy. These findings show that down regulation of Id2 induced tumor cell immunity and in combination with checkpoint blockade produced a novel, potent, T-cell mediated tumor vaccine strategy.	[Sandler, Anthony D.] George Washington Univ, Childrens Natl Med Ctr, Joseph E Robert Jr Ctr Surg Care, Washington, DC 20052 USA; George Washington Univ, Childrens Natl Med Ctr, Sheikh Zayed Inst Pediat Surg Innovat, Washington, DC USA	Children's National Health System; George Washington University; Children's National Health System; George Washington University	Sandler, AD (corresponding author), George Washington Univ, Childrens Natl Med Ctr, Joseph E Robert Jr Ctr Surg Care, Washington, DC 20052 USA.	asandler@childrensnational.org		Morgan, Clifford/0000-0001-9559-6860; Sandler, Anthony/0000-0001-9440-2964	Sheikh Zayed Institute for Pediatric Surgical Innovation; Michael Sandler Cancer research fund	Sheikh Zayed Institute for Pediatric Surgical Innovation; Michael Sandler Cancer research fund	The work is supported by grants from Sheikh Zayed Institute for Pediatric Surgical Innovation and Michael Sandler Cancer research fund to ADS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN AJ, 1976, CANCER, V37, P846, DOI 10.1002/1097-0142(197602)37:2<846::AID-CNCR2820370233>3.0.CO;2-L; Blank CU, 2014, CURR OPIN ONCOL, V26, P204, DOI 10.1097/CCO.0000000000000054; Boon T, 1997, IMMUNOL TODAY, V18, P267, DOI 10.1016/S0167-5699(97)80020-5; Brahmer JR, 2013, CANCER IMMUNOL RES, V1, P85, DOI 10.1158/2326-6066.CIR-13-0078; Carlson LM, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23618; CARREL S, 1982, ACTA NEUROPATHOL, V57, P158, DOI 10.1007/BF00685384; Castriconi R, 2004, P NATL ACAD SCI USA, V101, P12640, DOI 10.1073/pnas.0405025101; Ceschel S, 2006, PEDIATR BLOOD CANCER, V47, P560, DOI 10.1002/pbc.20726; Chakrabarti L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083521; Chakrabarti Lina, 2012, Front Oncol, V2, P82, DOI 10.3389/fonc.2012.00082; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Chung KY, 2010, J CLIN ONCOL, V28, P3485, DOI 10.1200/JCO.2010.28.3994; Cooper R, 2001, MED PEDIATR ONCOL, V36, P623, DOI 10.1002/mpo.1139; Coughlin CM, 2006, J CLIN ONCOL, V24, P5725, DOI 10.1200/JCO.2005.05.3314; Deschoolmeester V, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-19; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gray JC, 2006, CLIN SCI, V111, P93, DOI 10.1042/CS20060024; Grosso Joseph F, 2013, Cancer Immun, V13, P5; Gurney JG, 2007, PEDIATRICS, V120, pE1229, DOI 10.1542/peds.2007-0178; Gurney JG, 1997, J PEDIAT HEMATOL ONC, V19, P428, DOI 10.1097/00043426-199709000-00004; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hurwitz AA, 2000, CANCER RES, V60, P2444; Hurwitz AA, 1998, P NATL ACAD SCI USA, V95, P10067, DOI 10.1073/pnas.95.17.10067; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; Johnson BD, 2003, CELL IMMUNOL, V222, P15, DOI 10.1016/S0008-8749(03)00079-0; KOH PS, 1994, J PEDIATR-US, V125, P712, DOI 10.1016/S0022-3476(94)70062-1; Kyi C, 2014, FEBS LETT, V588, P368, DOI 10.1016/j.febslet.2013.10.015; Lasorella A, 2002, CANCER RES, V62, P301; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Lee S, 2012, CURR ONCOL REP, V14, P468, DOI 10.1007/s11912-012-0257-5; Liu DF, 2012, J CLIN INVEST, V122, P2221, DOI 10.1172/JCI59535; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Met O, 2006, CANCER LETT, V231, P247, DOI 10.1016/j.canlet.2005.02.005; Miska J, 2012, EUR J IMMUNOL, V42, P2584, DOI 10.1002/eji.201242590; Naidoo J, 2014, BR J CANCER; Nishikawa H, 2005, J EXP MED, V201, P681, DOI 10.1084/jem.20041959; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Plotkin SA, 2005, NAT MED, V11, pS5, DOI 10.1038/nm1209; Prigione I, 2004, ANN NY ACAD SCI, V1028, P69, DOI 10.1196/annals.1322.008; Raffaghello L, 2005, CANCER LETT, V228, P155, DOI 10.1016/j.canlet.2004.11.064; Raffaghello L, 2004, NEOPLASIA, V6, P558, DOI 10.1593/neo.04316; Ralph C, 2010, CLIN CANCER RES, V16, P1662, DOI 10.1158/1078-0432.CCR-09-2870; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Russo C, 1997, MED PEDIATR ONCOL, V28, P284, DOI 10.1002/(SICI)1096-911X(199704)28:4<284::AID-MPO7>3.0.CO;2-E; Salgia R, 2003, J CLIN ONCOL, V21, P624, DOI 10.1200/JCO.2003.03.091; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shurin GV, 1998, NAT IMMUN, V16, P263, DOI 10.1159/000069452; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Williams EL, 2013, CLIN CANCER RES, V19, P3545, DOI 10.1158/1078-0432.CCR-12-3226; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	58	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129237	10.1371/journal.pone.0129237	http://dx.doi.org/10.1371/journal.pone.0129237			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079374	Green Published, gold, Green Submitted			2022-12-27	WOS:000356542300020
J	Jung, S; Kim, MK; Choi, BY				Jung, Sukyoung; Kim, Mi Kyung; Choi, Bo Youl			The Relationship between Zinc Status and Inflammatory Marker Levels in Rural Korean Adults Aged 40 and Older	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; HEALTH; RISK; CONSUMPTION; PREVENTION; CYTOKINES; INTIMA; IRON	Background Serum cytokines and C-reactive protein (CRP) are known as one of the major risk factors in atherosclerosis. The antioxidant and anti-inflammatory properties of zinc have been suggested, but few data are available on the relationship between zinc status and inflammatory markers in epidemiological studies. Objective The present study aims to investigate the cross-sectional relationships of serum cytokines and CRP with dietary zinc intake and serum zinc levels in healthy men and women aged 40 and older in rural areas of South Korea. Materials and Methods A group of 1,055 subjects (404 men, 651 women) was included in dietary zinc analysis while another group of 695 subjects (263 men, 432 women) was included in serum zinc analysis. Serum IL-6, TNF-alpha, and CRP were measured as inflammatory markers. Results There was no significant inverse relationship between dietary zinc intake and inflammatory markers. We found a significant inverse relationship between serum zinc levels and all three inflammatory markers in women (P for trend = 0.0236 for IL-6; P for trend = 0.0017 for TNF-alpha; P for trend = 0.0301 for CRP) and between serum zinc levels and a single inflammatory marker (IL-6) in men (P for trend = 0.0191), although all R2 values by regression were less than 10%. Conclusion In conclusion, serum zinc levels may be inversely related to inflammatory markers (IL-6, TNF-alpha, and CRP), particularly in women.	[Jung, Sukyoung; Kim, Mi Kyung; Choi, Bo Youl] Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea; [Jung, Sukyoung; Kim, Mi Kyung; Choi, Bo Youl] Hanyang Univ, Inst Hlth & Soc, Seoul 133791, South Korea	Hanyang University; Hanyang University	Kim, MK (corresponding author), Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea.	kmkkim@hanyang.ac.kr		Jung, Sukyoung/0000-0001-9200-2158	National Research Foundation of Korea [NRF-2012R1A1A2001930]; Research of Korea Centers for Disease Control and Prevention [2004-E71004-00, 2005-E71011-00, 2006-E71009-00, 2007-E71002-00, 2008-E71004-00, 2009-E71006-00]	National Research Foundation of Korea(National Research Foundation of Korea); Research of Korea Centers for Disease Control and Prevention	This study was supported by the National Research Foundation of Korea (NRF-2012R1A1A2001930) with additional funding (2004-E71004-00, 2005-E71011-00, 2006-E71009-00, 2007-E71002-00, 2008-E71004-00 and 2009-E71006-00) from the Research of Korea Centers for Disease Control and Prevention. The funders played no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Andriollo-Sanchez M, 2005, EUR J CLIN NUTR, V59, pS37, DOI 10.1038/sj.ejcn.1602296; de Benoist B, 2007, FOOD NUTR BULL, V28, pS480, DOI 10.1177/15648265070283S306; De Paula R, 2014, BBA CLIN; Fabian E, 2008, ANN NUTR METAB, V52, P57, DOI 10.1159/000115352; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; Gibson RS, 2001, BRIT J NUTR, V86, P71, DOI 10.1079/BJN2001370; Harland B F, 1987, World Rev Nutr Diet, V52, P235; Health Canada, 2010, DIETARY REFERENCE IN; Hess SY, 2007, FOOD NUTR BULL, V28, pS403, DOI 10.1177/15648265070283S303; Joung H, 2004, J FOOD COMPOS ANAL, V17, P713, DOI 10.1016/j.jfca.2003.10.002; Jung SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080115; Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367; Kogirima M, 2007, EUR J CLIN NUTR, V61, P375, DOI 10.1038/sj.ejcn.1602520; Lee DH, 2005, AM J CLIN NUTR, V81, P787, DOI 10.1093/ajcn/81.4.787; Libby P, 2006, AM J CLIN NUTR, V83, p456S; LIBERATOS P, 1988, EPIDEMIOL REV, V10, P87, DOI 10.1093/oxfordjournals.epirev.a036030; Little PJ, 2010, NUTRITION, V26, P1050, DOI 10.1016/j.nut.2010.03.007; Lowe NM, 2012, BRIT J NUTR, V108, P1962, DOI 10.1017/S0007114512004382; Lowe NM, 2009, AM J CLIN NUTR, V89, p2040S, DOI 10.3945/ajcn.2009.27230G; Male D. K., 2012, IMMUNOLOGY; Maret W, 2013, METAL IONS LIFE SCI, V11, P1, DOI 10.1007/978-94-007-5179-8_1; Otto MCCD, 2011, J NUTR, V141, P1508, DOI 10.3945/jn.111.138115; Otto MCD, 2012, J NUTR, V142, P526, DOI 10.3945/jn.111.149781; Pasceri V, 2000, CIRCULATION, V102, P2165; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Prasad AS, 2008, EXP GERONTOL, V43, P370, DOI 10.1016/j.exger.2007.10.013; REEVES PG, 1995, J NUTR BIOCHEM, V6, P48, DOI 10.1016/0955-2863(94)00008-A; Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813; Roohani N, 2013, J RES MED SCI, V18, P144; Seo JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105990; The Korean Nutrition Society, 2011, REC DIET ALL KOR; The Korean Nutrition Society, 2000, RECOMMENDED DIETARY, V7th; Torzewski M, 2000, ARTERIOSCL THROM VAS, V20, P2094, DOI 10.1161/01.ATV.20.9.2094; Tsai DH, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-24; U.S. Department of Agriculture ARS, 2014, NUTR INT FOOD BEV ME; Uh HW, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-59; Willett W, 2012, NUTR EPIDEMIOLOGY; Wood RJ, 2000, J NUTR, V130, p1350S, DOI 10.1093/jn/130.5.1350S; Yang YJ, 2010, BRIT J NUTR, V104, P1202, DOI 10.1017/S0007114510001893; Yousuf O, 2013, J AM COLL CARDIOL, V62, P397, DOI 10.1016/j.jacc.2013.05.016; Zhao GX, 2007, AM J CLIN NUTR, V85, P385, DOI 10.1093/ajcn/85.2.385	44	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0130016	10.1371/journal.pone.0130016	http://dx.doi.org/10.1371/journal.pone.0130016			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080030	Green Published, gold, Green Submitted			2022-12-27	WOS:000356542300037
J	Fujita, S; Masago, K; Takeshita, J; Okuda, C; Otsuka, K; Hata, A; Kaji, R; Katakami, N; Hirata, Y				Fujita, Shiro; Masago, Katsuhiro; Takeshita, Jumpei; Okuda, Chiyuki; Otsuka, Kyoko; Hata, Akito; Kaji, Reiko; Katakami, Nobuyuki; Hirata, Yukio			Validation of an Ion Torrent Sequencing Platform for the Detection of Gene Mutations in Biopsy Specimens from Patients with Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							EGFR MUTATION; GEFITINIB	Background Treatment for patients with advanced non-small cell lung cancer (NSCLC) is often determined by the presence of biomarkers that predict the response to agents targeting specific molecular pathways. Demands for multiplex analysis of the genes involved in the pathogenesis of NSCLC are increasing. Methods We validated the Ion Torrent Personal Genome Machine (PGM) system using the Ion AmpliSeq Cancer Hotspot Panel and compared the results with those obtained using the gold standard methods, conventional PCR and Sanger sequencing. The cycleave PCR method was used to verify the results. Results and Conclusion The Ion Torrent PGM resulted in a similar level of accuracy in identifying multiple genetic mutations in parallel, compared with conventional PCR and Sanger sequencing; however, the Ion Torrent PGM was superior to the other sequencing methods in terms of increased ease of use, even when taking into account the small amount of DNA that was obtained from formalin-fixed paraffin embedded (FFPE) biopsy specimens.	[Fujita, Shiro; Masago, Katsuhiro; Takeshita, Jumpei; Okuda, Chiyuki; Otsuka, Kyoko; Hata, Akito; Kaji, Reiko; Katakami, Nobuyuki; Hirata, Yukio] Inst Biomed Res & Innovat, Div Integrated Oncol, Chuo Ku, Kobe, Hyogo 6500047, Japan	Institute for Biomedical Research & Innovation (IBRI)	Fujita, S (corresponding author), Inst Biomed Res & Innovat, Div Integrated Oncol, Chuo Ku, Kobe, Hyogo 6500047, Japan.	jp.shirofujita@gmail.com		Fujita, Shiro/0000-0002-2629-0152				Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kosaka T, 2009, J THORAC ONCOL, V4, P22, DOI 10.1097/JTO.0b013e3181914111; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Yatabe Y, 2006, J MOL DIAGN, V8, P335, DOI 10.2353/jmoldx.2006.050104	6	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130219	10.1371/journal.pone.0130219	http://dx.doi.org/10.1371/journal.pone.0130219			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076009	Green Submitted, gold, Green Published			2022-12-27	WOS:000356329900157
J	Jaiswal, V; Gahlaut, V; Mathur, S; Agarwal, P; Khandelwal, MK; Khurana, JP; Tyagi, AK; Balyan, HS; Gupta, PK				Jaiswal, Vandana; Gahlaut, Vijay; Mathur, Saloni; Agarwal, Priyanka; Khandelwal, Manoj Kumar; Khurana, Jitendra Paul; Tyagi, Akhilesh Kumar; Balyan, Harindra Singh; Gupta, Pushpendra Kumar			Identification of Novel SNP in Promoter Sequence of TaGW2-6A Associated with Grain Weight and Other Agronomic Traits in Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							QTL ANALYSIS; BREAD WHEAT; NATURAL VARIATION; PROTEIN-KINASE; GENETIC-MAP; KERNEL SIZE; MAJOR QTL; RICE; YIELD; WIDTH	TaGW2 is an orthologue of rice gene OsGW2, which encodes E3 RING ubiquitin ligase and controls the grain size in rice. In wheat, three copies of TaGW2 have been identified and mapped on wheat homoeologous group 6 viz. TaGW2-6A, TaGW2-6B and TaGW2-6D. In the present study, using as many as 207 Indian wheat genotypes, we identified four SNPs including two novel SNPs (SNP-988 and SNP-494) in the promoter sequence of TaGW2-6A. All the four SNPs were G/A or A/G substitutions (transitions). Out of the four SNPs, SNP-494 was causal, since it was found associated with grain weight. The mean TGW (41.1 g) of genotypes with the allele SNP-494_A was significantly higher than mean TGW (38.6 g) of genotypes with the allele SNP-494_G. SNP-494 also regulates the expression of TaGW2-6Aso that the wheat genotypes with SNP-494_G have higher expression and lower TGW and the genotypes with SNP-494_A have lower expression but higher TGW. Besides, SNP-494 was also found associated with grain length-width ratio, awn length, spike length, grain protein content, peduncle length and plant height. This suggested that gene TaGW2-6A not only controls grain size, but also controls other agronomic traits. In the promoter region, SNP-494 was present in 'CGCG' motif that plays an important role in Ca2+/calmodulin mediated regulation of genes. A user-friendly CAPS marker was also developed to identify the desirable allele of causal SNP (SNP-494) for use in marker-assisted selection for improvement of grain weight in wheat. Using four SNPs, five haplotypes were identified; of these, Hap_5 (G_A_G_A) was found to be a desirable haplotype having significantly higher grain weight (41.13g) relative to other four haplotypes (36.33-39.16 g).	[Jaiswal, Vandana; Gahlaut, Vijay; Agarwal, Priyanka; Balyan, Harindra Singh; Gupta, Pushpendra Kumar] Ch Charan Singh Univ, Dept Genet & Plant Breeding, Meerut, Uttar Pradesh, India; [Mathur, Saloni; Khurana, Jitendra Paul] Univ Delhi, Interdisciplinary Ctr Plant Genom, New Delhi, India; [Khandelwal, Manoj Kumar] Indian Agr Res Inst, New Delhi, India; [Khurana, Jitendra Paul] Univ Delhi, Dept Plant Mol Biol, New Delhi, India; [Tyagi, Akhilesh Kumar] Natl Inst Plant Genome Res, New Delhi, India	Chaudhary Charan Singh University; University of Delhi; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; University of Delhi; Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Gupta, PK (corresponding author), Ch Charan Singh Univ, Dept Genet & Plant Breeding, Meerut, Uttar Pradesh, India.	pkgupta36@gmail.com	Balyan, H./AAI-9077-2020; Gahlaut, Vijay/K-4904-2012	Gahlaut, Vijay/0000-0003-4381-3573; Jaiswal, Vandana/0000-0001-8620-7595	Department of Biotechnology, New Delhi; Department of Science Technology (Funds for Improvement of Science and Technology infrastructure program), New Delhi; University Grants Commission (Special Assistance Program-Departmental Research Support Program), New Delhi; NASI-Senior Scientist; SRF; CSIR	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); Department of Science Technology (Funds for Improvement of Science and Technology infrastructure program), New Delhi; University Grants Commission (Special Assistance Program-Departmental Research Support Program), New Delhi(University Grants Commission, India); NASI-Senior Scientist; SRF; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Thanks are due to the Department of Biotechnology, New Delhi, Department of Science Technology (Funds for Improvement of Science and Technology infrastructure program), New Delhi and University Grants Commission (Special Assistance Program-Departmental Research Support Program), New Delhi for support which facilitated this study. PKG was awarded the position of NASI-Senior Scientist, VG was awarded SRF under the same program. CSIR awarded SRF to VJ.	[Anonymous], 2014, OPEN J GENET, DOI DOI 10.4236/OJGEN.2014.43024; [Anonymous], RES B; Asano T, 2002, PLANT CELL, V14, P619, DOI 10.1105/tpc.010454; Bednarek J, 2012, J EXP BOT, V63, P5945, DOI 10.1093/jxb/ers249; Botwright TL, 2002, AUST J AGR RES, V53, P1137, DOI 10.1071/AR02007; Campos-Soriano L, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-90; Dholakia BB, 2003, PLANT BREEDING, V122, P392, DOI 10.1046/j.1439-0523.2003.00896.x; Dong LL, 2014, MOL BREEDING, V34, P937, DOI 10.1007/s11032-014-0087-2; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hong YT, 2014, FUNCT INTEGR GENOMIC, V14, P341, DOI 10.1007/s10142-014-0380-5; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; Ishimaru K, 2013, NAT GENET, V45, P707, DOI 10.1038/ng.2612; Kato K, 2000, THEOR APPL GENET, V101, P1114, DOI 10.1007/s001220051587; Kumar N, 2006, EUPHYTICA, V151, P135, DOI 10.1007/s10681-006-9133-4; Kunert A, 2007, THEOR APPL GENET, V115, P683, DOI 10.1007/s00122-007-0600-7; Li Q, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-143; Li SS, 2007, MOL BREEDING, V20, P167, DOI 10.1007/s11032-007-9080-3; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maphosa L, 2014, THEOR APPL GENET, V127, P1607, DOI 10.1007/s00122-014-2322-y; MARSHALL DR, 1986, AUST J AGR RES, V37, P331, DOI 10.1071/AR9860331; Marza F, 2005, THEOR APPL GENET, V21, P1, DOI DOI 10.1007/S00122-005-0172-3; McCartney CA, 2005, GENOME, V48, P870, DOI 10.1139/g05-055; Mir RR, 2012, MOL BREEDING, V29, P963, DOI 10.1007/s11032-011-9693-4; Nie HZ, 2012, PLANT PHYSIOL, V158, P1847, DOI 10.1104/pp.111.192310; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; Ramya P, 2010, J APPL GENET, V51, P421, DOI 10.1007/BF03208872; Roeder MIS, 2008, FUNCT INTEGR GENOMIC, V8, P79, DOI 10.1007/s10142-007-0053-8; Saghai-Maroof MA, 1984, P NATL ACAD SCI USA, V91, P5466, DOI DOI 10.1073/PNAS.91.12.5466; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Sun XY, 2009, EUPHYTICA, V165, P615, DOI 10.1007/s10681-008-9794-2; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Varshney RK, 2000, THEOR APPL GENET, V100, P1290, DOI 10.1007/s001220051437; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Wu QH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118144; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200; Yang ZB, 2012, THEOR APPL GENET, V125, P1057, DOI 10.1007/s00122-012-1895-6; Yue AQ, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0266-9; Zhang YJ, 2014, MOL BREEDING, V34, P1097, DOI 10.1007/s11032-014-0102-7	48	43	48	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129400	10.1371/journal.pone.0129400	http://dx.doi.org/10.1371/journal.pone.0129400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076351	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900069
J	Nebel, RA; Kirschen, J; Cai, JL; Woo, YJ; Cherian, K; Abrahams, BS				Nebel, Rebecca A.; Kirschen, Jill; Cai, Jinlu; Woo, Young Jae; Cherian, Koshi; Abrahams, Brett S.			Reciprocal Relationship between Head Size, an Autism Endophenotype, and Gene Dosage at 19p13.12 Points to AKAP8 and AKAP8L	PLOS ONE			English	Article							ANCHORING PROTEIN AKAP95; PTEN TUMOR-SUPPRESSOR; BURROWS-WHEELER TRANSFORM; DNA-SEQUENCING DATA; SPECTRUM DISORDERS; MENTAL-RETARDATION; COMMON VARIANTS; READ ALIGNMENT; CIRCUMFERENCE; ASSOCIATION	Microcephaly and macrocephaly are overrepresented in individuals with autism and are thought to be disease-related risk factors or endophenotypes. Analysis of DNA microarray results from a family with a low functioning autistic child determined that the proband and two additional unaffected family members who carry a rare inherited 760 kb duplication of unknown clinical significance at 19p13.12 are macrocephalic. Consideration alongside overlapping deletion and duplication events in the literature provides support for a strong relationship between gene dosage at this locus and head size, with losses and gains associated with microcephaly (p = 1.11x10(-11)) and macrocephaly (p = 2.47x10(-11)), respectively. Data support A kinase anchor protein 8 and 8-like (AKAP8 and AKAP8L) as candidate genes involved in regulation of head growth, an interesting finding given previous work implicating the AKAP gene family in autism. Towards determination of which of AKAP8 and AKAP8L may be involved in the modulation of head size and risk for disease, we analyzed exome sequencing data for 693 autism families (2591 individuals) where head circumference data were available. No predicted loss of function variants were observed, precluding insights into relationship to head size, but highlighting strong evolutionary conservation. Taken together, findings support the idea that gene dosage at 19p13.12, and AKAP8 and/or AKAP8L in particular, play an important role in modulation of head size and may contribute to autism risk. Exome sequencing of the family also identified a rare inherited variant predicted to disrupt splicing of TPTE/PTEN2, a PTEN homologue, which may likewise contribute to both macrocephaly and autism risk.	[Nebel, Rebecca A.; Kirschen, Jill; Cai, Jinlu; Woo, Young Jae; Abrahams, Brett S.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Kirschen, Jill; Abrahams, Brett S.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Kirschen, Jill] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Cherian, Koshi] Albert Einstein Coll Med, Saul R Korey Dept Neurol, Bronx, NY 10467 USA; [Cherian, Koshi] Montefiore Med Ctr, Bronx, NY 10467 USA; [Cherian, Koshi] Albert Einstein Coll Med, Epilepsy Management Ctr, Bronx, NY 10467 USA; [Cherian, Koshi] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Abrahams, BS (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	brett.abrahams@einstein.yu.edu		Woo, Young/0000-0002-9233-5099	National Institute of Child Health Development [P30HD071593]; Autism Center of Excellence Network Award (National Institute of Mental Health) [9R01 MH100027]; National Institute of General Medical Sciences [T32 GM007491]; National Center for Research Resources [UL1RR025750, KL2RR025749, TL1RR025748]; National Center for Advancing Translational Sciences;  [8UL1 TR000086]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD071593] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073, UL1TR000086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025748, UL1RR025750, KL2RR025749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100027] Funding Source: NIH RePORTER	National Institute of Child Health Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Autism Center of Excellence Network Award (National Institute of Mental Health); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported through an Albert Einstein New Investigator Development Award, an IDDRC pilot award (P30HD071593; National Institute of Child Health Development, http://www.nichd.nih.gov/Pages/index.aspx), and an Autism Center of Excellence Network Award (9R01 MH100027; National Institute of Mental Health; http://www.nimh.nih.gov/index.shtml) to BSA. Support for RAN was provided through the Training Program in Cellular and Molecular Biology and Genetics (T32 GM007491; National Institute of General Medical Sciences; http://www.nigms.nih.gov/Pages/default.aspx). Clinical recruitment efforts were supported by CTSA Grants (UL1RR025750, KL2RR025749, and TL1RR025748; National Center for Research Resources; http://www.nih.gov/about/almanac/organization/NCRR.htm and 8UL1 TR000086; National Center for Advancing Translational Sciences; http://www.ncats.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; Abrahams BS, 2010, VOGEL AND MOTULSKY'S HUMAN GENETICS, FOURTH EDITION, P699, DOI 10.1007/978-3-540-37654-5_23.4; Adzhubei IA, 2010, NATURE; Al-Tawashi A, 2012, J BIOL CHEM, V287, P14644, DOI 10.1074/jbc.M111.261875; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arsenijevic T, 2004, BIOCHEM J, V378, P673, DOI 10.1042/BJ20031765; Arsenijevic T, 2006, CELL CYCLE, V5, P1217, DOI 10.4161/cc.5.11.2802; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Bonaglia MC, 2010, EUR J HUM GENET, V18, P1302, DOI 10.1038/ejhg.2010.115; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; BUSHBY KMD, 1992, ARCH DIS CHILD, V67, P1286, DOI 10.1136/adc.67.10.1286; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Centers for Disease Control and Prevention (CDC), 2010, CDC MORB MORTAL WKLY, V63, P1; Chae TH, 2007, GENES CONTROL SIZE C; Chaste P, 2013, BIOL PSYCHIAT, V74, P576, DOI 10.1016/j.biopsych.2013.04.018; Chen HM, 1999, HUM GENET, V105, P399, DOI 10.1007/s004390051122; Collas P, 1999, J CELL BIOL, V147, P1167, DOI 10.1083/jcb.147.6.1167; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Deutsch CK, 2003, J AUTISM DEV DISORD, V33, P209, DOI 10.1023/A:1022903913547; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1035, DOI 10.1038/nbt0804-1035; Eide T, 2003, J BIOL CHEM, V278, P26750, DOI 10.1074/jbc.M300765200; Endris V, 2002, P NATL ACAD SCI USA, V99, P11754, DOI 10.1073/pnas.162241099; Engels H, 2007, NEUROLOGY, V68, P743, DOI 10.1212/01.wnl.0000256367.70365.e0; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fombonne E, 1999, J AUTISM DEV DISORD, V29, P113, DOI 10.1023/A:1023036509476; Gallant NM, 2011, AM J MED GENET A, V155A, P2871, DOI 10.1002/ajmg.a.34286; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; He X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003671; Hutton TJ, 2003, IEEE T MED IMAGING, V22, P747, DOI 10.1109/TMI.2003.814784; Ikram MA, 2012, NAT GENET, V44, P539, DOI 10.1038/ng.2245; Jelsig AM, 2012, EUR J MED GENET, V55, P564, DOI 10.1016/j.ejmg.2012.06.009; Kanner L, 1943, NERV CHILD, V2, P217; Kosaki K, 2011, AM J MED GENET A, V155A, P2212, DOI 10.1002/ajmg.a.33908; Lainhart JE, 2006, AM J MED GENET A, V140A, P2257, DOI 10.1002/ajmg.a.31465; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2006, GENES DEV, V20; Littlefield TR, 2004, J CRANIOFAC SURG, V15, P175, DOI 10.1097/00001665-200401000-00042; Lu ATH, 2013, MOL PSYCHIATR, V18, P226, DOI 10.1038/mp.2011.155; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Martins SB, 2000, J CELL SCI, V113, P3703; McCaffery P, 2005, PROG NEUROBIOL, V77, P38, DOI 10.1016/j.pneurobio.2005.10.005; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miles JH, 2000, AM J MED GENET, V95, P339, DOI 10.1002/1096-8628(20001211)95:4<339::AID-AJMG9>3.3.CO;2-2; Miller J. A, 2014, BRAINSPAN ATLAS DEVE; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Moreno-De-Luca D, 2010, AM J HUM GENET, V87, P618, DOI 10.1016/j.ajhg.2010.10.004; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Oksenberg N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003221; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Poelmans G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.48; Roche AF, 1987, HEAD CIRCUMFERENCE R; Ronemus M, 2014, NAT REV GENET, V15, P133, DOI 10.1038/nrg3585; Ryan AK, 1998, J MED GENET, V35, P558, DOI 10.1136/jmg.35.7.558; Sacco R, 2007, BIOL PSYCHIAT, V62, P1038, DOI 10.1016/j.biopsych.2007.04.039; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sarasua SM, 2014, GENET MED, V16, P318, DOI 10.1038/gim.2013.144; Schaefer GB, 2013, GENET MED, V15, P669, DOI 10.1038/gim.2013.32; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Skuse DH, 2014, P NATL ACAD SCI USA, V111, P1987, DOI 10.1073/pnas.1302985111; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Stevenson RE, 1997, LANCET, V349, P1744, DOI 10.1016/S0140-6736(05)62956-X; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Sunyaev S, 2001, PREDICTION DELETERIO; Van der Aa N, 2010, EUR J MED GENET, V53, P291, DOI 10.1016/j.ejmg.2010.05.006; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Whitehouse AJO, 2011, GENES BRAIN BEHAV, V10, P451, DOI 10.1111/j.1601-183X.2011.00684.x; Williams CA, 2008, J MED GENETICS; Wu Y, 2001, J BIOL CHEM, V276, P21745, DOI 10.1074/jbc.M101480200	73	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129270	10.1371/journal.pone.0129270	http://dx.doi.org/10.1371/journal.pone.0129270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076356	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900060
J	Khan, K; Agarwal, P; Shanware, A; Sane, VA				Khan, Kasim; Agarwal, Pallavi; Shanware, Arti; Sane, Vidhu Aniruddha			Heterologous Expression of Two Jatropha Aquaporins Imparts Drought and Salt Tolerance and Improves Seed Viability in Transgenic Arabidopsis thaliana	PLOS ONE			English	Article							WATER CHANNEL PROTEINS; MULTIFUNCTIONAL WATER; PLANT AQUAPORINS; OVER-EXPRESSION; MIP GENES; STRESS; MEMBRANE; RICE; PLASMA; PHOTOSYNTHESIS	Drought and high salinity are environmental conditions that cause adverse effects on the growth and productivity of crops. Aquaporins are small integral membrane proteins that belong to the family of the major intrinsic proteins (MIPs), with members in animals, plants and microbes, where they facilitate the transport of water and/or small neutral solutes thereby affecting water balance. In this study we characterized two aquaporin genes namely, plasma membrane intrinsic protein (PIP2; 7) and tonoplast intrinsic protein TIP1; 3 from Jatropha curcas that are localised to the plasma membrane and vacuole respectively. Transgenic Arabidopsis thaliana lines over-expressing JcPIP2; 7 and JcTIP1; 3 under a constitutive promoter show improved germination under high salt and mannitol compared to control seeds. These transgenic plants also show increased root length under abiotic stress conditions compared to wild type Col-0 plants. Transgenic lines exposed to drought conditions by withholding water for 20 days, were able to withstand water stress and attained normal growth after re-watering unlike control plants which could not survive. Transgenic lines also had better seed yield than control under salt stress. Importantly, seed viability of transgenic plants grown under high salt concentration was 35%-45% compared to less than 5% for control seeds obtained from plants growing under salt stress. The effect of JcPIP2; 7 and JcTIP1; 3 on improving germination and seed viability in drought and salinity make these important candidates for genetic manipulation of plants for growth in saline soils.	[Khan, Kasim; Agarwal, Pallavi; Sane, Vidhu Aniruddha] CSIR, Natl Bot Res Inst, Plant Gene Express Lab, Lucknow 226001, Uttar Pradesh, India; [Shanware, Arti] RTMNU, Rajiv Gandhi Biotechnol Ctr, Nagpur, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Rashtrasant Tukadoji Maharaj Nagpur University	Sane, VA (corresponding author), CSIR, Natl Bot Res Inst, Plant Gene Express Lab, Lucknow 226001, Uttar Pradesh, India.	sanevidhu@rediffmail.com	Khan, Kasim/GXV-3268-2022; Sane, Vidhu/AAN-2524-2020; Khan, Kasim/ABA-1117-2021	Khan, Kasim/0000-0001-7336-2764; 	Department of Biotechnology, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	Department of Biotechnology, India funded project.	AGRE P, 1992, CLIN RES, V40, P176; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AZAIZEH H, 1992, PLANT PHYSIOL, V99, P886, DOI 10.1104/pp.99.3.886; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Carvajal M, 1999, PHYSIOL PLANTARUM, V105, P95, DOI 10.1034/j.1399-3054.1999.105115.x; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; CHRISPEELS MJ, 1994, PLANT PHYSIOL, V105, P9, DOI 10.1104/pp.105.1.9; CHRISPEELS MJ, 1994, TRENDS BIOCHEM SCI, V19, P421, DOI 10.1016/0968-0004(94)90091-4; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cornic G, 2000, TRENDS PLANT SCI, V5, P187, DOI 10.1016/S1360-1385(00)01625-3; di Pietro M, 2013, MOL CELL PROTEOMICS, V12, P3886, DOI 10.1074/mcp.M113.028241; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Fouquet R, 2008, PLANT CELL REP, V27, P1541, DOI 10.1007/s00299-008-0566-1; Gao YP, 1999, PLANT MOL BIOL, V40, P635, DOI 10.1023/A:1006212216876; Gao ZX, 2010, PLANT CELL PHYSIOL, V51, P767, DOI 10.1093/pcp/pcq036; Gomes D, 2009, BBA-BIOMEMBRANES, V1788, P1213, DOI 10.1016/j.bbamem.2009.03.009; Guo L, 2006, CELL RES, V16, P277, DOI 10.1038/sj.cr.7310035; Hachez C, 2006, BBA-BIOMEMBRANES, V1758, P1142, DOI 10.1016/j.bbamem.2006.02.017; Han GL, 2014, PLANT MOL BIOL, V86, P237, DOI 10.1007/s11103-014-0226-5; Ishikawa F, 2005, FEBS LETT, V579, P5814, DOI 10.1016/j.febslet.2005.09.076; Jang HY, 2013, J PLANT PHYSIOL, V170, P1028, DOI 10.1016/j.jplph.2013.03.001; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Kaldenhoff R, 2008, PLANT CELL ENVIRON, V31, P658, DOI 10.1111/j.1365-3040.2008.01792.x; Katsuhara M, 2003, PLANT CELL PHYSIOL, V44, P1378, DOI 10.1093/pcp/pcg167; Krich HH, 2000, PLANT PHYSIOL, V123, P111; Laur J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111751; Lian HL, 2006, CELL RES, V16, P651, DOI 10.1038/sj.cr.7310068; Liu HY, 2007, CELL RES, V17, P638, DOI 10.1038/cr.2007.34; MAGGIO A, 1995, PLANT PHYSIOL, V109, P331, DOI 10.1104/pp.109.1.331; Maurel C, 1997, P NATL ACAD SCI USA, V94, P7103, DOI 10.1073/pnas.94.13.7103; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Misra A, 2013, PHYTOCHEMISTRY, V96, P37, DOI 10.1016/j.phytochem.2013.09.020; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Park W, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-142; Peng YH, 2007, PLANTA, V226, P729, DOI 10.1007/s00425-007-0520-4; Qadir M, 2014, NAT RESOUR FORUM, V38, P282, DOI 10.1111/1477-8947.12054; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; Sade N, 2009, NEW PHYTOL, V181, P651, DOI 10.1111/j.1469-8137.2008.02689.x; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Sato S, 2011, DNA RES, V18, P65, DOI 10.1093/dnares/dsq030; Schaffner AR, 1998, PLANTA, V204, P131, DOI 10.1007/s004250050239; Singh RK, 2009, J PLANT BIOCHEM BIOT, V18, P77, DOI 10.1007/BF03263299; Smart LB, 2001, PLANT CELL PHYSIOL, V42, P686, DOI 10.1093/pcp/pce085; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tyerman SD, 2002, PLANT CELL ENVIRON, V25, P173, DOI 10.1046/j.0016-8025.2001.00791.x; Wang LL, 2014, PLANT CELL PHYSIOL, V55, P148, DOI 10.1093/pcp/pct166; Weigel D., 2002, ARABIDOPSIS LAB MANU; Zhou Y, 2007, PLANT CELL ENVIRON, V30, P1566, DOI 10.1111/j.1365-3040.2007.01732.x; Zhu CF, 2005, J EXP BOT, V56, P2971, DOI 10.1093/jxb/eri294	51	45	49	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128866	10.1371/journal.pone.0128866	http://dx.doi.org/10.1371/journal.pone.0128866			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067295	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000032
J	Magalhaes, MF; Dibai, AV; Guirro, ECD; Girasol, CE; de Oliveira, AK; Dias, FRC; Guirro, RRDJ				Magalhaes, Marina Figueiredo; Dibai-Filho, Almir Vieira; de Oliveira Guirro, Elaine Caldeira; Girasol, Carlos Eduardo; de Oliveira, Alessandra Kelly; Cancio Dias, Fabiana Rodrigues; de Jesus Guirro, Rinaldo Roberto			Evolution of Skin Temperature after the Application of Compressive Forces on Tendon, Muscle and Myofascial Trigger Point	PLOS ONE			English	Article							UPPER TRAPEZIUS MUSCLE; INFRARED IMAGE-ANALYSIS; LOW-BACK-PAIN; TEMPOROMANDIBULAR DISORDER; INTERRATER RELIABILITY; CUTANEOUS TEMPERATURE; MASTICATORY MUSCLES; THERMOGRAPHY; DIAGNOSIS; MASSAGE	Some assessment and diagnosis methods require palpation or the application of certain forces on the skin, which affects the structures beneath, we highlight the importance of defining possible influences on skin temperature as a result of this physical contact. Thus, the aim of the present study is to determine the ideal time for performing thermographic examination after palpation based on the assessment of skin temperature evolution. Randomized and crossover study carried out with 15 computer-user volunteers of both genders, between 18 and 45 years of age, who were submitted to compressive forces of 0, 1, 2 and 3 kg/cm(2) for 30 seconds with a washout period of 48 hours using a portable digital dynamometer. Compressive forces were applied on the following spots on the dominant upper limb: myofascial trigger point in the levator scapulae, biceps brachii muscle and palmaris longus tendon. Volunteers were examined by means of infrared thermography before and after the application of compressive forces (15, 30, 45 and 60 minutes). In most comparisons made over time, a significant decrease was observed 30, 45 and 60 minutes after the application of compressive forces (p < 0.05) on the palmaris longus tendon and biceps brachii muscle. However, no difference was observed when comparing the different compressive forces (p > 0.05). In conclusion, infrared thermography can be used after assessment or diagnosis methods focused on the application of forces on tendons and muscles, provided the procedure is performed 15 minutes after contact with the skin. Regarding to the myofascial trigger point, the thermographic examination can be performed within 60 minutes after the contact with the skin.	[Magalhaes, Marina Figueiredo; Dibai-Filho, Almir Vieira; de Oliveira Guirro, Elaine Caldeira; Girasol, Carlos Eduardo; de Oliveira, Alessandra Kelly; Cancio Dias, Fabiana Rodrigues; de Jesus Guirro, Rinaldo Roberto] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Biomech Med & Rehabil Locomotor Apparatus, Postgrad Program Rehabil & Funct Performance, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Guirro, RRDJ (corresponding author), Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Biomech Med & Rehabil Locomotor Apparatus, Postgrad Program Rehabil & Funct Performance, BR-14049 Ribeirao Preto, SP, Brazil.	rguirro@fmrp.usp.br	Guirro, Elaine CO/C-3107-2015; Girasol, Carlos Eduardo/L-6628-2018; Dibai Filho, Almir Vieira/B-3871-2013; Guirro, Rinaldo R J/B-5134-2013	Girasol, Carlos Eduardo/0000-0002-3901-582X; Dibai Filho, Almir Vieira/0000-0001-5403-8248; Guirro, Rinaldo R J/0000-0001-7491-3388	Sao Paulo Research Foundation (FAPESP) [2013/07732-7, 2013/19368-8, 2013/09753-1]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Sao Paulo Research Foundation (FAPESP, grants 2013/07732-7, 2013/19368-8 and 2013/09753-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbinot LF, 2012, CLINICS, V67, P1419, DOI 10.6061/clinics/2012(12)12; Marins JCB, 2014, INFRARED PHYS TECHN, V65, P30, DOI 10.1016/j.infrared.2014.02.008; Marins JCB, 2014, J THERM BIOL, V42, P1, DOI 10.1016/j.jtherbio.2014.02.020; Bron C, 2012, CURR PAIN HEADACHE R, V16, P439, DOI 10.1007/s11916-012-0289-4; Costa ACS, 2013, REV BRAS FISIOTER, V17, P24, DOI 10.1590/S1413-35552012005000058; Dibai AV, 2013, J MANIP PHYSIOL THER, V36, P245, DOI 10.1016/j.jmpt.2013.04.007; Dibai AV, 2012, J MANIP PHYSIOL THER, V35, P413, DOI 10.1016/j.jmpt.2012.04.006; Dibai AV, 2015, BRAZ J PHYS THER, V19, P122, DOI 10.1590/bjpt-rbf.2014.0076; Dibai AV, 2015, J MANIP PHYSIOL THER, V38, P86, DOI 10.1016/j.jmpt.2014.10.010; Fernandez-de-las-Penas C, 2012, CLIN J PAIN, V28, P511, DOI 10.1097/AJP.0b013e31823984e2; Gerwin RD, 1997, PAIN, V69, P65, DOI 10.1016/S0304-3959(96)03248-4; Haddad DS, 2012, DENTOMAXILLOFAC RAD, V41, P621, DOI 10.1259/dmfr/98504520; Holey LA, 2011, J MANIP PHYSIOL THER, V34, P457, DOI 10.1016/j.jmpt.2011.05.012; Lahiri BB, 2012, INFRARED PHYS TECHN, V55, P221, DOI 10.1016/j.infrared.2012.03.007; Miller JM, 2012, INT J SPORTS PHYS TH, V7, P167; Oliveira-Campelo NM, 2013, J MANIP PHYSIOL THER, V36, P300, DOI 10.1016/j.jmpt.2013.04.008; Park JW, 2012, INT J ORAL MAX SURG, V41, P103, DOI 10.1016/j.ijom.2011.09.010; Reiman MP, 2013, J ORTHOP SPORT PHYS, V43, P222, DOI 10.2519/jospt.2013.4343; Ring EFJ, 2012, PHYSIOL MEAS, V33, pR33, DOI 10.1088/0967-3334/33/3/R33; Rodrigues-Bigaton D, 2013, J MANIP PHYSIOL THER, V36, P253, DOI 10.1016/j.jmpt.2013.04.006; Roy A, 2006, J MANIP PHYSIOL THER, V29; Roy RA, 2008, J MANIP PHYSIOL THER, V31, P230, DOI 10.1016/j.jmpt.2008.02.006; Roy RA, 2013, J MANIP PHYSIOL THER, V36, P44, DOI 10.1016/j.jmpt.2012.12.002; Roy RA, 2010, J MANIP PHYSIOL THER, V33, P238, DOI 10.1016/j.jmpt.2010.01.008; Sefton JM, 2010, J ALTERN COMPLEM MED, V16, P723, DOI 10.1089/acm.2009.0441; Shah JP, 2008, ARCH PHYS MED REHAB, V89, P16, DOI 10.1016/j.apmr.2007.10.018; Simons DG, 1999, MYOFASCIAL PAIN DYSF, V1, P2, DOI DOI 10.1097/00008506-200101000-00026; Szentkuti A, 2011, PERIOD BIOL, V113, P385; Wishart GC, 2010, EJSO-EUR J SURG ONC, V36, P535, DOI 10.1016/j.ejso.2010.04.003; Zaproudina N, 2006, J MANIP PHYSIOL THER, V29, P219, DOI 10.1016/j.jmpt.2006.01.003	30	21	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129034	10.1371/journal.pone.0129034	http://dx.doi.org/10.1371/journal.pone.0129034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070073	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000038
J	Punt, S; Thijssen, VL; Vrolijk, J; de Kroon, CD; Gorter, A; Jordanova, ES				Punt, Simone; Thijssen, Victor L.; Vrolijk, Johannes; de Kroon, Cornelis D.; Gorter, Arko; Jordanova, Ekaterina S.			Galectin-1,-3 and-9 Expression and Clinical Significance in Squamous Cervical Cancer	PLOS ONE			English	Article							TUMOR PROGRESSION; PROGNOSTIC-FACTOR; BIOLOGY; ANGIOGENESIS; CARCINOMA; TARGET	Galectins are proteins that bind beta-galactoside sugars and provide a new type of potential biomarkers and therapeutic targets in cancer. Galectin-1, -3 and -9 have become the focus of different research groups, but their expression and function in cervical cancer is still unclear. The aim of this study was to determine the phenotype of galectin-1, -3 and -9 expressing cells and the association with clinico-pathological parameters in cervical cancer. Galectin expression was scored in tumor cells, tumor epithelium infiltrating immune cells and stromal cells in squamous cervical cancer (n = 160). Correlations with clinico-pathological parameters and survival were studied according to the REMARK recommendations. We additionally investigated whether the galectins were expressed by tumor cells, fibroblasts, macrophages and T cells. Galectin-1 and -9 were both expressed by tumor cells in 11% of samples, while 84% expressed galectin-3. Strong galectin-1 expression by tumor cells was an independent predictor for poor survival (hazard ratio: 8.02, p = 0.001) and correlated with increased tumor invasion (p = 0.032) and receiving post-operative radiotherapy (p = 0.020). Weak and positive tumor cell galectin-3 expression were correlated with increased and decreased tumor invasion, respectively (p = 0.012). Tumor cell expression of galectin-9 showed a trend toward improved survival (p = 0.087). The predominant immune cell type expressing galectin-1, -3 and -9 were CD163(+) macrophages. Galectin-1 and -3 were expressed by a minor population of T cells. Galectin-1 was mainly expressed by fibroblasts in the tumor stroma. To conclude, while tumor cell expression of galectin-9 seemed to represent a beneficial response, galectin-1 expression might be used as a marker for a more aggressive anti-cancer treatment.	[Punt, Simone; Gorter, Arko; Jordanova, Ekaterina S.] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Thijssen, Victor L.] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Angiogenesis Lab, Amsterdam, Netherlands; [Vrolijk, Johannes] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [de Kroon, Cornelis D.] Leiden Univ, Med Ctr, Dept Gynecol, Leiden, Netherlands; [Jordanova, Ekaterina S.] Vrije Univ Amsterdam, Med Ctr, Ctr Gynecol Oncol Amsterdam, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Jordanova, ES (corresponding author), Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands.	E.S.Jordanova@lumc.nl	Thijssen, Victor LJL/B-2792-2009	Thijssen, Victor LJL/0000-0002-6146-1842; Jordanova, Ekaterina S./0000-0002-8121-1322; Punt, Simone/0000-0002-6675-728X	Dutch Cancer Society [UL2010-4801, VU2009-4358]	Dutch Cancer Society(KWF Kankerbestrijding)	The Dutch Cancer Society (http://www.kwf.nl) financially supported SP (grant UL2010-4801) and VLT (grant VU2009-4358). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Balan Vitaly, 2010, Cancers (Basel), V2, P592, DOI 10.3390/cancers2020592; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Compagno D, 2014, GLYCOBIOLOGY, V24, P899, DOI 10.1093/glycob/cwu055; Dalotto-Moreno T, 2013, CANCER RES, V73, P1107, DOI 10.1158/0008-5472.CAN-12-2418; Fortuna-Costa A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00138; Fu H, 2015, TUMOUR BIOL; Heusschen R, 2014, BBA-MOL BASIS DIS, V1842, P284, DOI 10.1016/j.bbadis.2013.12.003; Heusschen R, 2013, BBA-REV CANCER, V1836, P177, DOI 10.1016/j.bbcan.2013.04.006; Hirashima M, 2002, GLYCOCONJUGATE J, V19, P593, DOI 10.1023/B:GLYC.0000014090.63206.2f; Huang EY, 2013, INT J RADIAT ONCOL, V87, P975, DOI 10.1016/j.ijrobp.2013.08.037; Irie A, 2005, CLIN CANCER RES, V11, P2962, DOI 10.1158/1078-0432.CCR-04-0861; Jung EJ, 2007, INT J CANCER, V120, P2331, DOI 10.1002/ijc.22434; Kageshita T, 2002, INT J CANCER, V99, P809, DOI 10.1002/ijc.10436; Katoh S, 2014, TOHOKU J EXP MED, V232, P263, DOI 10.1620/tjem.232.263; Kim HJ, 2013, HUM PATHOL, V44, P62, DOI 10.1016/j.humpath.2012.04.010; Kim HJ, 2012, EUR J CANCER, V48, P1914, DOI 10.1016/j.ejca.2012.02.005; Kohrenhagen N, 2006, INT J GYNECOL CANCER, V16, P2018, DOI 10.1111/j.1525-1438.2006.00741.x; Laderach DJ, 2013, CANCER RES, V73, P86, DOI 10.1158/0008-5472.CAN-12-1260; Le QT, 2005, J CLIN ONCOL, V23, P8932, DOI 10.1200/JCO.2005.02.0206; Lee JW, 2006, J CANCER RES CLIN, V132, P241, DOI 10.1007/s00432-005-0069-1; Liang M, 2008, J CANCER RES CLIN, V134, P899, DOI 10.1007/s00432-008-0352-z; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; McSharry BP, 2014, J VIROL, V88, P10990, DOI 10.1128/JVI.01259-14; Miranda FA, 2009, J HISTOCHEM CYTOCHEM, V57, P665, DOI 10.1369/jhc.2009.952960; Novak R, 2012, BBA-GEN SUBJECTS, V1820, P1383, DOI 10.1016/j.bbagen.2011.11.014; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; Punt S, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.984539; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Righi A, 2013, HUM PATHOL, V44, P2400, DOI 10.1016/j.humpath.2013.05.020; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Ruiter DJ, 1998, EUR J CANCER, V34, P1334, DOI 10.1016/S0959-8049(98)00151-8; Schulkens IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107988; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Tandon R, 2014, AIDS RES HUM RETROV, V30, P654, DOI [10.1089/aid.2014.0004, 10.1089/AID.2014.0004]; Thijssen VL, 2015, BBA-REV CANCER, V1855, P235, DOI 10.1016/j.bbcan.2015.03.003; Thijssen VL, 2013, CYTOKINE GROWTH F R, V24, P547, DOI 10.1016/j.cytogfr.2013.07.003; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Van Vlierberghe RLP, 2005, MICROSC RES TECHNIQ, V67, P15, DOI 10.1002/jemt.20181; Veschi V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.68; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Zhang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103482; Zhou X, 2014, ONCOTARGET; Zhou XS, 2014, GENE, V546, P403, DOI 10.1016/j.gene.2014.04.066	46	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129119	10.1371/journal.pone.0129119	http://dx.doi.org/10.1371/journal.pone.0129119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066796	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000048
J	Stoy, PC; Quaife, T				Stoy, Paul C.; Quaife, Tristan			Probabilistic Downscaling of Remote Sensing Data with Applications for Multi-Scale Biogeochemical Flux Modeling	PLOS ONE			English	Article							LEAF-AREA INDEX; MAXIMUM-ENTROPY PRODUCTION; OPTIMUM PIXEL SIZE; ECOSYSTEM FUNCTION; ARCTIC LANDSCAPE; CO2 FLUX; VEGETATION; INFORMATION; MICROTOPOGRAPHY; PHOTOSYNTHESIS	Upscaling ecological information to larger scales in space and downscaling remote sensing observations or model simulations to finer scales remain grand challenges in Earth system science. Downscaling often involves inferring subgrid information from coarse-scale data, and such ill-posed problems are classically addressed using regularization. Here, we apply two-dimensional Tikhonov Regularization (2DTR) to simulate subgrid surface patterns for ecological applications. Specifically, we test the ability of 2DTR to simulate the spatial statistics of high-resolution (4 m) remote sensing observations of the normalized difference vegetation index (NDVI) in a tundra landscape. We find that the 2DTR approach as applied here can capture the major mode of spatial variability of the high-resolution information, but not multiple modes of spatial variability, and that the Lagrange multiplier (.) used to impose the condition of smoothness across space is related to the range of the experimental semivariogram. We used observed and 2DTR-simulated maps of NDVI to estimate landscape-level leaf area index (LAI) and gross primary productivity (GPP). NDVI maps simulated using a. value that approximates the range of observed NDVI result in a landscape-level GPP estimate that differs by ca 2% from those created using observed NDVI. Following findings that GPP per unit LAI is lower near vegetation patch edges, we simulated vegetation patch edges using multiple approaches and found that simulated GPP declined by up to 12% as a result. 2DTR can generate random landscapes rapidly and can be applied to disaggregate ecological information and compare of spatial observations against simulated landscapes.	[Stoy, Paul C.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Quaife, Tristan] Univ Reading, Dept Meteorol, Reading, Berks, England	Montana State University System; Montana State University Bozeman; University of Reading	Stoy, PC (corresponding author), Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA.	paul.stoy@montana.edu	Stoy, Paul/D-3709-2011; Quaife, Tristan L/C-1355-2008	Stoy, Paul/0000-0002-6053-6232; Quaife, Tristan L/0000-0001-6896-4613	National Science Foundation [1021095, 1241881]; Marie Curie Incoming International Fellowship programme; Montana State University; Natural Environment Research Council [ARSF 03/17]; Brian Huntley; USDA National Institute of Food and Agriculture, Hatch project [228396]; UK National Centre for Earth Observation; NERC [nceo020004] Funding Source: UKRI; Direct For Biological Sciences [1241881] Funding Source: National Science Foundation; Emerging Frontiers [1241810, 1241860] Funding Source: National Science Foundation; Natural Environment Research Council [nceo020004] Funding Source: researchfish	National Science Foundation(National Science Foundation (NSF)); Marie Curie Incoming International Fellowship programme; Montana State University; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Brian Huntley; USDA National Institute of Food and Agriculture, Hatch project; UK National Centre for Earth Observation; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors acknowledge funding from the National Science Foundation (Scaling ecosystem function: Novel Approaches from MaxEnt and Multiresolution', DBI #1021095 and Collaborative Research: Building Forest Management into Earth System Modeling: Scaling from Stand to Continent, EF #1241881), the Marie Curie Incoming International Fellowship programme, Montana State University, and the Natural Environment Research Council, grant number ARSF 03/17 for the ASRF flight that carried the ATM sensor, as well as Brian Huntley for financial support of this mission. This work was supported by the USDA National Institute of Food and Agriculture, Hatch project 228396. Quaife is supported by the UK National Centre for Earth Observation.	Aleina FC, 2013, EARTH SYST DYNAM, V4, P187, DOI 10.5194/esd-4-187-2013; Anderson MC, 2003, AGRON J, V95, P1408, DOI 10.2134/agronj2003.1408; Asner GP, 2003, GLOBAL ECOL BIOGEOGR, V12, P191, DOI 10.1046/j.1466-822X.2003.00026.x; BUBIER J, 1993, CAN J BOT, V71, P1056, DOI 10.1139/b93-122; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; CHEN JQ, 1992, ECOL APPL, V2, P387, DOI 10.2307/1941873; Datcu M, 1998, IEEE T GEOSCI REMOTE, V36, P1431, DOI 10.1109/36.718847; Dewar RC, 2005, UND COM SYS, P41; Dewar RC, 2008, J THEOR BIOL, V251, P389, DOI 10.1016/j.jtbi.2007.12.007; Dudik M, 2007, J MACH LEARN RES, V8, P1217; Fletcher BJ, 2012, J ECOL, V100, P441, DOI 10.1111/j.1365-2745.2011.01913.x; Fletcher BJ, 2010, OECOLOGIA, V163, P47, DOI 10.1007/s00442-009-1532-5; Fox AM, 2008, J GEOPHYS RES, V22; Gallagher M, 2006, IEEE T EVOLUT COMPUT, V10, P590, DOI 10.1109/TEVC.2005.863628; Gardner RH, 1987, LANDSCAPE ECOL, V1, P19, DOI 10.1007/BF02275262; GULL SF, 1984, IEE PROC-F, V131, P646, DOI 10.1049/ip-f-1.1984.0099; Hargitai H, 2014, ICE WEDGE POLYGON EN, P1, DOI [10.1007/978-1-4614-9213-9_193-1, DOI 10.1007/978-1-4614-9213-9_193-1]; Hargrove WW, 2002, CONSERV ECOL, V6; Harte J, 2008, ECOLOGY, V89, P2700, DOI 10.1890/07-1369.1; Harte J, 2009, ECOL LETT, V12, P789, DOI 10.1111/j.1461-0248.2009.01328.x; Hiebeler D, 2000, ECOLOGY, V81, P1629, DOI 10.1890/0012-9658(2000)081[1629:POFLWS]2.0.CO;2; JARVIS PG, 1995, PLANT CELL ENVIRON, V18, P1079, DOI 10.1111/j.1365-3040.1995.tb00620.x; Johnston CE, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/8/085004; Jupp TE, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007343; Kleidon A, 2009, NATURWISSENSCHAFTEN, V96, P653, DOI 10.1007/s00114-009-0509-x; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Kullback S., 1997, INFORM THEORY STAT; Kumar S, 2009, FRONT ECOL ENVIRON, V7, P415, DOI 10.1890/080054; Kustas WP, 2000, REMOTE SENS ENVIRON, V74, P327, DOI 10.1016/S0034-4257(99)00081-4; Lipson DA, 2012, BIOGEOSCIENCES, V9, P577, DOI 10.5194/bg-9-577-2012; MALCOLM JR, 1994, ECOLOGY, V75, P2438, DOI 10.2307/1940897; McGuire AD, 2009, ECOL MONOGR, V79, P523, DOI 10.1890/08-2025.1; MEJIA JM, 1974, WATER RESOUR RES, V10, P705, DOI 10.1029/WR010i004p00705; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Muster S, 2012, TELLUS B, V64, DOI 10.3402/tellusb.v64i0.17301; ONEILL RV, 1992, LANDSCAPE ECOL, V7, P55, DOI 10.1007/BF02573957; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Quaife T, 2010, IEEE T GEOSCI REMOTE, V48, P2445, DOI 10.1109/TGRS.2009.2038901; Rahman AF, 2003, REMOTE SENS ENVIRON, V84, P192, DOI 10.1016/S0034-4257(02)00107-4; RASTETTER EB, 1992, ECOL APPL, V2, P55, DOI 10.2307/1941889; Raynolds MK, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000512; Reza F. M., 1994, INTRO INFORM THEORY; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Saatchi S, 2008, REMOTE SENS ENVIRON, V112, P2000, DOI 10.1016/j.rse.2008.01.008; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shaver GR, 2007, J ECOL, V95, P802, DOI 10.1111/j.1365-2745.2007.01259.x; Shaver GR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0485; SKILLING J, 1984, MON NOT R ASTRON SOC, V211, P111, DOI 10.1093/mnras/211.1.111; Skurikhin AN, 2013, REMOTE SENS LETT, V4, P1077, DOI 10.1080/2150704X.2013.840404; Spadavecchia L, 2008, J ECOL, V96, P1238, DOI 10.1111/j.1365-2745.2008.01424.x; Stoy PC, 2009, ECOSYSTEMS, V12, P574, DOI 10.1007/s10021-009-9243-7; Stoy PC, 2013, ARCT ANTARCT ALP RES, V45, P275, DOI 10.1657/1938-4246-45.2.275; Stoy PC, 2009, LANDSCAPE ECOL, V24, P971, DOI 10.1007/s10980-009-9367-3; Street LE, 2007, J ECOL, V95, P139, DOI 10.1111/j.1365-2745.2006.01187.x; Street LE, 2012, FUNCT ECOL, V26, P365, DOI 10.1111/j.1365-2435.2011.01954.x; Tikhonov A., 1977, SOLUTION ILL POSED P; van Wijk MT, 2005, ECOL APPL, V15, P1462, DOI 10.1890/03-5354; Venema V, 2006, NONLINEAR PROC GEOPH, V13, P321, DOI 10.5194/npg-13-321-2006; Venema V, 2006, TELLUS A, V58, P104, DOI 10.1111/j.1600-0870.2006.00160.x; Walker DA, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000504; Walker DA, 2004, PERMAFROST PERIGLAC, V15, P171, DOI 10.1002/ppp.487; Williams M, 2008, GLOBAL CHANGE BIOL, V14, P1517, DOI 10.1111/j.1365-2486.2008.01590.x	62	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128935	10.1371/journal.pone.0128935	http://dx.doi.org/10.1371/journal.pone.0128935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067835	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000356327000034
J	Guo, J; Hao, CY; Zhang, Y; Zhang, BQ; Cheng, XM; Qin, L; Li, T; Shi, WP; Chang, XP; Jing, RL; Yang, WY; Hu, WJ; Zhang, XY; Cheng, SH				Guo, Jie; Hao, Chenyang; Zhang, Yong; Zhang, Boqiao; Cheng, Xiaoming; Qin, Lin; Li, Tian; Shi, Weiping; Chang, Xiaoping; Jing, Ruilian; Yang, Wuyun; Hu, Wenjing; Zhang, Xueyong; Cheng, Shunhe			Association and Validation of Yield-Favored Alleles in Chinese Cultivars of Common Wheat (Triticumaestivum L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LINEAR UNBIASED PREDICTION; SPATIAL GENETIC-STRUCTURE; LINKAGE DISEQUILIBRIUM; JOINT LINKAGE; AGRONOMIC TRAITS; CHROMOSOME 3A; MAPPING QTLS; GRAIN-YIELD; WEIGHT	Common wheat is one of the most important crops in China, which is the largest producer in the world. A set of 230 cultivars was used to identify yield-related loci by association mapping. This set was tested for seven yield-related traits, viz. plant height (PH), spike length (SL), spikelet number per spike (SNPS), kernel number per spike (KNPS), thousand-kernel weight (TKW), kernel weight per spike (KWPS), and sterile spikelet number (SSN) per plant in four environments. A total of 106 simple sequence repeat (SSR) markers distributed on all 21 chromosomes were used to screen the set. Twenty-one and 19 of them were associated with KNPS and TKW, respectively. Association mapping detected 73 significant associations across 50 SSRs, and the phenotypic variation explained (R-2) by the associations ranged from 1.54 to 23.93%. The associated loci were distributed on all chromosomes except 4A, 7A, and 7D. Significant and potentially new alleles were present on 8 chromosomes, namely1A, 1D, 2A, 2D, 3D, 4B, 5B, and 6B. Further analysis showed that genetic effects of associated loci were greatly influenced by association panels, and the R2 of crucial loci were lower in modern cultivars than in the mini core collection, probably caused by strong selection in wheat breeding. In order to confirm the results of association analysis, yield-related favorable alleles Xgwm135-1A(138), Xgwm337-1D(186), Xgwm102-2D(144), and Xgwm132-6B(128) were evaluated in a double haploid (DH) population derived from Hanxuan10 xLumai14. These favorable alleles that were validated in various populations might be valuable in breeding for high-yield.	[Guo, Jie; Qin, Lin; Cheng, Shunhe] Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Zhang, Yong; Zhang, Boqiao; Cheng, Xiaoming; Shi, Weiping; Hu, Wenjing; Cheng, Shunhe] Lixiahe Agr Inst Jiangsu Prov, Minist Agr, Key Lab Wheat Biol & Genet Improvement Low & Midd, Yangzhou, Jiangsu, Peoples R China; [Hao, Chenyang; Li, Tian; Chang, Xiaoping; Jing, Ruilian; Zhang, Xueyong] Chinese Acad Agr Sci, Key Lab Crop Gene Resources & Germplasm Enhanceme, Minist Agr, Inst Crop Sci, Beijing 100193, Peoples R China; [Yang, Wuyun] Sichuan Acad Agr Sci, Crop Res Inst, Chengdu, Sichuan, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Sichuan Academy of Agricultural Sciences (SAAS)	Zhang, XY (corresponding author), Chinese Acad Agr Sci, Key Lab Crop Gene Resources & Germplasm Enhanceme, Minist Agr, Inst Crop Sci, Beijing 100193, Peoples R China.	zhangxueyong@caas.cn; yzcsh1939@126.com			Chinese Ministry of Science and Technology [2011CB100100]; China Agricultural Research System [CARS-3-1-1]; National High-Tech R&D Program of China [2012AA101105]; National Science and Technology Infrastructure Program [2011BAD35B03]; National Natural Science Foundation of China [31301320]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); China Agricultural Research System; National High-Tech R&D Program of China(National High Technology Research and Development Program of China); National Science and Technology Infrastructure Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese Ministry of Science and Technology (2011CB100100; http://www.973.gov.cn/AreaAppl.aspx), the China Agricultural Research System (CARS-3-1-1; http://www.caaswheat.cn/), the National High-Tech R&D Program of China (2012AA101105; http://www.863.gov.cn/), the National Science and Technology Infrastructure Program (2011BAD35B03; http://www.nsfc.gov.cn/), and the National Natural Science Foundation of China (31301320; http://www.nsfc.gov.cn/).	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bernardo R, 1996, CROP SCI, V36, P50, DOI [10.2135/cropsci1996.0011183X003600040009x, 10.2135/cropsci1996.0011183X003600040007x]; Bernardo R, 1996, THEOR APPL GENET, V93, P262, DOI 10.1007/BF00225755; Bernardo R, 1996, THEOR APPL GENET, V93, P1098, DOI 10.1007/BF00230131; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Campbell BT, 2003, CROP SCI, V43, P1493, DOI 10.2135/cropsci2003.1493; Cui F, 2011, THEOR APPL GENET, V122, P1517, DOI 10.1007/s00122-011-1551-6; Cuthbert JL, 2008, THEOR APPL GENET, V117, P595, DOI 10.1007/s00122-008-0804-5; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAO (Food and Agricultural Organization of the United Nations), 2014, FAOSTAT DAT; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Ge HM, 2012, CROP SCI, V52, P1218, DOI 10.2135/cropsci2010.12.0680; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Hai L, 2008, PLANT SCI, V175, P226, DOI 10.1016/j.plantsci.2008.03.006; Hao CY, 2008, CHINESE SCI BULL, V53, P1518, DOI 10.1007/s11434-008-0212-x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hung HY, 2012, P NATL ACAD SCI USA, V109, pE1913, DOI 10.1073/pnas.1203189109; Jing RL, 1999, BIOTECHNOLOGY, V9, P4; Kato K, 2000, THEOR APPL GENET, V101, P1114, DOI 10.1007/s001220051587; Kato K, 1999, THEOR APPL GENET, V98, P472, DOI 10.1007/s001220051094; Korir PC, 2013, THEOR APPL GENET, V126, P1659, DOI 10.1007/s00122-013-2082-0; Korzun V, 1998, THEOR APPL GENET, V96, P1104, DOI 10.1007/s001220050845; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; Laperche A, 2007, THEOR APPL GENET, V115, P399, DOI 10.1007/s00122-007-0575-4; Li N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-114; Li SS, 2007, MOL BREEDING, V20, P167, DOI 10.1007/s11032-007-9080-3; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lu YL, 2010, P NATL ACAD SCI USA, V107, P19585, DOI 10.1073/pnas.1006105107; Ma ZQ, 2007, MOL GENET GENOMICS, V277, P31, DOI 10.1007/s00438-006-0166-0; Marza F, 2006, THEOR APPL GENET, V112, P688, DOI 10.1007/s00122-005-0172-3; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Qin L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-107; Quarrie SA, 2006, J EXP BOT, V57, P2627, DOI 10.1093/jxb/erl026; Ramya P, 2010, J APPL GENET, V51, P421, DOI 10.1007/BF03208872; Sajjad M, 2014, CEREAL RES COMMUN, V42, P177, DOI 10.1556/CRC.2013.0061; Schnurbusch T, 2003, THEOR APPL GENET, V107, P1226, DOI 10.1007/s00122-003-1372-3; Shah MM, 1999, CROP SCI, V39, P1728, DOI 10.2135/cropsci1999.3961728x; SHARP PJ, 1989, THEOR APPL GENET, V78, P342, DOI 10.1007/BF00265294; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Sun XC, 2010, THEOR APPL GENET, V120, P1041, DOI 10.1007/s00122-009-1232-x; Tyagi S, 2014, MOL BREEDING, V34, P167, DOI 10.1007/s11032-014-0027-1; Wang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047917; Wang RX, 2009, THEOR APPL GENET, V118, P313, DOI 10.1007/s00122-008-0901-5; Worland AJ, 1998, THEOR APPL GENET, V96, P1110, DOI 10.1007/s001220050846; Wu RL, 2002, GENETICS, V160, P779; Wu RL, 2001, GENETICS, V157, P899; Wu XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031249; Wu XY, 2014, MOL BREEDING, V33, P129, DOI 10.1007/s11032-013-9939-4; Xu YF, 2014, THEOR APPL GENET, V127, P59, DOI 10.1007/s00122-013-2201-y; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang DL, 2012, PLANTA, V236, P1507, DOI 10.1007/s00425-012-1708-9; Zhang LY, 2010, J INTEGR PLANT BIOL, V52, P996, DOI 10.1111/j.1744-7909.2010.00967.x; Zhang XY, 2002, THEOR APPL GENET, V106, P112, DOI 10.1007/s00122-002-1016-z; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou Yang, 2003, Acta Agronomica Sinica, V29, P810; Zhuang QS., 2003, CHINESE WHEAT IMPROV	61	10	11	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130029	10.1371/journal.pone.0130029	http://dx.doi.org/10.1371/journal.pone.0130029			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067129	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900093
J	Huh, WB; Kim, JE; Kang, YG; Park, G; Lim, TG; Kwon, JY; Song, DS; Jeong, EH; Lee, CC; Son, JE; Seo, SG; Lee, E; Kim, JR; Lee, CY; Park, JS; Lee, KW				Huh, Won Bum; Kim, Jong-Eun; Kang, Young-Gyu; Park, Gaeun; Lim, Tae-gyu; Kwon, Jung Yeon; Song, Da Som; Jeong, Eun Hee; Lee, Charles C.; Son, Joe Eun; Seo, Sang Gwon; Lee, Eunjung; Kim, Jong Rhan; Lee, Chang Yong; Park, Jun Seong; Lee, Ki Won			Brown Pine Leaf Extract and Its Active Component Trans-Communic Acid Inhibit UVB-Induced MMP-1 Expression by Targeting PI3K	PLOS ONE			English	Article							ULTRAVIOLET-B IRRADIATION; MATRIX METALLOPROTEINASES; MECHANISMS; ACTIVATION; MODEL; GENE; CONSTITUENTS; DITERPENES; DENSIFLORA; THICKNESS	Japanese red pine (Pinus densiflora) is widely present in China, Japan, and Korea. Its green pine leaves have traditionally been used as a food as well as a coloring agent. After being shed, pine leaves change their color from green to brown within two years, and although the brown pine leaves are abundantly available, their value has not been closely assessed. In this study, we investigated the potential anti-photoaging properties of brown pine leaves for skin. Brown pine leaf extract (BPLE) inhibited UVB-induced matrix metalloproteinase-1 (MMP-1) expression to a greater extent than pine leaf extract (PLE) in human keratinocytes and a human skin equivalent model. HPLC analysis revealed that the quantity of trans-communic acid (TCA) and dehydroabietic acid (DAA) significantly increases when the pine leaf color changes from green to brown. BPLE and TCA elicited reductions in UVB-induced MMP-1 mRNA expression and activator protein-1 (AP-1) transactivation by reducing DNA binding activity of phospho-c-Jun, c-fos and Fra-1. BPLE and TCA also inhibited UVB-induced Akt phosphorylation, but not mitogen activated protein kinase (MAPK), known regulators of AP-1 transactivation. We additionally found that BPLE and TCA inhibited phosphoinositide 3-kinase (PI3K), the upstream kinase of Akt, in vitro. In summary, both BPLE and its active component TCA exhibit protective effects against UVB-induced skin aging. Taken together, these findings underline the potential for BPLE and TCA to be utilized as anti-wrinkling agents and cosmetic ingredients, as they suppress UVB-induced MMP-1 expression.	[Huh, Won Bum; Kim, Jong-Eun; Park, Gaeun; Lim, Tae-gyu; Kwon, Jung Yeon; Song, Da Som; Jeong, Eun Hee; Son, Joe Eun; Seo, Sang Gwon; Lee, Eunjung; Kim, Jong Rhan; Lee, Ki Won] Seoul Natl Univ, Dept Agr Biotechnol, Ctr Food & Bioconvergence, WCU Biomodulat Major, Seoul, South Korea; [Huh, Won Bum; Kim, Jong-Eun; Park, Gaeun; Lim, Tae-gyu; Kwon, Jung Yeon; Song, Da Som; Jeong, Eun Hee; Son, Joe Eun; Seo, Sang Gwon; Lee, Eunjung; Kim, Jong Rhan; Lee, Ki Won] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon, South Korea; [Kang, Young-Gyu; Park, Jun Seong] Amorepacif Corp R&D Ctr, Skin Res Inst, Yongin, South Korea; [Lee, Charles C.; Lee, Chang Yong] Cornell Univ, Dept Food Sci & Technol, Ithaca, NY 14456 USA; [Lee, Eunjung] Korea Food Res Inst, Tradit Alcohol Beverage Res Team, Songnam, South Korea; [Lee, Chang Yong] King Abdulaziz Univ, Dept Biochem, Jeddah 21413, Saudi Arabia	Seoul National University (SNU); Seoul National University (SNU); Cornell University; Korea Food Research Institute (KFRI); King Abdulaziz University	Park, JS (corresponding author), Amorepacif Corp R&D Ctr, Skin Res Inst, Yongin, South Korea.	superbody@amorepacific.com; kiwon@snu.ac.kr	kim, jong-eun/B-3550-2017; Lee, Ki Won/M-4114-2018; Lim, Tae-Gyu/AAO-8475-2020; Son, Joe/AAB-7384-2020	kim, jong-eun/0000-0002-5030-6126; Lim, Tae-Gyu/0000-0001-6930-9565; Son, Joe/0000-0003-3066-2796	R & D program of MOTIE/KIAT (Establishment of Infra Structure for Anti-aging Industry Support) [N0000697]; Leap Research Program Grant through the National Research Foundation - Ministry of Science, ICT and Future Planning of Republic of Korea [2010-0029233]	R & D program of MOTIE/KIAT (Establishment of Infra Structure for Anti-aging Industry Support); Leap Research Program Grant through the National Research Foundation - Ministry of Science, ICT and Future Planning of Republic of Korea	This work was supported by the R & D program (N0000697) of MOTIE/KIAT (Establishment of Infra Structure for Anti-aging Industry Support) and the Leap Research Program Grant (2010-0029233) through the National Research Foundation funded by the Ministry of Science, ICT and Future Planning of Republic of Korea.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Aragane Y, 1997, P NATL ACAD SCI USA, V94, P11490, DOI 10.1073/pnas.94.21.11490; Barrero AF, 2012, MOLECULES, V17, P1448, DOI 10.3390/molecules17021448; Beissert S, 1999, J INVEST DERM SYMP P, V4, P61, DOI 10.1038/sj.jidsp.5640183; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bode A M, 2000, Lancet Oncol, V1, P181, DOI 10.1016/S1470-2045(00)00029-2; Bode Ann M, 2003, Sci STKE, V2003, pRE2, DOI 10.1126/stke.2003.167.re2; Brenneisen P, 2002, ANN NY ACAD SCI, V973, P31, DOI 10.1111/j.1749-6632.2002.tb04602.x; BRULS WAG, 1984, PHOTOCHEM PHOTOBIOL, V40, P485, DOI 10.1111/j.1751-1097.1984.tb04622.x; Chen WX, 1999, ONCOGENE, V18, P7469, DOI 10.1038/sj.onc.1203210; CHEUNG HTA, 1993, TETRAHEDRON, V49, P7903, DOI 10.1016/S0040-4020(01)88015-7; Chiang HM, 2011, FOOD CHEM TOXICOL, V49, P309, DOI 10.1016/j.fct.2010.10.034; Chung JH, 2003, PHOTODERMATOL PHOTO, V19, P109, DOI 10.1034/j.1600-0781.2003.00027.x; Dickinson SE, 2011, MOL CARCINOGEN, V50, P469, DOI 10.1002/mc.20734; Eckl KM, 2011, J INVEST DERMATOL, V131, P1938, DOI 10.1038/jid.2011.126; Evans-Johnson JA, 2013, J PHOTOCH PHOTOBIO B, V126, P17, DOI 10.1016/j.jphotobiol.2013.07.006; Fisher G J, 1998, J Investig Dermatol Symp Proc, V3, P61; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Fisher GJ, 1997, NEW ENGL J MED, V1997, P20; Fumarola C, 2014, BIOCHEM PHARMACOL, V90, P197, DOI 10.1016/j.bcp.2014.05.011; Gilchrest BA, 1996, PHOTOCHEM PHOTOBIOL, V63, P1, DOI 10.1111/j.1751-1097.1996.tb02988.x; Gordien AY, 2009, J ETHNOPHARMACOL, V126, P500, DOI 10.1016/j.jep.2009.09.007; Huang CS, 2000, MOL CARCINOGEN, V27, P65, DOI 10.1002/(SICI)1098-2744(200002)27:2<65::AID-MC2>3.0.CO;2-E; Hwang YP, 2011, J DERMATOL SCI, V61, P23, DOI 10.1016/j.jdermsci.2010.10.016; Jiang Yunyao, 2012, Prev Nutr Food Sci, V17, P116, DOI 10.3746/pnf.2012.17.2.116; Kahari VM, 1997, EXP DERMATOL, V6, P199, DOI 10.1111/j.1600-0625.1997.tb00164.x; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kim JE, 2010, BIOCHEM PHARMACOL, V79, P1473, DOI 10.1016/j.bcp.2010.01.008; Klotz LO, 1997, FEBS LETT, V408, P289, DOI 10.1016/S0014-5793(97)00440-7; Kwon JH, 2010, ARCH PHARM RES, V33, P2011, DOI 10.1007/s12272-010-1217-y; Li Y, 2010, J DERMATOL SCI, V60, P105, DOI 10.1016/j.jdermsci.2010.08.003; Lim JH, 2008, CHEMOSPHERE, V73, P470, DOI 10.1016/j.chemosphere.2008.06.048; Liu YB, 2011, FOOD CHEM, V124, P527, DOI 10.1016/j.foodchem.2010.06.064; Matsumura Yasuhiro, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S146239940200532X; MAUVIEL A, 1993, J CELL BIOCHEM, V53, P288, DOI 10.1002/jcb.240530404; Muhammad I, 1995, PHYTOTHER RES, V9, P584, DOI 10.1002/ptr.2650090810; Oh JH, 2006, J CELL PHYSIOL, V209, P775, DOI 10.1002/jcp.20754; Perez-Sanchez A, 2014, J PHOTOCH PHOTOBIO B, V136, P12, DOI 10.1016/j.jphotobiol.2014.04.007; Pinus desiflora, PIN DES; Rittie L, 2002, AGEING RES REV, V1, P705, DOI 10.1016/S1568-1637(02)00024-7; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; SHIMIZU M, 1994, BIOL PHARM BULL, V17, P665; Tanaka R, 2000, CANCER LETT, V161, P165, DOI 10.1016/S0304-3835(00)00584-X; van Beek TA, 2007, J NAT PROD, V70, P154, DOI 10.1021/np060325e; van den Bogaard EH, 2014, J INVEST DERMATOL, V134, P719, DOI 10.1038/jid.2013.417; Vincenti MP, 1996, CRIT REV EUKAR GENE, V6, P391, DOI 10.1615/CritRevEukarGeneExpr.v6.i4.40; Vogt P K, 1990, Adv Cancer Res, V55, P1, DOI 10.1016/S0065-230X(08)60466-2; Walker SL., 2003, FITZPATRICKS DERMATO, P1275; Wang S, 2014, EXP DERMATOL, V23, P524, DOI 10.1111/exd.12451; Xu YR, 2006, AM J PATHOL, V169, P823, DOI 10.2353/ajpath.2006.050449; Zhao Y, 1996, J BIOL CHEM, V271, P29773, DOI 10.1074/jbc.271.47.29773	53	18	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128365	10.1371/journal.pone.0128365	http://dx.doi.org/10.1371/journal.pone.0128365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066652	gold, Green Published, Green Submitted			2022-12-27	WOS:000356100900019
J	Lorente, L; Martin, MM; Borreguero-Leon, JM; Barrios, Y; Sole-Violan, J; Ferreres, J; Labarta, L; Diaz, C; Jimenez, A				Lorente, Leonardo; Martin, Maria M.; Borreguero-Leon, Juan M.; Barrios, Ysamar; Sole-Violan, Jordi; Ferreres, Jose; Labarta, Lorenzo; Diaz, Cesar; Jimenez, Alejandro			The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; 4G/5G PROMOTER POLYMORPHISM; ORGAN DYSFUNCTION; ENDOTHELIAL-CELL; SEPTIC SHOCK; GENE; DISEASE; COAGULATION; ALPHA	Objective Two studies have reported that patients with the 4G/4G genotype of the plasminogen activator inhibitor-1 (PAI-1) genetic polymorphism had higher plasma PAI-1 concentrations and higher risk of death than those with the 4G/5G or 5G/5G genotypes; one study involved 175 children with meningococcal disease, and the other included 88 adult patients with septic shock. Thus, the objective of this study was to determine whether there is an association between carriage of the 4G/4G genotype, plasma PAI-1 concentrations and mortality in a large series of adult septic patients. Methods An observational, prospective, multicenter study was carried out in six Spanish Intensive Care Units including severe septic patients. We determined the PAI-1 4G/5G polymorphism and plasma PAI-1 concentrations in all patients. The end-points of the study were 30-day and 6-month mortality. Results We included a total of 260 patients, 82 (31.5%) with 4G/4G, 126 (48.5%) with 4G/5G and 52 (20.0%) with 5G/5G genotype. Multivariate logistic regression analysis showed that the 4G/4G genotype was associated with higher mortality at 30 days (Odds Ratio = 1.95; 95% CI = 1.063-3.561; p = 0.03) and at 6 months (Odds Ratio = 2.19; 95% CI = 1.221-3.934; p = 0.01), and that higher plasma PAI-1 concentrations were associated with higher mortality at 30 days (Odds Ratio = 1.01; 95% CI = 1.002-1.022; p = 0.02) at 6months (Odds Ratio = 1.01; 95% CI = 1.003-1.023; p = 0.01). Multivariate linear regression analysis showed that increased plasma PAI-1 concentrations were associated with the PAI-1 4G/4G genotype (regression coefficient = 4.82; 95% CI = 3.227 to 6.406; p<0.001). Conclusions The major findings of our study, to our knowledge the largest series reporting data about 4G/5G polymorphism of the PAI-1 gene, plasma PAI-1 concentrations and mortality in septic patients, were that septic patients with the 4G/4G genotype had higher plasma PAI-1 concentrations and higher risk of death than those with 4G/5G or 5G/5G genotypes.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna, Santa Cruz De T, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Santa Cruz de Tenerife, Spain; [Borreguero-Leon, Juan M.] Hosp Univ Canarias, Lab Deparment, Tenerife, Spain; [Barrios, Ysamar] Hosp Univ Canarias, Res Unit, Lab Deparment, San Cristobal la Laguna, Santa Cruz De T, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, Intens Care Unit, Las Palmas Gran Canaria, Spain; [Ferreres, Jose] Hosp Clin Univ Valencia, Intens Care Unit, Valencia, Spain; [Labarta, Lorenzo] Hosp San Jorge, Intens Care Unit, Huesca, Spain; [Diaz, Cesar] Hosp Insular, Intens Care Unit, Las Palmas Gran Canaria, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, Stat Deparment, San Cristobal la Laguna, Santa Cruz De T, Spain	Universidad de la Laguna; Universidad de la Laguna; Universidad de la Laguna; Hospital Clinic Universitari de Valencia; Hospital Universidad San Jorge; Universidad de la Laguna	Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna, Santa Cruz De T, Spain.	lorentemartin@msn.com	Borreguero León, Juan María/ABQ-2161-2022; Martín, María/HDL-9512-2022	Borreguero León, Juan María/0000-0001-7414-5278; 	Instituto de Salud Carlos III (ISCIII)-Subdireccion General de Evaluacion y Fomento de la Investigacion (SGEFI) (Madrid, Spain) [PI14/00220]; Fondo Europeo de Desarrollo Regional (FEDER)	Instituto de Salud Carlos III (ISCIII)-Subdireccion General de Evaluacion y Fomento de la Investigacion (SGEFI) (Madrid, Spain); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government)	This study was supported by grants from Instituto de Salud Carlos III (ISCIII)-Subdireccion General de Evaluacion y Fomento de la Investigacion (SGEFI) (PI14/00220) (Madrid, Spain) and cofinanced with Fondo Europeo de Desarrollo Regional (FEDER). The funders have not affected study design; the collection, analysis, and interpretation of data; the writing of the manuscript; or the decision to submit the manuscript for publication.	Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; BIEMOND BJ, 1995, CIRCULATION, V91, P1175, DOI 10.1161/01.CIR.91.4.1175; BRANDTZAEG P, 1990, THROMB RES, V57, P271, DOI 10.1016/0049-3848(90)90326-8; Chavakis T, 2002, J BIOL CHEM, V277, P32677, DOI 10.1074/jbc.M204010200; Chikanishi T, 1999, J ANTIBIOT, V52, P797, DOI 10.7164/antibiotics.52.797; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; EITZMAN DT, 1995, J CLIN INVEST, V95, P2416, DOI 10.1172/JCI117937; Fay WP, 2007, ARTERIOSCL THROM VAS, V27, P1231, DOI 10.1161/ATVBAHA.107.140046; Garcia-Segarra G, 2007, INTENS CARE MED, V33, P1354, DOI 10.1007/s00134-007-0695-y; Haralambous E, 2003, CRIT CARE MED, V31, P2788, DOI 10.1097/01.CCM.0000100122.57249.5D; Henckaerts L, 2009, CRIT CARE MED, V37, P192, DOI 10.1097/CCM.0b013e31819263d8; Hermans PWM, 1999, LANCET, V354, P556, DOI 10.1016/S0140-6736(99)02220-5; Izuhara Y, 2008, ARTERIOSCL THROM VAS, V28, P672, DOI 10.1161/ATVBAHA.107.157479; Jessen KM, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-108; Kinasewitz GT, 2004, CRIT CARE, V8, pR82, DOI 10.1186/cc2459; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kornelisse RF, 1996, J INFECT DIS, V173, P1148, DOI 10.1093/infdis/173.5.1148; Li L., 2013, PLOS GENET, V9, DOI DOI 10.1371/; Lopez-Aguirre Y, 1999, THROMB RES, V94, P95, DOI 10.1016/S0049-3848(98)00200-X; LORENTE JA, 1993, CHEST, V103, P1536, DOI 10.1378/chest.103.5.1536; Lorente L, 2014, THROMB RES, V134, P182, DOI 10.1016/j.thromres.2014.04.013; Madach K, 2010, CRIT CARE, V14, DOI 10.1186/cc8992; Madoiwa S, 2006, INT J HEMATOL, V84, P398, DOI 10.1532/IJH97.05190; Murakami J, 1997, JPN J PHARMACOL, V75, P291; PARAMO JA, 1990, THROMB HAEMOSTASIS, V64, P3; PARAMO JA, 1988, THROMB HAEMOSTASIS, V59, P451; Wingeyer SP, 2012, J INFECT DEV COUNTR, V6, P555; Wingeyer SP, 2010, THROMB RES, V125, P367, DOI 10.1016/j.thromres.2009.04.006; PRALONG G, 1989, THROMB HAEMOSTASIS, V61, P459; Shapiro NI, 2010, CRIT CARE, V14, DOI 10.1186/cc9290; Shinohara C, 2000, J ANTIBIOT, V53, P262, DOI 10.7164/antibiotics.53.262; Sipahi T, 2006, CLIN APPL THROMB-HEM, V12, P47, DOI 10.1177/107602960601200108; Sutherland AM, 2009, CRIT CARE, V13, DOI 10.1186/cc7702; Tsantes AE, 2010, BLOOD COAGUL FIBRIN, V21, P175, DOI 10.1097/MBC.0b013e32833678a1; Urano T, 2001, J BIOL CHEM, V276, P24690, DOI 10.1074/jbc.M101751200; Verhamme I, 1999, J BIOL CHEM, V274, P17511, DOI 10.1074/jbc.274.25.17511; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wong HR, 2012, CRIT CARE MED, V40, P1618, DOI 10.1097/CCM.0b013e318246b546; Zeerleder S, 2006, THROMB RES, V118, P205, DOI 10.1016/j.thromres.2005.06.007; Zhan Zhi-ya, 2005, Zhonghua Yi Xue Za Zhi, V85, P2404	40	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129565	10.1371/journal.pone.0129565	http://dx.doi.org/10.1371/journal.pone.0129565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066833	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900058
J	Perez-Rios, M; Fernandez, E; Schiaffino, A; Nebot, M; Lopez, MJ				Perez-Rios, Monica; Fernandez, Esteve; Schiaffino, Anna; Nebot, Manel; Jose Lopez, Maria			Changes in the Prevalence of Tobacco Consumption and the Profile of Spanish Smokers after a Comprehensive Smoke-Free Policy	PLOS ONE			English	Article							SELF-REPORTED SMOKING; NICOTINE DEPENDENCE; FAGERSTROM TEST; GENERAL-POPULATION; ACCURACY; VALIDITY; EXPOSURE; COTININE; HEALTH; SPAIN	Background A partial smoke-free regulation in Spain was introduced on January 1, 2006, which was subsequently amended to introduce a comprehensive smoke-free policy from 2 January 2011 onward. The objective of this study was to compare the prevalence of tobacco consumption in Spain and the profile of smokers before (2006) and after (2011) the comprehensive smoking ban passed in 2010. Methods Two independent, cross-sectional, population-based surveys were carried out among the adult (>= 18 years old) Spanish population in 2006 and 2011 through telephone interviews. Both surveys used the same methods and questionnaire. Nicotine dependence was assessed with the Fagerstrom Test for nicotine dependence and readiness to quit according to the stages of change. Results The prevalence of tobacco consumption showed a nonsignificant decrease from 23.4% in 2006 to 20.7% in 2011. No changes were observed in nicotine dependence or readiness to quit. In 2011, most smokers (76%) showed low nicotine dependence and were mainly in the precontemplation stage (72%). Conclusions The prevalence of smokers has slightly decreased since the introduction of the total smoking ban in Spain. No differences were found in nicotine dependence or readiness to quit.	[Perez-Rios, Monica] Galician Hlth Author, Galician Directorate Publ Hlth, Epidemiol Unit, Santiago De Compostela, Spain; [Perez-Rios, Monica; Nebot, Manel; Jose Lopez, Maria] Biomed Res Ctr Network Epidemiol & Publ Hlth CIBE, Granada, Spain; [Perez-Rios, Monica] Univ Santiago de Compostela, Sch Med, Dept Prevent Med & Publ Hlth, Santiago De Compostela, Spain; [Fernandez, Esteve; Schiaffino, Anna] Inst Invest Biomed Bellvitge IDIBELL, ICO, Canc Control & Prevent Programme, Tobacco Control Unit, Barcelona, Spain; [Fernandez, Esteve] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [Nebot, Manel; Jose Lopez, Maria] Agencia Salut Publ Barcelona, Barcelona, Spain; [Jose Lopez, Maria] Inst Biomed Res IIB St Pau, Barcelona, Spain	Universidade de Santiago de Compostela; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Public Health Agency of Barcelona	Perez-Rios, M (corresponding author), Galician Hlth Author, Galician Directorate Publ Hlth, Epidemiol Unit, Santiago De Compostela, Spain.	monica.perez.rios@usc.es	Lopez, Maria/HHC-3659-2022; Pérez-Ríos, Mónica/AAA-5941-2019; Fernandez, Esteve/A-9750-2008	Fernandez, Esteve/0000-0003-4239-723X; Lopez Medina, Maria Jose/0000-0003-4402-2239; Perez-Rios, Monica/0000-0003-4456-6631	Instituto de Salud Carlos III, Ministry of Health, Government of Spain [FIS PI10/00400]; Ministry of Universities and Research of Catalonia [2009SGR192, 2009SGR1345]; Instituto de Salud Carlos III of Spain [RD12/0036/0053]	Instituto de Salud Carlos III, Ministry of Health, Government of Spain(Instituto de Salud Carlos III); Ministry of Universities and Research of Catalonia; Instituto de Salud Carlos III of Spain(Instituto de Salud Carlos III)	This work was supported by the Instituto de Salud Carlos III, Ministry of Health, Government of Spain (FIS PI10/00400). The Ministry of Universities and Research of Catalonia (grants 2009SGR192 and 2009SGR1345) partially supported the work of Perez-Rios, Schiaffino, Lopez and Fernandez, and the Instituto de Salud Carlos III of Spain (grant RD12/0036/0053) partially supported the work of Fernandez.	[Anonymous], 2009, EV IMP LEY MED SAN F; Callinan JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub2; Casado JB, 2001, ARCH BRONCONEUMOL, V37, P75, DOI 10.1016/S0300-2896(01)75018-1; Romero CC, 2012, REV ESP SALUD PUBLIC, V86, P177; Chaiton MO, 2008, J PUBLIC HEALTH POL, V29, P307, DOI 10.1057/jphp.2008.14; Etter JF, 2008, ADDICTION, V103, P1576, DOI 10.1111/j.1360-0443.2008.02300.x; Fagerstrom K, 2008, ADDICTION, V103, P841, DOI 10.1111/j.1360-0443.2008.02190.x; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; Fernandez E, 2003, MED CLIN-BARCELONA, V120, P14, DOI 10.1157/13042014; Fernandez E, 2011, TOB CONTROL, V20, P325; Fu M, 2011, ADICCIONES, V23, P103, DOI 10.20882/adicciones.153; Fu M, 2009, ADDICTION, V104, P326, DOI 10.1111/j.1360-0443.2008.02485.x; Gallus S, 2007, PREV MED, V45, P198, DOI 10.1016/j.ypmed.2007.03.009; Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010; HALEY NJ, 1985, CLIN CHEM, V31, P1598; Heloma A, 2003, ADDICTION, V98, P1111, DOI 10.1046/j.1360-0443.2003.00429.x; Jimenez Ruiz C A, 2000, Arch Bronconeumol, V36, P241; Ruiz CAJ, 2014, RESPIRATION, V87, P190, DOI 10.1159/000355083; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Lopez-Nicolas A, 2013, TOB CONTROL, V22, DOI 10.1136/tobaccocontrol-2011-050344; LUEPKER RV, 1989, AM J PUBLIC HEALTH, V79, P202, DOI 10.2105/AJPH.79.2.202; Lund M, 2011, NICOTINE TOB RES, V13, P1132, DOI 10.1093/ntr/ntr166; Lushchenkova O, 2008, REV ESP CARDIOL, V61, P687, DOI 10.1016/S1885-5857(08)60205-4; Marcus S, 2004, SMOKING TOBACCO CONT, V15; Martinez-Sanchez JM, 2013, GAC SANIT, V27, P61, DOI 10.1016/j.gaceta.2012.05.003; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; Perez-Rios M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-493; PETITTI DB, 1981, AM J PUBLIC HEALTH, V71, P308, DOI 10.2105/AJPH.71.3.308; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Thyrian JR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-2; Wilson LM, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/961724	31	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128305	10.1371/journal.pone.0128305	http://dx.doi.org/10.1371/journal.pone.0128305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK3FB	26066497	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900018
J	Lawson, A; Cogger, C; Bary, A; Fortuna, AM				Lawson, Andrew; Cogger, Craig; Bary, Andy; Fortuna, Ann-Marie			Influence of Seeding Ratio, Planting Date, and Termination Date on Rye-Hairy Vetch Cover Crop Mixture Performance under Organic Management	PLOS ONE			English	Article							NITROGEN AVAILABILITY; SOIL QUALITY; KILL DATE; CORN; TILLAGE; GRASS; TIME; RELEASE; GROWTH; CARBON	Cover crop benefits include nitrogen accumulation and retention, weed suppression, organic matter maintenance, and reduced erosion. Organic farmers need region-specific information on winter cover crop performance to effectively integrate cover crops into their crop rotations. Our research objective was to compare cover crop seeding mixtures, planting dates, and termination dates on performance of rye (Secale cereale L.) and hairy vetch (Vicia villosa Roth) monocultures and mixtures in the maritime Pacific Northwest USA. The study included four seed mixtures (100% hairy vetch, 25% rye-75% hairy vetch, 50% rye-50% hairy vetch, and 100% rye by seed weight), two planting dates, and two termination dates, using a split-split plot design with four replications over six years. Measurements included winter ground cover; stand composition; cover crop biomass, N concentration, and N uptake; and June soil NO3--N. Rye planted in mid-September and terminated in late April averaged 5.1 Mg ha(-1) biomass, whereas mixtures averaged 4.1 Mg ha(-1) and hairy vetch 2.3 Mg ha(-1). Delaying planting by 2.5 weeks reduced average winter ground cover by 65%, biomass by 50%, and cover crop N accumulation by 40%. Similar reductions in biomass and N accumulation occurred for late March termination, compared with late April termination. Mixtures had less annual biomass variability than rye. Mixtures accumulated 103 kg ha(-1) N and had mean C:N ratio <17:1 when planted in mid-September and terminated in late April. June soil NO3--N (0 to 30 cm depth) averaged 62 kg ha(-1) for rye, 97 kg ha(-1) for the mixtures, and 119 kg ha(-1) for hairy vetch. Weeds comprised less of the mixtures biomass (20% weeds by weight at termination) compared with the monocultures (29%). Cover crop mixtures provided a balance between biomass accumulation and N concentration, more consistent biomass over the six-year study, and were more effective at reducing winter weeds compared with monocultures.	[Lawson, Andrew; Cogger, Craig; Bary, Andy] Washington State Univ, Puyallup Res & Extens Ctr, Puyallup, WA 98371 USA; [Fortuna, Ann-Marie] N Dakota State Univ, Dept Soil Sci, Fargo, ND 58105 USA	Washington State University; North Dakota State University Fargo	Cogger, C (corresponding author), Washington State Univ, Puyallup Res & Extens Ctr, Puyallup, WA 98371 USA.	cogger@wsu.edu		Fortuna, Ann-Marie/0000-0002-6966-7781	Western Sustainable Agriculture Research and Education [SW03-040]; United States Department of Agriculture Integrated Organic Program [00394397]; Washington State University College of Agriculture Human and Natural Resource Sciences Emerging Research Issues; Washington State University College of Agriculture Human and Natural Resource Sciences Center for Sustaining Agriculture and Natural Resources Organic Cropping Research for the Northwest	Western Sustainable Agriculture Research and Education; United States Department of Agriculture Integrated Organic Program; Washington State University College of Agriculture Human and Natural Resource Sciences Emerging Research Issues; Washington State University College of Agriculture Human and Natural Resource Sciences Center for Sustaining Agriculture and Natural Resources Organic Cropping Research for the Northwest	Funding for this work came from Western Sustainable Agriculture Research and Education SW03-040 (http://www.westernsare.org/) to CC, United States Department of Agriculture Integrated Organic Program GRANT00394397 (http://www.csrees.usda.gov/) to CC and AF, and Washington State University College of Agriculture Human and Natural Resource Sciences Emerging Research Issues 2007 http://cahnrs.wsu.edu/ to CC, AF, and AB. Additional funding for this work came from the Washington State University College of Agriculture Human and Natural Resource Sciences Center for Sustaining Agriculture and Natural Resources Organic Cropping Research for the Northwest 2004 (http://csanr.wsu.edu/) to CC and AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Ayuso M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109587; Baributsa DN, 2008, AGRON J, V100, P981, DOI 10.2134/agronj2007.0110; Bich A. D., 2014, Crop Management, V13, pCM, DOI 10.2134/cm-2014-0009-rs; BrandiDohrn FM, 1997, J ENVIRON QUAL, V26, P181, DOI 10.2134/jeq1997.00472425002600010026x; Brennan EB, 2011, AGRON J, V103, P449, DOI 10.2134/agronj2010.0152; Brennan EB, 2012, AGRON J, V104, P684, DOI 10.2134/agronj2011.0330; CLARK AJ, 1995, AGRON J, V87, P579, DOI 10.2134/agronj1995.00021962008700030031x; Clark AJ, 1997, AGRON J, V89, P427, DOI 10.2134/agronj1997.00021962008900030010x; Cline GR, 2002, HORTTECHNOLOGY, V12, P118, DOI 10.21273/HORTTECH.12.1.118; Fortuna A, 2008, COMMUN SOIL SCI PLAN, V39, P1680, DOI 10.1080/00103620802073628; Gavlak RG, 2005, W REGIONAL EXT PUBL, V125; Hayden ZD, 2012, WEED TECHNOL, V26, P818, DOI 10.1614/WT-D-12-00084.1; Hively WD, 2001, AGRON J, V93, P308, DOI 10.2134/agronj2001.932308x; HOLDERBAUM JF, 1990, AGRON J, V82, P117, DOI 10.2134/agronj1990.00021962008200010026x; Horneck DA, 2011, OREGON STATE U EXTEN, V1478; Kruidhof HM, 2008, WEED RES, V48, P492, DOI 10.1111/j.1365-3180.2008.00665.x; Kuo S, 2000, BIOL FERT SOILS, V31, P470, DOI 10.1007/s003740000193; Kuo S, 1997, SOIL SCI SOC AM J, V61, P1392, DOI 10.2136/sssaj1997.03615995006100050016x; Kuo S, 2002, AGRON J, V94, P501; Lawson A, 2013, RENEW AGR FOOD SYST, V28, P59, DOI 10.1017/S1742170512000014; Odhiambo JJO, 2001, AGRON J, V93, P299, DOI 10.2134/agronj2001.932299x; Pritchett K, 2011, SOIL SCI SOC AM J, V75, P605, DOI 10.2136/sssaj2009.0294; Ranells NN, 1997, AGRON J, V89, P659, DOI 10.2134/agronj1997.00021962008900040019x; Ranells NN, 1996, AGRON J, V88, P777, DOI 10.2134/agronj1996.00021962008800050015x; Sainju UM, 2000, CAN J SOIL SCI, V80, P523, DOI 10.4141/S99-107; Sainju UM, 2005, AGRON J, V97, P1279, DOI 10.2134/agronj2004.0213; Sattel R, 1998, OREGON STATE U EXTEN, V8704; Sustainable Agriculture Network, 2007, MAN COV CROPS PROF; Teasdale JR, 2004, AGRON J, V96, P1429, DOI 10.2134/agronj2004.1429; Thorup-Kristensen K, 2010, SOIL USE MANAGE, V26, P27, DOI 10.1111/j.1475-2743.2009.00255.x; Vaughan JD, 1998, AGRON J, V90, P536, DOI 10.2134/agronj1998.00021962009000040016x; Vaughan JD, 2000, COMMUN SOIL SCI PLAN, V31, P1017, DOI 10.1080/00103620009370495; WAGGER MG, 1989, AGRON J, V81, P236, DOI 10.2134/agronj1989.00021962008100020020x; Wayman S, 2015, AGROECOL SU IN PRESS; Wayman S, 2015, RENEW AGR FOOD SYST, V30, P450, DOI 10.1017/S1742170514000246	35	63	64	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129597	10.1371/journal.pone.0129597	http://dx.doi.org/10.1371/journal.pone.0129597			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080008	Green Submitted, Green Published, gold			2022-12-27	WOS:000356542300026
J	Duarte-Guterman, P; Lieblich, SE; Chow, C; Galea, LAM				Duarte-Guterman, Paula; Lieblich, Stephanie E.; Chow, Carmen; Galea, Liisa A. M.			Estradiol and GPER Activation Differentially Affect Cell Proliferation but Not GPER Expression in the Hippocampus of Adult Female Rats	PLOS ONE			English	Article							COUPLED ESTROGEN-RECEPTOR; SPATIAL-LEARNING TASK; DENTATE GYRUS; NEUROGENESIS; PROTEIN; GPR30; MEMORY; BRAIN; NEURONS; HORMONES	Estradiol increases cell proliferation in the dentate gyrus of the female rodent but it is not known whether the G protein-coupled estrogen receptor (GPER), a membrane receptor, is involved in this process, nor whether there are regional differences in estradiol's effects on cell proliferation. Thus, we investigated whether estradiol exerts its effects on cell proliferation in the dorsal and ventral dentate gyrus through GPER, using the GPER agonist, G1, and antagonist, G15. Ovariectomized adult female rats received a single injection of either: 17 beta-estradiol (10 mu g), G1 (0.1, 5, 10 mu g), G15 (40 mu g), G15 and estradiol, or vehicle (oil, DMSO, or oil+DMSO). After 30 min, animals received an injection of bromodeoxyuridine (BrdU) and were perfused 24 h later. Acute treatment with estradiol increased, while the GPER agonist G1 (5 mu g) decreased, the number of BrdU+ cells in the dentate gyrus relative to controls. The GPER antagonist, G15 increased the number of BrdU+ cells relative to control in the dorsal region and decreased the number of BrdU+ cells in the ventral region. However, G15 treatment in conjunction with estradiol partially eliminated the estradiol-induced increase in cell proliferation in the dorsal dentate gyrus. Furthermore, G1 decreased the expression of GPER in the dentate gyrus but not the CA1 and CA3 regions of the hippocampus. In summary, we found that activation of GPER decreased cell proliferation and GPER expression in the dentate gyrus of young female rats, presenting a potential and novel estrogen- independent role for this receptor in the adult hippocampus.	[Duarte-Guterman, Paula; Lieblich, Stephanie E.; Chow, Carmen; Galea, Liisa A. M.] Univ British Columbia, Dept Psychol, Program Neurosci, Ctr Brain Hlth, Vancouver, BC, Canada	University of British Columbia	Galea, LAM (corresponding author), Univ British Columbia, Dept Psychol, Program Neurosci, Ctr Brain Hlth, Vancouver, BC, Canada.	lgalea@psych.ubc.ca	; Duarte-Guterman, Paula/C-9676-2013	Galea, Liisa/0000-0003-2874-9972; Duarte-Guterman, Paula/0000-0002-1695-8147	Canadian Institutes of Health Research (LAMG) [MOP102568]; Natural Sciences and Engineering Research Council of Canada (NSERC); Alzheimer Society of Canada; NSERC	Canadian Institutes of Health Research (LAMG)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alzheimer Society of Canada; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this research was provided by the Canadian Institutes of Health Research (LAMG; MOP102568). LAMG also has funding from the Natural Sciences and Engineering Research Council of Canada (NSERC) and Alzheimer Society of Canada. PDG was funded by a postdoctoral fellowship from NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Amrein I, 2009, BIOL LETTERS, V5, P141, DOI 10.1098/rsbl.2008.0511; Baker LD, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.002; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Barha CK, 2009, J NEUROENDOCRINOL, V21, P155, DOI 10.1111/j.1365-2826.2008.01809.x; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Batenburg WW, 2012, CARDIOVASC RES, V94, P136, DOI 10.1093/cvr/cvs016; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; Broughton BRS, 2013, NEUROSIGNALS, V21, P229, DOI 10.1159/000338019; Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023; Butz M, 2006, NEURAL NETWORKS, V19, P1490, DOI 10.1016/j.neunet.2006.07.007; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Cheng SB, 2014, MOL CELL ENDOCRINOL, V382, P950, DOI 10.1016/j.mce.2013.11.005; Chow C, 2013, PSYCHONEUROENDOCRINO, V38, P1236, DOI 10.1016/j.psyneuen.2012.11.007; Dennis MK, 2011, J STEROID BIOCHEM, V127, P358, DOI 10.1016/j.jsbmb.2011.07.002; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fowler CD, 2005, J COMP NEUROL, V489, P166, DOI 10.1002/cne.20638; Fuchs E, 2000, EUR J NEUROSCI, V12, P2211, DOI 10.1046/j.1460-9568.2000.00130.x; Galea LAM, 2013, J NEUROENDOCRINOL, V25, P1039, DOI 10.1111/jne.12070; Galea LAM, 2001, BEHAV BRAIN RES, V126, P115, DOI 10.1016/S0166-4328(01)00255-8; Galea LAM, 2008, CAN J EXP PSYCHOL, V62, P247, DOI 10.1037/a0014501; Gros R, 2013, AM J PHYSIOL-CELL PH, V304, pC532, DOI 10.1152/ajpcell.00203.2012; Gros R, 2011, HYPERTENSION, V57, P442, DOI 10.1161/HYPERTENSIONAHA.110.161653; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Hammond R, 2012, HORM BEHAV, V62, P367, DOI 10.1016/j.yhbeh.2012.07.004; Hammond R, 2009, HORM BEHAV, V56, P309, DOI 10.1016/j.yhbeh.2009.06.008; Hamson DK, 2013, ENDOCRINOLOGY, V154, P3294, DOI 10.1210/en.2013-1129; Hawley WR, 2014, BEHAV BRAIN RES, V262, P68, DOI 10.1016/j.bbr.2014.01.006; Hazell GGJ, 2009, J ENDOCRINOL, V202, P223, DOI 10.1677/JOE-09-0066; Holmes MM, 2002, BEHAV NEUROSCI, V116, P928, DOI 10.1037//0735-7044.116.5.928; Isgor C, 2005, NEUROSCIENCE, V134, P847, DOI 10.1016/j.neuroscience.2005.05.008; Kastenberger I, 2012, PSYCHOPHARMACOLOGY, V221, P527, DOI 10.1007/s00213-011-2599-3; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kim DS, 2008, J COMP NEUROL, V511, P581, DOI 10.1002/cne.21851; Langer G, 2010, STEROIDS, V75, P603, DOI 10.1016/j.steroids.2009.12.006; Liu NJ, 2011, J NEUROSCI, V31, P11836, DOI 10.1523/JNEUROSCI.1901-11.2011; Matsuda KI, 2008, NEUROSCI LETT, V441, P94, DOI 10.1016/j.neulet.2008.05.108; Mazzucco CA, 2006, NEUROSCIENCE, V141, P1793, DOI 10.1016/j.neuroscience.2006.05.032; Mazzucco CA, 2008, BEHAV BRAIN RES, V191, P111, DOI 10.1016/j.bbr.2008.03.016; McClure RES, 2013, HORM BEHAV, V63, P144, DOI 10.1016/j.yhbeh.2012.09.011; Micevych P, 2009, FRONT NEUROENDOCRIN, V30, P315, DOI 10.1016/j.yfrne.2009.04.011; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Nagy AI, 2005, DRUG DEVELOP RES, V66, P142, DOI 10.1002/ddr.20053; Ormerod BK, 2003, J NEUROBIOL, V55, P247, DOI 10.1002/neu.10181; Ormerod BK, 2001, NEUROSCIENCE, V102, P369, DOI 10.1016/S0306-4522(00)00474-7; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Petrie WK, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/472720; Prossnitz ER, 2008, J STEROID BIOCHEM, V109, P350, DOI 10.1016/j.jsbmb.2008.03.006; Qiu J, 2003, J NEUROSCI, V23, P9529; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shors TJ, 1998, NEUROREPORT, V9, P419, DOI 10.1097/00001756-199802160-00012; Snyder JS, 2009, HIPPOCAMPUS, V19, P360, DOI 10.1002/hipo.20525; Spary EJ, 2013, NEUROSIGNALS, V21, P14, DOI 10.1159/000333296; Srivastava DP, 2013, J NEUROENDOCRINOL, V25, P1219, DOI 10.1111/jne.12071; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Tanapat P, 2005, J COMP NEUROL, V481, P252, DOI 10.1002/cne.20385; ter Horst J, 2012, CELL MOL NEUROBIOL, V32, P725, DOI 10.1007/s10571-011-9774-2; Tian Z, 2013, PSYCHONEUROENDOCRINO, V38, P2218, DOI 10.1016/j.psyneuen.2013.04.011; Toran-Allerand CD, 2002, J NEUROSCI, V22, P8391; Vasudevan N, 2008, FRONT NEUROENDOCRIN, V29, P238, DOI 10.1016/j.yfrne.2007.08.003; VIAU V, 1991, ENDOCRINOLOGY, V129, P2503, DOI 10.1210/endo-129-5-2503; Wong EYH, 2005, EUR J NEUROSCI, V22, P785, DOI 10.1111/j.1460-9568.2005.04277.x; Wood GE, 2001, BEHAV NEUROSCI, V115, P175, DOI 10.1037//0735-7044.115.1.175; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Xu H, 2009, NEUROSCIENCE, V158, P1599, DOI 10.1016/j.neuroscience.2008.11.028	69	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129880	10.1371/journal.pone.0129880	http://dx.doi.org/10.1371/journal.pone.0129880			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075609	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900109
J	Hu, SF; Huang, YH; Lin, CP; Liu, LYD; Hong, SF; Yang, CY; Lo, HF; Tseng, TY; Chen, WY; Lin, SS				Hu, Sin-Fen; Huang, Yu-Hsin; Lin, Chan-Pin; Liu, Li-Yu Daisy; Hong, Syuan-Fei; Yang, Chiao-Yin; Lo, Hsiao-Feng; Tseng, Ting-Yu; Chen, Wei-Yao; Lin, Shih-Shun			Development of a Mild Viral Expression System for Gain-Of-Function Study of Phytoplasma Effector In Planta	PLOS ONE			English	Article							YELLOW-MOSAIC-VIRUS; GENE-EXPRESSION; VECTOR; SUPPRESSION; PROTEIN; MERISTEMS; INFECTION; PATHWAYS	PHYL1 and SAP54 are orthologs of pathogenic effectors of Aster yellow witches'-broom (AYWB) phytoplasma and Peanut witches'-broom (PnWB) phytoplasma, respectively. These effectors cause virescence and phyllody symptoms (hereafter leafy flower) in phytoplasma- infected plants. T-0 lines of transgenic Arabidopsis expressing the PHYL1 or SAP54 genes (PHYL1 or SAP54 plants) show a leafy flower phenotype and result in seedless, suggesting that PHYL1 and SAP54 interfere with reproduction stage that restrict gain-of-function studies in the next generation of transgenic plants. Turnip mosaic virus (TuMV) mild strain (TuGK) has an Arg182Lys mutation in the helper-component proteinase (HC-Pro(R182K)) that blocks suppression of the miRNA pathway and prevents symptom development in TuGK-infected plants. We exploited TuGK as a viral vector for gain-of-function studies of PHYL1 and SAP54 in Arabidopsis plants. TuGK-PHYL1-and TuGK-SAP54-infected Arabidopsis plants produced identical leafy flower phenotypes and similar gene expression profiles as PHYL1 and SAP54 plants. In addition, the leafy flower formation rate was enhanced in TuGK-PHYL1-or TuGK-SAP54-infected Arabidopsis plants that compared with the T-0 lines of PHYL1 plants. These results provide more evidence and novel directions for further studying the mechanism of PHYL1/SAP54-mediated leafy flower development. In addition, the TuGK vector is a good alternative in transgenic plant approaches for rapid gene expression in gain-of-function studies.	[Hu, Sin-Fen; Chen, Wei-Yao; Lin, Shih-Shun] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Lin, Shih-Shun] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan; [Lin, Shih-Shun] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Huang, Yu-Hsin; Lin, Chan-Pin; Yang, Chiao-Yin] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [Hong, Syuan-Fei; Lo, Hsiao-Feng] Natl Taiwan Univ, Dept Hort & Landscape Architecture, Taipei 10764, Taiwan; [Liu, Li-Yu Daisy] Natl Taiwan Univ, Dept Agron, Taipei 10764, Taiwan; [Tseng, Ting-Yu] Natl Taiwan Univ, Coll Bioresources & Agr, Joint Ctr Instruments & Res, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Lin, SS (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan.	linss01@ntu.edu.tw	Lin, Shih-Shun/HCH-9241-2022	Liu, Li-yu/0000-0001-6997-8101; LIN, SHIH-SHUN/0000-0002-7295-5004; LO, HSIAO-FENG/0000-0002-1574-2854; Lin, Chan-Pin/0000-0002-9951-687X	Ministry of Science and Technology, Taiwan [NSC-102-2313-B-002-068-MY3, NSC-102-2313-B-002066-B-MY3, NSC-103-2313-B-002-007]; National Taiwan University [104R7602B2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This study was supported by grants NSC-102-2313-B-002-068-MY3, NSC-102-2313-B-002066-B-MY3, and NSC-103-2313-B-002-007 from the Ministry of Science and Technology, Taiwan; and 104R7602B2 from National Taiwan University.	Aguero J, 2012, MOL PLANT MICROBE IN, V25, P1326, DOI 10.1094/MPMI-02-12-0048-R; Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; APPIANO A, 1972, J GEN VIROL, V14, P273, DOI 10.1099/0022-1317-14-3-273; Bai XD, 2009, MOL PLANT MICROBE IN, V22, P18, DOI 10.1094/MPMI-22-1-0018; Carrio-Segui A, 2015, PLANT CELL PHYSIOL, V56, P442, DOI 10.1093/pcp/pcu180; Chiu MingTzu, 2013, Plant Pathology Bulletin, V22, P21; Chung W-C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062770, DOI 10.1371/JOURNAL.PONE.0062770]; Collens JI, 2007, BIOTECHNOL PROGR, V23, P570, DOI 10.1021/bp060342u; Dhillon T, 2009, PLANT CELL REP, V28, P639, DOI 10.1007/s00299-009-0675-5; Gleba Y, 2004, CURR OPIN PLANT BIOL, V7, P182, DOI 10.1016/j.pbi.2004.01.003; Gleba Y, 2007, CURR OPIN BIOTECH, V18, P134, DOI 10.1016/j.copbio.2007.03.002; Haikonen T, 2013, J VIROL METHODS, V193, P687, DOI 10.1016/j.jviromet.2013.07.054; Hanley K, 2003, ASSAY DRUG DEV TECHN, V1, P147, DOI 10.1089/154065803762851315; Harpaz-Saad S, 2007, PLANT CELL, V19, P1007, DOI 10.1105/tpc.107.050633; Hsu CH, 2004, J ALLERGY CLIN IMMUN, V113, P1079, DOI 10.1016/j.jaci.2004.02.047; Huang CF, 2010, PLANT PHYSIOL, V153, P1669, DOI 10.1104/pp.110.155028; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; KITAJIMA EW, 1969, J GEN VIROL, V4, P177, DOI 10.1099/0022-1317-4-2-177; Kung YJ, 2014, MOL PLANT MICROBE IN, V27, P944, DOI 10.1094/MPMI-04-14-0116-R; Lacomme Christophe, 2008, Curr Protoc Microbiol, VChapter 16, DOI 10.1002/9780471729259.mc16i01s8; LIN NS, 1984, J GEN VIROL, V65, P2217, DOI 10.1099/0022-1317-65-12-2217; Lin YY, 2013, BOT STUD, V54, DOI 10.1186/1999-3110-54-22; Liu LYD, 2014, PLANT CELL PHYSIOL, V55, P942, DOI 10.1093/pcp/pcu029; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; MacLean AM, 2011, PLANT PHYSIOL, V157, P831, DOI 10.1104/pp.111.181586; Maejima K, 2014, PLANT J, V78, P541, DOI 10.1111/tpj.12495; Minato N, 2014, ARCH VIROL, V159, P885, DOI 10.1007/s00705-013-1860-y; Mochizuki T, 2015, METHODS MOL BIOL, V1236, P275, DOI 10.1007/978-1-4939-1743-3_20; ROBERTS DA, 1970, VIROLOGY, V42, P217, DOI 10.1016/0042-6822(70)90255-2; Ruiz-Ferrer V, 2007, BIOESSAYS, V29, P319, DOI 10.1002/bies.20556; Shamekova M, 2014, VIROLOGY, V452, P159, DOI 10.1016/j.virol.2013.12.031; Takeshita M, 2012, MOL PLANT MICROBE IN, V25, P18, DOI 10.1094/MPMI-06-11-0170; TOUSSAINT A, 1984, PHYSIOL PLANT PATHOL, V25, P297, DOI 10.1016/0048-4059(84)90037-7; Wu HW, 2010, MOL PLANT MICROBE IN, V23, P17, DOI 10.1094/MPMI-23-1-0017; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705; Zhao Y, 2014, PLANT PHYSIOL, V164, P1068, DOI 10.1104/pp.113.227595; Zwart MP, 2014, MOL BIOL EVOL, V31, P121, DOI 10.1093/molbev/mst175	38	2	2	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130139	10.1371/journal.pone.0130139	http://dx.doi.org/10.1371/journal.pone.0130139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076458	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900142
J	Reske, M; Stewart, JL; Flagan, TM; Paulus, MP				Reske, Martina; Stewart, Jennifer L.; Flagan, Taru M.; Paulus, Martin P.			Attenuated Neural Processing of Risk in Young Adults at Risk for Stimulant Dependence	PLOS ONE			English	Article							IOWA GAMBLING TASK; ANTERIOR CINGULATE CORTEX; DELAY DISCOUNTING TASK; TAKING DECISION-MAKING; PREFRONTAL CORTEX; COCAINE ADDICTION; COGNITIVE CONTROL; PRESCRIPTION STIMULANTS; COLLEGE-STUDENTS; NONMEDICAL USE	Objective Approximately 10% of young adults report non-medical use of stimulants (cocaine, amphetamine, methylphenidate), which puts them at risk for the development of dependence. This fMRI study investigates whether subjects at early stages of stimulant use show altered decision making processing. Methods 158 occasional stimulants users (OSU) and 50 comparison subjects (CS) performed a "risky gains" decision making task during which they could select safe options (cash in 20 cents) or gamble them for double or nothing in two consecutive gambles (win or lose 40 or 80 cents, "risky decisions"). The primary analysis focused on risky versus safe decisions. Three secondary analyses were conducted: First, a robust regression examined the effect of lifetime exposure to stimulants and marijuana; second, subgroups of OSU with > 1000 (n = 42), or <50 lifetime marijuana uses (n = 32), were compared to CS with <50 lifetime uses (n = 46) to examine potential marijuana effects; third, brain activation associated with behavioral adjustment following monetary losses was probed. Results There were no behavioral differences between groups. OSU showed attenuated activation across risky and safe decisions in prefrontal cortex, insula, and dorsal striatum, exhibited lower anterior cingulate cortex (ACC) and dorsal striatum activation for risky decisions and greater inferior frontal gyrus activation for safe decisions. Those OSU with relatively more stimulant use showed greater dorsal ACC and posterior insula attenuation. In comparison, greater lifetime marijuana use was associated with less neural differentiation between risky and safe decisions. OSU who chose more safe responses after losses exhibited similarities with CS relative to those preferring risky options. Discussion Individuals at risk for the development of stimulant use disorders presented less differentiated neural processing of risky and safe options. Specifically, OSU show attenuated brain response in regions critical for performance monitoring, reward processing and interoceptive awareness. Marijuana had additive effects by diminishing neural risk differentiation.	[Reske, Martina; Stewart, Jennifer L.; Flagan, Taru M.; Paulus, Martin P.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Reske, Martina] Forschungszentrum Julich, INM 6, Computat & Syst Neurosci, D-52425 Julich, Germany; [Reske, Martina] Forschungszentrum Julich, IAS 6, Theoret Neurosci, D-52425 Julich, Germany; [Reske, Martina] JARA BRAIN Inst 1, Julich, Germany; [Stewart, Jennifer L.] CUNY Queens Coll, New York, NY USA; [Flagan, Taru M.] Univ Texas Austin, Austin, TX 78712 USA; [Paulus, Martin P.] VA San Diego Healthcare Syst, Psychiat Serv, La Jolla, CA USA; [Paulus, Martin P.] Laureate Inst Brain Res, Tulsa, OK USA	University of California System; University of California San Diego; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; City University of New York (CUNY) System; University of Texas System; University of Texas Austin; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Laureate Institute for Brain Research, Inc.	Paulus, MP (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	mpaulus@laureateinstitute.org	Reske, Martina/M-6083-2013	Reske, Martina/0000-0001-5754-4795; Stewart, Jennifer/0000-0003-0123-9438	National Institute on Drug Abuse [R01-DA016663, P20-DA027834, R01-DA027797, R01-DA018307]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018307, R01DA027797, R01DA016663] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grants from the National Institute on Drug Abuse (Grants R01-DA016663, P20-DA027834, R01-DA027797, and R01-DA018307 to Martin Paulus). Funding authorities had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report or the decision to submit the manuscript for publication.	Arce E, 2006, PSYCHOPHARMACOLOGY, V189, P105, DOI 10.1007/s00213-006-0519-8; Arias AJ, 2008, ADDICT BEHAV, V33, P1199, DOI 10.1016/j.addbeh.2008.05.003; Asensio S, 2010, ADDICT BIOL, V15, P504, DOI 10.1111/j.1369-1600.2010.00230.x; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Barry D, 2008, BRAIN COGNITION, V66, P243, DOI 10.1016/j.bandc.2007.09.001; Bechara A, 2001, Semin Clin Neuropsychiatry, V6, P205, DOI 10.1053/scnp.2001.22927; Bechara Antoine, 2003, J Gambl Stud, V19, P23, DOI 10.1023/A:1021223113233; Bjork JM, 2008, DRUG ALCOHOL DEPEN, V95, P115, DOI 10.1016/j.drugalcdep.2007.12.014; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; Bolla KI, 2002, NEUROLOGY, V59, P1337, DOI 10.1212/01.WNL.0000031422.66442.49; Bolla KI, 1999, J NEUROPSYCH CLIN N, V11, P361, DOI 10.1176/jnp.11.3.361; Bolla KI, 2005, NEUROIMAGE, V26, P480, DOI 10.1016/j.neuroimage.2005.02.012; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; Camus M, 2009, EUR J NEUROSCI, V30, P1980, DOI 10.1111/j.1460-9568.2009.06991.x; Claus ED, 2012, ALCOHOL CLIN EXP RES, V36, P408, DOI 10.1111/j.1530-0277.2011.01694.x; Connolly CG, 2012, DRUG ALCOHOL DEPEN, V121, P45, DOI 10.1016/j.drugalcdep.2011.08.007; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Dietz P, 2013, PHARMACOTHERAPY, V33, P44, DOI 10.1002/phar.1166; Ersche KD, 2005, PSYCHOPHARMACOLOGY, V180, P612, DOI 10.1007/s00213-005-2205-7; Fellows Lesley K, 2004, Behav Cogn Neurosci Rev, V3, P159; Fishbein DH, 2005, COGNITIVE BRAIN RES, V23, P119, DOI 10.1016/j.cogbrainres.2004.12.010; Garavan H, 2008, PHILOS T R SOC B, V363, P3267, DOI 10.1098/rstb.2008.0106; Goldstein RZ, 2009, TRENDS COGN SCI, V13, P372, DOI 10.1016/j.tics.2009.06.004; Goldstein RZ, 2009, P NATL ACAD SCI USA, V106, P9453, DOI 10.1073/pnas.0900491106; Gowin JL, 2014, NEUROPSYCHOPHARMACOL; Gowin JL, 2014, ADDICTION, V109, P237, DOI 10.1111/add.12354; Hall KM, 2005, J AM COLL HEALTH, V53, P167, DOI 10.3200/JACH.53.4.167-174; Harle KM, 2014, J NEUROSCI, V34, P4567, DOI 10.1523/JNEUROSCI.2297-13.2014; Herman-Stahl MA, 2006, J ADOLESCENT HEALTH, V39, P374, DOI 10.1016/j.jadohealth.2006.01.006; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Hyatt CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034917; Kaufman JN, 2003, J NEUROSCI, V23, P7839; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Krain AL, 2006, NEUROIMAGE, V32, P477, DOI 10.1016/j.neuroimage.2006.02.047; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lane SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011591; Lawrence NS, 2009, CEREB CORTEX, V19, P1134, DOI 10.1093/cercor/bhn154; Leland DS, 2005, DRUG ALCOHOL DEPEN, V78, P83, DOI 10.1016/j.drugalcdep.2004.10.001; Levy I, 2010, J NEUROPHYSIOL, V103, P1036, DOI 10.1152/jn.00853.2009; McCabe SE, 2005, ADDICTION, V100, P96, DOI 10.1111/j.1360-0443.2005.00944.x; Meade CS, 2011, PSYCHIAT RES-NEUROIM, V192, P167, DOI 10.1016/j.pscychresns.2010.12.011; Meade CS, 2011, J BEHAV MED, V34, P128, DOI 10.1007/s10865-010-9293-5; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Mohr PNC, 2010, J NEUROSCI, V30, P6613, DOI 10.1523/JNEUROSCI.0003-10.2010; Monterosso J, 2001, ADDICTION, V96, P1825, DOI 10.1046/j.1360-0443.2001.9612182512.x; Monterosso JR, 2007, HUM BRAIN MAPP, V28, P383, DOI 10.1002/hbm.20281; Nestor LJ, 2011, PSYCHIAT RES-NEUROIM, V194, P287, DOI 10.1016/j.pscychresns.2011.04.010; Park SQ, 2011, J NEUROSCI, V31, P9307, DOI 10.1523/JNEUROSCI.4973-10.2011; Pattij T, 2008, EUR J PHARMACOL, V585, P458, DOI 10.1016/j.ejphar.2008.02.099; Paulus MP, 2008, BIOL PSYCHIAT, V63, P1054, DOI 10.1016/j.biopsych.2007.09.007; Paulus MP, 2007, SCIENCE, V318, P602, DOI 10.1126/science.1142997; Paulus MP, 2005, ARCH GEN PSYCHIAT, V62, P761, DOI 10.1001/archpsyc.62.7.761; Paulus MP, 2005, NEUROIMAGE, V25, P607, DOI 10.1016/j.neuroimage.2004.12.055; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Paulus MP, 2003, BIOL PSYCHIAT, V53, P65, DOI 10.1016/S0006-3223(02)01442-7; Paulus MP, 2002, NEUROIMAGE, V15, P836, DOI 10.1006/nimg.2001.1031; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Rao H, 2008, NEUROIMAGE, V42, P902, DOI 10.1016/j.neuroimage.2008.05.046; Reske M, 2011, J PSYCHIATR RES, V45, P361, DOI 10.1016/j.jpsychires.2010.07.005; Reske M, 2010, BIOL PSYCHIAT, V68, P762, DOI 10.1016/j.biopsych.2010.04.021; Rudorf S, 2012, J NEUROSCI, V32, P16683, DOI 10.1523/JNEUROSCI.4235-11.2012; Schonberg T, 2011, TRENDS COGN SCI, V15, P11, DOI 10.1016/j.tics.2010.10.002; Slovic P, 2000, PERCEPTION OF RISK; Smith BW, 2009, NEUROIMAGE, V44, P600, DOI 10.1016/j.neuroimage.2008.08.016; Sobell LC, 1996, DRUG ALCOHOL DEPEN, V42, P49, DOI 10.1016/0376-8716(96)01263-X; Stewart JL, 2013, BIOL PSYCHIAT, V73, P235, DOI 10.1016/j.biopsych.2012.08.018; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanabe J, 2007, HUM BRAIN MAPP, V28, P1276, DOI 10.1002/hbm.20344; Tapert SF, 2002, J INT NEUROPSYCH SOC, V8, P873, DOI 10.1017/S1355617702870011; Teter CJ, 2003, PHARMACOTHERAPY, V23, P609, DOI 10.1592/phco.23.5.609.34187; van der Plas EAA, 2009, J CLIN EXP NEUROPSYC, V31, P706, DOI 10.1080/13803390802484797; Verdejo-Garcia A, 2007, DRUG ALCOHOL DEPEN, V90, P2, DOI 10.1016/j.drugalcdep.2007.02.004; Vorhold V, 2008, ANN NY ACAD SCI, V1128, P41, DOI 10.1196/annals.1399.006; Wagner FA, 2002, NEUROPSYCHOPHARMACOL, V26, P479, DOI 10.1016/S0893-133X(01)00367-0; Ward B. D., 2000, SIMULTANEOUS INTERFE	80	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0127010	10.1371/journal.pone.0127010	http://dx.doi.org/10.1371/journal.pone.0127010			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076493	Green Published, gold			2022-12-27	WOS:000356329900008
J	Chiappini, N; Cantisani, R; Pancotto, L; Ruggiero, P; Rosa, D; Manetti, A; Romano, A; Montagnani, F; Bertholet, S; Castellino, F; Del Giudice, G				Chiappini, Nico; Cantisani, Rocco; Pancotto, Laura; Ruggiero, Paolo; Rosa, Domenico; Manetti, Andrea; Romano, Antonio; Montagnani, Francesca; Bertholet, Sylvie; Castellino, Flora; Del Giudice, Giuseppe			Innate Response Activator (IRA) B Cells Reside in Human Tonsils and Internalize Bacteria In Vitro	PLOS ONE			English	Article							MOUSE B-1 CELLS; MARGINAL ZONE; HUMAN EQUIVALENT; LYMPHOCYTES; ANTIBODY; CD43; PROTEINS; SEPSIS; SUBSET; CD5	Innate response activator (IRA) B cells have been described in mice as a subset of B-1a B cells that produce granulocyte/macrophage colony-stimulating factor (GM-CSF) and have been found in the spleen upon activation. In humans, identification, tissue localization and functionality of these lymphocytes are poorly understood. We hypothesized that IRA B cells could reside in human palatine tonsils, which are a first line of defense from infection of the upper respiratory tract. In the present work, we used flow cytometry and confocal microscopy to identify and characterize human IRA (hIRA) B cells in tonsils. We show that CD19(+)CD20(+)GM-CSF+ B cells are present in the tonsils of all the subjects studied at a frequency ranging between similar to 0.2% and similar to 0.4% of the conventional CD19(+)CD20(+)GM-CSF- B cells. These cells reside within the B cell follicles, are mostly IgM(+)IgD(+), express CD5 and show phagocytic activity. Our results support a role for hIRA B cells in the effector immune response to infections in tonsils.	[Chiappini, Nico; Cantisani, Rocco; Pancotto, Laura; Ruggiero, Paolo; Rosa, Domenico; Manetti, Andrea; Bertholet, Sylvie; Castellino, Flora; Del Giudice, Giuseppe] Novartis Vaccines & Diagnost, Res Ctr, Siena, Italy; [Romano, Antonio] Univ Hosp Le Scotte, Dept Otorhinolaryngol, Siena, Italy; [Montagnani, Francesca] Univ Hosp Le Scotte, Dept Med Biotechnol, Infect Unit, Siena, Italy	Novartis; University of Siena; University Hospital of Siena; University of Siena; University Hospital of Siena	Chiappini, N (corresponding author), Novartis Vaccines & Diagnost, Res Ctr, Via Fiorentina 1, Siena, Italy.	nico.x.chiappini@gsk.com; rocco.x.cantisani@gsk.com	Montagnani, Francesca/R-3334-2016; Cantisani, Rocco/K-2224-2018	Montagnani, Francesca/0000-0002-2267-1337; Cantisani, Rocco/0000-0002-6836-3399	Novartis Vaccines (GSK company)	Novartis Vaccines (GSK company)	Novartis Vaccines (a GSK company) provided support in the form of salaries for authors (NC, RC, LP, PR, DR, AGOM, SB, GDG), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; BURASTERO SE, 1988, J EXP MED, V168, P1979, DOI 10.1084/jem.168.6.1979; CASALI P, 1987, SCIENCE, V236, P77, DOI 10.1126/science.3105056; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; de Araujo TH, 2013, CELL IMMUNOL, V281, P27, DOI 10.1016/j.cellimm.2013.01.002; Descatoire M, 2011, J EXP MED, V208, P2563, DOI 10.1084/jem.20112232; Djoumerska-Alexieva I, 2013, AUTOIMMUN REV, V12, P653, DOI 10.1016/j.autrev.2012.10.010; Garcia-Perez BE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-246; Fuda FS, 2009, AM J CLIN PATHOL, V132, P733, DOI 10.1309/AJCPU5E3NXEKLFIY; Gao JX, 2012, EUR J IMMUNOL, V42, P982, DOI 10.1002/eji.201141519; Griffin DO, 2011, J EXP MED, V208, P2566, DOI 10.1084/jem.20111761; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Hilgendorf I, 2014, CIRCULATION, V129, P1677, DOI 10.1161/CIRCULATIONAHA.113.006381; Horikawa M, 2013, J IMMUNOL, V190, P1158, DOI 10.4049/jimmunol.1201427; Jackson SM, 2008, ADV IMMUNOL, V98, P151, DOI 10.1016/S0065-2776(08)00405-7; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Perez-Andres M, 2011, J EXP MED, V208, P2565, DOI 10.1084/jem.20112203; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Rothstein TL, 2013, ANN NY ACAD SCI, V1285, P97, DOI 10.1111/nyas.12137; Seveau S, 2000, BLOOD, V95, P2462; SHELLEY CS, 1990, BIOCHEM J, V270, P569, DOI 10.1042/bj2700569; Tedder TF, 2015, J IMMUNOL, V194, P1395, DOI 10.4049/jimmunol.1401329; Warren TL, 2000, CURR OPIN HEMATOL, V7, P168, DOI 10.1097/00062752-200005000-00007; Weber GF, 2014, J EXP MED, V211, P1243, DOI 10.1084/jem.20131471; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885	27	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129879	10.1371/journal.pone.0129879	http://dx.doi.org/10.1371/journal.pone.0129879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066485	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000118
J	Poncet, A; Gencer, B; Blondon, M; Gex-Fabry, M; Combescure, C; Shah, D; Schwartz, PJ; Besson, M; Girardin, FR				Poncet, Antoine; Gencer, Baris; Blondon, Marc; Gex-Fabry, Marianne; Combescure, Christophe; Shah, Dipen; Schwartz, Peter J.; Besson, Marie; Girardin, Francois R.			Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							INDUCED LONG QT; DRUG-THERAPY; DE-POINTES; RISK; HEALTH; ANTIPSYCHOTICS; ABNORMALITIES; TORSADE	Importance Sudden cardiac death is a leading cause of mortality in psychiatric patients. Long QT (LQT) is common in this population and predisposes to Torsades-de-Pointes (TdP) and subsequent mortality. Objective To estimate the cost-effectiveness of electrocardiographic screening to detect LQT in psychiatric inpatients. Design, Setting, and Participants We built a decision analytic model based on a decision tree to evaluate the cost-effectiveness and utility of LQT screening from a health care perspective. LQT proportion parameters were derived from an in-hospital cross-sectional study. We performed experts' elicitation to estimate the risk of TdP, given extent of QT prolongation. A TdP reduction of 65% after LQT detection was based on positive drug dechallenge rate and through adequate treatment and electrolyte adjustments. The base-case model uncertainty was assessed with one-way and probabilistic sensitivity analyses. Finally, the TdP related mortality and TdP avoidance parameters were varied in a two-way sensitivity analysis to assess their effect on the Incremental Cost-Effectiveness Ratio (ICER). Main Outcomes and Measures Costs, Quality Ajusted Life Year (QALY), ICER, and probability of cost effectiveness thresholds ($10 000, $25 000, and $50 000 per QALY). Results In the base-case scenario, the numbers of patients needed to screen were 1128 and 2817 to avoid one TdP and one death, respectively. The ICER of systematic ECG screening was $8644 (95%CI, 3144-82 498) per QALY. The probability of cost-effectiveness was 96% at a willingness-to-pay of $ 50 000 for one QALY. In sensitivity analyses, results were sensitive to the case-fatality of TdP episodes and to the TdP reduction following the diagnosis of LQT. Conclusion and Relevance In psychiatric hospitals, performing systematic ECG screening at admission help reduce the number of sudden cardiac deaths in a cost-effective fashion.	[Poncet, Antoine; Combescure, Christophe] Univ Hosp Geneva, Dept Hlth & Community Med, CH-1205 Geneva, Switzerland; [Gencer, Baris; Blondon, Marc; Gex-Fabry, Marianne; Combescure, Christophe; Shah, Dipen; Besson, Marie; Girardin, Francois R.] Univ Geneva, CH-1205 Geneva, Switzerland; [Gencer, Baris; Shah, Dipen] Univ Hosp Geneva, Div Cardiol, CH-1205 Geneva, Switzerland; [Blondon, Marc] Univ Hosp Geneva, Dept Internal Med, CH-1205 Geneva, Switzerland; [Gex-Fabry, Marianne] Univ Hosp Geneva, Dept Psychiat, CH-1205 Geneva, Switzerland; [Schwartz, Peter J.] IRCCS Ist Auxol Italiano, Ctr Cardiac Arrhythmias Genet Origin, Milan, Italy; [Besson, Marie; Girardin, Francois R.] Univ Hosp Geneva, Dept Anesthesiol Intens Care & Clin Pharmacol, CH-1205 Geneva, Switzerland; [Girardin, Francois R.] Univ Hosp Geneva, Med Directorate, CH-1205 Geneva, Switzerland; [Girardin, Francois R.] Univ York, Ctr Hlth Econ, York, N Yorkshire, England	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; IRCCS Istituto Auxologico Italiano; University of Geneva; University of Geneva; University of York - UK	Girardin, FR (corresponding author), Univ Hosp Geneva, Dept Anesthesiol Intens Care & Clin Pharmacol, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland.	francois.girardin@hcuge.ch	poncet, antoine/AAB-9984-2019; Besson, Marie/AAG-3253-2019; Gencer, Baris/AAO-2305-2020; Schwartz, Peter J/J-4267-2016; Girardin, Francois/F-5443-2017; Blondon, Marc/AAE-5464-2019	Schwartz, Peter J/0000-0003-0367-1048; Girardin, Francois/0000-0002-0842-927X; Gencer, Baris/0000-0002-8954-9694	Department of Anesthesiology, Intensive Care, Clinical Pharmacology and Toxicology (University Hospitals of Geneva); Medical Directorate of the University Hospitals of Geneva; Swiss National Science Foundation (SNSF, Inflammation and acute coronary syndromes (ACS) - Novel strategies for prevention and clinical management) [SPUM33C30-140336]; Geneva University Hospital (CRG) [71-225]	Department of Anesthesiology, Intensive Care, Clinical Pharmacology and Toxicology (University Hospitals of Geneva); Medical Directorate of the University Hospitals of Geneva; Swiss National Science Foundation (SNSF, Inflammation and acute coronary syndromes (ACS) - Novel strategies for prevention and clinical management)(Swiss National Science Foundation (SNSF)); Geneva University Hospital (CRG)	The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The Department of Anesthesiology, Intensive Care, Clinical Pharmacology and Toxicology (University Hospitals of Geneva), and the Medical Directorate of the University Hospitals of Geneva supported the economic assessment for safety guidance in psychiatry. BG's research on cardiovascular prevention is supported by a grant from the Swiss National Science Foundation (SNSF SPUM33C30-140336, Inflammation and acute coronary syndromes (ACS) - Novel strategies for prevention and clinical management) and by a grant from the Geneva University Hospital (CRG 71-225) for the development of research projects.	Auer R, 2012, JAMA-J AM MED ASSOC, V307, P1497, DOI 10.1001/jama.2012.434; Behr ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078511; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Chan A, 2007, QJM-INT J MED, V100, P609, DOI 10.1093/qjmed/hcm072; Claxton K, 2011, HEALTH ECON, V20, P2, DOI 10.1002/hec.1612; De Ponti F, 2000, LANCET, V356, P75, DOI 10.1016/S0140-6736(05)73412-7; Girardin FR, 2013, AM J PSYCHIAT, V170, P1468, DOI 10.1176/appi.ajp.2013.12060860; Grigore B, 2013, PHARMACOECONOMICS, V31, P991, DOI 10.1007/s40273-013-0092-z; Hannerz H, 2001, PUBLIC HEALTH, V115, P328; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; Moran PS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009586.pub2; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Quaglini S, 2006, EUR HEART J, V27, P1824, DOI 10.1093/eurheartj/ehl115; Ray WA, 2009, NEW ENGL J MED, V360, P225, DOI 10.1056/NEJMoa0806994; Reilly JG, 2000, LANCET, V355, P1048, DOI 10.1016/S0140-6736(00)02035-3; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; SALLE P, 1985, ANN CARDIOL ANGEIOL, V34, P381; Sarganas G, 2014, EUROPACE, V16, P101, DOI 10.1093/europace/eut214; Saul JP, 2014, HEART RYTHM; Schwartz PJ, 2009, CIRCULATION, V120, P1761, DOI 10.1161/CIRCULATIONAHA.109.863209; Straus SMJM, 2004, ARCH INTERN MED, V164, P1293, DOI 10.1001/archinte.164.12.1293; Straus SMJM, 2005, EUR HEART J, V26, P2007, DOI 10.1093/eurheartj/ehi312; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; TARMED, TARIFF BROWSER VERSI; Watanabe E, 2014, HEART RHYTHM, V11, P1418, DOI 10.1016/j.hrthm.2014.04.036; Weeke P, 2014, CLIN PHARMACOL THER, V96, P490, DOI 10.1038/clpt.2014.139; Weeke P, 2014, J AM COLL CARDIOL, V63, P1430, DOI 10.1016/j.jacc.2014.01.031; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253	28	18	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0127213	10.1371/journal.pone.0127213	http://dx.doi.org/10.1371/journal.pone.0127213			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26070071	Green Submitted, gold, Green Published			2022-12-27	WOS:000356327000006
J	Saumell, S; Sole, F; Arenillas, L; Montoro, J; Valcarcel, D; Pedro, C; Sanzo, C; Luno, E; Gimenez, T; Arnan, M; Pomares, H; De Paz, R; Arrizabalaga, B; Jerez, A; Martinez, AB; Sanchez-Castro, J; Rodriguez-Gambarte, JD; Raya, JM; Rios, E; Rodriguez-Rivera, M; Espinet, B; Florensa, L				Saumell, Silvia; Sole, Francesc; Arenillas, Leonor; Montoro, Julia; Valcarcel, David; Pedro, Carme; Sanzo, Carmen; Luno, Elisa; Gimenez, Teresa; Arnan, Montserrat; Pomares, Helena; De Paz, Raquel; Arrizabalaga, Beatriz; Jerez, Andres; Martinez, Ana B.; Sanchez-Castro, Judith; Rodriguez-Gambarte, Juan D.; Raya, Jose M.; Rios, Eduardo; Rodriguez-Rivera, Maria; Espinet, Blanca; Florensa, Lourdes			Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CELL LINEAGE INVOLVEMENT; ACUTE-LEUKEMIA; MOSAICISM; GROWTH	Isolated trisomy 8 is not considered presumptive evidence of myelodysplastic syndrome (MDS) in cases without minimal morphological criteria. One reason given is that trisomy 8 (+8) can be found as a constitutional mosaicism (cT8M). We tried to clarify the incidence of cT8M in myeloid neoplasms, specifically in MDS, and the diagnostic value of isolated +8 in MDS. Twenty-two MDS and 10 other myeloid neoplasms carrying +8 were studied. Trisomy 8 was determined in peripheral blood by conventional cytogenetics (CC) and on granulocytes, CD3+ lymphocytes and oral mucosa cells by fluorescence in situ hybridization (FISH). In peripheral blood CC, +8 was seen in 4/32 patients. By FISH, only one patient with chronic myelomonocytic leukemia showed +8 in all cell samples and was interpreted as a cT8M. In our series +8 was acquired in all MDS. Probably, once discarded cT8M by FISH from CD3+ lymphocytes and non-hematological cells, +8 should be considered with enough evidence to MDS.	[Saumell, Silvia; Arenillas, Leonor; Rodriguez-Rivera, Maria; Espinet, Blanca; Florensa, Lourdes] Hosp del Mar, Serv Patol, Lab Citol Hematol & Citogenet Mol, Barcelona, Spain; [Saumell, Silvia; Arenillas, Leonor; Pedro, Carme; Rodriguez-Rivera, Maria; Espinet, Blanca; Florensa, Lourdes] Hosp del Mar Med Res Inst IMIM, Canc Res Program, GRETNHE, Barcelona, Spain; [Saumell, Silvia] Univ Autonoma Barcelona, Fac Med, Dept Med, Bellaterra, Spain; [Sole, Francesc] Inst Recerca Leucemia Josep Carreras, Cytogenet Platform, Badalona, Spain; [Montoro, Julia; Valcarcel, David] Hosp Valle De Hebron, Serv Hematol, Barcelona, Spain; [Pedro, Carme] Hosp del Mar, Serv Hematol Clin, Barcelona, Spain; [Sanzo, Carmen; Luno, Elisa] Univ Oviedo, Hosp Cent Asturias, Serv Hematol, E-33080 Oviedo, Spain; [Gimenez, Teresa] Hosp Univ Joan XXIII, Serv Hematol, Tarragona, Spain; [Arnan, Montserrat; Pomares, Helena] Hosp Duran & Reynals, Inst Catala Oncol, Serv Hematol, Lhospitalet Llobregat, Spain; [De Paz, Raquel] Hosp Univ La Paz, Serv Hematol, Madrid, Spain; [Arrizabalaga, Beatriz] Hosp Univ Cruces, Serv Hematol, Baracaldo, Spain; [Jerez, Andres; Martinez, Ana B.] Hosp Morales Meseguer, Serv Hematol, Murcia, Spain; [Sanchez-Castro, Judith] Hosp Arnau Vilanova, Serv Hematol, Lleida, Spain; [Rodriguez-Gambarte, Juan D.] Hosp Univ Ramon & Cajal, Serv Hematol, Madrid, Spain; [Raya, Jose M.] Hosp Univ Canarias, Serv Hematol, San Cristobal la Laguna, Tenerife, Spain; [Rios, Eduardo] Hosp Univ Valme, Sevicio Hematol, Seville, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Institut de Recerca Contra la Leucemia Josep Carreras (IJC); Hospital Universitari Vall d'Hebron; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Central University Hospital Asturias; University of Oviedo; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Hospital Universitario La Paz; Hospital Universitario Cruces; University Hospital Arnau de Vilanova; Hospital Universitario Ramon y Cajal; Universidad de la Laguna; Hospital Valme	Florensa, L (corresponding author), Hosp del Mar, Serv Patol, Lab Citol Hematol & Citogenet Mol, Barcelona, Spain.	lflorensa@parcdesalutmar.cat	valcarcel, david/T-8770-2019; Valcárcel, David/AAE-6584-2019; Jerez, Andrés/AAF-1699-2019; Arenillas, Leonor/ABG-1057-2020; Solé, Francesc/K-8373-2012; Saumell, Silvia/H-6175-2017; MONTORO, JULIA/H-6174-2017	Valcárcel, David/0000-0002-8747-078X; Solé, Francesc/0000-0002-3251-2161; Arenillas, Leonor/0000-0002-8176-7179; Florensa, Lourdes/0000-0001-5906-3311; Espinet, Blanca/0000-0002-4294-8145; Rios Herranz, Eduardo/0000-0002-4072-3911; Saumell, Silvia/0000-0001-8635-4376; MONTORO, JULIA/0000-0001-9532-7417	Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain [FI07/00107, CA08/00141, PI07/1009, PI 11/02010]; Red Tematica de InvestigacionCooperativa en Cancer (RTICC, FEDER) [RD06/0020/0031, RD07/0020/2004, RD12/0036/0044]; Agencia de Gestio d'Ajuts Universitaris i de Recerca", Departament d'Innovacio, Universitats i Empresa [SGR 541/2009]; Accion COST: European Genetic and Epigentic Study on AML and MDS [BM0801]; Sociedad Espanola de Hematologia y Hemoterapia (SEHH)	Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain(Instituto de Salud Carlos III); Red Tematica de InvestigacionCooperativa en Cancer (RTICC, FEDER); Agencia de Gestio d'Ajuts Universitaris i de Recerca", Departament d'Innovacio, Universitats i Empresa; Accion COST: European Genetic and Epigentic Study on AML and MDS; Sociedad Espanola de Hematologia y Hemoterapia (SEHH)	This work was supported by Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain (FI07/00107, CA08/00141; PI07/1009 and PI 11/02010); Red Tematica de InvestigacionCooperativa en Cancer (RTICC, FEDER) (RD06/0020/0031 and RD07/0020/2004; RD12/0036/0044); SGR 541/2009 ("Agencia de Gestio d'Ajuts Universitaris i de Recerca", Departament d'Innovacio, Universitats i Empresa); Accion COST BM0801: European Genetic and Epigentic Study on AML and MDS; Sociedad Espanola de Hematologia y Hemoterapia (SEHH) 2011 and 2012 fellowships.	ANASTASI J, 1993, BLOOD, V81, P1580; Barrett J, 2000, SEMIN HEMATOL, V37, P15; Becker K, 2009, AM J MED GENET A, V149A, P982, DOI 10.1002/ajmg.a.32756; Bernell P, 1996, LEUKEMIA, V10, P662; Brunning RD, 2008, WHO CLASSIFICATION T; Danesino C, 1998, AM J MED GENET, V80, P540, DOI 10.1002/(SICI)1096-8628(19981228)80:5<540::AID-AJMG25>3.0.CO;2-8; FAGIOLI F, 1995, CANCER GENET CYTOGEN, V82, P116, DOI 10.1016/0165-4608(94)00228-4; Ganmore I, 2009, HUM MOL GENET, V18, pR84, DOI 10.1093/hmg/ddp084; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; HASLE H, 1995, CANCER GENET CYTOGEN, V79, P79, DOI 10.1016/0165-4608(94)00099-W; Hastings R, 2012, ECA NEWSLETTER, V30, P11; KIBBELAAR RE, 1992, BLOOD, V79, P1823; Maciejewski JP, 2002, BLOOD, V99, P3129, DOI 10.1182/blood.V99.9.3129; Mallo M, 2013, BRIT J HAEMATOL, V162, P74, DOI 10.1111/bjh.12354; Maserati E, 2002, GENE CHROMOSOME CANC, V33, P93, DOI 10.1002/gcc.1214; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; Ripperger T, 2011, BRIT J HAEMATOL, V155, P209, DOI 10.1111/j.1365-2141.2011.08817.x; Saitoh K, 1998, BLOOD, V92, P2886, DOI 10.1182/blood.V92.8.2886.420k11_2886_2892; Saumell S, 2012, BRIT J HAEMATOL, V159, P311, DOI 10.1111/bjh.12035; Seghezzi L, 1996, GENE CHROMOSOME CANC, V17, P94, DOI 10.1002/(SICI)1098-2264(199610)17:2<94::AID-GCC4>3.0.CO;2-W; Shaffer L.G., 2013, INT SYSTEM HUMAN CYT; Sloand EM, 2005, BLOOD, V106, P841, DOI 10.1182/blood-2004-05-2017; SOENEN V, 1995, BRIT J HAEMATOL, V90, P701, DOI 10.1111/j.1365-2141.1995.tb05604.x; Tefferi A, 2009, NEW ENGL J MED, V361, P1872, DOI 10.1056/NEJMra0902908; Tiu RV, 2011, BLOOD, V117, P4552, DOI 10.1182/blood-2010-07-295857; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	27	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129375	10.1371/journal.pone.0129375	http://dx.doi.org/10.1371/journal.pone.0129375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066831	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000069
J	Chowdhury, N; Sapru, S				Chowdhury, Nilotpal; Sapru, Shantanu			Association of Protein Translation and Extracellular Matrix Gene Sets with Breast Cancer Metastasis: Findings Uncovered on Analysis of Multiple Publicly Available Datasets Using Individual Patient Data Approach	PLOS ONE			English	Article							PROGNOSTIC SIGNATURE; MOLECULAR-MECHANISMS; EXPRESSION PROFILES; IMMUNE-RESPONSE; MICROARRAY DATA; SUBTYPES; IDENTIFICATION; CLASSIFICATION; RESOURCE; ONTOLOGY	Introduction Microarray analysis has revolutionized the role of genomic prognostication in breast cancer. However, most studies are single series studies, and suffer from methodological problems. We sought to use a meta-analytic approach in combining multiple publicly available datasets, while correcting for batch effects, to reach a more robust oncogenomic analysis. Aim The aim of the present study was to find gene sets associated with distant metastasis free survival (DMFS) in systemically untreated, node-negative breast cancer patients, from publicly available genomic microarray datasets. Methods Four microarray series (having 742 patients) were selected after a systematic search and combined. Cox regression for each gene was done for the combined dataset (univariate, as well as multivariate - adjusted for expression of Cell cycle related genes) and for the 4 major molecular subtypes. The centre and microarray batch effects were adjusted by including them as random effects variables. The Cox regression coefficients for each analysis were then ranked and subjected to a Gene Set Enrichment Analysis (GSEA). Results Gene sets representing protein translation were independently negatively associated with metastasis in the Luminal A and Luminal B subtypes, but positively associated with metastasis in Basal tumors. Proteinaceous extracellular matrix (ECM) gene set expression was positively associated with metastasis, after adjustment for expression of cell cycle related genes on the combined dataset. Finally, the positive association of the proliferation-related genes with metastases was confirmed. Conclusion To the best of our knowledge, the results depicting mixed prognostic significance of protein translation in breast cancer subtypes are being reported for the first time. We attribute this to our study combining multiple series and performing a more robust meta-analytic Cox regression modeling on the combined dataset, thus discovering 'hidden' associations. This methodology seems to yield new and interesting results and may be used as a tool to guide new research.	[Chowdhury, Nilotpal] All India Inst Med Sci, Dept Pathol & Lab Med, Rishikesh, Uttarakhand, India; [Sapru, Shantanu] All India Inst Med Sci, Dept Radiotherapy, Rishikesh, Uttarakhand, India	All India Institute of Medical Sciences (AIIMS) Rishikesh; All India Institute of Medical Sciences (AIIMS) Rishikesh	Sapru, S (corresponding author), Dr Ram Manohar Lohia Inst Med Sci, Dept Radiat Oncol, Lucknow, Uttar Pradesh, India.	nilotpal.chowdhury@gmail.com	Chowdhury, Nilotpal/GRJ-3148-2022	Chowdhury, Nilotpal/0000-0002-3178-2039				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Ejeh F, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.14; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Carlson M., HGU133A DB AFFYMETRI; Chanrion M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-39; Chen J, 2010, J BIOMED INFORM, V43, P385, DOI 10.1016/j.jbi.2010.03.009; Cheng WY, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005974; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Darlington RB, 2000, PSYCHOL METHODS, V5, P496, DOI 10.1037/1082-989X.5.4.496; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dressman HK, 2006, CLIN CANCER RES, V12, P819, DOI 10.1158/1078-0432.CCR-05-1447; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gordon AY, 2008, STAT PROBABIL LETT, V78, P1878, DOI 10.1016/j.spl.2008.01.055; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Griffith OL, 2013, GENOME MED, V5, DOI 10.1186/gm496; GSEA Team MSigDB Scientific Advisory Board, 2014, GSEA USER GUIDE; GSEA Team MSigDB Scientific Advisory Board, 2013, GSEA MSIGDB MSIGDB C; Hahne F, 2008, PROCESSING AFFYMETRI, P25; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; Haibe-Kains B, 2013, GENOM DATA, V1, P7, DOI 10.1016/j.gdata.2013.09.001; Haibe-Kains B, 2013, GENEFU RELEVANT FUNC; Hallett RM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00227; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kupfer P, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-23; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Liu JC, 2012, P NATL ACAD SCI USA, V109, P5832, DOI 10.1073/pnas.1201105109; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mulligan JM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt335; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Pusztai L, 2006, ONCOLOGIST, V11, P868, DOI 10.1634/theoncologist.11-8-868; R Core Team, 2014, R A LANGUAGE AND ENV; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; Sabatier R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-86; Sabatier R, 2011, BREAST CANCER RES TR, V126, P407, DOI 10.1007/s10549-010-0897-9; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Staaf J, 2010, J CLIN ONCOL, V28, P1813, DOI 10.1200/JCO.2009.22.8775; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Therneau T, 2012, COXME MIXED EFFECTS; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Woltmann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098229; Yau C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2753	64	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129610	10.1371/journal.pone.0129610	http://dx.doi.org/10.1371/journal.pone.0129610			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080057	Green Submitted, Green Published, gold			2022-12-27	WOS:000356542300027
J	van Breda, F; Emans, ME; van der Putten, K; Braam, B; van Ittersum, FJ; Kraaijenhagen, RJ; de Borst, MH; Vervloet, M; Gaillard, CAJM				van Breda, Fenna; Emans, Mireille E.; van der Putten, Karien; Braam, Branko; van Ittersum, Frans J.; Kraaijenhagen, Rob J.; de Borst, Martin H.; Vervloet, Marc; Gaillard, Carlo A. J. M.			Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; IRON-DEFICIENCY; CARDIOVASCULAR MORTALITY; VASCULAR DYSFUNCTION; PROGNOSTIC MARKER; LARGE COHORT; FGF23; RISK; ANEMIA; FIBROBLAST-GROWTH-FACTOR-23	Objective In chronic kidney disease (CKD), both anemia and deregulated phosphate metabolism are common and predictive of adverse outcome. Previous studies suggest that iron status influences phosphate metabolism by modulating proteolytic cleavage of FGF23 into C-terminal fragments. Red cell distribution width (RDW) was recently identified as a strong prognostic determinant for cardiovascular morbidity and mortality, independently of iron status. We assessed whether RDW is associated with FGF23 cleaving in CKD patients with heart failure. Materials and Methods The associations between RDW and either intact FGF23 (iFGF23), C-terminal FGF23 (cFGF23, reflecting iFGF23 and C-terminal fragments together) and the iFGF23/cFGF23 ratio were analyzed in 52 patients with CKD (eGFR 34,9 +/- 13.9 ml/min/1.73m(2)) and chronic heart failure (CHF). Associations between RDW and FGF23 forms were studied by linear regression analysis adjusted for parameters of renal function, iron metabolism, phosphate metabolism and inflammation. Results Median cFGF23 levels were 197.5 [110-408.5] RU/ml, median iFGF23 levels were 107.3 [65.1-162.2] pg/ml and median FGF23 ratio was 0.80 [0.37-0.86]. Mean RDW was 14.1 +/- 1.2%. cFGF23 and RDW were associated (beta = 1.63x10(-3), P < 0.001), whereas iFGF23 and RDW were not (beta = -1.38x10(-3), P = 0.336). The iFGF23/cFGF23 ratio was inversely associated with RDW. The difference between cFGF23 and iFGF23 (cFGF23-iFGF23) was positively associated with RDW(beta = 1.74x10(-3), P < 0.001). The association between cFGF23 and RDW persisted upon multivariable linear regression analysis, adjusted for parameters of renal function, phosphate metabolism, iron metabolism and inflammation (beta = 0.97x10(-3), P = 0.047). Conclusion RDW is associated with cFGF23 but not with iFGF23 levels in patients with CKD and CHF. This suggests a connection between RDW and FGF23 catabolism, independent of iron status and inflammation. Future studies are needed to unravel underlying mechanisms and whether these pertain to the link between RDW and outcome.	[van Breda, Fenna; van Ittersum, Frans J.; Vervloet, Marc] Vrije Univ Amsterdam Med Ctr, Dept Nephrol, Amsterdam, Netherlands; [van Breda, Fenna; van Ittersum, Frans J.; Vervloet, Marc] Vrije Univ Amsterdam Med Ctr, ICaR VU, Amsterdam, Netherlands; [Emans, Mireille E.] Ikazia Hosp, Dept Cardiol, Rotterdam, Netherlands; [van der Putten, Karien] TerGooi Hosp, Dept Internal Med, Hilversum, Netherlands; [Braam, Branko] Univ Alberta, Dept Med, Div Nephrol & Immunol, Edmonton, AB, Canada; [Kraaijenhagen, Rob J.] Meander Med Ctr, Dept Clin Chem, Amersfoort, Netherlands; [de Borst, Martin H.; Gaillard, Carlo A. J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Ikazia Hospital; University of Alberta; Meander Medisch Centrum; University of Groningen	van Breda, F (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Nephrol, Amsterdam, Netherlands.	g.vanbreda@vumc.nl	Gaillard, Carlo/AAC-6729-2022	Gaillard, Carlo/0000-0002-8964-0236; Vervloet, Marc/0000-0003-4607-9415; De Borst, Martin/0000-0002-4127-8733	dutch heart foundation/Netherlands heart foundation/nederlandse hartstichting [NHS2005B192]	dutch heart foundation/Netherlands heart foundation/nederlandse hartstichting	This work supported by the dutch heart foundation/Netherlands heart foundation/nederlandse hartstichting with grant number: NHS2005B192. There were no conflicts of financial interests.	Allen LA, 2010, J CARD FAIL, V16, P230, DOI 10.1016/j.cardfail.2009.11.003; Baia LC, 2013, CLIN J AM SOC NEPHRO, V8, P1968, DOI 10.2215/CJN.01880213; Bournier M, 2013, J BIOL CHEM, V288, P22670, DOI 10.1074/jbc.M113.482281; Emans ME, 2011, J CARD FAIL, V17, P626, DOI 10.1016/j.cardfail.2011.04.009; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Forhecz Z, 2009, AM HEART J, V158, P659, DOI 10.1016/j.ahj.2009.07.024; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Heijboer AC, 2009, ANN CLIN BIOCHEM, V46, P338, DOI 10.1258/acb.2009.009066; Hsu HJ, 2009, AM J MED SCI, V337, P116, DOI 10.1097/MAJ.0b013e3181815498; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P2792, DOI 10.1093/ndt/gfp191; Lippi G, 2009, ARCH PATHOL LAB MED, V133, P628, DOI 10.1043/1543-2165-133.4.628; Lippi G, 2008, SCAND J CLIN LAB INV, V68, P745, DOI 10.1080/00365510802213550; Mendoza FA, 2012, CLIN J AM SOC NEPHRO, V7, P1155, DOI 10.2215/CJN.13281211; Mirza MAI, 2011, ARTERIOSCL THROM VAS, V31, P219, DOI 10.1161/ATVBAHA.110.214619; Mirza MAI, 2009, ATHEROSCLEROSIS, V205, P385, DOI 10.1016/j.atherosclerosis.2009.01.001; Oh HJ, 2012, NEPHROL DIAL TRANSPL, V27, P589, DOI 10.1093/ndt/gfr307; Pascual-Figal DA, 2009, EUR J HEART FAIL, V11, P840, DOI 10.1093/eurjhf/hfp109; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp163; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Scrutinio D, 2011, EUR J HEART FAIL, V13, P61, DOI 10.1093/eurjhf/hfq167; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Smith GL, 2006, J AM COLL CARDIOL, V47, P1987, DOI 10.1016/j.jacc.2005.11.084; Tonelli M, 2008, CIRCULATION, V117, P163, DOI 10.1161/CIRCULATIONAHA.107.727545; van der Putten K, 2010, J NEPHROL, V23, P363; Vervloet MG, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-20; Wish JB, 2006, CLIN J AM SOC NEPHRO, V1, pS4, DOI 10.2215/CJN.01490506; Wolf M, 2014, CURR OPIN NEPHROL HY, V23, P411, DOI 10.1097/01.mnh.0000447020.74593.6f; Wolf M, 2013, J BONE MINER RES, V28, P1793, DOI 10.1002/jbmr.1923; Wolf M, 2012, KIDNEY INT, V82, P737, DOI 10.1038/ki.2012.176; Yilmaz MI, 2010, KIDNEY INT, V78, P679, DOI 10.1038/ki.2010.194; Yilmaz MI, 2013, AM J NEPHROL, V37, P126, DOI 10.1159/000346711; Zoccali C, 2013, BLOOD PURIFICAT, V36, P52, DOI 10.1159/000351001	37	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0128994	10.1371/journal.pone.0128994	http://dx.doi.org/10.1371/journal.pone.0128994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079688	gold, Green Published, Green Submitted			2022-12-27	WOS:000356542300012
J	Andrianavalona, TH; Ramihangihajason, TN; Rasoamiaramanana, A; Ward, DJ; Ali, JR; Samonds, KE				Andrianavalona, Tsiory H.; Ramihangihajason, Tolotra N.; Rasoamiaramanana, Armand; Ward, David J.; Ali, Jason R.; Samonds, Karen E.			Miocene Shark and Batoid Fauna from Nosy Makamby (Mahajanga Basin, Northwestern Madagascar)	PLOS ONE			English	Article							VERTEBRATE FAUNA; MAHAKAMBY; ISLAND; FISH	Madagascar is well known for producing exceptional fossils. However, the record for selachians remains relatively poorly known. Paleontological reconnaissance on the island of Nosy Makamby, off northwest Madagascar, has produced a previously undescribed assemblage of Miocene fossils. Based on isolated teeth, ten taxonomic groups are identified: Otodus, Carcharhinus, Galeocerdo, Rhizoprionodon, Sphyrna, Hemipristis, Squatina, Rostroraja, Himantura and Myliobatidae. Six are newly described from Madagascar for the Cenozoic (Galeocerdo, Rhizoprionodon, Sphyrna, Squatina, Rostroraja and Himantura). In association with these specimens, remains of both invertebrates (e.g., corals, gastropods, bivalves) and vertebrates (e.g., bony fish, turtles, crocodylians, and sirenianmammals) were also recovered. The sedimentary facies are highly suggestive of a near-shore/coastal plain depositional environment. This faunal association shares similarities to contemporaneous sites reported from North America and Europe and gives a glimpse into the paleoenvironment of Madagascar's Miocene, suggesting that this region was warm, tropical shallow-water marine.	[Andrianavalona, Tsiory H.; Ramihangihajason, Tolotra N.; Rasoamiaramanana, Armand] Fac Sci, Dept Paleontol & Anthropol Biol, Antananarivo, Madagascar; [Ward, David J.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Ali, Jason R.] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China; [Samonds, Karen E.] No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA	Natural History Museum London; University of Hong Kong; Northern Illinois University	Andrianavalona, TH (corresponding author), Fac Sci, Dept Paleontol & Anthropol Biol, Univ Antananarivo 101, Antananarivo, Madagascar.	tsioryandrianavalona@gmail.com	Samonds, Karen/AAL-1766-2021	Ali, Jason Richard/0000-0002-5214-620X; Samonds, Karen/0000-0003-3597-9215	University of Queensland; Northern Illinois University	University of Queensland(University of Queensland); Northern Illinois University	National Geographic supported fieldwork in 2010 and 2013; in 2011 it was funded by the University of Queensland, and in 2014 by Northern Illinois University.	Adnet S, 2010, GEOL MAG, V147, P860, DOI 10.1017/S0016756810000348; Ali JR, 2010, NATURE, V463, P653, DOI 10.1038/nature08706; Ameghino F., 1901, ANALES SOC CIENTIFIC, V51, P65; Ameghino F., 1901, ANALES SOC CIENTIFIC, V51, P65; Argyriou T, 2015, J AFR EARTH SCI, V102, P86, DOI 10.1016/j.jafrearsci.2014.11.008; Besairie H., 1972, GEOLOGIE MADAGASCAR, VI; Bor Taco, 2012, Palaeontos, V21, P1; Cappetta H., 2012, HDB PALAEOICHTHYOLOG; Cappetta Henri, 2006, Rivista Piemontese di Storia Naturale, V27, P33; Charbonnier S, 2012, GEODIVERSITAS, V34, P873, DOI 10.5252/g2012n4a9; COLLIGNON M., 1927, ANN PALEONTOL, V16, P135; Cooke A., 2003, P179; Dartevelle E., 1943, ANN MUSEE CONGO BE A, V2, P1; Dartevelle E., 1959, ANN MUSEE CONGO BELG, V2, P257; Goodman SM, 2003, NATURAL HIST MADAGAS; Gottfried MD, 2001, CRETACEOUS RES, V22, P491, DOI 10.1006/cres.2001.0269; JONET S, 1968, Revista da Faculdade de Ciencias Universidade de Lisboa Serie C Ciencias Naturais, V15, P233; Kent B. W., 1994, FOSSIL SHARKS CHESAP; Melluso L, 2009, J GEOL SOC LONDON, V166, P283, DOI 10.1144/0016-76492007-147; Mualler A., 1999, LEIPZEGER GEOWISSENS, V9-10, P1; Pickford M, 2008, S AFR J SCI, V104, P231; Priem F, 1914, B SOC GEOLOGIQUE FRA, V14, P118; Priem F, 1907, COM SERV GEOL PORTUG, V7, P74; Priem MF, 1907, B SOC GEOL FR, V4, P462; Purdy RW, 2001, SM C PALEOB, V90, P71; Rabarison JA, 1996, CONTRIBUTION ETUDE D; Ramihangihajason TN, 2014, J AFR EARTH SCI, V100, P409, DOI 10.1016/j.jafrearsci.2014.07.013; Rathbone J, 2011, CREATE SPACE INDEPEN, V236, P26; Reinecke Thomas, 2011, Palaeontos, V20, P1; Sahni A., 1981, BIOL MEMOIRS, V5, P83; Samonds K, 2007, J VERTEBR PALEONTOL, V27, p139A; Samonds Karen, 2002, Journal of Vertebrate Paleontology, V22, p102A; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; Samonds KE, MIDDLE EOCENE NEOSEL; Sharma KM, 2010, CURR SCI INDIA, V99, P804; THOMSON K S, 1982, Postilla, P1; Underwood CJ, 2011, P GEOLOGIST ASSOC, V122, P47, DOI 10.1016/j.pgeola.2010.09.004; Ward David J., 2001, Central Mediterranean Naturalist, V3, P131; Ward DJ, 1983, ZOOLOGICAL J LINNEAN, V82, P245	39	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129444	10.1371/journal.pone.0129444	http://dx.doi.org/10.1371/journal.pone.0129444			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075723	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900074
J	Cheng, XJ; Gao, Y; Zhao, YW; Cheng, XD				Cheng, Xiao-Juan; Gao, Yuan; Zhao, Yu-Wu; Cheng, Xiao-Dong			Sodium Chloride Increases A beta Levels by Suppressing A beta Clearance in Cultured Cells	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; BLOOD-PRESSURE; INDUCTION; STRESS; BRAIN	Recent studies suggest that high-salt diet is associated with cognitive decline in human and mouse. The fact that genetic factors account for less than 50% cases of sporadic Alzheimer's disease (AD) highlights the important contribution of environmental factors, such as high-salt diet, in AD pathogenesis. However, whether and how high-salt diet fits the "amyloid cascade" hypothesis remains unexplored. Here, we show sodium chloride (NaCl) could increase A beta levels in the medium of HEK293 cells overexpressing amyloid precursor protein (APP) or C99 fragment. NaCl treatment dose not affect APP level, gamma secretase level or activity. Instead, NaCl treatment suppresses the capacity of cells to clear A beta and reduces Apolipoprotein E (ApoE) level. Finally, NaCl treated THP-1 or BV2 cells are inefficient in clearing A beta when co-cultured with rat primary neurons. Our study suggests that high-salt diet may increase AD risk by directly modulating A beta levels.	[Cheng, Xiao-Juan; Zhao, Yu-Wu] Shanghai Jiao Tong Univ, Dept Neurol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Gao, Yuan] Shanghai Jiao Tong Univ, Sch Med, Dept Neurol, Shanghai 200030, Peoples R China; [Gao, Yuan] Shanghai Jiao Tong Univ, Sch Med, Inst Neurol, Rui Jin Hosp, Shanghai 200030, Peoples R China; [Gao, Yuan] Kunming Univ Sci & Technol, Dept Neurol, Peoples Hosp Yunnan Prov 1, Kunming, Peoples R China; [Cheng, Xiao-Dong] Tongji Univ, Sch Life Sci & Technol, East Hosp, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Kunming University of Science & Technology; Tongji University	Zhao, YW (corresponding author), Shanghai Jiao Tong Univ, Dept Neurol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China.	zhaoyuwu2005@126.com; xctj92@163.com						Afsar B, 2013, HIGH BLOOD PRESS CAR, V20, P19, DOI 10.1007/s40292-013-0002-7; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fiocco AJ, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.004; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jellinger KA, 2007, J NEUROL SCI, V257, P80, DOI 10.1016/j.jns.2007.01.045; Kilander L, 1998, HYPERTENSION, V31, P780, DOI 10.1161/01.HYP.31.3.780; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Liu YZ, 2014, NEUROBIOL LEARN MEM, V114, P10, DOI 10.1016/j.nlm.2014.04.010; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Rondanelli M, 1998, PANMINERVA MED, V40, P191; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; Stalder AK, 2005, J NEUROSCI, V25, P11125, DOI 10.1523/JNEUROSCI.2545-05.2005; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Zhao LZ, 2009, J NEUROSCI, V29, P3603, DOI 10.1523/JNEUROSCI.5302-08.2009	21	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130432	10.1371/journal.pone.0130432	http://dx.doi.org/10.1371/journal.pone.0130432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075716	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900173
J	Kean, TJ; Dennis, JE				Kean, Thomas J.; Dennis, James E.			Synoviocyte Derived-Extracellular Matrix Enhances Human Articular Chondrocyte Proliferation and Maintains Re-Differentiation Capacity at Both Low and Atmospheric Oxygen Tensions	PLOS ONE			English	Article							TERM-FOLLOW-UP; IN-VITRO; GENE-EXPRESSION; CULTURE-SYSTEM; II COLLAGEN; STEM-CELLS; OSTEOARTHRITIC CHONDROCYTES; HYALINE CARTILAGE; HYPOXIA PROMOTES; PROGENITOR CELLS	Background Current tissue engineering methods are insufficient for total joint resurfacing, and chondrocytes undergo de-differentiation when expanded on tissue culture plastic. De-differentiated chondrocytes show poor re-differentiation in culture, giving reduced glycosaminoglycan (GAG) and collagen matrix accumulation. To address this, porcine synoviocyte-derived extracellular matrix and low (5%) oxygen tension were assessed for their ability to enhance human articular chondrocyte expansion and maintain re-differentiation potential. Methods Porcine synoviocyte matrices were devitalized using 3 non-detergent methods. These devitalized synoviocyte matrices were compared against tissue culture plastic for their ability to support human chondrocyte expansion. Expansion was further compared at both low (5%), and atmospheric (20%) oxygen tension on all surfaces. Expanded cells then underwent chondrogenic re-differentiation in aggregate culture at both low and atmospheric oxygen tension. Aggregates were assessed for their GAG and collagen content both biochemically and histologically. Results Human chondrocytes expanded twice as fast on devitalized synoviocyte matrix vs. tissue culture plastic, and cells retained their re-differentiation capacity for twice the number of population doublings. There was no significant difference in growth rate between low and atmospheric oxygen tension. There was significantly less collagen type I, collagen type II, aggrecan and more MMP13 expression in cells expanded on synoviocyte matrix vs. tissue culture plastic. There were also significant effects due to oxygen tension on gene expression, wherein there was greater collagen type I, collagen type II, SOX9 and less MMP13 expression on tissue culture plastic compared to synoviocyte matrix. There was a significant increase in GAG, but not collagen, accumulation in chondrocyte aggregates re-differentiated at low oxygen tension over that achieved in atmospheric oxygen conditions. Conclusions Synoviocyte-derived matrix supports enhanced expansion of human chondrocytes such that the chondrocytes are maintained in a state from which they can re-differentiate into a cartilage phenotype after significantly more population doublings. Also, low oxygen tension supports GAG, but not collagen, accumulation. These findings are a step towards the production of a more functional, tissue engineered cartilage.	[Kean, Thomas J.; Dennis, James E.] Case Western Reserve Univ, Dept Orthopaed, Cleveland, OH 44106 USA; [Kean, Thomas J.; Dennis, James E.] Benaroya Res Inst Virginia Mason, Matrix Biol Program, Seattle, WA USA; [Kean, Thomas J.; Dennis, James E.] Baylor Coll Med, Orthoped Surg, Houston, TX 77030 USA	Case Western Reserve University; Benaroya Research Institute; Virginia Mason Medical Center; Baylor College of Medicine	Kean, TJ (corresponding author), Baylor Coll Med, Orthoped Surg, Houston, TX 77030 USA.	thomas.kean@bcm.edu	Kean, Thomas/AAI-8010-2021	Kean, Thomas/0000-0001-6844-3404	National Institutes of Health [AR053622, DE015322]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR053622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding was provided through National Institutes of Health (www.nih.gov) grants AR053622 (National Institute of Arthritis and Musculoskeletal and Skin Diseases) and DE015322 (National Institute of Dental & Craniofacial Research) to JED. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 2003, MATRIX BIOL, V22, P363, DOI 10.1016/S0945-053X(03)00049-0; Albrecht C, 2011, OSTEOARTHR CARTILAGE, V19, P1219, DOI 10.1016/j.joca.2011.07.004; Androjna C, 2008, TISSUE ENG PT A, V14, P559, DOI 10.1089/tea.2006.0361; Babur BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058865; BASSETT CA, 1961, NATURE, V190, P460, DOI 10.1038/190460a0; Beekhuizen M, 2011, ARTHRITIS RHEUM-US, V63, P1918, DOI 10.1002/art.30364; Beris AE, 2012, AM J SPORT MED, V40, P562, DOI 10.1177/0363546511428778; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CARRINO DA, 1991, BIOCHEM INT, V24, P485; Cebotari S, 2010, ARTIF ORGANS, V34, P206, DOI 10.1111/j.1525-1594.2009.00796.x; Collins JA, 2013, OSTEOARTHR CARTILAGE, V21, P1790, DOI 10.1016/j.joca.2013.06.028; Coyle CH, 2009, J ORTHOP RES, V27, P793, DOI 10.1002/jor.20816; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Dare EV, 2009, TISSUE ENG PT A, V15, P2285, DOI 10.1089/ten.tea.2008.0228; Das RHJ, 2010, J ORTHOP RES, V28, P537, DOI 10.1002/jor.20994; Dell'Accio F, 2001, ARTHRITIS RHEUM-US, V44, P1608, DOI 10.1002/1529-0131(200107)44:7<1608::AID-ART284>3.0.CO;2-T; Duval E, 2012, BIOMATERIALS, V33, P6042, DOI 10.1016/j.biomaterials.2012.04.061; Duval E, 2009, ARTHRITIS RHEUM-US, V60, P3038, DOI 10.1002/art.24851; Egli RJ, 2008, J ORTHOP RES, V26, P977, DOI 10.1002/jor.20603; Foldager CB, 2011, ACTA ORTHOP, V82, P234, DOI 10.3109/17453674.2011.566135; Gawlitta D, 2012, TISSUE ENG PT A, V18, P1957, DOI [10.1089/ten.tea.2011.0657, 10.1089/ten.TEA.2011.0657]; Gikas PD, 2009, J BONE JOINT SURG BR, V91B, P997, DOI 10.1302/0301-620X.91B8.21824; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Giovannini S, 2010, J CELL PHYSIOL, V222, P411, DOI 10.1002/jcp.21965; Grunder T, 2004, OSTEOARTHR CARTILAGE, V12, P559, DOI 10.1016/j.joca.2004.04.001; Gudas R, 2005, ARTHROSCOPY, V21, P1066, DOI 10.1016/j.arthro.2005.06.018; Ham KD, 2004, OSTEOARTHR CARTILAGE, V12, P160, DOI 10.1016/j.joca.2003.08.002; Hayes AJ, 2008, J HISTOCHEM CYTOCHEM, V56, P125, DOI 10.1369/jhc.7A7320.2007; He F, 2009, TISSUE ENG PT A, V15, P3809, DOI [10.1089/ten.tea.2009.0188, 10.1089/ten.TEA.2009.0188]; Hellingman CA, 2012, J TISSUE ENG REGEN M, V6, pe1, DOI 10.1002/term.502; Henderson JH, 2010, TISSUE ENG PT A, V16, P1585, DOI [10.1089/ten.tea.2009.0411, 10.1089/ten.TEA.2009.0411]; Hunter WVI, 1743, PHILOS T R SOC LOND, V42, P514, DOI [10.1098/rstl.1742.0079, DOI 10.1098/RSTL.1742.0079)]; Ignat'eva NY, 2007, J ANAL CHEM+, V62, P51, DOI 10.1134/S106193480701011X; Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1; Kon E, 2013, BONE JOINT RES, V2, P18, DOI 10.1302/2046-3758.22.2000092; Legendre F, 2013, TISSUE ENG PART C-ME, V19, P550, DOI [10.1089/ten.tec.2012.0508, 10.1089/ten.TEC.2012.0508]; Lennon Donald P., 1996, In Vitro Cellular and Developmental Biology Animal, V32, P602, DOI 10.1007/BF02724045; Lin Z, 2008, J ORTHOP RES, V26, P1230, DOI 10.1002/jor.20523; Ma B, 2013, OSTEOARTHR CARTILAGE, V21, P599, DOI 10.1016/j.joca.2013.01.014; Malda J, 2004, OSTEOARTHR CARTILAGE, V12, P306, DOI 10.1016/j.joca.2003.12.001; Malda J, 2003, CRIT REV BIOTECHNOL, V23, P175, DOI 10.1080/714037688; Markway BD, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4272; Murphy CL, 2004, J CELL PHYSIOL, V199, P451, DOI 10.1002/jcp.10481; Pei M, 2012, J CELL PHYSIOL, V227, P2163, DOI 10.1002/jcp.22950; Pei M, 2011, TISSUE ENG PT A, V17, P3067, DOI [10.1089/ten.TEA.2011.0158, 10.1089/ten.tea.2011.0158]; Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915; Qu CJ, 2012, CELL TISSUE RES, V348, P109, DOI 10.1007/s00441-012-1366-z; Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482; Schrobback K, 2012, CELL TISSUE RES, V347, P649, DOI 10.1007/s00441-011-1193-7; Shahdadfar A, 2008, TISSUE ENG PT A, V14, P1999, DOI 10.1089/ten.tea.2007.0344; Shekkeris A, 2012, J BONE JOINT SUR S36, V94-B, P12; Steinhagen J, 2010, TISSUE CELL, V42, P151, DOI 10.1016/j.tice.2010.03.003; Strobel S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2942; Thoms BL, 2013, ARTHRITIS RHEUM-US, V65, P1302, DOI 10.1002/art.37867; Thoms BL, 2010, J BIOL CHEM, V285, P20472, DOI 10.1074/jbc.M110.115238; van Osch GJVM, 2002, BIORHEOLOGY, V39, P215; Whitney GA, 2012, BIORESEARCH OPEN ACC, V1, P157, DOI 10.1089/biores.2012.0231; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Yang KGA, 2006, TISSUE ENG, V12, P2435, DOI 10.1089/ten.2006.12.2435	62	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129961	10.1371/journal.pone.0129961	http://dx.doi.org/10.1371/journal.pone.0129961			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075742	Green Submitted, gold, Green Published			2022-12-27	WOS:000356329900119
J	Li, YD; Wang, YD; Zhai, ZG; Guo, XJ; Yang, YH; Lu, XZ				Li, Yidan; Wang, Yidan; Zhai, Zhenguo; Guo, Xiaojuan; Yang, Yuanhua; Lu, Xiuzhang			Real-Time Three-Dimensional Echocardiography to Assess Right Ventricle Function in Patients with Pulmonary Hypertension	PLOS ONE			English	Article							HEART; VALIDATION; VOLUMES; ADULTS; MRI	Background The convenience and availability of real-time three-dimensional echocardiography (RT3DE) makes it an attractive candidate for assessing right ventricle function. However, the viability of RT3DE is not conclusive. Aim of Study This study aims to evaluate RT3DE relative to cardiac magnetic resonance and 2-dimensional echocardiography (2DE) for measuring right ventricular systolic function in patients with pulmonary hypertension. Methods Patients with pulmonary hypertension (n = 23) underwent cardiac magnetic resonance, 2DE, and RT3DE. Specifically, 2DE was used to measure the right ventricular index of myocardial performance (RIMP), fractional area change, tricuspid annular plane systolic excursion (TAPSE), and tissue Doppler-derived tricuspid annular systolic velocity (S'). Cardiac magnetic resonance and RT3DE were used to measure right ventricular end-diastolic volume (RVEDV) and end-systolic volume (RVESV). The right ventricular ejection fraction (RVEF) was calculated. Results Regarding the measurements taken by 2DE, RVEF positively correlated with fractional area change (r = 0.595, P = 0.003) and S'(r = 0.489, P = 0.018), and negatively correlated with RIMP (r = -0.745, P = 0.000). There was no association between RVEF and TAPSE (r = -0.029, P = 0.896). There existed a close correlation between the values of RVEDV, RVESV, and RVEF as measured by RT3DE and CMR respectively (P<0.001); Bland-Altmanan analyses showed good agreement between them. Conclusion RT3DE was a viable method for noninvasive, accurate assessment of right ventricular systolic function in patients with pulmonary hypertension.	[Li, Yidan; Wang, Yidan; Lu, Xiuzhang] Capital Med Univ, Beijing Chao Yang Hosp, Dept Echocardiog, Ctr Heart, Beijing 100020, Peoples R China; [Zhai, Zhenguo; Yang, Yuanhua] Capital Med Univ, Beijing Chao Yang Hosp, Dept Resp Med, Beijing 100020, Peoples R China; [Zhai, Zhenguo; Yang, Yuanhua] Capital Med Univ, Beijing Key Lab Resp & Pulm Circulat, Beijing Inst Resp Med, Beijing 100020, Peoples R China; [Guo, Xiaojuan] Capital Med Univ, Beijing Chao Yang Hosp, Dept Radiol, Beijing 100020, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Li, YD (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Echocardiog, Ctr Heart, Beijing 100020, Peoples R China.	chaoyanglxz@163.com	Zhai, Zhen/GYA-1598-2022		National Natural Science Foundation of China [81401420]; Fund of Beijing excellent talent training Plan [2013D003034000012]; Fund of clinical application of capital project [Z141107002514074]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of Beijing excellent talent training Plan; Fund of clinical application of capital project	This study was supported by the National Natural Science Foundation of China (Grant No. 81401420); the Fund of Beijing excellent talent training Plan (Grant No. 2013D003034000012), and Fund of clinical application of capital project (Grant No. Z141107002514074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell A, 2014, EUR HEART J-CARD IMG, V15, P257, DOI 10.1093/ehjci/jet145; Bradlow WM, 2010, J MAGN RESON IMAGING, V31, P117, DOI 10.1002/jmri.22011; Di Bello V, 2013, ECHOCARDIOGR-J CARD, V30, P820, DOI 10.1111/echo.12137; Hsiao SH, 2006, J AM SOC ECHOCARDIOG, V19, P902, DOI 10.1016/j.echo.2006.01.014; Inami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094587; Kind T, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-35; Krishnamurthy R, 2010, J MAGN RESON IMAGING, V31, P872, DOI 10.1002/jmri.22123; Lang RM, 2012, J AM SOC ECHOCARDIOG, V25, P3, DOI 10.1016/j.echo.2011.11.010; Malenfant S, 2013, PULM CIRC, V3, P278, DOI 10.4103/2045-8932.114752; Morcos P, 2009, INT J CARDIOVAS IMAG, V25, P263, DOI 10.1007/s10554-008-9387-0; Ostenfeld E, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-1; Pulver AF, 2009, PACE, V32, P450, DOI 10.1111/j.1540-8159.2009.02304.x; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sasaki T, 2011, CIRC-CARDIOVASC IMAG, V4, P662, DOI 10.1161/CIRCIMAGING.111.965764; Smith JL, 2003, INT J CARDIOVAS IMAG, V19, P189, DOI 10.1023/A:1023655705807; Sugeng L, 2010, JACC-CARDIOVASC IMAG, V3, P10, DOI 10.1016/j.jcmg.2009.09.017; van der Zwaan HB, 2010, J AM SOC ECHOCARDIOG, V23, P134, DOI 10.1016/j.echo.2009.12.001; Zheng MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058494	18	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129557	10.1371/journal.pone.0129557	http://dx.doi.org/10.1371/journal.pone.0129557			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075788	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900083
J	Wang, YN; Yang, CH; Gu, QQ; Sims, M; Gu, WW; Pfeffer, LM; Yue, JM				Wang, Yinan; Yang, Chuanhe; Gu, Qingqing; Sims, Michelle; Gu, Weiwang; Pfeffer, Lawrence M.; Yue, Junming			KLF4 Promotes Angiogenesis by Activating VEGF Signaling in Human Retinal Microvascular Endothelial Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; KRUPPEL-LIKE FACTOR-2; GROWTH-FACTOR; DIABETIC-RETINOPATHY; MEDIATED ANGIOGENESIS; CANCER; NEOVASCULARIZATION; PATHWAY; PROLIFERATION; METASTASIS	The transcription factor Kruppel-like factor 4 (KLF4) has been implicated in regulating cell proliferation, migration and differentiation in a variety of human cells and is one of four factors required for the induction of pluripotent stem cell reprogramming. However, its role has not been addressed in ocular neovascular diseases. This study investigated the role of KLF4 in angiogenesis and underlying molecular mechanisms in human retinal microvascular endothelial cells (HRMECs). The functional role of KLF4 in HRMECs was determined following lentiviral vector mediated inducible expression and shRNA knockdown of KLF4. Inducible expression of KLF4 promotes cell proliferation, migration and tube formation. In contrast, silencing KLF4 inhibits cell proliferation, migration, tube formation and induces apoptosis in HRMECs. KLF4 promotes angiogenesis by transcriptionally activating VEGF expression, thus activating the VEGF signaling pathway in HRMECs.	[Wang, Yinan; Yang, Chuanhe; Gu, Qingqing; Sims, Michelle; Pfeffer, Lawrence M.; Yue, Junming] Univ Tennessee, Dept Pathol & Lab Med, Hlth Sci Ctr, Memphis, TN USA; [Wang, Yinan; Yang, Chuanhe; Gu, Qingqing; Sims, Michelle; Pfeffer, Lawrence M.; Yue, Junming] Univ Tennessee, Ctr Canc Res, Hlth Sci Ctr, Memphis, TN USA; [Wang, Yinan; Gu, Weiwang] Southern Med Univ, Dept Lab Anim Ctr, Guangzhou, Guangdong, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Southern Medical University - China	Gu, WW (corresponding author), Southern Med Univ, Dept Lab Anim Ctr, Guangzhou, Guangdong, Peoples R China.	guww100@163.com; jyue@uthsc.eduf		Pfeffer, Lawrence/0000-0003-2809-1234	NIH [HL095957]; UTHSC startup and West Cancer Center; Chinese Government [2011DFA33290]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL095957] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UTHSC startup and West Cancer Center; Chinese Government; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from NIH (HL095957), UTHSC startup and West Cancer Center to JY and Chinese Government (2011DFA33290) to WG.	[Anonymous], 2007, DRUG THER B, V45, P49; Barot M, 2013, FUTURE MED CHEM, V5, P301, DOI [10.4155/fmc.12.206, 10.4155/FMC.12.206]; Bertolino P, 2005, CHEST, V128, p585S, DOI 10.1378/chest.128.6_suppl.585S; Bhattacharya R, 2005, J BIOL CHEM, V280, P28848, DOI 10.1074/jbc.C500200200; Boon RA, 2011, EUR HEART J, V32, P371, DOI 10.1093/eurheartj/ehq137; Browning AC, 2012, BRIT J OPHTHALMOL, V96, P128, DOI 10.1136/bjophthalmol-2011-300572; Chen ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105331; Chiplunkar AR, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-40; Cleaver N, 2013, J DRUGS DERMATOL, V12, P1052; Das A, 2006, J BIOL CHEM, V281, P39105, DOI 10.1074/jbc.M607720200; Fantozzi A, 2014, CANCER RES, V74, P1566, DOI 10.1158/0008-5472.CAN-13-1641; Gambrelle J, 2013, J FR OPHTALMOL, V36, P431, DOI 10.1016/j.jfo.2012.11.005; Hale AT, 2014, J BIOL CHEM, V289, P12016, DOI 10.1074/jbc.M113.530956; Helbing T, 2010, CARDIOVASC RES, V85, P551, DOI 10.1093/cvr/cvp314; Huang TS, 2014, J CELL MOL MED, V18, P1358, DOI 10.1111/jcmm.12300; Jang Jung Hyun, 2012, Korean J Ophthalmol, V26, P478, DOI 10.3341/kjo.2012.26.6.478; Lin ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043593; List AF, 2001, ONCOLOGIST, V6, P24, DOI 10.1634/theoncologist.6-suppl_5-24; Liu YN, 2012, MOL CELL BIOL, V32, P941, DOI 10.1128/MCB.06306-11; Maeshima Y, 2001, J BIOL CHEM, V276, P15240, DOI 10.1074/jbc.M007764200; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; Nagai R, 2005, J THROMB HAEMOST, V3, P1569, DOI 10.1111/j.1538-7836.2005.01366.x; Pei JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081109; Ptaszynska MM, 2010, MOL CANCER RES, V8, P309, DOI 10.1158/1541-7786.MCR-09-0288; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Shibuya M, 2006, ENDOTHELIUM-J ENDOTH, V13, P63, DOI 10.1080/10623320600697955; Shibuya M, 2014, BIOMOL THER, V22, P1, DOI 10.4062/biomolther.2013.113; Shiozaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038049; Spilsbury K, 2000, AM J PATHOL, V157, P135, DOI 10.1016/S0002-9440(10)64525-7; Villarreal G, 2010, BIOCHEM BIOPH RES CO, V391, P984, DOI 10.1016/j.bbrc.2009.12.002; Wara AK, 2011, BLOOD, V118, P6450, DOI 10.1182/blood-2011-06-363713; Yagi H, 2008, MOL CANCER THER, V7, P3441, DOI 10.1158/1535-7163.MCT-08-0417; Yang DHA, 2013, INT J BIOCHEM CELL B, V45, P419, DOI 10.1016/j.biocel.2012.11.007; Yang WZ, 2013, EXP EYE RES, V115, P96, DOI 10.1016/j.exer.2013.06.011; Yang Y, 2013, MOL CELL ENDOCRINOL, V378, P46, DOI 10.1016/j.mce.2013.04.021; Yang ZH, 2014, AM J PATHOL, V184, P1230, DOI 10.1016/j.ajpath.2013.12.023; Yori JL, 2011, NEOPLASIA, V13, P601, DOI 10.1593/neo.11260; Yue JM, 2010, BIOCHEM BIOPH RES CO, V394, P667, DOI 10.1016/j.bbrc.2010.03.047; Zheng XM, 2013, BIOCHEM BIOPH RES CO, V437, P625, DOI 10.1016/j.bbrc.2013.07.017	39	34	34	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130341	10.1371/journal.pone.0130341	http://dx.doi.org/10.1371/journal.pone.0130341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075898	gold, Green Submitted, Green Published			2022-12-27	WOS:000356329900165
J	Chan, KF; Alter, L; Barthold, SW; Parveen, N				Chan, Kamfai; Alter, Laura; Barthold, Stephen W.; Parveen, Nikhat			Disruption of bbe02 by Insertion of a Luciferase Gene Increases Transformation Efficiency of Borrelia burgdorferi and Allows Live Imaging in Lyme Disease Susceptible C3H Mice	PLOS ONE			English	Article							BINDING PROTEIN; PLASMID CONTENT; LIGHT-EMISSION; INFECTIVITY; SPIROCHETE; MICROBIOTA; EXPRESSION; KINETICS; IMPACT; BIOLUMINESCENCE	Lyme disease is the most prevalent tick-borne disease in North America and Europe. The causative agent, Borrelia burgdorferi persists in the white-footed mouse. Infection with B. burgdorferi can cause acute to persistent multisystemic Lyme disease in humans. Some disease manifestations are also exhibited in the mouse model of Lyme disease. Genetic manipulation of B. burgdorferi remains difficult. First, B. burgdorferi contains a large number of endogenous plasmids with unique sequences encoding unknown functions. The presence of these plasmids needs to be confirmed after each genetic manipulation. Second, the restriction modification defense systems, including that encoded by bbe02 gene lead to low transformation efficiency in B. burgdorferi. Therefore, studying the molecular basis of Lyme pathogenesis is a challenge. Furthermore, investigation of the role of a specific B. burgdorferi protein throughout infection requires a large number of mice, making it labor intensive and expensive. To overcome the problems associated with low transformation efficiency and to reduce the number of mice needed for experiments, we disrupted the bbe02 gene of a highly infectious and pathogenic B. burgdorferi strain, N40 D10/E9 through insertion of a firefly luciferase gene. The bbe02 mutant shows higher transformation efficiency and maintains luciferase activity throughout infection as detected by live imaging of mice. Infectivity and pathogenesis of this mutant were comparable to the wild-type N40 strain. This mutant will serve as an ideal parental strain to examine the roles of various B. burgdorferi proteins in Lyme pathogenesis in the mouse model in the future.	[Chan, Kamfai; Alter, Laura; Parveen, Nikhat] Rutgers State Univ, New Jersey Med Sch, Dept Mol Genet Biochem & Microbiol, Newark, NJ 07103 USA; [Barthold, Stephen W.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of California System; University of California Davis	Parveen, N (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Mol Genet Biochem & Microbiol, Newark, NJ 07103 USA.	Parveeni@njms.rutgers.edu		Parveen, Nikhat/0000-0003-0592-0693	National Institutes of Health [AI089921]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by AI089921 grant to NP from National Institutes of Health.	BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARTHOLD SW, 1992, AM J TROP MED HYG, V47, P605, DOI 10.4269/ajtmh.1992.47.605; BARTHOLD SW, 1990, J INFECT DIS, V162, P133, DOI 10.1093/infdis/162.1.133; BARTHOLD SW, 1991, AM J PATHOL, V139, P263; Blevins JS, 2007, APPL ENVIRON MICROB, V73, P1501, DOI 10.1128/AEM.02454-06; Blumenthal RM, 2002, MODERN MICROBIAL GEN, P177, DOI [10.1002/047122197X.ch7, DOI 10.1002/047122197X.CH7]; Brisson D, 2012, ANNU REV GENET, V46, P515, DOI 10.1146/annurev-genet-011112-112140; Bunikis I, 2011, J MICROBIOL METH, V86, P243, DOI 10.1016/j.mimet.2011.05.004; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Casjens SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033280; Casjens SR, 2010, BORRELIA MOLECULAR B, P550; Chan KF, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-157; Chan KF, 2012, INFECT IMMUN, V80, P1519, DOI 10.1128/IAI.06326-11; Chen Q, 2008, J BACTERIOL, V190, P7885, DOI 10.1128/JB.00324-08; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Foucault ML, 2010, APPL ENVIRON MICROB, V76, P264, DOI 10.1128/AEM.01686-09; Frank KL, 2003, J BACTERIOL, V185, P6723, DOI 10.1128/JB.185.22.6723-6727.2003; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gilbert MA, 2007, MOL MICROBIOL, V63, P1259, DOI 10.1111/j.1365-2958.2007.05593.x; Graham J, 2011, PEDIATR EMERG CARE, V27, P141, DOI [10.1097/PEC.0b013e318209f0b3, 10.1097/01.PEC.0000394507.43840.f1]; Greer LF, 2002, LUMINESCENCE, V17, P43, DOI 10.1002/bio.676; Hakkila K, 2002, ANAL BIOCHEM, V301, P235, DOI 10.1006/abio.2001.5517; Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x; Hyde JA, 2011, MOL MICROBIOL, V82, P99, DOI 10.1111/j.1365-2958.2011.07801.x; Iyer R, 2001, J CLIN MICROBIOL, V39, P2954, DOI 10.1128/JCM.39.8.2954-2957.2001; Jacobs MB, 2006, INFECT IMMUN, V74, P3678, DOI 10.1128/IAI.00043-06; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; Karp M, 1999, BIOMOL ENG, V16, P101, DOI 10.1016/S1050-3862(99)00039-X; Kawabata H, 2004, INFECT IMMUN, V72, P7147, DOI 10.1128/IAI.72.12.7147-7154.2004; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; Kurittu J, 2000, J FOOD PROTECT, V63, P953, DOI 10.4315/0362-028X-63.7.953; Labandeira-Rey M, 2003, INFECT IMMUN, V71, P4608, DOI 10.1128/IAI.71.8.4608-4613.2003; Lawrenz MB, 2002, INFECT IMMUN, V70, P4798, DOI 10.1128/IAI.70.9.4798-4804.2002; Lin T, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00063; Lin T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047532; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; MEIGHEN EA, 1993, FASEB J, V7, P1016, DOI 10.1096/fasebj.7.11.8370470; MEIGHEN EA, 1993, ADV MICROB PHYSIOL, V34, P1, DOI 10.1016/S0065-2911(08)60027-2; Moriarty TJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000090; Norman MU, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000169; Noverr MC, 2005, CLIN EXP ALLERGY, V35, P1511, DOI 10.1111/j.1365-2222.2005.02379.x; Ogden NH, 2011, APPL ENVIRON MICROB, V77, P3244, DOI 10.1128/AEM.02636-10; Parveen N, 2006, INFECT IMMUN, V74, P3016, DOI 10.1128/IAI.74.5.3016-3020.2006; Parveen N, 2000, MOL MICROBIOL, V35, P1220, DOI 10.1046/j.1365-2958.2000.01792.x; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Rego ROM, 2011, J BACTERIOL, V193, P1161, DOI 10.1128/JB.01176-10; Rizzoli A., 2011, EUROSURVEILLANCE, V16; Rosa PA, 2010, BORRELIA MOL BIOL HO, P550; Russell SL, 2013, GUT MICROBES, V4, P158, DOI 10.4161/gmic.23567; Saidac DS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-43; Samuels D S, 1995, Methods Mol Biol, V47, P253; SAMUELS DS, 1994, J BACTERIOL, V176, P6045, DOI 10.1128/jb.176.19.6045-6049.1994; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Shaw DK, 2012, MOL MICROBIOL, V83, P319, DOI 10.1111/j.1365-2958.2011.07932.x; STEERE AC, 1983, ANN INTERN MED, V99, P76, DOI 10.7326/0003-4819-99-1-76; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Thompson JF, 1997, J BIOL CHEM, V272, P18766, DOI 10.1074/jbc.272.30.18766; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Wang DC, 2003, MOL MICROBIOL, V47, P1407, DOI 10.1046/j.1365-2958.2003.03386.x; Wang G, 2001, INFECT IMMUN, V69, P4303, DOI 10.1128/IAI.69.7.4303-4312.2001; Wiles S, 2009, METHODS MOL BIOL, V574, P137, DOI 10.1007/978-1-60327-321-3_12	64	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129532	10.1371/journal.pone.0129532	http://dx.doi.org/10.1371/journal.pone.0129532			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069970	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000086
J	Cioffi, MD; Bertollo, LAC; Villa, MA; de Oliveira, EA; Tanomtong, A; Yano, CF; Supiwong, W; Chaveerach, A				Cioffi, Marcelo de Bello; Carlos Bertollo, Luiz Antonio; Villa, Mateo Andres; de Oliveira, Ezequiel Aguiar; Tanomtong, Alongklod; Yano, Cassia Fernanda; Supiwong, Weerayuth; Chaveerach, Arunrat			Genomic Organization of Repetitive DNA Elements and Its Implications for the Chromosomal Evolution of Channid Fishes (Actinopterygii, Perciformes)	PLOS ONE			English	Article							HOPLIAS-MALABARICUS; ERYTHRINIDAE FISH; SNAKEHEAD FISH; SPECIATION; DIFFERENTIATION; REARRANGEMENTS; CHARACIFORMES; EVENTS; PISCES	Channid fishes, commonly referred to as "snakeheads", are currently very important in Asian fishery and aquaculture due to the substantial decline in natural populations because of overexploitation. A large degree of chromosomal variation has been found in this family, mainly through the use of conventional cytogenetic investigations. In this study, we analyzed the karyotype structure and the distribution of 7 repetitive DNA sequences in several Channa species from different Thailand river basins. The aim of this study was to investigate the chromosomal differentiation among species and populations to improve upon the knowledge of its biodiversity and evolutionary history. Rearrangements, such as pericentric inversions, fusions and polyploidization, appear to be important events during the karyotypic evolution of this genus, resulting in the chromosomal diversity observed among the distinct species and even among populations of the same species. In addition, such variability is also increased by the genomic dynamism of repetitive elements, particularly by the differential distribution and accumulation of rDNA sequences on chromosomes. This marked diversity is likely linked to the lifestyle of the snakehead fishes and their population fragmentation, as already identified for other fish species. The karyotypic features highlight the biodiversity of the channid fishes and justify a taxonomic revision of the genus Channa, as well as of the Channidae family as a whole, as some nominal species may actually constitute species complexes.	[Cioffi, Marcelo de Bello; Carlos Bertollo, Luiz Antonio; de Oliveira, Ezequiel Aguiar; Yano, Cassia Fernanda] Univ Fed Sao Carlos, Dept Genet & Evolucao, Sao Paulo, Brazil; [Villa, Mateo Andres] Univ Georgia, Franklin Coll Arts & Sci, Athens, GA 30602 USA; [Tanomtong, Alongklod; Chaveerach, Arunrat] Khon Kaen Univ, Dept Biol, Fac Sci, Khon Kaen, Thailand; [Supiwong, Weerayuth] Khon Kaen Univ, Fac Engn & Appl Sci, Muang 43000, Nong Kai, Thailand; [Chaveerach, Arunrat] Khon Kaen Univ, Genet & Environm Toxicol Res Grp, Khon Kaen, Thailand	Universidade Federal de Sao Carlos; University System of Georgia; University of Georgia; Khon Kaen University; Khon Kaen University; Khon Kaen University	Chaveerach, A (corresponding author), Khon Kaen Univ, Dept Biol, Fac Sci, Khon Kaen, Thailand.	raccha@kku.ac.th	Supiwong, Weerayuth/ABA-4309-2020; Cioffi, Marcelo/AFK-6402-2022; de Oliveira, Ezequiel Aguiar/D-4925-2018; Cioffi, Marcelo/AAG-4675-2022; Tanomtong, Alongklod/ABA-4321-2020; Chaveerach, Arunrat/C-1364-2009	Cioffi, Marcelo/0000-0003-4340-1464; de Oliveira, Ezequiel Aguiar/0000-0002-8264-8884; Cioffi, Marcelo/0000-0003-4340-1464; Tanomtong, Alongklod/0000-0002-8466-3594; Yano, Cassia Fernanda/0000-0002-8118-2867; Chaveerach, Arunrat/0000-0002-7466-4243	Genetics and Environmental Toxicology Research Group (Khon Kaen University); Brazilian agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	Genetics and Environmental Toxicology Research Group (Khon Kaen University); Brazilian agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financially supported by the Genetics and Environmental Toxicology Research Group (Khon Kaen University) and by the Brazilian agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson EAS, 2010, MOL PHYLOGENET EVOL, V56, P707, DOI 10.1016/j.ympev.2010.03.027; [Anonymous], 2007, FRESHWATER FISH DIST; [Anonymous], 1990, GUIDE FRESHWATER FIS; BERTOLLO L A C, 1978, Revista Brasileira de Genetica, V1, P103; Bertollo LAC, 2000, CHROMOSOME RES, V8, P603, DOI 10.1023/A:1009233907558; Bertollo Luiz Antonio Carlos, 2007, P195; Brum M.J.I., 1997, J COMP BIOL, V2, P91; Butlin RK, 2005, MOL ECOL, V14, P2621, DOI 10.1111/j.1365-294X.2005.02617.x; Cioffi MB, 2012, GENOME DYNAM, V7, P197, DOI 10.1159/000337950; Cioffi MB, 2011, CYTOGENET GENOME RES, V132, P188, DOI 10.1159/000321571; Cioffi MB, 2009, CYTOGENET GENOME RES, V125, P132, DOI 10.1159/000227838; Cioffi MB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-271; David P, 2009, PLANT PHYSIOL, V151, P1048, DOI 10.1104/pp.109.142109; Dimitri P, 1997, P NATL ACAD SCI USA, V94, P8052, DOI 10.1073/pnas.94.15.8052; Donsakul T, 1991, FS DEP BIOL WICH MAG; Faria R, 2010, TRENDS ECOL EVOL, V25, P660, DOI 10.1016/j.tree.2010.07.008; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Karr J.R., 1975, P258; Kejnovsky E, 2009, HEREDITY, V102, P533, DOI 10.1038/hdy.2009.17; Kubat Z, 2008, GENOME, V51, P350, DOI 10.1139/G08-024; Kumar R, 2013, CARYOLOGIA, V66, P109, DOI 10.1080/00087114.2013.821829; Leggatt RA, 2003, REV FISH BIOL FISHER, V13, P237, DOI 10.1023/B:RFBF.0000033049.00668.fe; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; LIM JK, 1994, BIOESSAYS, V16, P269, DOI 10.1002/bies.950160410; Lima PA, 2014, CYTOGENET GENOME RES, V142, P197, DOI 10.1159/000360492; Ma XF, 2005, CYTOGENET GENOME RES, V109, P236, DOI 10.1159/000082406; Martins C, 2006, GENETICA, V127, P133, DOI 10.1007/s10709-005-2674-y; Martins NF, 2013, REV FISH BIOL FISHER, V23, P261, DOI 10.1007/s11160-012-9292-4; Matsunaga S, 2009, HEREDITY, V102, P525, DOI 10.1038/hdy.2009.36; Molina Wagner Franco, 2007, P69; Molina WF, 2002, CARYOLOGIA, V55, P299, DOI 10.1080/00087114.2002.10797880; Musikasinthorn P, 2001, ICHTHYOL RES, V48, P319, DOI 10.1007/s10228-001-8153-2; Naorem S, 2006, CARYOLOGIA, V59, P235, DOI 10.1080/00087114.2006.10797920; Near TJ, 2004, EVOLUTION, V58, P2798; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Poltronieri J, 2014, CYTOGENET GENOME RES, V142, P40, DOI 10.1159/000355908; Rahman AKA, 1989, FRESHWATERFISHES BAN; Rainboth WJ, 1996, TAXONOMY SYSTEMATICS; Raskina O, 2008, CYTOGENET GENOME RES, V120, P351, DOI 10.1159/000121084; RISHI KK, 1990, CARYOLOGIA, V43, P163, DOI 10.1080/00087114.1990.10796995; Sayer MDJ, 2005, FISH FISH, V6, P186, DOI 10.1111/j.1467-2979.2005.00193.x; SCHWARZACHER T, 1989, ANN BOT-LONDON, V64, P315, DOI 10.1093/oxfordjournals.aob.a087847; Singh M, 2013, MOL BIOL REP, V40, P723, DOI 10.1007/s11033-012-2112-z; Supiwong W, 2009, CYTOLOGIA, V74, P317, DOI 10.1508/cytologia.74.317; Symonova R, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-42; Tanomtong A, 2014, CYTOLOGIA, V79, P15, DOI 10.1508/cytologia.79.15; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Wainwright P.C., 1994, ECOLOGICAL MORPHOLOG; Xu DD, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-12; Yano CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090946	51	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130199	10.1371/journal.pone.0130199	http://dx.doi.org/10.1371/journal.pone.0130199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067030	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000148
J	Kerubo, G; Khamadi, S; Okoth, V; Madise, N; Ezeh, A; Abdalla, Z; Mwau, M				Kerubo, Glennah; Khamadi, Samoel; Okoth, Vincent; Madise, Nyovani; Ezeh, Alex; Abdalla, Ziraba; Mwau, Matilu			Hepatitis B, Hepatitis C and HIV-1 Coinfection in Two Informal Urban Settlements in Nairobi, Kenya	PLOS ONE			English	Article							INFECTED PATIENTS; VIRUS-INFECTIONS; PREVALENCE; RISK; METAANALYSIS; AFRICA; COHORT	Background HIV-1 and Hepatitis B and C viruses coinfection is common in Sub-Saharan Africa due to similar routes of transmission and high levels of poverty. Most studies on HIV-1 and Hepatitis B and C viruses have occurred in hospital settings and blood transfusion units. Data on Hepatitis B and C viruses and HIV-1 coinfection in informal urban settlements in Kenya are scanty, yet they could partly explain the disproportionately high morbidity and mortality associated with HIV-1 infections in these slums. Objectives The objective of this study was to determine the prevalence of HIV and Hepatitis B and C dual infection in urban slums in Nairobi. Methods Blood samples were collected from residents of Viwandani and Korogocho between 2006 and 2007. A structured questionnaire was used to obtain socio-demographic data from participants. Samples were screened for Hepatitis B surface antigen (HBsAg), anti-HCV and anti-HIV-1. Statistical analysis was done using STATA. Results Samples were successfully collected from 418 (32%) men and 890 (68%) females. The HIV-1, HBV and HCV prevalence was 20.4%, 13.3% and 0.76% respectively at the time of the study. Of the 268 (20.4%) HIV-1 positive participants, 56 (4.26%) had HBV while 6 (0.46%) had HCV. Of the 1041 HIV-1 negative participants, 117 (8.9%) had HBV while 4 (0.31%) had HCV. Only two people (0.15%) were co-infected with all the three viruses together. Discussion The odds of getting hepatitis infection were higher in HIV-1 participants (for HBV OR 2.08, p<0.005 and for HCV OR 5.93, p<0.005). HIV prevalence rates were similar in both informal settlements. HIV infection was highest in age group 35-39 years and among the divorced/separated or widowed. Prevalence of all viruses was highest in those who did not have any formal education. Conclusion The HIV prevalence in these informal settlements suggests a higher rate than what is observed nationally. The prevalence rates of HBV are significantly higher in the HIV-1 positive and negative populations. HCV as well as triple HIV-1, HBV and HCV coinfection are uncommon in Korogocho and Viwandani. This clearly indicates the need for HIV-1 control programmes and hepatitis B virus vaccination to be promoted through public awareness as preventive strategy.	[Kerubo, Glennah] Jomo Kenyatta Univ Agr & Technol, Inst Trop Med & Infect Dis, Nairobi, Kenya; [Khamadi, Samoel; Okoth, Vincent] Kenya Govt Med Res Ctr, Ctr Virus Res, Nairobi, Kenya; [Mwau, Matilu] Kenya Govt Med Res Ctr, Ctr Infect & Parasit Dis Control Res, Busia, Kenya; [Madise, Nyovani; Ezeh, Alex; Abdalla, Ziraba] African Populat Hlth Res Ctr, Nairobi, Kenya	Jomo Kenyatta University of Agriculture & Technology; Kenya Medical Research Institute; Kenya Medical Research Institute; African Population & Health Research Centre	Kerubo, G (corresponding author), Jomo Kenyatta Univ Agr & Technol, Inst Trop Med & Infect Dis, Nairobi, Kenya.	glenakerubo@gmail.com	Khamadi, Samoel Ashimosi/GXZ-6071-2022; Ezeh, Alex/AAN-8646-2020	Ezeh, Alex/0000-0002-1309-4697; Ziraba, Abdhalah/0000-0002-3417-6536; Madise, Nyovani/0000-0002-2813-5295	African Population Health Research Centre	African Population Health Research Centre	This work was supported by the African Population Health Research Centre, www.aphrc.org, in the design purchase of the laboratory requirements (to MM). The funders played a role in data collection and analysis, decision to publish and preparation of the manuscript.	Apurva A., 2007, AIDS REV, V9, P25; Ashraf H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-208; Barth RE, 2010, INT J INFECT DIS, V14, pE1024, DOI 10.1016/j.ijid.2010.06.013; Bigogo G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-376; Chen JJ, 2011, HEPATOB PANCREAT DIS, V10, P122, DOI 10.1016/S1499-3872(11)60020-9; Daw MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098793; Ezegbudo C., 2004, SHIRAZ E MED J, V5, P122; Goni BW, 2013, NIGER J CLIN PRACT, V16, P530, DOI 10.4103/1119-3077.116908; Harania R., 2008, 4 INT WORKSH HIV 1 H; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Hyams C., J MED VIROLOGY, V28; Jobarteh M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-230; Kabiru CW, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-685; Kapembwa KC, 2011, J GLOB INFECT DIS, V3, P269, DOI 10.4103/0974-777X.83534; Karoney MJ, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.44.2199; Lodenyo H, 2000, E AFR MED J, V77, P13; Madise NJ, 2012, HEALTH PLACE, V18, P1144, DOI 10.1016/j.healthplace.2012.04.003; Mboto CI, 2010, BRIT J BIOMED SCI, V67, P140, DOI 10.1080/09674845.2010.11730311; McKinnon LR, 2014, SEX TRANSM INFECT, V90, P237, DOI 10.1136/sextrans-2013-051310; Moore E, 2010, J INFECTION, V61, P155, DOI 10.1016/j.jinf.2010.04.009; Muasya T, 2008, East Afr Med J, V85, P318; Mwangi J., 1999, E AFR MED J, V76, P135; Otedo A E O, 2004, East Afr Med J, V81, P626; Otegbayo JA, 2008, ANN HEPATOL, V7, P152, DOI 10.1016/S1665-2681(19)31872-1; Rouet F, 2004, J MED VIROL, V74, P34, DOI 10.1002/jmv.20143; Rusine J, 2013, PLOS ONE, V8; Shimelis T, 2007, SEX TRANSM INFECT, V84, P37, DOI 10.1136/sti.2007.027326; Sims OT, 2015, SOCIAL WORK PUBLIC H, P1, DOI [10.1080/19371918.2014.938388, DOI 10.1080/19371918.2014.938388]; Singal AK, 2009, WORLD J GASTROENTERO, V15, P3713, DOI 10.3748/wjg.15.3713; Sy Theodore, 2006, Int J Med Sci, V3, P41; Taiwo Modupe B, 2012, PAN AFRICAN MED J; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; Zoufaly A, 2012, INT J STD AIDS, V23, P435, DOI 10.1258/ijsa.2011.011279	33	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129247	10.1371/journal.pone.0129247	http://dx.doi.org/10.1371/journal.pone.0129247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068212	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000058
J	Kuehne, BT; Estrella, JC; Nunes, LH; de Oliveira, EM; Nakamura, LH; Ferreira, CHG; Santana, RHC; Reiff-Marganiec, S; Santana, MJ				Kuehne, Bruno Tardiole; Estrella, Julio Cezar; Nunes, Luiz Henrique; de Oliveira, Edvard Martins; Nakamura, Luis Hideo; Gomes Ferreira, Carlos Henrique; Carlucci Santana, Regina Helena; Reiff-Marganiec, Stephan; Santana, Marcos Jose			AWSCS-A System to Evaluate Different Approaches for the Automatic Composition and Execution of Web Services Flows	PLOS ONE			English	Article								This paper proposes a system named AWSCS (Automatic Web Service Composition System) to evaluate different approaches for automatic composition of Web services, based on QoS parameters that are measured at execution time. The AWSCS is a system to implement different approaches for automatic composition of Web services and also to execute the resulting flows from these approaches. Aiming at demonstrating the results of this paper, a scenario was developed, where empirical flows were built to demonstrate the operation of AWSCS, since algorithms for automatic composition are not readily available to test. The results allow us to study the behaviour of running composite Web services, when flows with the same functionality but different problem-solving strategies were compared. Furthermore, we observed that the influence of the load applied on the running system as the type of load submitted to the system is an important factor to define which approach for the Web service composition can achieve the best performance in production.	[Kuehne, Bruno Tardiole] Univ Fed Itajuba, IESTI, Itajuba, MG, Brazil; [Estrella, Julio Cezar; Nunes, Luiz Henrique; de Oliveira, Edvard Martins; Nakamura, Luis Hideo; Gomes Ferreira, Carlos Henrique; Carlucci Santana, Regina Helena; Santana, Marcos Jose] Univ Sao Paulo, ICMC, Sao Carlos, SP, Brazil; [Reiff-Marganiec, Stephan] Univ Leicester, Dept Comp Sci, Leicester, Leics, England	Universidade Federal de Itajuba; Universidade de Sao Paulo; University of Leicester	Kuehne, BT (corresponding author), Univ Fed Itajuba, IESTI, Itajuba, MG, Brazil.	brunokuehne@unifei.edu.br	Oliveira, Edvard/V-3716-2019; Estrella, Julio Cezar/AAP-4484-2020; Ferreira, Carlos Henrique Gomes/AAF-7938-2020	Oliveira, Edvard/0000-0002-2842-2155; Estrella, Julio Cezar/0000-0003-0524-3274; Reiff-Marganiec, Stephan/0000-0001-6456-7063; tardiole kuehne, bruno/0000-0003-2529-225X	Coordination of Improvement of Personal Higher Education (CAPES); National Council for Scientific and Technological Development (CNPq); Sao Paulo Research Fundation (FAPESP) [processes 11/095247, processes 13/26420-6, processes 09/16055-3]	Coordination of Improvement of Personal Higher Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Fundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Coordination of Improvement of Personal Higher Education (CAPES), National Council for Scientific and Technological Development (CNPq), and Sao Paulo Research Fundation (FAPESP), processes 11/095247, 13/26420-6, 09/16055-3.	Cardellini V, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON WEB SERVICES, PROCEEDINGS, P743; De Paoli F, 2006, LECT NOTES COMPUT SC, V4294, P153; Dustdar S., 2005, International Journal of Web and Grid Services, V1, P1, DOI 10.1504/IJWGS.2005.007545; Estrella J. C., 2011, WSARCH ARCHITECTURE; Gronmo R, 2005, LECT NOTES COMPUT SC, V3543, P68; Hatzi O, 2012, IEEE T SERV COMPUT, V5, P319, DOI 10.1109/TSC.2011.20; He YX, 2008, 2008 IEEE ASIA-PACIFIC SERVICES COMPUTING CONFERENCE, VOLS 1-3, PROCEEDINGS, P476, DOI 10.1109/APSCC.2008.104; Jain R, 1990, ART COMPUTER SYSTEMS; Jing S., 2010, P 6 INT C NETW COMP, P1; Jordan Diane, 2007, 11 OASIS, V11, P11; Klusch M, 2010, OWL S SERVICE RETRIE; Lecue F, 2011, IEEE T KNOWL DATA EN, V23, P942, DOI 10.1109/TKDE.2010.237; Li WJ, 2008, INT CONF BIOMED, P648, DOI 10.1109/BMEI.2008.278; Lu JG, 2007, LECT NOTES COMPUT SC, V4831, P523; Milanovic N, 2004, IEEE INTERNET COMPUT, V8, P51, DOI 10.1109/MIC.2004.58; Nunes LH, 2014, 2014 IEEE 21ST INTERNATIONAL CONFERENCE ON WEB SERVICES (ICWS 2014), P606, DOI 10.1109/ICWS.2014.90; Oliveira EM, 2014, INT CONF NETW SER, P37, DOI 10.1109/CNSM.2014.7014139; Paolucci M, 2002, LECT NOTES COMPUT SC, V2342, P333; Pop CB, 2010, LECT NOTES COMPUT SC, V6162, P1; Prazeres CVS, 2009, ECOWS'09: PROCEEDINGS OF THE 7TH IEEE EUROPEAN CONFERENCE ON WEB SERVICES, P58, DOI 10.1109/ECOWS.2009.25; Puttonen J, 2013, IEEE T IND INFORM, V9, P2349, DOI 10.1109/TII.2012.2220554; Rao JH, 2005, LECT NOTES COMPUT SC, V3387, P43; Shen Lin-feng, 2010, Proceedings 2010 International Conference on Service Sciences (ICSS 2010), P180, DOI 10.1109/ICSS.2010.65; Song Juan, 2012, Proceedings of the 2012 IEEE 3rd International Conference on Software Engineering and Service Science (ICSESS), P501, DOI 10.1109/ICSESS.2012.6269514; Taher L, 2005, NEXT GEN WEB SERV PR, P6; Wei DP, 2011, J WEB SEMANT, V9, P402, DOI 10.1016/j.websem.2011.08.001; Xianwen Fang, 2010, Proceedings 2010 International Conference on Web Information Systems and Mining (WISM 2010), P113, DOI 10.1109/WISM.2010.49; Yichao Yang, 2012, 2012 IEEE 12th International Conference on Computer and Information Technology (CIT), P147, DOI 10.1109/CIT.2012.52; Yu HQ, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON SERVICES COMPUTING, P419, DOI 10.1109/SCC.2009.25; Yu Y, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P1740; Zeng Zhi-Hao, 2008, 2008 IEEE International Workshop on Semantic Computing and Systems (WSCS 2008), P95, DOI 10.1109/WSCS.2008.18; Zou GB, 2014, IEEE T SERV COMPUT, V7, P2, DOI 10.1109/TSC.2012.27	32	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0127677	10.1371/journal.pone.0127677	http://dx.doi.org/10.1371/journal.pone.0127677			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068216	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000010
J	Ma, XW; Fu, YN; Xiao, H; Song, Y; Chen, RF; Shen, J; An, XB; Shen, Q; Li, ZJ; Zhang, YY				Ma, Xiaowei; Fu, Yongnan; Xiao, Han; Song, Yao; Chen, Ruifei; Shen, Jing; An, Xiangbo; Shen, Qiang; Li, Zijian; Zhang, Youyi			Cardiac Fibrosis Alleviated by Exercise Training Is AMPK-Dependent	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; LEFT-VENTRICULAR HYPERTROPHY; VEIN ENDOTHELIAL-CELLS; KAPPA-B ACTIVATION; OXIDATIVE STRESS; HEART-FAILURE; NAD(P)H OXIDASE; SKELETAL-MUSCLE; UP-REGULATION; EXPRESSION	Regular exercise can protect the heart against external stimuli, but the mechanism is not well understood. We determined the role of adenosine monophosphate-activated protein kinase (AMPK) in regulating swimming exercise-mediated cardiac protection against beta-adrenergic receptor overstimulation with isoproterenol (ISO) in mice. Ten-week-old AMPK alpha 2(+/+) and AMPK alpha 2-knockout (AMPK alpha 2(-/-)) littermates were subjected to 4 weeks of swimming training (50 min daily, 6 days a week) or housed under sedentary conditions. The mice received daily subcutaneous injection of ISO (5 mg/kg/d), a nonselective beta-adrenergic receptor agonist, during the last 2 weeks of swimming training. Swimming training alleviated ISO-induced cardiac fibrosis in AMPK alpha 2(+/+) mice but not AMPK alpha 2(-/-) mice. Swimming training activated cardiac AMPK in AMPK alpha 2(+/+) mice. Furthermore, swimming training attenuated ISO-induced production of reactive oxygen species (ROS) and expression of NADPH oxidase and promoted the expression of antioxidant enzymes in AMPK alpha 2(+/+) mice but not AMPK alpha 2(-/-) mice. In conclusion, swimming training attenuates ISO-induced cardiac fibrosis by inhibiting the NADPH oxidase-ROS pathway mediated by AMPK activation. Our findings provide a new mechanism for the cardioprotective effects of exercise.	[Ma, Xiaowei; Fu, Yongnan; Xiao, Han; Song, Yao; Chen, Ruifei; Shen, Jing; An, Xiangbo; Shen, Qiang; Li, Zijian; Zhang, Youyi] Peking Univ, Hosp 3, Inst Vasc Med,Minist Hlth,Minist Educ, Key Lab Mol Cardiovasc Sci,Key Lab Cardiovasc Mol, Beijing 100871, Peoples R China; [Ma, Xiaowei; Fu, Yongnan; Xiao, Han; Song, Yao; Chen, Ruifei; Shen, Jing; An, Xiangbo; Shen, Qiang; Li, Zijian; Zhang, Youyi] Beijing Key Lab Cardiovasc Receptors Res, Beijing, Peoples R China; [Fu, Yongnan] Nanchang Univ, Affiliated Hosp 1, Nanchang, Peoples R China	Peking University; Nanchang University	Zhang, YY (corresponding author), Peking Univ, Hosp 3, Inst Vasc Med,Minist Hlth,Minist Educ, Key Lab Mol Cardiovasc Sci,Key Lab Cardiovasc Mol, Beijing 100871, Peoples R China.	zhangyy@bjmu.edu.cn	Xiao, Han/T-5032-2019	Song, Yao/0000-0003-1699-759X	Natural Science Foundation of China (NSFC) [81030001]; National Key Basic Research Program of the People's Republic of China [2012CB51800]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of the People's Republic of China	This work was supported by the Natural Science Foundation of China (NSFC, 81030001); the National Key Basic Research Program of the People's Republic of China (2012CB51800). YYZ received the fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2005, CIRCULATION, V111, P555, DOI 10.1161/01.CIR.0000154560.88933.7E; Ago T, 2010, CIRC RES, V106, P1253, DOI 10.1161/CIRCRESAHA.109.213116; Brooks SV, 2008, J PHYSIOL-LONDON, V586, P3979, DOI 10.1113/jphysiol.2008.155382; Coven DL, 2003, AM J PHYSIOL-ENDOC M, V285, pE629, DOI 10.1152/ajpendo.00171.2003; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Dean RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1245, DOI 10.1369/jhc.4A6560.2005; Devaraj S, 2008, ARTERIOSCL THROM VAS, V28, P1368, DOI 10.1161/ATVBAHA.108.163303; Dobrzyn P, 2013, AM J PHYSIOL-ENDOC M, V304, pE1348, DOI 10.1152/ajpendo.00603.2012; Fukuyama Y, 2007, J DENT RES, V86, P903, DOI 10.1177/154405910708600919; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Gundewar S, 2009, CIRC RES, V104, P403, DOI 10.1161/CIRCRESAHA.108.190918; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Ido Y, 2002, DIABETES, V51, P159, DOI 10.2337/diabetes.51.1.159; Kim HG, 2011, BRIT J PHARMACOL, V162, P1096, DOI 10.1111/j.1476-5381.2010.01101.x; Kirchhof P, 2006, CIRCULATION, V114, P1799, DOI 10.1161/CIRCULATIONAHA.106.624502; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107; Kwak HB, 2011, FASEB J, V25, P1106, DOI 10.1096/fj.10-172924; Leask A, 2007, CARDIOVASC RES, V74, P207, DOI 10.1016/j.cardiores.2006.07.012; Leosco D, 2008, CARDIOVASC RES, V78, P385, DOI 10.1093/cvr/cvm109; Li HL, 2007, J CELL BIOCHEM, V100, P1086, DOI 10.1002/jcb.21197; Li L, 2011, BASIC RES CARDIOL, V106, P1221, DOI 10.1007/s00395-011-0213-9; Li XN, 2009, DIABETES, V58, P2246, DOI 10.2337/db08-1512; Mou YA, 2009, CARDIOVASC RES, V81, P555, DOI 10.1093/cvr/cvn229; Musi N, 2005, FEBS LETT, V579, P2045, DOI 10.1016/j.febslet.2005.02.052; Peter PS, 2007, J CLIN INVEST, V117, P1335, DOI 10.1172/JCI29576; Purnomo Yudi, 2013, Cardiovascular & Hematological Disorders - Drug Targets, V13, P165; Radak Z, 2008, FREE RADICAL BIO MED, V44, P153, DOI 10.1016/j.freeradbiomed.2007.01.029; Sanderson JE, 2001, HEART, V86, P701, DOI 10.1136/heart.86.6.701; Sasaki H, 2009, CIRCULATION, V119, P2568, DOI 10.1161/CIRCULATIONAHA.108.798561; Seeland U, 2002, EUR J CLIN INVEST, V32, P295, DOI 10.1046/j.1365-2362.2002.00985.x; Srivastava S, 2007, CARDIOVASC RES, V74, P445, DOI 10.1016/j.cardiores.2007.02.016; Wang J, 2005, CIRC RES, V97, P821, DOI 10.1161/01.RES.0000185833.42544.06; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Xiao H, 2010, CARDIOVASC RES, V87, P504, DOI 10.1093/cvr/cvq066; Xiao XY, 2010, J NUTR BIOCHEM, V21, P621, DOI 10.1016/j.jnutbio.2009.03.011; Xu Q, 2011, BRIT J PHARMACOL, V162, P1012, DOI 10.1111/j.1476-5381.2010.01043.x; Xu XH, 2008, CARDIOVASC RES, V78, P523, DOI 10.1093/cvr/cvn028; Zhang GX, 2005, CARDIOVASC RES, V65, P230, DOI 10.1016/j.cardiores.2004.08.013; Zhang P, 2008, HYPERTENSION, V52, P918, DOI 10.1161/HYPERTENSIONAHA.108.114702; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	43	43	47	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129971	10.1371/journal.pone.0129971	http://dx.doi.org/10.1371/journal.pone.0129971			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068068	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000127
J	Seiler, SMF; Baumgartner, C; Hirschberger, J; Beer, AJ; Bruhschwein, A; Kreutzmann, N; Laberke, S; Wergin, MC; Meyer-Lindenberg, A; Brandl, J; von Thaden, AK; Farrell, E; Schwaiger, M				Seiler, Stefanie M. F.; Baumgartner, Christine; Hirschberger, Johannes; Beer, Ambros J.; Bruhschwein, Andreas; Kreutzmann, Nina; Laberke, Silja; Wergin, Melanie C.; Meyer-Lindenberg, Andrea; Brandl, Johanna; von Thaden, Anne-Kathrin; Farrell, Eliane; Schwaiger, Markus			Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors	PLOS ONE			English	Article							PRIMARY LUNG-TUMORS; HISTIOCYTIC SARCOMA; F-18-FDG UPTAKE; LYMPH-NODES; CANCER; THERAPY; CT; PROGNOSIS; DIAGNOSIS; (18)FDG	Introduction 2-Deoxy-2-[18F]fluoro-D-glucose PET/CT is a well-established imaging method for staging, restaging and therapy-control in human medicine. In veterinary medicine, this imaging method could prove to be an attractive and innovative alternative to conventional imaging in order to improve staging and restaging. The aim of this study was both to evaluate the effectiveness of this image-guided method in canine patients with spontaneously occurring cancer as well as to illustrate the dog as a well-suited animal model for comparative oncology. Methods Ten dogs with various malignant tumors were included in the study and underwent a whole body FDG PET/CT. One patient has a second PET-CT 5 months after the first study. Patients were diagnosed with histiocytic sarcoma (n = 1), malignant lymphoma (n = 2), mammary carcinoma (n = 4), sertoli cell tumor (n = 1), gastrointestinal stromal tumor (GIST) (n = 1) and lung tumor (n = 1). PET/CT data were analyzed with the help of a 5-point scale in consideration of the patients' medical histories. Results In seven of the ten dogs, the treatment protocol and prognosis were significantly changed due to the results of FDG PET/CT. In the patients with lymphoma (n = 2) tumor extent could be defined on PET/CT because of increased FDG uptake in multiple lymph nodes. This led to the recommendation for a therapeutic polychemotherapy as a treatment. In one of the dogs with mammary carcinoma (n = 4) and in the patient with the lung tumor (n = 1), surgery was cancelled due to the discovery of multiple metastasis. Consequently no treatment was recommended. Conclusion FDG PET/CT offers additional information in canine patients with malignant disease with a potential improvement of staging and restaging. The encouraging data of this clinical study highlights the possibility to further improve innovative diagnostic and staging methods with regard to comparative oncology. In the future, performing PET/CT not only for staging but also in therapy control could offer a significant improvement in the management of dogs with malignant tumors.	[Seiler, Stefanie M. F.; Hirschberger, Johannes; Kreutzmann, Nina; Laberke, Silja; Wergin, Melanie C.] Univ Munich, Clin Small Anim Med, Ctr Clin Vet Med, D-80539 Munich, Germany; [Seiler, Stefanie M. F.; Baumgartner, Christine; Brandl, Johanna; von Thaden, Anne-Kathrin] Tech Univ Munich, Ctr Preclin Res, D-81675 Munich, Germany; [Bruhschwein, Andreas; Meyer-Lindenberg, Andrea] Univ Munich, Clin Small Anim Surg & Reprod, Fac Vet, D-80539 Munich, Germany; [Beer, Ambros J.; Farrell, Eliane; Schwaiger, Markus] Univ Munich, Dept Nucl Med, D-81675 Munich, Germany	University of Munich; Technical University of Munich; University of Munich; University of Munich	Hirschberger, J (corresponding author), Univ Munich, Clin Small Anim Med, Ctr Clin Vet Med, D-80539 Munich, Germany.	hirschberger@lmu.de	Beer, Ambros J./AAA-5539-2022	Beer, Ambros J./0000-0001-9042-7806; schwaiger, markus/0000-0002-2305-7144; Wergin, Melanie/0000-0003-3224-3210; Hirschberger, Johannes/0000-0002-1382-6114; Meyer-Lindenberg, Andrea/0000-0001-6137-3773				Adams VJ, 2010, J SMALL ANIM PRACT, V51, P512, DOI 10.1111/j.1748-5827.2010.00974.x; Akgul AG, 2014, J BUON, V19, P836; Ballegeer EA, 2006, VET RADIOL ULTRASOUN, V47, P228, DOI 10.1111/j.1740-8261.2006.00132.x; Bangerter M, 1998, ANN ONCOL, V9, P1117, DOI 10.1023/A:1008486928190; Bednaruk-Mlynski E, 2015, LEUKEMIA LYMPHOMA, V56, P377, DOI 10.3109/10428194.2014.919635; Blodgett TM, 2007, RADIOLOGY, V242, P360, DOI 10.1148/radiol.2422051113; Bomanji JB, 2001, LANCET ONCOL, V2, P157, DOI 10.1016/S1470-2045(00)00257-6; Bombardieri E, 2001, Q J NUCL MED, V45, P245; Craig LE, 2002, VET PATHOL, V39, P66, DOI 10.1354/vp.39-1-66; De Leyn P, 2007, EUR J CARDIO-THORAC, V32, P1, DOI 10.1016/j.ejcts.2007.01.075; Eubank WB, 1998, AM J ROENTGENOL, V171, P1103, DOI 10.2214/ajr.171.4.9763005; Gayed I, 2004, J NUCL MED, V45, P17; Hansen AE, 2012, RADIOTHER ONCOL, V102, P424, DOI 10.1016/j.radonc.2011.10.021; Hansen AE, 2011, VET RADIOL ULTRASOUN, V52, P201, DOI 10.1111/j.1740-8261.2010.01757.x; Hansen K, 2004, EUR J CANCER, V40, P858, DOI 10.1016/j.ejca.2003.11.031; Herrmann K, 2007, CLIN CANCER RES, V13, P3552, DOI 10.1158/1078-0432.CCR-06-3025; Hutchings M, 2006, HAEMATOLOGICA, V91, P482; Ionut V, 2004, AM J VET RES, V65, P1124, DOI 10.2460/ajvr.2004.65.1124; Kamiyama Y, 2005, WORLD J SURG, V29, P1429, DOI 10.1007/s00268-005-0045-6; Kang BT, 2009, J VET MED SCI, V71, P1397, DOI 10.1292/jvms.001397; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; LARSON SM, 1981, J NUCL MED, V22, P875; Lawrence J, 2009, VET RADIOL ULTRASOUN, V50, P660, DOI 10.1111/j.1740-8261.2009.01612.x; LeBlanc AK, 2008, VET RADIOL ULTRASOUN, V49, P182, DOI 10.1111/j.1740-8261.2008.00348.x; LeBlanc AK, 2012, VET RADIOL ULTRASOUN, V53, P348, DOI 10.1111/j.1740-8261.2012.01925.x; LeBlanc AK, 2009, VET RADIOL ULTRASOUN, V50, P436, DOI 10.1111/j.1740-8261.2009.01562.x; Leblanc AK, 2009, VET RADIOL ULTRASOUN, V50, P215, DOI 10.1111/j.1740-8261.2009.01520.x; Lee MS, 2010, VET RADIOL ULTRASOUN, V51, P670, DOI 10.1111/j.1740-8261.2010.01727.x; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Makis W, 2011, CLIN NUCL MED, V36, pE37, DOI 10.1097/RLU.0b013e3182173979; McNiel EA, 1997, J AM VET MED ASSOC, V211, P1422; Munker R, 2004, ANN ONCOL, V15, P1699, DOI 10.1093/annonc/mdh426; OGILVIE GK, 1989, J AM VET MED ASSOC, V195, P106; Ozulker T, 2010, ANN NUCL MED, V24, P35, DOI 10.1007/s12149-009-0321-x; PAGE RL, 1994, J NUCL MED, V35, P1506; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Park JW, 2011, J GASTRIC CANCER, V11, P173, DOI 10.5230/jgc.2011.11.3.173; PIEPSZ A, 1990, EUR J NUCL MED, V17, P127; Raj P, 2013, UPDATES SURG-ITALY, V65, P103, DOI 10.1007/s13304-013-0205-4; Rashid RM, 2013, CUTIS, V91, P141; Rauscher I, 2014, J NUCL MED, V55, P724, DOI 10.2967/jnumed.113.129247; Roberts PF, 2000, ANN THORAC SURG, V70, P1154, DOI 10.1016/S0003-4975(00)01769-0; Song BI, 2012, J NUCL MED, V53, P1337, DOI 10.2967/jnumed.111.098640; Stroup SP, 2012, CLIN EXP METASTAS, V29, P673, DOI 10.1007/s10585-012-9498-9; Toloza EM, 2003, CHEST, V123, p137S, DOI 10.1378/chest.123.1_suppl.137S; Toriihara A, 2013, AM J ROENTGENOL, V201, P639, DOI 10.2214/AJR.12.10395; TRIM CM, 1983, AM J VET RES, V44, P329; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Ferrusola EV, 2012, REV ESP ENFERM DIG, V104, P360, DOI 10.4321/s1130-01082012000700005; Wagner M, 2003, CANCER RES, V63, P2681; Weber WA, 1999, STRAHLENTHER ONKOL, V175, P356, DOI 10.1007/s000660050022; Weber WA, 2000, NUCL MED BIOL, V27, P683, DOI 10.1016/S0969-8051(00)00141-4	52	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0127800	10.1371/journal.pone.0127800	http://dx.doi.org/10.1371/journal.pone.0127800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068641	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000011
J	Tsetsos, K; Pfeffer, T; Jentgens, P; Donner, TH				Tsetsos, Konstantinos; Pfeffer, Thomas; Jentgens, Pia; Donner, Tobias H.			Action Planning and the Timescale of Evidence Accumulation	PLOS ONE			English	Article							PERCEPTUAL DECISION-MAKING; LATERAL INTRAPARIETAL AREA; HUMAN BRAIN; OSCILLATORY ACTIVITY; SUPERIOR COLLICULUS; GENERAL MECHANISM; VISUAL-MOTION; EYE-MOVEMENTS; CORTEX; INTEGRATION	Perceptual decisions are based on the temporal integration of sensory evidence for different states of the outside world. The timescale of this integration process varies widely across behavioral contexts and individuals, and it is diagnostic for the underlying neural mechanisms. In many situations, the decision-maker knows the required mapping between perceptual evidence and motor response (henceforth termed "sensory-motor contingency") before decision formation. Here, the integrated evidence can be directly translated into a motor plan and, indeed, neural signatures of the integration process are evident as build-up activity in premotor brain regions. In other situations, however, the sensory-motor contingencies are unknown at the time of decision formation. We used behavioral psychophysics and computational modeling to test if knowledge about sensory-motor contingencies affects the timescale of perceptual evidence integration. We asked human observers to perform the same motion discrimination task, with or without trial-to-trial variations of the mapping between perceptual choice and motor response. When the mapping varied, it was either instructed before or after the stimulus presentation. We quantified the timescale of evidence integration under these different sensory-motor mapping conditions by means of two approaches. First, we analyzed subjects' discrimination threshold as a function of stimulus duration. Second, we fitted a dynamical decision-making model to subjects' choice behavior. The results from both approaches indicated that observers (i) integrated motion information for several hundred ms, (ii) used a shorter than optimal integration timescale, and (iii) used the same integration timescale under all sensory-motor mappings. We conclude that the mechanisms limiting the timescale of perceptual decisions are largely independent from long-term learning (under fixed mapping) or rapid acquisition (under variable mapping) of sensory-motor contingencies. This conclusion has implications for neurophysiological and neuroimaging studies of perceptual decision-making.	[Tsetsos, Konstantinos] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Pfeffer, Thomas; Jentgens, Pia; Donner, Tobias H.] Univ Amsterdam, Dept Psychol, NL-1018 XA Amsterdam, Netherlands; [Pfeffer, Thomas; Donner, Tobias H.] Univ Amsterdam, Amsterdam Brain & Cognit, NL-1018 WS Amsterdam, Netherlands; [Pfeffer, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, D-20246 Hamburg, Germany; [Jentgens, Pia] Netherlands Inst Neurosci, NL-1105 BA Amsterdam, Netherlands; [Donner, Tobias H.] Charitein Ctr Comput, Bernstein Ctr Computat Neurosci, D-10115 Berlin, Germany	University of Oxford; University of Amsterdam; University of Amsterdam; University of Hamburg; University Medical Center Hamburg-Eppendorf; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Donner, TH (corresponding author), Univ Amsterdam, Dept Psychol, Weesperpl 4, NL-1018 XA Amsterdam, Netherlands.	T.H.Donner@uva.nl	Tsetsos, Konstantinos/G-8302-2015	Tsetsos, Konstantinos/0000-0003-2709-7634; Pfeffer, Thomas/0000-0001-9561-3085; Donner, Tobias H./0000-0002-7559-6019	Amsterdam Brain and Cognition Priority Program [ABC2014-01]; European Union [604102(v1), Call-ID FP7-ICT-2013-FET-F]	Amsterdam Brain and Cognition Priority Program; European Union(European Commission)	This work was funded by the Amsterdam Brain and Cognition Priority Program (Grant number: ABC2014-01, http://abc.uva.nl/research/nav) and the European Union FP7, Human Brain Project (Grant number: Call-ID FP7-ICT-2013-FET-F, Project ID: 604102(v1), http://www.humanbrainproject.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Bennur S, 2011, J NEUROSCI, V31, P913, DOI 10.1523/JNEUROSCI.4417-10.2011; Bogacz R, 2004, BEHAV RES METH INS C, V36, P732, DOI 10.3758/BF03206554; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brody CD, 2003, CURR OPIN NEUROBIOL, V13, P204, DOI 10.1016/S0959-4388(03)00050-3; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Burr DC, 2001, VISION RES, V41, P1891, DOI 10.1016/S0042-6989(01)00072-4; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; Connolly PM, 2009, J NEUROSCI, V29, P2136, DOI 10.1523/JNEUROSCI.3962-08.2009; de Lange FP, 2013, J NEUROSCI, V33, P1400, DOI 10.1523/JNEUROSCI.1094-12.2013; Donner TH, 2007, J NEUROPHYSIOL, V98, P345, DOI 10.1152/jn.01141.2006; Donner TH, 2009, CURR BIOL, V19, P1581, DOI 10.1016/j.cub.2009.07.066; Efron B., 1993, INTRO BOOTSTRAP; Filimon F, 2013, J NEUROSCI, V33, P2121, DOI 10.1523/JNEUROSCI.2334-12.2013; Freedman DJ, 2011, NAT NEUROSCI, V14, P143, DOI 10.1038/nn.2740; Gao JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016749; Gold JI, 2003, J NEUROSCI, V23, P632, DOI 10.1523/JNEUROSCI.23-02-00632.2003; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gould IC, 2012, J NEUROSCI, V32, P13805, DOI 10.1523/JNEUROSCI.2200-12.2012; Hanks TD, 2015, NATURE, V520, P220, DOI 10.1038/nature14066; Hebart M.N., 2014, CEREB CORTEX; Hebart MN, 2012, NEUROIMAGE, V63, P1393, DOI 10.1016/j.neuroimage.2012.08.027; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Honey CJ, 2012, NEURON, V76, P423, DOI 10.1016/j.neuron.2012.08.011; Horwitz GD, 2004, J NEUROPHYSIOL, V91, P2281, DOI 10.1152/jn.00872.2003; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Liu TS, 2011, J NEUROPHYSIOL, V106, P2383, DOI 10.1152/jn.00413.2011; Luce RD, 1986, RESPONSE TIMES THEIR; Marshall JAR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043443; Merten K, 2012, P NATL ACAD SCI USA, V109, P6289, DOI 10.1073/pnas.1121084109; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; NICKERSON DM, 1989, PHYSIOL ZOOL, V62, P866, DOI 10.1086/physzool.62.4.30157934; O'Connell RG, 2012, NAT NEUROSCI, V15, P1729, DOI 10.1038/nn.3248; Ossmy O, 2013, CURR BIOL, V23, P981, DOI 10.1016/j.cub.2013.04.039; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; Rahnev D, 2011, J NEUROSCI, V31, P10741, DOI 10.1523/JNEUROSCI.1478-11.2011; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rorie AE, 2005, TRENDS COGN SCI, V9, P41, DOI 10.1016/j.tics.2004.12.007; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Siegel M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00021; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Tsetsos K, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00079; Tsetsos K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00063; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; WATAMANIUK SNJ, 1992, VISION RES, V32, P2341, DOI 10.1016/0042-6989(92)90097-3; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wyart V, 2012, NEURON, V76, P847, DOI 10.1016/j.neuron.2012.09.015; Zariwala HA, 2013, NEURON, V78, P339, DOI 10.1016/j.neuron.2013.02.010	58	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129473	10.1371/journal.pone.0129473	http://dx.doi.org/10.1371/journal.pone.0129473			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068458	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000079
J	Rose, SL; Sanghani, RM; Schmidt, C; Karafa, MT; Kodish, E; Chisolm, GM				Rose, Susannah L.; Sanghani, Ruchi M.; Schmidt, Cory; Karafa, Matthew T.; Kodish, Eric; Chisolm, Guy M.			Gender Differences in Physicians' Financial Ties to Industry: A Study of National Disclosure Data	PLOS ONE			English	Article							ACADEMIC MEDICINE; SIMILARITIES; PERCEPTIONS; ADVANCEMENT; WOMEN; GAP	Background Academic literature extensively documents gender disparities in the medical profession with regard to salary, promotion, and government funded research. However, gender differences in the value of financial ties to industry have not been adequately studied despite industry's increasing contribution to income and research funding to physicians in the U.S. Methods & Findings We analyzed publicly reported financial relationships among 747,603 physicians and 432 pharmaceutical, device and biomaterials companies. Demographic and payment information were analyzed using hierarchical regression models to determine if statistically significant gender differences exist in physician-industry interactions regarding financial ties, controlling for key covariates. In 2011, 432 biomedical companies made an excess of $17,991,000 in payments to 220,908 physicians. Of these physicians, 75.1% were male. Female physicians, on average, received fewer total dollars (-$3,598.63, p<0.001) per person than men. Additionally, female physicians received significantly lower amounts for meals (-$41.80, p<0.001), education (-$1,893.14, p<0.001), speaker fees (-$2,898.44, p<0.001), and sponsored research (-$15,049.62, p=0.05). For total dollars, an interaction between gender and institutional reputation was statistically significant, implying that the differences between women and men differed based on industry's preference for an institution, with larger differences at higher reputation institutions. Conclusions Female physicians receive significantly lower compensation for similarly described activities than their male counterparts after controlling for key covariates. As regulations lead to increased transparency regarding these relationships, efforts to standardize compensation should be considered to promote equitable opportunities for all physicians.	[Rose, Susannah L.; Sanghani, Ruchi M.; Kodish, Eric] Cleveland Clin, Dept Bioeth, Cleveland, OH 44106 USA; [Schmidt, Cory; Chisolm, Guy M.] Cleveland Clin, Innovat Management & Conflict Interest Program, Cleveland, OH 44106 USA; [Karafa, Matthew T.] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Rose, Susannah L.; Kodish, Eric] Case Western Reserve Univ, Dept Med, Lerner Coll Med, Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Rose, SL (corresponding author), Cleveland Clin, Innovat Management & Conflict Interest Program, Cleveland, OH 44106 USA.	roses2@ccf.org			Edmond J. Safra Center for Ethics at Harvard University; Clinical and Translational Science Collaborative of Cleveland; National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health; NIH road map for Medical Research [KL2TR000440]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000440] Funding Source: NIH RePORTER	Edmond J. Safra Center for Ethics at Harvard University; Clinical and Translational Science Collaborative of Cleveland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health; NIH road map for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was generously funded by the Edmond J. Safra Center for Ethics at Harvard University, the Clinical and Translational Science Collaborative of Cleveland, and the National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health and NIH road map for Medical Research (KL2TR000440). The contents of this study are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Hospital Association, 2013, AHA ANN SURV DAT; [Anonymous], 2012, KYRUUSONE BIG DATA P; Ash AS, 2004, ANN INTERN MED, V141, P205, DOI 10.7326/0003-4819-141-3-200408030-00009; Bateman CR, 2010, J BUS ETHICS, V95, P393, DOI 10.1007/s10551-010-0386-4; Beekun RI, 2010, BUS ETHICS, V19, P309, DOI 10.1111/j.1467-8608.2010.01600.x; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Campbell EG, 2007, JAMA-J AM MED ASSOC, V298, P1779, DOI 10.1001/jama.298.15.1779; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Carr PL, 2000, ANN INTERN MED, V132, P889, DOI 10.7326/0003-4819-132-11-200006060-00007; Erikson C, 2012, 2012 PHYS SPECIALTY; Esteyes-Sorenson C, 2012, ECON LETT, V116, P37, DOI 10.1016/j.econlet.2011.12.133; Field MJ, 2009, CONFLICT OF INTEREST; Franke GR, 1997, J APPL PSYCHOL, V82, P920, DOI 10.1037/0021-9010.82.6.920; Goldin C, 2014, AM ECON REV, V104, P1091, DOI 10.1257/aer.104.4.1091; Jagsi R, 2012, JAMA-J AM MED ASSOC, V307, P2410, DOI 10.1001/jama.2012.6183; Jagsi R, 2011, ACAD MED, V86, P1415, DOI 10.1097/ACM.0b013e3182305aa6; Kaplan SH, 1996, NEW ENGL J MED, V335, P1282, DOI 10.1056/NEJM199610243351706; Kennedy JA, 2013, SOCIAL PSYCHOL PERSO; Kray LJ, 2012, J EXP SOC PSYCHOL, V48, P1124, DOI 10.1016/j.jesp.2012.04.006; Little RC, 2006, SAS MIXED MODELS; Lo Sasso AT, 2011, HEALTH AFFAIR, V30, P193, DOI 10.1377/hlthaff.2010.0597; Miller Claire Cain, 2014, NY TIMES; National Institutes of Health (NIH), 2013, AW LOC ORG; Ornstein Charles, 2014, NY TIMES; Rose SL, 2010, J CLIN ONCOL, V28, P1316, DOI 10.1200/JCO.2008.21.6606; SAS_ Institute_ Inc, 2012, DAT AN PAP US SAS SO; TESCH BJ, 1995, JAMA-J AM MED ASSOC, V273, P1022, DOI 10.1001/jama.273.13.1022; Vedantam S, 2014, WHY MEN OUTNUMBER WO; Waisbren SE, 2008, J WOMENS HEALTH, V17, P207, DOI 10.1089/jwh.2007.0412; Ying ZG, 2011, ANN SURG, V253, P637, DOI 10.1097/SLA.0b013e3182111120	30	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129197	10.1371/journal.pone.0129197	http://dx.doi.org/10.1371/journal.pone.0129197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK3FB	26067810	gold, Green Submitted, Green Published			2022-12-27	WOS:000356100900046
J	Abd El Wahed, A; Patel, P; Faye, O; Thaloengsok, S; Heidenreich, D; Matangkasombut, P; Manopwisedjaroen, K; Sakuntabhai, A; Sall, AA; Hufert, FT; Weidmann, M				Abd El Wahed, Ahmed; Patel, Pranav; Faye, Oumar; Thaloengsok, Sasikanya; Heidenreich, Doris; Matangkasombut, Ponpan; Manopwisedjaroen, Khajohnpong; Sakuntabhai, Anavaj; Sall, Amadou A.; Hufert, Frank T.; Weidmann, Manfred			Recombinase Polymerase Amplification Assay for Rapid Diagnostics of Dengue Infection	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; TIME RT-PCR; VIRUS SEROTYPES; FEVER; DIFFERENTIATION; SENSITIVITY; PERFORMANCE; ANTIGEN; FROZEN	Background Over 2.5 billion people are exposed to the risk of contracting dengue fever (DF). Early diagnosis of DF helps to diminish its burden on public health. Real-time reverse transcription polymerase amplification assays (RT-PCR) are the standard method for molecular detection of the dengue virus (DENV). Real-time RT-PCR analysis is not suitable for on-site screening since mobile devices are large, expensive, and complex. In this study, two RT-recombinase polymerase amplification (RT-RPA) assays were developed to detect DENV1-4. Methodology/Principal Findings Using two quantitative RNA molecular standards, the analytical sensitivity of a RT-RPA targeting the 3'non-translated region of DENV1-4 was found to range from 14 (DENV4) to 241 (DENV1-3) RNA molecules detected. The assay was specific and did not cross detect other Flaviviruses. The RT-RPA assay was tested in a mobile laboratory combining magneticbead based total nucleic acid extraction and a portable detection device in Kedougou (Senegal) and in Bangkok (Thailand). In Kedougou, the RT-RPA was operated at an ambient temperature of 38 degrees C with auxiliary electricity tapped from a motor vehicle and yielded a clinical sensitivity and specificity of 98% (n=31) and 100% (n=23), respectively. While in the field trial in Bangkok, the clinical sensitivity and specificity were 72% (n=90) and 100% (n=41), respectively. Conclusions/Significance During the first 5 days of infection, the developed DENV1-4 RT-RPA assays constitute a suitable accurate and rapid assay for DENV diagnosis. Moreover, the use of a portable fluorescence-reading device broadens its application potential to the point-of-care for outbreak investigations.	[Abd El Wahed, Ahmed] German Primate Ctr, Unit Infect Models, Gottingen, Germany; [Abd El Wahed, Ahmed] Mansoura Univ, Dept Virol, Dakahlia, Egypt; [Patel, Pranav] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, CBS1 Highly Pathogen Viruses, Berlin, Germany; [Faye, Oumar; Sall, Amadou A.] Inst Pasteur, Arbovirus Unit, Dakar, Senegal; [Thaloengsok, Sasikanya; Matangkasombut, Ponpan; Manopwisedjaroen, Khajohnpong] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok 10700, Thailand; [Heidenreich, Doris] Univ Med Ctr, Dept Virol, Gottingen, Germany; [Matangkasombut, Ponpan] Mahidol Univ, Fac Sci, Syst Biol Dis Res Unit, Bangkok 10700, Thailand; [Matangkasombut, Ponpan] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Bangkok 10700, Thailand; [Sakuntabhai, Anavaj] Inst Pasteur, Funct Genet Infect Dis Unit, Paris, France; [Hufert, Frank T.] Brandenburg Med Sch Theodor Fontane Senftenberg, Inst Microbiol & Virol, Brandenburg, Germany; [Weidmann, Manfred] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland	Deutsches Primatenzentrum (DPZ); Egyptian Knowledge Bank (EKB); Mansoura University; Robert Koch Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Mahidol University; University of Gottingen; Mahidol University; Mahidol University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Stirling	Weidmann, M (corresponding author), Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland.	m.w.weidmann@stir.ac.uk	Weidmann, Manfred/G-1817-2015; Faye, Oumar/T-7168-2019	Weidmann, Manfred/0000-0002-7063-7491; Faye, Oumar/0000-0002-3478-1322; Abd El Wahed, Ahmed/0000-0003-3347-6075; Heidenreich, Doris/0000-0002-2010-9017	Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) [VN 811-40270]; Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative; European Commission [282 378]	Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ); Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was funded by a grant from the Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) contract no: VN 811-40270. http://www.giz.de. The Bangkok cohort study was funded by the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative, and European Commission Seventh Framework Programme [FP7/2007-2013] for the DENFREE project under Grant Agreement number 282 378.	Abd El Wahed A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071642, 10.1371/currents.outbreaks.62df1c7c75ffc96cd59034531e2e8364]; Amer HM, 2013, J VIROL METHODS, V193, P337, DOI 10.1016/j.jviromet.2013.06.027; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967; Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P804, DOI 10.1128/CVI.05717-11; Botling J, 2009, DIAGN MOL PATHOL, V18, P44, DOI 10.1097/PDM.0b013e3181857e92; Boyle DS, 2013, MBIO, V4, DOI 10.1128/mBio.00135-13; Carneiro AR, 2012, MEM I OSWALDO CRUZ, V107, P805, DOI 10.1590/S0074-02762012000600016; COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0; Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z; Daher RK, 2015, MOL CELL PROBE, V29, P116, DOI 10.1016/j.mcp.2014.11.005; Escadafal C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002730; Euler M, 2013, J CLIN MICROBIOL, V51, P1110, DOI 10.1128/JCM.02704-12; Euler M, 2012, J CLIN VIROL, V54, P308, DOI 10.1016/j.jcv.2012.05.006; Euler M, 2012, J CLIN MICROBIOL, V50, P2234, DOI 10.1128/JCM.06504-11; Felix AC, 2012, CLIN VACCINE IMMUNOL, V19, P1972, DOI 10.1128/CVI.00535-12; Gan VC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060946; Gusev Y, 2001, AM J PATHOL, V159, P63, DOI 10.1016/S0002-9440(10)61674-4; Holmes EC, 1998, BRIT MED BULL, V54, P533; Holmes KC, 1998, ACTA CRYSTALLOGR A, V54, P789, DOI 10.1107/S0108767398010307; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; Kien DTH, 2011, J VIROL METHODS, V177, P168, DOI 10.1016/j.jviromet.2011.08.002; Lai YL, 2007, J CLIN MICROBIOL, V45, P935, DOI 10.1128/JCM.01258-06; Li SH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-360; Medina Freddy, 2012, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15d02s27; Messer WB, 2003, EMERG INFECT DIS, V9, P800; Mutter GL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-88; Najioullah F, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-164; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Paranavitane SA, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0570-8; Parida M, 2005, J CLIN MICROBIOL, V43, P2895, DOI 10.1128/JCM.43.6.2895-2903.2005; Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Pongsiri P, 2012, ASIAN PAC J TROP MED, V5, P342, DOI 10.1016/S1995-7645(12)60055-8; Sahni Ajay Kumar, 2013, Med J Armed Forces India, V69, P246, DOI 10.1016/j.mjafi.2012.07.017; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311; Ibarra AMS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1135; Teoh BT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-387; Thisyakorn Usa, 2014, Ther Adv Vaccines, V2, P3, DOI 10.1177/2051013613507862; Torres C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-240; Van Ness J, 2003, P NATL ACAD SCI USA, V100, P4504, DOI 10.1073/pnas.0730811100; Vincent M, 2004, EMBO REP, V5, P795, DOI 10.1038/sj.embor.7400200; Wagner D, 2004, EMERG INFECT DIS, V10, P1872, DOI 10.3201/eid1010.031037; Weidmann M, 2003, J CLIN MICROBIOL, V41, P1565, DOI 10.1128/JCM.41.4.1565-1568.2003; Whiley DM, 2006, J CLIN VIROL, V35, P81, DOI 10.1016/j.jcv.2005.05.002; WHO, 2014, DENG FACT SHEETS; Wu SJL, 2001, J CLIN MICROBIOL, V39, P2794, DOI 10.1128/JCM.39.8.2794-2798.2001; Yamada KI, 2002, J CLIN VIROL, V24, P203, DOI 10.1016/S1386-6532(01)00250-5	49	92	95	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129682	10.1371/journal.pone.0129682	http://dx.doi.org/10.1371/journal.pone.0129682			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075598	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900091
J	Barbadoro, P; Di Tondo, E; Menditto, VG; Pennacchietti, L; Regnicoli, F; Di Stanislao, F; D'Errico, MM; Prospero, E				Barbadoro, Pamela; Di Tondo, Elena; Menditto, Vincenzo Giannicola; Pennacchietti, Lucia; Regnicoli, Februa; Di Stanislao, Francesco; D'Errico, Marcello Mario; Prospero, Emilia			Emergency Department Non-Urgent Visits and Hospital Readmissions Are Associated with Different Socio-Economic Variables in Italy	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PRIMARY-CARE; 30-DAY READMISSIONS; HEART-FAILURE; HEALTH; NEEDS	Objective The aim of this paper was to evaluate socio-economic factors associated to poor primary care utilization by studying two specific subjects: the hospital readmission rate, and the use of the Emergency Department (ED) for non-urgent visits. Methods The study was carried out by the analysis of administrative database for hospital readmission and with a specific survey for non-urgent ED use. Results Among the 416,698 sampled admissions, 6.39% (95% CI, 6.32-6.47) of re-admissions have been registered; the distribution shows a high frequency of events in the age 65-84 years group, and in the intermediate care hospitals (51.97%; 95% CI 51.37-52.57). The regression model has shown the significant role played by age, type of structure (geriatric acute care), and deprivation index of the area of residence on the readmission, however, after adjusting for the intensity of primary care, the role of deprivation was no more significant. Non-urgent ED visits accounted for the 12.10%, (95% CI 9.38-15.27) of the total number of respondents to the questionnaire (N = 504). The likelihood of performing a non-urgent ED visit was higher among patients aged <65 years (OR 3.2, 95% CI 1.3-7.8 p = 0.008), while it was lower among those perceiving as urgent their health problem (OR 0.50, 95% CI 0.30-0.90). Conclusions In the Italian context repeated readmissions and ED utilization are linked to different trajectories, besides the increasing age and comorbidity of patients are the factors that are related to repeated admissions, the self-perceived trust in diagnostic technologies is an important risk factor in determining ED visits. Better use of public national health care service is mandatory, since its correct utilization is associated to increasing equity and better health care utilization.	[Barbadoro, Pamela; Di Tondo, Elena; Pennacchietti, Lucia; Di Stanislao, Francesco; D'Errico, Marcello Mario; Prospero, Emilia] Univ Politecn Marche, Dept Biomed Sci & Publ Hlth, Ancona, Italy; [Barbadoro, Pamela; D'Errico, Marcello Mario; Prospero, Emilia] AOU Osped Riuniti, Hosp Hyg Serv, Ancona, Italy; [Menditto, Vincenzo Giannicola; Regnicoli, Februa] AOU Osped Riuniti, Dept Emergency Care, Ancona, Italy	Marche Polytechnic University	Barbadoro, P (corresponding author), Univ Politecn Marche, Dept Biomed Sci & Publ Hlth, Ancona, Italy.	p.barbadoro@univpm.it	barbadoro, pamela/AAC-5041-2022; Menditto, Vincenzo G/CAE-9845-2022; menditto, vincenzo g/ABF-1651-2020	Menditto, Vincenzo G/0000-0001-6231-2251; menditto, vincenzo g/0000-0001-6231-2251; Prospero, Emilia/0000-0002-2387-8639	ministry of health	ministry of health	The study was funded by the ministry of health.	Agency for Healthcare Research and Quality (AHRQ), AG HEALTHC RES QUAL; [Anonymous], 2014, INT J HLTH POLICY MA; Ansari Z, 2006, MED CARE RES REV, V63, P719, DOI 10.1177/1077558706293637; Bianco A, 2003, PUBLIC HEALTH, V117, P250, DOI 10.1016/S0033-3506(03)00069-6; Billings J, 2000, Issue Brief (Commonw Fund), P1; Billings J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001667; Cadum E, 1999, Epidemiol Prev, V23, P175; Chetty VK, 2011, AM FAM PHYSICIAN, V83, P1054; David G, 2015, HEALTH SERV RES, V50, P418, DOI 10.1111/1475-6773.12218; Devaux M., 2013, EUR J HLTH EC; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Fischer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112282; Friedman B, 2004, MED CARE RES REV, V61, P225, DOI 10.1177/1077558704263799; Gerhardt Geoffrey, 2014, Medicare Medicaid Res Rev, V4, DOI 10.5600/mmrr2014-004-01-b03; Grol R, 2006, HEALTH AFFAIR, V25, P1733, DOI 10.1377/hlthaff.25.6.1733; GRUMBACH K, 1993, AM J PUBLIC HEALTH, V83, P372, DOI 10.2105/AJPH.83.3.372; Halfon P, 2002, J CLIN EPIDEMIOL, V55, P573, DOI 10.1016/S0895-4356(01)00521-2; Hasan O, 2010, J GEN INTERN MED, V25, P211, DOI 10.1007/s11606-009-1196-1; Hebert C, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-65; Hoeck S, 2014, INT J ENV RES PUB HE, V11, P355, DOI 10.3390/ijerph110100355; Horwitz LI, 2014, ANN INTERN MED, V161, pS66, DOI 10.7326/M13-3000; Huibers L, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-105; Hurst J, 2001, OECD LABOUR MARKET S, V47; Italian National Institute of Health, NAT OUTC IND SYST; Kelley E., 2006, OECD HLTH WORKING PA, V23; Lang T, 1996, J EPIDEMIOL COMMUN H, V50, P456, DOI 10.1136/jech.50.4.456; Lee Eun Whan, 2012, J Prev Med Public Health, V45, P259, DOI 10.3961/jpmph.2012.45.4.259; Lindenauer PK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f521; Lowe RA, 2005, MED CARE, V43, P792, DOI 10.1097/01.mlr.0000170413.60054.54; Majeed A, 2012, ANN INTERN MED, V156, P67, DOI 10.7326/0003-4819-156-1-201201030-00019; Mckee M, 2009, LANCET, V373, P349, DOI 10.1016/S0140-6736(09)60098-2; Ministry of Health, 2011, REL SULL STAT SAN PA; Roberts L, 2014, EMERG MED J, V31, P786; Shadmi E, 2015, MED CARE, V53, P283, DOI 10.1097/MLR.0000000000000315; Shaw EK, 2013, J HEALTH CARE POOR U, V24, P1288, DOI 10.1353/hpu.2013.0140; Sibbritt D W, 1995, J Qual Clin Pract, V15, P211; van der Linden MC, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0028-1; van Walraven C, 2011, CAN MED ASSOC J, V183, pE391, DOI 10.1503/cmaj.101860; Vedovetto A, 2014, HEALTH SERV RES, V49, P1290, DOI 10.1111/1475-6773.12161; Wang M, 2014, J EVAL CLIN PRACT, V20, P20, DOI 10.1111/jep.12074; Zapatero A, 2012, EUR J INTERN MED, V23, P451, DOI 10.1016/j.ejim.2012.01.005	41	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0127823	10.1371/journal.pone.0127823	http://dx.doi.org/10.1371/journal.pone.0127823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076346	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900015
J	Chen, FF; Sun, DY; Guo, YM; Guo, W; Ding, ZW; Li, PL; Li, J; Ge, L; Li, N; Li, DM; Wang, Z; Wang, L				Chen, Fangfang; Sun, Dingyong; Guo, Yuming; Guo, Wei; Ding, Zhengwei; Li, Peilong; Li, Jie; Ge, Lin; Li, Ning; Li, Dongmin; Wang, Zhe; Wang, Lu			Spatiotemporal Scan and Age-Period-Cohort Analysis of Hepatitis C Virus in Henan, China: 2005-2012	PLOS ONE			English	Article							CANCER INCIDENCE; BLOOD-DONORS; INFECTION; EPIDEMIOLOGY; PREVALENCE; CLUSTER; HISTORY; MODELS; HIV	Background Studies have shown that hepatitis C virus (HCV) infection increased during the past decades in China. However, little evidence is available on when, where, and who were infected with HCV. There are gaps in knowledge on the epidemiological burden and evolution of the HCV epidemic in China. Methods Data on HCV cases were collected by the disease surveillance system from 2005 to 2012 to explore the epidemic in Henan province. Spatiotemporal scan statistics and age-period-cohort (APC) model were used to examine the effects of age, period, birth cohort, and spatiotemporal clustering. Results 177,171 HCV cases were reported in Henan province between 2005 and 2012. APC modelling showed that the HCV reported rates significantly increased in people aged > 50 years. A moderate increase in HCV reported rates was observed for females aged about 25 years. HCV reported rates increased over the study period. Infection rates were greatest among people born between 1960 and 1980. People born around 1970 had the highest relative risk of HCV infection. Women born between 1960 and 1980 had a five-fold increase in HCV infection rates compared to men, for the same birth cohort. Spatiotemporal mapping showed major clustering of cases in northern Henan, which probably evolved much earlier than other areas in the province. Conclusions Spatiotemporal mapping and APC methods are useful to help delineate the evolution of the HCV epidemic. Birth cohort should be part of the criteria screening programmes for HCV in order to identify those at highest risk of infection and unaware of their status. As Henan is unique in the transmission route for HCV, these methods should be used in other high burden provinces to help identify subpopulations at risk.	[Chen, Fangfang; Guo, Wei; Ding, Zhengwei; Li, Peilong; Ge, Lin; Li, Dongmin; Wang, Lu] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Sun, Dingyong; Li, Jie; Li, Ning; Wang, Zhe] Henan Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Zhengzhou, Peoples R China; [Guo, Yuming] Univ Queensland, Sch Publ Hlth, Div Epidemiol & Biostat, Brisbane, Qld, Australia	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; University of Queensland	Wang, Z (corresponding author), Henan Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Zhengzhou, Peoples R China.	wangzhe@hncdc.com.cn; wanglu64@163.com	Guo, Yuming/I-8353-2018	Guo, Yuming/0000-0002-1766-6592; chen, fang fang/0000-0002-0854-1667				Aamodt G, 2007, DIABETES CARE, V30, P884, DOI 10.2337/dc06-1568; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Amin R, 2014, STAT PUBLIC POLICY, V1, P69, DOI 10.1080/2330443X.2014.928245; [Anonymous], 1939, AM J EPIDEMIOL; [Anonymous], 1939, AM J EPIDEMIOL; [Anonymous], 2014, SATSCAN V9 3 SOFTWAR; Carstensen B, 2007, STAT MED, V26, P3018, DOI 10.1002/sim.2764; Chen FF, 2014, DIS SURVEILLANCE, V29, P581; Chen Yuan-sheng, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P888; Chen YZ, 2010, HENAN J PREVENTIVE M, V21, P299; Cui Y, 2013, J GASTROEN HEPATOL, V28, P7, DOI 10.1111/jgh.12220; Dai ZC, 1997, HEPATITIS VIRAL SERU, V1, P60; Dong PM, 2010, DIS SURVEILLANCE, V25, P986; Fan Pan-ying, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P557; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Gao XF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-88; Ge L, 2013, CHIN J AIDS STD, V19, P812; Guo W, 2011, PRACT PREV MED, V18, P54; Guo Yong-Hao, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P722; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; He N, 2005, CELL RES, V15, P825, DOI 10.1038/sj.cr.7290354; KANG LY, 1997, CHIN J INFECT DIS, V15, P71; Knipe DW, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-839; Kuehl KS, 2006, PEDIATR CARDIOL, V27, P25, DOI 10.1007/s00246-005-0859-x; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M., 1999, J NATL I PUBLIC HLTH, V48, P94; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Leung GM, 2006, J EPIDEMIOL COMMUN H, V60, P712, DOI 10.1136/jech.2005.042275; Li Jian, 2007, Fudan Xuebao (Yixueban), V34, P71; Morin T, 2010, EUR J GASTROEN HEPAT, V22, P157, DOI 10.1097/MEG.0b013e328330a8e8; Mortimer JT, 2003, DISTINGUISHING AGE P, P465; Oraby T, 2012, CONTINUUM HLTH RISK; Qin Qian-qian, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P548; Qin QQ, 2015, J VIRAL HEPATITIS, V22, P238, DOI 10.1111/jvh.12295; Robertson C, 1999, J CLIN EPIDEMIOL, V52, P569, DOI 10.1016/S0895-4356(99)00033-5; Seeff LB, 2009, LIVER INT, V29, P89, DOI 10.1111/j.1478-3231.2008.01927.x; Shaya FT, 2012, EXPERT REV PHARM OUT, V12, P19, DOI [10.1586/erp.11.101, 10.1586/ERP.11.101]; Sun D, 2014, CHINESE J DIS CONTRO, V18, P117; Sun X, 2008, CHINESE J AIDS STD, V14, P394; Trubnikov Max, 2014, CMAJ Open, V2, pE281, DOI 10.9778/cmajo.20140041; van den Wijngaard CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010406; World Health Organization, UNS INJ PRACT PLAG M; Wu SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040872; Wu SQ, 1999, CHINESE J HLTH LAB, V9, P302; Xinhua, 6 CONF INF HEP C VIR; Yang WT, ANAL RELIEF POLICY H; Yang Y, 2008, SOCIOL METHOD RES, V36, P297, DOI 10.1177/0049124106292360; Zhang L, 2015, EUR J GASTROEN HEPAT, V27, P550, DOI 10.1097/MEG.0000000000000321; Zhao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075586; Zhou YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042937	52	4	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129746	10.1371/journal.pone.0129746	http://dx.doi.org/10.1371/journal.pone.0129746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075599	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900100
J	Li, H; Shen, LY; Yan, WP; Dong, B; Kang, XZ; Dai, L; Yang, YB; Fu, H; Yang, HL; Zhou, HT; Huang, C; Liang, Z; Xiong, HC; Chen, KN				Li, Hui; Shen, Lu-Yan; Yan, Wan-Pu; Dong, Bin; Kang, Xiao-Zheng; Dai, Liang; Yang, Yong-Bo; Fu, Hao; Yang, He-Li; Zhou, Hai-Tao; Huang, Chuan; Liang, Zhen; Xiong, Hong-Chao; Chen, Ke-Neng			Deregulated HOXB7 Expression Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma and Regulates Cancer Cell Proliferation In Vitro and In Vivo	PLOS ONE			English	Article							HOMEOBOX GENE-EXPRESSION; MESSENGER-RNA; GROWTH-FACTOR; PROGRESSION; OVEREXPRESSION	Background We observed abnormal HOXB7 expression in esophageal squamous cell carcinoma (ESCC) previously. This study was to evaluate the prognostic significance of HOXB7 and reveal the potential mechanism. Methods Immunohistochemistry was used to confirm the abnormal expression of HOXB7 in ESCC. The prognostic significance of HOXB7 expression was analyzed in two independent cohorts. RNAi was used to establish two stable HOXB7-knockdown cell strains. CCK8 assay, cell growth curve assay, colony formation assay, flow cycle analysis and tumorigenicity assay in nude mice were employed to investigate the effect of HOXB7 on proliferation in vitro and in vivo. Results Immunohistochemistry confirmed the abnormal expression of HOXB7 in ESCC compared with paracancerous mucosa (18/23 vs. 9/23, p=0.039). HOXB7 expression was positively correlated with the T stage, lymph node metastasis and TNM stage. The median survival of patients with high HOXB7 expression was significantly shorter than that with low expression (45 months vs. 137 months, p = 0.007 for cohort 1; 19 months vs. 34 months, p = 0.001 for cohort 2). Multivariate survival analysis showed that HOXB7 expression was another independent prognostic factor (HR [95% CI] = 0.573 [0.341-0.963], p = 0.036 for cohort 1; HR [95% CI] = 0.543 [0.350-0.844], p = 0.024 for cohort 2). Experiments in vitro and in vivo showed that after knockdown of HOXB7, the proliferation rate dropped, growth rate descended, colony-formation ability reduced, G1-phase arrest occurred and the tumorigenicity reduced remarkably. Conclusions HOXB7 could promote cancer cell proliferation and might be an independent prognostic factor for patients with ESCC.	[Li, Hui; Shen, Lu-Yan; Yan, Wan-Pu; Kang, Xiao-Zheng; Dai, Liang; Yang, Yong-Bo; Fu, Hao; Yang, He-Li; Zhou, Hai-Tao; Huang, Chuan; Liang, Zhen; Xiong, Hong-Chao; Chen, Ke-Neng] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Thorac Surg 1, Beijing 100871, Peoples R China; [Dong, Bin] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Pathol, Beijing 100871, Peoples R China	Peking University; Peking University	Chen, KN (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Thorac Surg 1, Beijing 100871, Peoples R China.	chenkeneng@bjmu.edu.cn	Kang, Xiaozheng/J-1996-2019; Kang, Xiaozheng/CAF-6485-2022; LI, Hui/AHA-9715-2022	Kang, Xiaozheng/0000-0003-0334-1487; 				Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Agnelli L, 2011, AM J HEMATOL, V86, pE64, DOI 10.1002/ajh.22164; Kovochich AN, 2013, CANCER-AM CANCER SOC, V119, P529, DOI 10.1002/cncr.27725; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Care A, 1998, ONCOGENE, V16, P3285, DOI 10.1038/sj.onc.1201875; Care A, 1996, MOL CELL BIOL, V16, P4842; Care A, 1999, ONCOGENE, V18, P1993, DOI 10.1038/sj.onc.1202498; Care A, 2001, CANCER RES, V61, P6532; Chen HX, 2008, CANCER RES, V68, P3637, DOI 10.1158/0008-5472.CAN-07-2926; Chen KN, 2005, CLIN CANCER RES, V11, P1044; Chen WQ, 2015, CHINESE J CANCER RES, V27, P2, DOI 10.3978/j.issn.1000-9604.2015.01.06; Chile T, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-451; Destro MFDS, 2010, INT J ONCOL, V36, P141, DOI 10.3892/ijo_00000485; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; Liao WT, 2011, CLIN CANCER RES, V17, P3569, DOI 10.1158/1078-0432.CCR-10-2533; Liu S, 2015, CANCER RES, V75, P709, DOI 10.1158/0008-5472.CAN-14-3100; Long QY, 2014, ASIAN PAC J CANCER P, V15, P1563, DOI 10.7314/APJCP.2014.15.4.1563; Ma YL, 2010, J CELL MOL MED, V14, P2697, DOI 10.1111/j.1582-4934.2010.01191.x; Naora H, 2001, P NATL ACAD SCI USA, V98, P4060, DOI 10.1073/pnas.071594398; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Rustgi AK, 2014, NEW ENGL J MED, V371, P2499, DOI 10.1056/NEJMra1314530; Samuel S, 2005, EUR J CANCER, V41, P2428, DOI 10.1016/j.ejca.2005.08.014; Storti P, 2011, LEUKEMIA, V25, P527, DOI 10.1038/leu.2010.270; Takahashi O, 2007, ONCOL REP, V17, P753; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wu XY, 2006, CANCER RES, V66, P9527, DOI 10.1158/0008-5472.CAN-05-4470; Xie X, 2013, BIOMARKERS, V18, P297, DOI 10.3109/1354750X.2013.773380; Yahagi Naohisa, 2004, Congenital Anomalies, V44, P18, DOI 10.1111/j.1741-4520.2003.00004.x; Yuan WW, 2014, MOL CARCINOGEN, V53, P49, DOI 10.1002/mc.21947; Zhang R, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-61	30	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130551	10.1371/journal.pone.0130551	http://dx.doi.org/10.1371/journal.pone.0130551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076456	gold, Green Submitted, Green Published			2022-12-27	WOS:000356329900178
J	Lin, YS; Chen, TH; Hung, SP; Chen, DY; Mao, CT; Tsai, ML; Chang, ST; Wang, CC; Wen, MS; Chen, MC				Lin, Yu-Sheng; Chen, Tien-Hsing; Hung, Sheng-Ping; Chen, Dong Yi; Mao, Chun-Tai; Tsai, Ming-Lung; Chang, Shih-Tai; Wang, Chun-Chieh; Wen, Ming-Shien; Chen, Mien-Cheng			Impact of Pacemaker Lead Characteristics on Pacemaker Related Infection and Heart Perforation: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							ELECTRONIC DEVICE INFECTIONS; RISK-FACTORS; CARDIOVERTER-DEFIBRILLATORS; CONSECUTIVE PATIENTS; ESC GUIDELINES; RATES; MANAGEMENT; IMPLANTATION; COMPLICATION; PREDICTORS	Background Several risk factors for pacemaker (PM) related complications have been reported. However, no study has investigated the impact of lead characteristics on pacemaker-related complications. Methods and Results Patients who received a new pacemaker implant from January 1997 to December 2011 were selected from the Taiwan National Health Insurance Database. This population was grouped according to the pacemaker lead characteristics in terms of fixation and insulation. The impact of the characteristics of leads on early heart perforation was analyzed by multivariable logistic regression analysis, while the impact of the lead characteristics on early and late infection and late heart perforation over a three-year period were analyzed using Cox regression. This study included 36,104 patients with a mean age of 73.4 +/- 12.5 years. In terms of both early and late heart perforations, there were no significant differences between groups across the different types of fixation and insulations. In the multivariable Cox regression analysis, the pacemaker-related infection rate was significantly lower in the active fixation only group compared to either the both fixation (OR, 0.23; 95% CI, 0.07-0.80; P = 0.020) or the passive fixation group (OR, 0.26; 95% CI, 0.08-0.83; P = 0.023). Conclusions There was no difference in heart perforation between active and passive fixation leads. Active fixation leads were associated with reduced risk of pacemaker-related infection.	[Lin, Yu-Sheng; Chang, Shih-Tai] Chang Gung Mem Hosp, Div Cardiol, Dept Internal Med, Chiayi, Taiwan; [Lin, Yu-Sheng] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Kaohsiung, Taiwan; [Chen, Tien-Hsing; Chen, Dong Yi; Tsai, Ming-Lung; Wang, Chun-Chieh; Wen, Ming-Shien] Chang Gung Mem Hosp, Div Cardiol, Linkou, Taiwan; [Hung, Sheng-Ping] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Mao, Chun-Tai] Chang Gung Mem Hosp, Dept Med, Cardiol Sect, Keelung, Taiwan; [Chen, Mien-Cheng] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Div Cardiol, Kaohsiung, Taiwan; [Chen, Mien-Cheng] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chen, MC (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Div Cardiol, Kaohsiung, Taiwan.	chenmien@ms76.hinet.net						Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Cabell CH, 2004, AM HEART J, V147, P582, DOI 10.1016/j.ahj.2003.06.005; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Danik SB, 2007, HEART RHYTHM, V4, P439, DOI 10.1016/j.hrthm.2006.12.044; Dasgupta A, 2007, AM J KIDNEY DIS, V49, P656, DOI 10.1053/j.ajkd.2007.02.272; Dickstein K, 2010, EUR HEART J, V31, P2677, DOI 10.1093/eurheartj/ehq337; Geyfman V, 2007, PACE, V30, P498, DOI 10.1111/j.1540-8159.2007.00699.x; Johansen JB, 2011, EUR HEART J, V32, P991, DOI 10.1093/eurheartj/ehq497; Klug D, 2007, CIRCULATION, V116, P1349, DOI 10.1161/CIRCULATIONAHA.106.678664; Lekkerkerker JC, 2009, HEART, V95, P715, DOI 10.1136/hrt.2008.151985; Mahapatra S, 2005, HEART RHYTHM, V2, P907, DOI 10.1016/j.hrthm.2005.06.011; Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x; National Health Insurance Administration Ministry of Health and Welfare Taiwan ROC, 2014, NATL HLTH INSURANCE; Nery PB, 2010, J CARDIOVASC ELECTR, V21, P786, DOI 10.1111/j.1540-8167.2009.01690.x; Ohlow MA, 2013, CIRC J, V77, P975, DOI 10.1253/circj.CJ-12-0707; Piekarz J, 2012, ARCH MED SCI, V8, P70, DOI 10.5114/aoms.2012.27284; Refaat MM, 2010, CLIN CARDIOL, V33, P466, DOI 10.1002/clc.20803; Selcuk H, 2006, PACE, V29, P429, DOI 10.1111/j.1540-8159.2006.00366.x; Sohail MR, 2007, CLIN INFECT DIS, V45, P166, DOI 10.1086/518889; Sohail MR, 2011, ARCH INTERN MED, V171, P1821, DOI 10.1001/archinternmed.2011.441; Sohail MR, 2011, J INTERV CARD ELECTR, V31, P171, DOI 10.1007/s10840-010-9537-x; Sterlinski M, 2009, EUROPACE, V11, P206, DOI 10.1093/europace/eun363; Tompkins C, 2011, J CARDIOVASC ELECTR, V22, P1099, DOI 10.1111/j.1540-8167.2011.02066.x; Voigt A, 2010, PACE, V33, P414, DOI 10.1111/j.1540-8159.2009.02569.x	24	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128320	10.1371/journal.pone.0128320	http://dx.doi.org/10.1371/journal.pone.0128320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075602	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900019
J	Sonnaert, M; Kerckhofs, G; Papantoniou, I; Van Vlierberghe, S; Boterberg, V; Dubruel, P; Luyten, FP; Schrooten, J; Geris, L				Sonnaert, Maarten; Kerckhofs, Greet; Papantoniou, Ioannis; Van Vlierberghe, Sandra; Boterberg, Veerle; Dubruel, Peter; Luyten, Frank P.; Schrooten, Jan; Geris, Liesbet			Multifactorial Optimization of Contrast-Enhanced Nanofocus Computed Tomography for Quantitative Analysis of Neo-Tissue Formation in Tissue Engineering Constructs	PLOS ONE			English	Article							VERSATILE TOOL; MICRO-CT; SCAFFOLDS; BIOLOGY; 2D	To progress the fields of tissue engineering (TE) and regenerative medicine, development of quantitative methods for non-invasive three dimensional characterization of engineered constructs (i.e. cells/tissue combined with scaffolds) becomes essential. In this study, we have defined the most optimal staining conditions for contrast-enhanced nanofocus computed tomography for three dimensional visualization and quantitative analysis of in vitro engineered neo-tissue (i.e. extracellular matrix containing cells) in perfusion bioreactor-developed Ti6Al4V constructs. A fractional factorial 'design of experiments' approach was used to elucidate the influence of the staining time and concentration of two contrast agents (Hexabrix and phosphotungstic acid) and the neo-tissue volume on the image contrast and dataset quality. Additionally, the neo-tissue shrinkage that was induced by phosphotungstic acid staining was quantified to determine the operating window within which this contrast agent can be accurately applied. For Hexabrix the staining concentration was the main parameter influencing image contrast and dataset quality. Using phosphotungstic acid the staining concentration had a significant influence on the image contrast while both staining concentration and neo-tissue volume had an influence on the dataset quality. The use of high concentrations of phosphotungstic acid did however introduce significant shrinkage of the neo-tissue indicating that, despite sub-optimal image contrast, low concentrations of this staining agent should be used to enable quantitative analysis. To conclude, design of experiments allowed us to define the most optimal staining conditions for contrast-enhanced nanofocus computed tomography to be used as a routine screening tool of neo-tissue formation in Ti6Al4V constructs, transforming it into a robust three dimensional quality control methodology.	[Sonnaert, Maarten; Kerckhofs, Greet; Papantoniou, Ioannis; Luyten, Frank P.; Schrooten, Jan; Geris, Liesbet] Katholieke Univ Leuven, Div Skeletal Tissue Engn, Prometheus, Leuven, Belgium; [Sonnaert, Maarten; Schrooten, Jan] Katholieke Univ Leuven, Dept Mat Engn, Heverlee, Belgium; [Kerckhofs, Greet; Papantoniou, Ioannis; Luyten, Frank P.] Katholieke Univ Leuven, Dept Dev & Regenerat, Skeletal Biol & Engn Res Ctr, Leuven, Belgium; [Kerckhofs, Greet; Geris, Liesbet] Univ Liege, Biomech Res Unit, Liege, Belgium; [Van Vlierberghe, Sandra; Boterberg, Veerle; Dubruel, Peter] Univ Ghent, Polymer Chem & Biomat Grp, B-9000 Ghent, Belgium; [Geris, Liesbet] Katholieke Univ Leuven, Dept Mech Engn, Biomech Sect, Heverlee, Belgium	KU Leuven; KU Leuven; KU Leuven; University of Liege; Ghent University; KU Leuven	Kerckhofs, G (corresponding author), Katholieke Univ Leuven, Div Skeletal Tissue Engn, Prometheus, Leuven, Belgium.	greet.kerckhofs@med.kuleuven.be	Kerckhofs, Greet/J-5006-2016; Van Vlierberghe, Sandra./AAN-7863-2021; Papantoniou, Ioannis/ABF-1528-2021; Luyten, Frank/GPS-7793-2022; geris, liesbet/D-2343-2016	Kerckhofs, Greet/0000-0002-1750-8324; geris, liesbet/0000-0002-8180-1445; Dubruel, Peter/0000-0002-5928-7726; Van Vlierberghe, Sandra/0000-0001-7688-1682; Papantoniou, Ioannis/0000-0002-4754-5492	Ph.D. grant of the Agency for Innovation by Science and Technology [IWT/111457]; Research Foundation - Flanders [FWO/12R4315N]; European Research Council under the European Union's Seventh Framework Program (FP7)/ERC grant [279100, 294191]; Research Foundation Flanders (FWO, Belgium)	Ph.D. grant of the Agency for Innovation by Science and Technology; Research Foundation - Flanders(FWO); European Research Council under the European Union's Seventh Framework Program (FP7)/ERC grant(European Research Council (ERC)); Research Foundation Flanders (FWO, Belgium)(FWO)	MS is supported by a Ph.D. grant of the Agency for Innovation by Science and Technology (IWT/ 111457 - http://www.iwt.be/english/welcome). GK is currently financed by a postdoctoral grant of the Research Foundation - Flanders (FWO/12R4315N - http://www.fwo.be/en/). GK and LG acknowledge support by the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement no 279100 (http://erc.europa.eu/funding-and-grants). IP was supported by the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement REJOIND no 294191. SVV would like to acknowledge the Research Foundation Flanders (FWO, Belgium) for financial support under the form of a post-doctoral fellowship and a Research Grant ('Development of the ideal tissue engineering scaffold by merging state-of-the-art processing techniques', FWO Krediet aan Navorsers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel A, 2011, TISSUE ENG PART B-RE, V17, P321, DOI [10.1089/ten.teb.2011.0230, 10.1089/ten.TEB.2011.0230]; Berneel E, 2012, J BIOMED MATER RES A, V100A, P1783, DOI 10.1002/jbm.a.34125; Berneel EM, 2012, J TISSUE ENG REGEN M, V6, P372; Buytaert JAN, 2013, J HISTOCHEM CYTOCHEM, V61, P382, DOI 10.1369/0022155413478613; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; De Bari C, 2006, ARTHRITIS RHEUM, V54, P1209, DOI 10.1002/art.21753; Desmet T, 2010, MACROMOL BIOSCI, V10, P1484, DOI 10.1002/mabi.201000147; Eniwumide JO, 2007, EUR CELLS MATER, V14, P30, DOI 10.22203/eCM.v014a03; Fei J, 2010, ANAT REC, V293, P1984, DOI 10.1002/ar.21270; Granton PV, 2008, MED PHYS, V35, P5030, DOI 10.1118/1.2987668; Hedberg EL, 2005, TISSUE ENG, V11, P1356, DOI 10.1089/ten.2005.11.1356; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Jones AC, 2007, BIOMATERIALS, V28, P2491, DOI 10.1016/j.biomaterials.2007.01.046; Kerckhofs G, 2014, CARTILAGE, V5, P55, DOI 10.1177/1947603513501175; Kerckhofs G, 2013, EUR CELLS MATER, V25, P179, DOI 10.22203/eCM.v025a13; Kreutz C, 2009, FEBS J, V276, P923, DOI 10.1111/j.1742-4658.2008.06843.x; Lakin BA, 2013, OSTEOARTHR CARTILAGE, V21, P60, DOI 10.1016/j.joca.2012.09.007; Langer M, 2010, J MICROSC-OXFORD, V238, P230, DOI [10.1111/j.1365-2818.2009.03345.x, 10.1111/j.1365-2818.2009.03545.x]; Lusic H, 2013, CHEM REV, V113, P1641, DOI 10.1021/cr200358s; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Nam SY, 2015, TISSUE ENG PART B-RE, V21, P88, DOI [10.1089/ten.teb.2014.0180, 10.1089/ten.TEB.2014.0180]; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Papantoniou I, 2014, TISSUE ENG PART C-ME, V20, P177, DOI [10.1089/ten.tec.2013.0041, 10.1089/ten.TEC.2013.0041]; Papantoniou I, 2013, TISSUE ENG PART C-ME, V19, P596, DOI [10.1089/ten.tec.2012.0526, 10.1089/ten.TEC.2012.0526]; Pauwels E, 2013, J MICROSC-OXFORD, V250, P21, DOI 10.1111/jmi.12013; Schulz-Mirbach T, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-63; Smith LE, 2010, MICROSC RES TECHNIQ, V73, P1123, DOI 10.1002/jemt.20859; Sonnaert M, 2017, J TISSUE ENG REGEN M, V11, P519, DOI 10.1002/term.1951; Sonnaert M, 2015, TISSUE ENG PART C-ME, V21, P519, DOI [10.1089/ten.tec.2014.0255, 10.1089/ten.TEC.2014.0255]; Van Bael S, 2011, MAT SCI ENG A-STRUCT, V528, P7423, DOI 10.1016/j.msea.2011.06.045; van Lenthe GH, 2007, BIOMATERIALS, V28, P2479, DOI 10.1016/j.biomaterials.2007.01.017; Vickerton P, 2013, J ANAT, V223, P185, DOI 10.1111/joa.12068; Voronov RS, 2013, TISSUE ENG PART C-ME, V19, P327, DOI [10.1089/ten.tec.2011.0612, 10.1089/ten.TEC.2011.0612]; Wilkins SW, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0021; Wong MD, 2012, DEVELOPMENT, V139, P3248, DOI 10.1242/dev.082016; Xie L, 2010, OSTEOARTHR CARTILAGE, V18, P65, DOI 10.1016/j.joca.2009.07.014	37	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130227	10.1371/journal.pone.0130227	http://dx.doi.org/10.1371/journal.pone.0130227			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076131	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900158
J	Tookes, H; Chanelle, D; Li, H; Khalid, R; Doblecki-Lewis, S				Tookes, Hansel; Diaz, Chanelle; Li, Hua; Khalid, Rafi; Doblecki-Lewis, Susanne			A Cost Analysis of Hospitalizations for Infections Related to Injection Drug Use at a County Safety-Net Hospital in Miami, Florida	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; NECROTIZING FASCIITIS; NEEDLE EXCHANGE; RISK-FACTORS; BACTERIAL-INFECTIONS; SYRINGE PROGRAMS; SAN-FRANCISCO; ENDOCARDITIS; ABSCESSES; CARE	Background Infections related to injection drug use are common. Harm reduction strategies such as syringe exchange programs and skin care clinics aim to prevent these infections in injection drug users (IDUs). Syringe exchange programs are currently prohibited by law in Florida. The goal of this study was to estimate the mortality and cost of injection drug use-related bacterial infections over a 12-month period to the county safety-net hospital in Miami, Florida. Additionally, the prevalence of HIV and hepatitis C virus among this cohort of hospitalized IDUs was estimated. Methods and Findings IDUs discharged from Jackson Memorial Hospital were identified using the International Classification of Diseases, Ninth Revision, codes for illicit drug abuse and endocarditis, bacteremia or sepsis, osteomyelitis and skin and soft tissue infections (SSTIs). 349 IDUs were identified for chart abstraction and 92% were either uninsured or had publicly funded insurance. SSTIs, the most common infection, were reported in 64% of IDUs. HIV seroprevalence was 17%. Seventeen patients (4.9%) died during their hospitalization. The total cost for treatment for injection drug use-related infections to Jackson Memorial Hospital over the 12-month period was $11.4 million. Conclusions Injection drug use-related bacterial infections represent a significant morbidity for IDUs in Miami-Dade County and a substantial financial cost to the county hospital. Strategies aimed at reducing risk of infections associated with injection drug use could decrease morbidity and the cost associated with these common, yet preventable infections.	[Tookes, Hansel] Jackson Mem Hosp, Dept Internal Med, Miami, FL 33136 USA; [Diaz, Chanelle] Univ Miami, Miller Sch Med, Dept Med Educ, Miami, FL 33136 USA; [Li, Hua] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Khalid, Rafi] Jackson Mem Hosp, Dept Jackson Hlth Syst Res, Miami, FL 33136 USA; [Doblecki-Lewis, Susanne] Univ Miami, Miller Sch Med, Div Infect Dis, Dept Internal Med, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Tookes, H (corresponding author), Jackson Mem Hosp, Dept Internal Med, Miami, FL 33136 USA.	hetookes@med.miami.edu			Infectious Diseases Society of America Medical Scholars Program; Jackson Memorial Hospital Department of Internal Medicine Resident Scholarly Activity Program	Infectious Diseases Society of America Medical Scholars Program; Jackson Memorial Hospital Department of Internal Medicine Resident Scholarly Activity Program	This work was supported by the Infectious Diseases Society of America Medical Scholars Program to HT SD, (http://www.idsociety.org/Medical_Scholars_Program/) and the Jackson Memorial Hospital Department of Internal Medicine Resident Scholarly Activity Program to HT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Hospital Directory, 2015, JACKS MEM HOSP FAC P; Belani HK, 2008, J HIV-AIDS SOC SERV, V7, P229, DOI 10.1080/15381500802307492; Binswanger IA, 2000, CLIN INFECT DIS, V30, P579, DOI 10.1086/313703; Binswanger IA, 2008, J STUD ALCOHOL DRUGS, V69, P924, DOI 10.15288/jsad.2008.69.924; Broz D, 2014, MMWR SURVEILL SUMM, V63, P1; Centers for Disease Control and Prevention, 2012, HIV SURV REP DIAGN H, V24; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P381; Chen JL, 2001, CLIN INFECT DIS, V33, P6, DOI 10.1086/320874; Cooper HLF, 2007, CLIN INFECT DIS, V45, P1200, DOI 10.1086/522176; del Giudice P, 2004, BRIT J DERMATOL, V150, P1, DOI 10.1111/j.1365-2133.2004.05607.x; Department of Health, 2013, AG LEG BILL AN HB 73; Ebright JR, 2002, INFECT DIS CLIN N AM, V16, P697, DOI 10.1016/S0891-5520(02)00017-X; Frontera JA, 2000, CLIN INFECT DIS, V30, P374, DOI 10.1086/313664; Gebo KA, 2005, JAIDS-J ACQ IMM DEF, V40, P609, DOI 10.1097/01.qai.0000171727.55553.78; Gold M, 1997, CAN MED ASSOC J, V157, P255; Gordon RJ, 2005, NEW ENGL J MED, V353, P1945, DOI 10.1056/NEJMra042823; Hall JN, 2014, DRUG ABUSE TRENDS MI, P6; Harris HW, 2002, ARCH SURG-CHICAGO, V137, P1217, DOI 10.1001/archsurg.137.11.1217; Heinzerling KG, 2006, J URBAN HEALTH, V83, P176, DOI 10.1007/s11524-005-9021-6; Holtgrave DR, 1998, J ACQ IMMUN DEF SYND, V18, pS133, DOI 10.1097/00042560-199802001-00022; Hyshka E, 2012, INT J DRUG POLICY, V23, P261, DOI 10.1016/j.drugpo.2012.03.006; Jain V, 2008, J INFECTION, V57, P132, DOI 10.1016/j.jinf.2008.05.008; Kak V, 2002, INFECT DIS CLIN N AM, V16, P681, DOI 10.1016/S0891-5520(02)00016-8; Kimura AC, 2004, CLIN INFECT DIS, V38, pE87, DOI 10.1086/383471; Kwon JA, 2012, AIDS, V26, P2201, DOI 10.1097/QAD.0b013e3283578b5d; Lloyd-Smith Elisa, 2005, Harm Reduct J, V2, P24, DOI 10.1186/1477-7517-2-24; Lloyd-Smith E, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-405; Lonergan S, 2004, J EMERG MED, V26, P47, DOI 10.1016/j.jemermed.2003.06.003; Lurie P, 1998, J ACQ IMMUN DEF SYND, V18, pS126, DOI 10.1097/00042560-199802001-00021; Marks M, 2013, J INFECTION, V66, P95, DOI 10.1016/j.jinf.2012.10.004; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Murphy EL, 2001, CLIN INFECT DIS, V33, P35, DOI 10.1086/320879; Palepu A, 2001, CAN MED ASSOC J, V165, P415; Phillips KT, 2010, AM J DRUG ALCOHOL AB, V36, P92, DOI 10.3109/00952991003592311; Saydain G, 2010, J CRIT CARE, V25, P248, DOI 10.1016/j.jcrc.2009.09.007; Simmen HP, 1995, J HAND SURG-BRIT EUR, V20B, P797, DOI 10.1016/S0266-7681(95)80050-6; Spijkerman IJB, 1996, J CLIN EPIDEMIOL, V49, P1149, DOI 10.1016/0895-4356(96)00180-1; Stein MD, 2001, DRUG ALCOHOL DEPEN, V64, P117, DOI 10.1016/S0376-8716(00)00235-0; Sweeney R, 2009, AUST NZ J PUBL HEAL, V33, P352, DOI 10.1111/j.1753-6405.2009.00407.x; Takahashi TA, 2007, J GEN INTERN MED, V22, P382, DOI 10.1007/s11606-006-0079-y; Takahashi TA, 2010, J BEHAV HEALTH SER R, V37, P508, DOI 10.1007/s11414-009-9177-z; Tempalski B, 2009, J URBAN HEALTH, V86, P132, DOI 10.1007/s11524-008-9328-1; Tookes HE, 2012, DRUG ALCOHOL DEPEN, V123, P255, DOI 10.1016/j.drugalcdep.2011.12.001; Tunkel AR, 2002, INFECT DIS CLIN N AM, V16, P589, DOI 10.1016/S0891-5520(02)00015-6; U.S. Census Bureau, 2013, MIAM DAD COUNT QUICK	45	85	86	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129360	10.1371/journal.pone.0129360	http://dx.doi.org/10.1371/journal.pone.0129360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075888	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900066
J	Smorodinova, N; Lantova, L; Blaha, M; Melenovsky, V; Hanzelka, J; Pirk, J; Kautzner, J; Kucera, T				Smorodinova, Natalia; Lantova, Lucie; Blaha, Martin; Melenovsky, Vojtech; Hanzelka, Jan; Pirk, Jan; Kautzner, Josef; Kucera, Tomas			Bioptic Study of Left and Right Atrial Interstitium in Cardiac Patients with and without Atrial Fibrillation: Interatrial but Not Rhythm-Based Differences	PLOS ONE			English	Article							MITRAL-VALVE DISEASE; EXTRACELLULAR-MATRIX; HEART; FIBROSIS; TISSUE	One of the generally recognized factors contributing to the initiation and maintenance of atrial fibrillation (AF) is structural remodeling of the myocardium that affects both atrial cardiomyocytes as well as interstitium. The goal of this study was to characterize morphologically and functionally interstitium of atria in patients with AF or in sinus rhythm (SR) who were indicated to heart surgery. Patient population consisted of 46 subjects (19 with long-term persistent AF, and 27 in SR) undergoing coronary bypass or valve surgery. Peroperative bioptic samples of the left and the right atria were examined using immunohistochemistry to visualize and quantify collagen I, collagen III, elastin, desmin, smooth muscle actin, endothelium and Vascular Endothelial Growth Factor (VEGF). The content of interstitial elastin, collagen I, and collagen III in atrial tissue was similar in AF and SR groups. However, the right atrium was more than twofold more abundant in elastin as compared with the left atrium and similar difference was found for collagen I and III. The right atrium showed also higher VEGF expression and lower microvascular density as compared to the left atrium. No significant changes in atrial extracellular matrix fiber content, microvascular density and angiogenic signaling, attributable to AF, were found in this cohort of patients with structural heart disease. This finding suggests that interstitial fibrosis and other morphological changes in atrial tissue are rather linked to structural heart disease than to AF per se. Significant regional differences in interstitial structure between right and left atrium is a novel observation that deserves further investigation.	[Smorodinova, Natalia; Lantova, Lucie; Hanzelka, Jan; Kucera, Tomas] Charles Univ Prague, Fac Med 1, Inst Histol & Embryol, Prague, Czech Republic; [Blaha, Martin; Melenovsky, Vojtech; Kautzner, Josef] Inst Clin & Expt Med IKEM, Dept Cardiol, Prague, Czech Republic; [Pirk, Jan] Inst Clin & Expt Med IKEM, Dept Cardiovasc Surg, Prague, Czech Republic	Charles University Prague; Institute for Clinical & Experimental Medicine (IKEM); Institute for Clinical & Experimental Medicine (IKEM)	Kucera, T (corresponding author), Charles Univ Prague, Fac Med 1, Inst Histol & Embryol, Prague, Czech Republic.	tkucer@lf1.cuni.cz	Kučera, Tomáš/C-7532-2017; Smorodinova, Natalia/Q-6111-2017; Melenovsky, Vojtech/T-9422-2019; Blaha, Martin/G-5015-2015; lantova, Lucie/Q-9412-2017; Smorodinova, Natalia/AAK-6820-2020	Kučera, Tomáš/0000-0003-2134-4657; Smorodinova, Natalia/0000-0003-1211-8703; Melenovsky, Vojtech/0000-0001-8921-7078; Blaha, Martin/0000-0003-3597-6604; lantova, Lucie/0000-0002-4619-6059; Smorodinova, Natalia/0000-0003-1211-8703; Blaha, Martin/0000-0003-4626-3757	Research Program of Charles University [PRVOUK P25/LF1/2, P27/LF1/1]; Ministry of Health for Development of Research Organization [00023001]; EU Operational Program Prague -Competitiveness: project CEVKOON [CZ.2.16/3.1.00/22126]; UNCE (University research centre) [204013]; Charles University in Prague	Research Program of Charles University; Ministry of Health for Development of Research Organization; EU Operational Program Prague -Competitiveness: project CEVKOON; UNCE (University research centre); Charles University in Prague	This work was supported by the Research Program of Charles University - PRVOUK P25/LF1/2 and P27/LF1/1, Ministry of Health for Development of Research Organization 00023001 (IKEM, institutional support) and by the EU Operational Program Prague-Competitiveness: project CEVKOON (CZ.2.16/3.1.00/22126). Lucie Lantova was partially supported by UNCE (University research centre) 204013, a funding program of the Charles University in Prague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Anne W, 2005, CARDIOVASC RES, V67, P655, DOI 10.1016/j.cardiores.2005.04.016; Boldt A, 2004, HEART, V90, P400, DOI 10.1136/hrt.2003.015347; Darby AE, 2012, CIRCULATION, V125, P945, DOI 10.1161/CIRCULATIONAHA.111.019935; De Jong AM, 2011, CARDIOVASC RES, V89, P754, DOI 10.1093/cvr/cvq357; de Oliveira IM, 2013, CARDIOVASC PATHOL, V22, P65, DOI 10.1016/j.carpath.2012.06.001; Ferreira JP, 2015, INT J MOL SCI, V16, P3133, DOI 10.3390/ijms16023133; Fomovsky GM, 2010, J MOL CELL CARDIOL, V48, P490, DOI 10.1016/j.yjmcc.2009.08.003; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Gramley F, 2010, CARDIOVASC PATHOL, V19, P102, DOI 10.1016/j.carpath.2008.11.001; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Kostin S, 2002, CARDIOVASC RES, V54, P361, DOI 10.1016/S0008-6363(02)00273-0; Ogi H, 2010, CIRC J, V74, P1815, DOI 10.1253/circj.CJ-09-0969; Platonov PG, 2011, J AM COLL CARDIOL, V58, P2225, DOI 10.1016/j.jacc.2011.05.061; Polyakova V, 2008, J CELL MOL MED, V12, P189, DOI 10.1111/j.1582-4934.2008.00219.x; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; TILTON RG, 1979, MICROVASC RES, V18, P325, DOI 10.1016/0026-2862(79)90041-4; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Wyse DG, 2014, J AM COLL CARDIOL, V63, P1715, DOI 10.1016/j.jacc.2014.01.023; Zhao JC, 2012, CIRC-ARRHYTHMIA ELEC, V5, P361, DOI 10.1161/CIRCEP.111.967950	20	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129124	10.1371/journal.pone.0129124	http://dx.doi.org/10.1371/journal.pone.0129124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067062	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000050
J	LeBlanc, AG; Katzmarzyk, PT; Barreira, TV; Broyles, ST; Chaput, JP; Church, TS; Fogelholm, M; Harrington, DM; Hu, G; Kuriyan, R; Kurpad, A; Lambert, EV; Maher, C; Maia, J; Matsudo, V; Olds, T; Onywera, V; Sarmiento, OL; Standage, M; Tudor-Locke, C; Zhao, P; Tremblay, MS				LeBlanc, Allana G.; Katzmarzyk, Peter T.; Barreira, Tiago V.; Broyles, Stephanie T.; Chaput, Jean-Philippe; Church, Timothy S.; Fogelholm, Mikael; Harrington, Deirdre M.; Hu, Gang; Kuriyan, Rebecca; Kurpad, Anura; Lambert, Estelle V.; Maher, Carol; Maia, Jose; Matsudo, Victor; Olds, Timothy; Onywera, Vincent; Sarmiento, Olga L.; Standage, Martyn; Tudor-Locke, Catrine; Zhao, Pei; Tremblay, Mark S.		ISCOLE Res Grp	Correlates of Total Sedentary Time and Screen Time in 9-11 Year-Old Children around the World: The International Study of Childhood Obesity, Lifestyle and the Environment	PLOS ONE			English	Article							SCHOOL-AGED CHILDREN; PHYSICAL-ACTIVITY; HEALTH INDICATORS; UNITED-STATES; BEHAVIOR; TELEVISION; RISK; FITNESS; PATTERNS; BEDROOM	Purpose Previously, studies examining correlates of sedentary behavior have been limited by small sample size, restricted geographic area, and little socio-cultural variability. Further, few studies have examined correlates of total sedentary time (SED) and screen time (ST) in the same population. This study aimed to investigate correlates of SED and ST in children around the world. Methods The sample included 5,844 children (45.6% boys, mean age = 10.4 years) from study sites in Australia, Brazil, Canada, China, Colombia, Finland, India, Kenya, Portugal, South Africa, the United Kingdom, and the United States. Child- and parent-reported behavioral, household, and neighborhood characteristics and directly measured anthropometric and accelerometer data were obtained. Twenty-one potential correlates of SED and ST were examined using multilevel models, adjusting for sex, age, and highest parental education, with school and study site as random effects. Variables that were moderately associated with SED and/or ST in univariate analyses (p<0.10) were included in the final models. Variables that remained significant in the final models (p<0.05) were considered correlates of SED and/or ST. Results Children averaged 8.6 hours of daily SED, and 54.2% of children failed to meet ST guidelines. In all study sites, boys reported higher ST, were less likely to meet ST guidelines, and had higher BMI z-scores than girls. In 9 of 12 sites, girls engaged in significantly more SED than boys. Common correlates of higher SED and ST included poor weight status, not meeting physical activity guidelines, and having a TV or a computer in the bedroom. Conclusions In this global sample many common correlates of SED and ST were identified, some of which are easily modifiable (e.g., removing TV from the bedroom), and others that may require more intense behavioral interventions (e.g., increasing physical activity). Future work should incorporate these findings into the development of culturally meaningful public health messages.	[LeBlanc, Allana G.; Chaput, Jean-Philippe; Tremblay, Mark S.] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [LeBlanc, Allana G.; Chaput, Jean-Philippe] Univ Ottawa, Ottawa, ON, Canada; [Katzmarzyk, Peter T.; Barreira, Tiago V.; Broyles, Stephanie T.; Church, Timothy S.; Hu, Gang; Tudor-Locke, Catrine] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Barreira, Tiago V.] Syracuse Univ, Syracuse, NY USA; [Fogelholm, Mikael] Univ Helsinki, Helsinki, Finland; [Harrington, Deirdre M.] Univ Leicester, Leicester, Leics, England; [Kuriyan, Rebecca; Kurpad, Anura] St Johns Res Inst, Bangalore, Karnataka, India; [Lambert, Estelle V.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Maher, Carol; Olds, Timothy] Univ S Australia, Sch Hlth Sci, Sansom Inst, Adelaide, SA 5001, Australia; [Maia, Jose] Univ Porto, Fac Desporto, P-4100 Porto, Portugal; [Matsudo, Victor] Ctr Estudos Lab Aptidao Fis Sao Caetano do Sul CE, Sao Paulo, Brazil; [Onywera, Vincent] Kenyatta Univ, Nairobi, Kenya; [Sarmiento, Olga L.] Univ Los Andes, Sch Med, Bogota, Colombia; [Standage, Martyn] Univ Bath, Bath BA2 7AY, Avon, England; [Zhao, Pei] Tianjin Womens & Childrens Hlth Ctr, Tianjin, Peoples R China	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Syracuse University; University of Helsinki; University of Leicester; St. John's National Academy of Health Sciences; St. John's Research Institute; University of Cape Town; University of South Australia; Universidade do Porto; Kenyatta University; Universidad de los Andes (Colombia); University of Bath	LeBlanc, AG (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada.	alleblanc@cheo.on.ca	Tremblay, Mark/AAF-2981-2019; Maher, Carol/C-8169-2009; Hu, Gang/V-7947-2019; Lambert, Estelle/ABF-1268-2020; Katzmarzyk, Peter T/N-1974-2017; LeBlanc, Allana/AAX-1651-2021; Olds, Tim/A-1223-2008; Sarmiento, Olga L/AAS-4165-2020; Standage, Martyn/O-5545-2015; Tremblay, Mark/ABI-5477-2020; Broyles, Stephanie/C-8647-2011; Hu, Gang/N-1971-2017; Barreira, Tiago/AAD-9429-2021; Chaput, Jean-Philippe/ABE-6307-2020; Tudor-Locke, Catrine/AAC-2829-2021	Maher, Carol/0000-0002-8676-0224; Hu, Gang/0000-0002-6172-8017; Lambert, Estelle/0000-0003-4315-9153; Katzmarzyk, Peter T/0000-0002-9280-6022; LeBlanc, Allana/0000-0002-4468-6783; Olds, Tim/0000-0001-6894-5519; Sarmiento, Olga L/0000-0002-9190-3568; Standage, Martyn/0000-0002-9683-8590; Broyles, Stephanie/0000-0003-3168-0056; Hu, Gang/0000-0002-6172-8017; Chaput, Jean-Philippe/0000-0002-5607-5736; Harrington, Deirdre/0000-0003-0278-6812	Coca-Cola Company	Coca-Cola Company	ISCOLE was funded by The Coca-Cola Company. The funder had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the manuscript.	Adachi-Mejia AM, 2007, INT J OBESITY, V31, P644, DOI 10.1038/sj.ijo.0803455; Anderson SE, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-366; [Anonymous], 2012, US CENT DIS CONTR PR; Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Barreira TV, 2013, PEDIATR OBES, V8, pe29, DOI 10.1111/j.2047-6310.2012.00122.x; Barreira TV, 2015, MED SCI SPORT EXER, V47, P937, DOI 10.1249/MSS.0000000000000486; Biddle SJH, 2009, ANN BEHAV MED, V38, P147, DOI 10.1007/s12160-009-9136-1; Cameron AJ, 2013, PEDIATR OBES, V8, P130, DOI 10.1111/j.2047-6310.2012.00094.x; Cao H, 2011, PREV MED, V53, P316, DOI 10.1016/j.ypmed.2011.09.002; Caspersen CJ, 2000, MED SCI SPORT EXER, V32, P1601; Cespedes EM, 2014, PEDIATRICS, V133, pE1163, DOI 10.1542/peds.2013-3998; Colley Rachel, 2010, Health Rep, V21, P63; Colley RC, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-200, 10.1186/1471-2458-13-554]; Craney T. A., 2002, Quality Engineering, V14, P391, DOI 10.1081/QEN-120001878; Cui ZH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-93; Currie C, 2008, INEQUALITIES IN CHIL; de Onis M, 2010, INT J PEDIATR OBES, V5, P458, DOI 10.3109/17477161003615583; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Fakhouri THI, 2013, JAMA PEDIATR, V167, P223, DOI 10.1001/2013.jamapediatrics.122; Gorely T, 2004, INT J BEHAV MED, V11, P152, DOI 10.1207/s15327558ijbm1103_4; Hardy LL, 2013, J SCI MED SPORT, V16, P28, DOI 10.1016/j.jsams.2012.05.010; Brodersen NH, 2007, BRIT J SPORT MED, V41, P140, DOI 10.1136/bjsm.2006.031138; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Katzmarzyk PT, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-900; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; LeBlanc AG, 2012, APPL PHYSIOL NUTR ME, V37, P753, DOI [10.1139/h2012-063, 10.1139/H2012-063]; Rodrigues AMM, 2010, PEDIATR EXERC SCI, V22, P442, DOI 10.1123/pes.22.3.442; Muthuri SK, 2014, INT J ENV RES PUB HE, V11, P3327, DOI 10.3390/ijerph110303327; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Roemmich JN, 2007, ANN BEHAV MED, V33, P29, DOI 10.1207/s15324796abm3301_4; Saunders TJ, 2013, METABOLISM, V62, P1423, DOI 10.1016/j.metabol.2013.05.010; Schaefer L, 2014, J PEDIATR-US, V165, P516, DOI 10.1016/j.jpeds.2014.05.029; Staiano AE, 2013, AM J PREV MED, V44, P40, DOI 10.1016/j.amepre.2012.09.049; Temmel CSD, 2013, HLTH FIT J CAN, V6, P81, DOI DOI 10.14288/HFJC.V6I1.146; Timmons BW, 2012, APPL PHYSIOL NUTR ME, V37, P773, DOI [10.1139/h2012-070, 10.1139/H2012-070]; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P65, DOI 10.1139/H11-013; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P36, DOI [10.1139/H11-009, 10.1139/H11-010]; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e	40	99	102	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129622	10.1371/journal.pone.0129622	http://dx.doi.org/10.1371/journal.pone.0129622			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK3FB	26068231	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000356100900062
J	Pacheco-Colon, I; Washington, SD; Sprouse, C; Helman, G; Gropman, AL; VanMeter, JW				Pacheco-Colon, Ileana; Washington, Stuart D.; Sprouse, Courtney; Helman, Guy; Gropman, Andrea L.; VanMeter, John W.			Reduced Functional Connectivity of Default Mode and Set-Maintenance Networks in Ornithine Transcarbamylase Deficiency	PLOS ONE			English	Article							SUPERIOR FRONTAL GYRUS; WORKING-MEMORY; CINGULATE CORTEX; BRAIN NETWORKS; INBORN-ERRORS; ACTIVATION; COGNITION; CARRIERS; DISEASE; COMMON	Background and Purpose Ornithine transcarbamylase deficiency (OTCD) is an X-chromosome linked urea cycle disorder (UCD) that causes hyperammonemic episodes leading to white matter injury and impairments in executive functioning, working memory, and motor planning. This study aims to investigate differences in functional connectivity of two resting-state networks-default mode and set-maintenance-between OTCD patients and healthy controls. Methods Sixteen patients with partial OTCD and twenty-two control participants underwent a resting-state scan using 3T fMRI. Combining independent component analysis (ICA) and region-of-interest (ROI) analyses, we identified the nodes that comprised each network in each group, and assessed internodal connectivity. Results Group comparisons revealed reduced functional connectivity in the default mode network (DMN) of OTCD patients, particularly between the anterior cingulate cortex/medial prefrontal cortex (ACC/mPFC) node and bilateral inferior parietal lobule (IPL), as well as between the ACC/mPFC node and the posterior cingulate cortex (PCC) node. Patients also showed reduced connectivity in the set-maintenance network, especially between right anterior insula/frontal operculum (aI/fO) node and bilateral superior frontal gyrus (SFG), as well as between the right aI/fO and ACC and between the ACC and right SFG. Conclusion Internodal functional connectivity in the DMN and set-maintenance network is reduced in patients with partial OTCD compared to controls, most likely due to hyperammonemia-related white matter damage. Because several of the affected areas are involved in executive functioning, it is postulated that this reduced connectivity is an underlying cause of the deficits OTCD patients display in this cognitive domain.	[Pacheco-Colon, Ileana; Washington, Stuart D.; Gropman, Andrea L.; VanMeter, John W.] Georgetown Univ, Ctr Funct & Mol Imaging, Washington, DC 20057 USA; [Pacheco-Colon, Ileana; Washington, Stuart D.; VanMeter, John W.] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC USA; [Sprouse, Courtney; Helman, Guy; Gropman, Andrea L.] Childrens Natl Hlth Syst, Dept Neurogenet, Washington, DC USA; [Sprouse, Courtney; Gropman, Andrea L.] George Washington Univ Hlth Sci, Washington, DC USA; [Gropman, Andrea L.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA	Georgetown University; Georgetown University; Children's National Health System; George Washington University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Pacheco-Colon, I (corresponding author), Georgetown Univ, Ctr Funct & Mol Imaging, Washington, DC 20057 USA.	pachecoileana@gmail.com	VanMeter, John W/D-2589-2018; Helman, Guy T/C-7935-2017; Lang, Steven/AAE-8102-2021	VanMeter, John W/0000-0002-7012-5197; Helman, Guy T/0000-0002-4784-7423; Lang, Steven/0000-0003-1669-9146; Pacheco-Colon, Ileana/0000-0001-7908-8428	NIH-National Institute of Child Health and Human Development [5U54HD061221, 1KL2RR031974-01, 2P30HD040677-11]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677, U54HD061221] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031974] Funding Source: NIH RePORTER	NIH-National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was completed as part of NIH-funded grants National Institute of Child Health and Human Development 5U54HD061221, 1KL2RR031974-01, and 2P30HD040677-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Applegarth DA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.1.e10; BATSHAW ML, 1986, J PEDIATR-US, V108, P236, DOI 10.1016/S0022-3476(86)80989-1; BATSHAW ML, 1980, NEW ENGL J MED, V302, P482, DOI 10.1056/NEJM198002283020902; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Brusilow S W, 1996, Adv Pediatr, V43, P127; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Caldovic L, 2003, HUM GENET, V112, P364, DOI 10.1007/s00439-003-0909-5; Caldovic L, 2002, BIOCHEM BIOPH RES CO, V299, P581, DOI 10.1016/S0006-291X(02)02696-7; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Carter CS, 1995, NEUROIMAGE, V2, P264, DOI 10.1006/nimg.1995.1034; Cutini S, 2008, NEUROIMAGE, V42, P945, DOI 10.1016/j.neuroimage.2008.05.013; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dionisi-Vici C, 2002, J PEDIATR-US, V140, P321, DOI 10.1067/mpd.2002.122394; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Ford JH, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00307; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gropman AL, 2008, MOL GENET METAB, V95, P21, DOI 10.1016/j.ymgme.2008.06.003; Gropman AL, 2010, AM J NEURORADIOL, V31, P1719, DOI 10.3174/ajnr.A2122; Gropman AL, 2004, MOL GENET METAB, V81, pS58, DOI 10.1016/j.ymgme.2003.11.016; Gropman AL, 2013, HUM BRAIN MAPP, V34, P753, DOI 10.1002/hbm.21470; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Gyato K, 2004, ANN NEUROL, V55, P80, DOI 10.1002/ana.10794; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; KANG ES, 1973, J PEDIATR-US, V82, P642, DOI 10.1016/S0022-3476(73)80590-6; Kim H, 2010, NEUROIMAGE, V50, P1648, DOI 10.1016/j.neuroimage.2010.01.051; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; McCullough BA, 2000, AM J MED GENET, V93, P313, DOI 10.1002/1096-8628(20000814)93:4<313::AID-AJMG11>3.0.CO;2-M; MSALL M, 1984, NEW ENGL J MED, V310, P1500, DOI 10.1056/NEJM198406073102304; Msall M, 1988, Acta Paediatr Jpn, V30, P435; NAGATA N, 1991, AM J MED GENET, V39, P228, DOI 10.1002/ajmg.1320390226; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Nicolaides P, 2002, ARCH DIS CHILD, V86, P54, DOI 10.1136/adc.86.1.54; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041376; Rama P, 2001, NEUROIMAGE, V13, P1090, DOI 10.1006/nimg.2001.0777; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Sprouse C, 2014, MOL GENET METAB, V113, P136, DOI 10.1016/j.ymgme.2014.05.007; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Uddin LQ, 2013, TRENDS COGN SCI, V17, P600, DOI 10.1016/j.tics.2013.09.011; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Washington SD, 2014, HUM BRAIN MAPP, V35, P1284, DOI 10.1002/hbm.22252; Zhang LJ, 2012, HUM BRAIN MAPP, V33, P1384, DOI 10.1002/hbm.21295	55	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129595	10.1371/journal.pone.0129595	http://dx.doi.org/10.1371/journal.pone.0129595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067829	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900061
J	Varela, S; Lima-Ribeiro, MS; Terribile, LC				Varela, Sara; Lima-Ribeiro, Matheus S.; Terribile, Levi Carina			A Short Guide to the Climatic Variables of the Last Glacial Maximum for Biogeographers	PLOS ONE			English	Article							MODELS	Ecological niche models are widely used for mapping the distribution of species during the last glacial maximum (LGM). Although the selection of the variables and General Circulation Models (GCMs) used for constructing those maps determine the model predictions, we still lack a discussion about which variables and which GCM should be included in the analysis and why. Here, we analyzed the climatic predictions for the LGM of 9 different GCMs in order to help biogeographers to select their GCMs and climatic layers for mapping the species ranges in the LGM. We 1) map the discrepancies between the climatic predictions of the nine GCMs available for the LGM, 2) analyze the similarities and differences between the GCMs and group them to help researchers choose the appropriate GCMs for calibrating and projecting their ecological niche models (ENM) during the LGM, and 3) quantify the agreement of the predictions for each bioclimatic variable to help researchers avoid the environmental variables with a poor consensus between models. Our results indicate that, in absolute values, GCMs have a strong disagreement in their temperature predictions for temperate areas, while the uncertainties for the precipitation variables are in the tropics. In spite of the discrepancies between model predictions, temperature variables (BIO1-BIO11) are highly correlated between models. Precipitation variables (BIO12-BIO19) show no correlation between models, and specifically, BIO14 (precipitation of the driest month) and BIO15 (Precipitation Seasonality (Coefficient of Variation)) show the highest level of discrepancy between GCMs. Following our results, we strongly recommend the use of different GCMs for constructing or projecting ENMs, particularly when predicting the distribution of species that inhabit the tropics and the temperate areas of the Northern and Southern Hemispheres, because climatic predictions for those areas vary greatly among GCMs. We also recommend the exclusion of BIO14 and BIO15 from ENMs because those variables show a high level of discrepancy between GCMs. Thus, by excluding them, we decrease the level of uncertainty of our predictions.	[Varela, Sara] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic; [Varela, Sara] Leibniz Inst Evolut & Biodivers Sci, Museum Naturkunde, Berlin, Germany; [Lima-Ribeiro, Matheus S.; Terribile, Levi Carina] UFG, Dept Ciencias Biol, Jatai, Go, Brazil	Charles University Prague; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Universidade Federal de Goias	Varela, S (corresponding author), Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic.	svarela@paleobiogeography.org	Terribile, Levi Carina/AAW-1102-2021; LIMA-RIBEIRO, MATHEUS S./H-9503-2014; Varela, Sara/J-7725-2016	Terribile, Levi Carina/0000-0001-8420-9300; LIMA-RIBEIRO, MATHEUS S./0000-0002-3322-1702; Varela, Sara/0000-0002-5756-5737	Education for Competitiveness Operational Programme (ECOP) project 'Support of establishment, development and mobility of quality research teams at the Charles University' [CZ.1.07/2.3.00/30.0022]; European Science Foundation; Czech Republic; CNPq [563727/2010-1, 473811/2013-8]; FAPEG [2012/1026.700.1086, 2012-1026.700.1086]; CNPq researcher fellowship	Education for Competitiveness Operational Programme (ECOP) project 'Support of establishment, development and mobility of quality research teams at the Charles University'; European Science Foundation(European Science Foundation (ESF)European Commission); Czech Republic(Czech Republic Government); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEG(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG)); CNPq researcher fellowship	This paper was made possible by funding from the Education for Competitiveness Operational Programme (ECOP) project 'Support of establishment, development and mobility of quality research teams at the Charles University' (CZ.1.07/2.3.00/30.0022). SV is funded by the European Science Foundation and Czech Republic. Research projects of LCT and MSLR are supported by CNPq (processes 563727/2010-1 and 473811/2013-8) and FAPEG (2012/1026.700.1086). LCT is supported by a CNPq researcher fellowship. MSLR thanks FAPEG for financial support to his research in paleobiology (process number 2012-1026.700.1086).	Abellan P, 2011, GLOBAL ECOL BIOGEOGR, V20, P87, DOI 10.1111/j.1466-8238.2010.00572.x; [Anonymous], 2013, MAPTOOLS TOOLS READI; Barrientos R, 2014, MOL ECOL, V23, P390, DOI 10.1111/mec.12588; Collevatti RG, 2013, J BIOGEOGR, V40, P345, DOI 10.1111/jbi.12005; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; de Lima NE, 2014, J BIOGEOGR, V41, P673, DOI 10.1111/jbi.12269; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hartkamp A.D., 1999, NGG GIS SERIES, V99-01; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2013, RASTER GEOGRAPHIC DA; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Kohler P, 2010, QUATERNARY SCI REV, V29, P129, DOI 10.1016/j.quascirev.2009.09.026; Lima-Ribeiro MS, 2012, NAT CONSERVACAO, V10, P145, DOI 10.4322/natcon.2012.022; Lucas A., 2014, ANOTHER MULTIDIMENSI; McGuffie K., 2014, CLIMATE MODELLING PR; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Peltier WR, 2007, GEOL SOC AM SPEC PAP, V426, P5, DOI 10.1130/2007.2426(02); Pierce D, 2014, INTERFACE UNIDATA NE; Plate T., 2011, ABIND COMBINE MULTID; R Core Team, 2021, R LANGUAGE ENV STAT; Roberts DR, 2012, GLOBAL ECOL BIOGEOGR, V21, P121, DOI 10.1111/j.1466-8238.2011.00657.x; Shin SI, 2003, CLIM DYNAM, V20, P127, DOI 10.1007/s00382-002-0260-x; Svenning JC, 2011, QUATERNARY SCI REV, V30, P2930, DOI 10.1016/j.quascirev.2011.06.012; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Varela S, 2010, ZONA ARQUEOLOGICA, V13, P68; Varela S, 2011, APPL MODELOS DISTRIB; Varela S, 2014, ECOGRAPHY, V37, P1084, DOI 10.1111/j.1600-0587.2013.00441.x; Varela S, 2011, PALAEOGEOGR PALAEOCL, V310, P451, DOI 10.1016/j.palaeo.2011.07.021; Varela S, 2010, QUATERNARY SCI REV, V29, P2027, DOI 10.1016/j.quascirev.2010.04.017; Wilby RL, 2004, INTERGOVERNMENTAL PA	34	78	81	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129037	10.1371/journal.pone.0129037	http://dx.doi.org/10.1371/journal.pone.0129037			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068930	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900039
J	Xiong, HH; Huang, XQ; Li, Y; Li, JH; Xian, JF; Huang, YQ				Xiong, Huahui; Huang, Xiaoqing; Li, Yong; Li, Jianhong; Xian, Junfang; Huang, Yaqi			A Method for Accurate Reconstructions of the Upper Airway Using Magnetic Resonance Images	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; NASAL CAVITY; 3-DIMENSIONAL ANALYSIS; PHARYNGEAL COLLAPSE; ACOUSTIC RHINOMETRY; DRUG-DELIVERY; MODEL; FLOW; SURGERY; SEGMENTATION	Objective The purpose of this study is to provide an optimized method to reconstruct the structure of the upper airway (UA) based on magnetic resonance imaging (MRI) that can faithfully show the anatomical structure with a smooth surface without artificial modifications. Methods MRI was performed on the head and neck of a healthy young male participant in the axial, coronal and sagittal planes to acquire images of the UA. The level set method was used to segment the boundary of the UA. The boundaries in the three scanning planes were registered according to the positions of crossing points and anatomical characteristics using a Matlab program. Finally, the three-dimensional (3D) NURBS (Non-Uniform Rational B-Splines) surface of the UA was constructed using the registered boundaries in all three different planes. Results A smooth 3D structure of the UA was constructed, which captured the anatomical features from the three anatomical planes, particularly the location of the anterior wall of the nasopharynx. The volume and area of every cross section of the UA can be calculated from the constructed 3D model of UA. Conclusions A complete scheme of reconstruction of the UA was proposed, which can be used to measure and evaluate the 3D upper airway accurately.	[Xiong, Huahui; Huang, Xiaoqing; Li, Yong; Huang, Yaqi] Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China; [Xiong, Huahui; Huang, Xiaoqing; Li, Yong; Huang, Yaqi] Capital Med Univ, Beijing Key Lab Fundamental Res Biomech Clin Appl, Beijing, Peoples R China; [Li, Jianhong; Xian, Junfang] Capital Med Univ, Beijing Tongren Hosp, Dept Radiol, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Xian, JF (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Radiol, Beijing, Peoples R China.	cjr.xianjunfang@vip.163.com; yqhuang@ccmu.edu.cn			National Science and Technology Pillar Program of China [2012BAI05B03]; National Natural Science Foundation of China [81171422]; Key Projects in Science and Technology Program of Beijing Municipal Education Commission, China [KZ201210025022]; Beijing outstanding talent training program, China [2011D005018000009]; China postdoctoral science foundation [2011M500026]	National Science and Technology Pillar Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in Science and Technology Program of Beijing Municipal Education Commission, China; Beijing outstanding talent training program, China; China postdoctoral science foundation(China Postdoctoral Science Foundation)	YH is supported by grants from the National Science and Technology Pillar Program of China (2012BAI05B03), the National Natural Science Foundation of China (81171422), and the Key Projects in Science and Technology Program of Beijing Municipal Education Commission, China (KZ201210025022). HX is supported by a grant from the Beijing outstanding talent training program, China (2011D005018000009). JX is supported by a grant from the China postdoctoral science foundation (2011M500026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GM, 2004, J BIOMECH ENG-T ASME, V126, P604, DOI 10.1115/1.1800554; Alsufyani NA, 2012, DENTOMAXILLOFAC RAD, V41, P276, DOI 10.1259/dmfr/79433138; Chen XB, 2010, J AEROSOL MED PULM D, V23, P329, DOI 10.1089/jamp.2009.0776; Cisonni J, 2013, J BIOMECH, V46, P2504, DOI 10.1016/j.jbiomech.2013.07.007; El AS, 2011, J ORAL MAXIL SURG, V69, P2424, DOI 10.1016/j.joms.2010.11.046; Elad D, 2008, RESP PHYSIOL NEUROBI, V163, P121, DOI 10.1016/j.resp.2008.05.002; Furuhashi A, 2013, J ORAL REHABIL, V40, P582, DOI 10.1111/joor.12059; GRYMER LF, 1989, LARYNGOSCOPE, V99, P1180; Haralambidis A, 2009, AM J ORTHOD DENTOFAC, V136, P815, DOI 10.1016/j.ajodo.2008.03.020; Huang YQ, 2007, LARYNGOSCOPE, V117, P648, DOI 10.1097/MLG.0b013e318030ca55; Huang YQ, 2005, CHEST, V128, P1324, DOI 10.1378/chest.128.3.1324; Huang YQ, 2005, J APPL PHYSIOL, V99, P1138, DOI 10.1152/japplphysiol.00668.2004; Inthavong K, 2011, COMPUT METHOD BIOMEC, V14, P633, DOI 10.1080/10255842.2010.493510; Kim SK, 2013, J BIOMECH, V46, P299, DOI 10.1016/j.jbiomech.2012.11.022; Kleven M, 2005, FOOD BIOPROD PROCESS, V83, P107, DOI 10.1205/fbp.04403; Li CM, 2011, IEEE T IMAGE PROCESS, V20, P2007, DOI 10.1109/TIP.2011.2146190; Li CM, 2010, IEEE T IMAGE PROCESS, V19, P3243, DOI 10.1109/TIP.2010.2069690; Liu Y, 2009, J APPL PHYSIOL, V106, P784, DOI 10.1152/japplphysiol.90376.2008; Ma W, 1998, INT J ADV MANUF TECH, V14, P918, DOI 10.1007/BF01179082; Malhotra A, 2002, LANCET, V360, P237, DOI 10.1016/S0140-6736(02)09464-3; Malhotra A, 2002, AM J RESP CRIT CARE, V166, P1388, DOI 10.1164/rccm.2112072; Mihaescu M, 2008, ANN OTO RHINOL LARYN, V117, P303, DOI 10.1177/000348940811700411; Mitiche A, 2010, SPRINGER TOP SIGN PR, V5, P1; Mylavarapu G, 2013, J BIOMECH, V46, P1979, DOI 10.1016/j.jbiomech.2013.06.016; Mylavarapu G, 2009, J BIOMECH, V42, P1553, DOI 10.1016/j.jbiomech.2009.03.035; Schendel SA, 2014, AM J ORTHOD DENTOFAC, V146, P385, DOI 10.1016/j.ajodo.2014.01.026; Schwab RJ, 2003, AM J RESP CRIT CARE, V168, P522, DOI 10.1164/rccm.200208-866OC; Shome B, 1998, J BIOMECH ENG-T ASME, V120, P416, DOI 10.1115/1.2798009; Sievers KW, 2000, EUR J RADIOL, V33, P185, DOI 10.1016/S0720-048X(99)00142-4; Stratemann S, 2011, AM J ORTHOD DENTOFAC, V140, P607, DOI 10.1016/j.ajodo.2010.12.019; Stuck BA, 2008, SLEEP MED REV, V12, P411, DOI 10.1016/j.smrv.2007.08.009; Terheyden H, 2000, J APPL PHYSIOL, V89, P1013, DOI 10.1152/jappl.2000.89.3.1013; Tu JY, 2013, COMPUTATIONAL FLUID, P45; Wang TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095544; Wang Y, 2012, INT J NUMER METH BIO, V28, P528, DOI 10.1002/cnm.1486; Weissheimer A, 2012, AM J ORTHOD DENTOFAC, V142, P801, DOI 10.1016/j.ajodo.2012.07.015; Xu C, 2009, MED ENG PHYS, V31, P1343, DOI 10.1016/j.medengphy.2009.08.006; Zhao MY, 2013, J BIOMECH, V46, P42; Zhu JH, 2012, J BIOMECH, V45, P1992, DOI 10.1016/j.jbiomech.2012.04.027; ZINREICH SJ, 1988, J COMPUT ASSIST TOMO, V12, P1014, DOI 10.1097/00004728-198811000-00019	41	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130186	10.1371/journal.pone.0130186	http://dx.doi.org/10.1371/journal.pone.0130186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066461	Green Submitted, gold, Green Published			2022-12-27	WOS:000356100900102
J	Zhao, HP; Steiger, A; Nohner, M; Ye, H				Zhao, Huiping; Steiger, Amanda; Nohner, Mitch; Ye, Hui			Specific Intensity Direct Current (DC) Electric Field Improves Neural Stem Cell Migration and Enhances Differentiation towards beta-III-Tubulin plus Neurons	PLOS ONE			English	Article							FREQUENCY ELECTROMAGNETIC-FIELDS; SPINAL-CORD-INJURY; PROGENITOR CELLS; OSTEOGENIC DIFFERENTIATION; SUBVENTRICULAR ZONE; NEUROLOGICAL RECOVERY; CALCIUM; STROKE; RAT; NEUROGENESIS	Control of stem cell migration and differentiation is vital for efficient stem cell therapy. Literature reporting electric field-guided migration and differentiation is emerging. However, it is unknown if a field that causes cell migration is also capable of guiding cell differentiation- and the mechanisms for these processes remain unclear. Here, we report that a 115 V/m direct current (DC) electric field can induce directional migration of neural precursor cells (NPCs). Whole cell patching revealed that the cell membrane depolarized in the electric field, and buffering of extracellular calcium via EGTA prevented cell migration under these conditions. Immunocytochemical staining indicated that the same electric intensity could also be used to enhance differentiation and increase the percentage of cell differentiation into neurons, but not astrocytes and oligodendrocytes. The results indicate that DC electric field of this specific intensity is capable of promoting cell directional migration and orchestrating functional differentiation, suggestively mediated by calcium influx during DC field exposure.	[Zhao, Huiping; Steiger, Amanda; Nohner, Mitch; Ye, Hui] Loyola Univ, Dept Biol, Chicago, IL 60626 USA	Loyola University Chicago	Ye, H (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.	hye1@luc.edu			Loyola University Chicago	Loyola University Chicago	Amanda Steiger is supported by the MS program from Loyola University Chicago. Mitch Nohner is supported by the Mulcahy Scholars Program from Loyola University Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariza CA, 2010, STEM CELL REV REP, V6, P585, DOI 10.1007/s12015-010-9171-0; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ayoob JC, 2004, J NEUROSCI, V24, P6639, DOI 10.1523/JNEUROSCI.1104-04.2004; Babona-Pilipos R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023808; Bikson M, 2001, J PHYSIOL-LONDON, V531, P181, DOI 10.1111/j.1469-7793.2001.0181j.x; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; Cao L, 2015, STEM CELL REV REP, V11, P75, DOI 10.1007/s12015-014-9524-1; Cao L, 2013, EMBO REP, V14, P184, DOI 10.1038/embor.2012.215; Chan AY, 1998, J CELL SCI, V111, P199; COOPER MS, 1984, P NATL ACAD SCI-BIOL, V81, P160, DOI 10.1073/pnas.81.1.160; Coulter CB, 1921, J GEN PHYSIOL, V3, P309, DOI 10.1085/jgp.3.3.309; D'Ascenzo M, 2006, EUR J NEUROSCI, V23, P935, DOI 10.1111/j.1460-9568.2006.04628.x; Erlandsson A, 2011, EXP NEUROL, V230, P48, DOI 10.1016/j.expneurol.2010.05.018; Feng JF, 2012, STEM CELLS, V30, P349, DOI 10.1002/stem.779; Gaetani R, 2009, CARDIOVASC RES, V82, P411, DOI 10.1093/cvr/cvp067; Gao RC, 2011, EUKARYOT CELL, V10, P1251, DOI 10.1128/EC.05066-11; Hess R, 2012, BIOMATERIALS, V33, P8975, DOI 10.1016/j.biomaterials.2012.08.056; Hronik-Tupaj M, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-9; Jouni FJ, 2014, DIFFERENTIATION, V87, P230, DOI 10.1016/j.diff.2014.06.001; Kang KS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.11; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Kobelt LJ, 2014, ANN BIOMED ENG, V42, P2164, DOI 10.1007/s10439-014-1058-9; Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402; Komitova M, 2005, STROKE, V36, P1278, DOI 10.1161/01.STR.0000166197.94147.59; Kotnik T, 2006, BIOPHYS J, V90, P480, DOI 10.1529/biophysj.105.070771; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Li L, 2008, STEM CELLS, V26, P2193, DOI 10.1634/stemcells.2007-1022; Li YC, 2014, STEM CELL REV REP, V10, P653, DOI 10.1007/s12015-014-9518-z; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Liu J, 2015, EXP NEUROL, V263, P113, DOI 10.1016/j.expneurol.2014.09.014; Liu Y, 2013, ACTA BIOMATER, V9, P8075, DOI 10.1016/j.actbio.2013.06.001; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Matos MA, 2010, BIOTECHNOL PROGR, V26, P664, DOI 10.1002/btpr.389; McCullen SD, 2010, TISSUE ENG PART C-ME, V16, P1377, DOI [10.1089/ten.tec.2009.0751, 10.1089/ten.TEC.2009.0751]; Meng XT, 2011, EXP NEUROL, V227, P210, DOI 10.1016/j.expneurol.2010.11.002; Mycielska ME, 2004, J CELL SCI, V117, P1631, DOI 10.1242/jcs.01125; ONUMA EK, 1988, J CELL BIOL, V106, P2067, DOI 10.1083/jcb.106.6.2067; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Pavesi A, 2014, BIOTECHNOL BIOENG, V111, P1452, DOI 10.1002/bit.25201; Piacentini R, 2008, J CELL PHYSIOL, V215, P129, DOI 10.1002/jcp.21293; Postma M, 2004, EMBO REP, V5, P35, DOI 10.1038/sj.embor.7400051; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ruff CA, 2013, J NEUROSCI, V33, P11899, DOI 10.1523/JNEUROSCI.1131-13.2013; Scarlett SS, 2009, BBA-BIOMEMBRANES, V1788, P1168, DOI 10.1016/j.bbamem.2009.02.006; SCHWAN H P, 1957, Adv Biol Med Phys, V5, P147; Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9; Spedden E, 2012, BIOPHYS J, V103, P868, DOI 10.1016/j.bpj.2012.08.005; Stroh A, 2011, STEM CELLS, V29, P78, DOI 10.1002/stem.558; Tekle E, 2005, BIOPHYS J, V89, P274, DOI 10.1529/biophysj.104.054494; Teramoto T, 2003, J CLIN INVEST, V111, P1125, DOI 10.1172/JCI200317170; Thrivikraman G, 2014, BIOMATERIALS, V35, P6219, DOI 10.1016/j.biomaterials.2014.04.018; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; WERTH JL, 1994, J NEUROSCI, V14, P348; White JA, 2004, J BIOL CHEM, V279, P22964, DOI 10.1074/jbc.M311135200; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8	55	41	42	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129625	10.1371/journal.pone.0129625	http://dx.doi.org/10.1371/journal.pone.0129625			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068466	Green Submitted, Green Published, gold			2022-12-27	WOS:000356100900063
J	Taubert, M; Wenzel, U; Draganski, B; Kiebel, SJ; Ragert, P; Krug, J; Villringer, A				Taubert, Marco; Wenzel, Uwe; Draganski, Bogdan; Kiebel, Stefan J.; Ragert, Patrick; Krug, Juergen; Villringer, Arno			Investigating Neuroanatomical Features in Top Athletes at the Single Subject Level	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; MOTOR SKILL; INDIVIDUAL-DIFFERENCES; BRAIN; PLASTICITY; NETWORK; NEUROPLASTICITY; ARCHITECTURE; PERFORMANCE; MECHANISMS	In sport events like Olympic Games or World Championships competitive athletes keep pushing the boundaries of human performance. Compared to team sports, high achievements in many athletic disciplines depend solely on the individual's performance. Contrasting previous research looking for expertise-related differences in brain anatomy at the group level, we aim to demonstrate changes in individual top athlete's brain, which would be averaged out in a group analysis. We compared structural magnetic resonance images (MRI) of three professional track-and-field athletes to age-, gender- and education-matched control subjects. To determine brain features specific to these top athletes, we tested for significant deviations in structural grey matter density between each of the three top athletes and a carefully matched control sample. While total brain volumes were comparable between athletes and controls, we show regional grey matter differences in striatum and thalamus. The demonstrated brain anatomy patterns remained stable and were detected after 2 years with Olympic Games in between. We also found differences in the fusiform gyrus in two top long jumpers. We interpret our findings in reward-related areas as correlates of top athletes' persistency to reach top-level skill performance over years.	[Taubert, Marco; Draganski, Bogdan; Kiebel, Stefan J.; Ragert, Patrick; Villringer, Arno] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Wenzel, Uwe; Ragert, Patrick; Krug, Juergen] Univ Leipzig, Inst Gen Kinesiol & Athlet Training, D-04109 Leipzig, Germany; [Draganski, Bogdan] Univ Lausanne, CHUV, Dept Clin Neurosci, LREN, Lausanne, Switzerland; [Kiebel, Stefan J.] Tech Univ, Neuroimaging Ctr, Dept Psychol, Dresden, Germany	Max Planck Society; Leipzig University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Technische Universitat Dresden	Taubert, M (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	taubert@cbs.mpg.de	Ragert, Patrick/AAI-7290-2020; Draganski, Bogdan/C-3096-2016; Kiebel, Stefan J/B-1551-2009	Draganski, Bogdan/0000-0002-5159-5919; Kiebel, Stefan J/0000-0002-5052-1117; Villringer, Arno/0000-0003-2604-2404	European Union; European Regional Development Fund (ERDF); Free State of Saxony within the framework of the Excellence Initiative	European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony within the framework of the Excellence Initiative	This work was supported by the European Union, European Regional Development Fund (ERDF) and Free State of Saxony within the framework of the Excellence Initiative to LIFE-Leipzig Research Centre for Civilization Diseases at the University of Leipzig (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Berman Y, 2010, PHYSIOLOGY, V25, P250, DOI 10.1152/physiol.00008.2010; BOBBERT MF, 1986, EUR J APPL PHYSIOL O, V54, P566, DOI 10.1007/BF00943342; Bradshaw EJ, 2000, J APPL BIOMECH, V16, P331, DOI 10.1123/jab.16.4.331; Bradshaw EJ, 2006, SPORT BIOMECH, V5, P1, DOI 10.1080/14763141.2006.9628221; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Castro-Alamancos MA, 2009, NEUROSCIENTIST, V15, P625, DOI 10.1177/1073858409333074; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Gartner H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00636; Gaser C, 2003, J NEUROSCI, V23, P9240; Gerber P, 2014, NEUROIMAGE, V95, P320, DOI 10.1016/j.neuroimage.2014.04.023; Groenewegen Henk J., 2003, Neural Plasticity, V10, P107, DOI 10.1155/NP.2003.107; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Haith AM, 2013, ADV EXP MED BIOL, V782, P1, DOI 10.1007/978-1-4614-5465-6_1; HAY L, 1986, PERCEPT MOTOR SKILL, V62, P51, DOI 10.2466/pms.1986.62.1.51; HENSON R, 2006, COMP SINGLE PATIENT; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Johansen-Berg H, 2010, CURR OPIN NEUROL, V23, P351, DOI 10.1097/WCO.0b013e32833b7631; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kilavik BE, 2009, J NEUROSCI, V29, P12653, DOI 10.1523/JNEUROSCI.1554-09.2009; LEE DN, 1982, J EXP PSYCHOL HUMAN, V8, P448; Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517; Muhlau M, 2009, AM J NEURORADIOL, V30, P539, DOI 10.3174/ajnr.A1390; Muhlau M, 2012, PLOS ONE, V7; Noppeney U, 2007, BRAIN, V130, P1138, DOI 10.1093/brain/awl344; Park IS, 2011, HUM MOVEMENT SCI, V30, P56, DOI 10.1016/j.humov.2010.09.001; Park IS, 2009, CEREBELLUM, V8, P334, DOI 10.1007/s12311-009-0100-1; Pavlov I.P., 1927, CONDITIONED REFLEXES; Picard N, 2013, NAT NEUROSCI, V16, P1340, DOI 10.1038/nn.3477; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Roberts RE, 2013, CEREB CORTEX, V23, P2282, DOI 10.1093/cercor/bhs219; Salmond CH, 2003, PHILOS T R SOC B, V358, P405, DOI 10.1098/rstb.2002.1210; Scarpazza C, 2013, NEUROIMAGE, V70, P175, DOI 10.1016/j.neuroimage.2012.12.045; Schlaffke L, 2014, NEUROSCIENCE, V259, P35, DOI 10.1016/j.neuroscience.2013.11.046; Schultz J, 2008, CEREB CORTEX, V18, P1302, DOI 10.1093/cercor/bhm162; Schultz W, 2003, SCIENCE, V300, P1662, DOI 10.1126/science.1085353; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Schultz W, 2003, TRENDS NEUROSCI, V26, P321, DOI 10.1016/S0166-2236(03)00122-X; Shmuelof L, 2011, NEURON, V72, P469, DOI 10.1016/j.neuron.2011.10.017; Smesny S, 2010, NEUROIMAGE, V52, P1314, DOI 10.1016/j.neuroimage.2010.05.009; Stanley J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00503; Tennant KA, 2012, NEUROBIOL LEARN MEM, V98, P291, DOI 10.1016/j.nlm.2012.09.004; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Walsh V, 2014, CURR BIOL, V24, pR859, DOI 10.1016/j.cub.2014.08.003; Wang B, 2013, NEUROIMAGE, V65, P476, DOI 10.1016/j.neuroimage.2012.10.007; Wei GX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028309; Wenzel U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096871; WINNER E, 1993, J AESTHET EDUC, V27, P31, DOI 10.2307/3333498; Wong AL, 2014, NEUROSCIENTIST; Xu T., 2009, NATURE; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672	59	9	10	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129508	10.1371/journal.pone.0129508	http://dx.doi.org/10.1371/journal.pone.0129508			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9EB	26079870	Green Published, gold, Green Submitted			2022-12-27	WOS:000356542300025
J	Brenig, B; Schutz, E; Hardt, M; Scheuermann, P; Freick, M				Brenig, Bertram; Schuetz, Ekkehard; Hardt, Michael; Scheuermann, Petra; Freick, Markus			A 20 bp Duplication in Exon 2 of the Aristaless-Like Homeobox 4 Gene (ALX4) Is the Candidate Causative Mutation for Tibial Hemimelia Syndrome in Galloway Cattle	PLOS ONE			English	Article							COMPLEX VERTEBRAL MALFORMATION; GOLLOP-WOLFGANG COMPLEX; SWISS-MODEL WORKSPACE; LIMB DEVELOPMENT; FRONTONASAL DYSPLASIA; OSSIFICATION DEFECTS; HOMEODOMAIN; AGENESIS; CALF; DNA	Aristaless-like homeobox 4 (ALX4) gene is an important transcription regulator in skull and limb development. In humans and mice ALX4 mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis. Here we show that a complex skeletal malformation of the hind limb in Galloway cattle together with other developmental anomalies is a recessive autosomal disorder most likely caused by a duplication of 20 bp in exon 2 of the bovine ALX4 gene. A second duplication of 34 bp in exon 4 of the same gene has no known effect, although both duplications result in a frameshift and premature stop codon leading to a truncated protein. Genotyping of 1,688 Black/Red/Belted/Riggit Galloway (GA) and 289 White Galloway (WGA) cattle showed that the duplication in exon 2 has allele frequencies of 1% in GA and 6% in WGA and the duplication in exon 4 has frequencies of 23% in GA and 38% in WGA. Both duplications were not detected in 876 randomly selected German Holstein Friesian and 86 cattle of 21 other breeds. Hence, we have identified a candidate causative mutation for tibial hemimelia syndrome in Galloway cattle and selection against this mutation can be used to eliminate the mutant allele from the breed.	[Brenig, Bertram; Schuetz, Ekkehard] Univ Gottingen, Inst Vet Med, D-37077 Gottingen, Germany; [Hardt, Michael; Scheuermann, Petra] Landesuntersuchungsanstalt Gesundheits & Vet Sach, D-04158 Leipzig, Germany; [Freick, Markus] Vet Practice Zettlitz, D-09306 Zettlitz, Germany	University of Gottingen	Brenig, B (corresponding author), Univ Gottingen, Inst Vet Med, D-37077 Gottingen, Germany.	bbrenig@gwdg.de	Freick, Markus/H-6545-2019	Brenig, Bertram/0000-0002-7635-9656	Erxleben Research AMP; Innovation Council [ERIC-BR1959-2013-01]; Veterinary Practice Zettlitz	Erxleben Research AMP; Innovation Council; Veterinary Practice Zettlitz	This work was supported by a grant of the Erxleben Research & Innovation Council to BB (ERIC-BR1959-2013-01). Veterinary Practice Zettlitz provided support in the form of a salary for author MF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the "author contributions" section.	Agerholm JS, 2006, J VET DIAGN INVEST, V18, P418, DOI 10.1177/104063870601800421; Agerholm JS, 2001, J VET DIAGN INVEST, V13, P283, DOI 10.1177/104063870101300401; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beever J, 2012, INVENTORSSCREENING G; Benazet JD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001339; Bennett Robin L, 2008, J Genet Couns, V17, P424, DOI 10.1007/s10897-008-9169-9; Bertola DR, 2013, AM J MED GENET A, V161A, P600, DOI 10.1002/ajmg.a.35762; Boras-Granic K, 2006, INT J DEV BIOL, V50, P601, DOI 10.1387/ijdb.062153kb; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Brouwer A, 2003, MECH DEVELOP, V120, P241, DOI 10.1016/S0925-4773(02)00416-1; Charlier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043085; Chen B, 2013, GENET MOL RES, V12, P2771, DOI 10.4238/2013.August.2.2; Colloton J., 2014, BOVINE REPROD, P226; Dee CT, 2013, HUM MOL GENET, V22, P239, DOI 10.1093/hmg/dds423; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Drogemuller C, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-5; Drogemuller C, 2006, VET J, V171, P120, DOI 10.1016/j.tvjl.2004.09.009; Erickson RP, 2005, AM J MED GENET A, V134A, P315, DOI 10.1002/ajmg.a.30636; Ettensohn CA, 2003, DEVELOPMENT, V130, P2917, DOI 10.1242/dev.00511; Evans JA, 1999, AM J MED GENET, V85, P13, DOI 10.1002/(SICI)1096-8628(19990702)85:1<13::AID-AJMG5>3.0.CO;2-N; Ferrarini A, 2014, AM J MED GENET A, V164, P346, DOI 10.1002/ajmg.a.36140; GUFFY MM, 1977, J AM VET RADIOL SOC, V18, P109; Hall CR, 2001, CLIN GENET, V60, P356, DOI 10.1034/j.1399-0004.2001.600506.x; Hudson R, 1998, DEV DYNAM, V213, P159, DOI 10.1002/(SICI)1097-0177(199810)213:2<159::AID-AJA1>3.0.CO;2-F; JONES D, 1978, J BONE JOINT SURG BR, V60, P31, DOI 10.1302/0301-620X.60B1.627576; Kariminejad A, 2014, AM J MED GENET A, V164, P1322, DOI 10.1002/ajmg.a.36008; Kayserili H, 2012, AM J MED GENET A, V158A, P236, DOI 10.1002/ajmg.a.34390; Kayserili H, 2009, HUM MOL GENET, V18, P4357, DOI 10.1093/hmg/ddp391; Kuijper S, 2005, DEV BIOL, V285, P533, DOI 10.1016/j.ydbio.2005.06.017; Lapointe JM, 2000, VET PATHOL, V37, P508, DOI 10.1354/vp.37-5-508; Leipold HW, 1998, J VET DIAGN INVEST, V10, P247, DOI 10.1177/104063879801000304; Lynch VJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-86; Matsumaru D, 2014, EUR J HUM GENET, V22, P350, DOI 10.1038/ejhg.2013.160; Mavrogiannis LA, 2001, NAT GENET, V27, P17, DOI 10.1038/83703; Mendilcioglu I, 2009, PRENATAL DIAG, V29, P182, DOI 10.1002/pd.2204; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; OJO SA, 1974, J AM VET MED ASSOC, V165, P548; Panman L, 2005, INT J DEV BIOL, V49, P443, DOI 10.1387/ijdb.051984lp; POLLOCK DL, 1979, VET REC, V104, P258, DOI 10.1136/vr.104.12.258; Rice R, 2003, DEV BIOL, V262, P75, DOI 10.1016/S0012-1606(03)00355-5; Rozen S, 2000, Methods Mol Biol, V132, P365; SALAKO MA, 1982, VET REC, V110, P430, DOI 10.1136/vr.110.18.430; Schutz E, 1999, BIOTECHNIQUES, V27, P1218, DOI 10.2144/99276bc04; SHANG ZG, 1994, P NATL ACAD SCI USA, V91, P8373, DOI 10.1073/pnas.91.18.8373; Stevens CA, 1999, AM J MED GENET, V85, P409, DOI 10.1002/(SICI)1096-8628(19990806)85:4<409::AID-AJMG19>3.0.CO;2-6; Szczerbal I, 2006, VET PATHOL, V43, P789, DOI 10.1354/vp.43-5-789; Takahashi M, 1998, DEVELOPMENT, V125, P4417; Tavtigian SV, 2008, HUM MUTAT, V29, P1327, DOI 10.1002/humu.20892; Thomsen B, 2006, GENOME RES, V16, P97, DOI 10.1101/gr.3690506; Tung CS, 1999, J BIOMOL STRUCT DYN, V17, P347, DOI 10.1080/07391102.1999.10508366; von Ahsen N, 1999, CLIN CHEM, V45, P2094; Whitlock BK, 2008, THERIOGENOLOGY, V70, P535, DOI 10.1016/j.theriogenology.2008.04.016; Wohlke A, 2006, CYTOGENET GENOME RES, V115, P123, DOI 10.1159/000095231; Wuyts W, 2000, J MED GENET, V37, P916, DOI 10.1136/jmg.37.12.916; Xu Xianzhong, 2014, Journal of Structural and Functional Genomics, V15, P201, DOI 10.1007/s10969-014-9184-z; YOUNG G B, 1951, Br Vet J, V107, P23	58	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129208	10.1371/journal.pone.0129208	http://dx.doi.org/10.1371/journal.pone.0129208			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076463	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900052
J	Ctori, I; Huntjens, B				Ctori, Irene; Huntjens, Byki			Repeatability of Foveal Measurements Using Spectralis Optical Coherence Tomography Segmentation Software	PLOS ONE			English	Article							RETINAL THICKNESS MEASUREMENTS; MACULAR THICKNESS; TIME-DOMAIN; MULTIPLE-SCLEROSIS; LAYER THICKNESS; REPRODUCIBILITY; OCT; HEALTHY; PIGMENT; MORPHOLOGY	Purpose To investigate repeatability and reproducibility of thickness of eight individual retinal layers at axial and lateral foveal locations, as well as foveal width, measured from Spectralis spectral domain optical coherence tomography (SD-OCT) scans using newly available retinal layer segmentation software. Methods High-resolution SD-OCT scans were acquired for 40 eyes of 40 young healthy volunteers. Two scans were obtained in a single visit for each participant. Using new Spectralis segmentation software, two investigators independently obtained thickness of each of eight individual retinal layers at 0 degrees, 2 degrees and 5 degrees eccentricities nasal and temporal to foveal centre, as well as foveal width measurements. Bland-Altman Coefficient of Repeatability (CoR) was calculated for inter-investigator and inter-scan agreement of all retinal measurements. Spearman's. indicated correlation of manually located central retinal thickness (RT0) with automated minimum foveal thickness (MFT) measurements. In addition, we investigated nasal-temporal symmetry of individual retinal layer thickness within the foveal pit. Results Inter-scan CoR values ranged from 3.1 mu m for axial retinal nerve fibre layer thickness to 15.0 mu m for the ganglion cell layer at 5 degrees eccentricity. Mean foveal width was 2550 mu m +/- 322 mu m with a CoR of 13 mu m for inter-investigator and 40 mu m for inter-scan agreement. Correlation of RT0 and MFT was very good (rho = 0.97, P < 0.0005). There were no significant differences in thickness of any individual retinal layers at 2 degrees nasal compared to temporal to fovea (P > 0.05); however this symmetry could not be found at 5 degrees eccentricity. Conclusions We demonstrate excellent repeatability and reproducibility of each of eight individual retinal layer thickness measurements within the fovea as well as foveal width using Spectralis SDOCT segmentation software in a young, healthy cohort. Thickness of all individual retinal layers were symmetrical at 2 degrees, but not at 5 degrees eccentricity away from the fovea.	[Ctori, Irene; Huntjens, Byki] City Univ London, Henry Wellcome Labs Vis Sci, Appl Vis Res Ctr, London EC1V 0HB, England	City University London	Huntjens, B (corresponding author), City Univ London, Henry Wellcome Labs Vis Sci, Appl Vis Res Ctr, Northampton Sq, London EC1V 0HB, England.	Byki.Huntjens.1@city.ac.uk		Huntjens, Byki/0000-0002-4864-0723; ctori, irene/0000-0003-1523-4996				Anger EM, 2004, EXP EYE RES, V78, P1117, DOI 10.1016/j.exer.2004.01.011; [Anonymous], 2013, SPECTR HRA OCT US MA; Balasubramanian M, 2009, OPT EXPRESS, V17, P4019, DOI 10.1364/OE.17.004019; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bressler SB, 2014, JAMA OPHTHALMOL, V132, P1113, DOI 10.1001/jamaophthalmol.2014.1698; Carpineto P, 2010, EYE, V24, P251, DOI 10.1038/eye.2009.76; Chakravarthy U, 2013, EYE, V27, P1429, DOI 10.1038/eye.2013.233; Chiu SJ, 2012, INVEST OPHTH VIS SCI, V53, P53, DOI 10.1167/iovs.11-7640; Comyn O, 2012, INVEST OPHTH VIS SCI, V53, P7754, DOI 10.1167/iovs.12-10895; Ctori I, 2015, GRAEF ARCH CLIN EXP, V253, P733, DOI 10.1007/s00417-014-2915-9; Dubis AM, 2009, BRIT J OPHTHALMOL, V93, P1223, DOI 10.1136/bjo.2008.150110; El-Ashry M, 2008, CURR EYE RES, V33, P693, DOI 10.1080/02713680802323140; Eriksson U, 2009, ACTA OPHTHALMOL, V87, P725, DOI 10.1111/j.1755-3768.2008.01345.x; Fiore T, 2015, OPHTHALMOLOGICA, V233, P186, DOI 10.1159/000380832; Folgar FA, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016014; Gilmore ED, 2004, BRIT J OPHTHALMOL, V88, P62, DOI 10.1136/bjo.88.1.62; Hammer DX, 2008, INVEST OPHTH VIS SCI, V49, P2061, DOI 10.1167/iovs.07-1228; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Krebs I, 2011, INVEST OPHTH VIS SCI, V52, P6925, DOI 10.1167/iovs.10-6612; Langenegger SJ, 2011, INVEST OPHTH VIS SCI, V52, P3338, DOI 10.1167/iovs.10-6611; Lee S, 2013, INVEST OPHTH VIS SCI, V54, P2864, DOI 10.1167/iovs.12-11521; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4893, DOI 10.1167/iovs.07-1326; Matsumoto H, 2009, AM J OPHTHALMOL, V148, P105, DOI 10.1016/j.ajo.2009.01.018; McAlinden C, 2011, OPHTHAL PHYSL OPT, V31, P330, DOI 10.1111/j.1475-1313.2011.00851.x; Menke MN, 2009, AM J OPHTHALMOL, V147, P467, DOI 10.1016/j.ajo.2008.09.005; Mohammad S, 2011, OPHTHALMOLOGY, V118, P1645, DOI 10.1016/j.ophtha.2011.01.037; Mojana F, 2008, AM J OPHTHALMOL, V146, P218, DOI 10.1016/j.ajo.2008.04.027; Moreno-Montanes J, 2010, INVEST OPHTH VIS SCI, V51, P335, DOI 10.1167/iovs.08-2988; Nassif N, 2004, OPT LETT, V29, P480, DOI 10.1364/OL.29.000480; Nolan JM, 2008, INVEST OPHTH VIS SCI, V49, P2134, DOI 10.1167/iovs.07-0933; Oh J, 2010, INVEST OPHTH VIS SCI, V51, P1651, DOI 10.1167/iovs.09-4420; Patel PJ, 2008, INVEST OPHTH VIS SCI, V49, P1084, DOI 10.1167/iovs.07-1203; Patel PJ, 2011, ACTA OPHTHALMOL, V89, P229, DOI 10.1111/j.1755-3768.2009.01659.x; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Paunescu LA, 2004, INVEST OPHTH VIS SCI, V45, P1716, DOI 10.1167/iovs.03-0514; Pesudovs K, 2004, OPTOMETRY VISION SCI, V81, P554, DOI 10.1097/00006324-200407000-00018; Pierro L, 2010, AM J OPHTHALMOL, V150, P199, DOI 10.1016/j.ajo.2010.03.015; Pinilla I, 2013, RETINA-J RET VIT DIS, V33, P1448, DOI 10.1097/IAE.0b013e3182807683; Polito A, 2005, ARCH OPHTHALMOL-CHIC, V123, P1330, DOI 10.1001/archopht.123.10.1330; Putnam NM, 2005, J VISION, V5, P632, DOI 10.1167/5.7.3; Regatieri Caio V, 2011, Ophthalmic Surg Lasers Imaging, V42 Suppl, pS56, DOI 10.3928/15428877-20110627-05; Saidha S, 2011, MULT SCLER J, V17, P1449, DOI 10.1177/1352458511418630; Seigo MA, 2012, J NEUROL, V259, P2119, DOI 10.1007/s00415-012-6466-x; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Srinivasan VJ, 2008, INVEST OPHTH VIS SCI, V49, P1571, DOI 10.1167/iovs.07-0838; Tan CSH, 2012, INVEST OPHTH VIS SCI, V53, P5515, DOI 10.1167/iovs.12-9868; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Tick S, 2011, INVEST OPHTH VIS SCI, V52, P5105, DOI 10.1167/iovs.10-7005; Vajzovic L, 2012, AM J OPHTHALMOL, V154, P779, DOI 10.1016/j.ajo.2012.05.004; Van Der Veen RLP, 2009, EUR J OPHTHALMOL, V19, P836, DOI 10.1177/112067210901900524; Varma R, 1996, OPHTHALMOLOGY, V103, P2114, DOI 10.1016/S0161-6420(96)30381-3; Wagner-Schuman M, 2011, INVEST OPHTH VIS SCI, V52, P625, DOI 10.1167/iovs.10-5886; Westrup VMZ, 2014, INVEST OPHTH VIS SCI, V55, P1169, DOI 10.1167/iovs.13-12903; Wolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970; ZEFFREN BS, 1990, INVEST OPHTH VIS SCI, V31, P2099	56	79	79	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129005	10.1371/journal.pone.0129005	http://dx.doi.org/10.1371/journal.pone.0129005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076457	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000356329900043
J	Martins, TAF; Diniz, LD; Mazzeti, AL; do Nascimento, AFS; Caldas, S; Caldas, IS; de Andrade, IM; Ribeiro, I; Bahia, MT				Fontes Martins, Tassiane Assiria; Diniz, Livia de Figueiredo; Mazzeti, Ana Lia; da Silva do Nascimento, Alvaro Fernando; Caldas, Sergio; Caldas, Ivo Santana; de Andrade, Isabel Mayer; Ribeiro, Isabela; Bahia, Maria Terezinha			Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease	PLOS ONE			English	Article							EXPERIMENTAL CHEMOTHERAPY; ERGOSTEROL BIOSYNTHESIS; PARASITE PERSISTENCE; BENZNIDAZOLE; ITRACONAZOLE; INFECTION; TISSUE; PHASE; HOST	The nitroheterocyclic drugs nifurtimox and benznidazole are first-line drugs available to treat Chagas disease; however, they have limitations, including long treatment courses and toxicity. Strategies to overcome these limitations include the identification of new drugs with specific target profiles, re-dosing regimens for the current drugs, drug repositioning and combination therapy. In this work, we evaluated combination therapy as an approach for optimization of the current therapeutic regimen for Chagas disease. The curative action of benznidazole/itraconazole combinations was explored in an established infection of the mice model with the T. cruzi Y strain. The activities of the benznidazole/itraconazole combinations were compared with the results from those receiving the same dosage of each individual drug. The administration of benznidazole/itraconazole in combination eliminated parasites from the blood more efficiently than each drug alone. Here, there was a significant reduction of the number of treatment days (number of doses) necessary to induce parasitemia suppression with the benznidazole/itraconazole combination, as compared to each compound administered alone. These results clearly indicate the enhanced effects of these drugs in combination, particularly at the dose of 75 mg/kg, as the effects observed with the drug combinations were four times more effective than those of each drug used alone. Moreover, benznidazole/itraconazole treatment was shown to prevent or decrease the typical lesions associated with chronic experimental Chagas disease, as illustrated by similar levels of inflammatory cells and fibrosis in the cardiac muscle tissue of healthy and treated mice. These results emphasize the importance of exploring the potential of combination treatments with currently available compounds to specifically treat Chagas disease.	[Fontes Martins, Tassiane Assiria; Diniz, Livia de Figueiredo; Mazzeti, Ana Lia; da Silva do Nascimento, Alvaro Fernando; Caldas, Sergio; Caldas, Ivo Santana; de Andrade, Isabel Mayer; Bahia, Maria Terezinha] Univ Fed Ouro Preto, Escola Med, Lab Doencas Parasitarias, Ouro Preto, MG, Brazil; [Fontes Martins, Tassiane Assiria; Diniz, Livia de Figueiredo; Mazzeti, Ana Lia; da Silva do Nascimento, Alvaro Fernando; Caldas, Sergio; Caldas, Ivo Santana; de Andrade, Isabel Mayer; Bahia, Maria Terezinha] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Ouro Preto, MG, Brazil; [Caldas, Sergio] Fundacao Ezequiel Dias, Belo Horizonte, MG, Brazil; [Diniz, Livia de Figueiredo; Caldas, Ivo Santana] Univ Fed Alfenas, Inst Ciencias Biomed, Dept Patol & Parasitol, Alfenas, MG, Brazil; [Ribeiro, Isabela] DNDi, CH-1202 Geneva, Switzerland	Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Universidade Federal de Alfenas	Bahia, MT (corresponding author), Univ Fed Ouro Preto, Escola Med, Lab Doencas Parasitarias, Campus Univ, Ouro Preto, MG, Brazil.	mtbahia@nupeb.ufop.br	Mazzeti, Ana Lia/AAB-9944-2019; Diniz, Lívia F/I-7704-2018; Caldas, Ivo S/G-9531-2012; Diniz, Lívia F/Y-9853-2019; Caldas, Sérgio/P-3572-2015	Mazzeti, Ana Lia/0000-0003-1642-306X; Caldas, Ivo S/0000-0002-4937-2425; Caldas, Sérgio/0000-0003-1489-794X; Diniz, Livia/0000-0001-9398-6478	Drugs for Neglected Diseases initiative (DNDi; Geneva, Switzerland); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Universidade Federal de Ouro Preto (UFOP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CAPES; Department for International Development (DFID), UK; Medecins Sans Frontieres/Doctors without Borders (MSF), International; Spanish Agency for International Development Cooperation (AECID), Spain; Swiss Agency for Development and Cooperation (SDC), Switzerland	Drugs for Neglected Diseases initiative (DNDi; Geneva, Switzerland); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Universidade Federal de Ouro Preto (UFOP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Department for International Development (DFID), UK; Medecins Sans Frontieres/Doctors without Borders (MSF), International; Spanish Agency for International Development Cooperation (AECID), Spain; Swiss Agency for Development and Cooperation (SDC), Switzerland	This work received financial support from the Drugs for Neglected Diseases initiative (DNDi; Geneva, Switzerland); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Universidade Federal de Ouro Preto (UFOP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and research fellowships from CNPq (MTB) and CAPES (LFD). DNDi would like to thank the following donors for their support: Department for International Development (DFID), UK; Medecins Sans Frontieres/Doctors without Borders (MSF), International; Spanish Agency for International Development Cooperation (AECID), Spain; Swiss Agency for Development and Cooperation (SDC), Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, ANT DRUG COMB THER R; Apt W, 1998, AM J TROP MED HYG, V59, P133, DOI 10.4269/ajtmh.1998.59.133; Araujo MSS, 2000, J ANTIMICROB CHEMOTH, V45, P819, DOI 10.1093/jac/45.6.819; AVILA H, 1990, MOL BIOCHEM PARASIT, V42, P175, DOI 10.1016/0166-6851(90)90160-N; Bahia MT, 2014, EXPERT OPIN INV DRUG, V23, P1225, DOI 10.1517/13543784.2014.922952; Benvenuti LA, 2008, ANN TROP MED PARASIT, V102, P481, DOI 10.1179/136485908X311740; Bustamante JM, 2002, INT J PARASITOL, V32, P889, DOI 10.1016/S0020-7519(02)00023-1; Caldas IS, 2008, PARASITOL RES, V103, P413, DOI 10.1007/s00436-008-0992-6; Caldas S, 2008, EXP PARASITOL, V118, P315, DOI 10.1016/j.exppara.2007.08.016; Caldas S, 2012, ACTA TROP, V123, P170, DOI 10.1016/j.actatropica.2012.05.002; Cummings KL, 2003, MOL BIOCHEM PARASIT, V129, P53, DOI 10.1016/S0166-6851(03)00093-8; da Silva RM, 2012, ANTIMICROB AGENTS CH, V56, P3344, DOI 10.1128/AAC.05785-11; Diniz LD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002367; Dybul Mark, 2002, MMWR Recomm Rep, V51, P1; FILARDI LS, 1987, T ROY SOC TROP MED H, V81, P755, DOI 10.1016/0035-9203(87)90020-4; Garcia S, 2005, ANTIMICROB AGENTS CH, V49, P1521, DOI 10.1128/AAC.49.4.1521-1528.2005; Gomes ML, 1998, EXP PARASITOL, V88, P28, DOI 10.1006/expr.1998.4191; Guedes P. M. M., 2006, Anti-Infective Agents in Medicinal Chemistry, V5, P175, DOI 10.2174/187152106776359020; Lienhardt C, 2012, J INFECT DIS, V205, pS241, DOI 10.1093/infdis/jis034; Lo Presti MS, 2004, INT J ANTIMICROB AG, V23, P634, DOI 10.1016/j.ijantimicag.2003.10.006; MALDONADO RA, 1993, ANTIMICROB AGENTS CH, V37, P1353, DOI 10.1128/AAC.37.6.1353; Molina I, 2014, NEW ENGL J MED, V371, P966, DOI 10.1056/NEJMc1407914; MOREIRA AAB, 1992, REV I MED TROP, V34, P177, DOI 10.1590/S0036-46651992000200015; NYE FJ, 1979, J ANTIMICROB CHEMOTH, V5, P244, DOI 10.1093/jac/5.3.244; Soeiro MNC, 2009, EXPERT OPIN THER TAR, V13, P105, DOI [10.1517/14728220802623881, 10.1517/14728220802623881 ]; Tarleton RL, 2001, INT J PARASITOL, V31, P550, DOI 10.1016/S0020-7519(01)00158-8; Toledo MJD, 2003, ANTIMICROB AGENTS CH, V47, P223, DOI 10.1128/AAC.47.1.223-230.2003; Torrico F, 2013, ANN M AM SOC TROP ME; Urbina J A, 1988, Ann N Y Acad Sci, V544, P357, DOI 10.1111/j.1749-6632.1988.tb40421.x; Urbina JA, 2010, ACTA TROP, V115, P55, DOI 10.1016/j.actatropica.2009.10.023; Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041; Van Cauteren H, 1987, RECENT TRENDS DISCOV, P101; VOLLER A, 1976, B WORLD HEALTH ORGAN, V53, P55; WHO. World Health Organization, 2010, CHAG DIS	34	37	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128707	10.1371/journal.pone.0128707	http://dx.doi.org/10.1371/journal.pone.0128707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076455	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900025
J	Galloway, AWE; Winder, M				Galloway, Aaron W. E.; Winder, Monika			Partitioning the Relative Importance of Phylogeny and Environmental Conditions on Phytoplankton Fatty Acids	PLOS ONE			English	Article							CLIMATE-CHANGE IMPACTS; PLANKTONIC FOOD-WEB; MARINE ECOSYSTEMS; LIPID-COMPOSITION; ANTHROPOGENIC NITROGEN; DOCOSAHEXAENOIC ACID; AQUATIC ECOSYSTEMS; NANNOCHLOROPSIS SP; LIGHT-INTENSITY; LAKE WASHINGTON	Essential fatty acids (EFA), which are primarily generated by phytoplankton, limit growth and reproduction in diverse heterotrophs. The biochemical composition of phytoplankton is well-known to be governed both by phylogeny and environmental conditions. Nutrients, light, salinity, and temperature all affect both phytoplankton growth and fatty acid composition. However, the relative importance of taxonomy and environment on algal fatty acid content has yet to be comparatively quantified, thus inhibiting predictions of changes to phytoplankton food quality in response to global environmental change. We compiled 1145 published marine and freshwater phytoplankton fatty acid profiles, consisting of 208 species from six major taxonomic groups, cultured in a wide range of environmental conditions, and used a multivariate distance-based linear model to quantify the total variation explained by each variable. Our results show that taxonomic group accounts for 3-4 times more variation in phytoplankton fatty acids than the most important growth condition variables. The results underscore that environmental conditions clearly affect phytoplankton fatty acid profiles, but also show that conditions account for relatively low variation compared to phylogeny. This suggests that the underlying mechanism determining basal food quality in aquatic habitats is primarily phytoplankton community composition, and allows for prediction of environmental- scale EFA dynamics based on phytoplankton community data. We used the compiled dataset to calculate seasonal dynamics of long-chain EFA (LCEFA; >= C-20-omega 3 and omega-6 polyunsaturated fatty acid) concentrations and omega-3 omega-6 EFA ratios in Lake Washington using a multi-decadal phytoplankton community time series. These analyses quantify temporal dynamics of algal-derived LCEFA and food quality in a freshwater ecosystem that has undergone large community changes as a result of shifting resource management practices, highlighting diatoms, cryptophytes and dinoflagellates as key sources of LCEFA. Moreover, the analyses indicate that future shifts towards cyanobacteria-dominated communities will result in lower LCEFA content in aquatic ecosystems.	[Galloway, Aaron W. E.; Winder, Monika] Univ Calif Davis, Watershed Sci Ctr, John Muir Inst Environm, Davis, CA USA; [Winder, Monika] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden	University of California System; University of California Davis; Stockholm University	Galloway, AWE (corresponding author), Univ Oregon, Oregon Inst Marine Biol, Charleston, OR 97420 USA.	aaron.galloway@gmail.com			Interagency Ecological Program under California Department of Water Resources [4600008137T5]	Interagency Ecological Program under California Department of Water Resources	Financial support to MW and AWEG by the Interagency Ecological Program under California Department of Water Resources agreement number 4600008137T5 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKMAN RG, 1968, J FISH RES BOARD CAN, V25, P1603, DOI 10.1139/f68-145; AHLGREN G, 1990, J PLANKTON RES, V12, P809, DOI 10.1093/plankt/12.4.809; Ahlgren G, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P147, DOI 10.1007/978-0-387-89366-2_7; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arts MT, 2001, CAN J FISH AQUAT SCI, V58, P122, DOI 10.1139/cjfas-58-1-122; Bec A, 2010, FRESHWATER BIOL, V55, P1958, DOI 10.1111/j.1365-2427.2010.02429.x; BELL MV, 1995, LIPIDS, V30, P443, DOI 10.1007/BF02536303; Bi R, 2014, J PHYCOL, V50, P117, DOI 10.1111/jpy.12140; Breteler WCMK, 1999, MAR BIOL, V135, P191, DOI 10.1007/s002270050616; Brett MT, 2006, LIMNOL OCEANOGR, V51, P2428, DOI 10.4319/lo.2006.51.5.2428; Brett MT, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P115, DOI 10.1007/978-0-387-89366-2_6; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; Broglio E, 2003, AQUAT MICROB ECOL, V31, P267, DOI 10.3354/ame031267; Budge SM, 2014, ICES J MAR SCI, V71, P1885, DOI 10.1093/icesjms/fsu003; Cashman MJ, 2013, FRESHWATER BIOL, V58, P1447, DOI 10.1111/fwb.12142; Castell JD, 2004, AQUACULTURE, V242, P417, DOI 10.1016/j.aquaculture.2003.11.003; Cloern JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024465; Cloern JE, 1996, REV GEOPHYS, V34, P127, DOI 10.1029/96RG00986; Copeman LA, 2002, AQUACULTURE, V210, P285, DOI 10.1016/S0044-8486(01)00849-3; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; Danielsdottir MG, 2007, HYDROBIOLOGIA, V589, P29, DOI 10.1007/s10750-007-0714-6; Desvilettes C, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P25, DOI 10.1007/978-0-387-89366-2_2; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Downing J., 2014, GLOBAL ENVIRON CHANG, P221; Edmondson W. T., 1994, Lake and Reservoir Management, V10, P75; Fabregas J, 2004, WORLD J MICROB BIOT, V20, P31, DOI 10.1023/B:WIBI.0000013288.67536.ed; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Francis TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110363; Fuiman LA, 2015, ECOLOGY, V96, P362, DOI 10.1890/14-0571.1; Galloway AWE, 2012, J PHYCOL, V48, P956, DOI 10.1111/j.1529-8817.2012.01173.x; Gladyshev MI, 2013, PROSTAG OTH LIPID M, V107, P117, DOI 10.1016/j.prostaglandins.2013.03.002; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; Guschina IA, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P1, DOI 10.1007/978-0-387-89366-2_1; Hampton SE, 2006, LIMNOL OCEANOGR, V51, P2042, DOI 10.4319/lo.2006.51.5.2042; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hartwich M, 2012, FRESHWATER BIOL, V57, P1385, DOI 10.1111/j.1365-2427.2012.02799.x; Holtgrieve GW, 2011, SCIENCE, V334, P1545, DOI 10.1126/science.1212267; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Hughes AD, 2011, J EXP MAR BIOL ECOL, V409, P229, DOI 10.1016/j.jembe.2011.08.027; JONASDOTTIR SH, 1994, MAR BIOL, V121, P67, DOI 10.1007/BF00349475; Kahru M, 2014, BIOGEOSCIENCES, V11, P3619, DOI 10.5194/bg-11-3619-2014; Kaushal SS, 2010, FRONT ECOL ENVIRON, V8, P461, DOI 10.1890/090037; Kelly JR, 2012, MAR ECOL PROG SER, V446, P1, DOI 10.3354/meps09559; Lang I, 2011, BMC PLANT BIOL, V11, P124, DOI DOI 10.1186/1471-2229-11-124; Lau DCP, 2013, LIMNOL OCEANOGR, V58, P1149, DOI 10.4319/lo.2013.58.4.1149; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Leu E, 2006, CAN J FISH AQUAT SCI, V63, P2760, DOI 10.1139/F06-159; Lewis WM, 2011, ENVIRON SCI TECHNOL, V45, P10300, DOI 10.1021/es202401p; Litzow MA, 2006, MAR ECOL PROG SER, V315, P1, DOI 10.3354/meps315001; Lowe AT, 2014, OIKOS, V123, P1341, DOI 10.1111/oik.01392; Markensten H, 2010, ECOL APPL, V20, P752, DOI 10.1890/08-2109.1; Marshall CT, 1999, NATURE, V402, P288, DOI 10.1038/46272; Martin-Creuzburg D, 2005, AQUAT MICROB ECOL, V41, P271, DOI 10.3354/ame041271; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Milke LM, 2006, AQUACULTURE, V260, P272, DOI 10.1016/j.aquaculture.2006.06.004; Muller-Navarra DC, 2008, INT REV HYDROBIOL, V93, P489, DOI 10.1002/iroh.200711046; Muller-Navarra DC, 2004, NATURE, V427, P69, DOI 10.1038/nature02210; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; NIXON SW, 1988, LIMNOL OCEANOGR, V33, P1005, DOI 10.4319/lo.1988.33.4_part_2.1005; Paerl HW, 2012, WATER RES, V46, P1349, DOI 10.1016/j.watres.2011.08.002; Park S, 2003, AQUAT ECOL, V37, P123, DOI 10.1023/A:1023972425915; Parrish CC, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P309, DOI 10.1007/978-0-387-89366-2_13; Paulsen M, 2014, MAR BIOL, V161, P239, DOI 10.1007/s00227-013-2313-6; Pernet F, 2007, J EXP BIOL, V210, P2999, DOI 10.1242/jeb.006007; Piepho M, 2012, J PHYCOL, V48, P64, DOI 10.1111/j.1529-8817.2011.01103.x; Pond D, 1996, MAR ECOL PROG SER, V143, P45, DOI 10.3354/meps143045; R Development Core Team, 2014, R LANG ENV STAT COMP; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Ravet JL, 2010, ECOLOGY, V91, P180, DOI 10.1890/08-2037.1; Raymond WW, 2014, MAR ECOL PROG SER, V509, P213, DOI 10.3354/meps10888; REITAN KI, 1994, J PHYCOL, V30, P972, DOI 10.1111/j.0022-3646.1994.00972.x; RENAUD SM, 1991, J APPL PHYCOL, V3, P43, DOI 10.1007/BF00003918; Renaud SM, 2002, AQUACULTURE, V211, P195, DOI 10.1016/S0044-8486(01)00875-4; Reuss N, 2002, MAR BIOL, V141, P423, DOI 10.1007/s00227-002-0841-6; Rojbek MC, 2012, MAR ECOL PROG SER, V471, P215, DOI 10.3354/meps10012; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; Scavia D, 2002, ESTUARIES, V25, P149, DOI 10.1007/BF02691304; Schneider P, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045059; Schwenk D, 2013, AQUAT ECOL, V47, P415, DOI 10.1007/s10452-013-9454-z; SHERR E, 1988, LIMNOL OCEANOGR, V33, P1225, DOI 10.4319/lo.1988.33.5.1225; Sperfeld E, 2012, FRESHWATER BIOL, V57, P497, DOI 10.1111/j.1365-2427.2011.02719.x; Strandberg U, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00382.1; SUKENIK A, 1989, J PHYCOL, V25, P686, DOI 10.1111/j.0022-3646.1989.00686.x; Sushchik NN, 2004, FRESHWATER BIOL, V49, P1206, DOI 10.1111/j.1365-2427.2004.01263.x; Taipale S, 2013, AQUAT MICROB ECOL, V71, P165, DOI 10.3354/ame01671; THOMPSON PA, 1992, J PHYCOL, V28, P488, DOI 10.1111/j.0022-3646.1992.00488.x; Underwood GJC, 1999, ADV ECOL RES, V29, P93; Wacker A, 2012, FUNCT ECOL, V26, P1135, DOI 10.1111/j.1365-2435.2012.02047.x; Wagner ND, 2013, ECOL LETT, V16, P535, DOI 10.1111/ele.12067; WATANABE T, 1983, AQUACULTURE, V34, P115, DOI 10.1016/0044-8486(83)90296-X; Winder M, 2004, GLOBAL CHANGE BIOL, V10, P1844, DOI 10.1111/j.1365-2486.2004.00849.x; Winder M, 2012, HYDROBIOLOGIA, V698, P5, DOI 10.1007/s10750-012-1149-2; Winder M, 2011, ECOL LETT, V14, P749, DOI 10.1111/j.1461-0248.2011.01635.x; Winder M, 2011, ESTUAR COAST, V34, P675, DOI 10.1007/s12237-010-9342-x; Zhukova NV, 1999, AQUAT MICROB ECOL, V17, P153, DOI 10.3354/ame017153	99	114	114	5	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130053	10.1371/journal.pone.0130053	http://dx.doi.org/10.1371/journal.pone.0130053			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076015	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900130
J	Lee, JW; Park, JW; Khang, D				Lee, Jin Woo; Park, Jin-Woo; Khang, Dongwoo			Analysis of Osteoblast Differentiation on Polymer Thin Films Embedded with Carbon Nanotubes	PLOS ONE			English	Article							SUBMICRON-SURFACE-FEATURES; BONE-FORMATION; CELL-ADHESION; STEM-CELLS; IN-VIVO; TITANIUM; PROLIFERATION; OSTEOPONTIN; ROUGHNESS; SCALE	Osteoblast differentiation can be modulated by variations in order of nanoscale topography. Biopolymers embedded with carbon nanotubes can cause various orders of roughness at the nanoscale and can be used to investigate the dynamics of extracellular matrix interaction with cells. In this study, clear relationship between the response of osteoblasts to integrin receptor activation, their phenotype, and transcription of certain genes on polymer composites embedded with carbon nanotubes was demonstrated. We generated an ultrathin nanocomposite film embedded with carbon nanotubes and observed improved adhesion of pre-osteoblasts, with a subsequent increase in their proliferation. The expression of genes encoding integrin subunits alpha(5), alpha(v), beta(1), and beta(3) was significantly upregulated at the early of time-point when cells initially attached to the carbon nanotube/polymer composite. The advantage of ultrathin nanocomposite film for pre-osteoblasts was demonstrated by staining for the cytoskeletal protein vinculin and cell nuclei. The expression of essential transcription factors for osteoblastogenesis, such as Runx2 and Sp7 transcription factor 7 (known as osterix), was upregulated after 7 days. Consequently, the expression of genes that determine osteoblast phenotype, such as alkaline phosphatase, type I collagen, and osteocalcin, was accelerated on carbon nanotube embedded polymer matrix after 14 days. In conclusion, the ultrathin nanocomposite film generated various orders of nanoscale topography that triggered processes related to osteoblast bone formation.	[Lee, Jin Woo; Khang, Dongwoo] Gachon Univ, Sch Med, Dept Mol Med, Inchon, South Korea; [Park, Jin-Woo] Kyungpook Natl Univ, Sch Dent, Dept Periodontol, Daegu, South Korea	Gachon University; Kyungpook National University	Park, JW (corresponding author), Kyungpook Natl Univ, Sch Dent, Dept Periodontol, Daegu, South Korea.	jinwoo@knu.ac.kr; dkhang@gachon.ac.kr		Park, Jin-Woo/0000-0002-6632-023X; Khang, Dongwoo/0000-0003-2353-8017	National Research Foundation [NRF 2012R1A1A2041157, MSIP 2008-0062282]; Korea Health Industry Development Institute (KHIDI) by South Korea [HI14C3228]	National Research Foundation; Korea Health Industry Development Institute (KHIDI) by South Korea(Korea Health Industry Development Institute (KHIDI))	This research was supported by grants from National Research Foundation (NRF 2012R1A1A2041157 and MSIP 2008-0062282) and the Korea Health Industry Development Institute (KHIDI, HI14C3228) by South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aniket Reid R, 2014, J BIOMED MAT RES A; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Baik KY, 2011, SMALL, V7, P741, DOI 10.1002/smll.201001930; BLAU HM, 1991, J CELL BIOL, V112, P781, DOI 10.1083/jcb.112.5.781; Boskey AL, 2002, CALCIFIED TISSUE INT, V71, P145, DOI 10.1007/s00223-001-1121-z; Christenson EM, 2004, J BIOMED MATER RES A, V70A, P245, DOI 10.1002/jbm.a.30067; Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7; Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5; Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723; Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502; Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029; Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5; Harmey D, 2006, J BONE MINER RES, V21, P1377, DOI 10.1359/JBMR.060619; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Joy A, 2011, LANGMUIR, V27, P1891, DOI 10.1021/la103722m; Kato RB, 2014, J CELL PHYSIOL, V229, P1690, DOI 10.1002/jcp.24614; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898; Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102; Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009; Khang D, 2012, BIOMATERIALS, V33, P5997, DOI 10.1016/j.biomaterials.2012.05.005; Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005; Kunzler TP, 2007, BIOMATERIALS, V28, P5000, DOI 10.1016/j.biomaterials.2007.08.009; Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054; Marie PJ, 2013, NAT REV ENDOCRINOL, V9, P288, DOI 10.1038/nrendo.2013.4; Nayak TR, 2010, ACS NANO, V4, P7717, DOI 10.1021/nn102738c; Olivares-Navarrete R, 2008, P NATL ACAD SCI USA, V105, P15767, DOI 10.1073/pnas.0805420105; Pan LL, 2012, COLLOID SURFACE B, V93, P226, DOI 10.1016/j.colsurfb.2012.01.011; Park JW, 2008, J BIOMED MATER RES A, V86A, P117, DOI 10.1002/jbm.a.31618; Park JW, 2010, CLIN ORAL IMPLAN RES, V21, P398, DOI 10.1111/j.1600-0501.2009.01863.x; Sahithi K, 2010, INT J BIOL MACROMOL, V46, P281, DOI 10.1016/j.ijbiomac.2010.01.006; Sitharaman B, 2008, BONE, V43, P362, DOI 10.1016/j.bone.2008.04.013; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Sotobori T, 2006, EXP CELL RES, V312, P3927, DOI 10.1016/j.yexcr.2006.08.024; Stary V, 2014, J BIOMED MATER RES A, V102, P1868, DOI 10.1002/jbm.a.34833; Wade-Gueye NM, 2012, BONE, V50, P1064, DOI 10.1016/j.bone.2012.02.014; Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016; Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005; Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013; Yang JL, 2014, ACS NANO, V8, P9941, DOI 10.1021/nn504767g; Zamir E, 2001, J CELL SCI, V114, P3577; Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111	42	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129856	10.1371/journal.pone.0129856	http://dx.doi.org/10.1371/journal.pone.0129856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076355	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900105
J	Lee, SM; Park, JS; Norwitz, ER; Kim, SM; Lee, J; Park, CW; Kim, BJ; Jun, JK				Lee, Seung Mi; Park, Joong Shin; Norwitz, Errol R.; Kim, Sun Min; Lee, JoonHo; Park, Chan-Wook; Kim, Byoung Jae; Jun, Jong Kwan			Presenting Twins Are Exposed to Higher Levels of Inflammatory Mediators than Nonpresenting Twins as Early as the Midtrimester of Pregnancy	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; BIRTH-ORDER; NEONATAL MORBIDITY; GESTATIONAL-AGE; AMNIOTIC-FLUID; PRETERM LABOR; UREAPLASMA-UREALYTICUM; LUNG; DELIVERY; MODE	Objective Presenting twins are less likely to develop respiratory complications than non-presenting twins. The precise reason for this difference is not well understood, although it is known that the presence of inflammation reduces the risk of respiratory morbidity at birth. To further investigate this association, we compared the concentrations of inflammatory biomarkers in mid-trimester amniotic fluid (AF) of asymptomatic twin pairs. Study Design The study population consisted of women with twin pregnancies who underwent mid-trimester amniocentesis (15-20 weeks) for routine clinical indications and delivered at term. AF was analyzed for pro-inflammatory cytokines (IL-1 beta, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-13, IL-15, IFN-gamma, TNF-alpha), matrix metalloproteinases (MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-12), and chemokines (Complement Factor D/Adipsin, Serpin E1/PAI-1, Adiponectin/ Acrp30, CRP, CCL2/MCP-1, Leptin, Resistin) using Luminex Performance Assay multiplex kits. Data were analyzed using Wilcoxon signed rank test. Results A total of 82 twin pairs were enrolled. Mid-trimester AF concentrations of IL-8, MMP-8, CRP, MCP-1, leptin, and resistin were significantly higher in the presenting twin compared with the non-presenting twin (p<0.05 for each). Differences in AF concentrations of IL-8, MMP-8, and CRP persisted after adjustment for the fetal growth restriction at the time of birth and chorionicity. Conclusion These data suggest that, as early as the mid-trimester, the presenting fetus in an otherwise uncomplicated twin pregnancy is exposed to higher levels of pro-inflammatory mediators (especially IL-8, MMP-8, and CRP) than its non-presenting co-twin. Whether this pro-inflammatory milieu reduces the risk of neonatal respiratory morbidity at birth or has other functional implications needs to be further evaluated.	[Lee, Seung Mi; Park, Joong Shin; Kim, Sun Min; Lee, JoonHo; Park, Chan-Wook; Kim, Byoung Jae; Jun, Jong Kwan] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Lee, Seung Mi; Kim, Byoung Jae] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Norwitz, Errol R.] Tufts Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02111 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Tufts University	Park, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	jsparkmd@snu.ac.kr	Park, Joong Shin/D-5741-2012; PARK, Chan-Wook/G-3663-2013	Park, Joong Shin/0000-0002-5246-0477; PARK, Chan-Wook/0000-0002-1290-6438	Korea Health R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI12C00240300]	Korea Health R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korea Health R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI12C00240300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews WW, 2006, AM J OBSTET GYNECOL, V195, P803, DOI 10.1016/j.ajog.2006.06.083; Armson BA, 2006, OBSTET GYNECOL, V108, P556, DOI 10.1097/01.AOG.0000227747.37184.0a; ARNOLD C, 1987, NEW ENGL J MED, V317, P1121, DOI 10.1056/NEJM198710293171805; Been JV, 2009, ARCH DIS CHILD-FETAL, V94, pF218, DOI 10.1136/adc.2008.150458; Bry K, 1997, J CLIN INVEST, V99, P2992, DOI 10.1172/JCI119494; Bry K, 2001, ACTA PAEDIATR, V90, P74; CASSELL GH, 1983, SEX TRANSM DIS, V10, P294; Collins JJP, 2012, AM J PHYSIOL-LUNG C, V303, pL778, DOI 10.1152/ajplung.00280.2011; D'Antonio F, 2013, ULTRASOUND OBST GYN, V41, P274, DOI 10.1002/uog.12310; Dempsey E, 2005, AM J PERINAT, V22, P155, DOI 10.1055/s-2005-865020; Gerber S, 2003, J INFECT DIS, V187, P518, DOI 10.1086/368205; GRAY DJ, 1992, PRENATAL DIAG, V12, P111, DOI 10.1002/pd.1970120206; Hacking D, 2001, ARCH DIS CHILD-FETAL, V84, pF117, DOI 10.1136/fn.84.2.F117; Hartley RS, 2005, J MATERN-FETAL NEO M, V17, P375, DOI 10.1080/147670505000132484; Herbst A, 2008, BJOG-INT J OBSTET GY, V115, P1512, DOI 10.1111/j.1471-0528.2008.01899.x; HOROWITZ S, 1995, J REPROD MED, V40, P375; Jobe Alan H, 2005, J Perinatol, V25 Suppl 2, pS31, DOI 10.1038/sj.jp.7211317; Kaukola T, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.070; Khairy P, 2006, CIRCULATION, V113, P517, DOI 10.1161/CIRCULATIONAHA.105.589655; Kramer BW, 2008, J PERINATOL, V28, pS21, DOI 10.1038/jp.2008.46; Kuypers E, 2012, AM J PHYSIOL-LUNG C, V302, pL380, DOI 10.1152/ajplung.00338.2011; Lahra MM, 2009, ARCH DIS CHILD-FETAL, V94, pF13, DOI 10.1136/adc.2007.135889; Lambermont VA, 2014, PEDIATR RES, V75, P500, DOI 10.1038/pr.2014.3; Lee J, 2009, J PERINAT MED, V37, P53, DOI 10.1515/JPM.2009.036; Martin Joyce A, 2010, Natl Vital Stat Rep, V59, P3; PRINS RP, 1994, AM J OBSTET GYNECOL, V170, P1649; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; SHINWELL ES, 2004, ARCH DIS CHILD, V89, P145, DOI [DOI 10.1136/adc.2002.021584, DOI 10.1136/ADC.2002.021584]; Sibony O, 2003, EUR J OBSTET GYN R B, V108, P157; Smith GCS, 2002, BRIT MED J, V325, P1004, DOI 10.1136/bmj.325.7371.1004; Smith GCS, 2007, BMJ-BRIT MED J, V334, P576, DOI 10.1136/bmj.39118.483819.55; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Watterberg KL, 1996, PEDIATRICS, V97, P210; Wen SW, 2004, AM J OBSTET GYNECOL, V191, P773, DOI 10.1016/j.ajog.2004.04.009; Wen SW, 2004, AM J OBSTET GYNECOL, V191, P778, DOI 10.1016/j.ajog.2004.05.013; WYSHAK G, 1963, JAMA-J AM MED ASSOC, V186, P869; Xu WL, 2011, NEUROLOGY, V76, P1568, DOI 10.1212/WNL.0b013e3182190d09; Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1130, DOI 10.1067/mob.2001.117680; Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1162, DOI 10.1067/mob.2001.117678	39	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0125346	10.1371/journal.pone.0125346	http://dx.doi.org/10.1371/journal.pone.0125346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076029	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900004
J	Liu, SY; Manly, JJ; Capistrant, BD; Glymour, MM				Liu, Sze Yan; Manly, Jennifer J.; Capistrant, Benjamin D.; Glymour, M. Maria			Historical Differences in School Term Length and Measured Blood Pressure: Contributions to Persistent Racial Disparities among US-Born Adults	PLOS ONE			English	Article							RISK-FACTORS; EDUCATION; HEALTH; HYPERTENSION; PATHWAYS; QUALITY	Introduction Legally mandated segregation policies dictated significant differences in the educational experiences of black and white Americans through the first half of the 20th century, with markedly lower quality in schools attended by black children. We determined whether school term length, a common marker of school quality, was associated with blood pressure and hypertension among a cohort of older Americans who attended school during the de jure segregation era. Methods National Health and Nutrition Examination Survey I and II data were linked to state level historical information on school term length. We used race and gender-stratified linear regression models adjusted for age, state and year of birth to estimate effects of term length on systolic and diastolic blood pressure (SBP and DBP) and hypertension for US-born adults. We also tested whether correcting years of schooling for term length differences attenuated estimated racial disparities. Results Among black women, 10% longer school term was associated with lower SBP, DBP and hypertension prevalence (2.1 mmHg, 1.0 mmHg, and 5.0 percentage points respectively). Associations for whites and for black men were not statistically significant. Adjustment for education incorporating corrections for differences in school term length slightly attenuated estimated racial disparities. Conclusions Longer school term length predicted better BP outcomes among black women, but not black men or whites.	[Liu, Sze Yan] Harvard Univ, Sch Publ Hlth, Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; [Manly, Jennifer J.] Columbia Univ, Gertrude H Sergievsky Ctr, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Manly, Jennifer J.] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Capistrant, Benjamin D.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Glymour, M. Maria] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA	Harvard University; Harvard T.H. Chan School of Public Health; Columbia University; Columbia University; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco	Liu, SY (corresponding author), Harvard Univ, Sch Publ Hlth, Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA.	szeliu@hsph.harvard.edu	Capistrant, Benjamin/AAM-1169-2020; Liu, Sze/ABB-4170-2021	Capistrant, Benjamin/0000-0001-5841-6592; Liu, Sze Yan/0000-0002-7148-356X; Glymour, M. Maria/0000-0001-9644-3081	American Heart Association [10SDG2640243]	American Heart Association(American Heart Association)	The authors gratefully acknowledge financial support from the American Heart Association grant 10SDG2640243.	Ailshire JA, 2011, SOC FORCES, V90, P397, DOI 10.1093/sf/sor001; Balamurugan A, 2013, CIRC-CARDIOVASC QUAL, V6, P668, DOI 10.1161/CIRCOUTCOMES.113.000265; Bellei C, 2006, DOES LENGTHENING SCH; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; CARD D, 1992, J POLIT ECON, V100, P1, DOI 10.1086/261805; Carlsson AC, 2008, AM J HYPERTENS, V21, P771, DOI 10.1038/ajh.2008.167; CDC, 2011, LEAD CAUS DEATH; Chandola T, 2006, J R STAT SOC A STAT, V169, P337, DOI 10.1111/j.1467-985X.2006.00411.x; Cohen AK, 2013, AM J PUBLIC HEALTH, pe1; Collins WJ, 2003, IND LABOR RELAT REV, V56, P244, DOI 10.2307/3590937; Conti G, 2010, AM ECON REV, V100, P234, DOI 10.1257/aer.100.2.234; Crenshaw K., 1989, UNIV CHICAGO LEG FOR, V1989, P139; Crowe M, 2012, J GERONTOLOGY A; Cutler DM, 2010, J HEALTH ECON, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; Cutler DM, 2006, ED HLTH EVALUATING T; DYER AR, 1976, CIRCULATION, V54, P987, DOI 10.1161/01.CIR.54.6.987; ECS, 2011, NUMB INSTR DAYS HOUR; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Fletcher J, 2012, REV ECON HOUSEHOLD, P1; Fletcher JM, 2011, ECON EDUC REV, V30, P826, DOI 10.1016/j.econedurev.2011.04.005; FREEMAN RB, 1973, BROOKINGS PAP ECO AC, P67; Frisvold D, 2010, J HLTH EC, V30, P1232; Frisvold D, 2013, DEMOGRAPHY IN PRESS; Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008; Ganguli MC, 1999, AM J HYPERTENS, V12, P69, DOI 10.1016/S0895-7061(98)00218-0; Glymour MM, 2008, NEUROPSYCHOL REV, V18, P194, DOI 10.1007/s11065-008-9066-x; Haines DJ, 2007, J AM COLL HEALTH, V55, P219, DOI 10.3200/JACH.55.4.219-225; Heckman JJ, 2005, INVITED COMMENTS; Hoffmeister H, 1996, PREV MED, V25, P135, DOI 10.1006/pmed.1996.0039; Jones AM, 2011, J HUM CAPITAL, V5, P342, DOI 10.1086/662441; Kaplan G, 2008, MAKING AM HLTH SOCIA, P145; Knight EL, 2001, HYPERTENSION, V38, P809, DOI 10.1161/hy0901.091681; Kotchen TA, 1997, CIRCULATION, V96, P1071, DOI 10.1161/01.CIR.96.4.1071; Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778; Lahelma E, 2004, J EPIDEMIOL COMMUN H, V58, P327, DOI 10.1136/jech.2003.011148; Liu SY, 2011, ANN EPIDEMIOL, V21, P128, DOI 10.1016/j.annepidem.2010.11.004; Non AL, 2012, AM J PUBLIC HEALTH, V102, P1559, DOI 10.2105/AJPH.2011.300448; PLEIS JR, 2010, SUMMARY HLTH STAT US; Ross CE, 2006, SOC SCI MED, V63, P1400, DOI 10.1016/j.socscimed.2006.03.013; Ross CE, 2011, SOC SCI MED, V72, P591, DOI 10.1016/j.socscimed.2010.11.028; Ross CE, 2010, SOCIOL QUART, V51, P1, DOI 10.1111/j.1533-8525.2009.01164.x; Sansani S, 2011, ECON EDUC REV, V30, P1320, DOI 10.1016/j.econedurev.2011.06.003; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Walsemann KM, 2013, AM BEHAV SCI, V57, P1082, DOI 10.1177/0002764213487346; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979; Wooldridge JM, 2013, INTRO ECONOMETRICS M, V5th; World Health Organization, 2021, TOP 10 CAUS DEATH; Yeung Edwina H, 2014, Curr Epidemiol Rep, V1, P9; Yoon S, 2012, HYPERTENSION ADULTS	50	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129673	10.1371/journal.pone.0129673	http://dx.doi.org/10.1371/journal.pone.0129673			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076495	Green Submitted, gold, Green Published			2022-12-27	WOS:000356329900089
J	Sacco, ICN; Suda, EY; Vigneron, V; Sartor, CD				Sacco, Isabel C. N.; Suda, Eneida Yuri; Vigneron, Vincent; Sartor, Cristina Dallemole			An 'Importance' Map of Signs and Symptoms to Classify Diabetic Polyneuropathy: An Exploratory Data Analysis	PLOS ONE			English	Article							FOOT ULCER RISK; SCREENING-TESTS; NEUROPATHY; ASSOCIATION; DIAGNOSIS	Aims/Hypothesis Early diagnosis of diabetic polyneuropathy (DPN) is critical for a good prognosis. We aimed to identify different groups of patients, based on the various common clinical signs and symptoms of DPN, that represent a progressive worsening of the disease before the onset of plantar ulceration or amputation. We also sought to identify the most important DPN-related variables that can discriminate between groups, thus representing the most informative variables for early detection. Methods In 193 diabetic patients, we assessed 16 DPN-related signs, symptoms, and foot characteristics, based on the literature and the International Consensus on the Diabetic Foot. We used multiple correspondence analysis and the Kohonen algorithm to group the variables into micro and macro-classes and to identify clusters of patients that represent different DPN conditions. Results Four distinct groups were observed. One group showed no indication of DPN. The remaining groups were characterized by a progressive loss of the vibration perception, without a worsening of symptoms or tactile perception. The 2 intermediate groups presented different aspects of DPN: one showed mostly DPN symptoms and the other showed the incipient vibration impairment, callus and crack formation, and foot arch alteration. The fourth group showed more severe foot and DPN conditions, including ulceration and amputation, absence of vibration and tactile perception (irrespective of how many compromised foot areas), and worse foot deformities and callus and crack formation. Conclusion Vibration perception was more informative than tactile sensitivity in discriminating early DPN onset because its impairment was evident in more groups. Symptoms and callus and cracks did not discriminate the severity status and should be interpreted in association with other clinical variables. Reconsideration of the current screening techniques is needed to clinically determine the early onset of neuropathy using tactile perception.	[Sacco, Isabel C. N.; Suda, Eneida Yuri; Sartor, Cristina Dallemole] Univ Sao Paulo, Sch Med, Dept Phys Therapy & Speech & Occupat Therapy, Sao Paulo, Brazil; [Vigneron, Vincent] Univ Evry, Informat Biol Integrat & Syst Complexes, Evry, France	Universidade de Sao Paulo; UDICE-French Research Universities; Universite Paris Saclay	Sacco, ICN (corresponding author), Univ Sao Paulo, Sch Med, Dept Phys Therapy & Speech & Occupat Therapy, Sao Paulo, Brazil.	icnsacco@usp.br	Suda, Eneida Yuri/H-8534-2019; Suda, Eneida Yuri/C-7231-2013; Sacco, Isabel/T-2630-2019; Sacco, Isabel/D-7172-2011; Sartor, Cristina D/C-6806-2013	Suda, Eneida Yuri/0000-0002-6346-0317; Suda, Eneida Yuri/0000-0002-6346-0317; Sacco, Isabel/0000-0003-1254-0007; Sacco, Isabel/0000-0003-1254-0007; Sartor, Cristina D/0000-0002-8461-8048	Sao Paulo Research Foundation [2011/19304-4, 2013/06123-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [151531/2013-7]; Catedras Francesas no Estado Sao Paulo	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Catedras Francesas no Estado Sao Paulo	This study was funded by Sao Paulo Research Foundation (scholarship CDS process number 2011/19304-4, scholarship to EYS 2013/06123-7), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant for finantial support process number 151531/2013-7), and Catedras Francesas no Estado Sao Paulo 2013 (scholarship to VV).	Andersen EB, 1989, INTRO ANAL CATEGORIC; Asad A, 2010, J PAK MED ASSOC, V60, P166; Bakker K, 2012, DIABETES-METAB RES, V28, P225, DOI 10.1002/dmrr.2253; Boulton AJM, 2004, DIABETES CARE, V27, P1458, DOI 10.2337/diacare.27.6.1458; Boulton AJM, 2004, DIABETOLOGIA, V47, P1343, DOI 10.1007/s00125-004-1463-y; Cowley MS, 2008, DIABETES RES CLIN PR, V82, P226, DOI 10.1016/j.diabres.2008.07.025; Dyck PJ, 2011, DIABETES METAB RES R; England JD, 2005, NEUROLOGY, V64, P199, DOI 10.1212/01.WNL.0000149522.32823.EA; FELDMAN EL, 1994, DIABETES CARE, V17, P1281, DOI 10.2337/diacare.17.11.1281; Forouzandeh F, 2005, ACTA NEUROL SCAND, V112, P409, DOI 10.1111/j.1600-0404.2005.00494.x; Gin H, 2006, DIABETES METAB, V32, P367, DOI 10.1016/S1262-3636(07)70293-8; Kohonen T., 1995, SELF ORG MAPS, DOI [10.1007/978-3-642-97610-0, DOI 10.1007/978-3-642-97610-0]; KUMAR S, 1991, DIABETES RES CLIN PR, V13, P63, DOI 10.1016/0168-8227(91)90034-B; Lebart L, 1995, STAT EXPLORATOIRE DO; Ledoux WR, 2005, J REHABIL RES DEV, V42, P665, DOI 10.1682/JRRD.2004.11.0144; Leese GP, 2006, INT J CLIN PRACT, V60, P541, DOI 10.1111/j.1368-5031.2006.00899.x; Lunetta M, 1998, DIABETES RES CLIN PR, V39, P165, DOI 10.1016/S0168-8227(98)00005-9; Meijer JWG, 2002, DIABETIC MED, V19, P962, DOI 10.1046/j.1464-5491.2002.00819.x; Moghtaderi A, 2006, CLIN NEUROL NEUROSUR, V108, P477, DOI 10.1016/j.clineuro.2005.08.003; Perkins BA, 2003, CLIN NEUROPHYSIOL, V114, P1167, DOI 10.1016/S1388-2457(03)00025-7; Perkins BA, 2001, DIABETES CARE, V24, P250, DOI 10.2337/diacare.24.2.250; Ritter H., 1992, NEURAL COMPUTATION S; SAPORTA G, 1990, PROBABILITES ANAL DO; SOSENKO JM, 1990, DIABETES CARE, V13, P1057, DOI 10.2337/diacare.13.10.1057; VEVES A, 1992, DIABETOLOGIA, V35, P660, DOI 10.1007/BF00400259; Vigneron V., 2008, FUZZY EC REV, V13; Vigneron V, 1999, ACSEG 99 REUS SPAIN	27	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129763	10.1371/journal.pone.0129763	http://dx.doi.org/10.1371/journal.pone.0129763			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075711	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900101
J	Campos, SS; Diez, GR; Oresti, GM; Salvador, GA				Sanchez Campos, Sofia; Rodriguez Diez, Guadalupe; Martin Oresti, Gerardo; Alejandra Salvador, Gabriela			Dopaminergic Neurons Respond to Iron-Induced Oxidative Stress by Modulating Lipid Acylation and Deacylation Cycles	PLOS ONE			English	Article							SYNAPTIC ENDINGS; PARKINSONS; BRAIN; ALZHEIMERS; DEATH; PHOSPHOLIPASE-A(2); ACTIVATION; MEDIATORS; PATHWAY; ADULT	Metal-imbalance has been reported as a contributor factor for the degeneration of dopaminergic neurons in Parkinson Disease (PD). Specifically, iron (Fe)-overload and copper (Cu) mis-compartmentalization have been reported to be involved in the injury of dopaminergic neurons in this pathology. The aim of this work was to characterize the mechanisms of membrane repair by studying lipid acylation and deacylation reactions and their role in oxidative injury in N27 dopaminergic neurons exposed to Fe-overload and Cu-supplementation. N27 dopaminergic neurons incubated with Fe (1mM) for 24 hs displayed increased levels of reactive oxygen species (ROS), lipid peroxidation and elevated plasma membrane permeability. Cu-supplemented neurons (10, 50 mu M) showed no evidence of oxidative stress markers. A different lipid acylation profile was observed in N27 neurons pre-labeled with [H-3] arachidonic acid (AA) or [H-3] oleic acid (OA). In Fe-exposed neurons, AA uptake was increased in triacylglycerols (TAG) whereas its incorporation into the phospholipid (PL) fraction was diminished. TAG content was 40% higher in Fe-exposed neurons than in controls. This increase was accompanied by the appearance of Nile red positive lipid bodies. Contrariwise, OA incorporation increased in the PL fractions and showed no changes in TAG. Lipid acylation profile in Cu-supplemented neurons showed AA accumulation into phosphatidylserine and no changes in TAG. The inhibition of deacylation/acylation reactions prompted an increase in oxidative stress markers and mitochondrial dysfunction in Fe-overloaded neurons. These findings provide evidence about the participation of lipid acylation mechanisms against Fe-induced oxidative injury and postulate that dopaminergic neurons cleverly preserve AA in TAG in response to oxidative stress.	[Alejandra Salvador, Gabriela] Univ Nacl Sur UNS, Inst Invest Bioquim Bahia Blanca INIBIBB, Bahia Blanca, Buenos Aires, Argentina; Consejo Nacl Invest Cient & Tecn CONICET, Bahia Blanca, Buenos Aires, Argentina	National University of the South; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Salvador, GA (corresponding author), Univ Nacl Sur UNS, Inst Invest Bioquim Bahia Blanca INIBIBB, Bahia Blanca, Buenos Aires, Argentina.	salvador@criba.edu.ar	Salvador, Gabriela/GOJ-7718-2022		Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2010-0936, PICT-2013-0987]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP1122009010068]; Universidad Nacional del Sur [PGI24B179]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional del Sur	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica www.agencia.mincyt.gob.ar/ (PICT-2010-0936, PICT-2013-0987) to GAS, Consejo Nacional de Investigaciones Cientificas y Tecnicas www.conicet.gov.ar (PIP1122009010068) to GAS and the Universidad Nacional del Sur www.uns.edu.ar (PGI24B179) to GAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibhatla RM, 2003, ANTIOXID REDOX SIGN, V5, P647, DOI 10.1089/152308603770310329; Balboa MA, 2006, BBA-MOL CELL BIOL L, V1761, P385, DOI 10.1016/j.bbalip.2006.03.014; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Bazan NG, 2005, MOL NEUROBIOL, V32, P89, DOI 10.1385/MN:32:1:089; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Davies KM, 2014, NEUROBIOL AGING, V35, P858, DOI 10.1016/j.neurobiolaging.2013.09.034; Devos D, 2013, CLIN THER, V35, P1640, DOI 10.1016/j.clinthera.2013.08.011; Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230; Double Kay L, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS52, DOI 10.1016/S1353-8020(11)70018-9; Dusek P, 2012, NEUROBIOL DIS, V46, P1, DOI 10.1016/j.nbd.2011.12.054; Else PL, 2015, BBA-BIOMEMBRANES, V1848, P417, DOI 10.1016/j.bbamem.2014.10.039; Farooqui AA, 2006, NEUROSCIENTIST, V12, P245, DOI 10.1177/1073858405285923; Farooqui AA, 2009, NEUROSCIENTIST, V15, P392, DOI 10.1177/1073858409337035; Fonteh AN, 2013, J LIPID RES, V54, P2884, DOI 10.1194/jlr.M037622; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Gal S, 2006, J NEURAL TRANSM-SUPP, P447; Glynn P, 2013, BBA-MOL CELL BIOL L, V1831, P633, DOI 10.1016/j.bbalip.2012.07.023; Gui YX, 2013, PARKINSONISM RELAT D, V19, P21, DOI 10.1016/j.parkreldis.2012.07.016; He Q, 2013, INT J BIOCHEM CELL B, V45, P2749, DOI 10.1016/j.biocel.2013.09.011; Howitt J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087119; Hulbert AJ, 2003, J EXP BIOL, V206, P2303, DOI 10.1242/jeb.00399; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Khaselev N, 1999, FREE RADICAL BIO MED, V26, P275, DOI 10.1016/S0891-5849(98)00211-1; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015946; Uranga RM, 2013, J BIOL CHEM, V288, P19773, DOI 10.1074/jbc.M113.457622; Uranga RM, 2009, TOXICOL SCI, V111, P331, DOI 10.1093/toxsci/kfp152; Mateos MV, 2012, BBA-MOL CELL RES, V1823, P2136, DOI 10.1016/j.bbamcr.2012.09.005; Mateos MV, 2008, NEUROCHEM INT, V53, P199, DOI 10.1016/j.neuint.2008.07.005; Mounsey Ross B, 2012, Int J Cell Biol, V2012, P983245, DOI 10.1155/2012/983245; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Raha AA, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-55; Diez GR, 2013, EXP EYE RES, V113, P172, DOI 10.1016/j.exer.2013.05.019; Diez GR, 2012, NEUROCHEM INT, V61, P749, DOI 10.1016/j.neuint.2012.06.012; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Ruiperez V, 2010, PROG LIPID RES, V49, P420, DOI 10.1016/j.plipres.2010.05.004; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Sian-Hulsmann J, 2011, J NEUROCHEM, V118, P939, DOI 10.1111/j.1471-4159.2010.07132.x; Stayte S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00113; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; Ulmann L, 2001, PROSTAG LEUKOTR ESS, V64, P189, DOI 10.1054/plef.2001.0260; Uranga RM, 2007, J NEUROSCI RES, V85, P2924, DOI 10.1002/jnr.21406; Wilfling F, 2014, CURR OPIN CELL BIOL, V29, P39, DOI 10.1016/j.ceb.2014.03.008; Wilson-Ashworth HA, 2004, J MEMBRANE BIOL, V200, P25, DOI 10.1007/s00232-004-0691-x; Zhu Y, 2007, NEUROCHEM INT, V50, P507, DOI 10.1016/j.neuint.2006.10.010	46	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130726	10.1371/journal.pone.0130726	http://dx.doi.org/10.1371/journal.pone.0130726			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076361	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900186
J	Santio, NM; Eerola, SK; Paatero, I; Yli-Kauhaluoma, J; Anizon, F; Moreau, P; Tuomela, J; Harkonen, P; Koskinen, PJ				Santio, Niina M.; Eerola, Sini K.; Paatero, Ilkka; Yli-Kauhaluoma, Jari; Anizon, Fabrice; Moreau, Pascale; Tuomela, Johanna; Harkonen, Pirkko; Koskinen, Paivi J.			Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts	PLOS ONE			English	Article							SERINE/THREONINE KINASES; CELL-MIGRATION; TUMOR-GROWTH; NUDE-MICE; EXPRESSION; INHIBITORS; CARCINOMA; CXCR4; OVEREXPRESSION; ACTIVATION	Background and methods Pim family proteins are oncogenic kinases implicated in several types of cancer and involved in regulation of cell proliferation, survival as well as motility. Here we have investigated the ability of Pim kinases to promote metastatic growth of prostate cancer cells in two xenograft models for human prostate cancer. We have also evaluated the efficacy of Pim-selective inhibitors to antagonize these effects. Results We show here that tumorigenic growth of both subcutaneously and orthotopically inoculated prostate cancer xenografts is enhanced by stable overexpression of either Pim-1 or Pim-3. Moreover, Pim-overexpressing orthotopic prostate tumors are highly invasive and able to migrate not only to the nearby prostate-draining lymph nodes, but also into the lungs to form metastases. When the xenografted mice are daily treated with the Pim-selective inhibitor DHPCC-9, both the volumes as well as the metastatic capacity of the tumors are drastically decreased. Interestingly, the Pim-promoted metastatic growth of the orthotopic xenografts is associated with enhanced angiogenesis and lymphangiogenesis. Furthermore, forced Pim expression also increases phosphorylation of the CXCR4 chemokine receptor, which may enable the tumor cells to migrate towards tissues such as the lungs that express the CXCL12 chemokine ligand. Conclusions Our results indicate that Pim overexpression enhances the invasive properties of prostate cancer cells in vivo. These effects can be reduced by the Pim-selective inhibitor DHPCC-9, which can reach tumor tissues without serious side effects. Thus, Pim-targeting therapies with DHPCC-9-like compounds may help to prevent progression of local prostate carcinomas to fatally metastatic malignancies.	[Santio, Niina M.; Eerola, Sini K.; Koskinen, Paivi J.] Univ Turku, Dept Biol, Sect Genet & Physiol, SF-20500 Turku, Finland; [Santio, Niina M.] Univ Turku, Drug Res Doctoral Programme, FIN-20520 Turku, Finland; [Paatero, Ilkka] Univ Turku, Dept Med Biochem & Genet, Inst Biomed, FIN-20520 Turku, Finland; [Yli-Kauhaluoma, Jari] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem & Technol, FIN-00014 Helsinki, Finland; [Anizon, Fabrice; Moreau, Pascale] Univ Clermont Ferrand, Univ Clermont Auvergne, Inst Chim Clermont Ferrand, F-63000 Clermont Ferrand, France; [Anizon, Fabrice; Moreau, Pascale] CNRS, F-63178 Aubiere, France; [Tuomela, Johanna; Harkonen, Pirkko] Univ Turku, Dept Cell Biol & Anat, Inst Biomed, FIN-20520 Turku, Finland; [Tuomela, Johanna] Pharmatest Serv Ltd, Turku 20520, Finland	University of Turku; University of Turku; University of Turku; University of Helsinki; Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); University of Turku; Pharmatest Services	Koskinen, PJ (corresponding author), Univ Turku, Dept Biol, Sect Genet & Physiol, SF-20500 Turku, Finland.	paivi.koskinen@utu.fi	ANIZON, Fabrice/M-7940-2016; Koskinen, Päivi J/G-8939-2014; Paatero, Ilkka/AAE-7542-2019; Moreau, Pascale/M-9020-2016	ANIZON, Fabrice/0000-0001-7869-9622; Paatero, Ilkka/0000-0001-5926-2396; Moreau, Pascale/0000-0001-6527-7586; Yli-Kauhaluoma, Jari/0000-0003-0370-7653; Tuomela, Johanna/0000-0003-4390-4563; Koskinen, Paivi/0000-0002-6864-4457	Academy of Finland [121533, 269541]; TULI Program of the University of Turku; Sigrid Juselius Foundation; FinPharma Doctoral Program; Emil Aaltonen Foundation; Cancer Organizations for the Western Finland; Orion-Farmos Research Foundation; Finnish Cultural Foundation; Turku University Foundation; Walter och Lisi Wahls Stiftelse fur Naturvetenskaplig Forskning	Academy of Finland(Academy of Finland); TULI Program of the University of Turku; Sigrid Juselius Foundation(Sigrid Juselius Foundation); FinPharma Doctoral Program; Emil Aaltonen Foundation; Cancer Organizations for the Western Finland; Orion-Farmos Research Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Turku University Foundation; Walter och Lisi Wahls Stiftelse fur Naturvetenskaplig Forskning	This work was supported by the Academy of Finland (grant 121533 to PJK, grant 269541 to PH), TULI Program of the University of Turku (PJK), Sigrid Juselius Foundation (PH), FinPharma Doctoral Program (NMS), Emil Aaltonen Foundation (NMS), Cancer Organizations for the Western Finland (NMS), Orion-Farmos Research Foundation (NMS), Finnish Cultural Foundation (NMS), Turku University Foundation (SKE), and Walter och Lisi Wahls Stiftelse fur Naturvetenskaplig Forskning (JYK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Johanna Tuomela was employed by Pharmatest Services Ltd for a period during the study. Pharmatest did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of JT is articulated in the 'author contributions' section.	Akue-Gedu R, 2009, J MED CHEM, V52, P6369, DOI 10.1021/jm901018f; Anizon F, 2010, CURR MED CHEM, V17, P4114, DOI 10.2174/092986710793348554; Arunesh GM, 2014, EXPERT OPIN THER PAT, V24, P5, DOI 10.1517/13543776.2014.848196; Aumuller IB, 2009, ORG LETT, V11, P5363, DOI 10.1021/ol902283q; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Brault L, 2012, BRIT J CANCER, V107, P491, DOI 10.1038/bjc.2012.272; Brault L, 2010, HAEMATOL-HEMATOL J, V95, P1004, DOI 10.3324/haematol.2009.017079; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Chen WW, 2005, MOL CANCER RES, V3, P443, DOI 10.1158/1541-7786.MCR-05-0007; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; CUYPERS HT, 1984, CELL, V37, P141; Decker S, 2014, MOL CANCER THER, V13, P1231, DOI 10.1158/1535-7163.MCT-13-0575-T; Evans JD., 1996, STRAIGHTFORWARD STAT; Foulks JM, 2014, NEOPLASIA, V16, P403, DOI 10.1016/j.neo.2014.05.004; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Grundler R, 2009, J EXP MED, V206, P1957, DOI 10.1084/jem.20082074; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kiriazis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055409; Kukreja P, 2005, CANCER RES, V65, P9891, DOI 10.1158/0008-5472.CAN-05-1293; Liu HT, 2010, J SURG ONCOL, V102, P683, DOI 10.1002/jso.21627; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Morwick T, 2010, EXPERT OPIN THER PAT, V20, P193, DOI 10.1517/13543770903496442; Nuusslein-Volhard C, 2002, ZEBRAFISH PRACTICAL; Peltola K, 2009, NEOPLASIA, V11, P629, DOI 10.1593/neo.81038; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; Ruohola JK, 1999, MOL CELL ENDOCRINOL, V149, P29, DOI 10.1016/S0303-7207(99)00003-9; Santio NM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-279; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; STEPHENSON RA, 1992, J NATL CANCER I, V84, P951, DOI 10.1093/jnci/84.12.951; Sussman Mark A, 2009, Expert Rev Cardiovasc Ther, V7, P929, DOI 10.1586/erc.09.48; Taichman RS, 2002, CANCER RES, V62, P1832; Tanaka S, 2009, MOL MED REP, V2, P313, DOI 10.3892/mmr_00000102; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tuomela J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-362; Tuomela JM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-81; Zhang P, 2009, J CELL PHYSIOL, V220, P82, DOI 10.1002/jcp.21733	36	48	52	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130340	10.1371/journal.pone.0130340	http://dx.doi.org/10.1371/journal.pone.0130340			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075720	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900164
J	van Stuijvenberg, M; Stam, J; Gruber, C; Mosca, F; Arslanoglu, S; Chirico, G; Braegger, CP; Riedler, J; Boehm, G; Sauer, PJJ				van Stuijvenberg, Margriet; Stam, Jose; Grueber, Christoph; Mosca, Fabio; Arslanoglu, Sertac; Chirico, Gaetano; Braegger, Christian P.; Riedler, Josef; Boehm, Guenther; Sauer, Pieter J. J.		MIPS Study Grp	Similar Occurrence of Febrile Episodes Reported in Non-Atopic Children at Three to Five Years of Age after Prebiotics Supplemented Infant Formula	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; ACIDIC OLIGOSACCHARIDES; PRETERM INFANTS; INTESTINAL MICROBIOTA; INFECTIOUS-DISEASES; FOLLOW-UP; LIFE; MIXTURE; COHORT; CELLS	This is a follow up study of a multicenter randomised placebo-controlled trial in seven centres in five West European countries. The RCT assessed the effect of infant formula supplemented with a mixture of prebiotics (with neutral short-chain and long-chain oligosaccharides and pectin-derived acidic oligosaccharides) during infancy in term-born children (n=1130). In the follow-up study 672 children (60% of the study population) participated: 232 (56%) from the prebiotics group (PG), 243 (58%) from the control group (CG), and 197 (66%) from the non-randomised breast-fed group (BG). The primary outcome was the occurrence of febrile episodes at three to five years of age prospectively documented by the parents: in the PG 1.17 (interquartile range 0.50-2.08) episodes per year versus 1.20 (0.52-2.57) in the CG; and 1.48 (0.65-2.60) in the BG. This specific prebiotics mixture given during infancy in healthy non-atopic subjects does not decrease febrile episodes and therefore seems not to prevent infection between their third and fifth birthday.	[van Stuijvenberg, Margriet; Stam, Jose; Sauer, Pieter J. J.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Paediat, Groningen, Netherlands; [Grueber, Christoph] Charite, Dept Pediat Pulmonol & Immunol, D-13353 Berlin, Germany; [Mosca, Fabio] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, NICU, Milan, Italy; [Arslanoglu, Sertac] Macedonio Melloni Hosp, Ctr Infant Nutr, Milan, Italy; [Chirico, Gaetano] Spedali Civil Brescia, Dept Neonatol, I-25125 Brescia, Italy; [Braegger, Christian P.] Univ Childrens Hosp, Div Pediat Gastroenterol & Nutr, Zurich, Switzerland; [Riedler, Josef] Schwarzach Hosp, Schwarzach, Austria; [Boehm, Guenther] Danone Nutr Res, Utrecht, Netherlands	University of Groningen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Hospital Spedali Civili Brescia; University Children's Hospital Zurich; Danone Nutricia	van Stuijvenberg, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Paediat, Groningen, Netherlands.	m.van.stuijvenberg@umcg.nl	Knol, Jan/A-2178-2010; Braegger, Christian Peter/ABC-9884-2021; garssen, johan/I-7159-2016; riedler, josef/AAQ-4666-2020; Arslanoglu, Sertac/ABE-8915-2021; Mosca, Fabio/C-5826-2017; Knol, Jan/AAL-6487-2020; Gianni, Maria Lorella/C-2026-2017	Knol, Jan/0000-0002-2103-5961; Mosca, Fabio/0000-0001-6477-0299; Knol, Jan/0000-0002-2103-5961; Braegger, Christian/0000-0001-8069-9875; Gianni, Maria Lorella/0000-0003-3901-9131	Danone Research	Danone Research(Danone Nutricia)	The study was funded by Danone Research. The funder had a role in the design of the study, but had no role in the data collection, decision to publish, and preparation of the manuscript.	Arslanoglu S, 2008, J NUTR, V138, P1091, DOI 10.1093/jn/138.6.1091; Bakker-Zierikzee AM, 2005, BRIT J NUTR, V94, P783, DOI 10.1079/BJN20051451; Bernard H, 2015, J INFECT DIS, V211, P156, DOI 10.1093/infdis/jiu391; Bocquet A, 2013, J PEDIATR GASTR NUTR, V57, P180, DOI 10.1097/MPG.0b013e318297f35e; Duijts L, 2010, PEDIATRICS, V126, pE18, DOI 10.1542/peds.2008-3256; Eiwegger T, 2004, PEDIATR RES, V56, P536, DOI 10.1203/01.PDR.0000139411.35619.B4; Kuntz S, 2008, BRIT J NUTR, V99, P462, DOI 10.1017/S0007114507824068; Li F, 2014, PEDIATRICS, V133, pE1533, DOI 10.1542/peds.2013-3598; Luoto R, 2014, J ALLERGY CLIN IMMUN, V133, P405, DOI 10.1016/j.jaci.2013.08.020; Moecks Joachim, 2004, J Biopharm Stat, V14, P415, DOI 10.1081/BIP-120037190; Morrow AL, 2004, J PEDIATR-US, V145, P297, DOI 10.1016/j.jpeds.2004.04.054; Niele N, 2013, EUR J PEDIATR, V172, P317, DOI 10.1007/s00431-012-1886-2; Piemontese P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028010; Quigley MA, 2013, ARCH DIS CHILD, V98, P654, DOI 10.1136/archdischild-2013-304188; Sazawal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012164; Scheepers LEJM, 2015, INT J OBESITY, V39, P16, DOI 10.1038/ijo.2014.178; SMITH AH, 1992, EPIDEMIOLOGY, V3, P449, DOI 10.1097/00001648-199209000-00011; Terrin G, 2013, AM J CLIN NUTR, V98, P1468, DOI 10.3945/ajcn.112.054478; van Stuijvenberg M, 2011, BRIT J NUTR, V106, P1740, DOI 10.1017/S0007114511004053; Vos AP, 2007, PEDIAT ALLERG IMM-UK, V18, P304, DOI 10.1111/j.1399-3038.2007.00515.x; Westerbeek EAM, 2010, AM J CLIN NUTR, V91, P679, DOI 10.3945/ajcn.2009.28625; Wilson AC, 1998, BMJ-BRIT MED J, V316, P21, DOI 10.1136/bmj.316.7124.21; Yu ZT, 2013, GLYCOBIOLOGY, V23, P169, DOI 10.1093/glycob/cws138	23	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129927	10.1371/journal.pone.0129927	http://dx.doi.org/10.1371/journal.pone.0129927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076141	Green Published, gold, Green Accepted			2022-12-27	WOS:000356329900113
J	Girling, SJ; Campbell-Palmer, R; Pizzi, R; Fraser, MA; Cracknell, J; Arnemo, J; Rosell, F				Girling, Simon J.; Campbell-Palmer, Roisin; Pizzi, Romain; Fraser, Mary A.; Cracknell, Jonathan; Arnemo, Jon; Rosell, Frank			Haematology and Serum Biochemistry Parameters and Variations in the Eurasian Beaver (Castor fiber)	PLOS ONE			English	Article							WESTERN-EUROPE; GREAT-BRITAIN; REINTRODUCTIONS; POPULATION; CANADENSIS; ANESTHESIA; CHEMISTRY; CAPTURE; STOCK	Haematology parameters (N = 24) and serum biochemistry parameters (N = 35) were determined for wild Eurasian beavers (Castor fiber), between 6 months -12 years old. Of the population tested in this study, N = 18 Eurasian beavers were from Norway and N = 17 originating from Bavaria but now living extensively in a reserve in England. All blood samples were collected from beavers via the ventral tail vein. All beavers were chemically restrained using inhalant isoflurane in 100% oxygen prior to blood sampling. Results were determined for haematological and serum biochemical parameters for the species and were compared between the two different populations with differences in means estimated and significant differences being noted. Standard blood parameters for the Eurasian beaver were determined and their ranges characterised using percentiles. Whilst the majority of blood parameters between the two populations showed no significant variation, haemoglobin, packed cell volume, mean cell haemoglobin and white blood cell counts showed significantly greater values (p<0.01) in the Bavarian origin population than the Norwegian; neutrophil counts, alpha 2 globulins, cholesterol, sodium: potassium ratios and phosphorus levels showed significantly (p<0.05) greater values in Bavarian versus Norwegian; and potassium, bile acids, gamma globulins, urea, creatinine and total calcium values levels showed significantly (p<0.05) greater values in Norwegian versus Bavarian relict populations. No significant differences were noted between male and female beavers or between sexually immature (<3 years old) and sexually mature (>= 3 years old) beavers in the animals sampled. With Eurasian beaver reintroduction encouraged by legislation throughout Europe, knowledge of baseline blood values for the species and any variations therein is essential when assessing their health and welfare and the success or failure of any reintroduction program. This is the first study to produce base-line blood values and their variations for the Eurasian beaver.	[Girling, Simon J.; Pizzi, Romain] Royal Zool Soc Scotland, Living Collect, Vet Dept, Edinburgh, Midlothian, Scotland; [Campbell-Palmer, Roisin] Telemark Univ Coll, Dept Environm & Hlth Studies, Fac Arts & Sci, Bo I Telemark, Norway; [Campbell-Palmer, Roisin; Rosell, Frank] Royal Zool Soc Scotland, Conservat Programmes, Edinburgh, Midlothian, Scotland; [Fraser, Mary A.] Edinburgh Napier Univ, Sch Life Sport & Social Sci, Edinburgh, Midlothian, Scotland; [Cracknell, Jonathan] Longleat Safari & Adventure Pk, Warminster, Wilts, England; [Arnemo, Jon] Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Dept Forestry & Wildlife Management, Koppang, Norway; [Arnemo, Jon] Swedish Univ Agr Sci, Fac Forest Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden	University College of Southeast Norway; Edinburgh Napier University; Inland Norway University of Applied Sciences; Swedish University of Agricultural Sciences	Girling, SJ (corresponding author), Royal Zool Soc Scotland, Living Collect, Vet Dept, Edinburgh, Midlothian, Scotland.	sgirling@rzss.org.uk	Pizzi, Romain/AAW-6360-2020; Fraser, Mary/AAU-9232-2021	Pizzi, Romain/0000-0002-9030-9559; Fraser, Mary/0000-0002-2588-7520; Girling, Simon/0000-0001-9927-9491	Longleat Safari; Adventure Park	Longleat Safari; Adventure Park	The authors received no specific funding for this work. Longleat Safari and Adventure Park provided support in the form of salaries for authors [JC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	[Anonymous], 2004, SMALL ANIMAL CLIN DI; Barlow AM, 2011, VET REC, V169, DOI 10.1136/vr.d4673; BENNETT PM, 1991, VET REC, V128, P496, DOI 10.1136/vr.128.21.496; CLARK JD, 1986, ZOO WILD ANIMAL MED, P727; DiBartola S.P., 2004, SMALL ANIMAL CLIN DI, P117; Durka W, 2005, MOL ECOL, V14, P3843, DOI 10.1111/j.1365-294X.2005.02704.x; Eisele PH, 1997, CONTEMP TOP LAB ANIM, V36, P97; Goodman G, 2012, J WILDLIFE DIS, V48, P971, DOI 10.7589/2011-06-153; GREENE SA, 1991, AM J VET RES, V52, P665; Halley DJ, 2002, MAMMAL REV, V32, P153, DOI 10.1046/j.1365-2907.2002.00106.x; Halley D, 2012, BALT FOR, V18, P168; Halley Duncan J., 2003, Lutra, V46, P91; Halley DJ, 2011, MAMMAL REV, V41, P40, DOI 10.1111/j.1365-2907.2010.00167.x; ISIS, 2002, REF VAL CAPT N AM BE; Jenkins JR, 2008, J EXOT PET MED, V17, P16, DOI 10.1053/j.jepm.2007.12.004; Kaneko J., 2008, CLIN BIOCH DOMESTIC, V6th, P889; KITTS W. D., 1958, CANADIAN JOUR ZOOL, V36, P279, DOI 10.1139/z58-026; Marco I, 1999, RES VET SCI, V66, P81, DOI 10.1053/rvsc.1998.0248; Martino PE, 2012, J ZOO WILDLIFE MED, V43, P240, DOI 10.1638/2010-0154.1; Masek T, 2009, EUR J WILDLIFE RES, V55, P561, DOI 10.1007/s10344-009-0276-1; Mayer J., 2013, EXOTIC ANIMAL FORMUL, P476; Milner JM, 2003, CAN J ZOOL, V81, P1566, DOI [10.1139/z03-152, 10.1139/Z03-152]; Ness R. D., 2005, EXOTIC ANIMAL FORMUL, P375; Nolet BA, 1998, BIOL CONSERV, V83, P165, DOI 10.1016/S0006-3207(97)00066-9; Novak M., 1987, WILD FURBEARER MANAG, P283; Pilny Anthony A., 2008, Veterinary Clinics of North America Exotic Animal Practice, V11, P523, DOI 10.1016/j.cvex.2008.04.001; Rosef Oav, 2004, Rangifer, V24, P79; Rosell F, 1999, WILDLIFE BIOL, V5, P119, DOI 10.2981/wlb.1999.015; Rosell F, 2001, WILDLIFE SOC B, V29, P269; Rosell F, 2012, MAMMAL REV, V42, P319, DOI 10.1111/j.1365-2907.2011.00197.x; Senn H, 2014, EVOL APPL, V7, P645, DOI 10.1111/eva.12162; STEVENSON A. B., 1959, CANADIAN JOUR ZOOL, V37, P9, DOI 10.1139/z59-002; Swenson M. J, 1984, DUKES PHYSL DOMESTIC, P15; Thoresen SI, 2009, VET CLIN PATH, V38, P224, DOI 10.1111/j.1939-165X.2008.00105.x; Wesche P., 2009, BSAVA manual of rodents and ferrets, P42; Willard MD, 2004, SMALL ANIMAL CLIN DI, P208; Zharkov I. V., 1967, ACTA THERIOL, V12, P27, DOI 10.4098/AT.arch.67-3	37	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128775	10.1371/journal.pone.0128775	http://dx.doi.org/10.1371/journal.pone.0128775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066344	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000028
J	Novkovic, B; Kimura, MT				Novkovic, Biljana; Kimura, Masahito T.			Phylogeography, Interaction Patterns and the Evolution of Host Choice in Drosophila-Parasitoid Systems in Ryukyu Archipelago and Taiwan	PLOS ONE			English	Article							FRUGIVOROUS DROSOPHILIDS; SUBTROPICAL ISLAND; POPULATION-GROWTH; COEVOLUTION; SPECIATION; JAPAN; PARAMETERS; DISPERSAL; DIVERSITY; ABUNDANCE	Island biotas provide a great opportunity to study not only the phylogeographic patterns of a group of species, but also to explore the differentiation in their coevolutionary interactions. Drosophila and their parasitoids are exemplary systems for studying complex interaction patterns. However, there is a lack of studies combining interaction-based and molecular marker-based methods. We applied an integrated approach combining phylogeography, interaction, and host-choice behavior studies, with the aim to understand how coevolutionary interactions evolve in Drosophila-parasitoid island populations. The study focused on the three most abundant Drosophila species in Ryukyu archipelago and Taiwan: D. albomicans, D. bipectinata, and D. takahashii, and the Drosophila-parasitoid Leptopilina ryukyuensis. We determined mitochondrial COI haplotypes for samples representing five island populations of Drosophila and four island populations of L. ryukyuensis. We additionally sequenced parts of the autosomal Gpdh for Drosophila samples, and the ITS2 for parasitoid samples. Phylogenetic and coalescent analyses were used to test for demographic events and to place them in a temporal framework. Geographical differences in Drosophilaparasitoid interactions were studied in host-acceptance, host-suitability, and host-choice experiments. All four species showed species-specific phylogeographic patterns. A general trend of the haplotype diversity increasing towards the south was observed. D. albomicans showed very high COI haplotype diversity, and had the most phylogeographically structured populations, with differentiation into the northern and the southern population-group, divided by the Kerama gap. Differentiation in host suitability was observed only between highly structured populations of D. albomicans, possibly facilitated by restricted gene flow. Differentiation in host-acceptance in D. takahashii, and host-acceptance and host-choice in L. ryukyuensis was found, despite there being no differentiation in these two species according to molecular markers. Host choice assays show that L. ryukyuensis populations that have had more time to coevolve adapt their behavior to exploit the most suitable host - D. albomicans. L. ryukyuensis parasitoids on border ranges may, on the other hand, benefit from broader host-acceptance, that may facilitate adaptation to uncertain and variable environments. All results indicate that Drosophila-parasitoid populations in the Ryukyu archipelago and Taiwan have different evolutionary trajectories, and coevolve in a dynamic, complex, and local-specific way.	[Novkovic, Biljana; Kimura, Masahito T.] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan	Hokkaido University	Novkovic, B (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan.	biljanan@ees.hokudai.ac.jp		Novkovic, Biljana/0000-0002-7854-5006				Althoff DM, 2008, MOL ECOL, V17, P3917, DOI 10.1111/j.1365-294X.2008.03874.x; Althoff DM, 1999, EVOLUTION, V53, P818, DOI 10.1111/j.1558-5646.1999.tb05375.x; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Benkman CW, 2001, EVOLUTION, V55, P282, DOI 10.1111/j.0014-3820.2001.tb01293.x; Brodie ED, 2002, EVOLUTION, V56, P2067; Carroll SP, 1997, EVOLUTION, V51, P1182, DOI [10.1111/j.1558-5646.1997.tb03966.x, 10.2307/2411048]; CHANG HY, 1989, J MOL EVOL, V28, P337, DOI 10.1007/BF02103430; Chen Weijing, 1994, Acta Genetica Sinica, V21, P179; Chesser RK, 1996, GENETICS, V144, P1225; Chiang TY, 2006, TAXON, V55, P31, DOI 10.2307/25065526; Dubuffet A, 2006, PHYSIOL ENTOMOL, V31, P170, DOI 10.1111/j.1365-3032.2006.00505.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Filatov DA, 2009, BIOINFORMATICS, V25, P3189, DOI 10.1093/bioinformatics/btp572; Fitzpatrick BM, 2009, MOL ECOL, V18, P3961, DOI 10.1111/j.1365-294X.2009.04314.x; Fu YX, 1997, GENETICS, V147, P915; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hawkins BA, 1994, PATTERN PROCESS HOST; Hayward A, 2006, MOL ECOL, V15, P479, DOI 10.1111/j.1365-294X.2005.02811.x; Hirai Yoshiyuki, 2000, Entomological Science, V3, P273; Hurtado LA, 2004, MOL ECOL, V13, P1365, DOI 10.1111/j.1365-294X.2004.02169.x; Kimura M., 2000, TROPICS, V10, P5, DOI [10.3759/tropics.10.5, DOI 10.3759/TROPICS.10.5]; Kimura MT, 2012, J NAT HIST, V46, P1947, DOI 10.1080/00222933.2012.707239; Kohnen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047156; Kondo M, 2008, ENTOMOL SCI, V11, P7, DOI 10.1111/j.1479-8298.2007.00250.x; Kopp A, 2005, GENET RES, V85, P23, DOI 10.1017/S0016672305007317; KRAAIJEVELD AR, 1994, PHYSIOL ENTOMOL, V19, P9, DOI 10.1111/j.1365-3032.1994.tb01068.x; Lapchin L, 2002, AM NAT, V160, P245, DOI 10.1086/341020; MANTEL N, 1967, CANCER RES, V27, P209; Markow TA, 2000, OIKOS, V89, P378, DOI 10.1034/j.1600-0706.2000.890219.x; Moraes EM, 2009, J BIOGEOGR, V36, P2136, DOI 10.1111/j.1365-2699.2009.02145.x; Motokawa M., 2000, TROPICS, V10, P63, DOI [10.3759/tropics.10.63, DOI 10.3759/TR0PICS.10.63]; Nicholls JA, 2010, MOL ECOL, V19, P592, DOI 10.1111/j.1365-294X.2009.04499.x; Novkovic B, 2012, EUR J ENTOMOL, V109, P517, DOI 10.14411/eje.2012.065; Novkovic B, 2011, ENTOMOL SCI, V14, P333, DOI 10.1111/j.1479-8298.2011.00459.x; OHSAKO T, 1994, JPN J GENET, V69, P183, DOI 10.1266/jjg.69.183; Osozawa S, 2012, INT GEOL REV, V54, P1369, DOI 10.1080/00206814.2011.639954; Ota H, 1998, RES POPUL ECOL, V40, P189, DOI 10.1007/BF02763404; Otsuka H., 2000, TROPICS, V10, P25, DOI [10.3759/tropics.10.25, DOI 10.3759/TROPICS.10.25]; Pannebakker BA, 2008, ENTOMOL EXP APPL, V127, P48, DOI 10.1111/j.1570-7458.2008.00666.x; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; R Core Team, 2021, R LANGUAGE ENV STAT; Ravikumar H, 2011, J GENET, V90, P507; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schneider S, 1999, GENETICS, V152, P1079; SLATKIN M, 1991, GENETICS, V129, P555; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson J. N., 2005, INTERSPEC INTERACT; WANG W, 1994, SCI CHINA SER B, V37, P1329; WATANABE TK, 1983, JPN J GENET, V58, P269, DOI 10.1266/jjg.58.269; Watase S, 1912, ANNOT ZOOL JAPON, V8, P108; Withers T., 2005, Second International Symposium on Biological Control of Arthropods, Davos, Switzerland, 12-16 September, 2005, P620; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064	56	3	3	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129132	10.1371/journal.pone.0129132	http://dx.doi.org/10.1371/journal.pone.0129132			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070158	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000052
J	Yan, R; Zhang, YM; Cai, DW; Liu, YJ; Cuconati, A; Guo, HT				Yan, Ran; Zhang, Yongmei; Cai, Dawei; Liu, Yuanjie; Cuconati, Andrea; Guo, Haitao			Spinoculation Enhances HBV Infection in NTCP-Reconstituted Hepatocytes	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CLOSED CIRCULAR DNA; TAUROCHOLATE COTRANSPORTING POLYPEPTIDE; MEDIATED GENE-TRANSFER; CENTRIFUGAL ENHANCEMENT; MEMBRANE TRANSPORTER; CYCLOSPORINE-A; ENTRY; CELLS; IDENTIFICATION	Hepatitis B virus (HBV) infection and its sequelae remain a major public health burden, but both HBV basic research and the development of antiviral therapeutics have been hindered by the lack of an efficient in vitro infection system. Recently, sodium taurocholate cotransporting polypeptide (NTCP) has been identified as the HBV receptor. We herein report that we established a NTCP-complemented HepG2 cell line (HepG2-NTCP12) that supports HBV infection, albeit at a low infectivity level following the reported infection procedures. In our attempts to optimize the infection conditions, we found that the centrifugation of HepG2-NTCP12 cells during HBV inoculation (termed "spinoculation") significantly enhanced the virus infectivity. Moreover, the infection level gradually increased with accelerated speed of spinoculation up to 1,000g tested. However, the enhancement of HBV infection was not significantly dependent upon the duration of centrifugation. Furthermore, covalently closed circular (ccc) DNA was detected in infected cells under optimized infection condition by conventional Southern blot, suggesting a successful establishment of HBV infection after spinoculation. Finally, the parental HepG2 cells remained uninfected under HBV spinoculation, and HBV entry inhibitors targeting NTCP blocked HBV infection when cells were spinoculated, suggesting the authentic virus entry mechanism is unaltered under centrifugal inoculation. Our data suggest that spinoculation could serve as a standard protocol for enhancing the efficiency of HBV infection in vitro.	[Yan, Ran; Cai, Dawei; Liu, Yuanjie; Guo, Haitao] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Zhang, Yongmei] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200040, Peoples R China; [Cuconati, Andrea] Hepatitis B Fdn, Baruch S Blumberg Inst, Doylestown, PA 18902 USA	Indiana University System; Indiana University Bloomington; Fudan University	Guo, HT (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	haitguo@iupui.edu	Cuconati, Andrea/GWV-4662-2022; Cuconati, Andrea/AAI-7533-2020	Cuconati, Andrea/0000-0001-5123-0381	National Institutes of Health [R01AI094474, R21AI103838]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094474, R21AI103838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (grant numbers R01AI094474 and R21AI103838, http://nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asabe S, 2009, J VIROL, V83, P9652, DOI 10.1128/JVI.00867-09; BAHNSON AB, 1995, J VIROL METHODS, V54, P131, DOI 10.1016/0166-0934(95)00035-S; Bardens A, 2011, CELL MICROBIOL, V13, P602, DOI 10.1111/j.1462-5822.2010.01557.x; Block Timothy M, 2007, Clin Liver Dis, V11, P685, DOI 10.1016/j.cld.2007.08.002; BUNNELL BA, 1995, P NATL ACAD SCI USA, V92, P7739, DOI 10.1073/pnas.92.17.7739; Cai Dawei, 2013, Methods Mol Biol, V1030, P151, DOI 10.1007/978-1-62703-484-5_13; Cai DW, 2012, ANTIMICROB AGENTS CH, V56, P4277, DOI 10.1128/AAC.00473-12; Chai N, 2008, J VIROL, V82, P7812, DOI 10.1128/JVI.00561-08; Gao WF, 2007, J VIROL, V81, P6164, DOI 10.1128/JVI.02721-06; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Guo H, 2007, J VIROL, V81, P12472, DOI 10.1128/JVI.01123-07; Guo HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043270; Guo HT, 2011, ANTIMICROB AGENTS CH, V55, P478, DOI 10.1128/AAC.00989-10; Guo HT, 2010, J VIROL, V84, P387, DOI 10.1128/JVI.01921-09; Guo J, 2011, J VIROL, V85, P9824, DOI 10.1128/JVI.05170-11; HAGENBUCH B, 1994, J CLIN INVEST, V93, P1326, DOI 10.1172/JCI117091; HO WZ, 1993, J LEUKOCYTE BIOL, V53, P208, DOI 10.1002/jlb.53.2.208; Huang HC, 2012, J VIROL, V86, P9443, DOI 10.1128/JVI.00873-12; HUDSON JB, 1976, VIROLOGY, V72, P235, DOI 10.1016/0042-6822(76)90326-3; Iwamoto M, 2014, BIOCHEM BIOPH RES CO, V443, P808, DOI 10.1016/j.bbrc.2013.12.052; Kotani N, 2012, MOL PHARMACEUT, V9, P3434, DOI 10.1021/mp300171p; Lindenbach BD, 2013, NAT REV MICROBIOL, V11, P688, DOI 10.1038/nrmicro3098; Mao RC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003494; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Ning XJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002255; Nkongolo S, 2014, J HEPATOL, V60, P723, DOI 10.1016/j.jhep.2013.11.022; NybergHoffman C, 1997, NAT MED, V3, P808, DOI 10.1038/nm0797-808; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; OSBORN JE, 1968, J VIROL, V2, P853, DOI 10.1128/JVI.2.9.853-858.1968; PADGETT BL, 1962, P SOC EXP BIOL MED, V111, P364; Park IH, 2014, ANTIVIR RES, V104, P118, DOI 10.1016/j.antiviral.2014.01.021; Reading SA, 2001, J VIROL METHODS, V98, P167, DOI 10.1016/S0166-0934(01)00368-8; Scanlan PM, 2005, J VIROL METHODS, V128, P104, DOI 10.1016/j.jviromet.2005.04.008; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; Schulze-Bergkamen H, 2003, J HEPATOL, V38, P736, DOI 10.1016/S0168-8278(03)00120-X; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; Seeger C, 2013, GUT, V62, P1093, DOI 10.1136/gutjnl-2013-304594; SUNDIN DR, 1989, J CLIN MICROBIOL, V27, P1659, DOI 10.1128/JCM.27.7.1659-1660.1989; TENSER RB, 1978, INFECT IMMUN, V21, P281, DOI 10.1128/IAI.21.1.281-285.1978; Tong SP, 2014, GASTROENTEROLOGY, V146, P902, DOI 10.1053/j.gastro.2014.02.024; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; Watashi K, 2014, HEPATOLOGY, V59, P1726, DOI 10.1002/hep.26982; Yan H, 2014, J VIROL, V88, P3273, DOI 10.1128/JVI.03478-13; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Ye L, 2008, J VIROL METHODS, V148, P161, DOI 10.1016/j.jviromet.2007.11.002; Zhang YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110442	47	48	50	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129889	10.1371/journal.pone.0129889	http://dx.doi.org/10.1371/journal.pone.0129889			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070202	gold, Green Submitted, Green Published			2022-12-27	WOS:000356327000119
J	Cadario, F; Savastio, S; Magnani, C; Cena, T; Pagliardini, V; Bellomo, G; Bagnati, M; Vidali, M; Pozzi, E; Pamparana, S; Zaffaroni, M; Genoni, G; Bona, G				Cadario, Francesco; Savastio, Silvia; Magnani, Corrado; Cena, Tiziana; Pagliardini, Veronica; Bellomo, Giorgio; Bagnati, Marco; Vidali, Matteo; Pozzi, Erica; Pamparana, Stella; Zaffaroni, Mauro; Genoni, Giulia; Bona, Gianni			High Prevalence of Vitamin D Deficiency in Native versus Migrant Mothers and Newborns in the North of Italy: A Call to Act with a Stronger Prevention Program	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; D SUPPLEMENTATION; D INSUFFICIENCY; CORD-BLOOD; PREGNANCY; RISK; IMMUNOASSAYS; VALIDITY; HEALTH	Background Vitamin D status during pregnancy is related to neonatal vitamin D status. Vitamin D deficiency has been associated with an increased risk of rickets in children and osteomalacia in adults. Aim of this study was to investigate 25OHD levels in maternal serum and in neonatal blood spots in native and migrant populations living in Novara (North Italy, 45 degrees N latitude). Methods and Findings We carried out a cross sectional study from April 1st 2012 to March 30th 2013, in a tertiary Care Center. Maternal blood samples after delivery and newborns' blood spots were analyzed for 25OHD levels in 533 pairs. Maternal country of origin, skin phototype, vitamin D dietary intake and supplementation during pregnancy were recorded. Multivariate regression analysis, showed a link between neonatal and maternal 25OHD levels (R-square: 0.664). Severely deficient 25OHD values (<25 nmol/L) were found in 38% of Italian and in 76.2% of migrant's newborns (p < 0.0001), and in 18% of Italian and 48,4% of migrant mothers (p < 0.0001) while 25OHD deficiency (>= 25 and <50 nmol/L) was shown in 40.1% of Italian and 21.7% of migrant's newborns (p < 0.0001), and in 43.6% of Italian and 41.3% of migrant mothers (p < 0.0001). Italian newborns and mothers had higher 25OHD levels (34.4 +/- 19.2 and 44.9 +/- 21.2nmol/L) than migrants (17.7 +/- 13.7 and 29.7 +/- 16.5nmol/L; p < 0.0001). A linear decrease of 25OHD levels was found with increasing skin pigmentation (phototype I 42.1 +/- 18.2 vs phototype VI 17.9 +/- 10.1 nmol/l; p < 0.0001). Vitamin D supplementation resulted in higher 25OHD values both in mothers and in their newborns (p < 0.0001). Conclusions Vitamin D insufficiency in pregnancy and in newborns is frequent especially among migrants. A prevention program in Piedmont should urgently be considered and people identified as being at risk should be closely monitored. Vitamin D supplementation should be taken into account when considering a preventative health care policy.	[Cadario, Francesco; Savastio, Silvia; Pozzi, Erica; Pamparana, Stella; Zaffaroni, Mauro; Genoni, Giulia; Bona, Gianni] Univ Piemonte Orientale Amedeo Avogadro, Dept Hlth Sci, Div Pediat, Novara, Italy; [Cadario, Francesco; Bona, Gianni] IRCAD Interdisciplinary Res Ctr Autoimmune Dis, Novara, Italy; [Magnani, Corrado; Cena, Tiziana] Univ Piemonte Orientale Amedeo Avogadro, Dept Translat Med, Unit Med Stat & Canc Epidemiol, Novara, Italy; [Magnani, Corrado; Cena, Tiziana] CPO Piemonte, Novara, Italy; [Pagliardini, Veronica] Univ Turin, Turin, Italy; [Bellomo, Giorgio; Bagnati, Marco; Vidali, Matteo] Univ Piemonte Orientale Amedeo Avogadro, Cent Lab, Maggiore Carita Hosp, Novara, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; University of Turin; University of Eastern Piedmont Amedeo Avogadro	Cadario, F (corresponding author), Univ Piemonte Orientale Amedeo Avogadro, Dept Hlth Sci, Div Pediat, Novara, Italy.	francesco.cadario@maggioreosp.novara.it	Pozzi, Erica/AAC-2570-2022; Vidali, Matteo/T-2621-2019; Cadario, Francesco/AAA-1240-2019; Savastio, Silvia/AAC-6475-2022	Pozzi, Erica/0000-0003-0937-8010; Vidali, Matteo/0000-0001-9991-7502; Savastio, Silvia/0000-0002-5867-3246; Cadario, Francesco/0000-0001-8808-834X	De Agostini Foundation of Novara	De Agostini Foundation of Novara	This work was supported by De Agostini Foundation of Novara.	Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Baiz N, 2014, J ALLERGY CLIN IMMUN, V133, P147, DOI 10.1016/j.jaci.2013.05.017; Basile LA, 2007, J PERINATOL, V27, P568, DOI 10.1038/sj.jp.7211796; Bertino E, 2010, J PEDIATR GASTR NUTR, V51, P353, DOI 10.1097/MPG.0b013e3181da213e; Bodnar LM, 2010, J NUTR, V140, P999, DOI 10.3945/jn.109.119636; Bollati V, 2010, HEREDITY, V105, P105, DOI 10.1038/hdy.2010.2; Cadario F, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-35; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Cheung CL, 2013, J HUM GENET, V58, P749, DOI 10.1038/jhg.2013.84; Cooper JD, 2011, DIABETES, V60, P1624, DOI 10.2337/db10-1656; De-Regil LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008873.pub2; Elkum N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113102; Eyles D, 2009, CLIN CHIM ACTA, V403, P145, DOI 10.1016/j.cca.2009.02.005; Eyles DW, 2010, PAEDIATR PERINAT EP, V24, P303, DOI 10.1111/j.1365-3016.2010.01105.x; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Gaggero M, 2010, Minerva Ginecol, V62, P91; Gallo S, 2013, J NUTR, V143, P148, DOI 10.3945/jn.112.167858; Grant C.C., 2014, PEDIATRICS, V133, P143, DOI [DOI 10.1002/YD.20107, 10.1542/peds.2013-2602]; Heaney RP, 2008, AM J CLIN NUTR, V88, p541S, DOI 10.1093/ajcn/88.2.541S; Hewison M, 2012, CLIN ENDOCRINOL, V76, P315, DOI 10.1111/j.1365-2265.2011.04261.x; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hollis BW, 2006, AM J CLIN NUTR, V84, P273; Hollis BW, 2013, CALCIFIED TISSUE INT, V92, P128, DOI 10.1007/s00223-012-9607-4; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Hsu SA, 2013, J STEROID BIOCHEM, V136, P139, DOI 10.1016/j.jsbmb.2012.11.005; Kinder BW, 2011, EXPERT REV CLIN IMMU, V7, P255, DOI [10.1586/eci.11.12, 10.1586/ECI.11.12]; Koivula MK, 2013, CLIN LAB, V59, P397, DOI 10.7754/Clin.Lab.2012.120527; Lai JKC, 2010, MOL NUTR FOOD RES, V54, P1062, DOI 10.1002/mnfr.200900468; Mutlu GY, 2014, HORM RES PAEDIAT, V81, P402, DOI 10.1159/000358833; Pisani P, 1997, INT J EPIDEMIOL, V26, pS152, DOI 10.1093/ije/26.suppl_1.S152; Raab J, 2014, DIABETOLOGIA, V57, P902, DOI 10.1007/s00125-014-3181-4; Ross AC, 2011, Dietary Reference Intakes for Calcium and Vitamin D, P1; Thandrayen K, 2012, RHEUM DIS CLIN N AM, V38, P61, DOI 10.1016/j.rdc.2012.03.007; Thorne-Lyman A, 2012, PAEDIATR PERINAT EP, V26, P75, DOI 10.1111/j.1365-3016.2012.01283.x; Trump DL, 2010, CANCER J, V16, P1, DOI 10.1097/PPO.0b013e3181c51ee6; Wacker M, 2013, NUTRIENTS, V5, P111, DOI 10.3390/nu5010111; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Weinert LS, 2014, MATERN CHILD HLTH J, P19; Yap C, 2014, DIABETES CARE, V37, P1837, DOI 10.2337/dc14-0155	39	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129586	10.1371/journal.pone.0129586	http://dx.doi.org/10.1371/journal.pone.0129586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067469	gold, Green Published, Green Submitted			2022-12-27	WOS:000356100900059
J	Dozolme, D; Brunet-Gouet, E; Passerieux, C; Amorim, MA				Dozolme, Dorian; Brunet-Gouet, Eric; Passerieux, Christine; Amorim, Michel-Ange			Neuroelectric Correlates of Pragmatic Emotional Incongruence Processing: Empathy Matters	PLOS ONE			English	Article							EXPRESSION; N400; VALIDATION; POTENTIALS; QUOTIENT; N170	The emotions people feel can be simulated internally based on emotional situational contexts. In the present study, we assessed the behavioral and neuroelectric effects of seeing an unexpected emotional facial expression. We investigated the correct answer rate, response times and Event-Related Potential (ERP) effects during an incongruence paradigm between emotional faces and sentential contexts allowing emotional inferences. Most of the 36 healthy participants were recruited from a larger population (1 463 subjects), based on their scores on the Empathy Questionnaire (EQ). Regression analyses were conducted on these ratings using EQ factors as predictors (cognitive empathy, emotional reactivity and social skills). Recognition of pragmatic emotional incongruence was less accurate (P < .05) and slower (P < .05) than recognition of congruence. The incongruence effect on response times was inversely predicted by social skills. A significant N400 incongruence effect was found at the centro-parietal (P < .001) and centro-posterior midline (P < .01) electrodes. Cognitive empathy predicted the incongruence effect in the left occipital region, in the N400 time window. Finally, incongruence effects were also found on the LPP wave, in frontal midline and dorso-frontal regions, (P < .05), with no modulation by empathy. Processing pragmatic emotional incongruence is more cognitively demanding than congruence (as reflected by both behavioral and ERP data). This processing shows modulation by personality factors at the behavioral (through self-reported social skills) and neuroelectric levels (through self-reported cognitive empathy).	[Dozolme, Dorian; Amorim, Michel-Ange] Univ Paris 11, Lab CIAMS Complexite Innovat Act Motrices & Sport, Orsay, France; [Brunet-Gouet, Eric; Passerieux, Christine] Univ Versailles St Quentin, Ctr Hosp Versailles, HandiResp Rech Clin & Sante Publ Handicaps Psych, EA4047, Le Chesnay, France	UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay	Dozolme, D (corresponding author), Univ Paris 11, Lab CIAMS Complexite Innovat Act Motrices & Sport, Orsay, France.	dorian.dozolme@u-psud.fr	Amorim, Michel-Ange/E-7209-2017; brunet-gouet, eric/AAR-5741-2020	Amorim, Michel-Ange/0000-0002-8455-1437; brunet-gouet, eric/0000-0002-3784-7817; Dozolme, Dorian/0000-0001-9843-4277	Agence Nationale de la Recherche, EMCO (COMPARSE project)	Agence Nationale de la Recherche, EMCO (COMPARSE project)(French National Research Agency (ANR))	The reported research was funded by a grant from Agence Nationale de la Recherche, EMCO 2011 (COMPARSE project), received by MAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado L, 2013, COGN AFFECT BEHAV NE, V13, P284, DOI 10.3758/s13415-012-0137-3; Baetens K, 2011, BRAIN RES, V1418, P83, DOI 10.1016/j.brainres.2011.08.067; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Berthoz S, 2008, CAN J PSYCHIAT, V53, P469, DOI 10.1177/070674370805300712; Chakrabarti B, 2006, SOC NEUROSCI-UK, V1, P364, DOI 10.1080/17470910601041317; Chung G, 1996, PSYCHOPHYSIOLOGY, V33, P218, DOI 10.1111/j.1469-8986.1996.tb00419.x; Courgeon M, 2008, PROCEEDINGS OF THE A; Delaney-Busch N, 2013, COGN AFFECT BEHAV NE, V13, P473, DOI 10.3758/s13415-013-0159-5; deVega M, 1996, COGNITION EMOTION, V10, P303; Dieguez-Risco T, 2013, SOC NEUROSCI-UK, V8, P601, DOI 10.1080/17470919.2013.834842; Ekman P, 2003, UNMASKING THE FACE A; Farina E., 2007, PSYCHOL LANGUAGE COM, V11, P3; Ferstl EC, 2005, J COGNITIVE NEUROSCI, V17, P724, DOI 10.1162/0898929053747658; Forabosco Giovannantonio, 2008, LODZ PAPERS PRAGMATI, V4, P45, DOI DOI 10.2478/V10016-008-0003-5; GERNSBACHER MA, 1992, COGNITION EMOTION, V6, P89, DOI 10.1080/02699939208411061; Hietanen JK, 2013, BIOL PSYCHOL, V92, P114, DOI 10.1016/j.biopsycho.2012.10.005; Ibanez A, 2012, SOC NEUROSCI-UK, V7, P632, DOI 10.1080/17470919.2012.691078; Krombholz A, 2007, BIOL PSYCHOL, V76, P156, DOI 10.1016/j.biopsycho.2007.07.004; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Leon I, 2010, EMOTION, V10, P863, DOI 10.1037/a0019983; Leuthold H, 2012, SOC COGN AFFECT NEUR, V7, P457, DOI 10.1093/scan/nsr029; Moreno EM, 2011, BIOL PSYCHOL, V88, P131, DOI 10.1016/j.biopsycho.2011.07.003; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rak N, 2009, DOES THE SEMANTIC IN; Russ JB, 2008, BEHAV RES METHODS, V40, P935, DOI 10.3758/BRM.40.4.935; Schendan HE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00329; Siemer M, 2007, EMOTION, V7, P1, DOI 10.1037/1528-3542.7.1.1; Van Berkum JJA, 2009, PSYCHOL SCI, V20, P1092, DOI 10.1111/j.1467-9280.2009.02411.x; van den Brink D, 2012, SOC COGN AFFECT NEUR, V7, P173, DOI 10.1093/scan/nsq094; Zwaan RA, 2004, PSYCHOL LEARN MOTIV, V44, P35; Zwaan RolfA., 2005, GROUNDING COGNITION, P224, DOI DOI 10.1017/CBO9780511499968.010	32	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129770	10.1371/journal.pone.0129770	http://dx.doi.org/10.1371/journal.pone.0129770			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK3FB	26067672	Green Submitted, gold, Green Published			2022-12-27	WOS:000356100900076
J	Grant, WC				Grant, William C.			Run-Reversal Equilibrium for Clinical Trial Randomization	PLOS ONE			English	Article							TREATMENT ALLOCATION; RETAINING BALANCE; SELECTION BIAS; PREDICTABILITY; MINIMIZATION; DESIGN	In this paper, we describe a new restricted randomization method called run-reversal equilibrium (RRE), which is a Nash equilibrium of a game where (1) the clinical trial statistician chooses a sequence of medical treatments, and (2) clinical investigators make treatment predictions. RRE randomization counteracts how each investigator could observe treatment histories in order to forecast upcoming treatments. Computation of a run-reversal equilibrium reflects how the treatment history at a particular site is imperfectly correlated with the treatment imbalance for the overall trial. An attractive feature of RRE randomization is that treatment imbalance follows a random walk at each site, while treatment balance is tightly constrained and regularly restored for the overall trial. Less predictable and therefore more scientifically valid experiments can be facilitated by run-reversal equilibrium for multi-site clinical trials.	[Grant, William C.] James Madison Univ, Dept Econ, Harrisonburg, VA 22807 USA; [Grant, William C.] Duke Clin Res Inst, Visiting Fac, Durham, NC USA	James Madison University; Duke University	Grant, WC (corresponding author), James Madison Univ, Dept Econ, Harrisonburg, VA 22807 USA.	grantwc@jmu.edu		Grant, William/0000-0001-5101-2456				Berger VW, 2010, STAT METHODS MED RES, V19, P415, DOI 10.1177/0962280209359875; Berger VW, 2005, STAT PRACT, P1, DOI 10.1002/0470863641; Berger VW, 2003, STAT MED, V22, P3017, DOI 10.1002/sim.1538; Berger VW, 2014, RANDOMIZATION PROCED, V1; BLACKWELL D, 1957, ANN MATH STAT, V28, P449, DOI 10.1214/aoms/1177706973; Blackwell David, 1956, PAC J MATH, V6, P1, DOI [10.2140/pjm.1956.6.1, DOI 10.2140/PJM.1956.6.1]; Brown S, 2005, STAT MED, V24, P3715, DOI 10.1002/sim.2391; Buyse M, 2004, APPL CLIN TRIALS, P36; Dupin-Spriet T, 2005, J CLIN EPIDEMIOL, V58, P1269, DOI 10.1016/j.jclinepi.2005.04.008; EFRON B, 1971, BIOMETRIKA, V58, P403, DOI 10.2307/2334377; Foster DP, 1998, BIOMETRIKA, V85, P379, DOI 10.1093/biomet/85.2.379; Grant WC, 2008, J ECON BEHAV ORGAN, V66, P606, DOI 10.1016/j.jebo.2006.07.001; Hadorn DC, 1996, J CLIN EPIDEMIOL, V49, P749, DOI 10.1016/0895-4356(96)00019-4; Hills R, 2003, CONTROL CLIN TRIALS, V24, p70S; Hills Robert K, 2009, J Evid Based Med, V2, P196, DOI 10.1111/j.1756-5391.2009.01023.x; MATTS JP, 1988, CONTROL CLIN TRIALS, V9, P327, DOI 10.1016/0197-2456(88)90047-5; McEntegart D, 2010, CONTEMP CLIN TRIALS, V31, P507, DOI 10.1016/j.cct.2010.07.013; Rosenberger WF, 2002, RANDOMIZATION CLIN T; SMITH RL, 1984, J ROY STAT SOC B MET, V46, P519; SMITH RL, 1984, ANN STAT, V12, P1018, DOI 10.1214/aos/1176346718; Zhao WL, 2011, CONTEMP CLIN TRIALS, V32, P953, DOI 10.1016/j.cct.2011.08.004	22	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0128812	10.1371/journal.pone.0128812	http://dx.doi.org/10.1371/journal.pone.0128812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079608	Green Published, gold, Green Submitted			2022-12-27	WOS:000356542300011
J	Malik, FA; Meissner, A; Semenkov, I; Molinski, S; Pasyk, S; Ahmadi, S; Bui, HH; Bear, CE; Lidington, D; Bolz, SS				Malik, Firhan A.; Meissner, Anja; Semenkov, Illya; Molinski, Steven; Pasyk, Stan; Ahmadi, Saumel; Bui, Hai H.; Bear, Christine E.; Lidington, Darcy; Bolz, Steffen-Sebastian			Sphingosine-1-Phosphate Is a Novel Regulator of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SMALL-MOLECULE MODULATOR; HEART-FAILURE; R-DOMAIN; DELTA-F508-CFTR TRAFFICKING; MYOGENIC RESPONSIVENESS; ENDOTHELIAL-CELLS; CHLORIDE CHANNEL; MOUSE MODEL; PHOSPHORYLATION	The cystic fibrosis transmembrane conductance regulator (CFTR) attenuates sphingosine-1-phosphate (S1P) signaling in resistance arteries and has emerged as a prominent regulator of myogenic vasoconstriction. This investigation demonstrates that S1P inhibits CFTR activity via adenosine monophosphate-activated kinase (AMPK), establishing a potential feedback link. In Baby Hamster Kidney (BHK) cells expressing wild-type human CFTR, S1P (1 mu mol/L) attenuates forskolin-stimulated, CFTR-dependent iodide efflux. S1P's inhibitory effect is rapid (within 30 seconds), transient and correlates with CFTR serine residue 737 (S737) phosphorylation. Both S1P receptor antagonism (4 mu mol/L VPC 23019) and AMPK inhibition (80 mu mol/L Compound C or AMPK siRNA) attenuate S1P-stimluated (i) AMPK phosphorylation, (ii) CFTR S737 phosphorylation and (iii) CFTR activity inhibition. In BHK cells expressing the Delta F508 CFTR mutant (CFTR Delta F508), the most common mutation causing cystic fibrosis, both S1P receptor antagonism and AMPK inhibition enhance CFTR activity, without instigating discernable correction. In summary, we demonstrate that S1P/AMPK signaling transiently attenuates CFTR activity. Since our previous work positions CFTR as a negative S1P signaling regulator, this signaling link may positively reinforce S1P signals. This discovery has clinical ramifications for the treatment of disease states associated with enhanced S1P signaling and/or deficient CFTR activity (e.g. cystic fibrosis, heart failure). S1P receptor/AMPK inhibition could synergistically enhance the efficacy of therapeutic strategies aiming to correct aberrant CFTR trafficking.	[Malik, Firhan A.; Meissner, Anja; Semenkov, Illya; Ahmadi, Saumel; Bear, Christine E.; Lidington, Darcy; Bolz, Steffen-Sebastian] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Meissner, Anja] Inst Invest Biomed August Pi I Sunyer IDIBAPS, Dept Brain Ischemia & Neurodegenerat, Barcelona 08036, Spain; [Molinski, Steven; Pasyk, Stan; Bear, Christine E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Molinski, Steven; Pasyk, Stan; Ahmadi, Saumel; Bear, Christine E.] Hosp Sick Children, Programme Mol Struct & Funct, Res Inst, Toronto, ON MG5 1X8, Canada; [Bui, Hai H.] Lilly Res Labs, Indianapolis, IN 46285 USA; [Lidington, Darcy; Bolz, Steffen-Sebastian] Univ Toronto, Toronto Ctr Microvasc Med, Toronto, ON M5B 1T8, Canada; [Lidington, Darcy; Bolz, Steffen-Sebastian] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1T8, Canada; [Bolz, Steffen-Sebastian] Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON M5S 3E2, Canada	University of Toronto; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Eli Lilly; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Bolz, SS (corresponding author), Univ Toronto, Dept Physiol, Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	sts.bolz@utoronto.ca	Meissner, Anja/M-7666-2014; Ahmadi, Saumel/O-3570-2018; Molinski, Steven V/J-9509-2015	Meissner, Anja/0000-0002-0793-7213; Ahmadi, Saumel/0000-0002-5800-6945; Lidington, Darcy/0000-0001-7582-7924; Molinski, Steven/0000-0001-9215-8232	Heart and Stroke Foundation of Ontario [G13-0002610]; University of Toronto Research Funding; Heart and Stroke Foundation of Ontario Career Investigator Award [CI-7432]; HSFO [NIA-6581]; Natural Sciences and Engineering Research Council of Canada; Eli Lilly and Company	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); University of Toronto Research Funding; Heart and Stroke Foundation of Ontario Career Investigator Award(Heart & Stroke Foundation of Ontario); HSFO; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Eli Lilly and Company(Eli Lilly)	Operating Funding: Heart and Stroke Foundation of Ontario Grant in Aid G13-0002610 (Operating Grant to Steffen-Sebastian Bolz). University of Toronto Research Funding (Operations Funding provided to Steffen-Sebastian Bolz). Stipend Support: Heart and Stroke Foundation of Ontario Career Investigator Award CI-7432 (Stipend Support to Steffen-Sebastian Bolz). This work is also supported by HSFO New Investigator (SSB, NIA-6581) and the Natural Sciences and Engineering Research Council of Canada PGS-D Doctoral Scholarship (Stipend Support to Firhan A Malik). The funders had no role in study design, data collection and analysis, decision to publish or the preparation of the publication. Eli Lilly and Company provided support in the form of salaries for authors [HBH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bannykh SI, 2000, TRAFFIC, V1, P852, DOI 10.1034/j.1600-0854.2000.011105.x; Bigaud M, 2014, BBA-MOL CELL BIOL L, V1841, P745, DOI 10.1016/j.bbalip.2013.11.001; Bolz SS, 2003, CIRCULATION, V108, P342, DOI 10.1161/01.CIR.0000080324.12530.0D; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Chappe V, 2003, J PHYSIOL-LONDON, V548, P39, DOI 10.1113/jphysiol.2002.035790; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; DALEMANS W, 1992, EXP CELL RES, V201, P235, DOI 10.1016/0014-4827(92)90368-I; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; French PJ, 1996, J CLIN INVEST, V98, P1304, DOI 10.1172/JCI118917; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Hoefer J, 2010, CIRC RES, V107, P923, DOI 10.1161/CIRCRESAHA.110.226464; Kimura T, 2010, J BIOL CHEM, V285, P4387, DOI 10.1074/jbc.M109.043869; Kongsuphol P, 2009, J BIOL CHEM, V284, P5645, DOI 10.1074/jbc.M806780200; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Lidington D, 2013, CARDIOVASC RES, V97, P404, DOI 10.1093/cvr/cvs345; Lidington D, 2009, ARTERIOSCL THROM VAS, V29, P1916, DOI 10.1161/ATVBAHA.109.194803; Lim M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035177; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Luz S, 2014, J BIOL CHEM, V289, P15080, DOI 10.1074/jbc.M114.563742; Meissner A, 2012, CIRCULATION, V125, P2739, DOI 10.1161/CIRCULATIONAHA.111.047316; Pasyk S, 2015, PROTEOMICS, V15, P447, DOI 10.1002/pmic.201400218; Pasyk S, 2009, BIOCHEM J, V418, P185, DOI 10.1042/BJ20081424; Pedemonte N, 2010, AM J PHYSIOL-CELL PH, V298, pC866, DOI 10.1152/ajpcell.00404.2009; Peter BF, 2008, CIRC RES, V103, P315, DOI 10.1161/CIRCRESAHA.108.173575; PICCIOTTO MR, 1992, J BIOL CHEM, V267, P12742; Schmidt A, 2008, BRIT J PHARMACOL, V153, P1311, DOI 10.1038/sj.bjp.0707663; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; Wang Y, 2006, MOL PHARMACOL, V70, P297, DOI 10.1124/mol.106.023994; Wellhauser L, 2009, MOL PHARMACOL, V75, P1430, DOI 10.1124/mol.109.055608; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Yang JL, 2012, CIRCULATION, V126, P196, DOI 10.1161/CIRCULATIONAHA.111.039644; Yatomi Y, 1997, J BIOCHEM, V121, P969; Yu W, 2011, J BIOL CHEM, V286, P24714, DOI 10.1074/jbc.M111.239699	40	26	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0130313	10.1371/journal.pone.0130313	http://dx.doi.org/10.1371/journal.pone.0130313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079370	Green Submitted, gold, Green Published			2022-12-27	WOS:000356542300042
J	Cabana-Munoz, ME; Parmigiani-Izquierdo, JM; Bravo-Gonzalez, LA; Kyung, HM; Merino, JJ				Eugenia Cabana-Munoz, Maria; Maria Parmigiani-Izquierdo, Jose; Alberto Bravo-Gonzalez, Luis; Kyung, Hee-Moon; Joaquin Merino, Jose			Increased Zn/Glutathione Levels and Higher Superoxide Dismutase-1 Activity as Biomarkers of Oxidative Stress in Women with Long-Term Dental Amalgam Fillings: Correlation between Mercury/Aluminium Levels (in Hair) and Antioxidant Systems in Plasma	PLOS ONE			English	Article							MERCURY EXPOSURE; CORTICAL-NEURONS; GENE-EXPRESSION; IN-VITRO; METHYLMERCURY; GLUTATHIONE; BLOOD; METALLOTHIONEIN; POLYMORPHISMS; CONTAMINATION	Background The induction of oxidative stress by Hg can affect antioxidant enzymes. However, epidemiological studies have failed to establish clear association between dental fillings presence and health problems. Objectives To determine whether heavy metals (in hair), antioxidant enzymes (SOD-1) and glutathione levels could be affected by the chronic presence of heavy metals in women who had dental amalgam fillings. Materials and Methods 55 hair samples (42 females with amalgam fillings and 13 female control subjects) were obtained. All subjects (mean age 44 years) who had dental amalgam filling for more than 10 years (average 15 years). Certain metals were quantified by ICP-MS (Mass Spectrophotometry) in hair (mu g/g: Al, Hg, Ba, Ag, Sb, As, Be, Bi, Cd, Pb, Pt, Tl, Th, U, Ni, Sn, Ti) and SOD-1 and Glutathione (reduced form) levels in plasma. Data were compared with controls without amalgams, and analyzed to identify any significant relation between metals and the total number of amalgam fillings, comparing those with four or less (n = 27) with those with more than four (n = 15). As no significant differences were detected, the two groups were pooled (Amlgam; n = 42). Findings Hg, Ag, Al and Ba were higher in the amalgam group but without significant differences for most of the heavy metals analyzed. Increased SOD-1 activity and glutathione levels (reduced form) were observed in the amalgam group. Aluminum (Al) correlated with glutathione levels while Hg levels correlated with SOD-1. The observed Al/glutathione and Hg/SOD-1 correlation could be adaptive responses against the chronic presence of mercury. Conclusions Hg, Ag, Al and Ba levels increased in women who had dental amalgam fillings for long periods. Al correlated with glutathione, and Hg with SOD-1. SOD-1 may be a possible biomarker for assessing chronic Hg toxicity.	[Eugenia Cabana-Munoz, Maria; Maria Parmigiani-Izquierdo, Jose] Ctr CIROM, Murcia, Spain; [Eugenia Cabana-Munoz, Maria; Alberto Bravo-Gonzalez, Luis] Univ Murcia, Fac Med, Unidad Docente Ortodoncia, Murcia, Spain; [Kyung, Hee-Moon] Kyungpook Nacl Univ, Sch Dent, Dept Orthodont, Daegu, South Korea; [Joaquin Merino, Jose] Univ Complutense Madrid, IUIN, Inst Invest Neuroquim, Madrid, Spain	University of Murcia; Complutense University of Madrid	Merino, JJ (corresponding author), Univ Complutense Madrid, IUIN, Inst Invest Neuroquim, Madrid, Spain.	mecjj@clinicacirom.com; josem2005@yahoo.es	BRAVO-GONZÁLEZ, LUIS-ALBERTO/S-5963-2016	BRAVO-GONZÁLEZ, LUIS-ALBERTO/0000-0002-5141-4145	Maria Eugenia Cabana (CIROM Clinic (Murcia, Spain)	Maria Eugenia Cabana (CIROM Clinic (Murcia, Spain)	This study has been supported by own findings from Maria Eugenia Cabana (CIROM Clinic (Murcia, Spain; personnal money). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algarve TD, 2013, GENET MOL RES, V12, P5134, DOI 10.4238/2013.October.29.7; Ariza ME, 1998, ENVIRON MOL MUTAGEN, V31, P352, DOI 10.1002/(SICI)1098-2280(1998)31:4<352::AID-EM8>3.0.CO;2-K; Babi D, 2000, SCI TOTAL ENVIRON, V259, P55, DOI 10.1016/S0048-9697(00)00549-0; BARRETT RD, 1993, AM J ORTHOD DENTOFAC, V103, P8, DOI 10.1016/0889-5406(93)70098-9; Bellinger DC, 2006, JAMA-J AM MED ASSOC, V15, P1775; DIERICKX PJ, 1985, PHARMACOL RES COMMUN, V17, P489, DOI 10.1016/0031-6989(85)90084-0; Dziegielewska-Gesiak S, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/987303; Farina M, 2011, TOXICOL APPL PHARM, V256, P405, DOI 10.1016/j.taap.2011.05.001; Geier DA, 2011, BIOMETALS, V24, P215, DOI 10.1007/s10534-010-9387-0; Gibson LA, 2014, ECOTOXICOLOGY, V23, P1004, DOI 10.1007/s10646-014-1243-5; Grotto D, 2010, SCI TOTAL ENVIRON, V408, P806, DOI 10.1016/j.scitotenv.2009.10.053; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Homme KG, 2014, BIOMETALS, V27, P19, DOI 10.1007/s10534-013-9700-9; Hussain S, 1999, J ENVIRON SCI HEAL B, V34, P645, DOI 10.1080/03601239909373219; Jenko K, 2012, ENVIRON TOXICOL CHEM, V31, P2588, DOI 10.1002/etc.1985; Merino JJ, 2014, INT J MOL SCI, V15, P2475, DOI 10.3390/ijms15022475; Jones L, 2007, HUM EXP TOXICOL, V26, P367, DOI 10.1177/0960327107076824; Khwaja Mahmood A., 2014, Reviews on Environmental Health, V29, P29, DOI 10.1515/reveh-2014-0010; Kim M, 2013, ENVIRON MONIT ASSESS, V185, P2221, DOI 10.1007/s10661-012-2703-0; Lopez E, 2006, FREE RADICAL BIO MED, V40, P940, DOI 10.1016/j.freeradbiomed.2005.10.062; Makhija SK, 2011, J AM DENT ASSOC, V142, P622, DOI 10.14219/jada.archive.2011.0244; Marques RC, 2014, ENVIRON POLLUT, V187, P130, DOI 10.1016/j.envpol.2014.01.004; Barcelos GRM, 2013, SCI TOTAL ENVIRON, V463, P319, DOI 10.1016/j.scitotenv.2013.06.029; Mortazavi SMJ, 2014, INT J OCCUP ENV MED, V5, P101; Mutter J, 2004, INT J HYG ENVIR HEAL, V207, P391, DOI 10.1078/1438-4639-00305; Mutter J, 2011, J OCCUP MED TOXICOL, V6, DOI 10.1186/1745-6673-6-2; Naganuma A, 1998, LIFE SCI, V62, pPL157, DOI 10.1016/S0024-3205(98)00037-X; Nedd S, 2014, J MOL BIOL, V426, P4112, DOI 10.1016/j.jmb.2014.07.016; Okati N, 2012, BIOL TRACE ELEM RES, V149, P155, DOI 10.1007/s12011-012-9424-7; Park Jung-Duck, 2012, J Prev Med Public Health, V45, P344, DOI 10.3961/jpmph.2012.45.6.344; Pigatto PD, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/356235; Puchyr RF, 1998, BIOL TRACE ELEM RES, V62, P167, DOI 10.1007/BF02783969; Richardson GM, 2011, SCI TOTAL ENVIRON, V409, P4257, DOI 10.1016/j.scitotenv.2011.06.035; Saghiri MA, 2014, J TRACE ELEM MED BIO, V28, P200, DOI 10.1016/j.jtemb.2014.01.008; Shraim A, 2011, CHEMOSPHERE, V84, P1133, DOI 10.1016/j.chemosphere.2011.04.034; Soussa E, 2013, ARCH ORAL BIOL, V58, P981, DOI 10.1016/j.archoralbio.2013.03.012; Tiwari V, 2013, NEUROCHEM INT, V62, P861, DOI 10.1016/j.neuint.2013.02.012; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Woods JS, 2013, NEUROTOXICOL TERATOL, V39, P36, DOI 10.1016/j.ntt.2013.06.004	39	7	7	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0126339	10.1371/journal.pone.0126339	http://dx.doi.org/10.1371/journal.pone.0126339			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076368	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900006
J	Gupta, S; Smith, C; Auclair, S; Delgadillo, AD; Garg, NJ				Gupta, Shivali; Smith, Charity; Auclair, Sarah; Delgadillo, Anahi De Jesus; Garg, Nisha Jain			Therapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-Expression	PLOS ONE			English	Article							TERT-BUTYL-NITRONE; OXIDATIVE STRESS; DNA VACCINES; BENZNIDAZOLE; PROTEIN; MICE; CARDIOMYOPATHY; MECHANISMS; CANDIDATES	Trypanosoma cruzi-induced oxidative and inflammatory responses are implicated in chagasic cardiomyopathy. In this study, we examined the therapeutic utility of a subunit vaccine against T. cruzi and determined if glutathione peroxidase (GPx1, antioxidant) protects the heart from chagasic pathogenesis. C57BL/6 mice (wild-type (WT) and GPx1 transgenic (GPx(tg)) were infected with T. cruzi and at 45 days post-infection (dpi), immunized with TcG2/TcG4 vaccine delivered by a DNA-prime/Protein-boost (D/P) approach. The plasma and tissue-sections were analyzed on 150 dpi for parasite burden, inflammatory and oxidative stress markers, inflammatory infiltrate and fibrosis. WT mice infected with T. cruzi had significantly more blood and tissue parasite burden compared with infected/GPx(tg) mice (n = 5-8, p<0.01). Therapeutic vaccination provided > 15-fold reduction in blood and tissue parasites in both WT and GPx(tg) mice. The increase in plasma levels of myeloperoxidase (MPO, 24.7%) and nitrite (iNOS activity, 45%) was associated with myocardial increase in oxidant levels (3-4-fold) and non-responsive antioxidant status in chagasic/WT mice; and these responses were not controlled after vaccination (n = 5-7). The GPx(tg) mice were better equipped than the WT mice in controlling T. cruzi-induced inflammatory and oxidative stress markers. Extensive myocardial and skeletal tissue inflammation noted in chagasic/ WT mice, was significantly more compared with chagasic/GPx(tg) mice (n = 4-6, p<0.05). Vaccination was equally effective in reducing the chronic inflammatory infiltrate in the heart and skeletal tissue of infected WT and GPx(tg) mice (n = 6, p<0.05). Hypertrophy (increased BNP and ANP mRNA) and fibrosis (increased collagen) of the heart were extensively present in chronically-infected WT and GPx(tg) mice and notably decreased after therapeutic vaccination. We conclude the therapeutic delivery of D/P vaccine was effective in arresting the chronic parasite persistence and chagasic pathology; and GPx1 over-expression provided additive benefits in reducing the parasite burden, inflammatory/oxidative stress and cardiac remodeling in Chagas disease.	[Gupta, Shivali; Smith, Charity; Auclair, Sarah; Delgadillo, Anahi De Jesus; Garg, Nisha Jain] Univ Texas Med Branch, Sch Med, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Garg, Nisha Jain] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Garg, Nisha Jain] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Garg, Nisha Jain] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Gupta, S (corresponding author), Univ Texas Med Branch, Sch Med, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	shivali.04@gmail.com; nigarg@utmb.edu		Auclair, Sarah/0000-0002-4701-1087	National Institutes of Health/National Institute of Allergy and Infectious Diseases [2RO1AI05478-07]; Sealy Center for Vaccine Development (SCVD); National Institute of General Medicine Sciences [R25 GM069285]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM069285] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sealy Center for Vaccine Development (SCVD); National Institute of General Medicine Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (2RO1AI05478-07) to NJG. SG is a recipient of a Sealy Center for Vaccine Development (SCVD) postdoctoral fellowship. CS was a recipient of training fellowship on a grant from the National Institute of General Medicine Sciences (R25 GM069285) to Dr. David W Niesel.	Aparicio-Burgos JE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001050; Barbosa JL, 2014, AM J THER; Beck MA, 1998, FASEB J, V12, P1143, DOI 10.1096/fasebj.12.12.1143; Bern C, 2011, NEW ENGL J MED, V364, P2527, DOI 10.1056/NEJMct1014204; Bhatia V, 2004, INFECT IMMUN, V72, P6245, DOI 10.1128/IAI.72.11.6245-6254.2004; Bhatia V, 2008, CLIN VACCINE IMMUNOL, V15, P1158, DOI 10.1128/CVI.00144-08; Bhatia V, 2005, EXPERT REV VACCINES, V4, P867, DOI 10.1586/14760584.4.6.867; Bhatia V, 2009, VACCINES FOR BIODEFENSE AND EMERGING AND NEGLECTED DISEASES, P1423, DOI 10.1016/B978-0-12-369408-9.00069-X; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Caldas IS, 2008, PARASITOL RES, V103, P413, DOI 10.1007/s00436-008-0992-6; Castillo-Riquelme M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000336; Cunha-Neto E, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/683230; de Gusmao AS, 2012, REV SOC BRAS MED TRO, V45, P51, DOI 10.1590/S0037-86822012000100010; Dhiman M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000302; Dhiman M, 2011, J PATHOL, V225, P583, DOI 10.1002/path.2975; Donnelly JJ, 2005, J IMMUNOL, V175, P633, DOI 10.4049/jimmunol.175.2.633; Dreesen L, 2014, INFECT IMMUN, V82, P3333, DOI 10.1128/IAI.01536-14; Dumonteil E, 2004, INFECT IMMUN, V72, P46, DOI 10.1128/IAI.72.1.46-53.2004; Garg N, 2004, BIOCHEM J, V381, P743, DOI 10.1042/BJ20040356; Gupta S., 2009, INTERDISCIP PERSPECT, V2009, P1, DOI [DOI 10.1155/2009/190354, 10.1155/2009/190354]; Gupta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059434; Gupta S, 2012, VACCINE, V30, P7179, DOI 10.1016/j.vaccine.2012.10.018; Gupta S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000797; Halliwell B, 1999, FREE RADICAL RES, V31, P261, DOI 10.1080/10715769900300841; Huygen K, 2005, MICROBES INFECT, V7, P932, DOI 10.1016/j.micinf.2005.03.010; Kleinbongard P, 2002, METHOD ENZYMOL, V359, P158; Lee BY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000916; Lescure FX, 2010, LANCET INFECT DIS, V10, P556, DOI 10.1016/S1473-3099(10)70098-0; Macao LB, 2007, INT J CARDIOL, V123, P43, DOI 10.1016/j.ijcard.2006.11.118; Machado FS, 2012, SEMIN IMMUNOPATHOL, V34, P753, DOI 10.1007/s00281-012-0351-7; Miller Nicholas J., 1993, Biochemical Society Transactions, V21, p95S; Nagajyothi F, 2012, CELL MICROBIOL, V14, P634, DOI 10.1111/j.1462-5822.2012.01764.x; Pinazo MJ, 2013, ANTIMICROB AGENTS CH, V57, P390, DOI 10.1128/AAC.01401-12; Pinazo MJ, 2010, ANTIMICROB AGENTS CH, V54, P4896, DOI 10.1128/AAC.00537-10; Quijano-Hernandez I, 2011, HUM VACCINES, V7, P1184, DOI 10.4161/hv.7.11.17016; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Scharpe J, 2009, AM J KIDNEY DIS, V54, P77, DOI 10.1053/j.ajkd.2008.11.032; Sheldon RA, 2008, INT J DEV NEUROSCI, V26, P87, DOI 10.1016/j.ijdevneu.2007.08.010; Sheldon RA, 2007, PEDIATR RES, V61, P666, DOI 10.1203/pdr.0b013e318053664c; Carvalho MDT, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/230129; Vazquez-Chagoyan JC, 2011, ADV PARASIT, V75, P121, DOI 10.1016/B978-0-12-385863-4.00006-X; Wen JJ, 2008, MICROBES INFECT, V10, P1201, DOI 10.1016/j.micinf.2008.06.013; Wen JJ, 2006, AM J PATHOL, V169, P1953, DOI 10.2353/ajpath.2006.060475; Wen JJ, 2010, J AM COLL CARDIOL, V55, P2499, DOI 10.1016/j.jacc.2010.02.030; Wen JJ, 2004, FREE RADICAL BIO MED, V37, P1821, DOI 10.1016/j.freeradbiomed.2004.08.018; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; World Health Organization, 2010, CHAGAS DISEASE CONTR; Yatmaz S, 2013, AM J RESP CELL MOL, V48, P17, DOI 10.1165/rcmb.2011-0345OC; Zapata-Estrella H, 2006, IMMUNOL LETT, V103, P186, DOI 10.1016/j.imlet.2005.11.015; Zeng RH, 2008, BIOCHEM BIOPH RES CO, V377, P495, DOI 10.1016/j.bbrc.2008.10.002	50	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130562	10.1371/journal.pone.0130562	http://dx.doi.org/10.1371/journal.pone.0130562			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075398	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900180
J	Konoike, N; Kotozaki, Y; Jeong, HJ; Miyazaki, A; Sakaki, K; Shinada, T; Sugiura, M; Kawashima, R; Nakamura, K				Konoike, Naho; Kotozaki, Yuka; Jeong, Hyeonjeong; Miyazaki, Atsuko; Sakaki, Kohei; Shinada, Takamitsu; Sugiura, Motoaki; Kawashima, Ryuta; Nakamura, Katsuki			Temporal and Motor Representation of Rhythm in Fronto-Parietal Cortical Areas: An fMRI Study	PLOS ONE			English	Article							DORSAL PREMOTOR CORTEX; FUNCTIONAL-ANATOMY; BRAIN ACTIVATION; NEURAL BASIS; SEQUENCE; SUPPLEMENTARY; MOVEMENT; SYNCHRONIZATION; PERFORMANCE; MECHANISMS	When sounds occur with temporally structured patterns, we can feel a rhythm. To memorize a rhythm, perception of its temporal patterns and organization of them into a hierarchically structured sequence are necessary. On the other hand, rhythm perception can often cause unintentional body movements. Thus, we hypothesized that rhythm information can be manifested in two different ways; temporal and motor representations. The motor representation depends on effectors, such as the finger or foot, whereas the temporal representation is effector-independent. We tested our hypothesis with a working memory paradigm to elucidate neuronal correlates of temporal or motor representation of rhythm and to reveal the neural networks associated with these representations. We measured brain activity by fMRI while participants memorized rhythms and reproduced them by tapping with the right finger, left finger, or foot, or by articulation. The right inferior frontal gyrus and the inferior parietal lobule exhibited significant effector-independent activations during encoding and retrieval of rhythm information, whereas the left inferior parietal lobule and supplementary motor area (SMA) showed effector-dependent activations during retrieval. These results suggest that temporal sequences of rhythm are probably represented in the right fronto-parietal network, whereas motor sequences of rhythm can be represented in the SMA-parietal network.	[Konoike, Naho; Nakamura, Katsuki] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan; [Kotozaki, Yuka; Jeong, Hyeonjeong; Miyazaki, Atsuko; Sakaki, Kohei; Shinada, Takamitsu; Sugiura, Motoaki; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi 9808575, Japan	Kyoto University; Tohoku University	Nakamura, K (corresponding author), Kyoto Univ, Primate Res Inst, Kanrin 41-2, Inuyama, Aichi 4848506, Japan.	nakamura.katsuki.4z@kyoto-u.ac.jp	Kotozaki, Yuka/ABA-2267-2020; Kotozaki, Yuka/ABA-2922-2020; Jeong, Hyeonjeong/T-1958-2019	Kotozaki, Yuka/0000-0002-4659-1200; Konoike, Naho/0000-0003-2563-7537; Jeong, Hyeonjeong/0000-0002-5094-5390	Cooperative Research Project Program of the Institute of Development, Aging and Cancer, Tohoku University [25.39]; Ministry of Education, Culture, Sports, Science and Technology, Japan [4103, 21120009];  [26.40083]; Grants-in-Aid for Scientific Research [14J40083] Funding Source: KAKEN	Cooperative Research Project Program of the Institute of Development, Aging and Cancer, Tohoku University; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Cooperative Research Project Program of the Institute of Development, Aging and Cancer, Tohoku University (No. 25.39), http://www.idac.tohoku.ac.jp/ja/joint/; a Grant-in-Aid for Scientific Research on Innovative Areas "Neural creativity for communication (No. 4103)" of Ministry of Education, Culture, Sports, Science and Technology, Japan to KN (No. 21120009), http://dynamic-brain.jp/; and a Grant-in-Aid for Japan Society for the Promotion of Science Fellows to NK (No. 26.40083), http://www.jsps.go.jp/jpd/.	Battelli L, 2003, BRAIN, V126, P2164, DOI 10.1093/brain/awg221; Battellil L, 2008, CURR OPIN NEUROBIOL, V18, P120, DOI 10.1016/j.conb.2008.08.004; Bengtsson SL, 2009, CORTEX, V45, P62, DOI 10.1016/j.cortex.2008.07.002; Bengtsson SL, 2006, NEUROIMAGE, V30, P272, DOI 10.1016/j.neuroimage.2005.09.019; Bengtsson SL, 2005, EUR J NEUROSCI, V22, P3255, DOI 10.1111/j.1460-9568.2005.04517.x; Bengtsson SL, 2004, EUR J NEUROSCI, V19, P2591, DOI 10.1111/j.0953-816X.2004.03269.x; Chen JL, 2008, CEREB CORTEX, V18, P2844, DOI 10.1093/cercor/bhn042; Chen JL, 2006, NEUROIMAGE, V32, P1771, DOI 10.1016/j.neuroimage.2006.04.207; Chen SHA, 2005, NEUROIMAGE, V24, P332, DOI 10.1016/j.neuroimage.2004.08.032; Coull JT, 2013, NEUROPSYCHOLOGIA, V51, P309, DOI 10.1016/j.neuropsychologia.2012.08.017; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; Frey S, 2008, J NEUROSCI, V28, P11435, DOI 10.1523/JNEUROSCI.2388-08.2008; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Grahn JA, 2013, CEREB CORTEX, V23, P913, DOI 10.1093/cercor/bhs083; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Harrington DL, 2010, CEREB CORTEX, V20, P1274, DOI 10.1093/cercor/bhp194; Harrington DL, 1998, J NEUROSCI, V18, P1085; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; HINKE RM, 1993, NEUROREPORT, V4, P675, DOI 10.1097/00001756-199306000-00018; Karabanov A, 2009, NEUROIMAGE, V44, P480, DOI 10.1016/j.neuroimage.2008.08.047; Koelsch S, 2005, TRENDS COGN SCI, V9, P578, DOI 10.1016/j.tics.2005.10.001; Konoike N, 2012, NEUROIMAGE, V63, P328, DOI 10.1016/j.neuroimage.2012.07.002; Lacourse MG, 2005, NEUROIMAGE, V27, P505, DOI 10.1016/j.neuroimage.2005.04.025; Lewis PA, 2004, NEUROPSYCHOLOGIA, V42, P1301, DOI 10.1016/j.neuropsychologia.2004.03.001; Ligeois-Chauvel C, 1998, BRAIN, V121, P1853, DOI 10.1093/brain/121.10.1853; Lim CJ, 2006, ANAT REC PART A, V288A, P435, DOI 10.1002/ar.a.20316; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Meister IG, 2009, EUR J NEUROSCI, V29, P2074, DOI 10.1111/j.1460-9568.2009.06729.x; Midorikawa A, 2003, NEUROCASE, V9, P232, DOI 10.1076/neur.9.3.232.15558; MUSHIAKE H, 1990, EXP BRAIN RES, V82, P208; Oliveri M, 2009, NEUROIMAGE, V46, P1173, DOI 10.1016/j.neuroimage.2009.03.042; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; PETRIDES M, 1988, J COMP NEUROL, V273, P52, DOI 10.1002/cne.902730106; Ramnani N, 2001, J COGNITIVE NEUROSCI, V13, P952, DOI 10.1162/089892901753165863; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Sakai K, 1998, J NEUROSCI, V18, P1827; Sakai K, 1999, J NEUROSCI, V19, P10074; Schubotz RI, 2001, CEREB CORTEX, V11, P210, DOI 10.1093/cercor/11.3.210; Shima K, 1998, J NEUROPHYSIOL, V80, P3247, DOI 10.1152/jn.1998.80.6.3247; Stenneken P, 2006, BRAIN RES, V1084, P123, DOI 10.1016/j.brainres.2006.02.057; Thiebaut de Schotten M, 2012, CORTEX, V48, P82, DOI 10.1016/j.cortex.2011.10.001; Udden J, 2012, PHILOS T R SOC B, V367, P2023, DOI 10.1098/rstb.2012.0009; Ullen F, 2007, PHYSIOL BEHAV, V92, P193, DOI 10.1016/j.physbeh.2007.05.036	47	19	20	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130120	10.1371/journal.pone.0130120	http://dx.doi.org/10.1371/journal.pone.0130120			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076024	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900139
J	Liu, S; Niger, C; Koh, EY; Stains, JP				Liu, Shuo; Niger, Corinne; Koh, Eugene Y.; Stains, Joseph P.			Connexin43 Mediated Delivery of ADAMTS5 Targeting siRNAs from Mesenchymal Stem Cells to Synovial Fibroblasts	PLOS ONE			English	Article							ARTICULAR CHONDROCYTES; GAP-JUNCTIONS; FUNCTIONAL EXPRESSION; OSTEOARTHRITIS; INTERLEUKIN-1-BETA	Osteoarthritis is a joint-destructive disease that has no effective cure. Human mesenchymal stem cells (hMSCs) could offer therapeutic benefit in the treatment of arthritic diseases by suppressing inflammation and permitting tissue regeneration, but first these cells must overcome the catabolic environment of the diseased joint. Likewise, gene therapy also offers therapeutic promise given its ability to directly modulate key catabolic factors that mediate joint deterioration, although it too has limitations. In the current study, we explore an approach that combines hMSCs and gene therapy. Specifically, we test the use of hMSC as a vehicle to deliver ADAMTS5 (an aggrecanase with a key role in osteoarthritis)-targeting siRNAs to SW982 synovial fibroblast-like cells via connexin43 containing gap junctions. Accordingly, we transduced hMSCs with ADAMTS5-targeting shRNA or non-targeted shRNA, and co-cultured them with synovial fibroblasts to allow delivery of siRNAs from hMSC to synovial fibroblasts. We found that co-culture of hMSCs-shRNA-ADAMTS5 and synovial fibroblasts reduced ADAMTS5 expression relative to co-culture of hMSCs-shRNA-control and synovial fibroblasts. Furthermore, ADAMTS5 was specifically reduced in the synovial fibroblasts populations as determined by fluorescence-activated cell sorting, suggesting transfer of the siRNA between cells. To test if Cx43-containing gap junctions are involved in the transfer of siRNA, we co-cultured hMSCs-shRNA-ADAMTS5 cells with synovial fibroblasts in which connexin43 was knocked down. Under these conditions, ADAMTS5 levels were not inhibited by co-culture, indicating that connexin43 mediates the delivery of siRNA from hMSCs to synovial fibroblasts. In total, our findings demonstrate that hMSCs can function as donor cells to host and deliver siRNAs to synovial fibroblasts via connexin43 gap junction in vitro. These data may have implications in the combination of hMSCs and gene therapy to treat diseases like osteoarthritis, in vivo.	[Liu, Shuo; Niger, Corinne; Koh, Eugene Y.; Stains, Joseph P.] Univ Maryland, Sch Med, Dept Orthopaed, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Stains, JP (corresponding author), Univ Maryland, Sch Med, Dept Orthopaed, Baltimore, MD 21201 USA.	jstai002@umaryland.edu			National Institutes of Health/National Institute of Arthritis, Musculoskeletal and Skin Diseases [R01 AR063631, R01 AR052719]; Maryland Stem Cell Research Fund [2012-MSCRFE-0154]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052719, R01AR063631] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Maryland Stem Cell Research Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health/National Institute of Arthritis, Musculoskeletal and Skin Diseases, grants R01 AR063631 and R01 AR052719 (no role), and the Maryland Stem Cell Research Fund, grant 2012-MSCRFE-0154 (no role).	Aucher A, 2013, J IMMUNOL, V191, P6250, DOI 10.4049/jimmunol.1301728; Bondeson J, 2008, CLIN EXP RHEUMATOL, V26, P139; Brink PR, 2012, BBA-BIOMEMBRANES, V1818, P2076, DOI 10.1016/j.bbamem.2011.09.025; Buo AM, 2014, FEBS LETT, V588, P1315, DOI 10.1016/j.febslet.2014.01.025; Casagrande D, 2015, J SHOULDER ELB SURG, V24, P382, DOI 10.1016/j.jse.2014.11.039; Dazzi F, 2012, IMMUNOLOGY, V137, P206, DOI 10.1111/j.1365-2567.2012.03621.x; De Miguel MP, 2012, CURR MOL MED, V12, P574; Diao HJ, 2013, REGEN MED, V8, P257, DOI [10.2217/RME.13.22, 10.2217/rme.13.22]; Farini A, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/306573; Fosang AJ, 2008, EUR CELLS MATER, V15, P11, DOI 10.22203/eCM.v015a02; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Grigolo B, 2009, TISSUE ENG PART C-ME, V15, P647, DOI [10.1089/ten.tec.2008.0569, 10.1089/ten.TEC.2008.0569]; Gupta A, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-425; Herve JC, 2013, CELL TISSUE RES, V352, P21, DOI 10.1007/s00441-012-1485-6; Hou ML, 2013, J NEUROSCI METH, V220, P18, DOI 10.1016/j.jneumeth.2013.08.007; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; Kizana E, 2009, GENE THER, V16, P1163, DOI 10.1038/gt.2009.64; Kolomytkin OV, 1997, AM J PHYSIOL-REG I, V273, pR1822; Kolomytkin OV, 2002, AM J PHYSIOL-CELL PH, V282, pC1254, DOI 10.1152/ajpcell.01166.2000; Lee AS, 2013, GENE, V527, P440, DOI 10.1016/j.gene.2013.05.069; Lee CH, 2009, TISSUE ENG PT A, V15, P3923, DOI 10.1089/ten.TEA.2008.0653; Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Marino AA, 2004, CLIN ORTHOP RELAT R, P224, DOI 10.1097/01.blo.0000129346.29945.3b; Mayan MD, 2015, ANN RHEUM DIS, V74, P275, DOI 10.1136/annrheumdis-2013-204244; Mayan MD, 2013, AM J PATHOL, V182, P1337, DOI 10.1016/j.ajpath.2012.12.018; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; Nanjundaiah SM, 2012, J BIOL CHEM, V287, P22216, DOI 10.1074/jbc.M112.356816; Niger C, 2013, J BONE MINER RES, V28, P1468, DOI 10.1002/jbmr.1867; Niger C, 2010, BIOL CELL, V102, P37, DOI 10.1042/BC20090056; Re'em T, 2012, BIOMATERIALS, V33, P751, DOI 10.1016/j.biomaterials.2011.10.007; Scanzello CR, 2012, BONE, V51, P249, DOI 10.1016/j.bone.2012.02.012; Sohni A, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/130763; Tonon R, 2002, BIORHEOLOGY, V39, P153; Tonon R, 2000, J BONE MINER RES, V15, P1669, DOI 10.1359/jbmr.2000.15.9.1669; Valiunas V, 2005, J PHYSIOL-LONDON, V568, P459, DOI 10.1113/jphysiol.2005.090985; Valiunas V, 2004, J PHYSIOL-LONDON, V555, P617, DOI 10.1113/jphysiol.2003.058719; Vankemmelbeke MN, 2001, EUR J BIOCHEM, V268, P1259, DOI 10.1046/j.1432-1327.2001.01990.x; Wolvetang EJ, 2007, BIOCHEM BIOPH RES CO, V363, P610, DOI 10.1016/j.bbrc.2007.09.035; Wylie JD, 2012, J ORTHOP RES, V30, P226, DOI 10.1002/jor.21508	40	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129999	10.1371/journal.pone.0129999	http://dx.doi.org/10.1371/journal.pone.0129999			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076025	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900121
J	Tong, X; Zhang, DQ; Arthurs, B; Li, P; Durudogan, L; Gupta, N; Yin, L				Tong, Xin; Zhang, Deqiang; Arthurs, Blake; Li, Pei; Durudogan, Leigh; Gupta, Neil; Yin, Lei			Palmitate Inhibits SIRT1-Dependent BMAL1/CLOCK Interaction and Disrupts Circadian Gene Oscillations in Hepatocytes	PLOS ONE			English	Article							HIGH-FAT-DIET; CONTROLS LIPID-METABOLISM; PANCREATIC BETA-CELLS; INSULIN-RESISTANCE; DEACETYLASE SIRT1; ENERGY-METABOLISM; CLOCK GENES; RHYTHMS; EXPRESSION; OBESITY	Elevated levels of serum saturated fatty acid palmitate have been shown to promote insulin resistance, increase cellular ROS production, and trigger cell apoptosis in hepatocytes during the development of obesity. However, it remains unclear whether palmitate directly impacts the circadian clock in hepatocytes, which coordinates nutritional inputs and hormonal signaling with downstream metabolic outputs. Here we presented evidence that the molecular clock is a novel target of palmitate in hepatocytes. Palmitate exposure at low dose inhibits the molecular clock activity and suppresses the cyclic expression of circadian targets including Dbp, Nr1d1 and Per2 in hepatocytes. Palmitate treatment does not seem to alter localization or reduce protein expression of BMAL1 and CLOCK, the two core components of the molecular clock in hepatocytes. Instead, palmitate destabilizes the protein-protein interaction between BMAL1-CLOCK in a dose and time-dependent manner. Furthermore, we showed that SIRT1 activators could reverse the inhibitory action of palmitate on BMAL1-CLOCK interaction and the clock gene expression, whereas inhibitors of NAD synthesis mimic the palmitate effects on the clock function. In summary, our findings demonstrated that palmitate inhibits the clock function by suppressing SIRT1 function in hepatocytes.	[Tong, Xin; Zhang, Deqiang; Arthurs, Blake; Li, Pei; Durudogan, Leigh; Gupta, Neil; Yin, Lei] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Yin, L (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	leiyin@umich.edu	Zhang, Deqiang/J-9199-2016	TONG, XIN/0000-0002-4832-8940; Li, Pei/0000-0003-1837-2753	NIH [DK077449, AA022720, P30 DK089503]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH funding (DK077449 and AA022720 to LY) and a pilot grant from NIH P30 DK089503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P3333, DOI 10.1073/pnas.1214266110; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Caruso R, 2014, MUCOSAL IMMUNOL, V7, P1467, DOI 10.1038/mi.2014.35; Cazanave SC, 2011, J BIOL CHEM, V286, P39336, DOI 10.1074/jbc.M111.280420; Challet E, 2013, PROG MOL BIOL TRANSL, V119, P105, DOI 10.1016/B978-0-12-396971-2.00005-1; Challet E, 2010, J COMP PHYSIOL B, V180, P631, DOI 10.1007/s00360-010-0451-4; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Chavda B, 2014, EXPERT OPIN DRUG DIS, V9, P1005, DOI 10.1517/17460441.2014.933802; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Dardente H, 2007, BIOCHEM J, V402, P525, DOI 10.1042/BJ20060827; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dibner C, 2009, EMBO J, V28, P123, DOI 10.1038/emboj.2008.262; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fick LJ, 2011, BIOCHEM BIOPH RES CO, V413, P414, DOI 10.1016/j.bbrc.2011.08.103; Froy O, 2007, FRONT NEUROENDOCRIN, V28, P61, DOI 10.1016/j.yfrne.2007.03.001; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Greco JA, 2014, AM J PHYSIOL-REG I, V307, pR1049, DOI 10.1152/ajpregu.00100.2014; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Hasmann M, 2003, CANCER RES, V63, P7436; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hsieh MC, 2010, INT J OBESITY, V34, P227, DOI 10.1038/ijo.2009.228; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Kim EJ, 2012, HEPATOLOGY, V55, P1379, DOI 10.1002/hep.25529; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kraegen EW, 2001, EXP CLIN ENDOCR DIAB, V109, pS516; Kraegen EW, 2001, EXP CLIN ENDOCR DIAB, V109, pS189, DOI 10.1055/s-2001-18581; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lau P, 2008, J BIOL CHEM, V283, P18411, DOI 10.1074/jbc.M710526200; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Li SM, 2009, J APPL PHYSIOL, V107, P1959, DOI 10.1152/japplphysiol.00467.2009; Li XL, 2013, ACTA BIOCH BIOPH SIN, V45, P51, DOI 10.1093/abbs/gms108; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Mendoza J, 2007, J NEUROENDOCRINOL, V19, P127, DOI 10.1111/j.1365-2826.2006.01510.x; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Shao D, 2014, J BIOL CHEM, V289, P7293, DOI 10.1074/jbc.M113.520403; Shimba S, PLOS ONE, V6, DOI [10.1371/journal.pone.0025231PONE-D-11-09950, DOI 10.1371/JOURNAL.PONE.0025231PONE-D-11-09950]; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Thompson KJ, 2015, ADV EXP MED BIOL, V815, P361, DOI 10.1007/978-3-319-09614-8_21; Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; TURINSKY J, 1990, J BIOL CHEM, V265, P7933; Vetterli L, 2011, AGING-US, V3, P444, DOI 10.18632/aging.100304; Wu L, 2012, BBA-MOL BASIS DIS, V1822, P1815, DOI 10.1016/j.bbadis.2012.08.009; Yanagihara H, 2006, CHRONOBIOL INT, V23, P905, DOI 10.1080/07420520600827103; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Yuan HP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015726; Zhang DQ, 2014, J BIOL CHEM, V289, P25925, DOI 10.1074/jbc.M114.567628; Zhou B, 2014, HEPATOLOGY, V59, P2196, DOI 10.1002/hep.26992	72	24	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130047	10.1371/journal.pone.0130047	http://dx.doi.org/10.1371/journal.pone.0130047			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075729	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900128
J	Toyoshima, A; Yasuhara, T; Kameda, M; Morimoto, J; Takeuchi, H; Wang, FF; Sasaki, T; Sasada, S; Shinko, A; Wakamori, T; Okazaki, M; Kondo, A; Agari, T; Borlongan, CV; Date, I				Toyoshima, Atsuhiko; Yasuhara, Takao; Kameda, Masahiro; Morimoto, Jun; Takeuchi, Hayato; Wang, Feifei; Sasaki, Tatsuya; Sasada, Susumu; Shinko, Aiko; Wakamori, Takaaki; Okazaki, Mihoko; Kondo, Akihiko; Agari, Takashi; Borlongan, Cesario V.; Date, Isao			Intra-Arterial Transplantation of Allogeneic Mesenchymal Stem Cells Mounts Neuroprotective Effects in a Transient Ischemic Stroke Model in Rats: Analyses of Therapeutic Time Window and Its Mechanisms	PLOS ONE			English	Article							MARROW MONONUCLEAR-CELLS; BLOOD-BRAIN-BARRIER; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; CEREBRAL-ARTERY OCCLUSION; FACTOR-SECRETING CELLS; BONE-MARROW; FUNCTIONAL RECOVERY; STROMAL CELLS; REPERFUSION INJURY; NEURAL STEM	Objective Intra-arterial stem cell transplantation exerts neuroprotective effects for ischemic stroke. However, the optimal therapeutic time window and mechanisms have not been completely understood. In this study, we investigated the relationship between the timing of intra-arterial transplantation of allogeneic mesenchymal stem cells (MSCs) in ischemic stroke model in rats and its efficacy in acute phase. Methods Adult male Wistar rats weighing 200 to 250g received right middle cerebral artery occlusion (MCAO) for 90 minutes. MSCs (1x10(6)cells/ 1ml PBS) were intra-arterially injected at either 1, 6, 24, or 48 hours (1, 6, 24, 48h group) after MCAO. PBS (1ml) was intra-arterially injected to control rats at 1 hour after MCAO. Behavioral test was performed immediately after reperfusion, and at 3, 7 days after MCAO using the Modified Neurological Severity Score (mNSS). Rats were euthanized at 7 days after MCAO for evaluation of infarct volumes and the migration of MSCs. In order to explore potential mechanisms of action, the upregulation of neurotrophic factor and chemotactic cytokine (bFGF, SDF-1 alpha) induced by cell transplantation was examined in another cohort of rats that received intra-arterial transplantation at 24 hours after recanalization then euthanized at 7 days after MCAO for protein assays. Results Behavioral test at 3 and 7 days after transplantation revealed that stroke rats in 24h group displayed the most robust significant improvements in mNSS compared to stroke rats in all other groups (p's<0.05). Similarly, the infarct volumes of stroke rats in 24h group were much significantly decreased compared to those in all other groups (p's<0.05). These observed behavioral and histological effects were accompanied by MSC survival and migration, with the highest number of integrated MSCs detected in the 24h group. Moreover, bFGF and SDF-1 alpha levels of the infarcted cortex were highly elevated in the 24h group compared to control group (p's<0.05). Conclusions These results suggest that intra-arterial allogeneic transplantation of MSCs provides post-stroke functional recovery and reduction of infarct volumes in ischemic stroke model of rats. The upregulation of bFGF and SDF-1 alpha likely played a key mechanistic role in enabling MSC to afford functional effects in stroke. MSC transplantation at 24 hours after recanalization appears to be the optimal timing for ischemic stroke model, which should guide the design of clinical trials of cell transplantation for stroke patients.	[Toyoshima, Atsuhiko; Yasuhara, Takao; Kameda, Masahiro; Morimoto, Jun; Takeuchi, Hayato; Sasaki, Tatsuya; Sasada, Susumu; Shinko, Aiko; Wakamori, Takaaki; Okazaki, Mihoko; Kondo, Akihiko; Agari, Takashi; Date, Isao] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, Kita Ku, Okayama 7008558, Japan; [Wang, Feifei] Kochi Univ, Sch Med, Ctr Innovat & Translat Med, Nankoku, Kochi 7838505, Japan; [Borlongan, Cesario V.] Univ S Florida, Coll Med, Dept Neurosurg, Tampa, FL 33612 USA	Okayama University; Kochi University; State University System of Florida; University of South Florida	Yasuhara, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	tyasu37@cc.okayama-u.ac.jp	Yasuhara, Takao/AEU-1075-2022; Kondo, Akihiko/A-2130-2015		Kaken [26293323]; Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science (JSPS)	Kaken(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by all coauthors and by Kaken Grants-in-Aid for Scientific Research to Dr. Date (Grant Number #26293323). Kaken is a database provided by the National Institute of Informatics with support of the Ministry of Education, Culture, Sports, Science and Technology and the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2009, STROKE, V40, pE598, DOI 10.1161/STROKEAHA.109.563627; Bao XJ, 2011, BRAIN RES, V1367, P103, DOI 10.1016/j.brainres.2010.10.063; Battistella V, 2011, REGEN MED, V6, P45, DOI 10.2217/RME.10.97; Borlongan CV, 2012, CURR PHARM DESIGN, V18, P3670; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chua JY, 2011, J CEREBR BLOOD F MET, V31, P1263, DOI 10.1038/jcbfm.2010.213; Friedrich MAG, 2012, CELL TRANSPLANT, V21, pS13, DOI 10.3727/096368912X612512; Fujiwara K, 2003, J NEUROSURG, V99, P1053, DOI 10.3171/jns.2003.99.6.1053; Guzman R, 2008, STROKE, V39, P1300, DOI 10.1161/STROKEAHA.107.500470; Guzman R, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E14; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Horie N, 2011, STEM CELLS, V29, P274, DOI 10.1002/stem.584; Ishizaka S, 2013, STROKE, V44, P720, DOI 10.1161/STROKEAHA.112.677328; Jin KL, 2005, NEUROBIOL DIS, V18, P366, DOI 10.1016/j.nbd.2004.10.010; Kameda M, 2007, EUR J NEUROSCI, V26, P1462, DOI 10.1111/j.1460-9568.2007.05776.x; Kamiya N, 2008, LIFE SCI, V83, P433, DOI 10.1016/j.lfs.2008.07.018; Keimpema E, 2009, NEUROPATH APPL NEURO, V35, P89, DOI 10.1111/j.1365-2990.2008.00961.x; Khatri R, 2012, NEUROLOGY, V79, pS52, DOI 10.1212/WNL.0b013e3182697e70; Komatsu K, 2010, BRAIN RES, V1334, P84, DOI 10.1016/j.brainres.2010.04.006; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Mitkari B, 2013, EXP NEUROL, V239, P158, DOI 10.1016/j.expneurol.2012.09.018; Moisan A, 2012, NMR BIOMED, V25, P1340, DOI 10.1002/nbm.2806; Moniche F, 2012, STROKE, V43, P2242, DOI 10.1161/STROKEAHA.112.659409; Okuma Y, 2013, NEUROSCI LETT, V554, P156, DOI 10.1016/j.neulet.2013.08.058; Rosenblum S, 2012, STROKE, V43, P1624, DOI 10.1161/STROKEAHA.111.637884; Sato K, 2013, INT J MOL SCI, V14, P21513, DOI 10.3390/ijms141121513; Savitz SI, 2011, ANN NEUROL, V70, P59, DOI 10.1002/ana.22458; Seyfried D, 2004, J NEUROSURG, V101, P104, DOI 10.3171/jns.2004.101.1.0104; Seyfried DM, 2008, BRAIN RES, V1224, P12, DOI 10.1016/j.brainres.2008.05.080; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Shinozuka K, 2013, BRAIN SCI, V3, P239, DOI 10.3390/brainsci3010239; Shyu WC, 2008, J PHARMACOL EXP THER, V324, P834, DOI 10.1124/jpet.107.127746; Wakabayashi K, 2010, J NEUROSCI RES, V88, P1017, DOI 10.1002/jnr.22279; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Wang FF, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-52; Wang LQ, 2014, CNS NEUROSCI THER, V20, P317, DOI 10.1111/cns.12216; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Warach S, 2004, STROKE, V35, P2659, DOI 10.1161/01.STR.0000144051.32131.09; Yasuhara T, 2006, FRONT BIOSCI-LANDMRK, V11, P760, DOI 10.2741/1834	44	62	68	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0127302	10.1371/journal.pone.0127302	http://dx.doi.org/10.1371/journal.pone.0127302			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075717	Green Submitted, gold, Green Published			2022-12-27	WOS:000356329900011
J	Tse, A; Verkhivker, GM				Tse, Amanda; Verkhivker, Gennady M.			Molecular Determinants Underlying Binding Specificities of the ABL Kinase Inhibitors: Combining Alanine Scanning of Binding Hot Spots with Network Analysis of Residue Interactions and Coevolution	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; GENERAL FORCE-FIELD; FUNCTIONALLY IMPORTANT RESIDUES; PROTEIN CONFORMATIONAL-CHANGES; BCR-ABL; TYROSINE KINASE; C-SRC; DYNAMICS SIMULATIONS; DOMAIN MUTATIONS; IN-VITRO	Quantifying binding specificity and drug resistance of protein kinase inhibitors is of fundamental importance and remains highly challenging due to complex interplay of structural and thermodynamic factors. In this work, molecular simulations and computational alanine scanning are combined with the network-based approaches to characterize molecular determinants underlying binding specificities of the ABL kinase inhibitors. The proposed theoretical framework unveiled a relationship between ligand binding and inhibitor-mediated changes in the residue interaction networks. By using topological parameters, we have described the organization of the residue interaction networks and networks of coevolving residues in the ABL kinase structures. This analysis has shown that functionally critical regulatory residues can simultaneously embody strong coevolutionary signal and high network centrality with a propensity to be energetic hot spots for drug binding. We have found that selective (Nilotinib) and promiscuous (Bosutinib, Dasatinib) kinase inhibitors can use their energetic hot spots to differentially modulate stability of the residue interaction networks, thus inhibiting or promoting conformational equilibrium between inactive and active states. According to our results, Nilotinib binding may induce a significant network-bridging effect and enhance centrality of the hot spot residues that stabilize structural environment favored by the specific kinase form. In contrast, Bosutinib and Dasatinib can incur modest changes in the residue interaction network in which ligand binding is primarily coupled only with the identity of the gate-keeper residue. These factors may promote structural adaptability of the active kinase states in binding with these promiscuous inhibitors. Our results have related ligand-induced changes in the residue interaction networks with drug resistance effects, showing that network robustness may be compromised by targeted mutations of key mediating residues. This study has outlined mechanisms by which inhibitor binding could	[Tse, Amanda; Verkhivker, Gennady M.] Chapman Univ, Grad Program Computat & Data Sci, Schmid Coll Sci & Technol, Orange, CA 92866 USA; [Verkhivker, Gennady M.] Chapman Univ, Sch Pharm, Irvine, CA USA	Chapman University System; Chapman University; Chapman University System; Chapman University	Verkhivker, GM (corresponding author), Chapman Univ, Grad Program Computat & Data Sci, Schmid Coll Sci & Technol, Orange, CA 92866 USA.	verkhivk@chapman.edu	Verkhivker, Gennady/V-9404-2018	Verkhivker, Gennady/0000-0002-4507-4471	Chapman University	Chapman University	This work is supported by funding from Chapman University. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041430; Aleksandrov A, 2010, J BIOL CHEM, V285, P13807, DOI 10.1074/jbc.M110.109660; Aleksandrov A, 2010, J COMPUT CHEM, V31, P1550, DOI 10.1002/jcc.21442; Allen M., 2017, COMPUTER SIMULATIONS, V2nd; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; Artim SC, 2012, BIOCHEM J, V448, P213, DOI 10.1042/BJ20121365; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Beygelzimer A, 2005, PHYSICA A, V357, P593, DOI 10.1016/j.physa.2005.03.040; Boran ADW, 2010, CURR OPIN DRUG DISC, V13, P297; Branford S, 2009, BLOOD, V114, P5426, DOI 10.1182/blood-2009-08-215939; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Buffa P, 2014, FASEB J, V28, P1221, DOI 10.1096/fj.13-236992; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Cassuto O, 2012, ONCOTARGET, V3, P1557; Chakrabarti S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008591; Chakrabarti S, 2009, PROTEINS, V75, P231, DOI 10.1002/prot.22239; Cortes J, 2007, BLOOD, V110, P4005, DOI 10.1182/blood-2007-03-080838; Cowan-Jacob SW, 2014, FUTURE MED CHEM, V6, P541, DOI 10.4155/fmc.13.216; Csermely P, 2013, J COMPLEX NETW, V1, P93, DOI 10.1093/comnet/cnt016; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; del Sol A, 2005, BIOINFORMATICS, V21, P1311, DOI 10.1093/bioinformatics/bti167; del Sol A, 2005, PROTEINS, V58, P672, DOI 10.1002/prot.20348; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; del Sol A, 2010, CURR OPIN BIOTECH, V21, P566, DOI 10.1016/j.copbio.2010.07.010; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Dixit A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002179; Dixit A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000487; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P8637, DOI 10.1073/pnas.122076099; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Farenc C, 2011, FEBS LETT, V585, P3593, DOI 10.1016/j.febslet.2011.10.028; Fernandez-Fuentes N, 2006, NUCLEIC ACIDS RES, V34, pW173, DOI 10.1093/nar/gkl113; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD364, DOI 10.1093/nar/gkt1210; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Getlik M, 2009, J MED CHEM, V52, P3915, DOI 10.1021/jm9002928; Giansanti P, 2014, ACS CHEM BIOL, V9, P1490, DOI 10.1021/cb500116c; Gibbons DL, 2014, P NATL ACAD SCI USA, V111, P3550, DOI 10.1073/pnas.1321173111; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Hantschel Oliver, 2012, Genes Cancer, V3, P436, DOI 10.1177/1947601912458584; Hantschel O, 2012, CANCER RES, V72, P4890, DOI 10.1158/0008-5472.CAN-12-1276; Hari SB, 2013, ACS CHEM BIOL, V8, P2734, DOI 10.1021/cb400663k; Hoffman NG, 2003, VIROLOGY, V314, P536, DOI 10.1016/S0042-6822(03)00484-7; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hsu YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009455; Hu ZJ, 2007, PLOS COMPUT BIOL, V3, P1097, DOI 10.1371/journal.pcbi.0030117; Hughes T, 2009, J CLIN ONCOL, V27, P4204, DOI 10.1200/JCO.2009.21.8230; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Iacob RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015929; Jabbour E, 2009, BLOOD, V114, P2037, DOI 10.1182/blood-2009-01-197715; James KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113488; Jeon J, 2011, MOL BIOL EVOL, V28, P2675, DOI 10.1093/molbev/msr094; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kanna N, 1999, J MOL BIOL, V292, P441, DOI 10.1006/jmbi.1999.3058; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Koukos PI, 2013, J COMPUT CHEM, V34, P2310, DOI 10.1002/jcc.23381; Kowarsch A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000923; Lamontanara AJ, 2013, BBA-PROTEINS PROTEOM, V1834, P1449, DOI 10.1016/j.bbapap.2012.12.009; Laurini E, 2013, MOL ONCOL, V7, P968, DOI 10.1016/j.molonc.2013.06.001; Lee BC, 2008, PROTEINS, V72, P863, DOI 10.1002/prot.21972; Lee TS, 2008, CANCER-AM CANCER SOC, V112, P1744, DOI 10.1002/cncr.23355; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Levinson NM, 2014, NAT CHEM BIOL, V10, P127, DOI [10.1038/NCHEMBIO.1404, 10.1038/nchembio.1404]; Levinson NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029828; Lin YL, 2014, J AM CHEM SOC, V136, P14753, DOI 10.1021/ja504146x; Lin YL, 2013, J AM CHEM SOC, V135, P14741, DOI 10.1021/ja405939x; Lin YL, 2013, P NATL ACAD SCI USA, V110, P1664, DOI 10.1073/pnas.1214330110; Liu Y, 2012, MOL BIOL EVOL, V29, P2253, DOI 10.1093/molbev/mss097; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Louzada VHP, 2013, J COMPLEX NETW, V1, P150, DOI 10.1093/comnet/cnt010; Lovera S, 2012, J AM CHEM SOC, V134, P2496, DOI 10.1021/ja210751t; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MacKerell Alexander D. Jr., 2000, Biopolymers, V56, P257, DOI 10.1002/1097-0282(2000)56:4<257::AID-BIP10029>3.0.CO;2-W; Marcotte DJ, 2010, PROTEIN SCI, V19, P429, DOI 10.1002/pro.321; Buslje CM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000978; Buslje CM, 2009, BIOINFORMATICS, V25, P1125, DOI 10.1093/bioinformatics/btp135; Marsh JA, 2013, J MOL BIOL, V425, P3250, DOI 10.1016/j.jmb.2013.06.019; Marsh JA, 2011, STRUCTURE, V19, P859, DOI 10.1016/j.str.2011.03.010; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Mayne CG, 2013, J COMPUT CHEM, V34, P2757, DOI 10.1002/jcc.23422; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; McMurrough TA, 2014, P NATL ACAD SCI USA, V111, pE2376, DOI 10.1073/pnas.1322352111; Meharena HS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001680; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Moreira IS, 2007, J COMPUT CHEM, V28, P644, DOI 10.1002/jcc.20566; Muckelbauer J, 2011, CHEM BIOL DRUG DES, V78, P739, DOI 10.1111/j.1747-0285.2011.01230.x; Muller MC, 2009, BLOOD, V114, P4944, DOI 10.1182/blood-2009-04-214221; Muratore KE, 2009, BIOCHEMISTRY-US, V48, P3378, DOI 10.1021/bi900057g; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; O'Hare T, 2004, BLOOD, V104, P2532, DOI 10.1182/blood-2004-05-1851; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Oruganty K, 2012, PHILOS T R SOC B, V367, P2529, DOI 10.1098/rstb.2012.0015; Panjarian S, 2013, J BIOL CHEM, V288, P5443, DOI 10.1074/jbc.R112.438382; Pei JF, 2014, J AM CHEM SOC, V136, P11556, DOI 10.1021/ja504810z; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pricl S, 2005, MOL CANCER THER, V4, P1167, DOI 10.1158/1535-7163.MCT-05-0101; Puttini M, 2006, CANCER RES, V66, P11314, DOI 10.1158/0008-5472.CAN-06-1199; Redaelli S, 2012, AM J HEMATOL, V87, pE125, DOI 10.1002/ajh.23338; Redaelli S, 2009, J CLIN ONCOL, V27, P469, DOI 10.1200/JCO.2008.19.8853; Reddy E Premkumar, 2012, Genes Cancer, V3, P447, DOI 10.1177/1947601912462126; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schneider CM, 2011, P NATL ACAD SCI USA, V108, P3838, DOI 10.1073/pnas.1009440108; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Seeliger MA, 2009, CANCER RES, V69, P2384, DOI 10.1158/0008-5472.CAN-08-3953; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Simonetti FL, 2013, NUCLEIC ACIDS RES, V41, pW8, DOI 10.1093/nar/gkt427; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Soverini S, 2014, CANCER-AM CANCER SOC, V120, P1002, DOI 10.1002/cncr.28522; Soverini S, 2011, BLOOD, V118, P1208, DOI 10.1182/blood-2010-12-326405; Soverini S, 2011, ONCOLOGIST, V16, P868, DOI 10.1634/theoncologist.2010-0388; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Szilagyi A, 2013, CURR TOP MED CHEM, V13, P64, DOI 10.2174/1568026611313010007; Tanneeru K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078556; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Ten Eyck LF, 2008, BBA-PROTEINS PROTEOM, V1784, P238, DOI 10.1016/j.bbapap.2007.11.002; Teppa E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-235; Tokarski JS, 2006, CANCER RES, V66, P5790, DOI 10.1158/0008-5472.CAN-05-4187; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Verkhivker GA, 2007, BIOPOLYMERS, V85, P333, DOI 10.1002/bip.20656; Wang JW, 2013, FEBS LETT, V587, P136, DOI 10.1016/j.febslet.2012.11.001; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Williams NK, 2009, J BIOL CHEM, V284, P284, DOI 10.1074/jbc.M807850200; Wodicka LM, 2010, CHEM BIOL, V17, P1241, DOI 10.1016/j.chembiol.2010.09.010; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Xie L, 2012, ANNU REV PHARMACOL, V52, P361, DOI 10.1146/annurev-pharmtox-010611-134630; Xu F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005913; Yang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116551; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211; Yesselman JD, 2012, J COMPUT CHEM, V33, P189, DOI 10.1002/jcc.21963; Zabriskie MS, 2014, CANCER CELL, V26, P428, DOI 10.1016/j.ccr.2014.07.006; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhao YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117506; Zhao Z, 2014, ACS CHEM BIOL, V9, P1230, DOI 10.1021/cb500129t; Zhou TJ, 2011, CHEM BIOL DRUG DES, V77, P1, DOI 10.1111/j.1747-0285.2010.01054.x	183	28	28	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130203	10.1371/journal.pone.0130203	http://dx.doi.org/10.1371/journal.pone.0130203			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075886	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900156
J	Vitiazeva, V; Kattla, JJ; Flowers, SA; Linden, SK; Premaratne, P; Weijdegard, B; Sundfeldt, K; Karlsson, NG				Vitiazeva, Varvara; Kattla, Jayesh J.; Flowers, Sarah A.; Linden, Sara K.; Premaratne, Pushpa; Weijdegard, Birgitta; Sundfeldt, Karin; Karlsson, Niclas G.			The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial Ovarian Tumors	PLOS ONE			English	Article							CARBOHYDRATE ANTIGENS; BIOMARKERS HE-4; EXPRESSION; CANCER; PROTEINS; GLYCOSYLATION; IDENTIFICATION; DIAGNOSIS; GLYCANS; CA-125	Background Mucins are heavily O-glycosylated proteins where the glycosylation has been shown to play an important role in cancer. Normal epithelial ovarian cells do not express secreted mucins, but their abnormal expression has previously been described in epithelial ovarian cancer and may relate to tumor formation and progression. The cyst fluids were shown to be a rich source for acidic glycoproteins. The study of these proteins can potentially lead to the identification of more effective biomarkers for ovarian cancer. Methods In this study, we analyzed the expression of the MUC5AC and the O-glycosylation of acidic glycoproteins secreted into ovarian cyst fluids. The samples were obtained from patients with serous and mucinous ovarian tumors of different stages (benign, borderline, malignant) and grades. The O-linked oligosaccharides were released and analyzed by negative-ion graphitized carbon Liquid Chromatography (LC) coupled to Electrospray Ionization tandem Mass Spectrometry (ESI-MSn). The LC-ESI-MSn of the oligosaccharides from ovarian cyst fluids displayed differences in expression of fucose containing structures such as blood group ABO antigens and Lewis-type epitopes. Results The obtained data showed that serous and mucinous benign adenomas, mucinous low malignant potential carcinomas (LMPs, borderline) and mucinous low-grade carcinomas have a high level of blood groups and Lewis type epitopes. In contrast, this type of fucosylated structures were low abundant in the high-grade mucinous carcinomas or in serous carcinomas. In addition, the ovarian tumors that showed a high level of expression of blood group antigens also revealed a strong reactivity towards the MUC5AC antibody. To visualize the differences between serous and mucinous ovarian tumors based on the O-glycosylation, a hierarchical cluster analysis was performed using mass spectrometry average compositions (MSAC). Conclusion Mucinous benign and LMPs along with mucinous low-grade carcinomas appear to be different from serous and high-grade mucinous carcinomas based on their O-glycan profiles.	[Vitiazeva, Varvara; Kattla, Jayesh J.; Flowers, Sarah A.; Linden, Sara K.; Premaratne, Pushpa; Karlsson, Niclas G.] Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden; [Weijdegard, Birgitta; Sundfeldt, Karin] Univ Gothenburg, Inst Clin Sci, Sahlgrenska Canc Ctr, Dept Obstet & Gynecol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Vitiazeva, V (corresponding author), Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden.	varvara.vitiazeva@gu.se	Karlsson, Niclas/G-5235-2013; Lindén, Sara K/A-3271-2011	Karlsson, Niclas/0000-0002-3045-2628; Lindén, Sara K/0000-0002-7751-9586; Flowers, Sarah/0000-0002-3513-2260	Swedish Research Council [2013-5895, 2010-5322, 342-2004-4434]; County Council of Vastra Gotaland [ALFGBG-290371, 437281]; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Knut and Alice Wallenberg foundation [KAW2007.0118]	Swedish Research Council(Swedish Research CouncilEuropean Commission); County Council of Vastra Gotaland; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Research Council (http://www.vr.se/) (2013-5895 and 2010-5322) the County Council of Vastra Gotaland (http://www.fou.nu/is/alfgbg/) (ALFGBG-290371 and 437281) and by The Swedish Foundation for International Cooperation in Research and Higher Education (STINT) (http://www.stint.se/en/). The LTQ mass spectrometer was obtained by a grant from the Swedish Research Council (342-2004-4434) and the LTQ Orbitrap was obtained from a grant from Knut and Alice Wallenberg foundation (https://www.wallenberg.com/kaw/en) (KAW2007.0118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTARAS MM, 1988, GYNECOL ONCOL, V30, P26, DOI 10.1016/0090-8258(88)90042-X; Andersch-Bjorkman Y, 2007, MOL CELL PROTEOMICS, V6, P708, DOI 10.1074/mcp.M600439-MCP200; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Boman F, 2001, J PATHOL, V193, P339, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH798>3.0.CO;2-9; Byrd JC, 2004, CANCER METAST REV, V23, P77, DOI 10.1023/A:1025815113599; Chauhan SC, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-21; CORDONCARDO C, 1986, INT J CANCER, V37, P667, DOI 10.1002/ijc.2910370505; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; DALLENBACHHELLWEG G, 1984, J CANCER RES CLIN, V107, P71, DOI 10.1007/BF00399375; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Eriksson J, 2004, J PROTEOME RES, V3, P32, DOI 10.1021/pr034048y; Federici MF, 1999, INT J CANCER, V81, P193, DOI 10.1002/(SICI)1097-0215(19990412)81:2<193::AID-IJC5>3.0.CO;2-S; Feng H, 2002, JPN J CLIN ONCOL, V32, P525, DOI 10.1093/jjco/hyf111; Giuntoli RL, 1998, CANCER RES, V58, P5546; Gustafsson JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084430; Hayes CA, 2012, BIOINFORMATICS, V28, P1669, DOI 10.1093/bioinformatics/bts242; Hayes CA, 2011, BIOINFORMATICS, V27, P1343, DOI 10.1093/bioinformatics/btr137; Hess V, 2004, J CLIN ONCOL, V22, P1040, DOI 10.1200/JCO.2004.08.078; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; JACOBS I, 1989, HUM REPROD, V4, P1; Jin CS, 2012, J BIOL CHEM, V287, P35922, DOI 10.1074/jbc.M112.363119; Karlsson NG, 2004, J AM SOC MASS SPECTR, V15, P659, DOI 10.1016/j.jasms.2004.01.002; Karlsson NG, 2012, GLYCOBIOLOGY, V22, P918, DOI 10.1093/glycob/cws060; Kelemen LE, 2011, LANCET ONCOL, V12, P1071, DOI 10.1016/S1470-2045(11)70058-4; Kim YS, 1996, GLYCOCONJUGATE J, V13, P693, DOI 10.1007/BF00702333; Koda Y, 2001, Leg Med (Tokyo), V3, P2, DOI 10.1016/S1344-6223(01)00005-0; Kristjansdottir B, 2013, GYNECOL ONCOL, V131, P52, DOI 10.1016/j.ygyno.2013.07.094; Kristjansdottir Bjorg, 2012, Clin Proteomics, V9, P14, DOI 10.1186/1559-0275-9-14; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Lau SK, 2004, AM J CLIN PATHOL, V122, P61, DOI 10.1309/9R6673QEC06D86Y4; Le Pendu J, 2001, APMIS, V109, P9; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Linden S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040002; MATSUMOTO H, 1993, CANCER-AM CANCER SOC, V72, P75, DOI 10.1002/1097-0142(19930701)72:1<75::AID-CNCR2820720116>3.0.CO;2-Z; Medeiros LR, 2009, EUR J OBSTET GYN R B, V142, P99, DOI 10.1016/j.ejogrb.2008.08.011; Meyer T, 2000, BRIT J CANCER, V82, P1535; Moore RG, 2008, GYNECOL ONCOL, V108, P402, DOI 10.1016/j.ygyno.2007.10.017; Nolen B, 2009, GYNECOL ONCOL, V112, P47, DOI 10.1016/j.ygyno.2008.09.043; Partheen K, 2011, J GYNECOL ONCOL, V22, P244, DOI 10.3802/jgo.2011.22.4.244; Remmers N, 2013, CLIN CANCER RES, V19, P1981, DOI 10.1158/1078-0432.CCR-12-2662; Rosen DG, 2005, GYNECOL ONCOL, V99, P267, DOI 10.1016/j.ygyno.2005.06.040; Rossez Y, 2012, GLYCOBIOLOGY, V22, P1193, DOI 10.1093/glycob/cws072; SCHOENTAG R, 1987, CANCER RES, V47, P1695; Schulz BL, 2002, ANAL CHEM, V74, P6088, DOI 10.1021/ac025890a; Singh AP, 2008, LANCET ONCOL, V9, P1076, DOI 10.1016/S1470-2045(08)70277-8; Sugai M, 2008, PATHOL INT, V58, P681, DOI 10.1111/j.1440-1827.2008.02293.x; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; VOWDEN P, 1986, BRIT J CANCER, V53, P313, DOI 10.1038/bjc.1986.54; Wamunyokoli FW, 2006, CLIN CANCER RES, V12, P690, DOI 10.1158/1078-0432.CCR-05-1110; Welshinger M, 1996, GYNECOL ONCOL, V62, P106, DOI 10.1006/gyno.1996.0198; Wilson NL, 2002, J PROTEOME RES, V1, P521, DOI 10.1021/pr025538d; Wongkham S, 2003, CANCER LETT, V195, P93, DOI 10.1016/S0304-3835(02)00691-2; Yin BWT, 1996, INT J CANCER, V65, P406, DOI 10.1002/(SICI)1097-0215(19960208)65:4<406::AID-IJC2>3.3.CO;2-5; Zhuang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068994	56	19	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130197	10.1371/journal.pone.0130197	http://dx.doi.org/10.1371/journal.pone.0130197			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075384	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900153
J	Wylam, ME; Sathish, V; VanOosten, SK; Freeman, M; Burkholder, D; Thompson, MA; Pabelick, CM; Prakash, YS				Wylam, Mark E.; Sathish, Venkatachalem; VanOosten, Sarah Kay; Freeman, Michelle; Burkholder, David; Thompson, Michael A.; Pabelick, Christina M.; Prakash, Y. S.			Mechanisms of Cigarette Smoke Effects on Human Airway Smooth Muscle	PLOS ONE			English	Article							OPERATED CA2+ ENTRY; ION CHANNELS; ADP-RIBOSE; IN-VITRO; PROLIFERATION; RELEASE; INFLUX; RESPONSIVENESS; OSCILLATIONS; ASSOCIATION	Cigarette smoke contributes to or exacerbates airway diseases such as asthma and COPD, where airway hyperresponsiveness and airway smooth muscle (ASM) proliferation are key features. While factors such as inflammation contribute to asthma in part by enhancing agonist-induced intracellular Ca2+ ([Ca2+]i) responses of ASM, the mechanisms by which cigarette smoke affect ASM are still under investigation. In the present study, we tested the hypothesis that cigarette smoke enhances the expression and function of Ca2+ regulatory proteins leading to increased store operated Ca2+ entry (SOCE) and cell proliferation. Using isolated human ASM (hASM) cells, incubated in the presence and absence cigarette smoke extract (CSE) we determined ([Ca2+]i) responses and expression of relevant proteins as well as ASM proliferation, reactive oxidant species (ROS) and cytokine generation. CSE enhanced [Ca2+]i responses to agonist and SOCE: effects mediated by increased expression of TRPC3, CD38, STIM1, and/or Orai1, evident by attenuation of CSE effects when siRNAs against these proteins were used, particularly Orai1. CSE also increased hASM ROS generation and cytokine secretion. In addition, we found in the airways of patients with long-term smoking history, TRPC3 and CD38 expression were significantly increased compared to life-long never-smokers, supporting the role of these proteins in smoking effects. Finally, CSE enhanced hASM proliferation, an effect confirmed by upregulation of PCNA and Cyclin E. These results support a critical role for Ca2+ regulatory proteins and enhanced SOCE to alter airway structure and function in smoking-related airway disease.	[Wylam, Mark E.] Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA; [Wylam, Mark E.] Mayo Clin, Coll Med, Dept Pediat, Rochester, MN USA; [Sathish, Venkatachalem; VanOosten, Sarah Kay; Freeman, Michelle; Burkholder, David; Thompson, Michael A.; Pabelick, Christina M.; Prakash, Y. S.] Mayo Clin, Coll Med, Dept Anesthesiol, Rochester, MN USA; [Sathish, Venkatachalem; Pabelick, Christina M.; Prakash, Y. S.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Wylam, ME (corresponding author), Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA.	wylam.mark@mayo.edu		Prakash, Y S/0000-0002-2968-224X; venkatachalem, sathish/0000-0001-9770-8299	NIH [HL090595, HL088029, HL056470]; Career Development Award from the Annenberg Foundation Award; Flight Attendants Medical Research Institute (FAMRI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056470, R01HL088029] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award from the Annenberg Foundation Award; Flight Attendants Medical Research Institute (FAMRI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by a Career Development Award from the Annenberg Foundation Award (Wylam), the Flight Attendants Medical Research Institute (FAMRI; Sathish, Pabelick), and NIH R01 grants HL090595 (Pabelick), HL088029, and HL056470 (Prakash). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; Aravamudan B, 2012, J CELL MOL MED, V16, P812, DOI 10.1111/j.1582-4934.2011.01356.x; Ay B, 2006, AM J PHYSIOL-LUNG C, V290, pL278, DOI 10.1152/ajplung.00188.2005; Ay B, 2004, AM J PHYSIOL-LUNG C, V286, pL909, DOI 10.1152/ajplung.00317.2003; Billington CK, 2003, RESP RES, V4; BLUE ML, 1978, AM REV RESPIR DIS, V117, P317; Bogeski I, 2012, J PHYSIOL-LONDON, V590, P4193, DOI 10.1113/jphysiol.2012.230565; Chiba Y, 2005, AM J RESP CELL MOL, V33, P574, DOI 10.1165/rcmb.2005-0177OC; CHILMONCZYK BA, 1993, NEW ENGL J MED, V328, P1665, DOI 10.1056/NEJM199306103282303; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Deshpande DA, 2005, AM J RESP CELL MOL, V32, P149, DOI 10.1165/rcmb.2004-0243OC; Deshpande DA, 2003, FASEB J, V17, P452, DOI 10.1096/fj.02-0450fje; Fantozzi I, 2003, AM J PHYSIOL-LUNG C, V285, pL1233, DOI 10.1152/ajplung.00445.2002; Flouris AD, 2009, AM J RESP CRIT CARE, V179, P1029, DOI 10.1164/rccm.200812-1920OC; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Hall IP, 2000, EUR RESPIR J, V15, P1120, DOI 10.1034/j.1399-3003.2000.01523.x; Jude JA, 2012, AM J RESP CELL MOL, V47, P427, DOI 10.1165/rcmb.2012-0025OC; Kannan MS, 1997, AM J PHYSIOL-LUNG C, V272, pL659, DOI 10.1152/ajplung.1997.272.4.L659; Mahn K, 2009, P NATL ACAD SCI USA, V106, P10775, DOI 10.1073/pnas.0902295106; MURRAY AB, 1986, J ALLERGY CLIN IMMUN, V77, P575, DOI 10.1016/0091-6749(86)90348-9; Ohga K, 2008, PULM PHARMACOL THER, V21, P360, DOI 10.1016/j.pupt.2007.09.003; PANETTIERI RA, 1990, AM J PHYSIOL, V259, pL365, DOI 10.1152/ajplung.1990.259.6.L365; Pera T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-48; Prakash YS, 1998, AM J PHYSIOL-CELL PH, V274, pC1653, DOI 10.1152/ajpcell.1998.274.6.C1653; Prakash YS, 1997, AM J PHYSIOL-CELL PH, V272, pC966, DOI 10.1152/ajpcell.1997.272.3.C966; ROCHE E, 1994, CELL CALCIUM, V16, P331, DOI 10.1016/0143-4160(94)90097-3; Salido GM, 2011, ADV EXP MED BIOL, V704, P413, DOI 10.1007/978-94-007-0265-3_23; Sathish V, 2012, EUR RESPIR J, V40, P470, DOI 10.1183/09031936.00090511; Sieck GC, 2008, AM J PHYSIOL-LUNG C, V294, pL378, DOI 10.1152/ajplung.00394.2007; Smelter DF, 2010, J IMMUNOL, V185, P3035, DOI 10.4049/jimmunol.1000252; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Stephens NL, 2001, LUNG, V179, P333, DOI 10.1007/s004080000073; Sweeney M, 2002, J APPL PHYSIOL, V92, P1594, DOI 10.1152/japplphysiol.00722.2001; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; Vassallo R, 2005, J IMMUNOL, V175, P2684, DOI 10.4049/jimmunol.175.4.2684; White RA, 2003, FASEB J, V17, P482, DOI 10.1096/fj.02-0622fje; White TA, 2006, AM J RESP CELL MOL B; White TA, 2006, AM J RESP CELL MOL, V35, P243, DOI 10.1165/rcmb.2006-0003OC; Wylam ME, 2012, RESP PHYSIOL NEUROBI, V181, P99, DOI 10.1016/j.resp.2012.01.011; Xing A-p, 2012, J BIOMED BIOTECHNOL, V2012, P7; Yu Y, 2003, AM J PHYSIOL-CELL PH, V284, pC316, DOI 10.1152/ajpcell.00125.2002; Zou JJ, 2011, J APPL PHYSIOL, V110, P1256, DOI 10.1152/japplphysiol.01124.2010	42	35	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128778	10.1371/journal.pone.0128778	http://dx.doi.org/10.1371/journal.pone.0128778			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075746	Green Submitted, gold, Green Published			2022-12-27	WOS:000356329900029
J	Yin, W; Song, YL; Du, YG; Bian, Z				Yin, Wei; Song, Yaling; Du, Yangge; Bian, Zhuan			Differentially Expressed Genes in EEC and LMS Syndromes	PLOS ONE			English	Article							CLEFT LIP/PALATE SYNDROME; RAPP-HODGKIN-SYNDROME; ECTODERMAL DYSPLASIA; HAY-WELLS; AEC SYNDROME; TP63 GENE; P63 GENE; SPECTRUM; MUTATION; CANCER	Objectives Ectrodactyly ectodermal dysplasia cleft lip/palate (EEC) syndrome and limb-mammary syndrome (LMS) share a similar phenotype and the same pathogenic gene, which complicates the ability to distinguish between these diagnoses. The current study aims to identify a potential and practical clinical biomarker to distinguish EEC from LMS. Methods Two EEC pedigrees and one LMS pedigree that have been previously reported were reanalyzed. After confirmation of the causative mutations for these new patients, whole-genome expression microarray analysis was performed to assess the molecular genetic changes in these families. Results Five new patients with classic symptoms were reported, and these individuals exhibited the same mutation as their relatives (c.812G>C; c.611G>A; and c.680G>A). According to the whole genome expression results, the EEC patients exhibited different gene expression characteristics compared with the LMS patients. More than 5,000 genes were differentially expressed (changes >2 or <0.5-fold) among the EEC patients, LMS patients and healthy individuals. The top three altered pathways have been implicated in apoptosis, the hematopoietic cell lineage and the Toll-like receptor signaling pathway. Conclusion Our results provide additional clinical and molecular information regarding EEC and LMS and suggest that peripheral blood cytokines may represent a promising clinical biomarker for the diagnosis of these syndromes.	[Yin, Wei; Song, Yaling; Bian, Zhuan] Wuhan Univ, Minist Educ, Key Lab Oral Biomed Engn, Hosp & Sch Stomatol, Wuhan 430072, Hubei, Peoples R China; [Yin, Wei] Dalian Med Univ, Coll Stomatol, Dept Endodont & Periodont, Dalian, Liaoning, Peoples R China; [Du, Yangge] Wuhan Univ, Sch Stomatol, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Dalian Medical University; Wuhan University	Bian, Z (corresponding author), Wuhan Univ, Minist Educ, Key Lab Oral Biomed Engn, Hosp & Sch Stomatol, Wuhan 430072, Hubei, Peoples R China.	bianzhuan@whu.edu.cn		Song, Yaling/0000-0003-0747-7381	National Natural Scientific Foundation of China [81120108010]; Hubei-MOST KLOS KLOBME [201402]; China postdoctoral science foundation; Education Department of Liaoning Province [L2013347]; Natural Scientific Foundation of Liaoning [2014023037]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei-MOST KLOS KLOBME; China postdoctoral science foundation(China Postdoctoral Science Foundation); Education Department of Liaoning Province; Natural Scientific Foundation of Liaoning	This work was supported by grants from the National Natural Scientific Foundation of China (81120108010), the open research fund program of Hubei-MOST KLOS & KLOBME (201402), the China postdoctoral science foundation (2014), the general scientific research project of Education Department of Liaoning Province (L2013347) and the Natural Scientific Foundation of Liaoning (2014023037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avitan-Hersh E, 2010, PEDIATR DERMATOL, V27, P643, DOI 10.1111/j.1525-1470.2010.01131.x; Bertola DR, 2004, CLIN GENET, V66, P79, DOI 10.1111/j.0009-9163.2004.00278.x; Brunner HG, 2002, J MED GENET, V39, P377, DOI 10.1136/jmg.39.6.377; CAMBIAGHI S, 1994, BRIT J DERMATOL, V130, P97, DOI 10.1111/j.1365-2133.1994.tb06891.x; Chiu YE, 2011, PEDIATR DERMATOL, V28, P15, DOI 10.1111/j.1525-1470.2009.00976.x; Clements SE, 2010, BRIT J DERMATOL, V163, P624, DOI 10.1111/j.1365-2133.2010.09859.x; Dianzani I, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.12.e133; Feng YM, 2007, BREAST CANCER RES TR, V103, P319, DOI 10.1007/s10549-006-9385-7; Graziano V, 2011, BBA-REV CANCER, V1816, P57, DOI 10.1016/j.bbcan.2011.04.002; Kannu P, 2006, AM J MED GENET A, V140A, P887, DOI 10.1002/ajmg.a.31187; Prontera P, 2008, GENET COUNSEL, V19, P397; Rinne T, 2009, AM J MED GENET A, V149A, P1948, DOI 10.1002/ajmg.a.32793; Steele JA, 2005, PEDIATR DERMATOL, V22, P415, DOI 10.1111/j.1525-1470.2005.00105.x; The National Center for Biotechnology Information, 2015, TP63 TUMOR PROT; Vakonaki E, 2012, J CANCER RES CLIN, V138, P1271, DOI 10.1007/s00432-012-1200-8; Wei JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035337; Wu GJ, 2003, CANCER RES, V63, P2351; Yin W, 2010, J DENT RES, V89, P813, DOI 10.1177/0022034510366804	18	3	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129432	10.1371/journal.pone.0129432	http://dx.doi.org/10.1371/journal.pone.0129432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075610	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900073
J	Zhuang, XJ; Tang, WH; Liu, CY; Zhu, JL; Feng, X; Yan, J; Lian, Y; Liu, P; Qiao, J				Zhuang, Xin-Jie; Tang, Wen-hao; Liu, Chang-yu; Zhu, Jin-liang; Feng, Xue; Yan, Jie; Lian, Ying; Liu, Ping; Qiao, Jie			Identification and Characterization of Xlr5c as a Novel Nuclear Localization Protein in Mouse Germ Cells	PLOS ONE			English	Article							GENE FAMILY XLR; HISTONE ACETYLTRANSFERASE; COGNITIVE FUNCTION; EXPRESSION; INTERACTS; SYNAPSIS; SEQUENCE; ENCODES; ELEMENT; MICE	Background Spermatogenesis is the complex process by which diploid stem cells generate haploid germ cells in gamete production. Members of the Xlr (X-chromosome linked, lymphocyte regulated) superfamily play essential roles in spermatogenesis. The expression, localization and role in spermatogenesis of one such member, Xlr5c, has not been reported previously. Methodology/Principal Findings Xlr5c mRNA and protein levels in murine testes and other tissues were investigated using RT-PCR and Western blotting. Xlr5c was abundantly transcribed in mouse testes, particularly during the early stages of spermatogenesis and throughout prophase I in the nuclei of spermatocytes. Xlr5c was specifically localized at synaptonemal complexes(SCs) region in preleptotene and pachytene spermatocytes, as was the homologous Xlr protein Sycp3. Conclusions/Significance These results suggest that Xlr5c was abundantly transcribed in germ cells, localized at SCs region, where it may play a potential role during the early stages of spermatogenesis. Identification and characterization of this novel testis protein may offer a new perspective for understanding of the molecular mechanisms involved in germ cell differentiation.	[Zhuang, Xin-Jie; Liu, Chang-yu; Zhu, Jin-liang; Feng, Xue; Yan, Jie; Lian, Ying; Liu, Ping; Qiao, Jie] Peking Univ, Hosp 3, Ctr Reprod Med,Dept Obstet & Gynecol, Key Lab Assisted Reprod,Minist Educ, Beijing 100191, Peoples R China; [Tang, Wen-hao] Peking Univ, Hosp 3, Dept Urol, Beijing 100191, Peoples R China	Peking University; Peking University	Zhuang, XJ (corresponding author), Peking Univ, Hosp 3, Ctr Reprod Med,Dept Obstet & Gynecol, Key Lab Assisted Reprod,Minist Educ, Beijing 100191, Peoples R China.	Zhuangxinjie902@163.com; Bysylp@sina.com; Jie.qiao@263.net		Qiao, Jie/0000-0003-2126-1376	National Natural Science Foundation of China for Young Scholars [81200466, 81300483, 31401256, 81200470]; National Natural Science Foundation of China [81070534]	National Natural Science Foundation of China for Young Scholars(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China for Young Scholars (NO. 81200466, 81300483, 31401256 and 81200470) and National Natural Science Foundation of China (NO. 81070534).	BERGSAGEL PL, 1994, GENE, V150, P345, DOI 10.1016/0378-1119(94)90450-2; CALENDA A, 1994, EMBO J, V13, P100, DOI 10.1002/j.1460-2075.1994.tb06239.x; Cocquet J, 2010, MOL BIOL CELL, V21, P3497, DOI 10.1091/mbc.E10-07-0601; Cocquet J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000244; COHEN DI, 1985, NATURE, V314, P369, DOI 10.1038/314369a0; Davies W, 2005, NAT GENET, V37, P625, DOI 10.1038/ng1577; Escalier D, 1999, J IMMUNOL, V162, P292; Kesler SR, 2003, BIOL PSYCHIAT, V54, P636, DOI 10.1016/S0006-3223(03)00289-0; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; Raefski AS, 2005, NAT GENET, V37, P620, DOI 10.1038/ng1567; Reynard LN, 2007, BIOL REPROD, V77, P329, DOI 10.1095/biolreprod.107.061101; Reynard LN, 2009, BIOL REPROD, V81, P250, DOI 10.1095/biolreprod.108.075382; Shi YQ, 2013, GENE, V527, P352, DOI 10.1016/j.gene.2013.06.033; Shi YQ, 2011, GENE, V485, P153, DOI 10.1016/j.gene.2011.06.025; SIEGEL JN, 1987, J EXP MED, V166, P1702, DOI 10.1084/jem.166.6.1702; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; THORNHILL AR, 1993, DEVELOPMENT, V118, P171; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zhuang XJ, 2014, CELL CYCLE, V13, P2230, DOI 10.4161/cc.29265; Zhuang XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020866	20	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130087	10.1371/journal.pone.0130087	http://dx.doi.org/10.1371/journal.pone.0130087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075718	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900137
J	Bernhardt, A; Wehrl, M; Paul, B; Hochmuth, T; Schumacher, M; Schutz, K; Gelinsky, M				Bernhardt, Anne; Wehrl, Markus; Paul, Birgit; Hochmuth, Thomas; Schumacher, Matthias; Schuetz, Kathleen; Gelinsky, Michael			Improved Sterilization of Sensitive Biomaterials with Supercritical Carbon Dioxide at Low Temperature	PLOS ONE			English	Article							GAMMA-IRRADIATION; TERMINAL STERILIZATION; BACTERIAL-SPORES; ALGINATE HYDROGELS; INACTIVATION; DEGRADATION; COLLAGEN; MODEL; WATER	The development of bio-resorbable implant materials is rapidly going on. Sterilization of those materials is inevitable to assure the hygienic requirements for critical medical devices according to the medical device directive (MDD, 93/42/EG). Biopolymer-containing biomaterials are often highly sensitive towards classical sterilization procedures like steam, ethylene oxide treatment or gamma irradiation. Supercritical CO2 (scCO(2)) treatment is a promising strategy for the terminal sterilization of sensitive biomaterials at low temperature. In combination with low amounts of additives scCO(2) treatment effectively inactivates microorganisms including bacterial spores. We established a scCO(2) sterilization procedure under addition of 0.25% water, 0.15% hydrogen peroxide and 0.5% acetic anhydride. The procedure was successfully tested for the inactivation of a wide panel of microorganisms including endospores of different bacterial species, vegetative cells of gram positive and negative bacteria including mycobacteria, fungi including yeast, and bacteriophages. For robust testing of the sterilization effect with regard to later application of implant materials sterilization all microorganisms were embedded in alginate/agarose cylinders that were used as Process Challenge Devices (PCD). These PCD served as surrogate models for bioresorbable 3D scaffolds. Furthermore, the impact of scCO(2) sterilization on mechanical properties of polysaccharide-based hydrogels and collagen-based scaffolds was analyzed. The procedure was shown to be less compromising on mechanical and rheological properties compared to established low-temperature sterilization methods like gamma irradiation and ethylene oxide exposure as well as conventional steam sterilization. Cytocompatibility of alginate gels and scaffolds from mineralized collagen was compared after sterilization with ethylene oxide, gamma irradiation, steam sterilization and scCO(2) treatment. Human mesenchymal stem cell viability and proliferation were not compromised by scCO(2) treatment of these materials and scaffolds. We conclude that scCO(2) sterilization under addition of water, hydrogen peroxide and acetic anhydride is a very effective, gentle, non-cytotoxic and thus a promising alternative sterilization method especially for biomaterials.	[Bernhardt, Anne; Paul, Birgit; Schumacher, Matthias; Schuetz, Kathleen; Gelinsky, Michael] Tech Univ Dresden, Ctr Translat Bone Joint & Soft Tissue Res, Med Fak, D-01062 Dresden, Germany; [Wehrl, Markus; Hochmuth, Thomas] Wfk Cleaning Technol Inst eV, Krefeld, Germany	Technische Universitat Dresden	Bernhardt, A (corresponding author), Tech Univ Dresden, Ctr Translat Bone Joint & Soft Tissue Res, Med Fak, D-01062 Dresden, Germany.	anne.bernhardt@tu-dresden.de	Gelinsky, Michael/A-9680-2012; Bernhardt, Anne/O-1242-2015; Schumacher, Matthias/I-1530-2013	Gelinsky, Michael/0000-0001-9075-5121; Bernhardt, Anne/0000-0002-1903-1929; Schumacher, Matthias/0000-0001-7207-7355; Paul, Birgit/0000-0001-7963-1048	program Industrielle Gemeinschaftsforschung und - entwicklung (IGF) by the Federal Ministry of Economic Affairs and Energy (BMWi) [IGF 17455 BG]; German Research Foundation; Open Access Publication Funds of the TU Dresden	program Industrielle Gemeinschaftsforschung und - entwicklung (IGF) by the Federal Ministry of Economic Affairs and Energy (BMWi); German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the TU Dresden	This project was supported within the funding program Industrielle Gemeinschaftsforschung und - entwicklung (IGF) by the Federal Ministry of Economic Affairs and Energy (BMWi) due to a decision of the German Parliament (Grant number IGF 17455 BG). Support was also received from the German Research Foundation and the Open Access Publication Funds of the TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2013, J BIOMED MATER RES B, V101, P1182, DOI 10.1002/jbm.b.32928; [Anonymous], 5561 EN; Baldini T, 2016, KNEE SURG SPORT TR A, V24, P3971, DOI 10.1007/s00167-014-3221-0; Bernhardt A, 2009, J BIOMED MATER RES A, V90A, P852, DOI 10.1002/jbm.a.32144; Cardoso DA, 2014, MACROMOL BIOSCI, V14, P872, DOI 10.1002/mabi.201300415; Chang L., 2011, FORMOSAN J MUSCULOSK, V2, P55; Checinska A, 2011, J MICROBIOL METH, V87, P70, DOI 10.1016/j.mimet.2011.07.008; DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P149, DOI 10.1002/jbm.820290203; Delgado LM, 2014, EXPERT REV MED DEVIC, V11, P305, DOI 10.1586/17434440.2014.900436; Dillow A, 1999, Supercritical fluid sterilization method, Patent No. [WO 1999066960 A3, 1999066960]; Dillow AK, 1999, P NATL ACAD SCI USA, V96, P10344, DOI 10.1073/pnas.96.18.10344; Donati I, 2012, BIOMACROMOLECULES, V13, P1152, DOI 10.1021/bm300053d; Fatimi A, 2010, J MATER SCI-MATER M, V21, P1799, DOI 10.1007/s10856-010-4047-z; FRANCIS AW, 1954, J PHYS CHEM-US, V58, P1099, DOI 10.1021/j150522a014; Gelinsky M, 2008, CHEM ENG J, V137, P84, DOI 10.1016/j.cej.2007.09.029; Hemmer JD, 2007, J BIOMED MATER RES B, V80B, P511, DOI 10.1002/jbm.b.30625; Herdegen V, 2014, CHEM ENG TECHNOL, V37, P1891, DOI 10.1002/ceat.201300679; Hu TZ, 2014, BIO-MED MATER ENG, V24, P1837, DOI 10.3233/BME-140994; Jimenez A, 2008, BIOTECHNOL BIOENG, V101, P1344, DOI 10.1002/bit.21983; Karajanagi SS, 2011, BIOTECHNOL BIOENG, V108, P1716, DOI 10.1002/bit.23105; Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3; KUME T, 1983, AGR BIOL CHEM TOKYO, V47, P889, DOI 10.1080/00021369.1983.10865740; Lee DW, 2003, J AGR FOOD CHEM, V51, P4819, DOI 10.1021/jf021053y; Matthews KH, 2006, INT J PHARMACEUT, V313, P78, DOI 10.1016/j.ijpharm.2006.01.023; Matuska AM, 2015, J BIOMED MATER RES B, V103, P397, DOI 10.1002/jbm.b.33213; Murray KA, 2013, J MECH BEHAV BIOMED, V17, P252, DOI 10.1016/j.jmbbm.2012.09.011; Nichols A., 2009, J ORTHOP, V6; Ofori-Kwakye K, 2005, J SCI TECHNOL, V25, P46; Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482; Park HS, 2013, INT J FOOD MICROBIOL, V166, P207, DOI 10.1016/j.ijfoodmicro.2013.07.015; Phillip E, 2013, J BIOMED MATER RES B, V101B, P532, DOI 10.1002/jbm.b.32853; Qiu QQ, 2009, J BIOMED MATER RES B, V91B, P572, DOI 10.1002/jbm.b.31431; Reverchon Ernesto, 2010, Recent Patents on Chemical Engineering, V3, P142, DOI 10.2174/1874478811003020142; Russell N, 2013, BIOMATERIALS, V34, P8185, DOI 10.1016/j.biomaterials.2013.07.022; Russell N, 2013, J BIOMECH, V46, P1670, DOI 10.1016/j.jbiomech.2013.04.006; Sabirzyanov AN, 2002, HIGH TEMP+, V40, P203, DOI 10.1023/A:1015294905132; Shieh E, 2009, J MICROBIOL METH, V76, P247, DOI 10.1016/j.mimet.2008.11.005; Spilimbergo S, 2003, BIOTECHNOL BIOENG, V84, P627, DOI 10.1002/bit.10783; Stoppel WL, 2014, J BIOMED MATER RES B, V102, P877, DOI 10.1002/jbm.b.33070; Watanabe T, 2003, APPL ENVIRON MICROB, V69, P7124, DOI 10.1128/AEM.69.12.7124-7129.2003; Wehmeyer JL, 2015, TISSUE ENG PART C-ME, V21, P649, DOI [10.1089/ten.tec.2014.0304, 10.1089/ten.TEC.2014.0304]; White A, 2006, J BIOTECHNOL, V123, P504, DOI 10.1016/j.jbiotec.2005.12.033; Zhang J, 2006, J SUPERCRIT FLUID, V38, P354, DOI 10.1016/j.supflu.2005.05.005; Zhang J, 2006, J MICROBIOL METH, V66, P479, DOI 10.1016/j.mimet.2006.01.012	44	69	71	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129205	10.1371/journal.pone.0129205	http://dx.doi.org/10.1371/journal.pone.0129205			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067982	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000055
J	Zhang, T; Yao, YF				Zhang, Tao; Yao, Yi-Feng			Endophytic Fungal Communities Associated with Vascular Plants in the High Arctic Zone Are Highly Diverse and Host-Plant Specific	PLOS ONE			English	Article							ROOT-ASSOCIATED FUNGI; ARBUSCULAR MYCORRHIZAL; GEOGRAPHIC STRUCTURE; DRYAS-OCTOPETALA; SYMBIOTIC FUNGI; BIODIVERSITY; TUNDRA; DISTANCE; SVALBARD; HABITAT	This study assessed the diversity and distribution of endophytic fungal communities associated with the leaves and stems of four vascular plant species in the High Arctic using 454 pyrosequencing with fungal-specific primers targeting the ITS region. Endophytic fungal communities showed high diversity. The 76,691 sequences obtained belonged to 250 operational taxonomic units (OTUs). Of these OTUs, 190 belonged to Ascomycota, 50 to Basidiomycota, 1 to Chytridiomycota, and 9 to unknown fungi. The dominant orders were Helotiales, Pleosporales, Capnodiales, and Tremellales, whereas the common known fungal genera were Cryptococcus, Rhizosphaera, Mycopappus, Melampsora, Tetracladium, Phaeosphaeria, Mrakia, Venturia, and Leptosphaeria. Both the climate and host-related factors might shape the fungal communities associated with the four Arctic plant species in this region. These results suggested the presence of an interesting endophytic fungal community and could improve our understanding of fungal evolution and ecology in the Arctic terrestrial ecosystems.	[Zhang, Tao] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Zhang, Tao] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Zhang, Tao] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yao, Yi-Feng] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Botany, CAS	Zhang, T (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	zhangtaoim@126.com			National Natural Science Foundation of China (NSFC) [31300115, 41271222]; Polar Strategic Research Foundation of China [20120302]; Chinese Arctic and Antarctic Administration, State Oceanic Administration [2013YR06006, 2013YR05005]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Polar Strategic Research Foundation of China; Chinese Arctic and Antarctic Administration, State Oceanic Administration	Funding has been provided by the National Natural Science Foundation of China (NSFC) (Nos. 31300115 and 41271222), Polar Strategic Research Foundation of China (No. 20120302), and Projects of the Chinese Arctic and Antarctic Administration, State Oceanic Administration (Nos. 2013YR06006 and 2013YR05005). The funders had role in data collection.	Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold AE, 2001, MYCOL RES, V105, P1502, DOI 10.1017/S0953756201004956; Arnold AE, 2008, TROPICAL FOREST COMM, P254; Bastian M., 2009, ICWSM, DOI DOI 10.1136/QSHC.2004.010033; Bergero R, 1999, POLAR BIOL, V21, P361, DOI 10.1007/s003000050374; Bjorbaekmo MFM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-244; Blaalid R, 2014, MOL ECOL, V23, P649, DOI 10.1111/mec.12622; Botnen S, 2014, MOL ECOL, V23, P975, DOI 10.1111/mec.12646; Butinar L, 2007, ANTON LEEUW INT J G, V91, P277, DOI 10.1007/s10482-006-9117-3; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cordier T, 2012, FUNGAL ECOL, V5, P509, DOI 10.1016/j.funeco.2011.12.004; Costa I. P. M.W., 2012, MYCOTAXON, V119, P494, DOI DOI 10.5248/119.493; Dalpe Y, 1998, CAN J BOT, V76, P1930, DOI 10.1139/cjb-76-11-1930; Day MJ, 2006, MYCOTAXON, V98, P261; Elvebakk A., 1996, CATALOGUE SVALBARD P; FISHER PJ, 1995, MYCOLOGIA, V87, P319, DOI 10.2307/3760828; Ganley RJ, 2004, P NATL ACAD SCI USA, V101, P10107, DOI 10.1073/pnas.0401513101; Gardes M, 1996, NEW PHYTOL, V133, P147, DOI 10.1111/j.1469-8137.1996.tb04350.x; Gawas-Sakhalkar P, 2011, CURR SCI INDIA, V100, P1701; Geml J, 2012, J BIOGEOGR, V39, P74, DOI 10.1111/j.1365-2699.2011.02588.x; Gjoerevoll O, 1999, FLOWERS OF SVALBARD; Gunde-Cimerman N, 2003, PHYS CHEM EARTH, V28, P1273, DOI 10.1016/j.pce.2003.08.056; HELANDER ML, 1993, MICROBIAL ECOL, V26, P227, DOI 10.1007/BF00176955; Higgins KL, 2007, MOL PHYLOGENET EVOL, V42, P543, DOI 10.1016/j.ympev.2006.07.012; Hobbie JE, 2006, ECOLOGY, V87, P816, DOI 10.1890/0012-9658(2006)87[816:NISFAP]2.0.CO;2; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Kembel SW, 2014, BOTANY, V92, DOI 10.1139/cjb-2013-0194; Kurek Ewa, 2007, Polish Polar Research, V28, P57; Li HY, 2012, FUNGAL DIVERS, V54, P79, DOI 10.1007/s13225-012-0153-1; Mucciarelli M, 2003, NEW PHYTOL, V158, P579, DOI 10.1046/j.1469-8137.2003.00762.x; Nissinen RM, 2012, FEMS MICROBIOL ECOL, V82, P510, DOI 10.1111/j.1574-6941.2012.01464.x; Olsson PA, 2004, CAN J BOT, V82, P1547, DOI [10.1139/b04-111, 10.1139/B04-111]; Pang K., 2011, POLAR RES, V30, P1, DOI [10.3402/polar.v30i0.5859, DOI 10.3402/POLAR.V30I0.5859]; Paul Narayan Chandra, 2006, Mycobiology, V34, P185, DOI 10.4489/MYCO.2006.34.4.185; PETRINI O, 1988, T BRIT MYCOL SOC, V91, P233, DOI 10.1016/S0007-1536(88)80210-9; Petrini O, 1991, MICROBIAL ECOLOGY LE, P179, DOI DOI 10.1007/978-1-4612-3168-4_9; Robinson CH, 1998, MYCOL RES, V102, P573, DOI 10.1017/S0953756297005492; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Rosa LH, 2009, POLAR BIOL, V32, P161, DOI 10.1007/s00300-008-0515-z; Rosa LH, 2010, FEMS MICROBIOL ECOL, V73, P178, DOI 10.1111/j.1574-6941.2010.00872.x; Singh P, 2012, POLAR BIOL, V35, P575, DOI 10.1007/s00300-011-1103-1; Sun X, 2012, FUNGAL ECOL, V5, P624, DOI 10.1016/j.funeco.2012.04.001; Sun X, 2011, FUNGAL DIVERS, V47, P85, DOI 10.1007/s13225-010-0086-5; Timling I, 2014, MOL ECOL, V23, P3258, DOI 10.1111/mec.12743; U'Ren JM, 2012, AM J BOT, V99, P898, DOI 10.3732/ajb.1100459; Vare H., 1992, Mycorrhiza, V1, P93, DOI 10.1007/BF00203256; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; Vincent WF, 2010, ISME J, V4, P1089, DOI 10.1038/ismej.2010.108; Vishniac HS, 1996, BIODIVERS CONSERV, V5, P1365, DOI 10.1007/BF00051983; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WOOKEY PA, 1994, OIKOS, V70, P131, DOI 10.2307/3545708; Zalar P, 2014, COLD ADAPTED YEASTS, P49, DOI DOI 10.1007/978-3-642-39681-6_3	52	44	49	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130051	10.1371/journal.pone.0130051	http://dx.doi.org/10.1371/journal.pone.0130051			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067836	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000138
J	Leszczyszyn-Pynka, M; Aksak-Was, B; Urbanska, A; Parczewski, M				Leszczyszyn-Pynka, Magdalena; Aksak-Was, Bogusz; Urbanska, Anna; Parczewski, Milosz			Protective Effect of HLA-B*5701 and HLA-C-35 Genetic Variants in HIV-Positive Caucasians from Northern Poland	PLOS ONE			English	Article							HLA-C EXPRESSION; NATURAL-KILLER; SINGLE NUCLEOTIDE; ASSOCIATION; DETERMINANTS; PRESSURE; ALLELES; LIGAND	Aim of the Study Association of two HLA class I variants with HIV-1 pretreatment viremia, CD4+ T cell count at the care-entry and CD4+ T cell nadir. Methods 414 HIV-positive Caucasians (30% women) aged 19-73 years were genotyped for HLA-C -35 (rs9264942) and HLA-B*5701 variants. HIV-1 viral load, as well as CD4+ T cell count at care-entry and nadir, were compared across alleles, genotypes and haplotypes. Results HLA-C -35 C/C genotype was found in 17.6% patients, C/T genotype in 48.1%, and T/T genotype in 34.3% patients. HLA-B*5701 variant was present in 5.8% of studied population. HIV plasma viremia in the group with C allele was significantly lower (p=0.0002) compared to T/T group [mean:4.66 log (SD:1.03) vs. 5.07 (SD:0.85) log HIV-RNA copies/ml, respectively], while CD4+ T cell count at baseline was notably higher among C allele carriers compared to T/T homozygotes [median: 318 (IQR:127-537) cells/mu l vs. median: 203 (IQR:55-410) cells/mu l, respectively] (p=0.0007). Moreover, CD4+ T cell nadir among patients with C allele [median: 205 (IQR:83.5-390) cells/mu l] was significantly higher compared to T/T group [median: 133 (IQR:46-328) cells/mu l] (p=0.006). Among cases with HLA-B*5701 allele, significantly lower pretreatment viremia and higher baseline CD4+ T cell count were found (mean: 4.08 [SD:1.2] vs. mean: 4.84 [SD:0.97] log HIV-RNA copies/ml, p=0.003 and 431 vs. 270 cells/mu l, p=0.04, respectively) compared to HLA-B*5701 negative individuals. The lowest viremia (mean: 3.85 log [SD:1.3]) HIV-RNA copies/ml and the highest baseline and nadir CD4+ T cell [median: 476 (IQR:304-682) vs. median: 361 (IQR:205-574) cells/mu l, respectively) were found in individuals with HLA-B*5701(+)/HLA-C -35 C/C haplotype. Conclusions HLA-C -35 C and HLA-B*5701 allele exert a favorable effect on the immunological (higher baseline and nadir CD4+ T cell count) and virologic (lower pretreatment HIV viral load) variables. This protective effect is additive for the compound HLA-B*5701(+)/HLA-C -35 C/C haplotype.	[Leszczyszyn-Pynka, Magdalena; Aksak-Was, Bogusz; Urbanska, Anna; Parczewski, Milosz] Pomeranian Med Univ, Dept Infect Trop Dis & Acquired Immunodeficiency, Szczecin, Poland	Pomeranian Medical University	Leszczyszyn-Pynka, M (corresponding author), Pomeranian Med Univ, Dept Infect Trop Dis & Acquired Immunodeficiency, Szczecin, Poland.	mlpynka@interia.pl	Parczewski, Milosz/I-1869-2014; Aksak-Wąs, Bogusz/ABF-7068-2021; Aksak-Wąs, Bogusz/AFK-2240-2022	Parczewski, Milosz/0000-0003-1869-1084; Aksak-Wąs, Bogusz/0000-0003-2092-3737; Aksak-Wąs, Bogusz/0000-0003-2092-3737	Polish Ministry of Science and Higher Education [NCN NN 402613840]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was financially supported by the Polish Ministry of Science and Higher Education grant number NCN NN 402613840. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2009, J INTERN MED, V265, P29, DOI 10.1111/j.1365-2796.2008.02045.x; Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Ballana E, 2012, IMMUNOBIOLOGY, V217, P889, DOI 10.1016/j.imbio.2011.12.012; Blais ME, 2012, J IMMUNOL, V188, P4663, DOI 10.4049/jimmunol.1103472; Blais ME, 2011, IMMUNOLOGY, V133, P1, DOI 10.1111/j.1365-2567.2011.03422.x; Carrington M, 2012, ANNU REV MED, V63, P131, DOI 10.1146/annurev-med-062909-130018; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; Catano G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003636; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; Corrah TW, 2011, J VIROL, V85, P3367, DOI 10.1128/JVI.02276-10; Elahi S, 2012, INT J BIOCHEM CELL B, V44, P1361, DOI 10.1016/j.biocel.2012.05.003; Falk CS, 1997, IMMUNOL RES, V16, P203, DOI 10.1007/BF02786363; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Honda K, 2011, EUR J IMMUNOL, V41, P97, DOI 10.1002/eji.201040841; Jose MS, 2013, AIDS, V27, P2587, DOI 10.1097/01.aids.0000432613.95455.71; Kamya P, 2011, J VIROL, V85, P5949, DOI 10.1128/JVI.02652-10; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kloverpris HN, 2012, J VIROL, V86, P11493, DOI 10.1128/JVI.01020-12; Kloverpris HN, 2012, J VIROL, V86, P919, DOI 10.1128/JVI.06150-11; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Kulpa DA, 2011, IMMUNOLOGY, V134, P116, DOI 10.1111/j.1365-2567.2011.03474.x; Majorczyk E, 2014, HUM IMMUNOL, V75, P504, DOI 10.1016/j.humimm.2014.04.003; Matthews PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047799; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Shrestha S, 2009, AIDS, V23, P673, DOI 10.1097/QAD.0b013e328325d414; Suppiah V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001092; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Tiemessen CT, 2011, JAIDS-J ACQ IMM DEF, V57, P181, DOI 10.1097/QAI.0b013e3182174a76; Vaidya SA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-139; van Manen D, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-70	31	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0127867	10.1371/journal.pone.0127867	http://dx.doi.org/10.1371/journal.pone.0127867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068923	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900014
J	Selamat, W; Tay, PLF; Baskaran, Y; Manser, E				Selamat, Widyawilis; Tay, Pei-Ling Felicia; Baskaran, Yohendran; Manser, Ed			The Cdc42 Effector Kinase PAK4 Localizes to Cell-Cell Junctions and Contributes to Establishing Cell Polarity	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; BETA-CATENIN; MEDIATED PHOSPHORYLATION; P21-ACTIVATED KINASES; BINDING PARTNER; TIGHT JUNCTIONS; PROTEIN; ACTIN; MIGRATION; COMPLEX	The serine/threonine kinase PAK4 is a Cdc42 effector whose role is not well understood; overexpression of PAK4 has been associated with some cancers, and there are reports that correlate kinase level with increased cell migration in vitro. Here we report that PAK4 is primarily associated with cell-cell junctions in all the cell lines we tested, and fails to accumulate at focal adhesions or at the leading edge of migrating cells. In U2OS osteosarcoma and MCF-7 breast cancer cell lines, PAK4 depletion did not affect collective cell migration, but affected cell polarization. By contrast, Cdc42 depletion (as reported by many studies) caused a strong defect in junctional assembly in multiple cells lines. We also report that the depletion of PAK4 protein or treatment of cells with the PAK4 inhibitor PF-3758309 can lead to defects in centrosome reorientation (polarization) after cell monolayer wounding. These experiments are consistent with PAK4 forming part of a conserved cell-cell junctional polarity Cdc42 complex. We also confirm beta-catenin as a target for PAK4 in these cells. Treatment of cells with PF-3758309 caused inhibition of beta-catenin Ser-675 phosphorylation, which is located predominantly at cell-cell junctions.	[Selamat, Widyawilis; Tay, Pei-Ling Felicia; Baskaran, Yohendran; Manser, Ed] ASTAR, Inst Mol & Cell Biol, Small G Prot Signaling & Kinases sGSK Grp, Inst Mol & Cell Biol, Singapore, Singapore; [Manser, Ed] ASTAR, Inst Med Biol, Singapore, Singapore; [Manser, Ed] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore	Manser, E (corresponding author), ASTAR, Inst Mol & Cell Biol, Small G Prot Signaling & Kinases sGSK Grp, Inst Mol & Cell Biol, Singapore, Singapore.	ed.manser@imb.a-star.edu.sg	Manser, Edward/ABD-2301-2020	Baskaran, Yohendran/0000-0001-7021-3042	GSK-IMCB Research fund	GSK-IMCB Research fund	This work was supported by the GSK-IMCB Research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Ahmed T, 2008, CELL SIGNAL, V20, P1320, DOI 10.1016/j.cellsig.2008.02.021; Ang SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013064; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Arias-Romero LE, 2013, CANCER RES, V73, P3671, DOI 10.1158/0008-5472.CAN-12-4453; Barth AIM, 2008, SEMIN CELL DEV BIOL, V19, P245, DOI 10.1016/j.semcdb.2008.02.003; Baskaran Y, 2012, EMBO REP, V13, P653, DOI 10.1038/embor.2012.75; Bastea LI, 2013, BIOCHEM J, V455, P251, DOI 10.1042/BJ20130281; Bidlingmaier S, 2004, J CELL BIOL, V164, P207, DOI 10.1083/jcb.200307065; Bompard G, 2010, J CELL BIOL, V190, P807, DOI 10.1083/jcb.200912056; Callow MG, 2005, J CELL SCI, V118, P1861, DOI 10.1242/jcs.02313; Callow MG, 2002, J BIOL CHEM, V277, P550, DOI 10.1074/jbc.M105732200; Cau JL, 2005, J CELL SCI, V118, P2579, DOI 10.1242/jcs.02385; Chatterjee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034343; Chen SL, 2008, CANCER BIOL THER, V7, P1793, DOI 10.4161/cbt.7.11.6840; Chilov D, 2011, DEV BIOL, V357, P259, DOI 10.1016/j.ydbio.2011.06.029; Czuchra A, 2005, MOL BIOL CELL, V16, P4473, DOI 10.1091/mbc.E05-01-0061; Dart AE, 2013, EUR J CELL BIOL, V92, P129, DOI 10.1016/j.ejcb.2013.03.002; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; DRUBIN DG, 1991, CELL, V65, P1093, DOI 10.1016/0092-8674(91)90001-F; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Erasmus J, 2010, BIOL CELL, V102, P13, DOI 10.1042/BC20090048; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Faure S, 2005, DEV BIOL, V277, P472, DOI 10.1016/j.ydbio.2004.10.005; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Fukuhara A, 2003, J BIOL CHEM, V278, P51885, DOI 10.1074/jbc.M308015200; Gao L, 2002, CURR BIOL, V12, P221, DOI 10.1016/S0960-9822(01)00663-7; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Ha BH, 2012, P NATL ACAD SCI USA, V109, P16107, DOI 10.1073/pnas.1214447109; Haddad E, 2001, BLOOD, V97, P33, DOI 10.1182/blood.V97.1.33; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Huo L, 2011, EMBO J, V30, P665, DOI 10.1038/emboj.2010.353; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Ivanov AI, 2005, BIOESSAYS, V27, P356, DOI 10.1002/bies.20203; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Jin D, 2015, BIOCH J; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johansson AS, 2000, J CELL SCI, V113, P3267; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Koh W, 2009, J CELL SCI, V122, P1812, DOI 10.1242/jcs.045799; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Law SHW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100268; Li XD, 2010, INT J BIOCHEM CELL B, V42, P70, DOI 10.1016/j.biocel.2009.09.008; Li Y, 2012, BBA-MOL CELL RES, V1823, P465, DOI 10.1016/j.bbamcr.2011.11.013; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Liu YY, 2008, MOL CANCER RES, V6, P1215, DOI 10.1158/1541-7786.MCR-08-0087; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Melzig J, 1998, CURR BIOL, V8, P1223, DOI 10.1016/S0960-9822(07)00514-3; Menzel N, 2008, BIOCHEM J, V416, P231, DOI 10.1042/BJ20080465; Mitsushima M, 2009, MOL CELL BIOL, V29, P2816, DOI 10.1128/MCB.01713-08; Murray PJ, 2010, BIOPHYS J, V99, P716, DOI 10.1016/j.bpj.2010.05.016; Muthuswamy SK, 2012, ANNU REV CELL DEV BI, V28, P599, DOI 10.1146/annurev-cellbio-092910-154244; Nekrasova T, 2008, DEV BIOL, V322, P95, DOI 10.1016/j.ydbio.2008.07.006; Nekrasova T, 2012, TRANSGENIC RES, V21, P797, DOI 10.1007/s11248-011-9578-7; Ng YW, 2010, STRUCTURE, V18, P879, DOI 10.1016/j.str.2010.04.011; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Noritake J, 2004, MOL BIOL CELL, V15, P1065, DOI 10.1091/mbc.E03-08-0582; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Ozaki C, 2010, CELL STRUCT FUNCT, V35, P81, DOI 10.1247/csf.10009; Paliouras GN, 2009, MOL CELL BIOL, V29, P3018, DOI 10.1128/MCB.01286-08; Pandey A, 2002, ONCOGENE, V21, P3939, DOI 10.1038/sj.onc.1205478; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Qu J, 2003, MOL CELL BIOL, V23, P7122, DOI 10.1128/MCB.23.20.7122-7133.2003; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; Ryu BJ, 2014, MOL CELL BIOCHEM, V389, P69, DOI 10.1007/s11010-013-1928-8; Schneeberger D, 2003, DEVELOPMENT, V130, P427, DOI 10.1242/dev.00248; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Siu MKY, 2010, P NATL ACAD SCI USA, V107, P18622, DOI 10.1073/pnas.0907481107; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Tzima E, 2003, J BIOL CHEM, V278, P31020, DOI 10.1074/jbc.M301179200; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Wallace SW, 2010, MOL BIOL CELL, V21, P2996, DOI 10.1091/mbc.E10-05-0429; Welchman DP, 2007, DEV BIOL, V305, P347, DOI 10.1016/j.ydbio.2007.02.022; Wells CM, 2010, J CELL SCI, V123, P1663, DOI 10.1242/jcs.055707; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wells CM, 2002, J CELL SCI, V115, P3947, DOI 10.1242/jcs.00080; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Wu SK, 2014, NAT CELL BIOL, V16, P167, DOI 10.1038/ncb2900; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x; Zhang HQ, 2002, J CELL BIOL, V158, P1287, DOI 10.1083/jcb.200207008; Zhang HJ, 2011, CARCINOGENESIS, V32, P765, DOI 10.1093/carcin/bgr033; ZHANG SM, 1995, SEPAR SCI TECHNOL, V30, P1, DOI 10.1080/01496399508012211; Zhao Zhuo-Shen, 2012, Cell Logist, V2, P59; Zhu G, 2012, ONCOGENE, V31, P1001, DOI 10.1038/onc.2011.294	99	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129634	10.1371/journal.pone.0129634	http://dx.doi.org/10.1371/journal.pone.0129634			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068882	gold, Green Published, Green Submitted			2022-12-27	WOS:000356100900065
J	Butler, EE; Ward, R; Ramsey, R				Butler, Emily E.; Ward, Robert; Ramsey, Richard			Investigating the Relationship between Stable Personality Characteristics and Automatic Imitation	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; MIRROR-NEURON SYSTEM; SEX-DIFFERENCES; REGRESSION-ANALYSES; SOCIAL-INTERACTION; STATISTICAL POWER; EMOTIONAL EMPATHY; MIMICRY REACTIONS; 5-FACTOR MODEL; SCHIZOPHRENIA	Automatic imitation is a cornerstone of nonverbal communication that fosters rapport between interaction partners. Recent research has suggested that stable dimensions of personality are antecedents to automatic imitation, but the empirical evidence linking imitation with personality traits is restricted to a few studies with modest sample sizes. Additionally, atypical imitation has been documented in autism spectrum disorders and schizophrenia, but the mechanisms underpinning these behavioural profiles remain unclear. Using a larger sample than prior studies (N=243), the current study tested whether performance on a computer-based automatic imitation task could be predicted by personality traits associated with social behaviour (extraversion and agreeableness) and with disorders of social cognition (autistic-like and schizotypal traits). Further personality traits (narcissism and empathy) were assessed in a subsample of participants (N=57). Multiple regression analyses showed that personality measures did not predict automatic imitation. In addition, using a similar analytical approach to prior studies, no differences in imitation performance emerged when only the highest and lowest 20 participants on each trait variable were compared. These data weaken support for the view that stable personality traits are antecedents to automatic imitation and that neural mechanisms thought to support automatic imitation, such as the mirror neuron system, are dysfunctional in autism spectrum disorders or schizophrenia. In sum, the impact that personality variables have on automatic imitation is less universal than initial reports suggest.	[Butler, Emily E.; Ward, Robert; Ramsey, Richard] Bangor Univ, Sch Psychol, Wales Inst Cognit Neurosci, Bangor, Gwynedd, Wales	Bangor University	Butler, EE (corresponding author), Bangor Univ, Sch Psychol, Wales Inst Cognit Neurosci, Bangor, Gwynedd, Wales.	e.butler@bangor.ac.uk; r.ramsey@bangor.ac.uk		Ramsey, Richard/0000-0002-0329-2112	Economic and Social Research Council [ES/K001884/1]; ESRC [ES/K001884/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by a grant from the Economic and Social Research Council (grant number: ES/K001884/1 to RR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2013, NATURE, V497, P16, DOI 10.1038/497016a; Allison C, 2012, J AM ACAD CHILD PSY, V51, P202, DOI 10.1016/j.jaac.2011.11.003; Ames DR, 2006, J RES PERS, V40, P440, DOI 10.1016/j.jrp.2005.03.002; Ashton MC, 1998, EVOL HUM BEHAV, V19, P243, DOI 10.1016/S1090-5138(98)00009-9; Bayliss AP, 2005, Q J EXP PSYCHOL-A, V58, P631, DOI 10.1080/02724980443000124; Bird G, 2007, P ROY SOC B-BIOL SCI, V274, P3027, DOI 10.1098/rspb.2007.1019; Blair IV, 2004, PSYCHOL SCI, V15, P674, DOI 10.1111/j.0956-7976.2004.00739.x; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brass M, 2005, TRENDS COGN SCI, V9, P489, DOI 10.1016/j.tics.2005.08.007; Buttelmann D, 2014, PSYCHOL SCI, V25, P921, DOI 10.1177/0956797613516802; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Catmur C, 2011, J EXP PSYCHOL HUMAN, V37, P409, DOI 10.1037/a0019325; Chartrand TL, 2013, ANNU REV PSYCHOL, V64, P285, DOI 10.1146/annurev-psych-113011-143754; Chartrand TL, 2009, ADV EXP SOC PSYCHOL, V41, P219, DOI 10.1016/S0065-2601(08)00405-X; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Clayson PE, 2011, BIOL PSYCHOL, V87, P282, DOI 10.1016/j.biopsycho.2011.03.011; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cook J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00175; Cook J, 2011, EXP BRAIN RES, V211, P601, DOI 10.1007/s00221-011-2584-4; Cook JL, 2012, J AUTISM DEV DISORD, V42, P1045, DOI 10.1007/s10803-011-1341-7; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; del Barrio V, 2004, SOC BEHAV PERSONAL, V32, P677; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; Donnellan MB, 2006, PSYCHOL ASSESSMENT, V18, P192, DOI 10.1037/1040-3590.18.2.192; Durrett C, 2005, PSYCHOL ASSESSMENT, V17, P359, DOI 10.1037/1040-3590.17.3.359; Enticott PG, 2008, SCHIZOPHR RES, V102, P116, DOI 10.1016/j.schres.2008.04.001; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7; Hamilton AFD, 2013, DEV COGN NEUROS-NETH, V3, P91, DOI 10.1016/j.dcn.2012.09.008; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Hogeveen J, 2013, EXP BRAIN RES, V224, P613, DOI 10.1007/s00221-012-3339-6; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Kraemer HC, 2004, INT J METH PSYCH RES, V13, P141, DOI 10.1002/mpr.170; Leighton J, 2010, J EXP SOC PSYCHOL, V46, P905, DOI 10.1016/j.jesp.2010.07.001; LePine JA, 2001, J APPL PSYCHOL, V86, P326, DOI 10.1037//0021-9010.86.2.326; Lietz C. A., 2011, J SOC SOC WORK RES, V2, P104, DOI DOI 10.5243/JSSWR.2011.6; Lim BC, 2004, J APPL PSYCHOL, V89, P610, DOI 10.1037/0021-9010.89.4.610; Maxwell SE, 2008, ANNU REV PSYCHOL, V59, P537, DOI 10.1146/annurev.psych.59.103006.093735; McNamee R, 2005, OCCUP ENVIRON MED, V62, P500, DOI 10.1136/oem.2002.001115; Morf CC, 2001, PSYCHOL INQ, V12, P177, DOI 10.1207/S15327965PLI1204_1; Nelson MT, 2013, NEUROSCI BIOBEHAV R, V37, P317, DOI 10.1016/j.neubiorev.2013.01.004; Oberman LM, 2007, PSYCHOL BULL, V133, P310, DOI 10.1037/0033-2909.133.2.310; Obhi SS, 2014, J EXP PSYCHOL HUMAN, V40, P920, DOI 10.1037/a0034056; Park S, 2008, SCHIZOPHRENIA BULL, V34, P698, DOI 10.1093/schbul/sbn048; Pashler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042510; Press C, 2010, NEUROPSYCHOLOGIA, V48, P3291, DOI 10.1016/j.neuropsychologia.2010.07.012; Raine A, 1995, J PERS DISORD, V9, P346, DOI 10.1521/pedi.1995.9.4.346; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rogers SJ, 2003, J CHILD PSYCHOL PSYC, V44, P763, DOI 10.1111/1469-7610.00162; Rubia K, 2010, NEUROIMAGE, V51, P817, DOI 10.1016/j.neuroimage.2010.02.058; Schmitt DP, 2008, J PERS SOC PSYCHOL, V94, P168, DOI 10.1037/0022-3514.94.1.168; Shanks DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056515; SHAVER PR, 1992, PERS SOC PSYCHOL B, V18, P536, DOI 10.1177/0146167292185003; Shutts K, 2010, DEVELOPMENTAL SCI, V13, P599, DOI 10.1111/j.1467-7687.2009.00913.x; Sonnby-Borgstrom M, 2002, SCAND J PSYCHOL, V43, P433, DOI 10.1111/1467-9450.00312; Sonnby-Borgstrom M, 2003, J NONVERBAL BEHAV, V27, P3, DOI 10.1023/A:1023608506243; Southgate V, 2008, TRENDS COGN SCI, V12, P225, DOI 10.1016/j.tics.2008.03.005; Stel M, 2010, BRIT J PSYCHOL, V101, P311, DOI 10.1348/000712609X465424; Thakkar KN, 2014, AM J PSYCHIAT, V171, P539, DOI 10.1176/appi.ajp.2013.13040498; Tomasello Michael, 1996, P319, DOI 10.1016/B978-012273965-1/50016-9; Vik PW, 2013, REGRESSION ANOVA AND; Wai M, 2012, PERS INDIV DIFFER, V52, P794, DOI 10.1016/j.paid.2012.01.008; Wang Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00153; Wang Y, 2013, CURR TOP NUTRACEUT R, V11, P1; Williams JHG, 2004, J AUTISM DEV DISORD, V34, P285, DOI 10.1023/B:JADD.0000029551.56735.3a; Williams JHG, 2001, NEUROSCI BIOBEHAV R, V25, P287, DOI 10.1016/S0149-7634(01)00014-8	66	29	29	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129651	10.1371/journal.pone.0129651	http://dx.doi.org/10.1371/journal.pone.0129651			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9EB	26079137	gold, Green Published			2022-12-27	WOS:000356542300029
J	Lu, CF; Liu, YC; Yang, YR; Wu, YT; Wang, RY				Lu, Chia-Feng; Liu, Yan-Ci; Yang, Yea-Ru; Wu, Yu-Te; Wang, Ray-Yau			Maintaining Gait Performance by Cortical Activation during Dual-Task Interference: A Functional Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							COGNITIVE-MOTOR INTERFERENCE; GAITRITE(R) WALKWAY SYSTEM; STRIDE-TIME VARIABILITY; AGE-RELATED DIFFERENCES; CEREBRAL OXYGENATION; EXECUTIVE FUNCTION; BRAIN ACTIVATION; PARKINSONS-DISEASE; MOTION ARTIFACTS; ELDERLY FALLERS	In daily life, mobility requires walking while performing a cognitive or upper-extremity motor task. Although previous studies have evaluated the effects of dual tasks on gait performance, few studies have evaluated cortical activation and its association with gait disturbance during dual tasks. In this study, we simultaneously assessed gait performance and cerebral oxygenation in the bilateral prefrontal cortices (PFC), premotor cortices (PMC), and supplemental motor areas (SMA), using functional near-infrared spectroscopy, in 17 young adults performing dual tasks. Each participant was evaluated while performing normal-pace walking (NW), walking while performing a cognitive task (WCT), and walking while performing a motor task (WMT). Our results indicated that the left PFC exhibited the strongest and most sustained activation during WCT, and that NW and WMT were associated with minor increases in oxygenation levels during their initial phases. We observed increased activation in channels in the SMA and PMC during WCT and WMT. Gait data indicated that WCT and WMT both caused reductions in walking speed, but these reductions resulted from differing alterations in gait properties. WCT was associated with significant changes in cadence, stride time, and stride length, whereas WMT was associated with reductions in stride length only. During dual-task activities, increased activation of the PMC and SMA correlated with declines in gait performance, indicating a control mechanism for maintaining gait performance during dual tasks. Thus, the regulatory effects of cortical activation on gait behavior enable a second task to be performed while walking.	[Lu, Chia-Feng] Taipei Med Univ, Coll Med, Translat Imaging Res Ctr, Taipei, Taiwan; [Lu, Chia-Feng] Taipei Med Univ, Sch Med, Dept Radiol, Taipei, Taiwan; [Lu, Chia-Feng; Liu, Yan-Ci; Yang, Yea-Ru; Wang, Ray-Yau] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan; [Yang, Yea-Ru] Taipei City Hosp, Taipei, Taiwan; [Wu, Yu-Te] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Wu, Yu-Te] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Wu, Yu-Te] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan	Taipei Medical University; Taipei Medical University; National Yang Ming Chiao Tung University; Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Wu, YT (corresponding author), Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan.	ytwu@ym.edu.tw; rywang@ym.edu.tw			National Science Council [NSC102-2221-E-010-013-MY3, NSC102-2314-B-010-059, MOST103-2314-B-01-002-MY3]; Taipei City Hospital [102TPECH10]; National Science Council support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan [NSC 101-2911-I-008-001]; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan	National Science Council(Ministry of Science and Technology, Taiwan); Taipei City Hospital; National Science Council support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	The study was funded in part by the National Science Council (NSC102-2221-E-010-013-MY3, NSC102-2314-B-010-059, and MOST103-2314-B-01-002-MY3), the Taipei City Hospital (102TPECH10), the National Science Council support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 101-2911-I-008-001) and Brain Research Center, National Yang-Ming University and a grant from Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; ARMSTRONG DM, 1988, J PHYSIOL-LONDON, V405, P1, DOI 10.1113/jphysiol.1988.sp017319; Atsumori H, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3462996; Beauchet Olivier, 2005, J Neuroeng Rehabil, V2, P26, DOI 10.1186/1743-0003-2-26; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beurskens R, 2014, INT J PSYCHOPHYSIOL, V92, P122, DOI 10.1016/j.ijpsycho.2014.03.005; Beurskens R, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/131608; Bilney B, 2003, GAIT POSTURE, V17, P68, DOI 10.1016/S0966-6362(02)00053-X; Boas DA, 2001, NEUROIMAGE, V13, P76, DOI 10.1006/nimg.2000.0674; Bock O, 2011, GAIT POSTURE, V33, P190, DOI 10.1016/j.gaitpost.2010.10.095; Bond JM, 2000, ARCH PHYS MED REHAB, V81, P110, DOI 10.1016/S0003-9993(00)90230-2; Brigadoi S, 2014, NEUROIMAGE, V85, P181, DOI 10.1016/j.neuroimage.2013.04.082; Camicioli R, 1997, JOURNAL OF GERIATRIC, V11, P181; Camicioli R, 2006, J NEUROL SCI, V248, P205, DOI 10.1016/j.jns.2006.05.013; Castermans T, 2014, NEUROSCI LETT, V561, P166, DOI 10.1016/j.neulet.2013.12.059; Chetverikov D, 2002, 2002 PROCEEDINGS 16T; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; Cockburn J, 2003, CLIN REHABIL, V17, P167, DOI 10.1191/0269215503cr597oa; Collette F, 2006, NEUROSCIENCE, V139, P209, DOI 10.1016/j.neuroscience.2005.05.035; Collette F, 2005, HUM BRAIN MAPP, V25, P409, DOI 10.1002/hbm.20118; Cooper RJ, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00147; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; Coppin AK, 2006, AGE AGEING, V35, P619, DOI 10.1093/ageing/afl107; deTalhouet H, 1996, PHYSIOL MEAS, V17, P81, DOI 10.1088/0967-3334/17/2/003; Dubost V, 2006, HUM MOVEMENT SCI, V25, P372, DOI 10.1016/j.humov.2006.03.004; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; Franceschini MA, 2006, BIOMEDO, V11; Gagnon Roy E, 2002, J Clin Monit Comput, V17, P385, DOI 10.1023/A:1026274124837; Galletly R, 2005, AUST J PHYSIOTHER, V51, P175, DOI 10.1016/S0004-9514(05)70024-6; Grassi B, 1999, J APPL PHYSIOL, V87, P348, DOI 10.1152/jappl.1999.87.1.348; Grubhofer G, 1999, ACTA ANAESTH SCAND, V43, P470, DOI 10.1034/j.1399-6576.1999.430417.x; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Harada T, 2009, EXP BRAIN RES, V193, P445, DOI 10.1007/s00221-008-1643-y; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hausdorff JM, 2005, EXP BRAIN RES, V164, P541, DOI 10.1007/s00221-005-2280-3; Hodges PW, 2001, EXP BRAIN RES, V141, P261, DOI 10.1007/s002210100873; Hollman JH, 2007, GAIT POSTURE, V26, P113, DOI 10.1016/j.gaitpost.2006.08.005; Holtzer R, 2011, J GERONTOL A-BIOL, V66, P879, DOI 10.1093/gerona/glr068; HOSHI Y, 1993, BRAIN RES, V603, P215, DOI 10.1016/0006-8993(93)91240-S; Houglum PA, 2011, BRUNNSTROMS CLINICAL; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Immisch I, 2001, NEUROIMAGE, V14, P674, DOI 10.1006/nimg.2001.0856; Kleinschmidt A, 1996, J CEREBR BLOOD F MET, V16, P817, DOI 10.1097/00004647-199609000-00006; Kocsis L, 2006, PHYS MED BIOL, V51, pN91, DOI 10.1088/0031-9155/51/5/N02; Kurz MJ, 2012, NEUROIMAGE, V59, P1602, DOI 10.1016/j.neuroimage.2011.08.084; Lajoie Y, 1996, EXP AGING RES, V22, P185, DOI 10.1080/03610739608254006; Lassnigg A, 1999, J CARDIOTHOR VASC AN, V13, P544, DOI 10.1016/S1053-0770(99)90005-8; Lee KM, 2000, ANN NEUROL, V48, P657, DOI 10.1002/1531-8249(200010)48:4<657::AID-ANA13>3.3.CO;2-B; Leff DR, 2011, NEUROIMAGE, V54, P2922, DOI 10.1016/j.neuroimage.2010.10.058; Li KZH, 2001, PSYCHOL SCI, V12, P230, DOI 10.1111/1467-9280.00341; Liao LD, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-38; Lindenberger U, 2000, PSYCHOL AGING, V15, P417, DOI 10.1037//0882-7974.15.3.417; Lovden M, 2008, J GERONTOL B-PSYCHOL, V63, pP121; Meester D, 2014, FRONTIERS IN HUMAN N, P8; Mehagnoul-Schipper DJ, 2002, HUM BRAIN MAPP, V16, P14, DOI 10.1002/hbm.10026; Menz HB, 2004, GAIT POSTURE, V20, P20, DOI 10.1016/S0966-6362(03)00068-7; Mihara M, 2008, NEUROIMAGE, V43, P329, DOI 10.1016/j.neuroimage.2008.07.029; Mihara M, 2007, NEUROIMAGE, V37, P1338, DOI 10.1016/j.neuroimage.2007.06.014; Mirelman A, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-85; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Miyai I, 2003, STROKE, V34, P2866, DOI 10.1161/01.STR.0000100166.81077.8A; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; Nagdyman N, 2008, PEDIATR ANESTH, V18, P160, DOI 10.1111/j.1460-9592.2007.02365.x; O'Shea S, 2002, PHYS THER, V82, P888, DOI 10.1093/ptj/82.9.888; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Patel P, 2014, NEUROSCIENCE, V260, P140, DOI 10.1016/j.neuroscience.2013.12.016; Pettersson AF, 2007, J GERIATR PSYCH NEUR, V20, P58, DOI 10.1177/0891988706293528; Pfurtscheller G, 2010, INT J PSYCHOPHYSIOL, V76, P186, DOI 10.1016/j.ijpsycho.2010.03.013; Piper SK, 2014, NEUROIMAGE, V85, P64, DOI 10.1016/j.neuroimage.2013.06.062; Rochester L, 2005, ARCH PHYS MED REHAB, V86, P999, DOI 10.1016/j.apmr.2004.10.040; Ruthruff E, 2001, PSYCHON B REV, V8, P73, DOI 10.3758/BF03196141; Schmidt RA, 1988, MOTOR CONTROL AND LE; Schmitz CH, 2005, APPL OPTICS, V44, P2140, DOI 10.1364/AO.44.002140; Schneider P, 2011, ROFO-FORTSCHR RONTG, V183, P956, DOI 10.1055/s-0031-1281726; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Seitz RJ, 1998, ARCH NEUROL-CHICAGO, V55, P1081, DOI 10.1001/archneur.55.8.1081; Serrien DJ, 2002, NEUROSCI LETT, V328, P89, DOI 10.1016/S0304-3940(02)00499-8; Sparrow WA, 2002, HUM MOVEMENT SCI, V21, P961, DOI 10.1016/S0167-9457(02)00154-9; Sparrow WA, 2006, MOTOR CONTROL, V10, P201, DOI 10.1123/mcj.10.3.201; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Tian F, 2014, BIOMEDICAL OPTICS; Tombu M, 2003, J EXP PSYCHOL HUMAN, V29, P3, DOI 10.1037/0096-1523.29.1.3; Toulotte C, 2006, DISABIL REHABIL, V28, P125, DOI 10.1080/09638280500163653; VIALLET F, 1992, EXP BRAIN RES, V88, P674; Wilcox T, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852551; Wolf M, 2002, NEUROIMAGE, V16, P704, DOI 10.1006/nimg.2002.1128; Wu T, 2010, BRAIN; Wylie GR, 2009, NEUROIMAGE, V47, P473, DOI 10.1016/j.neuroimage.2009.04.056; Yennu AS, 2012, BIOMEDICAL OPTICS; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; Yogev G, 2007, EXP BRAIN RES, V177, P336, DOI 10.1007/s00221-006-0676-3; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Zago L, 2001, NEUROIMAGE, V13, P314, DOI 10.1006/nimg.2000.0697; Zhang YH, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852552	96	42	43	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129390	10.1371/journal.pone.0129390	http://dx.doi.org/10.1371/journal.pone.0129390			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9EB	26079605	Green Submitted, gold, Green Published			2022-12-27	WOS:000356542300022
J	Ekelund, F; Harder, CB; Knudsen, BE; Aamand, J				Ekelund, Flemming; Harder, Christoffer Bugge; Knudsen, Berith Elkaer; Aamand, Jens			Aminobacter MSH1-Mineralisation of BAM in Sand-Filters Depends on Biological Diversity	PLOS ONE			English	Article							2,6-DICHLOROBENZAMIDE BAM; HERBICIDE DICHLOBENIL; MICROBIAL DIVERSITY; COMMUNITY STRUCTURE; AGRICULTURAL SOIL; BATCH CULTURE; STERILE SOIL; DEGRADATION; MINERALIZATION; PROTOZOA	BAM (2,6-dichlorobenzamide) is a metabolite of the pesticide dichlobenil. Naturally occurring bacteria that can utilize BAM are rare. Often the compound cannot be degraded before it reaches the groundwater and therefore it poses a serious threat to drinking water supplies. The bacterial strain Aminobacter MSH1 is a BAM degrader and therefore a potential candidate to be amended to sand filters in waterworks to remediate BAM polluted drinking water. A common problem in bioremediation is that bacteria artificially introduced into new diverse environments often thrive poorly, which is even more unfortunate because biologically diverse environments may ensure a more complete decomposition. To test the bioaugmentative potential of MSH1, we used a serial dilution approach to construct microcosms with different biological diversity. Subsequently, we amended Aminobacter MSH1 to the microcosms in two final concentrations; i.e. 10(5) cells mL(-1) and 10(7) cells mL(-1). We anticipated that BAM degradation would be most efficient at " intermediate diversities" as low diversity would counteract decomposition because of incomplete decomposition of metabolites and high diversity would be detrimental because of eradication of Aminobacter MSH1. This hypothesis was only confirmed when Aminobacter MSH1 was amended in concentrations of 10(5) cells mL(-1). Our findings suggest that Aminobacter MSH1 is a very promising bioremediator at several diversity levels.	[Ekelund, Flemming; Harder, Christoffer Bugge] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen O, Denmark; [Knudsen, Berith Elkaer; Aamand, Jens] Geol Survey Denmark & Greenland, Dept Geochem, DK-1350 Copenhagen, Denmark	University of Copenhagen; Geological Survey Of Denmark & Greenland	Ekelund, F (corresponding author), Univ Copenhagen, Dept Biol, Univ Pk 15, DK-2100 Copenhagen O, Denmark.	fekelund@bio.ku.dk		Aamand, Jens/0000-0002-4641-639X	Danish Council for Strategic Research [DSF-2104- 08-0012]; Danish Council for Independent Research [DFF-4002-00274]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	All authors received funding from The Danish Council for Strategic Research (ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-strategic-research) (DSF-2104- 08-0012; MIRESOWA).FE received funding from the Danish Council for Independent Research (DFF-4002-00274, ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council- for-independent-research; OP-RICE-ING). No individuals employed or contracted by the funders (other than the named authors) played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CN, 2015, ENVIRON SCI TECHNOL, V49, P839, DOI 10.1021/es5046452; Albers CN, 2014, APPL MICROBIOL BIOT, V98, P957, DOI 10.1007/s00253-013-4942-6; Altenburger A, 2010, SOIL BIOL BIOCHEM, V42, P1636, DOI 10.1016/j.soilbio.2010.05.011; Benner J, 2013, WATER RES, V47, P5955, DOI 10.1016/j.watres.2013.07.015; Clausen L, 2007, J CONTAM HYDROL, V89, P157, DOI 10.1016/j.jconhyd.2006.04.004; Cutler DW, 1923, ANN APPL BIOL, V10, P137, DOI 10.1111/j.1744-7348.1923.tb05660.x; Darby BJ, 2014, OECOLOGIA, V175, P243, DOI 10.1007/s00442-014-2883-0; EKELUND F, 1994, FEMS MICROBIOL REV, V15, P321, DOI 10.1111/j.1574-6976.1994.tb00144.x; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Franklin RB, 2001, APPL ENVIRON MICROB, V67, P702, DOI 10.1128/AEM.67.2.702-712.2001; Fuentes MS, 2014, INT J ENVIRON SCI TE, V11, P1147, DOI 10.1007/s13762-013-0314-0; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Holtze MS, 2008, ENVIRON POLLUT, V154, P155, DOI 10.1016/j.envpol.2007.09.020; Johnke J, 2014, CURR OPIN BIOTECH, V27, P185, DOI 10.1016/j.copbio.2014.02.003; Liu MQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045306; Mattison RG, 2005, MICROBIAL ECOL, V49, P142, DOI 10.1007/s00248-003-0226-5; Pedersen AL, 2011, FEMS MICROBIOL LETT, V316, P16, DOI 10.1111/j.1574-6968.2010.02182.x; Ronn R, 2001, BIOL FERT SOILS, V33, P126, DOI 10.1007/s003740000299; Simonsen A, 2006, ENVIRON POLLUT, V144, P289, DOI 10.1016/j.envpol.2005.11.047; Siripattanakul S, 2009, J APPL MICROBIOL, V106, P986, DOI 10.1111/j.1365-2672.2008.04075.x; Sorensen SR, 2007, APPL ENVIRON MICROB, V73, P399, DOI 10.1128/AEM.01498-06; Sorensen SR, 2003, PEST MANAG SCI, V59, P1118, DOI [10.1002/ps.739, 10.1002/PS.739]; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Tso SF, 2006, MICROB ECOL, V51, P460, DOI 10.1007/s00248-006-9058-4; vanVeen JA, 1997, MICROBIOL MOL BIOL R, V61, P121, DOI 10.1128/.61.2.121-135.1997; Vestergard M, 2011, SOIL BIOL BIOCHEM, V43, P1379, DOI 10.1016/j.soilbio.2011.02.008; Wertz S, 2006, ENVIRON MICROBIOL, V8, P2162, DOI 10.1111/j.1462-2920.2006.01098.x; Yang CY, 2010, BIODEGRADATION, V21, P97, DOI 10.1007/s10532-009-9284-9; Yang WJ, 2014, SOIL BIOL BIOCHEM, V69, P197, DOI 10.1016/j.soilbio.2013.10.030	30	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128838	10.1371/journal.pone.0128838	http://dx.doi.org/10.1371/journal.pone.0128838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076202	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900032
J	Macfarlane, MD; Jakabek, D; Walterfang, M; Vestberg, S; Velakoulis, D; Wilkes, FA; Nilsson, C; van Westen, D; Looi, JCL; Santillo, AF				Macfarlane, Matthew D.; Jakabek, David; Walterfang, Mark; Vestberg, Susanna; Velakoulis, Dennis; Wilkes, Fiona A.; Nilsson, Christer; van Westen, Danielle; Looi, Jeffrey C. L.; Santillo, Alexander Frizell			Striatal Atrophy in the Behavioural Variant of Frontotemporal Dementia: Correlation with Diagnosis, Negative Symptoms and Disease Severity	PLOS ONE			English	Article							CAUDATE-NUCLEUS; BASAL GANGLIA; LOBAR DEGENERATION; RELIABILITY; CIRCUITS; PATTERNS; MRI; CONNECTIVITY; MORPHOLOGY; NETWORKS	Introduction Behavioural variant frontotemporal dementia (bvFTD) is associated with changes in dorsal striatal parts of the basal ganglia (caudate nucleus and putamen), related to dysfunction in the cortico-striato-thalamic circuits which help mediate executive and motor functions. We aimed to determine whether the size and shape of striatal structures correlated with diagnosis of bvFTD, and measures of clinical severity, behaviour and cognition. Materials and Methods Magnetic resonance imaging scans from 28 patients with bvFTD and 26 healthy controls were manually traced using image analysis software (ITK-SNAP). The resulting 3-D objects underwent volumetric analysis and shape analysis, through spherical harmonic description with point distribution models (SPHARM-PDM). Correlations with size and shape were sought with clinical measures in the bvTFD group, including Frontal Behavioural Inventory, Clinical Dementia Rating for bvFTD, Color Word Interference, Hayling part B and Brixton tests, and Trail-Making Test. Results Caudate nuclei and putamina were significantly smaller in the bvFTD group compared to controls (left caudate 16% smaller, partial eta squared 0.173, p=0.003; right caudate 11% smaller, partial eta squared 0.103, p=0.023; left putamen 18% smaller, partial eta squared 0.179, p=0.002; right putamen 12% smaller, partial eta squared 0.081, p=0.045), with global shape deflation in the caudate bilaterally but no localised shape change in putamen. In the bvFTD group, shape deflations on the left, corresponding to afferent connections from dorsolateral prefrontal mediofrontal/anterior cingulate and orbitofrontal cortex, correlated with worsening disease severity. Global shape deflation in the putamen correlated with Frontal Behavioural Inventory scores-higher scoring on negative symptoms was associated with the left putamen, while positive symptoms were associated with the right. Other cognitive tests had poor completion rates. Conclusion Behavioural symptoms and severity of bvFTD are correlated with abnormalities in striatal size and shape. This adds to the promise of imaging the striatum as a biomarker in this disease.	[Macfarlane, Matthew D.] Illawarra Shoalhaven Local Hlth Dist, Wollongong, NSW, Australia; [Macfarlane, Matthew D.; Jakabek, David] Univ Wollongong, Grad Sch Med, Wollongong, NSW, Australia; [Walterfang, Mark; Velakoulis, Dennis] Royal Melbourne Hosp, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia; [Walterfang, Mark; Velakoulis, Dennis] Univ Melbourne, Melbourne, Vic, Australia; [Vestberg, Susanna] Lund Univ, Dept Psychol, Lund, Sweden; [Wilkes, Fiona A.] Australian Natl Univ, Sch Med4, Sch Clin Med, Res Ctr Neurosci Ageing,Acad Unit Psychiat & Addi, Canberra, ACT, Australia; [Nilsson, Christer; Santillo, Alexander Frizell] Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Lund, Sweden; [van Westen, Danielle] Skane Univ Hosp, Ctr Med Imaging & Physiol, Lund, Sweden; [van Westen, Danielle] Lund Univ, Dept Clin Sci, Diagnost Radiol, Lund, Sweden; [Santillo, Alexander Frizell] Lund Univ, Dept Clin Sci, Geriatr Psychiat Unit, Lund, Sweden	University of Wollongong; Royal Melbourne Hospital; University of Melbourne; Lund University; Australian National University; Lund University; Lund University; Skane University Hospital; Lund University; Lund University	Santillo, AF (corresponding author), Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Lund, Sweden.	alexander.santillo@med.lu.se	Walterfang, Mark/H-4930-2011	Walterfang, Mark/0000-0002-1389-3691; Looi, Jeffrey/0000-0003-3351-6911; van Westen, Danielle/0000-0001-8649-9874; Santillo, Alexander/0000-0001-9717-0820	Swedish Alzheimer foundation; Thureus foundation	Swedish Alzheimer foundation; Thureus foundation	JCLL self-funded travel costs and computer infrastructure to coordinate research in Australia and Sweden. The LUPROFS study received funding from The Swedish Alzheimer foundation, Thureus foundation, and benefited from the regional agreement on medical training and clinical research (ALF) between the Skane Regional Council and Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Burgess P.W., 1997, HAYLING BRIXTON TEST; Delis DC, 2001, DELIS KAPLAN EXECUTI; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; ENIGMA-Consortium, ORG HUM BRAIN MAPP 2; Eslinger PJ, 2012, BEHAV NEUROL, V25, P127, DOI [10.3233/BEN-2011-0351, 10.1155/2012/286427]; Farb NAS, 2013, CORTEX, V49, P1856, DOI 10.1016/j.cortex.2012.09.008; Franceschi M, 2005, ANN NEUROL, V57, P216, DOI 10.1002/ana.20365; Garibotto V, 2011, NEUROBIOL AGING, V32, P875, DOI 10.1016/j.neurobiolaging.2009.05.004; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Grahn JA, 2009, BEHAV BRAIN RES, V199, P53, DOI 10.1016/j.bbr.2008.11.020; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Halabi C, 2013, ALZ DIS ASSOC DIS, V27, P74, DOI 10.1097/WAD.0b013e31824a7df4; Josephs KA, 2010, EUR J NEUROL, V17, P969, DOI 10.1111/j.1468-1331.2010.02975.x; Kertesz A, 1997, CAN J NEUROL SCI, V24, P29, DOI 10.1017/S0317167100021053; Kim EJ, 2007, J NEUROL NEUROSUR PS, V78, P1375, DOI 10.1136/jnnp.2006.114231; Looi JCL, 2008, AM J NEURORADIOL, V29, P1537, DOI 10.3174/ajnr.A1168; Looi JCL, 2013, MOL PSYCHIATR, V18, P417, DOI 10.1038/mp.2012.54; Looi JCL, 2009, AM J NEURORADIOL, V30, P1552, DOI 10.3174/ajnr.A1640; Looi JCL, 2012, AUST NZ J PSYCHIAT, V46, P1145, DOI 10.1177/0004867412457224; Looi JCL, 2012, AUST NZ J PSYCHIAT, V46, P422, DOI 10.1177/0004867411432076; Looi JCL, 2008, PSYCHIAT RES-NEUROIM, V163, P279, DOI 10.1016/j.pscychresns.2007.07.005; Looi JCL, 2011, PSYCHIAT RES-NEUROIM, V191, P98, DOI 10.1016/j.pscychresns.2010.09.014; Macfarlane MD, 2013, PSYCHIAT RES-NEUROIM, V214, P16, DOI 10.1016/j.pscychresns.2013.05.010; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; Perry DC, 2014, BRAIN, V137, P1621, DOI 10.1093/brain/awu075; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Reitan R.M, 1958, TRAIL MAKING TEST MA; Santillo AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066932; Schroeter ML, 2014, CORTEX, V57, P22, DOI 10.1016/j.cortex.2014.02.022; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Styner M, 2006, INSIGHT J, P1; Styner M., 2007, P SOC PHOTO-OPT INS, p[65123, z1], DOI DOI 10.1117/12.708467; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Wittenberg D, 2008, NEUROPSYCHOL REV, V18, P91, DOI 10.1007/s11065-008-9056-z; Woolley JD, 2007, NEUROLOGY, V69, P1424, DOI 10.1212/01.wnl.0000277461.06713.23; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zamboni G, 2008, NEUROLOGY, V71, P736, DOI 10.1212/01.wnl.0000324920.96835.95	42	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129692	10.1371/journal.pone.0129692	http://dx.doi.org/10.1371/journal.pone.0129692			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26075893	gold, Green Published			2022-12-27	WOS:000356329900093
J	Norman, BC; Xenopoulos, MA; Braun, D; Frost, PC				Norman, Beth C.; Xenopoulos, Marguerite A.; Braun, Daniel; Frost, Paul C.			Phosphorus Availability Alters the Effects of Silver Nanoparticles on Periphyton Growth and Stoichiometry	PLOS ONE			English	Article							CHLAMYDOMONAS-REINHARDTII; NATURAL-WATERS; PSEUDOKIRCHNERIELLA-SUBCAPITATA; DAPHNIA-MAGNA; GREEN-ALGA; TOXICITY; FRESH; IMPACT; NANOSILVER; SOILS	Exposure to silver nanoparticles (AgNPs) may alter the structure and function of freshwater ecosystems. However, there remains a paucity of studies investigating the effects of AgNP exposure on freshwater communities in the natural environment where interactions with the ambient environment may modify AgNP toxicity. We used nutrient diffusing substrates to determine the interactive effects of AgNP exposure and phosphorus (P) enrichment on natural assemblages of periphyton in three Canadian Shield lakes. The lakes were all phosphorus poor and spanned a gradient of dissolved organic carbon availability. Ag slowly accumulated in the exposed periphyton, which decreased periphyton carbon and chlorophyll a content and increased periphyton C:P and N:P in the carbon rich lakes. We found significant interactions between AgNP and P treatments on periphyton carbon, autotroph standing crop and periphyton stoichiometry in the carbon poor lake such that P enhanced the negative effects of AgNPs on chlorophyll a and lessened the impact of AgNP exposure on periphyton stoichiometry. Our results contrast with those of other studies demonstrating that P addition decreases metal toxicity for phytoplankton, suggesting that benthic and pelagic primary producers may react differently to AgNP exposure and highlighting the importance of in situ assays when assessing potential effects of AgNPs in fresh waters.	[Norman, Beth C.; Xenopoulos, Marguerite A.; Braun, Daniel; Frost, Paul C.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada	Trent University	Norman, BC (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	bcheever@msu.edu	Frost, Paul/AAT-6633-2021		Natural Sciences and Engineering Research Council of Canada; Environment Canada Youth Internship Science Horizon Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Environment Canada Youth Internship Science Horizon Program	This work was funded by the Natural Sciences and Engineering Research Council of Canada via a Strategic Grant as well as the Environment Canada Youth Internship Science Horizon Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaout CL, 2012, ENVIRON SCI TECHNOL, V46, P5387, DOI 10.1021/es204540z; Barranguet C, 2002, ENVIRON TOXICOL CHEM, V21, P1955, DOI 10.1002/etc.5620210925; Benn T, 2010, J ENVIRON QUAL, V39, P1875, DOI 10.2134/jeq2009.0363; Bernhardt ES, 2010, J ENVIRON QUAL, V39, P1954, DOI 10.2134/jeq2009.0479; CARRICK HJ, 1988, CAN J FISH AQUAT SCI, V45, P271, DOI 10.1139/f88-032; Choi OK, 2009, WATER SCI TECHNOL, V59, P1699, DOI 10.2166/wst.2009.205; Choi O, 2009, WATER RES, V43, P1879, DOI 10.1016/j.watres.2009.01.029; Colman BP, 2014, ENVIRON SCI TECHNOL, V48, P5229, DOI 10.1021/es405454v; Colman BP, 2012, ECOTOXICOLOGY, V21, P1867, DOI 10.1007/s10646-012-0920-5; Colman BP, 2013, PLOS ONE, P8; Cross WF, 2005, FRESHWATER BIOL, V50, P1895, DOI 10.1111/j.1365-2427.2005.01458.x; Das P, 2014, ENVIRON SCI TECHNOL, V48, P4573, DOI 10.1021/es405039w; Das P, 2012, ENVIRON SCI TECHNOL, V46, P9120, DOI 10.1021/es3019918; Das P, 2012, ENVIRON TOXICOL CHEM, V31, P122, DOI 10.1002/etc.716; Elias D, 2014, PLOS ONE, P9; Fabrega J, 2011, CHEMOSPHERE, V85, P961, DOI 10.1016/j.chemosphere.2011.06.066; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P7285, DOI 10.1021/es803259g; FAIRCHILD GW, 1985, ECOLOGY, V66, P465, DOI 10.2307/1940395; Fortin C, 2001, ENVIRON SCI TECHNOL, V35, P2214, DOI 10.1021/es0017965; Frost PC, 2002, FRESHWATER BIOL, V47, P173, DOI 10.1046/j.1365-2427.2002.00796.x; Funck JA, 2013, AQUAT TOXICOL, V144, P199, DOI 10.1016/j.aquatox.2013.10.001; Furtado LM, 2014, ENVIRON CHEM, V11, P419, DOI 10.1071/EN14064; Gao J, 2009, ENVIRON SCI TECHNOL, V43, P3322, DOI 10.1021/es803315v; Griffitt RJ, 2008, ENVIRON TOXICOL CHEM, V27, P1972, DOI 10.1897/08-002.1; Hiriart-Baer VP, 2006, AQUAT TOXICOL, V78, P136, DOI 10.1016/j.aquatox.2006.02.027; Hoppe M, 2014, ENVIRON SCI TECHNOL, V48, P12628, DOI 10.1021/es5026189; Jacobson AR, 2005, WATER AIR SOIL POLL, V160, P41, DOI 10.1007/s11270-005-3860-3; Jepersen A, 1987, ARCH HYDROBIOL, V109, P445; Jeppesen E, 2003, ECOSYSTEMS, V6, P313, DOI 10.1007/PL00021503; Kennedy AJ, 2012, ENVIRON SCI TECHNOL, V46, P10772, DOI 10.1021/es302322y; Kennedy AJ, 2010, ENVIRON SCI TECHNOL, V44, P9571, DOI 10.1021/es1025382; Leclerc S, 2014, ENVIRON SCI TECHNOL, V48, P358, DOI 10.1021/es404037z; Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5; Lowry GV, 2012, ENVIRON SCI TECHNOL, V46, P7027, DOI 10.1021/es204608d; Maurer-Jones MA, 2013, ANAL CHEM, V85, P3036, DOI 10.1021/ac303636s; McTeer J, 2014, NANOTOXICOLOGY, V8, P305, DOI 10.3109/17435390.2013.778346; Miao AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015196; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Oukarroum A, 2012, ECOTOX ENVIRON SAFE, V78, P80, DOI 10.1016/j.ecoenv.2011.11.012; Pan B, 2012, EUR J SOIL SCI, V63, P437, DOI 10.1111/j.1365-2389.2012.01475.x; Peyrot C, 2014, ENVIRON TOXICOL CHEM, V33, P115, DOI 10.1002/etc.2398; Pillai S, 2014, P NATL ACAD SCI USA, V111, P3490, DOI 10.1073/pnas.1319388111; Pradhan A, 2011, MICROB ECOL, V62, P58, DOI 10.1007/s00248-011-9861-4; Ribeiro F, 2014, SCI TOTAL ENVIRON, V466, P232, DOI 10.1016/j.scitotenv.2013.06.101; RIBER HH, 1987, LIMNOL OCEANOGR, V32, P1181, DOI 10.4319/lo.1987.32.6.1181; Riedel GF, 2003, ESTUARIES, V26, P339, DOI 10.1007/BF02695972; Rosi-Marshall EJ, 2012, ECOSYSTEMS, V15, P867, DOI 10.1007/s10021-012-9553-z; Serra A, 2010, ECOTOXICOLOGY, V19, P770, DOI 10.1007/s10646-009-0454-7; STEINMAN AD, 1995, J N AM BENTHOL SOC, V14, P371, DOI 10.2307/1467203; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Stevenson LM, 2013, PLOS ONE, P8; Turner A, 2012, ECOTOXICOLOGY, V21, P148, DOI 10.1007/s10646-011-0774-2; TURNER MA, 1994, CAN J FISH AQUAT SCI, V51, P2784, DOI 10.1139/f94-278; TWISS MR, 1992, J PHYCOL, V28, P291, DOI 10.1111/j.0022-3646.1992.00291.x; VALDERRAMA JC, 1981, MAR CHEM, V10, P109, DOI 10.1016/0304-4203(81)90027-X; Wang WX, 2006, ENVIRON POLLUT, V142, P303, DOI 10.1016/j.envpol.2005.10.005; Xiu ZM, 2011, ENVIRON SCI TECHNOL, V45, P9003, DOI 10.1021/es201918f; Yuan ZH, 2013, CHEMOSPHERE, V90, P1404, DOI 10.1016/j.chemosphere.2012.08.032	60	12	12	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129328	10.1371/journal.pone.0129328	http://dx.doi.org/10.1371/journal.pone.0129328			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075715	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900065
J	Vicario, R; Peg, V; Morancho, B; Zacarias-Fluck, M; Zhang, JJ; Martinez-Barriocanal, A; Jimenez, AN; Aura, C; Burgues, O; Lluch, A; Cortes, J; Nuciforo, P; Rubio, IT; Marangoni, E; Deeds, J; Boehm, M; Schlegel, R; Tabernero, J; Mosher, R; Arribas, J				Vicario, Rocio; Peg, Vicente; Morancho, Beatriz; Zacarias-Fluck, Mariano; Zhang, Junjie; Martinez-Barriocanal, Agueda; Navarro Jimenez, Alexandra; Aura, Claudia; Burgues, Octavio; Lluch, Ana; Cortes, Javier; Nuciforo, Paolo; Rubio, Isabel T.; Marangoni, Elisabetta; Deeds, James; Boehm, Markus; Schlegel, Robert; Tabernero, Josep; Mosher, Rebecca; Arribas, Joaquin			Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies	PLOS ONE			English	Article							BREAST-CANCER; GROWTH; NETWORK	A chromosomal region that includes the gene encoding HER2, a receptor tyrosine kinase (RTK), is amplified in 20% of breast cancers. Although these tumors tend to respond to drugs directed against HER2, they frequently become resistant and resume their malignant progression. Gene amplification in double minutes (DMs), which are extrachromosomal entities whose number can be dynamically regulated, has been suggested to facilitate the acquisition of resistance to therapies targeting RTKs. Here we show that similar to 30% of HER2-positive tumors show amplification in DMs. However, these tumors respond to trastuzumab in a similar fashion than those with amplification of the HER2 gene within chromosomes. Furthermore, in different models of resistance to anti-HER2 therapies, the number of DMs containing HER2 is maintained, even when the acquisition of resistance is concomitant with loss of HER2 protein expression. Thus, both clinical and preclinical data show that, despite expectations, loss of HER2 protein expression due to loss of DMs containing HER2 is not a likely mechanism of resistance to anti-HER2 therapies.	[Vicario, Rocio; Morancho, Beatriz; Zacarias-Fluck, Mariano; Zhang, Junjie; Martinez-Barriocanal, Agueda; Arribas, Joaquin] Univ Autonoma Barcelona, Vall dHebron Inst Oncol VHIO, Preclin Oncol Program, Barcelona 08035, Spain; [Cortes, Javier; Rubio, Isabel T.; Tabernero, Josep] Univ Autonoma Barcelona, Vall dHebron Inst Oncol VHIO, Clin Oncol Program, Barcelona 08035, Spain; [Aura, Claudia; Nuciforo, Paolo] Univ Autonoma Barcelona, Vall dHebron Inst Oncol VHIO, Mol Oncol Program, Barcelona 08035, Spain; [Peg, Vicente; Navarro Jimenez, Alexandra] Vall dHebron Univ Hosp, Dept Pathol, Barcelona 08035, Spain; [Burgues, Octavio] INCLIVA Biomed Res Inst, Hosp Clin Univ, Dept Pathol, Valencia 46010, Spain; [Lluch, Ana] INCLIVA Biomed Res Inst, Hosp Clin Univ, Dept Oncol, Valencia 46010, Spain; [Marangoni, Elisabetta] Inst Curie, Translat Res Dept, F-75005 Paris, France; [Deeds, James; Schlegel, Robert; Mosher, Rebecca] Novartis Oncol Translat Res, Cambridge, MA 02139 USA; [Boehm, Markus] Novartis Pharma AG, CH-4002 Basel, Switzerland; [Vicario, Rocio; Arribas, Joaquin] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Bellaterra 08193, Spain; [Arribas, Joaquin] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	Autonomous University of Barcelona; Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; Vall d'Hebron Institut d'Oncologia (VHIO); Hospital Universitari Vall d'Hebron; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Novartis; Autonomous University of Barcelona; ICREA	Mosher, R (corresponding author), Novartis Oncol Translat Res, Cambridge, MA 02139 USA.	rebecca.mosher@novartis.com; jarribas@vhio.net	Peg., Vicente/AAC-9447-2020; Nuciforo, Paolo/Q-2885-2019; rubio, isabel/U-4259-2018; Burgues, Octavio/ABH-9634-2020; Burgues, Octavio/ABC-8699-2021; Peg, Vicente/E-9160-2018; Marangoni, Elisabetta/GSO-3945-2022; Zacarias-Fluck, Mariano F./D-9406-2019; Martinez, Agueda/AAB-7186-2019; Morancho, Beatriz/AAD-3540-2021; Lluch, Ana/R-5493-2019; Tabernero, Josep/AAG-5026-2019; Arribas, Joaquin/M-4482-2014; Miquel, Josep Maria/AAG-3508-2019	Peg., Vicente/0000-0002-5203-6166; rubio, isabel/0000-0003-0035-0679; Peg, Vicente/0000-0002-5203-6166; Marangoni, Elisabetta/0000-0002-3337-6448; Zacarias-Fluck, Mariano F./0000-0002-7171-4268; Martinez, Agueda/0000-0002-8809-160X; Morancho, Beatriz/0000-0003-3369-8647; Lluch, Ana/0000-0003-2766-407X; Tabernero, Josep/0000-0002-2495-8139; Arribas, Joaquin/0000-0002-0504-0664; Nuciforo, Paolo/0000-0003-1380-0990; Cortes, Javier/0000-0001-7623-1583	Novartis Pharma within the Consorcio de Investigacion Biomedica y Oncologica Translacional Framework Programme; Breast Cancer Research Foundation (BCRF); Spanish Association Against Cancer (Asociacion Espanola Contra el Cancer, AECC); Instituto de Salud Carlos III (Intrasalud) [PI12/02536]; Network of Cooperative Cancer Research [RTICC-RD12/0036/0057/0070/0012]; Ministerio de Economia y Competitividad [JCI-2011-10960]; Novartis; ICREA Funding Source: Custom	Novartis Pharma within the Consorcio de Investigacion Biomedica y Oncologica Translacional Framework Programme; Breast Cancer Research Foundation (BCRF); Spanish Association Against Cancer (Asociacion Espanola Contra el Cancer, AECC); Instituto de Salud Carlos III (Intrasalud); Network of Cooperative Cancer Research; Ministerio de Economia y Competitividad(Spanish Government); Novartis(Novartis); ICREA(ICREA)	This work has been supported by Novartis Pharma within the Consorcio de Investigacion Biomedica y Oncologica Translacional Framework Programme, the Breast Cancer Research Foundation (BCRF), Spanish Association Against Cancer (Asociacion Espanola Contra el Cancer, AECC) and Instituto de Salud Carlos III (Intrasalud PI12/02536) to JA and the Network of Cooperative Cancer Research (RTICC-RD12/0036/0057/0070/0012) to JA, JT, JC and AL. AM-B is supported by a Juan de la Cierva postdoctoral fellow from Ministerio de Economia y Competitividad (JCI-2011-10960). JD, MB, RS, and RM are employed by Novartis and received funding in the form of salaries. The funders participated in study design, decision to publish, and preparation of the manuscript.	Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Gianni L, 2010, LANCET, V375, P377, DOI 10.1016/S0140-6736(09)61964-4; Gradishar WJ, 2012, NEW ENGL J MED, V366, P176, DOI 10.1056/NEJMe1113641; Hoff Von DD, 1992, P NATL ACAD SCI USA, V89, P8165; KAUFMAN RJ, 1981, MOL CELL BIOL, V1, P1084, DOI 10.1128/MCB.1.12.1084; Parra-Palau JL, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju291; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Mittendorf EA, 2009, CLIN CANCER RES, V15, P7381, DOI 10.1158/1078-0432.CCR-09-1735; Nathanson DA, 2014, SCIENCE, V343, P72, DOI 10.1126/science.1241328; Niikura N, 2012, J CLIN ONCOL, V30, P593, DOI 10.1200/JCO.2010.33.8889; Pedersen K, 2009, MOL CELL BIOL, V29, P3319, DOI 10.1128/MCB.01803-08; Sahlberg KK, 2013, MOL ONCOL, V7, P392, DOI 10.1016/j.molonc.2012.10.012; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Xuan QJ, 2015, BREAST CANCER RES TR, V150, P581, DOI 10.1007/s10549-015-3334-2; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Yu LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071988	18	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129876	10.1371/journal.pone.0129876	http://dx.doi.org/10.1371/journal.pone.0129876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075403	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900108
J	Wang, ZP; Niu, WB; Wang, YJ; Teng, Z; Wen, J; Xia, GL; Wang, C				Wang, Zhengpin; Niu, Wanbao; Wang, Yijing; Teng, Zhen; Wen, Jia; Xia, Guoliang; Wang, Chao			Follistatin288 Regulates Germ Cell Cyst Breakdown and Primordial Follicle Assembly in the Mouse Ovary	PLOS ONE			English	Article							OOCYTE NEST BREAKDOWN; INTRACELLULAR DOMAIN; GRANULOSA-CELL; IN-VITRO; ACTIVIN; NOTCH; PROTEINS; SURVIVAL; DEFECTS; BINDING	In mammals, the primordial follicle pool represents the entire reproductive potential of a female. The transforming growth factor-beta (TGF-beta) family member activin (ACT) contributes to folliculogenesis, although the exact mechanism is not known. The role of FST288, the strongest ACT-neutralizing isoform of follistatin (FST), during cyst breakdown and primordial follicle formation in the fetal mice ovary was assessed using an in vitro culture system. FST was continuously expressed in the oocytes as well as the cuboidal granulosa cells of growing follicles in perinatal mouse ovaries. Treatment with FST288 delayed germ cell nest breakdown, particularly near the periphery of the ovary, and dramatically decreased the percentage of primordial follicles. In addition, there was a dramatic decrease in proliferation of granulosa cells and somatic cell expression of Notch signaling was impaired. In conclusion, FST288 impacts germ cell nest breakdown and primordial follicle assembly by inhibiting somatic cell proliferation.	[Wang, Zhengpin; Niu, Wanbao; Wang, Yijing; Teng, Zhen; Wen, Jia; Xia, Guoliang; Wang, Chao] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China	China Agricultural University	Wang, C (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	wangcam@cau.edu.cn	Teng, Zhen/I-4601-2019; Wang, Zhengpin/AAM-3021-2020	Teng, Zhen/0000-0002-3827-2197; Wang, Zhengpin/0000-0001-5388-1516	National Basic Research Program of China (973) [2013CB945500, 2012CB944701]	National Basic Research Program of China (973)(National Basic Research Program of China)	This work was supported by the National Basic Research Program Grant 2013CB945500, 2012CB944701 of China (973).	Abe T, 2005, MECH DEVELOP, V122, P671, DOI 10.1016/j.mod.2004.12.006; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Chen Y, 2007, ENDOCRINOLOGY, V148, P3580, DOI 10.1210/en.2007-0088; Drummond AE, 2005, CELL TISSUE RES, V322, P107, DOI 10.1007/s00441-005-1153-1; Gao XW, 2010, J BIOL CHEM, V285, P36857, DOI 10.1074/jbc.M110.144477; Gosden RG, 1998, REPROD FERT DEVELOP, V10, P73, DOI 10.1071/R98043; Guo Meng, 2012, Front Biosci (Elite Ed), V4, P2631; Guo QX, 1998, MOL ENDOCRINOL, V12, P96, DOI 10.1210/mend.12.1.0053; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hiratochi M, 2007, NUCLEIC ACIDS RES, V35, P912, DOI 10.1093/nar/gkl1128; Jefferson W, 2006, BIOL REPROD, V74, P161, DOI 10.1095/biolreprod.105.045724; Jorgez CJ, 2004, MOL ENDOCRINOL, V18, P953, DOI 10.1210/me.2003-0301; Kaivo-Oja N, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-21; Kimura F, 2011, ENDOCRINOLOGY, V152, P697, DOI 10.1210/en.2010-0950; Kimura F, 2010, ENDOCRINOLOGY, V151, P1310, DOI 10.1210/en.2009-1176; KOGAWA K, 1991, ENDOCRINOL JAPON, V38, P383; LING N, 1985, P NATL ACAD SCI USA, V82, P7217, DOI 10.1073/pnas.82.21.7217; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; Myers M, 2009, DEV BIOL, V334, P458, DOI 10.1016/j.ydbio.2009.08.001; Parrott JA, 1999, ENDOCRINOLOGY, V140, P4262, DOI 10.1210/en.140.9.4262; Pepling ME, 1998, DEVELOPMENT, V125, P3323; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; RAJAH R, 1992, DEV DYNAM, V194, P177, DOI 10.1002/aja.1001940303; Rodrigues P, 2009, REPRODUCTION, V137, P709, DOI 10.1530/REP-08-0203; SHIMASAKI S, 1988, P NATL ACAD SCI USA, V85, P4218, DOI 10.1073/pnas.85.12.4218; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; SUGINO K, 1993, J BIOL CHEM, V268, P15579; Trombly DJ, 2009, ENDOCRINOLOGY, V150, P1014, DOI 10.1210/en.2008-0213; Trombly DJ, 2009, SEMIN REPROD MED, V27, P14, DOI 10.1055/s-0028-1108006; VALE W, 1988, RECENT PROG HORM RES, V44, P1; Vanorny DA, 2014, MOL ENDOCRINOL, V28, P499, DOI 10.1210/me.2013-1288; Wang HB, 2001, CHINESE SCI BULL, V46, P672, DOI 10.1007/BF03182833; Wang ZP, 2014, J BIOL CHEM, V289, P8299, DOI 10.1074/jbc.M113.532952; WEISS J, 1993, ENDOCRINOLOGY, V132, P2307, DOI 10.1210/en.132.6.2307; Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549; Xu JX, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-13; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	39	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129643	10.1371/journal.pone.0129643	http://dx.doi.org/10.1371/journal.pone.0129643			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076381	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900087
J	Cobaugh, KL; Schaeffer, SM; DeBruyn, JM				Cobaugh, Kelly L.; Schaeffer, Sean M.; DeBruyn, Jennifer M.			Functional and Structural Succession of Soil Microbial Communities below Decomposing Human Cadavers	PLOS ONE			English	Article							HERMETIA-ILLUCENS DIPTERA; NITROGEN-FERTILIZATION; CARRION DECOMPOSITION; LEUCINE INCORPORATION; OVIS-ARIES; TIME; STRATIOMYIDAE; TERRESTRIAL; INTERFACE; THYMIDINE	The ecological succession of microbes during cadaver decomposition has garnered interest in both basic and applied research contexts (e.g. community assembly and dynamics; forensic indicator of time since death). Yet current understanding of microbial ecology during decomposition is almost entirely based on plant litter. We know very little about microbes recycling carcass-derived organic matter despite the unique decomposition processes. Our objective was to quantify the taxonomic and functional succession of microbial populations in soils below decomposing cadavers, testing the hypotheses that a) periods of increased activity during decomposition are associated with particular taxa; and b) human-associated taxa are introduced to soils, but do not persist outside their host. We collected soils from beneath four cadavers throughout decomposition, and analyzed soil chemistry, microbial activity and bacterial community structure. As expected, decomposition resulted in pulses of soil C and nutrients (particularly ammonia) and stimulated microbial activity. There was no change in total bacterial abundances, however we observed distinct changes in both function and community composition. During active decay (7 - 12 days postmortem), respiration and biomass production rates were high: the community was dominated by Proteobacteria (increased from 15.0 to 26.1% relative abundance) and Firmicutes (increased from 1.0 to 29.0%), with reduced Acidobacteria abundances (decreased from 30.4 to 9.8%). Once decay rates slowed (10 - 23 d postmortem), respiration was elevated, but biomass production rates dropped dramatically; this community with low growth efficiency was dominated by Firmicutes (increased to 50.9%) and other anaerobic taxa. Human-associated bacteria, including the obligately anaerobic Bacteroides, were detected at high concentrations in soil throughout decomposition, up to 198 d postmortem. Our results revealed the pattern of functional and compositional succession in soil microbial communities during decomposition of human-derived organic matter, provided insight into decomposition processes, and identified putative predictor populations for time since death estimation.	[Cobaugh, Kelly L.; Schaeffer, Sean M.; DeBruyn, Jennifer M.] Univ Tennessee, Dept Biosyst Engn & Soil Sci, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	DeBruyn, JM (corresponding author), Univ Tennessee, Dept Biosyst Engn & Soil Sci, Knoxville, TN 37996 USA.	jdebruyn@utk.edu	Schaeffer, Sean M/G-5071-2012; DeBruyn, Jennifer M./A-8813-2010	DeBruyn, Jennifer M./0000-0002-2993-4144; Schaeffer, Sean/0000-0002-9684-2952	University of Tennessee AgResearch; Microbiology Across Campuses Educational and Research Venture	University of Tennessee AgResearch; Microbiology Across Campuses Educational and Research Venture	Funding for this study was provided by University of Tennessee AgResearch and Microbiology Across Campuses Educational and Research Venture to JMD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUASHOUR J, 1994, WATER AIR SOIL POLL, V75, P141, DOI 10.1007/BF01100406; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Amin MGM, 2013, APPL ENVIRON MICROB, V79, P535, DOI 10.1128/AEM.02506-12; Anderson J. P. E., 1982, METHODS SOIL ANAL 2; Baath E, 2001, SOIL BIOL BIOCHEM, V33, P1571, DOI 10.1016/S0038-0717(01)00073-6; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Bastviken D, 2001, APPL ENVIRON MICROB, V67, P2916, DOI 10.1128/AEM.67.7.2916-2921.2001; Benninger LA, 2008, FORENSIC SCI INT, V180, P70, DOI 10.1016/j.forsciint.2008.07.001; Berry D F, 1991, Biotechnology, V15, P57; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Carter DO, 2008, APPL SOIL ECOL, V40, P129, DOI 10.1016/j.apsoil.2008.03.010; Carter DO, 2007, NATURWISSENSCHAFTEN, V94, P12, DOI 10.1007/s00114-006-0159-1; Carter DO, 2006, SOIL BIOL BIOCHEM, V38, P1139, DOI 10.1016/j.soilbio.2005.09.014; Carter DO, 2010, FORENSIC SCI INT, V200, P60, DOI 10.1016/j.forsciint.2010.03.031; Creamer CA, 2015, SOIL BIOL BIOCHEM, V80, P175, DOI 10.1016/j.soilbio.2014.10.008; Damann FE, 2012, FORENSIC SCI INT, V222, P4, DOI 10.1016/j.forsciint.2012.04.028; Danell K, 2002, ARCTIC, V55, P389; DeBruyn JM, 2011, APPL ENVIRON MICROB, V77, P6295, DOI 10.1128/AEM.05005-11; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Finley S. J., 2014, INT J LEGAL MED, P1, DOI DOI 10.1007/S00414-014-0996-Y; Fonseca G, 2011, AQUAT BIOL, V13, P27, DOI 10.3354/ab00347; Gorley C.K., 2006, GETTING STARTED PRIM; Haskell Neal H., 1997, P415; Haslam TCF, 2009, J FORENSIC SCI, V54, P900, DOI 10.1111/j.1556-4029.2009.01070.x; Hauther KA, J FORENSIC IN PRESS; Heimesaat MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040758; Heinemeyer A, 2009, SOIL CARBON DYNAMICS, P76, DOI DOI 10.1017/CB09780511711794.006; Holley RA, 2006, J ENVIRON QUAL, V35, P1170, DOI 10.2134/jeq2005.0449; Hopkins DW, 2000, APPL SOIL ECOL, V14, P283, DOI 10.1016/S0929-1393(00)00063-9; Howard GT, 2010, INT BIODETER BIODEGR, V64, P300, DOI 10.1016/j.ibiod.2010.02.006; Hutchison ML, 2004, APPL ENVIRON MICROB, V70, P5111, DOI 10.1128/AEM.70.9.5111-5118.2004; Hyde ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077733; Jaenicke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014519; Jiang XP, 2002, APPL ENVIRON MICROB, V68, P2605, DOI 10.1128/AEM.68.5.2605-2609.2002; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Layton A, 2006, APPL ENVIRON MICROB, V72, P4214, DOI 10.1128/AEM.01036-05; Lee YY, 2013, INT J SYST EVOL MICR, V63, P4224, DOI 10.1099/ijs.0.049098-0; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Macdonald BCT, 2014, SOIL BIOL BIOCHEM, V69, P132, DOI 10.1016/j.soilbio.2013.10.042; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; McGuire KL, 2010, SOIL BIOL BIOCHEM, V42, P529, DOI 10.1016/j.soilbio.2009.11.016; Metcalf JL, 2013, ELIFE, V2, DOI 10.7554/eLife.01104; MICHEL PH, 1993, SOIL BIOL BIOCHEM, V25, P943, DOI 10.1016/0038-0717(93)90097-U; Moorhead DL, 2006, ECOL MONOGR, V76, P151, DOI 10.1890/0012-9615(2006)076[0151:ATMOLD]2.0.CO;2; Moreno LI, 2011, J MICROBIOL METH, V84, P388, DOI 10.1016/j.mimet.2010.11.023; Nemergut DR, 2008, ENVIRON MICROBIOL, V10, P3093, DOI 10.1111/j.1462-2920.2008.01735.x; OSTROLENK M, 1947, J BACTERIOL, V53, P197, DOI 10.1128/JB.53.2.197-203.1947; Parkinson RA, 2009, CRIMINAL AND ENVIRONMENTAL SOIL FORENSICS, P379, DOI 10.1007/978-1-4020-9204-6_24; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Parmenter RR, 2009, ECOL MONOGR, V79, P637, DOI 10.1890/08-0972.1; PAYNE JA, 1965, ECOLOGY, V46, P592, DOI 10.2307/1934999; Pechal JL, 2014, INT J LEGAL MED, V128, P193, DOI 10.1007/s00414-013-0872-1; Pujol-Luz JR, 2008, J FORENSIC SCI, V53, P476, DOI 10.1111/j.1556-4029.2008.00659.x; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Santarella-Mellwig R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000281; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Swann LM, 2010, ANAL CHIM ACTA, V682, P9, DOI 10.1016/j.aca.2010.09.052; Towne EG, 2000, OECOLOGIA, V122, P232, DOI 10.1007/PL00008851; Ueki A, 2009, INT J SYST EVOL MICR, V59, P3161, DOI 10.1099/ijs.0.011858-0; VASS AA, 1992, J FORENSIC SCI, V37, P1236; Voriskova J, 2013, ISME J, V7, P477, DOI 10.1038/ismej.2012.116; Wilson AS, 2007, FORENSIC SCI INT, V169, P6, DOI 10.1016/j.forsciint.2006.07.023; ZAK DR, 1990, ECOLOGY, V71, P651, DOI 10.2307/1940319	66	90	91	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130201	10.1371/journal.pone.0130201	http://dx.doi.org/10.1371/journal.pone.0130201			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067226	Green Submitted, gold, Green Published			2022-12-27	WOS:000356327000149
J	Perez-Roca, F; Rodrigo-Morales, E; Garzon, I; Oliveira, AC; Martin-Piedra, MA; Carriel, V; Ortiz-Perez, AI; Sanchez-Montesinos, I; Campos, A; Alaminos, M				Perez-Roca, Fernando; Rodrigo-Morales, Esther; Garzon, Ingrid; Oliveira, Ana-Celeste; Martin-Piedra, Miguel-Angel; Carriel, Victor; Ortiz-Perez, Ana-Isabel; Sanchez-Montesinos, Indalecio; Campos, Antonio; Alaminos, Miguel			Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study	PLOS ONE			English	Article							PRESERVATIVE-FREE TAFLUPROST; OPEN-ANGLE GLAUCOMA; BENZALKONIUM CHLORIDE; IN-VITRO; OCULAR HYPERTENSION; TOPICAL PROSTAGLANDINS; CONJUNCTIVAL HYPEREMIA; CHANG CONJUNCTIVAL; EPITHELIAL-CELLS; LATANOPROST	We evaluated the cytotoxic effects of four prostaglandin analogs (PGAs) used to treat glaucoma. First we established primary cultures of conjunctival stromal cells from healthy donors. Then cell cultures were incubated with different concentrations (0, 0.1, 1, 5, 25, 50 and 100%) of commercial formulations of bimatoprost, tafluprost, travoprost and latanoprost for increasing periods (5 and 30 min, 1 h, 6 h and 24 h) and cell survival was assessed with three different methods: WST-1, MTT and calcein/AM-ethidium homodimer-1 assays. Our results showed that all PGAs were associated with a certain level of cell damage, which correlated significantly with the concentration of PGA used, and to a lesser extent with culture time. Tafluprost tended to be less toxic than bimatoprost, travoprost and latanoprost after all culture periods. The results for WST-1, MTT and calcein/AM-ethidium homodimer-1 correlated closely. When the average lethal dose 50 was calculated, we found that the most cytotoxic drug was latanoprost, whereas tafluprost was the most sparing of the ocular surface in vitro. These results indicate the need to design novel PGAs with high effectiveness but free from the cytotoxic effects that we found, or at least to obtain drugs that are functional at low dosages. The fact that the commercial formulation of tafluprost used in this work was preservative-free may support the current tendency to eliminate preservatives from eye drops for clinical use.	[Perez-Roca, Fernando; Ortiz-Perez, Ana-Isabel] Hosp Gen Basico Baza, E-18800 Granada, Spain; [Perez-Roca, Fernando] Univ Granada, PhD Program Biomed, Granada 18012, Spain; [Rodrigo-Morales, Esther] Hosp La Inmaculada, Huercal Overa 04600, Almeria, Spain; [Garzon, Ingrid; Oliveira, Ana-Celeste; Martin-Piedra, Miguel-Angel; Carriel, Victor; Campos, Antonio; Alaminos, Miguel] Univ Granada, Dept Histol, Tissue Engn Grp, Granada 18012, Spain; [Garzon, Ingrid; Martin-Piedra, Miguel-Angel; Carriel, Victor; Campos, Antonio; Alaminos, Miguel] Inst Invest Biosanitaria Ibs GRANADA, Granada 18012, Spain; [Sanchez-Montesinos, Indalecio] Univ Granada, Dept Human Anat & Embryol, Granada 18012, Spain	University of Granada; University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada	Alaminos, M (corresponding author), Univ Granada, Dept Histol, Tissue Engn Grp, Granada 18012, Spain.	malaminos@ugr.es	Martin-Piedra, Miguel Angel/F-3664-2019; Oliveira, Ana Carolina/GRF-1435-2022; ALAMINOS, MIGUEL/N-9960-2016; ARAYA, VICTOR CARRIEL/H-9425-2018	Martin-Piedra, Miguel Angel/0000-0002-4639-3175; ALAMINOS, MIGUEL/0000-0003-4876-2672; ARAYA, VICTOR CARRIEL/0000-0002-8114-5644; Campos, A/0000-0003-4061-8182	Spanish Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I) from the Spanish Ministry of Economy and Competitiveness (Instituto de Salud Carlos III) [FIS PI11/1582, FIS PI14/0955]; FEDER; European Union; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia, Spain (Proyectos de Excelencia) [P10-CTS-6060]	Spanish Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I) from the Spanish Ministry of Economy and Competitiveness (Instituto de Salud Carlos III); FEDER(European Commission); European Union(European Commission); Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia, Spain (Proyectos de Excelencia)(Junta de Andalucia)	This study was supported by the Spanish Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I) from the Spanish Ministry of Economy and Competitiveness (Instituto de Salud Carlos III), grants FIS PI11/1582 and FIS PI14/0955 (co-financed by FEDER funds, European Union) and by Grant P10-CTS-6060 from the Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia, Spain (Proyectos de Excelencia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson MB, 2003, ADV THER, V20, P1, DOI 10.1007/BF02850114; Alm A, 2014, CLIN OPHTHALMOL, V8, P1967, DOI 10.2147/OPTH.S59162; Baudouin C, 2004, OPHTHALMOLOGY, V111, P2186, DOI 10.1016/j.ophtha.2004.06.023; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; Bean GW, 2008, SURV OPHTHALMOL, V53, pS69, DOI 10.1016/j.survophthal.2008.08.012; Bolivar G, 2015, ACTA OPHTHALMOL, V93, pE495, DOI 10.1111/aos.12689; Brasnu E, 2008, MOL VIS, V14, P394; Brasnu E, 2008, CURR EYE RES, V33, P303, DOI 10.1080/02713680801971857; Brignole-Baudouin F, 2011, CURR EYE RES, V36, P979, DOI 10.3109/02713683.2011.578781; BROADWAY DC, 1994, ARCH OPHTHALMOL-CHIC, V112, P1446, DOI 10.1001/archopht.1994.01090230060021; Oliveira AC, 2014, EXP BIOL MED, V239, P71, DOI 10.1177/1535370213503274; CRAWFORD K, 1987, ARCH OPHTHALMOL-CHIC, V105, P1112, DOI 10.1001/archopht.1987.01060080114039; Dutkiewicz R, 2000, EXP EYE RES, V70, P563, DOI 10.1006/exer.1999.0819; Feldman RM, 2003, J OCUL PHARMACOL TH, V19, P23, DOI 10.1089/108076803762718088; Guenoun JM, 2005, INVEST OPHTH VIS SCI, V46, P4594, DOI 10.1167/iovs.05-0776; Hu DN, 2000, EXP EYE RES, V70, P113, DOI 10.1006/exer.1999.0760; Jaenen N, 2007, EUR J OPHTHALMOL, V17, P341, DOI 10.1177/112067210701700311; Jean MD, 1999, INVEST OPHTH VIS SCI, V40, P619; Kim Eun Joo, 2013, Korean J Ophthalmol, V27, P446, DOI 10.3341/kjo.2013.27.6.446; Le Bourlais C, 1998, PROG RETIN EYE RES, V17, P33, DOI 10.1016/S1350-9462(97)00002-5; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Liang H, 2008, BRIT J OPHTHALMOL, V92, P1275, DOI 10.1136/bjo.2008.138768; Lindquist NG, 1999, EXP EYE RES, V69, P431, DOI 10.1006/exer.1999.0718; Michee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072459; Netland PA, 2001, AM J OPHTHALMOL, V132, P472, DOI 10.1016/S0002-9394(01)01177-1; Noecker RJ, 2004, CORNEA, V23, P490, DOI 10.1097/01.ico.0000116526.57227.82; Pellinen P, 2012, CURR EYE RES, V37, P145, DOI 10.3109/02713683.2011.626909; Pisella PJ, 2002, BRIT J OPHTHALMOL, V86, P418, DOI 10.1136/bjo.86.4.418; Pisella PJ, 2000, OPHTHALMIC RES, V32, P3, DOI 10.1159/000055579; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Radcliffe NM, 2014, CLIN OPHTHALMOL, V8, P2541, DOI 10.2147/OPTH.S76053; Schachtschabel U, 2000, Curr Opin Ophthalmol, V11, P112; Schmidl D, 2015, J OCUL PHARMACOL TH, V31, P63, DOI 10.1089/jop.2014.0067; Sjoquist B, 1998, DRUG METAB DISPOS, V26, P745; Spittel H, 2014, CYTOGENET GENOME RES, V142, P151, DOI 10.1159/000360776; Stalmans I, 2013, EUR J OPHTHALMOL, V23, P518, DOI 10.5301/ejo.5000270; Stewart WC, 2003, AM J OPHTHALMOL, V135, P314, DOI 10.1016/S0002-9394(02)01980-3; Toris CB, 2008, SURV OPHTHALMOL, V53, pS107, DOI 10.1016/j.survophthal.2008.08.010; Yamazaki S, 2010, JPN J OPHTHALMOL, V54, P7, DOI 10.1007/s10384-009-0754-8	39	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129419	10.1371/journal.pone.0129419	http://dx.doi.org/10.1371/journal.pone.0129419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067827	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000073
J	Phannasil, P; Thuwajit, C; Warnnissorn, M; Wallace, JC; MacDonald, MJ; Jitrapakdee, S				Phannasil, Phatchariya; Thuwajit, Chanitra; Warnnissorn, Malee; Wallace, John C.; MacDonald, Michael J.; Jitrapakdee, Sarawut			Pyruvate Carboxylase Is Up-Regulated in Breast Cancer and Essential to Support Growth and Invasion of MDA-MB-231 Cells	PLOS ONE			English	Article							INSULIN-SECRETION; FUNCTIONAL EXPRESSION; GLUTAMINE-METABOLISM; METASTASIS; MYC; HYPOXIA; TRANSFORMATION; CATAPLEROSIS; ANAPLEROSIS; OXIDATION	Pyruvate carboxylase (PC) is an anaplerotic enzyme that catalyzes the carboxylation of pyruvate to oxaloacetate, which is crucial for replenishing tricarboxylic acid cycle intermediates when they are used for biosynthetic purposes. We examined the expression of PC by immunohistochemistry of paraffin-embedded breast tissue sections of 57 breast cancer patients with different stages of cancer progression. PC was expressed in the cancerous areas of breast tissue at higher levels than in the non-cancerous areas. We also found statistical association between the levels of PC expression and tumor size and tumor stage (P < 0.05). The involvement of PC with these two parameters was further studied in four breast cancer cell lines with different metastatic potentials; i.e., MCF-7, SKBR3 (low metastasis), MDA-MB-435 (moderate metastasis) and MDA-MB-231 (high metastasis). The abundance of both PC mRNA and protein in MDA-MB-231 and MDA-MB-435 cells was 2-3-fold higher than that in MCF-7 and SKBR3 cells. siRNA-mediated knockdown of PC expression in MDA-MB-231 and MDA-MB-435 cells resulted in a 50% reduction of cell proliferation, migration and in vitro invasion ability, under both glutamine-dependent and glutamine-depleted conditions. Overexpression of PC in MCF-7 cells resulted in a 2-fold increase in their proliferation rate, migration and invasion abilities. Taken together the above results suggest that anaplerosis via PC is important for breast cancer cells to support their growth and motility.	[Phannasil, Phatchariya; Jitrapakdee, Sarawut] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Thuwajit, Chanitra] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Immunol, Bangkok 10700, Thailand; [Warnnissorn, Malee] Mahidol Univ, Fac Med, Dept Pathol, Bangkok 10700, Thailand; [Wallace, John C.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [MacDonald, Michael J.] Univ Wisconsin, Sch Med & Publ Hlth, Childrens Diabet Ctr, Madison, WI USA	Mahidol University; Mahidol University; Mahidol University; University of Adelaide; University of Wisconsin System; University of Wisconsin Madison	Jitrapakdee, S (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand.	sarawut.jit@mahidol.ac.th	Thuwajit, Chanitra/AAT-7933-2021; , John/AAP-5150-2020	MacDonald, Michael/0000-0002-0201-9245; Thuwajit, Chanitra/0000-0001-9506-6405	Thailand Research Fund [BRG5780007]; RGJ-PhD scholarship from Thailand Research Fund [PHD/0142/2552]; Mahidol University	Thailand Research Fund(Thailand Research Fund (TRF)); RGJ-PhD scholarship from Thailand Research Fund; Mahidol University	This work was supported by grant BRG5780007 from the Thailand Research Fund and Mahidol University to SJ. PP was supported by the RGJ-PhD scholarship (PHD/0142/2552) from the Thailand Research Fund. The funders had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; EAGLE H, 1955, SCIENCE, V122, P501, DOI 10.1126/science.122.3168.501; Fan TWM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-41; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Graham KA, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.3.12207; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Henry O, 2011, METAB ENG, V13, P499, DOI 10.1016/j.ymben.2011.05.004; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Hua YQ, 2011, J PROTEOME RES, V10, P3513, DOI 10.1021/pr200147g; Izquierdo-Garcia JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108289; Jitrapakdee S, 1999, BIOCHEM BIOPH RES CO, V266, P512, DOI 10.1006/bbrc.1999.1846; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim SH, 2007, APPL MICROBIOL BIOT, V76, P659, DOI 10.1007/s00253-007-1041-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SY, 2012, CANCER RES, V72, P3607, DOI 10.1158/0008-5472.CAN-12-0006; Leithner K, 2015, ONCOGENE, V34, P1044, DOI 10.1038/onc.2014.47; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu X, 2010, J BIOL CHEM, V285, P9317, DOI 10.1074/jbc.C110.104448; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Mego M, 2010, NAT REV CLIN ONCOL, V7, P693, DOI 10.1038/nrclinonc.2010.171; Mullen AR, 2014, CELL REP, V7, P1679, DOI 10.1016/j.celrep.2014.04.037; Nieman KM, 2013, BBA-MOL CELL BIOL L, V1831, P1533, DOI 10.1016/j.bbalip.2013.02.010; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; ROHDE M, 1991, ARCH BIOCHEM BIOPHYS, V290, P197, DOI 10.1016/0003-9861(91)90608-L; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Scott DA, 2011, J BIOL CHEM, V286, P42626, DOI 10.1074/jbc.M111.282046; Sellers K, 2015, J CLIN INVEST, V125, P687, DOI 10.1172/JCI72873; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thonpho A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055139; Thonpho A, 2010, BIOCHEM BIOPH RES CO, V393, P714, DOI 10.1016/j.bbrc.2010.02.067; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Vallee C, 2014, J BIOTECHNOL, V169, P63, DOI 10.1016/j.jbiotec.2013.11.002; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Yang M, 2011, J CLIN INVEST, V12, P3652; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508	53	64	66	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129848	10.1371/journal.pone.0129848	http://dx.doi.org/10.1371/journal.pone.0129848			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070193	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000114
J	Birko, S; Dove, ES; Ozdemir, V				Birko, Stanislav; Dove, Edward S.; Oezdemir, Vural			A Delphi Technology Foresight Study: Mapping Social Construction of Scientific Evidence on Metagenomics Tests for Water Safety	PLOS ONE			English	Article							PERSONALIZED MEDICINE; PATHOGENIC BACTERIA; SCIENCE; GOVERNANCE; PHARMACOGENOMICS; ASSOCIATION; FRAMEWORKS; INNOVATION; DIVERSITY; SOCIOLOGY	Access to clean water is a grand challenge in the 21st century. Water safety testing for pathogens currently depends on surrogate measures such as fecal indicator bacteria (e.g., E. coli). Metagenomics concerns high-throughput, culture-independent, unbiased shotgun sequencing of DNA from environmental samples that might transform water safety by detecting waterborne pathogens directly instead of their surrogates. Yet emerging innovations such as metagenomics are often fiercely contested. Innovations are subject to shaping/construction not only by technology but also social systems/values in which they are embedded, such as experts' attitudes towards new scientific evidence. We conducted a classic three-round Delphi survey, comprised of 107 questions. A multidisciplinary expert panel (n = 24) representing the continuum of discovery scientists and policymakers evaluated the emergence of metagenomics tests. To the best of our knowledge, we report here the first Delphi foresight study of experts' attitudes on (1) the top 10 priority evidentiary criteria for adoption of metagenomics tests for water safety, (2) the specific issues critical to governance of metagenomics innovation trajectory where there is consensus or dissensus among experts, (3) the anticipated time lapse from discovery to practice of metagenomics tests, and (4) the role and timing of public engagement in development of metagenomics tests. The ability of a test to distinguish between harmful and benign waterborne organisms, analytical/clinical sensitivity, and reproducibility were the top three evidentiary criteria for adoption of metagenomics. Experts agree that metagenomic testing will provide novel information but there is dissensus on whether metagenomics will replace the current water safety testing methods or impact the public health end points (e.g., reduction in boil water advisories). Interestingly, experts view the publics relevant in a "downstream capacity" for adoption of metagenomics rather than a co-productionist role at the "upstream" scientific design stage of metagenomics tests. In summary, these findings offer strategic foresight to govern metagenomics innovations symmetrically: by identifying areas where acceleration (e.g., consensus areas) and deceleration/reconsideration (e.g., dissensus areas) of the innovation trajectory might be warranted. Additionally, we show how scientific evidence is subject to potential social construction by experts' value systems and the need for greater upstream public engagement on metagenomics innovations.	[Oezdemir, Vural] Gaziantep Univ, Fac Commun, TR-27310 Sehitkamil, Gaziantep, Turkey; [Oezdemir, Vural] Gaziantep Univ, Dept Ind Engn, Off President Int Technol & Innovat Policy, TR-27310 Sehitkamil, Gaziantep, Turkey; [Oezdemir, Vural] Amrita Univ, Amrita Vishwa Vidyapeetham, Sch Biotechnol, Vallikavu, Kerala, India; [Birko, Stanislav] McGill Univ, Fac Med, Dept Human Genet, Ctr Genom & Policy, Montreal, PQ, Canada; [Dove, Edward S.] Univ Edinburgh, J Kenyon Mason Inst Med Life Sci & Law, Sch Law, Edinburgh, Midlothian, Scotland	Gaziantep University; Gaziantep University; Amrita Vishwa Vidyapeetham; McGill University; University of Edinburgh	Ozdemir, V (corresponding author), Gaziantep Univ, Fac Commun, Univ Bulvari, TR-27310 Sehitkamil, Gaziantep, Turkey.	vural.ozdemir@alumni.utoronto.ca			Genome Canada	Genome Canada(Genome Canada)	This work was supported by a research grant on technology governance to Dr. Vural Ozdemir from Genome Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akondi KB, 2013, OMICS, V17, P61, DOI 10.1089/omi.2012.0082; Beech B, 1997, J ADV NURS, V25, P331, DOI 10.1046/j.1365-2648.1997.1997025331.x; Birch K, 2013, SCI TECHNOL HUM VAL, V38, P299, DOI 10.1177/0162243912442398; Bonneuil C, 2014, SOC STUD SCI, V44, P901, DOI 10.1177/0306312714548258; Calvert J, 2013, BIOSOCIETIES, V8, P466, DOI 10.1057/biosoc.2013.27; Chow CET, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00265; Collingridge D, 1980, SOCIAL CONTROL TECHN; Cook C, 2013, CAN WATER RESOUR J, V38, P185, DOI 10.1080/07011784.2013.822186; Dandara C, 2014, OMICS, V18, P733, DOI 10.1089/omi.2014.0145; De Vries R, 2004, J LAW MED ETHICS, V32, P279, DOI 10.1111/j.1748-720X.2004.tb00475.x; Delbecq AL, 1975, J HUMAN SCI; Dove ES, 2014, EMBO REP, V15, P462, DOI 10.1002/embr.201438683; Dove Edward S., 2013, Current Pharmacogenomics & Personalized Medicine, V11, P253; Dove ES, 2013, PERS MED, V10, P213, DOI 10.2217/PME.13.10; Fancello L, 2013, ISME J, V7, P359, DOI 10.1038/ismej.2012.101; Ferguson AS, 2012, SCI TOTAL ENVIRON, V431, P314, DOI 10.1016/j.scitotenv.2012.05.060; Fisher E, 2011, SCI ENG ETHICS, V17, P607, DOI 10.1007/s11948-011-9331-x; Goldstein ST, 1996, ANN INTERN MED, V124, P459, DOI 10.7326/0003-4819-124-5-199603010-00001; Grantham TE, 2010, FRESHWATER BIOL, V55, P188, DOI 10.1111/j.1365-2427.2009.02379.x; Green B, 1999, HEALTH SOC CARE COMM, V7, P198, DOI 10.1046/j.1365-2524.1999.00176.x; GRIMES DJ, 1986, MICROBIOL SCI, V3, P324; Guston D.H., 2002, TECHNOL SOC, V24, P93, DOI [DOI 10.1016/S0160-791X(01)00047-1, https://doi.org/10.1016/S0160-791X(01)00047-1]; Guston DH, 2012, MINERVA, V50, P363, DOI 10.1007/s11024-012-9204-8; Haffeld Just, 2013, Current Pharmacogenomics & Personalized Medicine, V11, P309; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Harwood VJ, 2005, APPL ENVIRON MICROB, V71, P3163, DOI 10.1128/AEM.71.6.3163-3170.2005; Hekim N, 2014, OMICS, V18, P415, DOI 10.1089/omi.2014.0079; Hoover RS, 2011, IEEE T PROF COMMUN, V54, P68, DOI 10.1109/TPC.2009.2036896; Jasanoff S, 2013, GUARDIAN; Jin H, 2014, ANN MICROBIOL, V64, P689, DOI 10.1007/s13213-013-0704-z; McQuaig S, 2012, APPL ENVIRON MICROB, V78, P6423, DOI 10.1128/AEM.00024-12; Mead D., 2001, NURSE RES, V8, P4, DOI DOI 10.7748/nr2001.07.8.4.4.c6162; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING GE; Miller RR, 2013, GENOME MED, V5, DOI 10.1186/gm485; Neelakanta Girish, 2013, Microbiol Insights, V6, P37, DOI 10.4137/MBI.S10819; Ngueng Feze I, 2014, J ENV LAW PRACTICE, V26, P201; Ozdemir V, 2013, OMICS, V17, P1, DOI 10.1089/omi.2012.0111; Ostrom, 2015, GOVERNING COMMONS EV, DOI DOI 10.1017/CBO9780511807763; Ostrom E, 1999, ANNU REV POLIT SCI, V2, P493, DOI 10.1146/annurev.polisci.2.1.493; Ozdemir V, 2015, OXFORD TXB GLOBAL PU; Ozdemir V, 2014, ROUTLEDGE HDB GLOBAL, DOI [10.4324/9781315818719.ch6, DOI 10.4324/9781315818719.CH6]; Ozdemir V, 2015, NATURE INDI IN PRESS; Ozdemir V, 2015, AM J BIOETHICS, V15, P64, DOI 10.1080/15265161.2015.1021976; Ozdemir V, 2015, EMBO REP, V16, P267, DOI 10.15252/embr.201439548; Ozdemir V, 2014, PERS MED, V11, P687, DOI 10.2217/pme.14.70; Ozdemir V, 2014, OMICS, V18, P211, DOI 10.1089/omi.2014.0029; Ozdemir V, 2014, OMICS, V18, P1, DOI 10.1089/omi.2013.0170; Ozdemir V, 2011, OMICS, V15, P637, DOI 10.1089/omi.2011.0087; PACE NR, 1985, ASM NEWS, V51, P4; Petersen A, 2013, SOC SCI MED, V98, P264, DOI 10.1016/j.socscimed.2012.12.030; Port JA, 2014, ENVIRON HEALTH PERSP, V122, P222, DOI 10.1289/ehp.1307009; Qu XL, 2013, ACCOUNTS CHEM RES, V46, P834, DOI 10.1021/ar300029v; Rajan K.S., 2006, BIOCAPITAL CONSTITUT; Rose N, 2013, THEOR CULT SOC, V30, P3, DOI 10.1177/0263276412456569; Rowe G, 1999, INT J FORECASTING, V15, P353, DOI 10.1016/S0169-2070(99)00018-7; Staley C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00524; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Taylor-Alexander S, 2013, NEW GENET SOC, V32, P333, DOI 10.1080/14636778.2013.845076; Thoreau F, 2012, POLITICA SOC, V11, P205, DOI DOI 10.5007/2175-7984.2012v11n20p205; Tomaru A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096274; Tutton R, 2011, SOCIOL HEALTH ILL, V33, P1081, DOI 10.1111/j.1467-9566.2011.01348.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wicks P, 2011, NAT BIOTECHNOL, V29, P411, DOI 10.1038/nbt.1837; Yearley S, 2004, MAKING SENSE SCI UND; Zhao FF, 2014, OMICS, V18, P222, DOI 10.1089/omi.2013.0108; Zizek S, 2011, COMMUNICATION	67	14	15	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129706	10.1371/journal.pone.0129706	http://dx.doi.org/10.1371/journal.pone.0129706			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK3FB	26066837	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900073
J	Mancini, M; Greco, A; Tedeschi, E; Palma, G; Ragucci, M; Bruzzone, MG; Coda, ARD; Torino, E; Scotti, A; Zucca, I; Salvatore, M				Mancini, Marcello; Greco, Adelaide; Tedeschi, Enrico; Palma, Giuseppe; Ragucci, Monica; Bruzzone, Maria Grazia; Coda, Anna Rita Daniela; Torino, Enza; Scotti, Alessandro; Zucca, Ileana; Salvatore, Marco			Head and Neck Veins of the Mouse. A Magnetic Resonance, Micro Computed Tomography and High Frequency Color Doppler Ultrasound Study	PLOS ONE			English	Article							TRANSIENT GLOBAL AMNESIA; JUGULAR VENOUS REFLUX; CEREBRAL VASCULATURE; BRAIN; ANATOMY; SYSTEM	To characterize the anatomy of the venous outflow of the mouse brain using different imaging techniques. Ten C57/black male mice (age range: 7-8 weeks) were imaged with high-frequency Ultrasound, Magnetic Resonance Angiography and ex-vivo Microcomputed tomography of the head and neck. Under general anesthesia, Ultrasound of neck veins was performed with a 20MHz transducer; head and neck Magnetic Resonance Angiography data were collected on 9.4T or 7T scanners, and ex-vivo Microcomputed tomography angiography was obtained by filling the vessels with a radiopaque inert silicone rubber compound. All procedures were approved by the local ethical committee. The dorsal intracranial venous system is quite similar in mice and humans. Instead, the mouse Internal Jugular Veins are tiny vessels receiving the sigmoid sinuses and tributaries from cerebellum, occipital lobe and midbrain, while the majority of the cerebral blood, i.e. from the olfactory bulbs and fronto-parietal lobes, is apparently drained through skull base connections into the External Jugular Vein. Three main intra-extracranial anastomoses, absent in humans, are: 1) the petrosquamous sinus, draining into the posterior facial vein, 2) the veins of the olfactory bulb, draining into the superficial temporal vein through a foramen of the frontal bone 3) the cavernous sinus, draining in the External Jugular Vein through a foramen of the sphenoid bone. The anatomical structure of the mouse cranial venous outflow as depicted by Ultrasound, Microcomputed tomography and Magnetic Resonance Angiography is different from humans, with multiple connections between intra-and extra-cranial veins.	[Mancini, Marcello; Palma, Giuseppe; Coda, Anna Rita Daniela] CNR, Inst Biostruct & Bioimaging, Naples, Italy; [Greco, Adelaide; Tedeschi, Enrico; Ragucci, Monica] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [Greco, Adelaide] CEINGE Biotecnol Avanzate, Naples, Italy; [Bruzzone, Maria Grazia] IRCCS Fdn Carlo Besta Neurol Inst, Unit Neuroradiol, Milan, Italy; [Torino, Enza] Ist Italiano Tecnol, Ctr Adv Biomat Hlth Care CRIB, Naples, Italy; [Scotti, Alessandro; Zucca, Ileana] IRCCS Fdn Carlo Besta Neurol Inst, Sci Direct, Milan, Italy; [Salvatore, Marco] IRCCS SDN, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II; CEINGE Biotecnologie Avanzate; IRCCS Istituto Neurologico Besta; Istituto Italiano di Tecnologia - IIT; IRCCS Istituto Neurologico Besta; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN)	Mancini, M (corresponding author), CNR, Inst Biostruct & Bioimaging, Naples, Italy.	direttore@ibb.cnr.it	Palma, Giuseppe/GXV-0228-2022; Palma, Giuseppe/AAX-1413-2020; Greco, Adelaide/C-7679-2018; Bruzzone, Maria/AAM-4478-2021; Tedeschi, Enrico/AAN-7112-2020; Salvatore, Marco/K-8083-2016; Torino, Enza/E-9803-2011	Palma, Giuseppe/0000-0002-0210-268X; Greco, Adelaide/0000-0001-6841-1963; Bruzzone, Maria/0000-0002-2786-1471; Tedeschi, Enrico/0000-0002-0511-0132; Salvatore, Marco/0000-0001-9734-7702; Torino, Enza/0000-0002-8905-1925	Italian Ministry for Education University and Research [2010XE5L2R_004]	Italian Ministry for Education University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by a research grant from the Italian Ministry for Education University and Research in the framework of PRIN (2010XE5L2R_004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkawi NM, 2001, LANCET, V357, P639, DOI 10.1016/S0140-6736(05)71434-3; Atkinson W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033671; Beggs C, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-157; Beggs CB, 2014, J MAGN RESON IMAGING, V40, P1215, DOI 10.1002/jmri.24468; Chuang YM, 2005, EUR NEUROL, V53, P78, DOI 10.1159/000084651; Chung CP, 2007, ULTRASOUND MED BIOL, V33, P1727, DOI 10.1016/j.ultrasmedbio.2007.05.018; Chung CP, 2014, J ALZHEIMERS DIS, V39, P601, DOI 10.3233/JAD-131112; Chung CP, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-9; Chung CP, 2011, ANN NEUROL, V69, P553, DOI 10.1002/ana.22276; Chung CP, 2010, CEREBROVASC DIS, V29, P122, DOI 10.1159/000262307; Doepp F, 2008, CEPHALALGIA, V28, P182, DOI 10.1111/j.1468-2982.2007.01484.x; Dorr A, 2007, NEUROIMAGE, V35, P1409, DOI 10.1016/j.neuroimage.2006.12.040; Dorr AE, 2008, NEUROIMAGE, V42, P60, DOI 10.1016/j.neuroimage.2008.03.037; Ghanavati S, 2014, J NEUROSCI METH, V221, P70, DOI 10.1016/j.jneumeth.2013.09.002; Gisolf J, 2004, J PHYSIOL-LONDON, V560, P317, DOI 10.1113/jphysiol.2004.070409; Hofmann M, 1900, Z MORPHOL ANTHROPOL, V2, P247; Jeppsson PG, 1960, LUND U ARSSKR NF AVD, V256, P1; Krause W, 1884, ANATOMIE KANINCHENS; Lewis SL, 1998, LANCET, V352, P397, DOI 10.1016/S0140-6736(98)01442-1; Pathak AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022643; SCREMIN OU, 1982, J CEREBR BLOOD F MET, V2, P55, DOI 10.1038/jcbfm.1982.6; SZABO K, 1990, ANAT EMBRYOL, V182, P225; Valdueza JM, 2000, LANCET, V355, P200; Weyers JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3740; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zivadinov R, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-260	26	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129912	10.1371/journal.pone.0129912	http://dx.doi.org/10.1371/journal.pone.0129912			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067061	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900085
J	Bal, HK; Grewal, PS				Bal, Harit K.; Grewal, Parwinder S.			Lateral Dispersal and Foraging Behavior of Entomopathogenic Nematodes in the Absence and Presence of Mobile and Non-Mobile Hosts	PLOS ONE			English	Article							INSECT-PARASITIC NEMATODES; STEINERNEMA-CARPOCAPSAE; NEOAPLECTANA-CARPOCAPSAE; HETERORHABDITIS-MEGIDIS; FINDING ABILITY; PLANT-ROOTS; STRATEGIES; CUES; ORIENTATION; INFECTIVITY	Entomopathogenic nematodes have been classified into cruisers (active searchers) and ambushers (sit and wait foragers). However, little is known about their dispersal and foraging behavior at population level in soil. We studied lateral dispersal of the ambush foraging Steinernema carpocapsae (ALL strain) and cruise foraging Heterorhabditis bacteriophora (GPS11 strain) from infected host cadavers in microcosms (0.05 m(2)) containing Wooster silt-loam soil (Oxyaquic fragiudalf) and vegetation in the presence or absence of non-mobile and mobile hosts. Results showed that the presence of a non-mobile host (Galleria mellonella larva in a wire mesh cage) enhanced H. bacteriophora dispersal for up to 24 hr compared with no-host treatment, but had no impact on S. carpocapsae dispersal. In contrast, presence of a mobile host (G. mellonella larvae) increased dispersal of S. carpocapsae compared with no host treatment, but had no effect on H. bacteriophora dispersal. Also H. bacteriophora was better at infecting non-mobile than mobile hosts released into the microcosms and S. carpocapsae was better at infecting mobile than non-mobile hosts, thus affirming the established cruiser-ambusher theory. However, results also revealed that a large proportion of infective juveniles (IJs) of both species stayed near (<= 3.8 cm) the source cadaver (88-96% S. carpocapsae; 67-79% H. bacteriophora), and the proportion of IJs reaching the farthest distance (11.4 cm) was significantly higher for S. carpocapsae (1.4%) than H. bacteriophora (0.4%) in the presence of mobile hosts. S. carpocapsae also had higher average population displacement than H. bacteriophora in the presence of both the non-mobile (5.07 vs. 3.6 cm/day) and mobile (8.06 vs. 5.3 cm/day) hosts. We conclude that the two species differ in their dispersal and foraging behavior at the population level and this behavior is affected by both the presence and absence of hosts and by their mobility.	[Bal, Harit K.; Grewal, Parwinder S.] Ohio State Univ, Dept Entomol, OARDC, Wooster, OH USA	University System of Ohio; Ohio State University	Grewal, PS (corresponding author), Univ Tennessee, Dept Entomol Plant Pathol & Nematol, Knoxville, TN 37996 USA.	pgrewal@utk.edu			SEEDS: The OARDC Research Enhancement Competitive Grants Program The Ohio State University	SEEDS: The OARDC Research Enhancement Competitive Grants Program The Ohio State University	This work was supported by SEEDS: The OARDC Research Enhancement Competitive Grants Program The Ohio State University. (http://www.oardc.ohio-state.edu/seeds/t08_pageview/Home.htm) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATORREROSAS R, 1990, J INVERTEBR PATHOL, V55, P179, DOI 10.1016/0022-2011(90)90053-9; Ali JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038146; Ali JG, 2011, J ECOL, V99, P26, DOI 10.1111/j.1365-2745.2010.01758.x; Ali JG, 2010, J CHEM ECOL, V36, P361, DOI 10.1007/s10886-010-9773-7; Allendorf F., 2007, CONSERVATION GENETIC; Bal HK, 2014, J PARASITOL, V100, P422, DOI 10.1645/12-165.1; Bal HK, 2014, EVOL ECOL, V28, P923, DOI 10.1007/s10682-014-9706-y; BEDDING RA, 1975, NEMATOLOGICA, V21, P109, DOI 10.1163/187529275X00419; BIRD AF, 1986, INT J PARASITOL, V16, P511, DOI 10.1016/0020-7519(86)90086-X; Boff MIC, 2002, BIOCONTROL, V47, P67, DOI 10.1023/A:1014435627268; Boff MIC, 2001, ENTOMOL EXP APPL, V98, P329, DOI 10.1023/A:1018907812376; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Campbell JF, 1999, PARASITOLOGY, V118, P499, DOI 10.1017/S0031182099003984; Campbell JF, 1999, NATURE, V397, P485, DOI 10.1038/17254; Campbell JF, 1997, FUND APPL NEMATOL, V20, P393; Campbell JF, 2002, NEMATOLOGY, V4, P471, DOI 10.1163/156854102760290455; CAMPBELL JF, 1993, BEHAVIOUR, V126, P155, DOI 10.1163/156853993X00092; Cutler GC, 2003, NEMATOLOGY, V5, P601, DOI 10.1163/156854103322683319; Dillman AR, 2012, P NATL ACAD SCI USA, V109, pE2324, DOI 10.1073/pnas.1211436109; El-Borai FE, 2011, J INVERTEBR PATHOL, V106, P347, DOI 10.1016/j.jip.2010.12.001; GAUGLER R, 1989, J NEMATOL, V21, P247; GAUGLER R, 1980, ENVIRON ENTOMOL, V9, P649, DOI 10.1093/ee/9.5.649; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Glazer I, 1997, PARASITOLOGY, V114, P597; GREWAL PS, 1993, EXPERIENTIA, V49, P605, DOI 10.1007/BF01955173; GREWAL PS, 1994, PARASITOLOGY, V108, P207, DOI 10.1017/S003118200006830X; Grewal PS, 1997, J CHEM ECOL, V23, P503, DOI 10.1023/B:JOEC.0000006374.95624.7e; Griffin CT, 1996, FUND APPL NEMATOL, V19, P95; Hallem EA, 2011, CURR BIOL, V21, P377, DOI 10.1016/j.cub.2011.01.048; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; HASSELL MP, 1978, ANNU REV ECOL SYST, V9, P75, DOI 10.1146/annurev.es.09.110178.000451; Hominick W. M., 1990, Entomopathogenic nematodes in biological control., P327; Hui E, 2000, J INVERTEBR PATHOL, V75, P152, DOI 10.1006/jipa.1999.4910; Ishibashi N., 1990, P139; Kaplan F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038735; Kaya Harry K., 1997, P281, DOI 10.1016/B978-012432555-5/50016-6; Kruitbos LM, 2010, NEMATOLOGY, V12, P309, DOI 10.1163/138855409X12506855979794; Lewis EE, 2006, BIOL CONTROL, V38, P66, DOI 10.1016/j.biocontrol.2005.11.007; LEWIS EE, 1992, PARASITOLOGY, V105, P309, DOI 10.1017/S0031182000074230; LEWIS EE, 1995, PARASITOLOGY, V110, P207, DOI 10.1017/S0031182000063976; LEWIS EE, 1994, J INVERTEBR PATHOL, V64, P238, DOI 10.1016/S0022-2011(94)90325-5; LEWIS EE, 1993, CAN J ZOOL, V71, P765, DOI 10.1139/z93-101; Lewis EE, 2002, J NEMATOL, V34, P328; Mankin RW, 2002, J ECON ENTOMOL, V95, P981, DOI 10.1603/0022-0493-95.5.981; McCartney DA, 1997, SOIL BIOL BIOCHEM, V29, P397, DOI 10.1016/S0038-0717(96)00171-X; Neves JM, 1998, NEMATOLOGICA, V44, P95, DOI 10.1163/005225998X00109; O'Halloran DM, 2003, PARASITOLOGY, V127, P375, DOI 10.1017/S0031182003003688; OBRIEN WJ, 1989, OECOLOGIA, V80, P100, DOI 10.1007/BF00789938; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Rasmann S, 2012, J CHEM ECOL, V38, P615, DOI 10.1007/s10886-012-0118-6; SAS Institute Inc, 2012, WHATS NEW IN SAS 9 3; SCHMIDT J, 1979, ENVIRON ENTOMOL, V8, P55, DOI 10.1093/ee/8.1.55; SELVAN S, 1993, J PARASITOL, V79, P167, DOI 10.2307/3283503; Shapiro-Ilan DI, 2014, INT J PARASITOL, V44, P49, DOI 10.1016/j.ijpara.2013.10.002; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; SOUTHWOOD TRE, 1977, J ANIM ECOL, V46, P337; Taylor L.R., 1986, P265; TAYLOR LR, 1977, NATURE, V265, P415, DOI 10.1038/265415a0; Torr P, 2004, INT J PARASITOL, V34, P997, DOI 10.1016/j.ijpara.2004.05.003; Travis JMJ, 2001, ECOL RES, V16, P157, DOI 10.1046/j.1440-1703.2001.00381.x; Turlings TCJ, 2012, PLANT SOIL, V358, P47, DOI 10.1007/s11104-012-1295-3; van Tol RWHM, 2001, ECOL LETT, V4, P292, DOI 10.1046/j.1461-0248.2001.00227.x; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a; Wilson MJ, 2012, NEMATOLOGY, V14, P389, DOI 10.1163/156854111X617428; Yoder CA, 2004, J PARASITOL, V90, P1229, DOI 10.1645/GE-3315	66	25	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129887	10.1371/journal.pone.0129887	http://dx.doi.org/10.1371/journal.pone.0129887			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079715	Green Published, Green Submitted, gold			2022-12-27	WOS:000356542300034
J	Dal Bosco, L; Weber, GE; Parfitt, GM; Cordeiro, AP; Sahoo, SK; Fantini, C; Klosterhoff, MC; Romano, LA; Furtado, CA; Santos, AP; Monserrat, JM; Barros, DM				Dal Bosco, Lidiane; Weber, Gisele E.; Parfitt, Gustavo M.; Cordeiro, Arthur P.; Sahoo, Sangram K.; Fantini, Cristiano; Klosterhoff, Marta C.; Romano, Luis Alberto; Furtado, Clascidia A.; Santos, Adelina P.; Monserrat, Jose M.; Barros, Daniela M.			Biopersistence of PEGylated Carbon Nanotubes Promotes a Delayed Antioxidant Response after Infusion into the Rat Hippocampus	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; OXIDATIVE STRESS; BRAIN; DYSFUNCTION; EVALUATE; NEURONS; DAMAGE; SWCNT; FEAR	Carbon nanotubes are promising nanomaterials for the diagnosis and treatment of brain disorders. However, the ability of these nanomaterials to cross cell membranes and interact with neural cells brings the need for the assessment of their potential adverse effects on the nervous system. This study aimed to investigate the biopersistence of single-walled carbon nanotubes functionalized with polyethylene glycol (SWCNT-PEG) directly infused into the rat hippocampus. Contextual fear conditioning, Y-maze and open field tasks were performed to evaluate the effects of SWCNT-PEG on memory and locomotor activity. The effects of SWCNT-PEG on oxidative stress and morphology of the hippocampus were assessed 1 and 7 days after infusion of the dispersions at 0.5, 1.0 and 2.1 mg/mL. Raman analysis of the hippocampal homogenates indicates the biopersistence of SWCNT-PEG in the hippocampus 7 days post-injection. The infusion of the dispersions had no effect on the acquisition or persistence of the contextual fear memory; likewise, the spatial recognition memory and locomotor activity were not affected by SWCNT-PEG. Histological examination revealed no remarkable morphological alterations after nanomaterial exposure. One day after the infusion, SWCNT-PEG dispersions at 0.5 and 1.0 mg/mL were able to decrease total antioxidant capacity without modifying the levels of reactive oxygen species or lipid hydroperoxides in the hippocampus. Moreover, SWCNT-PEG dispersions at all concentrations induced antioxidant defenses and reduced reactive oxygen species production in the hippocampus at 7 days post-injection. In this work, we found a time-dependent change in antioxidant defenses after the exposure to SWCNT-PEG. We hypothesized that the persistence of the nanomaterial in the tissue can induce an antioxidant response that might have provided resistance to an initial insult. Such antioxidant delayed response may constitute an adaptive response to the biopersistence of SWCNT-PEG in the hippocampus.	[Dal Bosco, Lidiane; Weber, Gisele E.; Parfitt, Gustavo M.; Monserrat, Jose M.; Barros, Daniela M.] Univ Fed Rio Grande, Inst Ciencias Biol, Programa Posgrad Ciencias Fisiol Fisiol Anim Comp, Rio Grande, RS, Brazil; [Cordeiro, Arthur P.] Univ Fed Rio Grande, Escola Quim & Alimentos, Rio Grande, RS, Brazil; [Sahoo, Sangram K.; Fantini, Cristiano] Univ Fed Minas Gerais, Dept Fis, Inst Ciencias Exatas, BR-30161 Belo Horizonte, MG, Brazil; [Klosterhoff, Marta C.; Romano, Luis Alberto] Univ Fed Rio Grande, Inst Oceanog, Programa Posgrad Aquicultura, Rio Grande, RS, Brazil; [Furtado, Clascidia A.; Santos, Adelina P.] Ctr Desenvolvimento Tecnol Nucl, Lab Quim Nanoestruturas, Belo Horizonte, MG, Brazil	Universidade Federal do Rio Grande; Universidade Federal do Rio Grande; Universidade Federal de Minas Gerais; Universidade Federal do Rio Grande; Centro de Desenvolvimento da Tecnologia Nuclear (CDTN)	Barros, DM (corresponding author), Univ Fed Rio Grande, Inst Ciencias Biol, Programa Posgrad Ciencias Fisiol Fisiol Anim Comp, Rio Grande, RS, Brazil.	barrosdm@yahoo.com.br	Leite, Cristiano Fantini/N-3946-2017; Santos, Adelina/V-3087-2019; Monserrat, Jose Maria/L-1154-2014; Furtado, Clascidia/AAE-2801-2020	Monserrat, Jose Maria/0000-0002-9463-3049; Romano, Luis/0000-0003-3144-3579; Poester Cordeiro, Arthur/0000-0001-6660-004X; Parfitt, Gustavo/0000-0003-0168-4099	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul [11/2037-9]; Nanotoxicology Network - National Council for Scientific and Technological Development - CNPq [552131/2011-3]; Instituto Nacional de Ciencia e Tecnologia de Nanomateriais de Carbono - CNPq [574020/2008-0]; CNPq	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Nanotoxicology Network - National Council for Scientific and Technological Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Nanomateriais de Carbono - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	DB was supported by Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, process number 11/2037-9. www.fapergs.rs.gov.br. DB and JM were supported by Nanotoxicology Network - National Council for Scientific and Technological Development - CNPq, process number 552131/2011-3. www.cnpq.br. DB, JM, CF, CAF, AS were supported by Instituto Nacional de Ciencia e Tecnologia de Nanomateriais de Carbono - CNPq process number 574020/2008-0). www.cnpq.br. DB, JM, CF, CAF, AS were also supported by productivity research fellowships from CNPq. www.cnpq.br.	Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Acheson DT, 2012, NEUROPHARMACOLOGY, V62, P674, DOI 10.1016/j.neuropharm.2011.04.029; Al Faraj A, 2011, INT J NANOMED, V6, P351, DOI 10.2147/IJN.S16653; Al-Jamal KT, 2011, P NATL ACAD SCI USA, V108, P10952, DOI 10.1073/pnas.1100930108; Allen BL, 2009, J AM CHEM SOC, V131, P17194, DOI 10.1021/ja9083623; Amado LL, 2009, SCI TOTAL ENVIRON, V407, P2115, DOI 10.1016/j.scitotenv.2008.11.038; Bagheri M, 2011, NEUROBIOL LEARN MEM, V95, P270, DOI 10.1016/j.nlm.2010.12.001; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Cai XQ, 2008, J NEUROSCI RES, V86, P3622, DOI 10.1002/jnr.21805; Cellot G, 2010, SMALL, V6, P2630, DOI 10.1002/smll.201000906; Crouzier D, 2010, TOXICOLOGY, V272, P39, DOI 10.1016/j.tox.2010.04.001; da Rocha AM, 2013, COMP BIOCHEM PHYS A, V165, P460, DOI 10.1016/j.cbpa.2013.03.025; Dal Bosco L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/104135; de Aguiar RB, 2008, BIOGERONTOLOGY, V9, P285, DOI 10.1007/s10522-008-9137-7; Dillon AC, 2004, J NANOSCI NANOTECHNO, V4, P691, DOI 10.1166/jnn.2004.116; Dresselhaus MS, 2003, J NANOSCI NANOTECHNO, V3, P19, DOI 10.1166/jnn.2003.189; Fabbro A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073621; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Fenoglio I, 2006, FREE RADICAL BIO MED, V40, P1227, DOI 10.1016/j.freeradbiomed.2005.11.010; Galhardi F, 2009, FOOD CHEM TOXICOL, V47, P2655, DOI 10.1016/j.fct.2009.07.030; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Kagan VE, 2010, NAT NANOTECHNOL, V5, P354, DOI [10.1038/NNANO.2010.44, 10.1038/nnano.2010.44]; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kotchey GP, 2013, J MATER CHEM B, V1, P302, DOI 10.1039/c2tb00047d; Kuzmany H, 2001, EUR PHYS J B, V22, P307, DOI 10.1007/s100510170108; Lee HJ, 2011, NAT NANOTECHNOL, V6, P120, DOI 10.1038/nnano.2010.281; Liu XY, 2010, CARBON, V48, P1961, DOI 10.1016/j.carbon.2010.02.002; Liu XD, 2014, INT J NANOMED, V9, P823, DOI 10.2147/IJN.S56339; Liu Z, 2008, P NATL ACAD SCI USA, V105, P1410, DOI 10.1073/pnas.0707654105; Maher P, 2006, ANTIOXID REDOX SIGN, V8, P1941, DOI 10.1089/ars.2006.8.1941; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Meng L, 2013, TOXICOLOGY, V313, P49, DOI 10.1016/j.tox.2012.11.011; Monserrat JM, 2003, ARCH ENVIRON CON TOX, V45, P177, DOI 10.1007/s00244-003-0073-x; Nunes A, 2012, NANOMEDICINE-UK, V7, P1485, DOI [10.2217/NNM.12.33, 10.2217/nnm.12.33]; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pickering C, 2015, PHARMACOL BIOCHEM BE, V132, P63, DOI 10.1016/j.pbb.2015.02.021; Pioli EY, 2008, NEUROSCIENCE, V153, P1213, DOI 10.1016/j.neuroscience.2008.01.084; Ren JF, 2012, BIOMATERIALS, V33, P3324, DOI 10.1016/j.biomaterials.2012.01.025; Ren L, 2010, ENVIRON SCI TECHNOL, V44, P6954, DOI 10.1021/es101821m; Shvedova AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030923; Vlasova II, 2012, TOXICOL APPL PHARM, V264, P131, DOI 10.1016/j.taap.2012.07.027; Wang JY, 2012, TOXICOL IN VITRO, V26, P32, DOI 10.1016/j.tiv.2011.10.004; Weber GEB, 2014, TOXICOL APPL PHARM, V280, P484, DOI 10.1016/j.taap.2014.08.018; White CC, 2003, ANAL BIOCHEM, V318, P175, DOI 10.1016/S0003-2697(03)00143-X; Zhang YB, 2011, ACS NANO, V5, P7020, DOI 10.1021/nn2016259	45	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129156	10.1371/journal.pone.0129156	http://dx.doi.org/10.1371/journal.pone.0129156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075787	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900047
J	Merlin, A; Bonis, A; Damgaard, CF; Mesleard, F				Merlin, Amandine; Bonis, Anne; Damgaard, Christian F.; Mesleard, Francois			Competition Is a Strong Driving Factor in Wetlands, Peaking during Drying Out Periods	PLOS ONE			English	Article							SPATIAL-PATTERNS; POSITIVE INTERACTIONS; PLANT INTERACTIONS; FLOODING GRADIENT; GROWTH; VEGETATION; DEPTH; MARSH; DISTURBANCE; MECHANISMS	The aim of the study is to investigate the relative importance of plant-plant interactions with regard to flooding and drought effect on perennial plant performances in wetlands. Flooding is expected to be the major driver and, accordingly, the importance of drought is hardly if ever taken into account. Focusing on five widespread species, the growth, the survival and the competitive ability of plants were monitored on permanent plots spread along two elevation gradients. Flooding duration and drought intensity were found to vary substantially along the similar to 0.5 meter range elevation gradient. Flooding and drought alternate over the hydrological year and the pin-point surveys were thus conducted over the course of one year. The data were modeled taking into account survival, recruitment and competitive growth throughout flooding and drying out periods. Flooding and drought both directly impacted the plant performances and their competitive effect, with the effect of drought being much more general among species and of higher magnitude than flooding. The importance of competition was found to be high for all species, particularly during the drying out period. It varied more along the flooding gradient than along the drought gradient. The higher flooding tolerance shown by the studied species compared to drought may be related to species specific growth timing together with efficient response traits. These results offer new insights into the filters operating over the species pools. This suggests that the drying out period and drought conditions may be even more important for species' relative success and the importance of competition than the flooding pattern. The general applicability of this result, obtained in mild Atlantic climate and fertile wetlands, remains to be studied.	[Merlin, Amandine; Bonis, Anne] Univ Rennes 1, CNRS, OSUR, UMR ECOBIO Ecosyst 6553,Biodivers,Evolut, Rennes, France; [Merlin, Amandine; Mesleard, Francois] Ctr Rech Tour du Valat, Arles, France; [Damgaard, Christian F.] Aarhus Univ, Dept Biosci Plant & Insect Ecol, Silkeborg, Denmark; [Mesleard, Francois] UMR CNRS 7263 IRD 237 Aix Marseille Univ, IUT Univ Avignon & Pays Vaucluse, Inst Mediterraneen Biodivers & Ecol, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Universite Rennes 2; Universite de Rennes; Aarhus University; UDICE-French Research Universities; Aix-Marseille Universite	Bonis, A (corresponding author), Univ Rennes 1, CNRS, OSUR, UMR ECOBIO Ecosyst 6553,Biodivers,Evolut, Rennes, France.	anne.bonis@univ-rennes1.fr	Bonis, Anne/AAJ-1009-2021; Damgaard, Christian/G-2441-2010	Damgaard, Christian/0000-0003-3932-4312; Bonis, Anne/0000-0001-5034-9575	Ministere de l'Enseignement Superieur et de la Recherche Francais; Parc Naturel Regional du Marais poitevin	Ministere de l'Enseignement Superieur et de la Recherche Francais; Parc Naturel Regional du Marais poitevin	AM received a PhD grant from the Ministere de l'Enseignement Superieur et de la Recherche Francais. The Parc Naturel Regional du Marais poitevin provided the funding for maintaining the in situ grazing experimental setting. The authors thank the mairie des Magnils-Reigniers for granting permission to work in the common.	Aarssen LW, 2002, OIKOS, V96, P531, DOI 10.1034/j.1600-0706.2002.960314.x; Amiaud B, 1998, WETLANDS, V18, P482, DOI 10.1007/BF03161540; [Anonymous], 2001, PLANT STRATEGIES VEG; Baldwin AH, 2001, WETLANDS, V21, P519, DOI 10.1672/0277-5212(2001)021[0519:HCAVOT]2.0.CO;2; BARBOUR MG, 1978, OECOLOGIA, V37, P93, DOI 10.1007/BF00349995; Bartelheimer M, 2010, J ECOL, V98, P126, DOI 10.1111/j.1365-2745.2009.01598.x; Benot ML, 2011, BOTANY, V89, P43, DOI 10.1139/B10-082; Benot ML, 2010, EVOL ECOL, V24, P1475, DOI 10.1007/s10682-010-9415-0; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; BERTNESS MD, 1987, ECOL MONOGR, V57, P129, DOI 10.2307/1942621; Bouzille JB, 1997, PLANT ECOL, V132, P39, DOI 10.1023/A:1009743018006; Brooker RW, 2008, J ECOL, V96, P703, DOI 10.1111/j.1365-2745.2008.01373.x; Brooker RW, 1998, OIKOS, V81, P196, DOI 10.2307/3546481; Brose U, 2005, PLANT ECOL, V178, P51, DOI 10.1007/s11258-004-2487-6; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Casanova MT, 2000, PLANT ECOL, V147, P237, DOI 10.1023/A:1009875226637; CLEVERING OA, 1995, NEW PHYTOL, V130, P105, DOI 10.1111/j.1469-8137.1995.tb01820.x; COOPER A, 1982, NEW PHYTOL, V90, P263, DOI 10.1111/j.1469-8137.1982.tb03258.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Damgaard C, 2014, J ENVIRON SCI HEAL B, V49, P897, DOI 10.1080/03601234.2014.951571; Damgaard C, 2011, AGR ECOSYST ENVIRON, V142, P374, DOI 10.1016/j.agee.2011.06.008; Damgaard C, 2010, J ECOL, V98, P1, DOI 10.1111/j.1365-2745.2009.01587.x; Damgaard C, 2009, PLANT ECOL, V201, P687, DOI 10.1007/s11258-008-9521-z; De Wilde M, 2014, EVOL ECOL, V28, P1155, DOI 10.1007/s10682-014-9725-8; DONG M, 1994, OIKOS, V70, P99, DOI 10.2307/3545704; Dumont B, 2012, AGR ECOSYST ENVIRON, V153, P50, DOI 10.1016/j.agee.2012.03.003; Erler DV, 2010, LIMNOL OCEANOGR, V55, P1172, DOI 10.4319/lo.2010.55.3.1172; Fayolle A, 2009, OECOLOGIA, V159, P817, DOI 10.1007/s00442-008-1254-0; Feng S, 2014, WATER AIR SOIL POLL, V225, P1; Fraser LH, 2008, PLANT ECOL, V195, P33, DOI 10.1007/s11258-007-9296-7; Freckleton RP, 2009, J ECOL, V97, P379, DOI 10.1111/j.1365-2745.2009.01497.x; Gardarin A, 2014, J APPL ECOL, V51, P1207, DOI 10.1111/1365-2664.12293; Gaucherand S, 2006, J VEG SCI, V17, P455, DOI 10.1111/j.1654-1103.2006.tb02466.x; Goldberg D. E., 1990, Perspectives on plant competition., P27; Gowing D. J. G., 1998, HYDROLOGY CHANGING E, VI, P473; Guo HY, 2012, ECOLOGY, V93, P90, DOI 10.1890/11-0487.1; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; Howard TG, 2001, ECOLOGY, V82, P979, DOI 10.1890/0012-9658(2001)082[0979:CRHFGG]2.0.CO;2; Jung V, 2009, J VEG SCI, V20, P433, DOI 10.1111/j.1654-1103.2009.05786.x; La Peyre MKG, 2001, ECOLOGY, V82, P62, DOI 10.2307/2680086; Lenssen JPM, 2004, J ECOL, V92, P696, DOI 10.1111/j.0022-0477.2004.00895.x; Lenssen JPM, 2004, J VEG SCI, V15, P305, DOI 10.1658/1100-9233(2004)015[0305:DDFWCM]2.0.CO;2; Lenssen JPM, 1998, PLANT ECOL, V139, P13, DOI 10.1023/A:1009754505028; Lucassen ECHET, 2005, PLANT SOIL, V269, P109, DOI 10.1007/s11104-004-0554-3; Maalouf JP, 2012, ANN BOT-LONDON, V110, P821, DOI 10.1093/aob/mcs152; MESLEARD F, 1995, J VEG SCI, V6, P683, DOI 10.2307/3236438; Mony C, 2010, AQUAT BOT, V92, P99, DOI 10.1016/j.aquabot.2009.10.011; Mueller-Dombois D, 1996, ECOLOGY, V47, P644; Peltzer DA, 2001, J ECOL, V89, P519, DOI 10.1046/j.1365-2745.2001.00570.x; Rascio N, 2002, CRIT REV PLANT SCI, V21, P401, DOI 10.1080/0735-260291044296; Rossignol N, 2006, APPL SOIL ECOL, V31, P62, DOI 10.1016/j.apsoil.2005.04.004; SHIPLEY B, 1991, CAN J BOT, V69, P1420, DOI 10.1139/b91-184; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; SOUKUPOVA L, 1994, FOLIA GEOBOT PHYTOTX, V29, P227, DOI 10.1007/BF02803797; van Eck WHJM, 2004, OIKOS, V107, P393, DOI 10.1111/j.0030-1299.2004.13083.x; Violle C, 2006, IAHS-AISH P, V303, P334; Violle C, 2011, OIKOS, V120, P389, DOI 10.1111/j.1600-0706.2010.18525.x; Volder A, 1997, AQUAT BOT, V58, P113, DOI 10.1016/S0304-3770(97)00018-1; Warwick NWM, 2003, AQUAT BOT, V77, P153, DOI 10.1016/S0304-3770(03)00102-5; WELDEN CW, 1986, Q REV BIOL, V61, P23, DOI 10.1086/414724; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; WILSON SD, 1986, ECOLOGY, V67, P1236, DOI 10.2307/1938679	63	12	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130152	10.1371/journal.pone.0130152	http://dx.doi.org/10.1371/journal.pone.0130152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075597	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900145
J	Yuri, S; Nishikawa, M; Yanagawa, N; Jo, OD; Yanagawa, N				Yuri, Shunsuke; Nishikawa, Masaki; Yanagawa, Naomi; Jo, Oak D.; Yanagawa, Norimoto			Maintenance of Mouse Nephron Progenitor Cells in Aggregates with Gamma-Secretase Inhibitor	PLOS ONE			English	Article							KIDNEY DEVELOPMENT; IN-VIVO; DIFFERENTIATION; REAGGREGATION; DISSOCIATION; MESENCHYME; RENEWAL; IDENTIFICATION; ORGANOGENESIS; MORPHOGENESIS	Knowledge on how to maintain and expand nephron progenitor cells (NPC) in vitro is important to provide a potentially valuable source for kidney replacement therapies. In our present study, we examined the possibility of optimizing NPC maintenance in the "re-aggregate" system. We found that Six2-expressing (Six2(+))-NPC could be maintained in aggregates reconstituted with dispersed cells from E12.5 mouse embryonic kidneys for at least up to 21 days in culture. The maintenance of Six2(+)-NPC required the presence of ureteric bud cells. The number of Six2(+)-NPC increased by more than 20-fold at day 21, but plateaued after day 14. In an attempt to further sustain NPC proliferation by passage subculture, we found that the new (P1) aggregates reconstituted from the original (P0) aggregates failed to maintain NPC. However, based on the similarity between P1 aggregates and aggregates derived from E15.5 embryonic kidneys, we suspected that the differentiated NPC in P1 aggregates may interfere with NPC maintenance. In support of this notion, we found that preventing NPC differentiation by DAPT, a gamma-secretase inhibitor that inhibits Notch signaling pathway, was effective to maintain and expand Six2(+)-NPC in P1 aggregates by up to 65-fold. The Six2(+)-NPC in P1 aggregates retained their potential to epithelialize upon exposure to Wnt signal. In conclusion, we demonstrated in our present study that the "re-aggregation" system can be useful for in vitro maintenance of NPC when combined with gamma-secretase inhibitor.	[Yuri, Shunsuke; Nishikawa, Masaki; Yanagawa, Naomi; Jo, Oak D.; Yanagawa, Norimoto] Greater Los Angeles Vet Affairs Healthcare Syst S, Med & Res Serv, Sepulveda, CA 91343 USA; [Yuri, Shunsuke; Nishikawa, Masaki; Yanagawa, Naomi; Jo, Oak D.; Yanagawa, Norimoto] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Yuri, S (corresponding author), Greater Los Angeles Vet Affairs Healthcare Syst S, Med & Res Serv, Sepulveda, CA 91343 USA.	shunsukeyuri@ucla.edu; nori@ucla.edu			Chau-Li Foundation	Chau-Li Foundation	This study was supported by generous funds provided by the Chau-Li Foundation (to NY).	Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Blank U, 2009, DEVELOPMENT, V136, P3557, DOI 10.1242/dev.036335; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Brown AC, 2013, P NATL ACAD SCI USA, V110, P4640, DOI 10.1073/pnas.1213971110; Brown AC, 2011, DEVELOPMENT, V138, P5099, DOI 10.1242/dev.065995; Buck SB, 2008, BIOTECHNIQUES, V44, P927, DOI 10.2144/000112812; Carroll TJ, 2013, J AM SOC NEPHROL, V24, P873, DOI 10.1681/ASN.2012090931; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Chang CH, 2012, NEPHRON EXP NEPHROL, V121, pE79, DOI 10.1159/000345514; Cheng HT, 2003, DEVELOPMENT, V130, P5031, DOI 10.1242/dev.00697; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Chi X, 2009, GENESIS, V47, P61, DOI 10.1002/dvg.20452; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Das A, 2013, NAT CELL BIOL, V15, P1035, DOI 10.1038/ncb2828; Davies JA, 2014, PEDIATR NEPHROL, V29, P519, DOI 10.1007/s00467-013-2579-4; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; Fetting JL, 2014, DEVELOPMENT, V141, P17, DOI 10.1242/dev.089078; Fujimura S, 2010, J AM SOC NEPHROL, V21, P803, DOI 10.1681/ASN.2009040353; Ganeva V, 2011, ORGANOGENESIS, V7, P83, DOI 10.4161/org.7.2.14881; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; Hendry C, 2011, PEDIATR NEPHROL, V26, P1395, DOI 10.1007/s00467-010-1750-4; Herzlinger D, 2014, SEMIN CELL DEV BIOL, V36, P50, DOI 10.1016/j.semcdb.2014.08.002; Hum S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088400; Kanda S, 2014, J AM SOC NEPHROL, V25, P2584, DOI 10.1681/ASN.2013080896; Karner CM, 2011, DEVELOPMENT, V138, P1247, DOI 10.1242/dev.057646; Karner CM, 2010, DEV DYNAM, V239, P2014, DOI 10.1002/dvdy.22340; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kobayashi A, 2014, STEM CELL REP, V3, P650, DOI 10.1016/j.stemcr.2014.08.008; Kopan R, 2014, CURR TOP DEV BIOL, V107, P293, DOI 10.1016/B978-0-12-416022-4.00011-1; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuure S, 2007, J AM SOC NEPHROL, V18, P1130, DOI 10.1681/ASN.2006111206; Liu ZY, 2013, DEV CELL, V25, P585, DOI 10.1016/j.devcel.2013.05.022; Mendelsohn C, 1999, DEVELOPMENT, V126, P1139; Nishinakamura R, 2011, PEDIATR NEPHROL, V26, P1463, DOI 10.1007/s00467-011-1806-0; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Short KM, 2014, DEV CELL, V29, P188, DOI 10.1016/j.devcel.2014.02.017; Unbekandt M, 2010, KIDNEY INT, V77, P407, DOI 10.1038/ki.2009.482; Xinaris C, 2012, J AM SOC NEPHROL, V23, P1857, DOI 10.1681/ASN.2012050505	40	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129242	10.1371/journal.pone.0129242	http://dx.doi.org/10.1371/journal.pone.0129242			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075891	Green Published, gold			2022-12-27	WOS:000356329900057
J	El Majdoub, F; Hunsche, S; Igressa, A; Kocher, M; Sturm, V; Maarouf, M				El Majdoub, Faycal; Hunsche, Stefan; Igressa, Alhadi; Kocher, Martin; Sturm, Volker; Maarouf, Mohammad			Stereotactic LINAC-Radiosurgery for Glomus Jugulare Tumors: A Long-Term Follow-Up of 27 Patients	PLOS ONE			English	Article							GAMMA-KNIFE RADIOSURGERY; ACCELERATOR-BASED RADIOSURGERY; RADIATION-THERAPY; TEMPORAL BONE; SKULL BASE; SURGERY; PARAGANGLIOMAS; MANAGEMENT; RADIOTHERAPY; HEAD	Background The optimal treatment of glomus jugulare tumors (GJTs) remains controversial. Due to the critical location, microsurgery still provides high treatment-related morbidity and a decreased quality of life. Thus, we performed stereotactical radiosurgery (SRS) for the treatment of GJTs and evaluated the long-term outcome. Methods Between 1991 and 2011, 32 patients with GJTs underwent SRS using a linear accelerator (LINAC) either as primary or salvage therapy. Twenty-seven patients (median age 59.9 years, range 28.7-79.9 years) with a follow-up greater than five years (median 11 years, range 5.3-22.1 years) were selected for retrospective analysis. The median therapeutic single dose applied to the tumor surface was 15 Gy (range 11-20 Gy) and the median tumor volume was 9.5 ml (range 2.8-51 ml). Results Following LINAC-SRS, 10 of 27 patients showed a significant improvement of their previous neurological complaints, whereas 12 patients remained unchanged. Five patients died during follow-up due to old age or other, not treatment-related reasons. MR-imaging showed a partial remission in 12 and a stable disease in 15 patients. No tumor progression was observed. The actuarial overall survival rates after five, ten and 20 years were 100%, 95.2% and 79.4%, respectively. Conclusions Stereotactic LINAC-Radiosurgery can achieve an excellent long-term tumor control beside a low rate of morbidity in the treatment of GJTs. It should be considered as an alternative therapy regime to surgical resection or fractionated external beam radiation either as primary, adjuvant or salvage therapy.	[El Majdoub, Faycal; Hunsche, Stefan; Sturm, Volker; Maarouf, Mohammad] Univ Hosp Cologne, Dept Stereotaxy & Funct Neurosurg, Cologne, Germany; [El Majdoub, Faycal; Hunsche, Stefan; Maarouf, Mohammad] Univ Witten Herdecke, CMMC, Dept Stereotaxy & Funct Neurosurg, Cologne, Germany; [Igressa, Alhadi] Univ Witten Herdecke, CMMC, Dept Neurosurg, Cologne, Germany; [Kocher, Martin] Univ Hosp Cologne, Dept Radiat Oncol, Cologne, Germany; [Sturm, Volker] Univ Hosp Wurzburg, Dept Neurosurg, Wurzburg, Germany	University of Cologne; University of Cologne; Witten Herdecke University; University of Cologne; Witten Herdecke University; University of Cologne; University of Wurzburg	El Majdoub, F (corresponding author), Univ Hosp Cologne, Dept Stereotaxy & Funct Neurosurg, Cologne, Germany.	elmajdoubf@kliniken-koeln.de						Al-Mefty O, 2002, J NEUROSURG, V97, P1356, DOI 10.3171/jns.2002.97.6.1356; COLE JM, 1994, LARYNGOSCOPE, V104, P1461; DEJONG AL, 1995, AM J OTOL, V16, P283; Eustacchio S, 2002, ACT NEUR S, V84, P91; Eustacchio S, 1999, ACTA NEUROCHIR, V141, P811, DOI 10.1007/s007010050381; Feigenberg SJ, 2002, HEAD NECK-J SCI SPEC, V24, P384, DOI 10.1002/hed.10064; FISCH U, 1978, J LARYNGOL OTOL, V92, P949, DOI 10.1017/S0022215100086382; Foote RL, 1997, INT J RADIAT ONCOL, V38, P491, DOI 10.1016/S0360-3016(97)89482-5; Foote RL, 2002, HEAD NECK-J SCI SPEC, V24, P332, DOI 10.1002/hed.10005; FULLER AM, 1967, LARYNGOSCOPE, V77, P218, DOI 10.1288/00005537-196702000-00006; GABRIEL EM, 1995, NEUROSURGERY, V37, P1001, DOI 10.1227/00006123-199511000-00022; GHANI GA, 1983, ANESTH ANALG, V62, P686; GREEN JD, 1994, LARYNGOSCOPE, V104, P917; GULYA AJ, 1993, LARYNGOSCOPE, V103, P7; Guss ZD, 2011, INT J RADIAT ONCOL, V81, pE497, DOI 10.1016/j.ijrobp.2011.05.006; Ivan ME, 2011, J NEUROSURG, V114, P1299, DOI 10.3171/2010.9.JNS10699; Jackson CG, 2001, OTOL NEUROTOL, V22, P377, DOI 10.1097/00129492-200105000-00018; Jansen JC, 2000, CANCER-AM CANCER SOC, V88, P2811, DOI 10.1002/1097-0142(20000615)88:12<2811::AID-CNCR21>3.3.CO;2-Z; Jordan JA, 2000, LARYNGOSCOPE, V110, P35, DOI 10.1097/00005537-200001000-00007; LALWANI AK, 1993, AM J OTOL, V14, P398; LARNER JM, 1992, CANCER, V69, P1813; Lim M, 2003, TECHNOL CANCER RES T, V2, P261, DOI 10.1177/153303460300200308; Liscak R, 1999, ACTA NEUROCHIR, V141, P1141, DOI 10.1007/s007010050411; Maarouf M, 2003, CANCER, V97, P1093, DOI 10.1002/cncr.11118; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; MUKHERJI SK, 1994, AM J NEURORADIOL, V15, P357; Pareschi R, 2003, SKULL BASE-INTERD AP, V13, P149, DOI 10.1055/s-2003-43325; Petropoulos AE, 2000, LARYNGOSCOPE, V110, P1225, DOI 10.1097/00005537-200007000-00030; Pollock Bruce E, 2004, Neurosurg Focus, V17, pE10; POWELL S, 1992, INT J RADIAT ONCOL, V22, P919, DOI 10.1016/0360-3016(92)90788-J; Poznanovic SA, 2006, OTOLARYNG HEAD NECK, V134, P437, DOI 10.1016/j.otohns.2005.10.040; PREISSIG SH, 1979, CANCER, V43, P2243, DOI 10.1002/1097-0142(197906)43:6<2243::AID-CNCR2820430614>3.0.CO;2-K; Sanna M, 2006, OTOLARYNG CLIN N AM, V39, P763, DOI 10.1016/j.otc.2006.04.004; Saringer W, 2001, MINIM INVAS NEUROSUR, V44, P141, DOI 10.1055/s-2001-18162; Sheehan J, 2005, J NEUROSURG, V102, P241, DOI 10.3171/jns.2005.102.s_supplement.0241; SPRINGATE SC, 1990, HEAD NECK-J SCI SPEC, V12, P303, DOI 10.1002/hed.2880120405; STURM V, 1983, ACTA NEUROCHIR, V68, P11, DOI 10.1007/BF01406197; Suarez C, 2013, HEAD NECK-J SCI SPEC, V35, P1195, DOI 10.1002/hed.22976; THEDINGER BA, 1992, LARYNGOSCOPE, V102, P261; Treuer H, 2000, PHYS MED BIOL, V45, P2331, DOI 10.1088/0031-9155/45/8/318; Voges J, 1996, INT J RADIAT ONCOL, V36, P1055, DOI 10.1016/S0360-3016(96)00422-1; WATKINS LD, 1994, ACTA NEUROCHIR, V130, P66, DOI 10.1007/BF01405504; Zabel A, 2004, INT J RADIAT ONCOL, V58, P1445, DOI 10.1016/j.ijrobp.2003.09.070	43	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129057	10.1371/journal.pone.0129057	http://dx.doi.org/10.1371/journal.pone.0129057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069957	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000041
J	Freitas, J; Teixeira, A; Silva, S; Oliveira, C; Dias, MS				Freitas, Joao; Teixeira, Antonio; Silva, Samuel; Oliveira, Catarina; Dias, Miguel Sales			Detecting Nasal Vowels in Speech Interfaces Based on Surface Electromyography	PLOS ONE			English	Article							MUSCLE-ACTIVITY; UPRIGHT	Nasality is a very important characteristic of several languages, European Portuguese being one of them. This paper addresses the challenge of nasality detection in surface electromyography (EMG) based speech interfaces. We explore the existence of useful information about the velum movement and also assess if muscles deeper down in the face and neck region can be measured using surface electrodes, and the best electrode location to do so. The procedure we adopted uses Real-Time Magnetic Resonance Imaging (RT-MRI), collected from a set of speakers, providing a method to interpret EMG data. By ensuring compatible data recording conditions, and proper time alignment between the EMG and the RT-MRI data, we are able to accurately estimate the time when the velum moves and the type of movement when a nasal vowel occurs. The combination of these two sources revealed interesting and distinct characteristics in the EMG signal when a nasal vowel is uttered, which motivated a classification experiment. Overall results of this experiment provide evidence that it is possible to detect velum movement using sensors positioned below the ear, between mastoid process and the mandible, in the upper neck region. In a frame-based classification scenario, error rates as low as 32.5% for all speakers and 23.4% for the best speaker have been achieved, for nasal vowel detection. This outcome stands as an encouraging result, fostering the grounds for deeper exploration of the proposed approach as a promising route to the development of an EMG-based speech interface for languages with strong nasal characteristics.	[Freitas, Joao; Dias, Miguel Sales] Microsoft Portugal, Microsoft Language Dev Ctr, Lisbon, Portugal; [Freitas, Joao; Teixeira, Antonio; Silva, Samuel] Univ Aveiro, Dept Elect Telecommun & Informat, P-3800 Aveiro, Portugal; [Freitas, Joao; Teixeira, Antonio; Silva, Samuel; Oliveira, Catarina] Univ Aveiro, Inst Elect & Telemat Engn IEETA, P-3800 Aveiro, Portugal; [Oliveira, Catarina] Univ Aveiro, Hlth Sch, P-3800 Aveiro, Portugal; [Dias, Miguel Sales] Inst Univ Lisboa ISCTE IUL, ISTAR IUL, Lisbon, Portugal	Microsoft; Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; Instituto Universitario de Lisboa	Freitas, J (corresponding author), Microsoft Portugal, Microsoft Language Dev Ctr, Lisbon, Portugal.	t-joaof@microsoft.com; ajst@ua.pt	Tsoy, Tatiana/N-7096-2019; Darrigran, Gustavo/L-6191-2019; Gonzalez-Cabrera, Joel/B-2279-2013; Teixeira, António J. S./A-4958-2012; Dumas, Guillaume/E-3756-2012; 中谷, 壽男/C-3220-2015; Tomas, Acacio RG/K-1118-2012; Vitullo, Alfredo/F-9744-2015; Zandonai, Thomas/V-2946-2019; Su, Chien-Wei/C-1521-2012; Jaffé, Rodolfo/K-3230-2013; Mazzucchelli, Trevor G/B-6659-2013; Gahlaut, Vijay/K-4904-2012; Sim, Edmund Ui-Hang/J-2863-2019; Sandström, Ulf/G-2833-2011; Gul, Taza/R-7774-2019; Sales Dias, Jose/M-5392-2013	Gonzalez-Cabrera, Joel/0000-0002-8338-370X; Teixeira, António J. S./0000-0002-7675-1236; Dumas, Guillaume/0000-0002-2253-1844; 中谷, 壽男/0000-0003-4949-5123; Tomas, Acacio RG/0000-0002-5794-1819; Vitullo, Alfredo/0000-0002-4833-5147; Zandonai, Thomas/0000-0002-7606-9675; Su, Chien-Wei/0000-0003-3889-7004; Jaffé, Rodolfo/0000-0002-2101-5282; Mazzucchelli, Trevor G/0000-0002-8306-3917; Gahlaut, Vijay/0000-0003-4381-3573; Sim, Edmund Ui-Hang/0000-0001-8652-8495; Sandström, Ulf/0000-0003-1292-8239; Gul, Taza/0000-0003-1376-8345; Sales Dias, Jose/0000-0002-1445-2695; Silva, Samuel/0000-0002-9858-8249; Oliveira, Catarina/0000-0002-3389-3082	Marie Curie Actions, Project IRIS (FP7-PEOPLE-IAPP) [610986]; Marie Curie Golem (FP7-PEOPLE-IAPP) [251415]; National Funds through the Foundation for Science and Technology (FST); Institute for Electronics and Telematics Engineering (IEETA) Research Unit [UID/CEC/00127/2013, Incentivo/EEI/UI0127/2014]; Project HERON II [PTDC/EEA-PLP/098298/2008]; Quadro de Referencia Estrategico Nacional (QREN); Mais Centro Program, Project Cloud Thinking [CENTRO-07-ST24-FEDER-002031]; Fundação para a Ciência e a Tecnologia [Incentivo/EEI/UI0127/2014, PTDC/EEA-PLP/098298/2008, UID/CEC/00127/2013] Funding Source: FCT	Marie Curie Actions, Project IRIS (FP7-PEOPLE-IAPP); Marie Curie Golem (FP7-PEOPLE-IAPP); National Funds through the Foundation for Science and Technology (FST); Institute for Electronics and Telematics Engineering (IEETA) Research Unit; Project HERON II; Quadro de Referencia Estrategico Nacional (QREN); Mais Centro Program, Project Cloud Thinking; Fundação para a Ciência e a Tecnologia	JF, SS, AT, MSD: Marie Curie Actions, Project IRIS (ref. 610986, FP7-PEOPLE-2013-IAPP) JF, MSD: Marie Curie Golem (ref. 251415, FP7-PEOPLE-2009-IAPP). AT, SS, CO: National Funds through the Foundation for Science and Technology (FST), Institute for Electronics and Telematics Engineering (IEETA) Research Unit (ref. UID/CEC/00127/2013 and Incentivo/EEI/UI0127/2014) and Project HERON II (PTDC/EEA-PLP/098298/2008). SS: Quadro de Referencia Estrategico Nacional (QREN), Mais Centro Program, Project Cloud Thinking (ref. CENTRO-07-ST24-FEDER-002031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 1976, READINGS PORTUGUESE, P348; Beddor Patrice S., 1993, NASALS NASALIZATION, P171; BELLBERTI F, 1976, J SPEECH HEAR RES, V19, P225, DOI 10.1044/jshr.1902.225; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cover T.M., 2006, FDN CYBERNATICS, P748, DOI DOI 10.1002/047174882X; Denby B, 2010, SPEECH COMMUN, V52, P270, DOI 10.1016/j.specom.2009.08.002; Ellis D., 2003, DYNAMIC TIME WARP DT; Engwall O., 2006, SPEECH PRODUCTION MO, P301; Everitt B. H. T., 2009, HDB STAT ANAL USING; Feng JL, 2012, IEEE SIGNAL PROC MAG, V29, P177, DOI 10.1109/MSP.2011.943131; Flynn R, 2008, SPEECH COMMUN, V50, P797, DOI 10.1016/j.specom.2008.05.004; Freitas Joao, 2012, Proceedings of the International Conference on Bio-inspired Systems and Signal Processing (BIOSIGNALS 2012), P91; Freitas J, 2012, COMM COM INF SC, V328, P227; Fritzell B, 1969, ACTA OTOLARYNGOLICA, V50; Hardcastle W.J., 1976, PHYSL SPEECH PRODUCT; Heistermann T., 2014, P BIOS, P189; HUDGINS B, 1993, IEEE T BIO-MED ENG, V40, P82, DOI 10.1109/10.204774; Kitamura T, 2005, ACOUST SCI TECHNOL, V26, P465, DOI 10.1250/ast.26.465; KUEHN DP, 1982, CLEFT PALATE J, V19, P25; KUEHN DP, 1988, CLEFT PALATE J, V25, P348; Lacerda A, 1966, REV LAB FONETICA EXP, V6, P5; Lubker J F, 1968, Cleft Palate J, V5, P1; Maier-Hein L, 2005, 2005 IEEE Workshop on Automatic Speech Recognition and Understanding (ASRU), P331; McGill S, 1996, J BIOMECH, V29, P1503, DOI 10.1016/0021-9290(96)84547-7; MOON JB, 1995, CLEFT PALATE-CRAN J, V32, P371, DOI 10.1597/1545-1569(1995)032<0371:EOGOVM>2.3.CO;2; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Perry JL, 2011, CLEFT PALATE-CRAN J, V48, P123, DOI 10.1597/09-256; R Core Team, 2016, R FDN STAT COMP; Sampson R., 1999, NASAL VOWEL EVOLUTIO; Seikel J.A., 2009, ANATOMY PHYSL SPEECH, V4th; Silva S, 2012, LNCS; Stone M, 2007, J ACOUST SOC AM, V122, P532, DOI 10.1121/1.2715659; Teixeira A., 2012, LNCS, V7243, P306, DOI DOI 10.1007/978-3-642-28885-2_; Teixeira A, 2000, THESIS U AVEIRO; Tiede M.K., 2000, P 5 SEMINAR SPEECH P, P25; Wand M, 2011, BIOSIGNALS 2011, P295; WINTER DA, 1987, ELECTROEN CLIN NEURO, V67, P402, DOI 10.1016/0013-4694(87)90003-4; Wrench A., 2011, P INT C PHON SCI 17, P2161; Xuan Huang, 2021, 2021 IEEE Intl Conf on Dependable, Autonomic and Secure Computing, Intl Conf on Pervasive Intelligence and Computing, Intl Conf on Cloud and Big Data Computing, Intl Conf on Cyber Science and Technology Congress (DASC/PiCom/CBDCom/CyberSciTech), P867, DOI 10.1109/DASC-PICom-CBDCom-CyberSciTech52372.2021.00144; Yao YY, 2003, STUD FUZZ SOFT COMP, V119, P115	40	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0127040	10.1371/journal.pone.0127040	http://dx.doi.org/10.1371/journal.pone.0127040			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069968	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000005
J	Lin, CS; Wu, SY; Wu, LT				Lin, Chia-Shu; Wu, Shih-Yun; Wu, Long-Ting			Preferences for Analgesic Treatments Are Influenced by Probability of the Occurrence of Adverse Effects and the Time to Reach Maximal Therapeutic Effects	PLOS ONE			English	Article							FEAR-AVOIDANCE MODEL; HEALTH DECISIONS; PROSPECT-THEORY; PAIN; MANAGEMENT; CHOICE; COMMUNICATION; UNCERTAINTY; EXPERIENCE; ADHERENCE	Research on shared medical decision-making suggested that both the potency of a treatment and the probability of it being successful influence individual treatment preferences. Patients also need to consider the negative attributes of treatments, such as the occurrence of adverse effects or a slow start to the therapeutic effects. It remains unclear how these attributes influence individual treatment preferences. We investigated how the analgesic effect, the adverse effect, and the time-course effect influenced the preference of analgesic treatments. Forty-five healthy volunteers participated in three hypothetical analgesic decision- making tasks. They were instructed to imagine that they were experiencing pain and choose between two hypothetical analgesic treatments: the more potent radical treatment and the less potent conservative treatment. The potency of a treatment was countered by the following attributes: the probability of working successfully, the probability of inducing an adverse effect, and the time required for the treatment to reach its maximal effect. We found that (a) when the overall probability that a treatment would induce an adverse effect decreased, the participants changed their preference from a conservative treatment to a radical treatment; (b) when the time-course for a treatment to reach its maximal effect was shortened, the participants changed their preference from a conservative treatment to a radical treatment, and (c) individual differences in prior clinical pain and the degree of imagined pain relief were associated with preferences. The findings showed that the adverse effects and the time course of treatments guide the analgesic treatment preferences, highlighting the importance of sharing information about negative attributes of treatments in pain management. The findings imply that patients may over-emphasize the occurrence of adverse effect or a slow time-course of treatment effect. In terms of shared medical decision-making, clinicians should clarify these negative attributes related to treatment to patients.	[Lin, Chia-Shu; Wu, Shih-Yun; Wu, Long-Ting] Natl Yang Ming Univ, Sch Dent, Dept Dent, Taipei 112, Taiwan; [Wu, Shih-Yun] Taipei Vet Gen Hosp, Dept Stomatol, Div Family Dent, Taipei, Taiwan; [Wu, Long-Ting] Taipei Vet Gen Hosp, Dept Stomatol, Div Endodont & Periodontol, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Lin, CS (corresponding author), Natl Yang Ming Univ, Sch Dent, Dept Dent, Taipei 112, Taiwan.	winzlin@ym.edu.tw	Lin, Chia-Shu/HGD-7267-2022; Lin, Chia-shu/AAA-5143-2019	Lin, Chia-Shu/0000-0002-6575-0887; 	National Science Council of Taiwan [NSC 102-2314-B-010-049]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The study was funded by National Science Council of Taiwan (NSC 102-2314-B-010-049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong K, 2002, MED DECIS MAKING, V22, P76, DOI 10.1177/02729890222062946; Attema AE, 2013, J HEALTH ECON, V32, P1057, DOI 10.1016/j.jhealeco.2013.08.006; Baron J., 2007, THINKING DECIDING; Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011; Betsch C, 2011, MED DECIS MAKING, V31, P742, DOI 10.1177/0272989X11400419; Blondell RD, 2013, AM FAM PHYSICIAN, V87, P766; Bryan S, 1998, HEALTH ECON, V7, P595, DOI 10.1002/(SICI)1099-1050(1998110)7:7<595::AID-HEC381>3.3.CO;2-5; Butow P, 2013, PAIN, V154, pS101, DOI 10.1016/j.pain.2013.07.048; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; CHAPMAN GB, 1995, MED DECIS MAKING, V15, P373, DOI 10.1177/0272989X9501500408; Chen YX, 2003, BEHAV INHIBITION BEH; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; Corbiere M, 2011, PAIN, V152, P2543, DOI 10.1016/j.pain.2011.07.024; CURLEY SP, 1984, MED DECIS MAKING, V4, P501, DOI 10.1177/0272989X8400400412; Edwards A, 2001, QUAL HEALTH CARE, V10, pI9; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Eraker S A, 1981, Med Decis Making, V1, P29, DOI 10.1177/0272989X8100100105; Hertwig R, 2009, TRENDS COGN SCI, V13, P517, DOI 10.1016/j.tics.2009.09.004; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jenkins C, 2004, BMJ-BRIT MED J, V328, P434, DOI 10.1136/bmj.328.7437.434; Kahneman D, 1979, ECONOMETRICA, V47, P262; Lauriola M, 2005, PERS INDIV DIFFER, V38, P45, DOI 10.1016/j.paid.2004.03.020; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Leknes S, 2013, PAIN, V154, P402, DOI 10.1016/j.pain.2012.11.018; Lin C, 2013, EUR J PAIN, V17, P587, DOI 10.1002/j.1532-2149.2012.00214.x; Loewenstein G, 1996, ORGAN BEHAV HUM DEC, V65, P272, DOI 10.1006/obhd.1996.0028; McNeil DW, 1998, J BEHAV MED, V21, P389, DOI 10.1023/A:1018782831217; McNutt RA, 2004, JAMA-J AM MED ASSOC, V292, P2516, DOI 10.1001/jama.292.20.2516; Perkins DO, 1999, J CLIN PSYCHIAT, V60, P25; REDELMEIER DA, 1993, JAMA-J AM MED ASSOC, V270, P72, DOI 10.1001/jama.270.1.72; Robinson ME, 2004, J PAIN, V5, P264, DOI 10.1016/j.jpain.2004.04.003; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Ryan M, 1997, HEALTH ECON, V6, P261, DOI 10.1002/(SICI)1099-1050(199705)6:3<261::AID-HEC262>3.3.CO;2-E; Schwartz A, 2008, JUDGM DECIS MAK, V3, P174; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P9; Van Damme S, 2012, PAIN, V153, P800, DOI 10.1016/j.pain.2011.12.015; Vieta E, 2010, J AFFECT DISORDERS, V125, P61, DOI 10.1016/j.jad.2009.12.019; Voigt DC, 2009, PERS INDIV DIFFER, V47, P89, DOI 10.1016/j.paid.2009.02.003; Yang Z, 2012, PAIN, V153, P1742, DOI 10.1016/j.pain.2012.05.011; Yap JC, 2008, PAIN MED, V9, P186, DOI 10.1111/j.1526-4637.2007.00307.x	41	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130214	10.1371/journal.pone.0130214	http://dx.doi.org/10.1371/journal.pone.0130214			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26067778	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000152
J	Lin, IF; Yamada, T; Komine, Y; Kato, N; Kato, M; Kashino, M				Lin, I-Fan; Yamada, Takashi; Komine, Yoko; Kato, Nobumasa; Kato, Masaharu; Kashino, Makio			Vocal Identity Recognition in Autism Spectrum Disorder	PLOS ONE			English	Article							EMOTION RECOGNITION; VOICE PERCEPTION; COMPLEX SOUNDS; CHILDREN; SPEECH; GENDER; FACE	Voices can convey information about a speaker. When forming an abstract representation of a speaker, it is important to extract relevant features from acoustic signals that are invariant to the modulation of these signals. This study investigated the way in which individuals with autism spectrum disorder (ASD) recognize and memorize vocal identity. The ASD group and control group performed similarly in a task when asked to choose the name of the newly-learned speaker based on his or her voice, and the ASD group outperformed the control group in a subsequent familiarity test when asked to discriminate the previously trained voices and untrained voices. These findings suggest that individuals with ASD recognized and memorized voices as well as the neurotypical individuals did, but they categorized voices in a different way: individuals with ASD categorized voices quantitatively based on the exact acoustic features, while neurotypical individuals categorized voices qualitatively based on the acoustic patterns correlated to the speakers' physical and mental properties.	[Lin, I-Fan; Kato, Masaharu; Kashino, Makio] NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan; [Yamada, Takashi; Komine, Yoko; Kato, Nobumasa] Showa Univ, Med Inst Dev Disabil Res, Tokyo, Japan; [Yamada, Takashi] ATR Brain Informat Commun Res Lab Grp, Kyoto, Japan; [Kato, Masaharu] Doshisha Univ, Ctr Baby Sci, Kyoto 602, Japan; [Kashino, Makio] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Informat Proc, Yokohama, Kanagawa 227, Japan; [Kashino, Makio] JST, CREST, Atsugi, Kanagawa, Japan	Nippon Telegraph & Telephone Corporation; Showa University; Doshisha University; Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Lin, IF (corresponding author), NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan.	lin.ifan@lab.ntt.co.jp; kashino.makio@lab.ntt.co.jp	Lin, Ifan/HHM-7112-2022		Ministry of Education, Culture, Sports, Science and Technology [24119006]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work reported in this paper has been supported by Grant-in-Aid for Scientific Research on Innovative Areas "Constructive Developmental Science" (No. 24119006) from The Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NTT Corporation provided support in the form of salaries for authors [full: Makio Kashino; partial: I-Fan Lin and Masaharu Kato], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abrams DA, 2013, P NATL ACAD SCI USA, V110, P12060, DOI 10.1073/pnas.1302982110; American Psychatric Association, 2000, DIAGN STAT MAN MENT; Belin P, 2011, BRIT J PSYCHOL, V102, P711, DOI 10.1111/j.2044-8295.2011.02041.x; Boddaert N, 2004, AM J PSYCHIAT, V161, P2117, DOI 10.1176/appi.ajp.161.11.2117; Boddaert N, 2003, AM J PSYCHIAT, V160, P2057, DOI 10.1176/appi.ajp.160.11.2057; Boucher J, 1998, J CHILD PSYCHOL PSYC, V39, P171, DOI 10.1111/1469-7610.00311; Boucher J, 2000, J CHILD PSYCHOL PSYC, V41, P847, DOI 10.1017/S0021963099006149; CHILDERS DG, 1991, J ACOUST SOC AM, V90, P1841, DOI 10.1121/1.401664; Dawson G, 1998, J AUTISM DEV DISORD, V28, P479, DOI 10.1023/A:1026043926488; Garrido L, 2009, NEUROPSYCHOLOGIA, V47, P123, DOI 10.1016/j.neuropsychologia.2008.08.003; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; Golan O, 2007, J AUTISM DEV DISORD, V37, P1096, DOI 10.1007/s10803-006-0252-5; Groen W, 2008, J AUTISM DEV DISORD, V38, P1819, DOI 10.1007/s10803-008-0572-8; Heaton P, 2009, PHILOS T R SOC B, V364, P1443, DOI 10.1098/rstb.2008.0327; KASUYA H, 1986, SPEECH COMMUN, V5, P171, DOI 10.1016/0167-6393(86)90006-3; KLIN A, 1991, J AUTISM DEV DISORD, V21, P29, DOI 10.1007/BF02206995; KUWABARA H, 1995, SPEECH COMMUN, V16, P165, DOI 10.1016/0167-6393(94)00053-D; LANCKER DV, 1985, J PHON, V13, P19; Lancker DV, 1985, J PHONETICS, V13, P39; Loveland KA, 1997, DEV PSYCHOPATHOL, V9, P579, DOI 10.1017/S0954579497001351; MURRAY IR, 1993, J ACOUST SOC AM, V93, P1097, DOI 10.1121/1.405558; Peppe S, 2007, J SPEECH LANG HEAR R, V50, P1015, DOI 10.1044/1092-4388(2007/071); Simmons DR, 2009, VISION RES, V49, P2705, DOI 10.1016/j.visres.2009.08.005; Soulieres I, 2007, J AUTISM DEV DISORD, V37, P481, DOI 10.1007/s10803-006-0172-4; Weigelt S, 2012, NEUROSCI BIOBEHAV R, V36, P1060, DOI 10.1016/j.neubiorev.2011.12.008; Yovel G, 2013, TRENDS COGN SCI, V17, P263, DOI 10.1016/j.tics.2013.04.004; Zaske R, 2014, J NEUROSCI, V34, P10821, DOI 10.1523/JNEUROSCI.0581-14.2014; Zaske R, 2010, HEARING RES, V268, P38, DOI 10.1016/j.heares.2010.04.011	28	12	12	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129451	10.1371/journal.pone.0129451	http://dx.doi.org/10.1371/journal.pone.0129451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26070199	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000077
J	Mamonova, T; Zhang, QM; Khajeh, JA; Bu, ZM; Bisello, A; Friedman, PA				Mamonova, Tatyana; Zhang, Qiangmin; Khajeh, Jahan Ali; Bu, Zimei; Bisello, Alessandro; Friedman, Peter A.			Canonical and Noncanonical Sites Determine NPT2A Binding Selectivity to NHERF1 PDZ1	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PROTEIN INTERACTIONS; STRUCTURAL BASIS; DOMAIN; RECEPTOR; SEQUENCE; PARTNERS; CFTR; PH; RECOGNITION	Na+/H+ Exchanger Regulatory Factor-1 (NHERF1) is a scaffolding protein containing 2 PDZ domains that coordinates the assembly and trafficking of transmembrane receptors and ion channels. Most target proteins harboring a C-terminus recognition motif bind more-or-less equivalently to the either PDZ domain, which contain identical core-binding motifs. However some substrates such as the type II sodium-dependent phosphate co-transporter (NPT2A), uniquely bind only one PDZ domain. We sought to define the structural determinants responsible for the specificity of interaction between NHERF1 PDZ domains and NPT2A. By performing all-atom/explicit-solvent molecular dynamics (MD) simulations in combination with biological mutagenesis, fluorescent polarization (FP) binding assays, and isothermal titration calorimetry (ITC), we found that in addition to canonical interactions of residues at 0 and -2 positions, Arg at the -1 position of NPT2A plays a critical role in association with Glu43 and His27 of PDZ1 that are absent in PDZ2. Experimentally introduced mutation in PDZ1 (Glu43Asp and His27Asn) decreased binding to NPT2A. Conversely, introduction of Asp183Glu and Asn167His mutations in PDZ2 promoted the formation of favorable interactions yielding micromolar KDs. The results describe novel determinants within both the PDZ domain and outside the canonical PDZ-recognition motif that are responsible for discrimination of NPT2A between two PDZ domains. The results challenge general paradigms for PDZ recognition and suggest new targets for drug development.	[Mamonova, Tatyana; Zhang, Qiangmin; Bisello, Alessandro; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Khajeh, Jahan Ali] CUNY City Coll, Dept Chem & Biochem, Chem & Biochem PhD program, New York, NY 10031 USA; [Bu, Zimei] CUNY City Coll, Dept Chem, New York, NY 10031 USA; [Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mamonova, T (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	tbm7@pitt.edu			National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK069998]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069998] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support was provided by National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases grant DK069998.	Amacher JF, 2014, STRUCTURE, V22, P82, DOI 10.1016/j.str.2013.09.019; Amacher JF, 2013, J BIOL CHEM, V288, P5114, DOI 10.1074/jbc.M112.401588; Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Bhattacharya S, 2013, J MOL BIOL, V425, P2509, DOI 10.1016/j.jmb.2013.04.001; Bhattacharyya R, 2003, J PROTEOME RES, V2, P255, DOI 10.1021/pr025584d; Case D, 2006, AMBER 9; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Ernst A, 2014, J MOL BIOL, V426, P3509, DOI 10.1016/j.jmb.2014.08.012; Gisler SM, 2008, MOL CELL PROTEOMICS, V7, P1362, DOI 10.1074/mcp.M800079-MCP200; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hawkins JC, 2012, IEEE ACM T COMPUT BI, V9, P1492, DOI 10.1109/TCBB.2012.54; Heyda J, 2010, J PHYS CHEM B, V114, P8744, DOI 10.1021/jp101031v; Hui S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-27; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Karthikeyan S, 2001, J MOL BIOL, V308, P963, DOI 10.1006/jmbi.2001.4634; Khundmiri SJ, 2008, AM J PHYSIOL-RENAL, V294, pF840, DOI 10.1152/ajprenal.00180.2007; Kurnikov IV, HAMILTONIAN RES LARG; Lee RJ, 1996, BBA-MOL CELL RES, V1312, P237, DOI 10.1016/0167-4889(96)00041-9; Lu GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076219; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Mamonova T, 2012, BIOCHEMISTRY-US, V51, P3110, DOI 10.1021/bi201213w; Maouyo D, 2000, AM J PHYSIOL-CELL PH, V278, pC973, DOI 10.1152/ajpcell.2000.278.5.C973; Prasad H, 2015, J BIOL CHEM, V290, P5311, DOI 10.1074/jbc.M114.602219; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Shenolikar S, 2001, AM J PHYSIOL-RENAL, V280, pF389, DOI 10.1152/ajprenal.2001.280.3.F389; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; STICKLE DF, 1992, J MOL BIOL, V226, P1143, DOI 10.1016/0022-2836(92)91058-W; Tiwari G, 2014, J CHEM INF MODEL, V54, P1143, DOI 10.1021/ci400627y; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; Wang B, 2008, MOL BIOL CELL, V19, P1637, DOI 10.1091/mbc.E07-11-1114; Wang B, 2012, J BIOL CHEM, V287, P24148, DOI 10.1074/jbc.M112.369405; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999; Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783	38	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129554	10.1371/journal.pone.0129554	http://dx.doi.org/10.1371/journal.pone.0129554			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070212	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000356327000089
J	Mann, BF; Chen, HM; Herndon, EM; Chu, RK; Tolic, N; Portier, EF; Chowdhury, TR; Robinson, EW; Callister, SJ; Wullschleger, SD; Graham, DE; Liang, LY; Gu, BH				Mann, Benjamin F.; Chen, Hongmei; Herndon, Elizabeth M.; Chu, Rosalie K.; Tolic, Nikola; Portier, Evan F.; Chowdhury, Taniya Roy; Robinson, Errol W.; Callister, Stephen J.; Wullschleger, Stan D.; Graham, David E.; Liang, Liyuan; Gu, Baohua			Indexing Permafrost Soil Organic Matter Degradation Using High-Resolution Mass Spectrometry	PLOS ONE			English	Article							NITROGEN MINERALIZATION; TEMPERATURE SENSITIVITY; ALPINE TUNDRA; CARBON; SYSTEM; ECOSYSTEMS; PROTEOMICS; CHEMISTRY; TRANSECT; TURNOVER	Microbial degradation of soil organic matter (SOM) is a key process for terrestrial carbon cycling, although the molecular details of these transformations remain unclear. This study reports the application of ultrahigh resolution mass spectrometry to profile the molecular composition of SOM and its degradation during a simulated warming experiment. A soil sample, collected near Barrow, Alaska, USA, was subjected to a 40-day incubation under anoxic conditions and analyzed before and after the incubation to determine changes of SOM composition. A CHO index based on molecular C, H, and O data was utilized to codify SOM components according to their observed degradation potentials. Compounds with a CHO index score between -1 and 0 in a water-soluble fraction (WSF) demonstrated high degradation potential, with a highest shift of CHO index occurred in the N-containing group of compounds, while similar stoichiometries in a base-soluble fraction (BSF) did not. Additionally, compared with the classical H:C vs O:C van Krevelen diagram, CHO index allowed for direct visualization of the distribution of heteroatoms such as N in the identified SOM compounds. We demonstrate that CHO index is useful not only in characterizing arctic SOM at the molecular level but also enabling quantitative description of SOM degradation, thereby facilitating incorporation of the high resolution MS datasets to future mechanistic models of SOM degradation and prediction of greenhouse gas emissions.	[Mann, Benjamin F.; Chen, Hongmei; Herndon, Elizabeth M.; Portier, Evan F.; Wullschleger, Stan D.; Liang, Liyuan; Gu, Baohua] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Herndon, Elizabeth M.] Kent State Univ, Dept Geol, Kent, OH 44242 USA; [Chu, Rosalie K.; Tolic, Nikola; Robinson, Errol W.; Callister, Stephen J.] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; [Chowdhury, Taniya Roy; Graham, David E.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Gu, BH (corresponding author), Oak Ridge Natl Lab, Div Environm Sci, POB 2008, Oak Ridge, TN 37831 USA.	gub1@ornl.gov	Wullschleger, Stan D/B-8297-2012; Gu, Baohua/B-9511-2012; Graham, David E/F-8578-2010; Chen, Hongmei/S-3911-2019; Liang, Liyuan/O-7213-2014; Chen, Hongmei/T-9222-2017	Wullschleger, Stan D/0000-0002-9869-0446; Gu, Baohua/0000-0002-7299-2956; Graham, David E/0000-0001-8968-7344; Chen, Hongmei/0000-0003-2460-838X; Liang, Liyuan/0000-0003-1338-0324; Chen, Hongmei/0000-0003-2460-838X; Herndon, Elizabeth/0000-0002-9194-5493	U.S. Department of Energy (DOE), Office of Science, Biological and Environmental Research (BER) at Oak Ridge National Laboratory; BER Genome Sciences Program Pan-omics project	U.S. Department of Energy (DOE), Office of Science, Biological and Environmental Research (BER) at Oak Ridge National Laboratory(United States Department of Energy (DOE)); BER Genome Sciences Program Pan-omics project	This research was supported in part by the U.S. Department of Energy (DOE), Office of Science, Biological and Environmental Research (BER) at Oak Ridge National Laboratory. A portion of this research was funded by BER Genome Sciences Program Pan-omics project and performed in the Environmental Molecular Sciences Laboratory at Pacific Northwest National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2014, FRONT MICROBIOL, V5; Anderson NL, 1998, ELECTROPHORESIS, V19, P1853, DOI 10.1002/elps.1150191103; Bae E, 2011, ANAL CHEM, V83, P4193, DOI 10.1021/ac200464q; Bhatia MP, 2010, GEOCHIM COSMOCHIM AC, V74, P3768, DOI 10.1016/j.gca.2010.03.035; Biasi C, 2005, RAPID COMMUN MASS SP, V19, P1401, DOI 10.1002/rcm.1911; Brown TL, 2000, ANAL CHEM, V72, P384, DOI 10.1021/ac9902087; Chen HM, 2011, LIMNOL OCEANOGR-METH, V9, P582, DOI 10.4319/lom.2011.9.582; Chen J, 2003, CHEMOSPHERE, V50, P639, DOI 10.1016/S0045-6535(02)00616-1; Chen J, 2002, CHEMOSPHERE, V48, P59, DOI 10.1016/S0045-6535(02)00041-3; Chowdhury TR, 2015, GLOBAL CHANGE BIOL, V21, P722, DOI 10.1111/gcb.12762; Coolen MJL, 2011, ENVIRON MICROBIOL, V13, P2299, DOI 10.1111/j.1462-2920.2011.02489.x; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Dai XY, 2002, J ANAL APPL PYROL, V62, P249, DOI 10.1016/S0165-2370(01)00123-1; FISK MC, 1995, SOIL SCI SOC AM J, V59, P1036, DOI 10.2136/sssaj1995.03615995005900040012x; Haddix ML, 2011, SOIL SCI SOC AM J, V75, P56, DOI 10.2136/sssaj2010.0118; Jaffe R, 2012, GEOCHIM COSMOCHIM AC, V94, P95, DOI 10.1016/j.gca.2012.06.031; Jenkinson DS, 2008, EUR J SOIL SCI, V59, P400, DOI 10.1111/j.1365-2389.2008.01026.x; Kim S, 2003, ANAL CHEM, V75, P5336, DOI 10.1021/ac034415p; Kleber M, 2011, GLOBAL CHANGE BIOL, V17, P1097, DOI 10.1111/j.1365-2486.2010.02278.x; Koch BP, 2007, ANAL CHEM, V79, P1758, DOI 10.1021/ac061949s; Koch BP, 2006, RAPID COMMUN MASS SP, V20, P926, DOI 10.1002/rcm.2386; Kujawinski EB, 2006, ANAL CHEM, V78, P4363, DOI 10.1021/ac0600306; Kujawinski EB, 2009, GEOCHIM COSMOCHIM AC, V73, P4384, DOI 10.1016/j.gca.2009.04.033; Lipson DA, 2012, BIOGEOSCIENCES, V9, P577, DOI 10.5194/bg-9-577-2012; Lipson DA, 1998, OECOLOGIA, V113, P406, DOI 10.1007/s004420050393; Malik A, 2013, SOIL BIOL BIOCHEM, V62, P115, DOI 10.1016/j.soilbio.2013.02.022; Masiello CA, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000534; Monga O, 2014, BIOGEOSCIENCES, V11, P2201, DOI 10.5194/bg-11-2201-2014; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; OECHEL WC, 1993, NATURE, V361, P520, DOI 10.1038/361520a0; Pare MC, 2013, ARCT ANTARCT ALP RES, V45, P88, DOI 10.1657/1938-4246-45.1.88; Parton WJ, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001193; Perminova IV, 2014, ENVIRON SCI TECHNOL, V48, P7461, DOI 10.1021/es5015423; Riley WJ, 2014, GEOSCI MODEL DEV, V7, P1335, DOI 10.5194/gmd-7-1335-2014; Rostad CE, 2004, ANAL CHIM ACTA, V523, P269, DOI 10.1016/j.aca.2004.06.065; Roth VN, 2013, GEOCHIM COSMOCHIM AC, V123, P93, DOI 10.1016/j.gca.2013.09.002; RYAN MG, 1990, CAN J FOREST RES, V20, P166, DOI 10.1139/x90-023; Said-Pullicino D, 2007, CHEMOSPHERE, V66, P2166, DOI 10.1016/j.chemosphere.2006.09.010; Schulten HR, 1997, BIOL FERT SOILS, V26, P1, DOI 10.1007/s003740050335; Sistla SA, 2012, NEW PHYTOL, V196, P68, DOI 10.1111/j.1469-8137.2012.04234.x; Sleighter RL, 2008, MAR CHEM, V110, P140, DOI 10.1016/j.marchem.2008.04.008; Stevenson FJ, 1982, HUMUS CHEM; Tang JY, 2015, NAT CLIM CHANGE, V5, P56, DOI [10.1038/NCLIMATE2438, 10.1038/nclimate2438]; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Tfaily MM, 2015, ANAL CHEM, DOI [10.1021/acs.analchem.1025b00116, DOI 10.1021/ACS.ANALCHEM.1025B00116]; Trumbore S, 2009, ANNU REV EARTH PL SC, V37, P47, DOI 10.1146/annurev.earth.36.031207.124300; Van Krevelen D., 1950, GRAPHICAL STAT METHO, V29, P269, DOI DOI 10.1520/D0850-11.1; Weintraub MN, 2003, ECOSYSTEMS, V6, P129, DOI 10.1007/s10021-002-0124-6; White D, 1999, J ANAL APPL PYROL, V50, P63, DOI 10.1016/S0165-2370(99)00003-0; Xu XF, 2014, ECOL LETT, V17, P547, DOI 10.1111/ele.12254	50	59	61	11	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130557	10.1371/journal.pone.0130557	http://dx.doi.org/10.1371/journal.pone.0130557			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068586	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000158
J	Mugnai, R; Sattamini, A; dos Santos, JAA; Regua-Mangia, AH				Mugnai, Riccardo; Sattamini, Ana; Albuquerque dos Santos, Jose Augusto; Regua-Mangia, Adriana Hamond			A Survey of Escherichia coli and Salmonella in the Hyporheic Zone of a Subtropical Stream: Their Bacteriological, Physicochemical and Environmental Relationships	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; FECAL CONTAMINATION; INDICATOR BACTERIA; SURVIVAL; WATER; SEDIMENTS; FOREST; PATTERNS; SURFACE; GROWTH	The Hyporheic Zone is among the most important interstitial freshwater habitats, but the relationship between biotic and abiotic factors in this zone remains under-explored. Enterobacteria were expected to be present, but no specific studies had ever confirmed this prediction. The aim of this study was, therefore, to evaluate the total coliforms, Escherichia coli and Salmonella spp. in hyporheic water and to determine the relationship of the physical, chemical and environmental factors at different depths in a rainforest stream. To this end, thirty-six water samples were collected at three depths in sites located in the first, second and third orders in diverse substrates. The total coliforms, Escherichia coli and Salmonella sp. were evaluated in terms of their CFU/ml. In the interstitial samples, coliforms were detected in 100% of the samples. The total coliform counts had higher values at intermediate depths, while Escherichia coli and Salmonella spp. instead had higher values at intermediate and large depths, often reaching or exceeding the values of the surface samples. Our results revealed that Salmonella spp. and the coliforms have different microhabitat preferences. Salmonella spp. and coliform species prefer deposition areas, such as lateral sides of pools, curves and bars, but they have a tendency to distribute into different depths, likely due to temperature differences. Salmonella spp. prefer compact substrata, with fewer fluids passing through and with upwelling areas with lower oxygen inflow. The coliform species showed the opposite preference. Our results suggest that bacterial variation is related to environmental factors and physical-chemical parameters within the HZ and may play a key role in the microbial diversity and distribution in these ecosystems.	[Mugnai, Riccardo] Univ Fed Rio de Janeiro, Dept Invertebrados Museu Nacl, Lab Aracnol, Rio De Janeiro, Brazil; [Sattamini, Ana; Albuquerque dos Santos, Jose Augusto] Fundacao Oswaldo Cruz, Lab Avaliacao & Promocao Saude Ambiental, Rio De Janeiro, Brazil; [Regua-Mangia, Adriana Hamond] Fundacao Oswaldo Cruz, Dept Ciencias Biol, Lab Epidemiol Mol Doencas Infecciosas, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Mugnai, R (corresponding author), Univ Fed Rio de Janeiro, Dept Invertebrados Museu Nacl, Lab Aracnol, Rio De Janeiro, Brazil.	mugnai.riccardo@gmail.com	MUGNAI, RICCARDO/ABE-1180-2021	MUGNAI, RICCARDO/0000-0002-4476-3099				Akter S, 2013, EPIDEMIOL INFECT, V141, P2516, DOI 10.1017/S0950268813000320; Anderson JK, 2005, HYDROL PROCESS, V19, P2931, DOI 10.1002/hyp.5791; Anderson ML, 2005, APPL ENVIRON MICROB, V71, P3041, DOI 10.1128/AEM.71.6.3041-3048.2005; APHA, 2005, STAND METH EX WAT WA, V20th; Ateba BH, 2012, J ENV SCI WAT RES, V1, P243; Barbour M.T., 1999, EPA841B99002, P197; Barlocher F, 2006, MICROB ECOL, V52, P708, DOI 10.1007/s00248-006-9102-4; Bencala KE, 2000, HYDROL PROCESS, V14, P2797, DOI 10.1002/1099-1085(20001030)14:15<2797::AID-HYP402>3.0.CO;2-6; Berman GC, 2000, ENVIRON MANAGE, V1, P1; BERMUDEZ M, 1988, APPL ENVIRON MICROB, V54, P979; Braioni MG, 2002, FRESHWAT SCI, V2; Brasil. Ministerio da Saude Fundacao Nacional de Saude, 1999, MAN TECN AN AG CONS, P211; Brasil. Ministerio das Minas e Energia, 1987, IBGE BRASILIA, V32, P775; BRETSCHKO G, 1988, PROC INT ASSOC THE 3, V23, P1333; Brunke M, 1997, FRESHWATER BIOL, V37, P1, DOI 10.1046/j.1365-2427.1997.00143.x; BURTON GA, 1987, APPL ENVIRON MICROB, V53, P633, DOI 10.1128/AEM.53.4.633-638.1987; Byamukama D, 2000, APPL ENVIRON MICROB, V66, P864, DOI 10.1128/AEM.66.2.864-868.2000; Byappanahalli MN, 1998, WATER SCI TECHNOL, V38, P171, DOI 10.1016/S0273-1223(98)00820-8; CARRILLO M, 1985, APPL ENVIRON MICROB, V50, P468, DOI 10.1128/AEM.50.2.468-476.1985; Committee on Indicators for Waterborne Pathogens-National Research Council, 2004, IND WAT PATH; Danielpol DL, 2008, GROUNDWATER SCI POLI; Danyluk MD, 2008, J APPL MICROBIOL, V104, P1391, DOI 10.1111/j.1365-2672.2007.03662.x; Rebello RCD, 2014, SCI TOTAL ENVIRON, V490, P19, DOI 10.1016/j.scitotenv.2014.04.040; Desmarais TR, 2002, APPL ENVIRON MICROB, V68, P1165, DOI 10.1128/AEM.68.3.1165-1172.2002; Dole-Olivier MJ, 1998, FRESHWATER BIOL, V40, P93, DOI 10.1046/j.1365-2427.1998.00335.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Duke JR, 2007, HYDROL PROCESS, V21, P141, DOI 10.1002/hyp.6228; Eaton A.D., 2005, STANDARD METHODS EXA, P1368; FEEMA. Fundacao Estadual de Engenharia do Meio Ambiente (Rio de Janeiro), 1982, SUMULA, V3, P86; FISH JT, 1995, LETT APPL MICROBIOL, V20, P277, DOI 10.1111/j.1472-765X.1995.tb00445.x; Franken RJM, 2001, HYDROBIOLOGIA, V444, P183, DOI 10.1023/A:1017598005228; FUNASA. Ministerio da Saude (BR), 2006, MAN PRAT AN AG; Gibbons SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097435; Gilbride K., 2014, WATERBORNE PATHOGENS; Halda-Alija L, 2001, MICROBIAL ECOL, V42, P286, DOI 10.1007/s00248-001-0021-0; Harwood VJ, 2014, FEMS MICROBIOL REV, V38, P1, DOI 10.1111/1574-6976.12031; Harwood VJ, 2000, APPL ENVIRON MICROB, V66, P3698, DOI 10.1128/AEM.66.9.3698-3704.2000; HENDRICKS CW, 1967, WATER RES, V1, P567, DOI 10.1016/0043-1354(67)90039-5; HENDRICKS CW, 1971, APPL MICROBIOL, V21, P379, DOI 10.1128/AEM.21.2.379-380.1971; HOFF GL, 1977, J HERPETOL, V11, P123, DOI 10.2307/1563132; JIMENEZ L, 1989, J APPL BACTERIOL, V67, P61, DOI 10.1111/j.1365-2672.1989.tb04955.x; KAWAKAMI M, 1984, J IMMUNOL, V132, P2578; Khebiza MY, 2006, ITAL J ZOOL, V73, P153, DOI 10.1080/11250000600679462; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; LEICHTFRIED M, 1991, INT VER THEOR ANGEW, V24, P1921; Leichtfried M, 1988, VERH INT VEREIN LIMN, V23, P1325, DOI DOI 10.1080/03680770.1987.11898016-; Levantesi C, 2012, FOOD RES INT, V45, P587, DOI 10.1016/j.foodres.2011.06.037; LINS ZEA C., 1964, AN MICROBIOL, V12, P19; Maal-Bared R, 2013, SCI TOTAL ENVIRON, V443, P315, DOI 10.1016/j.scitotenv.2012.10.106; Malard F, 2002, EVKCT200100121 PASCA; Martins FD, 2011, BIOL J LINN SOC, V104, P499, DOI 10.1111/j.1095-8312.2011.01745.x; MCFETERS GA, 1974, APPL MICROBIOL, V27, P823, DOI 10.1128/AEM.27.5.823-829.1974; Orghidan T., 1959, ARCH HYDROBIOL, V55, P392; PEREZROSAS N, 1989, APPL ENVIRON MICROB, V55, P495; PUSCH M, 1994, ARCH HYDROBIOL, V130, P35; RICHARDS C, 1994, GREAT BASIN NAT, V54, P106; RIVERA SC, 1988, APPL ENVIRON MICROB, V54, P513, DOI 10.1128/AEM.54.2.513-517.1988; SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168; Savichtcheva O, 2006, WATER RES, V40, P2463, DOI 10.1016/j.watres.2006.04.040; SHERER BM, 1992, J ENVIRON QUAL, V21, P591, DOI 10.2134/jeq1992.00472425002100040011x; Simpson VR, 2002, VET J, V163, P128, DOI 10.1053/tvjl.2001.0662; Solo-Gabriele HM, 2000, APPL ENVIRON MICROB, V66, P230, DOI 10.1128/AEM.66.1.230-237.2000; STENSTROM TA, 1989, APPL ENVIRON MICROB, V55, P142; Storey RG, 1999, FRESHWATER BIOL, V41, P119, DOI 10.1046/j.1365-2427.1999.00377.x; Strahler A.N., 1957, EOS T AM GEOPHYS UNI, V38, P912, DOI [10.1029/TR038i006p00913, DOI 10.1029/TR038I006P00913]; Tallon P, 2005, WATER AIR SOIL POLL, V166, P139, DOI 10.1007/s11270-005-7905-4; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Toranzos G. A., 1997, Manual of environmental microbiology., P184; Torres AG, 2010, PATHOGENIC ESCHERICH, P1; Wang ZY, 2012, WORLD J MICROB BIOT, V28, P2741, DOI 10.1007/s11274-012-1085-3; WHITE D S, 1987, Journal of the North American Benthological Society, V6, P85, DOI 10.2307/1467218; WHITE DS, 1990, HYDROBIOLOGIA, V196, P149, DOI 10.1007/BF00006106; Williams N.D., 2010, PATHOGENIC ESCHERICH, V1st ed., P8; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003	74	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129382	10.1371/journal.pone.0129382	http://dx.doi.org/10.1371/journal.pone.0129382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067288	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000070
J	Chen, JQ; Mori, H; Cardiff, RD; Trott, JF; Hovey, RC; Hubbard, NE; Engelberg, JA; Tepper, CG; Willis, BJ; Khan, IH; Ravindran, RK; Chan, SR; Schreiber, RD; Borowsky, AD				Chen, Jane Q.; Mori, Hidetoshi; Cardiff, Robert D.; Trott, Josephine F.; Hovey, Russell C.; Hubbard, Neil E.; Engelberg, Jesse A.; Tepper, Clifford G.; Willis, Brandon J.; Khan, Imran H.; Ravindran, Resmi K.; Chan, Szeman R.; Schreiber, Robert D.; Borowsky, Alexander D.			Abnormal Mammary Development in 129: STAT1-Null Mice is Stroma-Dependent	PLOS ONE			English	Article							MOUSE MAMMARY; TARGETED DISRUPTION; GROWTH-FACTOR; TUMOR VIRUS; PROLACTIN; PROGESTERONE; CANCER; DIFFERENTIATION; CLASSIFICATION; MORPHOGENESIS	Female 129:Stat1-null mice (129S6/SvEvTac-Stat1(tm1Rds) homozygous) uniquely develop estrogen-receptor (ER)-positive mammary tumors. Herein we report that the mammary glands (MG) of these mice have altered growth and development with abnormal terminal end buds alongside defective branching morphogenesis and ductal elongation. We also find that the 129:Stat1-null mammary fat pad (MFP) fails to sustain the growth of 129S6/SvEv wild-type and Stat1-null epithelium. These abnormalities are partially reversed by elevated serum progesterone and prolactin whereas transplantation of wild-type bone marrow into 129:Stat1-null mice does not reverse the MG developmental defects. Medium conditioned by 129:Stat1-null epithelium-cleared MFP does not stimulate epithelial proliferation, whereas it is stimulated by medium conditioned by epithelium-cleared MFP from either wildtype or 129:Stat1-null females having elevated progesterone and prolactin. Microarrays and multiplexed cytokine assays reveal that the MG of 129:Stat1-null mice has lower levels of growth factors that have been implicated in normal MG growth and development. Transplanted 129:Stat1-null tumors and their isolated cells also grow slower in 129:Stat1-null MG compared to wild-type recipient MG. These studies demonstrate that growth of normal and neoplastic 129:Stat1-null epithelium is dependent on the hormonal milieu and on factors from the mammary stroma such as cytokines. While the individual or combined effects of these factors remains to be resolved, our data supports the role of STAT1 in maintaining a tumor-suppressive MG microenvironment.	[Chen, Jane Q.; Mori, Hidetoshi; Cardiff, Robert D.; Hubbard, Neil E.; Engelberg, Jesse A.; Khan, Imran H.; Ravindran, Resmi K.; Borowsky, Alexander D.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Trott, Josephine F.; Hovey, Russell C.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Tepper, Clifford G.] Univ Calif Davis, Sch Med, Ctr Canc, Div Basic Sci, Sacramento, CA 95817 USA; [Tepper, Clifford G.] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Willis, Brandon J.] Univ Calif Davis, Mouse Biol Program, Davis, CA 95616 USA; [Chan, Szeman R.; Schreiber, Robert D.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Borowsky, Alexander D.] Univ Calif Davis, Dept Pathol & Lab Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Washington University (WUSTL); University of California System; University of California Davis	Borowsky, AD (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	adborowsky@ucdavis.edu	Borowsky, Alexander D/S-5404-2017; Schreiber, Robert/Q-7550-2019; Khan, imran/GQQ-2176-2022; Khan, Imran Ali/GVT-0232-2022	Khan, Imran Ali/0000-0002-8774-2896; Schreiber, Robert/0000-0003-1590-2341	National Cancer Institute's Mouse Models of Human Cancers Consortium [U01 CA141541, U01 CA141582]; Congressionally Directed Medical Research Program [W81XWH-10-1-0855]; NATIONAL CANCER INSTITUTE [U01CA141582, U01CA141541, P30CA093373] Funding Source: NIH RePORTER	National Cancer Institute's Mouse Models of Human Cancers Consortium; Congressionally Directed Medical Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants U01 CA141541 and U01 CA141582 (RC, AB, RS) from the National Cancer Institute's Mouse Models of Human Cancers Consortium and from the Congressionally Directed Medical Research Program grant W81XWH-10-1-0855 (RH and RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annamalai D, 2014, J CELL BIOCHEM, V115, P1308, DOI 10.1002/jcb.24785; Aupperlee MD, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3431; Bailey Sarah G, 2012, JAKSTAT, V1, P197, DOI 10.4161/jkst.20967; BECK JC, 1989, IN VITRO CELL DEV B, V25, P409, DOI 10.1007/BF02624625; Borowsky AD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a009670; Brandebourg T, 2007, DIABETES OBES METAB, V9, P464, DOI 10.1111/j.1463-1326.2006.00671.x; Brooks CL, 2012, ENDOCR REV, V33, P504, DOI 10.1210/er.2011-1040; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Cardiff RD, 2000, J MAMMARY GLAND BIOL, V5, P421, DOI 10.1023/A:1009534129331; Cardiff RD, 2006, TOXICOL PATHOL, V34, P699, DOI 10.1080/01926230600930129; Cardiff RD, 2013, LAB INVEST, V93, P480, DOI 10.1038/labinvest.2013.10; Carre N, 2014, BIOCHIMIE, V97, P16, DOI 10.1016/j.biochi.2013.09.023; Chan SR, 2014, CELL DEATH DIFFER, V21, P234, DOI 10.1038/cdd.2013.116; Chan SR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3100; Chapman RS, 1999, BRIT J CANCER, V80, P10; Coussens LM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003285; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; DaSilva L, 1996, MOL CELL ENDOCRINOL, V117, P131, DOI 10.1016/0303-7207(95)03738-1; DAVID M, 1994, P NATL ACAD SCI USA, V91, P7174, DOI 10.1073/pnas.91.15.7174; DEOME KB, 1959, CANCER RES, V19, P515; Dunn T.B., 1958, PHYSIOPATHOLOGY CANC, P38; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; Haricharan S, 2014, MOL CELL ENDOCRINOL, V382, P560, DOI 10.1016/j.mce.2013.03.014; Hovey RC, 1998, IN VITRO CELL DEV-AN, V34, P385; Hovey RC, 2001, DEV DYNAM, V222, P192, DOI 10.1002/dvdy.1179; Hovey RC, 2010, J MAMMARY GLAND BIOL, V15, P279, DOI 10.1007/s10911-010-9187-8; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Hughes Katherine, 2012, JAKSTAT, V1, P151, DOI 10.4161/jkst.19691; Ignacak A, 2012, J PHYSIOL PHARMACOL, V63, P435; Ingman WV, 2006, DEV DYNAM, V235, P3222, DOI 10.1002/dvdy.20972; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Khaled WT, 2007, DEVELOPMENT, V134, P2739, DOI 10.1242/dev.003194; King JY, 2005, PHYSIOL GENOMICS, V23, P103, DOI 10.1152/physiolgenomics.00101.2005; Klover PJ, 2010, NEOPLASIA, V12, P899, DOI 10.1593/neo.10716; Koromilas Antonis E, 2013, JAKSTAT, V2, pe23353, DOI 10.4161/jkst.23353; Krishhan VV, 2009, CRIT REV BIOTECHNOL, V29, P29, DOI 10.1080/07388550802688847; Lee HJ, 2012, MOL CELL ENDOCRINOL, V357, P101, DOI 10.1016/j.mce.2011.09.020; Lee SH, 2013, J IMMUNOL, V191, P4223, DOI 10.4049/jimmunol.1300910; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Mantovani G, 1998, CRIT REV ONCOGENESIS, V9, P99, DOI 10.1615/CritRevOncog.v9.i2.10; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Morabito JE, 2008, J MOL ENDOCRINOL, V41, P75, DOI 10.1677/JME-08-0027; Mori H, 2012, AM J PATHOL, V180, P2249, DOI 10.1016/j.ajpath.2012.02.032; Neville MC, 1998, J MAMMARY GLAND BIOL, V3, P109, DOI 10.1023/A:1018786604818; O'Sullivan T, 2012, J EXP MED, V209, P1869, DOI 10.1084/jem.20112738; OLIVER MH, 1989, J CELL SCI, V92, P513; Philp JAC, 1996, FEBS LETT, V396, P77, DOI 10.1016/0014-5793(96)01069-1; PUMA JP, 1982, J VIROL, V43, P158, DOI 10.1128/JVI.43.1.158-165.1982; Raven JF, 2011, CELL CYCLE, V10, P794, DOI 10.4161/cc.10.5.14956; Ravindran R, 2013, CLIN VACCINE IMMUNOL, V20, P1283, DOI 10.1128/CVI.00213-13; Richer JK, 1998, J BIOL CHEM, V273, P31317, DOI 10.1074/jbc.273.47.31317; Rosner A, 2002, AM J PATHOL, V161, P1087, DOI 10.1016/S0002-9440(10)64269-1; Ruan WF, 2005, ENDOCRINOLOGY, V146, P1170, DOI 10.1210/en.2004-1360; Rudmann D, 2012, TOXICOL PATHOL, V40, p7S, DOI 10.1177/0192623312454242; SASS B, 1979, J NATL CANCER I, V62, P1287; Satoh J-i, 2013, CLIN EXP NEUROIMMUNO, V5, P1, DOI DOI 10.4137/GRSB.S11433GRSB-7-2013-041; Schedin P, 2010, J MAMMARY GLAND BIOL, V15, P275, DOI 10.1007/s10911-010-9191-z; Schneckenleithner C, 2011, ONCOTARGET, V2, P1043; SKARDA J, 1989, ENDOCRINOL EXP, V23, P17; Spath GF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000381; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Vesely MD, 2013, ANN NY ACAD SCI, V1284, P1, DOI 10.1111/nyas.12105; Wang YF, 1997, MOL ENDOCRINOL, V11, P1353, DOI 10.1210/me.11.9.1353; Xu Dong, 2013, JAKSTAT, V2, pe27203, DOI 10.4161/jkst.27203; YOUNG LJT, 1984, CANCER RES, V44, P4333	66	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129895	10.1371/journal.pone.0129895	http://dx.doi.org/10.1371/journal.pone.0129895			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075897	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900111
J	Soto-Mendez, MJ; Romero-Abal, ME; Aguilera, CM; Rico, MC; Solomons, NW; Schumann, K; Gil, A				Jose Soto-Mendez, Mara; Eugenia Romero-Abal, Maria; Maria Aguilera, Concepcion; Cruz Rico, Maria; Solomons, Noel W.; Schuemann, Klaus; Gil, Angel			Associations among Inflammatory Biomarkers in the Circulating, Plasmatic, Salivary and Intraluminal Anatomical Compartments in Apparently Healthy Preschool Children from the Western Highlands of Guatemala	PLOS ONE			English	Article							FECAL CALPROTECTIN; BOWEL-DISEASE; LINEAR GROWTH; YOUNG-ADULTS; SERUM; INTERLEUKIN-6; CYTOKINES; STRESS; INFECTION; RESPONSES	Background Undernutrition and inflammation are related in many ways; for instance, non-hygienic environments are associated with both poor growth and immunostimulation in children. Objective To describe any existing interaction among different inflammation biomarkers measured in the distinct anatomical compartments of whole blood, feces, plasma and saliva. Methods In this descriptive, cross-sectional study, samples of whole blood, feces, plasma and saliva were collected on the 8th and last week of observation among 87 attendees (42 girls and 45 boys) of 3 daycare centers offering a common 40-day rotating menu in Guatemala's Western Highlands. Analyses included white blood cell count (WBC), fecal calprotectin, and plasmatic and salivary cytokines including IL-1B, IL-6, IL-8, IL-10 and TNF-alpha. Associations were assessed using Spearman rank-order and goodness-of-fit correlations, as indicated, followed by backwards-elimination multiple regression analyses to determine predictor variables for IL-10 in both anatomical compartments. Results Of a total of 66 cross-tabulations in the Spearman hemi-matrix, 22 (33%) were significantly associated. All 10 paired associations among the salivary cytokines had a significant r value, whereas 7 of 10 possible associations among plasma cytokines were significant. Associations across anatomical compartments, however, were rarely significant. IL-10 in both biological fluids were higher than corresponding reference values. When a multiple regression model was run in order to determine independent predictors for IL-10 in each anatomical compartment separately, IL-6, IL-8 and TNF-alpha emerged as predictors in plasma (r(2) = 0.514) and IL-1B, IL-8 and TNF-alpha remained as independent predictors in saliva (r(2) = 0.762). Significant cross-interactions were seen with WBC, but not with fecal calprotectin. Conclusion Interactions ranged from robust within the same anatomical compartment to limited to nil across distinct anatomical compartments. The prominence of the anti-inflammatory cytokine, IL-10, in both plasma and saliva is consistent with its counter-regulatory role facing a broad front of elevated pro-inflammatory cytokines in the same compartment.	[Jose Soto-Mendez, Mara; Eugenia Romero-Abal, Maria; Solomons, Noel W.] Ctr Studies Sensory Impairment Aging & Metab CeSS, Guatemala City, Guatemala; [Maria Aguilera, Concepcion; Cruz Rico, Maria; Gil, Angel] Univ Granada, Ctr Biomed Res, Inst Nutr & Food Technol, Dept Biochem & Mol Biol 2, Granada, Spain; [Schuemann, Klaus] Tech Univ Munich, Res Ctr Nutr & Food Sci, ZIEL, Mol Nutr Unit, Freising Weihenstephan, Germany	University of Granada; Technical University of Munich	Soto-Mendez, MJ (corresponding author), Ctr Studies Sensory Impairment Aging & Metab CeSS, Guatemala City, Guatemala.	clinicanutricion@gmail.com	Gil, Angel/L-2275-2014; Gil, Angel/ABA-7621-2020; Aguilera, Concepcion M/M-1663-2014; Rico, Maria/G-4601-2016; Méndez, María José Soto/X-6982-2019	Gil, Angel/0000-0001-7663-0939; Gil, Angel/0000-0001-7663-0939; Aguilera, Concepcion M/0000-0002-1451-4788; Rico, Maria/0000-0001-7742-5742; Méndez, María José Soto/0000-0002-1012-4715	Hildegard Grunow Foundation, Munich, Germany; Department of Biochemistry and Molecular Biology II from Granada University, Granada, Spain	Hildegard Grunow Foundation, Munich, Germany; Department of Biochemistry and Molecular Biology II from Granada University, Granada, Spain	Studies were funded by the Hildegard Grunow Foundation, Munich, Germany and the Department of Biochemistry and Molecular Biology II from Granada University, Granada, Spain.	Abdel-Haq A, 2014, J ORAL PATHOL MED, V43, P734, DOI 10.1111/jop.12199; Assareh A, 2013, KOREAN CIRC J, V43, P246, DOI 10.4070/kcj.2013.43.4.246; Beard JL, 2006, AM J CLIN NUTR, V84, P1498, DOI 10.1093/ajcn/84.6.1498; BEISEL WR, 1995, AM J CLIN NUTR, V62, P813, DOI 10.1093/ajcn/62.4.813; Berngard SC, 2013, EARLY HUM DEV, V89, P967, DOI 10.1016/j.earlhumdev.2013.09.008; Boy E, 2002, ENVIRON HEALTH PERSP, V110, P109, DOI 10.1289/ehp.02110109; Brogden KA, 2013, EXPERT REV ANTI-INFE, V11, P1097, DOI 10.1586/14787210.2013.836059; Browne RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059498; Burri E, 2014, EXPERT REV GASTROENT, V8, P197, DOI 10.1586/17474124.2014.869476; Byrne ML, 2013, BRAIN BEHAV IMMUN, V34, P164, DOI 10.1016/j.bbi.2013.08.010; Chen W, 2010, DIABETES CARE, V33, P2474, DOI 10.2337/dc10-0619; COATES ME, 1963, BRIT J NUTR, V17, P141, DOI 10.1079/BJN19630015; Cvikl B, 2015, CLIN ORAL INVEST, V19, P385, DOI 10.1007/s00784-014-1232-3; Dafar A, 2014, J IMMUNOL METHODS, V408, P46, DOI 10.1016/j.jim.2014.04.013; Dakovic D, 2013, J CLIN PEDIATR DENT, V37, P377, DOI 10.17796/jcpd.37.4.l135531h4542gj66; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Duffy T, 2011, THESIS U ALBERTA EDM; Ersche KD, 2014, BIOL PSYCHIAT, V75, P140, DOI 10.1016/j.biopsych.2013.08.004; FAO, 2013, PAN SEG AL NUTR AM L; Fernandez-Botran R, 2011, BRAIN BEHAV IMMUN, V25, P314, DOI 10.1016/j.bbi.2010.09.023; Grisius MM, 1997, J RHEUMATOL, V24, P1089; Hamzavi M, 2013, ASIAN PAC J CANCER P, V14, P1681, DOI 10.7314/APJCP.2013.14.3.1681; HILL DC, 1953, POULTRY SCI, V32, P462, DOI 10.3382/ps.0320462; Izawa S, 2013, BIOL PSYCHOL, V94, P249, DOI 10.1016/j.biopsycho.2013.06.006; KEUSCH GT, 1986, ANNU REV NUTR, V6, P131, DOI 10.1146/annurev.nu.06.070186.001023; Minetto MA, 2007, EUR J APPL PHYSIOL, V101, P249, DOI 10.1007/s00421-007-0484-x; Moore HD, 2014, RADIAT RES, V181, P521, DOI 10.1667/RR13586.1; Newton TL, 2014, BIOL PSYCHOL, V99, P150, DOI 10.1016/j.biopsycho.2014.03.009; Ngure FM, 2014, ANN NY ACAD SCI, V1308, P118, DOI 10.1111/nyas.12330; Nizam N, 2014, J PERIODONTOL, V85, pE251, DOI 10.1902/jop.2014.130579; NOAKES PS, 2013, WOODHEAD PUBL FOOD S, P3, DOI DOI 10.1007/978-0-387-39241-7_2; Odiere MR, 2013, J NUTR, V143, P100, DOI 10.3945/jn.112.160457; Olza J, 2014, PUBLIC HEALTH NUTR, V2, P11; Olza J, 2012, DIABETES CARE, V35, P2373, DOI 10.2337/dc12-0614; Pfister KM, 2014, CLIN PERINATOL, V41, P309, DOI 10.1016/j.clp.2014.02.004; Prandelli C, 2013, INT J IMMUNOPATH PH, V26, P633, DOI 10.1177/039463201302600307; Prasad G, 2013, INT J DENT, V2013, DOI 10.1155/2013/813756; Prendergast AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086928; Rathnayake N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061356; Riis JL, 2014, DEV PSYCHOBIOL, V56, P797, DOI 10.1002/dev.21149; ROURA E, 1992, J NUTR, V122, P2383, DOI 10.1093/jn/122.12.2383; Rytter MJH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105017; Said HS, 2014, DNA RES, V21, P15, DOI 10.1093/dnares/dst037; Slavish DC, 2015, BRAIN BEHAV IMMUN, V44, P253, DOI 10.1016/j.bbi.2014.08.008; Smith DL, 2012, PREHOSP EMERG CARE, V16, P128, DOI 10.3109/10903127.2011.614044; Sobel J, 1998, AM J TROP MED HYG, V59, P380, DOI 10.4269/ajtmh.1998.59.380; Solomons NW, 2015, PUBLIC HEALTH NUTR, V18, P1737, DOI 10.1017/S136898001400264X; SOLOMONS NW, 1993, NUTR REV, V51, P327, DOI 10.1111/j.1753-4887.1993.tb03758.x; Thomas MV, 2009, J PERIODONTOL, V80, P1146, DOI 10.1902/jop.2009.080654; van Rheenen PF, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3369; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Yi B, 2014, BRAIN BEHAV IMMUN, V40, P203, DOI 10.1016/j.bbi.2014.03.018	52	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129158	10.1371/journal.pone.0129158	http://dx.doi.org/10.1371/journal.pone.0129158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075910	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900048
J	Kennedy, BL; Most, SB				Kennedy, Briana L.; Most, Steven B.			The Rapid Perceptual Impact of Emotional Distractors	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; ATTENTIONAL BLINK PARADIGM; TEMPORAL ATTENTION; INDUCED BLINDNESS; RUMINATION; COSTS; BENEFITS; STIMULUS; EVENTS; TASK	The brief presentation of an emotional distractor can temporarily impair perception of a subsequent, rapidly presented target, an effect known as emotion-induced blindness (EIB). How rapidly does this impairment unfold? To probe this question, we examined EIB for targets that immediately succeeded ("lag-1") emotional distractors in a rapid stream of items relative to EIB for targets at later serial positions. Experiments 1 and 2 suggested that emotional distractors interfere with items presented very soon after them, with impaired target perception emerging as early as lag-1. Experiment 3 included an exploratory examination of individual differences, which suggested that EIB onsets more rapidly among participants scoring high in measures linked to negative affect.	[Kennedy, Briana L.; Most, Steven B.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	University of New South Wales Sydney	Kennedy, BL (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	b.kennedy@unsw.edu.au; s.most@unsw.edu.au	Most, Steven B./X-3339-2018	Most, Steven B./0000-0001-9458-9597; Kennedy, Briana/0000-0002-3155-7800	National Institutes of Health [R03 MH091526]; Australian Research Council [FT120100707]; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH091526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health under Grant R03 MH091526 and by the Australian Research Council under Grant FT120100707. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyurek EG, 2005, ACTA PSYCHOL, V119, P305, DOI 10.1016/j.actpsy.2005.02.006; Akyurek EG, 2012, J EXP PSYCHOL HUMAN, V38, P1448, DOI 10.1037/a0027610; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Anderson AK, 2005, J EXP PSYCHOL GEN, V134, P258, DOI 10.1037/0096-3445.134.2.258; [Anonymous], 2001, A5 U FLOR CTR RES PS; BACON WF, 1994, PERCEPT PSYCHOPHYS, V55, P485, DOI 10.3758/BF03205306; Bowman H, 2007, PSYCHOL REV, V114, P38, DOI 10.1037/0033-295X.114.1.38; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Ciesielski BG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013860; Dell'Acqua R, 2009, J EXP PSYCHOL HUMAN, V35, P338, DOI 10.1037/a0013555; Derryberry D, 2002, J ABNORM PSYCHOL, V111, P225, DOI 10.1037//0021-843X.111.2.225; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; Donaldson C, 2007, BEHAV RES THER, V45, P2664, DOI 10.1016/j.brat.2007.07.002; Flaisch T, 2008, PSYCHOPHYSIOLOGY, V45, P1, DOI 10.1111/j.1469-8986.2007.00600.x; Hommel B, 2005, Q J EXP PSYCHOL-A, V58, P1415, DOI 10.1080/02724980443000647; Ihssen N, 2009, COGNITION EMOTION, V23, P296, DOI 10.1080/02699930801987504; Jefferies LN, 2008, PSYCHOL SCI, V19, P290, DOI 10.1111/j.1467-9280.2008.02082.x; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; Kennedy BL, 2014, COGN AFFECT BEHAV NE, V14, P1485, DOI 10.3758/s13415-014-0303-x; Kennedy BL, 2012, EMOTION, V12, P199, DOI 10.1037/a0026380; Keysers C, 2002, TRENDS COGN SCI, V6, P120, DOI 10.1016/S1364-6613(00)01852-0; Kristjansson A, 2002, VISION RES, V42, P2039, DOI 10.1016/S0042-6989(02)00129-3; Livesey EJ, 2011, ATTEN PERCEPT PSYCHO, V73, P2104, DOI 10.3758/s13414-011-0177-8; Lunau R, 2010, ATTEN PERCEPT PSYCHO, V72, P317, DOI 10.3758/APP.72.2.317; MacLean MH, 2010, COGNITION EMOTION, V24, P1431, DOI 10.1080/02699930903417897; MacLean MH, 2010, PSYCHON B REV, V17, P556, DOI 10.3758/PBR.17.4.556; Maljkovic V, 2005, J VISION, V5, P215, DOI 10.1167/5.3.6; Marois R, 2000, NEURON, V28, P299, DOI 10.1016/S0896-6273(00)00104-5; Most SB, 2005, PSYCHON B REV, V12, P654, DOI 10.3758/BF03196754; Most SB, 2008, VIS COGN, V16, P262, DOI 10.1080/13506280701490062; Most SB, 2007, COGNITION EMOTION, V21, P964, DOI 10.1080/02699930600959340; Most SB, 2011, PSYCHOL SCI, V22, P300, DOI 10.1177/0956797610397665; Moulds ML, 2007, BEHAV RES THER, V45, P251, DOI 10.1016/j.brat.2006.03.003; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2007, PSYCHOL RES-PSYCH FO, V71, P126, DOI 10.1007/s00426-005-0029-z; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Peers PV, 2009, EMOTION, V9, P140, DOI 10.1037/a0014507; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Potter MC, 2002, J EXP PSYCHOL HUMAN, V28, P1149, DOI 10.1037//0096-1523.28.5.1149; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rokke PD, 2002, J ABNORM PSYCHOL, V111, P370, DOI 10.1037//0021-843X.111.2.370; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; Schwabe L, 2011, NEUROPSYCHOLOGIA, V49, P416, DOI 10.1016/j.neuropsychologia.2010.12.037; Schwabe L, 2010, EMOTION, V10, P283, DOI 10.1037/a0017751; Sergent C, 2005, NAT NEUROSCI, V8, P1391, DOI 10.1038/nn1549; Shapiro K, 2006, NEUROREPORT, V17, P163, DOI 10.1097/01.wnr.0000195670.37892.1a; SHAPIRO KL, 1994, J EXP PSYCHOL HUMAN, V20, P357, DOI 10.1037/0096-1523.20.2.357; Siegle GJ, 2003, COGNITIVE THER RES, V27, P365, DOI 10.1023/A:1023974602357; Smith SD, 2006, EMOTION, V6, P523, DOI 10.1037/1528-3542.6.3.523; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Wang L, 2012, FRONT PSYCHOL, V3, DOI [10.3389/fpsyg.2012.00187, 10.3389/fpsyg.2012.00438]; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P787, DOI 10.1037/a0013902; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P324, DOI 10.1037/a0013903	57	23	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129320	10.1371/journal.pone.0129320	http://dx.doi.org/10.1371/journal.pone.0129320			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26075603	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900064
J	Mahe, I; Sterpu, R; Bertoletti, L; Lopez-Jimenez, L; Joan, MM; Trujillo-Santos, J; Ballaz, A; Blasco, LMH; Marchena, PJ; Monreal, M				Mahe, Isabelle; Sterpu, Raluca; Bertoletti, Laurent; Lopez-Jimenez, Luciano; Joan, Meritxell Mellado; Trujillo-Santos, Javier; Ballaz, Aitor; Hernandez Blasco, Luis Manuel; Javier Marchena, Pablo; Monreal, Manuel		RIETE Investigators	Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?	PLOS ONE			English	Article							LOW-MOLECULAR-WEIGHT; FATAL PULMONARY-EMBOLISM; RIETE REGISTRY; SECONDARY PREVENTION; MEDICAL PATIENTS; VEIN THROMBOSIS; CANCER; HEPARIN; GUIDELINES; RISK	Current guidelines of antithrombotic therapy suggest early initiation of vitamin K antagonists (VKA) in non-cancer patients with venous thromboembolism (VTE), and long-term therapy with low-molecular weight heparin (LMWH) for those with cancer. We used data from RIETE (international registry of patients with VTE) to report the use of long-term anticoagulant therapy over time and to identify predictors of anticoagulant choice (regarding international guidelines) in patients with-and without cancer. Among 35,280 patients without cancer, 82% received long-term VKA (but 17% started after the first week). Among 4,378 patients with cancer, 66% received long term LMWH as monotherapy. In patients without cancer, recent bleeding (odds ratio [OR] 2.70, 95% CI 2.26-3.23), age > 70 years (OR 1.15, 95% CI 1.06-1.24), immobility (OR 2.06, 95% CI 1.93-2.19), renal insufficiency (OR 2.42, 95% CI 2.15-2.71) and anemia (OR 1.75, 95% CI 1.65-1.87) predicted poor adherence to guidelines. In those with cancer, anemia (OR 1.83, 95% CI 1.64-2.06), immobility (OR 1.51, 95% CI 1.30-1.76) and metastases (OR 3.22, 95% CI 2.87-3.61) predicted long-term LMWH therapy. In conclusion, we report practices of VTE therapy in real life and found that a significant proportion of patients did not receive the recommended treatment. The perceived increased risk for bleeding has an impact on anticoagulant treatment decision.	[Mahe, Isabelle] Univ Paris Diderot, Univ Paris 07, Sorbonne Paris Cite,EA REMES 7334, Dept Internal Med,Hop Louis Mourier,Colombes APHP, Paris, France; [Sterpu, Raluca] Univ Paris 07, Hop Louis Mourier, Colombes APHP, Dept Internal Med, Paris, France; [Bertoletti, Laurent] CHU St Etienne, Hop Nord, Dept Vasc & Therapeut Med, St Etienne, France; [Lopez-Jimenez, Luciano] Hosp Prov Reina Sofia, Dept Internal Med, Cordoba, Spain; [Joan, Meritxell Mellado] Hosp Mar, Dept Angiol & Vasc Surg, Barcelona, Spain; [Trujillo-Santos, Javier] Complejo Hosp Univ Cartagena, Dept Internal Med, Murcia, Spain; [Ballaz, Aitor] Hosp Galdakao, Dept Pneumonol, Vizcaya, Spain; [Hernandez Blasco, Luis Manuel] Hosp Gen Univ Alicante, Dept Pneumonol, Alicante, Spain; [Javier Marchena, Pablo] Parc Sanitari St Joan de Deu Hosp Gen, Dept Internal Med, Barcelona, Spain; [Monreal, Manuel] Hosp Badalona Germans Trias & Pujol, Dept Internal Med, Badalona, Spain	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de St Etienne; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Galdakao Hospital; General University Hospital of Alicante; Hospital Germans Trias i Pujol	Mahe, I (corresponding author), Univ Paris Diderot, Univ Paris 07, Sorbonne Paris Cite,EA REMES 7334, Dept Internal Med,Hop Louis Mourier,Colombes APHP, Paris, France.	isabelle.mahe@lmr.aphp.fr	Mahé, Isabelle/ABA-3641-2020; Bertoletti, Laurent/X-1319-2019; Madridano, Olga/F-1745-2019; Tufano, Antonella/AHD-0570-2022; Pasca, Samantha/AAM-5310-2020; LOPEZ-SAEZ, JUAN-BOSCO/J-5449-2014	Mahé, Isabelle/0000-0003-1760-7880; Bertoletti, Laurent/0000-0001-8214-3010; Madridano, Olga/0000-0002-8872-8260; Tufano, Antonella/0000-0003-2398-6135; Pasca, Samantha/0000-0002-0954-013X; Jaras Hernandez, Maria Jesus/0000-0001-8477-0413; LOPEZ-SAEZ, JUAN-BOSCO/0000-0002-4897-5283; Sanchez Munoz-Torrero, Juan Francisco/0000-0003-0055-8875; Barillari, Giovanni/0000-0002-0706-8839; Porras Ledantes, Jose Antonio/0000-0001-6418-1822; Alatri, Adriano/0000-0001-7116-1846	Sanofi Spain; Bayer Pharma AG	Sanofi Spain(Sanofi-Aventis); Bayer Pharma AG	This Registry is supported by unrestricted educational grants from Sanofi Spain and Bayer Pharma AG. The funding source had no role in the design, protocol development, or conduct of the study; data collection, management, or analysis; interpretation, preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Bergmann JF, 2010, THROMB HAEMOSTASIS, V103, P736, DOI 10.1160/TH09-09-0667; Caprini JA, 2005, J VASC SURG, V42, P726, DOI 10.1016/j.jvs.2005.05.053; Cohen AT, 2014, ADV THER, V31, P473, DOI 10.1007/s12325-014-0119-7; Delate T, 2012, ONCOLOGIST, V17, P419, DOI 10.1634/theoncologist.2011-0323; Hull RD, 2006, AM J MED, V119, P1062, DOI 10.1016/j.amjmed.2006.02.022; Kahn SR, 2012, THROMB HAEMOSTASIS, V108, P493, DOI 10.1160/TH12-03-0169; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Laporte S, 2008, CIRCULATION, V117, P1711, DOI 10.1161/CIRCULATIONAHA.107.726232; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Meyer G, 2002, ARCH INTERN MED, V162, P1729, DOI 10.1001/archinte.162.15.1729; Monreal M, 2004, J THROMB HAEMOST, V2, P1892, DOI 10.1111/j.1538-7836.2004.01012.x; Monreal M, 2006, J THROMB HAEMOST, V4, P1950, DOI 10.1111/j.1538-7836.2006.02082.x; Palareti G, 2009, THROMB HAEMOSTASIS, V102, P268, DOI 10.1160/TH08-11-0730; Rahme E, 2013, THROMB RES, V131, P210, DOI 10.1016/j.thromres.2012.12.004; Ruiz-Gimenez N, 2008, THROMB HAEMOSTASIS, V100, P26, DOI 10.1160/TH08-03-0193; Munoz-Torrero JFS, 2011, J VASC SURG, V54, p26S, DOI 10.1016/j.jvs.2011.05.114; Tapson VF, 2007, CHEST, V132, P936, DOI 10.1378/chest.06-2993; Trujillo-Santos J, 2013, AM J MED, V126, P425, DOI 10.1016/j.amjmed.2012.09.021	19	34	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128741	10.1371/journal.pone.0128741	http://dx.doi.org/10.1371/journal.pone.0128741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076483	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900026
J	Wannier, TM; Moore, MM; Mou, Y; Mayo, SL				Wannier, Timothy M.; Moore, Matthew M.; Mou, Yun; Mayo, Stephen L.			Computational Design of the beta-Sheet Surface of a Red Fluorescent Protein Allows Control of Protein Oligomerization	PLOS ONE			English	Article							DIRECTED EVOLUTION; MONOMERIC RED; CHROMOPHORE; ISOMERIZATION; OPTIMIZATION; MATURATION; LIBRARY; VERSION; BRIGHT; ORANGE	Computational design has been used with mixed success for the design of protein surfaces, with directed evolution heretofore providing better practical solutions than explicit design. Directed evolution, however, requires a tractable high-throughput screen because the random nature of mutation does not enrich for desired traits. Here we demonstrate the successful design of the beta-sheet surface of a red fluorescent protein (RFP), enabling control over its oligomerization. To isolate the problem of surface design, we created a hybrid RFP from DsRed and mCherry with a stabilized protein core that allows for monomerization without loss of fluorescence. We designed an explicit library for which 93 of 96 (97%) of the protein variants are soluble, stably fluorescent, and monomeric. RFPs are heavily used in biology, but are natively tetrameric, and creating RFP monomers has proven extremely difficult. We show that surface design and core engineering are separate problems in RFP development and that the next generation of RFP markers will depend on improved methods for core design.	[Wannier, Timothy M.; Mayo, Stephen L.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Moore, Matthew M.; Mou, Yun; Mayo, Stephen L.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Mayo, SL (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	steve@mayo.caltech.edu	Mou, Yun/O-1080-2018; Wannier, Timothy/ABD-5479-2020	Mou, Yun/0000-0001-5423-9031; Wannier, Timothy/0000-0002-4165-4751	National Security Science and Engineering Faculty Fellowship (NSSEFF) [N00244-09-1-0011, N00244-09-1-0082]; Gordon and Betty Moore Foundation [GBMF2809]; National Institute of Health grant [1R21EB018579-01]; Defense Advanced Research Projects Agency Protein Design Processes Program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB018579] Funding Source: NIH RePORTER	National Security Science and Engineering Faculty Fellowship (NSSEFF); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Institute of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency Protein Design Processes Program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Defense Advanced Research Projects Agency Protein Design Processes Program, a National Security Science and Engineering Faculty Fellowship (NSSEFF N00244-09-1-0011, N00244-09-1-0082), the Gordon and Betty Moore Foundation through Grant GBMF2809 to the Caltech Programmable Molecular Technology Initiative and a National Institute of Health grant (1R21EB018579-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Ai HW, 2014, NAT PROTOC, V9, P910, DOI 10.1038/nprot.2014.054; Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Allen BD, 2006, J COMPUT CHEM, V27, P1071, DOI 10.1002/jcc.20420; Allen BD, 2010, P NATL ACAD SCI USA, V107, P19838, DOI 10.1073/pnas.1012985107; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Famm K, 2008, J MOL BIOL, V376, P926, DOI 10.1016/j.jmb.2007.10.075; Fukuchi S, 2001, J MOL BIOL, V309, P835, DOI 10.1006/jmbi.2001.4718; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Henderson JN, 2009, J AM CHEM SOC, V131, P13212, DOI 10.1021/ja904665x; Hu XZ, 2008, STRUCTURE, V16, P1799, DOI 10.1016/j.str.2008.09.013; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Kredel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004391; Nanda V, 2005, J AM CHEM SOC, V127, P5804, DOI 10.1021/ja050553f; Pletnev S, 2008, J BIOL CHEM, V283, P28980, DOI 10.1074/jbc.M800599200; Privett HK, 2012, P NATL ACAD SCI USA, V109, P3790, DOI 10.1073/pnas.1118082108; Samish I, 2011, ANNU REV PHYS CHEM, V62, P129, DOI 10.1146/annurev-physchem-032210-103509; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shemiakina II, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2208; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Street AG, 2000, PHYS REV LETT, V84, P5010, DOI 10.1103/PhysRevLett.84.5010; Strongin DE, 2007, PROTEIN ENG DES SEL, V20, P525, DOI 10.1093/protein/gzm046; Takako K, 2006, NAT BIOTECHNOL, V24, P577, DOI [10.1038/nbt1207, DOI 10.1038/NBT1207]; Tubbs JL, 2005, BIOCHEMISTRY-US, V44, P9833, DOI 10.1021/bi0472907; Wall MA, 2000, NAT STRUCT BIOL, V7, P1133; Wang SY, 2014, P NATL ACAD SCI USA, V111, P8452, DOI 10.1073/pnas.1406593111; Wannier TM, 2014, PROTEIN SCI, V23, P1148, DOI 10.1002/pro.2498; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101	36	8	10	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130582	10.1371/journal.pone.0130582	http://dx.doi.org/10.1371/journal.pone.0130582			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075618	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000356329900181
J	Cheng, P; Lin, CW; Pan, JS				Cheng, Peng; Lin, Chun-Wei; Pan, Jeng-Shyang			Use HypE to Hide Association Rules by Adding Items	PLOS ONE			English	Article							ALGORITHM	During business collaboration, partners may benefit through sharing data. People may use data mining tools to discover useful relationships from shared data. However, some relationships are sensitive to the data owners and they hope to conceal them before sharing. In this paper, we address this problem in forms of association rule hiding. A hiding method based on evolutionary multi-objective optimization (EMO) is proposed, which performs the hiding task by selectively inserting items into the database to decrease the confidence of sensitive rules below specified thresholds. The side effects generated during the hiding process are taken as optimization goals to be minimized. HypE, a recently proposed EMO algorithm, is utilized to identify promising transactions for modification to minimize side effects. Results on real datasets demonstrate that the proposed method can effectively perform sanitization with fewer damages to the non-sensitive knowledge in most cases.	[Cheng, Peng] Southwest Univ, Coll Comp & Informat Sci, Chongqing, Peoples R China; [Cheng, Peng; Lin, Chun-Wei; Pan, Jeng-Shyang] Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen, Guangdong, Peoples R China	Southwest University - China; Harbin Institute of Technology; University Town of Shenzhen	Pan, JS (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen, Guangdong, Peoples R China.	surf_mailbox@163.com	Pan, Jeng-Shyang/AEO-3450-2022; Lin, Jerry Chun-Wei/C-1514-2011	Pan, Jeng-Shyang/0000-0002-3128-9025; 				Agrawal R., 1994, P 20 INT C VER LARG, P487; Amiri A, 2007, DECIS SUPPORT SYST, V43, P181, DOI 10.1016/j.dss.2006.08.007; Atallah M., 1999, PROC WORKSHOP KNOWLE, P45, DOI DOI 10.1109/KDEX.1999.836532; Bader J, 2011, EVOL COMPUT, V19, P45, DOI 10.1162/EVCO_a_00009; Vo B, 2013, KNOWL-BASED SYST, V45, P20, DOI 10.1016/j.knosys.2013.02.003; Vo B, 2012, EXPERT SYST APPL, V39, P7196, DOI 10.1016/j.eswa.2012.01.062; Bayardo R. J.  Jr., 1998, SIGMOD Record, V27, P85, DOI 10.1145/276305.276313; Beume N, 2007, EUR J OPER RES, V181, P1653, DOI 10.1016/j.ejor.2006.08.008; Bleuler S, 2003, LECT NOTES COMPUT SC, V2632, P494; Bodon F, 2005, P 1 INT WORKSH OP SO, P56, DOI DOI 10.1145/1133905.1133913; Bodon F., 2003, P IEEE ICDM WORKSH F, V90; Branke E, 2004, LECT NOTES COMPUT SC, V3242, P722, DOI 10.1007/978-3-540-30217-9_73; Brijs Tom, 1999, P KNOWL DISC DAT MIN, P254, DOI [10.1145/312129.312241, DOI 10.1145/312129.312241]; Cheng P., 2014, P 2014 C COMP GEN EV, P65; Dasseni E., 2001, INT WORKSHOP INFORM, P369, DOI DOI 10.1007/3-540-45496-9_27; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, MULTIOBJECTIVE OPTIM; Deb K, 2007, INT J GEOTECH ENG, V1, P1, DOI 10.1051/ijsmdo:2007001; Gkoulalas-Divanis A., 2006, P 15 ACM INT C INFOR, P748, DOI DOI 10.1145/1183614.1183721; Gkoulalas-Divanis A, 2009, IEEE T KNOWL DATA EN, V21, P699, DOI 10.1109/TKDE.2008.199; GkoulalasDivanis A, 2010, ADV DATABASE SYST, V41, P1, DOI 10.1007/978-1-4419-6569-1; Hong TP, 2013, APPL INTELL, V38, P502, DOI 10.1007/s10489-012-0377-5; Kim JH, 2012, IEEE T EVOLUT COMPUT, V16, P20, DOI 10.1109/TEVC.2010.2098412; Menon S, 2005, INFORM SYST RES, V16, P256, DOI 10.1287/isre.1050.0056; Menon S, 2007, MANAGE SCI, V53, P101, DOI 10.1287/mnsc.1060.0603; Moustakides GV, 2008, DATA KNOWL ENG, V65, P75, DOI 10.1016/j.datak.2007.06.012; Oliveira SRM, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P613; Pontikakis E.D., 2004, P ACM WORKSH PRIVACY, P29; Saygin Y, 2001, SIGMOD REC, V30, P45, DOI 10.1145/604264.604271; Sun XZ, 2005, FIFTH IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P426; Van Veldhuizen D. A., 2007, EVOLUTIONARY ALGORIT, V5; Verykios VS, 2007, DISTRIB PARALLEL DAT, V22, P85, DOI 10.1007/s10619-007-7013-0; Verykios VS, 2013, WIRES DATA MIN KNOWL, V3, P28, DOI 10.1002/widm.1082; Verykios VS, 2004, IEEE T KNOWL DATA EN, V16, P434, DOI 10.1109/TKDE.2004.1269668; Wu YH, 2007, IEEE T KNOWL DATA EN, V19, P29, DOI 10.1109/TKDE.2007.250583; Zitzler E., 2001, 103 TIK ETH	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0127834	10.1371/journal.pone.0127834	http://dx.doi.org/10.1371/journal.pone.0127834			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070130	Green Submitted, gold, Green Published			2022-12-27	WOS:000356327000012
J	Putcha, BDK; Jia, X; Katkoori, VR; Salih, C; Shanmugam, C; Jadhav, T; Bovell, LC; Behring, MP; Callens, T; Messiaen, L; Bae, S; Grizzle, WE; Singh, KP; Manne, U				Putcha, Balananda-Dhurjati Kumar; Jia, Xu; Katkoori, Venkat Rao; Salih, Chura; Shanmugam, Chandrakumar; Jadhav, Trafina; Bovell, Liselle C.; Behring, Michael P.; Callens, Tom; Messiaen, Ludwine; Bae, Sejong; Grizzle, William E.; Singh, Karan P.; Manne, Upender			Clinical Implications of Rabphillin-3A-Like Gene Alterations in Breast Cancer	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; COLORECTAL ADENOCARCINOMA; ALLELIC LOSS; PROGNOSTIC-SIGNIFICANCE; P53; HETEROZYGOSITY; CARCINOMAS; 17P13.3; TUMORS; CHROMOSOME-17P	For the rabphillin-3A-like (RPH3AL) gene, a putative tumor suppressor, the clinical significance of genetic alterations in breast cancers was evaluated. DNA and RNA were extracted from formalin-fixed, paraffin-embedded (FFPE) cancers and matching normal tissues. DNA samples were assessed for loss of heterozygosity (LOH) at the 17p13.3 locus of RPH3AL and the 17p13.1 locus of the tumor suppressor, TP53. RPH3AL was sequenced, and single nucleotide polymorphisms (SNPs) were genotyped. RNA samples were evaluated for expression of RPH3AL, and FFPE tissues were profiled for its phenotypic expression. Alterations in RPH3AL were correlated with clinicopathological features, LOH of TP53, and patient survival. Of 121 cancers, 80 had LOH at one of the RPH3AL locus. LOH of RHP3AL was associated with nodal metastasis, advanced stage, large tumor size, and poor survival. Although similar to 50% were positive for LOH at the RPH3AL and TP53 loci, 19 of 105 exhibited LOH only at the RPH3AL locus. Of these, 12 were non-Hispanic Caucasians (Whites), 15 had large tumors, and 12 were older (>50 years). Patients exhibiting LOH at both loci had shorter survival than those without LOH at these loci (log-rank, P = 0.014). LOH at the TP53 locus alone was not associated with survival. Analyses of RPH3AL identified missense point mutations in 19 of 125 cases, a SNP (C>A) in the 5' untranslated region at -25 (5'UTR-25) in 26 of 104, and a SNP (G>T) in the intronic region at 43 bp downstream to exon-6 (intron-6-43) in 79 of 118. Genotype C/A or A/A of the SNP at 5'UTR-25 and genotype T/T of a SNP at intron-6-43 were predominantly in Whites. Low levels of RNA and protein expression of RPH3AL were present in cancers relative to normal tissues. Thus, genetic alterations in RPH3AL are associated with aggressive behavior of breast cancers and with short survival of patients.	[Putcha, Balananda-Dhurjati Kumar; Jia, Xu; Katkoori, Venkat Rao; Salih, Chura; Shanmugam, Chandrakumar; Jadhav, Trafina; Bovell, Liselle C.; Grizzle, William E.; Manne, Upender] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Behring, Michael P.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Callens, Tom; Messiaen, Ludwine] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Bae, Sejong; Singh, Karan P.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Bae, Sejong; Grizzle, William E.; Singh, Karan P.; Manne, Upender] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Manne, U (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	manne@uab.edu	B., Liselle/AAN-9721-2020	bae, sejong/0000-0001-9982-3223	UAB Breast SPORE grant of the National Institutes of Health/National Cancer Institute [3P50CA089019-08S1]; Susan G. Komen Grant [POP138306]; UAB SPORE; NATIONAL CANCER INSTITUTE [P30CA013148, P50CA089019] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL123767] Funding Source: NIH RePORTER	UAB Breast SPORE grant of the National Institutes of Health/National Cancer Institute; Susan G. Komen Grant(Susan G. Komen Breast Cancer Foundation); UAB SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a pilot grant from UAB Breast SPORE grant of the National Institutes of Health/National Cancer Institute (3P50CA089019-08S1) and Susan G. Komen Grant POP138306 to Dr. U. Manne. Supplemental funds of the UAB SPORE were used to train Dr. Liselle Bovell, a minority graduate student at UAB.	Allison P. D., 1995, SURVIVAL ANAL USING; BATRA SK, 1995, J NEURO-ONCOL, V24, P39, DOI 10.1007/BF01052657; BIEGEL JA, 1992, CANCER RES, V52, P3391; Chen JS, 2011, CLIN CHIM ACTA, V412, P1417, DOI 10.1016/j.cca.2011.04.020; Chopin V, 2006, M S-MED SCI, V22, P54, DOI 10.1051/medsci/200622154; COLES C, 1990, LANCET, V336, P761, DOI 10.1016/0140-6736(90)93236-I; CORNELIS RS, 1994, CANCER RES, V54, P4200; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Fredricks DN, 1999, BIOTECHNIQUES, V26, P198, DOI 10.2144/99262bm04; Goi T, 2002, ONCOL REP, V9, P1189; Ho JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039469; JIN XM, 1995, CARCINOGENESIS, V16, P2205, DOI 10.1093/carcin/16.9.2205; Johnson SM, 2002, INT J CANCER, V98, P205, DOI 10.1002/ijc.10197; Kamat N, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-373; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Katkoori VR, 2008, FRONT BIOSCI-LANDMRK, V13, P1050, DOI 10.2741/2742; Katkoori VR, 2009, CLIN CANCER RES, V15, P2406, DOI 10.1158/1078-0432.CCR-08-1719; Kato M, 1996, J BIOL CHEM, V271, P31775, DOI 10.1074/jbc.271.50.31775; Kawakami K, 2002, JPN J CANCER RES, V93, P1221, DOI 10.1111/j.1349-7006.2002.tb01227.x; Kleinbaum DG, 1996, SURVIVAL ANAL SELF L; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kotake K, 1997, J BIOL CHEM, V272, P29407, DOI 10.1074/jbc.272.47.29407; Kristensen VN, 1999, CANCER RES, V59, P2825; Letouze E, 2012, J CLIN ENDOCR METAB, V97, pE1284, DOI 10.1210/jc.2012-1184; Manne U, 1997, INT J CANCER, V74, P346, DOI 10.1002/(SICI)1097-0215(19970620)74:3<346::AID-IJC19>3.0.CO;2-9; Matsumoto M, 2004, P NATL ACAD SCI USA, V101, P8313, DOI 10.1073/pnas.0306709101; MATSUMURA K, 1992, CANCER RES, V52, P3474; MCDONALD JD, 1994, GENOMICS, V23, P229, DOI 10.1006/geno.1994.1481; MERLO GR, 1992, AM J PATHOL, V140, P215; Myers RB, 1994, J NATL CANC I, V86; NAGAI MA, 1994, BRIT J CANCER, V69, P754, DOI 10.1038/bjc.1994.142; Niederacher D, 1997, GENE CHROMOSOME CANC, V18, P181, DOI 10.1002/(SICI)1098-2264(199703)18:3<181::AID-GCC5>3.0.CO;2-Y; Ogata S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037048; Park WS, 2003, J KOREAN MED SCI, V18, P501, DOI 10.3346/jkms.2003.18.4.501; Phelan CM, 1998, CANCER RES, V58, P1004; Randerson-Moor JA, 2004, J INVEST DERMATOL, V123, P755, DOI 10.1111/j.0022-202X.2004.23304.x; Roncuzzi L, 2005, ONCOL REP, V14, P471; Sakano S, 2003, INT J CANCER, V104, P98, DOI 10.1002/ijc.10919; Shanmugam C, 2009, BIOTECH HISTOCHEM, V84, P39, DOI 10.1080/10520290902738878; Shirasaki F, 2001, CANCER RES, V61, P7422; Signori E, 2001, ONCOGENE, V20, P4596, DOI 10.1038/sj.onc.1204620; Smith JS, 1999, GENOMICS, V59, P97, DOI 10.1006/geno.1999.5864; Thiagalingam S, 2001, P NATL ACAD SCI USA, V98, P2698, DOI 10.1073/pnas.051625398; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wieland I, 1999, ONCOGENE, V18, P4530, DOI 10.1038/sj.onc.1202806; Wu XF, 2002, JNCI-J NATL CANCER I, V94, P681; Zhang JH, 2004, CARCINOGENESIS, V25, P2479, DOI 10.1093/carcin/bgh247	50	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129216	10.1371/journal.pone.0129216	http://dx.doi.org/10.1371/journal.pone.0129216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070152	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000056
J	Rocco-Machado, N; Cosentino-Gomes, D; Meyer-Fernandes, JR				Rocco-Machado, Nathalia; Cosentino-Gomes, Daniela; Meyer-Fernandes, Jose Roberto			Modulation of Na+/K+ ATPase Activity by Hydrogen Peroxide Generated through Heme in L-amazonensis	PLOS ONE			English	Article							PROTEIN-KINASE-C; LEISHMANIA-AMAZONENSIS; CUTANEOUS LEISHMANIASIS; RHODNIUS-PROLIXUS; ACTIVATION; IRON; BIOSYNTHESIS; MITOCHONDRIA; PHOSPHATASE; INHIBITION	Leishmania amazonensisis a protozoan parasite that occurs in many areas of Brazil and causes skin lesions. Using this parasite, our group showed the activation of Na+/K+ ATPase through a signaling cascade that involves the presence of heme and protein kinase C (PKC) activity. Heme is an important biomolecule that has pro-oxidant activity and signaling capacity. Reactive oxygen species (ROS) can act as second messengers, which are required in various signaling cascades. Our goal in this work is to investigate the role of hydrogen peroxide (H2O2) generated in the presence of heme in the Na+/K+ ATPase activity of L. amazonensis. Our results show that increasing concentrations of heme stimulates the production of H2O2 in a dose-dependent manner until a concentration of 2.5 mu M heme. To confirm that the effect of heme on the Na+/K+ ATPase is through the generation of H2O2, we measured enzyme activity using increasing concentrations of H2O2 and, as expected, the activity increased in a dose-dependent manner until a concentration of 0.1 mu M H2O2. To investigate the role of PKC in this signaling pathway, we observed the production of H2O2 in the presence of its activator phorbol 12-myristate 13-acetate (PMA) and its inhibitor calphostin C. Both showed no effect on the generation of H2O2. Furthermore, we found that PKC activity is increased in the presence of H2O2, and that in the presence of calphostin C, H2O2 is unable to activate the Na+/K+ ATPase. 100 mu M of Mito-TEMPO was capable of abolishing the stimulatory effect of heme on Na+/K+ ATPase activity, indicating that mitochondria might be the source of the hydrogen peroxide production induced by heme. The modulation of L. amazonensis Na+/K+ ATPase by H2O2 opens new possibilities for understanding the signaling pathways of this parasite.	[Rocco-Machado, Nathalia; Cosentino-Gomes, Daniela; Meyer-Fernandes, Jose Roberto] Univ Fed Rio de Janeiro, CCS, Inst Med Biochem Leopoldo Meis, Ilha Fundao, BR-21941590 Rio De Janeiro, RJ, Brazil; [Rocco-Machado, Nathalia; Cosentino-Gomes, Daniela; Meyer-Fernandes, Jose Roberto] CCS, Inst Natl Sci & Technol Struct Biol & Bioimage IN, Ilha Fundao, BR-21941590 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Rocco-Machado, N (corresponding author), Univ Fed Rio de Janeiro, CCS, Inst Med Biochem Leopoldo Meis, Ilha Fundao, Cidade Univ, BR-21941590 Rio De Janeiro, RJ, Brazil.	rocco@bioqmed.ufrj.br; meyer@bioqmed.ufrj.br	Cosentino-Gomes, Daniela/F-9374-2013; Machado, Nathalia Rocco/X-9731-2018	Cosentino-Gomes, Daniela/0000-0001-5690-5413; Rocco Machado, Nathalia/0000-0002-0127-3540	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPQ2014]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [CAPES2013]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro [FAPERJ2014]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from the following Brazilian Agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant: CNPQ2014, http://cnpq.br), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (grant: CAPES2013, http://www.capes.gov.br) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (grant: FAPERJ2014, www.faperj.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Amaral EE, 2010, EXP PARASITOL, V124, P436, DOI 10.1016/j.exppara.2009.12.012; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Alvarez N, 2002, J ENZYM INHIB MED CH, V17, P443, DOI 10.1080/1475636021000005749; Alvarez-Rueda N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007581; Antinori S, 2012, EUR J CLIN MICROBIOL, V31, P109, DOI 10.1007/s10096-011-1276-0; BALLA G, 1991, LAB INVEST, V64, P648; Barcellos-de-Souza P, 2013, AM J PHYSIOL-CELL PH, V304, pC170, DOI 10.1152/ajpcell.00078.2012; Campos-Salinas J, 2011, MOL MICROBIOL, V79, P1430, DOI 10.1111/j.1365-2958.2010.07531.x; Caruso-Neves C, 1988, COMP BIOCH PHYSL B, V119, P807; Carvalho S, 2009, ACTA TROP, V109, P131, DOI 10.1016/j.actatropica.2008.10.007; CHANG KP, 1975, P NATL ACAD SCI USA, V72, P2979, DOI 10.1073/pnas.72.8.2979; Huynh C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002795; Cosentino-Gomes D, 2012, INT J MOL SCI, V13, P10697, DOI 10.3390/ijms130910697; Cosentino-Gomes D, 2009, FREE RADICAL BIO MED, V47, P152, DOI 10.1016/j.freeradbiomed.2009.04.020; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; Das J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012602; Nogueira NPD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025935; de Almeida-Amaral EE, 2008, EXP PARASITOL, V118, P165, DOI 10.1016/j.exppara.2007.07.001; de Almeida-Amaral EE, 2007, EXP PARASITOL, V116, P419, DOI 10.1016/j.exppara.2007.02.010; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dutta S, 2008, EXP PARASITOL, V118, P629, DOI 10.1016/j.exppara.2007.11.013; Felibertt P, 1995, MOL BIOCHEM PARASIT, V74, P179, DOI 10.1016/0166-6851(95)02497-2; Fernandez PL, 2010, J BIOL CHEM, V285, P32844, DOI 10.1074/jbc.M110.146076; Flannery AR, 2011, J BIOL CHEM, V286, P23266, DOI 10.1074/jbc.M111.229674; GALBRAITH RA, 1988, MOL BIOCHEM PARASIT, V29, P47, DOI 10.1016/0166-6851(88)90118-1; Graca-Souza AV, 2002, BLOOD, V99, P4160, DOI 10.1182/blood.V99.11.4160; Graca-Souza AV, 1999, J BIOL CHEM, V274, P9673, DOI 10.1074/jbc.274.14.9673; Groeger G, 2009, J NEUROCHEM, V109, P1544, DOI 10.1111/j.1471-4159.2009.06081.x; Ijssennagger N, 2013, CARCINOGENESIS, V34, P1628, DOI 10.1093/carcin/bgt084; Kaur H, 2003, FEBS LETT, V543, P113, DOI 10.1016/S0014-5793(03)00420-4; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; Kunwar A, 2007, J CELL BIOCHEM, V102, P1214, DOI 10.1002/jcb.21348; Kupcho K, 2003, ANAL BIOCHEM, V317, P210, DOI 10.1016/S0003-2697(03)00094-0; Leite MS, 2009, EXP PARASITOL, V121, P137, DOI 10.1016/j.exppara.2008.10.018; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martiny A, 1999, MOL BIOCHEM PARASIT, V102, P1, DOI 10.1016/S0166-6851(99)00067-5; Miguel DC, 2013, INFECT IMMUN, V81, P3620, DOI 10.1128/IAI.00687-13; Mittra B, 2013, J EXP MED, V210, P401, DOI 10.1084/jem.20121368; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Otterbein LE, 2000, AM J PHYSIOL-LUNG C, V279, pL1029, DOI 10.1152/ajplung.2000.279.6.L1029; Paes Marcia Cristina, 2011, Journal of Parasitology Research, V2011, DOI 10.1155/2011/174614; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; SAITOH T, 1986, BRAIN RES, V379, P196, DOI 10.1016/0006-8993(86)90277-5; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Silveira FT, 2009, PARASITE IMMUNOL, V31, P423, DOI 10.1111/j.1365-3024.2009.01116.x; TAMAOKI T, 1990, ADV SEC MESS PHOSPH, V24, P497; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Vannier-Santos MA, 2002, CURR PHARM DESIGN, V8, P297, DOI 10.2174/1381612023396230; VANNIERSANTOS MA, 1995, EUR J CELL BIOL, V67, P112; Votyakova TV, 2004, ARCH BIOCHEM BIOPHYS, V431, P138, DOI 10.1016/j.abb.2004.07.025; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; WARREN LG, 1960, J PARASITOL, V46, P529, DOI 10.2307/3274932; Wilson R, 1987, Dev Biol Stand, V66, P161	56	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129604	10.1371/journal.pone.0129604	http://dx.doi.org/10.1371/journal.pone.0129604			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070143	gold, Green Submitted, Green Published			2022-12-27	WOS:000356327000093
J	Willemen, L; Cottam, AJ; Drakou, EG; Burgess, ND				Willemen, Louise; Cottam, Andrew J.; Drakou, Evangelia G.; Burgess, Neil D.			Using Social Media to Measure the Contribution of Red List Species to the Nature-Based Tourism Potential of African Protected Areas	PLOS ONE			English	Article							ECOSYSTEM SERVICES; PREFERENCES; SUPPORT; SCIENCE	Cultural ecosystem services are defined by people's perception of the environment, which make them hard to quantify systematically. Methods to describe cultural benefits from ecosystems typically include resource-demanding survey techniques, which are not suitable to assess cultural ecosystem services for large areas. In this paper we explore a method to quantify cultural benefits through the enjoyment of natured-based tourism, by assessing the potential tourism attractiveness of species for each protected area in Africa using the IUCN's Red List of Threatened Species. We use the number of pictures of wildlife posted on a photo sharing website as a proxy for charisma, popularity, and ease of observation, as these factors combined are assumed to determine how attractive species are for the global wildlife tourist. Based on photo counts of 2473 African animals and plants, species that seem most attractive to nature-based tourism are the Lion, African Elephant and Leopard. Combining the photo counts with species range data, African protected areas with the highest potential to attract wildlife tourists based on attractive species occurrence were Samburu National Reserve in Kenya, Mukogodo Forest Reserve located just north of Mount Kenya, and Addo Elephant National Park in South-Africa. The proposed method requires only three data sources which are freely accessible and available online, which could make the proposed index tractable for large scale quantitative ecosystem service assessments. The index directly links species presence to the tourism potential of protected areas, making the connection between nature and human benefits explicit, but excludes other important contributing factors for tourism, such as accessibility and safety. This social media based index provides a broad understanding of those species that are popular globally; in many cases these are not the species of highest conservation concern.	[Willemen, Louise] Univ Twente, Dept Nat Resources, Fac Geoinformat Sci & Earth Observat ITC, NL-7500 AE Enschede, Netherlands; [Cottam, Andrew J.; Drakou, Evangelia G.] European Commiss Joint Res Ctr, Inst Environm & Sustainabil, Ispra, Italy; [Burgess, Neil D.] UNEP World Conservat Monitoring Ctr, Cambridge, England; [Burgess, Neil D.] Nat Hist Museum Denmark, Ctr Marcoecol Evolut & Climate, Copenhagen, Denmark	University of Twente; European Commission Joint Research Centre; EC JRC ISPRA Site	Willemen, L (corresponding author), Univ Twente, Dept Nat Resources, Fac Geoinformat Sci & Earth Observat ITC, POB 217, NL-7500 AE Enschede, Netherlands.	l.l.Willemen@utwente.nl	Willemen, Louise/O-2306-2015; Drakou, Evangelia/S-9511-2019; Willemen, Louise/AAC-7935-2019	Willemen, Louise/0000-0003-1026-5865; Drakou, Evangelia/0000-0003-4404-629X; Willemen, Louise/0000-0003-1026-5865	European Union [CRIS DEC 2010/ 022-121]	European Union(European Commission)	Andrew Cottom and Evangelia Drakou were funded by the European Union under the 10th EDF for the BIOPAMA (Biodiversity and Protected Areas Management) project (Intra-ACP envelope: CRIS DEC 2010/ 022-121).	Balmford A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002074; Bayliss J, 2014, ECOSYST SERV, V8, P75, DOI 10.1016/j.ecoser.2014.02.006; CASALEGNO S, 2013, PLOS ONE, V8; Catlin J, 2013, BIOL CONSERV, V157, P93, DOI 10.1016/j.biocon.2012.07.022; Chan KMA, 2012, ECOL ECON, V74, P8, DOI 10.1016/j.ecolecon.2011.11.011; Crossman ND, 2013, ECOSYST SERV, V4, P4, DOI 10.1016/j.ecoser.2013.02.001; Daniel TC, 2012, P NATL ACAD SCI USA, V109, P8812, DOI 10.1073/pnas.1114773109; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; de Pinho JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088842; Di Minin E, 2013, ANIM CONSERV, V16, P249, DOI 10.1111/j.1469-1795.2012.00595.x; Dudley N., 2011, SOLUTIONS, V2, P87; Dudley N, 2008, GUIDELINES APPL PROT, DOI DOI 10.2305/IUCN.CH.2008.PAPS.2.EN; Egoh B, 2012, INDICATORS MAPPING E; Ghermandi A, 2013, ECOL ECON, V86, P1, DOI 10.1016/j.ecolecon.2012.11.006; Goldman RL, 2008, P NATL ACAD SCI USA, V105, P9445, DOI 10.1073/pnas.0800208105; Gomez-Baggethun E, 2011, PROG PHYS GEOG, V35, P613, DOI 10.1177/0309133311421708; Guimaraes MH, 2015, TOURISM MANAGE, V46, P102, DOI 10.1016/j.tourman.2014.06.016; Haines-Young R., 2010, ECOSYSTEM ECOLOGY NE, DOI DOI 10.1017/CBO9780511750458.007; Hernandez-Morcillo M, 2013, ECOL INDIC, V29, P434, DOI 10.1016/j.ecolind.2013.01.013; Juffe-Bignoli D, 2014, PROTECTED PLANET REP; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lindsey Peter A., 2007, Journal of Ecotourism, V6, P19, DOI 10.2167/joe133.0; Liu W., 2012, PLOS ONE, V7; Maciejewski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088192; Maes J, 2012, ECOSYST SERV, V1, P31, DOI 10.1016/j.ecoser.2012.06.004; Mansfeld Y., 2006, TOURISM SECURITY SAF, P29; Milcu AI, 2013, ECOL SOC, V18, DOI 10.5751/ES-05790-180344; Novelli M, 2012, ANN TOURISM RES, V39, P1446, DOI 10.1016/j.annals.2012.03.003; Osipova E., 2014, BENEFITS NATURAL WOR; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Seppelt R, 2011, J APPL ECOL; Stokes DL, 2007, HUM ECOL, V35, P361, DOI 10.1007/s10745-006-9056-7; Verissimo D, 2014, CONSERV BIOL, V28, P269, DOI 10.1111/cobi.12142; Ward PI, 1998, CONSERV BIOL, V12, P1408, DOI 10.1046/j.1523-1739.1998.97402.x; WBCSD - World Business Council for Sustainable Development, 2011, GUID CORP EC VAL FRA; Weyland F, 2014, ECOL INDIC, V39, P34, DOI 10.1016/j.ecolind.2013.11.023; Wood SA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02976	37	72	74	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129785	10.1371/journal.pone.0129785	http://dx.doi.org/10.1371/journal.pone.0129785			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26068111	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000104
J	Bayet, L; Quinn, PC; Tanaka, JW; Lee, K; Gentaz, E; Pascalis, O				Bayet, Laurie; Quinn, Paul C.; Tanaka, James W.; Lee, Kang; Gentaz, Edouard; Pascalis, Olivier			Face Gender Influences the Looking Preference for Smiling Expressions in 3.5-Month-Old Human Infants	PLOS ONE			English	Article							FACIAL EXPRESSIONS; EMOTION; REPRESENTATION; RECOGNITION; GAZE; 4-MONTH-OLD; PERCEPTION; GESTURES; FEMALE	Young infants are typically thought to prefer looking at smiling expressions. Although some accounts suggest that the preference is automatic and universal, we hypothesized that it is not rigid and may be influenced by other face dimensions, most notably the face's gender. Infants are sensitive to the gender of faces; for example, 3-month-olds raised by female caregivers typically prefer female over male faces. We presented neutral versus smiling pairs of faces from the same female or male individuals to 3.5-month-old infants (n = 25), controlling for low-level cues. Infants looked longer to the smiling face when faces were female but longer to the neutral face when faces were male, i.e., there was an effect of face gender on the looking preference for smiling. The results indicate that a preference for smiling in 3.5-month-olds is limited to female faces, possibly reflective of differential experience with male and female faces.	[Bayet, Laurie; Gentaz, Edouard; Pascalis, Olivier] Univ Grenoble Alps, LPNC, Grenoble, France; [Bayet, Laurie; Gentaz, Edouard; Pascalis, Olivier] CNRS, LPNC, Grenoble, France; [Quinn, Paul C.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE USA; [Tanaka, James W.] Univ Victoria, Dept Psychol, Victoria, BC, Canada; [Lee, Kang] Univ Toronto, Dr Eric Jackman Inst Child Study, Toronto, ON, Canada; [Gentaz, Edouard] Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); University of Delaware; University of Victoria; University of Toronto; University of Geneva	Bayet, L (corresponding author), Univ Grenoble Alps, LPNC, Grenoble, France.	laurie.bayet@upmf-grenoble.fr	Bayet, Laurie/R-7563-2018	Bayet, Laurie/0000-0002-0323-7949; pascalis, olivier/0000-0003-4609-3233	National Institute of Health (US) Grant [HD-46526]; FNS Grant [100019-156073]; French Department of Research and Higher Education; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046526] Funding Source: NIH RePORTER	National Institute of Health (US) Grant; FNS Grant; French Department of Research and Higher Education; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by the National Institute of Health (US) Grant HD-46526 to KL, OP, PCQ, and JT, the FNS Grant 100019-156073 to EG, and a PhD. scholarship from the French Department of Research and Higher Education to LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudouin JY, 2000, MEMORY, V8, P285, DOI 10.1080/09658210050117717; Beier JS, 2012, CHILD DEV, V83, P486, DOI 10.1111/j.1467-8624.2011.01702.x; Brenna V, 2013, INT J BEHAV DEV, V37, P137, DOI 10.1177/0165025412465363; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; de Boisferon AH, 2014, INFANT BEHAV DEV, V37, P676, DOI 10.1016/j.infbeh.2014.08.009; Dumas T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074145; EKMAN P, 1979, ANNU REV PSYCHOL, V30, P527, DOI 10.1146/annurev.ps.30.020179.002523; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; Farroni T, 2007, EUR J DEV PSYCHOL, V4, P2, DOI 10.1080/17405620601046832; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Goeleven E, 2008, COGNITION EMOTION, V22, P1094, DOI 10.1080/02699930701626582; Gredeback G, 2012, INFANCY, V17, P79, DOI 10.1111/j.1532-7078.2011.00091.x; HALBERSTADT AG, 1988, SEX ROLES, V19, P589, DOI 10.1007/BF00289738; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hoehl S, 2012, DEV COGN NEUROS-NETH, V2, P81, DOI 10.1016/j.dcn.2011.07.015; Hoehl S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002389; LABARBERA JD, 1976, CHILD DEV, V47, P535, DOI 10.2307/1128816; Leppanen JM, 2009, NAT REV NEUROSCI, V10, P37, DOI 10.1038/nrn2554; LUDEMANN PM, 1988, DEV PSYCHOL, V24, P492, DOI 10.1037/0012-1649.24.4.492; Lundqvist D., 1998, KAROLINSKA DIRECTED; MALATESTA CZ, 1982, CHILD DEV, V53, P991, DOI 10.2307/1129139; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; MELTZOFF AN, 1983, CHILD DEV, V54, P702, DOI 10.2307/1130058; Minagawa-Kawai Y, 2009, CEREB CORTEX, V19, P284, DOI 10.1093/cercor/bhn081; Oster H., 1981, INFANT SOCIAL COGNIT, P85; Quinn PC, 2011, EMOT REV, V3, P197, DOI 10.1177/1754073910387941; Quinn PC, 2002, PERCEPTION, V31, P1109, DOI 10.1068/p3331; Rennels JL, 2008, INFANT BEHAV DEV, V31, P665, DOI 10.1016/j.infbeh.2008.04.009; Schneider W, 2002, E PRIME USERS GUIDE, DOI [10.3758/s13428-012-0302-1, DOI 10.3758/S13428-012-0302-1]; Striano T, 2006, SOC COGN AFFECT NEUR, V1, P87, DOI 10.1093/scan/nsl008; Sugden NA, 2014, DEV PSYCHOBIOL, V56, P249, DOI 10.1002/dev.21183; Surian L, 2007, PSYCHOL SCI, V18, P580, DOI 10.1111/j.1467-9280.2007.01943.x; Tiddeman BP, 2005, COMPUT GRAPH FORUM, V24, P449, DOI 10.1111/j.1467-8659.2005.00870.x; Turati C, 2011, INFANCY, V16, P306, DOI 10.1111/j.1532-7078.2010.00047.x; Willenbockel V, 2010, BEHAV RES METHODS, V42, P671, DOI 10.3758/BRM.42.3.671	35	13	13	69	523	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129812	10.1371/journal.pone.0129812	http://dx.doi.org/10.1371/journal.pone.0129812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK3FB	26068460	gold, Green Published, Green Submitted			2022-12-27	WOS:000356100900080
J	Costela, FM; Otero-Millan, J; McCamy, MB; Macknik, SL; Di Stasi, LL; Rieiro, H; Leigh, JR; Troncoso, XG; Jazi, AN; Martinez-Conde, S				Costela, Francisco M.; Otero-Millan, Jorge; McCamy, Michael B.; Macknik, Stephen L.; Di Stasi, Leandro L.; Rieiro, Hector; Leigh, John R.; Troncoso, Xoana G.; Jazi, Ali Najafian; Martinez-Conde, Susana			Characteristics of Spontaneous Square-Wave Jerks in the Healthy Macaque Monkey during Visual Fixation	PLOS ONE			English	Article							SACCADIC INTRUSIONS; EYE-MOVEMENTS; SUPERIOR COLLICULUS; COVERT ATTENTION; RHESUS-MONKEY; MICROSACCADES; PERCEPTION; MECHANISMS; GENERATION; VISION	Saccadic intrusions (SIs), predominantly horizontal saccades that interrupt accurate fixation, include square-wave jerks (SWJs; the most common type of SI), which consist of an initial saccade away from the fixation target followed, after a short delay, by a return saccade that brings the eye back onto target. SWJs are present in most human subjects, but are prominent by their increased frequency and size in certain parkinsonian disorders and in recessive, hereditary spinocerebellar ataxias. SWJs have been also documented in monkeys with tectal and cerebellar etiologies, but no studies to date have investigated the occurrence of SWJs in healthy nonhuman primates. Here we set out to determine the characteristics of SWJs in healthy rhesus macaques (Macaca mulatta) during attempted fixation of a small visual target. Our results indicate that SWJs are common in healthy nonhuman primates. We moreover found primate SWJs to share many characteristics with human SWJs, including the relationship between the size of a saccade and its likelihood to be part of a SWJ. One main discrepancy between monkey and human SWJs was that monkey SWJs tended to be more vertical than horizontal, whereas human SWJs have a strong horizontal preference. Yet, our combined data indicate that primate and human SWJs play a similar role in fixation correction, suggesting that they share a comparable coupling mechanism at the oculomotor generation level. These findings constrain the potential brain areas and mechanisms underlying the generation of fixational saccades in human and nonhuman primates.	[Costela, Francisco M.; Otero-Millan, Jorge; McCamy, Michael B.; Macknik, Stephen L.; Di Stasi, Leandro L.; Rieiro, Hector; Troncoso, Xoana G.; Jazi, Ali Najafian; Martinez-Conde, Susana] Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA; [Costela, Francisco M.] Arizona State Univ, Interdisciplinary Grad program Neurosci, Tempe, AZ USA; [Otero-Millan, Jorge] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Macknik, Stephen L.; Martinez-Conde, Susana] Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; [Di Stasi, Leandro L.] Univ Granada, Mind Brain & Behav Res Ctr, Granada, Spain; [Rieiro, Hector] Univ Vigo, Dept Signal Theory & Commun, Vigo 36310, Spain; [Leigh, John R.] Case Western Reserve Univ, Vet Affairs Med Ctr, Cleveland, OH 44106 USA; [Troncoso, Xoana G.] UPR CNRS 3293, Unite Neurosci Informat & Complexite, Gif Sur Yvette, France	Barrow Neurological Institute; Arizona State University; Arizona State University-Tempe; Johns Hopkins University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Granada; Universidade de Vigo; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Martinez-Conde, S (corresponding author), Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA.	smart@neuralcorrelate.com	Di Stasi, Leandro Luigi/V-7551-2017; Costela, Francisco M/ABG-7910-2020; Otero-Millan, Jorge/A-4193-2014; Macknik, Stephen L./H-7704-2019	Di Stasi, Leandro Luigi/0000-0001-6763-6546; Costela, Francisco M/0000-0002-3530-6224; Otero-Millan, Jorge/0000-0002-9789-8392; Macknik, Stephen L./0000-0002-3143-9230; Troncoso, Xoana/0000-0001-7343-1272; Rieiro, Hector/0000-0002-4312-9432	Barrow Neurological Foundation; National Science Foundations [0852636, 1153786, 0726113]	Barrow Neurological Foundation; National Science Foundations(National Science Foundation (NSF))	This study was supported by Barrow Neurological Foundation (http://www.thebarrow.org/) to SLM and SMC. National Science Foundations (Awards 0852636 and 1153786 to SMC and Award 0726113 to SLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi R, 2004, VISION RES, V44, P2675, DOI 10.1016/j.visres.2004.05.009; Betta E, 2006, NEUROREPORT, V17, P1001, DOI 10.1097/01.wnr.0000223392.82198.6d; Carasig D, 2006, VISION RES, V46, P1161, DOI 10.1016/j.visres.2005.05.024; Costela FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110889; Cui J, 2009, VISION RES, V49, P228, DOI 10.1016/j.visres.2008.10.015; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; Engbert R, 2006, PROG BRAIN RES, V154, P177, DOI 10.1016/S0079-6123(06)54009-9; Fahey MC, 2008, BRAIN, V131, P1035, DOI 10.1093/brain/awm323; Gnadt JW, 2013, F1000RESEARCH, DOI 10.12688/f1000research.2-85.v1; Goffart L, 2012, J NEUROSCI, V32, P10627, DOI 10.1523/JNEUROSCI.0696-12.2012; Gowen E, 2007, BRAIN RES, V1141, P154, DOI 10.1016/j.brainres.2007.01.047; Hafed ZM, 2011, EUR J NEUROSCI, V33, P2101, DOI 10.1111/j.1460-9568.2011.07694.x; Hafed ZM, 2009, SCIENCE, V323, P940, DOI 10.1126/science.1166112; Izawa Y, 2009, J NEUROPHYSIOL, V102, P2410, DOI 10.1152/jn.00234.2009; KAPOULA ZA, 1986, EXP BRAIN RES, V61, P386; Laubrock J, 2005, VISION RES, V45, P721, DOI 10.1016/j.visres.2004.09.029; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2002, P NATL ACAD SCI USA, V99, P13920, DOI 10.1073/pnas.212500599; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; Martinez-Conde S, 2006, PROG BRAIN RES, V154, P151; Martinez-Conde S, 2013, NAT REV NEUROSCI, V14, P83, DOI 10.1038/nrn3405; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; Martinez-Conde S, 2008, J VISION, V8, DOI [10.1167/8.14.28, 10.1167/8.14.i]; McCamy MB, 2013, PEERJ, V1, DOI 10.7717/peerj.9; McCamy MB, 2013, PEERJ, V1, DOI 10.7717/peerj.14; Moller F, 2002, GRAEF ARCH CLIN EXP, V240, P765, DOI 10.1007/s00417-002-0519-2; Otero-Millan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058535; Otero-Millan J, 2011, ANN NY ACAD SCI, V1233, P107, DOI 10.1111/j.1749-6632.2011.06177.x; Otero-Millan J, 2011, J NEUROSCI, V31, P4379, DOI 10.1523/JNEUROSCI.2600-10.2011; RASCOL O, 1991, J NEUROL NEUROSUR PS, V54, P599, DOI 10.1136/jnnp.54.7.599; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Rolfs M, 2006, EXP BRAIN RES, V169, P369, DOI 10.1007/s00221-005-0148-1; Rolfs M, 2009, VISION RES, V49, P2415, DOI 10.1016/j.visres.2009.08.010; Rolfs M, 2008, J VISION, V8, DOI 10.1167/8.11.5; Siegenthaler E, 2014, EUR J NEUROSCI, V39, P287, DOI 10.1111/ejn.12395; Troncoso XG, 2005, PERCEPTION, V34, P409, DOI 10.1068/p5383; Troncoso XG, 2008, P NATL ACAD SCI USA, V105, P16033, DOI 10.1073/pnas.0709389105; Troncoso XG, 2008, J VISION, V8, DOI 10.1167/8.14.15; WEBER H, 1989, J HIRNFORSCH, V30, P603	42	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0126485	10.1371/journal.pone.0126485	http://dx.doi.org/10.1371/journal.pone.0126485			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067994	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900010
J	Schrandt, MN; Powers, SP				Schrandt, Meagan N.; Powers, Sean P.			Facilitation and Dominance in a Schooling Predator: Foraging Behavior of Florida Pompano, Trachinotus carolinus	PLOS ONE			English	Article							SHOAL SIZE; FISH; PROFITABILITY	Presumably an individual's risk of predation is reduced by group membership and this 'safety in numbers' concept has been readily applied to investigations of schooling prey; however, foraging in groups may also be beneficial. We tested the hypothesis that, when feeding in groups, foraging of a coastal fish (Florida Pompano, Trachinotus carolinus) on a benthic prey source would be facilitated (i.e. fish feeding in groups will consume more prey items). Although this question has been addressed for other fish species, it has not been previously addressed for Florida Pompano, a fish known to exhibit schooling behavior and that is used for aquaculture, where understanding the feeding ecology is important for healthy and efficient grow-out. In this experiment, juvenile Florida Pompano were offered a fixed number of coquina clams (Donax spp.) for one hour either in a group or as individuals. The following day they were tested in the opposite configuration. Fish in groups achieved greater consumption (average of 26 clams consumed by the entire group) than the individuals comprising the group (average of 14 clams consumed [sum of clams consumed by all individuals of the group]). Fish in groups also had fewer unsuccessful foraging attempts (2.75 compared to 4.75 hr(-1)) and tended to have a shorter latency until the first feeding activity. Our results suggest fish in groups were more comfortable feeding and more successful in their feeding attempts. Interestingly, the consumption benefit of group foraging was not shared by all not all fish within a group consumed equal numbers of clams. Taken together, the results support our hypothesis that foraging in a group provides facilitation, but the short-term benefits are not equally shared by all individuals.	[Schrandt, Meagan N.; Powers, Sean P.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; [Schrandt, Meagan N.; Powers, Sean P.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA	University of South Alabama; Dauphin Island Sea Lab	Schrandt, MN (corresponding author), Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA.	mschrandt@disl.org		Powers, Sean/0000-0002-4770-9944	University of South Alabama	University of South Alabama	Support for this project was provided by the University of South Alabama. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIRD TA, 1991, ENVIRON BIOL FISH, V31, P307, DOI 10.1007/BF00000697; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Ellers O, 1988, THESIS DUKE U DURHAM; Foster EG, 2001, J EXP MAR BIOL ECOL, V261, P93, DOI 10.1016/S0022-0981(01)00265-9; FOSTER WA, 1981, NATURE, V293, P466, DOI 10.1038/293466a0; GIBSON RN, 1992, J FISH BIOL, V40, P577, DOI 10.1111/j.1095-8649.1992.tb02607.x; Grand TC, 1999, ANIM BEHAV, V58, P443, DOI 10.1006/anbe.1999.1174; KNOTT DM, 1983, ESTUAR COAST SHELF S, V16, P573, DOI 10.1016/0272-7714(83)90087-2; Krause J, 2000, BIOL REV, V75, P477; Lindquist N, 2001, IMPACTS BEACH NOURIS; MAGURRAN AE, 1983, BEHAV ECOL SOCIOBIOL, V12, P147, DOI 10.1007/BF00343206; MAGURRAN AE, 1990, ANN ZOOL FENN, V27, P51; Manning LM, 2003, OECOLOGIA, V134, P415, DOI 10.1007/s00442-002-1134-y; McLachlan A., 1988, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, P449; MILINSKI M, 1984, ANIM BEHAV, V32, P233, DOI 10.1016/S0003-3472(84)80342-5; MODDE T, 1983, Northeast Gulf Science, V6, P109; Pavlov D.S., 2000, J ICHTHYOL+, V40, pS163; Pereira PHC, 2013, J FISH BIOL, V82, P1226, DOI 10.1111/jfb.12054; Pereira PHC, 2013, ACTA ETHOL, V16, P53, DOI 10.1007/s10211-012-0130-4; Pitcher T.J., 1986, P294; Pitcher T. J., 1993, BEHAV TELEOST FISHES, DOI [10.1007/978-94-011-1578-0_12, DOI 10.1007/978-94-011-1578-0_12, DOI 10.1007/978-94-011-1578-0_]; PITCHER TJ, 1983, ANIM BEHAV, V31, P546, DOI 10.1016/S0003-3472(83)80078-5; PITCHER TJ, 1982, BEHAV ECOL SOCIOBIOL, V10, P149, DOI 10.1007/BF00300175; Pitcher TJ., 2001, ENCY OCEAN SCI, P975, DOI DOI 10.1006/RWOS.2001.0022; RANTA E, 1991, J FISH BIOL, V39, P733, DOI 10.1111/j.1095-8649.1991.tb04402.x; Ross SW, 1996, REV SYNTHESIS DATA S; RYER CH, 1991, ENVIRON BIOL FISH, V30, P317, DOI 10.1007/BF02028847; Ryer CH, 1998, ENVIRON BIOL FISH, V52, P467, DOI 10.1023/A:1007433014921; Strubin C, 2011, ETHOLOGY, V117, P961, DOI 10.1111/j.1439-0310.2011.01966.x; Verweij MC, 2006, MAR BIOL, V149, P1291, DOI 10.1007/s00227-006-0305-5; Wheeler KN, 2002, PROCEEDINGS OF THE FIFTY-THIRD ANNUAL GULF AND CARIBBEAN FISHERIES INSTITUTE, P659	32	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130095	10.1371/journal.pone.0130095	http://dx.doi.org/10.1371/journal.pone.0130095			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068114	Green Submitted, Green Published, gold			2022-12-27	WOS:000356100900097
J	Zhang, W; Qu, HC; Yu, M; Zhang, Y				Zhang, Wei; Qu, Hong-Chen; Yu, Mo; Zhang, Yang			The Effects of Maxillary Protraction with or without Rapid Maxillary Expansion and Age Factors in Treating Class III Malocclusion: A Meta-Analysis	PLOS ONE			English	Article							FACEMASK THERAPY; PROFILE CHANGES; SKELETAL CHANGES; MASK; FORCE; COMPONENTS; STABILITY; HEADGEAR; IMPLANTS; TRIAL	We conducted a comprehensive meta-analysis of 12 studies to examine whether maxillary protraction face mask associated with rapid maxillary expansion (FM/RME) could be an effective treatment for Class III malocclusion and to evaluate the effect of timing on treatment response. Patients with a maxillary deficiency who were treated with FM with or without RME were compared with those who had an untreated Class III malocclusion. In both treatment groups, forward displacement of the maxilla and skeletal changes were found to be statistically significant. In addition, posterior rotation of the mandible and increased facial height were more evident in the FM group compared with the control group. However, no significant differences were observed between the early treatment groups and late treatment groups. The results indicated that both FM/RME and FM therapy produced favorable skeletal changes for correcting anterior crossbite, and the curative time was not affected by the presence of deciduous teeth, early mixed dentition or late mixed dentition in the patient.	[Zhang, Wei; Yu, Mo; Zhang, Yang] China Med Univ, Sch Stomatol, Dept Orthodont, Shenyang 110001, Liaoning, Peoples R China; [Qu, Hong-Chen] China Med Univ, Affiliated Hosp 4, Dept Urol Surg, Shenyang 110001, Liaoning, Peoples R China	China Medical University; China Medical University	Zhang, Y (corresponding author), China Med Univ, Sch Stomatol, Dept Orthodont, Shenyang 110001, Liaoning, Peoples R China.	zgykdxzhangyang@126.com						Allwright WC, 1964, INT DENT J, V14, P505; Arman A, 2004, ANGLE ORTHOD, V74, P733; Baccetti T, 2000, AM J ORTHOD DENTOFAC, V118, P404, DOI 10.1067/mod.2000.109840; Baccetti T, 2011, EUR J ORTHODONT, V33, P121, DOI 10.1093/ejo/cjq170; Baccetti T, 2011, EUR J ORTHODONT, V33, P332, DOI 10.1093/ejo/cjr066; Baik HS, 1995, AM J ORTHOD DENTOFAC, V108, P583, DOI 10.1016/S0889-5406(95)70003-X; Cevidanes L, 2010, ANGLE ORTHOD, V80, P799, DOI 10.2319/111709-651.1; Cha KS, 2003, ANGLE ORTHOD, V73, P26; Chen LL, 2012, EUR J ORTHODONT, V34, P88, DOI 10.1093/ejo/cjq185; Chong YH, 1996, ANGLE ORTHOD, V66, P351; Cohen P A, 1992, J Dent Educ, V56, P172; Dawson-Saunders B, 1990, BASIC CLIN BIOSTATIS, P222; De Clerck HJ, 2009, J ORAL MAXIL SURG, V67, P2123, DOI 10.1016/j.joms.2009.03.007; De Toffol L, 2008, ANGLE ORTHOD, V78, P561, DOI 10.2319/030207-108.1; Delaire J, 1972, Rev Stomatol Chir Maxillofac, V73, P633; DELLINGER EL, 1973, AM J ORTHOD DENTOFAC, V63, P509, DOI 10.1016/0002-9416(73)90163-2; ELLIS E, 1984, AM J ORTHOD DENTOFAC, V86, P277, DOI 10.1016/0002-9416(84)90138-6; Filho OGS, 1998, AM J ORTHOD DENTOFAC, V113, P196; Franchi L, 2004, AM J ORTHOD DENTOFAC, V126, P555, DOI 10.1016/j.ajodo.2003.10.036; Gallagher RW, 1998, AM J ORTHOD DENTOFAC, V113, P612, DOI 10.1016/S0889-5406(98)70220-3; Gencer D, 2014, ANGLE ORTHOD; Glass G.V., 1976, ED RES, V5, P3, DOI [10.2307/1174772, DOI 10.3102/0013189X005010003, 10.2307/1174772ISSN0536-1036]; GUYER EC, 1986, ANGLE ORTHOD, V56, P7; HATA S, 1987, AM J ORTHOD DENTOFAC, V91, P305, DOI 10.1016/0889-5406(87)90171-5; Haynes S, 1970, T EUR ORTHOD SOC, P89; IRIE M, 1975, AM J ORTHOD DENTOFAC, V67, P377, DOI 10.1016/0002-9416(75)90020-2; Iwagaki H, 1938, AM J ORTHOD ORAL SUR, V24, P328; JACKSON GW, 1979, AM J ORTHOD DENTOFAC, V75, P318, DOI 10.1016/0002-9416(79)90278-1; Jager A, 2001, J Orofac Orthop, V62, P275, DOI 10.1007/PL00001935; Jamilian Abdolreza, 2011, Int J Orthod Milwaukee, V22, P25; Jamilian A, 2010, J ORTHOD, V37, P56, DOI 10.1179/14653121042876; Kajiyama K, 2004, AM J ORTHOD DENTOFAC, V126, P23, DOI 10.1016/j.ajodo.2003.04.014; Kajiyama K, 2000, AM J ORTHOD DENTOFAC, V118, P549, DOI 10.1067/mod.2000.110169; KAMBARA T, 1977, AM J ORTHOD DENTOFAC, V71, P249, DOI 10.1016/0002-9416(77)90187-7; Kapust AJ, 1998, AM J ORTHOD DENTOFAC, V113, P204, DOI 10.1016/S0889-5406(98)70141-6; Kilicoglu H, 1998, AM J ORTHOD DENTOFAC, V113, P453, DOI 10.1016/S0889-5406(98)70256-2; Kim JH, 1999, AM J ORTHOD DENTOFAC, V115, P675, DOI 10.1016/S0889-5406(99)70294-5; KOKICH VG, 1985, AM J ORTHOD DENTOFAC, V88, P303, DOI 10.1016/0002-9416(85)90129-0; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; Lee DY, 2010, ANGLE ORTHOD, V80, P692, DOI 10.2319/091609-521.1; Mandall N, 2010, J ORTHOD, V37, P149, DOI 10.1179/14653121043056; Masaki F., 1980, J JPN ORTHOD SOC, V39, P436; Masucci C, 2011, AM J ORTHOD DENTOFAC, V140, P493, DOI 10.1016/j.ajodo.2010.09.031; McNamara J A Jr, 1987, J Clin Orthod, V21, P598; McNamara JA, 1993, ANN ARBOR, P285; Merwin D, 1997, AM J ORTHOD DENTOFAC, V112, P292, DOI 10.1016/S0889-5406(97)70259-2; Murphy GK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-544; NANDA R, 1980, AM J ORTHOD DENTOFAC, V78, P125, DOI 10.1016/0002-9416(80)90055-X; NANDA R, 1978, AM J ORTHOD DENTOFAC, V74, P121, DOI 10.1016/0002-9416(78)90080-5; Nartallo-Turley PE, 1998, ANGLE ORTHOD, V68, P217; Ngan P, 1996, EUR J ORTHODONT, V18, P151; Ngan P, 1996, AM J ORTHOD DENTOFAC, V109, P38, DOI 10.1016/S0889-5406(96)70161-0; Pangrazio-Kulbersh V, 1998, AM J ORTHOD DENTOFAC, V114, P484, DOI 10.1016/S0889-5406(98)70167-2; ROBERTS CA, 1988, AM J ORTHOD DENTOFAC, V93, P388, DOI 10.1016/0889-5406(88)90097-2; ROBERTS SA, 1994, PACE, V17, P1590, DOI 10.1111/j.1540-8159.1994.tb02352.x; Saadia M, 2000, AM J ORTHOD DENTOFAC, V117, P669, DOI 10.1016/S0889-5406(00)70176-4; Sanborn RT, 1955, ANGLE ORTHOD, V25, P208; Sar C, 2011, AM J ORTHOD DENTOFAC, V139, P636, DOI 10.1016/j.ajodo.2009.06.039; Shanker S, 1996, AM J ORTHOD DENTOFAC, V110, P423, DOI 10.1016/S0889-5406(96)70046-X; Showkatbakhsh Rahman, 2011, ISRN Surg, V2011, P854924, DOI 10.5402/2011/854924; Showkatbakhsh Rahman, 2010, Int J Orthod Milwaukee, V21, P27; Singer SL, 2000, ANGLE ORTHOD, V70, P253; Suda N, 2000, AM J ORTHOD DENTOFAC, V118, P55, DOI 10.1067/mod.2000.104491; Sung SJ, 1998, AM J ORTHOD DENTOFAC, V114, P492, DOI 10.1016/S0889-5406(98)70168-4; Takada K, 1993, Eur J Orthod, V15, P211; THILANDER B, 1973, SCAND J DENT RES, V81, P12; Turley P K, 1988, J Clin Orthod, V22, P314; Ucem TT, 2004, AM J ORTHOD DENTOFAC, V126, P672, DOI 10.1016/j.ajodo.2003.09.035; von Elm E, 2007, EPIDEMIOLOGY, V18, P800, DOI 10.1097/EDE.0b013e3181577654; Wolf F.M., 1986, METAANALYSIS QUANTIT; Yepes E, 2014, EUR J ORTHODONT, V36, P586, DOI 10.1093/ejo/cjt091; Yuksel S, 2001, EUR J ORTHODONT, V23, P559, DOI 10.1093/ejo/23.5.559	72	25	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130096	10.1371/journal.pone.0130096	http://dx.doi.org/10.1371/journal.pone.0130096			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068221	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900098
J	Zhang, S; Hu, SE; Hu, JP; Wu, PL; Chao, HH; Li, CSR				Zhang, Sheng; Hu, Sien; Hu, Jianping; Wu, Po-Lun; Chao, Herta H.; Li, Chiang-Shan R.			Barratt Impulsivity and Neural Regulation of Physiological Arousal	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; SKIN-CONDUCTANCE RESPONSES; STOP SIGNAL TASK; GENDER-DIFFERENCES; REWARD SENSITIVITY; SENSATION SEEKING; BRAIN ACTIVITY; INDIVIDUAL-DIFFERENCES; PSYCHOSOCIAL STRESS; GRANGER CAUSALITY	Background Theories of personality have posited an increased arousal response to external stimulation in impulsive individuals. However, there is a dearth of studies addressing the neural basis of this association. Methods We recorded skin conductance in 26 individuals who were assessed with Barratt Impulsivity Scale (BIS-11) and performed a stop signal task during functional magnetic resonance imaging. Imaging data were processed and modeled with Statistical Parametric Mapping. We used linear regressions to examine correlations between impulsivity and skin conductance response (SCR) to salient events, identify the neural substrates of arousal regulation, and examine the relationship between the regulatory mechanism and impulsivity. Results Across subjects, higher impulsivity is associated with greater SCR to stop trials. Activity of the ventromedial prefrontal cortex (vmPFC) negatively correlated to and Granger caused skin conductance time course. Furthermore, higher impulsivity is associated with a lesser strength of Granger causality of vmPFC activity on skin conductance, consistent with diminished control of physiological arousal to external stimulation. When men (n = 14) and women (n = 12) were examined separately, however, there was evidence suggesting association between impulsivity and vmPFC regulation of arousal only in women. Conclusions Together, these findings confirmed the link between Barratt impulsivity and heightened arousal to salient stimuli in both genders and suggested the neural bases of altered regulation of arousal in impulsive women. More research is needed to explore the neural processes of arousal regulation in impulsive individuals and in clinical conditions that implicate poor impulse control.	[Zhang, Sheng; Hu, Sien; Hu, Jianping; Wu, Po-Lun; Li, Chiang-Shan R.] Yale Univ, Dept Psychiat, New Haven, CT 06519 USA; [Hu, Jianping] S China Normal Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China; [Wu, Po-Lun] China Med Univ, Dept Psychiat, Taichung, Taiwan; [Chao, Herta H.] Yale Univ, Dept Med, New Haven, CT 06519 USA; [Chao, Herta H.] VA Connecticut Healthcare Syst, Dept Med, West Haven, CT 06516 USA; [Chao, Herta H.] Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA; [Li, Chiang-Shan R.] Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA	Yale University; South China Normal University; China Medical University Taiwan; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University	Zhang, S (corresponding author), Yale Univ, Dept Psychiat, New Haven, CT 06519 USA.	sheng.zhang@yale.edu; chiang-shan.li@yale.edu	Li, Chiang-Shan Ray/J-2813-2016	Li, Chiang-Shan Ray/0000-0002-9393-1212	NIH [R01DA023248, R21AA018004, R01AA021449, K02DA026990, R03CA138121]; NATIONAL CANCER INSTITUTE [R03CA138121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA018004, R01AA021449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026990, R01DA023248] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants R01DA023248, R21AA018004, R01AA021449, K02DA026990, R03CA138121. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abler B, 2006, MAGN RESON IMAGING, V24, P181, DOI 10.1016/j.mri.2005.10.022; Acton GS, 2003, SUBST USE MISUSE, V38, P67, DOI 10.1081/JA-120016566; [Anonymous], 1985, PERSONALITY INDIVIDU, DOI 13877; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Barratt ES, 1983, BIOL BASES IMPULSIVE; Barratt ES., 1985, MOTIVATION EMOTION P, P137, DOI DOI 10.1371/JOURNAL.PONE.0129139; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Berridge CW, 2013, NEUROSCI BIOBEHAV R, V37, P1976, DOI 10.1016/j.neubiorev.2012.11.005; Booth C, 2009, ADDICT BEHAV, V34, P730, DOI 10.1016/j.addbeh.2009.04.010; Boutrel B, 2008, PHYSIOL BEHAV, V93, P947, DOI 10.1016/j.physbeh.2007.11.022; CARRILLODELAPENA MT, 1993, PERS INDIV DIFFER, V15, P25, DOI 10.1016/0191-8869(93)90038-5; Castella J, 2004, ACCIDENT ANAL PREV, V36, P947, DOI 10.1016/j.aap.2003.10.003; Castellanos-Ryan N, 2014, AM J PSYCHIAT, V171, P1310, DOI 10.1176/appi.ajp.2014.13111499; Chao HHA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-75; Constantinou E, 2011, ACCIDENT ANAL PREV, V43, P1323, DOI 10.1016/j.aap.2011.02.002; Coskunpinar A, 2013, DRUG ALCOHOL DEPEN, V133, P1, DOI 10.1016/j.drugalcdep.2013.05.008; Coventry KR, 2001, ADDICTION, V96, P871, DOI 10.1046/j.1360-0443.2001.9668718.x; Critchley HD, 2000, J NEUROSCI, V20, P3033; Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Critchley HD, 2009, INT J PSYCHOPHYSIOL, V73, P88, DOI 10.1016/j.ijpsycho.2009.01.012; Cservenka A, 2013, NEUROIMAGE, V66, P184, DOI 10.1016/j.neuroimage.2012.11.003; Damasio A.R., 2005, DESCARTES ERROR EMOT; Davis C, 2008, APPETITE, V50, P43, DOI 10.1016/j.appet.2007.05.007; De Pascalis V, 2007, INT J PSYCHOPHYSIOL, V63, P16, DOI 10.1016/j.ijpsycho.2006.06.004; DEJONG R, 1990, J EXP PSYCHOL HUMAN, V16, P164, DOI 10.1037/0096-1523.16.1.164; Delgado MR, 2008, NEURON, V59, P829, DOI 10.1016/j.neuron.2008.06.029; Derefinko KJ, 2014, ARCH SEX BEHAV, V43, P1149, DOI 10.1007/s10508-014-0327-x; Deshpande G, 2008, NEUROIMAGE, V40, P1807, DOI 10.1016/j.neuroimage.2008.01.044; DeVito EE, 2013, NEUROPSYCHOPHARMACOL, V38, P1854, DOI 10.1038/npp.2013.92; Diekhof EK, 2012, BRAIN RES, V1473, P63, DOI 10.1016/j.brainres.2012.07.010; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Eysenck H.J., 1967, BIOL BASIS PERSONALI; EYSENCK SBG, 1977, BRIT J SOC CLIN PSYC, V16, P57, DOI 10.1111/j.2044-8260.1977.tb01003.x; Fan J, 2012, J NEUROSCI, V32, P11176, DOI 10.1523/JNEUROSCI.1172-12.2012; Farr OM, 2012, NEUROIMAGE, V63, P1070, DOI 10.1016/j.neuroimage.2012.07.049; Figner B., 2010, HDB PROCESS TRACING, P163; FIRESTONE P, 1975, J ABNORM CHILD PSYCH, V3, P201; First M.B., 2016, STRUCTURED CLIN INTE; Fischer H, 2004, COGN AFFECT BEHAV NE, V4, P326, DOI 10.3758/CABN.4.3.326; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FRITH CD, 1983, BIOL PSYCHOL, V17, P27, DOI 10.1016/0301-0511(83)90064-9; Gentle J. E., 2004, HDB COMPUTATIONAL ST; Giakoumaki SG, 2013, BIOL PSYCHOL, V94, P582, DOI 10.1016/j.biopsycho.2013.09.005; Goldstein JM, 2010, J NEUROSCI, V30, P431, DOI 10.1523/JNEUROSCI.3021-09.2010; Gomez P, 2010, PSYCHOPHYSIOLOGY, V47, P540, DOI 10.1111/j.1469-8986.2009.00953.x; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hahn T, 2009, NEUROIMAGE, V46, P1148, DOI 10.1016/j.neuroimage.2009.03.038; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Harrison L, 2003, NEUROIMAGE, V19, P1477, DOI 10.1016/S1053-8119(03)00160-5; Houston RJ, 2001, INT J PSYCHOPHYSIOL, V40, P1, DOI 10.1016/S0167-8760(00)00120-3; HUMPHREYS MS, 1984, PSYCHOL REV, V91, P153, DOI 10.1037/0033-295X.91.2.153; Ide JS, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00025; Ide JS, 2011, NEUROIMAGE, V54, P455, DOI 10.1016/j.neuroimage.2010.07.042; Kerr KL, 2015, SOC COGN AFFECT NEUR, V10, P36, DOI 10.1093/scan/nsu023; Kirkpatrick MG, 2013, J PSYCHOPHARMACOL, V27, P256, DOI 10.1177/0269881112472564; Leue A, 2008, BRIT J PSYCHOL, V99, P361, DOI 10.1348/000712607X228519; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li CSR, 2008, J COGNITIVE NEUROSCI, V20, P1021, DOI 10.1162/jocn.2008.20071; Li CSR, 2007, PERS INDIV DIFFER, V43, P475, DOI 10.1016/j.paid.2006.12.016; Li CSR, 2009, BRAIN IMAGING BEHAV, V3, P262, DOI 10.1007/s11682-009-9068-1; Li CSR, 2009, CEREB CORTEX, V19, P839, DOI 10.1093/cercor/bhn132; Li YD, 2014, BEHAV BRAIN RES, V274, P400, DOI 10.1016/j.bbr.2014.08.041; Lijffijt M, 2004, J Atten Disord, V8, P25, DOI 10.1177/108705470400800104; Litschauer B, 1998, PSYCHOSOM MED, V60, P219, DOI 10.1097/00006842-199803000-00019; Lombardo MV, 2012, BIOL PSYCHIAT, V72, P839, DOI 10.1016/j.biopsych.2012.05.027; Lyvers M, 2012, ADDICT BEHAV, V37, P940, DOI 10.1016/j.addbeh.2012.03.028; Mathias CW, 2003, PERS INDIV DIFFER, V35, P355, DOI 10.1016/S0191-8869(02)00195-2; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Moodie C, 2005, ADDICTION, V100, P51, DOI 10.1111/j.1360-0443.2005.00942.x; Muller VI, 2015, BRAIN STRUCT FUNCT, V220, P2401, DOI 10.1007/s00429-014-0797-6; Nagai Y, 2004, NEUROIMAGE, V22, P243, DOI 10.1016/j.neuroimage.2004.01.019; Nili U, 2010, NEURON, V66, P949, DOI 10.1016/j.neuron.2010.06.009; Paquet C, 2010, AM J CLIN NUTR, V91, P771, DOI 10.3945/ajcn.2009.28648; Patterson JC, 2002, NEUROIMAGE, V17, P1797, DOI 10.1006/nimg.2002.1306; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Paulus MP, 2014, NEUROPHARMACOLOGY, V76, P342, DOI 10.1016/j.neuropharm.2013.07.002; Penny W.D., 2004, HUMAN BRAIN FUNCTION, P843; Perkins KA, 2008, PSYCHOPHARMACOLOGY, V200, P529, DOI 10.1007/s00213-008-1231-7; Perry RI, 2013, DRUG ALCOHOL DEPEN, V133, P222, DOI 10.1016/j.drugalcdep.2013.04.032; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Rollins BY, 2014, APPETITE, V72, P21, DOI 10.1016/j.appet.2013.09.018; Romero-Martinez A, 2013, INT J PSYCHOPHYSIOL, V90, P329, DOI 10.1016/j.ijpsycho.2013.10.003; Roussos P, 2009, NEUROPSYCHOLOGIA, V47, P1654, DOI 10.1016/j.neuropsychologia.2009.02.005; Sarlo M, 2013, INT J PSYCHOL, V48, P263, DOI 10.1080/00207594.2012.656127; Sato JR, 2009, HUM BRAIN MAPP, V30, P452, DOI 10.1002/hbm.20513; Scarpa A, 2010, BIOL PSYCHOL, V84, P488, DOI 10.1016/j.biopsycho.2009.11.006; Schiller D, 2008, J NEUROSCI, V28, P11517, DOI 10.1523/JNEUROSCI.2265-08.2008; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Scott-Parker B, 2013, ACCIDENT ANAL PREV, V50, P465, DOI 10.1016/j.aap.2012.05.027; Scott-Parker B, 2012, BRIT J PSYCHOL, V103, P248, DOI 10.1111/j.2044-8295.2011.02069.x; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Simons JS, 2008, PSYCHOL ADDICT BEHAV, V22, P444, DOI 10.1037/0893-164X.22.3.444; Stankovic A, 2014, INT J PSYCHOPHYSIOL, V93, P22, DOI 10.1016/j.ijpsycho.2013.11.001; Stilla R, 2007, J NEUROSCI, V27, P11091, DOI 10.1523/JNEUROSCI.1808-07.2007; Suarez EC, 2004, PSYCHOPHYSIOLOGY, V41, P450, DOI 10.1111/j.1469-8986.00161.x; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Urosevic S, 2012, DEV PSYCHOL, V48, P1488, DOI 10.1037/a0027502; van den Bos W, 2014, J NEUROSCI, V34, P10298, DOI 10.1523/JNEUROSCI.4105-13.2014; Wang TS, 2013, J PHYSIOL SCI, V63, P87, DOI 10.1007/s12576-012-0238-3; Weiland BJ, 2014, PSYCHIAT RES-NEUROIM, V223, P244, DOI 10.1016/j.pscychresns.2014.05.015; Wen XT, 2012, J NEUROSCI, V32, P1284, DOI 10.1523/JNEUROSCI.2817-11.2012; White TL, 2007, EXP CLIN PSYCHOPHARM, V15, P599, DOI 10.1037/1064-1297.15.6.599; Whiteside SP, 2003, EXP CLIN PSYCHOPHARM, V11, P210, DOI 10.1037/1064-1297.11.3.210; Wilbertz T, 2014, NEUROIMAGE, V103, P241, DOI 10.1016/j.neuroimage.2014.09.021; Winhusen T, 2013, DRUG ALCOHOL DEPEN, V129, P158, DOI 10.1016/j.drugalcdep.2012.09.014; Zhang S, 2014, SOC COGN AFFECT NEUR, V9, P900, DOI 10.1093/scan/nst064; Zhang S, 2012, NEUROIMAGE, V62, P1489, DOI 10.1016/j.neuroimage.2012.05.036; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023; Zhang S, 2012, HUM BRAIN MAPP, V33, P89, DOI 10.1002/hbm.21197; Zuckerman M., 1991, PSYCHOBIOLOGY PERSON	113	19	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129139	10.1371/journal.pone.0129139	http://dx.doi.org/10.1371/journal.pone.0129139			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9EB	26079873	Green Submitted, gold, Green Published			2022-12-27	WOS:000356542300014
J	Allan, ERO; Yates, RM				Allan, Euan Ramsay Orr; Yates, Robin Michael			Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; LYSOSOMAL THIOL REDUCTASE; MYELIN BASIC-PROTEIN; T-CELL SELECTION; INVARIANT CHAIN; NADPH OXIDASE; PHAGOSOMAL PROTEOLYSIS; ANTIGEN PRESENTATION; MULTIPLE-SCLEROSIS; S INHIBITORS	The cysteine cathepsins B, S, and L are functionally linked to antigen processing, and hence to autoimmune disorders such as multiple sclerosis. Stemming from several studies that demonstrate that mice can be protected from experimental autoimmune encephalomyelitis (EAE) through the pharmacologic inhibition of cysteine cathepsins, it has been suggested that targeting these enzymes in multiple sclerosis may be of therapeutic benefit. Utilizing mice deficient in cysteine cathepsins both individually and in combination, we found that the myelin-associated antigen myelin oligodendrocyte glycoprotein (MOG) was efficiently processed and presented by macrophages to CD4+ T cells in the individual absence of cathepsin B, S or L. Similarly, mice deficient in cathepsin B or S were susceptible to MOG-induced EAE and displayed clinical progression and immune infiltration into the CNS, similar to their wild-type counterparts. Owing to a previously described CD4+ T cell deficiency in mice deficient in cathepsin L, such mice were protected from EAE. When multiple cysteine cathepsins were simultaneously inhibited via genetic deletion of both cathepsins B and S, or by a cathepsin inhibitor (LHVS), MHC-II surface expression, MOG antigen presentation and EAE were attenuated or prevented. This study demonstrates the functional redundancy between cathepsin B, S and L in EAE, and suggests that the inhibition of multiple cysteine cathepsins may be needed to modulate autoimmune disorders such as multiple sclerosis.	[Allan, Euan Ramsay Orr; Yates, Robin Michael] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB T2N 1N4, Canada; [Yates, Robin Michael] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Yates, RM (corresponding author), Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB T2N 1N4, Canada.	rmyates@ucalgary.ca	Yates, Robin/K-5032-2015	Yates, Robin/0000-0003-3122-1845	Canadian Institutes of Health Research [MOP-111256]; Multiple Sclerosis Society of Canada; EndMS training network and Alberta Innovates - Health Solutions	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada; EndMS training network and Alberta Innovates - Health Solutions	This work was supported by the Canadian Institutes of Health Research (MOP-111256) and the Multiple Sclerosis Society of Canada. Graduate student support was provided by the EndMS training network and Alberta Innovates - Health Solutions.	Agrawal SM, 2011, J NEUROSCI, V31, P669, DOI 10.1523/JNEUROSCI.3659-10.2011; Allan ERO, 2014, J IMMUNOL, V192, P4989, DOI 10.4049/jimmunol.1302896; Balce DR, 2014, J BIOL CHEM, V289, P31891, DOI 10.1074/jbc.M114.584391; Balce DR, 2011, BLOOD, V118, P4199, DOI 10.1182/blood-2011-01-328906; Baugh M, 2011, J AUTOIMMUN, V36, P201, DOI 10.1016/j.jaut.2011.01.003; Beck H, 2001, EUR J IMMUNOL, V31, P3726, DOI 10.1002/1521-4141(200112)31:12<3726::AID-IMMU3726>3.0.CO;2-O; Beers C, 2003, J EXP MED, V197, P169, DOI 10.1084/jem.20020978; Belizaire R, 2009, P NATL ACAD SCI USA, V106, P17463, DOI 10.1073/pnas.0908583106; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; BEVER CT, 1994, NEUROLOGY, V44, P745, DOI 10.1212/WNL.44.4.745; BOEHME DH, 1978, NEUROCHEM RES, V3, P185, DOI 10.1007/BF00964059; Brand DD, 2003, SPRINGER SEMIN IMMUN, V25, P3, DOI 10.1007/s00281-003-0127-1; Choi SH, 2005, J NEUROCHEM, V95, P1755, DOI 10.1111/j.1471-4159.2005.03503.x; Desai SN, 2006, EUR J PHARMACOL, V538, P168, DOI 10.1016/j.ejphar.2006.03.051; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Fissolo N, 2008, EUR J IMMUNOL, V38, P2401, DOI 10.1002/eji.200838413; Fujii H, 2012, BIOL BLOOD MARROW TR, V18, P546, DOI 10.1016/j.bbmt.2011.11.027; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; GOVINDARAJAN KR, 1974, BRAIN RES, V67, P141, DOI 10.1016/0006-8993(74)90304-7; GOVINDARAJAN KR, 1974, J NEUROL SCI, V23, P81, DOI 10.1016/0022-510X(74)90144-0; Gresser O, 2001, EUR J IMMUNOL, V31, P1813, DOI 10.1002/1521-4141(200106)31:6<1813::AID-IMMU1813>3.0.CO;2-8; Haves-Zburof D, 2011, J CELL MOL MED, V15, P2421, DOI 10.1111/j.1582-4934.2010.01229.x; Honey K, 2002, J EXP MED, V195, P1349, DOI 10.1084/jem.20011904; Honey K, 2001, J BIOL CHEM, V276, P22573, DOI 10.1074/jbc.M101851200; Hori S, 2003, ADV IMMUNOL, V81, P331, DOI 10.1016/S0065-2776(03)81008-8; Hsieh CS, 2002, J IMMUNOL, V168, P2618, DOI 10.4049/jimmunol.168.6.2618; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Irie O, 2008, BIOORG MED CHEM LETT, V18, P5280, DOI 10.1016/j.bmcl.2008.08.067; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; Kikuchi H, 2003, ACTA NEUROPATHOL, V105, P462, DOI 10.1007/s00401-002-0667-9; Lee-Dutra A, 2011, EXPERT OPIN THER PAT, V21, P311, DOI 10.1517/13543776.2011.553800; Liuzzo JP, 1999, MOL MED, V5, P334, DOI 10.1007/BF03402069; Lockwood TD, 2002, ANTIOXID REDOX SIGN, V4, P681, DOI 10.1089/15230860260220193; Manoury B, 2002, NAT IMMUNOL, V3, P169, DOI 10.1038/ni754; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Nakahara J, 2010, ARCH IMMUNOL THER EX, V58, P325, DOI 10.1007/s00005-010-0094-x; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Podolin PL, 2008, J IMMUNOL, V180, P7989, DOI 10.4049/jimmunol.180.12.7989; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; Rybicka JM, 2012, EMBO J, V31, P932, DOI 10.1038/emboj.2011.440; Rybicka JM, 2010, P NATL ACAD SCI USA, V107, P10496, DOI 10.1073/pnas.0914867107; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Stoeckle C, 2012, J AUTOIMMUN, V38, P332, DOI 10.1016/j.jaut.2012.02.003; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Underhill DM, 1999, J EXP MED, V190, P1909, DOI 10.1084/jem.190.12.1909; van der Veen RC, 2000, J IMMUNOL, V164, P5177, DOI 10.4049/jimmunol.164.10.5177; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477	51	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128945	10.1371/journal.pone.0128945	http://dx.doi.org/10.1371/journal.pone.0128945			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075905	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900039
J	Sachdeva, S; Iliev, R; Ekhtiari, H; Dehghani, M				Sachdeva, Sonya; Iliev, Rumen; Ekhtiari, Hamed; Dehghani, Morteza			The Role of Self-Sacrifice in Moral Dilemmas	PLOS ONE			English	Article							PERCEPTION; INTUITIONS	Centuries' worth of cultural stories suggest that self-sacrifice may be a cornerstone of our moral concepts, yet this notion is largely absent from recent theories in moral psychology. For instance, in the footbridge version of the well-known trolley car problem the only way to save five people from a runaway trolley is to push a single man on the tracks. It is explicitly specified that the bystander cannot sacrifice himself because his weight is insufficient to stop the trolley. But imagine if this were not the case. Would people rather sacrifice themselves than push another? In Study 1, we find that people approve of self-sacrifice more than directly harming another person to achieve the same outcome. In Studies 2 and 3, we demonstrate that the effect is not broadly about sensitivity to self-cost, instead there is something unique about sacrificing the self. Important theoretical implications about agent-relativity and the role of causality in moral judgments are discussed.	[Sachdeva, Sonya] US Forest Serv, Social Sci Res Unit, Evanston, IL USA; [Iliev, Rumen] Univ Michigan, Ford Sch Publ Policy, Ann Arbor, MI 48109 USA; [Ekhtiari, Hamed] Univ Tehran Med Sci, Iranian Natl Ctr Addict Studies, Res Ctr Mol & Cellular Imaging, Tehran, Iran; [Ekhtiari, Hamed] Inst Cognit Sci Studies, Translat Neurosci Program, Tehran, Iran; [Dehghani, Morteza] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Dehghani, Morteza] Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA	United States Department of Agriculture (USDA); United States Forest Service; University of Michigan System; University of Michigan; Tehran University of Medical Sciences; University of Southern California; University of Southern California	Dehghani, M (corresponding author), Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA.	mdehghan@usc.edu	Ponton, Twyla/X-3944-2019; Ekhtiari, Hamed/L-3639-2013	Ekhtiari, Hamed/0000-0001-6902-8798; Dehghani, Morteza/0000-0002-9478-4365	National Science Foundation [SES 0962185]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grant SES 0962185. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atran S, 2003, SCIENCE, V299, P1534, DOI 10.1126/science.1078854; Atran S, 2008, NEGOTIATION J, V24, P221, DOI 10.1111/j.1571-9979.2008.00182.x; Atran S, 2007, SCIENCE, V317, P1039, DOI 10.1126/science.1144241; Baron J, 1997, ORGAN BEHAV HUM DEC, V70, P1, DOI 10.1006/obhd.1997.2690; Becker SW, 2004, AM PSYCHOL, V59, P163, DOI 10.1037/0003-066X.59.3.163; Bloomfield Paul, 2008, MORALITY SELF INTERE; Dajani J, EGYPT MIDDLE E REVOL; Dehghani M., 2009, THESIS NW U EVANSTON; Di Nucci E., 2012, PHILOS PSYCHOL, P1; Fields RM, 2004, MARTYRDOM; Ginges J, 2011, AM PSYCHOL, V66, P507, DOI 10.1037/a0024715; Gray K, 2012, PSYCHOL INQ, V23, P101, DOI 10.1080/1047840X.2012.651387; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Haidt J, 1996, EUR J SOC PSYCHOL, V26, P201, DOI 10.1002/(SICI)1099-0992(199603)26:2<201::AID-EJSP745>3.0.CO;2-J; Haidt J., 2012, RIGHTEOUS MIND WHY G; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Hauser M.D., 2006, MORAL MINDS; Hollis M., 1996, REASON ACTION ESSAYS; Huebner B, 2011, PHILOS PSYCHOL, V24, P73, DOI 10.1080/09515089.2010.534447; Iliev RI, 2012, MEM COGNITION, V40, P1387, DOI 10.3758/s13421-012-0217-1; Kamm F. M., 2007, INTRICATE ETHICS RIG; Kirkpatrick DD, 2011, NY TIMES, P13; Libby LK, 2007, PSYCHOL SCI, V18, P199, DOI 10.1111/j.1467-9280.2007.01872.x; Lucas BJ, 2014, J EXP SOC PSYCHOL, V53, P1, DOI 10.1016/j.jesp.2014.01.011; Mikhail J, 2007, TRENDS COGN SCI, V11, P143, DOI 10.1016/j.tics.2006.12.007; Moore AB, 2008, PSYCHOL SCI, V19, P549, DOI 10.1111/j.1467-9280.2008.02122.x; Nagel T, 1989, VIEW NOWHERE; Olivola CY, 2013, J BEHAV DECIS MAKING, V26, P91, DOI 10.1002/bdm.767; PETRINOVICH L, 1993, J PERS SOC PSYCHOL, V64, P467, DOI 10.1037/0022-3514.64.3.467; Royzman E.B., 2002, SOCIAL JUSTICE RES, V15, P165, DOI [10.1023/a:1019923923537, DOI 10.1023/A:1019923923537]; Sachdeva S., 2010, THESIS NW U EVANSTON; Shallow C, 2011, JUDGM DECIS MAK, V6, P593; SIDER T, 1993, PHILOS STUD, V70, P117, DOI 10.1007/BF00989586; SLOTE M, 1984, J PHILOS, V81, P179, DOI 10.2307/2026119; STOCKER M, 1976, AUSTRALAS J PHILOS, V54, P206, DOI 10.1080/00048407612341221; Swann WB, 2014, J PERS SOC PSYCHOL, V106, P713, DOI 10.1037/a0035809; Swann WB, 2010, PSYCHOL SCI, V21, P1176, DOI 10.1177/0956797610376656; Tassy S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00250; THOMSON JJ, 1985, YALE LAW J, V94, P1395, DOI 10.2307/796133; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Waldmann MR, 2007, PSYCHOL SCI, V18, P247, DOI 10.1111/j.1467-9280.2007.01884.x	41	17	17	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0127409	10.1371/journal.pone.0127409	http://dx.doi.org/10.1371/journal.pone.0127409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CK6HU	26075881	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900012
J	Wang, QX; Yan, DD; Liu, PF; Mao, LG; Wang, D; Fang, WS; Li, Y; Ouyang, CB; Guo, MX; Cao, AC				Wang, Qiuxia; Yan, Dongdong; Liu, Pengfei; Mao, Liangang; Wang, Dong; Fang, Wensheng; Li, Yuan; Ouyang, Canbin; Guo, Meixia; Cao, Aocheng			Chloropicrin Emission Reduction by Soil Amendment with Biochar	PLOS ONE			English	Article							ROOT-KNOT NEMATODES; AGRICULTURAL FUMIGANTS; 1,3-DICHLOROPROPENE; EFFICACY; FUMIGATION; STRAWBERRY; TOMATOES; SORPTION; MANURE; FILMS	Biochar has sorption capacity, and can be used to enhance the sequestration of volatile organic contaminants such as pesticides in soil. Chloropicrin (CP) is an important soil fumigant for the production of many fruit and vegetable crops, but its emissions must be minimized to reduce exposure risks and air pollution. The objective of this study was to determine the capacity of biochar to adsorb CP and the effect of biochar amendments to soil on CP emission, concentration in the soil gas phase, degradation in soil and CP bioactivity for controlling soil borne pests. CP emission and concentration in the soil air phase were measured from packed soil columns after fumigant injection at 20-cm depth and application of selected doses of biocharto the surface 5 cm soil. Laboratory incubation and fumigation experiments were conducted to determine the capacity of biochar to adsorb CP, the effects on CP degradation and, separately, CP's bioactivity on soil borne pests in soil amended with biochar. Biochar amendment at 2% to 5% (w/w) greatly reduced total CP emission losses by 85.7% - 97.7% compared to fumigation without biochar. CP concentrations in the soil gas-phase, especially in the top 5 cm of soil, were reduced within 48 h following application. The half-life of CP decreased from 13.6 h to 6.4 h as the biochar rate increased from 0% to 5%. CP and its metabolite (dichloronitromethane) both degraded more rapidly in pure biochar than in soil. The biochar used in the present study had a maximum adsorption capacity for CP of less than 5 mg g(-1). There were no negative effects on pathogen and nematode control when the biochar used in this study was less than 1% (on a weight basis) in soil. Biochar amendment to soil reduced the emissions of CP. CP concentrations in the top 5 cm of soil gas-phase were reduced. CP degradation was accelerated with the addition of biochar. The biochar used in the present study had a low adsorption capacity for CP. There were no negative effects on pathogen and nematode control when the biochar amendment rate was less than 1% (by weight). The findings would be useful for establishing guidelines for biochar use in soil fumigation.	[Wang, Qiuxia; Yan, Dongdong; Liu, Pengfei; Mao, Liangang; Fang, Wensheng; Li, Yuan; Ouyang, Canbin; Guo, Meixia; Cao, Aocheng] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Wang, Dong] USDA ARS, San Joaquin Valley Agr Sci Ctr, Water Management Res Unit, Parlier, DC USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; United States Department of Agriculture (USDA)	Cao, AC (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	caoac@vip.sina.com	yan, dongdong/M-4629-2017	Yan, Dongdong/0000-0002-8196-4615	National Natural Science Foundation project of China [30900958]; Beijing Nova program [2010B064]	National Natural Science Foundation project of China(National Natural Science Foundation of China (NSFC)); Beijing Nova program(Beijing Municipal Science & Technology Commission)	This research was financially supported by the National Natural Science Foundation project of China (30900958) and Beijing Nova program (No. 2010B064).	Amonette J. E., 2009, CHARACTERISTICS BIOC; Ashworth DJ, 2009, ENVIRON SCI TECHNOL, V43, P5073, DOI 10.1021/es900049g; Cao XD, 2011, ENVIRON SCI TECHNOL, V45, P4884, DOI 10.1021/es103752u; Chellemi DO, 2011, J ENVIRON QUAL, V40, P1204, DOI 10.2134/jeq2010.0494; Cole SK, 2007, ENVIRON SCI TECHNOL, V41, P863, DOI 10.1021/es061410b; De Cal A, 2005, APPL SOIL ECOL, V28, P47, DOI 10.1016/j.apsoil.2004.06.005; Desaeger JA, 2008, PEST MANAG SCI, V64, P230, DOI 10.1002/ps.1503; Gan J, 1997, J ENVIRON QUAL, V26, P310, DOI 10.2134/jeq1997.00472425002600010043x; Gao SD, 2013, ENVIRON SCI TECHNOL, V47, P405, DOI 10.1021/es303557y; Gao SD, 2009, J AGR FOOD CHEM, V57, P5428, DOI 10.1021/jf900245f; Gilreath JP, 2005, CROP PROT, V24, P285, DOI 10.1016/j.cropro.2004.08.008; Graber ER, 2011, SOIL SCI SOC AM J, V75, P1365, DOI 10.2136/sssaj2010.0435; Hagner M, 2013, EUR J SOIL BIOL, V58, P1, DOI 10.1016/j.ejsobi.2013.05.002; Ji XX, 2013, CROP PROT, V45, P1, DOI 10.1016/j.cropro.2012.11.018; Jones DL, 2011, SOIL BIOL BIOCHEM, V43, P804, DOI 10.1016/j.soilbio.2010.12.015; KOMADA H, 1975, Review of Plant Protection Research, V8, P114; Lehmann J, 2007, FRONT ECOL ENVIRON, V5, P381, DOI 10.1890/1540-9295(2007)5[381:BITB]2.0.CO;2; Li JF, 2013, PLANT SOIL, V370, P333, DOI 10.1007/s11104-013-1639-7; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Lombardo S, 2012, CROP PROT, V37, P59, DOI 10.1016/j.cropro.2012.02.010; MASAGO H, 1977, PHYTOPATHOLOGY, V67, P425, DOI 10.1094/Phyto-67-425; Meszaros E, 2007, IND ENG CHEM RES, V46, P5943, DOI 10.1021/ie0615842; Minuto A, 2006, CROP PROT, V25, P1244, DOI 10.1016/j.cropro.2006.03.017; Oriel M, 2009, REV ENVIRON CONTAM T, V200, P1, DOI 10.1007/978-1-4419-0028-9_1; Pesonen M, 2012, TOXICOL LETT, V211, P239, DOI 10.1016/j.toxlet.2012.04.002; Qian YR, 2011, ENVIRON SCI TECHNOL, V45, P9711, DOI 10.1021/es201278p; Qin RJ, 2009, J AGR FOOD CHEM, V57, P9063, DOI 10.1021/jf901737a; Spotti C, 2011, ACTA HORTIC, V914, P267, DOI 10.17660/ActaHortic.2011.914.48; Tatarkova V, 2013, ECOTOX ENVIRON SAFE, V92, P215, DOI 10.1016/j.ecoenv.2013.02.005; United States Environmental Protection Agency, 2009, AM RER EL DEC RED CH; Wang QX, 2014, J ENVIRON QUAL, V43, P1656, DOI 10.2134/jeq2014.02.0075; Yan DD, 2012, J AGR FOOD CHEM, V60, P5023, DOI 10.1021/jf300532x; Yates SR, 2011, J ENVIRON QUAL, V40, P1347, DOI 10.2134/jeq2011.0142; Zhang Y, 2007, CHEMOSPHERE, V68, P445, DOI 10.1016/j.chemosphere.2006.12.083	34	8	10	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129448	10.1371/journal.pone.0129448	http://dx.doi.org/10.1371/journal.pone.0129448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075904	gold, Green Submitted, Green Published			2022-12-27	WOS:000356329900075
J	Kodama, K; Furuyama, N; Inamura, T				Kodama, Kentaro; Furuyama, Nobuhiro; Inamura, Tetsunari			Differing Dynamics of Intrapersonal and Interpersonal Coordination: Two-finger and Four-Finger Tapping Experiments	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; INTERLIMB COORDINATION; PHASE-TRANSITIONS; ENTRAINMENT; INFORMATION; ATTRACTORS; MOVEMENTS; MODEL; SPEED	Finger-tapping experiments were conducted to examine whether the dynamics of intrapersonal and interpersonal coordination systems can be described equally by the Haken-Kelso-Bunz model, which describes inter-limb coordination dynamics. This article reports the results of finger-tapping experiments conducted in both systems. Two within-subject factors were investigated: the phase mode and the number of fingers. In the intrapersonal experiment (Experiment 1), the participants were asked to tap, paced by a gradually hastening auditory metronome, looking at their fingers moving, using the index finger in the two finger condition, or the index and middle finger in the four-finger condition. In the interpersonal experiment (Experiment 2), pairs of participants performed the task while each participant used the outside hand, tapping with the index finger in the two finger condition, or the index and middle finger in the four-finger condition. Some results did not agree with the HKB model predictions. First, from Experiment 1, no significant difference was observed in the movement stability between the in-phase and anti-phase modes in the two finger condition. Second, from Experiment 2, no significant difference was found in the movement stability between the in-phase and anti-phase mode in the four-finger condition. From these findings, different coordination dynamics were inferred between intrapersonal and interpersonal coordination systems against prediction from the previous studies. Results were discussed according to differences between intrapersonal and interpersonal coordination systems in the availability of perceptual information and the complexity in the interaction between limbs derived from a nested structure.	[Kodama, Kentaro] Kanagawa Univ, Kanagawa Ku, Yokohama, Kanagawa, Japan; [Furuyama, Nobuhiro] Waseda Univ, Tokorozawa, Saitama, Japan; [Inamura, Tetsunari] Res Org Informat & Syst, Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; [Inamura, Tetsunari] Grad Univ Adv Studies, Chiyoda Ku, Tokyo, Japan	Kanagawa University; Waseda University; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Graduate University for Advanced Studies - Japan	Kodama, K (corresponding author), Kanagawa Univ, Kanagawa Ku, 3-27-1 Rokkakubashi, Yokohama, Kanagawa, Japan.	kkodama@kanagawa-u.ac.jp	Inamura, Tetsunari/ADW-8458-2022		 [12J02928]		This work was supported by a Grant-in-Aid for JSPS(The Japan Society for the Promotion of Science) Fellows Number 12J02928 to KK (http://www.jsps.go.jp/). The funder had roles in data analysis and preparation of the manuscript.	Beek PJ, 1996, J EXP PSYCHOL HUMAN, V22, P1077; Bernstein N.A., 1996, RES ECOL PS; Black DR, 2007, MOTOR CONTROL, V11, P348, DOI 10.1123/mcj.11.4.348; BUCHANAN JJ, 1993, EXP BRAIN RES, V94, P131; BYBLOW WD, 1994, HUM MOVEMENT SCI, V13, P3, DOI 10.1016/0167-9457(94)90027-2; CARSON RG, 1995, EXP BRAIN RES, V105, P465; Coco MI, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00510; Coey C, 2011, EXP BRAIN RES, V211, P483, DOI 10.1007/s00221-011-2689-9; Fink PW, 2000, EXP BRAIN RES, V134, P9, DOI 10.1007/s002210000439; Forrester L, 2000, J MOTOR BEHAV, V32, P176, DOI 10.1080/00222890009601369; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Haken H., 1977, SPRINGER SERIES SYNE; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; KAY BA, 1987, J EXP PSYCHOL HUMAN, V13, P178, DOI 10.1037/0096-1523.13.2.178; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; KELSO JAS, 1990, ATTENTION PERFORM, V8, P139; Kelso JAS, 2001, P ROY SOC B-BIOL SCI, V268, P1207; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kelty-Stephen DG, 2013, ECOL PSYCHOL, V25, P1, DOI 10.1080/10407413.2013.753804; Kodama K, 2012, 12 EUR WORKSH EC PSY, V32; Kudo K, 2006, J EXP PSYCHOL HUMAN, V32, P599, DOI 10.1037/0096-1523.32.3.599; Latash ML, 2008, SYNERGY; Lopresti-Goodman SM, 2008, J MOTOR BEHAV, V40, P3, DOI 10.3200/JMBR.40.1.3-10; Loseby PN, 2001, HUM MOVEMENT SCI, V20, P531, DOI 10.1016/S0167-9457(01)00066-5; MacKenzie CL, 1983, SOC NEUR ABSTR, V9, P1033; Marwan N, 2013, CROSSRECURRENCEPLOTT; Mechsner F, 2004, J EXP PSYCHOL HUMAN, V30, P490, DOI 10.1037/0096-1523.30.3.490; Mechsner F, 2001, NATURE, V414, P69, DOI 10.1038/35102060; Miles LK, 2010, EUR J SOC PSYCHOL, V40, P52, DOI 10.1002/ejsp.721; Miles LK, 2009, J EXP SOC PSYCHOL, V45, P585, DOI 10.1016/j.jesp.2009.02.002; Pellecchia GL, 2005, COGNITIVE SCI, V29, P531, DOI 10.1207/s15516709cog0000_12; PEPER CE, 1991, NATO ADV SCI I D-BEH, V62, P413; Ramenzoni VC, 2012, HUM MOVEMENT SCI, V31, P1253, DOI 10.1016/j.humov.2011.12.004; Ramenzoni VC, 2011, EXP BRAIN RES, V211, P447, DOI 10.1007/s00221-011-2653-8; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Richardson MJ, 2008, NEUROSCI LETT, V438, P340, DOI 10.1016/j.neulet.2008.04.083; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Riek S, 2005, HUM MOVEMENT SCI, V24, P798, DOI 10.1016/j.humov.2005.10.002; RYAN TA, 1960, PSYCHOL BULL, V57, P318, DOI 10.1037/h0044320; Schmidt RC, 2007, J EXP PSYCHOL HUMAN, V33, P860, DOI 10.1037/0096-1523.33.4.860; Schmidt RC, 1998, J EXP PSYCHOL HUMAN, V24, P884, DOI 10.1037/0096-1523.24.3.884; SCHMIDT RC, 1994, BIOL CYBERN, V70, P369, DOI 10.1007/BF00200334; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Shockley K, 2005, TUTORIALS CONT NONLI; SWINNEN SP, 1992, HUM MOVEMENT SCI, V11, P615, DOI 10.1016/0167-9457(92)90018-7; van Ulzen NR, 2008, NEUROSCI LETT, V432, P88, DOI 10.1016/j.neulet.2007.11.070; van Ulzen NR, 2010, NEUROSCI LETT, V474, P79, DOI 10.1016/j.neulet.2010.03.008; Varlet M, 2011, J EXP PSYCHOL HUMAN, V37, P473, DOI 10.1037/a0020552; Webber Jr C.L., 2005, TUTORIALS CONT NONLI, V94, P26; WING AM, 1989, PSYCHOL RES-PSYCH FO, V51, P28, DOI 10.1007/BF00309273; YAMANISHI J, 1980, BIOL CYBERN, V37, P219, DOI 10.1007/BF00337040; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403; ZBILUT JP, 1992, PHYS LETT A, V171, P199, DOI 10.1016/0375-9601(92)90426-M; Zbilut JP, 1998, PHYS LETT A, V246, P122, DOI 10.1016/S0375-9601(98)00457-5	55	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129358	10.1371/journal.pone.0129358	http://dx.doi.org/10.1371/journal.pone.0129358			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26070119	Green Submitted, gold, Green Published			2022-12-27	WOS:000356327000067
J	Tseng, CN; Huang, GS; Yu, PJ; Lou, MF				Tseng, Chien-Ning; Huang, Guey-Shiun; Yu, Po-Jui; Lou, Meei-Fang			A Qualitative Study of Family Caregiver Experiences of Managing Incontinence in Stroke Survivors	PLOS ONE			English	Article							URINARY-INCONTINENCE; OF-LIFE; IMPACT; PREVALENCE; BURDEN; HEALTH	Background Incontinence is a common problem faced by family caregivers that is recognized as a major burden and predictor of institutionalization. However, few studies have evaluated the experiences of family caregivers caring for stroke survivors with incontinence. Purpose To describe experiences of caregivers managing incontinence in stroke survivors. Design This qualitative descriptive study employed a grounded-theory approach. Methods Semi-structured in-depth interviews with ten family caregivers of stroke survivors with incontinence were conducted during 2011. Audiotaped interviews were transcribed and analyzed using content analysis. Findings Data analysis identified four themes: chaos, hypervigilance, exhaustion, and creating a new life. There were nine related subcategories: fluster, dirtiness, urgency, fear of potential health-hazard, physically demanding and time-consuming, mentally draining, financial burden, learning by doing, and attitude adjustment. Together, these described a process of struggling to cope with the care of stroke survivors with urinary/fecal incontinence. Of the four categories, "creating a new life" developed gradually over time to orient caregivers to their new life, while the other three categories occurred in a chronological order. Conclusion The research highlighted unique caring experiences of family caregivers of stroke patients, which focused solely on the 'incontinence issue'. Understanding these experiences may help nurses provide better support and resources for family caregivers when caring for stroke survivors with incontinence.	[Tseng, Chien-Ning] Cardinal Tien Coll Healthcare & Management, Dept Nursing, New Taipei City, Taiwan; [Huang, Guey-Shiun; Yu, Po-Jui; Lou, Meei-Fang] Natl Taiwan Univ, Coll Med, Sch Nursing, Taipei, Taiwan	National Taiwan University	Lou, MF (corresponding author), Natl Taiwan Univ, Coll Med, Sch Nursing, Taipei, Taiwan.	mfalou@ntu.edu.tw		LOU, MEEI-FANG/0000-0001-6574-8050; HUANG, GUEY-SHIUN/0000-0003-2170-0084	Ministry of Science and Technology of the Republic of China [NSC97-2314-B-002-159-MY3]	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by the Ministry of Science and Technology of the Republic of China (NSC97-2314-B-002-159-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaweel W, 2012, NEUROUROL URODYNAM, V31, P642, DOI 10.1002/nau.22201; Armstrong M, 2000, Nurs Stand, V14, P33; Backstrom B, 2010, SCAND J CARING SCI, V24, P116, DOI 10.1111/j.1471-6712.2009.00694.x; Bharucha AE, 2005, GASTROENTEROLOGY, V129, P42, DOI 10.1053/j.gastro.2005.04.006; Cassells C, 2003, J ADV NURS, V42, P607, DOI 10.1046/j.1365-2648.2003.02664.x; Chou KR, 1998, NURS RES, V6, P358; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Dalvandi A, 2010, INT NURS REV, V57, P247, DOI 10.1111/j.1466-7657.2009.00786.x; Franzen-Dahlin A, 2007, J CLIN NURS, V16, P885, DOI 10.1111/j.1365-2702.2006.01744.x; Gosman-Hedstrom G, 2012, SCAND J CARING SCI, V26, P587, DOI 10.1111/j.1471-6712.2012.00975.x; Green TL, 2010, J STROKE CEREBROVASC, V19, P10, DOI 10.1016/j.jstrokecerebrovasdis.2009.02.005; Green TL, 2009, INT J NURS STUD, V46, P1194, DOI 10.1016/j.ijnurstu.2009.02.008; Haley WE, 2009, STROKE, V40, P2129, DOI 10.1161/STROKEAHA.108.545269; Hayder D, 2008, Z GERONTOL GERIATR, V41, P261, DOI 10.1007/s00391-008-0560-9; Horrocks S, 2004, FAM PRACT, V21, P689, DOI 10.1093/fampra/cmh622; King BD, 1994, COPING BOWEL BLADDER; King RB, 2010, J NEUROSCI NURS, V42, P302, DOI 10.1097/JNN.0b013e3181f8a575; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; McCullagh E, 2005, STROKE, V36, P2181, DOI 10.1161/01.STR.0000181755.23914.53; Ministry of Health and Welfare, 2014, MOST STAT B 2013 STA; Olsson F, 2015, J CLIN NURS, V24, P141, DOI 10.1111/jocn.12617; OUSLANDER JG, 1990, J AM GERIATR SOC, V38, P440, DOI 10.1111/j.1532-5415.1990.tb03543.x; Peden-McAlpine C, 2008, WESTERN J NURS RES, V30, P817, DOI 10.1177/0193945907312974; Pierce LL, 2012, REHABIL NURS, V37, P258, DOI 10.1002/rnj.35; Rasmussen JL, 2010, SCAND J CARING SCI, V24, P108, DOI 10.1111/j.1471-6712.2009.00693.x; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Saban KL, 2012, J NEUROSCI NURS, V44, P2, DOI 10.1097/JNN.0b013e31823ae4f9; White Carole L, 2006, J Neurosci Nurs, V38, P354	28	14	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129540	10.1371/journal.pone.0129540	http://dx.doi.org/10.1371/journal.pone.0129540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26066345	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000087
J	Yeo, SH; Wolpert, DM; Franklin, DW				Yeo, Sang-Hoon; Wolpert, Daniel M.; Franklin, David W.			Coordinate Representations for Interference Reduction in Motor Learning	PLOS ONE			English	Article							SIMILAR HAND PATHS; ARM MOVEMENTS; REACHING MOVEMENTS; IMPEDANCE CONTROL; INTERNAL-MODELS; FORCE-FIELDS; BODY SCHEMA; VISUAL CUES; SHORT-TERM; ADAPTATION	When opposing force fields are presented alternately or randomly across trials for identical reaching movements, subjects learn neither force field, a behavior termed 'interference'. Studies have shown that a small difference in the endpoint posture of the limb reduces this interference. However, any difference in the limb's endpoint location typically changes the hand position, joint angles and the hand orientation making it ambiguous as to which of these changes underlies the ability to learn dynamics that normally interfere. Here we examine the extent to which each of these three possible coordinate systems-Cartesian hand position, shoulder and elbow joint angles, or hand orientation-underlies the reduction in interference. Subjects performed goal-directed reaching movements in five different limb configurations designed so that different pairs of these configurations involved a change in only one coordinate system. By specifically assigning clockwise and counter-clockwise force fields to the configurations we could create three different conditions in which the direction of the force field could only be uniquely distinguished in one of the three coordinate systems. We examined the ability to learn the two fields based on each of the coordinate systems. The largest reduction of interference was observed when the field direction was linked to the hand orientation with smaller reductions in the other two conditions. This result demonstrates that the strongest reduction in interference occurred with changes in the hand orientation, suggesting that hand orientation may have a privileged role in reducing motor interference for changes in the endpoint posture of the limb.	[Yeo, Sang-Hoon; Wolpert, Daniel M.; Franklin, David W.] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England; [Yeo, Sang-Hoon] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England	University of Cambridge; University of Birmingham	Yeo, SH (corresponding author), Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England.	s.yeo@bham.ac.uk	Franklin, David/A-2371-2009	Franklin, David/0000-0001-9530-0820; Wolpert, Daniel/0000-0003-2011-2790	Wellcome Trust [WT091547MA, WT097803MA]; Human Frontier Science Program; Royal Society Noreen Murray Professorship in Neurobiology	Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontier Science Program(Human Frontier Science Program); Royal Society Noreen Murray Professorship in Neurobiology	This work was financially supported by the Wellcome Trust (WT091547MA to DF, and WT097803MA, http://www.wellcome.ac.uk/, to DW), Human Frontier Science Program (http://www.hfsp.org/, to DW) and the Royal Society Noreen Murray Professorship in Neurobiology (https://royalsociety.org/, to DW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addou T, 2011, J NEUROPHYSIOL, V106, P163, DOI 10.1152/jn.00869.2010; Berniker M, 2014, J NEUROPHYSIOL, V111, P1165, DOI 10.1152/jn.00493.2013; Berniker M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002210; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Brayanov JB, 2012, J NEUROSCI, V32, P14951, DOI 10.1523/JNEUROSCI.1928-12.2012; Caithness G, 2004, J NEUROSCI, V24, P8662, DOI 10.1523/JNEUROSCI.2214-04.2004; Cothros N, 2009, J NEUROPHYSIOL, V102, P2112, DOI 10.1152/jn.00493.2009; Crevecoeur F, 2013, J NEUROPHYSIOL, V110, P1323, DOI 10.1152/jn.00216.2013; Eberman B., 1994, P ASME DYN SYS CONT, V55-1, P353; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Franklin S, 2012, J NEUROPHYSIOL, V108, P467, DOI 10.1152/jn.01123.2011; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Hirashima M, 2012, CURR BIOL, V22, P432, DOI 10.1016/j.cub.2012.01.042; Howard IS, 2013, J NEUROPHYSIOL, V109, P2632, DOI 10.1152/jn.00773.2012; Howard IS, 2012, J NEUROSCI, V32, P12756, DOI 10.1523/JNEUROSCI.5909-11.2012; Howard IS, 2009, J NEUROSCI METH, V181, P199, DOI 10.1016/j.jneumeth.2009.05.005; Hwang EJ, 2003, PLOS BIOL, V1, P209, DOI 10.1371/journal.pbio.0000025; Hwang EJ, 2006, EXP BRAIN RES, V173, P425, DOI 10.1007/s00221-006-0391-0; Ingram JN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002196; Ingram JN, 2010, CURR BIOL, V20, P618, DOI 10.1016/j.cub.2010.01.054; Iriki A, 1996, NEUROREPORT, V7, P2325; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Karniel A, 2002, EXP BRAIN RES, V143, P520, DOI 10.1007/s00221-002-1054-4; KETTNER RE, 1988, J NEUROSCI, V8, P2938; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Krouchev NI, 2003, J NEUROPHYSIOL, V89, P1165, DOI 10.1152/jn.00779.2002; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Malfait N, 2002, J NEUROSCI, V22, P9656; Malfait N, 2005, J NEUROPHYSIOL, V93, P3327, DOI 10.1152/jn.00883.2004; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Milner TE, 2005, J PHYSIOL-LONDON, V567, P651, DOI 10.1113/jphysiol.2005.090449; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osu R, 2004, NAT NEUROSCI, V7, P111, DOI 10.1038/nn1184; Osu R, 2002, J NEUROPHYSIOL, V88, P991, DOI 10.1152/jn.2002.88.2.991; Richter S, 2004, PSYCHOL RES-PSYCH FO, V68, P245, DOI 10.1007/s00426-003-0140-y; RUBY LK, 1988, J HAND SURG-AM, V13A, P1, DOI 10.1016/0363-5023(88)90189-X; Scheidt RA, 2000, J NEUROPHYSIOL, V84, P853, DOI 10.1152/jn.2000.84.2.853; Scott SH, 1997, J NEUROPHYSIOL, V77, P826, DOI 10.1152/jn.1997.77.2.826; SCOTT SH, 1995, J NEUROPHYSIOL, V73, P2563, DOI 10.1152/jn.1995.73.6.2563; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Shadmehr R, 2000, J NEUROSCI, V20, P7807; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Takahashi CD, 2001, J NEUROPHYSIOL, V86, P1047, DOI 10.1152/jn.2001.86.2.1047; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; Wada Y, 2003, NEUROSCI RES, V46, P319, DOI 10.1016/S0168-0102(03)00094-4	49	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129388	10.1371/journal.pone.0129388	http://dx.doi.org/10.1371/journal.pone.0129388			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26067480	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000071
J	Banni, M; Sforzini, S; Franzellitti, S; Oliveri, C; Viarengo, A; Fabbri, E				Banni, Mohamed; Sforzini, Susanna; Franzellitti, Silvia; Oliveri, Caterina; Viarengo, Aldo; Fabbri, Elena			Molecular and Cellular Effects Induced in Mytilus galloprovincialis Treated with Oxytetracycline at Different Temperatures	PLOS ONE			English	Article							SOLID-PHASE EXTRACTION; PERSONAL-CARE PRODUCTS; OXIDATIVE STRESS; CLIMATE-CHANGE; BIOCHEMICAL MARKERS; MESSENGER-RNA; EXPRESSION; PHYSIOLOGY; BIOMARKERS; EXPOSURE	The present study evaluatedthe interactive effects of temperature (16 degrees C and 24 degrees C) and a 4-day treatment with the antibiotic oxytetracycline (OTC) at 1 and 100 mu g/L on cellular and molecular parameters in the mussel Mytilus galloprovincialis. Lysosomal membrane stability (LMS), a sensitive biomarker of impaired health status in this organism, was assessed in the digestive glands. In addition, oxidative stress markers and the expression of mRNAs encoding proteins involved in antioxidant defense (catalase (cat) and glutathione-S-transferase (gst)) and the heat shock response (hsp90, hsp70, and hsp27) were evaluated in the gills, the target tissue of soluble chemicals. Finally, cAMP levels, which represent an important cell signaling pathway related to oxidative stress and the response to temperature challenges, were also determined in the gills. Exposure to heat stress as well as to OTC rendered a decrease in LMS and an increase in malonedialdehyde accumulation (MDA). CAT activity was not significantly modified, whereas GST activity decreased at 24 degrees C. Cat and gst expression levels were reduced in animals kept at 24 degrees C compared to 16 degrees C in the presence or absence of OTC. At 16 degrees C, treatment with OTC caused a significant increase in cat and gst transcript levels. Hsp27 mRNA was significantly up-regulated at all conditions compared to controls at 16 degrees C. cAMP levels were increased at 24 degrees C independent of the presence of OTC. PCA analysis showed that 37.21% and 25.89% of the total variance was explained by temperature and OTC treatment, respectively. Interestingly, a clear interaction was observed in animals exposed to both stressors increasing LMS and MDA accumulation and reducing hsp27 gene expression regulation. These interactions may suggest a risk for the organisms due to temperature increases in contaminated seawaters.	[Banni, Mohamed; Sforzini, Susanna; Oliveri, Caterina; Viarengo, Aldo] Univ Piemonte Orientale, Dept Sci & Technol Innovat DiSIT, I-15121 Alessandria, Italy; [Banni, Mohamed] ISA, Lab Biochem & Environm Toxicol, Sousse, Tunisia; [Franzellitti, Silvia; Fabbri, Elena] Univ Bologna, Dept Biol Geol & Environm Sci, I-40100 Bologna, Italy; [Franzellitti, Silvia; Fabbri, Elena] Univ Bologna, Interdept Ctr Environm Sci Res, I-48123 Ravenna, Italy	University of Eastern Piedmont Amedeo Avogadro; Universite de Tunis-El-Manar; Institut Salah Azaiez; University of Bologna; University of Bologna	Banni, M (corresponding author), Univ Piemonte Orientale, Dept Sci & Technol Innovat DiSIT, Vle T Michel 11, I-15121 Alessandria, Italy.	m_banni@yahoo.fr	; Banni, Mohamed/M-2144-2014	Viarengo, Aldo/0000-0002-1557-6526; Sforzini, Susanna/0000-0002-7310-7605; FABBRI, Elena/0000-0002-9957-8202; Banni, Mohamed/0000-0001-9764-0343; Franzellitti, Silvia/0000-0001-6104-7812	FP7 EU Project MEECE (Marine Ecosystem Evolution in a Changing Environment) [212085]	FP7 EU Project MEECE (Marine Ecosystem Evolution in a Changing Environment)	This work was funded by FP7 EU Project MEECE (Marine Ecosystem Evolution in a Changing Environment, Contract Number 212085) 2008-2013.	Allen JI, 2004, MAR ENVIRON RES, V58, P227, DOI 10.1016/j.marenvres.2004.03.119; Angilletta MJ, 2009, ECOLOGY, V90, P2933, DOI 10.1890/08-2224.1; Atli G, 2006, COMP BIOCHEM PHYS C, V143, P218, DOI 10.1016/j.cbpc.2006.02.003; Banni M, 2014, COMP BIOCHEM PHYS C, V160, P23, DOI 10.1016/j.cbpc.2013.11.005; Banni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018904; Banni M, 2009, COMP BIOCHEM PHYS C, V149, P414, DOI 10.1016/j.cbpc.2008.09.017; Bu Q, 2014, J HAZARD MATER, P189; Calamari D, 2003, ENVIRON SCI TECHNOL, V37, P1241, DOI 10.1021/es020158e; Canesi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019803; Carere M, 2012, TRAC-TREND ANAL CHEM, V36, P15, DOI 10.1016/j.trac.2012.03.005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Crane M, 2006, SCI TOTAL ENVIRON, V367, P23, DOI 10.1016/j.scitotenv.2006.04.010; Dondero F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-195; Elia AC, 2014, FISH PHYSIOL BIOCHEM, V40, P1055, DOI 10.1007/s10695-013-9905-4; Fabbri E, 2008, J EXP ZOOL PART A, V309A, P157, DOI 10.1002/jez.441; Fabbri E, 2010, J EXP ZOOL PART A, V313A, P179, DOI 10.1002/jez.592; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009; Franzellitti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061634; Franzellitti S, 2012, AQUAT TOXICOL, V124, P125, DOI 10.1016/j.aquatox.2012.07.011; Franzellitti S, 2011, AQUAT TOXICOL, V101, P299, DOI 10.1016/j.aquatox.2010.11.001; Gagne F, 2006, COMP BIOCHEM PHYS C, V143, P179, DOI 10.1016/j.cbpc.2006.01.008; Gao ML, 2014, ENVIRON TOXICOL PHAR, V37, P689, DOI 10.1016/j.etap.2014.02.004; Ruas CBG, 2008, ECOTOX ENVIRON SAFE, V71, P86, DOI 10.1016/j.ecoenv.2007.08.018; Gerard-Monnier D, 1998, CHEM RES TOXICOL, V11, P1176, DOI 10.1021/tx9701790; Gomiero A, 2014, ENVIRON POLLUT, V194, P262, DOI 10.1016/j.envpol.2014.07.035; Gust M, 2012, ENVIRON POLLUT, V169, P50, DOI 10.1016/j.envpol.2012.05.020; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Helmuth B, 2009, J EXP BIOL, V212, P753, DOI 10.1242/jeb.023861; Kamel N, 2012, ARCH ENVIRON CON TOX, V63, P534, DOI 10.1007/s00244-012-9790-3; Kolar B, 2014, CHEMOSPHERE, V115, P75, DOI 10.1016/j.chemosphere.2014.02.049; Kolodziejska M, 2013, CHEMOSPHERE, V92, P1253, DOI 10.1016/j.chemosphere.2013.04.057; Koutsogiannaki S, 2014, AQUAT TOXICOL, V146, P186, DOI 10.1016/j.aquatox.2013.11.005; Lee HB, 2005, J CHROMATOGR A, V1094, P122, DOI 10.1016/j.chroma.2005.07.070; Liu FJ, 2014, AQUAT TOXICOL, V146, P76, DOI 10.1016/j.aquatox.2013.10.028; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McVeigh A, 2004, MAR ENVIRON RES, V58, P821, DOI 10.1016/j.marenvres.2004.03.099; Mimeault C, 2006, TOXICOLOGY, V228, P140, DOI 10.1016/j.tox.2006.08.025; Monaco CJ, 2011, ADV MAR BIOL, V60, P123, DOI 10.1016/B978-0-12-385529-9.00003-2; Moore MN, 2008, METHOD ENZYMOL, V451, P581, DOI 10.1016/S0076-6879(08)03233-3; MOORE MN, 1987, EXPERIENTIA, V43, P320, DOI 10.1007/BF01945568; Na GS, 2013, MAR POLLUT BULL, V69, P233, DOI 10.1016/j.marpolbul.2012.12.028; Negri A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066802; Petrenko I U, 1995, Antibiot Khimioter, V40, P3; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Piano A, 2002, CELL STRESS CHAPERON, V7, P250, DOI 10.1379/1466-1268(2002)007<0250:HEITSO>2.0.CO;2; Pickens LB, 2010, J BIOL CHEM, V285, P27509, DOI 10.1074/jbc.R110.130419; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; QUINLAN GJ, 1988, FREE RADICAL BIO MED, V5, P341, DOI 10.1016/0891-5849(88)90106-2; Raftopoulou M, 2006, NAT CELL BIOL, V8, P429, DOI 10.1038/ncb0506-429; Rajagopal S, 2005, BIOFOULING, V21, P87, DOI 10.1080/08927010500133584; Ratasuk N, 2012, J ENVIRON SCI HEAL A, V47, P1687, DOI 10.1080/10934529.2012.687274; Reemtsma T., 2006, ORGANIC POLLUTANTS W; Santos LHMLM, 2010, J HAZARD MATER, V175, P45, DOI 10.1016/j.jhazmat.2009.10.100; Smit CE, 1997, ECOTOX ENVIRON SAFE, V37, P213, DOI 10.1006/eesa.1997.1558; Somero GN, 2012, ANNU REV MAR SCI, V4, P39, DOI 10.1146/annurev-marine-120710-100935; Tomanek L, 2010, J EXP BIOL, V213, P3559, DOI 10.1242/jeb.041228; Vergani L, 2005, FEBS J, V272, P6014, DOI 10.1111/j.1742-4658.2005.04993.x; Verlecar XN, 2007, CHEM-BIOL INTERACT, V167, P219, DOI 10.1016/j.cbi.2007.01.018; Viarengo A, 2007, COMP BIOCHEM PHYS C, V146, P281, DOI 10.1016/j.cbpc.2007.04.011; Vidal-Linan L, 2013, SCI TOTAL ENVIRON, V461, P56, DOI 10.1016/j.scitotenv.2013.04.079; Vieno NM, 2006, J CHROMATOGR A, V1134, P101, DOI 10.1016/j.chroma.2006.08.077; Weigel S, 2002, SCI TOTAL ENVIRON, V295, P131, DOI 10.1016/S0048-9697(02)00064-5	63	19	19	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128468	10.1371/journal.pone.0128468	http://dx.doi.org/10.1371/journal.pone.0128468			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067465	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900023
J	de Paula, FJA; de Araujo, IM; Carvalho, AL; Elias, J; Salmon, CEG; Nogueira-Barbosa, MH				de Paula, Francisco J. A.; de Araujo, Iana M.; Carvalho, Adriana L.; Elias, Jorge, Jr.; Salmon, Carlos E. G.; Nogueira-Barbosa, Marcello H.			The Relationship of Fat Distribution and Insulin Resistance with Lumbar Spine Bone Mass in Women	PLOS ONE			English	Article							ADIPOSE-TISSUE; MARROW FAT; DENSITY; OBESITY; OSTEOBLASTS; STRENGTH; DISEASE	Bone marrow harbors a significant amount of body adipose tissue (BMAT). While BMAT might be a source of energy for bone modeling and remodeling, its increment can also represent impairment of osteoblast differentiation. The relationship between BMAT, bone mass and insulin sensitivity is only partially understood and seems to depend on the circumstances. The present study was designed to assess the association of BMAT with bone mineral density in the lumbar spine as well as with visceral adipose tissue, intrahepatic lipids, HOMA-IR, and serum levels of insulin and glucose. This cross-sectional clinical investigation included 31 non-diabetic women, but 11 had a pre-diabetes status. Dual X-ray energy absorptiometry was used to measure bone mineral density and magnetic resonance imaging was used to assess fat deposition in BMAT, visceral adipose tissue and liver. Our results suggest that in non-diabetic, there is an inverse relationship between bone mineral density in lumbar spine and BMAT and a trend persists after adjustment for weight, age, BMI and height. While there is a positive association between visceral adipose tissue and intrahepatic lipids with serum insulin levels, there is no association between BMAT and serum levels of insulin. Conversely, a positive relationship was observed between BMAT and serum glucose levels, whereas this association was not observed with other fat deposits. These relationships did not apply after adjustment for body weight, BMI, height and age. The present study shows that in a group of predominantly non-obese women the association between insulin resistance and BMAT is not an early event, as occurs with visceral adipose tissue and intrahepatic lipids. On the other hand, BMAT has a negative relationship with bone mineral density. Taken together, the results support the view that bone has a complex and non-linear relationship with energy metabolism.	[de Paula, Francisco J. A.; de Araujo, Iana M.; Carvalho, Adriana L.; Elias, Jorge, Jr.; Nogueira-Barbosa, Marcello H.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, Ribeirao Preto, Brazil; [Salmon, Carlos E. G.] Univ Sao Paulo, Fac Philosophy Sci & Arts Ribeirao Preto, Dept Phys, Ribeirao Preto, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	de Paula, FJA (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, Ribeirao Preto, Brazil.	fjpaula@fmrp.usp.br	Salmon, Carlos Ernesto Garrido/C-6326-2012; Elias Junior, Jorge/A-6683-2008; Nogueira-Barbosa, Marcello H/D-7681-2012; de Paula, Francisco/D-5026-2012; de Araújo, Iana/S-3504-2017	Salmon, Carlos Ernesto Garrido/0000-0003-1441-1524; Elias Junior, Jorge/0000-0002-1158-1045; Nogueira-Barbosa, Marcello H/0000-0002-7436-5315; de Paula, Francisco/0000-0003-1262-3486; de Araújo, Iana/0000-0003-0903-4787	FAPESP [2012/14603-6, 2012/09527-9, 2013/09853-6]; NAP-DIN; FAEPA; National Council for Scientific and Technological Development (CNPq) [306027/2011-9]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NAP-DIN; FAEPA; National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by FAPESP 2012/14603-6, NAP-DIN and FAEPA. FJAP received financial support from the National Council for Scientific and Technological Development (CNPq) 306027/2011-9, IMA from FAPESP (2012/09527-9) and ALC from FAPESP (2013/09853-6).	Bredella MA, 2013, RADIOLOGY, V269, P533, DOI 10.1148/radiol.13130375; Bredella MA, 2011, BONE, V48, P748, DOI 10.1016/j.bone.2010.12.011; Bredella MA, 2009, J CLIN ENDOCR METAB, V94, P2129, DOI 10.1210/jc.2008-2532; Cawthorn WP, 2014, CELL METAB, V20, P368, DOI 10.1016/j.cmet.2014.06.003; Clark EM, 2006, J CLIN ENDOCR METAB, V91, P2534, DOI 10.1210/jc.2006-0332; de Paula FJA, 2010, DIABETES-METAB RES, V26, P622, DOI 10.1002/dmrr.1135; Dimitri P, 2015, J CLIN ENDOCR METAB, V100, P594, DOI 10.1210/jc.2014-3199; Fishbein M, 2005, J CLIN GASTROENTEROL, V39, P619, DOI 10.1097/00004836-200508000-00012; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Hanley DA, 2003, J BONE MINER RES, V18, P784, DOI 10.1359/jbmr.2003.18.4.784; Hatipoglu HG, 2007, AM J NEURORADIOL, V28, P1934, DOI 10.3174/ajnr.A0704; Kitajima M, 2007, MED MOL MORPHOL, V40, P150, DOI 10.1007/s00795-007-0367-6; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; Malkov S, 2015, J BONE MINER RES; Misra Madhusmita, 2013, Pediatr Endocrinol Rev, V11, P21; Moyer-Mileur LJ, 2008, J BONE MINER RES, V23, P1884, DOI 10.1359/JBMR.080713; Pasarin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032785; Premaor MO, 2014, ARQ BRAS ENDOCRINOL, V58, P470, DOI 10.1590/0004-2730000003274; Premaor MO, 2010, J BONE MINER RES, V25, P292, DOI 10.1359/jbmr.091004; Reid IR, 2008, OSTEOPOROSIS INT, V19, P595, DOI 10.1007/s00198-007-0492-z; REID IR, 1994, OSTEOPOROSIS INT, V4, P362, DOI 10.1007/BF01622199; Riddle RC, 2014, J CLIN INVEST, V124, P1465, DOI 10.1172/JCI75554; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Russell M, 2010, J CLIN ENDOCR METAB, V95, P1247, DOI 10.1210/jc.2009-1475; Saito M, 2006, OSTEOPOROSIS INT, V17, P1514, DOI 10.1007/s00198-006-0155-5; Sroga GE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117046; Tsatsoulis A, 2013, METABOLISM, V62, P622, DOI 10.1016/j.metabol.2012.11.004	27	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129764	10.1371/journal.pone.0129764	http://dx.doi.org/10.1371/journal.pone.0129764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067489	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900075
J	Moreira, PFD; Gangl, K; Vieira, FDM; Ynoue, LH; Linhart, B; Flicker, S; Fiebig, H; Swoboda, I; Focke-Tejkl, M; Taketomi, EA; Valenta, R; Niederberger, V				de Sousa Moreira, Priscila Ferreira; Gangl, Katharina; Machado Vieira, Francisco de Assis; Ynoue, Leandro Hideki; Linhart, Birgit; Flicker, Sabine; Fiebig, Helmut; Swoboda, Ines; Focke-Tejkl, Margarete; Taketomi, Ernesto Akio; Valenta, Rudolf; Niederberger, Verena			Allergen Microarray Indicates Pooideae Sensitization in Brazilian Grass Pollen Allergic Patients	PLOS ONE			English	Article							PHLEUM-PRATENSE POLLEN; DIAGNOSTIC GATEKEEPERS; LOLIUM-MULTIFLORUM; RECOMBINANT; IGE; IMMUNOTHERAPY; POLLINOSIS; PREVALENCE; ANTIBODIES; PROTEIN	Background Grass pollen, in particular from Lolium multiflorum is a major allergen source in temperate climate zones of Southern Brazil. The IgE sensitization profile of Brazilian grass pollen allergic patients to individual allergen molecules has not been analyzed yet. Objective To analyze the IgE sensitization profile of a Brazilian grass pollen allergic population using individual allergen molecules. Methods We analyzed sera from 78 grass pollen allergic patients for the presence of IgE antibodies specific for 103 purified micro-arrayed natural and recombinant allergens by chip technology. IgE-ELISA inhibition experiments with Lolium multiflorum, Phleum pratense extracts and a recombinant fusion protein consisting of Phl p 1, Phl p 2, Phl p 5 and Phl p 6 were performed to investigate cross-reactivities. Results Within the Brazilian grass pollen allergic patients, the most frequently recognized allergens were Phl p 1 (95%), Phl p 5 (82%), Phl p 2 (76%) followed by Phl p 4 (64%), Phl p 6 (45%), Phl p 11 (18%) and Phl p 12 (18%). Most patients were sensitized only to grass pollen allergens but not to allergens from other sources. A high degree of IgE cross-reactivity between Phleum pratense, Lolium multiflorum and the recombinant timothy grass fusion protein was found. Conclusions Component-resolved analysis of sera from Brazilian grass pollen allergic patients reveals an IgE recognition profile compatible with a typical Pooideae sensitization. The high degree of cross-reactivity between Phleum pratense and Lolium multiflorum allergens suggests that diagnosis and immunotherapy can be achieved with timothy grass pollen allergens in the studied population.	[de Sousa Moreira, Priscila Ferreira; Ynoue, Leandro Hideki; Taketomi, Ernesto Akio] Univ Fed Uberlandia, Inst Biomed Sci, Lab Allergy & Clin Immunol, BR-38400 Uberlandia, MG, Brazil; [de Sousa Moreira, Priscila Ferreira; Gangl, Katharina; Niederberger, Verena] Med Univ Vienna, Dept Otorhinolaryngol, Vienna, Austria; [de Sousa Moreira, Priscila Ferreira; Gangl, Katharina; Swoboda, Ines; Focke-Tejkl, Margarete; Valenta, Rudolf] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Div Immunopathol,Christian Doppler Lab Allergy Re, Vienna, Austria; [Machado Vieira, Francisco de Assis] Univ Caxias, Dept Med, Caxias, RS, Brazil; [Linhart, Birgit; Flicker, Sabine] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Div Immunopathol, Vienna, Austria; [Fiebig, Helmut] Allergopharma J Ganzer KG, Reinbek, Germany	Universidade Federal de Uberlandia; Medical University of Vienna; Medical University of Vienna; Universidade de Caxias do Sul; Medical University of Vienna; Allergopharma	Valenta, R (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Div Immunopathol,Christian Doppler Lab Allergy Re, Vienna, Austria.	rudolf.valenta@meduniwien.ac.at		Flicker, Sabine/0000-0003-4768-8693; Linhart, Birgit/0000-0001-6857-3049; Valenta, Rudolf/0000-0001-5944-3365; Swoboda, Ines/0000-0002-9164-1721	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior = Coordination for the Improvement of Higher Education Personnel) [BEX 3442/08-0]; FWF (Fonds zur Forderung der wissenschaftlichen Forschung = Austrian Science Fund) [SFB 4613, SFB4605, P23350-B11, F4607]; Biomay AG Research Grant; Christian Doppler Laboratory for Allergy Research	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior = Coordination for the Improvement of Higher Education Personnel); FWF (Fonds zur Forderung der wissenschaftlichen Forschung = Austrian Science Fund); Biomay AG Research Grant; Christian Doppler Laboratory for Allergy Research	Funding for this study was received from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior = Coordination for the Improvement of Higher Education Personnel) Grant Number: BEX 3442/08-0; to EAT. URL: http://www.capes.gov.br/; FWF (Fonds zur Forderung der wissenschaftlichen Forschung = Austrian Science Fund) Grant Number: SFB 4613 to VN; Grant Number SFB4605 to RV; Grant Number P23350-B11 to BL; Grant Number F4607 to SF. URL: http://www.fwf.ac.at/de/projects/sfb.html; Biomay AG Research Grant to RV. URL: http://www.biomay.com/; Christian Doppler Laboratory for Allergy Research to RV. URL: https://www.cdg.ac.at/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson K, 2003, INT ARCH ALLERGY IMM, V130, P87, DOI 10.1159/000069013; ARRUDA LK, 1991, CLIN EXP ALLERGY, V21, P433, DOI 10.1111/j.1365-2222.1991.tb01683.x; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bernardes CT, 2010, BRAZ J MED BIOL RES, V43, P166, DOI 10.1590/S0100-879X2010005000004; Bousquet PJ, 2010, ANN EPIDEMIOL, V20, P797, DOI 10.1016/j.annepidem.2010.05.012; Eckl-Dorna J, 2010, J ALLERGY CLIN IMMUN, V126, P1315, DOI 10.1016/j.jaci.2010.06.012; Hiller R, 2002, FASEB J, V16, P414, DOI 10.1096/fj.01-0711fje; Jutel M, 2005, J ALLERGY CLIN IMMUN, V116, P608, DOI 10.1016/j.jaci.2005.06.004; Kazemi-Shirazi L, 2002, INT ARCH ALLERGY IMM, V127, P259, DOI 10.1159/000057742; KNOX RB, 1993, MOLECULAR BIOLOGY AND IMMUNOLOGY OF ALLERGENS, P31; Linhart B, 2005, J ALLERGY CLIN IMMUN, V115, P1010, DOI 10.1016/j.jaci.2004.12.1142; Marth K, 2004, J ALLERGY CLIN IMMUN, V113, P470, DOI 10.1016/j.jaci.2003.11.042; Niederberger V, 1998, J ALLERGY CLIN IMMUN, V101, P258, DOI 10.1016/S0091-6749(98)70391-4; Pastorino AC, 2008, ALLERGOL IMMUNOPATH, V36, P9, DOI 10.1157/13115665; PETERSEN A, 1995, INT ARCH ALLERGY IMM, V108, P49, DOI 10.1159/000237117; Sopelete MC, 2006, INT ARCH ALLERGY IMM, V140, P121, DOI 10.1159/000092531; Suck R, 2000, CLIN EXP ALLERGY, V30, P1395, DOI 10.1046/j.1365-2222.2000.00886.x; Suphioglu C, 2000, CLIN EXP ALLERGY, V30, P1335, DOI 10.1046/j.1365-2222.2000.00955.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VALENTA R, 1992, INT ARCH ALLERGY IMM, V97, P287, DOI 10.1159/000236135; Valenta R, 1999, CLIN EXP ALLERGY, V29, P896; Vergamini SMN, 2006, RS REV BRAS ALEG IMU, V29, P14; Vieira FAM, 2003, REV BRAS ALERGIA IMU, V26, P37; VIEIRA FAM, 1989, REV BRAS ALERGIA IMU, V12, P73; Vrtala S, 1999, J IMMUNOL, V163, P5489; Weber RW, 2003, J ALLERGY CLIN IMMUN, V112, P229, DOI 10.1067/mai.2003.1683; Weghofer M, 2008, ALLERGY, V63, P758, DOI 10.1111/j.1398-9995.2008.01647.x; Weghofer M, 2008, INT ARCH ALLERGY IMM, V147, P101, DOI 10.1159/000135696; Weghofer M, 2013, J IMMUNOL, V190, P3059, DOI 10.4049/jimmunol.1202288; Weinmayr G, 2008, EUR RESPIR J, V32, P1250, DOI 10.1183/09031936.00157807	30	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128402	10.1371/journal.pone.0128402	http://dx.doi.org/10.1371/journal.pone.0128402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067084	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900021
J	Kourtidis, A; Yanagisawa, M; Huveldt, D; Copland, JA; Anastasiadis, PZ				Kourtidis, Antonis; Yanagisawa, Masahiro; Huveldt, Deborah; Copland, John A.; Anastasiadis, Panos Z.			Pro-Tumorigenic Phosphorylation of p120 Catenin in Renal and Breast Cancer	PLOS ONE			English	Article							HUMAN P120(CTN) CATENIN; E-CADHERIN; BETA-CATENIN; TYROSINE PHOSPHORYLATION; MESENCHYMAL TRANSITION; ALPHA-CATENIN; CELL-ADHESION; EXPRESSION; P120-CATENIN; PROTEIN	Altered protein expression and phosphorylation are common events during malignant transformation. These perturbations have been widely explored in the context of E-cadherin cell-cell adhesion complexes, which are central in the maintenance of the normal epithelial phenotype. A major component of these complexes is p120 catenin (p120), which binds and stabilizes E-cadherin to promote its adhesive and tumor suppressing function. However, p120 is also an essential mediator of pro-tumorigenic signals driven by oncogenes, such as Src, and can be phosphorylated at multiple sites. Although alterations in p120 expression have been extensively studied by immunohistochemistry (IHC) in the context of tumor progression, little is known about the status and role of p120 phosphorylation in cancer. Here we show that tyrosine and threonine phosphorylation of p120 in two sites, Y228 and T916, is elevated in renal and breast tumor tissue samples. We also show that tyrosine phosphorylation of p120 at its N-terminus, including at the Y228 site is required for its pro-tumorigenic potential. In contrast, phosphorylation of p120 at T916 does not affect this p120 function. However, phosphorylation of p120 at T916 interferes with epitope recognition of the most commonly used p120 antibody, namely pp120. As a result, this antibody selectively under-represents p120 levels in tumor tissues, where p120 is phosphorylated. Overall, our data support a role of p120 phosphorylation as a marker and mediator of tumor transformation. Importantly, they also argue that the level and localization of p120 in human cancer tissues immunostained with pp120 needs to be re-evaluated.	[Kourtidis, Antonis; Yanagisawa, Masahiro; Huveldt, Deborah; Copland, John A.; Anastasiadis, Panos Z.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Anastasiadis, PZ (corresponding author), Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA.	panos@mayo.edu		Kourtidis, Antonis/0000-0002-8128-6391	National Institute of Neurological Disorders and Stroke R01 grant [NS069753]; Jay and Deanie Stein Career Development Award for Cancer Research at Mayo Clinic; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069753] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke R01 grant; Jay and Deanie Stein Career Development Award for Cancer Research at Mayo Clinic; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by a National Institute of Neurological Disorders and Stroke R01 grant to P.Z.A. (NS069753). http://www.ninds.nih.gov. AK is supported by the Jay and Deanie Stein Career Development Award for Cancer Research at Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho S, 1999, J CELL BIOCHEM, V73, P390, DOI 10.1002/(SICI)1097-4644(19990601)73:3<390::AID-JCB10>3.3.CO;2-T; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Bellovin DI, 2005, CANCER RES, V65, P10938, DOI 10.1158/0008-5472.CAN-05-1947; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Campbell M, 2006, EXP EYE RES, V83, P484, DOI 10.1016/j.exer.2006.01.032; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Chauvet N, 2004, J COMP NEUROL, V479, P15, DOI 10.1002/cne.20301; Chetty R, 2008, AM J CLIN PATHOL, V130, P71, DOI 10.1309/FEYD99TXC4LMYVA5; Corsino PE, 2008, NEOPLASIA, V10, P1240, DOI 10.1593/neo.08710; Dabbs DJ, 2007, AM J SURG PATHOL, V31, P427, DOI 10.1097/01.pas.0000213386.63160.3f; Dai SD, 2007, LUNG CANCER, V57, P54, DOI 10.1016/j.lungcan.2007.02.008; Dann SG, 2014, ONCOGENE, V33, P1385, DOI 10.1038/onc.2013.91; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; del Valle-Perez B, 2011, J CELL SCI, V124, P2298, DOI 10.1242/jcs.082693; Dohn MR, 2009, J CELL BIOL, V184, P437, DOI 10.1083/jcb.200807096; Esposito NN, 2007, MODERN PATHOL, V20, P130, DOI 10.1038/modpathol.3800721; Fukumoto Y, 2008, EXP CELL RES, V314, P52, DOI 10.1016/j.yexcr.2007.07.024; Greco C, 2010, CANCER RES, V70, P7674, DOI 10.1158/0008-5472.CAN-09-4482; Hamada S, 2013, J CELL PHYSIOL, V228, P1255, DOI 10.1002/jcp.24280; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoshino T, 2005, J BIOL CHEM, V280, P24095, DOI 10.1074/jbc.M414447200; Humar B, 2007, CANCER RES, V67, P2480, DOI 10.1158/0008-5472.CAN-06-3021; Huveldt D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056505; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Johnson E, 2010, J BIOL CHEM, V285, P29491, DOI 10.1074/jbc.M110.136770; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Kourtidis A, 2013, PROG MOL BIOL TRANSL, V116, P409, DOI 10.1016/B978-0-12-394311-8.00018-2; Liapis G, 2007, APMIS, V115, P104, DOI 10.1111/j.1600-0463.2007.apm_517.x; Liu Y, 2009, LUNG CANCER, V63, P375, DOI 10.1016/j.lungcan.2008.12.012; Ma LW, 2012, J CLIN PATHOL, V65, P315, DOI 10.1136/jclinpath-2011-200516; Mariner DJ, 2004, J CELL SCI, V117, P1339, DOI 10.1242/jcs.01001; Mariner DJ, 2001, J BIOL CHEM, V276, P28006, DOI 10.1074/jbc.M102443200; Mayerle J, 2003, GASTROENTEROLOGY, V124, P949, DOI 10.1053/gast.2003.50142; Miao YA, 2010, MED ONCOL, V27, P880, DOI 10.1007/s12032-009-9300-2; Mo YY, 1996, CANCER RES, V56, P2633; Nakopoulou L, 2002, HISTOPATHOLOGY, V40, P536, DOI 10.1046/j.1365-2559.2002.01392.x; Neto BS, 2008, BJU INT, V101, P746, DOI 10.1111/j.1464-410X.2007.07264.x; Ozawa M, 2001, J CELL SCI, V114, P503; Peglion F, 2014, NAT CELL BIOL, V16, P639, DOI 10.1038/ncb2985; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Petrova YI, 2012, MOL BIOL CELL, V23, P2092, DOI 10.1091/mbc.E11-12-1060; Pieters T, 2012, FRONT BIOSCI-LANDMRK, V17, P1669, DOI 10.2741/4012; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; REYNOLDS AB, 1992, ONCOGENE, V7, P2439; Sarrio D, 2004, ONCOGENE, V23, P3272, DOI 10.1038/sj.onc.1207439; Sarrio D, 2006, HUM PATHOL, V37, P1042, DOI 10.1016/j.humpath.2006.03.003; Schackmann RCJ, 2013, CANCER RES, V73, P4937, DOI 10.1158/0008-5472.CAN-13-0180; Smalley-Freed WG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019880; Smalley-Freed WG, 2010, J CLIN INVEST, V120, P1824, DOI 10.1172/JCI41414; Soto E, 2008, J CELL BIOL, V183, P737, DOI 10.1083/jcb.200805113; STADDON JM, 1995, J CELL BIOL, V130, P369, DOI 10.1083/jcb.130.2.369; Stefansson IM, 2004, J CLIN ONCOL, V22, P1242, DOI 10.1200/JCO.2004.09.034; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; van Oort IM, 2007, PROSTATE, V67, P1432, DOI 10.1002/pros.20626; Wang EH, 2006, HISTOL HISTOPATHOL, V21, P841, DOI 10.14670/HH-21.841; Wu J, 1998, HYBRIDOMA, V17, P175, DOI 10.1089/hyb.1998.17.175; Xia XB, 2004, HYBRIDOMA HYBRIDOM, V23, P343, DOI 10.1089/hyb.2004.23.343; Xia XB, 2003, BIOCHEMISTRY-US, V42, P9195, DOI 10.1021/bi034597h; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022; Yang ZQ, 2010, MOL CARCINOGEN, V49, P508, DOI 10.1002/mc.20622; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yu J, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-36; Zhang PX, 2011, INT J ONCOL, V38, P1625, DOI 10.3892/ijo.2011.995; Zhu JXX, 2013, SCI CHINA CHEM, V56, P1, DOI 10.1007/s11426-012-4811-7	68	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129964	10.1371/journal.pone.0129964	http://dx.doi.org/10.1371/journal.pone.0129964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067913	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900087
J	Mangino, G; Famiglietti, M; Capone, C; Veroni, C; Percario, ZA; Leone, S; Fiorucci, G; Lulf, S; Romeo, G; Agresti, C; Persichini, T; Geyer, M; Affabris, E				Mangino, Giorgio; Famiglietti, Marylinda; Capone, Caterina; Veroni, Caterina; Percario, Zulema Antonia; Leone, Stefano; Fiorucci, Gianna; Luelf, Sebastian; Romeo, Giovanna; Agresti, Cristina; Persichini, Tiziana; Geyer, Matthias; Affabris, Elisabetta			HIV-1 Myristoylated Nef Treatment of Murine Microglial Cells Activates Inducible Nitric Oxide Synthase, NO2 Production and Neurotoxic Activity	PLOS ONE			English	Article							NF-KAPPA-B; VIRUS TYPE-1 NEF; HIGHLY SELECTIVE INHIBITOR; IMMUNODEFICIENCY-VIRUS; HUMAN MONOCYTES/MACROPHAGES; HUMAN MONOCYTE/MACROPHAGES; SIGNALING PATHWAY; TRANSGENIC MICE; SOLUBLE FACTORS; NERVOUS-SYSTEM	Background The potential role of the human immunodeficiency virus-1 (HIV-1) accessory protein Nef in the pathogenesis of neuroAIDS is still poorly understood. Nef is a molecular adapter that influences several cellular signal transduction events and membrane trafficking. In human macrophages, Nef expression induces the production of extracellular factors (e.g. pro-inflammatory chemokines and cytokines) and the recruitment of T cells, thus favoring their infection and its own transfer to uninfected cells via exosomes, cellular protrusions or cell-to-cell contacts. Murine cells are normally not permissive for HIV-1 but, in transgenic mice, Nef is a major disease determinant. Both in human and murine macrophages, myristoylated Nef (myr(+)Nef) treatment has been shown to activate NF-kappa B, MAP kinases and interferon responsive factor 3 (IRF-3), thereby inducing tyrosine phosphorylation of signal transducers and activator of transcription (STAT)-1, STAT-2 and STAT-3 through the production of proinflammatory factors. Methodology/Principal Findings We report that treatment of BV-2 murine microglial cells with myr(+)Nef leads to STAT-1, -2 and -3 tyrosine phosphorylation and upregulates the expression of inducible nitric oxide synthase (iNOS) with production of nitric oxide. We provide evidence that extracellular Nef regulates iNOS expression through NF-kappa B activation and, at least in part, interferon-beta (IFN beta) release that acts in concert with Nef. All of these effects require both myristoylation and a highly conserved acidic cluster in the viral protein. Finally, we report that Nef induces the release of neurotoxic factors in the supernatants of microglial cells. Conclusions These results suggest a potential role of extracellular Nef in promoting neuronal injury in the murine model. They also indicate a possible interplay between Nef and host factors in the pathogenesis of neuroAIDS through the production of reactive nitrogen species in microglial cells.	[Mangino, Giorgio; Famiglietti, Marylinda; Capone, Caterina; Percario, Zulema Antonia; Leone, Stefano; Persichini, Tiziana; Affabris, Elisabetta] Univ Rome Tre, Dept Sci, I-00146 Rome, Italy; [Mangino, Giorgio; Romeo, Giovanna] Sapienza Univ Rome, Dept Medicosurg Sci & Biotechnol, Latina, Italy; [Veroni, Caterina; Agresti, Cristina] Ist Super Sanita, Dept Cell Biol & Neurosci, Rome, Italy; [Fiorucci, Gianna; Romeo, Giovanna] CNR, Inst Mol Biol & Pathol, Rome, Italy; [Geyer, Matthias] Ctr Adv European Studies & Res, Grp Phys Biochem, Bonn, Germany	Italfarmaco; Roma Tre University; Sapienza University Rome; Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Center of Advanced European Studies & Research (CAESAR)	Affabris, E (corresponding author), Univ Rome Tre, Dept Sci, I-00146 Rome, Italy.	elisabetta.affabris@uniroma3.it	Veroni, Caterina/AAA-5454-2021; Fiorucci, Gianna/B-3064-2013; Mangino, Giorgio/C-7310-2009; Veroni, Caterina/J-5795-2016; Romeo, Giovanna/AAB-2613-2019; romeo, giovanna/P-8348-2015	Veroni, Caterina/0000-0002-6043-1051; Mangino, Giorgio/0000-0002-8950-9780; Veroni, Caterina/0000-0002-6043-1051; Geyer, Matthias/0000-0002-7718-5002; AFFABRIS, Elisabetta/0000-0001-5142-8144; Agresti, Cristina/0000-0002-9225-7190; Leone, Stefano/0000-0001-6339-6397; romeo, giovanna/0000-0002-7638-1001; PERSICHINI, TIZIANA/0000-0001-8291-6706	Italian National Research Program on AIDS of the Istituto Superiore di Sanita, Rome, Italy [N.40.G1]; PRIN-MIUR (Progetti Rilevante Interesse Nazionale-Ministero dell'Universita e della Ricerca Scientifica), Italy [20072J9RWM_002]	Italian National Research Program on AIDS of the Istituto Superiore di Sanita, Rome, Italy; PRIN-MIUR (Progetti Rilevante Interesse Nazionale-Ministero dell'Universita e della Ricerca Scientifica), Italy(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by grants from the Italian National Research Program on AIDS of the Istituto Superiore di Sanita (Affabris N.40.G1), Rome, Italy, and from PRIN-MIUR (Progetti Rilevante Interesse Nazionale-Ministero dell'Universita e della Ricerca Scientifica) 2007 (Affabris prot. 20072J9RWM_002), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharjee S, 2014, BRAIN BEHAV IMMUN, V40, P74, DOI 10.1016/j.bbi.2014.02.016; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Baur AS, 2011, TRENDS MICROBIOL, V19, P435, DOI 10.1016/j.tim.2011.06.002; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045466; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Breuer S, 2006, BIOCHEMISTRY-US, V45, P2339, DOI 10.1021/bi052052c; Brigino E, 1997, P NATL ACAD SCI USA, V94, P3178, DOI 10.1073/pnas.94.7.3178; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; BUONASSISI V, 1962, P NATL ACAD SCI USA, V48, P1184, DOI 10.1073/pnas.48.7.1184; Burdo TH, 2013, IMMUNOL REV, V254, P102, DOI 10.1111/imr.12068; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; BURN JH, 1965, ANNU REV PHARMACOLOG, V5, P163, DOI 10.1146/annurev.pa.05.040165.001115; Colasanti M, 1997, J BIOL CHEM, V272, P7582, DOI 10.1074/jbc.272.12.7582; Colasanti M, 2000, BRAIN RES BULL, V52, P155, DOI 10.1016/S0361-9230(00)00262-8; COLASANTI M, 1995, NEUROSCI LETT, V200, P144, DOI 10.1016/0304-3940(95)12101-9; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dube B, 2005, J PSYCHIATR NEUROSCI, V30, P237; Federico M, 2001, BLOOD, V98, P2752, DOI 10.1182/blood.V98.9.2752; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; GELBARD HA, 1994, J VIROL, V68, P4628, DOI 10.1128/JVI.68.7.4628-4635.1994; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Griffin DE, 1997, J CLIN INVEST, V100, P2948, DOI 10.1172/JCI119847; Gulizia RJ, 1997, J VIROL, V71, P4161, DOI 10.1128/JVI.71.5.4161-4164.1997; Hanna Z, 1998, J VIROL, V72, P121, DOI 10.1128/JVI.72.1.121-132.1998; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Joska JA, 2011, AFR J PSYCHIATRY, V14, P17; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kirchhoff F, 2008, CELL MOL LIFE SCI, V65, P2621, DOI 10.1007/s00018-008-8094-2; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; KORBER BTM, 1994, J VIROL, V68, P7467, DOI 10.1128/JVI.68.11.7467-7481.1994; Lamers SL, 2012, INT REV IMMUNOL, V31, P432, DOI 10.3109/08830185.2012.737073; Lamers SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016659; LASSMANN H, 1991, REV NEUROL-FRANCE, V147, P763; LEONARD JM, 1988, SCIENCE, V242, P1665, DOI 10.1126/science.3201255; Mangino G, 2007, J VIROL, V81, P2777, DOI 10.1128/JVI.01640-06; Mangino G, 2012, VIRAL IMMUNOL, V25, P117, DOI 10.1089/vim.2011.0082; Mangino G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022982; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mayer B, 1997, TRENDS BIOCHEM SCI, V22, P477, DOI 10.1016/S0968-0004(97)01147-X; McIntyre KW, 2003, ARTHRITIS RHEUM-US, V48, P2652, DOI 10.1002/art.11131; Messmer D, 2002, AIDS RES HUM RETROV, V18, P1043, DOI 10.1089/08892220260235407; Olivetta E, 2003, J IMMUNOL, V170, P1716, DOI 10.4049/jimmunol.170.4.1716; PELUSO R, 1985, VIROLOGY, V147, P231, DOI 10.1016/0042-6822(85)90246-6; Percario Z, 2003, J LEUKOCYTE BIOL, V74, P821, DOI 10.1189/jlb.0403161; Percario Z, 2011, HIV HOST INTERACTION, P61; Percario ZA, 2015, CYTOKINE GROWTH F R, V26, P159, DOI 10.1016/j.cytogfr.2014.11.010; POWER C, 1994, J VIROL, V68, P4643, DOI 10.1128/JVI.68.7.4643-4649.1994; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; PULLIAM L, 1991, J CLIN INVEST, V87, P503, DOI 10.1172/JCI115024; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Quaranta MG, 2003, FASEB J, V17, P2025, DOI 10.1096/fj.03-0272com; Quaranta MG, 2002, EXP CELL RES, V275, P243, DOI 10.1006/excr.2002.5497; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Radja F, 2003, J VIROL, V77, P11745, DOI 10.1128/JVI.77.21.11745-11753.2003; RESNICK L, 1988, NEUROLOGY, V38, P9, DOI 10.1212/WNL.38.1.9; Rodriguez-Pascual F, 2000, J BIOL CHEM, V275, P26040, DOI 10.1074/jbc.M910460199; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Saha RN, 2006, ANTIOXID REDOX SIGN, V8, P929, DOI 10.1089/ars.2006.8.929; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Shi B, 1996, J CLIN INVEST, V98, P1979, DOI 10.1172/JCI119002; Stansley B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-115; STUEHR DJ, 1987, J IMMUNOL, V139, P518; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; Tsikas D, 2005, FREE RADICAL RES, V39, P797, DOI 10.1080/10715760500053651; van Marle G, 2004, VIROLOGY, V329, P302, DOI 10.1016/j.virol.2004.08.024; Veroni C, 2010, MOL CELL NEUROSCI, V45, P234, DOI 10.1016/j.mcn.2010.06.014; WERNER T, 1991, AIDS, V5, P1301, DOI 10.1097/00002030-199111000-00003; WESSELINGH SL, 1993, ANN NEUROL, V33, P576, DOI 10.1002/ana.410330604; Williams KC, 2001, J EXP MED, V193, P905, DOI 10.1084/jem.193.8.905; Woods SP, 2009, NEUROPSYCHOL REV, V19, P152, DOI 10.1007/s11065-009-9102-5; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yoshioka M, 1995, ADV NEUROIMMUNOL, V5, P335, DOI 10.1016/0960-5428(95)00012-Q; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	80	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130189	10.1371/journal.pone.0130189	http://dx.doi.org/10.1371/journal.pone.0130189			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066624	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900103
J	Ssemakalu, CC; Ubomba-Jaswa, E; Motaung, KS; Pillay, M				Ssemakalu, Cornelius Cano; Ubomba-Jaswa, Eunice; Motaung, Keolebogile Shirley; Pillay, Michael			The Effect of Solar Irradiated Vibrio cholerae on the Secretion of Pro-Inflammatory Cytokines and Chemokines by the JAWS II Dendritic Cell Line In Vitro	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; DISINFECTION SODIS; DRINKING-WATER; ESCHERICHIA-COLI; MACROPHAGES; INACTIVATION; ALPHA; MIP-1-ALPHA; NEUTROPHIL; POLIOVIRUS	The use of solar irradiation to sterilize water prior to its consumption has resulted in the reduction of water related illnesses in waterborne disease endemic communities worldwide. Currently, research on solar water disinfection (SODIS) has been directed towards understanding the underlying mechanisms through which solar irradiation inactivates the culturability of microorganisms in water, enhancement of the disinfection process, and the health impact of SODIS water consumption. However, the immunological consequences of SODIS water consumption have not been explored. In this study, we investigated the effect that solar irradiated V. cholerae may have had on the secretion of cytokines and chemokines by the JAWS II dendritic cell line in vitro. The JAWS II dendritic cell line was stimulated with the different strains of V. cholerae that had been: (i) prepared in PBS, (ii) inactivated through a combination of heat and chemical, (iii) solar irradiated, and (iv) non-solar irradiated, in bottled water. As controls, LPS (1 mu g/ml) and CTB (1 mu g/ml) were used as stimulants. After 48 hours of stimulation the tissue culture media from each treatment was qualitatively and quantitatively analysed for the presence of IL-1 alpha, IL-1 beta, IL-6, IL-7, IL-10, IL-12p40, IL-12p70, IL-15, MIP-1 alpha, MIP-1 beta, MIP-2, RANTES, TNF-alpha, IL-23 and IL-27. Results showed that solar irradiated cultures of V. cholerae induced dendritic cells to secrete significant (p<0.05) levels of pro-inflammatory cytokines in comparison to the unstimulated dendritic cells. Furthermore, the amount of pro-inflammatory cytokines secreted by the dendritic cells in response to solar irradiated cultures of V. cholerae was not as high as observed in treatments involving non-solar irradiated cultures of V. cholerae or LPS. Our results suggest that solar irradiated microorganisms are capable of inducing the secretion of pro-inflammatory cytokines and chemokines. This novel finding is key towards understanding the possible immunological consequences of consuming SODIS treated water.	[Ssemakalu, Cornelius Cano; Pillay, Michael] Vaal Univ Technol, Fac Appl & Comp Sci, Dept Biotechnol, ZA-1900 Gauteng, South Africa; [Ubomba-Jaswa, Eunice] CSIR, Nat Resources & Environm, ZA-0001 Pretoria, Gauteng, South Africa; [Motaung, Keolebogile Shirley] Tshwane Univ Technol, Dept Biomed Sci, ZA-0001 Pretoria, Gauteng, South Africa	Vaal University of Technology (VUT); Council for Scientific & Industrial Research (CSIR) - South Africa; Tshwane University of Technology	Pillay, M (corresponding author), Vaal Univ Technol, Fac Appl & Comp Sci, Dept Biotechnol, Vanderbijlpk, ZA-1900 Gauteng, South Africa.	mpillay@vut.ac.za	Motaung, Shirley/AAD-1428-2019	Motaung, Keolebogile Shirley Caroline Mamotswere/0000-0001-8503-9868; Ssemakalu, Cornelius/0000-0003-3895-2018	Vaal University of Technology	Vaal University of Technology	The Vaal University of Technology provided the funds to carry out this work through the Hubs and Spoke Scholarship programme. Other than that, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2006, APPL ENVIRON MICROB, V72, P5806, DOI 10.1128/AEM.00597-06; BAILEY CA, 1983, APPL ENVIRON MICROB, V46, P44, DOI 10.1128/AEM.46.1.44-49.1983; Bandyopadhaya A, 2007, FEBS J, V274, P4631, DOI 10.1111/j.1742-4658.2007.05991.x; Berney M, 2006, MICROBIOL-SGM, V152, P1719, DOI 10.1099/mic.0.28617-0; Bolger CE, 2005, J LEUKOCYTE BIOL, V77, P893, DOI 10.1189/jlb.1104637; Bondeson J, 1997, GEN PHARMACOL-VASC S, V29, P127, DOI 10.1016/S0306-3623(96)00419-3; Bosshard F, 2010, ENVIRON MICROBIOL, V12, P2931, DOI 10.1111/j.1462-2920.2010.02268.x; Bosshard F, 2010, MICROBIOL-SGM, V156, P2006, DOI 10.1099/mic.0.038471-0; Burkart V, 2002, J IMMUNOL, V168, P1730, DOI 10.4049/jimmunol.168.4.1730; Chatterjee D, 2013, J BIOL CHEM, V288, P4299, DOI 10.1074/jbc.M112.408302; Connolly NC, 2005, AIDS REV, V7, P168; Conroy RM, 2001, ARCH DIS CHILD, V85, P293, DOI 10.1136/adc.85.4.293; CRYZ SJ, 1982, INFECT IMMUN, V38, P21, DOI 10.1128/IAI.38.1.21-26.1982; CRYZ SJ, 1982, DEV BIOLOGICALS, V53, P67; Daudelin JF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/126189; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dixon GLJ, 2001, INFECT IMMUN, V69, P4351, DOI 10.1128/IAI.69.7.4351-4357.2001; du Preez M, 2010, ENVIRON SCI TECHNOL, V44, P8744, DOI 10.1021/es103328j; Egger M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017278; Elasri MO, 1999, APPL ENVIRON MICROB, V65, P2025; Ertl H, 2003, DNA VACCINES; Heaselgrave W, 2006, LETT APPL MICROBIOL, V43, P125, DOI 10.1111/j.1472-765X.2006.01940.x; Heaselgrave W, 2012, J WATER HEALTH, V10, P531, DOI 10.2166/wh.2012.128; Hsieh CH, 2008, J IMMUNOL, V181, P2806, DOI 10.4049/jimmunol.181.4.2806; Jiang XZ, 2008, INFECT IMMUN, V76, P2392, DOI 10.1128/IAI.01584-07; Kernacki KA, 2000, J IMMUNOL, V164, P1037, DOI 10.4049/jimmunol.164.2.1037; Lavelle EC, 2003, J IMMUNOL, V171, P2384, DOI 10.4049/jimmunol.171.5.2384; Lore K, 1998, J IMMUNOL METHODS, V214, P97, DOI 10.1016/S0022-1759(98)00040-4; Mackay V. L., 1997, IMMORTALIZED DENDRIT; McGuigan KG, 2012, J HAZARD MATER, V235, P29, DOI 10.1016/j.jhazmat.2012.07.053; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Merrell DS, 2000, INFECT IMMUN, V68, P6691, DOI 10.1128/IAI.68.12.6691-6696.2000; Muriel M., 2003, FUNDAMENTAL IMMUNOLO, P840; Nath A, 1999, J BIOL CHEM, V274, P17098, DOI 10.1074/jbc.274.24.17098; Navntoft C, 2008, J PHOTOCH PHOTOBIO B, V93, P155, DOI 10.1016/j.jphotobiol.2008.08.002; Ohtsuka Y, 2001, GUT, V49, P526, DOI 10.1136/gut.49.4.526; Pastor CM, 2003, LAB INVEST, V83, P471, DOI 10.1097/01.LAB.0000063928.91314.9F; POLI G, 1992, PATHOBIOLOGY, V60, P246, DOI 10.1159/000163729; Qiu XY, 2004, APPL ENVIRON MICROB, V70, P6435, DOI 10.1128/AEM.70.11.6435-6443.2004; Queen J, 2012, INFECT IMMUN, V80, P2905, DOI 10.1128/IAI.00356-12; Rosellini N., 2010, MILLENNIUM DEV GOALS, P63; Rowan NJ, 2004, TRENDS FOOD SCI TECH, V15, P462, DOI 10.1016/j.tifs.2004.02.009; Rufener S, 2010, J HEALTH POPUL NUTR, V28, P34, DOI 10.3329/jhpn.v28i1.4521; Rui HP, 2010, P NATL ACAD SCI USA, V107, P4359, DOI 10.1073/pnas.0915164107; Satchell KJF, 2003, MICROBES INFECT, V5, P1241, DOI 10.1016/j.micinf.2003.08.007; Schytte Blix IJ, 1999, J PERIODONTAL RES, V34, P30; Sieve AN, 2010, EUR J IMMUNOL, V40, P2236, DOI 10.1002/eji.200939759; Ssemakalu CC, 2011, EVALUATION EFFECTS S; Ssemakalu CC, 2013, S AFR J SCI, V109, DOI 10.1590/sajs.2013/20130061; Ssemakalu CC, 2014, J WATER HEALTH, V12, P393, DOI 10.2166/wh.2014.158; Tanabe SI, 2008, J PERIODONTAL RES, V43, P372, DOI 10.1111/j.1600-0765.2007.01049.x; Terpos E, 2003, BRIT J HAEMATOL, V123, P106, DOI 10.1046/j.1365-2141.2003.04561.x; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Turner DA, 2010, J CELL SCI, V123, P2834, DOI 10.1242/jcs.069641; Ubomba-Jaswa E, 2010, J CHEM TECHNOL BIOT, V85, P1028, DOI 10.1002/jctb.2398; WHO, 1996, GUID DRINK WAT QUAL; WHO, 2014, WEEKLY EPIDEMIOLOGIC; WHO/UNICEF(WHO/UnitedNationsInternationalChildren's Fund), 2014, PROGR DRINK WAT SAN; Zychlinsky A, 1997, TRENDS MICROBIOL, V5, P201, DOI 10.1016/S0966-842X(97)01044-5	59	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130190	10.1371/journal.pone.0130190	http://dx.doi.org/10.1371/journal.pone.0130190			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066787	gold, Green Published			2022-12-27	WOS:000356100900104
J	Sun, JY; Li, LT; Yuan, S; Zhou, YQ				Sun, Jiuyi; Li, Lintao; Yuan, Shuai; Zhou, Yiqin			Analysis of Early Postoperative Pain in the First and Second Knee in Staged Bilateral Total Knee Arthroplasty: A Retrospective Controlled Study	PLOS ONE			English	Article							CENTRAL SENSITIZATION; REPLACEMENT; SAFETY; METAANALYSIS; TOLERANCE; MORTALITY; EFFICACY; EMBOLISM; SURGERY	Objective A retrospective analysis of early postoperative pain in the first and second knee in staged bilateral total knee arthroplasty (TKA) to provide a clinical evidence for the change of analgesic strategy. Methods From January 2009 to January 2013, 87 cases which meet the inclusion criterion were retrospectively reviewed. In stage TKA, the postoperative pain in the first and second knee at 24h, 48h, 72h after operation were compared using the visual analogue scale (VAS) score in the rest and maximum knee flexion position. The difference in pain scores (Delta VAS) was also compared between the second and first knee at different time intervals (less than 6 months, 6-12 months, more than 12 months). Results The VAS scores in the second knee were significantly higher than those in the first knee at 24h, 48h after surgery, but with no difference at 72h. The Delta VAS in the group of less than 6 months was significantly higher than of those more than 6 months, and there was no difference in Delta VAS between group of 6-12 months and group of more than 12 months. Conclusions Patient receiving staged bilateral TKA experiences greater postoperative pain within 48h after operation in the second knee than in the first knee, which can provide a clinical evidence to enhance the analgesic strategy in the second operation of the staged bilateral TKA. And for the management of postoperative pain in staged bilateral TKA, it's better to recommend that the interval between two operations should be more than 6 months, which may reduce the postoperative pain in the second knee, improve patient satisfaction, and speed up patient's rehabilitation process.	[Sun, Jiuyi] PLA 455 Hosp, Dept Orthoped, Shanghai, Peoples R China; [Li, Lintao; Yuan, Shuai; Zhou, Yiqin] Second Mil Med Univ, Dept Orthoped, Affiliated Hosp 2, Shanghai, Peoples R China	Naval Medical University	Zhou, YQ (corresponding author), Second Mil Med Univ, Dept Orthoped, Affiliated Hosp 2, Shanghai, Peoples R China.	drzhouyq@gmail.com						Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Barrett J, 2006, J BONE JOINT SURG AM, V88A, P2146, DOI 10.2106/JBJS.E.01323; Carli F, 2010, BRIT J SURG, V97, P1187, DOI 10.1002/bjs.7102; Cheng Long, 2009, CHIN J JOINT SURG, V3, P30; Cohen RG, 1997, J ARTHROPLASTY, V12, P497, DOI 10.1016/S0883-5403(97)90171-6; Collett BJ, 1998, BRIT J ANAESTH, V81, P58, DOI 10.1093/bja/81.1.58; Cross 3rd WW, 2006, CLIN ORTHOP RELAT R, V446, P34, DOI [10.1097/01.blo.0000214436.49527.5e, DOI 10.1097/01.BLO.0000214436.49527.5E]; Dalury DF, 2009, J BONE JOINT SURG BR, V91B, P357, DOI 10.1302/0301-620X.91B3.21771; Fei Zhang, 2013, CHIN J JOINT SURG, V7, P33; Fu PeiLiang, 2008, Chinese Journal of Orthopaedics, V28, P541; GOLDSTEIN A, 1969, J PHARMACOL EXP THER, V169, P175; Hu J, 2011, ARCH ORTHOP TRAUM SU, V131, P1291, DOI 10.1007/s00402-011-1287-4; Husted H, 2011, J BONE JOINT SURG BR, V93B, P351, DOI 10.1302/0301-620X.93B3.25296; JANKIEWICZ JJ, 1994, CLIN ORTHOP RELAT R, P94; Jenny JY, 2013, ORTHOP TRAUMATOL-SUR, V99, P191, DOI 10.1016/j.otsr.2012.12.015; Kim MH, 2014, PAIN, V155, P22, DOI 10.1016/j.pain.2013.08.027; Kim S, 2011, J ARTHROPLASTY, V26, P1198, DOI 10.1016/j.arth.2011.01.004; Kim YH, 2001, J ARTHROPLASTY, V16, P730, DOI 10.1054/arth.2001.23723; Leitch KK, 2005, CAN J SURG, V48, P273; Leonard L, 2003, J ARTHROPLASTY, V18, P972, DOI 10.1016/S0883-5403(03)00282-1; Mangaleshkar SR, 2001, KNEE, V8, P207, DOI 10.1016/S0968-0160(01)00085-0; Memtsoudis SG, 2013, CLIN ORTHOP RELAT R, V471, P17, DOI [10.1007/s11999-012-2608-9, 10.1007/s11999-012-2682-z]; MORREY BF, 1987, J BONE JOINT SURG AM, V69A, P484, DOI 10.2106/00004623-198769040-00002; Oakes DA, 2004, CLIN ORTHOP RELAT R, P87, DOI 10.1097/01.blo.0000147133.75432.86; Odum SM, 2013, J BONE JOINT SURG AM, V95A, P1441, DOI 10.2106/JBJS.L.00373; Patil N, 2008, ORTHOPEDICS, V31, P780, DOI 10.3928/01477447-20080801-23; Qutob M, 2013, J ARTHROPLASTY, V28, P1148, DOI 10.1016/j.arth.2013.01.022; Restrepo C, 2007, J BONE JOINT SURG AM, V89A, P1220, DOI 10.2106/JBJS.F.01353; Ritter M, 1997, CLIN ORTHOP RELAT R, P99; SOUDRY M, 1985, J BONE JOINT SURG AM, V67A, P573, DOI 10.2106/00004623-198567040-00011; Suokas AK, 2012, OSTEOARTHR CARTILAGE, V20, P1075, DOI 10.1016/j.joca.2012.06.009; Suzuki R, 2005, NEUROSIGNALS, V14, P175, DOI 10.1159/000087656; Vulcano E, 2013, J KNEE SURG, V26, P273, DOI 10.1055/s-0032-1329721; Wieseler-Frank J, 2004, NEUROCHEM INT, V45, P389, DOI 10.1016/j.neuint.2003.09.009; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Wortzel HS, 2009, J NEUROPSYCH CLIN N, V21, P463, DOI 10.1176/appi.neuropsych.21.4.463; YAKSH TL, 1983, J PHARMACOL EXP THER, V226, P303	38	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129973	10.1371/journal.pone.0129973	http://dx.doi.org/10.1371/journal.pone.0129973			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068371	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900088
J	Hasan, MM; Zhou, Y; Lu, XT; Li, JY; Song, JN; Zhang, ZD				Hasan, Md. Mehedi; Zhou, Yuan; Lu, Xiaotian; Li, Jinyan; Song, Jiangning; Zhang, Ziding			Computational Identification of Protein Pupylation Sites by Using Profile-Based Composition of k-Spaced Amino Acid Pairs	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEIN; PROTEASOMAL DEGRADATION; PUP; PREDICTION; SIGNAL; METHYLATION; CASCLEAVE; CASPASE; PATHWAY	Prokaryotic proteins are regulated by pupylation, a type of post-translational modification that contributes to cellular function in bacterial organisms. In pupylation process, the prokaryotic ubiquitin-like protein (Pup) tagging is functionally analogous to ubiquitination in order to tag target proteins for proteasomal degradation. To date, several experimental methods have been developed to identify pupylated proteins and their pupylation sites, but these experimental methods are generally laborious and costly. Therefore, computational methods that can accurately predict potential pupylation sites based on protein sequence information are highly desirable. In this paper, a novel predictor termed as pbPUP has been developed for accurate prediction of pupylation sites. In particular, a sophisticated sequence encoding scheme [i.e. the profile-based composition of k-spaced amino acid pairs (pbCKSAAP)] is used to represent the sequence patterns and evolutionary information of the sequence fragments surrounding pupylation sites. Then, a Support Vector Machine (SVM) classifier is trained using the pbCKSAAP encoding scheme. The final pbPUP predictor achieves an AUC value of 0.849 in 10-fold cross-validation tests and outperforms other existing predictors on a comprehensive independent test dataset. The proposed method is anticipated to be a helpful computational resource for the prediction of pupylation sites. The web server and curated datasets in this study are freely available at http://protein.cau.edu.cn/pbPUP/.	[Hasan, Md. Mehedi; Zhou, Yuan; Lu, Xiaotian; Zhang, Ziding] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Li, Jinyan] Univ Technol Sydney, Adv Analyt Inst & Ctr Hlth Technol, Sydney, NSW 2007, Australia; [Song, Jiangning] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Natl Engn Lab Ind Enzymes, Tianjin 300308, Peoples R China; [Song, Jiangning] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China; [Song, Jiangning] Monash Univ, Fac Med, Monash Bioinformat Platform, Melbourne, Vic 3800, Australia; [Song, Jiangning] Monash Univ, Fac Med, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia	China Agricultural University; University of Technology Sydney; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Monash University; Monash University	Zhang, ZD (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	zidingzhang@cau.edu.cn	, zidingzhang/E-9320-2011; Song, Jiangning/F-9787-2010; Hasan, Mehedi/HHC-4236-2022	, zidingzhang/0000-0002-9296-571X; Song, Jiangning/0000-0001-8031-9086; HASAN, MD. MEHEDI/0000-0003-4952-0739; Li, Jinyan/0000-0003-1833-7413	China Scholarship Council (CSC); ARC Discovery Project [DP130102124]; Hundred Talents Program of the Chinese Academy of Sciences (CAS)	China Scholarship Council (CSC)(China Scholarship Council); ARC Discovery Project(Australian Research Council); Hundred Talents Program of the Chinese Academy of Sciences (CAS)	MMH was financially supported by the China Scholarship Council (CSC). JL was supported by an ARC Discovery Project (DP130102124). JS is a recipient of the Hundred Talents Program of the Chinese Academy of Sciences (CAS).	Barandun J, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-95; Burns KE, 2010, SUBCELL BIOCHEM, V54, P149, DOI 10.1007/978-1-4419-6676-6_12; Burns KE, 2010, CELL MICROBIOL, V12, P424, DOI 10.1111/j.1462-5822.2010.01447.x; CENTOR RM, 1991, MED DECIS MAKING, V11, P102, DOI 10.1177/0272989X9101100205; Cerda-Maira FA, 2011, EMBO REP, V12, P863, DOI 10.1038/embor.2011.109; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen K, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-25; Chen K, 2009, J COMPUT CHEM, V30, P163, DOI 10.1002/jcc.21053; Chen X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074002; Chen X, 2009, J MOL BIOL, V392, P208, DOI 10.1016/j.jmb.2009.07.018; Chen YZ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-101; Chen Z, 2015, BRIEF BIOINFORM, V16, P640, DOI 10.1093/bib/bbu031; Chen Z, 2013, BBA-PROTEINS PROTEOM, V1834, P1461, DOI 10.1016/j.bbapap.2013.04.006; Chen Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022930; Darwin KH, 2009, NAT REV MICROBIOL, V7, P485, DOI 10.1038/nrmicro2148; DeMartino GN, 2009, TRENDS BIOCHEM SCI, V34, P155, DOI 10.1016/j.tibs.2008.12.005; Dong XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056632; Elharar Y, 2014, EMBO J, V33, P1802, DOI 10.15252/embj.201387076; ETLINGER JD, 1977, P NATL ACAD SCI USA, V74, P54, DOI 10.1073/pnas.74.1.54; Festa RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008589; Goldberg AL, 2005, NEURON, V45, P339, DOI 10.1016/j.neuron.2005.01.019; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; Guth E, 2011, J BIOL CHEM, V286, P4412, DOI 10.1074/jbc.M110.189282; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Imkamp F, 2010, EMBO REP, V11, P791, DOI 10.1038/embor.2010.119; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-45; Kraut DA, 2010, EMBO J, V29, P1163, DOI 10.1038/emboj.2010.40; Kuberl A, 2014, PROTEOMICS, V14, P1531, DOI 10.1002/pmic.201300531; Li Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05765; Liao SH, 2009, BIOCHEM J, V422, P207, DOI 10.1042/BJ20090738; Lin C-J, 2003, NIPS 2003 FEATURE SE, P1; Liu ZX, 2011, MOL BIOSYST, V7, P2737, DOI 10.1039/c1mb05217a; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Poulsen C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.39; Provost F, 2000, AAAI 2000 WORKSH IMB; Salgame P, 2008, CELL HOST MICROBE, V4, P415, DOI 10.1016/j.chom.2008.10.009; Shi SP, 2012, MOL BIOSYST, V8, P1520, DOI 10.1039/c2mb05502c; Si JN, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-73; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Striebel F, 2014, BBA-MOL CELL RES, V1843, P103, DOI 10.1016/j.bbamcr.2013.03.022; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Sutter M, 2010, J AM CHEM SOC, V132, P5610, DOI 10.1021/ja910546x; Sutter M, 2009, FEBS LETT, V583, P3151, DOI 10.1016/j.febslet.2009.09.020; Tung CW, 2013, J THEOR BIOL, V336, P11, DOI 10.1016/j.jtbi.2013.07.009; Tung CW, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-40; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Wang MJ, 2014, BIOINFORMATICS, V30, P71, DOI 10.1093/bioinformatics/btt603; Wang XB, 2009, PROTEIN ENG DES SEL, V22, P707, DOI 10.1093/protein/gzp055; Watrous J, 2010, MOL BIOSYST, V6, P376, DOI 10.1039/b916104j; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Yan RX, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-416; Yun HY, 2012, BIOSCI BIOTECH BIOCH, V76, P1959, DOI 10.1271/bbb.120458; Zhang WY, 2013, PROTEIN PEPTIDE LETT, V20, P911, DOI 10.2174/0929866511320080008; ZHAO XA, 2012, PLOS GENET, V8, DOI DOI 10.1371/JOURNAL.PONE.0046302; Zhao XW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/109549; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083167	56	56	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129635	10.1371/journal.pone.0129635	http://dx.doi.org/10.1371/journal.pone.0129635			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080082	Green Published, gold, Green Submitted			2022-12-27	WOS:000356542300028
J	Wang, Q; Ke, JT; Song, QB; Hu, WG; Lu, XZ; Wang, ZL; Gong, HY; Xu, TP; Chen, XQ; Xu, B; Liu, C; Sun, Y; Gong, YJ; Yang, Y; Zhu, Y				Wang, Qi; Ke, Juntao; Song, Qibin; Hu, Weiguo; Lu, Xuzai; Wang, Zhenling; Gong, Hongyun; Xu, Tangpeng; Chen, Xueqin; Xu, Bin; Liu, Cheng; Sun, Yun; Gong, Yajie; Yang, Yang; Zhu, Ying			The SNP rs931794 in 15q25.1 Is Associated with Lung Cancer Risk: A Hospital-Based Case-Control Study and Meta-Analysis	PLOS ONE			English	Article							SUSCEPTIBILITY LOCUS; SEQUENCE VARIANTS; SMOKING; MAPS; BIAS	Background Lung cancer is one of the most common human malignant diseases and the leading cause of cancer death worldwide. The rs931794, a SNP located in 15q25.1, has been suggested to be associated with lung cancer risk. Nevertheless, several genetic association studies yielded controversial results. Methods and Findings A hospital-based case-control study involving 611 cases and 1062 controls revealed the variant of rs931794 was related to increased lung cancer risk. Stratified analyses revealed the G allele was significantly associated with lung cancer risk among smokers. Following meta-analysis including 6616 cases and 7697 controls confirmed the relevance of rs931794 variant with increased lung cancer risk once again. Heterogeneity should be taken into account when interpreting the consequences. Stratified analysis found ethnicity, histological type and genotyping method were not the sources of between-study heterogeneity. Further sensitivity analysis revealed that the study "Hsiung et al (2010)" might be the major contributor to heterogeneity. Cumulative meta-analysis showed the trend was increasingly obvious with adding studies, confirming the significant association. Conclusions Results from our current case-control study and meta-analysis offered insight of association between rs931794 and lung cancer risk, suggesting the variant of rs931794 might be related with increased lung cancer risk.	[Wang, Qi; Song, Qibin; Hu, Weiguo; Gong, Hongyun; Xu, Tangpeng; Xu, Bin] Wuhan Univ, Renmin Hosp, Dept Oncol, Wuhan 430072, Peoples R China; [Ke, Juntao; Chen, Xueqin; Liu, Cheng; Sun, Yun; Gong, Yajie; Yang, Yang; Zhu, Ying] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Ke, Juntao; Chen, Xueqin; Liu, Cheng; Sun, Yun; Gong, Yajie; Yang, Yang; Zhu, Ying] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth,Minist Educ, Wuhan 430074, Peoples R China; [Lu, Xuzai] Guangdong Maternal & Child Hlth Care Hosp, Guangzhou, Guangdong, Peoples R China; [Wang, Zhenling] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Hosp Infect Control, Wuhan 430074, Peoples R China	Wuhan University; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Song, QB (corresponding author), Wuhan Univ, Renmin Hosp, Dept Oncol, Wuhan 430072, Peoples R China.	qibinsong@163.com	wang, qi/AAV-8721-2021	Wang, Qi/0000-0001-7155-8878	National Natural Science Foundation of China [81372407]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China 81372407 to Q. S.; http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashford NA, 2015, SCIENCE, V347, P727, DOI 10.1126/science.aaa6246; Bailey-Wilson JE, 2004, AM J HUM GENET, V75, P460, DOI 10.1086/423857; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gotay C, 2015, SCIENCE, V347, P728, DOI 10.1126/science.aaa6462; Gu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037970; HABER M, 1981, HUM HERED, V31, P161, DOI 10.1159/000153199; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Improgo MRD, 2010, ONCOGENE, V29, P4874, DOI 10.1038/onc.2010.256; Ito H, 2012, J THORAC ONCOL, V7, P790, DOI 10.1097/JTO.0b013e3182475028; Krais AM, 2011, CARCINOGENESIS, V32, P1388, DOI 10.1093/carcin/bgr090; Li L, 1997, Zhonghua Zhong Liu Za Zhi, V19, P3; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Liu PY, 2008, JNCI-J NATL CANCER I, V100, P1326, DOI 10.1093/jnci/djn268; MANTEL N, 1959, J NATL CANCER I, V22, P719; Minna JD, 2003, J CLIN INVEST, V111, P31, DOI 10.1172/JCI200317492; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Munafo MR, 2012, JNCI-J NATL CANCER I, V104, P740, DOI 10.1093/jnci/djs191; Ruano-Ravina A, 2003, PUBLIC HEALTH, V117, P149, DOI 10.1016/S0033-3506(02)00023-9; Schwartz AG, 2009, J THORAC ONCOL, V4, P1195, DOI 10.1097/JTO.0b013e3181b244ef; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Song FJ, 1998, BRIT MED J, V316, P471; Song MY, 2015, SCIENCE, V347, P728, DOI 10.1126/science.aaa6094; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sterne J.A., 2008, COCHRANE HDB SYSTEMA, DOI [10.1002/9780470712184.ch10, DOI 10.1002/9780470712184.CH10]; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Tournier JM, 2006, AM J PATHOL, V168, P55, DOI 10.2353/ajpath.2006.050333; Truong T, 2010, JNCI-J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178; Wild C, 2015, SCIENCE, V347, P728, DOI 10.1126/science.aaa6799; Zhu BB, 2015, MOL CARCINOGEN, V54, P761, DOI 10.1002/mc.22140; Zhu BB, 2014, CLIN GASTROENTEROL H, V12, P1991, DOI 10.1016/j.cgh.2014.03.019	41	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0128201	10.1371/journal.pone.0128201	http://dx.doi.org/10.1371/journal.pone.0128201			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079375	Green Submitted, gold, Green Published			2022-12-27	WOS:000356542300009
J	Xie, SL; Chen, TZ; Huang, XL; Chen, C; Jin, R; Huang, ZM; Zhou, MT				Xie, Sai-Li; Chen, Tan-Zhou; Huang, Xie-Lin; Chen, Chao; Jin, Rong; Huang, Zhi-Ming; Zhou, Meng-Tao			Genetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE GENE; APOLIPOPROTEIN A5 GENE; PLASMA TRIGLYCERIDE LEVELS; CORONARY-ARTERY-DISEASE; HYPERLIPIDEMIC PANCREATITIS; CHINESE POPULATION; PREGNANCY; RISK; POLYMORPHISMS; MUTATIONS	Severe hypertriglyceridemia is a well-known cause of pancreatitis. Usually, there is a moderate increase in plasma triglyceride level during pregnancy. Additionally, certain pre-existing genetic traits may render a pregnant woman susceptible to development of severe hypertriglyceridemia and pancreatitis, especially in the third trimester. To elucidate the underlying mechanism of gestational hypertriglyceridemic pancreatitis, we undertook DNA mutation analysis of the lipoprotein lipase (LPL), apolipoprotein C2 (APOC2), apolipoprotein A5 (APOA5), lipase maturation factor 1 (LMF1), and glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1) genes in five unrelated pregnant Chinese women with severe hypertriglyceridemia and pancreatitis. DNA sequencing showed that three out of five patients had the same homozygous variation, p.G185C, in APOA5 gene. One patient had a compound heterozygous mutation, p.A98T and p.L279V, in LPL gene. Another patient had a compound heterozygous mutation, p.A98T & p.C14F in LPL and GPIHBP1 gene, respectively. No mutations were seen in APOC2 or LMF1 genes. All patients were diagnosed with partial LPL deficiency in non-pregnant state. As revealed in our study, genetic variants appear to play an important role in the development of severe gestational hypertriglyceridemia, and, p.G185C mutation in APOA5 gene appears to be the most common variant implicated in the Chinese population. Antenatal screening for mutations in susceptible women, combined with subsequent interventions may be invaluable in the prevention of potentially life threatening gestational hypertriglyceridemia-induced pancreatitis.	[Xie, Sai-Li; Chen, Tan-Zhou; Chen, Chao; Jin, Rong; Huang, Zhi-Ming; Zhou, Meng-Tao] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China; [Huang, Xie-Lin] Wenzhou Med Univ, Ren Ji Study, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Huang, ZM (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China.	hzmwenzhou@163.com; zmt0417@hotmail.com		Jin, Rong/0000-0003-3342-8970				Alvarez JJ, 1996, J LIPID RES, V37, P299; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Crisan LS, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.003; DECHALAIN TMB, 1988, SURG GYNECOL OBSTET, V167, P469; Demirdogen BC, 2012, MOL BIOL REP, V39, P10459, DOI 10.1007/s11033-012-1926-z; Eskandar O, 2007, J OBSTET GYNAECOL RE, V33, P186, DOI 10.1111/j.1447-0756.2007.00506.x; Fisher RM, 1997, ATHEROSCLEROSIS, V135, P145, DOI 10.1016/S0021-9150(97)00199-8; FOJO SS, 1992, J INTERN MED, V231, P669, DOI 10.1111/j.1365-2796.1992.tb01256.x; Fruchart-Najib J, 2004, BIOCHEM BIOPH RES CO, V319, P397, DOI 10.1016/j.bbrc.2004.05.003; Henderson H, 1998, CLIN CHIM ACTA, V269, P1, DOI 10.1016/S0009-8981(97)00144-7; Hishida A, 2012, ENDOCR J, V59, P589, DOI 10.1507/endocrj.EJ11-0310; Hodoglugil U, 2006, J LIPID RES, V47, P144, DOI 10.1194/jlr.M500343-JLR200; HSIA SH, 1995, AM J MED SCI, V309, P213, DOI 10.1097/00000441-199504000-00005; Hsu LA, 2006, ATHEROSCLEROSIS, V185, P143, DOI 10.1016/j.atherosclerosis.2005.05.031; Hubacek JA, 2004, PHYSIOL RES, V53, P225; Kao JT, 2003, HUM MOL GENET, V12, P2533, DOI 10.1093/hmg/ddg255; Lee MJ, 2013, CLIN CHIM ACTA, V416, P31, DOI 10.1016/j.cca.2012.10.054; MA YH, 1994, J LIPID RES, V35, P1066; MA YH, 1993, J CLIN INVEST, V91, P1953, DOI 10.1172/JCI116414; Matsunaga A, 2007, CIRC J, V71, P746, DOI 10.1253/circj.71.746; McGladdery SH, 2001, J LIPID RES, V42, P1905; Merkel M, 2005, J BIOL CHEM, V280, P21553, DOI 10.1074/jbc.M411412200; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; MISRA KB, 1994, J BIOL CHEM, V269, P23838; Murugasu CG, 1998, J ROY SOC MED, V91, P205, DOI 10.1177/014107689809100410; Nasstrom B, 2001, J LAB CLIN MED, V138, P206, DOI 10.1067/mlc.2001.117666; Olivecrona G, 2010, J LIPID RES, V51, P1535, DOI 10.1194/jlr.M002717; Pennacchio LA, 2003, ARTERIOSCL THROM VAS, V23, P529, DOI 10.1161/01.ATV.0000054194.78240.45; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Peterfy M, 2007, NAT GENET, V39, P1483, DOI 10.1038/ng.2007.24; Pullinger CR, 2008, J LIPID RES, V49, P1846, DOI 10.1194/jlr.P800011-JLR200; Shenhav S, 2002, ACTA OBSTET GYN SCAN, V81, P788, DOI 10.1034/j.1600-0412.2002.810819.x; Sivakumaran P, 2009, J CLIN APHERESIS, V24, P42, DOI 10.1002/jca.20192; Suga S, 1998, J INTERN MED, V243, P317, DOI 10.1046/j.1365-2796.1998.00306.x; Surendran RP, 2012, J INTERN MED, V272, P185, DOI 10.1111/j.1365-2796.2012.02516.x; SWOBODA K, 1993, GASTROENTEROLOGY, V104, P1527, DOI 10.1016/0016-5085(93)90366-K; Talmud PJ, 2002, HUM MOL GENET, V11, P3039, DOI 10.1093/hmg/11.24.3039; Tang YB, 2006, ATHEROSCLEROSIS, V185, P433, DOI 10.1016/j.atherosclerosis.2005.06.026; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsuang W, 2009, AM J GASTROENTEROL, V104, P984, DOI 10.1038/ajg.2009.27; Yadav D, 2003, J CLIN GASTROENTEROL, V36, P54, DOI 10.1097/00004836-200301000-00016; Yamamoto H, 2013, J ATHEROSCLER THROMB, V20, P777; Yin RX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017954; Zhai GH, 2006, CLIN CHEM LAB MED, V44, P1313, DOI 10.1515/CCLM.2006.255	45	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129488	10.1371/journal.pone.0129488	http://dx.doi.org/10.1371/journal.pone.0129488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079787	Green Published, gold, Green Submitted			2022-12-27	WOS:000356542300024
J	Borghini, A; Manetti, M; Nacci, F; Bellando-Randone, S; Guiducci, S; Matucci-Cerinic, M; Ibba-Manneschi, L; Weber, E				Borghini, Annalisa; Manetti, Mirko; Nacci, Francesca; Bellando-Randone, Silvia; Guiducci, Serena; Matucci-Cerinic, Marco; Ibba-Manneschi, Lidia; Weber, Elisabetta			Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide	PLOS ONE			English	Article							VEGF(165)B SPLICE VARIANT; EULAR SCLERODERMA TRIALS; PULMONARY-FIBROSIS; CLINICAL-FEATURES; PROGENITOR CELLS; PLASMA-LEVELS; LUNG-DISEASE; PENTRAXIN 3; EXPRESSION; MECHANISMS	In systemic sclerosis (SSc), dermal capillaries are progressively lost with consequent chronic tissue hypoxia insufficiently compensated by angiogenesis. Clinical studies reported that intravenous cyclophosphamide (CYC) may improve SSc-related peripheral microvascular damage. Recently, we showed that CYC treatment may normalize SSc sera-induced abnormalities in endothelial cell-matrix interactions. Our objective was to evaluate in vitro the effects of sera from treatment-naive or CYC-treated SSc patients on dermal blood microvascular endothelial cell (dMVEC) angiogenesis, migration, proliferation and apoptosis. dMVECs were challenged with sera from 21 SSc patients, treatment-naive (n = 8) or under CYC treatment (n = 13), and 8 healthy controls. Capillary morphogenesis on Geltrex matrix was significantly reduced upon challenge with sera from naive SSc patients compared with healthy controls. When dMVECs were challenged with sera from CYC-treated SSc patients, their angiogenic capacity was comparable to that of cells treated with healthy sera. Wound healing capacity and chemotaxis in Boyden chamber were both significantly decreased in the presence either of naive or CYC-treated SSc sera compared with healthy sera. WST-1 assay revealed that cell proliferation was significantly decreased in dMVECs challenged with sera from naive SSc patients compared with healthy sera. Conversely, dMVEC proliferation was not impaired in the presence of sera from CYC-treated SSc patients. Accordingly, the percentage of TUNEL-positive apoptotic dMVECs was significantly higher in the presence of sera from naive SSc patients than healthy controls, while CYC-treated SSc sera did not induce dMVEC apoptosis. Levels of the angiostatic mediators endostatin, pentraxin 3, angiostatin and matrix metalloproteinase-12 were all significantly elevated in sera from naive SSc patients compared with sera from both healthy controls and CYC-treated SSc patients. In SSc, CYC treatment might boost angiogenesis and consequently improve peripheral microangiopathy through the normalization of the endothelial cell-matrix interactions, reduction of endothelial cell apoptosis and rebalance of dysregulated angiostatic factors.	[Borghini, Annalisa; Weber, Elisabetta] Univ Siena, Dept Mol & Dev Med, I-53100 Siena, Italy; [Manetti, Mirko; Ibba-Manneschi, Lidia] Univ Florence, Sect Anat & Histol, Dept Expt & Clin Med, Florence, Italy; [Nacci, Francesca; Bellando-Randone, Silvia; Guiducci, Serena; Matucci-Cerinic, Marco] Univ Florence, Div Rheumatol, Dept Expt & Clin Med, Azienda Osped Univ Careggi, Florence, Italy	University of Siena; University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi	Manetti, M (corresponding author), Univ Florence, Sect Anat & Histol, Dept Expt & Clin Med, Florence, Italy.	mirkomanetti@yahoo.it	CERINIC, marco MATUCCI/AAO-2769-2020; Manetti, Mirko/AEH-9944-2022; Guiducci, Serena/AAB-9949-2019	Manetti, Mirko/0000-0003-3956-8480; Guiducci, Serena/0000-0003-2722-6475				Avouac J, 2012, ANN RHEUM DIS, V71, P394, DOI 10.1136/annrheumdis-2011-200143; Avouac J, 2011, ARTHRITIS RHEUM-US, V63, P3552, DOI 10.1002/art.30536; Caramaschi P, 2009, CLIN RHEUMATOL, V28, P391, DOI 10.1007/s10067-008-1058-y; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chung L, 2006, CLIN DERMATOL, V24, P374, DOI 10.1016/j.clindermatol.2006.07.004; Cutolo A, 2004, Z RHEUMATOL, V63, P457, DOI 10.1007/s00393-004-0673-5; Cutolo M, 2013, J RHEUMATOL, V40, P40, DOI 10.3899/jrheum.120416; Cutolo M, 2010, NAT REV RHEUMATOL, V6, P578, DOI 10.1038/nrrheum.2010.104; Dib H, 2012, EUR RESPIR J, V39, P1405, DOI 10.1183/09031936.00181410; Eliceiri BP, 2000, CANCER J SUPPL 3, V6; Farouk HM, 2013, INT J RHEUM DIS, V16, P448, DOI 10.1111/1756-185X.12130; Fleming JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001452; Furuya Y, 2010, RHEUMATOLOGY, V49, P2375, DOI 10.1093/rheumatology/keq259; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Giusti B, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2002; Goldin J, 2009, CHEST, V136, P1333, DOI 10.1378/chest.09-0108; Guiducci S, 2012, CLIN RHEUMATOL, V31, P1723, DOI 10.1007/s10067-012-2074-5; Guiducci S, 2010, ANN INTERN MED, V153, P650, DOI 10.7326/0003-4819-153-10-201011160-00007; Hummers LK, 2009, J RHEUMATOL, V36, P576, DOI 10.3899/jrheum.080516; Hyman KM, 2002, SURGERY, V132, P173, DOI 10.1067/msy.2002.125304; Ihn H, 2000, CLIN EXP IMMUNOL, V119, P203, DOI 10.1046/j.1365-2249.2000.01115.x; Ingegnoli F, 2013, MICROVASC RES, V89, P122, DOI 10.1016/j.mvr.2013.06.003; KAHALEH MB, 1986, CLIN IMMUNOL IMMUNOP, V39, P242, DOI 10.1016/0090-1229(86)90088-7; KAMINSKI MJ, 1984, J INVEST DERMATOL, V82, P239, DOI 10.1111/1523-1747.ep12260139; KOCH AE, 1992, CLIN IMMUNOL IMMUNOP, V64, P153, DOI 10.1016/0090-1229(92)90193-R; Kuwana M, 2004, LANCET, V364, P603, DOI 10.1016/S0140-6736(04)16853-0; Kuwana M, 2014, ARTHRITIS RHEUMATOL, V66, P1300, DOI 10.1002/art.38326; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; LEROY EC, 1988, J RHEUMATOL, V15, P202; Lu Q, 2009, AM J PHYSIOL-LUNG C, V296, pL825, DOI 10.1152/ajplung.90307.2008; MAJEWSKI S, 1985, ARTHRITIS RHEUM, V28, P1133, DOI 10.1002/art.1780281009; Manetti M, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4349; Manetti M, 2013, ANN RHEUM DIS, V72, P1425, DOI 10.1136/annrheumdis-2012-203183; Manetti M, 2011, TRENDS CARDIOVAS MED, V21, P204, DOI 10.1016/j.tcm.2012.05.011; Manetti M, 2012, ANN RHEUM DIS, V71, P1064, DOI 10.1136/annrheumdis-2011-200837; Manetti M, 2011, CIRC RES, V109, pE14, DOI 10.1161/CIRCRESAHA.111.242057; Manetti M, 2010, J CELL MOL MED, V14, P1241, DOI 10.1111/j.1582-4934.2010.01027.x; Marder W, 2007, SEMIN RESP CRIT CARE, V28, P398, DOI 10.1055/s-2007-985612; Margheri F, 2006, ARTHRITIS RHEUM-US, V54, P3926, DOI 10.1002/art.22263; Margheri F, 2010, ARTHRITIS RHEUM-US, V62, P2488, DOI 10.1002/art.27522; Mariko B, 2010, AM J PHYSIOL-CELL PH, V299, pC977, DOI 10.1152/ajpcell.00377.2009; Matucci-Cerinic M, 2013, ARTHRITIS RHEUM-US, V65, P1953, DOI 10.1002/art.37988; Meier FMP, 2012, ANN RHEUM DIS, V71, P1355, DOI 10.1136/annrheumdis-2011-200742; Mihai C, 2010, ANN RHEUM DIS, V69, P319, DOI 10.1136/ard.2008.102400; Miniati I, 2009, ANN RHEUM DIS, V68, P94, DOI 10.1136/ard.2007.082495; Mulligan-Kehoe MJ, 2007, ARTHRITIS RHEUM-US, V56, P3448, DOI 10.1002/art.22861; Ostojic P, 2006, CLIN RHEUMATOL, V25, P453, DOI 10.1007/s10067-005-0041-0; Rabquer BJ, 2012, CURR RHEUMATOL REP, V14, P56, DOI 10.1007/s11926-011-0219-1; Rabquer BJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3242; Ribatti D, 2009, J CELL MOL MED, V13, P2822, DOI 10.1111/j.1582-4934.2009.00810.x; Riccieri V, 2011, CLIN EXP RHEUMATOL, V29, pS46; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Shirai Y, 2015, ARTHRITIS RHEUMATOL, V67, P498, DOI 10.1002/art.38953; Tan FK, 2000, ARTHRITIS RHEUM-US, V43, P2464, DOI 10.1002/1529-0131(200011)43:11<2464::AID-ANR13>3.0.CO;2-F; Tan FK, 1999, J IMMUNOL, V163, P1066; Tashkin DP, 2006, NEW ENGL J MED, V354, P2655, DOI 10.1056/NEJMoa055120; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI [10.1136/annrheumdis-2013-204424, 10.1002/art.38098]; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Varga J, 2008, BULL HOSP JT DIS, V66, P198; Villano M, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4270; Wang YQ, 2013, J CELL MOL MED, V17, P1291, DOI 10.1111/jcmm.12105; Yamaguchi N, 1999, EMBO J, V18, P4414, DOI 10.1093/emboj/18.16.4414; Yamaguchi Y, 2013, HISTOL HISTOPATHOL, V28, P175, DOI 10.14670/HH-28.175	64	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130166	10.1371/journal.pone.0130166	http://dx.doi.org/10.1371/journal.pone.0130166			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076019	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900148
J	van Leeuwen, J; Berg, DK; Pfeffer, PL				van Leeuwen, Jessica; Berg, Debra K.; Pfeffer, Peter L.			Morphological and Gene Expression Changes in Cattle Embryos from Hatched Blastocyst to Early Gastrulation Stages after Transfer of In Vitro Produced Embryos	PLOS ONE			English	Article							ANTERIOR VISCERAL ENDODERM; POSTHATCHING DEVELOPMENT; TROPHOBLAST DEVELOPMENT; PRIMITIVE STREAK; BEEF HEIFERS; MOUSE; EOMESODERMIN; CELLS; BRACHYURY; PATTERN	A detailed morphological staging system for cattle embryos at stages following blastocyst hatching and preceding gastrulation is presented here together with spatiotemporal mapping of gene expression for BMP4, BRACHYURY, CERBERUS1 (CER1), CRIPTO, EOMESODERMIN, FURIN and NODAL. Five stages are defined based on distinct developmental events. The first of these is the differentiation of the visceral hypoblast underlying the epiblast, from the parietal hypoblast underlying the mural trophoblast. The second concerns the formation of an asymmetrically positioned, morphologically recognisable region within the visceral hypoblast that is marked by the presence of CER1 and absence of BMP4 expression. We have termed this the anterior visceral hypoblast or AVH. Intra-epiblast cavity formation and the disappearance of the polar trophoblast overlying the epiblast (Rauber's layer) have been mapped in relation to AVH formation. The third chronological event involves the transition of the epiblast into the embryonic ectoderm with concomitant onset of posterior NODAL, EOMES and BRACHYURY expression. Lastly, gastrulation commences as the posterior medial embryonic ectoderm layer thickens to form the primitive streak and cells ingress between the embryonic ectoderm and hypoblast. At this stage a novel domain of CER1 expression is seen whereas the AVH disappears. Comparison with the mouse reveals that while gene expression patterns at the onset of gastrulation are well conserved, asymmetry establishment, which relies on extraembryonic tissues such as the hypoblast and trophoblast, has diverged in terms of both gene expression and morphology.	[van Leeuwen, Jessica; Berg, Debra K.] AgRes Ruakura, Anim Prod Sect, Hamilton, New Zealand; [van Leeuwen, Jessica] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand; [Pfeffer, Peter L.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	AgResearch - New Zealand; University of Waikato; Victoria University Wellington	Pfeffer, PL (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	peter.pfeffer@vuw.ac.nz	Pfeffer, Peter/J-7675-2017; Berg, Debbie/GYJ-3287-2022	Pfeffer, Peter/0000-0001-5933-9728; Berg, Debbie/0000-0002-3287-0356	AgResearch Ruakura	AgResearch Ruakura	AgResearch Ruakura provided support in the form of salaries for authors JvL, DKB and PLP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; AYALON N, 1978, J REPROD FERTIL, V54, P483, DOI 10.1530/jrf.0.0540483; Beck S, 2002, NAT CELL BIOL, V4, P981, DOI 10.1038/ncb890; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Berg DK, 2010, THERIOGENOLOGY, V73, P250, DOI 10.1016/j.theriogenology.2009.09.005; Blomberg L, 2008, REPRODUCTION, V135, P181, DOI 10.1530/REP-07-0355; BOYD H, 1969, BRIT VET J, V125, P87, DOI 10.1016/S0007-1935(17)49112-3; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Chu JH, 2010, DEV BIOL, V342, P63, DOI 10.1016/j.ydbio.2010.03.009; COPP AJ, 1988, PLACENTA, V9, P643, DOI 10.1016/0143-4004(88)90008-2; Degrelle SA, 2005, DEV BIOL, V288, P448, DOI 10.1016/j.ydbio.2005.09.043; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; Diskin MG, 2008, REPROD DOMEST ANIM, V43, P260, DOI 10.1111/j.1439-0531.2008.01171.x; Diskin MG, 2012, REPROD FERT DEVELOP, V24, P244, DOI 10.1071/RD11914; DISKIN MG, 1980, J REPROD FERTIL, V59, P463, DOI 10.1530/jrf.0.0590463; Donnison M, 2015, DEV BIOL, V397, P77, DOI 10.1016/j.ydbio.2014.10.011; Dunne LD, 2000, ANIM REPROD SCI, V58, P39, DOI 10.1016/S0378-4320(99)00088-3; Guillomot M, 2004, REPRODUCTION, V127, P491, DOI 10.1530/rep.1.00057; Hassoun R, 2009, DIFFERENTIATION, V78, P301, DOI 10.1016/j.diff.2009.07.006; Hopf C, 2011, DEV GENES EVOL, V221, P209, DOI 10.1007/s00427-011-0373-5; Hue I, 2001, DEV GENES EVOL, V211, P157, DOI 10.1007/s004270100138; Idkowiak J, 2004, DEV GENES EVOL, V214, P591, DOI 10.1007/s00427-004-0436-y; Idkowiak J, 2004, SEMIN CELL DEV BIOL, V15, P607, DOI 10.1016/j.semcdb.2004.04.007; Kaufman MH, 1995, ATLAS MOUSE DEV; Kinder SJ, 2001, DEVELOPMENT, V128, P3623; Kumar A, 2015, DEV BIOL, V400, P1, DOI 10.1016/j.ydbio.2014.12.016; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maddox-Hyttel P, 2003, REPRODUCTION, V125, P607, DOI 10.1530/rep.0.1250607; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Nagy A., 2003, MANIPULATING MOUSE E; Nowotschin S, 2013, GENE DEV, V27, P997, DOI 10.1101/gad.215152.113; Oestrup O, 2009, REPROD DOMEST ANIM, V44, P39, DOI 10.1111/j.1439-0531.2009.01482.x; Pearton DJ, 2011, DEV BIOL, V360, P343, DOI 10.1016/j.ydbio.2011.10.007; Perea-Gomez A, 2002, DEV CELL, V3, P745, DOI 10.1016/S1534-5807(02)00321-0; Pfeffer PL, 2014, REPROD DOMESTIC RUMI, VVIII, P89; Pfister S, 2007, GENE EXPR PATTERNS, V7, P558, DOI 10.1016/j.modgep.2007.01.005; Rivera-Perez JA, 2005, DEV BIOL, V288, P363, DOI 10.1016/j.ydbio.2005.09.012; ROCHE JF, 1981, VET REC, V109, P401, DOI 10.1136/vr.109.18.401; Rodriguez TA, 2005, DEVELOPMENT, V132, P2513, DOI 10.1242/dev.01847; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Sheng G, 2014, DEV BIOL; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Smith C, 2007, REPRODUCTION, V133, P231, DOI 10.1530/rep.1.0966; Smith CS, 2010, CELL REPROGRAM, V12, P699, DOI 10.1089/cell.2010.0040; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Stern CD, 2012, DEVELOPMENT, V139, P1059, DOI 10.1242/dev.070730; Sun RZ, 2015, ZYGOTE, V23, P266, DOI 10.1017/S0967199413000531; Takaoka K, 2011, NAT CELL BIOL, V13, P743, DOI 10.1038/ncb2251; Magana GV, 2014, DEV BIOL, V387, P15, DOI 10.1016/j.ydbio.2014.01.008; van Leeuwen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096843; Vejlsted M, 2006, THERIOGENOLOGY, V65, P153, DOI 10.1016/j.theriogenology.2005.09.021; Wolf XA, 2012, GENE EXPR PATTERNS, V12, P85, DOI 10.1016/j.gep.2011.06.003; Yamamoto M, 2009, J CELL BIOL, V184, P323, DOI 10.1083/jcb.200808044	54	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129787	10.1371/journal.pone.0129787	http://dx.doi.org/10.1371/journal.pone.0129787			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076128	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900104
J	Worby, CJ; Read, TD				Worby, Colin J.; Read, Timothy D.			'SEEDY' (Simulation of Evolutionary and Epidemiological Dynamics): An R Package to Follow Accumulation of Within-Host Mutation in Pathogens	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; TRANSMISSION TREES; MODELS	Genome sequencing is an increasingly common component of infectious disease outbreak investigations. However, the relationship between pathogen transmission and observed genetic data is complex, and dependent on several uncertain factors. As such, simulation of pathogen dynamics is an important tool for interpreting observed genomic data in an infectious disease outbreak setting, in order to test hypotheses and to explore the range of outcomes consistent with a given set of parameters. We introduce 'seedy', an R package for the simulation of evolutionary and epidemiological dynamics (http://cran.r-project.org/web/packages/seedy/). Our software implements stochastic models for the accumulation of mutations within hosts, as well as individual-level disease transmission. By allowing variables such as the transmission bottleneck size, within-host effective population size and population mixing rates to be specified by the user, our package offers a flexible framework to investigate evolutionary dynamics during disease outbreaks. Furthermore, our software provides theoretical pairwise genetic distance distributions to provide a likelihood of person-to-person transmission based on genomic observations, and using this framework, implements transmission route assessment for genomic data collected during an outbreak. Our open source software provides an accessible platform for users to explore pathogen evolution and outbreak dynamics via simulation, and offers tools to assess observed genomic data in this context.	[Worby, Colin J.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Read, Timothy D.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Read, Timothy D.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA	Harvard University; Harvard T.H. Chan School of Public Health; Emory University; Emory University	Worby, CJ (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA.	cworby@hsph.harvard.edu		Read, Timothy/0000-0001-8966-9680; Worby, Colin/0000-0002-9132-7249	National Institute of General Medical Sciences of the National Institutes of Health [U54GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number U54GM088558. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aring;ogren J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089112; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Cottam EM, 2008, P ROY SOC B-BIOL SCI, V275, P887, DOI 10.1098/rspb.2007.1442; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Didelot X, 2014, MOL BIOL EVOL, V31, P1869, DOI 10.1093/molbev/msu121; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Golubchik T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061319; Jenness SM, 2014, EPIMODEL MATH MODELI; Jombart T, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003457; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Koelle K, 2012, J R SOC INTERFACE, V9, P997, DOI 10.1098/rsif.2011.0495; Koelle K, 2010, J R SOC INTERFACE, V7, P1257, DOI 10.1098/rsif.2010.0007; Leventhal GE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002413; Long SW, 2014, MBIO, V5, DOI 10.1128/mBio.01692-14; Maddison DR, 1997, SYST BIOL, V46, P590, DOI 10.2307/2413497; Morelli MJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002768; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Price JR, 2014, CLIN INFECT DIS, V58, P609, DOI 10.1093/cid/cit807; R Core Team, 2021, R LANGUAGE ENV STAT; Reuter S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002175; Robinson K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003105; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Somboonna N, 2011, MBIO, V2, DOI 10.1128/mBio.00045-11; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Torok ME, 2013, J CLIN MICROBIOL, V51, P611, DOI 10.1128/JCM.02279-12; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Worby CJ, 2014, GENETICS, V198, P1395, DOI 10.1534/genetics.114.171538; Ypma RJF, 2012, P ROY SOC B-BIOL SCI, V279, P444, DOI 10.1098/rspb.2011.0913; Ypma RJF, 2013, GENETICS, V195, P1055, DOI 10.1534/genetics.113.154856	31	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129745	10.1371/journal.pone.0129745	http://dx.doi.org/10.1371/journal.pone.0129745			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075402	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900099
J	Zheng, YX; Wu, JM; Feng, XS; Jia, Y; Huang, J; Hao, ZH; Zhao, SY; Wang, JH				Zheng, Yaxin; Wu, Jiming; Feng, Xuesong; Jia, Ying; Huang, Jian; Hao, Zhihui; Zhao, Songyan; Wang, Jinhui			In silico Analysis and Experimental Validation of Lignan Extracts from Kadsura longipedunculata for Potential 5-HT1AR Agonists	PLOS ONE			English	Article							C-18 DIBENZOCYCLOOCTADIENE LIGNANS; MODULATE MEMORY CONSOLIDATION; ANTIDEPRESSANT-LIKE ACTIVITY; CHINENSIS TURCZ. BAILL.; NITRIC-OXIDE SYNTHASE; BLOOD-BRAIN-BARRIER; MASS-SPECTROMETRY; MAJOR DEPRESSION; RAT HIPPOCAMPUS; STRESSED MICE	Objectives Kadsura longipedunculata (KL) has been widely used for the treatment of insomnia in traditional Chinese medicine. The aim of this study was to explore the mechanism of the sedative and hypnotic effects of KL. Materials and Methods The content of KL was evaluated by HPLC-TOF-MS, and a potential target was found and used to construct its 3D structure to screen for potential ligands among the compounds in KL by using bioinformatics analysis, including similarity ensemble approach (SEA) docking, homology modeling, molecular docking and ligand-based pharmacophore. The PCPA-induced insomnia rat model was then applied to confirm the potential targets related to the sedative effects of KL by performing the forced swimming test (FST), the tail suspension test (TST) and the measurement of target-related proteins using western blotting and immunofluorescence. Results Bioinformatics analysis showed that most of lignan compounds in KL were optimal ligands for the 5-HT1A receptor (5-HT1AR), and they were found to be potential targets related to sedative effects; the main lignan content of KL extracts was characterized by HPLC-TOFMS, with 7 proposed lignans detected. Administration of KL could significantly reduce FST and TST immobility time in the PCPA-induced 5HT-depleted insomnia rat model. The expressions of proteins related to the 5-HT1AR pathway were regulated by extracts of KL in a concentration-dependent manner, indicating that extracts of KL had 5-HT1AR agonist-like effects. Conclusion In silico analysis and experimental validation together demonstrated that lignan extracts from KL can target 5-HT1AR in insomniac rats, which could shed light on its use as a potential 5-HT1AR agonist drug.	[Zheng, Yaxin; Wu, Jiming; Huang, Jian; Wang, Jinhui] Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Peoples R China; [Feng, Xuesong] China Med Univ, Sch Pharm, Shenyang 110122, Peoples R China; [Jia, Ying] Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Shenyang 110016, Peoples R China; [Hao, Zhihui] Shenyang Pharmaceut Univ, Anim Ctr, Shenyang 110016, Peoples R China; [Zhao, Songyan] Shenyang Pharmaceut Univ, Sch Life Sci, Shenyang 110016, Peoples R China	Shenyang Pharmaceutical University; China Medical University; Shenyang Pharmaceutical University; Shenyang Pharmaceutical University; Shenyang Pharmaceutical University	Huang, J (corresponding author), Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Peoples R China.	13504051049@163.com; 15999290001@163.com			Key Projects of the National Science and Technology Pillar Program [2012BAI30B02]; National Natural Science Foundation of China [U1303124, 81260628]; Shengyang Science and Technology Project [F12-157-9-00]; Liaoning Science and Technology Project [2013226027-4]; Natural Science Foundation of Liaoning Province, China [201202252]	Key Projects of the National Science and Technology Pillar Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shengyang Science and Technology Project; Liaoning Science and Technology Project; Natural Science Foundation of Liaoning Province, China(Natural Science Foundation of Liaoning Province)	The authors gratefully acknowledge the financial support of the Key Projects of the National Science and Technology Pillar Program (No. 2012BAI30B02), the National Natural Science Foundation of China (U1303124, 81260628), the Shengyang Science and Technology Project (F12-157-9-00), the Liaoning Science and Technology Project (2013226027-4), and the Natural Science Foundation of Liaoning Province, China (No. 201202252). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00035; Alfajaro MM, 2014, RES VET SCI, V96, P567, DOI 10.1016/j.rvsc.2014.03.011; Bevilaqua L, 1997, BEHAV PHARMACOL, V8, P331, DOI 10.1097/00008877-199708000-00006; Bevilaqua L, 1997, BRAZ J MED BIOL RES, V30, P967, DOI 10.1590/S0100-879X1997000800009; Chen WW, 2011, PHYTOMEDICINE, V18, P1144, DOI 10.1016/j.phymed.2011.06.004; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; Chun JN, 2014, FITOTERAPIA, V97, P224, DOI 10.1016/j.fitote.2014.06.014; Clark DE, 1999, J PHARM SCI, V88, P815, DOI 10.1021/js980402t; Cortes-Canteli M, 2008, J CELL SCI, V121, P1224, DOI 10.1242/jcs.025031; Datla KP, 1996, NEUROPHARMACOLOGY, V35, P315, DOI 10.1016/0028-3908(96)00175-X; Deacon RMJ, 2002, BEHAV NEUROSCI, V116, P494, DOI 10.1037//0735-7044.116.3.494; Dhingra D, 2012, PHARMACOL REP, V64, P796, DOI 10.1016/S1734-1140(12)70875-7; Dong K, 2012, J NAT PROD, V75, P249, DOI 10.1021/np200937h; Einat H, 2001, BEHAV BRAIN RES, V118, P77, DOI 10.1016/S0166-4328(00)00314-4; Gautam BK, 2013, PHARMACOL BIOCHEM BE, V109, P91, DOI 10.1016/j.pbb.2013.05.006; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Han Y, 2015, ANAL METHODS-UK, V7, P830, DOI 10.1039/c4ay02340d; Heusler P, 2010, N-S ARCH PHARMACOL, V382, P321, DOI 10.1007/s00210-010-0551-4; Hou CW, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-15; Huang X, 2007, J MASS SPECTROM, V42, P1148, DOI 10.1002/jms.1246; Jeong JJ, 2012, INT J ONCOL, V41, P1358, DOI 10.3892/ijo.2012.1582; Jin Z, 2013, PLANTA MED, V79, P1408, DOI 10.1055/s-0033-1350698; Kempermann G, 2002, BIPOLAR DISORD, V4, P17, DOI 10.1034/j.1399-5618.2002.40101.x; Kim Mun Hee, 2014, J Exerc Nutrition Biochem, V18, P97, DOI 10.5717/jenb.2014.18.1.97; Kuo YH, 2005, PLANTA MED, V71, P646, DOI 10.1055/s-2005-871271; Lauder JM, 2000, INT J DEV NEUROSCI, V18, P171, DOI 10.1016/S0736-5748(99)00085-4; Lin JW, 2012, NEURO-ONCOLOGY, V14, P302, DOI 10.1093/neuonc/nor217; Liu HT, 2009, MAGN RESON CHEM, V47, P609, DOI 10.1002/mrc.2430; Liu MM, 2012, EUR J MED CHEM, V52, P33, DOI 10.1016/j.ejmech.2012.03.002; Lu XY, 2008, NEUROPEPTIDES, V42, P387, DOI 10.1016/j.npep.2008.04.009; Ma WH, 2007, CHEM BIODIVERS, V4, P966, DOI 10.1002/cbdv.200790087; Mizrahi C, 2004, INT IMMUNOPHARMACOL, V4, P1125, DOI 10.1016/j.intimp.2004.05.001; Mulyaningsih S, 2010, J PHARM PHARMACOL, V62, P1037, DOI 10.1111/j.2042-7158.2010.01119.x; Pu JX, 2008, CHEM PHARM BULL, V56, P1143, DOI 10.1248/cpb.56.1143; Pu JX, 2008, PHYTOCHEMISTRY, V69, P1266, DOI 10.1016/j.phytochem.2007.11.019; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shen YC, 2007, CHEM PHARM BULL, V55, P280, DOI 10.1248/cpb.55.280; Sullivan SS, 2009, EXPERT OPIN EMERG DR, V14, P411, DOI 10.1517/14728210903171948; Wang HJ, 2013, CARBOHYD POLYM, V97, P710, DOI 10.1016/j.carbpol.2013.05.042; Wang SY, 2015, CELL PROLIFERAT, V48, P86, DOI 10.1111/cpr.12157; Wang W, 2006, PLANTA MED, V72, P450, DOI 10.1055/s-2005-916263; Wei BB, 2013, J MASS SPECTROM, V48, P448, DOI 10.1002/jms.3176; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Xu LL, 2013, J CHEM INF MODEL, V53, P3202, DOI 10.1021/ci400481p; Yang CP, 2013, TOXICOL APPL PHARM, V273, P561, DOI 10.1016/j.taap.2013.09.030; Zaugg J, 2011, PHYTOCHEMISTRY, V72, P2385, DOI 10.1016/j.phytochem.2011.08.014; Zhang J, 2010, J NEUROSCI, V30, P2433, DOI 10.1523/JNEUROSCI.5880-09.2010; Zhou Y, 2011, J PHARMACEUT BIOMED, V56, P916, DOI 10.1016/j.jpba.2011.07.045; Zisapel N, 2012, EXPERT OPIN EMERG DR, V17, P299, DOI 10.1517/14728214.2012.690735	49	5	6	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130055	10.1371/journal.pone.0130055	http://dx.doi.org/10.1371/journal.pone.0130055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076134	gold, Green Submitted, Green Published			2022-12-27	WOS:000356329900131
J	Contini, E; Paganini, I; Sestini, R; Candita, L; Capone, GL; Barbetti, L; Falconi, S; Frusconi, S; Giotti, I; Giuliani, C; Torricelli, F; Benelli, M; Papi, L				Contini, Elisa; Paganini, Irene; Sestini, Roberta; Candita, Luisa; Capone, Gabriele Lorenzo; Barbetti, Lorenzo; Falconi, Serena; Frusconi, Sabrina; Giotti, Irene; Giuliani, Costanza; Torricelli, Francesca; Benelli, Matteo; Papi, Laura			A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene	PLOS ONE			English	Article							RESOLUTION MELTING ANALYSIS; NEUROFIBROMATOSIS 2; COLD-PCR; TYPE-2 NEUROFIBROMATOSIS; UNITED-KINGDOM; DIGITAL PCR; MUTATIONS; TRANSMISSION; SENSITIVITY; PREVALENCE	The accurate detection of low-allelic variants is still challenging, particularly for the identification of somatic mosaicism, where matched control sample is not available. High throughput sequencing, by the simultaneous and independent analysis of thousands of different DNA fragments, might overcome many of the limits of traditional methods, greatly increasing the sensitivity. However, it is necessary to take into account the high number of false positives that may arise due to the lack of matched control samples. Here, we applied deep amplicon sequencing to the analysis of samples with known genotype and variant allele fraction (VAF) followed by a tailored statistical analysis. This method allowed to define a minimum value of VAF for detecting mosaic variants with high accuracy. Then, we exploited the estimated VAF to select candidate alterations in NF2 gene in 34 samples with unknown genotype (30 blood and 4 tumor DNAs), demonstrating the suitability of our method. The strategy we propose optimizes the use of deep amplicon sequencing for the identification of low abundance variants. Moreover, our method can be applied to different high throughput sequencing approaches to estimate the background noise and define the accuracy of the experimental design.	[Contini, Elisa; Falconi, Serena; Frusconi, Sabrina; Giotti, Irene; Giuliani, Costanza; Torricelli, Francesca; Benelli, Matteo] Careggi Univ Hosp, Diagnost Genet Unit, Florence, Italy; [Paganini, Irene; Sestini, Roberta; Candita, Luisa; Capone, Gabriele Lorenzo; Barbetti, Lorenzo; Papi, Laura] Univ Florence, Dept Biomed Expt & Clin Sci, Med Genet, Florence, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence	Benelli, M (corresponding author), Careggi Univ Hosp, Diagnost Genet Unit, Florence, Italy.	ire.paganini@gmail.com; ire.paganini@gmail.com	Paganini, Irene/AHH-4604-2022; Benelli, Matteo/I-2497-2018; Candita, Luisa/AAC-1562-2019	Benelli, Matteo/0000-0003-1227-356X; Papi, Laura/0000-0003-4552-9517; SESTINI, ROBERTA/0000-0002-7500-9988; Contini, Elisa/0000-0003-2111-6435; Paganini, Irene/0000-0001-6867-0244	Istituto Toscano Tumori	Istituto Toscano Tumori	This project is funded by Istituto Toscano Tumori (www.ittumori.it) LP received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Z, 2014, HUM MUTAT, V35, P384, DOI 10.1002/humu.22488; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; EVANS DGR, 1992, J MED GENET, V29, P847, DOI 10.1136/jmg.29.12.847; EVANS DGR, 1992, J MED GENET, V29, P841, DOI 10.1136/jmg.29.12.841; Evans GR, 2007, J MED GENET, V44, P424, DOI 10.1136/jmg.2006.047753; Flaherty P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr861; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; Harismendy O, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3584; Kluwe L, 2003, J MED GENET, V40, P109, DOI 10.1136/jmg.40.2.109; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Milbury CA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq899; Milbury CA, 2009, CLIN CHEM, V55, P2130, DOI 10.1373/clinchem.2009.131029; Miotke L, 2014, ANAL CHEM, V86, P2618, DOI 10.1021/ac403843j; Moyhuddin A, 2003, J MED GENET, V40, P459, DOI 10.1136/jmg.40.6.459; MULVIHILL JJ, 1990, ANN INTERN MED, V113, P39, DOI 10.7326/0003-4819-113-1-39; Paganini I, 2014, J MOL DIAGN, V16, P393, DOI 10.1016/j.jmoldx.2014.02.007; PARRY DM, 1994, AM J MED GENET, V52, P450, DOI 10.1002/ajmg.1320520411; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Sestini R, 2008, GENET TEST, V12, P311, DOI 10.1089/gte.2007.0096; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xu HL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-244; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906	26	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129099	10.1371/journal.pone.0129099	http://dx.doi.org/10.1371/journal.pone.0129099			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066488	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000045
J	Niedringhaus, M; Chen, X; Dzakpasu, R				Niedringhaus, Mark; Chen, Xin; Dzakpasu, Rhonda			Long-Term Dynamical Constraints on Pharmacologically Evoked Potentiation Imply Activity Conservation within In Vitro Hippocampal Networks	PLOS ONE			English	Article							SYNAPTIC-TRANSMISSION; DENTATE AREA; MEMORY; PLASTICITY; PHASE; LTP	This paper describes a long-term study of network dynamics from in vitro, cultured hippocampal neurons after a pharmacological induction of synaptic potentiation. We plate a suspension of hippocampal neurons on an array of extracellular electrodes and record electrical activity in the absence of the drugs several days after treatment. While previous studies have reported on potentiation lasting up to a few hours after treatment, to the best of our knowledge, this is the first report to characterize the network effects of a potentiating mechanism several days after treatment. Using this reduced, two-dimensional in vitro network of hippocampal neurons, we show that the effects of potentiation are persistent over time but are modulated under a conservation of spike principle. We suggest that this conservation principle might be mediated by the appearance of a resonant inter-spike interval that prevents the network from advancing towards a state of hyperexcitability.	[Niedringhaus, Mark; Dzakpasu, Rhonda] Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA; [Chen, Xin; Dzakpasu, Rhonda] Georgetown Univ, Dept Phys, Washington, DC 20057 USA; [Chen, Xin; Dzakpasu, Rhonda] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA	Georgetown University; Georgetown University; Georgetown University	Dzakpasu, R (corresponding author), Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA.	rd259@georgetown.edu	Dzakpasu, Rhonda/F-8060-2019	Dzakpasu, Rhonda/0000-0002-7223-4602	National Science Foundation [1205919]; Luce Foundation	National Science Foundation(National Science Foundation (NSF)); Luce Foundation	Dr. Niedringhaus, Dr. Chen, and Dr. Dzakpasu were supported by the National Science Foundation (grant no. 1205919) and the Luce Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bakkum DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002088; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1970, J PHYSIOL-LONDON, V207, pP61; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bologna LL, 2010, NEUROSCIENCE, V165, P692, DOI 10.1016/j.neuroscience.2009.11.018; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Esposti F, 2009, IEEE T NEUR SYS REH, V17, P364, DOI 10.1109/TNSRE.2009.2022832; FANO U, 1947, PHYS REV, V72, P26, DOI 10.1103/PhysRev.72.26; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Gandolfo M, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056001; Grabrucker A, 2009, CELL TISSUE RES, V338, P333, DOI 10.1007/s00441-009-0881-z; Granger AJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0136; Guitart-Masip M, 2013, J NEUROSCI, V33, P442, DOI 10.1523/JNEUROSCI.2573-12.2013; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Jacobs J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0304; Jezek K, 2011, NATURE, V478, P246, DOI 10.1038/nature10439; Kaplan R, 2014, HIPPOCAMPUS, V24, P656, DOI 10.1002/hipo.22255; Leondopulos SS, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026015; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; LOMO T, 1966, ACTA PHYSIOL SCAND, VS 68, P128; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; Malenka RC, 2003, NAT REV NEUROSCI, V4, P923, DOI 10.1038/nrn1258; Meyer D, 2014, NEURON, V82, P430, DOI 10.1016/j.neuron.2014.02.031; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; Niedringhaus M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057144; Niedringhaus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042631; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Payne HL, 2008, MOL MEMBR BIOL, V25, P353, DOI 10.1080/09687680801986480; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; Segev R, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011920; Tabak J, 2010, J NEUROPHYSIOL, V103, P2208, DOI 10.1152/jn.00857.2009; Takesian AE, 2013, PROG BRAIN RES, V207, P3, DOI 10.1016/B978-0-444-63327-9.00001-1; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11	43	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129324	10.1371/journal.pone.0129324	http://dx.doi.org/10.1371/journal.pone.0129324			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070215	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000064
J	Xia, ZY; Sun, QJ; Yang, H; Zhang, MX; Ban, R; Xu, GL; Wu, YP; Wang, LX; Du, YF				Xia, Zhang Yong; Sun, Qin Jian; Yang, Hua; Zhang, Ming Xia; Ban, Ru; Xu, Ge Lin; Wu, Ya Ping; Wang, Le Xin; Du, Yi Feng			Effect of Carotid Artery Stenting on Cognitive Function in Patients with Internal Carotid Artery Stenosis and Cerebral Lacunar Infarction: A 3-Year Follow-Up Study in China	PLOS ONE			English	Article							STROKE; PERFORMANCE; PREVALENCE; REVASCULARIZATION; SUBTYPES; RISKS; AGE	Background and Objectives Carotid artery stenting (CAS) is an important therapeutic strategy for patients with carotid artery stenosis. However, the potential influence of CAS on cognitive function in patients with carotid artery stenosis and cerebral lacunar infarction has not been determined. This study investigated changes in cognitive function associated with CAS and the factors related to these changes. Methods This prospective cohort study comprised 579 Chinese patients with cerebral lacunar infarction and carotid artery stenosis for whom CAS was indicated, and a matched control group of 552 healthy individuals. Cognitive function before CAS and at scheduled intervals from 6 months to 3 years was assessed with instruments that included the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) scale. Potential factors that might affect cognitive function were analyzed via logistic regression. Results The MMSE and MoCA scores of the patients before CAS were significantly lower than that of the control subjects. These scores were significantly higher 6 months after CAS and sustained or increased throughout the 3-year follow-up. Also significantly improved after CAS from baseline were scores for an alternating trail test, cube copying, clock-drawing, attention, and delayed recall in an auditory-verbal learning test. Logistic regression analyses showed that age greater than 65 y, little education, diabetes, and hypertension were independent risk factors for deteriorated MoCA scores 3 years after CAS. Conclusion CAS was associated with significantly improved cognitive function in cerebral lacunar infarction patients with severe stenosis.	[Xia, Zhang Yong; Sun, Qin Jian; Du, Yi Feng] Shandong Univ, Dept Neurol, Shandong Prov Hosp, Jinan 250021, Shandong, Peoples R China; [Xia, Zhang Yong; Zhang, Ming Xia; Ban, Ru; Wu, Ya Ping] Taishan Med Univ, Dept Neurol, Liaocheng Peoples Hosp, Liaocheng 252000, Shandong, Peoples R China; [Xia, Zhang Yong; Zhang, Ming Xia; Ban, Ru; Wu, Ya Ping] Taishan Med Univ, Liaocheng Clin Sch, Liaocheng 252000, Shandong, Peoples R China; [Yang, Hua] Third Peoples Hosp Liaocheng, Dept Neurol, Shandong 252000, PR, Peoples R China; [Xu, Ge Lin] Nanjing Univ, Jinling Hosp, Dept Neurol, Sch Med, Nanjing 210002, Jiangsu, Peoples R China; [Wang, Le Xin] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Nanjing University; Charles Sturt University	Du, YF (corresponding author), Shandong Univ, Dept Neurol, Shandong Prov Hosp, Jinan 250021, Shandong, Peoples R China.	LCXYT2015@163.com		Xu, Gelin/0000-0002-6194-0341	"Twelfth Five Year" National Science and technology program of the Ministry of Science and Technology of China [2011BAI08B02]; Science and Technology Development Program of Shandong province [2014GSF118106]	"Twelfth Five Year" National Science and technology program of the Ministry of Science and Technology of China; Science and Technology Development Program of Shandong province	This study was supported by funding from the "Twelfth Five Year" National Science and technology program of the Ministry of Science and Technology of China (No. 2011BAI08B02) and the Science and Technology Development Program of Shandong province (No. 2014GSF118106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADMANI AK, 1991, ATHEROSCLEROSIS, V86, P31, DOI 10.1016/0021-9150(91)90096-L; Balucani C, 2012, NEUROLOGY, V79, P1788, DOI 10.1212/WNL.0b013e318270402e; Chmayssani M, 2007, NEUROIMAG CLIN N AM, V17, P313, DOI 10.1016/j.nic.2007.03.002; Dag E, 2014, EUR REV MED PHARMACO, V18, P3025; De Rango P, 2008, STROKE, V39, P3116, DOI 10.1161/STROKEAHA.108.518357; Ferri CP, 2011, J NEUROL NEUROSUR PS, V82, P1074, DOI 10.1136/jnnp.2010.234153; Gaudet JG, 2009, NEUROSURGERY, V65, P325, DOI 10.1227/01.NEU.0000349920.69637.78; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hu JB, 2013, ARCH GERONTOL GERIAT, V56, P38, DOI 10.1016/j.archger.2012.05.008; Jackson C, 2005, BRAIN, V128, P2507, DOI 10.1093/brain/awh636; Kitagawa K, 2014, EUR J NEUROL; Liu HC, 1998, ALZ DIS ASSOC DIS, V12, P127, DOI 10.1097/00002093-199809000-00002; Liu XF, 2013, CEREBROVASC DIS, V35, P349, DOI 10.1159/000350210; Norrving B, 2003, LANCET NEUROL, V2, P238, DOI 10.1016/S1474-4422(03)00352-1; O'Brien M, 2014, VASC HEALTH RISK MAN, V10, P403, DOI 10.2147/VHRM.S48923; Ortega G, 2013, CEREBROVASC DIS, V35, P124, DOI 10.1159/000346102; Pearson S, 2003, J VASC SURG, V38, P1248, DOI 10.1016/S0741-5214(03)00786-9; Petty GW, 2000, STROKE, V31, P1062, DOI 10.1161/01.STR.31.5.1062; Piccinin AM, 2013, J GERONTOL B-PSYCHOL, V68, P374, DOI 10.1093/geronb/gbs077; Plessers M, 2014, CEREBROVASC DIS EXTR, V4, P132, DOI 10.1159/000362921; Romanini CV, 2013, BEHAV BRAIN RES, V252, P214, DOI 10.1016/j.bbr.2013.05.043; Saw J, 2014, CAN J CARDIOL, V30, P22, DOI 10.1016/j.cjca.2013.09.030; Shishehbor MH, 2014, JACC-CARDIOVASC INTE; Stone MB, 2013, ACAD EMERG MED, V20, pE14, DOI 10.1111/acem.12139; Sun QJ, 2014, TOHOKU J EXP MED, V233, P257, DOI 10.1620/tjem.233.257; Tan JP, 2014, J ALZHEIMERS DIS; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Tiffin-Richards FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106700; Yan YX, 2014, MED SCI MONITOR, V20, P1461, DOI 10.12659/MSM.890847; Zavoreo I, 2013, ACTA NEUROL BELG, V113, P453, DOI 10.1007/s13760-013-0196-4; Zhou W, 2012, J VASC SURG, V56, P1571, DOI 10.1016/j.jvs.2012.05.092	31	16	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129917	10.1371/journal.pone.0129917	http://dx.doi.org/10.1371/journal.pone.0129917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067432	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900086
J	Carpenter, D; Boutin, C; Allison, JE; Parsons, JL; Ellis, DM				Carpenter, David; Boutin, Celine; Allison, Jane E.; Parsons, Jessica L.; Ellis, Deanna M.			Uptake and Effects of Six Rare Earth Elements (REEs) on Selected Native and Crop Species Growing in Contaminated Soils	PLOS ONE			English	Article							LANTHANIDE ELEMENTS; GROWTH; PLANTS; ACCUMULATION; CHLORIDE; CERIUM; CHINA; GERMINATION; METABOLISM; PATTERN	Rare earth elements (REEs) have become increasingly important metals used in modern technology. Processes including mining, oil refining, discarding of obsolete equipment containing REEs, and the use of REE-containing phosphate fertilizers may increase the likelihood of environmental contamination. However, there is a scarcity of information on the toxicity and accumulation of these metals to terrestrial primary producers in contaminated soils. The objective of this work was to assess the phytotoxicity and uptake from contaminated soil of six REEs (chloride forms of praseodymium, neodymium, samarium, terbium, dysprosium, and erbium) on three native plants (Asclepias syriaca L., Desmodium canadense (L.) DC., Panicum virgatum L.) and two crop species (Raphanus sativus L., Solanum lycopersicum L.) in separate dose-response experiments under growth chamber conditions. Limited effects of REEs were found on seed germination and speed of germination. Effects on aboveground and belowground biomass were more pronounced, especially for the three native species, which were always more sensitive than the crop species tested. Inhibition concentrations (IC25 and IC50) causing 25 or 50% reductions in plant biomass respectively, were measured. For the native species, the majority of aboveground biomass IC25s (11 out of 18) fell within 100 to 300 mg REE/kg dry soil. In comparison to the native species, IC25s for the crops were always greater than 400 mg REE/kg, with the majority of results (seven out of 12) falling above 700 mg REE/kg. IC50s were often not detected for the crops. Root biomass of native species was also affected at lower doses than in crops. REE uptake by plants was higher in the belowground parts than in the above-ground plant tissues. Results also revealed that chloride may have contributed to the sensitivity of the native species, Desmodium canadense, one of the most sensitive species studied. Nevertheless, these results demonstrated that phytotoxicity may be a concern in contaminated areas.	[Carpenter, David; Boutin, Celine; Allison, Jane E.; Parsons, Jessica L.; Ellis, Deanna M.] Environm Canada, Sci & Technol Branch, Ottawa, ON K1A 0H3, Canada; [Allison, Jane E.] Univ Ottawa, Ottawa Carleton Inst Biol, Dept Biol, Ottawa, ON K1N 6N5, Canada; [Parsons, Jessica L.] Carleton Univ, Ottawa Carleton Inst Biol, Dept Biol, Ottawa, ON K1S 5B6, Canada	Environment & Climate Change Canada; University of Ottawa; Carleton University; University of Ottawa	Boutin, C (corresponding author), Environm Canada, Sci & Technol Branch, Ottawa, ON K1A 0H3, Canada.	Celine.Boutin@ec.gc.ca			Science and Risk Assessment Directorate of Environment Canada; National Science and Engineering Research Council	Science and Risk Assessment Directorate of Environment Canada; National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this work was provided by the Science and Risk Assessment Directorate of Environment Canada to CB and DC: they provided most of the funding for material and technical assistance. This funder had a role in the study design, data collection and analysis, but had no role in the decision to publish, or preparation of the manuscript. National Science and Engineering Research Council provided funding (to CB) for students. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, Better Crops with Plant Food, V83, P4; Avalon Rare Metals Inc, 2015, NECH RAR EARTH EL PR; Babula P, 2008, ENVIRON CHEM LETT, V6, P189, DOI 10.1007/s10311-008-0159-9; BANULS J, 1992, PHYSIOL PLANTARUM, V86, P115, DOI 10.1111/j.1399-3054.1992.tb01319.x; Bar Y, 1997, J PLANT NUTR, V20, P715, DOI 10.1080/01904169709365288; Bibak A, 1999, COMMUN SOIL SCI PLAN, V30, P2409, DOI 10.1080/00103629909370382; Boutin C, 2012, LANTHANUM CHLORIDE L; Brioschi L, 2013, PLANT SOIL, V366, P143, DOI 10.1007/s11104-012-1407-0; Cao XD, 2001, CHEMOSPHERE, V44, P655, DOI 10.1016/S0045-6535(00)00492-6; Carpenter D, 2014, HEAVY RARE EARTH ELE; Carpenter D, 2013, SAMARIUM CHLORIDE HE; COWGILL U M, 1973, Science of the Total Environment, V2, P259, DOI 10.1016/0048-9697(73)90020-X; d'Aquino L, 2009, CHEMOSPHERE, V75, P900, DOI 10.1016/j.chemosphere.2009.01.026; de Boer MA, 2013, CHEMSUSCHEM, V6, P2045, DOI 10.1002/cssc.201200794; Diatloff E, 2008, ANN BOT-LONDON, V101, P971, DOI 10.1093/aob/mcn021; Du XY, 2011, J IND ECOL, V15, P836, DOI 10.1111/j.1530-9290.2011.00362.x; Environment Canada, 2007, BIOLOGICAL TEST METH; Fashui H, 2005, BIOL TRACE ELEM RES, V104, P185, DOI 10.1385/BTER:104:2:185; Franca E. J. de, 2011, International Journal of Environment and Health, V5, P32, DOI 10.1504/IJENVH.2011.039854; Fu FF, 2001, PLANT SOIL, V235, P53, DOI 10.1023/A:1011837326556; Fu FF, 1998, BIOL TRACE ELEM RES, V64, P13, DOI 10.1007/BF02783321; Gonzalez V, 2014, ENVIRON INT, V71, P148, DOI 10.1016/j.envint.2014.06.019; Greenwood N.N., 1997, CHEM ELEMENTS; Hayes-Labruto L, 2013, ENERG POLICY, V63, P55, DOI 10.1016/j.enpol.2013.07.121; He YW, 2000, PLANT SCI, V159, P117, DOI 10.1016/S0168-9452(00)00338-1; Hong FS, 2003, BIOL TRACE ELEM RES, V94, P273, DOI 10.1385/BTER:94:3:273; Hu X, 2002, CHEMOSPHERE, V48, P621, DOI 10.1016/S0045-6535(02)00109-1; Hu ZY, 2006, COMMUN SOIL SCI PLAN, V37, P1381, DOI 10.1080/00103620600628680; Hu ZY, 2004, J PLANT NUTR, V27, P183, DOI 10.1081/PLN-120027555; Hurst C., 2010, CHINAS RARE EARTH EL, V43; ICHIHASHI H, 1992, ENVIRON POLLUT, V76, P157, DOI 10.1016/0269-7491(92)90103-H; Kataoka T, 2002, PLANT CELL ENVIRON, V25, P453, DOI 10.1046/j.0016-8025.2001.00821.x; Li JX, 2010, J RARE EARTH, V28, P957, DOI 10.1016/S1002-0721(09)60233-7; Liang T, 2014, ENVIRON MONIT ASSESS, V186, P1499, DOI 10.1007/s10661-013-3469-8; Liu M, 2005, PLANTA, V220, P658, DOI 10.1007/s00425-004-1379-2; Liu XQ, 2009, BIOL TRACE ELEM RES, V130, P141, DOI 10.1007/s12011-009-8321-1; Long KR, 2012, NONRENEWABLE RESOURC, P131, DOI DOI 10.1007/978-90-481-8679-2_7; MACKENZIE RC, 1951, J COLL SCI IMP U TOK, V6, P219; MARKERT B, 1987, PHYTOCHEMISTRY, V26, P3167, DOI 10.1016/S0031-9422(00)82463-2; MARKERT B, 1991, SCI TOTAL ENVIRON, V103, P27, DOI 10.1016/0048-9697(91)90350-N; Masau M, 2000, CAN MINERAL, V38, P899, DOI 10.2113/gscanmin.38.4.899; Norberg-King T. J., 1993, 0393 US EPA ENV RES; OLDHAM MJ, 1995, FLORISTIC QUALITY AS; Pang X, 2002, ENVIRON SCI POLLUT R, V9, P143, DOI [10.1007/BF02987462, 10.1007/BF02987718]; Patnaik P., 2003, HDB INORGANIC CHEM; PICKARD BG, 1970, PLANTA, V91, P314, DOI 10.1007/BF00387504; Redling K., 2006, THESIS LUDWIG MAXIMI; Shi P, 2006, BIOL TRACE ELEM RES, V109, P181, DOI 10.1385/BTER:109:2:181; Slooff W, 1993, 710401025 NAT I PUBL; Sneller FEC, 2000, 601501 RIVM NAT I PU; Stone R, 2009, SCIENCE, V325, P1336, DOI 10.1126/science.325_1336; Thomas PJ, 2014, CHEMOSPHERE, V96, P57, DOI 10.1016/j.chemosphere.2013.07.020; Turra C., 2011, J ENV CHEM ECOTOXICO, V3, P86, DOI DOI 10.1590/1806; Tyler G, 2005, BIOL TRACE ELEM RES, V106, P177, DOI 10.1385/BTER:106:2:177; Tyler G, 2004, PLANT SOIL, V267, P191, DOI 10.1007/s11104-005-4888-2; Tyler G, 2001, PLANT SOIL, V230, P307, DOI 10.1023/A:1010314400976; U.S. Department of Energy, 2010, CRITICAL MAT STRATEG; U. S. Environmental Protection Agency (USEPA), 1996, 1638 USEPA; VOLOKH AA, 1990, SCI TOTAL ENVIRON, V95, P141, DOI 10.1016/0048-9697(90)90059-4; von Tucher S, 2005, J PLANT NUTR SOIL SC, V168, P574, DOI 10.1002/jpln.200520506; Wahid PA, 2003, J PLANT NUTR, V26, P1427, DOI 10.1081/PLN-120021052; Wang LH, 2009, CHEMOSPHERE, V77, P1019, DOI 10.1016/j.chemosphere.2009.07.065; Wyttenbach A, 1998, PLANT SOIL, V199, P267, DOI 10.1023/A:1004331826160; Xie ZB, 2002, J PLANT NUTR, V25, P2315, DOI 10.1081/PLN-120014078; Yang Q, 2015, ECOTOX ENVIRON SAFE, V111, P48, DOI 10.1016/j.ecoenv.2014.10.002; Yoshida S, 1998, ENVIRON INT, V24, P275, DOI 10.1016/S0160-4120(98)00006-3; Yufeng Z, 2001, B ENVIRON CONTAM TOX, V67, P399; Zeng FL, 1999, BIOL TRACE ELEM RES, V67, P277, DOI 10.1007/BF02784427; Zeng Q, 2006, ECOTOX ENVIRON SAFE, V64, P226, DOI 10.1016/j.ecoenv.2005.03.016; Zhang CH, 2013, ACTA PHARM SIN B, V3, P20, DOI 10.1016/j.apsb.2012.12.005; Zhang SZ, 2001, ENVIRON POLLUT, V112, P395, DOI 10.1016/S0269-7491(00)00143-3; Zhang ZY, 2002, J RADIOANAL NUCL CH, V252, P461, DOI 10.1023/A:1015834232718	72	80	83	4	144	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129936	10.1371/journal.pone.0129936	http://dx.doi.org/10.1371/journal.pone.0129936			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076480	Green Submitted, gold, Green Published			2022-12-27	WOS:000356329900116
J	Choi, EPH; Chin, WY; Lam, CLK; Wan, EYF; Chan, AKC; Chan, KHY				Choi, Edmond P. H.; Chin, Weng-Yee; Lam, Cindy L. K.; Wan, Eric Y. F.; Chan, Anca K. C.; Chan, Karina H. Y.			Evaluation of the Effectiveness of Nurse-Led Continence Care Treatments for Chinese Primary Care Patients with Lower Urinary Tract Symptoms	PLOS ONE			English	Article							SELF-MANAGEMENT; INCONTINENCE; ENABLEMENT; DEPRIVATION; HYPERPLASIA; POPULATION	Background The aim of this study was to evaluate whether community-based nurse-led continence care interventions are effective in improving outcomes for adult Chinese primary care patients with lower urinary tract symptoms (LUTS). Research Design and Subjects A case-controlled intervention study was conducted. An intervention group of 360 primary care patients enrolled into a nurse-led continence care programme were recruited by consecutive sampling. A control group of 360 primary care patients with LUTS identified by screening were recruited from the waiting rooms of primary care clinics by consecutive sampling. Both groups were monitored at baseline and at 12 months. Measures Outcome measures included symptom severity, health-related quality of life (HRQOL), self-efficacy, global health and self-reported health service utilization at 12-months. The effect of the continence care programme on symptom severity and HRQOL was assessed by the difference- in-difference estimation, using independent t-test and multiple liner regression. Chi-square test was used to compare the self-efficacy, global health and self-reported health service utilization between the two groups at 12-months. Results After adjusting for baseline severity and socio-demographics, the intervention group had significant improvements in LUTS severity (P<0.05) and HRQOL (P<0.05). Improvements in the amount of urine leakage were not significantly different between the two groups. A higher proportion of subjects in the intervention group reported increased self-efficacy (43.48% vs. 66.83%), improved global health condition (17.74% vs. 41.5%), having doctor consultation (18.5% vs. 8.06), having medication due to LUTS (26.50% vs. 11.29%) and having non-drug therapy due to LUTS (59.5% vs. 9.68%). Conclusions Community-based nurse-led continence care can effectively alleviate symptoms, improve health-related quality of life, and enhance self-efficacy and the global health condition of Chinese male and female primary care patients with LUTS.	[Choi, Edmond P. H.; Chin, Weng-Yee; Lam, Cindy L. K.; Wan, Eric Y. F.; Chan, Anca K. C.; Chan, Karina H. Y.] Univ Hong Kong, Ap Lei Chau Clin, Dept Family Med & Primary Care, Ap Lei Chau, Hong Kong, Peoples R China	University of Hong Kong	Choi, EPH (corresponding author), Univ Hong Kong, Ap Lei Chau Clin, Dept Family Med & Primary Care, Ap Lei Chau, Hong Kong, Peoples R China.	h0714919@connect.hku.hk	Choi, Edmond/HDN-8462-2022; Choi, Edmond/H-4187-2019	Choi, Edmond/0000-0001-9062-3540	University of Hong Kong [201209176016]; Health and Health Services Research Fund; Food and Health Bureau; HKSAR Commissioned Research on Enhancing Primary Care Study [EPC-HKU-2]	University of Hong Kong(University of Hong Kong); Health and Health Services Research Fund; Food and Health Bureau; HKSAR Commissioned Research on Enhancing Primary Care Study	WYC, EPHC, and CLKL received support from The Small Project Funding, Committee on Research and Conference Grants of the University of Hong Kong (reference no: 201209176016). University internal grant: no link provided. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CLKL and WYC received support from The Health and Health Services Research Fund, Food and Health Bureau, HKSAR Commissioned Research on Enhancing Primary Care Study (reference no: EPC-HKU-2). Link: http://hub.hku.hk/cris/project/hkugrant105312. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery K, 2004, NEUROUROL URODYNAM, V23, P322, DOI 10.1002/nau.20041; Baessler K, 2010, PELVIC FLOOR REEDUCA; Chen Y, 2012, UROLOGY, V79, P1385, DOI 10.1016/j.urology.2011.11.091; Choi EPH, 2015, J ADV NURS, V71, P1857, DOI 10.1111/jan.12662; Choi EPH, 2014, PATIENT, V7, P403, DOI 10.1007/s40271-014-0062-3; Choi EPH, 2014, QUAL LIFE RES, V23, P2723, DOI 10.1007/s11136-014-0725-5; Choi EPH, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-1; Clarke LH, 2013, HEALTH-LONDON, V17, P211, DOI 10.1177/1363459312451181; Du Moulin MFMT, 2005, INT J NURS STUD, V42, P479, DOI 10.1016/j.ijnurstu.2004.08.002; Emberton M, 2006, EUR UROL SUPPL, V5, P704, DOI 10.1016/j.eursup.2006.06.008; Espuna-Pons M, 2007, NEUROUROL URODYNAM, V26, P836, DOI 10.1002/nau.20379; Fitzpatrick JM, 2006, BJU INT, V97, P3, DOI 10.1111/j.1464-410X.2006.06097.x; Fung CH, 2007, J AM GERIATR SOC, V55, pS443, DOI 10.1111/j.1532-5415.2007.01354.x; Haughney John, 2007, Prim Care Respir J, V16, P89; Irwin DE, 2011, BJU INT, V108, P1132, DOI 10.1111/j.1464-410X.2010.09993.x; Kamper SJ, 2009, J MAN MANIP THER, V17, P163, DOI 10.1179/jmt.2009.17.3.163; Lam CLK, 2010, FAM PRACT, V27, P395, DOI 10.1093/fampra/cmq021; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Linmans JJ, 2012, J CLIN EPIDEMIOL, V65, P785, DOI 10.1016/j.jclinepi.2012.01.010; Mercer SW, 2008, PATIENT EDUC COUNS, V73, P240, DOI 10.1016/j.pec.2008.07.022; Mercer SW, 2007, BRIT J GEN PRACT, V57, P960, DOI 10.3399/096016407782604910; Milne Jill L, 2004, J Wound Ostomy Continence Nurs, V31, P367; National Clinical Guideline Centre, 2010, MAN LOW UR TRACT SYM; Pang M. W., 2005, Hong Kong Medical Journal, V11, P158; Sexton CC, 2009, BJU INT, V103, P12, DOI 10.1111/j.1464-410X.2009.08369.x; Singer J., 2012, HDB HLTH PSYCHOL; Siu AMH, 2007, PATIENT EDUC COUNS, V65, P42, DOI 10.1016/j.pec.2006.04.013; T Brown C, 2007, BRIT MED J, V334, P25, DOI 10.1136/bmj.39010.551319.AE; Thom DH, 1997, AGE AGEING, V26, P367, DOI 10.1093/ageing/26.5.367; Thomas LH, 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000349, DOI 10.1002/14651858.CD000349]; Wagg A, 2009, AGE AGEING, V38, P730, DOI 10.1093/ageing/afp177	31	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129875	10.1371/journal.pone.0129875	http://dx.doi.org/10.1371/journal.pone.0129875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076486	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900107
J	Ganss, C; Lussi, A; Peutzfeldt, A; Attia, NN; Schlueter, N				Ganss, Carolina; Lussi, Adrian; Peutzfeldt, Anne; Attia, Nader Naguib; Schlueter, Nadine			Impact of Sn/F Pre-Treatments on the Durability of Protective Coatings against Dentine Erosion/Abrasion	PLOS ONE			English	Article							BOND STRENGTH; ADHESIVE SYSTEMS; EROSION; TOOTHPASTES; ABRASION; EFFICACY; SURFACES; RINSE	For preventing erosive wear in dentine, coating with adhesives has been suggested as an alternative to fluoridation. However, clinical studies have revealed limited efficacy. As there is first evidence that Sn2+ increases bond strength of the adhesive Clearfil SE (Kuraray), the aim of the present study was to investigate whether pre-treatment with different Sn2+/F- solutions improves the durability of Clearfil SE coatings. Dentine samples (eight groups, n=16/group) were freed of smear layer (0.5% citric acid, 10 s), treated (15 s) either with no solution (control), aminefluoride (AmF, 500 ppm F-, pH 4.5), SnCl2 (800/1600 ppm Sn2+; pH 1.5), SnCl2/AmF (500 ppm F-, 800 ppm Sn2+, pH 1.5/3.0/4.5), or Elmex Erosion Protection Rinse (EP, 500 ppm F-, 800 ppm Sn2+, pH 4.5; GABA International), then rinsed with water (15 s) and individually covered with Clearfil SE. Subsequently the specimens were subjected to an erosion/abrasion protocol consisting of 1320 cycles of immersion in 0.5% citric acid (5 degrees C/55 degrees C; 2 min) and automated brushing (15 s, 200 g, NaF-toothpaste, RDA 80). As the coatings proved stable up to 1320 cycles, 60 modified cycles (brushing time 30 min/cycle) were added. Wear was measured profilometrically. After SnCl2/AmF, pH 4.5 or EP pretreatment all except one coating survived. In the other groups, almost all coatings were lost and there was no significant difference to the control group. Pre-treatment with a Sn2+/F- solution at pH 4.5 seems able to improve the durability of adhesive coatings, rendering these an attractive option in preventing erosive wear in dentine.	[Ganss, Carolina; Attia, Nader Naguib; Schlueter, Nadine] Univ Giessen, Dept Conservat & Prevent Dent, Dent Clin, D-35390 Giessen, Germany; [Lussi, Adrian; Peutzfeldt, Anne] Univ Bern, Sch Dent Med, Dept Prevent Restorat & Pediat Dent, Bern, Switzerland	Justus Liebig University Giessen; University of Bern	Ganss, C (corresponding author), Univ Giessen, Dept Conservat & Prevent Dent, Dent Clin, D-35390 Giessen, Germany.	carolina.ganss@dentist.med.uni-giessen.de	Schlueter, Nadine/AAV-3591-2021					Azzopardi A, 2004, BRIT DENT J, V196, P351, DOI 10.1038/sj.bdj.4811083; Flury S, 2013, CLIN ORAL INVEST, V17, P217, DOI 10.1007/s00784-012-0697-1; Fukegawa D, 2006, J DENT RES, V85, P941, DOI 10.1177/154405910608501014; Ganss C, 2014, CARIES RES, V48, P163, DOI 10.1159/000354679; Ganss C, 2012, J DENT, V40, P1036, DOI 10.1016/j.jdent.2012.08.005; Ganss C, 2010, J DENT RES, V89, P1214, DOI 10.1177/0022034510375291; Ganss C, 2013, MONOGR ORAL SCI, V23, P88, DOI 10.1159/000350475; Ganss C, 2012, AM J DENT, V25, P351; Ghahremani D, 2017, ARAB J CHEM, V10, pS461, DOI 10.1016/j.arabjc.2012.10.006; Hiraishi N, 2014, J DENT, V42, P484, DOI 10.1016/j.jdent.2013.12.016; Lussi A, 2011, CARIES RES, V45, P2, DOI 10.1159/000325915; Peumans M, 2005, DENT MATER, V21, P864, DOI 10.1016/j.dental.2005.02.003; Peutzfeldt A, 2014, CLIN ORAL INVEST, V18, P535, DOI 10.1007/s00784-013-0975-6; Scherrer SS, 2010, DENT MATER, V26, pE78, DOI 10.1016/j.dental.2009.12.002; Schlueter N, 2013, J DENT, V41, P642, DOI 10.1016/j.jdent.2013.03.009; Sundaram G, 2007, OPER DENT, V32, P539, DOI 10.2341/06-177; Sundaram G, 2007, J DENT, V35, P814, DOI 10.1016/j.jdent.2007.07.015; Sundaram G, 2004, J ORAL REHABIL, V31, P505, DOI 10.1111/j.1365-2842.2004.01243.x; Van Landuyt KL, 2007, BIOMATERIALS, V28, P3757, DOI 10.1016/j.biomaterials.2007.04.044; Van Landuyt KL, 2006, J DENT, V34, P77, DOI 10.1016/j.jdent.2005.04.001; Wegehaupt FJ, 2012, INT J DENT, V2012, DOI 10.1155/2012/874359; Wegehaupt FJ, 2013, ACTA ODONTOL SCAND, V71, P1188, DOI 10.3109/00016357.2012.757361; Yoshida Y, 2012, J DENT RES, V91, P1060, DOI 10.1177/0022034512460396; Yoshida Y, 2012, J DENT RES, V91, P376, DOI 10.1177/0022034512437375; Zimmerli B, 2012, CLIN ORAL INVEST, V16, P1451, DOI 10.1007/s00784-011-0650-8	25	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0123889	10.1371/journal.pone.0123889	http://dx.doi.org/10.1371/journal.pone.0123889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075906	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900003
J	Priori, D; Colombo, M; Clavenzani, P; Jansman, AJM; Lalles, JP; Trevisi, P; Bosi, P				Priori, Davide; Colombo, Michela; Clavenzani, Paolo; Jansman, Alfons J. M.; Lalles, Jean-Paul; Trevisi, Paolo; Bosi, Paolo			The Olfactory Receptor OR51E1 Is Present along the Gastrointestinal Tract of Pigs, Co-Localizes with Enteroendocrine Cells and Is Modulated by Intestinal Microbiota	PLOS ONE			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; BUTYRATE-PRODUCING BACTERIA; FATTY-ACID RECEPTOR; NET ABSORPTION; GENE-EXPRESSION; TASTE RECEPTORS; GUT MICROBIOTA; ODORANT; SEROTONIN; COLOSTRUM	The relevance of the butyrate-sensing olfactory receptor OR51E1 for gastrointestinal (GIT) functioning has not been considered so far. We investigated in young pigs the distribution of OR51E1 along the GIT, its relation with some endocrine markers, its variation with age and after interventions affecting the gut environment and intestinal microbiota. Immuno-reactive cells for OR51E1 and chromogranin A (CgA) were counted in cardial (CA), fundic (FU), pyloric (PL) duodenal (DU), jejunal (JE), ileal (IL), cecal (CE), colonic (CO) and rectal (RE) mucosae. OR51E1 co-localization with serotonin (5HT) and peptide YY (PYY) were evaluated in PL and CO respectively. FU and PL tissues were also sampled from 84 piglets reared from sows receiving either or not oral antibiotics (amoxicillin) around parturition, and sacrificed at days 14, 21, 28 (weaning) and 42 of age. JE samples were also obtained from 12 caesarean-derived piglets that were orally associated with simple (SA) or complex (CA) microbiota in the postnatal phase, and of which on days 26-37 of age jejunal loops were perfused for 8 h with enterotoxigenic Escherichia coli F4 (ETEC), Lactobacillus amylovorus or saline (CTRL). Tissue densities of OR51E1+ cells were in decreasing order: PL=DU>FU=CA>JE=IL=CE=CO=RE. OR51E1+ cells showed an enteroendocrine nature containing gastrointestinal hormones such as PYY or 5HT. OR51E1 gene expression in PL and FU increased during and after the suckling period (p<0.05). It was marginally reduced in offspring from antibiotic-treated sows (tendency, p=0.073), vs. control. Jejunal OR51E1 gene expression was reduced in piglets early associated with SA, compared with CA, and in ETEC-perfused loops vs. CTRL (p<0.01). Our results indicate that OR51E1 is related to GIT enteroendocrine activity. Moreover age, pathogen challenge and dietary manipulations influencing the gastrointestinal luminal microenvironment significantly affect the OR51E1 gene expression in GIT tissues presumably in association with the release of microbial metabolites.	[Priori, Davide; Colombo, Michela; Trevisi, Paolo; Bosi, Paolo] Univ Bologna, DISTAL, Bologna, Italy; [Clavenzani, Paolo] Univ Bologna, Dept Vet Sci, Ozzano Nellemilia, BO, Italy; [Jansman, Alfons J. M.] Wageningen UR Livestock Res, Wageningen, Netherlands; [Lalles, Jean-Paul] INRA, ADNC UR1341, St Gilles, France	University of Bologna; University of Bologna; Wageningen University & Research; INRAE	Bosi, P (corresponding author), Univ Bologna, DISTAL, Bologna, Italy.	paolo.bosi@unibo.it		TREVISI, PAOLO/0000-0001-7019-6828; Lalles, Jean-Paul/0000-0003-2732-5350	European Union [227549]	European Union(European Commission)	This work was financially supported by the European Union (contract No. 227549) through the Interplay project. The authors are solely responsible for the work described in this paper, and their opinions are not necessarily those of the European Union.	Adipietro KA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002821; Arnal ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118092; Arnal ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087967; Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; BERG RD, 1975, INFECT IMMUN, V11, P320, DOI 10.1128/IAI.11.2.320-329.1975; Bosi P, 2004, J ANIM SCI, V82, P1764; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Cherbut C, 1988, AM J PHYSIOL-GASTR L, V275, pG1415; Colombo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111447; Depoortere I, 2014, GUT, V63, P179, DOI 10.1136/gutjnl-2013-305112; Dibner JJ, 2008, J APPL POULTRY RES, V17, P174, DOI 10.3382/japr.2007-00100; Nguyen DT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-584; Elizondo-Salazar JA, 2009, J DAIRY SCI, V92, P4565, DOI 10.3168/jds.2009-2188; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Foster SR, 2014, PHARMACOL THERAPEUT, V142, P41, DOI 10.1016/j.pharmthera.2013.11.004; Fujita Y, 2007, J RECEPT SIG TRANSD, V27, P323, DOI 10.1080/10799890701534180; Gershon MD, 2013, CURR OPIN ENDOCRINOL, V20, P14, DOI 10.1097/MED.0b013e32835bc703; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Godden S, 2006, J DAIRY SCI, V89, P3476, DOI 10.3168/jds.S0022-0302(06)72386-4; Gu XL, 2014, AM J RESP CELL MOL, V50, P637, DOI 10.1165/rcmb.2013-0199OC; Jansman AJM, 2012, J ANIM SCI, V90, P433, DOI 10.2527/jas.53850; Kang N, 2012, BMB REP, V45, P612, DOI 10.5483/BMBRep.2012.45.11.232; Karaki SI, 2008, J MOL HISTOL, V39, P135, DOI 10.1007/s10735-007-9145-y; Kiers JL, 2006, BRIT J NUTR, V95, P1193, DOI 10.1079/BJN20061772; Laycock G, 2012, VET IMMUNOL IMMUNOP, V149, P216, DOI 10.1016/j.vetimm.2012.07.004; Lee K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-596; Leja J, 2009, MODERN PATHOL, V22, P261, DOI 10.1038/modpathol.2008.174; Levine UY, 2013, APPL ENVIRON MICROB, V79, P3879, DOI 10.1128/AEM.00589-13; Li N, 2011, AM J PATHOL, V178, P662, DOI 10.1016/j.ajpath.2010.10.028; Li YR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001230; LONGO WE, 1991, SCAND J GASTROENTERO, V26, P442, DOI 10.3109/00365529108996507; Mazzoni M, 2013, J CELL MOL MED, V17, P466, DOI 10.1111/jcmm.12026; Metzler-Zebeli BU, 2011, FEMS MICROBIOL ECOL, V75, P402, DOI 10.1111/j.1574-6941.2010.01017.x; NABUURS MJA, 1993, RES VET SCI, V55, P108, DOI 10.1016/0034-5288(93)90043-F; NABUURS MJA, 1994, RES VET SCI, V56, P379, DOI 10.1016/0034-5288(94)90156-2; Nutten S, 2007, CLIN VACCINE IMMUNOL, V14, P190, DOI 10.1128/CVI.00055-06; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Priori D, 2013, ENERGY PROTEIN METAB, P295; Schumann A, 2005, PHYSIOL GENOMICS, V23, P235, DOI 10.1152/physiolgenomics.00057.2005; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Tajima K, 2010, ANAEROBE, V16, P6, DOI 10.1016/j.anaerobe.2009.04.002; Tazoe H, 2009, BIOMED RES-TOKYO, V30, P149, DOI 10.2220/biomedres.30.149; Theodorakis MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE550, DOI 10.1152/ajpendo.00326.2004; Thompson CL, 2008, ISME J, V2, P739, DOI 10.1038/ismej.2008.29; Trevisi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081473; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Warner MJ, 2010, BIOCHEM J, V427, P333, DOI 10.1042/BJ20091861; Zentek J, 2012, ARCH ANIM NUTR, V66, P14, DOI 10.1080/1745039X.2011.644916; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	52	38	39	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129501	10.1371/journal.pone.0129501	http://dx.doi.org/10.1371/journal.pone.0129501			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076344	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900078
J	Tan, K; An, L; Wang, SM; Wang, XD; Zhang, ZN; Miao, K; Sui, LL; He, SZ; Nie, JZ; Wu, ZH; Tian, JH				Tan, Kun; An, Lei; Wang, Shu-Min; Wang, Xiao-Dong; Zhang, Zhen-Ni; Miao, Kai; Sui, Lin-Lin; He, Shu-Zhi; Nie, Jing-Zhou; Wu, Zhong-Hong; Tian, Jian-Hui			Actin Disorganization Plays a Vital Role in Impaired Embryonic Development of In Vitro-Produced Mouse Preimplantation Embryos	PLOS ONE			English	Article							MELATONIN PROMOTES; CELLULAR CONTROL; GENE-EXPRESSION; 2-CELL EMBRYOS; BOVINE OOCYTES; FERTILIZATION; MICE; VIVO; MICROFILAMENTS; IMPLANTATION	Assisted reproductive technology (ART) is being increasingly applied to overcome infertility. However, the in vitro production process, the main procedure of ART, can lead to aberrant embryonic development and health-related problems in offspring. Understanding the mechanisms underlying the ART-induced side effects is important to improve the ART process. In this study, we carried out comparative transcriptome profiling between in vivo-(IVO) and in vitro-produced (IVP) mouse blastocysts. Our results suggested that aberrant actin organization might be a major factor contributing to the impaired development of IVP embryos. To test this, we examined the effect of actin disorganization on the development of IVP preimplantation embryos. Specific disruption of actin organization by cytochalasin B (CB) indicated that well-organized actin is essential for in vitro embryonic development. Supplementing the culture medium with 10(-9) M melatonin, a cytoskeletal modulator in adult somatic cells, significantly reversed the disrupted expression patterns of genes related to actin organization, including Arhgef2, Bcl2, Coro2b, Flnc, and Palld. Immunofluorescence analysis showed that melatonin treatment of IVP embryos significantly improved the distribution and organization of actin filaments (F-actin) from the 8-cell stage onwards. More importantly, we found that melatonin alleviated the CB-mediated aberrant F-actin distribution and organization and rescued CB-induced impaired embryonic development. This is the first study to indicate that actin disorganization is implicated in impaired development of IVP embryos during the preimplantation stage. We also demonstrated that improving actin organization is a promising strategy to optimize existing IVP systems.	[Tan, Kun; An, Lei; Wang, Shu-Min; Wang, Xiao-Dong; Zhang, Zhen-Ni; Miao, Kai; Sui, Lin-Lin; He, Shu-Zhi; Nie, Jing-Zhou; Wu, Zhong-Hong; Tian, Jian-Hui] China Agr Univ, Natl Engn Lab Anim Breeding, Key Lab Anim Genet Breeding & Reprod, Minist Agr,Coll Anim Sci & Technol, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Tian, JH (corresponding author), China Agr Univ, Natl Engn Lab Anim Breeding, Key Lab Anim Genet Breeding & Reprod, Minist Agr,Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	tianjh@cau.edu.cn	Tan, Kun/Z-1045-2019; An, Lei/GQB-0039-2022	Tan, Kun/0000-0002-8567-7795; 	National Natural Science Foundation of China [31472092]; Earmarked Fund for the Innovative Teams of Beijing Swine Industrialization Research Program; National High-Tech RD Program [2011AA100303, 2013AA102506]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for the Innovative Teams of Beijing Swine Industrialization Research Program; National High-Tech RD Program(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (No. 31472092), the Earmarked Fund for the Innovative Teams of Beijing Swine Industrialization Research Program, and the National High-Tech R&D Program (Nos. 2011AA100303, 2013AA102506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecia JA, 2002, VET RES COMMUN, V26, P151, DOI 10.1023/A:1014099719034; Abeydeera LR, 2002, THERIOGENOLOGY, V57, P257, DOI 10.1016/S0093-691X(01)00670-7; Ali AA, 2003, THERIOGENOLOGY, V59, P939, DOI 10.1016/S0093-691X(02)01125-1; Benitez-King G, 2009, HISTOL HISTOPATHOL, V24, P789, DOI 10.14670/HH-24.789; Biggers JD, 2005, HUM REPROD, V20, P3376, DOI 10.1093/humrep/dei228; Boumela I, 2011, REPRODUCTION, V141, P549, DOI 10.1530/REP-10-0504; Bovellan M, 2014, CURR BIOL, V24, P1628, DOI 10.1016/j.cub.2014.05.069; Delle Piane L, 2010, HUM REPROD, V25, P2039, DOI 10.1093/humrep/deq165; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Driver AM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-118; Duan X, 2015, HUM REPROD, V30, P1643, DOI 10.1093/humrep/dev091; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Gao C, 2012, J PINEAL RES, V52, P305, DOI 10.1111/j.1600-079X.2011.00944.x; Giritharan G, 2007, REPRODUCTION, V134, P63, DOI 10.1530/REP-06-0247; Ishizuka B, 2000, J PINEAL RES, V28, P48, DOI 10.1034/j.1600-079x.2000.280107.x; Ke HN, 2010, CELL RES, V20, P458, DOI 10.1038/cr.2010.21; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Long CR, 1998, MOL REPROD DEV, V51, P59, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;59::AID-MRD7&gt;3.0.CO;2-V; Luo HJ, 2005, MOL CELL NEUROSCI, V29, P507, DOI 10.1016/j.mcn.2004.12.002; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Mathes AM, 2008, J PINEAL RES, V45, P337, DOI 10.1111/j.1600-079X.2008.00583.x; Nagy A., 2003, MANIPULATING MOUSE E; Natarajan M, 2001, J PINEAL RES, V31, P228, DOI 10.1034/j.1600-079X.2001.310306.x; Nie JZ, 2013, J PROTEOME RES, V12, P3843, DOI 10.1021/pr301044b; Niedenberger BA, 2014, REPRODUCTION; Okamoto H, 2004, J CLIN INVEST, V114, P214, DOI 10.1172/JCI200421645; Oliver VF, 2012, FERTIL STERIL, V97, P147, DOI 10.1016/j.fertnstert.2011.10.027; Pang YW, 2013, J PINEAL RES, V54, P389, DOI 10.1111/jpi.12024; PINYOPUMMINTR T, 1991, BIOL REPROD, V45, P736, DOI 10.1095/biolreprod45.5.736; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rivera RM, 2008, HUM MOL GENET, V17, P1, DOI 10.1093/hmg/ddm280; Rosenwaks Z, 2007, P NATL ACAD SCI USA, V104, P5709, DOI 10.1073/pnas.0701316104; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Shawlot W, 1998, TRANSGENIC RES, V7, P95, DOI 10.1023/A:1008816308171; Sun QY, 2006, REPRODUCTION, V131, P193, DOI 10.1530/rep.1.00847; Tamura H, 2008, J PINEAL RES, V44, P280, DOI 10.1111/j.1600-079X.2007.00524.X; Teodoro BG, 2014, J PINEAL RES; Tian XZ, 2010, ENDOCR RES, V35, P17, DOI 10.3109/07435800903539607; Tremoleda JL, 2003, BIOL REPROD, V69, P1895, DOI 10.1095/biolreprod.103.018515; Wang F, 2014, J PINEAL RES, V56, P333, DOI 10.1111/jpi.12126; Wang F, 2013, J PINEAL RES, V55, P267, DOI 10.1111/jpi.12069; Wang P, 2013, ZYGOTE, V26, P1; Wang WH, 1999, BIOL REPROD, V60, P1020, DOI 10.1095/biolreprod60.4.1020; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; Zhu ZY, 2003, BIOL REPROD, V68, P943, DOI 10.1095/biolreprod.102.009910	48	20	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130382	10.1371/journal.pone.0130382	http://dx.doi.org/10.1371/journal.pone.0130382			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076347	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900168
J	Wang, K; Wang, DM; Pan, L; Yu, YW; Dong, F; Li, L; Wang, L; Liu, T; Zeng, XJ; Sun, LX; Zhu, GJ; Feng, K; Jonasson, JM; Wu, ZL; Xu, K; Pang, XL; Chen, T; Pan, H; Ma, J; Zhong, Y; Ping, B; Shan, GL				Wang, Ke; Wang, Dingming; Pan, Li; Yu, Yangwen; Dong, Fen; Li, Ling; Wang, Li; Liu, Tao; Zeng, Xianjia; Sun, Liangxian; Zhu, Guangjin; Feng, Kui; Jonasson, Junmei Miao; Wu, Zhenglai; Xu, Ke; Pang, Xinglong; Chen, Ting; Pan, Hui; Ma, Jin; Zhong, Yong; Ping, Bo; Shan, Guangliang			Prevalence of Obesity and Related Factors among Bouyei and Han Peoples in Guizhou Province, Southwest China	PLOS ONE			English	Article							BODY-MASS INDEX; WAIST CIRCUMFERENCE; RISK-FACTORS; SOCIOECONOMIC-STATUS; ABDOMINAL OBESITY; BLOOD-PRESSURE; OVERWEIGHT; HYPERTENSION; ASSOCIATION; COUNTRIES	Objective To investigate the prevalence of general and abdominal obesity and associated factors in Bouyei and Han peoples. Design A cross-sectional study was carried out in Guizhou province, southwest China in 2012, with multi-stage sampling to enroll 4551 participants aged 20 to 80 years. General and abdominal obesity were defined by World Health Organization (WHO) for Chinese. A design-based analysis was performed to evaluate prevalence of obesity and its related factors. Results Bouyei people had a significantly lower prevalence of general obesity (4.8% vs. 10.9%, p < 0.05) and abdominal obesity (13.6% vs. 26.8%, p < 0.05) than that in Han people. Prevalence of obesity increased with age until middle-age period and declined thereafter. Men aged 40-49 years group and women aged 50-59 years group have the highest prevalence of general obesity. Prevalence of abdominal obesity was higher than that of general obesity. Middle-age, Higher income, Han people were significantly associated with an increased risk of General/abdominal obesity. Conclusions Bouyei people had a lower prevalence of general and abdominal obesity than the Han people. Etiological studies should be conducted to determine underlying genetic factors and dietary factors.	[Wang, Ke; Pan, Li; Dong, Fen; Wang, Li; Zeng, Xianjia; Zhu, Guangjin; Feng, Kui; Wu, Zhenglai; Shan, Guangliang] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Inst Basic Med Sci, Beijing 100005, Peoples R China; [Wang, Dingming; Yu, Yangwen; Li, Ling; Liu, Tao; Sun, Liangxian] Guizhou Ctr Dis Control & Prevent, Guiyang 550004, Guizhou, Peoples R China; [Jonasson, Junmei Miao] Univ Gothenburg, Sahlgrenska Acad, Dept Publ Hlth & Community Med, Sect Social Med,Inst Med, Gothenburg, Sweden; [Xu, Ke; Pang, Xinglong; Chen, Ting; Pan, Hui; Ma, Jin; Zhong, Yong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Xu, Ke; Pang, Xinglong; Chen, Ting; Pan, Hui; Ma, Jin; Zhong, Yong] Peking Union Med Coll, Beijing 100730, Peoples R China; [Ping, Bo] Longli Ctr Dis Control & Prevent, Longli 551200, Guizhou, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; University of Gothenburg; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Ping, B (corresponding author), Longli Ctr Dis Control & Prevent, Longli 551200, Guizhou, Peoples R China.	gzlljkpb@126.com; guangliang_shan@hotmail.com	Jonasson, Junmei Miao/AAB-8053-2019	Jonasson, Junmei Miao/0000-0003-0206-8538	National Science and Technology Pillar Program during the Twelfth Five-Year Plan Period; Ministry of Science and Technology of China [2012BAI37B02]	National Science and Technology Pillar Program during the Twelfth Five-Year Plan Period; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This study was supported by the National Science and Technology Pillar Program during the Twelfth Five-Year Plan Period sponsored by the Ministry of Science and Technology of China (Grant No. 2012BAI37B02). GS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi Kiyoshi, 2006, Journal of Physiological Anthropology, V25, P371, DOI 10.2114/jpa2.25.371; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Berg AO, 2004, ANN INTERN MED, V140, P554, DOI 10.7326/0003-4819-140-7-200404060-00016; Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Deitel M, 2003, OBES SURG, V13, P329, DOI 10.1381/096089203765887598; Doll S, 2002, INT J OBESITY, V26, P48, DOI 10.1038/sj.ijo.0801854; Erem C, 2004, OBES RES, V12, P1117, DOI 10.1038/oby.2004.140; FLEGAL KM, 1995, NEW ENGL J MED, V333, P1165, DOI 10.1056/NEJM199511023331801; Gao Y, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-919; HALL JE, 1993, HYPERTENSION, V22, P292, DOI 10.1161/01.HYP.22.3.292; HE J, 1991, AM J EPIDEMIOL, V134, P1085, DOI 10.1093/oxfordjournals.aje.a116012; Hong SY, 2012, EUR J CANCER PREV, V21, P523, DOI 10.1097/CEJ.0b013e328351c775; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Katulanda P, 2010, OBES REV, V11, P751, DOI 10.1111/j.1467-789X.2010.00746.x; Kim JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045815; Lee CMY, 2007, OBES REV, V8, P191, DOI 10.1111/j.1467-789X.2006.00292.x; Lemeshow S, 1998, AM J EPIDEMIOL, V148, P298; Li Bai-hui, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P915; Li Shengmei ZY, 2014, CHINA FOREIGN MED TR, V33; Li Xiao-yan, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P683; Liu Cheng, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P1139; Liu L, 2004, INT C SER, V262, P168; Lumley T., 2004, J STAT SOFTWARE, V9, P1; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Otgontuya D Jr, 2009, Malays J Nutr, V15, P185; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Wang W, 2001, Zhonghua Liu Xing Bing Xue Za Zhi, V22, P129; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Xu Y, 2003, CHINESE J DIS CONTRO, V7	35	9	11	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129230	10.1371/journal.pone.0129230	http://dx.doi.org/10.1371/journal.pone.0129230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075708	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900056
J	Zhang, W; Kong, X; Wang, ZJ; Luo, S; Huang, W; Zhang, LJ				Zhang, Wei; Kong, Xiang; Wang, Zhen J.; Luo, Song; Huang, Wei; Zhang, Long Jiang			Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats	PLOS ONE			English	Article							HEPATIC-FIBROSIS; NONINVASIVE ASSESSMENT; DCE-MRI; CIRRHOSIS; PARAMETERS; QUANTIFICATION; ELASTOGRAPHY; EXPERIENCE; CARCINOMA; CANCER	Purpose To investigate the utility of dynamic contrast-enhanced MRI (DCE-MRI) with Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for detecting liver fibrosis induced by carbon tetrachloride (CCl4) in rats. Methods This study was approved by the institutional animal care and use committee. Liver fibrosis in rats was induced by intraperitoneal injection of 1 mL/kg 50% CCl4 twice a week for 4-13 weeks. Control rats were injected with saline. Liver fibrosis was graded using the Metaviar score: no fibrosis (F0), mild fibrosis (F1-F2) and advanced fibrosis (F3-F4). DCE-MRI with Gd-EOB-DTPA was performed for all rats. K-trans, K-ep, V-e and iAUC of the liver parenchyma were measured. Relative enhancement (RE) value of the liver was calculated on T-1-weighted images at 15, 20 and 25 min after Gd-EOB-DTPA administration. Results Thirty-five rats were included: no fibrosis (n=13), mild fibrosis (n=11) and advanced fibrosis (n=11). K-trans and iAUC values were highest in advanced fibrosis group and lowest in no fibrosis group (P<0.05). The area under the receiver operating characteristic curve (AUROC) for fibrosis (stages F1 and greater) were 0.773 and 0.882 for K-trans and iAUC, respectively. AUROC for advanced fibrosis were 0.835 and 0.867 for K-trans and iAUC, respectively. K-ep and RE values were not able to differentiate fibrosis stages (all P>0.05). Conclusion K-trans and iAUC obtained from DCE-MRI with Gd-EOB-DTPA are useful for the detection and staging of rat liver fibrosis induced by CCl4.	[Zhang, Wei; Kong, Xiang; Luo, Song; Huang, Wei; Zhang, Long Jiang] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Imaging, Nanjing 210002, Jiangsu, Peoples R China; [Wang, Zhen J.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA	Nanjing University; University of California System; University of California San Francisco	Huang, W (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Imaging, Nanjing 210002, Jiangsu, Peoples R China.	radiology@126.com; kevinzhlj@163.com			National Natural Science Foundation of China [81171313]; Program for New Century Excellent Talents in the University [NCET-12-0260]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in the University(Program for New Century Excellent Talents in University (NCET))	This work was supported by grants from National Natural Science Foundation of China (grant No. 81171313 to L.J.Z.), and the Program for New Century Excellent Talents in the University (NCET-12-0260 to L.J.Z.).	Alonzi R, 2007, EUR J RADIOL, V63, P335, DOI 10.1016/j.ejrad.2007.06.028; Aryal MP, 2014, MAGN RESON MED, V71, P2206, DOI 10.1002/mrm.24873; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Boss MK, 2013, VET COMP ONCOL, V11, P87, DOI 10.1111/j.1476-5829.2011.00305.x; Chen BB, 2012, EUR RADIOL, V22, P171, DOI 10.1007/s00330-011-2249-5; Dyvorne HA, 2013, RADIOLOGY, V266, P920, DOI 10.1148/radiol.12120686; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Faria SC, 2009, RADIOGRAPHICS, V29, P1615, DOI 10.1148/rg.296095512; Feier D, 2013, RADIOLOGY, V269, P459, DOI 10.1148/radiol.13122482; Gulberg V, 2002, HEPATOLOGY, V35, P630, DOI 10.1053/jhep.2002.31722; Hahn OM, 2008, J CLIN ONCOL, V26, P4572, DOI 10.1200/JCO.2007.15.5655; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Jaw TS, 2012, KAOHSIUNG J MED SCI, V28, P130, DOI 10.1016/j.kjms.2011.10.017; Kim D, 2013, RADIOLOGY, V268, P411, DOI 10.1148/radiol.13121193; Leach MO, 2012, EUR RADIOL, V22, P1451, DOI 10.1007/s00330-012-2446-x; Leung VYF, 2013, RADIOLOGY, V269, P910, DOI 10.1148/radiol.13130128; Ma CM, 2014, LIFE SCI, V108, P104, DOI 10.1016/j.lfs.2014.05.016; Mross K, 2009, VASC CELL, V1, DOI 10.1186/2040-2384-1-5; Noren B, 2013, EUR RADIOL, V23, P174, DOI 10.1007/s00330-012-2583-2; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Sahin S, 2000, J PHYSIOL-LONDON, V528, P199, DOI 10.1111/j.1469-7793.2000.00199.x; Saito S, 2013, INVEST RADIOL, V48, P548, DOI 10.1097/RLI.0b013e3182856a06; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Seale MK, 2009, RADIOGRAPHICS, V29, P1725, DOI 10.1148/rg.296095515; Thukral A, 2007, RADIOLOGY, V244, P727, DOI 10.1148/radiol.2443060926; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tsai JH, 2008, J VIRAL HEPATITIS, V15, P508, DOI 10.1111/j.1365-2893.2008.00971.x; Tsuda N, 2010, RADIOLOGY, V256, P767, DOI 10.1148/radiol.10092065; Van Beers BE, 2003, MAGN RESON MED, V49, P692, DOI 10.1002/mrm.10420; Varenika V, 2013, RADIOLOGY, V266, P151, DOI 10.1148/radiol.12112452; Verloh N, 2013, EUR J RADIOL, V82, P1710, DOI 10.1016/j.ejrad.2013.05.033; Walker-Samuel S, 2006, PHYS MED BIOL, V51, P3593, DOI 10.1088/0031-9155/51/14/021; Zissen MH, 2013, AM J ROENTGENOL, V201, P1204, DOI 10.2214/AJR.12.10039	34	22	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129621	10.1371/journal.pone.0129621	http://dx.doi.org/10.1371/journal.pone.0129621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076199	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900086
J	Zhang, YL; Lin, CR; Zhang, LL; Cui, YW; Gu, Y; Guo, JK; Wu, D; Li, Q; Song, WS				Zhang, Yulian; Lin, Cuiru; Zhang, Linlin; Cui, Yuanwu; Gu, Yun; Guo, Jiakui; Wu, Di; Li, Qiang; Song, Wanshan			Cognitive Improvement during Treatment for Mild Alzheimer's Disease with a Chinese Herbal Formula: A Randomized Controlled Trial	PLOS ONE			English	Article							DOUBLE-BLIND; TETRAHYDROXYSTILBENE GLUCOSIDE; MEMORY ABILITIES; 23 MG/D; DONEPEZIL; ICARIIN; MODERATE; TETRAMETHYLPYRAZINE; 24-WEEK; DEFICITS	Objectives To explore the efficacy of Chinese herbal formula compared with donepezil 5mg/day in patients with mild Alzheimer's disease (AD). Methods Patients with mild AD meeting the criteria were randomized into Chinese herbal formula Yishen Huazhuo decoction (YHD) group and donepezil hydrochloride (DH) group during the 24-week trial. The outcomes were measured by ADAS-cog, MMSE, ADL, and NPI with linear mixed-effect models. Results 144 patients were randomized. The mean scores of ADAS-cog and MMSE in both YHD group and DH group both improved at the end of the 24-week treatment period. The results also revealed that YHD was better at improving the mean scores of ADAS-cog and MMSE than DH. Linear mixed-effect models with repeated measures showed statistical significance in time x group interaction effect of ADAS-cog and also in time x group interaction effect of MMSE. The data showed YHD was superior to DH in improving the scores and long term efficacy. Conclusions Our study suggests that Chinese herbal formula YHD is beneficial and effective for cognitive improvement in patients with mild AD and the mechanism might be through reducing amyloid-beta (A beta) plaque deposition in the hippocampus.	[Zhang, Yulian; Lin, Cuiru; Cui, Yuanwu; Guo, Jiakui; Song, Wanshan] Tianjin Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Acupuncture & Cerebropathy, Tianjin, Peoples R China; [Zhang, Linlin; Gu, Yun] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Geriatr, Tianjin, Peoples R China; [Wu, Di] Tianjin Huanhu Hosp, Dept Tradit Chinese Med, Tianjin, Peoples R China; [Li, Qiang] Tianjin Univ Tradit Chinese Med, Grad Inst, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine	Zhang, YL (corresponding author), Tianjin Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Acupuncture & Cerebropathy, Tianjin, Peoples R China.	zhyl220@126.com			973 Program [2010CB530405]	973 Program(National Basic Research Program of China)	This work was supported by the 973 Program: 2010CB530405 (http://www.973.gov.cn/English/Index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, GERIATRICS; Bi M, 2011, NEUROSCI LETT, V501, P35, DOI 10.1016/j.neulet.2011.06.036; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Burns A, 1999, DEMENT GERIATR COGN, V10, P237, DOI 10.1159/000017126; Cheng XR, 2007, CELL BIOL INT, V31, P438, DOI 10.1016/j.cellbi.2006.10.001; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Cummings JL, 1999, INT J NEUROPSYCHOPH, V2, P59, DOI 10.1017/S1461145799001340; Fan LH, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-48; Farlow MR, 2010, CLIN THER, V32, P1234, DOI 10.1016/j.clinthera.2010.06.019; Feldman H, 2001, NEUROLOGY, V57, P613, DOI 10.1212/WNL.57.4.613; Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Geng YT, 2010, BIOL PHARM BULL, V33, P836, DOI 10.1248/bpb.33.836; Goedert M, 1991, BRAIN PATHOL, V1, P279, DOI 10.1111/j.1750-3639.1991.tb00671.x; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Homma A, 2008, DEMENT GERIATR COGN, V25, P399, DOI 10.1159/000122961; Itzhaki RF, 2008, J ALZHEIMERS DIS, V13, P393; Kim M, 2014, EUR J PHARMACOL, V740, P504, DOI 10.1016/j.ejphar.2014.06.037; Lange S, 2005, BIOMETRICAL J, V47, P12, DOI 10.1002/bimj.200410085; Lei H, 2003, ACTA PHARMACOL SIN, V24, P230; Li F, 2010, PHARMACOL BIOCHEM BE, V96, P301, DOI 10.1016/j.pbb.2010.05.021; Liu JC, 2010, YAKUGAKU ZASSHI, V130, P737, DOI 10.1248/yakushi.130.737; Liu P, 2013, J TRADIT CHIN MED, V33, P449, DOI 10.1016/S0254-6272(13)60147-8; Luo Y, 2007, CLIN EXP PHARMACOL P, V34, P792, DOI 10.1111/j.1440-1681.2007.04647.x; Miao Ying-chun, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P390, DOI 10.3736/jcim20120407; Mohs R C, 1997, ADV ALZ DIS, P407; MUNGAS D, 1991, GERIATRICS, V46, P54; Nadkarni NK, 2006, TRIAL DESIGNS OUTCOM, P85, DOI [10.1080/19552068.2010.9635845, DOI 10.1080/19552068.2010.9635845]; Nie J, 2010, EUR J PHARMACOL, V626, P213, DOI 10.1016/j.ejphar.2009.09.039; Nozawa M, 2009, PSYCHOGERIATRICS, V9, P50, DOI 10.1111/j.1479-8301.2009.00291.x; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Rogers SL, 1998, ARCH INTERN MED, V158, P1021, DOI 10.1001/archinte.158.9.1021; Rogers SL, 1998, EUR NEUROPSYCHOPHARM, V8, P67, DOI 10.1016/S0924-977X(97)00079-5; Sabbagh M, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-56; Sabbagh M, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-21; Sasaki S, 2014, DEMENT GER COGN D EX, V4, P131, DOI 10.1159/000362871; Shcherbatykh I, 2007, J ALZHEIMERS DIS, V11, P191; Song YH, 2011, J PHARM PHARMACOL, V63, P541, DOI 10.1111/j.2042-7158.2010.01241.x; Tohda C, 2006, BRIT J PHARMACOL, V149, P532, DOI 10.1038/sj.bjp.0706865; Wang R, 2007, NEUROSCIENCE, V149, P739, DOI 10.1016/j.neuroscience.2007.07.065; Wang T, 2009, FREE RADICAL BIO MED, V47, P229, DOI 10.1016/j.freeradbiomed.2009.02.027; Wang Y, 2010, ACTA PHARMACOL SIN, V31, P649, DOI 10.1038/aps.2010.46; Waring SC, 2008, ARCH NEUROL-CHICAGO, V65, P329, DOI 10.1001/archneur.65.3.329; Whitehead A, 2004, INT J GERIATR PSYCH, V19, P624, DOI 10.1002/gps.1133; Wu B, 2012, J ETHNOPHARMACOL, V142, P746, DOI 10.1016/j.jep.2012.05.056; Xu CQ, 2010, EUR J PHARMACOL, V642, P146, DOI 10.1016/j.ejphar.2010.05.012; Yan H, 2007, CLIN INTERV AGING, V2, P201; Yatabe Y, 2013, PSYCHOGERIATRICS, V13, P88, DOI 10.1111/psyg.12004; Zeng KW, 2010, NEUROPHARMACOLOGY, V59, P542, DOI 10.1016/j.neuropharm.2010.07.020; Zhang L, 2006, BEHAV BRAIN RES, V173, P246, DOI 10.1016/j.bbr.2006.06.034; Zhang L, 2014, INT J BIOL SCI, V10, P181, DOI 10.7150/ijbs.6232; Zhang SJ, 2012, ASIAN PAC J TROP MED, V5, P661, DOI 10.1016/S1995-7645(12)60135-7; Zhao Lin, 2008, Zhongguo Yaolixue Tongbao, V24, P1088; Zhou JM, 2011, INT IMMUNOPHARMACOL, V11, P890, DOI 10.1016/j.intimp.2011.01.007; Zhou L, 2012, CAN J PHYSIOL PHARM, V90, P1446, DOI 10.1139/y2012-121	56	30	37	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130353	10.1371/journal.pone.0130353	http://dx.doi.org/10.1371/journal.pone.0130353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076022	Green Submitted, gold, Green Published			2022-12-27	WOS:000356329900166
J	Andersen, JM; Herning, H; Aschim, EL; Hjelmesaeth, J; Mala, T; Hanevik, HI; Bungum, M; Haugen, TB; Witczak, O				Andersen, Jorunn M.; Herning, Hilde; Aschim, Elin L.; Hjelmesaeth, Joran; Mala, Tom; Hanevik, Hans Ivar; Bungum, Mona; Haugen, Trine B.; Witczak, Oliwia			Body Mass Index Is Associated With Impaired Semen CHaracteristics and Reduced Levels of Anti-Mullerian Hormone across a Wide Weight Range	PLOS ONE			English	Article							CHROMATIN-STRUCTURE ASSAY; SPERM DNA FRAGMENTATION; REPRODUCTIVE HORMONES; MALE OBESITY; INHIBIN-B; QUALITY; MEN; OVERWEIGHT; FERTILITY; PARAMETERS	There is still controversy as to how body mass index (BMI) affects male reproduction. We investigated how BMI is associated with semen quality and reproductive hormones in 166 men, including 38 severely obese men. Standard semen analysis and sperm DNA integrity analysis were performed, and blood samples were analysed for reproductive hormones. Adjusted for age and time of abstinence, BMI was negatively associated with sperm concentration (B = -0.088, P = 0.009), total sperm count (B = -0.223, P = 0.001), progressive sperm motility (B = -0.675, P = 0.007), normal sperm morphology (B = -0.078, P = 0.001), and percentage of vital spermatozoa (B = -0.006, P = 0.027). A negative relationship was observed between BMI and total testosterone (B = -0.378, P < 0.001), sex hormone binding globulin (B = -0.572, P < 0.001), inhibin B (B = -3.120, P < 0.001) and anti-Mullerian hormone (AMH) (B = -0.009, P < 0.001). Our findings suggest that high BMI is negatively associated with semen characteristics and serum levels of AMH.	[Andersen, Jorunn M.; Herning, Hilde; Aschim, Elin L.; Haugen, Trine B.; Witczak, Oliwia] Oslo & Akershus Univ, Coll Appl Sci, Fac Hlth Sci, Oslo, Norway; [Hjelmesaeth, Joran] Vestfold Hosp Trust, Morbid Obes Ctr, Tonsberg, Norway; [Hjelmesaeth, Joran] Univ Oslo, Inst Clin Med, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway; [Mala, Tom] Oslo Univ Hosp, Dept Morbid Obes & Bariatr Surg, Oslo, Norway; [Hanevik, Hans Ivar] Telemark Hosp, Fertilitetsklinikken Sor, Porsgrunn, Norway; [Bungum, Mona] Skane Univ Hosp, Reprod Med Ctr, Malmo, Sweden	Oslo Metropolitan University (OsloMet); University of Oslo; University of Oslo; Telemark Hospital Trust; Lund University; Skane University Hospital	Andersen, JM (corresponding author), Oslo & Akershus Univ, Coll Appl Sci, Fac Hlth Sci, Oslo, Norway.	Jorunn.Andersen@hioa.no	Mala, Tom/J-5418-2019	Mala, Tom/0000-0003-3058-4775; Haugen, Trine Berit/0000-0002-8814-3393	Oslo and Akershus University College of Applied Sciences	Oslo and Akershus University College of Applied Sciences	All funding for this study was received from Oslo and Akershus University College of Applied Sciences.	Aggerholm AS, 2008, FERTIL STERIL, V90, P619, DOI 10.1016/j.fertnstert.2007.07.1292; Al-Qahtani A, 2005, CLIN ENDOCRINOL, V63, P267, DOI 10.1111/j.1365-2265.2005.02336.x; [Anonymous], 2014, OV OB NORW FACT SHEE; Attaman JA, 2012, HUM REPROD, V27, P1466, DOI 10.1093/humrep/des065; Belloc S, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.1212; Bungum M, 2007, HUM REPROD, V22, P174, DOI 10.1093/humrep/del326; Chavarro JE, 2010, FERTIL STERIL, V93, P2222, DOI 10.1016/j.fertnstert.2009.01.100; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Du Plessis SS, 2010, NAT REV UROL, V7, P153, DOI 10.1038/nrurol.2010.6; Dupont C, 2013, ASIAN J ANDROL, V15, P622, DOI 10.1038/aja.2013.65; Eisenberg ML, 2014, HUM REPROD, V29, P193, DOI 10.1093/humrep/det428; Evenson DP, 2006, THERIOGENOLOGY, V65, P979, DOI 10.1016/j.theriogenology.2005.09.011; EVENSON DP, 1980, SCIENCE, V210, P1131, DOI 10.1126/science.7444440; Evenson DP, 1999, HUM REPROD, V14, P1039, DOI 10.1093/humrep/14.4.1039; Evenson DP, 2002, J ANDROL, V23, P25, DOI 10.1002/j.1939-4640.2002.tb02599.x; Fejes I, 2005, ANDROLOGIA, V37, P155, DOI 10.1111/j.1439-0272.2005.00671.x; Gascon F, 2000, EUR J ENDOCRINOL, V143, P85, DOI 10.1530/eje.0.1430085; Goulis DG, 2008, GYNECOL ENDOCRINOL, V24, P158, DOI 10.1080/09513590701672314; Hakonsen LB, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-24; Hammiche F, 2012, HUM REPROD, V27, P2365, DOI 10.1093/humrep/des177; Hammoud AO, 2008, FERTIL STERIL, V90, P2222, DOI 10.1016/j.fertnstert.2007.10.011; Hautanen A, 2000, INT J OBESITY, V24, pS64, DOI 10.1038/sj.ijo.0801281; Hofny ERM, 2010, FERTIL STERIL, V94, P581, DOI 10.1016/j.fertnstert.2009.03.085; Jensen TK, 2004, FERTIL STERIL, V82, P863, DOI 10.1016/j.fertnstert.2004.03.056; Kort HI, 2006, J ANDROL, V27, P450, DOI 10.2164/jandrol.05124; La Vignera S, 2011, J ANDROL, V33, P53, DOI 10.2164/jandrol.110.012120; MacDonald AA, 2013, HUM REPROD, V28, P3178, DOI 10.1093/humrep/det379; MacDonald AA, 2010, HUM REPROD UPDATE, V16, P293, DOI 10.1093/humupd/dmp047; Matuszczak E, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/128907; Menkveld R, 1995, INT J ANDROL, V18, P36; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nguyen RHN, 2007, HUM REPROD, V22, P2488, DOI 10.1093/humrep/dem139; Paasch U, 2010, FERTIL STERIL, V94, P2898, DOI 10.1016/j.fertnstert.2010.06.047; Pasquali R, 2003, HUM REPROD UPDATE, V9, P359, DOI 10.1093/humupd/dmg024; Pauli EM, 2008, FERTIL STERIL, V90, P346, DOI 10.1016/j.fertnstert.2007.06.046; Pellitero S, 2012, OBES SURG, V22, P1835, DOI 10.1007/s11695-012-0734-9; Pierik FH, 1998, J CLIN ENDOCR METAB, V83, P3110, DOI 10.1210/jc.83.9.3110; Pietilainen KH, 2012, J CLIN ENDOCR METAB, V97, pE161, DOI 10.1210/jc.2011-1697; Qin DD, 2007, ASIAN J ANDROL, V9, P827, DOI 10.1111/j.1745-7262.2007.00268.x; Ramlau-Hansen CH, 2007, HUM REPROD, V22, P1634, DOI 10.1093/humrep/dem035; Robeva R, 2012, ANDROLOGIA, V44, P329, DOI 10.1111/j.1439-0272.2011.01185.x; Rybar R, 2011, ANDROLOGIA, V43, P286, DOI 10.1111/j.1439-0272.2010.01057.x; Sallmen M, 2006, EPIDEMIOLOGY, V17, P520, DOI 10.1097/01.ede.0000229953.76862.e5; Sermondade N, 2013, HUM REPROD UPDATE, V19, P221, DOI 10.1093/humupd/dms050; Smit M, 2010, FERTIL STERIL, V94, P1748, DOI 10.1016/j.fertnstert.2009.10.030; Spano M, 2000, FERTIL STERIL, V73, P43, DOI 10.1016/S0015-0282(99)00462-8; Teerds KJ, 2011, HUM REPROD UPDATE, V17, P667, DOI 10.1093/humupd/dmr017; Thomsen L, 2014, ASIAN J ANDROL, V16, P749, DOI 10.4103/1008-682X.125398; Tuttelmann F, 2009, FERTIL STERIL, V91, P1812, DOI 10.1016/j.fertnstert.2008.02.118; Winters SJ, 2006, J ANDROL, V27, P560, DOI 10.2164/jandrol.05193; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th	51	43	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130210	10.1371/journal.pone.0130210	http://dx.doi.org/10.1371/journal.pone.0130210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067627	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000151
J	Hue, I; Evain-Brion, D; Fournier, T; Degrelle, SA				Hue, Isabelle; Evain-Brion, Daniele; Fournier, Thierry; Degrelle, Severine A.			Primary Bovine Extra-Embryonic Cultured Cells: A New Resource for the Study of In Vivo Peri-Implanting Phenotypes and Mesoderm Formation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; EPITHELIAL-MESENCHYMAL TRANSITIONS; MOUSE EMBRYO; TROPHOBLAST DEVELOPMENT; FETAL MEMBRANES; INTERFERON TAU; CT-1 CELLS; EXPRESSION; GENES; DIFFERENTIATION	In addition to nourishing the embryo, extra-embryonic tissues (EETs) contribute to early embryonic patterning, primitive hematopoiesis, and fetal health. These tissues are of major importance for human medicine, as well as for efforts to improve livestock efficiency, but they remain incompletely understood. In bovines, EETs are accessible easily, in large amounts, and prior to implantation. We took advantage of this system to describe, in vitro and in vivo, the cell types present in bovine EETs at Day 18 of development. Specifically, we characterized the gene expression patterns and phenotypes of bovine extra-embryonic ectoderm (or trophoblast; bTC), endoderm (bXEC), and mesoderm (bXMC) cells in culture and compared them to their respective in vivo micro-dissected cells. After a week of culture, certain characteristics (e.g., gene expression) of the in vitro cells were altered with respect to the in vivo cells, but we were able to identify "cores" of cell-type-specific (and substrate-independent) genes that were shared between in vitro and in vivo samples. In addition, many cellular phenotypes were cell-type-specific with regard to extracellular adhesion. We evaluated the ability of individual bXMCs to migrate and spread on micro-patterns, and observed that they easily adapted to diverse environments, similar to in vivo EE mesoderm cells, which encounter different EE epithelia to form chorion, yolk sac, and allantois. With these tissue interactions, different functions arose that were detected in silico and corroborated in vivo at D21-D25. Moreover, analysis of bXMCs allowed us to identify the EE cell ring surrounding the embryonic disc (ED) at D14-15 as mesoderm cells, which had been hypothesized but not shown prior to this study. We envision these data will serve as a major resource for the future in the analysis of peri-implanting phenotypes in response to the maternal metabolism and contribute to subsequent studies of placental/fetal development in eutherians.	[Hue, Isabelle; Degrelle, Severine A.] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Evain-Brion, Daniele; Fournier, Thierry; Degrelle, Severine A.] INSERM, Fac Sci Pharmaceut & Biol, UMR S1139, U767, Paris, France; [Evain-Brion, Daniele; Fournier, Thierry; Degrelle, Severine A.] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Evain-Brion, Daniele; Degrelle, Severine A.] PremUp Fdn, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Degrelle, SA (corresponding author), INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France.	severine.degrelle@inserm.fr	Hue, Isabelle/AAD-2341-2020; Degrelle, Severine/AAC-1726-2020; Fournier, Thierry C/E-5836-2016	Hue, Isabelle/0000-0002-3873-9738; Degrelle, Severine/0000-0001-6263-4875; Fournier, Thierry/0000-0002-7515-339X	PremUp foundation; INRA Department program ACI PHASE; INRA Department program AIP AGROBI; INRA Department program EMBIC European network of excellence headed at INRA	PremUp foundation; INRA Department program ACI PHASE; INRA Department program AIP AGROBI; INRA Department program EMBIC European network of excellence headed at INRA	This work was supported by PremUp foundation (S.A.D. post-doctoral fellowship), INRA Department programs ACI PHASE 2008, 2009, AIP AGROBI and EMBIC European network of excellence headed at INRA by O. Sandra.	Alev C, 2013, DEVELOPMENT, V140, P2691, DOI 10.1242/dev.094318; Arora R, 2012, BLOOD, V120, P2562, DOI 10.1182/blood-2012-03-390070; Bai H, 2011, J REPROD DEVELOP, V57, P518, DOI 10.1262/jrd.10-186K; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Blomberg LA, 2006, MOL REPROD DEV, V73, P1491, DOI 10.1002/mrd.20503; Brown K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012016; Bruderer M, 2013, J VASC RES, V50, P265, DOI 10.1159/000353287; Bruhl T, 2004, CIRC RES, V94, P743, DOI 10.1161/01.RES.0000120861.27064.09; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Costello I, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-54; Degrelle SA, 2011, PLACENTA, V32, P917, DOI 10.1016/j.placenta.2011.08.014; Degrelle SA, 2005, DEV BIOL, V288, P448, DOI 10.1016/j.ydbio.2005.09.043; Degrelle SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038309; Degrelle SA, 2011, REPRODUCTION, V141, P79, DOI 10.1530/REP-10-0174; Degrelle SA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-46; Evseenko D, 2010, P NATL ACAD SCI USA, V107, P13742, DOI 10.1073/pnas.1002077107; Ferner K, 2011, RESP PHYSIOL NEUROBI, V178, P39, DOI 10.1016/j.resp.2011.03.029; Ferrer-Vaquer A, 2010, CELL ADHES MIGR, V4, P447, DOI 10.4161/cam.4.3.10771; Flechon JE, 2004, GENESIS, V38, P13, DOI 10.1002/gene.10244; Fraser ST, 2009, J CELL BIOCHEM, V107, P586, DOI 10.1002/jcb.22165; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gaivao MMF, 2014, THERIOGENOLOGY, V82, P354, DOI 10.1016/j.theriogenology.2014.04.018; Galat V, 2012, STEM CELLS DEV, V21, P1250, DOI 10.1089/scd.2010.0578; Genbacev O, 2011, STEM CELLS, V29, P1427, DOI 10.1002/stem.686; Gerbaud P, 2011, ENDOCRINOLOGY, V152, P5017, DOI 10.1210/en.2011-1193; Guillomot M, 2004, REPRODUCTION, V127, P491, DOI 10.1530/rep.1.00057; Guo W, 2014, ONCOGENE, V33, P537, DOI 10.1038/onc.2013.260; Hassoun R, 2009, DIFFERENTIATION, V78, P301, DOI 10.1016/j.diff.2009.07.006; Horejs CM, 2014, P NATL ACAD SCI USA, V111, P5908, DOI 10.1073/pnas.1403139111; Hue I, 2001, DEV GENES EVOL, V211, P157, DOI 10.1007/s004270100138; Hue I, 2013, METHODS MOL BIOL, V1074, P125, DOI 10.1007/978-1-62703-628-3_10; Hue I, 2012, ANIM REPROD SCI, V134, P19, DOI 10.1016/j.anireprosci.2012.08.007; Katsumoto K, 2011, DEVELOPMENT, V138, P1947, DOI 10.1242/dev.058719; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; Koh S, 2014, THERIOGENOLOGY, V81, P103, DOI 10.1016/j.theriogenology.2013.09.009; Li HS, 2014, EMBO J, V33, P1383, DOI 10.15252/embj.201387594; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Maddox-Hyttel P, 2003, REPRODUCTION, V125, P607, DOI 10.1530/rep.0.1250607; Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005; Mancanares CAF, 2013, MICROSC RES TECHNIQ, V76, P756, DOI 10.1002/jemt.22227; Martal JL, 1998, BIOCHIMIE, V80, P755, DOI 10.1016/S0300-9084(99)80029-7; Maruotti J, 2012, MOL REPROD DEV, V79, P461, DOI 10.1002/mrd.22051; Mendjan S., 2014, CELL STEM CELL; Miyazaki H, 2002, PLACENTA, V23, P613, DOI 10.1053/plac.2002.0846; Moerkamp AT, 2013, DEV GROWTH DIFFER, V55, P301, DOI 10.1111/dgd.12036; Moissoglu K, 2014, CURR BIOL, V24, pR23, DOI 10.1016/j.cub.2013.10.075; Nagatomo H, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108993; Oliveira VC, 2015, J TISSUE ENG REGENER; Palis J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00003; Pennington KA, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-12; PERRY JS, 1981, J REPROD FERTIL, V62, P321; Pfeffer PL, 2012, REPRODUCTION, V143, P231, DOI 10.1530/REP-11-0374; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Ramos-Ibeas P, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.118430; Richard C, 2014, THERIOGENOLOGY; Roberts RM, 2014, REPRODUCTION, V147, pD1, DOI 10.1530/REP-14-0080; Rugg-Gunn PJ, 2012, DEV CELL, V22, P887, DOI 10.1016/j.devcel.2012.01.005; Sakurai T, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100180; Schiffmacher AT, 2013, MOL REPROD DEV, V80, P826, DOI 10.1002/mrd.22212; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Schwartz B, 2014, MECH DEV; Scotti M, 2012, DEVELOPMENT, V139, P731, DOI 10.1242/dev.075408; Shimada A, 2001, PLACENTA, V22, P652, DOI 10.1053/plac.2001.0702; Smith M.A., 2014, TRENDS CELL BIOL; Swiers G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3924; Talbot NC, 2000, BIOL REPROD, V62, P235, DOI 10.1095/biolreprod62.2.235; Talbot NC, 2014, CYTOTECHNOLOGY; Talbot NC, 2007, IN VITRO CELL DEV-AN, V43, P72, DOI 10.1007/s11626-007-9014-8; TAM PPL, 1987, DEVELOPMENT, V99, P109; Tarrade A, 2001, LAB INVEST, V81, P1199, DOI 10.1038/labinvest.3780334; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Touzard E, 2013, REPRODUCTION, V146, P347, DOI 10.1530/REP-13-0143; Valour D, 2014, PHYSIOL GENOMICS, V46, P39, DOI 10.1152/physiolgenomics.00091.2013; Wang JH, 2009, CR BIOL, V332, P986, DOI 10.1016/j.crvi.2009.09.004; Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/nmeth.3016, 10.1038/NMETH.3016]; WHEATLEY SC, 1993, DEVELOPMENT, V119, P295; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; WOODING FBP, 1992, PLACENTA, V13, P101, DOI 10.1016/0143-4004(92)90025-O; Yamakoshi S, 2012, REPRODUCTION, V143, P377, DOI 10.1530/REP-11-0364; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001	80	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0127330	10.1371/journal.pone.0127330	http://dx.doi.org/10.1371/journal.pone.0127330			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070137	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000007
J	Martin-Moreno, AM; Roncador, G; Maestre, L; Mata, E; Jimenez, S; Martinez-Torrecuadrada, JL; Reyes-Garcia, AI; Rubio, C; Tomas, JF; Estevez, M; Pulford, K; Piris, MA; Garcia, JF				Martin-Moreno, Ana M.; Roncador, Giovanna; Maestre, Lorena; Mata, Elena; Jimenez, Scherezade; Martinez-Torrecuadrada, Jorge L.; Reyes-Garcia, Ana I.; Rubio, Carmen; Tomas, Jose F.; Estevez, Monica; Pulford, Karen; Piris, Miguel A.; Garcia, Juan F.			CSF1R Protein Expression in Reactive Lymphoid Tissues and Lymphoma: Its Relevance in Classical Hodgkin Lymphoma	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; COLONY-STIMULATING FACTOR; REED-STERNBERG CELLS; FOLLICULAR LYMPHOMA; FACTOR-I; SURVIVAL; PROGRESSION; PROGNOSIS; MICROENVIRONMENT; INHIBITOR	Tumour-associated macrophages (TAMs) have been associated with survival in classic Hodgkin lymphoma (cHL) and other lymphoma types. The maturation and differentiation of tissue macrophages depends upon interactions between colony-stimulating factor 1 receptor (CSF1R) and its ligands. There remains, however, a lack of consistent information on CSF1R expression in TAMs. A new monoclonal antibody, FER216, was generated to investigate CSF1R protein distribution in formalin fixed tissue samples from 24 reactive lymphoid tissues and 187 different lymphoma types. We also analysed the distribution of CSF1R+, CD68+ and CD163+ macrophages by double immunostaining, and studied the relationship between CSF1R expression and survival in an independent series of 249 cHL patients. CSF1R+ TAMs were less frequent in B-cell lymphocytic leukaemia and lymphoblastic B-cell lymphoma than in diffuse large B-cell lymphoma, peripheral T-cell lymphoma, angioimmunoblastic T-cell lymphoma and cHL. HRS cells in cHL and, with the exception of three cases of anaplastic large cell lymphoma, the neoplastic cells in NHLs, lacked detectable CSF1R protein. A CSF1R+ enriched microenvironment in cHL was associated with shorter survival in an independent series of 249 cHL patients. CSF1R pathway activation was evident in the cHL and inactivation of this pathway could be a potential therapeutic target in cHL cases.	[Martin-Moreno, Ana M.; Mata, Elena; Rubio, Carmen; Garcia, Juan F.] MD Anderson Canc Ctr, Dept Pathol, Madrid, Spain; [Roncador, Giovanna; Maestre, Lorena; Jimenez, Scherezade; Reyes-Garcia, Ana I.] Spanish Natl Canc Ctr CNIO, Monoclonal Antibodies Unit, Madrid, Spain; [Martinez-Torrecuadrada, Jorge L.] Spanish Natl Canc Ctr CNIO, Prote Unit, Madrid, Spain; [Tomas, Jose F.; Estevez, Monica] MD Anderson Canc Ctr, Dept Haematol, Madrid, Spain; [Pulford, Karen] Univ Oxford, John Radcliffe Hosp, Nuffield Div Clin Lab Sci, Radcliffe Dept Med, Oxford OX3 9DU, England; [Piris, Miguel A.] Hosp Univ Marques de Valdecilla, Dept Pathol, Santander, Spain	University of Texas System; UTMD Anderson Cancer Center; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); University of Texas System; UTMD Anderson Cancer Center; University of Oxford; Hospital Universitario Marques de Valdecilla (HUMV)	Garcia, JF (corresponding author), MD Anderson Canc Ctr, Dept Pathol, Madrid, Spain.	jfgarcia@mdanderson.es	GARCIA, JUAN/L-2118-2016; Martinez-Torrecuadrada, Jorge L./AAG-1090-2019; Piris, Miguel A/AAP-1445-2020; Piris, Miguel A/B-7067-2008; Maestre, Lorena/L-1352-2014; Roncador, Giovanna/L-1764-2014	Piris, Miguel A/0000-0001-5839-3634; Piris, Miguel A/0000-0001-5839-3634; Maestre, Lorena/0000-0001-8743-0422; Roncador, Giovanna/0000-0002-9807-2875; Martinez-Torrecuadrada, Jorge Luis/0000-0002-8240-6623; Rubio, Carmen/0000-0002-8275-5866	Fondo de Investigaciones Sanitarias - Ministerio de Ciencia e Innovacion [PI12/1832]; Spanish Cancer Research Networks-RTICC [RD12/0036/0060]; Fondo Europeo de Desarrollo Regional (FEDER); Asociacion Espanola Contra el Cancer (AECC Scientific Foundation)	Fondo de Investigaciones Sanitarias - Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentInstituto de Salud Carlos III); Spanish Cancer Research Networks-RTICC; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Asociacion Espanola Contra el Cancer (AECC Scientific Foundation)	This work was supported by grants from the Fondo de Investigaciones Sanitarias - Ministerio de Ciencia e Innovacion (PI12/1832), and Spanish Cancer Research Networks-RTICC (RD12/0036/0060), cofunded by the Fondo Europeo de Desarrollo Regional (FEDER), and the Asociacion Espanola Contra el Cancer (AECC Scientific Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli C, 2011, ANN ONCOL, V22, P153; Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Alvaro T, 2006, HAEMATOLOGICA, V91, P1605; Azambuja D, 2012, ANN ONCOL, V23, P736, DOI 10.1093/annonc/mdr157; Canioni D, 2008, J CLIN ONCOL, V26, P440, DOI 10.1200/JCO.2007.12.8298; Chetaille B, 2009, BLOOD, V113, P2765, DOI 10.1182/blood-2008-07-168096; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Devilard E, 2002, ONCOGENE, V21, P3095, DOI 10.1038/sj.onc.1205418; Dominguez-Soto A, 2011, J IMMUNOL, V186, P2192, DOI 10.4049/jimmunol.1000475; Espinosa I, 2011, AM J PATHOL, V179, P2100, DOI 10.1016/j.ajpath.2011.06.021; Espinosa I, 2009, AM J PATHOL, V174, P2347, DOI 10.2353/ajpath.2009.081037; Farinha P, 2005, BLOOD, V106, P2169, DOI 10.1182/blood-2005-04-1565; He HH, 2012, BLOOD, V120, P3152, DOI 10.1182/blood-2012-04-422758; HSU PL, 1991, INT J HEMATOL, V54, P315; Jakovic LR, 2011, LEUKEMIA LYMPHOMA, V52, P1913, DOI 10.3109/10428194.2011.580026; Kamper P, 2011, HAEMATOL-HEMATOL J, V96, P269, DOI 10.3324/haematol.2010.031542; Kanzler H, 1996, J EXP MED, V184, P1495, DOI 10.1084/jem.184.4.1495; Koh YW, 2014, AM J CLIN PATHOL, V141, P573, DOI 10.1309/AJCPR92TDDFARISU; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P705, DOI 10.1189/jlb.1105656; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Madan B, 2012, J IMMUNOL, V189, P4123, DOI 10.4049/jimmunol.1200675; Manthey CL, 2009, MOL CANCER THER, V8, P3151, DOI 10.1158/1535-7163.MCT-09-0255; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Muenst S, 2009, HUM PATHOL, V40, P1715, DOI 10.1016/j.humpath.2009.03.025; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Sanchez-Aguilera A, 2006, BLOOD, V108, P662, DOI 10.1182/blood-2005-12-5125; Sanchez-Espiridion B, 2012, HAEMATOL-HEMATOL J, V97, P1080, DOI 10.3324/haematol.2011.055459; Sielska M, 2013, J PATHOL, V230, P310, DOI 10.1002/path.4192; Skinnider BF, 2002, BLOOD, V99, P4283, DOI 10.1182/blood-2002-01-0099; Steidl C, 2012, BLOOD, V120, P3530, DOI 10.1182/blood-2012-06-439570; Steidl C, 2011, J CLIN ONCOL, V29, P1812, DOI 10.1200/JCO.2010.32.8401; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Tan KL, 2012, BLOOD, V120, P3280, DOI 10.1182/blood-2012-04-421057; TANG RP, 1992, J CELL BIOCHEM, V50, P350, DOI 10.1002/jcb.240500403; Tzankov A, 2008, HAEMATOLOGICA, V93, P193, DOI 10.3324/haematol.11702; Ullrich K, 2011, BRIT J HAEMATOL, V155, P398, DOI 10.1111/j.1365-2141.2011.08685.x; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Xu JY, 2013, CANCER RES, V73, P2782, DOI 10.1158/0008-5472.CAN-12-3981	46	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0125203	10.1371/journal.pone.0125203	http://dx.doi.org/10.1371/journal.pone.0125203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066800	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000002
J	Park, KA; Lyu, I; Yoon, J; Jeong, U; Oh, JE; Lim, HW; Oh, SY				Park, Kyung-Ah; Lyu, Injeong; Yoon, Jungmin; Jeong, Unchang; Oh, Jae-Eung; Lim, Han Woong; Oh, Sei Yeul			Muscle Union Procedure in Patients with Paralytic Strabismus	PLOS ONE			English	Article							TRANSPOSITION; RECTUS	To present the surgical outcomes of a muscle union procedure in patients with paralytic strabismus, this retrospective study included 27 patients with paralytic strabismus who underwent a muscle union procedure. In this procedure, the two vertical rectus muscles are united with the paralytic horizontal muscle without splitting the muscles. Postoperative ocular deviations, complications, surgical success rates, and reoperation rates were obtained by examining the medical records of the patients. Seventeen patients had a sixth cranial nerve palsy, seven patients had a third cranial nerve palsy, and three patients had a medial rectus muscle palsy after endoscopic sinus surgery. The mean preoperative angle of horizontal deviation in the primary position was 56 +/- 21 prism diopters. The mean follow-up period was 12 +/-+/- 9 months. The mean final postoperative ocular deviation was 8 +/- 13 prism diopters. The success rate was 74%, and the reoperation rate was 0%. No significant complications, including anterior ischemia, occurred in any of the patients. One patient exhibited an increase in intraocular pressure in the immediate postoperative period, but this resolved spontaneously within 1 week. Our muscle union procedure was effective in patients with paralytic strabismus, especially in patients with a large angle of deviation. This muscle union procedure is potentially a suitable option for muscle transposition in patients with paralytic strabismus who have large-angle deviation or a significant residual angle after conventional surgery.	[Park, Kyung-Ah; Lyu, Injeong; Oh, Sei Yeul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Yoon, Jungmin; Jeong, Unchang; Oh, Jae-Eung] Hanyang Univ, Sch Mech Engn, Seoul 133791, South Korea; [Lim, Han Woong] Hanyang Univ, Coll Med, Dept Ophthalmol, Seoul 133791, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Hanyang University; Hanyang University	Oh, SY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	syoh@skku.edu	Lim, HW/GRY-3517-2022		Korea Healthcare Technology RD Project; Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Korea Healthcare Technology RD Project; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI10C2020).	Buckley EG, 1995, ATLAS OPHTHALMIC SUR, P140; Clark RA, 2002, AM J OPHTHALMOL, V133, P119, DOI 10.1016/S0002-9394(01)01264-8; Foster R S, 1997, J AAPOS, V1, P20, DOI 10.1016/S1091-8531(97)90019-7; Hussein MAW, 2003, AM J OPHTHALMOL, V136, P947, DOI 10.1016/S0002-9394(03)00486-0; Iizuka M, 2008, J AAPOS, V12, P27, DOI 10.1016/j.jaapos.2007.06.017; JENSEN C D, 1964, Trans Pac Coast Otoophthalmol Soc Annu Meet, V45, P359; KEECH RV, 1990, ARCH OPHTHALMOL-CHIC, V108, P176, DOI 10.1001/archopht.1990.01070040028016; Park Kyung-Ah, 2013, J Pediatr Ophthalmol Strabismus, V50 Online, pe11, DOI 10.3928/01913913-20130306-01; ROSENBAUM AL, 1989, ARCH OPHTHALMOL-CHIC, V107, P820, DOI 10.1001/archopht.1989.01070010842025	9	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129035	10.1371/journal.pone.0129035	http://dx.doi.org/10.1371/journal.pone.0129035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070148	gold, Green Submitted, Green Published			2022-12-27	WOS:000356327000039
J	Puerto, G; Erazo, L; Wintaco, M; Castro, C; Ribon, W; Guerrero, MI				Puerto, Gloria; Erazo, Lina; Wintaco, Maira; Castro, Claudia; Ribon, Wellman; Inrida Guerrero, Martha			Mycobacterium tuberculosis Genotypes Determined by Spoligotyping to Be Circulating in Colombia between 1999 and 2012 and Their Possible Associations with Transmission and Susceptibility to First-Line Drugs	PLOS ONE			English	Article							GENETIC DIVERSITY; BEIJING GENOTYPE; EPIDEMIOLOGY; STRAINS; COMPLEX; IS6110; DIFFERENTIATION; DATABASE	Introduction Tuberculosis (TB) remains a primary public health problem worldwide. The number of multi-drug- resistant tuberculosis (MDR TB) cases has increased in recent years in Colombia. Knowledge of M. tuberculosis genotypes defined by spoligotyping can help determine the circulation of genotypes that must be controlled to prevent the spread of TB. Objective To describe the genotypes of M. tuberculosis using spoligotyping in resistant and drug-sensitive isolates and their possible associations with susceptibility to first-line drugs. Methods An analytical observational study was conducted that included 741 isolates of M. tuberculosis from patients. The isolates originated from 31 departments and were obtained by systematic surveillance between 1999 and 2012. Results In total 61.94% of the isolates were resistant to 1 or more drugs, and 147 isolates were MDR. In total, 170 genotypes were found in the population structure of Colombian M. tuberculosis isolates. The isolates were mainly represented by four families: LAM (39.9%), Haarlem (19%), Orphan (17%) and T (9%). The SIT42 (LAM 9) was the most common genotype and contained 24.7% of the isolates, followed by the genotypes SIT62 (Haarlem1), SIT53 (T1), and SIT50 (H3). A high clustering of isolates was evident with 79.8% of the isolates classified into 32 groups. The Beijing family was associated with resistant isolates, whereas the Haarlem and T families were associated with sensitive isolates. The Haarlem family was also associated with grouped isolates (p = 0.031). Conclusions A high proportion (approximately 80%) of isolates was found in clusters; these clusters were not associated with resistance to first-line drugs. The Beijing family was associated with drug resistance, whereas the T and Haarlem families were associated with susceptibility in the Colombian isolates studied.	[Puerto, Gloria; Erazo, Lina; Wintaco, Maira; Castro, Claudia; Ribon, Wellman; Inrida Guerrero, Martha] Inst Nacl Salud, Direcc Invest Salud Publ, Grp Micobacterias, Bogota, Colombia	Instituto Nacional de Salud (Colombia)	Puerto, G (corresponding author), Inst Nacl Salud, Direcc Invest Salud Publ, Grp Micobacterias, Bogota, Colombia.	gpuerto@ins.gov.co		Castro Osorio, Claudia Marcela/0000-0002-8792-2002	National Institute of Health	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was fully funded by the National Institute of Health.	[Anonymous], GLOB TUB CONTR WHO R; Bauer J, 1999, J CLIN MICROBIOL, V37, P2602, DOI 10.1128/JCM.37.8.2602-2606.1999; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Candia N, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-75; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Centers for Disease Control and Prevention, 2012, MMWR-MORBID MORTAL W, V36, P723; Cerezo I, 2012, INFECT GENET EVOL, V12, P657, DOI 10.1016/j.meegid.2011.07.006; Chang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043018; Cronin WA, 2001, J CLIN MICROBIOL, V39, P3709, DOI 10.1128/JCM.39.10.3709-3711.2001; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Departamento Administrativo Nacional de Estadistica, 2007, CENS COL 2005; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Garzon MC, 2012, DIAGNOSTICO BACTERIO; Gori A, 2005, EMERG INFECT DIS, V11, P1242, DOI 10.3201/1108.040982; Goyal M, 1997, J CLIN MICROBIOL, V35, P647, DOI 10.1128/JCM.35.3.647-651.1997; Guernier V, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-46; Hernández Johana E, 2008, Rev. salud pública, V10, P126, DOI 10.1590/S0124-00642008000100012; Instituto Nacional de Salud, 2014, DIR VIG AN RIESG SAL; Iwamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049651; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kent PT, 1985, GUIDE LEVEL 3 LAB; Organizacion Panamericana de la Salud Instituto Nacional de Salud Ministerio de la Proteccion social, 2009, PLAN ESTR COL LIBR T; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Realpe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093848; Ritacco V, 2008, MEM I OSWALDO CRUZ, V103, P489, DOI 10.1590/S0074-02762008000500014; Roetzer A, 2011, J CLIN MICROBIOL, V49, P4173, DOI 10.1128/JCM.05293-11; Rosero Doris Amanda, 2008, Infect., V12, P175; Sebban M, 2002, BIOINFORMATICS, V18, P235, DOI 10.1093/bioinformatics/18.2.235; Sequera M, 2008, REV CHIL INFECTOL, V25, P362, DOI /S0716-10182008000500009; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tessema B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-131; Van Soolingen D, 2001, RESTRICTION FRAGMENT, DOI [10.1385/1-59259-147-7:165, DOI 10.1385/1-59259-147-7:165]; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160	34	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0124308	10.1371/journal.pone.0124308	http://dx.doi.org/10.1371/journal.pone.0124308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066494	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900003
J	Saia, S; Ruisi, P; Fileccia, V; Di Miceli, G; Amato, G; Martinelli, F				Saia, Sergio; Ruisi, Paolo; Fileccia, Veronica; Di Miceli, Giuseppe; Amato, Gaetano; Martinelli, Federico			Metabolomics Suggests That Soil Inoculation with Arbuscular Mycorrhizal Fungi Decreased Free Amino Acid Content in Roots of Durum Wheat Grown under N-Limited, P-Rich Field Conditions	PLOS ONE			English	Article							REGULATORY NETWORKS; NITROGEN UPTAKE; PIPECOLIC ACID; METABOLISM; TRANSPORT; COLONIZATION; ARABIDOPSIS; RHIZOBACTERIA; TRANSLOCATION; CARBOHYDRATE	Arbuscular mycorrhizal fungi (AMF) have a major impact on plant nutrition, defence against pathogens, a plant's reaction to stressful environments, soil fertility, and a plant's relationship with other microorganisms. Such effects imply a broad reprogramming of the plant's metabolic activity. However, little information is available regarding the role of AMF and their relation to other soil plant growth-promoting microorganisms in the plant metabolome, especially under realistic field conditions. In the present experiment, we evaluated the effects of inoculation with AMF, either alone or in combination with plant growth-promoting rhizobacteria (PGPR), on the metabolome and changes in metabolic pathways in the roots of durum wheat (Triticum durum Desf.) grown under N-limited agronomic conditions in a P-rich environment. These two treatments were compared to infection by the natural AMF population (NAT). Soil inoculation with AMF almost doubled wheat root colonization by AMF and decreased the root concentrations of most compounds in all metabolic pathways, especially amino acids (AA) and saturated fatty acids, whereas inoculation with AMF+ PGPR increased the concentrations of such compounds compared to inoculation with AMF alone. Enrichment metabolomics analyses showed that AA metabolic pathways were mostly changed by the treatments, with reduced amination activity in roots most likely due to a shift from the biosynthesis of common AA to Y-amino butyric acid. The root metabolome differed between AMF and NAT but not AMF+ PGPR and AMF or NAT. Because the PGPR used were potent mineralisers, and AMF can retain most nitrogen (N) taken as organic compounds for their own growth, it is likely that this result was due to an increased concentration of mineral N in soil inoculated with AMF+ PGPR compared to AMF alone.	[Saia, Sergio; Ruisi, Paolo; Fileccia, Veronica; Di Miceli, Giuseppe; Amato, Gaetano; Martinelli, Federico] Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy; [Saia, Sergio; Di Miceli, Giuseppe] Univ Palermo, Fdn A&S Lima Mancuso, Palermo, Italy	University of Palermo; University of Palermo	Martinelli, F (corresponding author), Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy.	federico.martinelli@unipa.it	Amato, Gaetano/E-1105-2011; Saia, Sergio/K-7535-2012; Martinelli, Federico/F-7697-2013; Amato, Gaetano/AAT-2213-2020; Ruisi, Paolo/L-9337-2015	Amato, Gaetano/0000-0003-0660-7594; Saia, Sergio/0000-0001-5465-8500; Amato, Gaetano/0000-0003-0660-7594; DI MICELI, Giuseppe/0000-0002-8076-5972; Ruisi, Paolo/0000-0002-5807-6986	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Italy [PON01 01145-ISCOCEM]	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Italy(Ministry of Education, Universities and Research (MIUR))	The present research was funded by the project "Sviluppo tecnologico e innovazione per la sostenibilita e competitivita della cerealicoltura meridionale (PON01 01145-ISCOCEM)" (person in charge: Dr. Giuseppe Di Miceli - Fondazione A. e S. Lima Mancuso) of the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Karaki G, 2004, MYCORRHIZA, V14, P263, DOI 10.1007/s00572-003-0265-2; Artursson V, 2006, ENVIRON MICROBIOL, V8, P1, DOI 10.1111/j.1462-2920.2005.00942.x; Bago B, 2003, PLANT PHYSIOL, V131, P1496, DOI 10.1104/pp.102.007765; Bago B, 2002, PLANT PHYSIOL, V128, P108, DOI 10.1104/pp.010466; Barea JM, 2002, NUTR CYCL AGROECOSYS, V63, P35, DOI 10.1023/A:1020589732436; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Carvalhais LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068555; Carvalhais LC, 2011, J PLANT NUTR SOIL SC, V174, P3, DOI 10.1002/jpln.201000085; Ceccarelli N, 2010, PLANT SOIL, V335, P311, DOI 10.1007/s11104-010-0417-z; Chagoyen M, 2011, BIOINFORMATICS, V27, P730, DOI 10.1093/bioinformatics/btr001; Fellbaum CR, 2012, P NATL ACAD SCI USA, V109, P2666, DOI 10.1073/pnas.1118650109; Fester T, 2011, OECOLOGIA, V167, P913, DOI 10.1007/s00442-011-2037-6; Gao XP, 2010, J SCI FOOD AGR, V90, P750, DOI 10.1002/jsfa.3878; Germida JJ, 1996, BIOL FERT SOILS, V23, P113, DOI 10.1007/s003740050147; Gika HG, 2014, J CHROMATOGR B, V966, P1, DOI 10.1016/j.jchromb.2014.01.054; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Glick BR, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/963401; Govindarajulu M, 2005, NATURE, V435, P819, DOI 10.1038/nature03610; Guether M, 2009, PLANT PHYSIOL, V150, P73, DOI 10.1104/pp.109.136390; Guether M, 2009, NEW PHYTOL, V182, P200, DOI 10.1111/j.1469-8137.2008.02725.x; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; Helber N, 2011, PLANT CELL, V23, P3812, DOI 10.1105/tpc.111.089813; Hodge A, 2015, PLANT SOIL, V386, P1, DOI 10.1007/s11104-014-2162-1; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; Jin H, 2005, NEW PHYTOL, V168, P687, DOI 10.1111/j.1469-8137.2005.01536.x; Johnson NC, 2015, NEW PHYTOL, V205, P1473, DOI 10.1111/nph.13172; Justes E, 1997, DIAGNOSTIC PROCED CR; Kind T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-234; Kobae Y, 2014, PLANT CELL PHYSIOL, V55, P1945, DOI 10.1093/pcp/pcu123; Laparre J, 2014, MOL PLANT, V7, P554, DOI 10.1093/mp/sst136; Larimer AL, 2010, SYMBIOSIS, V51, P139, DOI 10.1007/s13199-010-0083-1; Leader DP, 2011, RAPID COMMUN MASS SP, V25, P3422, DOI 10.1002/rcm.5245; Lee DY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-7; Leigh J, 2011, FEMS MICROBIOL ECOL, V76, P428, DOI 10.1111/j.1574-6941.2011.01066.x; Lekberg Y, 2014, BOTANY, V92, DOI 10.1139/cjb-2013-0182; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; LONGNECKER N, 1993, CROP SCI, V33, P154, DOI 10.2135/cropsci1993.0011183X003300010028x; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Martinelli F, 2013, SCI HORTIC-AMSTERDAM, V159, P52, DOI 10.1016/j.scienta.2013.04.039; Martinelli F, 2012, SCI HORTIC-AMSTERDAM, V144, P201, DOI 10.1016/j.scienta.2012.07.012; Moche M, 2010, PLANTA, V231, P425, DOI 10.1007/s00425-009-1057-5; Mohammad A, 2004, AGR ECOSYST ENVIRON, V103, P245, DOI 10.1016/j.agee.2003.09.017; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Navarova H, 2012, PLANT CELL, V24, P5123, DOI 10.1105/tpc.112.103564; PALFI G, 1968, PLANT SOIL, V29, P285, DOI 10.1007/BF01348946; Pfeffer PE, 1999, PLANT PHYSIOL, V120, P587, DOI 10.1104/pp.120.2.587; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Pii Y, 2015, BIOL FERT SOILS, V51, P403, DOI 10.1007/s00374-015-0996-1; Ramos-Gonzalez MI, 2005, J BACTERIOL, V187, P4033, DOI 10.1128/JB.187.12.4033-4041.2005; Rasmussen S, 2008, PLANT PHYSIOL, V146, P1440, DOI 10.1104/pp.107.111898; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Saia S, 2014, J AGR SCI-CAMBRIDGE, V152, P370, DOI 10.1017/S002185961300004X; Saia S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090738; SAS, 2008, SAS STAT 9 2 USER S; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Schliemann W, 2008, PHYTOCHEMISTRY, V69, P112, DOI 10.1016/j.phytochem.2007.06.032; Smith SE, 2011, ANNU REV PLANT BIOL, V62, P227, DOI 10.1146/annurev-arplant-042110-103846; Smith SE, 2008, MYCORRHIZAL SYMBIOSI, DOI [10.1126/science.1208473, DOI 10.1126/SCIENCE.1208473]; Somers E, 2004, CRIT REV MICROBIOL, V30, P205, DOI 10.1080/10408410490468786; Strehmel N, 2014, METABOLOMICS, V10, P324, DOI 10.1007/s11306-013-0569-y; Tanaka Y, 2005, PLANT CELL ENVIRON, V28, P1247, DOI 10.1111/j.1365-3040.2005.01360.x; Teng W, 2013, J EXP BOT, V64, P1403, DOI 10.1093/jxb/ert023; Vogel-Adghough D, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26366; Vranova V, 2011, PLANT SOIL, V342, P31, DOI 10.1007/s11104-010-0673-y; Walker V, 2012, PLANT SOIL, V356, P151, DOI 10.1007/s11104-011-0960-2; Weckwerth W, 2004, PROTEOMICS, V4, P78, DOI 10.1002/pmic.200200500	68	39	44	3	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129591	10.1371/journal.pone.0129591	http://dx.doi.org/10.1371/journal.pone.0129591			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067663	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900060
J	Zhao, H; Li, XX; Wu, WB; Li, Z; Qian, L; Li, SS; Zhang, B; Xu, Y				Zhao, Hui; Li, Xiaoxi; Wu, Wenbo; Li, Zheng; Qian, Lai; Li, ShanShan; Zhang, Bing; Xu, Yun			Atrophic Patterns of the Frontal-Subcortical Circuits in Patients with Mild Cognitive Impairment and Alzheimer's Disease	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; CORTICAL THICKNESS; MRI; BRAIN; MORPHOLOGY; CLASSIFICATION; ABNORMALITIES; SEGMENTATION; INTEGRITY; ACCUMBENS	Atrophy of the cortical thickness and gray matter volume are regarded as sensitive markers for the early clinical diagnosis of Alzheimer's disease (AD). This study aimed to investigate differences in atrophy patterns in the frontal-subcortical circuits between MCI and AD, assess whether these differences were essential for the pathologic basis of cognitive impairment. A total of 131 individuals were recruited, including 45 with cognitively normal controls (CN), 46 with MCI, and 40 with AD. FreeSurfer software was used to perform volumetric measurements of the frontal-subcortical circuits from 3.0T magnetic resonance (MR) scans. Data revealed that both MCI and AD subjects had a thinner cortex in the left caudal middle frontal gyrus and the left lateral orbitofrontal gyrus compared with CN individuals. The left lateral orbitofrontal gyrus was also thinner in AD compared with MCI patients. There were no statistically significant differences in the cortical mean curvature among the three groups. Both MCI and AD subjects exhibited smaller bilateral hippocampus volumes compared with CN individuals. The volumes of the bilateral hippocampus and the right putamen were also smaller in AD compared with MCI patients. Logistic regression analyses revealed that the left lateral orbitofrontal gyrus and bilateral hippocampus were risk factors for cognitive impairment. These current results suggest that atrophy was heterogeneous in subregions of the frontal-subcortical circuits in MCI and AD patients. Among these subregions, the reduced thickness of the left lateral orbitofrontal and the smaller volume of the bilateral hippocampus seemed to be markers for predicting cognitive impairment.	[Zhao, Hui; Li, Xiaoxi; Li, Zheng; Qian, Lai; Li, ShanShan; Zhang, Bing; Xu, Yun] Nanjing Univ, Dept Neurol & Radiol, Affiliated Drum Tower Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhao, Hui; Wu, Wenbo; Zhang, Bing; Xu, Yun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Zhao, Hui; Qian, Lai; Zhang, Bing; Xu, Yun] Nanjing Univ, Jiangsu Key Lab Mol Med, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhao, Hui; Qian, Lai; Zhang, Bing; Xu, Yun] Nanjing Clin Med Ctr Neurol & Psychiat Dis, Nanjing, Peoples R China; [Wu, Wenbo] Nanjing Med Univ, Affiliated Drum Tower Hosp, Dept Neurol & Radiol, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing Medical University	Zhang, B (corresponding author), Nanjing Univ, Dept Neurol & Radiol, Affiliated Drum Tower Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China.	zhangbing_nanjing@vip.163.com; xuyun20042001@aliyun.com			National Science Foundation of China [81471102, 30971010, 81230026, 81171085, 81300925]; Outstanding Researcher Program of Jiangsu Province [LJ201101]; National Natural Science Foundation of Jiangsu Province of China [BK2009037]; Provincial Natural Science Foundation of Jiangsu of China [BK20131085]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Researcher Program of Jiangsu Province; National Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Provincial Natural Science Foundation of Jiangsu of China(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Science Foundation of China (81471102 HZ30971010 YX, 81230026 YX, 81171085 YX and 81300925 BZ), Outstanding Researcher Program of Jiangsu Province (LJ201101 YX), the National Natural Science Foundation (BK2009037 YX) of Jiangsu Province of China, the Provincial Natural Science Foundation of Jiangsu of China (BK20131085 BZ).	Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; BUTTER C M, 1972, Acta Neurobiologiae Experimentalis (Warsaw), V32, P525; Cherbuin N, 2006, NEUROPSYCHOLOGY, V20, P700, DOI 10.1037/0894-4105.20.6.700; Chetelat G, 2010, ANN NEUROL, V67, P317, DOI 10.1002/ana.21955; Clark AM, 2013, J NEUROSCI, V33, P1833, DOI 10.1523/JNEUROSCI.3605-12.2013; Cross DJ, 2013, J NUCL MED, V54, P1278, DOI 10.2967/jnumed.112.116558; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; DAMASIO AR, 1994, SCI AM, V271, P144, DOI 10.1038/scientificamerican1094-144; de Jong LW, 2008, BRAIN, V131, P3277, DOI 10.1093/brain/awn278; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Du AT, 2007, BRAIN, V130, P1159, DOI 10.1093/brain/awm016; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fennema-Notestine C, 2009, HUM BRAIN MAPP, V30, P3238, DOI 10.1002/hbm.20744; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Girard SD, 2013, J ALZHEIMERS DIS, V33, P781, DOI 10.3233/JAD-2012-120982; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Guo XJ, 2010, NEUROSCI LETT, V468, P146, DOI 10.1016/j.neulet.2009.10.086; Im K, 2008, NEUROIMAGE, V43, P103, DOI 10.1016/j.neuroimage.2008.07.016; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Kawakami I, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-40; Kirchhoff BA, 2013, DIABETIC MED, V30, pe151, DOI 10.1111/dme.12135; Li CM, 2011, J ALZHEIMERS DIS, V27, P281, DOI 10.3233/JAD-2011-110497; Madsen SK, 2010, NEUROBIOL AGING, V31, P1312, DOI 10.1016/j.neurobiolaging.2010.05.002; Masterman DL, 1997, J PSYCHOPHARMACOL, V11, P107, DOI 10.1177/026988119701100203; McDonald CR, 2009, NEUROLOGY, V73, P457, DOI 10.1212/WNL.0b013e3181b16431; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miller Michael I, 2012, Med Image Comput Comput Assist Interv, V2012, P155; Noel-Storr Anna H, 2013, Alzheimers Dement, V9, pe96, DOI 10.1016/j.jalz.2012.01.014; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2006, ARCH NEUROL-CHICAGO, V63, P665, DOI 10.1001/archneur.63.5.665; Pievani M, 2013, NEUROBIOL AGING, V34, P1728, DOI 10.1016/j.neurobiolaging.2013.01.016; Pihlajamaki M, 2009, CURR ALZHEIMER RES, V6, P179, DOI 10.2174/156720509787602898; Poulin SP, 2011, PSYCHIAT RES-NEUROIM, V194, P7, DOI 10.1016/j.pscychresns.2011.06.014; Rolls ET, 1996, PHILOS T ROY SOC B, V351, P1433, DOI 10.1098/rstb.1996.0128; Ryan NS, 2013, BRAIN, V136, P1399, DOI 10.1093/brain/awt065; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Singh V, 2006, BRAIN, V129, P2885, DOI 10.1093/brain/awl256; Tang XY, 2015, HUM BRAIN MAPP, V36, P2093, DOI 10.1002/hbm.22758; Tang XY, 2014, HUM BRAIN MAPP, V35, P3701, DOI 10.1002/hbm.22431; Thomann PA, 2012, CURR ALZHEIMER RES, V9, P507, DOI 10.2174/156720512800492558; van den Bogaard SJA, 2011, J NEUROL, V258, P412, DOI 10.1007/s00415-010-5768-0; Van Hoesen GW, 2000, CEREB CORTEX, V10, P243, DOI 10.1093/cercor/10.3.243; VanEssen DC, 1997, J NEUROSCI, V17, P7079; VANHOESEN GW, 1980, BRAIN RES, V186, P365, DOI 10.1016/0006-8993(80)90982-8; Wang L, 2009, AM J NEURORADIOL, V30, P893, DOI 10.3174/ajnr.A1484; Westman E, 2012, NEUROIMAGE, V62, P229, DOI 10.1016/j.neuroimage.2012.04.056; Willette AA, 2014, PSYCHIAT RES-NEUROIM, V224, P81, DOI 10.1016/j.pscychresns.2014.08.005	50	21	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130017	10.1371/journal.pone.0130017	http://dx.doi.org/10.1371/journal.pone.0130017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066658	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900092
J	Darienko, T; Gustavs, L; Eggert, A; Wolf, W; Proschold, T				Darienko, Tatyana; Gustavs, Lydia; Eggert, Anja; Wolf, Wiebke; Proeschold, Thomas			Evaluating the Species Boundaries of Green Microalgae (Coccomyxa, Trebouxiophyceae, Chlorophyta) Using Integrative Taxonomy and DNA Barcoding with Further Implications for the Species Identification in Environmental Samples	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MORPHOLOGICAL CHARACTERIZATION; SECONDARY STRUCTURE; ALGAE; SYSTEMATICS; PREDICTION; DIVERSITY; CHLORELLA; DISCOVERY; SEQUENCES	Integrative taxonomy is an approach for defining species and genera by taking phylogenetic, morphological, physiological, and ecological data into account. This approach is appropriate for microalgae, where morphological convergence and high levels of morphological plasticity complicate the application of the traditional classification. Although DNA barcode markers are well-established for animals, fungi, and higher plants, there is an ongoing discussion about suitable markers for microalgae and protists because these organisms are genetically more diverse compared to the former groups. To solve these problems, we assess the usage of a polyphasic approach combining phenotypic and genetic parameters for species and generic characterization. The application of barcode markers for database queries further allows conclusions about the 'coverage' of culture-based approaches in biodiversity studies and integrates additional aspects into modern taxonomic concepts. Although the culture-dependent approach revealed three new lineages, which are described as new species in this paper, the culture-independent analyses discovered additional putative new species. We evaluated three barcode markers (V4, V9 and ITS-2 regions, nuclear ribosomal operon) and studied the morphological and physiological plasticity of Coccomyxa, which became a model organism because its whole genome sequence has been published. In addition, several biotechnological patents have been registered for Coccomyxa. Coccomyxa representatives are distributed worldwide, are free-living or in symbioses, and colonize terrestrial and aquatic habitats. We investigated more than 40 strains and reviewed the biodiversity and biogeographical distribution of Coccomyxa species using DNA barcoding. The genus Coccomyxa formed a monophyletic group within the Trebouxiophyceae separated into seven independent phylogenetic lineages representing species. Summarizing, the combination of different characteristics in an integrative approach helps to evaluate environmental data and clearly identifies microalgae at generic and species levels.	[Darienko, Tatyana] Natl Acad Sci Ukraine, MG Kholodny Inst Bot, UA-01601 Kiev, Ukraine; [Gustavs, Lydia; Wolf, Wiebke; Proeschold, Thomas] Univ Rostock, Inst Biol Sci Appl Ecol & Phycol, D-18059 Rostock, Germany; [Eggert, Anja] Leibniz Inst Balt Sea Res Warnemunde Phys Oceano, D-18119 Rostock, Germany; [Proeschold, Thomas] Univ Vienna, Dept Limnol & Biooceanog, A-1090 Vienna, Austria	National Academy of Sciences Ukraine; M.G. Kholodny Institute of Botany, NAS of Ukraine; University of Rostock; University of Vienna	Proschold, T (corresponding author), Univ Rostock, Inst Biol Sci Appl Ecol & Phycol, Albert Einstein Str 3, D-18059 Rostock, Germany.	Thomas.Proeschold@univie.ac.at		Proeschold, Thomas/0000-0002-7858-0434; Gustavs, Lydia/0000-0003-3621-8864; Darienko, Tatyana/0000-0002-1957-0076	Deutsche Forschungsgemeinschaft [DFG GU 1278/1-1 : LG]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, grant number DFG GU 1278/1-1 : LG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton E, 1909, ANN BOT-LONDON, V23, P573, DOI 10.1093/oxfordjournals.aob.a089239; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; [Anonymous], 2013, SYST BIOL, V62, P707, DOI [10.1093/sysbio/syt033, DOI 10.1093/SYSBIO/SYT033]; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Birky CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010609; Blanc G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r39; BRAUNE W, 1964, ARCH MIKROBIOL, V49, P176, DOI 10.1007/BF00422141; Byun Y, 2009, BIOINFORMATICS, V25, P1435, DOI 10.1093/bioinformatics/btp252; Caisova L, 2013, PROTIST, V164, P482, DOI 10.1016/j.protis.2013.04.005; Caisova L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-262; Chodat R, 1913, MATERIAUX FLORE CRYP, V4, P1; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Coleman AW, 2000, PROTIST, V151, P1, DOI 10.1078/1434-4610-00002; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Darienko T, 2010, EUR J PHYCOL, V45, P79, DOI 10.1080/09670260903362820; Demchenko E, 2012, EUR J PHYCOL, V47, P264, DOI 10.1080/09670262.2012.678388; Dentinger BTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025081; DeSalle R, 2006, CONSERV BIOL, V20, P1545, DOI 10.1111/j.1523-1739.2006.00543.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ettl H, 2014, SYLLABUS BODEN LUFT; Falagan C, 2014, FEMS MICROBIOL ECOL, V87, P231, DOI 10.1111/1574-6941.12218; Fontaneto D, 2015, MAR BIODIV IN PRESS; Fott B, 1976, ALGOLOGICAL STUDIES, V17, P382; Garbayo I, 2012, J PHYCOL, V48, P607, DOI 10.1111/j.1529-8817.2012.01160.x; Gartner G, 1993, MITT ABT BOT LANDESM, V21, P33; Gibson A, 2005, MOL BIOL EVOL, V22, P251, DOI 10.1093/molbev/msi012; Gustavs L, 2009, AQUAT MICROB ECOL, V55, P95, DOI 10.3354/ame01291; Hall JD, 2010, CRYPTOGAMIE ALGOL, V31, P529; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Higgs PG, 2003, J MOL EVOL, V57, P435, DOI 10.1007/s00239-003-2494-6; Hudelot C, 2003, MOL PHYLOGENET EVOL, V28, P241, DOI 10.1016/S1055-7903(03)00061-7; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaag O, 1934, BER SCHWEIZ BOT GES, V34, P79; Jaag O, 1933, BEITR KRYPTOGAM SCHW, V8, P1; Jow H, 2002, MOL BIOL EVOL, V19, P1591, DOI 10.1093/oxfordjournals.molbev.a004221; Kiss L, 2012, P NATL ACAD SCI USA, V109, pE1811, DOI 10.1073/pnas.1207143109; Kitzing C, 2014, MICROB ECOL, V67, P327, DOI 10.1007/s00248-013-0317-x; Komarek J., 1983, PHYTOPLANKTON SUSSWA; KRIENITZ L, 1994, BIOLOGIA, V49, P463; Krienitz L, 2012, HYDROBIOLOGIA, V698, P295, DOI 10.1007/s10750-012-1079-z; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Lohtander K, 2003, LICHENOLOGIST, V35, P325, DOI 10.1016/S0024-2829(03)00051-3; Luo W, 2006, PROTIST, V157, P315, DOI 10.1016/j.protis.2006.05.006; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McNeill J, 2012, REGNUM VEG, V154, P1; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; PEVELING E, 1976, NEW PHYTOL, V77, P713, DOI 10.1111/j.1469-8137.1976.tb04665.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Proschold T, 2011, ENVIRON MICROBIOL, V13, P350, DOI 10.1111/j.1462-2920.2010.02333.x; Proschold T, 2001, PROTIST, V152, P265, DOI 10.1078/1434-4610-00068; Proschold Thomas, 2007, Systematics Association Special Volume Series, V75, P123; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rivasseau C, 2013, ENERG ENVIRON SCI, V6, P1230, DOI 10.1039/c2ee23129h; Rodriguez F, 2008, DIS AQUAT ORGAN, V81, P231, DOI 10.3354/dao01956; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schlosser UG, 1997, BOT ACTA, V110, P424, DOI 10.1111/j.1438-8677.1997.tb00659.x; Schmidle W, 1901, BERICHTE DTSCH BOT G, V19, P10; Schoch CL, 2012, P NATL ACAD SCI USA, V109, pE1812, DOI 10.1073/pnas.1207508109; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Seibel Philipp N, 2008, BMC Res Notes, V1, P91, DOI 10.1186/1756-0500-1-91; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Siebert S, 2005, BIOINFORMATICS, V21, P3352, DOI 10.1093/bioinformatics/bti550; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEVENSON R N, 1974, British Phycological Journal, V9, P319; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Syasina IG, 2012, J INVERTEBR PATHOL, V111, P175, DOI 10.1016/j.jip.2012.08.001; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Telford MJ, 2005, MOL BIOL EVOL, V22, P1129, DOI 10.1093/molbev/msi099; Tillier E, 1998, J MOL EVOL, V39, P409; Tremouillaux-Guiller J, 2007, PLANTA, V226, P553, DOI 10.1007/s00425-007-0526-y; Vazquez N, 2010, J INVERTEBR PATHOL, V105, P254, DOI 10.1016/j.jip.2010.07.005; Verma V, 2009, J PHYCOL, V45, P847, DOI 10.1111/j.1529-8817.2009.00718.x; Vinatzer G, 1975, THESIS U INNSBRUCK A; VISCHER WILHELM, 1932, ARCH PROTISTENK, V76, P257; Wuyts J, 2000, NUCLEIC ACIDS RES, V28, P4698, DOI 10.1093/nar/28.23.4698; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zimmermann J, 2011, ORG DIVERS EVOL, V11, P173, DOI 10.1007/s13127-011-0050-6; Zoller S, 2003, MOL PHYLOGENET EVOL, V29, P629, DOI 10.1016/S1055-7903(03)00215-X; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	83	98	104	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0127838	10.1371/journal.pone.0127838	http://dx.doi.org/10.1371/journal.pone.0127838			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080086	Green Submitted, gold, Green Published			2022-12-27	WOS:000356542300006
J	Zhu, Z; Zhao, XM; Zhao, YF; Wang, XY; Zhou, CW				Zhu, Zheng; Zhao, Xin-ming; Zhao, Yan-feng; Wang, Xiao-yi; Zhou, Chun-wu			Feasibility Study of Using Gemstone Spectral Imaging (GSI) and Adaptive Statistical Iterative Reconstruction (ASIR) for Reducing Radiation and Iodine Contrast Dose in Abdominal CT Patients with High BMI Values	PLOS ONE			English	Article							LOW-TUBE-VOLTAGE; QUALITY; EXPOSURE; NOISE; RISK	Purpose To prospectively investigate the effect of using Gemstone Spectral Imaging (GSI) and adaptive statistical iterative reconstruction (ASIR) for reducing radiation and iodine contrast dose in abdominal CT patients with high BMI values. Materials and Methods 26 patients (weight > 65kg and BMI >= 22) underwent abdominal CT using GSI mode with 300mgI/kg contrast material as study group (group A). Another 21 patients (weight <= 65kg and BMI >= 22) were scanned with a conventional 120 kVp tube voltage for noise index (NI) of 11 with 450mgI/kg contrast material as control group (group B). GSI images were reconstructed at 60keV with 50% ASIR and the conventional 120kVp images were reconstructed with FBP reconstruction. The CT values, standard deviation (SD), signal-noise-ratio (SNR), contrast-noise-ratio (CNR) of 26 landmarks were quantitatively measured and image quality qualitatively assessed using statistical analysis. Results As for the quantitative analysis, the difference of CNR between groups A and B was all significant except for the mesenteric vein. The SNR in group A was higher than B except the mesenteric artery and splenic artery. As for the qualitative analysis, all images had diagnostic quality and the agreement for image quality assessment between the reviewers was substantial (kappa = 0.684). CT dose index (CTDI) values for non-enhanced, arterial phase and portal phase in group A were decreased by 49.04%, 40.51% and 40.54% compared with group B (P = 0.000), respectively. The total dose and the injection rate for the contrast material were reduced by 14.40% and 14.95% in A compared with B. Conclusion The use of GSI and ASIR provides similar enhancement in vessels and image quality with reduced radiation dose and contrast dose, compared with the use of conventional scan protocol.	[Zhu, Zheng; Zhao, Xin-ming; Zhao, Yan-feng; Wang, Xiao-yi; Zhou, Chun-wu] Chinese Acad Med Sci, Canc Inst & Hosp, Peking Union Med Coll, Dept Diagnost Radiol, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College	Zhao, XM (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Peking Union Med Coll, Dept Diagnost Radiol, Beijing 100021, Peoples R China.	xinmingzh@sina.com	Zhao, Yanfeng/GQQ-8053-2022					Amis E Stephen Jr, 2007, J Am Coll Radiol, V4, P272, DOI 10.1016/j.jacr.2007.03.002; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Funama Y, 2005, RADIOLOGY, V237, P905, DOI 10.1148/radiol.2373041643; Gervaise A, 2012, EUR RADIOL, V22, P295, DOI 10.1007/s00330-011-2271-7; Kalra MK, 2004, RADIOLOGY, V230, P619, DOI 10.1148/radiol.2303021726; Korn A, 2012, AM J NEURORADIOL, V33, P218, DOI 10.3174/ajnr.A2749; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lauer MS, 2009, NEW ENGL J MED, V361, P841, DOI 10.1056/NEJMp0904735; Leipsic J, 2010, AM J ROENTGENOL, V195, P649, DOI 10.2214/AJR.10.4285; Maldjian PD, 2013, AM J ROENTGENOL, V200, P741, DOI 10.2214/AJR.12.9768; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; Mettler FA, 2009, RADIOLOGY, V253, P520, DOI 10.1148/radiol.2532082010; Nakayama Y, 2005, RADIOLOGY, V237, P945, DOI 10.1148/radiol.2373041655; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pontana F, 2011, EUR RADIOL, V21, P627, DOI 10.1007/s00330-010-1990-5; Singh S, 2011, RADIOLOGY, V259, P565, DOI 10.1148/radiol.11101450; SVANHOLM H, 1989, APMIS, V97, P689, DOI 10.1111/j.1699-0463.1989.tb00464.x; Thrall JH, 2012, RADIOLOGY, V264, P325, DOI 10.1148/radiol.12121137; Wagner LK, 2004, RADIOLOGY, V233, P307, DOI 10.1148/radiol.2332040584; Yeh BM, 2009, AM J ROENTGENOL, V193, P47, DOI 10.2214/AJR.09.2592; Yoshinaga S, 2004, RADIOLOGY, V233, P313, DOI 10.1148/radiol.2332031119; Zhang D, 2011, MED PHYS, V38, P1178, DOI 10.1118/1.3551999	22	18	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129201	10.1371/journal.pone.0129201	http://dx.doi.org/10.1371/journal.pone.0129201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079259	Green Published, gold, Green Submitted			2022-12-27	WOS:000356542300019
J	Bollmann, F; Jackel, S; Schmidtke, L; Schrick, K; Reinhardt, C; Jurk, K; Wu, ZX; Xia, N; Li, HG; Erkel, G; Walter, U; Kleinert, H; Pautz, A				Bollmann, Franziska; Jaeckel, Sven; Schmidtke, Lisa; Schrick, Katharina; Reinhardt, Christoph; Jurk, Kerstin; Wu, Zhixiong; Xia, Ning; Li, Huige; Erkel, Gerhard; Walter, Ulrich; Kleinert, Hartmut; Pautz, Andrea			Anti-Inflammatory and Anti-Thrombotic Effects of the Fungal Metabolite Galiellalactone in Apolipoprotein E-Deficient Mice	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; ALPHA BLOCKADE; TNF-ALPHA; ATHEROSCLEROSIS; INFLAMMATION; RECRUITMENT; MECHANISMS; GENERATION; INHIBITOR	Patients suffering from chronic inflammatory diseases have an increased mortality risk resulting from cardiovascular disorders due to enhanced atherosclerotic and thrombotic events. Until now, it is not completely understood in which way an abnormal expression of pro-inflammatory mediators contributes to this elevated cardiovascular risk, but there is a need for new drugs that on the one hand suppress the expression of pro-inflammatory mediators and on the other hand inhibit arterial platelet adhesion. Thus, we analyzed the anti-inflammatory and anti-thrombotic capacity of the fungal metabolite Galiellalactone in atherosclerosis-prone apolipoprotein E-deficient mice. Treatment of the mice with Galiellalactone lowered the inflammatory expression profile and improved blood clotting times, as well as platelet adhesion to the injured common carotid artery. The results indicate that administration of Galiellalactone is able to reduce the extent of inflammation and arterial platelet adhesion in this mouse model.	[Bollmann, Franziska; Schmidtke, Lisa; Schrick, Katharina; Wu, Zhixiong; Xia, Ning; Li, Huige; Kleinert, Hartmut; Pautz, Andrea] Johannes Gutenberg Univ Mainz, Dept Pharmacol, Univ Med Ctr, Mainz, Germany; [Bollmann, Franziska; Jaeckel, Sven; Reinhardt, Christoph; Jurk, Kerstin; Walter, Ulrich] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Thrombosis & Hemostasis CTH, D-55122 Mainz, Germany; [Erkel, Gerhard] Tech Univ Kaiserslautern, Dept Mol Biotechnol & Syst Biol, Kaiserslautern, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Kaiserslautern	Kleinert, H (corresponding author), Johannes Gutenberg Univ Mainz, Dept Pharmacol, Univ Med Ctr, Mainz, Germany.	kleinert@uni-mainz.de	Jurk, Kerstin/AAT-7768-2020; Li, Huige/M-2662-2013; Kleinert, Hartmut/M-2988-2018; Walter, ulrich/W-2478-2017; Xia, Ning/P-3535-2015; Xia, Ning/AFT-8078-2022	Li, Huige/0000-0003-3458-7391; Kleinert, Hartmut/0000-0003-2202-3548; Walter, ulrich/0000-0001-6784-2307; Xia, Ning/0000-0002-5553-1752; Xia, Ning/0000-0002-5553-1752	Federal Ministry of Education and Research BMBF [01EO1003]; Innovation Foundation of the State of Rhineland-Palatinate [961-386261/917K, 961-386261/1105AP]; DFG [LI 1759/1-1, RE 3450/3-1, PA 1933/2-3]	Federal Ministry of Education and Research BMBF(Federal Ministry of Education & Research (BMBF)); Innovation Foundation of the State of Rhineland-Palatinate; DFG(German Research Foundation (DFG))	Funding provided by Federal Ministry of Education and Research BMBF 01EO1003 http://www.bmbf.de/ (UW); Innovation Foundation of the State of Rhineland-Palatinate 961-386261/917K http://stiftung-innovation.rlp.de/ (HK); Innovation Foundation of the State of Rhineland-Palatinate 961-386261/1105AP http://stiftung-innovation.rlp.de/ (AP); DFG LI 1759/1-1 http://www.dfg.de/ (HK); DFG RE 3450/3-1 http://www.dfg.de/ (CR); DFG PA 1933/2-3 http://www.dfg.de/ (AP).	Al-Aly Z, 2011, TRANSL RES, V157, P10, DOI 10.1016/j.trsl.2010.09.005; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Bollmann F, 2014, NUCLEIC ACIDS RES, V42, P12555, DOI 10.1093/nar/gku1033; Bosello S, 2008, CLIN RHEUMATOL, V27, P833, DOI 10.1007/s10067-007-0803-y; Castro C, 2005, FRONT BIOSCI-LANDMRK, V10, P1932, DOI 10.2741/1669; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; Don-Doncow N, 2014, J BIOL CHEM, V289, P15969, DOI 10.1074/jbc.M114.564252; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Goodson N, 2005, ANN RHEUM DIS, V64, P1595, DOI 10.1136/ard.2004.034777; Greenberg JD, 2011, ANN RHEUM DIS, V70, P576, DOI 10.1136/ard.2010.129916; Grignani G, 2000, HAEMATOLOGICA, V85, P967; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Hausding M, 2011, INT IMMUNOL, V23, P1, DOI 10.1093/intimm/dxq451; Kalz J, 2014, J THROMB THROMBOLYS, V37, P45, DOI 10.1007/s11239-013-1026-5; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madhur MS, 2011, ARTERIOSCL THROM VAS, V31, P1565, DOI 10.1161/ATVBAHA.111.227629; Magro F, 2014, WORLD J GASTROENTERO, V20, P4857, DOI 10.3748/wjg.v20.i17.4857; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; McNeill E, 2010, CLIN SCI, V118, P641, DOI 10.1042/CS20090488; Noh JR, 2011, ANN NUTR METAB, V59, P145, DOI 10.1159/000334264; Ohta H, 2005, ATHEROSCLEROSIS, V180, P11, DOI 10.1016/j.atherosclerosis.2004.11.016; Perez M, 2014, CHEM-BIOL INTERACT, V214, P69, DOI 10.1016/j.cbi.2014.02.012; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; Roman MJ, 2006, ANN INTERN MED, V144, P249, DOI 10.7326/0003-4819-144-4-200602210-00006; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Schmidt N, 2012, J PHARMACOL EXP THER, V343, P106, DOI 10.1124/jpet.112.192047; Stoll G, 2006, STROKE, V37, P1923, DOI 10.1161/01.STR.0000226901.34927.10; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Weidler M, 2000, FEBS LETT, V484, P1, DOI 10.1016/S0014-5793(00)02115-3	36	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130401	10.1371/journal.pone.0130401	http://dx.doi.org/10.1371/journal.pone.0130401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076475	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900170
J	Chan, WK; Howe, K; Clegg, JM; Guimond, SE; Price, DJ; Turnbull, JE; Pratt, T				Chan, Wai Kit; Howe, Katherine; Clegg, James M.; Guimond, Scott E.; Price, David J.; Turnbull, Jeremy E.; Pratt, Thomas			2-O Heparan Sulfate Sulfation by Hs2st Is Required for Erk/Mapk Signalling Activation at the Mid-Gestational Mouse Telencephalic Midline	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FACTOR RECEPTOR; CRYSTAL-STRUCTURE; FGF; SPECIFICITY; EXPRESSION; PROLIFERATION; NEUROGENESIS; NEURONS; BINDING	Heparan sulfate (HS) is a linear carbohydrate composed of polymerized uronateglucosamine disaccharide units that decorates cell surface and secreted glycoproteins in the extracellular matrix. In mammals HS is subjected to differential sulfation by fifteen different heparan sulfotransferase (HST) enzymes of which Hs2st uniquely catalyzes the sulfation of the 2-O position of the uronate in HS. HS sulfation is postulated to be important for regulation of signaling pathways by facilitating the interaction of HS with signaling proteins including those of the Fibroblast Growth Factor (Fgf) family which signal through phosphorylation of extracellular signal-regulated kinases Erk1/2. In the developing mouse telencephalon Fgf2 signaling regulates proliferation and neurogenesis. Loss of Hs2st function phenocopies the thinned cerebral cortex of mutant mice in which Fgf2 or Erk1/2 function are abrogated, suggesting the hypothesis that 2-O-sulfated HS structures play a specific role in Fgf2/Erk signaling pathway in this context in vivo. This study investigated the molecular role of 2-O sulfation in Fgf2/Erk signaling in the developing telencephalic midline midway through mouse embryogenesis at E12.5. We examined the expression of Hs2st, Fgf2, and Erk1/2 activity in wild-type and Hs2st(-/-) mice. We found that Hs2st is expressed at high levels at the midline correlating with high levels of Erk1/2 activation and Erk1/2 activation was drastically reduced in the Hs2st(-/-) mutant at the rostral telencephalic midline. We also found that 2-O sulfation is specifically required for the binding of Fgf2 protein to Fgfr1, its major cell-surface receptor at the rostral telencephalic midline. We conclude that 2-O sulfated HS structures generated by Hs2st are needed to form productive signaling complexes between HS, Fgf2 and Fgfr1 that activate Erk1/2 at the midline. Overall, our data suggest the interesting possibility that differential expression of Hs2st targets the rostral telencephalic midline for high levels of Erk signaling by increasing the sensitivity of cells to an Fgf2 signal that is rather more widespread.	[Chan, Wai Kit; Howe, Katherine; Clegg, James M.; Price, David J.; Pratt, Thomas] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Guimond, Scott E.; Turnbull, Jeremy E.] Univ Liverpool, Inst Integrat Biol, Dept Biochem, Ctr Glycobiol, Liverpool L69 7ZB, Merseyside, England	University of Edinburgh; University of Liverpool	Pratt, T (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	t.pratt@ed.ac.uk		Price, David/0000-0002-5318-307X; Chan, Kit Yee/0000-0002-3465-8383; Chan, Wai Kit/0000-0002-8097-0802; Pratt, Thomas/0000-0002-7105-3527; Guimond, Scott/0000-0002-5903-418X	MRC [G0701460]; Darwin International Scholarship; University of Edinburgh Global Research Scholarship; Medical Research Council [G0701460]; Wellcome Trust [094832/Z/10/Z]; Biotechnology and Biological Sciences Research Council [BB/M00693X/1] Funding Source: researchfish; BBSRC [BB/M00693X/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Darwin International Scholarship; University of Edinburgh Global Research Scholarship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grants to TP from the MRC (G0701460). WKC is supported by a studentship from the Darwin International Scholarship and University of Edinburgh Global Research Scholarship. This work was also supported by the Medical Research Council (Grant G0701460), http://www.mrc.ac.uk/, and The Wellcome Trust (Grants 094832/Z/10/Z), http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; Bansal R, 2003, DEV NEUROSCI-BASEL, V25, P83, DOI 10.1159/000072258; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Carlsson Pernilla, 2012, Handb Exp Pharmacol, P23, DOI 10.1007/978-3-642-23056-1_2; Clegg JM, 2014, J NEUROSCI, V34, P2389, DOI 10.1523/JNEUROSCI.3157-13.2014; Conway CD, 2011, J NEUROSCI, V31, P1955, DOI 10.1523/JNEUROSCI.2579-10.2011; Guimond SE, 2009, J BIOL CHEM, V284, P25714, DOI 10.1074/jbc.M109.032755; HABUCHI H, 1992, BIOCHEM J, V285, P805, DOI 10.1042/bj2850805; Holt CE, 2005, NEURON, V46, P169, DOI 10.1016/j.neuron.2005.03.021; Iwata T, 2009, DEV GROWTH DIFFER, V51, P299, DOI 10.1111/j.1440-169X.2009.01104.x; Kinnunen T, 2005, P NATL ACAD SCI USA, V102, P1507, DOI 10.1073/pnas.0401591102; Kobayashi M, 1997, J BIOL CHEM, V272, P13980, DOI 10.1074/jbc.272.21.13980; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lee JS, 2004, NAT REV GENET, V5, P923, DOI 10.1038/nrg1490; Liu X, 2014, CELL SIGNAL; Loo BM, 2000, INT J BIOCHEM CELL B, V32, P489, DOI 10.1016/S1357-2725(99)00145-4; MACCARANA M, 1994, J BIOL CHEM, V269, P3903; McLaughlin D, 2003, MECH DEVELOP, V120, P1481, DOI 10.1016/j.mod.2003.08.008; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Pan Y, 2006, DEVELOPMENT, V133, P4933, DOI 10.1242/dev.02679; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Pucilowska J, 2012, J NEUROSCI, V32, P8663, DOI 10.1523/JNEUROSCI.1107-12.2012; Qu XX, 2011, J BIOL CHEM, V286, P14435, DOI 10.1074/jbc.M111.225003; Raballo R, 2000, J NEUROSCI, V20, P5012; Sahara S, 2009, NEURON, V63, P48, DOI 10.1016/j.neuron.2009.06.006; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Shin DM, 2004, J NEUROSCI, V24, P2247, DOI 10.1523/JNEUROSCI.5285-03.2004; Skidmore MA, 2006, J CHROMATOGR A, V1135, P52, DOI 10.1016/j.chroma.2006.09.064; Skidmore MA, 2010, NAT PROTOC, V5, P1983, DOI 10.1038/nprot.2010.145; Stauber DJ, 2000, P NATL ACAD SCI USA, V97, P49, DOI 10.1073/pnas.97.1.49; Toyoda R, 2010, DEVELOPMENT, V137, P3439, DOI 10.1242/dev.055392; Vaccarino FM, 2009, J AUTISM DEV DISORD, V39, P511, DOI 10.1007/s10803-008-0653-8; Vaccarino FM, 1999, NAT NEUROSCI, V2, P485, DOI 10.1038/8163; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004	40	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130147	10.1371/journal.pone.0130147	http://dx.doi.org/10.1371/journal.pone.0130147			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075383	Green Published, gold			2022-12-27	WOS:000356329900144
J	Diaz, A; Perez, A; Sreevatsan, S; Davies, P; Culhane, M; Torremorell, M				Diaz, Andres; Perez, Andres; Sreevatsan, Srinand; Davies, Peter; Culhane, Marie; Torremorell, Montserrat			Association between Influenza A Virus Infection and Pigs Subpopulations in Endemically Infected Breeding Herds	PLOS ONE			English	Article							PANDEMIC H1N1 2009; UNITED-STATES; SWINE; DYNAMICS; SURVEILLANCE; TRANSMISSION; EVOLUTION; H3N2	Influenza A viruses (IAVs) are distributed worldwide in birds, pigs and humans, and cause important endemic disease affecting hosts in all countries. Although pigs play a key role in the ecology of IAVs, the epidemiology of IAVs within swine herds is poorly understood. In this longitudinal study we describe the prevalence of IAVs infection in three subpopulations of pigs in 5 breeding herds in the Midwestern USA. Each herd was sampled monthly for a year and, at each visit, 30 individual nasal swabs were collected from the three subpopulations, namely, a) replacement females, resident on-farm for less than 4 weeks (new gilts), b) replacement females, resident on-farmfor more than 4 weeks (gilts), and c) neonatal pigs less than 21 days of age (piglets). Real time reverse transcriptase polymerase chain reaction (RRT-PCR) was used to detect IAVs, and the association between IAVs infection and pig subpopulation was measured using a mixed logistic regression model. Nasal swabs (n = 4,190) were collected from 141 groups of pigs. At least, one IAV-positive nasal swab was found in 19.9%(n = 28) of the sampled groups, and 7.7% (n = 324) of all nasal swabs tested positive. After adjusting by annual quarter and sampling event, the odds of testing IAV positive were 7.9 (95% CI 1.4, 43.9) and 4.4 (95% CI 1.1, 17.1) times higher in groups of new gilts and piglets compared to groups of gilts, respectively. Results indicate that new gilts and piglets had higher odds of testing IAV positive than gilts in swine breeding herds and that season influences IAV infection in pigs. Based on these findings, we recommend that IAV control strategies be aimed at preventing infection before gilts are introduced into the farm, and in pigs prior to weaning.	[Diaz, Andres; Perez, Andres; Sreevatsan, Srinand; Davies, Peter; Culhane, Marie; Torremorell, Montserrat] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Torremorell, M (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	torr0033@umn.edu	Culhane, Marie/H-3143-2019; Sreevatsan, Srinand/V-6808-2019; Perez, Andres/HGD-8377-2022	Sreevatsan, Srinand/0000-0002-5162-2403; Culhane, Marie/0000-0002-3547-7576	NIH, National Institute of Allergy and Infectious Diseases; Department of Health and Human Services [HHSN266200700007C]; COLCIENCIAS: Departamento Administrativo de Ciencia, Tecnologia e Innovacion	NIH, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Health and Human Services; COLCIENCIAS: Departamento Administrativo de Ciencia, Tecnologia e Innovacion(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This study was supported in whole or in part with federal funds from the NIH, National Institute of Allergy and Infectious Diseases and Department of Health and Human Services under the contract No. HHSN266200700007C and COLCIENCIAS: Departamento Administrativo de Ciencia, Tecnologia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerson M, 2012, TRANSBOUNDA IN PRESS; Allerson MW, 2014, TRANSBOUND EMERG DIS, V61, P490, DOI 10.1111/tbed.12053; Anderson TK, 2013, INFLUENZA OTHER RESP, V7, P42, DOI 10.1111/irv.12193; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; CHAMBERS TM, 1991, ARCH VIROL, V116, P261, DOI 10.1007/BF01319247; Chen RB, 2010, J MOL EVOL, V70, P98, DOI 10.1007/s00239-009-9312-8; Corzo CA, 2013, EMERG INFECT DIS, V19, P954, DOI 10.3201/eid1906.121637; Corzo CA, 2012, J SWINE HEALTH PROD, V20, P283; Ducatez MF, 2011, EMERG INFECT DIS, V17, P1624, DOI 10.3201/eid1709.110338; HINSHAW VS, 1978, VIROLOGY, V84, P51, DOI 10.1016/0042-6822(78)90217-9; Knauer MT, 2013, J SWINE HEALTH PROD, V21, P248; Kyriakis CS, 2013, VET MICROBIOL, V162, P543, DOI 10.1016/j.vetmic.2012.11.014; Lesnoff M, 2012, AOD ANAL DISPERSED D; Maldonado J, 2006, VET J, V172, P377, DOI 10.1016/j.tvjl.2005.04.014; MEGURO H, 1979, J CLIN MICROBIOL, V9, P175; Meiners C, 2014, TIERARZTL PRAX AUSG, V42, DOI 10.15653/tpg-131130; Nelson MI, 2014, J VIROL, V88, P10110, DOI 10.1128/JVI.01080-14; Nelson MI, 2012, J GEN VIROL, V93, P2195, DOI 10.1099/vir.0.044974-0; Nelson MI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002077; Nelson MI, NAT COMMUN, P6696; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Olsen CW, 2000, ARCH VIROL, V145, P1399, DOI 10.1007/s007050070098; Poljak Z, 2014, INFLUENZA OTHER RESP, V8, P482, DOI 10.1111/irv.12248; Ramakrishnan MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007105; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Revelle W., 2014, PSYCH PROCEDURES PER; Sarkar D, 2008, USE R, P1; Schultz-Cherry S, 2013, CURR TOP MICROBIOL, V370, P21, DOI 10.1007/82_2011_197; Simon G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115815; Slomka MJ, 2010, INFLUENZA OTHER RESP, V4, P277, DOI 10.1111/j.1750-2659.2010.00149.x; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Spackman Erica, 2008, V436, P19, DOI 10.1007/978-1-59745-279-3_4; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Torremorell M, 2012, TRANSBOUND EMERG DIS, V59, P68, DOI 10.1111/j.1865-1682.2011.01300.x; Van Reeth K, 2008, INFLUENZA OTHER RESP, V2, P99, DOI 10.1111/j.1750-2659.2008.00043.x; Vincent AL, ADV VIRUS RES, V72, P127; Webby RJ, 2004, VIRUS RES, V103, P67, DOI 10.1016/j.virusres.2004.02.015; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	38	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129213	10.1371/journal.pone.0129213	http://dx.doi.org/10.1371/journal.pone.0129213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076494	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900053
J	Espinosa-Carrasco, G; Villard, M; Le Saout, C; Louis-Plence, P; Vicente, R; Hernandez, J				Espinosa-Carrasco, Gabriel; Villard, Marine; Le Saout, Cecile; Louis-Plence, Pascale; Vicente, Rita; Hernandez, Javier			Systemic LPS Translocation Activates Cross-Presenting Dendritic Cells but Is Dispensable for the Breakdown of CD8(+) T Cell Peripheral Tolerance in Irradiated Mice	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; TOTAL-BODY IRRADIATION; MEMORY-LIKE CD8(+); HOMEOSTATIC PROLIFERATION; CUTTING EDGE; MICROBIAL TRANSLOCATION; IMMUNE-SYSTEM; IN-VIVO; SELF-ANTIGENS; HELPER-CELLS	Lymphodepletion is currently used to enhance the efficacy of cytotoxic T lymphocyte adoptive transfer immunotherapy against cancer. This beneficial effect of conditioning regimens is due, at least in part, to promoting the breakdown of peripheral CD8(+) T cell tolerance. Lymphodepletion by total body irradiation induces systemic translocation of commensal bacteria LPS from the gastrointestinal tract. Since LPS is a potent activator of the innate immune system, including antigen presenting dendritic cells, we hypothesized that LPS translocation could be required for the breakdown of peripheral tolerance observed in irradiated mice. To address this issue, we have treated irradiated mice with antibiotics in order to prevent LPS translocation and utilized them in T cell adoptive transfer experiments. Surprisingly, we found that despite of completely blocking LPS translocation into the bloodstream, antibiotic treatment did not prevent the breakdown of peripheral tolerance. Although irradiation induced the activation of cross-presenting CD8(+) dendritic cells in the lymphoid tissue, LPS could not solely account for this effect. Activation of dendritic cells by mechanisms other than LPS translocation is sufficient to promote the differentiation of potentially autoreactive CD8(+) T cells into effectors in irradiated mice. Our data indicate that LPS translocation is dispensable for the breakdown of CD8(+) T cell tolerance in irradiated mice.	[Espinosa-Carrasco, Gabriel; Villard, Marine; Louis-Plence, Pascale; Vicente, Rita; Hernandez, Javier] INSERM, Inst Regenerat Med & Biotherapy, U1183, F-34295 Montpellier, France; [Espinosa-Carrasco, Gabriel; Villard, Marine; Louis-Plence, Pascale; Vicente, Rita; Hernandez, Javier] Univ Montpellier, UFR Med, F-34000 Montpellier, France; [Le Saout, Cecile] NIAID, CMRS, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hernandez, J (corresponding author), INSERM, Inst Regenerat Med & Biotherapy, U1183, F-34295 Montpellier, France.	francisco-javier.hernandez@inserm.fr	Espinosa Carrasco, Gabriel/AFR-8047-2022; Louis-Plence, Pascale/H-1553-2015	Louis-Plence, Pascale/0000-0001-7701-5241; VILLARD, Marine/0000-0002-3905-8993; Hernandez, Javier/0000-0002-7218-7519	European Community SUDOE-FEDER [IMMUNONET SOE1/P1/E014]; La Ligue Contre le Cancer Herault	European Community SUDOE-FEDER; La Ligue Contre le Cancer Herault	This work was supported by grants from the European Community SUDOE-FEDER (Contract # IMMUNONET SOE1/P1/E014) and La Ligue Contre le Cancer Herault to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Bogdandi EN, 2010, RADIAT RES, V174, P480, DOI 10.1667/RR2160.1; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2012, ANNU REV IMMUNOL, V30, P149, DOI 10.1146/annurev-immunol-020711-075001; Brown IE, 2006, J IMMUNOL, V177, P4521, DOI 10.4049/jimmunol.177.7.4521; Caradonna L, 2000, J ENDOTOXIN RES, V6, P205, DOI 10.1177/09680519000060030101; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; Cooke KR, 1998, J CLIN INVEST, V102, P1882, DOI 10.1172/JCI4285; Cooke KR, 2002, J ENDOTOXIN RES, V8, P441, DOI 10.1179/096805102125001046; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Dummer W, 2002, J CLIN INVEST, V110, P185, DOI 10.1172/JCI200215175; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Gallo PM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00138; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Hamilton-Williams EE, 2005, J IMMUNOL, V174, P1159, DOI 10.4049/jimmunol.174.3.1159; Hernandez J, 2002, J EXP MED, V196, P323, DOI 10.1084/jem.20011612; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; Hill GR, 1997, BLOOD, V90, P3204, DOI 10.1182/blood.V90.8.3204; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Jankovic D, 2013, J EXP MED, V210, P1899, DOI 10.1084/jem.20130084; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khoruts A, 2005, IMMUNOL LETT, V98, P23, DOI 10.1016/j.imlet.2004.10.022; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Langrehr JM, 2000, TRANSPLANTATION, V69, P2415, DOI 10.1097/00007890-200006150-00035; Le Saout C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012659; Le Saout C, 2008, P NATL ACAD SCI USA, V105, P19414, DOI 10.1073/pnas.0807743105; LO D, 1992, EUR J IMMUNOL, V22, P1013, DOI 10.1002/eji.1830220421; LUMSDEN AB, 1988, HEPATOLOGY, V8, P232, DOI 10.1002/hep.1840080207; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Morgan DJ, 1996, J IMMUNOL, V157, P978; Murali-Krishna K, 2000, J IMMUNOL, V165, P1733, DOI 10.4049/jimmunol.165.4.1733; NANDA NK, 1995, CELL, V82, P13, DOI 10.1016/0092-8674(95)90047-0; Oelert T, 2010, BLOOD, V115, P2196, DOI 10.1182/blood-2009-06-227298; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; Scott MJ, 2009, HEPATOLOGY, V49, P1695, DOI 10.1002/hep.22839; Shalapour S, 2010, EUR J IMMUNOL, V40, P2391, DOI 10.1002/eji.201040441; Sirinivasan M, 2009, CYTOKINE, V46, P147, DOI 10.1016/j.cyto.2009.01.010; Surana NK, 2014, J CLIN INVEST, V124, P4197, DOI 10.1172/JCI72332; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Xing Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006957	59	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130041	10.1371/journal.pone.0130041	http://dx.doi.org/10.1371/journal.pone.0130041			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075613	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900127
J	Inoue, S; Kobayashi, F; Nishihara, M; Arai, YCP; Ikemoto, T; Kawai, T; Inoue, M; Hasegawa, T; Ushida, T				Inoue, Shinsuke; Kobayashi, Fumio; Nishihara, Makoto; Arai, Young-Chang P.; Ikemoto, Tatsunori; Kawai, Takashi; Inoue, Masayuki; Hasegawa, Tomomi; Ushida, Takahiro			Chronic Pain in the Japanese Community-Prevalence, Characteristics and Impact on Quality of Life	PLOS ONE			English	Article							PRIMARY-CARE PATIENTS; GENERAL-POPULATION; MUSCULOSKELETAL PAIN; RHEUMATOID-ARTHRITIS; WEATHER SENSITIVITY; EPIDEMIOLOGY; DEPRESSION; ASSOCIATION; DISABILITY; COMPLAINTS	Background Chronic pain is recognized as a public health problem that affects the general population physically, psychologically, and socially. However, there is little knowledge about the associated factors of chronic pain, such as the influence of weather, family structure, daily exercise, and work status. Objectives This survey had three aims: 1) to estimate the prevalence of chronic pain in Japan, 2) to analyze these associated factors, and 3) to evaluate the social burden due to chronic pain. Methods We conducted a cross-sectional postal survey in a sample of 6000 adults aged >= 20 years. The response rate was 43.8%. Results The mean age of the respondents was 57.7 years (range 20-99 years); 39.3% met the criteria for chronic pain (lasting >= 3 months). Approximately a quarter of the respondents reported that their chronic pain was adversely influenced by bad weather and also oncoming bad weather. Risk factors for chronic pain, as determined by a logistic regression model, included being an older female, being unemployed, living alone, and no daily exercise. Individuals with chronic pain showed significantly lower quality of life and significantly higher psychological distress scores than those without chronic pain. The mean annual duration of absence from work of working-age respondents was 9.6 days (range 1-365 days). Conclusions Our findings revealed that high prevalence and severity of chronic pain, associated factors, and significant impact on quality of life in the adult Japanese population. A detailed understanding of factors associated with chronic pain is essential for establishing a management strategy for primary care.	[Inoue, Shinsuke; Nishihara, Makoto; Arai, Young-Chang P.; Kawai, Takashi; Ushida, Takahiro] Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakuteshi, Aichi 4801195, Japan; [Kobayashi, Fumio; Hasegawa, Tomomi] Aichi Med Univ, Dept Hlth & Psychosocial Med, Nagakuteshi, Aichi 4801195, Japan; [Ikemoto, Tatsunori; Inoue, Masayuki] Aichi Med Univ, Sch Med, Inst Phys Fitness Sports Med & Rehabil, Nagakuteshi, Aichi 4801195, Japan	Aichi Medical University; Aichi Medical University; Aichi Medical University	Inoue, S (corresponding author), Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakuteshi, Aichi 4801195, Japan.	misty-ssk@umin.net	Ikemoto, Tatsunori/E-3839-2018	Ikemoto, Tatsunori/0000-0002-4521-7639	Ministry of Health, Labour and Welfare of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was a multidisciplinary research project supported by a Grant-in-Aid (2010-2013) for Scientific Research from the Ministry of Health, Labour and Welfare of Japan. http://www.mhlw.go.jp/english/.	ANDERSSON HI, 1993, CLIN J PAIN, V9, P174, DOI 10.1097/00002508-199309000-00004; [Anonymous], 2012, JAP STAT YB; ARAMOTO H, 2003, J JPN COLL ANGIOL, V43, P9; Azevedo LF, 2012, J PAIN, V13, P773, DOI 10.1016/j.jpain.2012.05.012; Bair MJ, 2008, PSYCHOSOM MED, V70, P890, DOI 10.1097/PSY.0b013e318185c510; Becker N, 2000, PAIN, V84, P203, DOI 10.1016/S0304-3959(99)00209-2; Blyth FM, 2001, PAIN, V89, P127, DOI 10.1016/S0304-3959(00)00355-9; BOWSHER D, 1991, Pain Clinic, V4, P223; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Catala E, 2002, EUR J PAIN-LONDON, V6, P133, DOI 10.1053/eujp.2001.0310; CROFT P, 1993, J RHEUMATOL, V20, P710; CROOK J, 1984, PAIN, V18, P299, DOI 10.1016/0304-3959(84)90824-8; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Gorin AA, 1999, PAIN, V81, P173, DOI 10.1016/S0304-3959(99)00010-X; Guo HR, 1999, AM J PUBLIC HEALTH, V89, P1029, DOI 10.2105/AJPH.89.7.1029; Hachimori A, 2009, JPN J GERIATRIC PSYC, V20, P1009; Hattori S, 2004, PAIN CLINIC, V25, P1541; Hildebrandt VH, 2002, ERGONOMICS, V45, P32, DOI 10.1080/00140130110110629; Ikeda S, 2001, QOL MEASUREMENT HDB; Johannes CB, 2010, J PAIN, V11, P1230, DOI 10.1016/j.jpain.2010.07.002; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kurita GP, 2012, PAIN, V153, P2332, DOI 10.1016/j.pain.2012.07.023; Ministry of Health Labour and Welfare Japan, FIN REP MONTHL LAB S; Mitchell SW, 1877, AM J MED SCI, V73, P305; Moulin Dwight E, 2002, Pain Res Manag, V7, P179; Nakamae T, 2010, PSYCHIAT CLIN NEUROS, V64, P372, DOI 10.1111/j.1440-1819.2010.02100.x; Nakamura M, 2011, J ORTHOP SCI, V16, P424, DOI 10.1007/s00776-011-0102-y; National Tax Agency Japan, NAT TAX AG REP 2012; Neville A, 2008, ISR MED ASSOC J, V10, P676; Ng KFJ, 2002, CLIN J PAIN, V18, P275, DOI 10.1097/00002508-200209000-00001; Oga T, 2003, QUAL LIFE RES, V12, P555, DOI 10.1023/A:1025051829223; Ohayon MM, 2004, J CLIN PSYCHIAT, V65, P5; PATBERG WR, 1985, J RHEUMATOL, V12, P711; Pizzi LT, 2005, DIS MANAG HEALTH OUT, V13, P201, DOI 10.2165/00115677-200513030-00005; Raftery MN, 2011, PAIN, V152, P1096, DOI 10.1016/j.pain.2011.01.019; Redelmeier DA, 1996, P NATL ACAD SCI USA, V93, P2895, DOI 10.1073/pnas.93.7.2895; Rustoen T, 2004, EUR J PAIN, V8, P555, DOI 10.1016/j.ejpain.2004.02.002; Sa KN, 2008, PAIN, V139, P498, DOI 10.1016/j.pain.2008.06.008; Sakamaki H, 2006, VALUE HEALTH, V9, P47, DOI 10.1111/j.1524-4733.2006.00080.x; Sato J, 2011, NEUROSCI LETT, V503, P152, DOI 10.1016/j.neulet.2011.08.030; Shibata M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090984; SHUTTY MS, 1992, PAIN, V49, P199, DOI 10.1016/0304-3959(92)90143-Y; SMITH GR, 1992, GEN HOSP PSYCHIAT, V14, P265, DOI 10.1016/0163-8343(92)90097-T; Soares JJF, 2004, EUR J PAIN, V8, P79, DOI 10.1016/S1090-3801(03)00083-1; Soares JJF, 2003, INT J BEHAV MED, V10, P181, DOI 10.1207/S15327558IJBM1002_07; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Strusberg I, 2002, J RHEUMATOL, V29, P335; Tajima R, 2010, CLIN EXP NEPHROL, V14, P340, DOI 10.1007/s10157-010-0304-1; Toblin RL, 2011, PAIN, V152, P1249, DOI 10.1016/j.pain.2010.12.036; Uehara M, 2013, SPINE J, V13, P391, DOI 10.1016/j.spinee.2012.11.012; VonKorff M, 1996, BRIT J PSYCHIAT, V168, P101, DOI 10.1192/S0007125000298474; Wilder FV, 2003, RHEUMATOLOGY, V42, P955, DOI 10.1093/rheumatology/keg264; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yeo SN, 2009, ANN ACAD MED SINGAP, V38, P937	55	77	80	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129262	10.1371/journal.pone.0129262	http://dx.doi.org/10.1371/journal.pone.0129262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076135	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900059
J	Ye, L; Yu, HS; Li, CW; Hirsch, ML; Zhang, LG; Samulski, RJ; Li, WP; Liu, Z				Ye, Lei; Yu, Haisheng; Li, Chengwen; Hirsch, Matthew L.; Zhang, Liguo; Samulski, R. Jude; Li, Wuping; Liu, Zhong			Adeno-Associated Virus Vector Mediated Delivery of the HBV Genome Induces Chronic Hepatitis B Virus Infection and Liver Fibrosis in Mice	PLOS ONE			English	Article							TAUROCHOLATE COTRANSPORTING POLYPEPTIDE; CHRONIC VIRAL-HEPATITIS; TRANSGENIC MICE; SURFACE-ANTIGEN; MOUSE MODEL; TUPAIA HEPATOCYTES; CARRIER STATE; T-LYMPHOCYTE; IN-VITRO; EXPRESSION	Liver cirrhosis and hepatocellular carcinomas are major health problems of chronic hepatitis B virus (HBV) infection. To date, rare model has reproduced liver fibrosis associated with long-term HBV infection which in turn has hindered both the understanding of HBV biology and the development of new treatment options. Here, using adeno-associated virus serotype 8 (AAV8) mediated delivery of a 1.2-kb HBV genome, we successfully generated a chronic HBV infectious mouse model that presents the associated liver fibrosis observed following human infection. After AAV8/HBV1.2 vector administration, mice demonstrated effective HBV replication and transcription which resulted in HBV antigen expression and viremia over 6 months. Although no obvious acute inflammatory response was noted, these mice still developed chronic liver disease and hepatic fibrogenesis as demonstrated by increased ground glass-like hepatocytes, an increasing trend of collagen deposition and upregulated fibrosis markers, including type I collagen, type III collagen, tissue inhibitor of metalloproteinase (TIMP), and transforming growth factor-beta 1(TGF-beta 1). Taken together, AAV-mediated HBV gene delivery to the mouse liver, induced HBV persistent infection accompanied by liver fibrosis which can serve as a model for investigating the precise mechanisms underlying liver fibrosis following chronic HBV infection as well as for the potential development of novel therapeutics.	[Ye, Lei; Li, Wuping; Liu, Zhong] Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Peoples R China; [Ye, Lei; Li, Wuping; Liu, Zhong] Peking Union Med Coll, Chengdu, Peoples R China; [Yu, Haisheng; Zhang, Liguo] Chinese Acad Sci, Inst Biophys, Key Lab Immun & Infect, Beijing 100080, Peoples R China; [Li, Chengwen; Hirsch, Matthew L.; Samulski, R. Jude] Univ N Carolina, Dept Pharmacol, Gene Therapy Ctr, Chapel Hill, NC USA; [Li, Wuping] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Chengdu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of North Carolina; University of North Carolina Chapel Hill; Chinese Academy of Medical Sciences - Peking Union Medical College	Li, WP (corresponding author), Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Peoples R China.	lwpzhr@sina.com	Liu, Zhong/ABH-8584-2020	liu, zhong/0000-0001-8173-9656; zhang, li guo/0000-0002-9795-0314	Peking Union Medical College graduated student innovation fund [2011-1001-033]; Institute of Pathogen Biology, Chinese Academy of Medical Sciences [2011IPB106]	Peking Union Medical College graduated student innovation fund; Institute of Pathogen Biology, Chinese Academy of Medical Sciences	Peking Union Medical College graduated student innovation fund, 2011-1001-033, LY. The basic grant of Institute of Pathogen Biology, Chinese Academy of Medical Sciences, 2011IPB106, WPL.	ARAKI K, 1989, P NATL ACAD SCI USA, V86, P207, DOI 10.1073/pnas.86.1.207; ARTHUR MJP, 1995, J HEPATOL, V22, P43; BARKER LF, 1973, J INFECT DIS, V127, P648, DOI 10.1093/infdis/127.6.648; Barrera A, 2005, J VIROL, V79, P9786, DOI 10.1128/JVI.79.15.9786-9798.2005; Baumert TF, 2005, HEPATOLOGY, V41, P247, DOI 10.1002/hep.20553; Bedossa P, 2003, J PATHOL, V200, P504, DOI 10.1002/path.1397; Bertoni R, 1998, J IMMUNOL, V161, P4447; Bility MT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004032; BRATTIG NW, 1983, HEPATOLOGY, V3, P638; Brunetto MR, 2013, J HEPATOL, V59, P1153, DOI 10.1016/j.jhep.2013.07.017; CHISARI FV, 1985, SCIENCE, V230, P1157, DOI 10.1126/science.3865369; CHISARI FV, 1995, HEPATOLOGY, V22, P1316, DOI 10.1016/0270-9139(95)90645-2; CHISARI FV, 1987, P NATL ACAD SCI USA, V84, P6909, DOI 10.1073/pnas.84.19.6909; Constandinou C, 2005, METH MOLEC MED, V117, P237; Dion S, 2013, J VIROL, V87, P5554, DOI 10.1128/JVI.03134-12; Dong QM, 2009, J VIROL METHODS, V159, P135, DOI 10.1016/j.jviromet.2009.03.012; DUSHEIKO GM, 1983, J CLIN INVEST, V71, P1104, DOI 10.1172/JCI110860; Eng FJ, 2000, AM J PHYSIOL-GASTR L, V279, pG7, DOI 10.1152/ajpgi.2000.279.1.G7; FERNAN A, 1989, CLIN EXP IMMUNOL, V76, P222; GERBER MA, 1974, AM J PATHOL, V75, P489; GERBER MA, 1974, P SOC EXP BIOL MED, V145, P863, DOI 10.3181/00379727-145-37912; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Gutierrez-Reyes G, 2007, ARCH MED RES, V38, P644, DOI 10.1016/j.arcmed.2006.10.001; HOOFNAGLE JH, 1987, HEPATOLOGY, V7, P758, DOI 10.1002/hep.1840070424; Hoofnagle JH, 1997, NEW ENGL J MED, V336, P347, DOI 10.1056/NEJM199701303360507; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Iredale JP, 1996, HEPATOLOGY, V24, P176, DOI 10.1002/hep.510240129; Isogawa M, 2005, VIROLOGY, V333, P293, DOI 10.1016/j.virol.2005.01.004; Ke L, 2011, TRANSFUSION, V51, P1909, DOI 10.1111/j.1537-2995.2011.03067.x; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kim H, 2008, RADIOLOGY, V247, P696, DOI 10.1148/radiol.2473070605; KNITTEL T, 1992, GASTROENTEROLOGY, V102, P1724, DOI 10.1016/0016-5085(92)91736-N; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Lalazar A, 1997, GENE, V195, P235, DOI 10.1016/S0378-1119(97)00159-5; Lau DTY, 1997, GASTROENTEROLOGY, V113, P1660, DOI 10.1053/gast.1997.v113.pm9352870; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; MABIT H, 1994, J GEN VIROL, V75, P2681, DOI 10.1099/0022-1317-75-10-2681; McMahon BJ, 2001, ANN INTERN MED, V135, P759, DOI 10.7326/0003-4819-135-9-200111060-00006; Nebbia G, 2012, QJM-INT J MED, V105, P109, DOI 10.1093/qjmed/hcr270; NOWICKI MJ, 1986, HEPATOLOGY, V6, P180, DOI 10.1002/hep.1840060205; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; PETERS M, 1991, HEPATOLOGY, V13, P977, DOI 10.1016/0270-9139(91)90273-X; Sprinzl MF, 2001, J VIROL, V75, P5108, DOI 10.1128/JVI.75.11.5108-5118.2001; TSUKAMOTO H, 1990, SEMIN LIVER DIS, V10, P56, DOI 10.1055/s-2008-1040457; World health organisation (WHO), 2015, GLOB ACT PLAN ANT RE, V19; Wu EX, 2007, MAGN RESON MED, V58, P687, DOI 10.1002/mrm.21350; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; YAMADA G, 1993, INTERNAL MED, V32, P911, DOI 10.2169/internalmedicine.32.911; Yan H, 2013, J VIROL, V87, P7977, DOI 10.1128/JVI.03540-12; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Yang D, 2014, CELL MOL IMMUNOL, V11, P71, DOI 10.1038/cmi.2013.43; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Zhang Q, 2014, J VIRAL HEPATITIS, V21, P525, DOI 10.1111/jvh.12177; Zhong GC, 2013, J VIROL, V87, P7176, DOI 10.1128/JVI.03533-12	55	28	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130052	10.1371/journal.pone.0130052	http://dx.doi.org/10.1371/journal.pone.0130052			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075890	Green Submitted, gold, Green Published			2022-12-27	WOS:000356329900129
J	Evans, N; Gale, S; Schurger, A; Blanke, O				Evans, Nathan; Gale, Steven; Schurger, Aaron; Blanke, Olaf			Visual Feedback Dominates the Sense of Agency for Brain-Machine Actions	PLOS ONE			English	Article							COMPUTER INTERFACE; CORTICAL CONTROL; SELF; EXPERIENCE; ABNORMALITIES; CONSEQUENCES; AWARENESS; MOVEMENT; LEADS; MODEL	Recent advances in neuroscience and engineering have led to the development of technologies that permit the control of external devices through real-time decoding of brain activity (brain-machine interfaces; BMI). Though the feeling of controlling bodily movements (sense of agency; SOA) has been well studied and a number of well-defined sensorimotor and cognitive mechanisms have been put forth, very little is known about the SOA for BMI-actions. Using an on-line BMI, and verifying that our subjects achieved a reasonable level of control, we sought to describe the SOA for BMI-mediated actions. Our results demonstrate that discrepancies between decoded neural activity and its resultant real-time sensory feedback are associated with a decrease in the SOA, similar to SOA mechanisms proposed for bodily actions. However, if the feedback discrepancy serves to correct a poorly controlled BMI-action, then the SOA can be high and can increase with increasing discrepancy, demonstrating the dominance of visual feedback on the SOA. Taken together, our results suggest that bodily and BMI-actions rely on common mechanisms of sensorimotor integration for agency judgments, but that visual feedback dominates the SOA in the absence of overt bodily movements or proprioceptive feedback, however erroneous the visual feedback may be.	[Evans, Nathan; Gale, Steven; Schurger, Aaron; Blanke, Olaf] Ecole Polytech Fed Lausanne, Ctr Neuroprosthet, CH-1015 Lausanne, Switzerland; [Evans, Nathan; Gale, Steven; Schurger, Aaron; Blanke, Olaf] Ecole Polytech Fed Lausanne, Brain Mind Inst, Cognit Neurosci Lab, CH-1015 Lausanne, Switzerland; [Blanke, Olaf] Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Blanke, O (corresponding author), Ecole Polytech Fed Lausanne, Ctr Neuroprosthet, CH-1015 Lausanne, Switzerland.	olaf.blanke@epfl.ch	Schurger, Aaron/Y-4459-2018	Schurger, Aaron/0000-0003-2985-3253; Evans, Nathaniel/0000-0002-3692-5334	VERE project: FP7-ICT-5 [257695]	VERE project: FP7-ICT-5	This research was supported by VERE project: FP7-ICT-2009-5 - Project 257695. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; Blanke O, 2009, NATURE, V458, P703, DOI 10.1038/458703b; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Borton D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005968; David N, 2008, CONSCIOUS COGN, V17, P523, DOI 10.1016/j.concog.2008.03.004; David N, 2007, NEUROIMAGE, V36, P1004, DOI 10.1016/j.neuroimage.2007.03.030; de Vignemont F, 2004, CONSCIOUS COGN, V13, P1, DOI 10.1016/S1053-8100(03)00022-9; Fabiani GE, 2004, IEEE T NEUR SYS REH, V12, P331, DOI 10.1109/TNSRE.2004.834627; Farrer C, 2008, BEHAV NEUROL, V19, P53, DOI 10.1155/2008/425267; Farrer C, 2013, CONSCIOUS COGN, V22, P1431, DOI 10.1016/j.concog.2013.09.010; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; Fourneret P, 1998, NEUROPSYCHOLOGIA, V36, P1133, DOI 10.1016/S0028-3932(98)00006-2; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Guger C, 2000, IEEE T REHABIL ENG, V8, P447, DOI 10.1109/86.895947; Haggard P, 2009, CURR DIR PSYCHOL SCI, V18, P242, DOI 10.1111/j.1467-8721.2009.01644.x; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Jeannerod M, 2004, MIND LANG, V19, P113, DOI 10.1111/j.1468-0017.2004.00251.x; Jeannerod M, 2006, MOTOR COGNITION WHAT, DOI 10.1093/acprof:oso/9780198569657.001.0001/acprof-9780198569657; Kannape OA, 2010, NEUROPSYCHOLOGIA, V48, P1628, DOI 10.1016/j.neuropsychologia.2010.02.005; Kawabe T, 2013, CONSCIOUS COGN, V22, P407, DOI 10.1016/j.concog.2013.01.006; Knoblich G, 2005, TRENDS COGN SCI, V9, P259, DOI 10.1016/j.tics.2005.04.006; Knoblich G, 2009, COGNITION, V111, P248, DOI 10.1016/j.cognition.2009.02.007; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; Miall R, 1996, FORWARD MODELS PHYSL; Millan JDR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00161; Moore JW, 2009, CONSCIOUS COGN, V18, P1056, DOI 10.1016/j.concog.2009.05.004; Moretto G, 2011, CONSCIOUS COGN, V20, P1847, DOI 10.1016/j.concog.2011.08.014; Nicolelis MAL, 2003, NAT REV NEUROSCI, V4, P417, DOI 10.1038/nrn1105; Pacherie E, 2008, COGNITION, V107, P179, DOI 10.1016/j.cognition.2007.09.003; Pfurtscheller G, 1997, ELECTROEN CLIN NEURO, V103, P642, DOI 10.1016/S0013-4694(97)00080-1; Prsa M, 2012, J NEUROPHYSIOL, V108, P2282, DOI 10.1152/jn.00439.2012; Sato A, 2005, COGNITION, V94, P241, DOI 10.1016/j.cognition.2004.04.003; Sperry R, 1950, J COMP PHYSL PSYCHOL, V43; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Synofzik M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00127; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Thakor NV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007303; Tsakiris M, 2005, COGNITION, V96, P215, DOI 10.1016/j.cognition.2004.08.002; van der Wel RPRD, 2012, CONSCIOUS COGN, V21, P1267, DOI 10.1016/j.concog.2012.04.001; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Von Holst E, 1950, NATURWISSENSCHAFTEN, V37; Wegner D., 2002, ILLUSION CONSCIOUS W; Wegner DM, 2003, TRENDS COGN SCI, V7, P65, DOI 10.1016/S1364-6613(03)00002-0; Wolpaw JR, 2007, J PHYSIOL-LONDON, V579, P613, DOI 10.1113/jphysiol.2006.125948; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	49	37	37	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130019	10.1371/journal.pone.0130019	http://dx.doi.org/10.1371/journal.pone.0130019			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26066840	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000135
J	Hu, HT; Rashotte, AM; Singh, NK; Weaver, DB; Goertzen, LR; Singh, SR; Locy, RD				Hu, Hongtao; Rashotte, Aaron M.; Singh, Narendra K.; Weaver, David B.; Goertzen, Leslie R.; Singh, Shree R.; Locy, Robert D.			The Complexity of Posttranscriptional Small RNA Regulatory Networks Revealed by In Silico Analysis of Gossypium arboreum L. Leaf, Flower and Boll Small Regulatory RNAs	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; TRANS-ACTING SIRNAS; ANTISENSE TRANSCRIPTS; NAT-SIRNAS; ARABIDOPSIS; MICRORNAS; BIOGENESIS; EXPRESSION; SEQUENCE; GENES	MicroRNAs (miRNAs) and secondary small interfering RNAs (principally phased siRNAs or trans-acting siRNAs) are two distinct subfamilies of small RNAs (sRNAs) that are emerging as key regulators of posttranscriptional gene expression in plants. Both miRNAs and secondary-siRNAs (sec-siRNAs) are processed from longer RNA precursors by DICER-LIKE proteins (DCLs). Gossypium arboreum L., also known as tree cotton or Asian cotton, is a diploid, possibly ancestral relative of tetraploid Gossypium hirsutum L., the predominant type of commercially grown cotton worldwide known as upland cotton. To understand the biological significance of these gene regulators in G. arboreum, a bioinformatics analysis was performed on G. arboreum small RNAs produced from G. arboreum leaf, flower, and boll tissues. Consequently, 263 miRNAs derived from 353 precursors, including 155 conserved miRNAs (cs-miRNAs) and 108 novel lineage-specific miRNAs (ls-miRNAs). Along with miRNAs, 2,033 miRNA variants (isomiRNAs) were identified as well. Those isomiRNAs with variation at the 3'-miRNA end were expressed at the highest levels, compared to other types of variants. In addition, 755 pha-siRNAs derived 319 pha-siRNA gene transcripts (PGTs) were identified, and the potential pha-siRNA initiators were predicted. Also, 2,251 non-phased siRNAs were found as well, of which 1,088 appeared to be produced by socalled cis-or trans-cleavage of the PGTs observed at positions differing from pha-siRNAs. Of those sRNAs, 148 miRNAs/isomiRNAs and 274 phased/non-phased siRNAs were differentially expressed in one or more pairs of tissues examined. Target analysis revealed that target genes for both miRNAs and pha-siRNAs are involved a broad range of metabolic and enzymatic activities. We demonstrate that secondary siRNA production could result from initial cleavage of precursors by both miRNAs or isomiRNAs, and that subsequently produced phased and unphased siRNAs could result that also serve as triggers of a second round of both cis- and trans-cleavage of additional siRNAs, leading to the formation of complex sRNA regulatory networks mediating posttranscriptional gene silencing. Results from this study extended our knowledge on G. arboreum sRNAs and their biological importance, which would facilitate future studies on regulatory mechanism of tissue development in cotton and other plant species.	[Hu, Hongtao; Rashotte, Aaron M.; Singh, Narendra K.; Goertzen, Leslie R.; Locy, Robert D.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Weaver, David B.] Auburn Univ, Dept Crop Soil & Environm Sci, Auburn, AL 36849 USA; [Hu, Hongtao; Singh, Shree R.] Alabama State Univ, Ctr Nano Biotechnol Res, Montgomery, AL 36104 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Locy, RD (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	hzh0005@tigermail.auburn.edu; locyrob@auburn.edu		Rashotte, Aaron/0000-0001-5034-4395; Singh, Shree R./0000-0002-3571-2222	Cotton, Inc.; Alabama Cotton Commission [07-936AL, 10-675AL]; Hatch Multistate [ALA021-1-10008]; National Institute of Food and Agriculture, USDA; NIFA-USDA Grant; Department of Biological Sciences, Auburn University	Cotton, Inc.; Alabama Cotton Commission; Hatch Multistate; National Institute of Food and Agriculture, USDA(United States Department of Agriculture (USDA)); NIFA-USDA Grant; Department of Biological Sciences, Auburn University	This work was funded in part with funding from Cotton, Inc.; Cary, NC. This funding was obtained in conjunction with the Alabama Cotton Commission - the grant numbers that funded these efforts were: 07-936AL; 10-675AL. This funding was awarded to RDL, NKS, & DBW. Further, the authors declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The primary research funding for this work was derived from a Hatch Multistate Grant No. ALA021-1-10008 Awarded by the National Institute of Food and Agriculture, USDA. The award was made through the Alabama Agricultural Experiment Station to RDL, DBW, & NKS. Funding during the course of his PhD program to HH was obtained as a Teaching Assistantship from the Department of Biological Sciences, Auburn University, and Research Assistantship funding was obtained from the above mentioned NIFA-USDA Grant.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Axtell MJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-221; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Cho SH, 2012, PLANT CELL, V24, P4837, DOI 10.1105/tpc.112.103176; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Dai XB, 2008, NUCLEIC ACIDS RES, V36, pW114, DOI 10.1093/nar/gkn297; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Eamens AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035933; Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909; Fei Q, 2013, PLANT CELL; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gong L, 2013, GENOME BIOL EVOL, V5, P2449, DOI 10.1093/gbe/evt196; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Groszmann M, 2011, P NATL ACAD SCI USA, V108, P2617, DOI 10.1073/pnas.1019217108; Hackenberg M, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-214; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Jeong DH, 2013, PLANT PHYSIOL, V162, P1225, DOI 10.1104/pp.113.219873; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Liu DQ, 2006, GENET RESOUR CROP EV, V53, P1145, DOI 10.1007/s10722-005-1304-y; Llorens F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-104; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; Marker S, 2010, NUCLEIC ACIDS RES, V38, P4092, DOI 10.1093/nar/gkq131; McGahon MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065809; Mehetre SS, 2003, CURR SCI INDIA, V84, P1510; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Pang MX, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r122; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Romanel E, 2012, PLANT MOL BIOL; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shin JH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003411; Si-Ammour A, 2011, PLANT PHYSIOL, V157, P683, DOI 10.1104/pp.111.180083; Song XW, 2012, PLANT J, V69, P462, DOI 10.1111/j.1365-313X.2011.04805.x; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Thieme CJ, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00272; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Visser M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095782; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Xia R, 2013, PLANT CELL; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Xue W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-629; Yan Z, 2013, MOL PLANT MICROBE IN, V26, P1371, DOI 10.1094/MPMI-04-13-0111-R; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Yoon EK, 2010, NUCLEIC ACIDS RES, V38, P1382, DOI 10.1093/nar/gkp1128; Yoshikawa M, 2013, P NATL ACAD SCI USA, V110, P4117, DOI 10.1073/pnas.1217050110; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Yu X, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-208; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang CQ, 2013, INT J MOL SCI, V14, P14689, DOI 10.3390/ijms140714689; Zhang CQ, 2012, BIOINFORMATICS, V28, P2561, DOI 10.1093/bioinformatics/bts500; Zhang XM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r20; Zhao HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078755; Zhao XP, 1998, GENOME RES, V8, P479, DOI 10.1101/gr.8.5.479; Zhou HJ, 2012, NUCLEIC ACIDS RES, V40, P5864, DOI 10.1093/nar/gks247; Zhu QH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084390; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295	79	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0127468	10.1371/journal.pone.0127468	http://dx.doi.org/10.1371/journal.pone.0127468			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070200	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000008
J	Larson, FV; Lai, MC; Wagner, AP; Baron-Cohen, S; Holland, AJ				Larson, Felicity V.; Lai, Meng-Chuan; Wagner, Adam P.; Baron-Cohen, Simon; Holland, Anthony J.		MRC AIMS Consortium	Testing the 'Extreme Female Brain' Theory of Psychosis in Adults with Autism Spectrum Disorder with or without Co-Morbid Psychosis	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; SYSTEMATIZING QUOTIENT; EMPATHY QUOTIENT; DIAGNOSTIC INTERVIEW; ASPERGER-SYNDROME; SCHIZOPHRENIA; RELIABILITY; SCHIZOTYPY; MALES; AQ	Introduction Males and females in the general population differ, on average, in their drive for empathizing (higher in females) and systemizing (higher in males). People with autism spectrum disorder (ASD) show a drive for systemizing over empathizing, irrespective of sex, which led to the conceptualisation of ASD as an 'extreme of the typical male brain'. The opposite cognitive profile, an 'extreme of the typical female brain', has been proposed to be linked to conditions such as psychosis and mania/hypomania. Methods We compared an empathizing-over-systemizing bias (for short 'empathizing bias') in individuals with ASD, who had experienced psychotic illness (N = 64) and who had not (N = 71). Results There were overall differences in the distribution of cognitive style. Adults with ASD who had experienced psychosis were more likely to show an empathizing bias than adults with ASD who had no history of psychosis. This was modulated by IQ, and the group-difference was driven mainly by individuals with above-average IQ. In women with ASD and psychosis, the link between mania/ hypomania and an empathizing bias was greater than in men with ASD. Conclusions The bias for empathizing over systemizing may be linked to the presence of psychosis in people with ASD. Further research is needed in a variety of clinical populations, to understand the role an empathizing bias may play in the development and manifestation of mental illness.	[Larson, Felicity V.; Wagner, Adam P.; Holland, Anthony J.] Univ Cambridge, Dept Psychiat, Cambridge Intellectual & Dev Disabil Res Grp, Cambridge, England; [Lai, Meng-Chuan; Baron-Cohen, Simon] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England; [Lai, Meng-Chuan] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Lai, Meng-Chuan] Coll Med, Taipei, Taiwan; [Wagner, Adam P.; Baron-Cohen, Simon; Holland, Anthony J.] NIHR CLAHRC East England, Cambridge, England; [Baron-Cohen, Simon; Holland, Anthony J.] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England	University of Cambridge; University of Cambridge; National Taiwan University; National Taiwan University Hospital	Holland, AJ (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge Intellectual & Dev Disabil Res Grp, Cambridge, England.	ajh1008@cam.ac.uk	Murphy, Clodagh M/F-1464-2010; Wagner, Adam P/AAA-4346-2019; Williams, Steve C/D-6979-2011; Lai, Meng-Chuan/K-7407-2016; Ecker, Christine/E-5194-2010; Catani, Marco/H-7801-2012	Murphy, Clodagh M/0000-0002-6350-0155; Wagner, Adam P/0000-0002-9101-3477; Williams, Steve C/0000-0003-4299-1941; Lai, Meng-Chuan/0000-0002-9593-5508; Ecker, Christine/0000-0002-1003-5931; Chakrabarti, Bhismadev/0000-0002-6649-7895; Wheelwright, Sally/0000-0003-0657-2483; Happe, Francesca/0000-0001-9226-4000; Catani, Marco/0000-0002-5488-6463; Henty, Julian/0000-0001-8694-451X; Baron-Cohen, Simon/0000-0001-9217-2544	Medical Research Council (United Kingdom) [G0400061]; Baily Thomas Charitable Trust; Medical Research Council (MRC) United Kingdom; William Binks Autism Neuroscience Fellowship; European Autism Interventions-A Multicentre Study for Developing New Medications (EU-AIMS); Wolfson College, Cambridge; NIHR Collaboration for Leadership in Applied Health Research and Care East of England at the Cambridgeshire; Peterborough NHS Foundation Trust; MRC; Autism Research Trust; EU-AIMS; MRC [G0400061, G0600977] Funding Source: UKRI; Medical Research Council [G0400061, 1127912, G0600977] Funding Source: researchfish; National Institute for Health Research [RP-PG-0606-1045, NF-SI-0510-10268, NF-SI-0509-10211] Funding Source: researchfish	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Baily Thomas Charitable Trust; Medical Research Council (MRC) United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); William Binks Autism Neuroscience Fellowship; European Autism Interventions-A Multicentre Study for Developing New Medications (EU-AIMS); Wolfson College, Cambridge; NIHR Collaboration for Leadership in Applied Health Research and Care East of England at the Cambridgeshire; Peterborough NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Autism Research Trust; EU-AIMS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Medical Research Council (United Kingdom); http://www.mrc.ac.uk/; Grant number G0400061; funding received by MCL and SBC. FVL was supported by the Medical Research Council (MRC) United Kingdom and the Baily Thomas Charitable Trust. M-CL was supported by the William Binks Autism Neuroscience Fellowship, the European Autism Interventions-A Multicentre Study for Developing New Medications (EU-AIMS), and Wolfson College, Cambridge. APW and AJH received support from the NIHR Collaboration for Leadership in Applied Health Research and Care East of England at the Cambridgeshire and Peterborough NHS Foundation Trust during the preparation of this manuscript. SB-C was supported by the MRC, EU-AIMS, and the Autism Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Asperger H, 1944, ARCH PSYCHIAT NERVEN, V117, P76, DOI 10.1007/BF01837709; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2015, MOL PSYCHIATR, V20, P369, DOI 10.1038/mp.2014.48; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S, 2005, J AUTISM DEV DISORD, V35, P807, DOI 10.1007/s10803-005-0026-5; Baron-Cohen S., 1997, MINDBLINDNESS ESSAY; Baron-Cohen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102251; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Bejerot S, 2012, BRIT J PSYCHIAT, V201, P116, DOI 10.1192/bjp.bp.111.097899; Brosnan M, 2014, J AUTISM DEV DISORD, V44, P513, DOI 10.1007/s10803-013-1897-5; Brosnan M, 2013, PSYCHOSIS, V5, P71, DOI 10.1080/17522439.2011.626526; Brosnan M, 2010, PERS INDIV DIFFER, V49, P738, DOI 10.1016/j.paid.2010.06.018; Castle DJ, 2006, PSYCHOL MED, V36, P69, DOI 10.1017/S0033291705005969; Cohen J., 1983, APPL MULTIPLE REGRES; Crespi B, 2008, BEHAV BRAIN SCI, V31, P241, DOI 10.1017/S0140525X08004214; Crespi B, 2010, P NATL ACAD SCI USA, V107, P1736, DOI 10.1073/pnas.0906080106; Dammann G., 2003, SOCIAL BRAIN EVOLUTI, P373; Davies W, 2008, BEHAV BRAIN SCI, V31, P265, DOI 10.1017/S0140525X08004263; Dinsdale NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063316; Fanous A, 2001, ARCH GEN PSYCHIAT, V58, P669, DOI 10.1001/archpsyc.58.7.669; GAZZANIGA M. S., 1985, SOCIAL BRAIN DISCOVE; Goldenfeld N, 2005, CLIN NEUROPSYCHIATR, V2, P338; Hallerback MU, 2012, PSYCHIAT RES, V198, P12, DOI 10.1016/j.psychres.2012.01.016; Konstantareas MM, 2006, J AUTISM DEV DISORD, V36, P143, DOI 10.1007/s10803-005-0051-4; Lai MC, 2013, BRAIN, V136, P2799, DOI 10.1093/brain/awt216; Lai MC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001544; Lai MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047198; Lai MC, 2012, NEUROIMAGE, V61, P1347, DOI 10.1016/j.neuroimage.2012.03.018; Lai MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020835; Langdon R, 1999, COGNITION, V71, P43, DOI 10.1016/S0010-0277(99)00018-9; Larson FV, 2015, PSYCHOSIS AUTI UNPUB; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; Montag C, 2011, PSYCHIAT RES, V186, P203, DOI 10.1016/j.psychres.2010.09.006; O'Connor BP, 1998, EDUC PSYCHOL MEAS, V58, P836, DOI 10.1177/0013164498058005009; Ousley Opal, 2014, Curr Dev Disord Rep, V1, P20; Prosser H, 1998, J INTELL DISABIL RES, V42, P264, DOI 10.1046/j.1365-2788.1998.00146.x; Russell-Smith SN, 2013, J AUTISM DEV DISORD, V43, P695, DOI 10.1007/s10803-012-1614-9; Samson AC, 2012, EMOTION, V12, P659, DOI 10.1037/a0027975; Schurhoff F, 2005, SCHIZOPHR RES, V80, P235, DOI 10.1016/j.schres.2005.07.009; Skokauskas N, 2010, PSYCHOPATHOLOGY, V43, P8, DOI 10.1159/000255958; SPITZER RL, 1979, ARCH GEN PSYCHIAT, V36, P1381; Starling J, 2009, CURR PSYCHIAT REP, V11, P190, DOI 10.1007/s11920-009-0030-0; Tantam D., 1991, AUTISM ASPERGER SYND, P147, DOI DOI 10.1017/CBO9780511526770.005; Wakabayashi A, 2006, PERS INDIV DIFFER, V41, P929, DOI 10.1016/j.paid.2006.03.017; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wheelwright S, 2006, BRAIN RES, V1079, P47, DOI 10.1016/j.brainres.2006.01.012; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn; Zahn-Waxler C, 2008, ANNU REV CLIN PSYCHO, V4, P275, DOI 10.1146/annurev.clinpsy.3.022806.091358	54	12	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128102	10.1371/journal.pone.0128102	http://dx.doi.org/10.1371/journal.pone.0128102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26069955	Green Accepted, gold, Green Published			2022-12-27	WOS:000356327000014
J	Liu, X; Wang, BJ; Xu, L				Liu, Xiao; Wang, Baojin; Xu, Luo			Statistical Analysis of Hurst Exponents of Essential/Nonessential Genes in 33 Bacterial Genomes	PLOS ONE			English	Article							CONDITIONALLY ESSENTIAL GENES; LONG-RANGE CORRELATIONS; DNA-SEQUENCES; VIBRIO-CHOLERAE; IDENTIFICATION	Methods for identifying essential genes currently depend predominantly on biochemical experiments. However, there is demand for improved computational methods for determining gene essentiality. In this study, we used the Hurst exponent, a characteristic parameter to describe long-range correlation in DNA, and analyzed its distribution in 33 bacterial genomes. In most genomes (31 out of 33) the significance levels of the Hurst exponents of the essential genes were significantly higher than for the corresponding full-gene-set, whereas the significance levels of the Hurst exponents of the nonessential genes remained unchanged or increased only slightly. All of the Hurst exponents of essential genes followed a normal distribution, with one exception. We therefore propose that the distribution feature of Hurst exponents of essential genes can be used as a classification index for essential gene prediction in bacteria. For computer-aided design in the field of synthetic biology, this feature can build a restraint for pre- or post-design checking of bacterial essential genes. Moreover, considering the relationship between gene essentiality and evolution, the Hurst exponents could be used as a descriptive parameter related to evolutionary level, or be added to the annotation of each gene.	[Liu, Xiao; Wang, Baojin; Xu, Luo] Chongqing Univ, Coll Commun Engn, Chongqing 400044, Peoples R China	Chongqing University	Liu, X (corresponding author), Chongqing Univ, Coll Commun Engn, 174 ShaPingBa Dist, Chongqing 400044, Peoples R China.	liuxiao@cqu.edu.cn			National Natural Science Foundation of China [61001157]; China Postdoctoral Science Foundation [2012M521673]; Fundamental Research Funds for the Central Universities [106112014CDJZR165503, CDJRC10160011, CDJZR12160007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 61001157), China Postdoctoral Science Foundation funded project (Grant No. 2012M521673) and the Fundamental Research Funds for the Central Universities (Project No. 106112014CDJZR165503, CDJRC10160011, CDJZR12160007).	Bergmiller T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002803; Bijlsma JJE, 2007, APPL ENVIRON MICROB, V73, P1514, DOI 10.1128/AEM.01900-06; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Chao MC, 2013, NUCLEIC ACIDS RES, V41, P9033, DOI 10.1093/nar/gkt654; CHATZIDIMITRIOUDREISMANN CA, 1993, NATURE, V361, P212, DOI 10.1038/361212b0; Clay O, 2001, GENE, V276, P33, DOI 10.1016/S0378-1119(01)00666-7; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Commichau FM, 2013, MOL BIOSYST, V9, P1068, DOI 10.1039/c3mb25595f; CONSTANTINE W, 2014, FRACTAL TIME SERIES; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Juhas M, 2011, TRENDS CELL BIOL, V21, P562, DOI 10.1016/j.tcb.2011.07.005; Liu X, 2012, INTEGR BIOL-UK, V4, P93, DOI 10.1039/c1ib00030f; Liu XL, 2010, PHYS LETT A, V374, P2163, DOI 10.1016/j.physleta.2010.03.024; Lu X, 1998, PHYS REV E, V58, P3578, DOI 10.1103/PhysRevE.58.3578; Lu Y, 2014, CURR BIOINFORM, V9, P89, DOI 10.2174/1574893608999140109113434; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; R Core Team, 2014, R FDN STAT COMP R LA; Stan C, 2013, J THEOR BIOL, V321, P54, DOI 10.1016/j.jtbi.2012.12.027; STANLEY HE, 1994, PHYSICA A, V205, P214, DOI 10.1016/0378-4371(94)90502-9; Yamada M, 2014, NEURAL COMPUT, V26, P185, DOI 10.1162/NECO_a_00537; Yang L, 2014, GENE, V551, P138, DOI 10.1016/j.gene.2014.08.046; Yu ZG, 2002, CHINESE PHYS, V11, P1313, DOI 10.1088/1009-1963/11/12/318	22	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129716	10.1371/journal.pone.0129716	http://dx.doi.org/10.1371/journal.pone.0129716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067107	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000100
J	Luo, HY; Wang, XJ; Zhan, GM; Wei, GR; Zhou, XL; Zhao, J; Huang, LL; Kang, ZS				Luo, Huaiyong; Wang, Xiaojie; Zhan, Gangming; Wei, Guorong; Zhou, Xinli; Zhao, Jing; Huang, Lili; Kang, Zhensheng			Genome-Wide Analysis of Simple Sequence Repeats and Efficient Development of Polymorphic SSR Markers Based on Whole Genome Re-Sequencing of Multiple Isolates of the Wheat Stripe Rust Fungus	PLOS ONE			English	Article							F-SP TRITICI; PUCCINIA-STRIIFORMIS; MICROSATELLITE MARKERS; PHI-BASE; YELLOW RUST; PATHOGEN; RECOMBINATION; ASSOCIATION; DIVERSITY; LOCI	The biotrophic parasitic fungus Puccinia striiformis f. sp. tritici (Pst) causes stripe rust, a devastating disease of wheat, endangering global food security. Because the Pst population is highly dynamic, it is difficult to develop wheat cultivars with durable and highly effective resistance. Simple sequence repeats (SSRs) are widely used as molecular markers in genetic studies to determine population structure in many organisms. However, only a small number of SSR markers have been developed for Pst. In this study, a total of 4,792 SSR loci were identified using the whole genome sequences of six isolates from different regions of the world, with a marker density of one SSR per 22.95 kb. The majority of the SSRs were di- and tri-nucleotide repeats. A database containing 1,113 SSR markers were established. Through in silico comparison, the previously reported SSR markers were found mainly in exons, whereas the SSR markers in the database were mostly in intergenic regions. Furthermore, 105 polymorphic SSR markers were confirmed in silico by their identical positions and nucleotide variations with INDELs identified among the six isolates. When 104 in silico polymorphic SSR markers were used to genotype 21 Pst isolates, 84 produced the target bands, and 82 of them were polymorphic and revealed the genetic relationships among the isolates. The results show that whole genome re-sequencing of multiple isolates provides an ideal resource for developing SSR markers, and the newly developed SSR markers are useful for genetic and population studies of the wheat stripe rust fungus.	[Luo, Huaiyong; Wang, Xiaojie; Zhan, Gangming; Wei, Guorong; Zhou, Xinli; Zhao, Jing; Huang, Lili; Kang, Zhensheng] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Luo, Huaiyong; Wang, Xiaojie; Zhan, Gangming; Wei, Guorong; Zhou, Xinli; Zhao, Jing; Huang, Lili; Kang, Zhensheng] State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Kang, ZS (corresponding author), Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China.	wangxiaojie@nwsuaf.edu.cn; kangzs@nwsuaf.edu.cn		Kang, Zhensheng/0000-0001-5575-0122; Huang, Lan/0000-0001-9594-4722	National High Technology Research and Development Program of China [2012AA101503]; National Basic Research Program [2013CB127700]; Chinese Ministry of Education [313048]; young star of science and technology, Shaanxi [2012KJXX-15]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program(National Basic Research Program of China); Chinese Ministry of Education(Ministry of Education, China); young star of science and technology, Shaanxi	This research was supported by the grant No.2012AA101503 from the National High Technology Research and Development Program of China (www.863.gov.cn) to XW, the grant No.2013CB127700 from National Basic Research Program (www.973.gov.cn) to KZ, the Key Grant Project No.313048 from the Chinese Ministry of Education (http://www.moe.gov.cn/) to XW, and the grant NO.2012KJXX-15 from the young star of science and technology, Shaanxi to XW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003903; Ali Sajid, 2011, BMC Res Notes, V4, P240, DOI 10.1186/1756-0500-4-240; Andris M, 2012, MOL ECOL RESOUR, V12, P779, DOI 10.1111/j.1755-0998.2012.03155.x; Arias MC, 2013, MOL ECOL RESOUR, V13, P760, DOI 10.1111/1755-0998.12121; Bahri B, 2009, CONSERV GENET, V10, P1425, DOI 10.1007/s10592-008-9752-5; Bayles RA, 2000, AGRONOMIE, V20, P805, DOI 10.1051/agro:2000176; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Cai GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082408; Cantu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024230; Chen CQ, 2009, MOL ECOL RESOUR, V9, P236, DOI 10.1111/j.1755-0998.2008.02423.x; Chen WQ, 2014, MOL PLANT PATHOL, V15, P433, DOI 10.1111/mpp.12116; Cheng P, 2014, PHYTOPATHOLOGY, V104, P1208, DOI 10.1094/PHYTO-11-13-0314-R; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Dai M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S7; Dempewolf H, 2010, MOL ECOL RESOUR, V10, P1048, DOI 10.1111/j.1755-0998.2010.02859.x; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duan X, 2010, MYCOLOGIA, V102, P44, DOI 10.3852/08-098; Dutech C, 2007, FUNGAL GENET BIOL, V44, P933, DOI 10.1016/j.fgb.2007.05.003; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Enjalbert J, 2002, MOL ECOL NOTES, V2, P563, DOI 10.1046/j.1471-8286.2002.00322.x; Feng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110896; Gow JL, 2006, MOL ECOL NOTES, V6, P873, DOI 10.1111/j.1471-8286.2006.01382.x; Gow JL, 2011, EVOL APPL, V4, P763, DOI 10.1111/j.1752-4571.2011.00198.x; Gow JL, 2005, GENETICA, V124, P77, DOI 10.1007/s10709-005-0204-6; Hasan M, 2008, THEOR APPL GENET, V116, P1035, DOI 10.1007/s00122-008-0733-3; Hovmoller MS, 2008, MOL ECOL, V17, P3818, DOI 10.1111/j.1365-294X.2008.03886.x; Hovmoller MS, 2011, ANNU REV PHYTOPATHOL, V49, P197, DOI 10.1146/annurev-phyto-072910-095230; Huang J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1268-z; Johansson H, 2008, MOL ECOL RESOUR, V8, P1408, DOI 10.1111/j.1755-0998.2008.02206.x; Karaoglu H, 2005, MOL BIOL EVOL, V22, P639, DOI [10.1093/molbev/mis057, 10.1093/molbev/msi057]; Kolmer JA, 2005, CURR OPIN PLANT BIOL, V8, P441, DOI 10.1016/j.pbi.2005.05.001; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075149; Mboup M, 2009, FUNGAL GENET BIOL, V46, P299, DOI 10.1016/j.fgb.2008.12.007; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Metzgar D, 2000, GENOME RES, V10, P72; NELSON RJ, 1994, APPL ENVIRON MICROB, V60, P3275, DOI 10.1128/AEM.60.9.3275-3283.1994; Park R, 2011, EUPHYTICA, V179, P109, DOI 10.1007/s10681-011-0375-4; Pembleton LW, 2013, CROP PASTURE SCI, V64, P244, DOI 10.1071/CP12392; Rodriguez-Algaba J, 2014, FUNGAL GENET BIOL, V70, P77, DOI 10.1016/j.fgb.2014.07.005; Rohlf F, 2008, NTSYSPC NUMERICAL TA, DOI [10.1080/10934529.2012.645784, DOI 10.1080/10934529.2012.645784]; Rotmistrovsky K, 2004, NUCLEIC ACIDS RES, V32, pW108, DOI 10.1093/nar/gkh450; Schlotterer C, 1998, CURR BIOL, V8, pR132, DOI 10.1016/S0960-9822(98)70989-3; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Shigemizu D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02161; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Sweet MJ, 2012, ADV APPL MICROBIOL, V81, P169, DOI 10.1016/B978-0-12-394382-8.00005-8; Urban M, 2015, NUCLEIC ACIDS RES, V43, pD645, DOI 10.1093/nar/gku1165; Vik U, 2012, AM J BOT, V99, pE344, DOI 10.3732/ajb.1200028; WELLINGS CR, 1990, PLANT PATHOL, V39, P316, DOI 10.1111/j.1365-3059.1990.tb02509.x; Winnenburg R, 2008, NUCLEIC ACIDS RES, V36, pD572, DOI 10.1093/nar/gkm858; Winnenburg R, 2006, NUCLEIC ACIDS RES, V34, pD459, DOI 10.1093/nar/gkj047; Xia W, 2014, MOL BREEDING, V34, P525, DOI 10.1007/s11032-014-0055-x; Xu J, 2013, DNA RES, V20, P497, DOI 10.1093/dnares/dst026; Zhan GM, 2013, WORLD J MICROB BIOT, V29, P173, DOI 10.1007/s11274-012-1170-7; Zhan GM, 2012, FUNGAL BIOL-UK, V116, P643, DOI 10.1016/j.funbio.2012.03.004; Zheng WM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3673	58	24	30	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130362	10.1371/journal.pone.0130362	http://dx.doi.org/10.1371/journal.pone.0130362			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068192	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000156
J	Marciente, R; Bobrowiec, PED; Magnusson, WE				Marciente, Rodrigo; Bobrowiec, Paulo Estefano D.; Magnusson, William E.			Ground-Vegetation Clutter Affects Phyllostomid Bat Assemblage Structure in Lowland Amazonian Forest	PLOS ONE			English	Article							CAROLLIA-PERSPICILLATA; INSECTIVOROUS BATS; SPECIES-DIVERSITY; FORAGING BEHAVIOR; FRUGIVOROUS BATS; NESTED SUBSETS; FRUIT BATS; HABITAT; ABUNDANCE; PREY	Vegetation clutter is a limiting factor for bats that forage near ground level, and may determine the distribution of species and guilds. However, many studies that evaluated the effects of vegetation clutter on bats have used qualitative descriptions rather than direct measurements of vegetation density. Moreover, few studies have evaluated the effect of vegetation clutter on a regional scale. Here, we evaluate the influence of the physical obstruction of vegetation on phyllostomid-bat assemblages along a 520 km transect in continuous Amazonian forest. We sampled bats using mist nets in eight localities during 80 nights (3840 net-hours) and estimated the ground-vegetation density with digital photographs. The total number of species, number of animalivorous species, total number of frugivorous species, number of understory frugivorous species, and abundance of canopy frugivorous bats were negatively associated with vegetation clutter. The bat assemblages showed a nested structure in relation to degree of clutter, with animalivorous and understory frugivorous bats distributed throughout the vegetation-clutter gradient, while canopy frugivores were restricted to sites with more open vegetation. The species distribution along the gradient of vegetation clutter was not closely associated with wing morphology, but aspect ratio and wing load differed between frugivores and animalivores. Vegetation structure plays an important role in structuring assemblages of the bats at the regional scale by increasing beta diversity between sites. Differences in foraging strategy and diet of the guilds seem to have contributed more to the spatial distribution of bats than the wing characteristics of the species alone.	[Marciente, Rodrigo; Bobrowiec, Paulo Estefano D.; Magnusson, William E.] Inst Nacl Pesquisas Amazozia, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil		Bobrowiec, PED (corresponding author), Inst Nacl Pesquisas Amazozia, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil.	paulobobro@gmail.com	Bobrowiec, Paulo Estefano D./A-2630-2013; Marciente, Rodrigo/AAP-1710-2021	Dineli Bobrowiec, Paulo Estefano/0000-0002-8945-6105	Programa de Pesquisa em Biodiversidade (PPBio); National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM); Instituto Nacional de Pesquisas da Amazonia (INPA); Bat Conservation International; Fundacao de Amparo a Pesquisa do Amazonas (FAPEAM); Instituto Chico Mendes de Conservacao da Biodiversidade (ICMBio) of Humaita; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [132573/2010-5]; Fundacao Amazonica de Defesa da Biosfera (FDB); PEDB by a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [02499/09-6]	Programa de Pesquisa em Biodiversidade (PPBio); National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM); Instituto Nacional de Pesquisas da Amazonia (INPA); Bat Conservation International; Fundacao de Amparo a Pesquisa do Amazonas (FAPEAM); Instituto Chico Mendes de Conservacao da Biodiversidade (ICMBio) of Humaita; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Amazonica de Defesa da Biosfera (FDB); PEDB by a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Programa de Pesquisa em Biodiversidade (PPBio), National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM), Instituto Nacional de Pesquisas da Amazonia (INPA), Bat Conservation International, Fundacao de Amparo a Pesquisa do Amazonas (FAPEAM), and Instituto Chico Mendes de Conservacao da Biodiversidade (ICMBio) of Humaita have funded field work. RM was supported by a fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq 132573/2010-5) and Fundacao Amazonica de Defesa da Biosfera (FDB) and PEDB by a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) post-doctoral scholarship (02499/09-6).	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Andrade TY, 2013, J MAMMAL, V94, P1094, DOI 10.1644/12-MAMM-A-244.1; [Anonymous], 2014, R LANG ENV STAT COMP; Arlettaz R, 2001, NATURE, V414, P742, DOI 10.1038/414742a; BARCLAY RMR, 1994, ANIM BEHAV, V48, P1013, DOI 10.1006/anbe.1994.1334; Bernard E, 2003, BIOTROPICA, V35, P262, DOI 10.1111/j.1744-7429.2003.tb00285.x; Bernardes C, 2011, BIOTA NEOTROP, V11, P83, DOI 10.1590/S1676-06032011000300006; Bobrowiec PED, 2010, ANIM CONSERV, V13, P204, DOI 10.1111/j.1469-1795.2009.00322.x; Bobrowiec PED, 2014, BIOTROPICA, V46, P312, DOI 10.1111/btp.12102; BONACCORSO FJ, 1987, J ANIM ECOL, V56, P907, DOI 10.2307/4956; Costa FRC, 2010, NAT CONSERVACAO, V8, P3, DOI 10.4322/natcon.00801001; Caras T, 2009, J TROP ECOL, V25, P97, DOI 10.1017/S0266467408005671; Charles-Dominique P., 2001, PATRIMOINES NATURELS, V49, P1; Colwell RK, 2013, ESTIMATES STAT ESTIM; Cosson JF, 1999, J TROP ECOL, V15, P515, DOI 10.1017/S026646749900098X; Denzinger A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00164; Dinnage R, 2012, ECOL LETT, V15, P1308, DOI 10.1111/j.1461-0248.2012.01854.x; Estrada A., 2004, Animal Biodiversity and Conservation, V27, P5; Estrada-Villegas S, 2012, ECOLOGY, V93, P1183, DOI 10.1890/11-0275.1; Fahr J, 2011, ECOGRAPHY, V34, P177, DOI 10.1111/j.1600-0587.2010.05510.x; FENTON MB, 1990, CAN J ZOOL, V68, P411, DOI 10.1139/z90-061; Fleming, 1986, FRUGIVORES SEED DISP, P105, DOI DOI 10.1007/978-94-009-4812-9_11; FLEMING TH, 1977, ECOLOGY, V58, P619, DOI 10.2307/1939011; FLEMING TH, 1991, J MAMMAL, V72, P493, DOI 10.2307/1382132; Ford WM, 2005, BIOL CONSERV, V126, P528, DOI 10.1016/j.biocon.2005.07.003; Galindo-Gonzalez J, 2000, CONSERV BIOL, V14, P1693, DOI [10.1046/j.1523-1739.2000.99072.x, 10.1111/j.1523-1739.2000.99072.x]; Gardner A.L., 2008, MAMMALS S AM MARSUPI; Giannini NP, 2004, OIKOS, V105, P209, DOI 10.1111/j.0030-1299.2004.12690.x; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hagen EM, 2011, OECOLOGIA, V166, P751, DOI 10.1007/s00442-011-1913-4; HEITHAUS ER, 1978, ECOL MONOGR, V48, P127, DOI 10.2307/2937296; Henry M, 2007, J ANIM ECOL, V76, P801, DOI 10.1111/j.1365-2656.2007.01258.x; IBGE-Instituto Brasileiro de Geografia e Estatistica, 2004, EST AM VEG; Jensen ME, 2001, J EXP BIOL, V204, P199; Jung K, 2012, J APPL ECOL, V49, P523, DOI 10.1111/j.1365-2664.2012.02116.x; Jung K, 2011, DIVERS DISTRIB, V17, P262, DOI 10.1111/j.1472-4642.2010.00738.x; Kalko EKV, 1998, ZOOL-ANAL COMPLEX SY, V101, P281; Kalko Elisabeth K.V., 1996, P503, DOI 10.1016/B978-012178075-3/50017-9; Kalko Elisabeth K.V., 1998, P197; Kusch J, 2004, FOLIA ZOOL, V53, P113; Law B, 2002, J APPL ECOL, V39, P605, DOI 10.1046/j.1365-2664.2002.00739.x; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 2012, NUMERICAL ECOLOGY, V3rd ed.; Lim BK, 2001, BIODIVERS CONSERV, V10, P613, DOI 10.1023/A:1016660123189; Lobova TA, 2009, SEED DISPERSAL BATS; Lopez-Gonzalez C, 2004, J BIOGEOGR, V31, P33, DOI 10.1111/j.1365-2699.2004.00940.x; Magnusson William E., 2005, Biota Neotrop., V5, P19, DOI 10.1590/S1676-06032005000300002; Marinello MM, 2014, CAN J ZOOL, V92, P141, DOI 10.1139/cjz-2013-0127; Marques JT, 2012, ACTA CHIROPTEROL, V14, P183, DOI 10.3161/150811012X654862; Marsden SJ, 2002, FOREST ECOL MANAG, V165, P117, DOI 10.1016/S0378-1127(01)00653-3; McGill BJ, 2010, SCIENCE, V328, P575, DOI 10.1126/science.1188528; Medellin RA, 2000, CONSERV BIOL, V14, P1666, DOI [10.1046/j.1523-1739.2000.99068.x, 10.1111/j.1523-1739.2000.99068.x]; Meyer CFJ, 2008, DIVERS DISTRIB, V14, P644, DOI 10.1111/j.1472-4642.2007.00462.x; MORRISON DW, 1980, J MAMMAL, V61, P20, DOI 10.2307/1379953; Moulatlet GM, 2014, BIOTROPICA, V46, P395, DOI 10.1111/btp.12117; Muller J, 2012, OECOLOGIA, V169, P673, DOI 10.1007/s00442-011-2247-y; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Oksanen J., 2016, R PACKAG; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Patterson BD, 2003, BAT ECOLOGY, P536; Pellissier L, 2013, ECOL LETT, V16, P600, DOI 10.1111/ele.12083; Peters SL, 2006, CONSERV BIOL, V20, P1410, DOI 10.1111/j.1523-1739.2006.00526.x; Rainho A, 2010, J APPL ECOL, V47, P850, DOI 10.1111/j.1365-2664.2010.01820.x; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rex K, 2011, J TROP ECOL, V27, P211, DOI 10.1017/S0266467411000022; Rodriguez-San Pedro A, 2015, EUR J WILDLIFE RES, V61, P177, DOI 10.1007/s10344-014-0871-7; Schietti J, 2014, PLANT ECOL DIVERS, V7, P241, DOI 10.1080/17550874.2013.783642; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Simmons JB, 2002, AM MUS NOVIT, P1; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thies W, 1998, BEHAV ECOL SOCIOBIOL, V42, P397, DOI 10.1007/s002650050454; Walsh AL, 1996, J APPL ECOL, V33, P519, DOI 10.2307/2404981; Whitfeld TJS, 2012, ECOLOGY, V93, pS211, DOI 10.1890/11-0503.1; Willig MR, 2007, BIOTROPICA, V39, P737, DOI 10.1111/j.1744-7429.2007.00322.x; Zehm A, 2003, FLORA, V198, P142, DOI 10.1078/0367-2530-00086; Zuur Alain F., 2009, P1	80	22	23	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129560	10.1371/journal.pone.0129560	http://dx.doi.org/10.1371/journal.pone.0129560			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066654	Green Submitted, gold, Green Published			2022-12-27	WOS:000356327000090
J	McCabe, RM; Grutsch, JF; Braun, DP; Nutakki, SB				McCabe, Ryan M.; Grutsch, James F.; Braun, Donald P.; Nutakki, Swetha B.			Fatigue as a Driver of Overall Quality of Life in Cancer Patients	PLOS ONE			English	Article							LUNG; ONCOLOGY; DETERMINANTS; VARIABLES; SURVIVAL	Background This manuscript describes an approach for analyzing large amounts of disparate clinical data to elucidate the most impactful factor(s) that relate to a meaningful clinical outcome, in this case, the quality of life of cancer patients. The relationships between clinical and quality of life variables were evaluated using the EORTC QLQ-C30 global health domain-a validated surrogate variable for overall cancer patient well-being. Methods A cross-sectional study design was used to evaluate the determinants of global health in cancer patients who initiated treatment at two regional medical centers between January 2001 and December 2009. Variables analyzed included 15 EORTC QLQ-C30 scales, age at diagnosis, gender, newly diagnosed/recurrent disease status, and stage. The decision tree algorithm, perhaps unfamiliar to practicing clinicians, evaluates the relative contribution of individual parameters in classifying a clinically meaningful functional endpoint, such as the global health of a patient. Findings Multiple patient characteristics were identified as important contributors. Fatigue, in particular, emerged as the most prevalent indicator of cancer patients' quality of life in 16/23 clinically relevant subsets. This analysis allowed results to be stated in a clinically-intuitive, rule set format using the language and quantities of the Quality of Life (QoL) tool itself. Interpretation By applying the classification algorithms to a large data set, identification of fatigue as a root factor in driving global health and overall QoL was revealed. The ability to practice mining of clinical data sets to uncover critical clinical insights that are immediately applicable to patient care practices is illustrated.	[McCabe, Ryan M.; Grutsch, James F.; Braun, Donald P.; Nutakki, Swetha B.] Canc Treatment Ctr Amer, Med & Sci, Zion, IL 60099 USA; [Grutsch, James F.] Univ Illinois, Sch Publ Hlth, Dept Epidemiol, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Nutakki, SB (corresponding author), Canc Treatment Ctr Amer, Med & Sci, Zion, IL 60099 USA.	swetha.bose@gmail.com			Cancer Treatment Centers of America	Cancer Treatment Centers of America	The research program is funded by Cancer Treatment Centers of America. Cancer Treatment Centers of America provided support in the form of salaries for authors Ryan M McCabe, James F Grutsch, Donald P Braun and Swetha B Nutakki but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Altman D, 2000, 6 INT C PHOT CORR OT, P175; Bakas T, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-134; Beijer S, 2008, INT J CANCER, V123, P232, DOI 10.1002/ijc.23497; Bingener J, 2014, J GASTROINTESTINAL S; Bowling A, 2001, MEASURING DIS REV DI, V18; Breiman L., 1984, WADSWORTH STAT PROBA, V19, P368, DOI DOI 10.1111/gcb.12809; Cleeland CS, 2013, CANCER-AM CANCER SOC, V119, P4333, DOI 10.1002/cncr.28376; Cocks K, 2011, J CLIN ONCOL, V29, P89, DOI 10.1200/JCO.2010.28.0107; Dagnelie PC, 2007, ANN ONCOL, V18, P940, DOI 10.1093/annonc/mdm057; Ferrans Carol Estwing, 2007, J Natl Cancer Inst Monogr, P22, DOI 10.1093/jncimonographs/lgm008; Grutsch JF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-193; Gundy CM, 2012, QUAL LIFE RES, V21, P1607, DOI 10.1007/s11136-011-0082-6; Hubbard JM, 2014, J ONCOL PRACT, V10, P248, DOI 10.1200/JOP.2013.001276; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Levin RD, 2005, BRIT J CANCER, V93, P1202, DOI 10.1038/sj.bjc.6602859; Lior R., 2007, DATA MINING DECISION; Lis CG, 2009, PATIENT PREFER ADHER, V3, P287; McCabe RM, 2008, USING DATA MINING PR, V3; McCabe RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099445; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Podgorelec Vili, 2002, J Med Syst, V26, P445, DOI 10.1023/A:1016409317640; Qi YW, 2009, J THORAC ONCOL, V4, P1075, DOI 10.1097/JTO.0b013e3181ae27f5; Quinten C, 2009, LANCET ONCOL, V10, P865, DOI 10.1016/S1470-2045(09)70200-1; Scott N., 2008, EORTC QLQ C30 REFERE; Sloan JA, 2012, J CLIN ONCOL, V30, P1699, DOI 10.1200/JCO.2010.34.5629; Sprangers MAG, 2010, QUAL LIFE RES, V19, P1395, DOI 10.1007/s11136-010-9759-5; Steptoe A, 2005, P NATL ACAD SCI USA, V102, P6508, DOI 10.1073/pnas.0409174102; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Witten I.H., 2005, MOR KAUF D, P560	30	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130023	10.1371/journal.pone.0130023	http://dx.doi.org/10.1371/journal.pone.0130023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070133	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000136
J	Salat, D; Winkler, A; Urlaub, H; Gessler, M				Salat, Daniela; Winkler, Anja; Urlaub, Henning; Gessler, Manfred			Hey bHLH Proteins Interact with a FBXO45 Containing SCF Ubiquitin Ligase Complex and Induce Its Translocation into the Nucleus	PLOS ONE			English	Article							F-BOX PROTEIN; SYNAPSE FORMATION; BINDING-PROTEIN; IDENTIFICATION; PROMOTES; GENE; PROTEOLYSIS; DEGRADATION; REPRESSION; EXPRESSION	The Hey protein family, comprising Hey1, Hey2 and HeyL in mammals, conveys Notch signals in many cell types. The helix-loop-helix (HLH) domain as well as the Orange domain, mediate homo- and heterodimerization of these transcription factors. Although distinct interaction partners have been identified so far, their physiological relevance for Hey functions is still largely unclear. Using a tandem affinity purification approach and mass spectrometry analysis we identified members of an ubiquitin E3-ligase complex consisting of FBXO45, PAM and SKP1 as novel Hey1 associated proteins. There is a direct interaction between Hey1 and FBXO45, whereas FBXO45 is needed to mediate indirect Hey1 binding to SKP1. Expression of Hey1 induces translocation of FBXO45 and PAM into the nucleus. Hey1 is a short-lived protein that is degraded by the proteasome, but there is no evidence for FBXO45-dependent ubiquitination of Hey1. On the contrary, Hey1 mediated nuclear translocation of FBXO45 and its associated ubiquitin ligase complex may extend its spectrum to additional nuclear targets triggering their ubiquitination. This suggests a novel mechanism of action for Hey bHLH factors.	[Salat, Daniela; Winkler, Anja; Gessler, Manfred] Univ Wurzburg, Bioctr, Theodor Boveri Inst, Dev Biochem, D-97070 Wurzburg, Germany; [Urlaub, Henning] Max Planck Inst Biophys Chem, Univ Med Ctr, Inst Clin Chem, Bioanalyt Mass Spectrometry, D-37077 Gottingen, Germany; [Gessler, Manfred] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97070 Wurzburg, Germany	University of Wurzburg; Max Planck Society; University of Gottingen; University of Wurzburg	Gessler, M (corresponding author), Univ Wurzburg, Bioctr, Theodor Boveri Inst, Dev Biochem, D-97070 Wurzburg, Germany.	gessler@biozentrum.uni-wuerzburg.de		Gessler, Manfred/0000-0002-7915-6045	German Research Foundation (DFG); University of Wuerzburg; Deutsche Forschungsgemeinschaft [SFB 688 (TP A16)]	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. This work was supported by the Deutsche Forschungsgemeinschaft through SFB 688 (TP A16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Belandia B, 2005, MOL CELL BIOL, V25, P1425, DOI 10.1128/MCB.25.4.1425-1436.2005; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chen XR, 2014, IEEE T DIELECT EL IN, V21, P45, DOI [10.1109/TDEI.2013.004108, 10.1109/TDEI.2014.6740724]; Chin MT, 2000, J BIOL CHEM, V275, P6381, DOI 10.1074/jbc.275.9.6381; Chung FZ, 2014, J BIOL CHEM, V289, P28448, DOI 10.1074/jbc.M114.561241; Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Fischer A, 2005, MOL CELL BIOL, V25, P8960, DOI 10.1128/MCB.25.20.8960-8970.2005; Fischer A, 2002, COLD SPRING HARB SYM, V67, P63, DOI 10.1101/sqb.2002.67.63; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; Fukada S, 2011, DEVELOPMENT, V138, P4609, DOI 10.1242/dev.067165; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Gould F, 2009, J VIROL, V83, P6727, DOI 10.1128/JVI.00351-09; Grill B, 2012, J NEUROSCI, V32, P2628, DOI 10.1523/JNEUROSCI.2901-11.2012; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Han LF, 2014, CANCER RES, V74, P6509, DOI 10.1158/0008-5472.CAN-14-0816; Heisig J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002728; Holland S, 2011, J BIOL CHEM, V286, P3671, DOI 10.1074/jbc.M110.154765; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Jalali A, 2011, J NEUROSCI RES, V89, P299, DOI 10.1002/jnr.22562; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Lavery DN, 2011, J BIOL CHEM, V286, P17796, DOI 10.1074/jbc.M110.198655; Leimeister C, 2000, DEV BIOL, V227, P91, DOI 10.1006/dbio.2000.9884; Nelson DE, 2011, J BIOL CHEM, V286, P19804, DOI 10.1074/jbc.M111.220079; Nguyen BA, 2009, BMC BIOINFORMATICS, V10, P202, DOI [10.1186/1471-2105-10-202, DOI 10.1186/1471-2105-10-202]; Peschiaroli A, 2009, ONCOGENE, V28, P3157, DOI 10.1038/onc.2009.177; Po MD, 2010, CURR OPIN NEUROBIOL, V20, P100, DOI 10.1016/j.conb.2009.12.007; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Satow T, 2001, J NEUROSCI, V21, P1265; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Scholich K, 2001, J BIOL CHEM, V276, P47583, DOI 10.1074/jbc.M107816200; Sharma J, 2014, J BIOL CHEM, V289, P34654, DOI 10.1074/jbc.M114.614065; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Smaldone S, 2004, MOL CELL BIOL, V24, P1058, DOI 10.1128/MCB.24.3.1058-1069.2004; Tada H, 2010, J BIOL CHEM, V285, P3840, DOI 10.1074/jbc.M109.046284; Tu XL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002577; Van Wayenbergh R, 2003, DEV DYNAM, V228, P716, DOI 10.1002/dvdy.10406; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wiese C, 2010, PEDIATR CARDIOL, V31, P363, DOI 10.1007/s00246-009-9609-9; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Xu M, 2015, ONCOTARGET, V6, P979, DOI 10.18632/oncotarget.2825; Yoshida K, 2005, ONCOL REP, V14, P531; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130288	10.1371/journal.pone.0130288	http://dx.doi.org/10.1371/journal.pone.0130288			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068074	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000153
J	Wu, ZZ; Zhang, H; Wang, ZB; Bin, SY; He, HL; Lin, JT				Wu, Zhongzhen; Zhang, He; Wang, Zhengbing; Bin, Shuying; He, Hualiang; Lin, Jintian			Discovery of Chemosensory Genes in the Oriental Fruit Fly, Bactrocera dorsalis	PLOS ONE			English	Article							ODORANT-BINDING-PROTEINS; COMPARATIVE GENOMIC ANALYSIS; EXPRESSED SEQUENCE TAGS; PHEROMONE-BINDING; METHYL EUGENOL; OLFACTORY RECEPTORS; SOLUBLE-PROTEINS; IDENTIFICATION; DIPTERA; FAMILY	The oriental fruit fly, Bactrocera dorsalis, is a devastating fruit fly pest in tropical and subtropical countries. Like other insects, this fly uses its chemosensory system to efficiently interact with its environment. However, our understanding of the molecular components comprising B. dorsalis chemosensory system is limited. Using next generation sequencing technologies, we sequenced the transcriptome of four B. dorsalis developmental stages: egg, larva, pupa and adult chemosensory tissues. A total of 31 candidate odorant binding proteins (OBPs), 4 candidate chemosensory proteins (CSPs), 23 candidate odorant receptors (ORs), 11 candidate ionotropic receptors (IRs), 6 candidate gustatory receptors (GRs) and 3 candidate sensory neuron membrane proteins (SNMPs) were identified. The tissue distributions of the OBP and CSP transcripts were determined by RT-PCR and a subset of nine genes were further characterized. The predicted proteins from these genes shared high sequence similarity to Drosophila melanogaster pheromone binding protein related proteins (PBPRPs). Interestingly, one OBP (BdorOBP19c) was exclusively expressed in the sex pheromone glands of mature females. RT-PCR was also used to compare the expression of the candidate genes in the antennae of male and female B. dorsalis adults. These antennae-enriched OBPs, CSPs, ORs, IRs and SNMPs could play a role in the detection of pheromones and general odorants and thus could be useful target genes for the integrated pest management of B. dorsalis and other agricultural pests.	[Wu, Zhongzhen; Zhang, He; Wang, Zhengbing; Bin, Shuying; He, Hualiang; Lin, Jintian] Zhongkai Univ Agr & Engn, Inst Management Invas Alien Species, Guangzhou, Guangdong, Peoples R China	Zhongkai University of Agriculture & Engineering	Lin, JT (corresponding author), Zhongkai Univ Agr & Engn, Inst Management Invas Alien Species, Guangzhou, Guangdong, Peoples R China.	linjtian@163.com		Wang, Zhengbing/0000-0003-4460-0369	National Natural Science Foundation of China [31171852]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31171852).	Allwood AJ, 1999, RAFFLES B ZOOL, P1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asahina K, 2008, CURR BIOL, V18, P1153, DOI 10.1016/j.cub.2008.06.075; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Chen YA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-416; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croset V, 2010, J NEUROGENET, V24, P30; Damodaram KJP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085764; Dani FR, 2011, CHEM SENSES, V36, P335, DOI 10.1093/chemse/bjq137; Findlay GD, 2008, PLOS BIOL, V6, P1417, DOI 10.1371/journal.pbio.0060178; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Geib SM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-942; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Graham LA, 2003, MOL CELL PROTEOMICS, V2, P541, DOI 10.1074/mcp.M300018-MCP200; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Gu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-636; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Hsu JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040950; Iovinella I, 2011, J PROTEOME RES, V10, P3439, DOI 10.1021/pr2000754; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jayanthi PDK, 2014, J CHEM ECOL, V40, P259, DOI 10.1007/s10886-014-0403-7; Jayanthi PDK, 2002, CURR SCI INDIA, V82, P266; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594; Kaissling KE, 2001, CHEM SENSES, V26, P125, DOI 10.1093/chemse/26.2.125; Katoh Kazutaka, 2010, Bioinformatics, V26, P1899, DOI 10.1093/bioinformatics/btq224; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumaran N, 2013, ANIM BEHAV, V85, P781, DOI 10.1016/j.anbehav.2013.01.024; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Li S, 2008, BIOCHEM BIOPH RES CO, V372, P464, DOI 10.1016/j.bbrc.2008.05.064; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017788; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; Marinotti O, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-15; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; Pelosi P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00320; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Pophof B, 2004, CHEM SENSES, V29, P117, DOI 10.1093/chemse/bjh012; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Schumacher MC, 2015, SCAND J UROL, V49, P35, DOI 10.3109/21681805.2014.932840; Schwarz D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-633; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Shen GM, 2013, INSECT MOL BIOL, V22, P354, DOI 10.1111/imb.12026; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Siciliano P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085523; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan KH, 2012, J INSECT SCI, V12, P1, DOI 10.1673/031.012.5601; Tauxe GM, 2013, CELL, V155, P1365, DOI 10.1016/j.cell.2013.11.013; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vargas RI, 2010, VITAM HORM, V83, P575, DOI 10.1016/S0083-6729(10)83023-7; Vieira FG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r235; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Wan XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036176; Whiteman NK, 2008, TRENDS ECOL EVOL, V23, P473, DOI 10.1016/j.tree.2008.05.010; Wu ZZ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-55; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Yang WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094470; Yi X, 2014, J CHEM ECOL, V40, P267, DOI 10.1007/s10886-014-0406-4; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077295; Zhang TT, 2013, J INTEGR AGR, V12, P853, DOI 10.1016/S2095-3119(13)60304-4; Zhang YN, 2014, GENE, V536, P279, DOI 10.1016/j.gene.2013.12.011; Zheng WW, 2013, INT J MOL SCI, V14, P14936, DOI 10.3390/ijms140714936; Zheng WW, 2012, J INSECT PHYSIOL, V58, P1122, DOI 10.1016/j.jinsphys.2012.05.011; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou XH, 2013, BIOL CHEM, V394, P43, DOI 10.1515/hsz-2012-0114	88	34	38	6	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129794	10.1371/journal.pone.0129794	http://dx.doi.org/10.1371/journal.pone.0129794			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070069	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000108
J	Laulumaa, S; Nieminen, T; Lehtimaki, M; Aggarwal, S; Simons, M; Koza, MM; Vattulainen, I; Kursula, P; Natali, F				Laulumaa, Saara; Nieminen, Tuomo; Lehtimaeki, Mari; Aggarwal, Shweta; Simons, Mikael; Koza, Michael M.; Vattulainen, Ilpo; Kursula, Petri; Natali, Francesca			Dynamics of the Peripheral Membrane Protein P2 from Human Myelin Measured by Neutron Scattering-A Comparison between Wild-Type Protein and a Hinge Mutant	PLOS ONE			English	Article							SIDE-CHAIN DYNAMICS; BASIC-PROTEIN; REFINEMENT; STABILITY; CRYSTALS	Myelin protein P2 is a fatty acid-binding structural component of the myelin sheath in the peripheral nervous system, and its function is related to its membrane binding capacity. Here, the link between P2 protein dynamics and structure and function was studied using elastic incoherent neutron scattering (EINS). The P38G mutation, at the hinge between the beta barrel and the alpha-helical lid, increased the lipid stacking capacity of human P2 in vitro, and the mutated protein was also functional in cultured cells. The P38G mutation did not change the overall structure of the protein. For a deeper insight into P2 structure-function relationships, information on protein dynamics in the 10 ps to 1 ns time scale was obtained using EINS. Values of mean square displacements mainly from protein H atoms were extracted for wildtype P2 and the P38G mutant and compared. Our results show that at physiological temperatures, the P38G mutant is more dynamic than the wild-type P2 protein, especially on a slow 1-ns time scale. Molecular dynamics simulations confirmed the enhanced dynamics of the mutant variant, especially within the portal region in the presence of bound fatty acid. The increased softness of the hinge mutant of human myelin P2 protein is likely related to an enhanced flexibility of the portal region of this fatty acid-binding protein, as well as to its interactions with the lipid bilayer surface requiring conformational adaptations.	[Laulumaa, Saara; Lehtimaeki, Mari; Kursula, Petri] Univ Oulu, Biochem & Mol Med & Bioctr Oulu, Oulu, Finland; [Laulumaa, Saara; Kursula, Petri] German Elect Synchrotron DESY, Hamburg, Germany; [Laulumaa, Saara] European Spallat Source ESS, Lund, Sweden; [Nieminen, Tuomo; Vattulainen, Ilpo] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland; [Aggarwal, Shweta; Simons, Mikael] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Koza, Michael M.; Natali, Francesca] Inst Laue Langevin ILL, Grenoble, France; [Kursula, Petri] Univ Bergen, Dept Biomed, Bergen, Norway; [Natali, Francesca] CNR IOM, OGG, Grenoble, France	University of Oulu; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); European Spallation Source (ESS); Tampere University; Max Planck Society; Institut Laue-Langevin (ILL); University of Bergen	Kursula, P (corresponding author), Univ Oulu, Biochem & Mol Med & Bioctr Oulu, Oulu, Finland.	petri.kursula@biomed.uib.no; natali@ill.fr	Kursula, Petri/AAF-4563-2020; Vattulainen, Ilpo T/G-4224-2014	Kursula, Petri/0000-0001-8529-3751; Natali, Francesca/0000-0002-1631-4624; Laulumaa, Saara Kaisa/0000-0003-4836-9256; Simons, Mikael/0000-0001-5329-192X; Vattulainen, Ilpo/0000-0001-7408-3214; Koza, Michael/0000-0002-5133-8584	Academy of Finland; Sigrid Juselius Foundation; Emil Aaltonen Foundation; European Spallation Source; Research and Science Foundation of the City of Hamburg; Academy of Finland (Center of Excellence programme); European Research Council (Advanced Grant CROWDED-PRO-LIPIDS)	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Emil Aaltonen Foundation; European Spallation Source; Research and Science Foundation of the City of Hamburg; Academy of Finland (Center of Excellence programme); European Research Council (Advanced Grant CROWDED-PRO-LIPIDS)	This study was supported by the Academy of Finland (www.aka.fi), the Sigrid Juselius Foundation (www.sigridjuselius.fi), the Emil Aaltonen Foundation (www.emilaaltonen.fi), the European Spallation Source (www.europeanspallationsource.se), and the Research and Science Foundation of the City of Hamburg (http://www.hamburg.de/bwf/forschungs-und-wissenschaftsstiftung-hamburg/)(all to PK), as well as the Academy of Finland (Center of Excellence programme) and the European Research Council (Advanced Grant CROWDED-PRO-LIPIDS) (both to IV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aggarwal S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001577; Best RB, 2005, J MOL BIOL, V349, P185, DOI 10.1016/j.jmb.2005.03.001; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Buttermore ED, 2013, J NEUROSCI RES, V91, P603, DOI 10.1002/jnr.23197; Carbonell P, 2009, BIOINFORMATICS, V25, P2552, DOI 10.1093/bioinformatics/btp463; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dhindsa GK, 2014, J PHYS CHEM B, V118, P10821, DOI 10.1021/jp504548w; Doster W, 2011, J NON-CRYST SOLIDS, V357, P622, DOI 10.1016/j.jnoncrysol.2010.08.002; DOSTER W, 1989, NATURE, V337, P754, DOI 10.1038/337754a0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frick B, 1997, PHYSICA B, V234, P1177, DOI 10.1016/S0921-4526(96)00212-8; Gabel F, 2005, EUR BIOPHYS J BIOPHY, V34, P1, DOI 10.1007/s00249-004-0433-0; GREENFIELD S, 1973, J NEUROCHEM, V20, P1207, DOI 10.1111/j.1471-4159.1973.tb00089.x; Han HJ, 2013, BIOFACTORS, V39, P233, DOI 10.1002/biof.1076; Hensen U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033931; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KIDERA A, 1990, P NATL ACAD SCI USA, V87, P3718, DOI 10.1073/pnas.87.10.3718; Kneller GR, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4769782; Knoll W, 2010, SPECTROSC-INT J, V24, P585, DOI 10.1155/2010/317525; Knoll W, 2014, SOFT MATTER, V10, P519, DOI 10.1039/c3sm51393a; Kursula P, 2008, AMINO ACIDS, V34, P175, DOI 10.1007/s00726-006-0479-7; Laulumaa S, 2015, EPJ WEB CONF, V83, DOI 10.1051/epjconf/20158302010; Lehtimaki M, 2012, ACTA CRYSTALLOGR F, V68, P1359, DOI 10.1107/S1744309112039036; Liu W, 2003, BIOPHYS J, V84, P1263, DOI 10.1016/S0006-3495(03)74941-8; Majava V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010300; Meinhold L, 2008, BIOPHYS J, V94, P4812, DOI 10.1529/biophysj.107.121418; Miao YL, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13072-5; Micheletti C, 2013, PHYS LIFE REV, V10, P1, DOI 10.1016/j.plrev.2012.10.009; Nakagawa H, 2004, J PHYS SOC JPN, V73, P491, DOI 10.1143/JPSJ.73.491; Nakagawa H, 2010, BBA-PROTEINS PROTEOM, V1804, P27, DOI 10.1016/j.bbapap.2009.06.025; Natali F, 2001, PHYSICA B, V301, P145, DOI 10.1016/S0921-4526(01)00528-2; Natali F, 2008, NEUTRON NEWS, V19, P14, DOI [10.1080/10448630802474083, DOI 10.1080/10448630802474083]; OBRIEN JS, 1965, J LIPID RES, V6, P537; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patzig J, 2011, J NEUROSCI, V31, P16369, DOI 10.1523/JNEUROSCI.4016-11.2011; Pereira JA, 2012, TRENDS NEUROSCI, V35, P123, DOI 10.1016/j.tins.2011.11.006; Perticaroli S, 2014, J PHYS CHEM B, V118, P7317, DOI 10.1021/jp503788r; Richard D., 1996, J NEUTRON RES, V4, P33, DOI [DOI 10.1080/10238169608200065, 10.1080/10238169608200065]; Roh JH, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.038101; Ruskamo S, 2014, ACTA CRYSTALLOGR D, V70, P165, DOI 10.1107/S1399004713027910; Sacquin-Mora S, 2007, BIOCHEMISTRY-US, V46, P14960, DOI 10.1021/bi7004416; Schiro G, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.128102; Schiro G, 2010, J AM CHEM SOC, V132, P1371, DOI 10.1021/ja908611p; Sears V.F., 1992, NEUTRON NEWS, V3, P26, DOI [10.1080/10448639208218770, DOI 10.1080/10448639208218770]; SEDZIK J, 1985, J NEUROCHEM, V45, P844, DOI 10.1111/j.1471-4159.1985.tb04071.x; Stadler AM, 2012, BIOPHYS J, V102, P351, DOI 10.1016/j.bpj.2011.12.031; Suresh S, 2010, BIOCHEMISTRY-US, V49, P3456, DOI 10.1021/bi100128h; TRAPP BD, 1979, P NATL ACAD SCI USA, V76, P3552, DOI 10.1073/pnas.76.7.3552; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wood K, 2010, J AM CHEM SOC, V132, P4990, DOI 10.1021/ja910502g; Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604; Zenker J, 2014, GLIA, V62, P1502, DOI 10.1002/glia.22696	56	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128954	10.1371/journal.pone.0128954	http://dx.doi.org/10.1371/journal.pone.0128954			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068118	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900035
J	Pereira, MG; Visbal, G; Salgado, LT; Vidal, JC; Godinho, JLP; De Cicco, NNT; Atella, GC; de Souza, W; Cunha-e-Silva, N				Pereira, Miria Gomes; Visbal, Gonzalo; Salgado, Leonardo T.; Vidal, Juliana Cunha; Godinho, Joseane L. P.; De Cicco, Nuccia N. T.; Atella, Georgia C.; de Souza, Wanderley; Cunha-e-Silva, Narcisa			Trypanosoma cruzi Epimastigotes Are Able to Manage Internal Cholesterol Levels under Nutritional Lipid Stress Conditions	PLOS ONE			English	Article							ACYL-COENZYME-A; ACYLTRANSFERASE INHIBITOR; PLASMA-MEMBRANE; CYTO-TOXICITY; PROLIFERATION; STORAGE; METHYLTRANSFERASE; COMPLEXES; CYTOSTOME; SURVIVAL	Trypanosoma cruzi epimastigotes store high amounts of cholesterol and cholesteryl esters in reservosomes. These unique organelles are responsible for cellular digestion by providing substrates for homeostasis and parasite differentiation. Here we demonstrate that under nutritional lipid stress, epimastigotes preferentially mobilized reservosome lipid stocks, instead of lipid bodies, leading to the consumption of parasite cholesterol reservoirs and production of ergosterol. Starved epimastigotes acquired more LDL-NBD-cholesterol by endocytosis and distributed the exogenous cholesterol to their membranes faster than control parasites. Moreover, the parasites were able to manage internal cholesterol levels, alternating between consumption and accumulation. With normal lipid availability, parasites esterified cholesterol exhibiting an ACAT-like activity that was sensitive to Avasimibe in a dose-dependent manner. This result also implies that exogenous cholesterol has a role in lipid reservoirs in epimastigotes.	[Pereira, Miria Gomes; Vidal, Juliana Cunha; Godinho, Joseane L. P.; de Souza, Wanderley; Cunha-e-Silva, Narcisa] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil; [Visbal, Gonzalo; de Souza, Wanderley] Qualidade & Tecnol INMETRO, Inst Nacl Metrol, Rio De Janeiro, Brazil; [Salgado, Leonardo T.] Inst Pesquisas Jardim Bot Rio de Janerio, Rio De Janeiro, Brazil; [Pereira, Miria Gomes; De Cicco, Nuccia N. T.; Atella, Georgia C.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Lab Bioquim Lipidios & Lipoprot, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade Federal do Rio de Janeiro	Cunha-e-Silva, N (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil.	narcisa@biof.ufrj.br	Atella, Georgia/AAK-7897-2020; Pereira, Miria G/AAJ-9998-2021; Cunha-e-Silva, Narcisa L/Q-2902-2018; Visbal, Gonzalo/AAT-2766-2020; Salgado, Leonardo T/F-1123-2013	Cunha-e-Silva, Narcisa L/0000-0003-4863-4945; Pereira, Miria G/0000-0001-9103-0448	Fundacao Carlos Chagas Filho de Amparo a Pesquisa no Estado do Rio de Janeiro (FAPERJ) [E-26/102.850/2012, E26/110.576/2010, E-26/101.023/2011]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305599/2010-0]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa no Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the following sources of funding: grants E-26/102.850/2012 from Fundacao Carlos Chagas Filho de Amparo a Pesquisa no Estado do Rio de Janeiro (FAPERJ) e 305599/2010-0 from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) to NCS, Grants E26/110.576/2010 from Fundacao Carlos Chagas Filho de Amparo a Pesquisa no Estado do Rio de Janeiro (FAPERJ) to WDS and NCS, Fellowship E-26/101.023/2011 from Fundacao Carlos Chagas Filho de Amparo a Pesquisa no Estado do Rio de Janeiro (FAPERJ) to MGP.	Batetta B, 2003, FASEB J, V17, P746, DOI 10.1096/fj.02-0396fje; BELLINI F, 1984, BIOCHIM BIOPHYS ACTA, V777, P209, DOI 10.1016/0005-2736(84)90422-X; Bemlih S, 2010, CANCER BIOL THER, V9, P1025, DOI 10.4161/cbt.9.12.11875; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; CASSEL DL, 1984, ATHEROSCLEROSIS, V52, P203, DOI 10.1016/0021-9150(84)90119-9; CHAM BE, 1976, J LIPID RES, V17, P176; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; CHAPMAN MJ, 1981, J LIPID RES, V22, P339; COPPENS I, 1995, J BIOL CHEM, V270, P5736, DOI 10.1074/jbc.270.11.5736; COPPENS I, 1995, MOL BIOCHEM PARASIT, V73, P179, DOI 10.1016/0166-6851(95)00114-G; Correa JR, 2008, EXP PARASITOL, V119, P58, DOI 10.1016/j.exppara.2007.12.010; Cosentino RO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096762; De Cicco NNT, 2012, EXP PARASITOL, V130, P330, DOI 10.1016/j.exppara.2012.02.014; GROSSMANN A, 1976, MILCHWISSENSCHAFT, V31, P721; JACOBS DB, 1983, J IMMUNOL METHODS, V62, P101, DOI 10.1016/0022-1759(83)90115-1; LAZARDI K, 1990, ANTIMICROB AGENTS CH, V34, P2097, DOI 10.1128/AAC.34.11.2097; Lige B, 2013, MOL MICROBIOL, V87, P951, DOI 10.1111/mmi.12142; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nishikawa Y, 2005, CELL MICROBIOL, V7, P849, DOI 10.1111/j.1462-5822.2005.00518.x; Pereira MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022359; Porto-Carreiro I, 2000, EUR J CELL BIOL, V79, P858, DOI 10.1078/0171-9335-00112; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Rodriguez A, 2002, ATHEROSCLEROSIS, V161, P45, DOI 10.1016/S0021-9150(01)00620-7; Rodriguez A, 1999, ARTERIOSCL THROM VAS, V19, P2199, DOI 10.1161/01.ATV.19.9.2199; ROSS AC, 1984, J BIOL CHEM, V259, P815; Sant'Anna C, 2009, PROTEOMICS, V9, P1782, DOI 10.1002/pmic.200800730; SILVA NLD, 1989, MOL BIOCHEM PARASIT, V37, P129, DOI 10.1016/0166-6851(89)90109-6; SOARES MJ, 1991, PARASITOL RES, V77, P461, DOI 10.1007/BF00928410; SOARES MJ, 1989, PARASITOL RES, V75, P522, DOI 10.1007/BF00931160; SOUTOPADRON T, 1983, J PARASITOL, V69, P129, DOI 10.2307/3281287; Torres C, 2004, MOL MICROBIOL, V54, P632, DOI 10.1111/j.1365-2958.2004.04304.x; URBINA JA, 1995, MOL BIOCHEM PARASIT, V73, P199, DOI 10.1016/0166-6851(95)00117-J; Urbina JA, 1997, ANTIMICROB AGENTS CH, V41, P1428, DOI 10.1128/AAC.41.7.1428; Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041; Visbal G, 2003, ANTIMICROB AGENTS CH, V47, P2966, DOI 10.1128/AAC.47.9.2966-2970.2003; VOGEL WC, 1962, J LAB CLIN MED, V59, P335	36	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128949	10.1371/journal.pone.0128949	http://dx.doi.org/10.1371/journal.pone.0128949			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068009	Green Submitted, Green Published, gold			2022-12-27	WOS:000356100900034
J	Ainai, A; Hasegawa, H; Obuchi, M; Odagiri, T; Ujike, M; Shirakura, M; Nobusawa, E; Tashiro, M; Asanuma, H				Ainai, Akira; Hasegawa, Hideki; Obuchi, Masatsugu; Odagiri, Takato; Ujike, Makoto; Shirakura, Masayuki; Nobusawa, Eri; Tashiro, Masato; Asanuma, Hideki			Host Adaptation and the Alteration of Viral Properties of the First Influenza A/H1N1pdm09 Virus Isolated in Japan	PLOS ONE			English	Article							AMINO-ACID; ESTABLISHED LINE; PANDEMIC H1N1; PLAQUE-ASSAY; A VIRUSES; VACCINES; DETERMINANT; EVOLUTION; SWINE; MDCK	A/Narita/1/2009 (A/N) was the first H1N1 virus from the 2009 pandemic (H1pdm) to be isolated in Japan. To better understand and predict the possible development of this virus strain, the effect of passaging A/N was investigated in Madin-Darby canine kidney cells, chicken eggs and mice. A/N that had been continuously passaged in cells, eggs, or mice obtained the ability to grow efficiently in each host. Moreover, A/N grown in mice had both a high level of pathogenicity in mice and an increased growth rate in cells and eggs. Changes in growth and pathogenicity were accompanied by amino acid substitutions in viral hemagglutinin (HA) and PB2. In addition, the adapted viruses exhibited a reduced ability to react with ferret antisera against A/N. In conclusion, prolonged passaging allowed influenza A/N to adapt to different hosts, as indicated by a high increase in proliferative capacity that was accompanied by an antigenic alteration leading to amino acid substitutions.	[Ainai, Akira; Obuchi, Masatsugu; Odagiri, Takato; Ujike, Makoto; Shirakura, Masayuki; Nobusawa, Eri; Tashiro, Masato; Asanuma, Hideki] Natl Inst Infect Dis, Influenza Virus Res Ctr, Musashimurayama, Tokyo 2080011, Japan; [Ainai, Akira; Hasegawa, Hideki; Asanuma, Hideki] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan; [Ujike, Makoto] Nippon Vet & Life Sci Univ, Dept Vet Med, Musashino, Tokyo 1808602, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Nippon Veterinary & Life Science University	Asanuma, H (corresponding author), Natl Inst Infect Dis, Influenza Virus Res Ctr, Gakuen 4-7-1, Musashimurayama, Tokyo 2080011, Japan.	asanuma@nih.go.jp	Hasegawa, Hideki/C-7978-2014; Ujike, Makoto/W-3508-2019	Ujike, Makoto/0000-0002-7145-7126	Health and Labour Sciences Research Grant [08-16]; Grants-in-Aid for Scientific Research [25286062] Funding Source: KAKEN	Health and Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Health and Labour Sciences Research Grant (ID: 08-16).	Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Centers for Disease Control and Prevention, 2012, CELL BAS FLU VACC; Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; Doroshenko A, 2009, EXPERT REV VACCINES, V8, P679, DOI 10.1586/ERV.09.31; European Centre for Disease Prevention and Control and the Community Network of Reference Laboratories for Human Influenza in Europe, 2011, INFL VIR CHAR; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; KATZ JM, 1992, J GEN VIROL, V73, P1159, DOI 10.1099/0022-1317-73-5-1159; Lakspere T, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01004-13; Minor PD, 2010, CLIN INFECT DIS, V50, P560, DOI 10.1086/650171; Minor PD, 2009, VACCINE, V27, P2907, DOI 10.1016/j.vaccine.2009.02.064; National Institute of Technology and Evaluation and ational Institute of Infectious Diseases in Japan, 2009, NITE NIID PROT SEQ I; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reynales H, 2012, VACCINE, V30, P6436, DOI 10.1016/j.vaccine.2012.08.005; Schrauwen EJA, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.9; Shimada T, 2009, EUROSURVEILLANCE, V14; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; TAMURA SI, 1992, J IMMUNOL, V149, P981; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; Wang W, 2010, VIROLOGY, V407, P374, DOI 10.1016/j.virol.2010.08.027; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; World Health Organization, 2011, MAN LAB DIAGN VIR SU; World Health Organization, 2009, AV CAND REASS VACC V; Zhou B, 2011, J VIROL, V85, P357, DOI 10.1128/JVI.01694-10	27	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0130208	10.1371/journal.pone.0130208	http://dx.doi.org/10.1371/journal.pone.0130208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079133	gold, Green Published, Green Submitted			2022-12-27	WOS:000356542300040
J	Alqarni, AS; Rushdi, AI; Owayss, AA; Raweh, HS; El-Mubarak, AH; Simoneit, BRT				Alqarni, Abdulaziz S.; Rushdi, Ahmed I.; Owayss, Ayman A.; Raweh, Hael S.; El-Mubarak, Aarif H.; Simoneit, Bernd R. T.			Organic Tracers from Asphalt in Propolis Produced by Urban Honey Bees, Apis mellifera Linn.	PLOS ONE			English	Article							NORTHEASTERN PACIFIC-OCEAN; CHEMICAL-COMPOSITION; HYDROTHERMAL ALTERATION; EGYPTIAN PROPOLIS; CUTICULAR LIPIDS; MOLECULAR MARKER; ESCANABA TROUGH; FUGITIVE DUST; SAO-PAULO; MATTER	Propolis is a gummy material produced by honey bees to protect their hives and currently has drawn the attention of researchers due to its broad clinical use. It has been reported, based only on observations, that honey bees also collect other non-vegetation substances such as paint or asphalt/tar to make propolis. Therefore, propolis samples were collected from bee hives in Riyadh and Al-Bahah, a natural area, Saudi Arabia to determine their compositional characteristics and possible sources of the neutral organic compounds. The samples were extracted with hexane and analyzed by gas chromatography-mass spectrometry. The results showed that the major compounds were (n) under bar -alkanes, (n) under bar -alkenes, methyl (n) under bar -alkanoates, long chain wax esters, triterpenoids and hopanes. The (n) under bar -alkanes (ranging from C-17 to C-40) were significant with relative concentrations varying from 23.8 to 56.8% (mean = 44.9 +/- 9.4%) of the total extracts. Their odd carbon preference index (CPI) ranged from 3.6 to 7.7, with a maximum concentration at heptacosane indicating inputs from higher plant vegetation wax. The relative concentrations of the (n) under bar -alkenes varied from 23.8 to 41.19% (mean = 35.6 +/- 5.1%), with CPI = 12.4-31.4, range from C-25 to C-35 and maximum at tritriacontane. Methyl (n) under bar -alkanoates, ranged from C-12 to C-26 as acids, with concentrations from 3.11 to 33.2%(mean = 9.6 +/- 9.5%). Long chain wax esters and triterpenoids were minor. The main triterpenoids were alpha- and beta-amyrins, amyrones and amyryl acetates. The presence of hopanes in some total extracts (up to 12.5%) indicated that the bees also collected petroleum derivatives from vicinal asphalt and used that as an additional ingredient to make propolis. Therefore, caution should be taken when considering the chemical compositions of propolis as potential sources of natural products for biological and pharmacological applications. Moreover, beekeepers should be aware of the proper source of propolis in the flight range of their bee colonies.	[Alqarni, Abdulaziz S.; Owayss, Ayman A.; Raweh, Hael S.] King Saud Univ, Dept Plant Protect, Coll Food & Agr Sci, Riyadh 11451, Saudi Arabia; [Rushdi, Ahmed I.; El-Mubarak, Aarif H.; Simoneit, Bernd R. T.] King Saud Univ, Coll Food & Agr Sci, Chair Green Energy Res, Riyadh 11451, Saudi Arabia; [Rushdi, Ahmed I.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97333 USA; [Rushdi, Ahmed I.] Sanaa Univ, Dept Earth & Environm Sci, Sanaa, Yemen; [Simoneit, Bernd R. T.] Oregon State Univ, Dept Chem, Corvallis, OR 97331 USA	King Saud University; King Saud University; Oregon State University; Oregon State University	Rushdi, AI (corresponding author), King Saud Univ, Coll Food & Agr Sci, Chair Green Energy Res, Riyadh 11451, Saudi Arabia.	arushdi@ksu.edu.sa	Rushdi, Ahmed/AAF-1679-2019; Alqarni, Abdulaziz S./D-5246-2015	Alqarni, Abdulaziz S./0000-0003-1324-332X	National Plan for Scientific Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia [12-AGR2510.02, 09-ENV842-02]; Distinguished Scientist Program of King Saud University	National Plan for Scientific Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia; Distinguished Scientist Program of King Saud University	This project was funded by the National Plan for Scientific Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia, Awards Numbers (12-AGR2510.02 and 09-ENV842-02). BRTS thanks the Distinguished Scientist Program of King Saud University for partial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Mawla A.M.A., 2011, SPATULA DD, V1, P119; AVATO P, 1990, PHYTOCHEMISTRY, V29, P1571, DOI 10.1016/0031-9422(90)80124-Y; Baker E.A., 1982, PLANT CUTICLE; BANKOVA V, 1992, APIDOLOGIE, V23, P79, DOI 10.1051/apido:19920109; Banskota AH, 2001, PHYTOTHER RES, V15, P561, DOI 10.1002/ptr.1029; BIANCHI G, 1989, PHYTOCHEMISTRY, V28, P165, DOI 10.1016/0031-9422(89)85031-9; Christov R, 1998, Z NATURFORSCH C, V53, P197; CIRASINO L, 1987, CONTACT DERMATITIS, V16, P110, DOI 10.1111/j.1600-0536.1987.tb01394.x; Custodio AR, 2003, J BRAZIL CHEM SOC, V14, P354, DOI 10.1590/S0103-50532003000300003; De Castro S. L., 2001, ARBS Annual Review of Biomedical Sciences, V3, P49; EGLINTON G, 1967, SCIENCE, V156, P1322, DOI 10.1126/science.156.3780.1322; El Hady FKA, 2002, Z NATURFORSCH C, V57, P386; Faure P, 2000, ENVIRON SCI TECHNOL, V34, P1174, DOI 10.1021/es9909733; Ficken KJ, 2000, ORG GEOCHEM, V31, P745, DOI 10.1016/S0146-6380(00)00081-4; Fokt H., 2010, CURR RES TECHNOL ED, P481; HAMILTON RJ, 1995, WAXES CHEM MOL BIOL; Harwood J.L., 1984, LIPIDS PLANTS MICROB; Hegazi AG, 2002, Z NATURFORSCH C, V57, P395; JACKSON LL, 1970, LIPIDS, V5, P239, DOI 10.1007/BF02532475; JACKSON LL, 1972, COMP BIOCHEM PHYSIOL, V41, P331, DOI 10.1016/0305-0491(72)90035-1; KatzavGozansky T, 1997, NATURWISSENSCHAFTEN, V84, P238, DOI 10.1007/s001140050386; Kolattukudy P.E., 1976, CHEM BIOCH NATURAL W, P289; Kolattukudy P.E., 1976, CHEM BIOCH NATURAL W; Kujumgiev A, 1999, J ETHNOPHARMACOL, V64, P235, DOI 10.1016/S0378-8741(98)00131-7; KVENVOLDEN KA, 1990, APPL GEOCHEM, V5, P83, DOI 10.1016/0883-2927(90)90039-8; Marcucci MC, 1998, Z NATURFORSCH C, V53, P117; MARCUCCI MC, 1995, APIDOLOGIE, V26, P83, DOI 10.1051/apido:19950202; Hernandez IM, 2010, J AGR FOOD CHEM, V58, P4725, DOI 10.1021/jf904527n; Mazurek M.A., 1984, IDENTIF ANAL ORGANIC, V22, P353; MONTI M, 1983, CONTACT DERMATITIS, V9, P163, DOI 10.1111/j.1600-0536.1983.tb04341.x; Negri G, 2000, J BRAZIL CHEM SOC, V11, P453; Negri G, 1998, APIDOLOGIE, V29, P305, DOI 10.1051/apido:19980401; Nelson D.R., 1995, WAXES CHEM MOL BIOL, P1; NYEIN MM, 1983, AM BEE J, V123, P732; Peters K. E., 1993, BIOMARKER GUIDE INTE; Popova M, 2011, FOOD CHEM, V126, P1431, DOI 10.1016/j.foodchem.2010.11.130; Rogge WF, 2006, ATMOS ENVIRON, V40, P27, DOI 10.1016/j.atmosenv.2005.07.076; Rogge WF, 2007, ATMOS ENVIRON, V41, P8183, DOI 10.1016/j.atmosenv.2007.06.030; Rushdi AI, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-253; Rushdi AI, 2005, ARCH ENVIRON CON TOX, V49, P457, DOI 10.1007/s00244-004-0002-7; Rushdi AI, 2002, APPL GEOCHEM, V17, P1467, DOI 10.1016/S0883-2927(02)00113-0; Rushdi AI, 2002, APPL GEOCHEM, V17, P1401, DOI 10.1016/S0883-2927(02)00109-9; Sforcin JM, 2011, J ETHNOPHARMACOL, V133, P253, DOI 10.1016/j.jep.2010.10.032; Simone M, 2009, EVOLUTION, V63, P3016, DOI 10.1111/j.1558-5646.2009.00772.x; Simone-Finstrom M, 2010, APIDOLOGIE, V41, P295, DOI 10.1051/apido/2010016; Simoneit B.R.T., 1978, CHEM OCEANOGR, V7, P233; SIMONEIT BRT, 1990, CHEMOSPHERE, V21, P1285, DOI 10.1016/0045-6535(90)90145-J; SIMONEIT BRT, 1991, ENVIRON INT, V17, P405, DOI 10.1016/0160-4120(91)90274-T; SIMONEIT BRT, 1984, ATMOS ENVIRON, V18, P51, DOI 10.1016/0004-6981(84)90228-2; SIMONEIT BRT, 1989, J ATMOS CHEM, V8, P251, DOI 10.1007/BF00051497; SIMONEIT BRT, 1991, ATMOS ENVIRON A-GEN, V25, P2111, DOI 10.1016/0960-1686(91)90088-O; TULLOCH AP, 1971, CHEM PHYS LIPIDS, V6, P235, DOI 10.1016/0009-3084(71)90063-6	52	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128311	10.1371/journal.pone.0128311	http://dx.doi.org/10.1371/journal.pone.0128311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075382	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900018
J	Bannantine, JP; Stabel, JR; Laws, E; Cardieri, MCD; Souza, CD				Bannantine, John P.; Stabel, Judith R.; Laws, Elizabeth; Cardieri, Maria Clara D.; Souza, Cleverson D.			Mycobacterium avium Subspecies paratuberculosis Recombinant Proteins Modulate Antimycobacterial Functions of Bovine Macrophages	PLOS ONE			English	Article							GAMMA-INTERFERON; NITRIC-OXIDE; DAIRY-COWS; TUBERCULOSIS; INTERLEUKIN-10; EXPRESSION; MATURATION; INFECTION; CATTLE; LIPOPROTEINS	It has been shown that Mycobacterium avium subspecies paratuberculosis (M. paratuberculosis) activates the Mitogen Activated Protein Kinase (MAPK) p38 pathway, yet it is unclear which components of M. paratuberculosis are involved in the process. Therefore, a set of 42 M. paratuberculosis recombinant proteins expressed from coding sequences annotated as lipoproteins were screened for their ability to induce IL-10 expression, an indicator of MAPKp38 activation, in bovine monocyte-derived macrophages. A recombinant lipoprotein, designated as MAP3837c, was among a group of 6 proteins that strongly induced IL-10 gene transcription in bovine macrophages, averaging a 3.1-fold increase compared to non-stimulated macrophages. However, a parallel increase in expression of IL-12 and TNF-alpha was only observed in macrophages exposed to a subset of these 6 proteins. Selected recombinant proteins were further analyzed for their ability to enhance survival of M. avium within bovine macrophages as measured by recovered viable bacteria and nitrite production. All 6 IL-10 inducing MAP recombinant proteins along with M. paratuberculosis cells significantly enhanced phosphorylation of MAPK-p38 in bovine macrophages. Although these proteins are likely not post translationally lipidated in E. coli and thus is a limitation in this study, these results form the foundation of how the protein component of the lipoprotein interacts with the immune system. Collectively, these data reveal M. paratuberculosis proteins that might play a role in MAPK-p38 pathway activation and hence in survival of this organism within bovine macrophages.	[Bannantine, John P.; Stabel, Judith R.] USDA ARS, Natl Anim Dis Ctr, Ames, IA 50010 USA; [Laws, Elizabeth; Cardieri, Maria Clara D.; Souza, Cleverson D.] Washington State Univ, Dept Vet Clin Sci, Pullman, WA 99164 USA	United States Department of Agriculture (USDA); Washington State University	Souza, CD (corresponding author), Washington State Univ, Dept Vet Clin Sci, Pullman, WA 99164 USA.	souza@vetmed.wsu.edu		Bannantine, John/0000-0002-5692-7898				Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Bannantine JP, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-2; Bannantine JP, 2010, PROTEIN EXPRES PURIF, V72, P223, DOI 10.1016/j.pep.2010.03.019; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brulle JK, 2010, BIOCHEM BIOPH RES CO, V391, P679, DOI 10.1016/j.bbrc.2009.11.120; Clark IA, 2007, CYTOKINE GROWTH F R, V18, P335, DOI 10.1016/j.cytogfr.2007.04.002; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Dennis MM, 2008, VET MICROBIOL, V131, P154, DOI 10.1016/j.vetmic.2008.02.017; Early J, 2011, MICROB PATHOGENESIS, V50, P132, DOI 10.1016/j.micpath.2010.12.004; Harris NB, 2001, CLIN MICROBIOL REV, V14, P489, DOI 10.1128/CMR.14.3.489-512.2001; Hostetter JM, 2002, FEMS IMMUNOL MED MIC, V34, P127, DOI 10.1111/j.1574-695X.2002.tb00613.x; JACOBSEN CN, 1993, VET IMMUNOL IMMUNOP, V39, P461, DOI 10.1016/0165-2427(93)90075-F; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Khalifeh MS, 2004, INFECT IMMUN, V72, P1974, DOI 10.1128/IAI.72.4.1974-1982.2004; Kuehnel MP, 2001, CELL MICROBIOL, V3, P551, DOI 10.1046/j.1462-5822.2001.00139.x; Leopold I, 1997, ANAL BIOCHEM, V252, P277, DOI 10.1006/abio.1997.2329; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Raizman EA, 2009, J DAIRY SCI, V92, P4929, DOI 10.3168/jds.2009-2133; Rampini SK, 2008, MICROBIOL-SGM, V154, P2991, DOI 10.1099/mic.0.2008/018895-0; Sakthi S, 2013, MICROBIOL RES, V168, P407, DOI 10.1016/j.micres.2013.02.007; Simutis FJ, 2007, VET IMMUNOL IMMUNOP, V116, P1, DOI 10.1016/j.vetimm.2006.12.005; Souza C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075924; Souza CD, 2006, MICROB PATHOGENESIS, V41, P59, DOI 10.1016/j.micpath.2006.04.002; Stabel JR, 2008, J DAIRY SCI, V91, P3600, DOI 10.3168/jds.2008-1107; Stabel JR, 2014, J DAIRY SCI, V97, P6296, DOI 10.3168/jds.2014-8204; SUTCLIFFE IC, 1995, J BACTERIOL, V177, P1123, DOI 10.1128/jb.177.5.1123-1128.1995; Tschumi A, 2009, J BIOL CHEM, V284, P27146, DOI 10.1074/jbc.M109.022715; Weiss DJ, 2005, AM J VET RES, V66, P1114, DOI 10.2460/ajvr.2005.66.1114; Weiss DJ, 2005, AM J VET RES, V66, P721, DOI 10.2460/ajvr.2005.66.721; Weiss DJ, 2002, INFECT IMMUN, V70, P5556, DOI 10.1128/IAI.70.10.5556-5561.2002; Weiss DJ, 2008, J LEUKOCYTE BIOL, V83, P48, DOI 10.1189/jlb.0707490; Zhao BY, 1997, INFECT IMMUN, V65, P1761, DOI 10.1128/IAI.65.5.1761-1766.1997	35	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128966	10.1371/journal.pone.0128966	http://dx.doi.org/10.1371/journal.pone.0128966			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076028	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900040
J	Freedman, SB; Pasichnyk, D; Black, KJL; Fitzpatrick, E; Gouin, S; Milne, A; Hartling, L				Freedman, Stephen B.; Pasichnyk, Dion; Black, Karen J. L.; Fitzpatrick, Eleanor; Gouin, Serge; Milne, Andrea; Hartling, Lisa		Pediat Emergency Res Canada	Gastroenteritis Therapies in Developed Countries: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RANDOMIZED CLINICAL-TRIAL; ACUTE INFECTIOUS DIARRHEA; ORAL ONDANSETRON; PEDIATRIC GASTROENTERITIS; LACTOBACILLUS GG; CHILDREN; MANAGEMENT; INFANTS; HETEROGENEITY; REHYDRATION	Context Gastroenteritis remains a leading cause of childhood morbidity. Objective Because prior reviews have focused on isolated symptoms and studies conducted in developing countries, this study focused on interventions commonly considered for use in developed countries. Intervention specific, patient-centered outcomes were selected. Data Sources MEDLINE, EMBASE, the Cochrane Database of Systematic Reviews, trial registries, grey literature, and scientific meetings. Study Selection Randomized controlled trials, conducted in developed countries, of children aged < 18 years, with gastroenteritis, performed in emergency department or outpatient settings which evaluated oral rehydration therapy (ORT), antiemetics, probiotics or intravenous fluid administration rate. Data Extraction The study was conducted in accordance with the Cochrane Handbook for Systematic Reviews of Interventions and the PRISMA guidelines. Data were independently extracted by multiple investigators. Analyses employed random effects models. Results 31 trials (4,444 patients) were included. ORT: Compared with intravenous rehydration, hospitalization (RR 0.80, 95% CI 0.24, 2.71) and emergency department return visits (RR 0.86, 95% CI 0.39, 1.89) were similar. Antiemetics: Fewer children administered an antiemetic required intravenous rehydration (RR 0.40, 95% CI 0.26, 0.60) While the data could not be meta-analyzed, three studies reported that ondansetron administration does increase the frequency of diarrhea. Probiotics: No studies reported on the primary outcome, three studies evaluated hospitalization within 7 days (RR 0.87, 95% CI 0.25, 2.98). Rehydration: No difference in length of stay was identified for rapid vs. standard intravenous or nasogastric rehydration. A single study found that 5% dextrose in normal saline reduced hospitalizations compared with normal saline alone (RR 0.70, 95% CI 0.53, 0.92). Conclusions There is a paucity of patient-centered outcome evidence to support many interventions. Since ORT is a low-cost, non-invasive intervention, it should continue to be used. Routine probiotic use cannot be endorsed at this time in outpatient children with gastroenteritis. Despite some evidence that ondansetron administration increases diarrhea frequency, emergency department use leads to reductions in intravenous rehydration and hospitalization. No benefits were associated with ondansetron use following emergency department discharge.	[Freedman, Stephen B.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Cumming Sch Med,Sect Pediat Emergency Med, Calgary, AB, Canada; [Freedman, Stephen B.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Cumming Sch Med,Sect Gastroenterol, Calgary, AB, Canada; [Pasichnyk, Dion; Milne, Andrea; Hartling, Lisa] Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada; [Black, Karen J. L.] Univ British Columbia, BC Childrens Hosp, Div Pediat Emergency Med, Vancouver, BC V5Z 1M9, Canada; [Fitzpatrick, Eleanor] Dalhousie Univ, Dept Emergency Med, Emergency Dept, IWK Hlth Ctr, Halifax, NS, Canada; [Gouin, Serge] Univ Montreal, Ctr Hosp Univ Ste Justine, Sect Pediat Emergency Med, Montreal, PQ, Canada	Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Alberta; BC Childrens Hospital; University of British Columbia; Dalhousie University; Universite de Montreal	Freedman, SB (corresponding author), Univ Calgary, Alberta Childrens Hosp, Res Inst, Cumming Sch Med,Sect Pediat Emergency Med, Calgary, AB, Canada.	stephen.freedman@albertahealthservices.ca	Pasichnyk, Dion/AAP-2716-2020; Freedman, Stephen/H-9102-2012	Freedman, Stephen/0000-0003-2319-6192; Klassen, Terry/0000-0002-5309-7091; Doan, Quynh/0000-0002-8435-7837	Canadian Institutes of Health Research; Alberta Innovates [201300680] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	This study was funded by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Jarousha AMK, 2011, INDIAN J PEDIATR, V78, P165, DOI 10.1007/s12098-010-0249-0; Allen SJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003048.pub3; [Anonymous], 2011, COMP MACR CONT REG G; Buscemi N, 2006, J CLIN EPIDEMIOL, V59, P697, DOI 10.1016/j.jclinepi.2005.11.010; Campbell H, 1998, ARCH DIS CHILD, V79, P192, DOI 10.1136/adc.79.2.192; Canani RB, 2007, BMJ-BRIT MED J, V335, P340, DOI 10.1136/bmj.39272.581736.55; Carter B, 2012, BMJ OPEN, P2; Cheng A, 2011, PAED CHILD HEALT-CAN, V16, P177, DOI 10.1093/pch/16.3.177; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; DeCamp LR, 2008, ARCH PEDIAT ADOL MED, V162, P858, DOI 10.1001/archpedi.162.9.858; Deeks~ JJ, 2001, SYSTEMATIC REV HLTH; Eltorki M, 2014, PAED CHILD HEALT-CAN, V19, P500, DOI 10.1093/pch/19.9.500; Fontaine Olivier, 2007, BMJ, V334 Suppl 1, ps14, DOI 10.1136/bmj.39044.725949.94; Freedman SB, 2006, NEW ENGL J MED, V354, P1698, DOI 10.1056/NEJMoa055119; Freedman SB, 2010, PLOS MED, P7; Freedman SB, 2013, ANN EMERG MED; Freedman SB, 2013, J PEDIATR GASTR NUTR, V57, P612, DOI 10.1097/MPG.0b013e3182a1dd93; Freedman Stephen B, 2013, Evid Based Child Health, V8, P1123, DOI 10.1002/ebch.1932; Freedman SB, 2011, PEDIATRICS, V127, pE287, DOI 10.1542/peds.2010-2214; Freedman SB, 2011, ACAD EMERG MED, V18, P38, DOI 10.1111/j.1553-2712.2010.00960.x; Guarino A, 2014, J PEDIATR GASTR NUTR, V59, P132, DOI 10.1097/MPG.0000000000000375; Gui J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064585; Harting L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004390.pub2; Hartling L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1714; Higgins J., 2009, COCHRANE HDB SYSTEMA; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang JS, 2002, DIGEST DIS SCI, V47, P2625, DOI 10.1023/A:1020501202369; Johnston BC, 2010, PEDIATRICS, V126, pE222, DOI 10.1542/peds.2009-3667; Keren R, 2014, JAMA PEDIATR, V168, P308, DOI 10.1001/jamapediatrics.2013.5378; Kharbanda AB, 2013, J PEDIATR-US, V163, P230, DOI 10.1016/j.jpeds.2012.12.013; King Caleb K, 2003, MMWR Recomm Rep, V52, P1; Lee BE, 2013, CAN MED ASSOC J, V185, P1381, DOI 10.1503/cmaj.130426; National Collaborating Centre for Women's and Children's Health Diarrhoea and vomiting caused by gastroenteritis: diagnosis assessment and management in children younger than 5 years, NAT COLL CTR WOM CHI; Nixon AF, 2012, PEDIATR EMERG CARE, V28, P1048, DOI 10.1097/PEC.0b013e31826cad9f; Opintan JA, 2010, AM J TROP MED HYG, V83, P936, DOI 10.4269/ajtmh.2010.09-0792; Parker MW, 2013, PEDIATRICS, V131, pS96, DOI 10.1542/peds.2012-1427l; Passariello A, 2012, ALIMENT PHARM THER, V35, P782, DOI 10.1111/j.1365-2036.2012.05015.x; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Petitti DB, 2001, STAT MED, V20, P3625, DOI 10.1002/sim.1091; Piescik-Lech M, 2013, ALIMENT PHARM THER, V37, P289, DOI 10.1111/apt.12163; Powell EC, 2003, ARCH PEDIAT ADOL MED, V157, P978, DOI 10.1001/archpedi.157.10.978; Pringle K, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-58; Qazi K, 2014, AM J EMERG MED, V32, P1046, DOI 10.1016/j.ajem.2014.06.018; Ramsook C, 2002, ANN EMERG MED, V39, P397, DOI 10.1067/mem.2002.122706; Reeves JJ, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.4.e62; Roslund G, 2008, ANN EMERG MED, V52, P22, DOI 10.1016/j.annemergmed.2007.09.010; Schunemann HJ, 2009, GRADE HDB GRADING QU; Scott SD, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-133; Seida JC, 2010, ANN INTERN MED, V153, P246, DOI 10.7326/0003-4819-153-4-201008170-00263; Szajewska H, 2013, ALIMENT PHARM THER, V38, P467, DOI 10.1111/apt.12403; Szajewska H, 2001, J PEDIATR GASTR NUTR, V33, pS17, DOI 10.1097/00005176-200110002-00004; TAMER AM, 1985, J PEDIATR-US, V107, P14, DOI 10.1016/S0022-3476(85)80606-5; Tate JE, 2009, PEDIATRICS, V124, P465, DOI 10.1542/peds.2008-3528; U. S. Department of Health & Human Services, 2014, CHILD HLTH CAR QUAL; Van Niel CW, 2002, PEDIATRICS, V109, P678, DOI 10.1542/peds.109.4.678	56	44	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128754	10.1371/journal.pone.0128754	http://dx.doi.org/10.1371/journal.pone.0128754			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075617	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900028
J	Lai, HM; Li, XM; Yang, YN; Ma, YT; Xu, R; Pan, S; Zhai, H; Liu, F; Chen, BD; Zhao, Q				Lai, Hong-Mei; Li, Xiao-Mei; Yang, Yi-Ning; Ma, Yi-Tong; Xu, Rui; Pan, Shuo; Zhai, Hui; Liu, Fen; Chen, Bang-Dang; Zhao, Qian			Genetic Variation in NFKB1 and NFKBIA and Susceptibility to Coronary Artery Disease in a Chinese Uygur Population	PLOS ONE			English	Article							C-REACTIVE PROTEIN; HEART-DISEASE; PROMOTER POLYMORPHISM; MYOCARDIAL-INFARCTION; UIGHUR POPULATION; KAPPA-B; ASSOCIATION; INTERLEUKIN-6; RISK; ATHEROSCLEROSIS	Objectives Coronary artery disease (CAD) is the most common chronic inflammatory disease worldwide. NF-kappa B, a central regulator of inflammation, is involved in various inflammatory diseases. The aim of this study was to investigate the association between NFKB1 and NFKBIA polymorphisms and the susceptibility to CAD and their impact on plasma levels of IL-6 in a Chinese Uygur population. Methods We genotyped NFKB1-94ins/del ATTG (rs28362491) and NFKBIA3' UTR A/G (rs696) using TaqMan SNP genotyping assays in 960 Uygur CAD cases and Uygur 1060 CAD-negtive controls. IL-6 plasma levels were measured in 360 stable angina pectoris (SAP) cases and 360 controls using ELISA method. Results There was no significant difference in the distribution of the genotypes and alleles of rs696 polymorphism in CAD cases and controls. Significant difference in the frequency of genotypes (P = 0.001) and alleles (P = 0.001) of rs28362491 polymorphism was observed in CAD cases compared to controls. In multivariate logistic regression analysis, SNP rs28362491 was consistently associated with CAD risk in a recessive model after adjustment for cardiovascular risk factors (OR = 1.581, 95% CI 1.222 to 2.046, P<0.001). SAP cases had significantly higher plasma levels of IL-6 compared to controls (P<0.001). General linear model analysis showed rs28362491 was independently associated with increased IL-6 levels by analyses of a recessive model (P<0.001) after adjustment for covariates. Conclusions Our study indicates that NFKB1-94 ins/del ATTG polymorphism may play a role in CAD susceptibility in Chinese Uygur population and is functionally associated with IL-6 expression, suggesting a mechanistic link between NFKB1-94 ins/del ATTG polymorphism and CAD susceptibility.	[Lai, Hong-Mei; Li, Xiao-Mei; Yang, Yi-Ning; Ma, Yi-Tong; Xu, Rui; Zhai, Hui; Zhao, Qian] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China; [Lai, Hong-Mei] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Cardiol, Urumqi, Peoples R China; [Lai, Hong-Mei; Li, Xiao-Mei; Yang, Yi-Ning; Ma, Yi-Tong; Xu, Rui; Zhai, Hui; Liu, Fen; Chen, Bang-Dang] Xinjiang Key Lab Cardiovasc Dis Res, Urumqi, Peoples R China; [Liu, Fen; Chen, Bang-Dang] Xinjiang Med Univ, Clin Res Inst, Urumqi, Peoples R China; [Pan, Shuo] Peoples Hosp Shaanxi Prov, Dept Cardiol 1, Xian, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xi'an Medical University	Yang, YN (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China.	yangyn5126@163.com; myt-xj@163.com			High-technology research and development planning of Xinjiang Uygur Autonomous Region [201417102]	High-technology research and development planning of Xinjiang Uygur Autonomous Region	This work was supported by High-technology research and development planning of Xinjiang Uygur Autonomous Region (201417102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biasillo G, 2010, INTERN EMERG MED, V5, P225, DOI 10.1007/s11739-010-0361-1; Boccardi V, 2011, NUTR METAB CARDIOVAS, V21, P679, DOI 10.1016/j.numecd.2009.12.012; Borm MEA, 2005, INT J IMMUNOGENET, V32, P401, DOI 10.1111/j.1744-313X.2005.00546.x; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Fontaine-Bisson B, 2009, ATHEROSCLEROSIS, V204, P465, DOI 10.1016/j.atherosclerosis.2008.10.037; Gao M, 2012, DNA CELL BIOL, V31, P611, DOI 10.1089/dna.2011.1389; Goto Y, 2001, CLIN CANCER RES, V7, P1952; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Koc A, 2014, IMMUNOBIOLOGY, V219, P531, DOI 10.1016/j.imbio.2014.03.009; Koenig W, 2006, ARTERIOSCL THROM VAS, V26, P2745, DOI 10.1161/01.ATV.0000248096.62495.73; Kume K, 2011, J RHEUMATOL, V38, P2169, DOI 10.3899/jrheum.110340; Kuo LT, 2008, INT HEART J, V49, P391, DOI 10.1536/ihj.49.391; Kurylowicz A, 2007, GENES IMMUN, V8, P532, DOI 10.1038/sj.gene.6364418; Li X, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-84; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Luc G, 2003, ARTERIOSCL THROM VAS, V23, P1255, DOI 10.1161/01.ATV.0000079512.66448.1D; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mishra A, 2013, CYTOKINE, V61, P856, DOI 10.1016/j.cyto.2012.12.020; Pereira SG, 2008, INT J BIOCHEM CELL B, V40, P1425, DOI 10.1016/j.biocel.2007.05.004; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Romzova M, 2006, HUM IMMUNOL, V67, P706, DOI 10.1016/j.humimm.2006.05.006; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; SEINO Y, 1994, CYTOKINE, V6, P87, DOI 10.1016/1043-4666(94)90013-2; Vogel U, 2011, ATHEROSCLEROSIS, V219, P200, DOI 10.1016/j.atherosclerosis.2011.06.018; Xie XA, 2011, CLIN CHEM LAB MED, V49, P55, DOI 10.1515/CCLM.2011.024; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015181; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013997; Yang YN, 2010, CLIN APPL THROMB-HEM, V16, P579, DOI 10.1177/1076029610364522; Zou JG, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-145; Zuccala A, 2009, G Ital Nefrol, V26, P226	34	22	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129144	10.1371/journal.pone.0129144	http://dx.doi.org/10.1371/journal.pone.0129144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075620	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900046
J	Zhu, S; Guo, X; Keyes, LR; Yang, HC; Ge, XN				Zhu, Shu; Guo, Xin; Keyes, Lisa R.; Yang, Hanchun; Ge, Xinna			Recombinant Encephalomyocarditis Viruses Elicit Neutralizing Antibodies against PRRSV and CSFV in Mice	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; ATTENUATED MENGO-VIRUS; MOUTH-DISEASE VIRUS; GENETIC STABILITY; IMMUNE-RESPONSE; POLIOVIRUS; VECTOR; INFECTION; PROTEIN; PIGS	Encephalomyocarditis virus (EMCV) is capable of infecting a wide range of species and the infection can cause myocarditis and reproductive failure in pigs as well as febrile illness in human beings. In this study, we introduced the entire ORF5 of the porcine reproductive and respiratory syndrome virus (PRRSV) or the neutralization epitope regions in the E2 gene of the classical swine fever virus (CSFV), into the genome of a stably attenuated EMCV strain, T1100I. The resultant viable recombinant viruses, CvBJC3m/I-Delta GP5 and CvBJC3m/I-E2, respectively expressed partial PRRSV envelope protein GP5 or CSFV neutralization epitope A1A2 along with EMCV proteins. These heterologous proteins fused to the N-terminal of the nonstructural leader protein could be recognized by anti-GP5 or anti-E2 antibody. We also tested the immunogenicity of these fusion proteins by immunizing BALB/c mice with the recombinant viruses. The immunized animals elicited neutralizing antibodies against PRRSV and CSFV. Our results suggest that EMCV can be engineered as an expression vector and serve as a tool in the development of novel live vaccines in various animal species.	[Zhu, Shu; Guo, Xin; Yang, Hanchun; Ge, Xinna] China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Beijing 100193, Peoples R China; [Zhu, Shu; Guo, Xin; Yang, Hanchun; Ge, Xinna] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Keyes, Lisa R.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University; State University System of Florida; University of Florida	Yang, HC (corresponding author), China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Beijing 100193, Peoples R China.	yanghanchun1@cau.edu.cn; gexn@cau.edu.cn			National Natural Science Foundation of China [30700589]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 30700589) [http://www.nsfc.gov.cn/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMEYER R, 1994, P NATL ACAD SCI USA, V91, P9775, DOI 10.1073/pnas.91.21.9775; ALTMEYER R, 1995, J VIROL, V69, P3193, DOI 10.1128/JVI.69.5.3193-3196.1995; ANDINO R, 1994, SCIENCE, V265, P1448, DOI 10.1126/science.8073288; Binder JJ, 2003, VIROLOGY, V312, P481, DOI 10.1016/S0042-6822(03)00245-9; BURKE KL, 1988, NATURE, V332, P81, DOI 10.1038/332081a0; Canelli E, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-64; Dvorak CMT, 2001, VIROLOGY, V290, P261, DOI 10.1006/viro.2001.1193; EVANS DJ, 1989, NATURE, V339, P385, DOI 10.1038/339385a0; Faaberg KS, 2006, VIRAL IMMUNOL, V19, P294, DOI 10.1089/vim.2006.19.294; Ge X, 2010, VET REC, V166, P145, DOI 10.1136/vr.b4766; GIRARD M, 1995, BIOLOGICALS, V23, P165, DOI 10.1006/biol.1995.0027; Hammoumi S, 2006, ARCH VIROL, V151, P1783, DOI 10.1007/s00705-006-0746-7; Hato SV, 2010, CELL MICROBIOL, V12, P310, DOI 10.1111/j.1462-5822.2009.01395.x; Jia H, 2008, ANTIVIR RES, V79, P95, DOI 10.1016/j.antiviral.2007.12.003; Kheyar A, 2005, VACCINE, V23, P4016, DOI 10.1016/j.vaccine.2005.03.012; KITSON JDA, 1991, J VIROL, V65, P3068, DOI 10.1128/JVI.65.6.3068-3075.1991; KOENEN F, 1994, VET MICROBIOL, V39, P111, DOI 10.1016/0378-1135(94)90091-4; LaRue R, 2003, J VIROL, V77, P9136, DOI 10.1128/JVI.77.17.9136-9146.2003; Lee SG, 2002, J VIROL, V76, P1649, DOI 10.1128/JVI.76.4.1649-1662.2002; Liu H, 2013, GENOME ANNOUNC, V1, P12; MARTIN A, 1988, EMBO J, V7, P2839, DOI 10.1002/j.1460-2075.1988.tb03140.x; Masek-Hammerman K, 2012, VET PATHOL, V49, P386, DOI 10.1177/0300985811409254; MURNANE TG, 1960, SCIENCE, V131, P498, DOI 10.1126/science.131.3399.498; MURRAY MG, 1988, P NATL ACAD SCI USA, V85, P3203, DOI 10.1073/pnas.85.9.3203; Nam HM, 2013, ARCH VIROL, V158, P1275, DOI 10.1007/s00705-013-1612-z; Petty RV, 2014, J VIROL, V88, P13503, DOI 10.1128/JVI.02148-14; Qiu HJ, 2005, VET IMMUNOL IMMUNOP, V106, P309, DOI 10.1016/j.vetimm.2005.03.008; Ricour C, 2009, J VIROL, V83, P11223, DOI 10.1128/JVI.00829-09; Robinson SR, 2013, VET MICROBIOL, V164, P281, DOI 10.1016/j.vetmic.2013.03.006; Van der Ryst E, 1998, RES VIROLOGY, V149, P5, DOI 10.1016/S0923-2516(97)86896-3; Yeo DSY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-248; ZHANG L, 1995, J VIROL, V69, P3171, DOI 10.1128/JVI.69.5.3171-3175.1995; Zhu S, 2011, SCI CHINA LIFE SCI, V54, P535, DOI 10.1007/s11427-011-4172-z	33	2	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129729	10.1371/journal.pone.0129729	http://dx.doi.org/10.1371/journal.pone.0129729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076449	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900097
J	Chen, LC; Ho, CW; Sun, CH; Lee, JT; Li, TY; Shih, FM; Wu, YT				Chen, Liang-Cheng; Ho, Cheng-Wen; Sun, Chia-Hung; Lee, Jiunn-Tay; Li, Tsung-Ying; Shih, Feng-Mei; Wu, Yung-Tsan			Ultrasound-Guided Pulsed Radiofrequency for Carpal Tunnel Syndrome: A Single-Blinded Randomized Controlled Study	PLOS ONE			English	Article							NERVE-CONDUCTION; SUPRASCAPULAR NERVE; STEROID INJECTIONS; FUNCTIONAL STATUS; SYMPTOMS; PAIN; SEVERITY	Objective We assessed the therapeutic efficiency of ultrasound-guided pulsed radiofrequency (PRF) treatment of the median nerve in patients with carpal tunnel syndrome (CTS). Methods We conducted a prospective, randomized, controlled, single-blinded study. Forty-four patients with CTS were randomized into intervention or control groups. Patients in the intervention group were treated with PRF and night splint, and the control group was prescribed night splint alone. Primary outcome was the onset time of significant pain relief assessed using the visual analog scale (VAS), and secondary outcomes included evaluation of the Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) results, cross-sectional area (CSA) of the median nerve, sensory nerve conduction velocity (SNCV) of the median nerve, and finger pinch strength. All outcome measurements were performed at 1, 4, 8, and 12 weeks after treatment. Results Thirty-six patients completed the study. The onset time of pain relief in the intervention group was significantly shorter (median onset time of 2 days vs. 14 days; hazard ratio = 7.37; 95% CI, 3.04-17.87) compared to the control group (p < 0.001). Significant improvement in VAS and BCTQ scores (p < 0.05) was detected in the intervention group at all follow-up periods compared to the controls (except for the severity subscale of BCTQ at week 1). Ultrasound-guided PRF treatment resulted in a lower VAS score and stronger finger pinch compared to the control group over the entire study. Conclusions Our study shows that ultrasound-guided PRF serves as a better approach for pain relief in patients with CTS.	[Chen, Liang-Cheng; Sun, Chia-Hung; Li, Tsung-Ying; Shih, Feng-Mei; Wu, Yung-Tsan] Natl Def Med Ctr, Triserv Gen Hosp, Sch Med, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chen, Liang-Cheng] Hualien Armed Forces Gen Hosp, Dept Phys Med & Rehabil, Xincheng, Hualien County, Taiwan; [Ho, Cheng-Wen] Natl Def Med Ctr, Sch Med, Grad Inst Aerosp Med, Taipei, Taiwan; [Lee, Jiunn-Tay] Natl Def Med Ctr, Triserv Gen Hosp, Sch Med, Dept Neurol, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Wu, YT (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Sch Med, Dept Phys Med & Rehabil, Taipei, Taiwan.	crwu98@gmail.com	Li, Tsung-Ying/AAJ-2359-2020		Tri-Service General Hospital, Taipei, Taiwan, Republic of China [TSGH-C102-105]	Tri-Service General Hospital, Taipei, Taiwan, Republic of China	The study is (only) supported by the Tri-Service General Hospital (grant no. TSGH-C102-105), Taipei, Taiwan, Republic of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atroshi I, 2000, Lakartidningen, V97, P1668; Chan L, 2007, ARCH PHYS MED REHAB, V88, P19, DOI 10.1016/j.apmr.2006.10.013; Chua NHL, 2011, ACTA NEUROCHIR, V153, P763, DOI 10.1007/s00701-010-0881-5; El Miedany YM, 2004, RHEUMATOLOGY, V43, P887, DOI 10.1093/rheumatology/keh190; Erdine S, 2009, PAIN PRACT, V9, P407, DOI 10.1111/j.1533-2500.2009.00317.x; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Gerritsen AAM, 2003, J NEUROL NEUROSUR PS, V74, P1342, DOI 10.1136/jnnp.74.9.1342; Gofeld M, 2013, PAIN PRACT, V13, P96, DOI 10.1111/j.1533-2500.2012.00560.x; Gursoy AE, 2013, NEUROPSYCH DIS TREAT, V9, P65, DOI 10.2147/NDT.S38513; Haider Naeem, 2007, Pain Physician, V10, P765; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; JABLECKI CK, 1993, MUSCLE NERVE, V16, P1392; Karadag YS, 2010, RHEUMATOL INT, V30, P761, DOI 10.1007/s00296-009-1061-x; Katz JN, 1998, J HAND SURG-AM, V23A, P697, DOI 10.1016/S0363-5023(98)80058-0; Kaymak B, 2008, ARCH PHYS MED REHAB, V89, P743, DOI 10.1016/j.apmr.2007.09.041; Lakemeier S, 2013, ANESTH ANALG, V117, P228, DOI 10.1213/ANE.0b013e3182910c4d; Lee CH, 2005, ANN PLAS SURG, V54, P20, DOI 10.1097/01.sap.0000141942.27182.55; LEVINE DW, 1993, J BONE JOINT SURG AM, V75A, P1585, DOI 10.2106/00004623-199311000-00002; O'Connor D, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003219, DOI 10.1002/14651858.CD003219]; Sites BD, 2006, CURR OPIN ANESTHESIO, V19, P630, DOI 10.1097/ACO.0b013e3280101423; Sluijter ME, 1998, SPINE, V23, P745, DOI 10.1097/00007632-199803150-00022; Soyupek F, 2012, RHEUMATOL INT, V32, P3229, DOI 10.1007/s00296-011-2173-7; Stegink Jansen Caroline W, 2003, J Hand Ther, V16, P326; Taylor-Gjevre RM, 2010, CAN FAM PHYSICIAN, V56, pE250; Ustun N, 2013, AM J PHYS MED REHAB, V92, P999, DOI 10.1097/PHM.0b013e31829b4d72; Van Zundert J, 2005, ANESTHESIOLOGY, V102, P125, DOI 10.1097/00000542-200501000-00021; Werner RA, 2002, CLIN NEUROPHYSIOL, V113, P1373, DOI 10.1016/S1388-2457(02)00169-4; Wong SM, 2002, ARTHRITIS RHEUM, V46, P1914, DOI 10.1002/art.10385; Wu YT, 2014, ANESTH ANALG, V119, P686, DOI 10.1213/ANE.0000000000000354	29	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129918	10.1371/journal.pone.0129918	http://dx.doi.org/10.1371/journal.pone.0129918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067628	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000124
J	Ha, BG; Park, JE; Cho, HJ; Shon, YH				Ha, Byung Geun; Park, Jung-Eun; Cho, Hyun-Jung; Shon, Yun Hee			Stimulatory Effects of Balanced Deep Sea Water on Mitochondrial Biogenesis and Function	PLOS ONE			English	Article							MAGNESIUM-DEFICIENCY; ADIPOSE-TISSUE; HIGH-FAT; CALCIUM; PATHWAY; AMPK; APOPTOSIS; PROTEIN; OBESITY; CELLS	The worldwide prevalence of metabolic diseases, including obesity and diabetes, is increasing. Mitochondrial dysfunction is recognized as a core feature of these diseases. Emerging evidence also suggests that defects in mitochondrial biogenesis, number, morphology, fusion, and fission, contribute to the development and progression of metabolic diseases. Our previous studies revealed that balanced deep-sea water (BDSW) has potential as a treatment for diabetes and obesity. In this study, we aimed to investigate the mechanism by which BDSWregulates diabetes and obesity by studying its effects on mitochondrial metabolism. To determine whether BDSWregulates mitochondrial biogenesis and function, we investigated its effects on mitochondrial DNA (mtDNA) content, mitochondrial enzyme activity, and the expression of transcription factors and mitochondria specific genes, as well as on the phosphorylation of signaling molecules associated with mitochondria biogenesis and its function in C2C12 myotubes. BDSWincreased mitochondrial biogenesis in a time and dose-dependent manner. Quantitative real-time PCR revealed that BDSW enhances gene expression of PGC-1 alpha, NRF1, and TFAM for mitochondrial transcription; MFN1/2 and DRP1 for mitochondrial fusion; OPA1 for mitochondrial fission; TOMM40 and TIMM44 for mitochondrial protein import; CPT-1 alpha and MCAD for fatty acid oxidation; CYTC for oxidative phosphorylation. Upregulation of these genes was validated by increased mitochondria staining, CS activity, CytC oxidase activity, NAD(+) to NADH ratio, and the phosphorylation of signaling molecules such as AMPK and SIRT1. Moreover, drinking BDSWremarkably improved mtDNA content in the muscles of HFD-induced obese mice. Taken together, these results suggest that the stimulatory effect of BDSWon mitochondrial biogenesis and function may provide further insights into the regulatory mechanism of BDSW-induced anti-diabetic and anti-obesity action.	[Ha, Byung Geun; Park, Jung-Eun; Cho, Hyun-Jung; Shon, Yun Hee] Kyungpook Natl Univ Hosp, Biomed Res Inst, Taegu, South Korea	Kyungpook National University; Kyungpook National University Hospital	Shon, YH (corresponding author), Kyungpook Natl Univ Hosp, Biomed Res Inst, Taegu, South Korea.	yhshon@hmail.knu.ac.kr			Ministry of Oceans and Fisheries of the Republic of Korea	Ministry of Oceans and Fisheries of the Republic of Korea	This research was supported by a grant (technical development for supporting the DSW industry) from the Ministry of Oceans and Fisheries of the Republic of Korea.	Aguer C, 2012, BEST PRACT RES CL EN, V26, P805, DOI 10.1016/j.beem.2012.06.001; Ames Bruce N., 2005, Molecular Aspects of Medicine, V26, P363, DOI 10.1016/j.mam.2005.07.007; Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023; [Anonymous], STANDARD METHODS FOR; Bak JP, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-108; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Bussiere FI, 2002, BRIT J NUTR, V87, P107, DOI 10.1079/BJN2001498; Cheng ZY, 2014, CELL CYCLE, V13, P890, DOI 10.4161/cc.28189; Chomentowski P, 2011, J CLIN ENDOCR METAB, V96, P494, DOI 10.1210/jc.2010-0822; Clark TA, 2014, HEART FAIL REV, V19, P123, DOI 10.1007/s10741-013-9380-0; Fujisawa K, 2009, BIOCHEM BIOPH RES CO, V379, P43, DOI 10.1016/j.bbrc.2008.11.141; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Gao AW, 2014, EMBO MOL MED, V6, P580, DOI 10.1002/emmm.201303782; Ha BG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102095; Ha BG, 2014, OBESITY, V22, P1669, DOI 10.1002/oby.20740; Ha BG, 2013, MAR DRUGS, V11, P4193, DOI 10.3390/md11114193; Higashida K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001603; Hiraoka Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4224; Hsieh CJ, 2011, DIABETES RES CLIN PR, V92, P106, DOI 10.1016/j.diabres.2011.01.010; Huang Han-Yo, 2006, Evid Rep Technol Assess (Full Rep), P1; Hui KY, 2014, CANCER LETT, V354, P189, DOI 10.1016/j.canlet.2014.08.009; Huskisson E, 2007, J INT MED RES, V35, P277, DOI 10.1177/147323000703500301; Katsuda S, 2008, BIOL PHARM BULL, V31, P38, DOI 10.1248/bpb.31.38; Killilea DW, 2008, P NATL ACAD SCI USA, V105, P5768, DOI 10.1073/pnas.0712401105; Kumar SD, 2012, FREE RADICAL BIO MED, V53, P1595, DOI 10.1016/j.freeradbiomed.2012.07.008; Lee H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055106; Lee S, 2015, PEDIATR DIABETES, V16, P211, DOI 10.1111/pedi.12141; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Martin SD, 2014, BBA-GEN SUBJECTS, V1840, P1303, DOI 10.1016/j.bbagen.2013.09.019; Mendelev N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047910; Mostafavi E, 2013, CLIN HEMORHEOL MICRO, V53, P239, DOI 10.3233/CH-2012-1546; Panee J, 2007, J BIOL CHEM, V282, P23759, DOI 10.1074/jbc.M702267200; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Prior SJ, 2014, OBESITY, V22, P451, DOI 10.1002/oby.20609; Rees K, 2013, COCHRANE DB SYST REV, V1; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Sheu MJ, 2013, MAR DRUGS, V11, P2183, DOI 10.3390/md11062183; Sparks LM, 2009, DIABETES RES CLIN PR, V83, P32, DOI 10.1016/j.diabres.2008.09.052; van de Weijer T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051648; Vijgen GHEJ, 2013, SURG OBES RELAT DIS, V9, P936, DOI 10.1016/j.soard.2013.03.009; Volpe SL, 2013, ADV NUTR, V4, p378S, DOI 10.3945/an.112.003483; Wenz T, 2013, MITOCHONDRION, V13, P134, DOI 10.1016/j.mito.2013.01.006; Wolf Federica I., 2003, Molecular Aspects of Medicine, V24, P11, DOI 10.1016/S0098-2997(02)00088-2; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Yeh TS, 2005, ANN NY ACAD SCI, V1042, P157, DOI 10.1196/annals.1338.017; Yoon SO, 2001, FASEB J, V15, P111, DOI 10.1096/fj.01-0398fje; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zhang W, 2014, INFLAMMATION, V37, P478, DOI 10.1007/s10753-013-9761-5	50	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129972	10.1371/journal.pone.0129972	http://dx.doi.org/10.1371/journal.pone.0129972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068191	Green Submitted, gold, Green Published			2022-12-27	WOS:000356327000128
J	Hoffman-Luca, CG; Yang, CY; Lu, JF; Ziazadeh, D; McEachern, D; Debussche, L; Wang, SM				Hoffman-Luca, C. Gianna; Yang, Chao-Yie; Lu, Jianfeng; Ziazadeh, Daniel; McEachern, Donna; Debussche, Laurent; Wang, Shaomeng			Significant Differences in the Development of Acquired Resistance to the MDM2 Inhibitor SAR405838 between In Vitro and In Vivo Drug Treatment	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; P53 MUTATIONS; CANCER; DNA; ACTIVATION; SENSITIVITY; MECHANISMS; APOPTOSIS; NUTLIN-3; PATHWAY	SAR405838 is a potent and specific MDM2 inhibitor currently being evaluated in Phase I clinical trials for the treatment of human cancer. Using the SJSA-1 osteosarcoma cell line which harbors an amplified MDM2 gene and wild-type p53, we have investigated the acquired resistance mechanisms both in vitro and in vivo to SAR405838. Treatment of SJSA-1 cells with SAR405838 in vitro leads to dose-dependent cell growth inhibition, cell cycle arrest and robust apoptosis. However, prolonged treatment of SJSA-1 cells in vitro with SAR405838 results in profound acquired resistance to the drug. Analysis of in vitro-derived resistant cell lines showed that p53 is mutated in the DNA binding domain and can no longer be activated by SAR405838. Treatment of the parental SJSA-1 xenograft tumors with SAR405838 in mice yields rapid tumor regression but the tumors eventually regrow. Culturing the regrown tumors established a number of sublines, which showed only modest (3-5 times) loss of sensitivity to SAR405838 in vitro. Sequencing of the p53 showed that it retains its wild-type status in these in vivo sublines, with the exception of one subline, which harbors a single heterozygous C176F p53 mutation. Using xenograft models of two in vivo derived sublines, which has either wild-type p53 or p53 containing a single heterozygous C176F mutation, we showed that while SAR405838 effectively achieves partial tumor regression in these models, it no longer induces complete tumor regression and tumors resume growth once the treatment is stopped. Harvesting and culturing tumors obtained from a prolonged treatment with SAR405838 in mice established additional in vivo sublines, which all contain a single heterozygous C176F mutation with no additional p53 mutation detected. Interestingly, SAR405838 can still effectively activate p53 in all sublines containing a single heterozygous C176F mutation, with a moderately reduced potency as compared to that in the parental cell line. Consistently, SAR405838 is 3-5 times less effective in all the in vivo derived sublines containing a single heterozygous C176F p53 mutation than in the SJSA-1 parental cell line in assays of cell growth and apoptosis. Computational modeling suggested that a p53 tetramer containing two wild-type p53 molecules and two C176F mutated molecules can maintain the structural stability and interactions with DNA by formation of additional hydrophobic and cation-p interactions which compensate for the loss of sulphur-zinc coordination. Our data thus show that SJSA-1 tumor cells acquire very different levels of resistance in vitro and in vivo to the MDM2 inhibitor SAR405838. Our present study may have a significant implication for the investigation of resistant mechanisms for other classes of anticancer drugs.	[Hoffman-Luca, C. Gianna; Yang, Chao-Yie; Lu, Jianfeng; Ziazadeh, Daniel; McEachern, Donna; Wang, Shaomeng] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Hoffman-Luca, C. Gianna; Ziazadeh, Daniel; Wang, Shaomeng] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Yang, Chao-Yie; Lu, Jianfeng; McEachern, Donna; Wang, Shaomeng] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wang, Shaomeng] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Debussche, Laurent] Sanofi Oncol, Vitry Sur Seine, France	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wang, SM (corresponding author), Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.	shaomeng@umich.edu	Yang, Chao-Yie/A-3930-2015	Yang, Chao-Yie/0000-0002-5445-0109; Wang, Shaomeng/0000-0002-8782-6950	National Institutes of Health, US [R01CA121279, P30CA046592]; University of Michigan; Sanofi Oncology; NATIONAL CANCER INSTITUTE [R01CA121279, P30CA046592] Funding Source: NIH RePORTER	National Institutes of Health, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); Sanofi Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported with funding from the National Institutes of Health, US (R01CA121279 and P30CA046592) and internal funding from the University of Michigan. Sanofi Oncology provided support in the form of salaries for author(s) LD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz MH, 2011, ONCOGENE, V30, P4678, DOI 10.1038/onc.2011.185; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Case DA, 2012, AMBER 12; Chen YH, 2013, NUCLEIC ACIDS RES, V41, P8368, DOI 10.1093/nar/gkt584; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; FAKHARZADEH SS, 1993, GENOMICS, V15, P283, DOI 10.1006/geno.1993.1058; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hoffman-Luca CG, 2015, CLIN CANC R IN PRESS; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Long JT, 2010, BLOOD, V116, P71, DOI 10.1182/blood-2010-01-261628; Lu JF, 2008, CANCER RES, V68, P9384, DOI 10.1158/0008-5472.CAN-08-2655; Lu Q, 2007, J PHYS CHEM B, V111, P11538, DOI 10.1021/jp0742261; Michaelis M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.129; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Olivier M, 2005, 25 YEARS OF P53 RESEARCH, P321, DOI 10.1007/1-4020-2922-5_14; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saha MN, 2010, J CLIN PATHOL, V63, P204, DOI 10.1136/jcp.2009.070961; Shangary S, 2008, CLIN CANCER RES, V14, P5318, DOI 10.1158/1078-0432.CCR-07-5136; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Teodoro JG, 2007, J MOL MED-JMM, V85, P1175, DOI 10.1007/s00109-007-0221-2; Tovar C, 2013, CANCER RES, V73, P2587, DOI 10.1158/0008-5472.CAN-12-2807; Valentine JM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-79; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Verma R, 2010, BIOCHEM PHARMACOL, V79, P565, DOI 10.1016/j.bcp.2009.09.020; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Vu B, 2013, ACS MED CHEM LETT, V4, P466, DOI 10.1021/ml4000657; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang S., 2014, CANC RES; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; YANG LY, 1990, CANCER RES, V50, P3218; Zhao YJ, 2015, J MED CHEM, V58, P1038, DOI 10.1021/jm501092z; Zhao YJ, 2013, J MED CHEM, V56, P5553, DOI 10.1021/jm4005708	44	21	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128807	10.1371/journal.pone.0128807	http://dx.doi.org/10.1371/journal.pone.0128807			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070072	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000030
J	Weiss, RF; Smith, MR; Miller, MG; Cronin, JF				Weiss, Robert F.; Smith, Mitchell R.; Miller, Merlin G.; Cronin, John F.			Progression and Transformation of Clonally Heterogeneous B-cell Lymphoma	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; FOLLICULAR LYMPHOMA; EVOLUTION; IMPACT	Indolent B- cell non-Hodgkin lymphoma can transform into aggressive lymphoma. We extend our prior mathematical model to analyze and predict transformation. To provide additional confidence in our model, we compare it with SCID mouse data for combination therapy of Diffuse Large B-cell Lymphoma, an aggressive form of the disease. We develop a two cell model that includes indolent and aggressive clones but no immune response and use it to predict transformation. An approximate model for the time to transformation is derived that provides insight regarding scaling effects. We then add an immune response and therapeutic measures, and illustrate the complex interactions among the various processes, with a focus on transformation. The implications for initial diagnosis and treatment of non-Hodgkin lymphoma are discussed.	[Weiss, Robert F.; Miller, Merlin G.] Back Bay Biosci LLC, Computat Biol, Boston, MA 02115 USA; [Smith, Mitchell R.] Cleveland Clin, Hematol & Oncol, Cleveland, OH 44106 USA; [Cronin, John F.] Phys Sci Inc, Comp Serv, Andover, MA USA	Cleveland Clinic Foundation; Physical Sciences Inc.	Weiss, RF (corresponding author), Back Bay Biosci LLC, Computat Biol, Boston, MA 02115 USA.	rfdweiss@outlook.com						Carlotti E, 2009, BLOOD, V113, P3553, DOI 10.1182/blood-2008-08-174839; Goldsby RA, 2000, KUBY IMMUNOLOGY; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Link BK, 2013, J CLIN ONCOL, V31, P3272, DOI 10.1200/JCO.2012.48.3990; NORTON L, 1986, CANCER TREAT REP, V70, P163; Rossi D, 2014, BLOOD, V123, P2139, DOI 10.1182/blood-2013-11-539726; Tse Shoemaker AR, 2008, CANCER RES, V68, P3421, DOI [10.1158/0008-5472.CAN-07-5836, DOI 10.1158/0008-5472.CAN-07-5836]; Vandenberg CJ, 2013, BLOOD, V121, P2285, DOI 10.1182/blood-2013-01-475855; Weiss RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081672; Weiss RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051736	11	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130590	10.1371/journal.pone.0130590	http://dx.doi.org/10.1371/journal.pone.0130590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068800	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000159
J	Zhang, CY; Zhu, SS; Wei, L; Yan, X; Wang, J; Quan, R; She, RP; Hu, FJ; Liu, J				Zhang, Chunyan; Zhu, Shanshan; Wei, Li; Yan, Xu; Wang, Jing; Quan, Rong; She, Ruiping; Hu, Fengjiao; Liu, Jue			Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein Promotes Protective Immune Responses in Mice	PLOS ONE			English	Article							MULTISYSTEMIC WASTING SYNDROME; MUCOSAL ADJUVANT ACTIVITY; BACTERIAL FLAGELLIN; RESPIRATORY CHALLENGE; CELLULAR MECHANISMS; PCV2; VACCINES; VIRUS; IMMUNOGENICITY; PIGS	The Cap protein of porcine circovirus type 2 (PCV2) that serves as a major host-protective immunogen was used to develop recombinant vaccines for control of PCV2-associated diseases. Growing research data have demonstrated the high effectiveness of flagellin as an adjuvant for humoral and cellular immune responses. Here, a recombinant protein was designed by fusing a modified version of bacterial flagellin to PCV2 Cap protein and expressed in a baculovirus system. When administered without adjuvant to BALB/c mice, the flagellin-Cap fusion protein elicited stronger PCV2-specific IgG antibody response, higher neutralizing antibody levels, milder histopathological changes and lower viremia, as well as higher secretion of cytokines such as TNF-alpha and IFN-gamma that conferred better protection against virus challenge than those in the recombinant Cap alone-inoculated mice. These results suggest that the recombinant Cap protein when fused to flagellin could elicit better humoral and cellular immune responses against PCV2 infection in a mouse model, thereby acting as an attractive candidate vaccine for control of the PCV2-associated diseases.	[Zhang, Chunyan; Zhu, Shanshan; Wei, Li; Yan, Xu; Wang, Jing; Liu, Jue] Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing Key Lab Prevent & Control Infect Dis Live, Beijing 100097, Peoples R China; [Quan, Rong; She, Ruiping; Hu, Fengjiao] China Agr Univ, Coll Vet Med, Beijing 100197, Peoples R China	Beijing Academy of Agriculture & Forestry; China Agricultural University	Liu, J (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing Key Lab Prevent & Control Infect Dis Live, 9 Shuguang Garden Middle Rd, Beijing 100097, Peoples R China.	liujue@263.net			National Science Fund for Distinguished Young Scholars [31025028]; Beijing Municipal Science and Technology; People's Republic of China	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Beijing Municipal Science and Technology; People's Republic of China	This work was supported by grants from the National Science Fund for Distinguished Young Scholars (31025028) and the Beijing Municipal Science and Technology Contract Project (Z07010501780701), People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan G, 1998, VET REC, V142, P467; ALLAN GM, 1995, VET MICROBIOL, V44, P49, DOI 10.1016/0378-1135(94)00136-K; Bates JT, 2008, MECH AGEING DEV, V129, P271, DOI 10.1016/j.mad.2008.01.009; Bates JT, 2011, J IMMUNOL, V186, P6255, DOI 10.4049/jimmunol.1001855; Ben-Yedidia T, 1998, IMMUNOL LETT, V64, P9, DOI 10.1016/S0165-2478(98)00073-X; Blanchard P, 2003, VACCINE, V21, P4565, DOI 10.1016/S0264-410X(03)00503-6; Bucarey SA, 2009, VACCINE, V27, P5781, DOI 10.1016/j.vaccine.2009.07.061; Carasova P, 2007, RES VET SCI, V83, P274, DOI 10.1016/j.rvsc.2006.11.013; Cheung AK, 2003, VIROLOGY, V305, P168, DOI 10.1006/viro.2002.1733; Cuadros C, 2004, INFECT IMMUN, V72, P2810, DOI 10.1128/IAI.72.5.2810-2816.2004; Del Prete G, 1998, Int Rev Immunol, V16, P427, DOI 10.3109/08830189809043004; Delaney KN, 2010, VIRAL IMMUNOL, V23, P201, DOI 10.1089/vim.2009.0107; Fan HY, 2008, J VIROL METHODS, V150, P21, DOI 10.1016/j.jviromet.2008.02.011; Fort M, 2008, VACCINE, V26, P1063, DOI 10.1016/j.vaccine.2007.12.019; Fort M, 2009, VACCINE, V27, P4031, DOI 10.1016/j.vaccine.2009.04.028; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083; Ju CM, 2005, VET MICROBIOL, V109, P179, DOI 10.1016/j.vetmic.2005.06.001; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim T, 2009, VET MICROBIOL, V138, P318, DOI 10.1016/j.vetmic.2009.04.014; Kiupel M, 2001, VET PATHOL, V38, P74, DOI 10.1354/vp.38-1-74; Kixmoller M, 2008, VACCINE, V26, P3443, DOI 10.1016/j.vaccine.2008.04.032; Lee SE, 2006, INFECT IMMUN, V74, P694, DOI 10.1128/IAI.74.1.694-702.2006; Letran SE, 2011, EUR J IMMUNOL, V41, P29, DOI 10.1002/eji.201040717; Liu G, 2012, VACCINE, V30, P6833, DOI 10.1016/j.vaccine.2012.09.013; Liu GM, 2011, VACCINE, V29, P8677, DOI 10.1016/j.vaccine.2011.08.118; Liu J, 2005, J VIROL, V79, P8262, DOI 10.1128/JVI.79.13.8262-8274.2005; Liu J, 2006, J VIROL, V80, P5065, DOI 10.1128/JVI.80.10.5065-5073.2006; Liu Q, 2001, PROTEIN EXPRES PURIF, V21, P115, DOI 10.1006/prep.2000.1356; Mankertz A, 1998, J GEN VIROL, V79, P381, DOI 10.1099/0022-1317-79-2-381; Martelli P, 2011, VET MICROBIOL, V149, P339, DOI 10.1016/j.vetmic.2010.12.008; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; McIntosh KA, 2006, CAN J VET RES, V70, P58; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Mizel SB, 2009, CLIN VACCINE IMMUNOL, V16, P21, DOI 10.1128/CVI.00333-08; Nawagitgul P, 2000, J GEN VIROL, V81, P2281, DOI 10.1099/0022-1317-81-9-2281; Opriessnig T, 2009, VACCINE, V27, P1002, DOI 10.1016/j.vaccine.2008.11.105; Opriessnig T, 2007, J VET DIAGN INVEST, V19, P591, DOI 10.1177/104063870701900601; Perez-Martin E, 2010, VACCINE, V28, P2340, DOI 10.1016/j.vaccine.2009.12.061; Pino O, 2005, INFECT IMMUN, V73, P6763, DOI 10.1128/IAI.73.10.6763-6770.2005; Quintana J, 2002, VET RES, V33, P229, DOI 10.1051/vetres:2002011; Seder RA, 2000, NATURE, V406, P793, DOI 10.1038/35021239; Segales J, 2004, VET MICROBIOL, V98, P151, DOI 10.1016/j.vetmic.2003.10.007; Segales Joaquim, 2005, Animal Health Research Reviews, V6, P119, DOI 10.1079/AHR2005106; Shen HG, 2008, J GEN VIROL, V89, P1857, DOI 10.1099/vir.0.2008/000125-0; TISCHER I, 1987, ARCH VIROL, V96, P39, DOI 10.1007/BF01310989; Wang K, 2008, J VIROL METHODS, V150, P1, DOI 10.1016/j.jviromet.2008.02.014; Wang XW, 2007, VET MICROBIOL, V121, P215, DOI 10.1016/j.vetmic.2006.11.027; Wang XW, 2006, VACCINE, V24, P3374, DOI 10.1016/j.vaccine.2005.12.068; Wang YP, 2013, VACCINE, V31, P833, DOI 10.1016/j.vaccine.2012.11.062	55	9	10	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129617	10.1371/journal.pone.0129617	http://dx.doi.org/10.1371/journal.pone.0129617			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070075	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000096
J	Zhang, D; Zhao, H; Fan, ZJ; Li, MJ; Du, PH; Liu, CM; Li, YP; Li, HT; Cao, HB				Zhang, Di; Zhao, He; Fan, Zhuangjun; Li, Mingjie; Du, Penghui; Liu, Chenming; Li, Yuping; Li, Haitao; Cao, Hongbin			A Highly Sensitive and Selective Hydrogen Peroxide Biosensor Based on Gold Nanoparticles and Three-Dimensional Porous Carbonized Chicken Eggshell Membrane	PLOS ONE			English	Article							DIRECT ELECTRON-TRANSFER; HORSERADISH-PEROXIDASE; ELECTROCHEMICAL BIOSENSOR; FUNCTIONALIZED-GRAPHENE; BIOMASS CARBON; NANOTUBE; IMMOBILIZATION; THIONINE; MEDIATOR; HRP	A sensitive and noble amperometric horseradish peroxidase (HRP) biosensor is fabricated via the deposition of gold nanoparticles (AuNPs) onto a three-dimensional (3D) porous carbonized chicken eggshell membrane (CESM). Due to the synergistic effects of the unique porous carbon architecture and well-distributed AuNPs, the enzyme-modified electrode shows an excellent electrochemical redox behavior. Compared with bare glass carbon electrode (GCE), the cathodic peak current of the enzymatic electrode increases 12.6 times at a formal potential of -100mV (vs. SCE) and charge-transfer resistance decreases 62.8%. Additionally, the AuNPs-CESM electrode exhibits a good biocompatibility, which effectively retains its bioactivity with a surface coverage of HRP 6.39x10(-9)mol cm(-2) (752 times higher than the theoretical monolayer coverage of HRP). Furthermore, the HRP-AuNPs-CESM-GCE electrode, as a biosensor for H2O2 detection, has a good accuracy and high sensitivity with the linear range of 0.01-2.7 mM H2O2 and the detection limit of 3 mu M H2O2(S/N = 3).	[Zhang, Di; Zhao, He; Li, Mingjie; Du, Penghui; Liu, Chenming; Li, Yuping; Cao, Hongbin] Chinese Acad Sci, Beijing Engn Res Ctr Proc Pollut Control, Key Lab Green Proc & Engn, Inst Proc Engn, Beijing 100190, Peoples R China; [Fan, Zhuangjun] Harbin Engn Univ, Key Lab Superlight Mat & Surface Technol, Minist Educ, Coll Mat Sci & Chem Engn, Harbin, Peoples R China; [Li, Haitao] Beijing Acad Sci & Technol, Environm Protect Res Inst Light Ind, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Process Engineering, CAS; Harbin Engineering University; Beijing Academy of Science & Technology	Zhao, H (corresponding author), Chinese Acad Sci, Beijing Engn Res Ctr Proc Pollut Control, Key Lab Green Proc & Engn, Inst Proc Engn, Beijing 100190, Peoples R China.	hzhao@ipe.ac.cn	Zhao, He/D-6011-2014; Fan, Zhuangjun/B-3878-2011	Zhao, He/0000-0002-0162-7388; Du, Penghui/0000-0001-7409-0983; Fan, Zhuangjun/0000-0001-5639-0675	National Natural Science Foundation of China [51108441, 51102238, 21177130, 51209191]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China, grant numbers 51108441 (HZ), 51102238 (CML), 21177130 (YPL), and 51209191 (HTL). HZ participated in the study design, data analysis, decision to publish and preparation of the manuscript. CML, YPL and HTL participated in the data analysis.	Arami M, 2006, CHEMOSPHERE, V65, P1999, DOI 10.1016/j.chemosphere.2006.06.074; Chai HM, 2012, ELECTROANAL, V24, P1129, DOI 10.1002/elan.201200079; Cho SH, 2009, J HAZARD MATER, V162, P1014, DOI 10.1016/j.jhazmat.2008.05.133; Choi MMF, 2004, ENZYME MICROB TECH, V34, P41, DOI 10.1016/j.enzmictec.2003.08.005; Farma R, 2013, INT J ELECTROCHEM SC, V8, P257; Freire RS, 2003, J BRAZIL CHEM SOC, V14, P230, DOI 10.1590/S0103-50532003000200008; Gao FX, 2007, J BIOCHEM BIOPH METH, V70, P407, DOI 10.1016/j.jbbm.2006.09.007; Jeykumari DRS, 2007, CARBON, V45, P1340, DOI 10.1016/j.carbon.2007.01.006; Jeykumari DRS, 2009, CARBON, V47, P957, DOI 10.1016/j.carbon.2008.11.050; Jose MV, 2012, CARBON, V50, P4010, DOI 10.1016/j.carbon.2012.04.044; Kalyani P, 2013, INT J HYDROGEN ENERG, V38, P4034, DOI 10.1016/j.ijhydene.2013.01.048; Koumanova B, 2002, J CHEM TECHNOL BIOT, V77, P539, DOI 10.1002/jctb.601; Li MJ, 2015, CARBON, V86, P197, DOI 10.1016/j.carbon.2015.01.029; Li Z, 2012, ADV ENERGY MATER, V2, P431, DOI 10.1002/aenm.201100548; Liu RJ, 2012, SMALL, V8, P1398, DOI 10.1002/smll.201102298; Liu XQ, 2012, BIOSENS BIOELECTRON, V32, P188, DOI 10.1016/j.bios.2011.12.002; Ma LP, 2009, BIOPROC BIOSYST ENG, V32, P537, DOI 10.1007/s00449-008-0275-8; Nandini S, 2013, J ELECTROANAL CHEM, V689, P233, DOI 10.1016/j.jelechem.2012.11.004; Ruzgas T, 1996, ANAL CHIM ACTA, V330, P123, DOI 10.1016/0003-2670(96)00169-9; Shleev S, 2005, BIOSENS BIOELECTRON, V20, P2517, DOI 10.1016/j.bios.2004.10.003; Su HL, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/1/015045; Tsai WT, 2006, BIORESOURCE TECHNOL, V97, P488, DOI 10.1016/j.biortech.2005.02.050; Ueda A, 2011, J AM CHEM SOC, V133, P4840, DOI 10.1021/ja108614d; Wang L, 2014, ANAL CHEM, V86, P1414, DOI 10.1021/ac401563m; Wang QX, 2012, MICROCHIM ACTA, V176, P279, DOI 10.1007/s00604-011-0716-y; Yang GH, 2013, CARBON, V61, P357, DOI 10.1016/j.carbon.2013.05.016; Yang GH, 2013, CARBON, V51, P124, DOI 10.1016/j.carbon.2012.08.020; Yin HS, 2009, SENSOR ACTUAT B-CHEM, V137, P747, DOI 10.1016/j.snb.2008.12.046; Zebda A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1365; Zhang KY, 2011, MICROCHIM ACTA, V173, P135, DOI 10.1007/s00604-010-0534-7; Zhao J, 2011, BIOSENS BIOELECTRON, V26, P2297, DOI 10.1016/j.bios.2010.09.056; Zheng Y, 2008, CHINESE J ANAL CHEM, V36, P604, DOI 10.1016/S1872-2040(08)60034-1	32	23	24	0	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130156	10.1371/journal.pone.0130156	http://dx.doi.org/10.1371/journal.pone.0130156			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069960	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000144
J	Chao, A; Jost, L; Hsieh, TC; Ma, KH; Sherwin, WB; Rollins, LA				Chao, Anne; Jost, Lou; Hsieh, T. C.; Ma, K. H.; Sherwin, William B.; Rollins, Lee Ann			Expected Shannon Entropy and Shannon Differentiation between Subpopulations for Neutral Genes under the Finite Island Model	PLOS ONE			English	Article							MUTUAL INFORMATION; PHYLOGENETIC DIVERSITY; PARTITIONING DIVERSITY; FUNCTIONAL DIVERSITY; ALLELIC FREQUENCIES; SPECIES-DIVERSITY; POPULATION; NUMBER; INDEX; POLYMORPHISMS	Shannon entropy H and related measures are increasingly used in molecular ecology and population genetics because (1) unlike measures based on heterozygosity or allele number, these measures weigh alleles in proportion to their population fraction, thus capturing a previously-ignored aspect of allele frequency distributions that may be important in many applications; (2) these measures connect directly to the rich predictive mathematics of information theory; (3) Shannon entropy is completely additive and has an explicitly hierarchical nature; and (4) Shannon entropy-based differentiation measures obey strong monotonicity properties that heterozygosity-based measures lack. We derive simple new expressions for the expected values of the Shannon entropy of the equilibrium allele distribution at a neutral locus in a single isolated population under two models of mutation: the infinite allele model and the stepwise mutation model. Surprisingly, this complex stochastic system for each model has an entropy expressable as a simple combination of well-known mathematical functions. Moreover, entropy- and heterozygosity-based measures for each model are linked by simple relationships that are shown by simulations to be approximately valid even far from equilibrium. We also identify a bridge between the two models of mutation. We apply our approach to subdivided populations which follow the finite island model, obtaining the Shannon entropy of the equilibrium allele distributions of the subpopulations and of the total population. We also derive the expected mutual information and normalized mutual information ("Shannon differentiation") between subpopulations at equilibrium, and identify the model parameters that determine them. We apply our measures to data from the common starling (Sturnus vulgaris) in Australia. Our measures provide a test for neutrality that is robust to violations of equilibrium assumptions, as verified on real world data from starlings.	[Chao, Anne; Hsieh, T. C.; Ma, K. H.] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan; [Jost, Lou] EcoMinga Fdn, Banos, Tungurahua, Ecuador; [Sherwin, William B.] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Sherwin, William B.] Murdoch Univ, Cetacean Res Unit, Murdoch, WA 6150, Australia; [Rollins, Lee Ann] Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Geelong, Vic 3217, Australia	National Tsing Hua University; University of New South Wales Sydney; Murdoch University; Deakin University	Chao, A (corresponding author), Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan.	chao@stat.nthu.edu.tw	Rollins, Lee/G-3688-2011; Sherwin, William B B/C-3432-2008	Rollins, Lee/0000-0002-3279-7005; Sherwin, William B B/0000-0002-1578-8473	Mathematics Research Center (of Taiwan Ministry of Science and Technology); Population Biology Foundation; Ministry of Science and Technology, Taiwan [100-2118-M007-006-MY3]	Mathematics Research Center (of Taiwan Ministry of Science and Technology); Population Biology Foundation; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The Mathematics Research Center (of Taiwan Ministry of Science and Technology), The Population Biology Foundation, and the Ministry of Science and Technology, Taiwan, Contract 100-2118-M007-006-MY3 (http://www.most.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aczel J, 1975, MEASURES INFORM THEI; Allen B, 2009, AM NAT, V174, P236, DOI 10.1086/600101; Andrew RL, 2012, MOL ECOL, V21, P2078, DOI 10.1111/j.1365-294X.2012.05454.x; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Blum MJ, 2012, OECOLOGIA, V168, P83, DOI 10.1007/s00442-011-2078-x; BLYTH CR, 1959, ANN MATH STAT, V30, P71, DOI 10.1214/aoms/1177706360; Brunel H, 2010, BIOINFORMATICS, V26, P1811, DOI 10.1093/bioinformatics/btq273; Buddle CM, 2005, CAN ENTOMOL, V137, P120; Bulit C, 2009, HYDROBIOLOGIA, V624, P29, DOI 10.1007/s10750-008-9664-x; Cadotte MW, 2010, ECOL LETT, V13, P96, DOI 10.1111/j.1461-0248.2009.01405.x; Chanda P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-509; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Chao A, 2008, BIOMETRICS, V64, P1178, DOI 10.1111/j.1541-0420.2008.01010.x; Chao AN, 2014, ANNU REV ECOL EVOL S, V45, P297, DOI 10.1146/annurev-ecolsys-120213-091540; Chao AN, 2013, METHODS ECOL EVOL, V4, P1091, DOI 10.1111/2041-210X.12108; Chao A, 2012, ECOLOGY, V93, P2037, DOI 10.1890/11-1817.1; Chen S, 2013, J HERED, V104, P416, DOI 10.1093/jhered/est015; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dewar RC, 2011, MOL ECOL, V20, P3156, DOI 10.1111/j.1365-294X.2011.05171.x; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Ellison AM, 2010, ECOLOGY, V91, P1962, DOI 10.1890/09-1692.1; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Fidler AE, 2007, P ROY SOC B-BIOL SCI, V274, P1685, DOI 10.1098/rspb.2007.0337; Gailing O, 2012, BIOCHEM SYST ECOL, V45, P23, DOI 10.1016/j.bse.2012.07.018; Hedrick P.W., 2011, GENETICS POPULATIONS; Higgins SJ, 2006, HDB AUSTR NZ ANTARCT, V7; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jost Lou, 2011, P66; Jost L, 2010, DIVERS DISTRIB, V16, P65, DOI 10.1111/j.1472-4642.2009.00626.x; Karlin EF, 2011, MOL ECOL, V20, P753, DOI 10.1111/j.1365-294X.2010.04982.x; Keylock CJ, 2005, OIKOS, V109, P203, DOI 10.1111/j.0030-1299.2005.13735.x; KIMURA M, 1964, GENETICS, V49, P725; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; KIMURA M, 1975, P NATL ACAD SCI USA, V72, P2761, DOI 10.1073/pnas.72.7.2761; Kitchovitch S, 2009, LECT NOTES COMPUT SC, V5851, P259, DOI 10.1007/978-3-642-11169-3_19; LATTER BDH, 1973, GENETICS, V73, P147; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; MARUYAMA T, 1970, Theoretical Population Biology, V1, P273, DOI 10.1016/0040-5809(70)90047-X; Mellick R, 2011, AUST J BOT, V59, P351, DOI 10.1071/BT10291; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Mueller JC, 2014, MOL ECOL, V23, P2876, DOI 10.1111/mec.12763; Niederstatter H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041885; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Penner O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014373; Priness I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-111; Renyi A, 1961, ON MEASURES OF ENTRO, V1, P547; Ribeiro AS, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011901; Ricotta C, 2008, COMMUNITY ECOL, V9, P11, DOI 10.1556/ComEc.9.2008.1.2; Rivers MC, 2011, CONSERV GENET, V12, P1333, DOI 10.1007/s10592-011-0234-9; Rollins LA, 2009, THESIS; Rollins LA, 2011, MOL ECOL, V20, P2307, DOI 10.1111/j.1365-294X.2011.05101.x; Rollins LA, 2009, MOL ECOL, V18, P1560, DOI 10.1111/j.1365-294X.2009.04132.x; Rossetto M, 2008, AM J BOT, V95, P321, DOI 10.3732/ajb.95.3.321; Rossetto M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-126; Rousset F, 1996, GENETICS, V142, P1357; Roussett F, 2004, GENETIC STRUCTURE SE; Schall JJ, 2013, PARASITOLOGY, V140, P21, DOI 10.1017/S0031182012001217; Schwanz LE, 2008, P ROY SOC B-BIOL SCI, V275, P2441, DOI 10.1098/rspb.2008.0427; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shapcott A, 2011, AUST J BOT, V59, P215, DOI 10.1071/BT10132; Sherwin WB, 2006, MOL ECOL, V15, P2857, DOI 10.1111/j.1365-294X.2006.02992.x; Sherwin WB, 2010, ENTROPY-SWITZ, V12, P1765, DOI 10.3390/e12071765; Shlush LI, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-47; Smith RD, 2011, ARXIV PREPRINT ARXIV; Swati D, 2007, J BIOSCIENCES, V32, P1169, DOI 10.1007/s12038-007-0119-8; Tsallis C, 2004, CONTINUUM MECH THERM, V16, P223, DOI 10.1007/s00161-004-0174-4; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Whitlock MC, 1997, GENETICS, V146, P427; Woolnough AP, 2005, OUT BORDER KEEPING S, P183; Wright S, 1931, GENETICS, V16, P0097; Wright S, 1938, P NATL ACAD SCI USA, V24, P253, DOI 10.1073/pnas.24.7.253; Wright S, 1969, EVOLUTION AND THE GE, V2; Wu XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004578; Xia Z, 2009, BIOINFORMATICS, V25, P2309, DOI 10.1093/bioinformatics/btp423; Yuan XG, 2011, GENES GENOM, V33, P65, DOI 10.1007/s13258-010-0094-6; Zhang J, 2009, INTERNATIONAL JOINT CONFERENCE ON COMPUTATIONAL SCIENCES AND OPTIMIZATION, VOL 1, PROCEEDINGS, P1003, DOI 10.1109/CSO.2009.469; Zhang L, 2009, GENETICA, V137, P355, DOI 10.1007/s10709-009-9399-2	84	31	32	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0125471	10.1371/journal.pone.0125471	http://dx.doi.org/10.1371/journal.pone.0125471			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067448	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900007
J	Fujisawa, TX; Yatsuga, C; Mabe, H; Yamada, E; Masuda, M; Tomoda, A				Fujisawa, Takashi X.; Yatsuga, Chiho; Mabe, Hiroyo; Yamada, Eiji; Masuda, Masato; Tomoda, Akemi			Anorexia Nervosa during Adolescence Is Associated with Decreased Gray Matter Volume in the Inferior Frontal Gyrus	PLOS ONE			English	Article							INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; STRUCTURAL BRAIN CHANGES; VOXEL-BASED MORPHOMETRY; COGNITIVE CONTROL; CORTEX; INHIBITION; CHILDREN; NEUROBIOLOGY; INFERENCE; RECOVERY	Anorexia nervosa (AN) is an eating disorder characterized by the relentless pursuit to lose weight, mostly through self-starvation, and a distorted body image. AN tends to begin during adolescence among women. However, the underlying neural mechanisms related to AN remain unclear. Using voxel-based morphometry based on magnetic resonance imaging scans, we investigated whether the presence of AN was associated with discernible changes in brain morphology. Participants were 20 un-medicated, right-handed patients with early-onset AN and 14 healthy control subjects. Group differences in gray matter volume (GMV) were assessed using high-resolution, T1-weighted, volumetric magnetic resonance imaging datasets (3T Trio scanner; Siemens AG) and analyzed after controlling for age and total GMV, which was decreased in the bilateral inferior frontal gyrus (IFG) ( left IFG: FWE corrected, p < 0.05; right IFG: uncorrected, p < 0.05) of patients with AN. The GMV in the bilateral IFG correlated significantly with current age (left IFG: r = -.481, p < .05; right IFG: r = -.601, p < .01) and was limited to the AN group. We speculate that decreased IFG volume might lead to deficits in executive functioning or inhibitory control within neural reward systems. Precocious or unbalanced neurological trimming within this particular region might be an important factor for the pathogenesis of AN onset.	[Fujisawa, Takashi X.; Yatsuga, Chiho; Tomoda, Akemi] Univ Fukui, Res Ctr Child Mental Dev, Fukui 910, Japan; [Fujisawa, Takashi X.; Yatsuga, Chiho; Tomoda, Akemi] Chiba Univ, Hamamatsu Univ Sch Med, Kanazawa Univ, Osaka Univ,United Grad Sch Child Dev,Dept Child D, Fukui, Japan; [Mabe, Hiroyo; Yamada, Eiji; Masuda, Masato] Kumamoto Univ, Fac Life Sci, Dept Child Dev, Kumamoto, Japan	University of Fukui; Kanazawa University; Osaka University; Kumamoto University	Tomoda, A (corresponding author), Univ Fukui, Res Ctr Child Mental Dev, Fukui 910, Japan.	atomoda@u-fukui.ac.jp	Fujisawa, Takashi/Z-4461-2019		Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (KAKENHI) [24300149, 25560386, 25750405]; Grants-in-Aid for Scientific Research [25560386] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (B), Young Scientists (B) and Challenging Exploratory Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (KAKENHI: grant numbers 24300149 and 25560386 to Akemi Tomoda, grant number 25750405 to Takashi X, Fujisawa; http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Asahi S, 2004, EUR ARCH PSY CLIN N, V254, P245, DOI 10.1007/s00406-004-0488-z; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Askenazy F, 1998, BIOL PSYCHIAT, V43, P188, DOI 10.1016/S0006-3223(97)00299-0; Brooks SJ, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-179; Campbell K, 2014, PEDIATRICS, V134, P582, DOI 10.1542/peds.2014-0194; Castro-Fornieles J, 2008, J PSYCHIATR RES, V43, P331, DOI 10.1016/j.jpsychires.2008.03.013; Chowdhury U, 2003, INT J EAT DISORDER, V33, P388, DOI 10.1002/eat.10155; Chui HT, 2008, PEDIATRICS, V122, pE426, DOI 10.1542/peds.2008-0170; DOLAN RJ, 1988, PSYCHOL MED, V18, P349, DOI 10.1017/S0033291700007893; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Fladung AK, 2010, AM J PSYCHIAT, V167, P206, DOI 10.1176/appi.ajp.2009.09010071; Frank GK, 2005, BIOL PSYCHIAT, V58, P908, DOI 10.1016/j.biopsych.2005.05.003; Frank GK, 2004, CNS SPECTRUMS, V9, P539, DOI 10.1017/S1092852900009639; Frank GKW, 2012, NEUROPSYCHOPHARMACOL, V37, P2031, DOI 10.1038/npp.2012.51; Friederich HC, 2012, NEUROIMAGE, V59, P1106, DOI 10.1016/j.neuroimage.2011.09.042; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Galimberti E, 2012, PROG NEURO-PSYCHOPH, V36, P307, DOI 10.1016/j.pnpbp.2011.10.017; Gaudio S, 2011, PSYCHIAT RES-NEUROIM, V191, P24, DOI 10.1016/j.pscychresns.2010.06.007; Golden NH, 1996, J PEDIATR-US, V128, P296, DOI 10.1016/S0022-3476(96)70414-6; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Joos A, 2010, PSYCHIAT RES-NEUROIM, V182, P146, DOI 10.1016/j.pscychresns.2010.02.004; Katzman DK, 1997, ARCH PEDIAT ADOL MED, V151, P793, DOI 10.1001/archpedi.1997.02170450043006; Katzman DK, 1996, J PEDIATR-US, V129, P794, DOI 10.1016/S0022-3476(96)70021-5; Kaye WH, 2013, TRENDS NEUROSCI, V36, P110, DOI 10.1016/j.tins.2013.01.003; Kaye WH, 2009, NAT REV NEUROSCI, V10, P573, DOI 10.1038/nrn2682; King JA, 2015, BIOL PSYCHIAT, V77, P624, DOI 10.1016/j.biopsych.2014.09.005; KOHLMEYER K, 1983, AM J NEURORADIOL, V4, P437; Kohn MR, 1997, ANN NY ACAD SCI, V817, P398, DOI 10.1111/j.1749-6632.1997.tb48238.x; KRIEG JC, 1988, BIOL PSYCHIAT, V23, P377, DOI 10.1016/0006-3223(88)90288-0; Kullmann S, 2014, NEUROIMAGE-CLIN, V4, P615, DOI 10.1016/j.nicl.2014.04.002; Lambe EK, 1997, ARCH GEN PSYCHIAT, V54, P537; Lock J, 2011, AM J PSYCHIAT, V168, P55, DOI 10.1176/appi.ajp.2010.10010056; Luijten M, 2015, PSYCHIAT RES-NEUROIM, V231, P262, DOI 10.1016/j.pscychresns.2015.01.004; Moorhead TWJ, 2005, NEUROIMAGE, V28, P544, DOI 10.1016/j.neuroimage.2005.04.045; Nagamitsu S, 2011, BRAIN DEV-JPN, V33, P35, DOI 10.1016/j.braindev.2009.12.010; Nagamitsu S, 2010, BRAIN DEV-JPN, V32, P162, DOI 10.1016/j.braindev.2009.01.002; Oberndorfer TA, 2011, INT J EAT DISORDER, V44, P1, DOI 10.1002/eat.20750; Schilling C, 2012, NEUROIMAGE, V59, P824, DOI 10.1016/j.neuroimage.2011.07.058; Sheehan DV, 2010, J CLIN PSYCHIAT, V71, P313, DOI 10.4088/JCP.09m05305whi; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sigel Eric, 2008, Adolesc Med State Art Rev, V19, P547; Somerville LH, 2010, CURR OPIN NEUROBIOL, V20, P236, DOI 10.1016/j.conb.2010.01.006; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Talairach J., 1988, COPLANAR STEREOTAXIC; Titova OE, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-110; Tomoda A, 2009, BIOL PSYCHIAT, V66, P642, DOI 10.1016/j.biopsych.2009.04.021; Treasure J, 2010, LANCET, V375, P583, DOI 10.1016/S0140-6736(09)61748-7; Uher R, 2004, AM J PSYCHIAT, V161, P1238, DOI 10.1176/appi.ajp.161.7.1238; Vara AS, 2014, DEV COGN NEUROS-NETH, V10, P129, DOI 10.1016/j.dcn.2014.08.009; Weaver L, 2011, CURR PSYCHIAT REP, V13, P93, DOI 10.1007/s11920-010-0174-y; Wechsler D, 1974, WECHSLER INTELLIGENC; Worsley KJ, 1999, HUM BRAIN MAPP, V8, P98, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<98::AID-HBM5>3.3.CO;2-6	57	25	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128548	10.1371/journal.pone.0128548	http://dx.doi.org/10.1371/journal.pone.0128548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067825	gold, Green Published, Green Submitted			2022-12-27	WOS:000356100900024
J	Johnson, A; Chen, LM; Winne, E; Santana, W; Metcalfe, MG; Mateu-Petit, G; Ridenour, C; Hossain, MJ; Villanueva, J; Zaki, SR; Williams, TL; Cox, NJ; Barr, JR; Donis, RO				Johnson, Adam; Chen, Li-Mei; Winne, Emily; Santana, Wanda; Metcalfe, Maureen G.; Mateu-Petit, Guaniri; Ridenour, Callie; Hossain, M. Jaber; Villanueva, Julie; Zaki, Sherif R.; Williams, Tracie L.; Cox, Nancy J.; Barr, John R.; Donis, Ruben O.			Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs	PLOS ONE			English	Article							A VIRUS; PANDEMIC INFLUENZA; MASS-SPECTROMETRY; REVERSE GENETICS; ANTIGEN YIELD; SEED VIRUSES; M2 PROTEIN; PB1 GENE; NEURAMINIDASE; STRAINS	One of the important lessons learned from the 2009 H1N1 pandemic is that a high yield influenza vaccine virus is essential for efficient and timely production of pandemic vaccines in eggs. The current seasonal and pre-pandemic vaccine viruses are generated either by classical reassortment or reverse genetics. Both approaches utilize a high growth virus, generally A/Puerto Rico/8/1934 (PR8), as the donor of all or most of the internal genes, and the wild type virus recommended for inclusion in the vaccine to contribute the hemagglutinin (HA) and neuraminidase (NA) genes encoding the surface glycoproteins. As a result of extensive adaptation through sequential egg passaging, PR8 viruses with different gene sequences and high growth properties have been selected at different laboratories in past decades. The effect of these related but distinct internal PR8 genes on the growth of vaccine viruses in eggs has not been examined previously. Here, we use reverse genetics to analyze systematically the growth and HA antigen yield of reassortant viruses with 3 different PR8 backbones. A panel of 9 different HA/NA gene pairs in combination with each of the 3 different lineages of PR8 internal genes (27 reassortant viruses) was generated to evaluate their performance. Virus and HA yield assays showed that the PR8 internal genes influence HA yields in most subtypes. Although no single PR8 internal gene set outperformed the others in all candidate vaccine viruses, a combination of specific PR8 backbone with individual HA/NA pairs demonstrated improved HA yield and consequently the speed of vaccine production. These findings may be important both for production of seasonal vaccines and for a rapid global vaccine response during a pandemic.	[Johnson, Adam; Chen, Li-Mei; Mateu-Petit, Guaniri; Ridenour, Callie; Hossain, M. Jaber; Villanueva, Julie; Cox, Nancy J.; Donis, Ruben O.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30329 USA; [Winne, Emily; Santana, Wanda; Williams, Tracie L.; Barr, John R.] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA USA; [Metcalfe, Maureen G.; Zaki, Sherif R.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Chen, LM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30329 USA.	bpr5@cdc.gov; rvd6@cdc.gov		Johnson, Adam/0000-0002-3364-1184	US Department of Health and Human Services	US Department of Health and Human Services	The study was funded by the US Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelin A, 2011, VACCINE, V29, P1135, DOI 10.1016/j.vaccine.2010.11.042; Abt M, 2011, VACCINE, V29, P5153, DOI 10.1016/j.vaccine.2011.05.036; Adamo JE, 2009, J VIROL, V83, P4023, DOI 10.1128/JVI.02391-08; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P405; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; BAEZ M, 1980, J INFECT DIS, V141, P362, DOI 10.1093/infdis/141.3.362; Beale R, 2014, CELL HOST MICROBE, V15, P239, DOI 10.1016/j.chom.2014.01.006; Bialas KM, 2014, J VIROL, V88, P2227, DOI 10.1128/JVI.03354-13; Bin L, 2005, J VIROL, V79, P6763, DOI 10.1128/JVI.79.11.6763-6771.2005; Broadbent AJ, 2011, CURR OPIN VIROL, V1, P254, DOI 10.1016/j.coviro.2011.08.002; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Chen HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046378; Cobbin JCA, 2013, J VIROL, V87, P5577, DOI 10.1128/JVI.02856-12; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; de Blasio BF, 2012, PLOS ONE, V7, P327, DOI 10.1371/journal.pone.0030018; de Vries E, 2012, P NATL ACAD SCI USA, V109, P7457, DOI 10.1073/pnas.1200987109; FDA, 2012, SUMM BAS REG ACT FLU; FLUSECURE, 2005, 2 FLUSECURE; Gambaryan AS, 1999, VIROLOGY, V258, P232, DOI 10.1006/viro.1999.9732; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; GREGORY D W, 1973, Journal of Microscopy (Oxford), V99, P251, DOI 10.1111/j.1365-2818.1973.tb04625.x; Harris JR, 2006, MICROSC ANAL, V44, P17; Harvey R, 2008, VACCINE; Harvey R, 2011, J VIROL, V85, P6086, DOI 10.1128/JVI.00096-11; Harvey R, 2010, VACCINE, V28, P8008, DOI 10.1016/j.vaccine.2010.09.006; Hollingsworth TD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001076; Horimoto T, 2006, VACCINE, V24, P3669, DOI 10.1016/j.vaccine.2005.07.005; Horimoto T, 2007, VIROLOGY, V366, P23, DOI 10.1016/j.virol.2007.07.002; Horimoto T, 2006, TRENDS MOL MED, V12, P506, DOI 10.1016/j.molmed.2006.09.003; Jing XH, 2012, VACCINE, V30, P4144, DOI 10.1016/j.vaccine.2012.04.073; Katz G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088288; KILBOURN.ED, 1971, J INFECT DIS, V124, P449, DOI 10.1093/infdis/124.5.449; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; Lakdawala SS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002443; Matthews J.T., 2006, BRIDGE, DOI DOI 10.1002/jmv.26320; Moules V, 2011, VIROLOGY, V414, P51, DOI 10.1016/j.virol.2011.03.011; Murakami S, 2008, J VIROL, V82, P10502, DOI 10.1128/JVI.00970-08; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Nicolson C, 2012, VACCINE, V30, P745, DOI 10.1016/j.vaccine.2011.11.081; Noda T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00269; PHEMCE, 2012, 2012 PUBL HLTH EM ME; Plant EP, 2012, VACCINE, V31, P207, DOI 10.1016/j.vaccine.2012.10.060; Ramanunninair M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065955; Roberts KL, 2013, J VIROL, V87, P9973, DOI 10.1128/JVI.01363-13; Roberts PC, 1998, VIROLOGY, V240, P127, DOI 10.1006/viro.1997.8916; Robertson JS, 2011, VACCINE, V29, P1836, DOI 10.1016/j.vaccine.2010.12.044; Rossman JS, 2010, J VIROL, V84, P5078, DOI 10.1128/JVI.00119-10; Rudneva IA, 2007, ARCH VIROL, V152, P1139, DOI 10.1007/s00705-006-0931-8; Santana WI, 2014, ANAL CHEM; Seladi-Schulman J, 2013, J VIROL, V87, P13343, DOI 10.1128/JVI.02004-13; Stevens J, 2010, J VIROL, V84, P8287, DOI 10.1128/JVI.00058-10; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; Sugita Y, 2011, J GEN VIROL; (U.S.) PsCoAoSaT, 2010, REP PRES REENG INFL; Webby RJ, 2004, LANCET, V363, P1099, DOI 10.1016/S0140-6736(04)15892-3; WHO, 2013, UPD WHO BIOS RISK AS; *WHO, 2006, REV PROD TECHN INFL; WHO-GISRS, 2015, INFL VACC VIR REAG; Widjaja L, 2006, VIROLOGY; Williams TL, 2008, VACCINE, V26, P2510, DOI 10.1016/j.vaccine.2008.03.014; Williams TL, 2012, VACCINE, V30, P2475, DOI 10.1016/j.vaccine.2011.12.056	61	9	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128982	10.1371/journal.pone.0128982	http://dx.doi.org/10.1371/journal.pone.0128982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068666	Green Submitted, Green Published, gold			2022-12-27	WOS:000356100900038
J	Repetto-Llamazares, AHV; Larsen, RH; Patzke, S; Fleten, KG; Didierlaurent, D; Pichard, A; Pouget, JP; Dahle, J				Repetto-Llamazares, Ada H. V.; Larsen, Roy H.; Patzke, Sebastian; Fleten, Karianne G.; Didierlaurent, David; Pichard, Alexandre; Pouget, Jean Pierre; Dahle, Jostein			Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma	PLOS ONE			English	Article							B-CELL LYMPHOMA; IBRITUMOMAB TIUXETAN RADIOIMMUNOTHERAPY; ANTIBODY-DRUG CONJUGATE; MONOCLONAL-ANTIBODIES; NUDE-MICE; ANTITUMOR-ACTIVITY; PRETARGETED RADIOIMMUNOTHERAPY; INTERNALIZATION; XENOGRAFTS; RITUXIMAB	Lu-177-DOTA-HH1 (Lu-177-HH1) is a novel anti-CD37 radioimmunoconjugate developed to treat non-Hodgkin lymphoma. Mice with subcutaneous Ramos xenografts were treated with different activities of Lu-177-HH1, Lu-177-DOTA-rituximab (Lu-177-rituximab) and non-specific Lu-177-DOTA-IgG(1) (Lu-177-IgG(1)) and therapeutic effect and toxicity of the treatment were monitored. Significant tumor growth delay and increased survival of mice were observed in mice treated with 530 MBq/kg Lu-177-HH1 as compared with mice treated with similar activities of Lu-177-rituximab or non-specific Lu-177-IgG1, 0.9% NaCl or unlabeled HH1. All mice injected with 530 MBq/kg of Lu-177-HH1 tolerated the treatment well. In contrast, 6 out of 10 mice treated with 530 MBq/kg Lu-177-rituximab experienced severe radiation toxicity. The retention of Lu-177-rituximab in organs of the mononuclear phagocyte system was longer than for Lu-177-HH1, which explains the higher toxicity observed in mice treated with Lu-177-rituximab. In vitro internalization studies showed that Lu-177-HH1 internalizes faster and to a higher extent than Lu-177-rituximab which might be the reason for the better therapeutic effect of Lu-177-HH1.	[Repetto-Llamazares, Ada H. V.; Dahle, Jostein] Nord Nanovector ASA, N-0884 Oslo, Norway; [Repetto-Llamazares, Ada H. V.; Patzke, Sebastian] Oslo Univ Hosp, Inst Canc Res, Dept Radiat Biol, N-0310 Oslo, Norway; [Larsen, Roy H.] Sciencons AS, N-0884 Oslo, Norway; [Fleten, Karianne G.] Oslo Univ Hosp, Inst Canc Res, Dept Tumor Biol, Montebello, N-0310 Oslo, Norway; [Didierlaurent, David] Ctr Rech Canc Toulouse, INSERM, UMR 1037, UPS, F-31062 Toulouse, France; [Pichard, Alexandre; Pouget, Jean Pierre] Univ Montpellier, Inst Natl Sante & Rech Med, Inst Rech Cancerol Montpellier, U896, F-34059 Montpellier, France	University of Oslo; University of Oslo; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Repetto-Llamazares, AHV (corresponding author), Nord Nanovector ASA, Kjelsasveien 168, N-0884 Oslo, Norway.	arepetto@nordicnanovector.com	POUGET, Jean-Pierre/R-6697-2019; Patzke, Sebastian/G-9909-2019; Dahle, Jostein/AAE-7776-2020	POUGET, Jean-Pierre/0000-0001-8551-2029; Patzke, Sebastian/0000-0001-6821-197X; Dahle, Jostein/0000-0002-1447-6005; Pichard, Alexandre/0000-0001-6564-0998	Norwegian Research Council [213633, 219454]; Nordic Nanovector ASA	Norwegian Research Council(Research Council of NorwayEuropean Commission); Nordic Nanovector ASA	This study was partially funded by the Norwegian Research Council (http://www.forskningsradet.no) grant numbers 213633 and 219454 and by Nordic Nanovector ASA (http://www.nordicnanovector.com). Co-authors Ada H. V. Repetto-Llamazares and Jostein Dahle are employed by Nordic Nanovector ASA. Nordic Nanovector ASA provided support in the form of salaries for authors AHVR-L and JD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Roy H. Larsen is affiliated to Sciencons AS. Sciencons AS is a shareholder of Nordic Nanovector ASA. Sciencons AS did not provide support in the form of salary for author RHL, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ansell SM, 2014, BLOOD; Beckwith KA, 2014, LEUKEMIA, V28, P1501, DOI 10.1038/leu.2014.32; Beers SA, 2010, BLOOD, V115, P5191, DOI 10.1182/blood-2010-01-263533; Beers SA, 2010, SEMIN HEMATOL, V47, P107, DOI 10.1053/j.seminhematol.2010.01.001; Beum PV, 2011, J IMMUNOL, V187, P3438, DOI 10.4049/jimmunol.1101189; Boross P, 2012, AM J CANCER RES, V2, P676; BRASLAWSKY GR, 1991, CANCER IMMUNOL IMMUN, V33, P367, DOI 10.1007/BF01741596; Brown RS, 1997, NUCL MED BIOL, V24, P657, DOI 10.1016/S0969-8051(97)00099-1; BUCHSBAUM DJ, 1992, CANCER RES, V52, P6476; CAVACINI LA, 1992, CELL IMMUNOL, V144, P296, DOI 10.1016/0008-8749(92)90246-L; Dahle J, 2013, ANTICANCER RES, V33, P85; Davis TA, 2000, J CLIN ONCOL, V18, P3135, DOI 10.1200/JCO.2000.18.17.3135; Deckert J, 2013, BLOOD, V122, P3500, DOI 10.1182/blood-2013-05-505685; EARY JF, 1990, J NUCL MED, V31, P1257; Flinn IW, 2014, BLOOD, V123, P2944, DOI 10.1182/blood-2013-11-531327; Forrer F, 2013, J NUCL MED, V54, P1045, DOI 10.2967/jnumed.112.115170; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; GOLDSMITH MA, 1975, CANCER RES, V35, P1354; Gopal AK, 2014, INVEST NEW DRUGS; Graff BA, 2003, BRIT J CANCER, V88, P291, DOI 10.1038/sj.bjc.6600680; Greaves P, 2004, NAT REV DRUG DISCOV, V3, P226, DOI 10.1038/nrd1329; Heider KH, 2011, BLOOD, V118, P4159, DOI 10.1182/blood-2011-04-351932; Kaminski MS, 2005, NEW ENGL J MED, V352, P441, DOI 10.1056/NEJMoa041511; Kaminski MS, 2000, BLOOD, V96, P1259, DOI 10.1182/blood.V96.4.1259.h8001259_1259_1266; KAMINSKI MS, 1992, J CLIN ONCOL, V10, P1696, DOI 10.1200/JCO.1992.10.11.1696; Kvinnsland Y, 2001, RADIAT RES, V155, P288, DOI 10.1667/0033-7587(2001)155[0288:RWAPEM]2.0.CO;2; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Manders JMB, 2002, COMPARATIVE MED, V52, P36; Martin SM, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-49; Mattes MJ, 2008, CLIN CANCER RES, V14, P6154, DOI 10.1158/1078-0432.CCR-08-0404; Michel RB, 2002, CLIN CANCER RES, V8, P2701; Miller WH, 2005, CANCER BIOTHER RADIO, V20, P436, DOI 10.1089/cbr.2005.20.436; Moldenhauer G, 2000, J BIOL REG HOMEOS AG, V14, P281; National Nuclear Data Center, ENSDF DEC DAT MIRD M; Naumovski L, 2005, MOL CANCER THER, V4, P968, DOI 10.1158/1535-7163.MCT-04-0339; NAUTA MM, 1986, BRIT J CANCER, V54, P331, DOI 10.1038/bjc.1986.181; Olson H, 2000, REGUL TOXICOL PHARM, V32, P56, DOI 10.1006/rtph.2000.1399; Oostra DR, 2014, BREAST CANCER-TARGET, V6, P103, DOI 10.2147/BCTT.S67297; Park SI, 2010, BLOOD, V116, P4231, DOI 10.1182/blood-2010-05-282327; Pham T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014498; Postema EJ, 2003, CANCER BIOTHER RADIO, V18, P525, DOI 10.1089/108497803322287592; PRESS OW, 1989, J CLIN ONCOL, V7, P1027, DOI 10.1200/JCO.1989.7.8.1027; PRESS OW, 1993, NEW ENGL J MED, V329, P1219, DOI 10.1056/NEJM199310213291702; PRESS OW, 1989, CANCER RES, V49, P4906; PRESS OW, 1994, BLOOD, V83, P1390; Press OW, 2001, BLOOD, V98, P2535, DOI 10.1182/blood.V98.8.2535; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Repetto-Llamazares A, 2014, ANTICANCER RES, V34, P3263; Repetto-Llamazares AHV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103070; Repetto-Llamazares AHV, 2013, CURR RADIOPHARM, V6, P20, DOI 10.2174/1874471011306010004; Robak T, 2013, 55 AM SOC HEM ANN M; SHARKEY RM, 1990, CANCER RES, V50, pS964; Sieber T, 2003, BRIT J HAEMATOL, V121, P458, DOI 10.1046/j.1365-2141.2003.04305.x; SILOBRCIC V, 1990, INT J CANCER, V45, P325, DOI 10.1002/ijc.2910450220; SMELAND E, 1985, SCAND J IMMUNOL, V21, P205, DOI 10.1111/j.1365-3083.1985.tb01422.x; Vaughan AT, 2014, BLOOD, V123, P669, DOI 10.1182/blood-2013-04-490821; Vervoordeldonk SF, 1996, CANCER IMMUNOL IMMUN, V42, P24, DOI 10.1007/s002620050247; Witzig TE, 2002, J CLIN ONCOL, V20, P3262, DOI 10.1200/JCO.2002.11.017; Witzig TE, 2002, J CLIN ONCOL, V20, P2453, DOI 10.1200/JCO.2002.11.076	60	24	24	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128816	10.1371/journal.pone.0128816	http://dx.doi.org/10.1371/journal.pone.0128816			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066655	Green Submitted, Green Published, gold			2022-12-27	WOS:000356100900030
J	Liu, NC; Sargan, DR; Adams, VJ; Ladlow, JF				Liu, Nai-Chieh; Sargan, David R.; Adams, Vicki J.; Ladlow, Jane F.			Characterisation of Brachycephalic Obstructive Airway Syndrome in French Bulldogs Using Whole-Body Barometric Plethysmography	PLOS ONE			English	Article							CADMIUM CHLORIDE INHALATION; VOLUME LOOP ANALYSIS; HEALTHY DOGS; CATS; REACTIVITY	Brachycephalic obstructive airway syndrome (BOAS) is an important health and welfare problem in several popular dog breeds. Whole-body barometric plethysmography (WBBP) is a non-invasive method that allows safe and repeated quantitative measurements of respiratory cycles on unsedated dogs. Here respiratory flow traces in French bulldogs from the pet population were characterised using WBBP, and a computational application was developed to recognise affected animals. Eighty-nine French bulldogs and twenty non-brachycephalic controls underwent WBBP testing. A respiratory functional grading system was used on each dog based on respiratory signs (i.e. respiratory noise, effort, etc.) before and after exercise. For development of an objective BOAS classifier, functional Grades 0 and I were considered to have insignificant clinical signs (termed here BOAS-) and Grades II and III to have significant signs (termed here BOAS+). A comparison between owner-perception of BOAS and functional grading revealed that 60% of owners failed to recognise BOAS in dogs that graded BOAS+ in this study. WBBP flow traces were found to be significantly different between non-brachycephalic controls and Grade 0 French bulldogs; BOAS-and BOAS+ French bulldogs. A classifier was developed using quadratic discriminant analysis of the respiratory parameters to distinguish BOAS-and BOAS + French bulldogs, and a BOAS Index was calculated for each dog. A cut-off value of the BOAS Index was selected based on a receiver operating characteristic (ROC) curve. Sensitivity, specificity, positive predictive value, and negative predictive value of the classifier on the training group (n=69) were 0.97, 0.93, 0.95, and 0.97, respectively. The classifier was validated using a test group of French bulldogs (n=20) with an accuracy of 0.95. WBBP offers objective screening for the diagnosis of BOAS in French Bulldogs. The technique may be applied to other brachycephalic breeds affected by BOAS, and possibly to other respiratory disease in dogs.	[Liu, Nai-Chieh; Sargan, David R.; Ladlow, Jane F.] Univ Cambridge, Dept Vet Med, Cambridge, Cambs, England; [Adams, Vicki J.] Vet Epi Ltd, Birmingham, W Midlands, England	University of Cambridge	Ladlow, JF (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, Cambs, England.	jfl1001@cam.ac.uk	Ladlow, Jane/AAM-1595-2020	Ladlow, Jane/0000-0002-8076-4021; Sargan, David Richard/0000-0001-9897-2489; Adams, Vicki/0000-0001-5427-251X	The Kennel Club Charitable Trust (KCCT) [RG 71960]; Cambridge Overseas Trust (Taiwan Cambridge Scholarship)	The Kennel Club Charitable Trust (KCCT); Cambridge Overseas Trust (Taiwan Cambridge Scholarship)	Funding was provided by (1) The Kennel Club Charitable Trust (KCCT), Grant no.: RG 71960, http://www.thekennelclub.org.uk/our-resources/kennel-club-charitable-trust/, to DRS JFL; and (2) Cambridge Overseas Trust (Taiwan Cambridge Scholarship), https://www.cambridgetrust.org/about/cambridge-overseas-trust/, to NCL.	AMIS TC, 1986, AM J VET RES, V47, P2200; AMIS TC, 1986, AM J VET RES, V47, P1002; [Anonymous], 2015, DOG BREEDS REG STAT; Bedenice D, 2006, RESP PHYSIOL NEUROBI, V151, P61, DOI 10.1016/j.resp.2005.05.030; Bernaerts F, 2010, VET J, V183, P95, DOI 10.1016/j.tvjl.2008.09.009; Bolognin M, 2009, VET J, V179, P443, DOI 10.1016/j.tvjl.2007.10.004; CLARKE KW, 1989, J SMALL ANIM PRACT, V30, P343, DOI 10.1111/j.1748-5827.1989.tb01575.x; Dugdale A., 2010, VET ANAESTHESIA PRIN, P30; Dye J, 2004, TXB RESP DIS DOG CAT, P160; Elizabeth A, 1999, CLIN TECH SMALL AMIN, V14, P237; Fasanella FJ, 2010, JAVMA-J AM VET MED A, V237, P1048, DOI 10.2460/javma.237.9.1048; Findji L., 2009, EUROPEAN J COMPANION, V19, P125; Ginn JA, 2008, J AM ANIM HOSP ASSOC, V44, P243, DOI 10.5326/0440243; Grubb T. L., 2011, Essentials of small animal anesthesia and analgesia, P387; HENDRICKS JC, 1987, J APPL PHYSIOL, V63, P1344, DOI 10.1152/jappl.1987.63.4.1344; HENDRICKS JC, 1992, VET CLIN N AM-SMALL, V22, P1145, DOI 10.1016/S0195-5616(92)50306-0; Hendricks JC, 2004, TXB RESP DIS DOGS CA, P310; Hirt RA, 2008, VET J, V176, P232, DOI 10.1016/j.tvjl.2007.05.025; Hirt RA, 2007, VET J, V173, P62, DOI 10.1016/j.tvjl.2005.09.016; Hoffman AM, 1999, AM J VET RES, V60, P1487; Holt D., 2004, TXB RESP DIS DOGS CA, P35; JACKY JP, 1978, J APPL PHYSIOL, V45, P644, DOI 10.1152/jappl.1978.45.4.644; Kimoff RJ, 2005, PHYSL BASIS RESP DIS, P581; Kirschvink N, 2007, VET J, V173, P343, DOI 10.1016/j.tvjl.2005.10.007; Lin CH, 2014, J FELINE MED SURG, V16, P616, DOI 10.1177/1098612X13515461; Manens J, 2012, VET J, V193, P217, DOI 10.1016/j.tvjl.2011.10.013; Milic-Emili J, 2011, COMPR PHYSL, V11, P751; Murphy DJ, 2010, J PHARMACOL TOX MET, V62, P47, DOI 10.1016/j.vascn.2010.04.006; Oechtering G., 2010, Veterinary Focus, V20, P2; Packer RMA, 2012, ANIM WELFARE, V21, P81, DOI 10.7120/096272812X13345905673809; Pardali D, 2010, J VET INTERN MED, V24, P832, DOI 10.1111/j.1939-1676.2010.0513.x; Poncet CM, 2005, J SMALL ANIM PRACT, V46, P273, DOI 10.1111/j.1748-5827.2005.tb00320.x; Roedler FS, 2013, VET J, V198, P606, DOI 10.1016/j.tvjl.2013.09.009; ROZANSKI EA, 2004, TXB RESP DIS DOGS CA, P175; Talavera J, 2006, VET J, V172, P67, DOI 10.1016/j.tvjl.2005.04.019; VGONTZAS AN, 1994, ARCH INTERN MED, V154, P1705, DOI 10.1001/archinte.154.15.1705; Wykes P M, 1991, Probl Vet Med, V3, P188	37	49	49	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0130741	10.1371/journal.pone.0130741	http://dx.doi.org/10.1371/journal.pone.0130741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079684	Green Submitted, Green Published, gold			2022-12-27	WOS:000356542300045
J	Dhondt, A; Pauwels, R; Devreese, K; Eloot, S; Glorieux, G; Vanholder, R				Dhondt, Annemieke; Pauwels, Ruben; Devreese, Katrien; Eloot, Sunny; Glorieux, Griet; Vanholder, Raymond			Where and When To Inject Low Molecular Weight Heparin in Hemodiafiltration? A Cross Over Randomised Trial	PLOS ONE			English	Article							THROMBIN GENERATION; UNFRACTIONATED HEPARIN; CHRONIC-HEMODIALYSIS; ENOXAPARIN SODIUM; ANTICOAGULATION; TINZAPARIN; PLASMA; FIBRINOLYSIS; EFFICACY; SAFETY	Background and Objective Low molecular weight heparins (LMWHs) are small enough to pass large pore dialysis membranes. Removal of LMWH if injected before the start of the session is possible during high-flux dialysis and hemodiafiltration. The aim of this study was to determine the optimal mode (place and time) of tinzaparin administration during postdilution hemodiafiltration. Study Design, Setting, Patients In 13 chronic hemodiafiltration patients, 3 approaches of injection were compared in a randomised cross over trial: i) before the start of the session at the inlet blood line filled with rinsing solution (IN0), ii) 5 min after the start at the inlet line filled with blood (IN5) and iii) before the start of the session at the outlet blood line (OUT0). Anti-Xa activity, thrombin generation, visual clotting score and reduction ratios of urea and beta2microglobulin were measured. Results Anti-Xa activity was lower with IN0 compared with IN5 and OUT0, and also more thrombin generation was observed with IN0. No differences were observed in visual clotting scores and no clinically relevant differences were observed in solute reduction ratio. An anti-Xa of 0.3 IU/mL was discriminative for thrombin generation. Anti-Xa levels below 0.3 IU/mL at the end of the session were associated with worse clotting scores and lower reduction ratio of urea and beta2microglobulin. Conclusions Injection of tinzaparin at the inlet line before the start of postdilution hemodiafiltration is associated with loss of anticoagulant activity and can therefore not be recommended. Additionally, we found that an anti-Xa above 0.3 IU/mL at the end of the session is associated with less clotting and higher dialysis adequacy.	[Dhondt, Annemieke; Pauwels, Ruben; Eloot, Sunny; Glorieux, Griet; Vanholder, Raymond] Ghent Univ Hosp, Dept Nephrol, Ghent, Belgium; [Devreese, Katrien] Ghent Univ Hosp, Dept Clin Chem Microbiol & Immunol, Coagulat Lab, Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital	Dhondt, A (corresponding author), Ghent Univ Hosp, Dept Nephrol, Ghent, Belgium.	annemie.dhondt@ugent.be	Devreese, Katrien/T-3912-2019; Devreese, Katrien/AAL-5807-2021; Pauwels, Ruben/G-9041-2017	Devreese, Katrien/0000-0002-7559-2579; Pauwels, Ruben/0000-0002-9462-7546				Al Dieri R, 2004, J THROMB HAEMOST, V2, P1395, DOI 10.1111/j.1538-7836.2004.00798.x; Badawi L, 2005, SAUDI J KIDNEY DIS T, V16, P161; Bramham K, 2008, NEPHRON CLIN PRACT, V110, pC107, DOI 10.1159/000158561; Burton JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072663; Davenport A, 2008, HEMODIAL INT, V12, pS34, DOI 10.1111/j.1542-4758.2008.00322.x; Davenport A, 2011, NAT REV NEPHROL, V7, P499, DOI 10.1038/nrneph.2011.88; Davenport A, 2009, NEPHROLOGY, V14, P455, DOI 10.1111/j.1440-1797.2009.01135.x; Devreese K, 2007, THROMB HAEMOSTASIS, V98, P600, DOI 10.1160/TH07-03-0210; EBPG, 2002, NEPHROL DIAL TRANSPL, V17, P64; Egfjord M, 1998, ARTIF ORGANS, V22, P633, DOI 10.1046/j.1525-1594.1998.06008.x; Guillet B, 2003, NEPHROL DIAL TRANSPL, V18, P2348, DOI 10.1093/ndt/gfg396; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Jeong JC, 2013, THROMB RES, V132, P604, DOI 10.1016/j.thromres.2013.09.002; Kirwan CJ, 2013, NEPHRON CLIN PRACT, V123, P7, DOI 10.1159/000351047; Klingel R, 2004, KIDNEY BLOOD PRESS R, V27, P211, DOI 10.1159/000079866; Krummel T, 2014, NEPHROL DIAL TRANSPL, V29, P906, DOI 10.1093/ndt/gft522; Lai KN, 1998, INT J ARTIF ORGANS, V21, P196, DOI 10.1177/039139889802100404; Lim W, 2004, J AM SOC NEPHROL, V15, P3192, DOI 10.1097/01.ASN.0000145014.80714.35; Malyszko J, 2004, AM J NEPHROL, V24, P624, DOI 10.1159/000082862; Pauwels R, 2014, NEPHROL DIAL TRANSPL, V29, P1092, DOI 10.1093/ndt/gft508; Sabovic M, 2005, PATHOPHYSIOL HAEMO T, V34, P274, DOI 10.1159/000093107; Sabry A, 2009, BLOOD COAGUL FIBRIN, V20, P57, DOI 10.1097/MBC.0b013e32831bec0f; Sagedal S, 1999, NEPHROL DIAL TRANSPL, V14, P1943, DOI 10.1093/ndt/14.8.1943; Saltissi D, 1999, NEPHROL DIAL TRANSPL, V14, P2698, DOI 10.1093/ndt/14.11.2698; SCHRADER J, 1985, KIDNEY INT, V28, P823, DOI 10.1038/ki.1985.204; Simpson HKL, 1996, HAEMOSTASIS, V26, P90; Sombolos KI, 2009, HEMODIAL INT, V13, P43, DOI 10.1111/j.1542-4758.2009.00336.x; Sridharan S, 2012, NEPHRON CLIN PRACT, V122, P53, DOI 10.1159/000348830; Vanuytsel JL, 1999, CLIN NEPHROL, V52, P322; Vernon K, 2011, NEPHRON CLIN PRACT, V117, pC403, DOI 10.1159/000319884	30	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128634	10.1371/journal.pone.0128634	http://dx.doi.org/10.1371/journal.pone.0128634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076014	gold, Green Submitted, Green Published			2022-12-27	WOS:000356329900022
J	Han, JF; Zhang, M; Froese, S; Dai, FF; Robitaille, M; Bhattacharjee, A; Huang, XY; Jia, WP; Angers, S; Wheeler, MB; Wei, L				Han, Junfeng; Zhang, Ming; Froese, Sean; Dai, Feihan F.; Robitaille, Melanie; Bhattacharjee, Alpana; Huang, Xinyi; Jia, Weiping; Angers, Stephane; Wheeler, Michael B.; Wei, Li			The Identification of Novel Protein-Protein Interactions in Liver that Affect Glucagon Receptor Activity	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; AFFINITY-PURIFICATION; TAU-PHOSPHORYLATION; COUPLED RECEPTORS; GLP-1 RECEPTOR; INSULIN; FAMILY; HYPERGLYCEMIA; INHIBITION; ANTAGONIST	Glucagon regulates glucose homeostasis by controlling glycogenolysis and gluconeogenesis in the liver. Exaggerated and dysregulated glucagon secretion can exacerbate hyperglycemia contributing to type 2 diabetes (T2D). Thus, it is important to understand how glucagon receptor (GCGR) activity and signaling is controlled in hepatocytes. To better understand this, we sought to identify proteins that interact with the GCGR to affect ligand-dependent receptor activation. A Flag-tagged human GCGR was recombinantly expressed in Chinese hamster ovary (CHO) cells, and GCGR complexes were isolated by affinity purification (AP). Complexes were then analyzed by mass spectrometry (MS), and protein-GCGR interactions were validated by co-immunoprecipitation (Co-IP) and Western blot. This was followed by studies in primary hepatocytes to assess the effects of each interactor on glucagon-dependent glucose production and intracellular cAMP accumulation, and then in immortalized CHO and liver cell lines to further examine cell signaling. Thirty-three unique interactors were identified from the AP-MS screening of GCGR expressing CHO cells in both glucagon liganded and unliganded states. These studies revealed a particularly robust interaction between GCGR and 5 proteins, further validated by Co-IP, Western blot and qPCR. Overexpression of selected interactors in mouse hepatocytes indicated that two interactors, LDLR and TMED2, significantly enhanced glucagon-stimulated glucose production, while YWHAB inhibited glucose production. This was mirrored with glucagon-stimulated cAMP production, with LDLR and TMED2 enhancing and YWHAB inhibiting cAMP accumulation. To further link these interactors to glucose production, key gluconeogenic genes were assessed. Both LDLR and TMED2 stimulated while YWHAB inhibited PEPCK and G6Pase gene expression. In the present study, we have probed the GCGR interactome and found three novel GCGR interactors that control glucagon-stimulated glucose production by modulating cAMP accumulation and genes that control gluconeogenesis. These interactors may be useful targets to control glucose homeostasis in T2D.	[Han, Junfeng; Zhang, Ming; Froese, Sean; Dai, Feihan F.; Bhattacharjee, Alpana; Huang, Xinyi; Wheeler, Michael B.] Univ Toronto, Dept Physiol & Med, Toronto, ON, Canada; [Han, Junfeng; Jia, Weiping; Wei, Li] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai 200030, Peoples R China; [Robitaille, Melanie; Angers, Stephane] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 1A8, Canada	University of Toronto; Shanghai Jiao Tong University; University of Toronto	Wheeler, MB (corresponding author), Univ Toronto, Dept Physiol & Med, Toronto, ON, Canada.	Michael.Wheeler@utoronto.ca; weili63@hotmail.com	Robitaille, Melanie/ABA-5861-2020; Angers, Stephane/E-1432-2014	Robitaille, Melanie/0000-0001-9354-5162; Angers, Stephane/0000-0001-7241-9044; Wheeler, Michael B./0000-0002-7480-7267	Canadian Institutes of Health Research [MOP-102588, MOP-324754]; Novo Nordisk Diabetes Innovation Award, Natural Science and Engineering Research Council [RGPIN-2015-05286]; Shanghai Jiao Tong University Wuxi Research Institute Operating Grant [2011JDZX021]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Novo Nordisk Diabetes Innovation Award, Natural Science and Engineering Research Council; Shanghai Jiao Tong University Wuxi Research Institute Operating Grant	This work was supported by the Canadian Institutes of Health Research (MOP-102588 and MOP-324754), the Novo Nordisk Diabetes Innovation Award, Natural Science and Engineering Research Council (RGPIN-2015-05286) and the Shanghai Jiao Tong University Wuxi Research Institute Operating Grant (2011JDZX021). The funder had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Adiels M, 2005, ARTERIOSCL THROM VAS, V25, P1697, DOI 10.1161/01.ATV.0000172689.53992.25; Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; Ahmed SM, 2011, METHODS MOL BIOL, V756, P357, DOI 10.1007/978-1-61779-160-4_22; Anastas JN, 2012, ONCOGENE, V31, P3696, DOI 10.1038/onc.2011.528; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brubaker PL, 2002, RECEPTOR CHANNEL, V8, P179, DOI 10.1080/1060682020005155; Chen GI, 2007, METHODS, V42, P298, DOI 10.1016/j.ymeth.2007.02.018; Cho YM, 2012, PHARMACOL THERAPEUT, V135, P247, DOI 10.1016/j.pharmthera.2012.05.009; Contreras I, 2004, PLANT J, V38, P685, DOI 10.1111/j.1365-313X.2004.02075.x; Cryer PE, 2012, ENDOCRINOLOGY, V153, P1039, DOI 10.1210/en.2011-1499; Dai FHF, 2006, J BIOL CHEM, V281, P21942, DOI 10.1074/jbc.M512924200; Daulat AM, 2007, MOL CELL PROTEOMICS, V6, P835, DOI 10.1074/mcp.M600298-MCP200; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gommel DU, 2001, EMBO J, V20, P6751, DOI 10.1093/emboj/20.23.6751; Gu W, 2010, AM J PHYSIOL-ENDOC M, V299, pE624, DOI 10.1152/ajpendo.00102.2010; Hardy AB, 2009, J BIOL CHEM, V284, P30441, DOI 10.1074/jbc.M109.040659; Huang X, 2013, MOL ENDOCRINOL, V27, P1550, DOI 10.1210/me.2013-1047; Kaiser C, 2000, P NATL ACAD SCI USA, V97, P3783, DOI 10.1073/pnas.97.8.3783; Ke JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033676; Kim GH, 2013, PROTEOMICS, V13, P1164, DOI 10.1002/pmic.201200210; KISSEBAH AH, 1983, J CLIN INVEST, V71, P655, DOI 10.1172/JCI110812; Li T, 2007, NEUROSCI LETT, V414, P203, DOI 10.1016/j.neulet.2006.11.073; Li XC, 2006, HYPERTENSION, V47, P580, DOI 10.1161/01.HYP.0000197946.81754.0a; Liu HY, 2012, J PROTEOME RES, V11, P4803, DOI 10.1021/pr2012297; Majoul I, 2001, DEV CELL, V1, P139, DOI 10.1016/S1534-5807(01)00004-1; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Mu J, 2011, DIABETOLOGIA, V54, P2381, DOI 10.1007/s00125-011-2217-2; Mu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049572; Parker JC, 2000, DIABETES, V49, P2079, DOI 10.2337/diabetes.49.12.2079; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Salehi A, 2006, DIABETES, V55, P2318, DOI 10.2337/db06-0080; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Sekar N, 2004, AM J PHYSIOL-ENDOC M, V287, pE128, DOI 10.1152/ajpendo.00400.2003; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Song J, 2012, J PROTEOME RES, V11, P5630, DOI 10.1021/pr300598t; Sonoda N, 2008, P NATL ACAD SCI USA, V105, P6614, DOI 10.1073/pnas.0710402105; Stepanchick A, 2010, BIOCHEM BIOPH RES CO, V395, P136, DOI 10.1016/j.bbrc.2010.03.156; Streicher R, 1996, J BIOL CHEM, V271, P7128, DOI 10.1074/jbc.271.12.7128; Syme CA, 2006, MOL ENDOCRINOL, V20, P3400, DOI 10.1210/me.2006-0178; Tseng CC, 2000, ENDOCRINOLOGY, V141, P947, DOI 10.1210/en.141.3.947; Wu JH, 2003, J BIOL CHEM, V278, P44238, DOI 10.1074/jbc.M309450200; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Xu YZ, 2009, J RECEPT SIG TRANSD, V29, P318, DOI 10.3109/10799890903295150; Yabaluri N, 2010, J BIOSCIENCES, V35, P473, DOI 10.1007/s12038-010-0052-0; Yuan ZF, 2004, J BIOL CHEM, V279, P26105, DOI 10.1074/jbc.M308298200; Zhang M, 2014, MOL CELL PROTEOMICS, V13, P3049, DOI 10.1074/mcp.M114.040196	49	16	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129226	10.1371/journal.pone.0129226	http://dx.doi.org/10.1371/journal.pone.0129226			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075596	Green Submitted, gold, Green Published			2022-12-27	WOS:000356329900055
J	Lee, YR; Na, BK; Moon, EK; Song, SM; Joo, SY; Kong, HH; Goo, YK; Chung, DI; Hong, Y				Lee, Yu-Ran; Na, Byoung-Kuk; Moon, Eun-Kyung; Song, Su-Min; Joo, So-Young; Kong, Hyun-Hee; Goo, Youn-Kyoung; Chung, Dong-Il; Hong, Yeonchul			Essential Role for an M17 Leucine Aminopeptidase in Encystation of Acanthamoeba castellanii	PLOS ONE			English	Article							GIARDIA-LAMBLIA DIFFERENTIATION; LEUCYL AMINOPEPTIDASE; ENTAMOEBA-INVADENS; CYSTEINE PROTEASE; CRYPTOSPORIDIUM-PARVUM; TOXOPLASMA-GONDII; MESSENGER-RNA; SOIL AMOEBA; EXPRESSION; AUTOPHAGY	Encystation of Acanthamoeba leads to the formation of resilient cysts from vegetative trophozoites. This process is essential for parasite survival under unfavorable conditions such as starvation, low temperatures, and exposure to biocides. During encystation, a massive turnover of intracellular components occurs, and a large number of organelles and proteins are degraded by proteases. Previous studies with specific protease inhibitors have shown that cysteine and serine proteases are involved in encystation of Acanthamoeba, but little is known about the role of metalloproteases in this process. Here, we have biochemically characterized an M17 leucine aminopeptidase of Acanthamoeba castellanii (AcLAP) and analyzed its functional involvement in encystation of the parasite. Recombinant AcLAP shared biochemical properties such as optimal pH, requirement of divalent metal ions for activity, substrate specificity for Leu, and inhibition profile by aminopeptidase inhibitors and metal chelators with other characterized M17 family LAPs. AcLAP was highly expressed at a late stage of encystation and mainly localized in the cytoplasm of A. castellanii. Knockdown of AcLAP using small interfering RNA induced a decrease of LAP activity during encystation, a reduction of mature cyst formation, and the formation of abnormal cyst walls. In summary, these results indicate that AcLAP is a typical M17 family enzyme that plays an essential role during encystation of Acanthamoeba.	[Lee, Yu-Ran; Moon, Eun-Kyung; Song, Su-Min; Joo, So-Young; Goo, Youn-Kyoung; Chung, Dong-Il; Hong, Yeonchul] Kyungpook Natl Univ, Sch Med, Dept Parasitol & Trop Med, Daegu 700422, South Korea; [Na, Byoung-Kuk] Gyeongsang Natl Univ, Sch Med, Dept Parasitol & Trop Med, Jinju 660751, South Korea; [Na, Byoung-Kuk] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Jinju 660751, South Korea; [Kong, Hyun-Hee] Dong A Univ, Coll Med, Dept Parasitol, Busan 602714, South Korea	Kyungpook National University; Gyeongsang National University; Gyeongsang National University; Dong A University	Hong, Y (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Parasitol & Trop Med, Daegu 700422, South Korea.	ychong@knu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2009802]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2009802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsam S, 2005, J INFECTION, V51, P150, DOI 10.1016/j.jinf.2004.09.001; BAND RN, 1963, J PROTOZOOL, V10, P101, DOI 10.1111/j.1550-7408.1963.tb01642.x; Bateman E, 2010, PROTEIN EXPRES PURIF, V70, P95, DOI 10.1016/j.pep.2009.10.008; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; BOWERS B, 1969, J CELL BIOL, V41, P786, DOI 10.1083/jcb.41.3.786; Bruchhaus I, 2003, EUKARYOT CELL, V2, P501, DOI 10.1128/EC.2.3.501-509.2003; Cadavid-Restrepo G, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-46; Cao ZY, 1998, J BIOL CHEM, V273, P15838, DOI 10.1074/jbc.273.25.15838; Davids BJ, 2011, MOL BIOCHEM PARASIT, V175, P169, DOI 10.1016/j.molbiopara.2010.11.008; DuBois KN, 2008, J BIOL CHEM, V283, P18024, DOI 10.1074/jbc.M802133200; Dudley R, 2008, FEMS MICROBIOL LETT, V286, P9, DOI 10.1111/j.1574-6968.2008.01249.x; Ebert F, 2008, PARASITOL INT, V57, P521, DOI 10.1016/j.parint.2008.07.002; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gonzalez J, 1999, EUR J BIOCHEM, V264, P897, DOI 10.1046/j.1432-1327.1999.00682.x; Griffiths A, 1970, ENCYSTMENT AMOEBAE, P105; Hehl AB, 2000, MOL BIOL CELL, V11, P1789, DOI 10.1091/mbc.11.5.1789; Herrera-Camacho I, 2007, FEBS J, V274, P6228, DOI 10.1111/j.1742-4658.2007.06142.x; Jia HL, 2010, MOL BIOCHEM PARASIT, V170, P1, DOI 10.1016/j.molbiopara.2009.11.005; Kang JM, 2011, PARASITOLOGY, V138, P682, DOI 10.1017/S0031182011000199; Khan, 2009, ACANTHAMOEBA BIOL PA; Khunkitti W, 1996, J APPL BACTERIOL, V81, P73, DOI 10.1111/j.1365-2672.1996.tb03284.x; KIM HD, 1993, P NATL ACAD SCI USA, V90, P5006, DOI 10.1073/pnas.90.11.5006; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lee JY, 2013, EUKARYOT CELL, V12, P567, DOI 10.1128/EC.00308-12; Lee JY, 2010, MOL BIOCHEM PARASIT, V170, P45, DOI 10.1016/j.molbiopara.2009.11.003; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Linder M, 2002, APPL ENVIRON MICROB, V68, P2503, DOI 10.1128/AEM.68.5.2503-2508.2002; Lloyd D, 2001, J EUKARYOT MICROBIOL, V48, P11, DOI 10.1111/j.1550-7408.2001.tb00410.x; Lujan HD, 1997, MICROBIOL MOL BIOL R, V61, P294; Makioka A, 2002, PARASITOL RES, V88, P454, DOI 10.1007/s00436-002-0601-z; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Matsui M, 2006, BIOL CHEM, V387, P1535, DOI 10.1515/BC.2006.191; MATSUSHIMA M, 1991, BIOCHEM BIOPH RES CO, V178, P1459, DOI 10.1016/0006-291X(91)91057-J; Mazur T, 1988, WIAD PARAZYTOL, V35, P11; Moon EK, 2008, EUKARYOT CELL, V7, P1513, DOI 10.1128/EC.00068-08; Moon EK, 2012, MOL BIOCHEM PARASIT, V185, P121, DOI 10.1016/j.molbiopara.2012.07.008; Moon EK, 2011, KOREAN J PARASITOL, V49, P341, DOI 10.3347/kjp.2011.49.4.341; Morty RE, 2002, J BIOL CHEM, V277, P26057, DOI 10.1074/jbc.M202779200; Neff R, ACANTHAMOEBA; NELLEN W, 1982, J MOL BIOL, V159, P1, DOI 10.1016/0022-2836(82)90028-6; Okhuysen PC, 1996, ANTIMICROB AGENTS CH, V40, P2781, DOI 10.1128/AAC.40.12.2781; Picazarri K, 2008, INFECT IMMUN, V76, P278, DOI 10.1128/IAI.00636-07; Poloz Y, 2012, EUKARYOT CELL, V11, P545, DOI 10.1128/EC.05311-11; Rascon AA, 2013, CURR MED CHEM, V20, P3078; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Schaeffer M, 2006, MOL BIOCHEM PARASIT, V150, P318, DOI 10.1016/j.molbiopara.2006.09.004; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Sharma M, 1996, EXP PARASITOL, V84, P84, DOI 10.1006/expr.1996.0092; Singh U, 2002, MOL MICROBIOL, V44, P721, DOI 10.1046/j.1365-2958.2002.02903.x; Sissons J, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-42; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; TAYLOR A, 1993, TRENDS BIOCHEM SCI, V18, P167; TAYLOR A, 1993, FASEB J, V7, P290, DOI 10.1096/fasebj.7.2.8440407; Tomkinson B, 1999, TRENDS BIOCHEM SCI, V24, P355, DOI 10.1016/S0968-0004(99)01435-8; TOMLINSON G, 1962, BIOCHIM BIOPHYS ACTA, V63, P194, DOI 10.1016/0006-3002(62)90353-0; Touz Maria C., 2002, Biochemical Journal, V364, P703, DOI 10.1042/BJ20020025; Touz MC, 2002, J BIOL CHEM, V277, P8474, DOI 10.1074/jbc.M110250200; Turner NA, 2000, J ANTIMICROB CHEMOTH, V46, P27, DOI 10.1093/jac/46.1.27; WEISMAN RA, 1976, ANNU REV MICROBIOL, V30, P189, DOI 10.1146/annurev.mi.30.100176.001201; York IA, 2003, IMMUNITY, V18, P429, DOI 10.1016/S1074-7613(03)00058-X	61	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129884	10.1371/journal.pone.0129884	http://dx.doi.org/10.1371/journal.pone.0129884			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075721	gold, Green Submitted, Green Published			2022-12-27	WOS:000356329900110
J	Sjostedt, E; Fagerberg, L; Hallstrom, BM; Haggmark, A; Mitsios, N; Nilsson, P; Ponten, F; Hokfelt, T; Uhlen, M; Mulder, J				Sjostedt, Evelina; Fagerberg, Linn; Hallstrom, Bjorn M.; Haggmark, Anna; Mitsios, Nicholas; Nilsson, Peter; Ponten, Fredrik; Hokfelt, Tomas; Uhlen, Mathias; Mulder, Jan			Defining the Human Brain Proteome Using Transcriptomics and Antibody-Based Profiling with a Focus on the Cerebral Cortex	PLOS ONE			English	Article							GENE-EXPRESSION; NONCODING RNA; GLUTAMATE TRANSPORTER; REVEALS 2; LOCALIZATION; CELLS; LONG; GENOME; TOOL; SEQ	The mammalian brain is a complex organ composed of many specialized cells, harboring sets of both common, widely distributed, as well as specialized and discretely localized proteins. Here we focus on the human brain, utilizing transcriptomics and public available Human Protein Atlas (HPA) data to analyze brain-enriched (frontal cortex) polyadenylated messenger RNA and long non-coding RNA and generate a genome-wide draft of global and cellular expression patterns of the brain. Based on transcriptomics analysis of altogether 27 tissues, we have estimated that approximately 3% (n=571) of all protein coding genes and 13% (n=87) of the long non-coding genes expressed in the human brain are enriched, having at least five times higher expression levels in brain as compared to any of the other analyzed peripheral tissues. Based on gene ontology analysis and detailed annotation using antibody-based tissue micro array analysis of the corresponding proteins, we found the majority of brain-enriched protein coding genes to be expressed in astrocytes, oligodendrocytes or in neurons with molecular properties linked to synaptic transmission and brain development. Detailed analysis of the transcripts and the genetic landscape of brainenriched coding and non-coding genes revealed brain-enriched splice variants. Several clusters of neighboring brain-enriched genes were also identified, suggesting regulation of gene expression on the chromatin level. This multi-angle approach uncovered the brainenriched transcriptome and linked genes to cell types and functions, providing novel insights into the molecular foundation of this highly specialized organ.	[Sjostedt, Evelina; Fagerberg, Linn; Hallstrom, Bjorn M.; Haggmark, Anna; Nilsson, Peter; Uhlen, Mathias] KTH Royal Inst Technol, Sch Biotechnol, Sci Life Lab, Stockholm, Sweden; [Sjostedt, Evelina; Ponten, Fredrik] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Mitsios, Nicholas; Hokfelt, Tomas; Mulder, Jan] Karolinska Inst, Dept Neurosci, Sci Life Lab, Stockholm, Sweden	Royal Institute of Technology; Uppsala University; Karolinska Institutet	Mulder, J (corresponding author), Karolinska Inst, Dept Neurosci, Sci Life Lab, Stockholm, Sweden.	jan.mulder@ki.se	Uhlen, Mathias/B-3262-2016; Uhlen, Mathias/AAV-8746-2021; Mulder, Jan/AAG-9761-2021; Mulder, Jan/G-3909-2011; Nilsson, Peter/E-4547-2010	Uhlen, Mathias/0000-0002-4858-8056; Mulder, Jan/0000-0003-3717-5018; Nilsson, Peter/0000-0002-4657-8532; Fagerberg, Linn/0000-0003-0198-7137; Sjostedt, Evelina/0000-0002-0327-7377; Mitsios, Nicholas/0000-0001-6243-4953	Knut and Alice Wallenberg Foundation; European Directorate [HEALTH-F4-2008-201648/PROSPECTS]; Swedish research council [VR 4x-2887]; Alzheimerfonden [03-216]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Directorate; Swedish research council(Swedish Research CouncilEuropean Commission); Alzheimerfonden	Funding was provided by: Knut and Alice Wallenberg Foundation (MU, FP, ES, LF, BMH,PN) -https://www.wallenberg.com/kaw/; PROSPECTS, a 7th Framework grant by the European Directorate (grant agreement HEALTH-F4-2008-201648/PROSPECTS, MU, PN)-http://www.prospects-fp7.eu/index.html; Swedish research council (VR 4x-2887, TH)-http://www.vr.se; Alzheimerfonden (grant 03-216, JM)-http://www.alzheimerfonden.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai LQ, 2001, J BIOL CHEM, V276, P36764, DOI 10.1074/jbc.M104578200; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Barry G, 2014, MOL PSYCHIATR, V19, P410, DOI 10.1038/mp.2013.196; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Clark BS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00164; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djureinovic D, 2014, MOL HUM REPROD, V20, P476, DOI 10.1093/molehr/gau018; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; ELFERINK LA, 1993, J CELL SCI, P75; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Francescatto M, 2014, INT J BIOCHEM CELL B, V54, P331, DOI 10.1016/j.biocel.2014.06.014; Gonchar Y, 2001, J COMP NEUROL, V431, P182, DOI 10.1002/1096-9861(20010305)431:2<182::AID-CNE1064>3.0.CO;2-K; Gremel G, 2015, J GASTROENTEROL, V50, P46, DOI 10.1007/s00535-014-0958-7; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Hooper SD, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-123; Hoque M, 2013, NAT METHODS, V10, P133, DOI [10.1038/NMETH.2288, 10.1038/nmeth.2288]; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jahn O, 2009, MOL NEUROBIOL, V40, P55, DOI 10.1007/s12035-009-8071-2; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kampf C., 2004, CLIN PROTEOM, V1, P285, DOI DOI 10.1385/CP:1:3-4:285; Kampf C, 2014, PROTEOMICS, V14, P2498, DOI 10.1002/pmic.201400201; Kampf C, 2014, FASEB J, V28, P2901, DOI 10.1096/fj.14-250555; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lindskog C, 2014, FASEB J, V28, P5184, DOI 10.1096/fj.14-254862; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Mardinoglu A, 2014, J PROTEOME RES, V13, P5106, DOI 10.1021/pr500586e; Milton ID, 1997, MOL BRAIN RES, V52, P17, DOI 10.1016/S0169-328X(97)00233-7; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muhleisen TW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4339; Nielsen S, 1997, J NEUROSCI, V17, P171; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Ohtsuki S, 2004, BIOL PHARM BULL, V27, P1489, DOI 10.1248/bpb.27.1489; Okaty BW, 2011, J NEUROSCI, V31, P6939, DOI 10.1523/JNEUROSCI.0626-11.2011; Paavilainen L, 2010, J HISTOCHEM CYTOCHEM, V58, P237, DOI 10.1369/jhc.2009.954321; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; REPRESA A, 1990, J NEUROSCI, V10, P3782, DOI 10.1523/JNEUROSCI.10-12-03782.1990; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Takano M, 2006, PHARMACOL THERAPEUT, V109, P137, DOI 10.1016/j.pharmthera.2005.06.005; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	57	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130028	10.1371/journal.pone.0130028	http://dx.doi.org/10.1371/journal.pone.0130028			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076492	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900125
J	Wang, MZ; Kou, HM; Deng, J; Wang, HF; Guo, T; Mei, H; Hu, Y				Wang, Manzhi; Kou, Haiming; Deng, Jun; Wang, Huafang; Guo, Tao; Mei, Heng; Hu, Yu			Retrospective Evaluation of New Chinese Diagnostic Scoring System for Disseminated Intravascular Coagulation	PLOS ONE			English	Article							INTERNATIONAL SOCIETY; BLEEDING COMPLICATIONS; PROSPECTIVE VALIDATION; JAPANESE ASSOCIATION; NATURAL-HISTORY; CRITERIA; THROMBOSIS; CLASSIFICATION; MULTICENTER; SEPSIS	Objectives To retrospectively validate the new Chinese DIC scoring system (CDSS). Methods This study retrospectively collected the information of 619 patients (371 cases with non-hematologic malignancies, 248 cases with hematologic malignancies) who suspected of DIC in Wuhan Union Hospital during 2013-4 to 2014-6. We validated CDSS by comparing it with three leading scoring systems, from International Society on Thrombosis and Haemostasis (ISTH), Japanese Association for Acute Medicine (JAAM) and Japanese Ministry of Health and Welfare (JMHW), and evaluated its prognostic value by 28 days mortality, APACHE II and SOFA score. Results In non-hematologic malignancies, CDSS was more specific than JAAM (72.55% vs. 50.49%, p<0.05) and more sensitive than ISTH (77.07% vs. 62.03%, p<0.05). In hematologic malignancies, the area under the ROC curve of CDSS was larger than ISTH and JMHW (0.933 vs. 0.889, p<0.01 with ISTH, 0.944 vs. 0.845, p<0.01 with JMHW). In addition, the 28-day mortality rate, SOFA scores, APACHE II scores of DIC patients diagnosed by CDSS were significantly greater than non-DIC (P<0.05). Conclusions We are the first group to propose CDSS. It emphasized the values of the clinical manifestations, the rapidly declining platelet count, APTT in the diagnosis of DIC and used D-dimer as the fibrin-related maker. DIC with hematological malignancies was treated as a special part. In this study we can see that CDSS displayed an acceptable property for the diagnosis of DIC with appropriate sensitivity and specificity, and also had a good prognostic value for DIC patients.	[Wang, Manzhi; Kou, Haiming; Deng, Jun; Wang, Huafang; Guo, Tao; Mei, Heng; Hu, Yu] Huazhong Univ Sci & Technol, Inst Hematol, Union Hosp, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Mei, H (corresponding author), Huazhong Univ Sci & Technol, Inst Hematol, Union Hosp, Wuhan 430074, Peoples R China.	mayheng@126.com; dr_huyu@126.com						Bakhtiari K, 2004, CRIT CARE MED, V32, P2416, DOI 10.1097/01.CCM.0000147769.07699.E3; Bates SM, 2012, SEMIN THROMB HEMOST, V38, P673, DOI 10.1055/s-0032-1326782; Cartoni C, 2009, LEUKEMIA LYMPHOMA, V50, P387, DOI 10.1080/10428190802714024; Dremsizov T, 2006, CHEST, V129, P968, DOI 10.1378/chest.129.4.968; Franchini M, 2013, SEMIN THROMB HEMOST, V39, P94, DOI 10.1055/s-0032-1331154; Franchini M, 2010, SEMIN THROMB HEMOST, V36, P388, DOI 10.1055/s-0030-1254048; Gando S, 2005, CLIN APPL THROMB-HEM, V11, P71, DOI 10.1177/107602960501100108; Gando S, 2008, CRIT CARE MED, V36, P145, DOI 10.1097/01.CCM.0000295317.97245.2D; Gando S, 2013, CRIT CARE, V17, DOI 10.1186/cc12783; Hu Y, 2013, J CLIN HEMATOL CHINA, V26, P149; Kobayashi N, 1983, Bibl Haematol, P265; Kwaan HC, 2010, EXPERT REV HEMATOL, V3, P719, DOI [10.1586/ehm.10.71, 10.1586/EHM.10.71]; LEGALL JR, 1986, CRIT CARE MED, V14, P754; Levi M, 2013, INTERN EMERG MED, V8, P23, DOI 10.1007/s11739-012-0859-9; Levi M, 2011, BLOOD REV, V25, P33, DOI 10.1016/j.blre.2010.09.002; Li TongYi, 1987, SHANGDONG MED J, P38; Liu ZeLin, DIAGNOSIS TREATMENT; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Ruan XiaoLan, 2013, J CLIN HEMATOL CHINA, V26, P615; Satoshi G TI, 2006, CRIT CARE MED, V34, P625; Singh RK, 2012, THROMB RES, V129, pE119, DOI 10.1016/j.thromres.2011.11.017; Solano C, 2009, CLIN EXP RHEUMATOL, V27, P914; Takemitsu T, 2011, THROMB HAEMOSTASIS, V105, P40, DOI 10.1160/TH10-05-0293; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Thrombosis and hemostasis study group in hematology branch of the Chinese Medical Association, 2012, CHIN J HEMATOL, V33, P978; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Webert KE, 2006, HAEMATOLOGICA, V91, P1530	27	13	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129170	10.1371/journal.pone.0129170	http://dx.doi.org/10.1371/journal.pone.0129170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076032	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900049
J	Yue, YJ; Guo, TT; Liu, JB; Guo, J; Yuan, C; Feng, RL; Niu, CN; Sun, XP; Yang, BH				Yue, Yaojing; Guo, Tingting; Liu, Jianbin; Guo, Jian; Yuan, Chao; Feng, Ruilin; Niu, Chune; Sun, Xiaoping; Yang, Bohui			Exploring Differentially Expressed Genes and Natural Antisense Transcripts in Sheep (Ovis aries) Skin with Different Wool Fiber Diameters by Digital Gene Expression Profiling	PLOS ONE			English	Article							HAIR FOLLICLE DEVELOPMENT; PROLINE-RICH PROTEINS; DERMAL PAPILLA VOLUME; REGULATES CELL-CYCLE; RNA-SEQ; NONCODING RNA; INDUCED APOPTOSIS; BOVINE DANDER; STEM-CELLS; BIOLOGY	Wool fiber diameter (WFD) is the most important economic trait of wool. However, the genes specifically controlling WFD remain elusive. In this study, the expression profiles of skin from two groups of Gansu Alpine merino sheep with different WFD (a super-fine wool group [FD = 18.0 +/- 0.5 mu m, n = 3] and a fine wool group [FD= 23.0 +/- 0.5 mu m, n = 3]) were analyzed using next-generation sequencing-based digital gene expression profiling. A total of 40 significant differentially expressed genes (DEGs) were detected, including 9 up-regulated genes and 31 down-regulated genes. Further expression profile analysis of natural antisense transcripts (NATs) showed that more than 30% of the genes presented in sheep skin expression profiles had NATs. A total of 7 NATs with significant differential expression were detected, and all were down-regulated. Among of 40 DEGs, 3 DEGs (AQP8, Bos d2, and SPRR) had significant NATs which were all significantly down-regulated in the super-fine wool group. In total of DEGs and NATs were summarized as 3 main GO categories and 38 subcategories. Among the molecular functions, cellular components and biological processes categories, binding, cell part and metabolic process were the most dominant subcategories, respectively. However, no significant enrichment of GO terms was found (corrected P-value >0.05). The pathways that were significantly enriched with significant DEGs and NATs were mainly the lipoic acid metabolism, bile secretion, salivary secretion and ribosome and phenylalanine metabolism pathways (P < 0.05). The results indicated that expression of NATs and gene transcripts were correlated, suggesting a role in gene regulation. The discovery of these DEGs and NATs could facilitate enhanced selection for super-fine wool sheep through gene-assisted selection or targeted gene manipulation in the future.	[Yue, Yaojing; Guo, Tingting; Liu, Jianbin; Guo, Jian; Yuan, Chao; Feng, Ruilin; Niu, Chune; Sun, Xiaoping; Yang, Bohui] Chinese Acad Agr Sci, Lanzhou Inst Husb & Pharmaceut Sci, Lanzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS	Yang, BH (corresponding author), Chinese Acad Agr Sci, Lanzhou Inst Husb & Pharmaceut Sci, Jiangouyan St, Lanzhou, Peoples R China.	lzyangbohui@163.com			Central Level, Scientific Research Institutes for Basic R & D Special Fund Business [1610322015014]; Earmarked Fund for Modern China Wool & Cashmere Technology Research System [nycytx-40-3]; National Natural Science Foundation for Young Scholars of China [31402057]	Central Level, Scientific Research Institutes for Basic R & D Special Fund Business; Earmarked Fund for Modern China Wool & Cashmere Technology Research System; National Natural Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the Central Level, Scientific Research Institutes for Basic R & D Special Fund Business (Grant no. 1610322015014); the Earmarked Fund for Modern China Wool & Cashmere Technology Research System (Grant no. nycytx-40-3); and the National Natural Science Foundation for Young Scholars of China (Grant no. 31402057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson DL, 2004, GENOMICS, V83, P95, DOI 10.1016/S0888-7543(03)00210-6; Adelson DL, 2002, AUST J AGR RES, V53, P1003, DOI 10.1071/AR01200; ALCARAZ MV, 1993, J CUTAN PATHOL, V20, P344, DOI 10.1111/j.1600-0560.1993.tb01273.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Bostjancic E, 2008, ACTA DERMATOVEN ALP, V17, P95; Botchkarev VA, 2003, J EXP ZOOL PART B, V298B, P164, DOI 10.1002/jez.b.00033; Botchkarev VA, 2006, J INVEST DERMATOL, V126, P1719, DOI 10.1038/sj.jid.5700270; Cadau S, 2013, EUR J DERMATOL, V23, P4, DOI 10.1684/ejd.2013.1972; Calamita G, 2007, J ENDOCRINOL, V192, P111, DOI 10.1677/JOE-06-0058; CANDI E, 1995, J BIOL CHEM, V270, P26382, DOI 10.1074/jbc.270.44.26382; Carmichael GG, 2003, NAT BIOTECHNOL, V21, P371, DOI 10.1038/nbt0403-371; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carregaro F, 2013, ARCH DERMATOL RES, V305, P857, DOI 10.1007/s00403-013-1415-9; Carter HB, 1947, COMMONWEALTH AUSTR C, V215; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; CHASE HB, 1953, ANAT REC, V116, P75, DOI 10.1002/ar.1091160107; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Chi W, 2013, DEVELOPMENT, V140, P1676, DOI 10.1242/dev.090662; Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Das E, 2013, BIOCHEM BIOPH RES CO, V437, P217, DOI 10.1016/j.bbrc.2013.06.041; De Bessa SA, 2006, INT J MOL MED, V17, P363; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446; Elliott K, 1999, J INVEST DERMATOL, V113, P873, DOI 10.1046/j.1523-1747.1999.00797.x; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Filipczak PT, 2012, BIOCHEM CELL BIOL, V90, P224, DOI [10.1139/O11-083, 10.1139/o11-083]; Fonseca DJ, 2013, BRIT J DERMATOL, V168, P456, DOI 10.1111/j.1365-2133.2012.11181.x; Galbraith H, 2010, ANIMAL, V4, P1447, DOI 10.1017/S1751731110000741; Galbraith H, 2010, ANIMAL, V4, P1490, DOI 10.1017/S175173111000025X; GIBBS S, 1993, GENOMICS, V16, P630, DOI 10.1006/geno.1993.1240; Glotzer DJ, 2008, DEV BIOL, V315, P459, DOI 10.1016/j.ydbio.2008.01.005; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Haddad F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-21; Hagedorn C, 2007, EUR HEART J, V28, P249; HARDY MARGARET H., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P423; HAUSMAN GJ, 1982, J ANIM SCI, V54, P1286, DOI 10.2527/jas1982.5461286x; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Hoen PAC, 2008, NUCL ACIDS RES, V36; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; Holmes RS, 2010, COMP BIOCHEM PHYS D, V5, P217, DOI 10.1016/j.cbd.2010.05.004; IBRAHIM L, 1982, J EMBRYOL EXP MORPH, V72, P209; IMAN NY, 1992, J ANIM SCI, V70, P1110, DOI 10.2527/1992.7041110x; Ishibashi K, 1997, BIOCHEM BIOPH RES CO, V237, P714, DOI 10.1006/bbrc.1997.7219; IshidaYamamoto A, 1997, J INVEST DERMATOL, V108, P12, DOI 10.1111/1523-1747.ep12285611; Jager M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-158; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; Legue E, 2005, DEVELOPMENT, V132, P4143, DOI 10.1242/dev.01975; Lei MX, 2014, EXP DERMATOL, V23, P407, DOI 10.1111/exd.12416; Lei MX, 2012, HISTOCHEM CELL BIOL, V138, P385, DOI 10.1007/s00418-012-0960-1; Levy-Strumpf N, 1998, ONCOGENE, V17, P3331, DOI 10.1038/sj.onc.1202588; Liu H, 2011, AUSTRALASIAN AGRIBUS, V2011, P19; Ma TH, 1997, BIOCHEM BIOPH RES CO, V240, P324, DOI 10.1006/bbrc.1997.7664; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Mantyjarvi R, 1996, J ALLERGY CLIN IMMUN, V97, P1297, DOI 10.1016/S0091-6749(96)70198-7; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Moore GPM, 1998, J THEOR BIOL, V191, P87, DOI 10.1006/jtbi.1997.0567; MOORE GPM, 1989, GENET RES, V53, P57, DOI 10.1017/S0016672300027865; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Norris BJ, 2005, AUST J EXP AGR, V45, P867, DOI 10.1071/EA05050; Otberg N, 2004, J INVEST DERMATOL, V122, P14, DOI 10.1046/j.0022-202X.2003.22110.x; Pariset L, 2009, NEW BIOTECHNOL, V25, P272, DOI 10.1016/j.nbt.2009.03.013; Plikus MV, 2011, SCIENCE, V332, P586, DOI 10.1126/science.1201647; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Purvis IW, 2007, SMALL RUMINANT RES, V70, P42, DOI 10.1016/j.smallrumres.2007.01.002; Purvis IW, 2005, GENET SEL EVOL, V37, pS97, DOI 10.1051/gse:2004028; Rautiainen J, 1998, J ALLERGY CLIN IMMUN, V101, P349, DOI 10.1016/S0091-6749(98)70247-7; Reiner G, 2000, CYTOGENET CELL GENET, V89, P59, DOI 10.1159/000015565; Rogers GE, 2006, EXP DERMATOL, V15, P931, DOI 10.1111/j.1600-0625.2006.00512.x; Sandilands A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064404; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Scobie DR, 2000, P NZ SOC ANIMAL PROD; Seiberg M, 2001, EXP DERMATOL, V10, P405, DOI 10.1034/j.1600-0625.2001.100603.x; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; Senshu T, 1999, EXP DERMATOL, V8, P392, DOI 10.1111/j.1600-0625.1999.tb00388.x; Shen Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069854; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Smith FJD, 2002, BIOCHEM BIOPH RES CO, V297, P818, DOI 10.1016/S0006-291X(02)02288-X; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Strappazzon F, 2010, BIOCHEM BIOPH RES CO, V397, P64, DOI 10.1016/j.bbrc.2010.05.062; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tiganescu A, 2011, J INVEST DERMATOL, V131, P30, DOI 10.1038/jid.2010.257; Wahlestedt C, 2006, DRUG DISCOV TODAY, V11, P503, DOI 10.1016/j.drudis.2006.04.013; Waluk DP, 2010, FASEB J, V24, P2795, DOI 10.1096/fj.09-148551; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang HC, 2014, BIOCHEM BIOPH RES CO, V446, P1204, DOI 10.1016/j.bbrc.2014.03.086; Wang LQ, 1996, BIOCHEM J, V317, P225, DOI 10.1042/bj3170225; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang XS, 2012, STEM CELLS DEV, V21, P7, DOI 10.1089/scd.2011.0230; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xing K, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-32; YANG K, 1992, ENDOCRINOLOGY, V131, P2120, DOI 10.1210/en.131.5.2120; Yano K, 2001, J CLIN INVEST, V107, P409, DOI 10.1172/JCI11317; Yoshiura K, 2006, NAT GENET, V38, P324, DOI 10.1038/ng1733; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zimmermann N, 2005, AM J RESP CELL MOL, V32, P428, DOI 10.1165/rcmb.2004-0269OC	106	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129249	10.1371/journal.pone.0129249	http://dx.doi.org/10.1371/journal.pone.0129249			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076016	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900058
J	Berents, TL; Carlsen, KCL; Mowinckel, P; Skjerven, HO; Kvenshagen, B; Rolfsjord, LB; Bradley, M; Lieden, A; Carlsen, KH; Gaustad, P; Gjersvik, P				Berents, Teresa Lovold; Carlsen, Karin Cecilie Lodrup; Mowinckel, Petter; Skjerven, Havard Ove; Kvenshagen, Bente; Rolfsjord, Leif Bjarte; Bradley, Maria; Lieden, Agne; Carlsen, Kai-Hakon; Gaustad, Peter; Gjersvik, Petter			Skin Barrier Function and Staphylococcus aureus Colonization in Vestibulum Nasi and Fauces in Healthy Infants and Infants with Eczema: A Population-Based Cohort Study	PLOS ONE			English	Article							TRANSEPIDERMAL WATER-LOSS; ALLERGY CLIN IMMUNOL; ATOPIC-DERMATITIS; LINE VALUES; FILAGGRIN; MUTATIONS; DISEASE; MECHANISMS; GUIDELINES; FEATURES	Atopic eczema (AE) is associated with Staphylococcus aureus (S. aureus) colonization and skin barrier dysfunction, often measured by increased transepidermal water loss (TEWL). In the present study, the primary aim was to see whether Staphylococcus aureus colonization in the vestibulum nasi and/or fauces was associated with increased TEWL in infants with healthy skin and infants with eczema. Secondarily, we aimed to investigate whether TEWL measurements on non-lesional skin on the lateral upper arm is equivalent to volar forearm in infants. In 167 of 240 infants, recruited from the general population, TEWL measurements on the lateral upper arm and volar forearm, using a DermaLab USB, fulfilled our environmental requirements. The mean of three TEWL measurements from each site was used for analysis. The infants were diagnosed with no eczema (n = 110), possible AE (n = 28) or AE (n = 29). DNA samples were analysed for mutations in the filaggrin gene (FLG). Bacterial cultures were reported positive with the identification of at least one culture with Staphylococcus aureus from vestibulum nasi and/or fauces. Staphylococcus aureus colonization, found in 89 infants (53%), was not associated with increased TEWL (i.e. TEWL in the upper quartile), neither on the lateral upper arm or volar forearm (p = 0.08 and p = 0.98, respectively), nor with AE (p = 0.10) or FLG mutation (p = 0.17). TEWL was significantly higher on both measuring sites in infants with AE compared to infants with possible AE and no eczema. FLG mutation was significantly associated with increased TEWL, with a 47% difference in TEWL. We conclude that Staphylococcus aureus in vestibulum nasi and/or fauces was not associated with TEWL, whereas TEWL measurements on the lateral upper arm and volar forearm appear equally appropriate in infants.	[Berents, Teresa Lovold; Carlsen, Karin Cecilie Lodrup; Mowinckel, Petter; Skjerven, Havard Ove; Rolfsjord, Leif Bjarte; Carlsen, Kai-Hakon; Gaustad, Peter; Gjersvik, Petter] Univ Oslo, Inst Clin Med, Oslo, Norway; [Berents, Teresa Lovold; Gjersvik, Petter] Oslo Univ Hosp, Dept Dermatol, N-0450 Oslo, Norway; [Carlsen, Karin Cecilie Lodrup; Mowinckel, Petter; Skjerven, Havard Ove; Carlsen, Kai-Hakon] Oslo Univ Hosp, Dept Pediat, N-0450 Oslo, Norway; [Kvenshagen, Bente] Ostfold Hosp, Dept Pediat, Fredrikstad, Norway; [Rolfsjord, Leif Bjarte] Innlandet Hosp Trust, Dept Pediat, Elverum, Norway; [Bradley, Maria; Lieden, Agne] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med, Stockholm, Sweden; [Bradley, Maria] Karolinska Univ Hosp, Dept Dermatol, Stockholm, Sweden; [Gaustad, Peter] Oslo Univ Hosp, Dept Microbiol, N-0450 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Innlandet Hospital Trust; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Oslo	Berents, TL (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	t.l.berents@medisin.uio.no			Arne Ingels Foundation; Norwegian Asthma and Allergy Association	Arne Ingels Foundation; Norwegian Asthma and Allergy Association	This work was supported by the Arne Ingels Foundation (https://www.unifor.no/Fund.aspx?fund=77) (TLB), and the Norwegian Asthma and Allergy Association (http://www.naaf.no/no/tjenester/Prosjektstotte/Forskningsfondet/) (TLB). The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	AOKI T, 1992, ACTA DERM-VENEREOL, P19; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bath-Hextall FJ, 2010, BRIT J DERMATOL, V163, P12, DOI 10.1111/j.1365-2133.2010.09743.x; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Breuer K, 2002, BRIT J DERMATOL, V147, P55, DOI 10.1046/j.1365-2133.2002.04872.x; Brook I, 1996, INT J DERMATOL, V35, P791, DOI 10.1111/j.1365-4362.1996.tb02975.x; Carson CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048678; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cravello B, 2008, SKIN RES TECHNOL, V14, P180, DOI 10.1111/j.1600-0846.2007.00275.x; Elkeeb R, 2010, SKIN RES TECHNOL, V16, P9, DOI 10.1111/j.1600-0846.2009.00406.x; Flohr C, 2010, BRIT J DERMATOL, V163, P1333, DOI 10.1111/j.1365-2133.2010.10068.x; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Gupta J, 2008, J ALLERGY CLIN IMMUN, V121, P725, DOI 10.1016/j.jaci.2007.12.1161; Halkjaer LB, 2006, ARCH DERMATOL, V142, P561, DOI 10.1001/archderm.142.5.561; Hamilton LC, 1991, REGRESSION WITH GRAP; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Howell MD, 2009, J ALLERGY CLIN IMMUN, V124, pR7, DOI 10.1016/j.jaci.2009.07.012; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Jinnestal CL, 2014, INT J DERMATOL, V53, P27, DOI 10.1111/ijd.12198; Kelleher MM, 2013, PEDIATR DERMATOL, V30, P712, DOI 10.1111/pde.12106; Kleesz P, 2012, SKIN PHARMACOL PHYS, V25, P25, DOI 10.1159/000330721; Kottner J, 2013, ARCH DERMATOL RES, V305, P315, DOI 10.1007/s00403-012-1313-6; Kunz B, 1997, DERMATOLOGY, V195, P10, DOI 10.1159/000245677; Lebon A, 2009, ARCH PEDIAT ADOL MED, V163, P745, DOI 10.1001/archpediatrics.2009.117; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; Miajlovic H, 2010, J ALLERGY CLIN IMMUN, V126, P1184, DOI 10.1016/j.jaci.2010.09.015; Na SY, 2012, ANN DERMATOL, V24, P413, DOI 10.5021/ad.2012.24.4.413; Nilsson P, 2006, J CLIN MICROBIOL, V44, P3334, DOI 10.1128/JCM.00880-06; O'Regan GM, 2009, J ALLERGY CLIN IMMUN, V124, pR2, DOI 10.1016/j.jaci.2009.07.013; Ong PY, 2008, PRIMARY CARE, V35, P105, DOI 10.1016/j.pop.2007.09.006; Ong PY, 2014, PEDIATR RES, V75, P171, DOI 10.1038/pr.2013.196; Ong PY, 2010, IMMUNOL ALLERGY CLIN, V30, P309, DOI 10.1016/j.iac.2010.05.001; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; PINNAGODA J, 1990, CONTACT DERMATITIS, V22, P164, DOI 10.1111/j.1600-0536.1990.tb01553.x; Raone B, 2014, PEDIATR DERMATOL, V31, P191, DOI 10.1111/pde.12274; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Sergeant A, 2009, J INVEST DERMATOL, V129, P1042, DOI 10.1038/jid.2008.324; Shin K, 2011, J DERMATOL SCI, V63, P201, DOI 10.1016/j.jdermsci.2011.05.003; Singh B, 2013, SKIN RES TECHNOL, V19, P207, DOI 10.1111/srt.12043; Skjerven HO, 2013, NEW ENGL J MED, V368, P2286, DOI 10.1056/NEJMoa1301839; Skov L, 2009, BRIT J DERMATOL, V160, P1286, DOI 10.1111/j.1365-2133.2009.09051.x; SOMERVILLE DA, 1969, BRIT J DERMATOL, V81, P248, DOI 10.1111/j.1365-2133.1969.tb13976.x; Steiner M, 2011, SKIN RES TECHNOL, V17, P366, DOI 10.1111/j.1600-0846.2011.00509.x; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; Williams JV, 1999, J EMERG MED, V17, P207, DOI 10.1016/S0736-4679(98)00151-6; Yosipovitch G, 2000, PEDIATRICS, V106, P105, DOI 10.1542/peds.106.1.105	48	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130145	10.1371/journal.pone.0130145	http://dx.doi.org/10.1371/journal.pone.0130145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070153	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000142
J	Ceglie, FG; Bustamante, MA; Ben Amara, M; Tittarelli, F				Ceglie, Francesco Giovanni; Bustamante, Maria Angeles; Ben Amara, Mouna; Tittarelli, Fabio			The Challenge of Peat Substitution in Organic Seedling Production: Optimization of Growing Media Formulation through Mixture Design and Response Surface Analysis	PLOS ONE			English	Article							SOLID-WASTE COMPOST; SUBSTRATE; ROSEMARY; SPAIN; MELON	Peat replacement is an increasing demand in containerized and transplant production, due to the environmental constraints associated to peat use. However, despite the wide information concerning the use of alternative materials as substrates, it is very complex to establish the best materials and mixtures. This work evaluates the use of mixture design and surface response methodology in a peat substitution experiment using two alternative materials (green compost and palm fibre trunk waste) for transplant production of tomato (Lycopersicon esculentum Mill.); melon, (Cucumis melo L.); and lettuce (Lactuca sativa L.) in organic farming conditions. In general, the substrates showed suitable properties for their use in seedling production, showing the best plant response the mixture of 20% green compost, 39% palm fibre and 31% peat. The mixture design and applied response surface methodology has shown to be an useful approach to optimize substrate formulations in peat substitution experiments to standardize plant responses.	[Ceglie, Francesco Giovanni; Ben Amara, Mouna] Ctr Int Hautes Etud Agronom Mediterraneennes, Mediterranean Agron Inst Bari, Dept Organ Agr, Bari, Italy; [Bustamante, Maria Angeles] Miguel Hernandez Univ, Dept Agrochem & Environm, Alicante, Spain; [Tittarelli, Fabio] Consiglio Ric Sperimentaz Agr, Res Ctr Soil Plant Syst, Rome, Italy	CIHEAM; CIHEAM BARI; Universidad Miguel Hernandez de Elche; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Ceglie, FG (corresponding author), Ctr Int Hautes Etud Agronom Mediterraneennes, Mediterranean Agron Inst Bari, Dept Organ Agr, Bari, Italy.	ceglie@iamb.it	Bustamante, Maria Angeles/ABF-3793-2020; Bustamante, Maria Angeles/H-9171-2013; ceglie, francesco giovanni/E-8323-2015	Bustamante, Maria Angeles/0000-0001-9931-1711; Bustamante, Maria Angeles/0000-0001-9931-1711; ceglie, francesco giovanni/0000-0003-0255-0439; Tittarelli, Fabio/0000-0002-5766-4428	Organic Farming Office of the Italian Ministry of Agriculture	Organic Farming Office of the Italian Ministry of Agriculture	The Organic Farming Office of the Italian Ministry of Agriculture has supported the open access fees of this publication.	Abad M, 2001, BIORESOURCE TECHNOL, V77, P197, DOI 10.1016/S0960-8524(00)00152-8; Altland JE, 2009, HORTSCIENCE, V44, P1861, DOI 10.21273/HORTSCI.44.7.1861; Altmann M., 2008, SOCIOECONOMIC IMPACT; Andreu-Rodriguez J, 2013, COMMUN SOIL SCI PLAN, V44, P598, DOI 10.1080/00103624.2013.745363; Boodt M. de, 1972, Acta Horticulturae, P37; Carmona E, 2012, SCI HORTIC-AMSTERDAM, V137, P69, DOI 10.1016/j.scienta.2012.01.023; Ceglie F, 2014, COMPOSTING SUSTAINAB, P1; Ceglie FG, 2011, COMPOST SCI UTIL, V19, P293; Chong C, 2005, HORTTECHNOLOGY, V15, P739, DOI 10.21273/HORTTECH.15.4.0739; Cocozza C, 2011, BIOMASS BIOENERG, V35, P799, DOI 10.1016/j.biombioe.2010.10.033; De Lucia B, 2013, J PLANT NUTR, V36, P863, DOI 10.1080/01904167.2013.770018; DERRINGER G, 1980, J QUAL TECHNOL, V12, P214, DOI 10.1080/00224065.1980.11980968; Evans MR, 2007, HORTTECHNOLOGY, V17, P312, DOI 10.21273/HORTTECH.17.3.312; Herrera F, 2008, BIORESOURCE TECHNOL, V99, P287, DOI 10.1016/j.biortech.2006.12.042; Holmes S, 2009, ACTA HORTIC, V819, P23; Institute for Environmental Protection and Research (ISPRA), 2001, METH COMP AN ANPA HD, V3; Jayasinghe GY, 2010, J HAZARD MATER, V174, P700, DOI 10.1016/j.jhazmat.2009.09.107; Komilis D, 2011, J ENVIRON MANAGE, V92, P2241, DOI 10.1016/j.jenvman.2011.04.012; Kritsotakis IK, 2011, J CROP IMPROV, V25, P664, DOI 10.1080/15427528.2011.600425; Medina E, 2009, BIORESOURCE TECHNOL, V100, P4227, DOI 10.1016/j.biortech.2009.03.055; Mininni C, 2013, J HORTIC SCI BIOTECH, V88, P345, DOI 10.1080/14620316.2013.11512975; Mininni C, 2012, HORTSCIENCE, V47, P1438, DOI 10.21273/HORTSCI.47.10.1438; Moldes A, 2007, BIORESOURCE TECHNOL, V98, P3069, DOI 10.1016/j.biortech.2006.10.021; Moral R, 2013, ACTA HORTIC, V1013, P25, DOI 10.17660/ActaHortic.2013.1013.1; Nardi JV, 2004, J EUR CERAM SOC, V24, P375, DOI 10.1016/S0955-2219(03)00219-X; Noguera P, 2003, COMMUN SOIL SCI PLAN, V34, P593, DOI 10.1081/CSS-120017842; Raviv M, 2011, ACTA HORTIC, V891, P19; Rea E, 2009, ACTA HORTIC, V807, P541; Rinaldi S, 2014, SCI HORTIC-AMSTERDAM, V176, P218, DOI 10.1016/j.scienta.2014.07.011; SCHEFFE H, 1963, J ROY STAT SOC B, V25, P235; Schmilewski G, 2009, ACTA HORTIC, V819, P33; Tittarelli F, 2009, COMPOST SCI UTIL, V17, P220; Vaughn SF, 2011, IND CROP PROD, V33, P514, DOI 10.1016/j.indcrop.2010.10.034; ZUCCONI F, 1981, BIOCYCLE, V22, P27	34	53	54	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128600	10.1371/journal.pone.0128600	http://dx.doi.org/10.1371/journal.pone.0128600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070163	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000021
J	Deiana, M; Matczyszyn, K; Massin, J; Olesiak-Banska, J; Andraud, C; Samoc, M				Deiana, Marco; Matczyszyn, Katarzyna; Massin, Julien; Olesiak-Banska, Joanna; Andraud, Chantal; Samoc, Marek			Interactions of Isophorone Derivatives with DNA: Spectroscopic Studies	PLOS ONE			English	Article							HUMAN HOLO-TRANSFERRIN; HUMAN SERUM-ALBUMIN; PROTEIN INTERACTIONS; BINDING MECHANISM; ETHIDIUM-BROMIDE; FLUORESCENCE; ABSORPTION; COMPLEXES; MODE; TAMOXIFEN	Interactions of three new isophorone derivatives, Isoa Isob and Isoc with salmon testes DNA have been investigated using UV-Vis, fluorescence and circular dichroism spectroscopic methods. All the studied compounds interact with DNA through intercalative binding mode. The stoichiometry of the isophorone/DNA adducts was found to be 1:1. The fluorescence quenching data revealed a binding interaction with the base pairs of DNA. The CD data indicate that all the investigated isophorones induce DNA modifications.	[Deiana, Marco; Matczyszyn, Katarzyna; Olesiak-Banska, Joanna; Samoc, Marek] Wroclaw Univ Technol, Fac Chem, Adv Mat Engn & Modelling Grp, PL-50370 Wroclaw, Poland; [Massin, Julien; Andraud, Chantal] Univ Lyon 1, Ecole Normale Super Lyon, CNRS UMR 5182, Lab Chim, F-69365 Lyon, France	Wroclaw University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Matczyszyn, K (corresponding author), Wroclaw Univ Technol, Fac Chem, Adv Mat Engn & Modelling Grp, Wyb Wyspianskiego 27, PL-50370 Wroclaw, Poland.	katarzyna.matczyszyn@pwr.edu.pl	Deiana, Marco/AHB-4469-2022; Samoc, Marek/AAK-9439-2020; Olesiak-Banska, Joanna/AAZ-6918-2020; Massin, julien/Q-2724-2017	Samoc, Marek/0000-0002-5404-2455; Massin, julien/0000-0002-9484-1286; Olesiak-Banska, Joanna/0000-0002-7226-0077; Matczyszyn, Katarzyna/0000-0001-8578-8340; Deiana, Marco/0000-0002-7815-4494	NCN Opus grant [DEC-2013/09/B/ST5/03417]; Region Rhone-Alpes (cluster5)	NCN Opus grant; Region Rhone-Alpes (cluster5)(Region Auvergne-Rhone-Alpes)	The financing from NCN Opus grant DEC-2013/09/B/ST5/03417 is highly acknowledged. The authors thank the Region Rhone-Alpes (cluster5) for a grant to J.M. and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton JK, 2011, COORDIN CHEM REV, V255, P619, DOI 10.1016/j.ccr.2010.09.002; Biver T, 2012, APPL SPECTROSC REV, V47, P272, DOI 10.1080/05704928.2011.641044; Bourassa P, 2014, J PHARMACEUT BIOMED, V95, P193, DOI 10.1016/j.jpba.2014.02.028; Cai X, 2009, CANC TREAT REV, V35, P347; Delplanque A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117277; Dewey T.G., 1991, BIOPHYSICAL BIOCH AS; Dogra S, 2013, J PHOTOCH PHOTOBIO B, V123, P48, DOI 10.1016/j.jphotobiol.2013.03.015; Dorraji PS, 2013, J BRAZIL CHEM SOC, V24, P939, DOI 10.5935/0103-5053.20130123; Grote JG, 2004, J PHYS CHEM B, V108, P8584, DOI 10.1021/jp038056d; Han L, 2014, ACTA A, V123, P487; Han LN, 2014, SPECTROCHIM ACTA A, V123, P497, DOI 10.1016/j.saa.2013.11.088; Kabiri M, 2012, MOLECULES, V17, P3114, DOI 10.3390/molecules17033114; Kashida H, 2006, CHEM-EUR J, V12, P777, DOI 10.1002/chem.200500111; Khalaf AI, 2009, CURR TRENDS MED CHEM, V6, P53; KLOTZ IM, 1971, BIOCHEMISTRY-US, V10, P3065, DOI 10.1021/bi00792a013; LERMAN LS, 1961, J MOL BIOL, V3, P18, DOI 10.1016/S0022-2836(61)80004-1; Lincoln P, 1997, J AM CHEM SOC, V119, P1454, DOI 10.1021/ja9631965; Lorusso D, 2009, EXPERT OPIN INV DRUG, V10, P1703; Mansouri M, 2013, MOLECULES, V18, P789, DOI 10.3390/molecules18010789; Marshall MM, 2015, LANGMUIR, V31, P4582, DOI 10.1021/acs.langmuir.5b00457; Massin J, 2013, OPT MATER, V35, P1810, DOI 10.1016/j.optmat.2013.04.021; Massin J, 2011, CHEM MATER, V23, P862, DOI 10.1021/cm102165r; Matczyszyn K, 2012, J NANOPHOTONICS, V6, DOI 10.1117/1.JNP.6.064505; Nafisi S, 2007, J MOL STRUCT, V827, P35, DOI 10.1016/j.molstruc.2006.05.004; Nakamoto Kazuo, 2008, Methods Biochem Anal, V51, P1; Olesiak-Banska J, 2013, J PHYS CHEM B, V117, P12013, DOI 10.1021/jp407144k; Olesiak-Banska J, 2012, CHEM PHYS, V404, P33, DOI 10.1016/j.chemphys.2012.02.001; Ouameur AA, 2005, BIOPOLYMERS, V77, P129, DOI 10.1002/bip.20173; Purcell M, 1999, J BIOMOL STRUCT DYN, V17, P473, DOI 10.1080/07391102.1999.10508378; Rafique B, 2013, BIOSENS BIOELECTRON, V44, P21, DOI 10.1016/j.bios.2012.12.028; Sahoo BK, 2008, CHEM PHYS, V351, P163, DOI 10.1016/j.chemphys.2008.05.008; Samoc M, 2014, MRS P, P1698; Sarzehi S, 2010, INT J BIOL MACROMOL, V47, P558, DOI 10.1016/j.ijbiomac.2010.08.002; Sattar Z, 2012, SPECTROCHIM ACTA A, V97, P1089, DOI 10.1016/j.saa.2012.07.034; Shakir M, 2009, SPECTROCHIM ACTA A, V71, P1851, DOI 10.1016/j.saa.2008.07.002; Sirajuddin M, 2013, J PHOTOCH PHOTOBIO B, V124, P1, DOI 10.1016/j.jphotobiol.2013.03.013; Steckl AJ, 2007, NAT PHOTONICS, V1, P3, DOI 10.1038/nphoton.2006.56; Stephanos JJ, 1996, J INORG BIOCHEM, V62, P155, DOI 10.1016/0162-0134(95)00144-1; Wang XZ, 2014, SPECTROCHIM ACTA A, V118, P448, DOI 10.1016/j.saa.2013.09.028; WARE WR, 1962, J PHYS CHEM-US, V66, P455, DOI 10.1021/j100809a020; Zhang GW, 2013, SENSOR ACTUAT B-CHEM, V182, P453, DOI 10.1016/j.snb.2013.03.038; Zhong WY, 2004, J PHARM SCI-US, V93, P1039, DOI 10.1002/jps.20005; Zhou XY, 2014, INT J BIOL MACROMOL, V67, P228, DOI 10.1016/j.ijbiomac.2014.03.038	43	28	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129817	10.1371/journal.pone.0129817	http://dx.doi.org/10.1371/journal.pone.0129817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069963	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000111
J	Di Grazia, A; Cappiello, F; Imanishi, A; Mastrofrancesco, A; Picardo, M; Paus, R; Mangoni, ML				Di Grazia, Antonio; Cappiello, Floriana; Imanishi, Akiko; Mastrofrancesco, Arianna; Picardo, Mauro; Paus, Ralf; Mangoni, Maria Luisa			The Frog Skin-Derived Antimicrobial Peptide Esculentin-1a(1-21)NH2 Promotes the Migration of Human HaCaT Keratinocytes in an EGF Receptor-Dependent Manner: A Novel Promoter of Human Skin Wound Healing?	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; IN-VITRO ACTIVITY; RANA-ESCULENTA; SIGNAL-TRANSDUCTION; EFFECTOR MOLECULES; EPIDERMAL LAYERS; INNATE IMMUNITY; AMPHIBIAN SKIN; LEOPARD FROGS; LL-37	One of the many functions of skin is to protect the organism against a wide range of pathogens. Antimicrobial peptides (AMPs) produced by the skin epithelium provide an effective chemical shield against microbial pathogens. However, whereas antibacterial/antifungal activities of AMPs have been extensively characterized, much less is known regarding their wound healing-modulatory properties. By using an in vitro re-epithelialisation assay employing special cell-culture inserts, we detected that a derivative of the frog-skin AMP esculentin-1a, named esculentin-1a(1-21)NH2, significantly stimulates migration of immortalized human keratinocytes (HaCaT cells) over a wide range of peptide concentrations (0.025-4 mu M), and this notably more efficiently than human cathelicidin (LL-37). This activity is preserved in primary human epidermal keratinocytes. By using appropriate inhibitors and an enzyme-linked immunosorbent assay we found that the peptide-induced cell migration involves activation of the epidermal growth factor receptor and STAT3 protein. These results suggest that esculentin-1a(1-21)NH2 now deserves to be tested in standard wound healing assays as a novel candidate promoter of skin re-epithelialisation. The established ability of esculentin-1a(1-21)NH2 to kill microbes without harming mammalian cells, namely its high anti-Pseudomonal activity, makes this AMP a particularly attractive candidate wound healing promoter, especially in the management of chronic, often Pseudomonas-infected, skin ulcers.	[Di Grazia, Antonio; Cappiello, Floriana; Mangoni, Maria Luisa] Univ Roma La Sapienza, Fdn Cenci Bolognetti, Ist Pasteur, Dept Biochem Sci, I-00185 Rome, Italy; [Imanishi, Akiko; Paus, Ralf] Univ Manchester, Ctr Dermatol Res, Inst Inflammat & Repair, Manchester, Lancs, England; [Mastrofrancesco, Arianna; Picardo, Mauro] San Gallicano Dermatol Inst, Lab Cutaneous Physiopathol, Rome, Italy; [Mastrofrancesco, Arianna; Picardo, Mauro] San Gallicano Dermatol Inst, Integrated Ctr Metabol Res, Rome, Italy; [Paus, Ralf] Univ Munster, Dept Dermatol, D-48149 Munster, Germany	Fondazione Cenci Bolognetti; Sapienza University Rome; University of Manchester; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); University of Munster	Mangoni, ML (corresponding author), Univ Roma La Sapienza, Fdn Cenci Bolognetti, Ist Pasteur, Dept Biochem Sci, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	marialuisa.mangoni@uniroma1.it	Mastrofrancesco, Arianna/K-2433-2018; Paus, Ralf/B-5279-2015	Mastrofrancesco, Arianna/0000-0003-1231-3832; Paus, Ralf/0000-0002-3492-9358	Sapienza Universita di Roma Project [C26A12NPXZ]	Sapienza Universita di Roma Project	This study was supported by Sapienza Universita di Roma Project C26A12NPXZ (2012) (to M.L.M.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KM, 2008, J INVEST DERMATOL, V128, P917, DOI 10.1038/sj.jid.5701099; Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Andl CD, 2004, AM J PHYSIOL-GASTR L, V287, pG1227, DOI 10.1152/ajpgi.00253.2004; Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Bals R, 1998, INFECT IMMUN, V66, P1225, DOI 10.1128/IAI.66.3.1225-1232.1998; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; BODEY GP, 1983, REV INFECT DIS, V5, P279; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Bowers G, 2001, ONCOGENE, V20, P1388, DOI 10.1038/sj.onc.1204255; Braff MH, 2005, J INVEST DERMATOL, V124, P394, DOI 10.1111/j.0022-202X.2004.23443.x; Braff MH, 2005, INFECT IMMUN, V73, P6771, DOI 10.1128/IAI.73.10.6771-6781.2005; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Conlon JM, 2014, PEPTIDES, V57, P67, DOI 10.1016/j.peptides.2014.04.019; Conlon JM, 2009, BBA-BIOMEMBRANES, V1788, P1556, DOI 10.1016/j.bbamem.2008.09.018; Conlon JM, 2009, ANN NY ACAD SCI, V1163, P75, DOI 10.1111/j.1749-6632.2008.03618.x; De Potter IY, 2001, EXP CELL RES, V271, P315, DOI 10.1006/excr.2001.5390; Demidova-Rice TN, 2012, ADV SKIN WOUND CARE, V25, P304, DOI 10.1097/01.ASW.0000416006.55218.d0; Di Grazia A, 2014, ANTIMICROB AGENTS CH, V58, P2520, DOI 10.1128/AAC.02801-13; Di Nardo A, 2003, J IMMUNOL, V170, P2274, DOI 10.4049/jimmunol.170.5.2274; Do N, 2014, EXP DERMATOL, V23, P326, DOI 10.1111/exd.12384; Islas-Rodriguez AE, 2009, J PEPT SCI, V15, P607, DOI 10.1002/psc.1148; Erspamer V, 1994, AMPHIBIAN BIOL, V1, P395; Feingold KR, 2012, J INVEST DERMATOL, V132, P1951, DOI 10.1038/jid.2012.177; Firat YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093941; Gallo RL, 2013, EXP DERMATOL, V22, P517, DOI 10.1111/exd.12197; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Garcia JRC, 2001, FASEB J, V15, P1819, DOI 10.1096/fj.00-0865fje; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Glaser R, 2014, J INVEST DERMATOL, V134, P2347, DOI 10.1038/jid.2014.176; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Grieco P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061614; Groner ML, 2014, J EXP BIOL, V217, P351, DOI 10.1242/jeb.091611; Gudmundsson GH, 1999, J IMMUNOL METHODS, V232, P45, DOI 10.1016/S0022-1759(99)00152-0; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Haney EF, 2013, BIOPOLYMERS, V100, P572, DOI 10.1002/bip.22250; Harder Juergen, 2005, V86, P22, DOI 10.1159/000086650; Haslam IS, 2014, BIOL REV, V89, P618, DOI 10.1111/brv.12072; He YY, 2008, CANCER RES, V68, P3752, DOI 10.1158/0008-5472.CAN-07-6138; Hoq MI, 2011, J DERMATOL SCI, V64, P108, DOI 10.1016/j.jdermsci.2011.08.001; Huang LC, 2007, CURR EYE RES, V32, P595, DOI 10.1080/02713680701446653; Hulkower Keren I, 2011, Pharmaceutics, V3, P107, DOI 10.3390/pharmaceutics3010107; Ishikawa T, 2009, J DERMATOL SCI, V56, P121, DOI 10.1016/j.jdermsci.2009.07.012; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kolar SSN, 2015, CELL MOL LIFE SCI, V72, P617, DOI 10.1007/s00018-014-1694-0; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Liu H, 2014, INT J BIOCHEM CELL B, V49, P32, DOI 10.1016/j.biocel.2014.01.010; Luca V, 2013, CELL MOL LIFE SCI, V70, P2773, DOI 10.1007/s00018-013-1291-7; Mangoni ML, 2006, CELL MOL LIFE SCI, V63, P1060, DOI 10.1007/s00018-005-5536-y; Mangoni ML, 2011, CELL MOL LIFE SCI, V68, P2157, DOI 10.1007/s00018-011-0709-3; Mangoni ML, 2009, BBA-BIOMEMBRANES, V1788, P1610, DOI 10.1016/j.bbamem.2009.04.021; Mangoni ML, 2003, PEPTIDES, V24, P1771, DOI 10.1016/j.peptides.2003.07.029; Mangoni ML, 2001, FASEB J, V15, P1431, DOI 10.1096/fj.00-0695fje; Mansour SC, 2014, TRENDS IMMUNOL, V35, P443, DOI 10.1016/j.it.2014.07.004; Marques MM, 1999, EXP CELL RES, V252, P432, DOI 10.1006/excr.1999.4634; Mastrofrancesco A, 2010, EXP DERMATOL, V19, P813, DOI 10.1111/j.1600-0625.2010.01107.x; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McDermott AM, 2006, BRIT J OPHTHALMOL, V90, P609, DOI 10.1136/bjo.2005.083428; Meier NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073596; Morizane S, 2012, J DERMATOL, V39, P225, DOI 10.1111/j.1346-8138.2011.01483.x; OSHEROV N, 1994, EUR J BIOCHEM, V225, P1047, DOI 10.1111/j.1432-1033.1994.1047b.x; Oudhoff MJ, 2008, FASEB J, V22, P3805, DOI 10.1096/fj.08-112003; Pask JD, 2013, J EXP BIOL, V216, P2908, DOI 10.1242/jeb.084145; Percival SL, 2012, WOUND REPAIR REGEN, V20, P647, DOI 10.1111/j.1524-475X.2012.00836.x; Percoco G, 2013, EXP DERMATOL, V22, P800, DOI 10.1111/exd.12259; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Ramos R, 2011, PEPTIDES, V32, P1469, DOI 10.1016/j.peptides.2011.06.005; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Rollins-Smith LA, 2005, INTEGR COMP BIOL, V45, P137, DOI 10.1093/icb/45.1.137; Salzer S, 2014, J DERMATOL SCI, V76, P173, DOI 10.1016/j.jdermsci.2014.09.002; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Schafer C, 2010, CELL ADHES MIGR, V4, P215, DOI 10.4161/cam.4.2.10745; Schroder JM, 2010, CURR OPIN INFECT DIS, V23, P106, DOI 10.1097/QCO.0b013e328335b004; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Semple F, 2012, J INNATE IMMUN, V4, P337, DOI 10.1159/000336619; Simanski M, 2014, EXP DERMATOL, V23, P230, DOI 10.1111/exd.12365; Simmaco M, 1998, SCAND J IMMUNOL, V48, P357; SIMMACO M, 1994, J BIOL CHEM, V269, P11956; Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#; Spohn D, 2013, MOL PHARMACOL, V78, P865; Steinstraesser L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039373; Steinstraesser L, 2009, INT J MOL SCI, V10, P3951, DOI 10.3390/ijms10093951; Stoll SW, 2012, J INVEST DERMATOL, V132, P2148, DOI 10.1038/jid.2012.78; Taboubi S, 2007, FASEB J, V21, P4047, DOI 10.1096/fj.06-7476com; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Tokumaru S, 2005, J IMMUNOL, V175, P4662, DOI 10.4049/jimmunol.175.7.4662; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; Uccelletti D, 2010, ANTIMICROB AGENTS CH, V54, P3853, DOI 10.1128/AAC.00154-10; Walter MNM, 2010, EXP CELL RES, V316, P1271, DOI 10.1016/j.yexcr.2010.02.026; Wang G, 2010, ADV M C M, P1, DOI 10.1079/9781845936570.0000; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wittersheim M, 2013, EXP DERMATOL, V22, P364, DOI 10.1111/exd.12133; Wolcott R D, 2008, J Wound Care, V17, P513; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Yin J, 2010, INVEST OPHTH VIS SCI, V51, P1891, DOI 10.1167/iovs.09-3904; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	100	57	58	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128663	10.1371/journal.pone.0128663	http://dx.doi.org/10.1371/journal.pone.0128663			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068861	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000022
J	Pereira, AJ; Correa, TD; de Almeida, FP; Deliberato, RO; Lobato, MD; Akamine, N; Silva, E; Cavalcanti, AB				Pereira, Adriano Jose; Correa, Thiago Domingos; de Almeida, Francisca Pereira; Deliberato, Rodrigo Octavio; Lobato, Michelle dos Santos; Akamine, Nelson; Silva, Eliezer; Cavalcanti, Alexandre Biasi			Inaccuracy of Venous Point-of-Care Glucose Measurements in Critically Ill Patients: A Cross-Sectional Study	PLOS ONE			English	Article							BLOOD-GLUCOSE; BEDSIDE GLUCOMETRY; GLYCEMIC CONTROL; ACCURACY; METERS; CAPILLARY; ARTERIAL; RECOMMENDATIONS; HEMATOCRIT; GUIDELINES	Introduction Current guidelines and consensus recommend arterial and venous samples as equally acceptable for blood glucose assessment in point-of-care devices, but there is limited evidence to support this recommendation. We evaluated the accuracy of two devices for bedside point-of-care blood glucose measurements using arterial, fingerstick and catheter venous blood samples in ICU patients, and assessed which factors could impair their accuracy. Methods 145 patients from a 41-bed adult mixed-ICU, in a tertiary care hospital were prospectively enrolled. Fingerstick, central venous (catheter) and arterial blood (indwelling catheter) samples were simultaneously collected, once per patient. Arterial measurements obtained with Precision PCx, and arterial, fingerstick and venous measurements obtained with Accu-chek Advantage II were compared to arterial central lab measurements. Agreement between point-of-care and laboratory measurements were evaluated with Bland-Altman, and multiple linear regression models were used to investigate interference of associated factors. Results Mean difference between Accu-chek arterial samples versus central lab was 10.7 mg/dL (95% LA -21.3 to 42.7 mg/dL), and between Precision PCx versus central lab was 18.6 mg/dL (95% LA -12.6 to 49.5 mg/dL). Accu-chek fingerstick versus central lab arterial samples presented a similar bias (10.0 mg/dL) but a wider 95% LA (-31.8 to 51.8 mg/dL). Agreement between venous samples with arterial central lab was the poorest (mean bias 15.1 mg/dL; 95% LA -51.7 to 81.9). Hyperglycemia, low hematocrit, and acidosis were associated with larger differences between arterial and venous blood measurements with the two glucometers and central lab. Vasopressor administration was associated with increased error for fingerstick measurements. Conclusions Sampling from central venous catheters should not be used for glycemic control in ICU patients. In addition, reliability of the two evaluated glucometers was insufficient. Error with Accu-chek Advantage II increases mostly with central venous samples. Hyperglycemia, lower hematocrit, acidosis, and vasopressor administration increase measurement error.	[Pereira, Adriano Jose; Correa, Thiago Domingos; de Almeida, Francisca Pereira; Deliberato, Rodrigo Octavio; Lobato, Michelle dos Santos; Akamine, Nelson; Silva, Eliezer] Hosp Israelita Albert Einstein, Intens Care Unit, Sao Paulo, SP, Brazil; [Pereira, Adriano Jose] Univ Fed Lavras UFLA, Sch Med, Lavras, MG, Brazil; [Cavalcanti, Alexandre Biasi] Hosp Coracao, Res Inst HCor, Sao Paulo, SP, Brazil	Hospital Israelita Albert Einstein; Universidade Federal de Lavras; Hospital do Coracao - HCor	Pereira, AJ (corresponding author), Hosp Israelita Albert Einstein, Intens Care Unit, Sao Paulo, SP, Brazil.	adrianojop@einstein.br	Pereira, Adriano/F-9342-2014; Cavalcanti, Alexandre/K-5529-2013	Pereira, Adriano/0000-0002-3528-3800; Domingos Correa, Thiago/0000-0001-9546-3910; Cavalcanti, Alexandre/0000-0003-2798-6263	Instituto de Ensino e Pesquisa (IIEP) - Hospital Israelita Albert Einstein [80-05]	Instituto de Ensino e Pesquisa (IIEP) - Hospital Israelita Albert Einstein	This work was funded by "Instituto de Ensino e Pesquisa (IIEP) - Hospital Israelita Albert Einstein" (grant number: 80-05; responsible for the grant: AJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, ARROW MULTILUMEN CEN; [Anonymous], 1997, TEST METH VITROS CHE; ATKIN SH, 1991, ANN INTERN MED, V114, P1020, DOI 10.7326/0003-4819-114-12-1020; Balion Cynthia, 2006, BMC Pediatr, V6, P28, DOI 10.1186/1471-2431-6-28; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boyd R, 2005, EMERG MED J, V22, P177, DOI 10.1136/emj.2003.011619; BURNETT RW, 1995, EUR J CLIN CHEM CLIN, V33, P247; Critchell CD, 2007, INTENS CARE MED, V33, P2079, DOI 10.1007/s00134-007-0835-4; Desachy A, 2008, MAYO CLIN PROC, V83, P400, DOI 10.4065/83.4.400; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finfer S, 2013, CRIT CARE, V17, DOI 10.1186/cc12537; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Finkielman JDW, 2005, CHEST, V127, P1749, DOI 10.1378/chest.127.5.1749; Hoedemaekers CWE, 2008, CRIT CARE MED, V36, P3062, DOI 10.1097/CCM.0b013e318186ffe6; Inoue S, 2013, CRIT CARE, V17, DOI 10.1186/cc12567; Jacobi J, 2012, CRIT CARE MED, V40, P3251, DOI 10.1097/CCM.0b013e3182653269; Kanji S, 2005, CRIT CARE MED, V33, P2778, DOI 10.1097/01.CCM.0000189939.10881.60; Karon BS, 2007, AM J CLIN PATHOL, V127, P919, DOI 10.1309/6RFQCKAAJGKWB8M4; Karon BS, 2009, DIABETES TECHNOL THE, V11, P819, DOI 10.1089/dia.2009.0074; Katz MH, 2003, ANN INTERN MED, V138, P644, DOI 10.7326/0003-4819-138-8-200304150-00012; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krinsley JS, 2013, CRIT CARE, V17, DOI 10.1186/cc12547; Lacara T, 2007, AM J CRIT CARE, V16, P336; Meex C, 2006, CLIN CHEM LAB MED, V44, P1376, DOI 10.1515/CCLM.2006.249; Meynaar IA, 2009, CRIT CARE MED; Petersen JR, 2008, CLIN CHIM ACTA, V396, P10, DOI 10.1016/j.cca.2008.06.010; Ray JG, 2001, CRIT CARE MED, V29, P2205, DOI 10.1097/00003246-200111000-00025; Rickard CM, 2003, CRIT CARE MED, V31, P1654, DOI 10.1097/01.CCM.0000063448.98777.EF; Sacks DB, 2011, CLIN CHEM, V57, pE1, DOI 10.1373/clinchem.2010.161596; Sacks DB, 2002, CLIN CHEM, V48, P436; Scott MG, 2009, CLIN CHEM, V55, P18, DOI 10.1373/clinchem.2008.117291; STRIJDOM JG, 1993, S AFR MED J, V83, P64; Tang Z, 2000, Diabetes Technol Ther, V2, P349, DOI 10.1089/15209150050194215; Tang ZP, 2000, ARCH PATHOL LAB MED, V124, P1135; Tang ZP, 2000, AM J CLIN PATHOL, V113, P75, DOI 10.1309/QAW1-X5XW-BVRQ-5LKQ; Trajanoski Z, 1996, DIABETES CARE, V19, P1412, DOI 10.2337/diacare.19.12.1412; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Watkinson PJ, 2012, ANN CLIN BIOCHEM, V49, P144, DOI 10.1258/acb.2011.011162	39	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129568	10.1371/journal.pone.0129568	http://dx.doi.org/10.1371/journal.pone.0129568			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067093	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000091
J	Roy, S; Banerjee, A; Mawkhlieng, B; Misra, AK; Pattanayak, A; Harish, GD; Singh, SK; Ngachan, SV; Bansal, KC				Roy, Somnath; Banerjee, Amrita; Mawkhlieng, Bandapkuper; Misra, A. K.; Pattanayak, A.; Harish, G. D.; Singh, S. K.; Ngachan, S. V.; Bansal, K. C.			Genetic Diversity and Population Structure in Aromatic and Quality Rice (Oryza sativa L.) Landraces from North-Eastern India	PLOS ONE			English	Article							CONSERVATION; COLLECTION; SOFTWARE; CLASSIFICATION; VARIETIES; INFERENCE; BASMATI; ASSAM; TOOL	The North-eastern (NE) India, comprising of Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Sikkim and Tripura, possess diverse array of locally adapted non-Basmati aromatic germplasm. The germplasm collections from this region could serve as valuable resources in breeding for abiotic stress tolerance, grain yield and cooking/eating quality. To utilize such collections, however, breeders need information about the extent and distribution of genetic diversity present within collections. In this study, we report the result of population genetic analysis of 107 aromatic and quality rice accessions collected from different parts of NE India, as well as classified these accessions in the context of a set of structured global rice cultivars. A total of 322 alleles were amplified by 40 simple sequence repeat (SSR) markers with an average of 8.03 alleles per locus. Average gene diversity was 0.67. Population structure analysis revealed that NE Indian aromatic rice can be subdivided into three genetically distinct population clusters: P1, joha rice accessions from Assam, tai rices from Mizoram and those from Sikkim; P2, chakhao rice germplasm from Manipur; and P3, aromatic rice accessions from Nagaland. Pair-wise F-ST between three groups varied from 0.223 (P1 vs P2) to 0.453 (P2 vs P3). With reference to the global classification of rice cultivars, two major groups (Indica and Japonica) were identified in NE Indian germplasm. The aromatic accessions from Assam, Manipur and Sikkim were assigned to the Indica group, while the accessions from Nagaland exhibited close association with Japonica. The tai accessions of Mizoram along with few chakhao accessions collected from the hill districts of Manipur were identified as admixed. The results highlight the importance of regional genetic studies for understanding diversification of aromatic rice in India. The data also suggest that there is scope for exploiting the genetic diversity of aromatic and quality rice germplasm of NE India for rice improvement.	[Roy, Somnath; Mawkhlieng, Bandapkuper; Misra, A. K.; Harish, G. D.; Singh, S. K.] ICAR Natl Bur Plant Genet Resources, Reg Stn, Umiam, Meghalaya, India; [Banerjee, Amrita; Pattanayak, A.; Ngachan, S. V.] ICAR Res Complex North Eastern Hill Reg, Umiam, Meghalaya, India; [Bansal, K. C.] ICAR Natl Bur Plant Genet Resources, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - ICAR Research Complex for NEH Region; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources	Roy, S (corresponding author), ICAR Natl Bur Plant Genet Resources, Reg Stn, Umiam, Meghalaya, India.	sroypbr@gmail.com		Roy, Somnath/0000-0001-6590-9758; MAWKHLIENG, BANDAPKUPAR/0000-0003-2999-1584	ICAR-NBPGR	ICAR-NBPGR	This work is carried out under institutional project of ICAR-National Bureau of Plant Genetic Resources (ICAR-NBPGR). The fund utilized from the budget for the North-eastern hill region of ICAR-NBPGR.	Aggarwal RK, 2002, THEOR APPL GENET, V105, P680, DOI 10.1007/s00122-002-0973-6; Bhuyan N, 2007, CURR SCI INDIA, V93, P967; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Choudhury B, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-228; Choudhury DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113094; Das A., 2010, Agricultural Reviews, V31, P1; Das B, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-71; Borba TCD, 2009, GENETICA, V137, P293, DOI 10.1007/s10709-009-9380-0; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; GLASZMANN JC, 1987, THEOR APPL GENET, V74, P21, DOI 10.1007/BF00290078; Hore DK, 2005, GENET RESOUR CROP EV, V52, P1129, DOI 10.1007/s10722-004-6084-2; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Jain S, 2004, THEOR APPL GENET, V109, P965, DOI 10.1007/s00122-004-1700-2; Khush G. S., 2000, P5; Kovach MJ, 2009, P NATL ACAD SCI USA, V106, P14444, DOI 10.1073/pnas.0904077106; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagaraju J, 2002, P NATL ACAD SCI USA, V99, P5836, DOI 10.1073/pnas.042099099; Ni J, 2002, CROP SCI, V42, P601, DOI 10.2135/cropsci2002.0601; Pavel AB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-9; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Ren XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088091; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Roy S, 2014, PLANT GENET RESOUR-C, V12, P264, DOI 10.1017/S1479262113000580; Roy S, 2014, PLANT GENET RESOUR-C, V12, P58, DOI 10.1017/S1479262113000282; Sang T, 2007, CURR OPIN GENET DEV, V17, P533, DOI 10.1016/j.gde.2007.09.005; Sarma R. N., 2005, Plant Genetic Resources Newsletter, P34; Singh R. K., 2000, P155; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Thomson MJ, 2007, THEOR APPL GENET, V114, P559, DOI 10.1007/s00122-006-0457-1; VAIRAVAN S, 1973, THEOR APPL GENET, V43, P213, DOI 10.1007/BF00309136; Wang CH, 2014, HEREDITY, V112, P489, DOI 10.1038/hdy.2013.130; Xu YB, 2004, CROP SCI, V44, P1947, DOI 10.2135/cropsci2004.1947; ZHANG QF, 1992, THEOR APPL GENET, V83, P495, DOI 10.1007/BF00226539; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780	41	43	46	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129607	10.1371/journal.pone.0129607	http://dx.doi.org/10.1371/journal.pone.0129607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067999	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000094
J	Sasaki, R; Yamasaki, K; Abiru, S; Komori, A; Nagaoka, S; Saeki, A; Hashimoto, S; Bekki, S; Kugiyama, Y; Kuno, A; Korenaga, M; Togayachi, A; Ocho, M; Mizokami, M; Narimatsu, H; Ichikawa, T; Nakao, K; Yatsuhashi, H				Sasaki, Ryu; Yamasaki, Kazumi; Abiru, Seigo; Komori, Atsumasa; Nagaoka, Shinya; Saeki, Akira; Hashimoto, Satoru; Bekki, Shigemune; Kugiyama, Yuki; Kuno, Atsushi; Korenaga, Masaaki; Togayachi, Akira; Ocho, Makoto; Mizokami, Masashi; Narimatsu, Hisashi; Ichikawa, Tatsuki; Nakao, Kazuhiko; Yatsuhashi, Hiroshi			Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response	PLOS ONE			English	Article							TERM-FOLLOW-UP; ALPHA-FETOPROTEIN LEVELS; GENOTYPE 1 INFECTION; INTERFERON THERAPY; VIRUS-INFECTION; RISK-FACTORS; PEGYLATED INTERFERON-ALPHA-2B; LIVER FIBROSIS; STELLATE CELLS; CLASSIFICATION	Measurement of Wisteria floribundaagglutinin-positive human Mac-2 binding protein (WFA(+)-M2BP) in serum was recently shown to be a noninvasive method to assess liver fibrosis. The aim of this study was to evaluate the utility of serum WFA+-M2BP values to predict the development of hepatocellular carcinoma (HCC) in patients who achieved a sustained virological response (SVR) by interferon treatment. For this purpose, we retrospectively analyzed 238 patients with SVR who were treated with interferon in our department. Serum WFA+-M2BP values were measured at pre-treatment (pre-Tx), post-treatment (24 weeks after completion of interferon; post-Tx), the time of HCC diagnosis, and the last clinical visit. Of 238 patients with SVR, HCC developed in 16 (6.8%) patients. The average follow-up period was 9.1 years. The cumulative incidence of HCC was 3.4% at 5 years and 7.5% at 10 years. The median pre-Tx and post-Tx WFA+-M2BP values were 1.69 (range: 0.28 to 12.04 cutoff index (COI)) and 0.80 (range: 0.17 to 5.29 COI), respectively. The WFA+-M2BP values decreased significantly after SVR (P < 0.001). The median post-Tx WFA+-M2BP value in patients who developed HCC was significantly higher than that in patients who did not (P < 0.01). Multivariate analysis disclosed that age (> 60 years), sex (male), pre-Tx platelet count (< 15.0x103/mu L), and post-Tx WFA+-M2BP (> 2.0 COI) were associated with the development of HCC after SVR.	[Sasaki, Ryu; Yamasaki, Kazumi; Abiru, Seigo; Komori, Atsumasa; Nagaoka, Shinya; Saeki, Akira; Hashimoto, Satoru; Bekki, Shigemune; Kugiyama, Yuki; Yatsuhashi, Hiroshi] Natl Hosp Org, Nagasaki Med Ctr, Clin Res Ctr, Omura, Japan; [Kuno, Atsushi; Togayachi, Akira; Ocho, Makoto; Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki, Japan; [Korenaga, Masaaki; Mizokami, Masashi] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Japan; [Ichikawa, Tatsuki; Nakao, Kazuhiko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Hepatol, Nagasaki 852, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Center for Global Health & Medicine - Japan; Nagasaki University	Yatsuhashi, H (corresponding author), Natl Hosp Org, Nagasaki Med Ctr, Clin Res Ctr, Omura, Japan.	yatsuhashi@nagasaki-mc.com	Togayachi, Akira/M-4144-2018; Kuno, Atsushi/M-2151-2018; Narimatsu, Hisashi/M-4757-2018; Korenaga, Masaaki/AAE-7479-2020	Togayachi, Akira/0000-0003-3600-9149; Kuno, Atsushi/0000-0002-6147-6171; Narimatsu, Hisashi/0000-0002-8402-133X; 	Ministry of Health, Labour and Welfare of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by Health and Labour Sciences Research Grants for Research on Hepatitis from the Ministry of Health, Labour and Welfare of Japan.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Artini M, 1996, J HEPATOL, V25, P212, DOI 10.1016/S0168-8278(96)80076-6; Asahina Y, 2013, HEPATOLOGY, V58, P1253, DOI 10.1002/hep.26442; Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Cheung KJ, 2009, J VIRAL HEPATITIS, V16, P418, DOI 10.1111/j.1365-2893.2009.01083.x; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Di Bisceglie AM, 2005, J HEPATOL, V43, P434, DOI 10.1016/j.jhep.2005.03.019; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hasegawa E, 2007, HEPATOL RES, V37, P793, DOI 10.1111/j.1872-034X.2007.00140.x; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hu JX, 2013, EXP THER MED, V5, P181, DOI 10.3892/etm.2012.768; Ikeda M, 2005, J GASTROENTEROL, V40, P148, DOI 10.1007/s00535-004-1519-2; Iwasaki Y, 2004, LIVER INT, V24, P603, DOI 10.1111/j.1478-3231.2004.0956.x; Kim KI, 2005, INTERVIROLOGY, V48, P52, DOI 10.1159/000082095; Kiyosawa K, 2004, GASTROENTEROLOGY, V127, pS17, DOI 10.1053/j.gastro.2004.09.012; Kobayashi S, 2007, LIVER INT, V27, P186, DOI 10.1111/j.1478-3231.2006.01406.x; Kuno A, 2013, PROTEOM CLIN APPL, V7, P642, DOI 10.1002/prca.201300010; Kuno A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01065; Lacovazzi PA, 2001, CLIN CHEM LAB MED, V39, P961; Makiyama A, 2004, CANCER-AM CANCER SOC, V101, P1616, DOI 10.1002/cncr.20537; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Narimatsu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091079; Ogawa E, 2013, J HEPATOL, V58, P495, DOI 10.1016/j.jhep.2012.10.017; Ohno T, 1997, J CLIN MICROBIOL, V35, P201, DOI 10.1128/JCM.35.1.201-207.1997; Pradat P, 2007, J VIRAL HEPATITIS, V14, P556, DOI 10.1111/j.1365-2893.2006.00829.x; Rodriguez-Diaz JL, 2007, CLIN ONCOL-UK, V19, P197, DOI 10.1016/j.clon.2006.12.005; Sasaki T, 1998, EMBO J, V17, P1606, DOI 10.1093/emboj/17.6.1606; Sherman M, 2005, SEMIN LIVER DIS, V25, P143, DOI 10.1055/s-2005-871194; Shindo M, 2001, HEPATOLOGY, V33, P1299, DOI 10.1053/jhep.2001.24100; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Sun LC, 2013, MOL CELL PROTEOMICS, V12, P395, DOI 10.1074/mcp.M112.020784; Tanaka A, 2007, WORLD J GASTROENTERO, V13, P5180, DOI 10.3748/wjg.v13.i39.5180; Tateyama M, 2011, J GASTROENTEROL, V46, P92, DOI 10.1007/s00535-010-0293-6; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; Tokita H, 2005, J GASTROEN HEPATOL, V20, P752, DOI 10.1111/j.1440-1746.2005.03800.x; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Watanabe S, 2011, HEPATOL RES, V41, P955, DOI 10.1111/j.1872-034X.2011.00847.x; Yamasaki K, 2014, HEPATOLOGY, V60, P1563, DOI 10.1002/hep.27305; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003	49	56	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129053	10.1371/journal.pone.0129053	http://dx.doi.org/10.1371/journal.pone.0129053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070204	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000040
J	Vainio, I; Abu Khamidakh, A; Paci, M; Skottman, H; Juuti-Uusitalo, K; Hyttinen, J; Nymark, S				Vainio, Iina; Abu Khamidakh, Amna; Paci, Michelangelo; Skottman, Heli; Juuti-Uusitalo, Kati; Hyttinen, Jari; Nymark, Soile			Computational Model of Ca2+ Wave Propagation in Human Retinal Pigment Epithelial ARPE-19 Cells	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; KINASE-A INCREASES; PROTEIN-KINASE; CALCIUM OSCILLATIONS; EXTRACELLULAR ATP; FLUID TRANSPORT; TIGHT JUNCTIONS; IN-VITRO; RELEASE; RPE	Objective Computational models of calcium (Ca2+) signaling have been constructed for several cell types. There are, however, no such models for retinal pigment epithelium (RPE). Our aim was to construct a Ca2+ signaling model for RPE based on our experimental data of mechanically induced Ca2+ wave in the in vitro model of RPE, the ARPE-19 monolayer. Methods We combined six essential Ca2+ signaling components into a model: stretch-sensitive Ca2+ channels (SSCCs), P2Y2 receptors, IP3 receptors, ryanodine receptors, Ca2+ pumps, and gap junctions. The cells in our epithelial model are connected to each other to enable transport of signaling molecules. Parameterization was done by tuning the above model components so that the simulated Ca2+ waves reproduced our control experimental data and data where gap junctions were blocked. Results Our model was able to explain Ca2+ signaling in ARPE-19 cells, and the basic mechanism was found to be as follows: 1) Cells near the stimulus site are likely to conduct Ca2+ through plasma membrane SSCCs and gap junctions conduct the Ca2+ and IP3 between cells further away. 2) Most likely the stimulated cell secretes ligand to the extracellular space where the ligand diffusion mediates the Ca2+ signal so that the ligand concentration decreases with distance. 3) The phosphorylation of the IP3 receptor defines the cell's sensitivity to the extracellular ligand attenuating the Ca2+ signal in the distance. Conclusions The developed model was able to simulate an array of experimental data including drug effects. Furthermore, our simulations predict that suramin may interfere ligand binding on P2Y2 receptors or accelerate P2Y2 receptor phosphorylation, which may partially be the reason for Ca2+ wave attenuation by suramin. Being the first RPE Ca2+ signaling model created based on experimental data on ARPE-19 cell line, the model offers a platform for further modeling of native RPE functions.	[Vainio, Iina; Abu Khamidakh, Amna; Paci, Michelangelo; Hyttinen, Jari; Nymark, Soile] Tampere Univ Technol, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland; [Vainio, Iina; Abu Khamidakh, Amna; Paci, Michelangelo; Hyttinen, Jari; Nymark, Soile] Tampere Univ Technol, Inst Biosci & Med Technol, FIN-33101 Tampere, Finland; [Skottman, Heli; Juuti-Uusitalo, Kati] Univ Tampere, Inst Biosci & Med Technol, FIN-33101 Tampere, Finland	Tampere University; Tampere University; Tampere University	Vainio, I (corresponding author), Tampere Univ Technol, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland.	iina.vainio@tut.fi	Hyttinen, Jari A/G-4280-2014; Nymark, Soile/M-9453-2016	Hyttinen, Jari A/0000-0003-1850-3055; Nymark, Soile/0000-0002-9274-0123; Juuti-Uusitalo, Kati/0000-0003-2275-5562; Skottman, Heli/0000-0002-4127-8792	Academy of Finland [252225, 260375, 218050, 137801]; TEKES-the finnish funding agency; Tampere University of Technology	Academy of Finland(Academy of Finland); TEKES-the finnish funding agency; Tampere University of Technology	This study was financially supported by the Academy of Finland (grant numbers 252225, 260375, 218050 and 137801), TEKES-the finnish funding agency for innovation (Human Spare Part Project), and Doctoral Programme of the President of the Tampere University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablonczy Z, 2011, INVEST OPHTH VIS SCI, V52, P8614, DOI 10.1167/iovs.11-8021; Abu Khamidakh AE, 2013, EXP EYE RES, V108, P129, DOI 10.1016/j.exer.2013.01.009; Ahmado A, 2011, INVEST OPHTH VIS SCI, V52, P7148, DOI 10.1167/iovs.10-6374; Appleby PA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0487; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; Caron AZ, 2007, CELL CALCIUM, V42, P323, DOI 10.1016/j.ceca.2007.01.002; Chaloux B, 2007, BIOL CELL, V99, P379, DOI 10.1042/BC20060121; Chi KR, 2013, NAT REV DRUG DISCOV, V12, P564, DOI 10.1038/nrd4083; Chung WC, 2005, J PHARMACOL EXP THER, V313, P191, DOI 10.1124/jpet.104.078311; De Pitta M, 2009, J BIOL PHYS, V35, P383, DOI 10.1007/s10867-009-9155-y; Dunn KC, 1998, INVEST OPHTH VIS SCI, V39, P2744; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Fall CP., 2002, COMPUTATIONAL CELL B; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; Fink CC, 1999, BIOPHYS J, V77, P617, DOI 10.1016/S0006-3495(99)76918-3; Garg S, 2008, CLIN EXP OPHTHALMOL, V36, P252, DOI 10.1111/j.1442-9071.2008.01710.x; Garrad RC, 1998, J BIOL CHEM, V273, P29437, DOI 10.1074/jbc.273.45.29437; Gelisken F, 2001, AM J OPHTHALMOL, V131, P518, DOI 10.1016/S0002-9394(00)00813-8; Giancoli D. S., 2000, PHYS SCI ENG MODERN; Glotin AL, 2008, FREE RADICAL BIO MED, V44, P1348, DOI 10.1016/j.freeradbiomed.2007.12.023; Guo CM, 2009, CURR EYE RES, V34, P852, DOI 10.3109/02713680903128935; Hamill OP, 2006, PFLUG ARCH EUR J PHY, V453, P333, DOI 10.1007/s00424-006-0131-0; HANSEN M, 1993, J CELL SCI, V106, P995; Himpens B, 1999, FASEB J, V13, pS63; Hofer T, 2002, J NEUROSCI, V22, P4850, DOI 10.1523/JNEUROSCI.22-12-04850.2002; Homolya L, 2000, J CELL BIOL, V150, P1349, DOI 10.1083/jcb.150.6.1349; Huang W, 2004, INVEST OPHTH VIS SCI, V45, P1507, DOI 10.1167/iovs.03-0731; Keizer J, 1996, BIOPHYS J, V71, P3477, DOI 10.1016/S0006-3495(96)79543-7; Kennedy BG, 1996, EXP EYE RES, V63, P547, DOI 10.1006/exer.1996.0145; KONARI K, 1995, EXP EYE RES, V61, P99, DOI 10.1016/S0014-4835(95)80063-8; LeBeau AP, 1999, J GEN PHYSIOL, V113, P851, DOI 10.1085/jgp.113.6.851; Lemon G, 2003, J THEOR BIOL, V223, P93, DOI 10.1016/S0022-5193(03)00079-1; Loeffler KU, 1998, GRAEF ARCH CLIN EXP, V236, P929, DOI 10.1007/s004170050182; Luo Y, 2006, INVEST OPHTH VIS SCI, V47, P3644, DOI 10.1167/iovs.06-0166; MAHAMA PA, 1994, BIOPHYS J, V67, P1345, DOI 10.1016/S0006-3495(94)80606-X; Maminishkis A, 2002, INVEST OPHTH VIS SCI, V43, P3555; MARANTO AR, 1994, J BIOL CHEM, V269, P1222; Mitchell CH, 2001, J PHYSIOL-LONDON, V534, P193, DOI 10.1111/j.1469-7793.2001.00193.x; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Peng SM, 2003, INVEST OPHTH VIS SCI, V44, P808, DOI 10.1167/iovs.02-0473; Peterson WM, 1997, J NEUROSCI, V17, P2324; Reigada D, 2005, AM J PHYSIOL-CELL PH, V289, pC617, DOI 10.1152/ajpcell.00542.2004; Reigada D, 2005, AM J PHYSIOL-CELL PH, V288, pC132, DOI 10.1152/ajpcell.00201.2004; Rizzolo LJ, 2007, INT REV CYTOL, V258, P195, DOI 10.1016/S0074-7696(07)58004-6; Ross MH., 1995, HISTOLOGY TEXT ATLAS, V3; SANDERSON MJ, 1994, MOL CELL ENDOCRINOL, V98, P173, DOI 10.1016/0303-7207(94)90136-8; Savolainen V, 2011, ANN BIOMED ENG, V39, P3055, DOI 10.1007/s10439-011-0387-1; SHEN J, 1993, BIOPHYS J, V64, P1323, DOI 10.1016/S0006-3495(93)81498-X; Siefjediers A, 2007, CELL CALCIUM, V41, P303, DOI 10.1016/j.ceca.2006.07.009; Singh RP, 2006, AM J OPHTHALMOL, V142, P160, DOI 10.1016/j.ajo.2006.03.051; Sneyd J, 2003, BIOPHYS J, V85, P1392, DOI 10.1016/S0006-3495(03)74572-X; Stalmans P, 1997, INVEST OPHTH VIS SCI, V38, P176; Stalmans P, 1998, INVEST OPHTH VIS SCI, V39, P1493; Sugiyama T, 1996, J HISTOCHEM CYTOCHEM, V44, P1237, DOI 10.1177/44.11.8918898; Sullivan DM, 1997, J NEUROSCI RES, V49, P43, DOI 10.1002/(SICI)1097-4547(19970701)49:1<43::AID-JNR5>3.0.CO;2-D; Wang JH, 2007, J THEOR BIOL, V245, P510, DOI 10.1016/j.jtbi.2006.11.007; Warren NJ, 2010, EXP PHYSIOL, V95, P232, DOI 10.1113/expphysiol.2009.049585; Wimmers S, 2007, PROG RETIN EYE RES, V26, P263, DOI 10.1016/j.preteyeres.2006.12.002; Wimmers S, 2008, MOL VIS, V14, P2340; Wojcikiewicz RJH, 1998, J BIOL CHEM, V273, P5670, DOI 10.1074/jbc.273.10.5670; Wu D, 2005, BIOPHYS CHEM, V113, P145, DOI 10.1016/j.bpc.2004.09.001; Yamamoto A, 2010, J PHARM SCI-US, V99, P2475, DOI 10.1002/jps.21991; Yang DL, 2011, INVEST OPHTH VIS SCI, V52, P1522, DOI 10.1167/iovs.10-6172; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003	64	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128434	10.1371/journal.pone.0128434	http://dx.doi.org/10.1371/journal.pone.0128434			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070134	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000017
J	Wei, YJ; Zhou, HK; Zhang, J; Zhang, L; Geng, AL; Liu, FH; Zhao, GP; Wang, SY; Zhou, ZH; Yan, X				Wei, Yongjun; Zhou, Haokui; Zhang, Jun; Zhang, Lei; Geng, Alei; Liu, Fanghua; Zhao, Guoping; Wang, Shengyue; Zhou, Zhihua; Yan, Xing			Insight into Dominant Cellulolytic Bacteria from Two Biogas Digesters and Their Glycoside Hydrolase Genes	PLOS ONE			English	Article							MICROBIAL COMMUNITY; ANAEROBIC-DIGESTION; METAGENOME; DATABASE; REACTOR; DEGRADATION; CELLULASES; GENERATION; CHEMOTAXIS; DISCOVERY	Diverse cellulolytic bacteria are essential for maintaining high lignocellulose degradation ability in biogas digesters. However, little was known about functional genes and gene clusters of dominant cellulolytic bacteria in biogas digesters. This is the foundation to understand lignocellulose degradation mechanisms of biogas digesters and apply these gene resource for optimizing biofuel production. A combination of metagenomic and 16S rRNA gene clone library methods was used to investigate the dominant cellulolytic bacteria and their glycoside hydrolase (GH) genes in two biogas digesters. The 16S rRNA gene analysis revealed that the dominant cellulolytic bacteria were strains closely related to Clostridium straminisolvens and an uncultured cellulolytic bacterium designated BG-1. To recover GH genes from cellulolytic bacteria in general, and BG-1 in particular, a refined assembly approach developed in this study was used to assemble GH genes from metagenomic reads; 163 GH-containing contigs >= 1 kb in length were obtained. Six recovered GH5 genes that were expressed in E. coli demonstrated multiple lignocellulase activities and one had high mannanase activity (1255 U/mg). Eleven fosmid clones harboring the recovered GH-containing contigs were sequenced and assembled into 10 fosmid contigs. The composition of GH genes in the 163 assembled metagenomic contigs and 10 fosmid contigs indicated that diverse GHs and lignocellulose degradation mechanisms were present in the biogas digesters. In particular, a small portion of BG-1 genome information was recovered by PhyloPythiaS analysis. The lignocellulase gene clusters in BG-1 suggested that it might use a possible novel lignocellulose degradation mechanism to efficiently degrade lignocellulose. Dominant cellulolytic bacteria of biogas digester possess diverse GH genes, not only in sequences but also in their functions, which may be applied for production of biofuel in the future.	[Wei, Yongjun; Zhang, Jun; Zhang, Lei; Geng, Alei; Liu, Fanghua; Zhao, Guoping; Zhou, Zhihua; Yan, Xing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, CAS Key Lab Synthet Biol, Shanghai, Peoples R China; [Zhou, Haokui; Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Zhao, Guoping; Wang, Shengyue] Chinese Natl Human Genome Ctr, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese University of Hong Kong; Prince of Wales Hospital	Zhou, ZH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, CAS Key Lab Synthet Biol, Shanghai, Peoples R China.	zhouzhihua@sippe.ac.cn; yanxing@sippe.ac.cn	Wei, Yongjun/AAY-5100-2021; 刘, 芳华/H-7907-2014	Wei, Yongjun/0000-0002-1554-1999; 刘, 芳华/0000-0002-1934-3674	National Basic Research Program of China (973 program) [2012CB721103, 2011CB707403]; International Joint Research Program [GJHZ1128]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-12]	National Basic Research Program of China (973 program)(National Basic Research Program of China); International Joint Research Program; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported financially by the National Basic Research Program of China (973 program: 2012CB721103; 2011CB707403), the International Joint Research Program (GJHZ1128), and the Knowledge Innovation Program of the Chinese Academy of Sciences (No. KSCX2-EW-J-12).	Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039331; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Burrell PC, 2004, APPL ENVIRON MICROB, V70, P2414, DOI 10.1128/AEM.70.4.2414-2419.2004; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Dai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040430; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Geng AL, 2012, APPL MICROBIOL BIOT, V96, P951, DOI 10.1007/s00253-012-3873-y; Goberna M, 2009, APPL ENVIRON MICROB, V75, P2566, DOI 10.1128/AEM.02260-08; HEALY FG, 1995, APPL MICROBIOL BIOT, V43, P667, DOI [10.1007/s002530050468, 10.1007/BF00164771]; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jiang XY, 2011, ENERG POLICY, V39, P6073, DOI 10.1016/j.enpol.2011.07.007; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kato S, 2004, INT J SYST EVOL MICR, V54, P2043, DOI 10.1099/ijs.0.63148-0; Kirby JR, 2009, ANNU REV MICROBIOL, V63, P45, DOI 10.1146/annurev.micro.091208.073221; Krause L, 2008, J BIOTECHNOL, V136, P91, DOI 10.1016/j.jbiotec.2008.06.003; Li LL, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-23; Li LL, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-10; Li TL, 2009, ENVIRON MICROBIOL, V11, P889, DOI 10.1111/j.1462-2920.2008.01810.x; Liu FH, 2009, J APPL MICROBIOL, V106, P952, DOI 10.1111/j.1365-2672.2008.04064.x; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Merlino G, 2012, J CHEM TECHNOL BIOT, V87, P1302, DOI 10.1002/jctb.3784; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; Nelson MC, 2011, BIORESOURCE TECHNOL, V102, P3730, DOI 10.1016/j.biortech.2010.11.119; Newcomb M, 2007, P NATL ACAD SCI USA, V104, P3747, DOI 10.1073/pnas.0700087104; NOIKE T, 1985, BIOTECHNOL BIOENG, V27, P1482, DOI 10.1002/bit.260271013; O'Sullivan C, 2007, J APPL MICROBIOL, V103, P1332, DOI 10.1111/j.1365-2672.2007.03362.x; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Patil KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038581; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Safro M., 2004, HDB MOL MICROBIAL EC, P250, DOI DOI 10.1002/9781118010518.CH46; Schluter A, 2008, J BIOTECHNOL, V136, P77, DOI 10.1016/j.jbiotec.2008.05.008; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sukharnikov LO, 2011, TRENDS BIOTECHNOL, V29, P473, DOI 10.1016/j.tibtech.2011.04.008; Tang YQ, 2011, APPL MICROBIOL BIOT, V91, P1447, DOI 10.1007/s00253-011-3479-9; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Ueno Y, 2001, APPL MICROBIOL BIOT, V57, P65; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Weiland P, 2010, APPL MICROBIOL BIOT, V85, P849, DOI 10.1007/s00253-009-2246-7; Wirth R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-41; Xia Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053779; Yan X, 2013, APPL MICROBIOL BIOT, V97, P8173, DOI 10.1007/s00253-013-4927-5	47	23	25	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129921	10.1371/journal.pone.0129921	http://dx.doi.org/10.1371/journal.pone.0129921			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070087	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000125
J	Goebes, P; Bruelheide, H; Hardtle, W; Krober, W; Kuhn, P; Li, Y; Seitz, S; von Oheimb, G; Scholten, T				Goebes, Philipp; Bruelheide, Helge; Haerdtle, Werner; Kroeber, Wenzel; Kuehn, Peter; Li, Ying; Seitz, Steffen; von Oheimb, Goddert; Scholten, Thomas			Species-Specific Effects on Throughfall Kinetic Energy in Subtropical Forest Plantations Are Related to Leaf Traits and Tree Architecture	PLOS ONE			English	Article							DROP SIZE DISTRIBUTIONS; SOIL-EROSION; RAINFALL INTERCEPTION; RAINDROP IMPACT; CANOPY; PLANT; STEMFLOW; CHINA; BIODIVERSITY; SAPLINGS	Soil erosion is a key threat to many ecosystems, especially in subtropical China where high erosion rates occur. While the mechanisms that induce soil erosion on agricultural land are well understood, soil erosion processes in forests have rarely been studied. Throughfall kinetic energy (TKE) is influenced in manifold ways and often determined by the tree's leaf and architectural traits. We investigated the role of species identity in mono-specific stands on TKE by asking to what extent TKE is species-specific and which leaf and architectural traits account for variation in TKE. We measured TKE of 11 different tree species planted in monocultures in a biodiversity-ecosystem-functioning experiment in subtropical China, using sand-filled splash cups during five natural rainfall events in summer 2013. In addition, 14 leaf and tree architectural traits were measured and linked to TKE. Our results showed that TKE was highly species-specific. Highest TKE was found below Choerospondias axillaris and Sapindus saponaria, while Schima superba showed lowest TKE. These species-specific effects were mediated by leaf habit, leaf area (LA), leaf pinnation, leaf margin, stem diameter at ground level (GD), crown base height (CBH), tree height, number of branches and leaf area index (LAI) as biotic factors and throughfall as abiotic factor. Among these, leaf habit, tree height and LA showed the highest effect sizes on TKE and can be considered as major drivers of TKE. TKE was positively influenced by LA, GD, CBH, tree height, LAI, and throughfall amount while it was negatively influenced by the number of branches. TKE was lower in evergreen, simple leaved and dentate leaved than in deciduous, pinnated or entire leaved species. Our results clearly showed that soil erosion in forest plantations can be mitigated by the appropriate choice of tree species.	[Goebes, Philipp; Kuehn, Peter; Seitz, Steffen; Scholten, Thomas] Univ Tubingen, Inst Geog, Dept Geosci, Chair Soil Sci & Geomorphol, D-72070 Tubingen, Germany; [Bruelheide, Helge; Kroeber, Wenzel] Univ Halle Wittenberg, D-06108 Halle, Germany; [Bruelheide, Helge] German Ctr Integrat Biodivers Res iDiv, D-04103 Leipzig, Germany; [Haerdtle, Werner; Li, Ying] Univ Luneburg, Fac Sustainabil, Inst Ecol, D-21335 Luneburg, Germany; [von Oheimb, Goddert] Tech Univ Dresden, Inst Gen Ecol & Environm Protect, D-01737 Tharandt, Germany	Eberhard Karls University of Tubingen; Martin Luther University Halle Wittenberg; Leuphana University Luneburg; Technische Universitat Dresden	Goebes, P (corresponding author), Univ Tubingen, Inst Geog, Dept Geosci, Chair Soil Sci & Geomorphol, Rumelinstr 19-23, D-72070 Tubingen, Germany.	philipp.goebes@uni-tuebingen.de	von Oheimb, Goddert/O-9483-2015; Seitz, Steffen/B-7627-2016; Haerdtle, Werner/B-2568-2016; Scholten, Thomas/E-4024-2012; Kühn, Peter/A-9146-2009; Bruelheide, Helge/G-3907-2013	von Oheimb, Goddert/0000-0001-7408-425X; Seitz, Steffen/0000-0003-4911-3906; Scholten, Thomas/0000-0002-4875-2602; Kühn, Peter/0000-0002-4417-5633; Bruelheide, Helge/0000-0003-3135-0356; Goebes, Philipp/0000-0001-8264-9070; Hardtle, Werner/0000-0002-5599-5792	German Research Foundation [DFG FOR 891/1, DFG FOR 891/2]; Sino-German Centre for Research Promotion in Beijing [GZ 524, GZ 592, GZ 698, GZ 699, GZ 785]; University of Tubingen	German Research Foundation(German Research Foundation (DFG)); Sino-German Centre for Research Promotion in Beijing; University of Tubingen	The authors gratefully acknowledge funding by the German Research Foundation, (DFG FOR 891/1 and 2). Travel grants and summer schools were granted through the Sino-German Centre for Research Promotion in Beijing, (GZ 524,592,698,699 and 785). Support was also received from the Open Access Publishing Fund of the University of Tubingen.	AERTS R, 1995, TRENDS ECOL EVOL, V10, P402, DOI 10.1016/S0169-5347(00)89156-9; Andre F, 2011, J HYDROL, V400, P244, DOI 10.1016/j.jhydrol.2011.01.037; ASTON AR, 1979, J HYDROL, V42, P383, DOI 10.1016/0022-1694(79)90057-X; Bates B., 2013, [lme4: linear mixed-effects models using S4 classes, R package version 0.999375-39]; Bauhus J., 2010, ECOSYSTEM GOODS SERV; BRANDT CJ, 1989, CATENA, V16, P507, DOI 10.1016/0341-8162(89)90032-5; BRANDT J, 1988, J BIOGEOGR, V15, P41, DOI 10.2307/2845044; Bruelheide H, 2014, METHODS ECOL EVOL, V5, P74, DOI 10.1111/2041-210X.12126; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Bugmann H, 1996, J VEG SCI, V7, P359, DOI 10.2307/3236279; Butler D, 2009, ASREML ASREML FITS L; Cao Y, 2008, LAND DEGRAD DEV, V19, P321, DOI 10.1002/ldr.812; Dixon RK, 1995, WATER AIR SOIL POLL, V85, P101, DOI 10.1007/BF00483692; Foot K, 2005, EARTH SURF PROC LAND, V30, P1509, DOI 10.1002/esp.1207; Geissler C, 2012, CATENA, V91, P85, DOI 10.1016/j.catena.2010.10.009; Geissler C, 2012, AGR FOREST METEOROL, V156, P31, DOI 10.1016/j.agrformet.2011.12.005; Geissler C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049618; Geissler C, 2010, J EARTH SCI-CHINA, V21, P897, DOI 10.1007/s12583-010-0132-y; GIVNISH T J, 1978, P351; Gomez JA, 2001, AGR WATER MANAGE, V49, P65, DOI 10.1016/S0378-3774(00)00116-5; GUNN R, 1949, J METEOROL, V6, P243, DOI 10.1175/1520-0469(1949)006<0243:TTVOFF>2.0.CO;2; Guo JianFen, 2006, Journal of Northeast Forestry University, V34, P49; HALL RL, 1993, J GEOPHYS RES-ATMOS, V98, P18465, DOI 10.1029/93JD01498; HERWITZ SR, 1987, EARTH SURF PROC LAND, V12, P425, DOI 10.1002/esp.3290120408; Hill RD, 1998, JOHN; Kelty MJ, 2006, FOREST ECOL MANAG, V233, P195, DOI 10.1016/j.foreco.2006.05.011; Krober W, 2015, PLANT BIOLOGY, V17, P373, DOI 10.1111/plb.12250; Krober W, 2014, TREES-STRUCT FUNCT, V28, P901, DOI 10.1007/s00468-014-1004-3; Krober W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035742; Kundela A., 2009, THESIS U ZURICH; Lal R, 1998, SOIL TILL RES, V48, P103, DOI 10.1016/S0167-1987(98)00109-3; Levia DF, 2006, PROG PHYS GEOG, V30, P605, DOI 10.1177/0309133306071145; Li Y, 2014, FOREST ECOL MANAG, V327, P118, DOI 10.1016/j.foreco.2014.04.039; Loescher HW, 2002, J TROP ECOL, V18, P397, DOI 10.1017/S0266467402002274; Montgomery DR, 2007, P NATL ACAD SCI USA, V104, P13268, DOI 10.1073/pnas.0611508104; MOSLEY MP, 1982, EARTH SURF PROC LAND, V7, P103, DOI 10.1002/esp.3290070204; Nanko K, 2004, J FOREST RES-JPN, V9, P157, DOI 10.1007/s10310-003-0067-6; Nanko K, 2006, J HYDROL, V329, P422, DOI 10.1016/j.jhydrol.2006.02.036; Nanko K, 2013, AGR FOREST METEOROL, V169, P74, DOI 10.1016/j.agrformet.2012.09.018; Nanko K, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL033010; Park A, 2008, FOREST ECOL MANAG, V255, P1915, DOI 10.1016/j.foreco.2007.12.025; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pimentel David, 2006, Environment Development and Sustainability, V8, P119, DOI 10.1007/s10668-005-1262-8; R Core Team, 2021, R LANGUAGE ENV STAT; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; RENARD KG, 1994, J HYDROL, V157, P287, DOI 10.1016/0022-1694(94)90110-4; Scholten T, 2011, J PLANT NUTR SOIL SC, V174, P596, DOI 10.1002/jpln.201000349; Staelens J, 2008, HYDROL PROCESS, V22, P33, DOI 10.1002/hyp.6610; Tanaka N, 2015, INT J BIOMETEOROL, V59, P1145, DOI 10.1007/s00484-014-0926-1; VIS M, 1986, EARTH SURF PROC LAND, V11, P591, DOI 10.1002/esp.3290110603; Wang K, 2005, PEDOSPHERE, V15, P620; Wei LH, 2007, AGR WATER MANAGE, V94, P54, DOI 10.1016/j.agwat.2007.08.007; Wright IJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P411, DOI 10.1111/j.1466-822x.2005.00172.x; Xu XL, 2009, ECOL RES, V24, P37, DOI 10.1007/s11284-008-0479-z; Yang XF, 2013, EUR J FOREST RES, V132, P593, DOI 10.1007/s10342-013-0696-z; Zhang PC, 2000, SCIENCE, V288, P2135, DOI 10.1126/science.288.5474.2135; Zuur Alain F., 2009, P1	57	33	34	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0128084	10.1371/journal.pone.0128084	http://dx.doi.org/10.1371/journal.pone.0128084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079260	gold, Green Submitted, Green Published			2022-12-27	WOS:000356542300008
J	Caldas-Morgan, M; Alvarez-Rosario, A; Padovese, LR				Caldas-Morgan, Manuel; Alvarez-Rosario, Alexander; Padovese, Linilson Rodrigues			An Autonomous Underwater Recorder Based on a Single Board Computer	PLOS ONE			English	Article							ACOUSTIC RECORDER	As industrial activities continue to grow on the Brazilian coast, underwater sound measurements are becoming of great scientific importance as they are essential to evaluate the impact of these activities on local ecosystems. In this context, the use of commercial underwater recorders is not always the most feasible alternative, due to their high cost and lack of flexibility. Design and construction of more affordable alternatives from scratch can become complex because it requires profound knowledge in areas such as electronics and low-level programming. With the aim of providing a solution; a well succeeded model of a highly flexible, low-cost alternative to commercial recorders was built based on a Raspberry Pi single board computer. A properly working prototype was assembled and it demonstrated adequate performance levels in all tested situations. The prototype was equipped with a power management module which was thoroughly evaluated. It is estimated that it will allow for great battery savings on long-term scheduled recordings. The underwater recording device was successfully deployed at selected locations along the Brazilian coast, where it adequately recorded animal and manmade acoustic events, among others. Although power consumption may not be as efficient as that of commercial and/or micro-processed solutions, the advantage offered by the proposed device is its high customizability, lower development time and inherently, its cost.	[Caldas-Morgan, Manuel; Alvarez-Rosario, Alexander; Padovese, Linilson Rodrigues] Univ Sao Paulo, Dept Mech Engn, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Caldas-Morgan, M (corresponding author), Univ Sao Paulo, Dept Mech Engn, Sao Paulo, SP, Brazil.	manuel.caldas@gmail.com	Padovese, Linilson R/J-9642-2012; Alvarez-Rosario, Alexander/D-8249-2013	Padovese, Linilson R/0000-0001-6228-8941; Alvarez-Rosario, Alexander/0000-0002-2063-0849	Brazilian research foundation agency FAPESP [2012/04785-0, 2012/23016-7]; Brazilian research foundation agency CNPQ	Brazilian research foundation agency FAPESP; Brazilian research foundation agency CNPQ	This work was supported by grants from Brazilian research foundation agencies FAPESP (process numbers 2012/04785-0 and 2012/23016-7) and CNPQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruel & Kjaer, STAND MEAS HYDR INT; Develogic GmbH, VAULT AC REC SIGN AN; DolphinEar Hydrophones, PROD; DolphinEar Hydrophones, DE200 SER COMPL READ; Hamilton LJ, 2009, ACOUST AUST, V37, P57; Lammers MO, 2008, J ACOUST SOC AM, V123, P1720, DOI 10.1121/1.2836780; Loggerhead Instruments, DSG ST OC AC DAT; Martinez JJ, 2011, SENSORS-BASEL, V11, P8519, DOI 10.3390/s110908519; Maxim Integrated, DS3231 EXTR ACC I2C; Ming-Hao C, 2007, UND TECHN WORKSH SCI; Monolithic Power Systems, MP2307 3A 23V 340KHZ; Multi-Electronique (MTE) Inc, AURAL M2 AUT UND REC; Raspberry Pi Foundation, WHAT IS RASPB PI; Raspberry Pi Foundation, GPIO INTR GPIO PHYS; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Romero Vivas E, 2012, P M AC, V11; Sousa-Lima RS, 2013, AQUAT MAMM, V39, P205, DOI 10.1578/AM.39.2.2013.205; SoX-Sound eXchange, DOC; Texas Instruments, STER AUD COD USB INT; Wang CC, 2009, OCEAN ENG, V36, P446, DOI 10.1016/j.oceaneng.2009.01.008; Wiggins S.M., 2007, UND TECHN WORKSH SCI, P7; Wildlife Acoustics Inc, SONG MET SM2M MAR RE; Zerbini Alexandre N., 2011, Journal of Cetacean Research and Management, P113; Zimmer WM., 2011, PASSIVE ACOUSTIC MON, DOI 10.1017/CBO9780511977107	24	13	14	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130297	10.1371/journal.pone.0130297	http://dx.doi.org/10.1371/journal.pone.0130297			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076479	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900161
J	Choi, MK; Bae, YJ				Choi, Mi-Kyeong; Bae, Yun Jung			Association of Magnesium Intake with High Blood Pressure in Korean Adults: Korea National Health and Nutrition Examination Survey 2007-2009	PLOS ONE			English	Article							DIETARY MAGNESIUM; METABOLIC SYNDROME; ORAL MAGNESIUM; HYPERTENSION; RISK; SUPPLEMENTATION; PREVALENCE; MANAGEMENT; MANGANESE; COPPER	Background Magnesium is known to lower the risk of cardiovascular disease. However, studies on its relationship with hypertension, a single and common cause of various chronic diseases, are limited and their findings are not consistent. The purpose of the present study is to identify the relationship between magnesium intake and high blood pressure (HBP) risk in Koreans. Methods This research is a cross-sectional study based on the 2007 similar to 2009 Korean National Health and Nutritional Examination Survey data. This study investigated 11,685 adults aged over 20 to examine their general characteristics, anthropometry and blood pressure. Daily magnesium intake was analyzed using the 24-hour dietary recall method. To calculate the odds ratio (OR) of HBP risk (130/85 mmHg or over) according to the quartile of magnesium intake (mg/1000kcal) together with its 95% confidence interval (CI), multivariable logistic regression analysis was performed. Results No significant association between dietary magnesium intake and the risk of HBP was found. In obese women, particularly, after adjusting relevant factors, the adjusted odds ratio of HBP prevalence in the highest magnesium intake quartile was 0.40 compared with the lowest magnesium intake quartile (95% CI = 0.25 similar to 0.63, P for trend = 0.0014). Women, especially obese women, were found to have a negative relationship of magnesium intake with HBP. Conclusions The present results indicate that sufficient magnesium intake could be useful in decreasing the high blood pressure risk of obese women.	[Choi, Mi-Kyeong] Kongju Natl Univ, Div Food Sci, Yesan, South Korea; [Bae, Yun Jung] Shinhan Univ, Div Food Sci & Culinary Arts, Uijongbu, South Korea	Kongju National University	Bae, YJ (corresponding author), Shinhan Univ, Div Food Sci & Culinary Arts, Uijongbu, South Korea.	byj@shinhan.ac.kr		Choi, Mi-Kyeong/0000-0002-6227-4053; BAE, YUN JUNG/0000-0003-1185-3095				ALTURA BM, 1994, SCAND J CLIN LAB INV, V54, P5, DOI 10.3109/00365519409095206; Ascherio A, 1996, HYPERTENSION, V27, P1065, DOI 10.1161/01.HYP.27.5.1065; Bae YJ, 2011, BIOL TRACE ELEM RES, V143, P213, DOI 10.1007/s12011-010-8883-y; Bae YJ, 2010, BIOL TRACE ELEM RES, V135, P182, DOI 10.1007/s12011-009-8511-x; Bursztyn M, 2013, J HYPERTENS, V31, P900, DOI 10.1097/HJH.0b013e32835f29f4; CAPPUCCIO FP, 1985, BRIT MED J, V291, P235, DOI 10.1136/bmj.291.6490.235; Choi MK, 2013, BIOL TRACE ELEM RES, V156, P56, DOI 10.1007/s12011-013-9852-z; Damasceno A, 2009, HYPERTENSION, V54, P77, DOI 10.1161/HYPERTENSIONAHA.109.132423; Ford ES, 2007, OBESITY, V15, P1139, DOI 10.1038/oby.2007.628; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; He J, 2009, J HYPERTENS, V27, P48, DOI 10.1097/HJH.0b013e328316bb87; He K, 2006, CIRCULATION, V113, P1675, DOI 10.1161/CIRCULATIONAHA.105.588327; Health Canada, 2010, DIETARY REFERENCE IN; Houston MC, 2008, J CLIN HYPERTENS, V10, P3, DOI 10.1111/j.1751-7176.2008.08575.x; Hruby A, 2014, JACC-CARDIOVASC IMAG, V7, P59, DOI 10.1016/j.jcmg.2013.10.006; *I NAT RUR RES DEV, 2006, FOOD COMP TABL; Itoh K, 1997, BRIT J NUTR, V78, P737, DOI 10.1079/BJN19970191; Jee SH, 2002, AM J HYPERTENS, V15, P691, DOI 10.1016/S0895-7061(02)02964-3; Kang Young Sun, 2013, Electrolyte Blood Press, V11, P46, DOI 10.5049/EBP.2013.11.2.46; Klevay LM, 2002, AM J CLIN NUTR, V75, P550, DOI 10.1093/ajcn/75.3.550; Liu SM, 2006, DIABETES CARE, V29, P1579, DOI 10.2337/dc06-0256; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; MCNEILL DA, 1985, J AM DIET ASSOC, V85, P569; Miura K, 2010, J EPIDEMIOL, V20, pS524, DOI 10.2188/jea.JE20090220; National Statistical Office, 2013, DEATH DEATH RAT CAUS; Resnick LM, 1997, AM J HYPERTENS, V10, P368; Song YQ, 2006, AM J CARDIOL, V98, P1616, DOI 10.1016/j.amjcard.2006.07.040; Sontia Bruno, 2007, Pathophysiology, V14, P205, DOI 10.1016/j.pathophys.2007.09.005; Steffen LM, 2005, AM J CLIN NUTR, V82, P1169, DOI 10.1093/ajcn/82.6.1169; SUNG C-J, 1990, Korean Journal of Nutrition, V23, P25; Sung ChungJa, 2002, Korean Journal of Community Nutrition, V7, P111; The Ministry of Health and Welfare, 2013, NAT HLTH STAT; The Ministry of Health and Welfare Korean Center for Disease Control and Prevention, 2009, NAT HLTH STAT; Touyz R. M., 2003, Molecular Aspects of Medicine, V24, P107, DOI 10.1016/S0098-2997(02)00094-8; Touyz RM, 2006, CURR OPIN NEPHROL HY, V15, P141, DOI 10.1097/01.mnh.0000214773.34480.d4; Yamori Y, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S21; Zhang W, 2012, ATHEROSCLEROSIS, V221, P587, DOI 10.1016/j.atherosclerosis.2012.01.034; Zhao D, 2011, NAT REV CARDIOL, V8, P456, DOI 10.1038/nrcardio.2011.75	38	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130405	10.1371/journal.pone.0130405	http://dx.doi.org/10.1371/journal.pone.0130405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075385	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900171
J	Liu, HW; Luo, LX; Liang, CQ; Jiang, N; Liu, PF; Li, JQ				Liu, H. W.; Luo, L. X.; Liang, C. Q.; Jiang, N.; Liu, P. F.; Li, J. Q.			High-Throughput Sequencing Identifies Novel and Conserved Cucumber (Cucumis sativus L.) microRNAs in Response to Cucumber Green Mottle Mosaic Virus Infection	PLOS ONE			English	Article							BZIP TRANSCRIPTION FACTORS; SMALL RNAS; GENE-EXPRESSION; PLANT MICRORNA; PROTEIN; TOMATO; SEED; RESISTANCE; TOBACCO; GENOME	Seedlings of Cucumis sativus L. (cv. 'Zhongnong 16') were artificially inoculated with Cucumber green mottle mosaic virus (CGMMV) at the three-true-leaf stage. Leaf and flower samples were collected at different time points post-inoculation (10, 30 and 50 d), and processed by high throughput sequencing analysis to identify candidate miRNA sequences. Bioinformatic analysis using screening criteria, and secondary structure prediction, indicated that 8 novel and 23 known miRNAs (including 15 miRNAs described for the first time in vivo) were produced by cucumber plants in response to CGMMV infection. Moreover, gene expression profiles (p-value <0.01) validated the expression of 3 of the novel miRNAs and 3 of the putative candidate miRNAs and identified a further 82 conserved miRNAs in CGMMV-infected cucumbers. Gene ontology (GO) analysis revealed that the predicted target genes of these 88 miRNAs, which were screened using the psRNATarget and miRanda algorithms, were involved in three functional categories: 2265 in molecular function, 1362 as cellular components and 276 in biological process. The subsequent Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis revealed that the predicted target genes were frequently involved in metabolic processes (166 pathways) and genetic information processes (40 pathways) and to a lesser degree the biosynthesis of secondary metabolites (12 pathways). These results could provide useful clues to help elucidate host-pathogen interactions in CGMMV and cucumber, as well as for the screening of resistance genes.	[Liu, H. W.; Luo, L. X.; Liang, C. Q.; Jiang, N.; Liu, P. F.; Li, J. Q.] China Agr Univ, Dept Plant Pathol, Key Lab Plant Pathol, Beijing 100094, Peoples R China; [Liu, H. W.; Luo, L. X.; Liang, C. Q.; Jiang, N.; Liu, P. F.; Li, J. Q.] Beijing Engn Res Ctr Seed & Plant Hlth, Beijing Key Lab Seed Dis Testing & Control, Beijing, Peoples R China; [Liu, H. W.] ARS, Mol Plant Pathol Lab, US Dept, Beltsville, MD USA	China Agricultural University	Li, JQ (corresponding author), China Agr Univ, Dept Plant Pathol, Key Lab Plant Pathol, Beijing 100094, Peoples R China.	lijq231@cau.edu.cn			National Science Foundation of China (NSFC) [31371910]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1042]; Special Fund for Agroscientific Research in the Public Interest of China [201303028]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Special Fund for Agroscientific Research in the Public Interest of China	This work was supported by the National Science Foundation of China (NSFC) project (Grant No. 31371910), the Program for Changjiang Scholars and Innovative Research Team in University (Grant No. IRT1042) and the Special Fund for Agroscientific Research in the Public Interest of China (Grant No. 201303028). All the funding was received by Dr. Jianqiang Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge C, 2009, FEBS J, V276, P1177, DOI 10.1111/j.1742-4658.2009.06875.x; Alvaro LPQ, 2010, BMC PLANT BIOL, V10, P138, DOI [10.1186/1471-2229-10-138, DOI 10.1186/1471-2229-10-138]; Alves MS, 2013, INT J MOL SCI, V14, P7815, DOI 10.3390/ijms14047815; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; ANTIGNUS Y, 1990, PHYTOPARASITICA, V18, P50, DOI 10.1007/BF02980826; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Baker C, 2013, CUCUMBER GREEN MOTTL; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Cho SH, 2012, PLANT CELL, V24, P4837, DOI 10.1105/tpc.112.103176; Choi GugSeoun, 2001, Plant Pathology Journal, V17, P243; Chung KM, 2007, PLANT BIOTECHNOL-NAR, V24, P307, DOI 10.5511/plantbiotechnology.24.307; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; DrogeLaser W, 1997, EMBO J, V16, P726, DOI 10.1093/emboj/16.4.726; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Foyer CH, 2001, TRENDS PLANT SCI, V6, P486, DOI 10.1016/S1360-1385(01)02086-6; Fu CX, 2012, PLANT BIOTECHNOL J, V10, P443, DOI 10.1111/j.1467-7652.2011.00677.x; Gachon C, 2004, PLANT MOL BIOL, V54, P137, DOI 10.1023/B:PLAN.0000028775.58537.fe; Garcia-Masa J, 2012, PNAS, V109, P11882; Grant-Downton R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-643; Gu XingFang, 2005, Acta Horticulturae Sinica, V32, P762; Correa LGG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002944; Guo ChengJin, 2011, Frontiers of Agriculture in China, V5, P291, DOI 10.1007/s11703-011-1067-5; Hammerschmidt R, 1999, PHYSIOL MOL PLANT P, V55, P77, DOI 10.1006/pmpp.1999.0215; Hannoufa A, 2015, GEN M; Herbette S, 2005, BBA-GEN SUBJECTS, V1724, P108, DOI 10.1016/j.bbagen.2005.04.018; Hollings M, 1975, CMI AAB DESCRIPTIONS; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KOMURO Y., 1971, Japan Agricultural Research Quarterly, V6, P41; Laliberte JF, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00203; Langlois-Meurinne M, 2005, PLANT PHYSIOL, V139, P1890, DOI 10.1104/pp.105.067223; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082445; Li CH, 2014, PHYSIOL PLANTARUM, V151, P406, DOI 10.1111/ppl.12122; Liu HW, 2014, PLANT PATHOL, V63, P72, DOI 10.1111/ppa.12065; Lough TJ, 2006, ANNU REV PLANT BIOL, V57, P203, DOI 10.1146/annurev.arplant.56.032604.144145; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Moreno IM, 2004, J GEN VIROL, V85, P749, DOI 10.1099/vir.0.19540-0; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pitrat M., 1999, Acta Horticulturae, P21; Prade RA, 1999, BIOTECHNOL GENET ENG, V16, P361, DOI 10.1080/02648725.1999.10647984; Qi JJ, 2013, NAT GENET, V45, P1510, DOI 10.1038/ng.2801; Raisley B, 2004, DEV BIOL, V265, P433, DOI 10.1016/j.ydbio.2003.09.035; Rausch T, 2005, TRENDS PLANT SCI, V10, P503, DOI 10.1016/j.tplants.2005.08.006; Reingold V., 2013, New Disease Reports, V28, P11, DOI 10.5197/j.2044-0588.2013.028.011; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; Riyahi TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027311; Rottiers V, 2011, COLD SH Q B, V76, P225, DOI 10.1101/sqb.2011.76.011049; Rushton PJ, 1998, CURR OPIN PLANT BIOL, V1, P311, DOI 10.1016/1369-5266(88)80052-9; Satoh K, 2010, J GEN VIROL, V91, P294, DOI 10.1099/vir.0.015990-0; Schommer C, 2014, MOL PLANT, V7, P1533, DOI 10.1093/mp/ssu084; Simon-Buela L, 1999, MOL PLANT MICROBE IN, V12, P112, DOI 10.1094/MPMI.1999.12.2.112; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tanurdzic M, 2004, PLANT CELL, V16, pS61, DOI 10.1105/tpc.016667; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Uzarowska A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-15; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; Wang JW, 2014, J EXP BOT, V65, P4723, DOI 10.1093/jxb/eru246; Wei S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-169; Wellmer F, 2014, J EXP BOT, V65, P1, DOI 10.1093/jxb/ert385; Wu HuiJie, 2011, Scientia Agricultura Sinica, V44, P1527; Yan YS, 2011, MOL PLANT, V4, P190, DOI 10.1093/mp/ssq066; Yang YO, 1996, P NATL ACAD SCI USA, V93, P14972, DOI 10.1073/pnas.93.25.14972; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zou MJ, 2008, PLANT MOL BIOL, V66, P675, DOI 10.1007/s11103-008-9298-4	88	23	25	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129002	10.1371/journal.pone.0129002	http://dx.doi.org/10.1371/journal.pone.0129002			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076360	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900042
J	Martini, C; van Velzen, M; Drewes, A; Aarts, L; Dahan, A; Niesters, M				Martini, Chris; van Velzen, Monique; Drewes, Asbjorn; Aarts, Leon; Dahan, Albert; Niesters, Marieke			A Randomized Controlled Trial on the Effect of Tapentadol and Morphine on Conditioned Pain Modulation in Healthy Volunteers	PLOS ONE			English	Article							NOXIOUS INHIBITORY CONTROLS; POSTOPERATIVE PAIN; DOUBLE-BLIND; MECHANISMS; ANALGESIA; EFFICACY	Background Modulatory descending pathways, originating at supraspinal sites that converge at dorsal horn neurons, influence pain perception in humans. Defects in descending pain control are linked to chronic pain states and its restoration may be a valuable analgesic tool. Conditioned pain modulation (CPM) is a surrogate marker of descending inhibition that reduces the perception of pain from a primary test stimulus during application of a conditioning stimulus. Here the effects of the analgesics tapentadol, a combined mu-opioid receptor agonist and noradrenaline reuptake inhibitor, and morphine, a strong mu-opioid receptor agonist, were tested on CPM in a randomized, double-blind, placebo-controlled crossover trial in 12 healthy pain-free volunteers, to understand possible differences in mechanism of action between these opioids. Methods and Results On three occasions CPM responses were obtained 60-90 and 120-150 min following intake of tapentadol (100 mg immediate release tablet), morphine (40 mg immediate release tablet) or placebo. At both time points, CPM was detectable after treatment with placebo and tapentadol (peak pain ratings reduced by 20-30% after application of the conditioning stimulus) but not after morphine. Compared to placebo morphine displayed significantly less CPM: mean treatment difference 18.2% (95% CI 3.4 to 32.9%) at 60-90 min after drug intake and 19.5% (95% CI 5.7 to 33.2%) at 120-150 min after drug intake (p = 0.001). No difference in CPM between placebo and tapentadol was detected: mean treatment difference 1.5% (95% CI -11.6 to 14.6%) at 60-90 min after drug intake and 1.5% (95% CI -16.0 to 18.9%) at 120-150 min after drug intake (p = 0.60). Conclusions Our data show that in volunteers morphine affects CPM, while tapentadol was without effect despite identical experimental conditions. These data confirm that tapentadol's main mechanism of action is distinct from that of morphine and likely related to the effect of adrenergic stimulation on descending controls.	[Martini, Chris; van Velzen, Monique; Aarts, Leon; Dahan, Albert; Niesters, Marieke] Leiden Univ, Med Ctr, Dept Anesthesiol, Leiden, Netherlands; [Drewes, Asbjorn] Aalborg Univ Hosp, Dept Gastroenterol & Hepatol, Mech Sense, Aalborg, Denmark	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Aalborg University; Aalborg University Hospital	Niesters, M (corresponding author), Leiden Univ, Med Ctr, Dept Anesthesiol, Leiden, Netherlands.	m.niesters@lumc.nl	Drewes, Asbjørn/AAR-7479-2021; Dahan, Albert/B-8845-2008; van Velzen, Monique/H-7697-2019	Drewes, Asbjørn/0000-0001-7465-964X; Dahan, Albert/0000-0003-3161-3945; van Velzen, Monique/0000-0002-0289-6432	Grunenthal GmbH (Aachen, Germany); Danish Research Council (Copenhagen, Danmark)	Grunenthal GmbH (Aachen, Germany); Danish Research Council (Copenhagen, Danmark)	This Investigator Initiated Trial was funded in part by an educational grant from Grunenthal GmbH (Aachen, Germany), and by the Danish Research Council (Copenhagen, Danmark). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt-Nielsen L, 2012, CLIN J PAIN, V28, P623, DOI 10.1097/AJP.0b013e31823e15cb; De Felice M, 2011, PAIN, V152, P2701, DOI 10.1016/j.pain.2011.06.008; DICKENSON AH, 1987, J PHYSIOL-LONDON, V384, P81, DOI 10.1113/jphysiol.1987.sp016444; Edwards RR, 2004, PERCEPT MOTOR SKILL, V99, P679, DOI 10.2466/pms.99.2.679-687; Grill JD, 2002, J NEUROPHYSIOL, V87, P2205, DOI 10.1152/jn.00730.2001; King CD, 2013, J BEHAV MED, V36, P315, DOI 10.1007/s10865-012-9424-2; King CD, 2009, PAIN, V143, P172, DOI 10.1016/j.pain.2008.12.027; Kleinert R, 2008, ANESTH ANALG, V107, P2048, DOI 10.1213/ane.0b013e31818881ca; Kogel B, 2011, NEUROSCI LETT, V491, P104, DOI 10.1016/j.neulet.2011.01.014; Kress HG, 2012, ASRA M; Landau Ruth, 2010, J Vis Exp, DOI 10.3791/1671; Lautenbacher S, 1997, CLIN J PAIN, V13, P189, DOI 10.1097/00002508-199709000-00003; Le Bars D, 1992, Patol Fiziol Eksp Ter, P55; LEBARS D, 1992, PAIN, V48, P13, DOI 10.1016/0304-3959(92)90126-V; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Nahman-Averbuch H, 2014, PAIN, V155, P2491, DOI 10.1016/j.pain.2014.07.008; Nahman-Averbuch H, 2011, J PAIN SYMPTOM MANAG, V42, P229, DOI 10.1016/j.jpainsymman.2010.10.268; Niesters M, 2014, BRIT J ANAESTH, V113, P148, DOI 10.1093/bja/aeu056; Niesters M, 2013, BRIT J ANAESTH, V110, P1010, DOI 10.1093/bja/aes578; Niesters M, 2014, THESIS LEIDEN U; Niesters M, 2011, ANESTHESIOLOGY, V115, P1063, DOI 10.1097/ALN.0b013e31822fd03a; Niesters M, 2011, PAIN, V152, P656, DOI 10.1016/j.pain.2010.12.015; Olesen AE, 2012, PHARMACOL REV, V64, P722, DOI 10.1124/pr.111.005447; Olesen SS, 2010, CLIN GASTROENTEROL H, V8, P724, DOI 10.1016/j.cgh.2010.03.005; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; PERTOVAARA A, 1982, BRAIN RES, V251, P83, DOI 10.1016/0006-8993(82)91276-8; PETERS ML, 1992, PAIN, V50, P177, DOI 10.1016/0304-3959(92)90159-9; Pud D, 2009, PAIN, V144, P16, DOI 10.1016/j.pain.2009.02.015; Sarton E, 2000, ANESTHESIOLOGY, V93, P1245, DOI 10.1097/00000542-200011000-00018; Schroder W, 2011, J PHARMACOL EXP THER, V337, P312, DOI 10.1124/jpet.110.175042; Seifert F, 2009, BRAIN, V132, P788, DOI 10.1093/brain/awn346; Sprenger C, 2011, PAIN, V152, P428, DOI 10.1016/j.pain.2010.11.018; Steigerwald Ilona, 2012, J Pain Res, V5, P121, DOI 10.2147/JPR.S30540; Suzan E, 2013, PAIN, V154, P1413, DOI 10.1016/j.pain.2013.04.036; Tzschentke TM, 2007, J PHARMACOL EXP THER, V323, P265, DOI 10.1124/jpet.107.126052; van Wijk G, 2010, J PAIN, V11, P408, DOI 10.1016/j.jpain.2009.10.009; Wilder-Smith Oliver Hamilton, 2010, J Pain Palliat Care Pharmacother, V24, P119, DOI 10.3109/15360281003706069; WILLER JC, 1990, EUR J PHARMACOL, V182, P347, DOI 10.1016/0014-2999(90)90293-F; Yarnitsky D, 2015, EUR J PAIN, V19, P805, DOI 10.1002/ejp.605; Yarnitsky D, 2008, PAIN, V138, P22, DOI 10.1016/j.pain.2007.10.033; Yarnitsky D, 2014, PAIN, V155, P663, DOI 10.1016/j.pain.2013.11.005; Yarnitsky D, 2010, EUR J PAIN, V14, P339, DOI 10.1016/j.ejpain.2010.02.004	42	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128997	10.1371/journal.pone.0128997	http://dx.doi.org/10.1371/journal.pone.0128997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076171	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900041
J	McElroy, A; Hiraide, R; Bexfield, N; Jalal, H; Brownlie, J; Goodfellow, I; Caddy, SL				McElroy, Aoife; Hiraide, Rintaro; Bexfield, Nick; Jalal, Hamid; Brownlie, Joe; Goodfellow, Ian; Caddy, Sarah L.			Detection of Hepatitis E Virus Antibodies in Dogs in the United Kingdom	PLOS ONE			English	Article							BLOOD-DONORS; GENOTYPES 1; INFECTION; PREVALENCE; SWINE; STRAINS; VETERINARIANS; PATHOGENESIS; REPLICATION; PARTICLES	Hepatitis E virus (HEV) genotypes 3 and 4 are zoonotic pathogens, with pigs predominantly implicated in disease transmission. The rapid rise in human cases in developed countries over the past decade indicates a change in epidemiology of HEV, and it has been suggested that additional animal species may be involved in transmission of infection. Multiple studies have identified contact with dogs as a risk factor for HEV infection in industrialised nations, and a low seroprevalence to HEV has previously been reported in dogs in low-income countries. In this study we aimed to evaluate the possibility that dogs are susceptible to HEV, and determine the frequency with which this occurs. Serum samples from UK dogs with and without hepatitis were screened for HEV-specific antibodies, and canine liver and stool samples were analysed by qPCR for the presence of HEV RNA. We describe evidence to show HEV infection occurs at low levels in dogs in the UK, but the strain of origin is undetermined. The low seroprevalence level of HEV in dogs implies the risk of zoonotic disease transmission is likely to be limited, but further investigations will be required to determine if HEV-infected dogs can transmit HEV to man.	[McElroy, Aoife; Hiraide, Rintaro; Goodfellow, Ian; Caddy, Sarah L.] Univ Cambridge, Addenbrookes Hosp, Div Virol, Dept Pathol, Cambridge CB2 2QQ, England; [Bexfield, Nick] Univ Nottingham, Sch Vet Med & Sci, Loughborough LE12 5RD, Leics, England; [Jalal, Hamid] Addenbrookes Hosp, Publ Hlth Lab Cambridge, Publ Hlth England, Cambridge CB2 2QQ, England; [Brownlie, Joe] Royal Vet Coll, Dept Pathol & Pathogen Biol, Hatfield AL9 7TA, Herts, England; [Caddy, Sarah L.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Virol Sect, London W2 1NY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Nottingham; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Public Health England; University of Cambridge; University of London; University of London Royal Veterinary College; Imperial College London	Goodfellow, I (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Virol, Dept Pathol, Hills Rd, Cambridge CB2 2QQ, England.	ig299@cam.ac.uk; slc50@cam.ac.uk	Caddy, Sarah/AAG-9891-2019	Caddy, Sarah/0000-0002-9790-7420; Goodfellow, Ian/0000-0002-9483-510X; Bexfield, Nicholas/0000-0001-6830-8296	Wellcome Trust [WT088619MA, WT097997MA]; Medical Research Council; Medical Research Council [1110704] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Wellcome Trust Vacation Scholarship to AM, Wellcome Trust Research Training Fellowship to NB (Ref: WT088619MA), Wellcome Trust Senior Fellowship to IG (Ref: WT097997MA) (http://www.wellcome.ac.uk/), and a PhD studentship from the Medical Research Council to SC (http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arankalle VA, 2001, J VIRAL HEPATITIS, V8, P223, DOI 10.1046/j.1365-2893.2001.00290.x; Arankalle VA, 1999, J GEN VIROL, V80, P1691, DOI 10.1099/0022-1317-80-7-1691; Arends JE, 2014, J CLIN VIROL, V59, P81, DOI 10.1016/j.jcv.2013.11.013; Asher L, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-74; Baechlein C, 2013, BERL MUNCH TIERARZTL, V126, P25, DOI 10.2376/0005-9366-126-25; BALAYAN MS, 1983, INTERVIROLOGY, V20, P23, DOI 10.1159/000149370; Banks M, 2004, EMERG INFECT DIS, V10, P953, DOI 10.3201/eid1005.030908; Bexfield NH, 2014, J VIRAL HEPATITIS, V21, P223, DOI 10.1111/jvh.12150; Bexfield NH, 2011, VET REC, V169, P415, DOI 10.1136/vr.d4665; Billam P, 2005, J VIROL, V79, P3429, DOI 10.1128/JVI.79.6.3429-3437.2005; Boomkens SY, 2005, VET MICROBIOL, V108, P49, DOI 10.1016/j.vetmic.2005.03.003; Borgen K, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-61; Caddy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081596; Dong C, 2011, J CLIN MICROBIOL, V49, P4164, DOI 10.1128/JCM.05481-11; Emerson SU, 2003, REV MED VIROL, V13, P145, DOI 10.1002/rmv.384; Gallian P, 2014, EMERG INFECT DIS, V20, P1914, DOI 10.3201/eid2011.140516; Geng Jia-bao, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P47; GRAY JJ, 1993, J CLIN MICROBIOL, V31, P1022, DOI 10.1128/JCM.31.4.1022-1025.1993; Guu TSY, 2009, P NATL ACAD SCI USA, V106, P12992, DOI 10.1073/pnas.0904848106; Halbur PG, 2001, J CLIN MICROBIOL, V39, P918, DOI 10.1128/JCM.39.3.918-923.2001; Harvala H, 2014, J CLIN VIROL, V59, P184, DOI 10.1016/j.jcv.2014.01.001; Hewitt PE, 2014, LANCET, V384, P1766, DOI 10.1016/S0140-6736(14)61034-5; Ijaz S, 2009, J CLIN VIROL, V44, P272, DOI 10.1016/j.jcv.2009.01.005; Jothikumar N, 2006, J VIROL METHODS, V131, P65, DOI 10.1016/j.jviromet.2005.07.004; Lewis HC, 2008, EMERG INFECT DIS, V14, P2003; Li TC, 1997, J VIROL, V71, P7207, DOI 10.1128/JVI.71.10.7207-7213.1997; Liang HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098068; Liu JF, 2009, SCAND J INFECT DIS, V41, P291, DOI 10.1080/00365540902767031; Ma HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009160; McCreary C, 2008, VET REC, V163, P261, DOI 10.1136/vr.163.9.261; Meng XJ, 2010, VET MICROBIOL, V140, P256, DOI 10.1016/j.vetmic.2009.03.017; Meng XJ, 2002, J CLIN MICROBIOL, V40, P117, DOI 10.1128/JCM.40.1.117-122.2002; Meng XJ, 1998, J VIROL, V72, P9714, DOI 10.1128/JVI.72.12.9714-9721.1998; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Mesquita JR, 2014, J MED VIROL, V86, P954, DOI 10.1002/jmv.23927; Mochizuki M, 2006, VET REC, V159, P853; Poldervaart JH, 2009, J VET INTERN MED, V23, P72, DOI 10.1111/j.1939-1676.2008.0215.x; Sanford BJ, 2013, TRANSBOUND EMERG DIS, V60, P538, DOI 10.1111/tbed.12001; Sauleda S, 2014, TRANSFUSION, DOI [10.1111/trf.12929.10.1111/trf.12929, DOI 10.1111/TRF.12929.10.1111/TRF.12929]; Schielke A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-58; Shukla P, 2012, J VIROL, V86, P5697, DOI 10.1128/JVI.00146-12; Takahashi M, 2010, J CLIN MICROBIOL, V48, P1112, DOI 10.1128/JCM.02002-09; Takeda H, 2010, VOX SANG, V99, P307, DOI 10.1111/j.1423-0410.2010.01362.x; Vitral CL, 2005, MEM I OSWALDO CRUZ, V100, P117, DOI 10.1590/S0074-02762005000200003; Wang S, 2013, VIRUS RES, V176, P101, DOI 10.1016/j.virusres.2013.05.013; Williams TPE, 2001, J CLIN MICROBIOL, V39, P3040, DOI 10.1128/JCM.39.9.3040-3046.2001; Xing L, 2011, J VIROL, V85, P1117, DOI 10.1128/JVI.00657-10; Yamashita T, 2009, P NATL ACAD SCI USA, V106, P12986, DOI 10.1073/pnas.0903699106; Zhang W, 2008, ZOONOSES PUBLIC HLTH, V55, P291, DOI 10.1111/j.1863-2378.2008.01136.x; Zhuang WC, 2014, INT J INFECT DIS, V26, P9, DOI 10.1016/j.ijid.2014.04.022	50	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128703	10.1371/journal.pone.0128703	http://dx.doi.org/10.1371/journal.pone.0128703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076364	Green Submitted, gold, Green Published			2022-12-27	WOS:000356329900024
J	Metzler-Zebeli, BU; Eberspacher, E; Grull, D; Kowalczyk, L; Molnar, T; Zebeli, Q				Metzler-Zebeli, Barbara U.; Eberspaecher, Eva; Gruell, Dietmar; Kowalczyk, Lidia; Molnar, Timea; Zebeli, Qendrim			Enzymatically Modified Starch Ameliorates Postprandial Serum Triglycerides and Lipid Metabolome in Growing Pigs	PLOS ONE			English	Article							RESISTANT STARCH; PROTEIN-SYNTHESIS; LEUCINE SUPPLEMENTATION; NUTRIENT ABSORPTION; SKELETAL-MUSCLE; NEONATAL PIGS; PLASMA; CHOLESTEROL; OXIDATION; AMYLOSE	Developing host digestion-resistant starches to promote human health is of great research interest. Chemically modified starches (CMS) are widely used in processed foods and although the modification of the starch molecule allows specific reduction in digestibility, the metabolic effects of CMS have been less well described. This short-term study evaluated the impact of enzymatically modified starch (EMS) on fasting and postprandial profiles of blood glucose, insulin and lipids, and serum metabolome in growing pigs. Eight jugular-vein catheterized pigs (initial body weight, 37.4 kg; 4 months of age) were fed 2 diets containing 72% purified starch (EMS or waxy corn starch (control)) in a cross-over design for 7 days. On day 8, an 8-hour meal tolerance test (MTT) was performed with serial blood samplings. Besides biochemical analysis, serum was analysed for 201 metabolites through targeted mass spectrometry-based metabolomic approaches. Pigs fed the EMS diet showed increased (P<0.05) immediate serum insulin and plasma glucose response compared to pigs fed the control diet; however, area-under-the-curves for insulin and glucose were not different among diets. Results from MTT indicated reduced postprandial serum triglycerides with EMS versus control diet (P<0.05). Likewise, serum metabolome profiling identified characteristic changes in glycerophospholipid, lysophospholipids, sphingomyelins and amino acid metabolome profiles with EMS diet compared to control diet. Results showed rapid adaptations of blood metabolites to dietary starch shifts within 7 days. In conclusion, EMS ingestion showed potential to attenuate postprandial raise in serum lipids and suggested constant alteration in the synthesis or breakdown of sphingolipids and phospholipids which might be a health benefit of EMS consumption. Because serum insulin was not lowered, more research is warranted to reveal possible underlying mechanisms behind the observed changes in the profile of serum lipid metabolome in response to EMS consumption.	[Metzler-Zebeli, Barbara U.] Univ Vet Med Vienna, Univ Clin Swine, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Eberspaecher, Eva; Kowalczyk, Lidia] Univ Vet Med Vienna, Dept Compan Anim & Horses, Anaesthesiol & Perioperat Intens Care, Vienna, Austria; [Gruell, Dietmar; Molnar, Timea] Agrana Res & Innovat Ctr GmbH, Tulln, Austria; [Zebeli, Qendrim] Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Metzler-Zebeli, BU (corresponding author), Univ Vet Med Vienna, Univ Clin Swine, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria.	barbara.metzler@vetmeduni.ac.at			Austrian Research Promotion Agency (FFG) [836447]; Agrana Research & Innovation Center GmbH	Austrian Research Promotion Agency (FFG); Agrana Research & Innovation Center GmbH	This work was supported by the Austrian Research Promotion Agency (FFG), BRIDGE project No. 836447 - 'Healthy Carbohydrates' to QZ (www.ffg.at/en/bridge), and the Agrana Research & Innovation Center GmbH provided support in the form of salaries for authors DG and TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tamimi EK, 2010, J NUTR METAB, V2010, DOI 10.1155/2010/651063; Bird AR, 2004, BRIT J NUTR, V92, P607, DOI 10.1079/BJN20041248; Birt DF, 2013, ADV NUTR, V4, P587, DOI 10.3945/an.113.004325; Brites CM, 2011, NUTR RES, V31, P302, DOI 10.1016/j.nutres.2011.02.001; da Silva CS, 2014, ANIMAL, V8, P1917, DOI 10.1017/S1751731114001840; den Besten G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107392; den Besten G, 2013, AM J PHYSIOL-GASTR L, V305, pG900, DOI 10.1152/ajpgi.00265.2013; Deng J, 2010, J ANIM PHYSIOL AN N, V94, P220, DOI 10.1111/j.1439-0396.2008.00902.x; Dunn WB, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/011001; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Garlick PJ, 2005, J NUTR, V135, p1553S, DOI 10.1093/jn/135.6.1553S; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gootenberg DB, 2011, J ANIM SCI, V89, P1531, DOI 10.2527/jas.2010-3371; Granfeldt Y, 2006, EUR J CLIN NUTR, V60, P104, DOI 10.1038/sj.ejcn.1602273; Greenbaum CJ, 2008, DIABETES CARE, V31, P1966, DOI 10.2337/dc07-2451; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; Han KH, 2005, BRIT J NUTR, V94, P902, DOI 10.1079/BJN20051598; Haub MD, 2010, J NUTR METAB, V2010, DOI 10.1155/2010/230501; He QH, 2011, J PROTEOME RES, V10, P5214, DOI 10.1021/pr200688u; Hooda S, 2009, J ANIM SCI, V87, P2013, DOI 10.2527/jas.2008-1423; Ishikawa M, 2013, BIOL PHARM BULL, V36, P682; Iverson Jennifer F, 2013, J Amino Acids, V2013, P964637, DOI 10.1155/2013/964637; Lattimer JM, 2010, NUTRIENTS, V2, P1266, DOI 10.3390/nu2121266; Levitan I, 2010, ANTIOXID REDOX SIGN, V13, P39, DOI 10.1089/ars.2009.2733; Mace OJ, 2009, J PHYSIOL-LONDON, V587, P195, DOI 10.1113/jphysiol.2008.159616; Metzler-Zebeli BU, 2014, METABOLOMIC IN PRESS; Michal G, 1999, BIOCH PATHWAYS ATLAS; Murugesan G, 2003, J MOL CELL CARDIOL, V35, P1375, DOI 10.1016/j.yjmcc.2003.08.004; Nugent AP, 2005, NUTR BULL, V30, P27, DOI 10.1111/j.1467-3010.2005.00481.x; Nutrient Research Council, 2012, NUTRIENT REQUIREMENT; Rasmussen BB, 2002, J CLIN INVEST, V110, P1687, DOI 10.1172/JCI200215715; Regmi PR, 2011, J NUTR, V141, P398, DOI 10.3945/jn.110.132449; Robertson MD, 2005, AM J CLIN NUTR, V82, P559, DOI 10.1093/ajcn/82.3.559; Shimano H, 2002, VITAM HORM, V65, P167, DOI 10.1016/S0083-6729(02)65064-2; Shimotoyodome A, 2010, AM J PHYSIOL-ENDOC M, V298, pE652, DOI 10.1152/ajpendo.00468.2009; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Singh J, 2010, TRENDS FOOD SCI TECH, V21, P168, DOI 10.1016/j.tifs.2009.12.001; Suryawan A, 2012, PEDIATR RES, V71, P324, DOI 10.1038/pr.2011.79; TAGLIABUE A, 1995, AM J CLIN NUTR, V61, P1070, DOI 10.1093/ajcn/61.5.1070; Then C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078430; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Torrazza RM, 2010, J NUTR, V140, P2145, DOI 10.3945/jn.110.128421; VDLUFA, 2007, METHODENBUCH; Wahl S, 2012, OBESITY FACTS, V5, P660, DOI 10.1159/000343204; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43	45	15	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130553	10.1371/journal.pone.0130553	http://dx.doi.org/10.1371/journal.pone.0130553			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076487	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900179
J	Naughtin, M; Haftek-Terreau, Z; Xavier, J; Meyer, S; Silvain, M; Jaszczyszyn, Y; Levy, N; Miele, V; Benleulmi, MS; Ruff, M; Parissi, V; Vaillant, C; Lavigne, M				Naughtin, Monica; Haftek-Terreau, Zofia; Xavier, Johan; Meyer, Sam; Silvain, Maud; Jaszczyszyn, Yan; Levy, Nicolas; Miele, Vincent; Benleulmi, Mohamed Salah; Ruff, Marc; Parissi, Vincent; Vaillant, Cedric; Lavigne, Marc			DNA Physical Properties and Nucleosome Positions Are Major Determinants of HIV-1 Integrase Selectivity	PLOS ONE			English	Article							MODULATE RETROVIRAL INTEGRATION; LEUKEMIA-VIRUS INTEGRATION; IN-VITRO; HUMAN GENOME; STRUCTURAL BASIS; SITE SELECTION; PWWP DOMAIN; LEDGF/P75; SEQUENCE; BINDING	Retroviral integrases (INs) catalyse the integration of the reverse transcribed viral DNA into the host cell genome. This process is selective, and chromatin has been proposed to be a major factor regulating this step in the viral life cycle. However, the precise underlying mechanisms are still under investigation. We have developed a new in vitro integration assay using physiologically-relevant, reconstituted genomic acceptor chromatin and high-throughput determination of nucleosome positions and integration sites, in parallel. A quantitative analysis of the resulting data reveals a chromatin-dependent redistribution of the integration sites and establishes a link between integration sites and nucleosome positions. The co-activator LEDGF/p75 enhanced integration but did not modify the integration sites under these conditions. We also conducted an in cellulo genome-wide comparative study of nucleosome positions and human immunodeficiency virus type-1 (HIV-1) integration sites identified experimentally in vivo. These studies confirm a preferential integration in nucleosome-covered regions. Using a DNA mechanical energy model, we show that the physical properties of DNA probed by IN binding are important in determining IN selectivity. These novel in vitro and in vivo approaches confirm that IN has a preference for integration into a nucleosome, and suggest the existence of two levels of IN selectivity. The first depends on the physical properties of the target DNA and notably, the energy required to fit DNA into the IN catalytic pocket. The second depends on the DNA deformation associated with DNA wrapping around a nucleosome. Taken together, these results indicate that HIV-1 IN is a shape-readout DNA binding protein.	[Naughtin, Monica; Haftek-Terreau, Zofia; Xavier, Johan; Lavigne, Marc] Ecole Normale Super Lyon, Lab Joliot Curie, CNRS USR 3010, F-69364 Lyon, France; [Meyer, Sam] Univ Lyon, Microbiol Adaptat & Pathogenie, INSA Lyon, CNRS UMR 5240, Lyon, France; [Silvain, Maud; Jaszczyszyn, Yan] Univ Paris 11, CNRS UMR9198, CEA, Inst Integrat Biol Cell I2BC, F-91198 Gif Sur Yvette, France; [Levy, Nicolas; Ruff, Marc] CNRS, UMR 7104, INSERM U964,UDS, Inst Genet & Biol Mol & Cellulaire,Dept Biol Stru, Illkirch Graffenstaden, France; [Miele, Vincent] Univ Lyon 1, CNRS UMR 5558, Lab Biometrie & Biol Evolut, F-69365 Lyon, France; [Benleulmi, Mohamed Salah; Parissi, Vincent] Univ Bordeaux 2, CNRS, UMR 5234, Lab Microbiol Fondamentale & Pathogenicite, Bordeaux, France; [Vaillant, Cedric] Ecole Normale Super Lyon, Phys Lab, CNRS UMR 5672, F-69364 Lyon, France; [Lavigne, Marc] CNRS, UMR 3569, Dept Virol, Inst Pasteur, Paris, France	Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lavigne, M (corresponding author), Ecole Normale Super Lyon, Lab Joliot Curie, CNRS USR 3010, F-69364 Lyon, France.	marc.lavigne@pasteur.fr	HAFTEK-TERREAU, Zofia/F-5127-2018; ruff, marc/J-3011-2013; Meyer, Sam/AAC-8052-2019	HAFTEK-TERREAU, Zofia/0000-0002-4028-3362; ruff, marc/0000-0001-5451-6377; Meyer, Sam/0000-0001-7206-6226; LAVIGNE, Marc/0000-0002-3131-2539; Miele, Vincent/0000-0001-7584-0088	Agence Nationale de recherche sur le VIH et les hepatites; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche; Sidaction; Ecole Normale Superieure de Lyon; Institut Pasteiur de Paris	Agence Nationale de recherche sur le VIH et les hepatites(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Sidaction; Ecole Normale Superieure de Lyon(Grant Agency of the Czech Republic); Institut Pasteiur de Paris	This work was supported by Agence Nationale de recherche sur le VIH et les hepatites: JX VP CV ML; Centre National de la Recherche Scientifique: MN, MR, VP, CV, ML; Agence Nationale de la Recherche: MSB, VP, MR; Sidaction: MR; Ecole Normale Superieure de Lyon: CV, ML; and Institut Pasteiur de Paris: ML.	Allan J, 2012, J MOL BIOL, V417, P152, DOI 10.1016/j.jmb.2012.01.043; Balasubramanian S, 2009, BIOPHYS J, V96, P2245, DOI 10.1016/j.bpj.2008.11.040; Benleulmi MS, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0145-9; Botbol YR, 2008, NUCLEIC ACIDS RES, V36, P1237, DOI 10.1093/nar/gkm1127; Brin E, 2002, J BIOL CHEM, V277, P18357, DOI 10.1074/jbc.M201354200; Brin E, 2002, J BIOL CHEM, V277, P10938, DOI 10.1074/jbc.M108116200; Carteau S, 1999, J VIROL, V73, P6670, DOI 10.1128/JVI.73.8.6670-6679.1999; Carteau S, 1998, J VIROL, V72, P4005, DOI 10.1128/JVI.72.5.4005-4014.1998; Cattoglio C, 2010, BLOOD, V116, P5507, DOI 10.1182/blood-2010-05-283523; Cavazza A, 2013, HUM GENE THER, V24, P119, DOI 10.1089/hum.2012.203; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Chevereau G, 2011, FRONT LIFE SCI, V5, P29, DOI 10.1080/21553769.2012.708882; Chevereau G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.188103; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; De Rijck J, 2013, CELL REP, V5, P886, DOI 10.1016/j.celrep.2013.09.040; Delelis O, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-31; Delelis O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000608; Di Nunzio F, 2013, VIRUS RES, V178, P187, DOI 10.1016/j.virusres.2013.09.003; Eidahl JO, 2013, NUCLEIC ACIDS RES, V41, P3924, DOI 10.1093/nar/gkt074; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; GOODARZI G, 1995, J VIROL, V69, P6090, DOI 10.1128/JVI.69.10.6090-6097.1995; Gupta SS, 2013, J VIROL, V87, P12721, DOI 10.1128/JVI.01942-13; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Henikoff JG, 2011, P NATL ACAD SCI USA, V108, P18318, DOI 10.1073/pnas.1110731108; Hughes AL, 2012, MOL CELL, V48, P5, DOI 10.1016/j.molcel.2012.07.003; Kessl JJ, 2011, NUCLEIC ACIDS RES, V39, P9009, DOI 10.1093/nar/gkr581; Kvaratskhelia M, 2014, NUCLEIC ACIDS RES, V42, P10209, DOI 10.1093/nar/gku769; LaFave MC, 2014, NUCLEIC ACIDS RES, V42, P4257, DOI 10.1093/nar/gkt1399; Leh H, 2000, BIOCHEMISTRY-US, V39, P9285, DOI 10.1021/bi000398b; Lelek M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7483; Lesbats P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001280; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Li M, 2009, METHODS, V47, P237, DOI 10.1016/j.ymeth.2009.02.001; Llano M, 2006, J MOL BIOL; Llano M, 2006, SCIENCE; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Maillot B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060734; Marini B, 2015, NATURE, V521, P227, DOI 10.1038/nature14226; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Michel F, 2009, EMBO J, V28, P980, DOI 10.1038/emboj.2009.41; Miele V, 2008, NUCLEIC ACIDS RES, V36, P3746, DOI 10.1093/nar/gkn262; Milani P, 2009, P NATL ACAD SCI USA, V106, P22257, DOI 10.1073/pnas.0909511106; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Morchikh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081217; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; Pandey KK, 2007, J VIROL, V81, P3969, DOI 10.1128/JVI.02322-06; PERCUS JK, 1976, J STAT PHYS, V15, P505, DOI 10.1007/BF01020803; Pradeepa MM, 2014, NUCLEIC ACIDS RES, V42, P9021, DOI 10.1093/nar/gku647; Pradeepa MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002717; PRUSS D, 1994, J BIOL CHEM, V269, P25031; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; Quashie PK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-34; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Roth SL, 2011, J VIROL, V85, P7393, DOI 10.1128/JVI.00635-11; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Schrijvers R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002558; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Serrao E, 2014, NUCLEIC ACIDS RES, V42, P5164, DOI 10.1093/nar/gku136; Sexton BS, 2014, GENOME RES, V24, P251, DOI 10.1101/gr.160150.113; Sharma A, 2013, P NATL ACAD SCI USA, V110, P12036, DOI 10.1073/pnas.1307157110; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Shun MC, 2008, J VIROL, V82, P11555, DOI 10.1128/JVI.01561-08; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Taganov KD, 2004, J VIROL, V78, P5848, DOI 10.1128/JVI.78.11.5848-5855.2004; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Thierry S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0153-9; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; Vaillant C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.218103; Vaillant C, 2010, GENOME RES, V20, P59, DOI 10.1101/gr.096644.109; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; van Nuland R, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-12; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; WORKMAN JL, 1991, METHOD CELL BIOL, V35, P419; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508	85	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129427	10.1371/journal.pone.0129427	http://dx.doi.org/10.1371/journal.pone.0129427			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075397	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900072
J	Zou, L; Yli-Halla, M; Stoddard, FL; Makela, PSA				Zou, Ling; Yli-Halla, Markku; Stoddard, Frederick L.; Makela, Pirjo S. A.			Effects of Break Crops on Yield and Grain Protein Concentration of Barley in a Boreal Climate	PLOS ONE			English	Article							SOIL MINERAL NITROGEN; ORGANIC-MATTER; CATCH CROPS; ALLELOPATHY; GERMINATION; LEGUMES; LOSSES	Rotation with dicotyledonous crops to break cereal monoculture has proven to be beneficial to successive cereals. In two fields where the soil had been subjected to prolonged, continuous cereal production, two 3-year rotation trials were established. In the first year, faba bean, turnip rape and barley were grown, as first crops, in large blocks and their residues tilled into the soil after harvest. In the following year, barley, buckwheat, caraway, faba bean, hemp and white lupin were sown, as second crops, in each block and incorporated either at flowering stage (except barley) or after harvest. In the third year, barley was grown in all plots and its yield and grain protein concentration were determined. Mineral N in the plough layer was determined two months after incorporation of crops and again before sowing barley in the following year. The effect of faba bean and turnip rape on improving barley yields and grain protein concentration was still detectable two years after they were grown. The yield response of barley was not sensitive to the growth stage of second crops when they were incorporated, but was to different second crops, showing clear benefits averaging 6-7% after white lupin, faba bean and hemp but no benefit from caraway or buckwheat. The effect of increased N in the plough layer derived from rotation crops on barley yields was minor. Incorporation of plants at flowering stage slightly increased third-year barley grain protein concentration but posed a great potential for N loss compared with incorporation of crop residues after harvest, showing the value of either delayed incorporation or using catch crops.	[Zou, Ling; Stoddard, Frederick L.; Makela, Pirjo S. A.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Yli-Halla, Markku] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland	University of Helsinki; University of Helsinki	Zou, L (corresponding author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.	ling.zou@helsinki.fi	Stoddard, Frederick/E-6436-2015; Mäkelä, Pirjo/N-7863-2013	Stoddard, Frederick/0000-0002-8097-5750; Mäkelä, Pirjo/0000-0002-8757-6015; Yli-Halla, Markku/0000-0002-8062-7019	Maj and Tor Nessling Foundation; Finnish Cultural foundation; Olvi foundation; Niemi Foundation	Maj and Tor Nessling Foundation; Finnish Cultural foundation(Finnish Cultural FoundationFinnish IT center for science); Olvi foundation; Niemi Foundation	This work was supported by Maj and Tor Nessling Foundation (http://www.nessling.fi/en/), Finnish Cultural foundation (https://www.skr.fi/en), Olvi foundation (http://www.olvisaatio.fi/web/olvisaatio/) and the Niemi Foundation (http://www.aurora-tietokanta.fi/foundation/details/id/336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcand MM, 2013, PLANT SOIL, V371, P67, DOI 10.1007/s11104-013-1626-z; Azirak S, 2008, ACTA AGR SCAND B-S P, V58, P88, DOI 10.1080/09064710701228353; Campiglia E, 2014, SOIL TILL RES, V139, P1, DOI 10.1016/j.still.2014.01.003; Chen YH, 2012, BIOL RES, V45, P171, DOI 10.4067/S0716-97602012000200009; DALAL RC, 1987, AUST J SOIL RES, V25, P83, DOI 10.1071/SR9870083; FAO, 2006, WORLD SOIL RES REP; Felipe M., 2012, STAT PROCEDURES AGR; Hamza MA, 2007, SOIL TILL RES, V82, P121; Hauggaard-Nielsen H, 2009, NUTR CYCL AGROECOSYS, V84, P281, DOI 10.1007/s10705-008-9242-7; Heikinkeimo M., 1992, STAT SOIL TEMPERATUR, V22, P75; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; INAM B, 1989, Pakistan Journal of Scientific and Industrial Research, V32, P617; Johnston AE, 2009, ADV AGRON, V101, P1, DOI 10.1016/S0065-2113(08)00801-8; Kaul H. P., 2004, Bodenkultur, V55, P95; Kirkegaard J, 2008, FIELD CROP RES, V107, P185, DOI 10.1016/j.fcr.2008.02.010; Kraljevic D, 2007, CEREAL RES COMMUN, V35, P665, DOI 10.1556/CRC.35.2007.2.125; Kramberger B, 2009, EUR J AGRON, V31, P103, DOI 10.1016/j.eja.2009.05.006; LINDEN B, 1992, SWED J AGR RES, V22, P3; LOVETT JV, 1991, BIOL AGRIC HORTIC, V8, P89, DOI 10.1080/01448765.1991.9754583; Macias FA, 2007, PEST MANAG SCI, V63, P327, DOI 10.1002/ps.1342; Mandal N, 2013, FIELD CROP RES, V154, P178, DOI 10.1016/j.fcr.2013.08.007; Meier U., 2001, GROWTH STAGES MONO D; Ministry of Agriculture and Forestry of Finland, 2010, CER PROD; Miransari M, 2012, COMMUN SOIL SCI PLAN, V43, P799, DOI 10.1080/00103624.2012.648357; Neumann G, 2000, ANN BOT-LONDON, V85, P909, DOI 10.1006/anbo.2000.1135; Paasonen-Kivekas M, 2005, AGR FOOD SCI, V14, P57, DOI 10.2137/1459606054224174; Peoples MB, 2009, SYMBIOSIS, V48, P1, DOI 10.1007/BF03179980; Pietikainen J, 2005, FEMS MICROBIOL ECOL, V52, P49, DOI 10.1016/j.femsec.2004.10.002; R Core Team, 2020, R LANG ENV STAT COMP; Salo T, 2006, AGR ECOSYST ENVIRON, V113, P98, DOI 10.1016/j.agee.2005.09.002; St Luce M, 2013, CAN J SOIL SCI, V93, P607, DOI [10.4141/CJSS2013-005, 10.4141/cjss2013-005]; Stenberg M, 1999, SOIL TILL RES, V50, P115, DOI 10.1016/S0167-1987(98)00197-4; Tekauz A., 2003, DIS FIELD CROPS CANA, P30; Thorup-Kristensen K, 2010, SOIL USE MANAGE, V26, P27, DOI 10.1111/j.1475-2743.2009.00255.x; Turtola E, 1998, AGR FOOD SCI FINLAND, V7, P569, DOI 10.23986/afsci.5614; Valkama E, 2013, AGR ECOSYST ENVIRON, V164, P1, DOI 10.1016/j.agee.2012.09.010; Weinert TL, 2002, AGRON J, V94, P365, DOI 10.2134/agronj2002.0365; WINK M, 1983, PLANTA, V158, P365, DOI 10.1007/BF00397339; YLARANTA T, 1993, AGR SCI FINLAND, V2, P281, DOI 10.23986/afsci.72651; Zou L, 2014, ALLELOPATHY J, V33, P227	40	4	4	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130765	10.1371/journal.pone.0130765	http://dx.doi.org/10.1371/journal.pone.0130765			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076452	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900187
J	Castelein, S; Liemburg, EJ; de Lange, JS; van Es, FD; Visser, E; Aleman, A; Bruggeman, R; Knegtering, H				Castelein, Stynke; Liemburg, Edith J.; de Lange, Jill S.; van Es, Frank D.; Visser, Ellen; Aleman, Andre; Bruggeman, Richard; Knegtering, Henderikus			Suicide in Recent Onset Psychosis Revisited: Significant Reduction of Suicide Rate over the Last Two Decades - A Replication Study of a Dutch Incidence Cohort	PLOS ONE			English	Article							RISK-FACTORS; 1ST EPISODE; COMPLETED SUICIDE; SCHIZOPHRENIC-PATIENTS; 5-FACTOR MODEL; PREDICTORS; 1ST-EPISODE; DISORDERS; PERSONALITY; IMPULSIVITY	This study aims to compare the suicide risk over the past decade following recent onset psychosis to findings from the eighties and nineties in the same catchment area and to identify predictors of suicide in the context of the Psychosis Recent Onset Groningen-Survey (PROGR-S). A medical file search was carried out to determine the current status of all patients admitted between 2000 and 2009. The suicide rate was compared with a study executed in 1973-1988 in the same catchment area. Predictors of suicide were investigated using Cox regression. The status of 424 of the 614 patients was known in July 2014. Suicide occurred in 2.4% of patients with psychosis disorders (n = 10; mean follow-up 5.6 years); 6 out of 10 suicides took place within two years. Within two decades, the suicide rate dropped from 11% (follow-up 15 years, 8.5% after 5 years) to 2.4%. The Standardized Mortality Rate (SMR) of suicides compared with the general population was 41.6. A higher age was the only significant predictor for suicide. Neuroticism, living situation, disorganized and negative symptoms, and passive coping style all showed a trend for significance. A significant reduction in the suicide rate was found for people with psychosis over the past decades. Given the high SMR, suicide research should be given the highest priority. Identifying predictors may contribute to further reduction of suicide among patients with psychosis.	[Castelein, Stynke; Liemburg, Edith J.; de Lange, Jill S.; van Es, Frank D.; Visser, Ellen; Bruggeman, Richard; Knegtering, Henderikus] Univ Groningen, Univ Med Ctr Groningen, Rob Giel Res Ctr, Groningen, Netherlands; [Castelein, Stynke; Knegtering, Henderikus] Lentis Psychiat Inst, Lentis Res, Groningen, Netherlands; [Liemburg, Edith J.; Aleman, Andre; Knegtering, Henderikus] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NeuroImaging Ctr, Groningen, Netherlands; [van Es, Frank D.; Bruggeman, Richard] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Groningen, Netherlands; [Aleman, Andre] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Liemburg, EJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Rob Giel Res Ctr, Groningen, Netherlands.	e.j.liemburg@umcg.nl		Bruggeman, Richard/0000-0002-3238-8471; Castelein, Stynke/0000-0002-8419-568X				Agerbo E, 2007, ARCH GEN PSYCHIAT, V64, P1377, DOI 10.1001/archpsyc.64.12.1377; Aleman A, 2014, NATURE, V509, P421, DOI 10.1038/509421a; Altamura AC, 2003, SCHIZOPHR RES, V60, P47, DOI 10.1016/S0920-9964(02)00164-0; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Austad G, 2013, EARLY INTERV PSYCHIA; Bertelsen M, 2007, BRIT J PSYCHIAT, V191, pS140, DOI 10.1192/bjp.191.51.s140; Brugnoli R, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-83; Cheng ATA, 2000, BRIT J PSYCHIAT, V177, P360, DOI 10.1192/bjp.177.4.360; Delaney C, 2012, SCHIZOPHR RES, V140, P232, DOI 10.1016/j.schres.2012.06.017; Doihara C, 2012, PSYCHIAT CLIN NEUROS, V66, P529, DOI 10.1111/j.1440-1819.2012.02379.x; DRAKE RE, 1985, COMPR PSYCHIAT, V26, P90, DOI 10.1016/0010-440X(85)90053-7; Dutta R, 2011, SCHIZOPHR RES, V126, P11, DOI 10.1016/j.schres.2010.11.021; Dutta R, 2010, ARCH GEN PSYCHIAT, V67, P1230, DOI 10.1001/archgenpsychiatry.2010.157; Fang L, 2012, J NERV MENT DIS, V200, P598, DOI 10.1097/NMD.0b013e31825bfb53; Fedyszyn IE, 2012, SCHIZOPHR RES, V140, P17, DOI 10.1016/j.schres.2012.06.022; Fenton WS, 1997, AM J PSYCHIAT, V154, P199; Fleischhacker WW, 2014, J CLIN PSYCHIAT, V75, pE184, DOI 10.4088/JCP.13m08563; Giel R., 1996, SCAN 2 1 SCHEDULES C; Haw C, 2005, SUICIDE LIFE-THREAT, V35, P50, DOI 10.1521/suli.35.1.50.59260; Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9; Healy D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001810; Hor K, 2010, J PSYCHOPHARMACOL, V24, P81, DOI 10.1177/1359786810385490; Kay S, 1987, SCHIZOPHR B, V13, P231; Kelly DL, 2004, J PSYCHIAT RES, V38, P531, DOI 10.1016/j.jpsychires.2004.02.001; Kim CH, 2003, SCHIZOPHR RES, V60, P71, DOI 10.1016/S0920-9964(02)00310-9; Koletsi M, 2009, SOC PSYCH PSYCH EPID, V44, P961, DOI 10.1007/s00127-009-0017-5; Kreyenbuhl JA, 2002, SCHIZOPHR RES, V58, P253, DOI 10.1016/S0920-9964(01)00379-6; Kuo CJ, 2005, J CLIN PSYCHIAT, V66, P579, DOI 10.4088/JCP.v66n0506; Laursen TM, 2011, SCHIZOPHR RES, V131, P101, DOI 10.1016/j.schres.2011.06.008; Lester D, 2006, SUICIDE LIFE-THREAT, V36, P50, DOI 10.1521/suli.2006.36.1.50; Li ZY, 2012, J NERV MENT DIS, V200, P885, DOI 10.1097/NMD.0b013e31826b6ecc; Liemburg EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113521; Lonnqvist JE, 2009, J ABNORM PSYCHOL, V118, P418, DOI 10.1037/a0015127; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; McGirr A, 2006, SCHIZOPHR RES, V84, P132, DOI 10.1016/j.schres.2006.02.025; Melle I, 2006, AM J PSYCHIAT, V163, P800, DOI 10.1176/appi.ajp.163.5.800; Melle I, 2010, ARCH SUICIDE RES, V14, P158, DOI 10.1080/13811111003704787; MILES CP, 1977, J NERV MENT DIS, V164, P231, DOI 10.1097/00005053-197704000-00002; Mitter N, 2013, SCHIZOPHR RES, V151, P274, DOI 10.1016/j.schres.2013.10.006; Moller-Leimkuhler AM, 2003, EUR ARCH PSY CLIN N, V253, P1, DOI 10.1007/s00406-003-0397-6; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nangle JM, 2006, SCHIZOPHR RES, V85, P196, DOI 10.1016/j.schres.2006.03.035; Nordentoft M, 2004, BRIT MED J, V329, P261, DOI 10.1136/bmj.38133.622488.63; Nordentoft M, 2011, ARCH GEN PSYCHIAT, V68, P1058, DOI 10.1001/archgenpsychiatry.2011.113; Palmer BA, 2005, ARCH GEN PSYCHIAT, V62, P247, DOI 10.1001/archpsyc.62.3.247; Pompili M, 2011, SCHIZOPHR RES, V129, P1, DOI 10.1016/j.schres.2011.03.008; Pompili M, 2009, PSYCHIAT RES, V167, P251, DOI 10.1016/j.psychres.2008.03.018; Potkin SG, 2003, BIOL PSYCHIAT, V54, P444, DOI 10.1016/S0006-3223(03)00178-1; Pratt D, 2010, BEHAV RES THER, V48, P1211, DOI 10.1016/j.brat.2010.08.005; Reutfor J, 2009, SCHIZOPHR RES, V108, P231, DOI 10.1016/j.schres.2008.12.023; Schreurs PJG, 1988, COPING PROBLEMS EVEN; Wallwork RS, 2012, SCHIZOPHR RES, V137, P246, DOI 10.1016/j.schres.2012.01.031; Webb RT, 2011, SCHIZOPHR RES, V130, P143, DOI 10.1016/j.schres.2011.04.031; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wiersma D, 1998, SCHIZOPHRENIA BULL, V24, P75, DOI 10.1093/oxfordjournals.schbul.a033315; Witt K, 2014, SCHIZOPHR RES; Wolters HA, 2009, SCHIZOPHR RES, V112, P114, DOI 10.1016/j.schres.2009.03.026; Wu CS, 2009, COMPR PSYCHIAT, V50, P315, DOI 10.1016/j.comppsych.2008.09.006; Yan F, 2013, SOC PSYCH PSYCH EPID, V48, P447, DOI 10.1007/s00127-012-0555-0; Zhang DG, 2012, BRAIN IMAGING BEHAV, V6, P27, DOI 10.1007/s11682-011-9138-z	60	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129263	10.1371/journal.pone.0129263	http://dx.doi.org/10.1371/journal.pone.0129263			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26068417	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000059
J	Mao, XY; Jia, PL; Zhang, LH; Zhao, PJ; Chen, Y; Zhang, MM				Mao, Xuanyue; Jia, Pengli; Zhang, Longhao; Zhao, Pujing; Chen, Ying; Zhang, Mingming			An Evaluation of the Effects of Human Factors and Ergonomics on Health Care and Patient Safety Practices: A Systematic Review	PLOS ONE			English	Article							DECISION-SUPPORT-SYSTEMS; INTERVENTION PROGRAM; PARTICIPATORY ERGONOMICS; TASK-PERFORMANCE; BACK-PAIN; IMPACT; DESIGN; MUSCULOSKELETAL; IMPLEMENTATION; SIMULATION	Background From the viewpoint of human factors and ergonomics (HFE), errors often occur because of the mismatch between the system, technique and characteristics of the human body. HFE is a scientific discipline concerned with understanding interactions between human behavior, system design and safety. Objective To evaluate the effectiveness of HFE interventions in improving health care workers' outcomes and patient safety and to assess the quality of the available evidence. Methods We searched databases, including MEDLINE, EMBASE, BIOSIS Previews and the CBM (Chinese BioMedical Literature Database), for articles published from 1996 to Mar. 2015. The quality assessment tool was based on the risk of bias criteria developed by the Cochrane Effective Practice and Organization of Care (EPOC) Group. The interventions of the included studies were categorized into four relevant domains, as defined by the International Ergonomics Association. Results For this descriptive study, we identified 8, 949 studies based on our initial search. Finally, 28 studies with 3,227 participants were included. Among the 28 included studies, 20 studies were controlled studies, two of which were randomized controlled trials. The other eight studies were before/after surveys, without controls. Most of the studies were of moderate or low quality. Five broad categories of outcomes were identified in this study: 1) medical errors or patient safety, 2) health care workers' quality of working life (e.g. reduced fatigue, discomfort, workload, pain and injury), 3) user performance (e.g., efficiency or accuracy), 4) health care workers' attitudes towards the interventions( e.g., satisfaction and preference), and 5) economic evaluations. Conclusion The results showed that the interventions positively affected the outcomes of health care workers. Few studies considered the financial merits of these interventions. Most of the included studies were of moderate quality. This review highlights the need for scientific and standardized guidelines regarding how HFE should be implemented in health care.	[Mao, Xuanyue; Jia, Pengli; Zhang, Longhao; Zhao, Pujing; Zhang, Mingming] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610041, Peoples R China; [Chen, Ying] Sichuan Univ, Sch Foreign Languages, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University	Zhang, MM (corresponding author), Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610041, Peoples R China.	mingming-zhang@163.com	Imtiaz, Ahmed S/O-6563-2016		National Natural Science foundation of China (NSFC) [70973083]	National Natural Science foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science foundation of China (NSFC) No. 70973083 (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre NMC, 2001, REV SAUDE PUBL, V35, P356, DOI 10.1590/S0034-89102001000400004; Amalberti R, 2006, HDB HUMAN FACTORS HL, P361; Amick BC, 2009, PROF SAF, V54, P24; Bauman EB, 2010, RESUSCITATION, V81, P1161, DOI 10.1016/j.resuscitation.2010.05.005; Berthelette D, 2012, APPL ERGON, V43, P239, DOI 10.1016/j.apergo.2011.05.008; Boggild H, 2001, SCAND J WORK ENV HEA, V27, P87, DOI 10.5271/sjweh.594; Brewer S, 2006, J OCCUP REHABIL, V16, P325, DOI 10.1007/s10926-006-9031-6; Cahan MA, 2010, ARCH SURG-CHICAGO, V145, P1151, DOI 10.1001/archsurg.2010.252; Carayon P, 2006, QUAL SAF HEALTH CARE, V15, pI50, DOI 10.1136/qshc.2005.015842; Carayon P, 2006, HDB HUMAN FACTORS HL; Carayon P, 2014, BMJ QUAL SAF, V23, P196, DOI 10.1136/bmjqs-2013-001812; Carayon P, 2010, APPL ERGON, V41, P657, DOI 10.1016/j.apergo.2009.12.011; Cochrane Effective Practice and Organization of Care Group, 2013, POPULATION HLTH, V8, P12; Egger M, 2005, SYSTEMATIC REV HLTH, P211; Engels JA, 1998, INT ARCH OCC ENV HEA, V71, P336, DOI 10.1007/s004200050289; Engels JA, 1997, INT ARCH OCC ENV HEA, V69, P475, DOI 10.1007/s004200050176; Evanoff BA, 1999, AM J IND MED, V35, P358, DOI 10.1002/(SICI)1097-0274(199904)35:4<358::AID-AJIM6>3.0.CO;2-R; Fujishiro K, 2006, AM J IND MED, V49, P65, DOI 10.1002/ajim.20245; Galleano R, 2006, ANN SURG, V243, P329, DOI 10.1097/01.sla.0000201481.08336.dc; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Gurses AP, 2012, BMJ QUAL SAF, V21, P347, DOI 10.1136/bmjqs-2011-000421; Haddad O, 2012, INT J OCCUP ENV MED, V3, P76; Hakola T, 2010, IND HEALTH, V48, P390, DOI 10.2486/indhealth.MSSW-02; Hemens BJ, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-89; Institute of Medicine, 2006, PREV MED ERR; Institute of Medicine Committee on the Work Environment for Nurses and Patient Safety, 2004, KEEPING PATIENTS SAF; International ergonomic association (IEA), 2000, HUM FACTORS, V1, P01; Jarvelin-Pasanen S, 2013, J OCCUP HEALTH, V55, P225, DOI 10.1539/joh.12-0250-OA; Jaspers MWM, 2011, J AM MED INFORM ASSN, V18, P327, DOI 10.1136/amiajnl-2011-000094; Jeffcott SA, 2009, QUAL SAF HEALTH CARE, V18, P256, DOI 10.1136/qshc.2008.030163; Karsh B.-T., 2001, THEORETICAL ISSUES E, V2, P23, DOI DOI 10.1080/14639220152644533; Kobayashi L, 2013, BMJ QUAL SAF, V22, P72, DOI 10.1136/bmjqs-2012-001134; Lim HJ, 2011, J SAFETY RES, V42, P185, DOI 10.1016/j.jsr.2011.05.002; Lin L, 2001, J BIOMED INFORM, V34, P274, DOI 10.1006/jbin.2001.1028; Lin L, 1998, J CLIN MONITOR COMP, V14, P253, DOI 10.1023/A:1009928203196; Luttmann A, 1998, EUR UROL, V34, P6, DOI 10.1159/000019670; Marshall David A, 2007, AORN J, V86, P994, DOI 10.1016/j.aorn.2007.11.026; McCulloch P, 2002, BRIT MED J, V324, P1448, DOI 10.1136/bmj.324.7351.1448; Nelson A, 2006, INT J NURS STUD, V43, P717, DOI 10.1016/j.ijnurstu.2005.09.004; Nieuwlaat R, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-90; Park RM, 2009, AM J IND MED, V52, P683, DOI 10.1002/ajim.20731; Perrow C, 1984, NORMAL ACCIDENTS; Pohjonen T, 1998, INT J IND ERGONOM, V21, P345, DOI 10.1016/S0169-8141(96)00083-2; Quoted in Institute of Medicine, 2000, ERR HUM BUILD SAF HL; Reed D, 2005, ANN INTERN MED, V142, P1080, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00008; Reid PP, 2005, BUILDING BETTER DELI; Rivilis I, 2008, APPL ERGON, V39, P342, DOI 10.1016/j.apergo.2007.08.006; Rozenbaum H, 2013, INT J QUAL HEALTH C, V25, P188, DOI 10.1093/intqhc/mzt005; Sahota N, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-91; Santa M, 1998, HUMAN FACTORS DIRECT; Shamliyan TA, 2008, HEALTH SERV RES, V43, P32, DOI 10.1111/j.1475-6773.2007.00751.x; Smedley J, 2003, SCAND J WORK ENV HEA, V29, P117, DOI 10.5271/sjweh.713; Smith CA, 2002, APPL ERGON, V33, P175, DOI 10.1016/S0003-6870(01)00060-6; Smith M, 1999, WORK RELATED MUSCULO; Szeto GPY, 2013, APPL ERGON, V44, P414, DOI 10.1016/j.apergo.2012.10.004; Szeto GPY, 2010, J ADV NURS, V66, P1022, DOI 10.1111/j.1365-2648.2009.05255.x; Tompa E, 2010, J OCCUP REHABIL, V20, P220, DOI 10.1007/s10926-009-9210-3; Trejo AE, 2006, INT J IND ERGONOM, V36, P25, DOI 10.1016/j.ergon.2005.06.008; U.S. Food and Drug Administration, 1998, HUM FACT IMPL NEW GM, V2; Ulmer C, 2009, RESIDENT DUTY HOURS: ENHANCING SLEEP, SUPERVISION, AND SAFETY, P1; Wegman D, 2002, J OCCUPATIONAL ENV M, V44, P380, DOI DOI 10.1097/00043764-200204000-00021; Woods D., 2006, RESILIENCE ENG CONCE, P1; World Health Organization (WHO), 2009, HUM FACT PAT SAF REV, V4; Xiao DJ, 2012, APPL ERGON, V43, P548, DOI 10.1016/j.apergo.2011.08.010	64	15	15	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129948	10.1371/journal.pone.0129948	http://dx.doi.org/10.1371/journal.pone.0129948			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26067774	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000126
J	Silva, DP; Varela, S; Nemesio, A; De Marco, P				Silva, Daniel Paiva; Varela, Sara; Nemesio, Andre; De Marco, Paulo, Jr.			Adding Biotic Interactions into Paleodistribution Models: A Host-Cleptoparasite Complex of Neotropical Orchid Bees	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; NICHE MODELS; IMPROVE PREDICTION; CLIMATE STABILITY; EUGLOSSINE BEES; SOUTH-AMERICA; SAMPLING BIAS; GLOBAL CHANGE; APIDAE; EXTINCTION	Orchid bees compose an exclusive Neotropical pollinators group, with bright body coloration. Several of those species build their own nests, while others are reported as nest cleptoparasites. Here, the objective was to evaluate whether the inclusion of a strong biotic interaction, such as the presence of a host species, improved the ability of species distribution models (SDMs) to predict the geographic range of the cleptoparasite species. The target species were Aglae caerulea and its host species Eulaema nigrita. Additionally, since Aglae caerulea is more frequently found in the Amazon rather than the Cerrado areas, a secondary objective was to evaluate whether this species is increasing or decreasing its distribution given South American past and current climatic conditions. SDMs methods (Maxent and Bioclim), in addition with current and past South American climatic conditions, as well as the occurrences for Aglae caerulea and Eulaema nigrita were used to generate the distribution models. The distribution of Aglae caerulea was generated with and without the inclusion of the distribution of Eulaema nigrita as a predictor variable. The results indicate Aglae caerulea was barely affected by past climatic conditions and the populations from the Cerrado savanna could be at least 21,000 years old (the last glacial maximum), as well as the Amazonian ones. On the other hand, in this study, the inclusion of the host-cleptoparasite interaction complex did not statistically improve the quality of the produced models, which means that the geographic range of this cleptoparasite species is mainly constrained by climate and not by the presence of the host species. Nonetheless, this could also be caused by unknown complexes of other Euglossini hosts with Aglae caerulea, which still are still needed to be described by science.	[Silva, Daniel Paiva] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Varela, Sara] Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, Berlin, Germany; [Nemesio, Andre] Univ Fed Uberlandia, Inst Biol, BR-38400 Uberlandia, MG, Brazil; [De Marco, Paulo, Jr.] Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Theory Metapopulat & Landscape Lab, Goiania, Go, Brazil	Universidade Federal do Para; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Universidade Federal de Uberlandia; Universidade Federal de Goias	Silva, DP (corresponding author), Fed Univ Para, Inst Ciencias Biol, Rua Augusto Correia, BR-66059 Belem, Para, Brazil.	daniel.paivasilva@gmail.com	Nemésio, André/D-1920-2012; Silva, Daniel Paiva/F-8052-2010; De Marco, Paulo/B-2209-2009; Varela, Sara/J-7725-2016	Silva, Daniel Paiva/0000-0002-2457-6245; De Marco, Paulo/0000-0002-3628-6405; Varela, Sara/0000-0002-5756-5737	CNPq grant	CNPq grant(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	PDMJ was continuously supported by several CNPq grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab'Saber A.N, 1977, GEOMORFOLOGIA, V52, P1, DOI DOI 10.3897/ZOOKEYS.150.2109; Abrahamczyk S, 2011, BIODIVERS CONSERV, V20, P2981, DOI 10.1007/s10531-011-0105-1; Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Batalha H, 2013, J ORNITHOL, V154, P41, DOI 10.1007/s10336-012-0866-7; Bigarella JJ, 1975, AN ACAD BRAS CIENC, V47, P411; Burnham K P, 2003, MODEL SELECT MULTIMO; Coimbra-Filho AF, 1996, LIMITES ORIGINAIS BI; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; de Oliveira G, 2014, ECOGRAPHY, V37, P637, DOI 10.1111/j.1600-0587.2013.00564.x; De Oliveira PE, 1999, PALAEOGEOGR PALAEOCL, V152, P319, DOI 10.1016/S0031-0182(99)00061-9; de Vivo M, 2004, J BIOGEOGR, V31, P943, DOI 10.1111/j.1365-2699.2004.01068.x; de Vivo Mario, 1997, Journal of Comparative Biology, V2, P65; dos Anjos-Silva EJ, 2006, NEOTROP ENTOMOL, V35, P868, DOI 10.1590/S1519-566X2006000600024; DRESSLER RL, 1982, ANNU REV ECOL SYST, V13, P373, DOI 10.1146/annurev.es.13.110182.002105; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ferro VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107792; Filz KJ, 2015, ORG DIVERS EVOL, V15, P555, DOI 10.1007/s13127-015-0210-1; Freitas F V, 2010, AN 9 ENC AB RIB PRET, P425; Giannini TC, 2013, ECOGRAPHY, V36, P649, DOI 10.1111/j.1600-0587.2012.07191.x; Google Inc, 2015, GOOGL EARTH VERS 7 0; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Gutierrez EE, 2014, ECOGRAPHY, V37, P741, DOI 10.1111/ecog.00620; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2012, PACKAGE DISMO SPECIE; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Kimsey L.S., 1982, University of California Publications in Entomology, V95, P1; LEDRU MP, 1993, QUATERNARY RES, V39, P90, DOI 10.1006/qres.1993.1011; Lenoir J, 2015, ECOGRAPHY, V38, P15, DOI 10.1111/ecog.00967; Lentz DL, 2008, INT J PLANT SCI, V169, P541, DOI 10.1086/528754; Lima-Ribeiro MD, 2010, QUATERN INT, V222, P230, DOI 10.1016/j.quaint.2009.10.003; Lima-Ribeiro MS, 2012, NAT CONSERVACAO, V10, P145, DOI 10.4322/natcon.2012.022; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loyola RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046257; Meier ES, 2010, ECOGRAPHY, V33, P1038, DOI 10.1111/j.1600-0587.2010.06229.x; Méio Beatriz B., 2003, Braz. J. Bot., V26, P437, DOI 10.1590/S0100-84042003000400002; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Michener C.D., 2007, BEES WORLD, Vsecond; Morato E.F, 1998, ANAIS ENCONTRO ABELH, P135; Moura DC, 2009, NEOTROP ENTOMOL, V38, P281, DOI 10.1590/S1519-566X2009000200018; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; MYERS J. G., 1935, TRANS ROY ENT SOC LONDON, V83, P131; Nemesio A, 2006, J BIOGEOGR, V33, P91, DOI 10.1111/j.1365-2699.2005.01370.x; Nemesio A, 2014, REV BRAS BIOL, V74; Nemesio A, 2006, NEOTROP ENTOMOL, V35, P313, DOI 10.1590/S1519-566X2006000300004; Nemesio A, 2011, ZOOTAXA, P1; Nemesio A, 2013, BIODIVERS CONSERV, V22, P1647, DOI 10.1007/s10531-013-0500-x; Nemesio Andre, 2004, Lundiana, V5, P113; Nix H.A., 1986, ATLAS ELAPID SNAKES, P4; Nogues-Bravo D, 2008, PLOS BIOL, V6, P685, DOI 10.1371/journal.pbio.0060079; Parida M, 2015, J BIOGEOGR, V42, P1210, DOI 10.1111/jbi.12490; Pellissier L, 2010, ECOGRAPHY, V33, P1004, DOI 10.1111/j.1600-0587.2010.06386.x; Peruquetti Rui Carlos, 1999, Revista Brasileira de Zoologia, V16, P101, DOI 10.1590/S0101-81751999000600012; Peterson AT, 2011, MONOGRAPHS POPULATIO, P328, DOI [DOI 10.5860/CHOICE.49-6266, 10.1515/9781400840670, DOI 10.1515/9781400840670]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Rizzini C. T., 1963, REV BRASILEIRA GEOGR, V25, P1; Schweiger O, 2012, GLOBAL ECOL BIOGEOGR, V21, P88, DOI 10.1111/j.1466-8238.2010.00607.x; Silva DP, 2014, NEOTROP ENTOMOL, V43, P509, DOI 10.1007/s13744-014-0244-7; Silva DP, 2014, ECOL MODEL, V273, P200, DOI 10.1016/j.ecolmodel.2013.11.016; Silva DP, 2013, APIDOLOGIE, V44, P673, DOI 10.1007/s13592-013-0216-7; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Svenning J-C, 2014, ECOGRAPHY; Terribile LC, 2012, NAT CONSERVACAO, V10, P152, DOI 10.4322/natcon.2012.025; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tonhasca A, 2002, BIOTROPICA, V34, P416, DOI 10.1111/j.1744-7429.2002.tb00555.x; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Varela S., 2014, Ecosistemas, V23, P46; Varela S, 2014, ECOGRAPHY, V37, P1084, DOI 10.1111/j.1600-0587.2013.00441.x; Varela S, 2010, QUATERNARY SCI REV, V29, P2027, DOI 10.1016/j.quascirev.2010.04.017; Warren RJ, 2014, GLOBAL CHANGE BIOL, V20, P466, DOI 10.1111/gcb.12407; Werneck FP, 2011, QUATERNARY SCI REV, V30, P1630, DOI 10.1016/j.quascirev.2011.03.009; Werneck FP, 2011, GLOBAL ECOL BIOGEOGR, V20, P272, DOI 10.1111/j.1466-8238.2010.00596.x; WILLIAMS NH, 1983, BIOL BULL, V164, P355, DOI 10.2307/1541248; Zucchi R., 1969, Journal of the Faculty of Science Hokkaido University Zoology (6), V17, P271	84	9	10	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129890	10.1371/journal.pone.0129890	http://dx.doi.org/10.1371/journal.pone.0129890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069956	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000120
J	Choi, SA; Lee, JY; Kwon, SE; Wang, KC; Phi, JH; Choi, JW; Jin, X; Lim, JY; Kim, H; Kim, SK				Choi, Seung Ah; Lee, Ji Yeoun; Kwon, Sung Eun; Wang, Kyu-Chang; Phi, Ji Hoon; Choi, Jung Won; Jin, Xiong; Lim, Ja Yun; Kim, Hyunggee; Kim, Seung-Ki			Human Adipose Tissue-Derived Mesenchymal Stem Cells Target Brain Tumor-Initiating Cells	PLOS ONE			English	Article							CANCER; GLIOBLASTOMA; IDENTIFICATION; RECEPTORS; EXOSOMES; GLIOMAS; MICE	In neuro-oncology, the biology of neural stem cells (NSCs) has been pursued in two ways: as tumor-initiating cells (TICs) and as a potential cell-based vehicle for gene therapy. NSCs as well as mesenchymal stem cells (MSCs) have been reported to possess tumor tropism capacities. However, there is little data on the migratory capacity of MSCs toward brain tumor-initiating cells (BTICs). This study focuses on the ability of human adipose tissue derived MSCs (hAT-MSCs) to target BTICs and their crosstalk in the microenvironment. BTICs were isolated from three different types of brain tumors. The migration capacities of hAT-MSCs toward BTICs were examined using an in vitro migration assay and in vivo bioluminescence imaging analysis. To investigate the crosstalk between hAT-MSCs and BTICs, we analyzed the mRNA expression patterns of cyto-chemokine receptors by RT-qPCR and the protein level of their ligands in co-cultured medium. The candidate cyto-chemokine receptors were selectively inhibited using siRNAs. Both in vitro and in vivo experiments showed that hAT-MSCs possess migratory abilities to target BTICs isolated from medulloblastoma, atypical teratoid/rhabdoid tumors (AT/RT) and glioblastoma. Different types of cyto-chemokines are involved in the crosstalk between hAT-MSCs and BTICs (medulloblastoma and AT/RT: CXCR4/SDF-1, CCR5/RANTES, IL6R/IL-6 and IL8R/IL8; glioblastoma: CXCR4/SDF-1, IL6R/IL-6, IL8R/IL-8 and IGF1R/IGF-1). Our findings demonstrated the migratory ability of hAT-MSCs for BTICs, implying the potential use of MSCs as a delivery vehicle for gene therapy. This study also confirmed the expression of hAT-MSCs cytokine receptors and the BTIC ligands that play roles in their crosstalk.	[Choi, Seung Ah; Lee, Ji Yeoun; Wang, Kyu-Chang; Phi, Ji Hoon; Choi, Jung Won; Kim, Seung-Ki] Seoul Natl Univ, Coll Med, Childrens Hosp, Div Pediat Neurosurg,Pediat Clin Neurosci Ctr, Seoul, South Korea; [Choi, Seung Ah; Wang, Kyu-Chang; Phi, Ji Hoon; Choi, Jung Won; Kim, Seung-Ki] Seoul Natl Univ, Canc Hosp, Adolescent Canc Ctr, Seoul, South Korea; [Lee, Ji Yeoun] Seoul Natl Univ, Dept Anat, Coll Med, Seoul, South Korea; [Kwon, Sung Eun] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Jin, Xiong; Lim, Ja Yun; Kim, Hyunggee] Korea Univ, Sch Life Sci & Biotechnol, Cell Growth Regulat Lab, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); University of Pennsylvania; Korea University	Kim, SK (corresponding author), Seoul Natl Univ, Coll Med, Childrens Hosp, Div Pediat Neurosurg,Pediat Clin Neurosci Ctr, Seoul, South Korea.	nsthomas@snu.ac.kr	Kim, Hyunggee/F-2673-2013; Jin, Xiong/I-7609-2015	Kim, Hyunggee/0000-0002-4738-0990; Jin, Xiong/0000-0001-9252-1441	National Research Foundation of Korea (NRF) - Korean government (MEST) [2012011770]; Seoul National University Hospital Research Fund [3020140270]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Seoul National University Hospital Research Fund	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (2012011770) and the Seoul National University Hospital Research Fund (3020140270, http://bri.snuh.org).	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Altaner C, 2014, INT J CANCER, V134, P1458, DOI 10.1002/ijc.28455; Altanerova V, 2012, INT J CANCER, V130, P2455, DOI 10.1002/ijc.26278; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Choi SA, 2014, EUR J CANCER, V50, P137, DOI 10.1016/j.ejca.2013.09.004; Choi SA, 2012, CANCER LETT, V324, P221, DOI 10.1016/j.canlet.2012.05.026; Choi SA, 2012, EUR J CANCER, V48, P129, DOI 10.1016/j.ejca.2011.04.033; Choi SA, 2011, NEURO-ONCOLOGY, V13, P61, DOI 10.1093/neuonc/noq147; Corrado C, 2014, CANCER LETT, V348, P71, DOI 10.1016/j.canlet.2014.03.009; Fang XG, 2014, STEM CELLS, V32, P2033, DOI 10.1002/stem.1730; Feng Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.521; Fox JM, 2007, BRIT J HAEMATOL, V137, P491, DOI 10.1111/j.1365-2141.2007.06610.x; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kan I, 2005, CURR DRUG TARGETS, V6, P31, DOI 10.2174/1389450053344902; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Koyama Y, 2007, NEOPLASIA, V9, P1021, DOI 10.1593/neo.07787; Lee DH, 2009, CLIN CANCER RES, V15, P4925, DOI 10.1158/1078-0432.CCR-08-3076; Lee JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084256; Leo AJ, 2006, CELLS TISSUES ORGANS, V183, P112, DOI 10.1159/000095985; Lim SH, 2011, CANCER GENE THER, V18, P817, DOI 10.1038/cgt.2011.52; Malik Babar, 2012, Front Biosci (Elite Ed), V4, P2142; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakano I., 2006, PEDIAT RES, V59; Ono M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005231; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Rao G, 2004, ONCOGENE, V23, P6156, DOI 10.1038/sj.onc.1207818; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ringe J, 2007, J CELL BIOCHEM, V101, P135, DOI 10.1002/jcb.21172; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Spaeth E, 2008, GENE THER, V15, P730, DOI 10.1038/gt.2008.39; Studeny M, 2002, CANCER RES, V62, P3603; Yu B, 2014, INT J MOL SCI, V15, P4142, DOI 10.3390/ijms15034142; Zhang B, 2014, STEM CELLS DEV, V23, P1233, DOI 10.1089/scd.2013.0479	36	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129292	10.1371/journal.pone.0129292	http://dx.doi.org/10.1371/journal.pone.0129292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076490	gold, Green Published			2022-12-27	WOS:000356329900062
J	Chola, L; McGee, S; Tugendhaft, A; Buchmann, E; Hofman, K				Chola, Lumbwe; McGee, Shelley; Tugendhaft, Aviva; Buchmann, Eckhart; Hofman, Karen			Scaling Up Family Planning to Reduce Maternal and Child Mortality: The Potential Costs and Benefits of Modern Contraceptive Use in South Africa	PLOS ONE			English	Article							PROXIMATE DETERMINANTS; MOTHERS; BABIES; HEALTH; LIVES; FERTILITY; FRAMEWORK; INFANT; ACCESS	Introduction Family planning contributes significantly to the prevention of maternal and child mortality. However, many women still do not use modern contraception and the numbers of unintended pregnancies, abortions and subsequent deaths are high. In this paper, we estimate the service delivery costs of scaling up modern contraception, and the potential impact on maternal, newborn and child survival in South Africa. Methods The Family Planning model in Spectrum was used to project the impact of modern contraception on pregnancies, abortions and births in South Africa (2015-2030). The contraceptive prevalence rate (CPR) was increased annually by 0.68 percentage points. The Lives Saved Tool was used to estimate maternal and child deaths, with coverage of essential maternal and child health interventions increasing by 5% annually. A scenario analysis was done to test impacts when: the change in CPR was 0.1% annually; and intervention coverage increased linearly to 99% in 2030. Results If CPR increased by 0.68% annually, the number of pregnancies would reduce from 1.3 million in 2014 to one million in 2030. Unintended pregnancies, abortions and births decrease by approximately 20%. Family planning can avert approximately 7,000 newborn and child and 600 maternal deaths. The total annual costs of providing modern contraception in 2030 are estimated to be US$33 million and the cost per user of modern contraception is US$7 per year. The incremental cost per life year gained is US$40 for children and US$1,000 for mothers. Conclusion Maternal and child mortality remain high in South Africa, and scaling up family planning together with optimal maternal, newborn and child care is crucial. A huge impact can be made on maternal and child mortality, with a minimal investment per user of modern contraception.	[Chola, Lumbwe; McGee, Shelley; Tugendhaft, Aviva; Hofman, Karen] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, PRICELESS MRC Wits Rural Publ Hlth & Hlth Transit, Johannesburg, South Africa; [Buchmann, Eckhart] Univ Witwatersrand, Fac Hlth Sci, Dept Obstet & Gynaecol, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand	Hofman, K (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, PRICELESS MRC Wits Rural Publ Hlth & Hlth Transit, Johannesburg, South Africa.	karen.hofman@wits.ac.za	Chola, Lumbwe/AFX-3377-2022	Chola, Lumbwe/0000-0001-6488-2813; HOFMAN, KAREN/0000-0001-9512-7220				[Anonymous], 2013, STAT WORLD CHILDR CH; Baumgartner JN, 2007, INT FAM PLAN PERSPEC, V33, P66, DOI 10.1363/3306607; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; BONGAARTS J, 1978, POPUL DEV REV, V4, P105, DOI 10.2307/1972149; Bradshaw D., 2014, RAPID MORTALITY SURV; Bradshaw D, 2008, LANCET, V371, P1294, DOI 10.1016/S0140-6736(08)60564-4; Canudas-Romo V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086694; Cates W, 2010, CONTRACEPTION, V81, P460, DOI 10.1016/j.contraception.2010.01.002; Chopra M, 2009, LANCET, V374, P835, DOI 10.1016/S0140-6736(09)61123-5; Collumbien M., 2004, COMP QUANTIFICATION, P1255; Culwell KR, 2010, INT J GYNECOL OBSTET, V110, pS13, DOI 10.1016/j.ijgo.2010.04.003; DaVanzo J, 2008, POP STUD-J DEMOG, V62, P131, DOI 10.1080/00324720802022089; Fabic MS, 2015, LANCET, V385, P1928, DOI 10.1016/S0140-6736(14)61055-2; FP2020, 2013, PROGR REPORT 2012 20; Halperin DT, 2009, AIDS, V23, pS123, DOI 10.1097/01.aids.0000363785.73450.5a; Health Systems Trust, 2013, TERM PREGN DURB; Lebese RT, 2013, HEALTH SA GESONDHEID, V18, DOI 10.4102/hsag.v18i1.654; National Department of Health, 2007, S AFR DEM HLTH SURV; National Department of Health, 2012, NAT CONTR FERT PLANN; NCCEMD, 2012, 5 NCCEMD NDOH; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Petruney T, 2014, B WORLD HEALTH ORGAN, V92, P548, DOI 10.2471/BLT.14.142893; Pillay-van Wyk V, 2013, LANCET, V381, pS113; Prata N, 2009, PHILOS T R SOC B, V364, P3093, DOI 10.1098/rstb.2009.0172; Richter MS, 2005, HLTH SA GESONDHEID, V10, P61, DOI DOI 10.4102/HSAG.V10I2.195; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, pS7, DOI 10.1016/j.ijgo.2004.11.012; Singh S, 2012, ADDING IT COSTS BENE; Singh S, 2009, ADDING IT COSTS BENE; SINGH Susheela, 2009, ABORTION WORLDWIDE D; Stats S, 2014, MORTALITY CAUSES DEA; Stats SA, 2013, MID YEAR POPULATION; Stats SA, 2013, MILLENNIUM DEV GOALS; Stover J, 1998, STUD FAMILY PLANN, V29, P255, DOI 10.2307/172272; Stover J, 2010, INT J EPIDEMIOL, V39, P7, DOI 10.1093/ije/dyq016; Tathiah N, 2013, DISTRICT HLTH BAROME; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD FERT REP 2012; Walker N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S1; Willan W, 2013, REV TEENAGE PREGNANC; Wood K, 2006, REPROD HEALTH MATTER, V14, P109, DOI 10.1016/S0968-8080(06)27231-8; World Health Organization, 2003, GUID COST EFF AN; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	41	51	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130077	10.1371/journal.pone.0130077	http://dx.doi.org/10.1371/journal.pone.0130077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076482	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900134
J	Colby-Milley, J; Cavanagh, C; Jego, S; Breitner, JCS; Quirion, R; Adamantidis, A				Colby-Milley, Jessica; Cavanagh, Chelsea; Jego, Sonia; Breitner, John C. S.; Quirion, Remi; Adamantidis, Antoine			Sleep-Wake Cycle Dysfunction in the TgCRND8 Mouse Model of Alzheimer's Disease: From Early to Advanced Pathological Stages	PLOS ONE			English	Article							EYE-MOVEMENT SLEEP; LOCUS-CERULEUS; DAYTIME SLEEPINESS; DEMENTIA; NEURONS; DISTURBANCES; MILD; NOREPINEPHRINE; EEG; ARCHITECTURE	In addition to cognitive decline, individuals affected by Alzheimer's disease (AD) can experience important neuropsychiatric symptoms including sleep disturbances. We characterized the sleep-wake cycle in the TgCRND8 mouse model of AD, which overexpresses a mutant human form of amyloid precursor protein resulting in high levels of beta-amyloid and plaque formation by 3 months of age. Polysomnographic recordings in freely-moving mice were conducted to study sleep-wake cycle architecture at 3, 7 and 11 months of age and corresponding levels of beta-amyloid in brain regions regulating sleep-wake states were measured. At all ages, TgCRND8 mice showed increased wakefulness and reduced non-rapid eye movement (NREM) sleep during the resting and active phases. Increased wakefulness in TgCRND8 mice was accompanied by a shift in the waking power spectrum towards fast frequency oscillations in the beta (14-20 Hz) and low gamma range (20-50 Hz). Given the phenotype of hyperarousal observed in TgCRND8 mice, the role of noradrenergic transmission in the promotion of arousal, and previous work reporting an early disruption of the noradrenergic system in TgCRND8, we tested the effects of the alpha-1-adrenoreceptor antagonist, prazosin, on sleep-wake patterns in TgCRND8 and non-transgenic (NTg) mice. We found that a lower dose (2 mg/kg) of prazosin increased NREM sleep in NTg but not in TgCRND8 mice, whereas a higher dose (5 mg/kg) increased NREM sleep in both genotypes, suggesting altered sensitivity to noradrenergic blockade in TgCRND8 mice. Collectively our results demonstrate that amyloidosis in TgCRND8 mice is associated with sleep-wake cycle dysfunction, characterized by hyperarousal, validating this model as a tool towards understanding the relationship between beta-amyloid overproduction and disrupted sleep-wake patterns in AD.	[Colby-Milley, Jessica; Cavanagh, Chelsea; Jego, Sonia; Breitner, John C. S.; Quirion, Remi; Adamantidis, Antoine] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ H4H 1R3, Canada; [Adamantidis, Antoine] Univ Bern, Univ Hosp Bern, Dept Neurol, Inselspital, CH-3010 Bern, Switzerland	McGill University; University of Bern; University Hospital of Bern	Adamantidis, A (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ H4H 1R3, Canada.	antoine.adamantidis@dkf.unibe.ch		Adamantidis, Antoine/0000-0003-2531-5175	Canadian Insitutes for Health Research (CIHR); Stop-AD Centre of the Douglas Institute; Human Frontier Science Program; Douglas Foundation; McGill University; Canadian Fund for Innovation (CFI); Canadian Research Chair (CRC Tier 2); Natural Science and Engineering Council of Canada (NSERC); University of Bern (Switzerland); Inselspital; CIHR	Canadian Insitutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Stop-AD Centre of the Douglas Institute; Human Frontier Science Program(Human Frontier Science Program); Douglas Foundation; McGill University; Canadian Fund for Innovation (CFI)(Canada Foundation for Innovation); Canadian Research Chair (CRC Tier 2); Natural Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Bern (Switzerland); Inselspital; CIHR(Canadian Institutes of Health Research (CIHR))	Financial support for this study was granted by the Canadian Insitutes for Health Research (CIHR) to RQ and the Stop-AD Centre of the Douglas Institute to JCM. JCM and AA are supported by the Human Frontier Science Program, the Douglas Foundation, McGill University, Canadian Fund for Innovation (CFI), Canadian Research Chair (CRC Tier 2), CIHR and the Natural Science and Engineering Council of Canada (NSERC), the Inselspital and the University of Bern (Switzerland).	Adamantidis A, 2008, EUR J NEUROSCI, V27, P1793, DOI 10.1111/j.1460-9568.2008.06129.x; Berridge CW, 2012, SLEEP MED REV, V16, P187, DOI 10.1016/j.smrv.2011.12.003; Bonanni E, 2005, J SLEEP RES, V14, P311, DOI 10.1111/j.1365-2869.2005.00462.x; BONDAREFF W, 1982, NEUROLOGY, V32, P164, DOI 10.1212/WNL.32.2.164; BORBELY AA, 1992, J SLEEP RES, V1, P63, DOI 10.1111/j.1365-2869.1992.tb00013.x; Brian D., 1996, CLIN GERONTOLOGIST, V16, P35; Broese M, 2012, PHARMACOPSYCHIATRY, V45, P209, DOI 10.1055/s-0031-1299728; CHANPALAY V, 1989, J COMP NEUROL, V287, P373, DOI 10.1002/cne.902870308; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Clement O, 2011, SLEEP, V34, P419, DOI 10.1093/sleep/34.4.419; Elrod R, 1997, AM J PSYCHIAT, V154, P25; Espana RA, 2011, SLEEP, V34, P845, DOI 10.5665/SLEEP.1112; EVANS LK, 1987, J AM GERIATR SOC, V35, P101, DOI 10.1111/j.1532-5415.1987.tb01337.x; Francis BM, 2012, NEUROPSYCHOPHARMACOL, V37, P1934, DOI 10.1038/npp.2012.40; Gary Aston-Jones PD, 2007, BRAIN NOREPINEPHRINE; GERMAN DC, 1992, ANN NEUROL, V32, P667, DOI 10.1002/ana.410320510; Hasan S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.010; Herrmann N, 2004, J NEUROPSYCH CLIN N, V16, P261, DOI 10.1176/appi.neuropsych.16.3.261; Hita-Yanez E, 2013, SLEEP, V36, P1327, DOI 10.5665/sleep.2956; Hoogendijk WJG, 1999, ANN NEUROL, V45, P82, DOI 10.1002/1531-8249(199901)45:1<82::AID-ART14>3.0.CO;2-T; Huitron-Resendiz S, 2002, BRAIN RES, V928, P126, DOI 10.1016/S0006-8993(01)03373-X; Jego S, 2013, NAT NEUROSCI, V16, P1637, DOI 10.1038/nn.3522; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; JONES BE, 1993, PROG BRAIN RES, V98, P61; JOUVET M., 1960, JOUR PHYSIOL [PARIS], V52, P130; Ju YES, 2013, JAMA NEUROL, V70, P587, DOI 10.1001/jamaneurol.2013.2334; Jyoti A, 2010, J ALZHEIMERS DIS, V22, P873, DOI 10.3233/JAD-2010-100879; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Lee JH, 2007, AM J GERIAT PSYCHIAT, V15, P620, DOI 10.1097/JGP.0b013e3180381521; Lim ASP, 2013, SLEEP, V36, P1027, DOI 10.5665/sleep.2802; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Lyketsos Constantine G, 2011, Alzheimers Dement, V7, P532, DOI 10.1016/j.jalz.2011.05.2410; MANN DM, 1982, J NEUROL NEUROSUR PS, V45, P113, DOI 10.1136/jnnp.45.2.113; McCurry SM, 1999, J GERIATR PSYCH NEUR, V12, P53, DOI 10.1177/089198879901200203; Munk MHJ, 1996, SCIENCE, V272, P271, DOI 10.1126/science.272.5259.271; Platt B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027068; PRINZ PN, 1982, NEUROBIOL AGING, V3, P361, DOI 10.1016/0197-4580(82)90024-0; PRINZ PN, 1982, J AM GERIATR SOC, V30, P86, DOI 10.1111/j.1532-5415.1982.tb01279.x; RASKIND MA, 1984, ARCH GEN PSYCHIAT, V41, P343; Roh JH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004291; Rothman SM, 2013, BRAIN RES, V1529, P200, DOI 10.1016/j.brainres.2013.07.010; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sethi M, 2015, NEUROSCIENCE, V290, P80, DOI 10.1016/j.neuroscience.2015.01.035; Spira AP, 2013, JAMA NEUROL, V70, P1537, DOI 10.1001/jamaneurol.2013.4258; STERIADE M, 1991, P NATL ACAD SCI USA, V88, P4396, DOI 10.1073/pnas.88.10.4396; Stern AL, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-014-0777-6; Sterniczuk R, 2013, CURR ALZHEIMER RES, V10, P767, DOI 10.2174/15672050113109990134; Sterniczuk R, 2010, BRAIN RES, V1348, P139, DOI 10.1016/j.brainres.2010.05.013; Szot P, 2007, NEUROSCIENCE, V146, P471, DOI 10.1016/j.neuroscience.2007.01.031; Szot P, 2006, J NEUROSCI, V26, P467, DOI 10.1523/JNEUROSCI.4265-05.2006; TOBLER I, 1986, ELECTROEN CLIN NEURO, V64, P74, DOI 10.1016/0013-4694(86)90044-1; Toth LA, 2013, COMPARATIVE MED, V63, P91; Tractenberg RE, 2003, J SLEEP RES, V12, P331, DOI 10.1046/j.0962-1105.2003.00374.x; Vecchierini MF, 2010, PSYCHOL NEUROPSYCHIA, V8, P15, DOI 10.1684/pnv.2010.0203; Vitiello M V, 1989, Clin Geriatr Med, V5, P289; Vitiello MV, 1997, J GERONTOL A-BIOL, V52, pM189, DOI 10.1093/gerona/52A.4.M189; VITIELLO MV, 1990, J GERONTOL, V45, pM131, DOI 10.1093/geronj/45.4.M131; VITIELLO MV, 1992, NEUROLOGY, V42, P83; VITIELLO MV, 1984, BIOL PSYCHIAT, V19, P721; Vitiello MV, 2001, CNS DRUGS, V15, P777, DOI 10.2165/00023210-200115100-00004; Volicer L, 2001, AM J PSYCHIAT, V158, P704, DOI 10.1176/appi.ajp.158.5.704; Wisor JP, 2005, NEUROSCIENCE, V131, P375, DOI 10.1016/j.neuroscience.2004.11.018; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zahs KR, 2010, TRENDS NEUROSCI, V33, P381, DOI 10.1016/j.tins.2010.05.004; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337; Zhang B, 2005, AM J PATHOL, V167, P1361, DOI 10.1016/S0002-9440(10)61223-0	68	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130177	10.1371/journal.pone.0130177	http://dx.doi.org/10.1371/journal.pone.0130177			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076358	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900150
J	Cotero, VE; Kimm, SY; Siclovan, TM; Zhang, R; Kim, EM; Matsumoto, K; Gondo, T; Scardino, PT; Yazdanfar, S; Laudone, VP; Hehir, CAT				Cotero, Victoria E.; Kimm, Simon Y.; Siclovan, Tiberiu M.; Zhang, Rong; Kim, Evgenia M.; Matsumoto, Kazuhiro; Gondo, Tatsuo; Scardino, Peter T.; Yazdanfar, Siavash; Laudone, Vincent P.; Hehir, Cristina A. Tan			Improved Intraoperative Visualization of Nerves through a Myelin-Binding Fluorophore and Dual-Mode Laparoscopic Imaging	PLOS ONE			English	Article							CORONARY-ARTERY-BYPASS; LYMPH-NODE DISSECTION; GUIDED SURGERY; BREAST-CANCER; RISK-FACTORS; INJURY; PAIN; IDENTIFICATION; MORBIDITY; CARCINOMA	The ability to visualize and spare nerves during surgery is critical for avoiding chronic morbidity, pain, and loss of function. Visualization of such critical anatomic structures is even more challenging during minimal access procedures because the small incisions limit visibility. In this study, we focus on improving imaging of nerves through the use of a new small molecule fluorophore, GE3126, used in conjunction with our dual-mode (color and fluorescence) laparoscopic imaging instrument. GE3126 has higher aqueous solubility, improved pharmacokinetics, and reduced non-specific adipose tissue fluorescence compared to previous myelin-binding fluorophores. Dosing and kinetics were initially optimized in mice. A non-clinical modified Irwin study in rats, performed to assess the potential of GE3126 to induce nervous system injuries, showed the absence of major adverse reactions. Real-time intraoperative imaging was performed in a porcine model. Compared to white light imaging, nerve visibility was enhanced under fluorescence guidance, especially for small diameter nerves obscured by fascia, blood vessels, or adipose tissue. In the porcine model, nerve visualization was observed rapidly, within 5 to 10 minutes post-intravenous injection and the nerve fluorescence signal was maintained for up to 80 minutes. The use of GE3126, coupled with practical implementation of an imaging instrument may be an important step forward in preventing nerve damage in the operating room.	[Cotero, Victoria E.; Siclovan, Tiberiu M.; Zhang, Rong; Kim, Evgenia M.; Yazdanfar, Siavash; Hehir, Cristina A. Tan] GE Global Res, Diagnost Imaging & Biomed Technol, Niskayuna, NY 12309 USA; [Kimm, Simon Y.; Matsumoto, Kazuhiro; Gondo, Tatsuo; Scardino, Peter T.; Laudone, Vincent P.] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA	General Electric; Memorial Sloan Kettering Cancer Center	Hehir, CAT (corresponding author), GE Global Res, Diagnost Imaging & Biomed Technol, Niskayuna, NY 12309 USA.	tanhehir@ge.com	Yazdanfar, Siavash/A-9013-2009	Yazdanfar, Siavash/0000-0003-2768-6199	National Institutes of Health [R01-EB-022872]; GE Global Research; Sidney Kimmel Center for Prostate and Urologic Cancers; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GE Global Research(General Electric); Sidney Kimmel Center for Prostate and Urologic Cancers; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by a grant from the National Institutes of Health, under award number R01-EB-022872 (CTH), by GE Global Research, and by the Sidney Kimmel Center for Prostate and Urologic Cancers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions, findings, conclusions or other recommendations expressed herein are those of the authors and do not necessarily reflect the views of the funders.	[Anonymous], 2011, GUIDE CARE USE LAB A; Baima J, 2008, CURR REV MUSCULOSKE, V1, P147, DOI 10.1007/s12178-008-9023-6; Bajaj A, 2013, J HISTOCHEM CYTOCHEM, V61, P19, DOI 10.1369/0022155412467353; Bizzarri F, 2001, TEX HEART I J, V28, P315; Canbaz Suat, 2004, BMC Surg, V4, P2, DOI 10.1186/1471-2482-4-2; Carpenter JS, 1999, CANCER PRACT, V7, P66, DOI 10.1046/j.1523-5394.1999.07208.x; Charoenkwan K, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.09.027; Costello AJ, 2004, BJU INT, V94, P1071, DOI 10.1111/j.1464-410X.2004.05106.x; Cotero VE, 2012, MOL IMAGING BIOL, V14, P708, DOI 10.1007/s11307-012-0555-1; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Gibbs SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073493; Gibbs-Strauss SL, 2011, MOL IMAGING, V10, P91, DOI 10.2310/7290.2010.00026; Gioux S, 2010, MOL IMAGING, V9, P237, DOI 10.2310/7290.2010.00034; Gray D, 2012, PROC SPIE, V8214, DOI 10.1117/12.905757; Gray DC, 2012, BIOMED OPT EXPRESS, V3, P1880, DOI 10.1364/BOE.3.001880; GUINN GA, 1990, TEX HEART I J, V17, P48; Gustafson TP, 2012, MEDCHEMCOMM, V3, P685, DOI 10.1039/c2md00297c; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Katz MG, 1998, ANN THORAC SURG, V65, P32, DOI 10.1016/S0003-4975(97)00915-6; Keereweer S, 2011, MOL IMAGING BIOL, V13, P199, DOI 10.1007/s11307-010-0373-2; KOKATNUR MG, 1979, AM J CLIN NUTR, V32, P2198, DOI 10.1093/ajcn/32.11.2198; Kretschmer T, 2009, NEUROSURG CLIN N AM, V20, P73, DOI 10.1016/j.nec.2008.07.025; London J, 1996, ANN ROY COLL SURG, V78, P146; Macdonald L, 2005, BRIT J CANCER, V92, P225, DOI 10.1038/sj.bjc.6602304; Marien TP, 2008, BJU INT, V102, P1581, DOI 10.1111/j.1464-410X.2008.07921.x; Markman J, MERCK MANUAL2014; Ntziachristos V., 2010, J BIOMED OPT, V15, DOI DOI 10.1117/1.3523364; Park MH, 2014, THERANOSTICS, V4, P823, DOI 10.7150/thno.8696; Penson DF, 2008, J UROLOGY, V179, pS40, DOI 10.1016/j.juro.2008.03.136; Pogue BW, 2010, IEEE J SEL TOP QUANT, V16, P493, DOI 10.1109/JSTQE.2009.2034541; Poleshuck EL, 2006, J PAIN, V7, P626, DOI 10.1016/j.jpain.2006.02.007; Rehman J, 1999, BJU INT, V84, P305; Roux S, 2001, CURR PROTOC PHARM; Schellingerhout D, 2009, MOL IMAGING, V8, P319, DOI 10.2310/7290.2009.00029; Schrenk P, 2000, CANCER, V88, P608, DOI 10.1002/(SICI)1097-0142(20000201)88:3<608::AID-CNCR17>3.0.CO;2-K; Sevick-Muraca E. M., 2008, J BIOMED OPT, V13, DOI DOI 10.1117/1.2953185; Tagaya N, 2011, WORLD J SURG, V35, P154, DOI 10.1007/s00268-010-0811-y; Takenaka A, 2005, UROLOGY, V65, P136, DOI 10.1016/j.urology.2004.08.028; Tobis S, 2011, J UROLOGY, V186, P47, DOI 10.1016/j.juro.2011.02.2701; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; Vaz C, 2012, VASCULAR SURG; Warmuth MA, 1998, CANCER, V83, P1362, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1362::AID-CNCR13>3.0.CO;2-2; Whitney MA, 2011, NAT BIOTECHNOL, V29, P352, DOI 10.1038/nbt.1764; Wilbourn AJ, 1998, NEUROL CLIN, V16, P55, DOI 10.1016/S0733-8619(05)70367-4; Yuan X, 2007, DRUGS PHARM SCI, V172, P303	45	20	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130276	10.1371/journal.pone.0130276	http://dx.doi.org/10.1371/journal.pone.0130276			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076448	Green Submitted, gold, Green Published			2022-12-27	WOS:000356329900160
J	Huang, J; Frimpong, EA				Huang, Jian; Frimpong, Emmanuel A.			Using Historical Atlas Data to Develop High-Resolution Distribution Models of Freshwater Fishes	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; CLIMATE-CHANGE; SPATIAL AUTOCORRELATION; ECOLOGICAL DATA; HABITAT; COMMUNITY; AREA; TRANSFERABILITY; PREDICTION; NETWORK	Understanding the spatial pattern of species distributions is fundamental in biogeography, and conservation and resource management applications. Most species distribution models (SDMs) require or prefer species presence and absence data for adequate estimation of model parameters. However, observations with unreliable or unreported species absences dominate and limit the implementation of SDMs. Presence-only models generally yield less accurate predictions of species distribution, and make it difficult to incorporate spatial autocorrelation. The availability of large amounts of historical presence records for freshwater fishes of the United States provides an opportunity for deriving reliable absences from data reported as presence-only, when sampling was predominantly community-based. In this study, we used boosted regression trees (BRT), logistic regression, and MaxEnt models to assess the performance of a historical metacommunity database with inferred absences, for modeling fish distributions, investigating the effect of model choice and data properties thereby. With models of the distribution of 76 native, non-game fish species of varied traits and rarity attributes in four river basins across the United States, we show that model accuracy depends on data quality (e.g., sample size, location precision), species' rarity, statistical modeling technique, and consideration of spatial autocorrelation. The cross-validation area under the receiver-operating-characteristic curve (AUC) tended to be high in the spatial presence-absence models at the highest level of resolution for species with large geographic ranges and small local populations. Prevalence affected training but not validation AUC. The key habitat predictors identified and the fish-habitat relationships evaluated through partial dependence plots corroborated most previous studies. The communitybased SDM framework broadens our capability to model species distributions by innovatively removing the constraint of lack of species absence data, thus providing a robust prediction of distribution for stream fishes in other regions where historical data exist, and for other taxa (e.g., benthic macroinvertebrates, birds) usually observed by community-based sampling designs.	[Huang, Jian; Frimpong, Emmanuel A.] Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Frimpong, EA (corresponding author), Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.	frimp@vt.edu			US Geological Survey Aquatic Gap Analysis Program [RWO 156]; Virginia Tech Libraries	US Geological Survey Aquatic Gap Analysis Program; Virginia Tech Libraries	US Geological Survey Aquatic Gap Analysis Program funded this work under fund # RWO 156. Virginia Tech Libraries fully funded the publication of this article through its Open Access Subvention Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Bahn V, 2008, ECOL MODEL, V213, P285, DOI 10.1016/j.ecolmodel.2007.12.005; Bani L, 2002, CONSERV BIOL, V16, P826, DOI 10.1046/j.1523-1739.2002.01082.x; Bond N, 2011, MAR FRESHWATER RES, V62, P1043, DOI 10.1071/MF10286; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brind'Amour A, 2005, LIMNOL OCEANOGR, V50, P465, DOI 10.4319/lo.2005.50.2.0465; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Brown Larry R., 2009, Urban Ecosystems, V12, P391, DOI 10.1007/s11252-009-0082-2; Chu C, 2005, DIVERS DISTRIB, V11, P299, DOI 10.1111/j.1366-9516.2005.00153.x; Clark ME, 2001, ECOL APPL, V11, P161, DOI 10.1890/1051-0761(2001)011[0161:PCCEOA]2.0.CO;2; Diez JM, 2007, ECOLOGY, V88, P3144, DOI 10.1890/07-0047.1; Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Environmental Protection Agency (EPA) United States Geological Survey (USGS) Horizon Systems Corporations, 2012, DAT NHDPLUSV2 DAT; Environmental Protection Agency (EPA) United States Geological Survey (USGS) Horizon Systems Corporations, 2010, DAT NHDPLUSV1 DAT; Esselman PC, 2011, FRESHWATER BIOL, V56, P71, DOI 10.1111/j.1365-2427.2010.02417.x; Franklin J, 2009, MAPPING SPECIES DIST; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Frimpong EA, 2009, FISHERIES, V34, P487, DOI 10.1577/1548-8446-34.10.487; Gilpin M.E., 1991, METAPOPULATION DYNAM; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Herborg LM, 2007, CAN J FISH AQUAT SCI, V64, P1723, DOI 10.1139/F07-130; Hijmans R.J., 2013, DISMO SPECIES DISTRI, V0, P8; Hirzel AH, 2004, J APPL ECOL, V41, P1103, DOI 10.1111/j.0021-8901.2004.00980.x; Huang J, 2011, J N AM BENTHOL SOC, V30, P923, DOI 10.1899/10-172.1; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jobson HE, 1996, US GEOLOGICAL SURVEY, V96, P4013; Kearney M, 2006, OIKOS, V115, P186, DOI 10.1111/j.2006.0030-1299.14908.x; Kelly M, 2002, PHOTOGRAMM ENG REM S, V68, P1001; Legendre P. D., 2012, PCNM MEM SPATIAL EIG; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lyons J, 2010, J FISH BIOL, V77, P1867, DOI 10.1111/j.1095-8649.2010.02763.x; MacKenzie DI, 2002, ECOLOGY, V83, P2387, DOI 10.2307/3071800; McKay L, 2012, NHDPLUS VERSION 2 US; Michener W.K., 2000, ECOLOGICAL DATA DESI; Miller J, 2010, HDB APPL SPATIAL ANA, P685; Moisen GG, 2006, ECOL MODEL, V199, P176, DOI 10.1016/j.ecolmodel.2006.05.021; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Mugodo J, 2006, HYDROBIOLOGIA, V572, P59, DOI 10.1007/s10750-006-0252-7; National Fish Habitat Board, 2012, NAT FISH HAB ACT PLA; NatureServe, 2014, IUCN RED LIST THREAT; NELSON J S, 1976, P416; Niu SQ, 2012, FRESHWATER BIOL, V57, P2367, DOI 10.1111/fwb.12016; Pacifici K, 2012, METHODS ECOL EVOL, V3, P721, DOI 10.1111/j.2041-210X.2012.00201.x; Pearce J, 1998, RESTOR ECOL, V6, P238, DOI 10.1046/j.1526-100X.1998.00636.x; Peres-Neto PR, 2010, AM FISHERIES SOC S, P685; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pollock LJ, 2014, METHODS ECOL EVOL, V5, P397, DOI 10.1111/2041-210X.12180; Price CP, 2006, US GEOLOGICAL SURVEY, V240; PRISM Climate Group Oregon State University, 2004, DAT PRISM CLIM DAT; Pritt JJ, 2014, ECOL INDIC, V39, P169, DOI 10.1016/j.ecolind.2013.12.016; Pritt JJ, 2010, CONSERV BIOL, V24, P1249, DOI 10.1111/j.1523-1739.2010.01488.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rabinowitz D., 1981, BIOL ASPECTS RARE PL, P205, DOI DOI 10.1177/004728702237415; Santika T, 2011, GLOBAL ECOL BIOGEOGR, V20, P181, DOI 10.1111/j.1466-8238.2010.00581.x; Schlosser IJ, 1995, AM FISH S S, V17, P392; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; STRAHLER AN, 1952, GEOL SOC AM BULL, V63, P1117, DOI 10.1130/0016-7606(1952)63[1117:HAAOET]2.0.CO;2; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; Wildt A., 1978, ANAL COVARIANCE; WILSON DS, 1992, ECOLOGY, V73, P1984, DOI 10.2307/1941449; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Zarkami R, 2012, ECOL MODEL, V230, P44, DOI 10.1016/j.ecolmodel.2012.01.011; Zimmermann NE, 2010, ECOGRAPHY, V33, P985, DOI 10.1111/j.1600-0587.2010.06953.x; Zuckerberg B, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P45, DOI 10.1007/978-1-4419-7390-0_4	80	19	20	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129995	10.1371/journal.pone.0129995	http://dx.doi.org/10.1371/journal.pone.0129995			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075902	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900120
J	Ma, WQ; Li, Y; Wang, M; Li, HX; Su, TF; Li, Y; Wang, SX				Ma, Wenqing; Li, Ya; Wang, Man; Li, Haixia; Su, Tiefen; Li, Yan; Wang, Shixuan			Associations of Polymorphisms in WNT9B and PBX1 with Mayer-Rokitansky-Kuster-Hauser Syndrome in Chinese Han	PLOS ONE			English	Article							MULLERIAN DUCT ABNORMALITIES; INHIBITING SUBSTANCE; CONGENITAL ABSENCE; REPRODUCTIVE-TRACT; BETA-CATENIN; MUTATIONS; HORMONE; WOMEN; GENE; REGRESSION	Background Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome is a rare syndrome that is characterized by congenital aplasia of the uterus and the upper portion (2/3) of the vagina. Previous attempts to identify causal mutations of MRKH syndrome have primarily resulted in negative outcomes. We investigated whether these reported variants are associated with MRKH syndrome (types I and II) in a relatively large sample size of Chinese Han patients, and whether any gene-gene epistatic interactions exist among these variants. Methods This study included 182 unrelated Chinese women with MRKH syndrome (155 with type I and 27 with type II) and 228 randomized female controls. Seventeen candidate loci in the AMH, PBX1, WNT4, WNT7A, WNT9B, HOXA10, HOXA11, LHXA1 and GALT genes were genotyped using the Sequenom MassARRAY iPLEX platform. Single-marker association, additive effects and multifactor interactions were investigated. Results The gene frequency distributions of MRKH type 1 and type 2 were similar. Rs34072914 in WNT9B was found to be associated with MRKH syndrome (P = 0.024, OR = 2.65, 95%CI = 1.14-6.17). The dominant models of rs34072914 and rs2275558 in WNT9B and PBX1, respectively, were significantly associated with MRKH syndrome risk in the Chinese Han patients. Additive gene-gene interaction analyses indicated a significant synergetic interaction between WNT9B and PBX1 (RERI = 1.397, AP = 0.493, SI = 4.204). Multifactor dimensionality reduction (MDR) analysis revealed novel dimensional epistatic four-gene effects (AMH, PBX1, WNT7A and WNT9B) in MRKH syndrome. Conclusions This association study successfully identified two susceptibility SNPs (WNT9B and PBX1) associated with MRKH syndrome risk, both separately and interactively. The discovery of a four-gene epistatic effect (AMH, PBX1, WNT7A and WNT9B) in MRKH syndrome provides novel information for the elucidation of the genetic mechanism underlying the etiology of MRKH syndrome.	[Ma, Wenqing; Li, Ya; Wang, Man; Li, Haixia; Li, Yan; Wang, Shixuan] Huazhong Univ Sci & Technol, Dept Gynecol & Obstet, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Su, Tiefen] Huazhong Univ Sci & Technol, Dept Pathol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Li, Y (corresponding author), Huazhong Univ Sci & Technol, Dept Gynecol & Obstet, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	liyan.christine@gmail.com; sxwang2012@hotmail.com			National Natural Science Foundation of China [81401164]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (Grant No. 81401164), named with "Effects and molecular mechanism of phthalic acid ester (PAEs) in MRKH syndrom". TS received the funding and participated in the study design and data collection.	Allard S, 2000, DEVELOPMENT, V127, P3349; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; [Anonymous], 2013, ISRN OBSTET GYNECOLO, DOI DOI 10.1155/2013/628717; Bergstein I, 1997, GENOMICS, V46, P450, DOI 10.1006/geno.1997.5041; Burell A, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-4; Carroll Thomas J., 2005, DEV CELL, V9, P283, DOI [10.1016/j.devcel.2005.05.016, DOI 10.1016/J.DEVCEL.2005.05.016]; Chang XY, 2012, REPROD BIOMED ONLINE, V24, P630, DOI 10.1016/j.rbmo.2012.03.008; Cheng Z, 2011, HUM REPROD, V26, P3197, DOI 10.1093/humrep/der290; Dang YJ, 2012, FERTIL STERIL, V97, P391, DOI 10.1016/j.fertnstert.2011.11.025; Ferretti E, 2011, DEV CELL, V21, P627, DOI 10.1016/j.devcel.2011.08.005; Gervasini C, 2010, GENET MED, V12, P634, DOI 10.1097/GIM.0b013e3181ed6185; GRIFFIN JE, 1976, ANN INTERN MED, V85, P224, DOI 10.7326/0003-4819-85-2-224; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hossain A, 2003, J BIOL CHEM, V278, P26511, DOI 10.1074/jbc.M300804200; Hunt R, 2009, METHODS MOL BIOL, V578, P23, DOI 10.1007/978-1-60327-411-1_2; Klattig J, 2007, SEX DEV, V1, P271, DOI 10.1159/000108929; Kobayashi A, 2003, NAT REV GENET, V4, P969, DOI 10.1038/nrg1225; Lane AH, 1998, J ENDOCRINOL, V158, P1, DOI 10.1677/joe.0.1580001; Ledig S, 2011, FERTIL STERIL, V95, P1589, DOI 10.1016/j.fertnstert.2010.07.1062; Liatsikos SA, 2010, REPROD BIOMED ONLINE, V21, P126, DOI 10.1016/j.rbmo.2010.03.015; Ma JL, 2011, FERTIL STERIL, V95, P2615, DOI 10.1016/j.fertnstert.2011.04.074; Martinez-Frias ML, 1998, AM J MED GENET, V78, P140, DOI 10.1002/(SICI)1096-8628(19980630)78:2<140::AID-AJMG8>3.0.CO;2-S; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Morcel K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-13; Nodale C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091010; Oppelt P, 2005, HUM REPROD, V20, P149, DOI 10.1093/humrep/deh547; Parr BA, 1998, NATURE, V395, P707, DOI 10.1038/27221; Philibert P, 2008, J CLIN ENDOCR METAB, V93, P895, DOI 10.1210/jc.2007-2023; Philibert P, 2011, FERTIL STERIL, V95, P2683, DOI 10.1016/j.fertnstert.2011.01.152; Raga F, 1997, HUM REPROD, V12, P2277, DOI 10.1093/humrep/12.10.2277; Rall K, 2015, FERTIL STERIL, V103, P494, DOI 10.1016/j.fertnstert.2014.10.053; Ravel C, 2009, FERTIL STERIL, V91, P1604, DOI 10.1016/j.fertnstert.2008.12.006; Resendes BL, 2001, AM J MED GENET, V98, P129, DOI 10.1002/1096-8628(20010115)98:2<129::AID-AJMG1021>3.0.CO;2-3; Schnabel CA, 2003, GENESIS, V37, P123, DOI 10.1002/gene.10235; Simpson JL, 1999, AM J MED GENET, V89, P224, DOI 10.1002/(SICI)1096-8628(19991229)89:4<224::AID-AJMG7>3.0.CO;2-C; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Timmreck L S, 2003, J Pediatr Adolesc Gynecol, V16, P217, DOI 10.1016/S1083-3188(03)00124-4; Troiano RN, 2004, RADIOLOGY, V233, P19, DOI 10.1148/radiol.2331020777; Wang M, 2014, REPROD BIOMED ONLINE, V28, P80, DOI 10.1016/j.rbmo.2013.09.022; Zenteno Juan Carlos, 2004, Archives of Gynecology and Obstetrics, V269, P270, DOI 10.1007/s00404-002-0456-7	40	17	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130202	10.1371/journal.pone.0130202	http://dx.doi.org/10.1371/journal.pone.0130202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075712	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900155
J	Reddy, NM; Potteti, HR; Vegiraju, S; Chen, HJ; Tamatam, CM; Reddy, SP				Reddy, Narsa M.; Potteti, Haranatha R.; Vegiraju, Suryanarayana; Chen, Hsin-Jou; Tamatam, Chandra Mohan; Reddy, Sekhar P.			PI3K-AKT Signaling via Nrf2 Protects against Hyperoxia-Induced Acute Lung Injury, but Promotes Inflammation Post-Injury Independent of Nrf2 in Mice	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; PULMONARY EPITHELIAL-CELLS; TRANSCRIPTION FACTOR NRF2; OXIDATIVE STRESS; ANTIOXIDANT RESPONSE; CYCLE PROGRESSION; PI3K/AKT PATHWAY; IN-VITRO; APOPTOSIS; IMPAIRS	Lung epithelial and endothelial cell death accompanied by inflammation contributes to hyperoxia-induced acute lung injury (ALI). Impaired resolution of ALI can promote and/or perpetuate lung pathogenesis, including fibrosis. Previously, we have shown that the transcription factor Nrf2 induces cytoprotective gene expression and confers protection against hyperoxic lung injury, and that Nrf2-mediated signaling is also crucial for the restoration of lung homeostasis post-injury. Although we have reported that PI3K/AKT signaling is required for Nrf2 activation in lung epithelial cells, significance of the PI3K/AKT-Nrf2 crosstalk during hyperoxic lung injury and repair remains unclear. Thus, we evaluated this aspect using Nrf2 knockout (Nrf2(-/-)) and wild-type (Nrf2(+/+)) mouse models. Here, we show that pharmacologic inhibition of PI3K/AKT signaling increased lung inflammation and alveolar permeability in Nrf2(+/+) mice, accompanied by decreased expression of Nrf2-target genes such as Nqo1 and Hmox1. PI3K/AKT inhibition dampened hyperoxia-stimulated Nqo1 and Hmox1 expression in lung epithelial cells and alveolar macrophages. Contrasting with its protective effects, PI3K/AKT inhibition suppressed lung inflammation in Nrf2(+/+) mice during post-injury. In Nrf2(-/-) mice exposed to room-air, PI3K/AKT inhibition caused lung injury and inflammation, but it did not exaggerate hyperoxia-induced ALI. During post-injury, PI3K/AKT inhibition did not augment, but rather attenuated, lung inflammation in Nrf2(-/-) mice. These results suggest that PI3K/AKT-Nrf2 signaling is required to dampen hyperoxia-induced lung injury and inflammation. Paradoxically, the PI3K/AKT pathway promotes lung inflammation, independent of Nrf2, during post-injury.	[Reddy, Narsa M.; Potteti, Haranatha R.; Chen, Hsin-Jou; Tamatam, Chandra Mohan; Reddy, Sekhar P.] Univ Illinois, Dept Pediat, Chicago, IL 60612 USA; [Vegiraju, Suryanarayana] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Reddy, SP (corresponding author), Univ Illinois, Dept Pediat, Chicago, IL 60612 USA.	sreddy03@uic.edu	Reddy, Narsa/AHE-5604-2022		National Institutes of Health [HL66109, ES11863]; National Institutes of Environmental Health Sciences training [ES007141]; National Institutes of Environmental Health Sciences Center [P30ES03819]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011863, P30ES003819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Environmental Health Sciences training; National Institutes of Environmental Health Sciences Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health grants HL66109 and ES11863(to SPR) and the National Institutes of Environmental Health Sciences training grant ES007141 (to SV) and by the National Institutes of Environmental Health Sciences Center supported by P30ES03819 (to Johns Hopkins Environmental Health Sciences), for utilizing its facilities and services.	Ahmad A, 2006, FREE RADICAL BIO MED, V40, P1108, DOI 10.1016/j.freeradbiomed.2005.10.045; Altemeier WA, 2007, CURR OPIN CRIT CARE, V13, P73, DOI 10.1097/MCC.0b013e32801162cb; Arisawa T, 2007, INT J MOL MED, V20, P849; Bailey TC, 2003, J APPL PHYSIOL, V94, P975, DOI 10.1152/japplphysiol.00619.2002; Chabot F, 1998, EUR RESPIR J, V11, P745; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Cho HY, 2002, AM J RESP CELL MOL, V26, P42, DOI 10.1165/ajrcmb.26.1.4536; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Duan W, 2005, INT IMMUNOPHARMACOL, V5, P495, DOI 10.1016/j.intimp.2004.10.015; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Henson PM, 2008, AM J PHYSIOL-LUNG C, V294, pL601, DOI 10.1152/ajplung.00320.2007; Janssen WJ, 2012, TOXICOL PATHOL, V40, P166, DOI 10.1177/0192623311428477; Kim DI, 2012, J CLIN IMMUNOL, V32, P340, DOI 10.1007/s10875-011-9628-1; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Li LF, 2013, BIOMATERIALS, V34, P78, DOI 10.1016/j.biomaterials.2012.09.042; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lu YB, 2001, J EXP MED, V193, P545, DOI 10.1084/jem.193.4.545; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Matthay MA, 2002, AM J PHYSIOL-LUNG C, V283, pL678, DOI 10.1152/ajplung.00154.2002; Morito N, 2003, ONCOGENE, V22, P9275, DOI 10.1038/sj.onc.1207024; Ong E, 2005, AM J PHYSIOL-LUNG C, V289, pL1094, DOI 10.1152/ajplung.00179.2005; Pagano A, 2003, ANN NY ACAD SCI, V1010, P405, DOI 10.1196/annals.1299.074; Papaiahgari S, 2006, ANTIOXID REDOX SIGN, V8, P43, DOI 10.1089/ars.2006.8.43; Papaiahgari S, 2004, J BIOL CHEM, V279, P42302, DOI 10.1074/jbc.M408275200; Qi YC, 2001, DEVELOPMENT, V128, P2723; Rahman Irfan, 2002, Current Drug Targets - Inflammation and Allergy, V1, P291, DOI 10.2174/1568010023344607; Reddy NM, 2008, ONCOGENE, V27, P5821, DOI 10.1038/onc.2008.188; Reddy NM, 2007, AM J RESP CELL MOL, V37, P3, DOI 10.1165/rcmb.2007-0004RC; Reddy NM, 2009, J IMMUNOL, V182, P7264, DOI 10.4049/jimmunol.0804248; Reddy SP, 2008, CURR MOL MED, V8, P376, DOI 10.2174/156652408785160925; Rizvi F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.118; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Wang Z, 2013, FREE RADICAL BIO MED, V65, P849, DOI 10.1016/j.freeradbiomed.2013.08.169; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010	41	35	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129676	10.1371/journal.pone.0129676	http://dx.doi.org/10.1371/journal.pone.0129676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075390	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900090
J	Zhao, X; Xue, JF; Zhang, XQ; Kong, FL; Chen, F; Lal, R; Zhang, HL				Zhao, Xin; Xue, Jian-Fu; Zhang, Xiang-Qian; Kong, Fan-Lei; Chen, Fu; Lal, Rattan; Zhang, Hai-Lin			Stratification and Storage of Soil Organic Carbon and Nitrogen as Affected by Tillage Practices in the North China Plain	PLOS ONE			English	Article							LONG-TERM TILLAGE; CLIMATE-CHANGE; RESIDUE MANAGEMENT; QUALITY ASSESSMENT; CROPPING SYSTEM; PADDY SOILS; CLAY LOAM; SEQUESTRATION; RATIO; AGRICULTURE	Tillage practices can redistribute the soil profiles, and thus affects soil organic carbon (SOC), and its storage. The stratification ratio (SR) can be an indicator of soil quality. This study was conducted to determine tillage effects on the profile distribution of certain soil properties in winter wheat (Triticum aestivum L.) and summer maize (Zea mays L.) systems in the North China Plain (NCP). Three tillage treatments, including no till (NT), rotary tillage (RT), and plow tillage (PT), were established in 2001 in Luancheng County, Hebei Province. The concentration, storage, and SR of SOC and soil total nitrogen (TN) were assessed in both the wheat and maize seasons. Compared with RT and PT, the mean SRs for all depth ratios of SOC under NT increased by 7.85% and 30.61% during the maize season, and by 14.67% and 30.91% during the wheat season, respectively. The SR of TN for 0-5:30-50 cm increased by 140%, 161%, and 161% in the maize season, and 266%, 154%, and 122% in the wheat season compared to the SR for 0-5:5-10 cm under NT, RT and PT, respectively. The data indicated that SOC and TN were both concentrated in the surface-soil layers (0-10 cm) under NT but were distributed relatively evenly through the soil profile under PT. Meanwhile, the storage of SOC and TN was higher under NT for the surface soil (0-10 cm) but was higher under PT for the deeper soil (30-50 cm). Furthermore, the storage of SOC and TN was significantly related to SR of SOC and TN along the whole soil profile (P< 0.0001). Therefore, SR could be used to explain and indicate the changes in the storage of SOC and TN. Further, NT stratifies SOC and TN, enhances the topsoil SOC storage, and helps to improve SOC sequestration and soil quality.	[Zhao, Xin; Xue, Jian-Fu; Zhang, Xiang-Qian; Kong, Fan-Lei; Chen, Fu; Zhang, Hai-Lin] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Zhao, Xin; Xue, Jian-Fu; Zhang, Xiang-Qian; Kong, Fan-Lei; Chen, Fu; Zhang, Hai-Lin] Minist Agr China, Key Lab Farming Syst, Beijing, Peoples R China; [Kong, Fan-Lei] Sichuan Agr Univ, Coll Agron, Chengdu, Peoples R China; [Lal, Rattan] Ohio State Univ, Sch Environm & Nat Resources, Carbon Management & Sequestrat Ctr, Columbus, OH 43210 USA	China Agricultural University; Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University; University System of Ohio; Ohio State University	Zhang, HL (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China.	hailin@cau.edu.cn	Zhao, Xin/AAH-5629-2019; Lal, Rattan/D-2505-2013; Zhang, Hai-Lin/H-2715-2017	Zhao, Xin/0000-0002-2977-6430; Zhang, Hai-Lin/0000-0002-7426-2885; Zhao, Xu/0000-0001-7875-4863	Chinese Universities Scientific Fund [2014FG055]; Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-13-0567]; Special Fund for Agro-scientific Research in the Public Interest in China [201103001]	Chinese Universities Scientific Fund; Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Special Fund for Agro-scientific Research in the Public Interest in China	This work was funded by Chinese Universities Scientific Fund (2014FG055), Program for New Century Excellent Talents in University of Ministry of Education of China (NCET-13-0567) and Special Fund for Agro-scientific Research in the Public Interest in China (201103001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao S.D, 2000, SOIL AGR CHEM ANAL; Blake G. R., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P363; Churka Blum S, 2014, STRATIFICATION RATIO, P427; Corral-Fernandez R, 2013, AGR ECOSYST ENVIRON, V164, P252, DOI 10.1016/j.agee.2012.11.002; Dalal RC, 2011, SOIL TILL RES, V112, P133, DOI 10.1016/j.still.2010.12.006; Dikgwatlhe SB, 2014, SOIL TILL RES, V144, P110, DOI 10.1016/j.still.2014.07.014; Du ZL, 2013, J INTEGR AGR, V12, P2114, DOI 10.1016/S2095-3119(13)60428-1; Du ZL, 2010, SOIL SCI SOC AM J, V74, P196, DOI 10.2136/sssaj2009.0048; Ellert BH, 1995, CAN J SOIL SCI, V75, P529, DOI 10.4141/cjss95-075; Ferreira AD, 2013, SOIL TILL RES, V133, P65, DOI 10.1016/j.still.2013.05.011; Franzluebbers AJ, 2007, SOIL TILL RES, V96, P303, DOI 10.1016/j.still.2007.07.001; Franzluebbers AJ, 2002, SOIL TILL RES, V66, P197, DOI 10.1016/S0167-1987(02)00027-2; Franzluebbers AJ, 2013, SOIL TILL RES, V134, P83, DOI 10.1016/j.still.2013.07.010; Hou RX, 2012, SOIL SCI SOC AM J, V76, P230, DOI 10.2136/sssaj2011.0107; Kong XB, 2014, ADV AGRON, V125, P135, DOI 10.1016/B978-0-12-800137-0.00004-2; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2004, ENVIRON MANAGE, V33, P528, DOI 10.1007/s00267-003-9110-9; Liu ZJ, 2014, J INTEGR AGR, V13, P177, DOI 10.1016/S2095-3119(13)60594-8; Lopez-Garrido R, 2011, AGR ECOSYST ENVIRON, V140, P182, DOI 10.1016/j.agee.2010.12.001; Lopez-Garrido R, 2009, SPAN J AGRIC RES, V7, P706; Lou YL, 2012, CATENA, V95, P124, DOI 10.1016/j.catena.2012.02.009; Luo ZK, 2010, AGR ECOSYST ENVIRON, V139, P224, DOI 10.1016/j.agee.2010.08.006; Melero S, 2012, SOIL TILL RES, V119, P7, DOI 10.1016/j.still.2011.11.012; Noellemeyer E, 2006, J ARID ENVIRON, V65, P142, DOI 10.1016/j.jaridenv.2005.07.007; NRCS, SOIL QUAL CONC; Pan GX, 2008, J ENVIRON SCI, V20, P456, DOI 10.1016/S1001-0742(08)62079-3; Peregrina F, 2014, J PLANT NUTR SOIL SC, V177, P548, DOI 10.1002/jpln.201300371; Powlson DS, 2014, NAT CLIM CHANGE, V4, P678, DOI 10.1038/NCLIMATE2292; Reynolds WD, 2007, SOIL TILL RES, V96, P316, DOI 10.1016/j.still.2007.07.003; Sa JCD, 2009, SOIL TILL RES, V103, P46, DOI 10.1016/j.still.2008.09.003; Shi XH, 2012, SOIL TILL RES, V120, P1, DOI [10.1016/j.still.2012.01.003, 10.1016/j.sti1l.2012.01.003]; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stockmann U, 2013, AGR ECOSYST ENVIRON, V164, P80, DOI 10.1016/j.agee.2012.10.001; Ussiri DAN, 2009, SOIL TILL RES, V104, P39, DOI 10.1016/j.still.2008.11.008; Wang Y, 2011, SOIL TILL RES, V117, P8, DOI 10.1016/j.still.2011.08.002; Wei YanHua, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P87; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Yang XM, 2013, ACTA AGR SCAND B-S P, V63, P523, DOI 10.1080/09064710.2013.816363; Zhang HL, 2015, CLIMATIC CHANGE, V129, P213, DOI 10.1007/s10584-015-1337-y; Zhang HL, 2014, ADV AGRON, V124, P1, DOI 10.1016/B978-0-12-800138-7.00001-2; Zhang MY, 2013, J CLEAN PROD, V54, P101, DOI 10.1016/j.jclepro.2013.04.033	41	35	39	9	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128873	10.1371/journal.pone.0128873	http://dx.doi.org/10.1371/journal.pone.0128873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075391	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900036
J	Bosco-Lauth, AM; Han, SS; Hartwig, A; Bowen, RA				Bosco-Lauth, Angela M.; Han, Sushan; Hartwig, Airn; Bowen, Richard A.			Development of a Hamster Model for Chikungunya Virus Infection and Pathogenesis	PLOS ONE			English	Article							MESOCRICETUS-AURATUS; MOUSE MODEL; DISEASE; PERSISTENCE; ARTHRITIS; EPIDEMIC; OUTBREAK	Chikungunya virus is transmitted by mosquitoes and causes severe, debilitating infectious arthritis in humans. The need for an animal model to study the disease process and evaluate potential treatments is imminent as the virus continues its spread into novel geographic locations. Golden hamsters (Mesocricetus auratus) are often used as outbred laboratory animal models for arboviral diseases. Here we demonstrate that hamsters inoculated with chikungunya virus developed viremia and histopathologic lesions in their limbs and joints similar to those seen in human patients. The virus disseminated rapidly and was found in every major organ, including brain, within a few days of infection. Hamsters did not manifest overt clinical signs, and the virus was generally cleared within 4 days, followed by a strong neutralizing antibody response. These results indicate that hamsters are highly susceptible to chikungunya virus infection and develop myositis and tenosynovitis similar to human patients followed by a complete recovery. This animal model may be useful for testing antiviral drugs and vaccines.	[Bosco-Lauth, Angela M.; Hartwig, Airn; Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Han, Sushan] Colorado State Univ, Diagnost Med Lab, Ft Collins, CO 80523 USA; [Han, Sushan] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University	Bowen, RA (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.	Richard.Bowen@colostate.edu			National Institute of Allergy and Infectious Disease (NIAID) [N01-AI25489]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025489] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported through contract N01-AI25489 from National Institute of Allergy and Infectious Disease (NIAID). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaty BJ, 1995, DIAGNOSTIC PROCEDURE, P189; Bordi L, 2008, CLIN INFECT DIS, V47, P428, DOI 10.1086/589925; Bosco-Lauth A, 2011, AM J TROP MED HYG, V84, P727, DOI 10.4269/ajtmh.2011.11-0012; Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Couderc T, 2009, MICROBES INFECT, V11, P1197, DOI 10.1016/j.micinf.2009.09.002; Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09; Her Z, 2009, MICROBES INFECT, V11, P1165, DOI 10.1016/j.micinf.2009.09.004; Higgs S, 2010, J CLIN INVEST, V120, P657, DOI 10.1172/JCI42392; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X; Morrison TE, 2011, AM J PATHOL, V178, P32, DOI 10.1016/j.ajpath.2010.11.018; Ng LC, 2010, INFECT GENET EVOL, V10, P876, DOI 10.1016/j.meegid.2010.07.012; Pesko K, 2009, J MED ENTOMOL, V46, P395, DOI 10.1603/033.046.0228; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Renault P, 2007, AM J TROP MED HYG, V77, P727; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; ROBINSON M. C., 1955, TANGANYIKA TERRITORY IN 1952 53 I TRANS ROY SOC TROP MED AND HYG, V49, P28, DOI 10.1016/0035-9203(55)90080-8; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Soumahoro MK, 2009, PLOS ONE, V4, pA221, DOI 10.1371/journal.pone.0007800; Teo TH, 2012, IMMUNOL RES, V53, P136, DOI 10.1007/s12026-012-8266-x; Tesh RB, 2001, J INFECT DIS, V183, P1431, DOI 10.1086/320199; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Xiao SY, 2001, EMERG INFECT DIS, V7, P714; Ziegler SA, 2008, AM J TROP MED HYG, V79, P133, DOI 10.4269/ajtmh.2008.79.133	26	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130150	10.1371/journal.pone.0130150	http://dx.doi.org/10.1371/journal.pone.0130150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070211	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000143
J	Celdran, D; Lloret, J; Verduin, J; van Keulen, M; Marin, A				Celdran, David; Lloret, Javier; Verduin, Jennifer; van Keulen, Mike; Marin, Arnaldo			Linking Seed Photosynthesis and Evolution of the Australian and Mediterranean Seagrass Genus Posidonia	PLOS ONE			English	Article								Recent findings have shown that photosynthesis in the skin of the seed of Posidonia oceanica enhances seedling growth. The seagrass genus Posidoniais found only in two distant parts of the world, the Mediterranean Sea and southern Australia. This fact led us to question whether the acquisition of this novel mechanism in the evolution of this seagrass was a pre-adaptation prior to geological isolation of the Mediterranean from Tethys Sea in the Eocene. Photosynthetic activity in seeds of Australian species of Posidoniais still unknown. This study shows oxygen production and respiration rates, and maximum PSII photochemical efficiency (Fv : Fm) in seeds of two Australian Posidonia species (P. australis and P. sinuosa), and compares these with previous results for Posidonia oceanica. Results showed relatively high oxygen production and respiratory rates in all three species but with significant differences among them, suggesting the existence of an adaptive mechanism to compensate for the relatively high oxygen demands of the seeds. In all cases maximal photochemical efficiency of photosystem II rates reached similar values. The existence of photosynthetic activity in the seeds of all three species implicates that it was an ability probably acquired from a common ancestor during the Late Eocene, when this adaptive strategy could have helped Posidonia species to survive in nutrient-poor temperate seas. This study sheds new light on some aspects of the evolution of marine plants and represents an important contribution to global knowledge of the paleogeographic patterns of seagrass distribution.	[Celdran, David] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales Puerto Morelos, Cancun 77500, Quintana Roo, Mexico; [Lloret, Javier] Marine Biol Lab, Ecosyst Ctr, Woods Hole, MA 02543 USA; [Verduin, Jennifer; van Keulen, Mike] Murdoch Univ, Sch Vet & Life Sci Environm & Conservat Sci, Murdoch, WA 6150, Australia; [Marin, Arnaldo] Univ Murcia, Fac Biol, Dept Ecol & Hidrol, E-30100 Murcia, Spain	Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico; Marine Biological Laboratory - Woods Hole; Murdoch University; University of Murcia	Celdran, D (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales Puerto Morelos, Apto Postal 1152, Cancun 77500, Quintana Roo, Mexico.	davidceldran1@hotmail.com	Atucha, Arnaldo Marín/R-3801-2019; Lloret, Javier/C-1994-2016; Verduin, Jennifer J/B-2102-2014; van Keulen, Mike/Q-9856-2019	Atucha, Arnaldo Marín/0000-0001-8439-4104; Lloret, Javier/0000-0003-3916-884X; Verduin, Jennifer J/0000-0002-1538-7813; van Keulen, Mike/0000-0001-6235-5788	Ministerio de Ciencia e Innovacion Espanol, Programa Nacional de Formacion de Profesorado Universitario, Spain; project "Desarroyo de tecnicas de reimplante con semillas para la recuperacion y expansion de las praderas de Posidonia oceanica", from Ministerio de Innovacion y Ciencia, Spain [116/SGTB/2007/1.3]	Ministerio de Ciencia e Innovacion Espanol, Programa Nacional de Formacion de Profesorado Universitario, Spain; project "Desarroyo de tecnicas de reimplante con semillas para la recuperacion y expansion de las praderas de Posidonia oceanica", from Ministerio de Innovacion y Ciencia, Spain	This research was further facilitated by a grant to D.C. from the Ministerio de Ciencia e Innovacion Espanol, Programa Nacional de Formacion de Profesorado Universitario, Spain; and the project "Desarroyo de tecnicas de reimplante con semillas para la recuperacion y expansion de las praderas de Posidonia oceanica", from the Ministerio de Innovacion y Ciencia (project number 116/SGTB/2007/1.3), Spain.	Aires T, 2011, MAR ECOL PROG SER, V421, P117, DOI 10.3354/meps08879; Boudouresque C.-F, 2004, TRAV SCI PARC NATL P, V20, P97; CAMBRIDGE ML, 1979, AQUAT BOT, V6, P307, DOI 10.1016/0304-3770(79)90071-8; Celdran D, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00104.1; Gessner F, 1970, INT REV GESAMTEN HYD, V56, P141, DOI [10.1002/iroh.19710560139, DOI 10.1002/IROH.19710560139]; KUO J, 1984, AQUAT BOT, V20, P267, DOI 10.1016/0304-3770(84)90092-5; KUO J, 1990, PLANT SYST EVOL, V171, P199, DOI 10.1007/BF00940605; Larkum AW., 2006, SEAGRASSES BIOL ECOL, P691; Roberts A. C., 1998, PREFRONTAL CORTEX EX, P1; Rolletschek H, 2002, J EXP BOT, V53, P1099, DOI 10.1093/jexbot/53.371.1099; SEARLE MP, 1987, GEOL SOC AM BULL, V98, P678, DOI 10.1130/0016-7606(1987)98<678:TCOTAT>2.0.CO;2; Souvermezoglou E, 1988, OCEANOL ACTA, V9, P103; STOCKMANS F., 1932, BULL MUS ROY HIST NAT BELGIQUE, V8, P1; Tschiersch H, 2011, BIOSYSTEMS, V103, P302, DOI 10.1016/j.biosystems.2010.08.007; Vigeolas H, 2003, PLANT PHYSIOL, V133, P2048, DOI 10.1104/pp.103.031963; Waycott M, 1997, HEREDITY, V79, P408, DOI 10.1038/sj.hdy.6881900	16	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130015	10.1371/journal.pone.0130015	http://dx.doi.org/10.1371/journal.pone.0130015			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066515	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000134
J	de Melo, SM; Bittencourt, S; Ferrazoli, EG; da Silva, CS; da Cunha, FF; da Silva, FH; Stilhano, RS; Denapoli, PMA; Zanetti, BF; Martin, PKM; Silva, LM; dos Santos, AA; Baptista, LS; Longo, BM; Han, SW				de Melo, Suely Maymone; Bittencourt, Simone; Ferrazoli, Eneas Galdini; da Silva, Clivandir Severino; da Cunha, Flavia Franco; da Silva, Flavia Helena; Stilhano, Roberta Sessa; Andrade Denapoli, Priscila Martins; Zanetti, Bianca Ferrarini; Matsumoto Martin, Priscila Keiko; Silva, Leonardo Martins; dos Santos, Adara Aurea; Baptista, Leandra Santos; Longo, Beatriz Monteiro; Han, Sang Won			The Anti-Tumor Effects of Adipose Tissue Mesenchymal Stem Cell Transduced with HSV-Tk Gene on U-87-Driven Brain Tumor	PLOS ONE			English	Article							HUMAN BONE-MARROW; THYMIDINE KINASE GENE; SUICIDE-GENE; PROGENITOR CELLS; STROMAL CELLS; MALIGNANT GLIOMA; GAP-JUNCTIONS; PHASE-III; IN-VITRO; THERAPY	Glioblastoma (GBM) is an infiltrative tumor that is difficult to eradicate. Treating GBM with mesenchymal stem cells (MSCs) that have been modified with the HSV-Tk suicide gene has brought significant advances mainly because MSCs are chemoattracted to GBM and kill tumor cells via a bystander effect. To use this strategy, abundantly present adipose-tissue-derived mesenchymal stem cells (AT-MSCs) were evaluated for the treatment of GBM in mice. AT-MSCs were prepared using a mechanical protocol to avoid contamination with animal protein and transduced with HSV-Tk via a lentiviral vector. The U-87 glioblastoma cells cultured with AT-MSC-HSV-Tk died in the presence of 25 or 50 mu M ganciclovir (GCV). U-87 glioblastoma cells injected into the brains of nude mice generated tumors larger than 3.5 mm(2) after 4 weeks, but the injection of AT-MSC-HSV-Tk cells one week after the U-87 injection, combined with GCV treatment, drastically reduced tumors to smaller than 0.5 mm(2). Immunohistochemical analysis of the tumors showed the presence of AT-MSC-HSV-Tk cells only within the tumor and its vicinity, but not in other areas of the brain, showing chemoattraction between them. The abundance of AT-MSCs and the easier to obtain them mechanically are strong advantages when compared to using MSCs from other tissues.	[de Melo, Suely Maymone; da Cunha, Flavia Franco; da Silva, Flavia Helena; Stilhano, Roberta Sessa; Andrade Denapoli, Priscila Martins; Zanetti, Bianca Ferrarini; Matsumoto Martin, Priscila Keiko; Silva, Leonardo Martins; dos Santos, Adara Aurea; Han, Sang Won] Univ Fed Sao Paulo, Res Ctr Gene Therapy CINTERGEN, Sao Paulo, Brazil; [Bittencourt, Simone; Ferrazoli, Eneas Galdini; da Silva, Clivandir Severino; Longo, Beatriz Monteiro] Univ Fed Sao Paulo, Dept Physiol, Sao Paulo, Brazil; [Baptista, Leandra Santos] Univ Fed Rio de Janeiro Xerem, Nucleus Multidisciplinary Res Biol, Numpex Bio, Sao Paulo, Brazil; [Han, Sang Won] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Han, SW (corresponding author), Univ Fed Sao Paulo, Res Ctr Gene Therapy CINTERGEN, Sao Paulo, Brazil.	sang.han@unifesp.br	Bittencourt, Simone/N-9393-2019; Baptista, Leandra/D-4259-2013; Martins, Leonardo/N-9454-2013; STILHANO, roberta/F-6923-2015; Monteiro Longo, Beatriz/D-2216-2012	Bittencourt, Simone/0000-0003-4872-0747; Baptista, Leandra/0000-0001-9998-8044; Martins, Leonardo/0000-0003-3524-4876; STILHANO, roberta/0000-0002-0653-5968; DOS SANTOS, ADARA AUREA/0000-0003-2309-4890; Monteiro Longo, Beatriz/0000-0002-2638-8061	Fundacao de ampara a pesquisa do estado de Sao Paulo (FAPESP) [2012/21861-1]	Fundacao de ampara a pesquisa do estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by the Fundacao de ampara a pesquisa do estado de Sao Paulo (FAPESP): 2012/21861-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Amano S, 2011, CANCER LETT, V306, P99, DOI 10.1016/j.canlet.2011.02.037; [Anonymous], NEUROSURG FOCUS; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Baptista LS, 2009, CYTOTHERAPY, V11, P706, DOI 10.3109/14653240902981144; Benedetti S, 2000, NAT MED, V6, P447, DOI 10.1038/74710; Bexell D, 2009, MOL THER, V17, P183, DOI 10.1038/mt.2008.229; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; Brown AB, 2003, HUM GENE THER, V14, P1777, DOI 10.1089/104303403322611782; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Carvalho PP, 2011, CYTOTHERAPY, V13, P594, DOI 10.3109/14653249.2010.544721; Choi SA, 2011, NEURO-ONCOLOGY, V13, P61, DOI 10.1093/neuonc/noq147; COLOMBO BM, 1995, HUM GENE THER, V6, P763, DOI 10.1089/hum.1995.6.6-763; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Cottin S, 2011, CANCER GENE THER, V18, P674, DOI 10.1038/cgt.2011.38; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; Elshami AA, 1996, GENE THER, V3, P85; EZZEDDINE ZD, 1991, NEW BIOL, V3, P608; FREEMAN SM, 1993, CANCER RES, V53, P5274; Freeman SM, 1997, LANCET, V349, P2, DOI 10.1016/S0140-6736(97)22001-5; Gagandeep S, 1996, CANCER GENE THER, V3, P83; GOLUMBEK PT, 1992, J IMMUNOTHER, V12, P224, DOI 10.1097/00002371-199211000-00002; Grogan SP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2719; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kruse CA, 1997, CANCER GENE THER, V4, P118; Ladd B, 2011, CANCER GENE THER, V18, P751, DOI 10.1038/cgt.2011.51; Li SY, 2007, CANCER LETT, V251, P220, DOI 10.1016/j.canlet.2006.11.024; Li SY, 2012, STEM CELL RES, V9, P270, DOI 10.1016/j.scr.2012.08.002; Miletic H, 2004, HUM GENE THER, V15, P1091, DOI 10.1089/hum.2004.15.1091; Miletic H, 2007, MOL THER, V15, P1373, DOI 10.1038/sj.mt.6300155; Morizono K, 2003, HUM GENE THER, V14, P59, DOI 10.1089/10430340360464714; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Namba H, 2001, CANCER GENE THER, V8, P414, DOI 10.1038/sj.cgt.7700317; Nestler U, 2004, J NEURO-ONCOL, V67, P177, DOI 10.1023/B:NEON.0000021897.53969.ca; Pachon-Pena G, 2011, J CELL PHYSIOL, V226, P843, DOI 10.1002/jcp.22408; Pendleton C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058198; Rainov NG, 2000, HUM GENE THER, V11, P2389, DOI 10.1089/104303400750038499; Rainov NG, 2001, CANCER GENE THER, V8, P662, DOI 10.1038/sj.cgt.7700355; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Schmidt A, 2006, EUR J CELL BIOL, V85, P1179, DOI 10.1016/j.ejcb.2006.05.015; Studeny M, 2002, CANCER RES, V62, P3603; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Uhl M, 2005, BIOCHEM BIOPH RES CO, V328, P125, DOI 10.1016/j.bbrc.2004.12.164; WILLIAMS SK, 1995, CELL TRANSPLANT, V4, P281, DOI 10.1016/0963-6897(95)00006-J; Yamamoto S, 1997, CANCER GENE THER, V4, P91; Zhang Y, 2012, CANCER RES, V72, P5198, DOI 10.1158/0008-5472.CAN-12-0294; Zimmerlin L, 2010, CYTOM PART A, V77A, P22, DOI 10.1002/cyto.a.20813; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	51	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128922	10.1371/journal.pone.0128922	http://dx.doi.org/10.1371/journal.pone.0128922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067671	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000033
J	Engqvist, I; Wyss, K; Asker-Hagelberg, C; Bergman, U; Odar-Cederlof, I; Stiller, CO; Fryckstedt, J				Engqvist, Ida; Wyss, Katja; Asker-Hagelberg, Charlotte; Bergman, Ulf; Odar-Cederloef, Ingegerd; Stiller, Carl-Olav; Fryckstedt, Jessica			Which Medication Is the Patient Taking at Admission to the Emergency Ward? Still Unclear Despite the Swedish Prescribed Drug Register	PLOS ONE			English	Article							RECONCILIATION; DISCREPANCIES; QUALITY	Introduction Correct information on patients' medication is crucial for diagnosis and treatment in the Emergency Department. The aim of this study was to investigate the concordance between the admission chart and two other records of the patient's medication. Methods This cohort study includes data on 168 patients over 18 years admitted to the Emergency Ward between September 1 and 30, 2008. The record kept by the general practitioner and the patient record of dispensed drugs in the Swedish Prescribed Drug Register were compared to the admission chart record. Results Drug record discrepancies of potential clinical significance between the admission chart record and the Swedish Prescribed Drug Register or general practitioner record were present in 79 and 82 percent, respectively. For 63 percent of the studied patients the admission chart record did not include all drugs registered in the Swedish Prescribed Drug Register. For 62 percent the admission chart record did not include all drugs registered in the general practitioner record. In addition, for 32 percent of the patients the admission chart record included drugs not registered in the Swedish Prescribed Drug Register and for 52 percent the admission chart record included drugs not found in the general practitioner record. The most discordant drug classes were cardiovascular and CNS-active drugs. Clinically significant drug record discrepancies were more frequent in older patients with multiple medication and caregivers. Conclusion The apparent absence of an accurate record of the patient's drugs at admission to the Emergency Ward constitutes a potential patient safety hazard. The available sources in Sweden, containing information on the drugs a particular patient is taking, do not seem to be up to date. These results highlight the importance of an accurate list of currently used drugs that follows the patient and can be accessed upon acute admission to the hospital.	[Engqvist, Ida; Wyss, Katja; Fryckstedt, Jessica] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Med,Dept Emergency Med, SE-17176 Stockholm, Sweden; [Asker-Hagelberg, Charlotte; Stiller, Carl-Olav] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Clin Pharmacol Unit, SE-17176 Stockholm, Sweden; [Asker-Hagelberg, Charlotte] Med Prod Agcy, SE-75103 Uppsala, Sweden; [Bergman, Ulf; Odar-Cederloef, Ingegerd] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, SE-14186 Huddinge, Sweden; [Bergman, Ulf] Karolinska Univ, Hosp Solna, Ctr Pharmacoepidemiol, Karolinska Inst,Dept Med, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Medical Products Agency; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Odar-Cederlof, I (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, SE-14186 Huddinge, Sweden.	ingegerd.odar-cederlof@karolinska.se; jessica.fryckstedt@karolinska.se	; Stiller, Carl-Olav/P-4582-2016	Fryckstedt, Jessica/0000-0003-4944-8909; Stiller, Carl-Olav/0000-0003-0684-635X	National Board of Health and Welfare [800 000 SEK about 85 000 EURO]	National Board of Health and Welfare	This project received a grant (800 000 SEK about 85 000 EURO) from the National Board of Health and Welfare, administrated by the Stockholm county council. It was mainly used for salaries (for IE, KW and JF). The remaining authors contributed within their ordinary positions in the county.	Akwagyriam I, 1996, J ACCID EMERG MED, V13, P166; Bedell SE, 2000, ARCH INTERN MED, V160, P2129, DOI 10.1001/archinte.160.14.2129; Bjerrum L, 2000, SCAND J PRIM HEALTH, V18, P94; Cars T, 2013, BASIC CLIN PHARM FEB; Cornish PL, 2005, ARCH INTERN MED, V165, P424, DOI 10.1001/archinte.165.4.424; Department of Health, 2000, STAT B; Ekedahl A, 2011, PHARMACOEPIDEM DR S, V20, P1177, DOI 10.1002/pds.2226; Eriksson U, 2007, LAKEMEDELSFORTECKNIN; Fryckstedt Jessica, 2008, Lakartidningen, V105, P894; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Hellden A, 2009, DRUG AGING, V26, P595, DOI 10.2165/11315790-000000000-00000; LINDLEY CM, 1992, AGE AGEING, V21, P294, DOI 10.1093/ageing/21.4.294; Loikas D, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002378; Lubowski TJ, 2007, AM J PHARM EDUC, V71, DOI 10.5688/aj710594; Miller SL, 2008, ANN EMERG MED, V52, P483, DOI 10.1016/j.annemergmed.2008.03.021; Nassaralla CL, 2007, QUAL SAF HEALTH CARE, V16, P90, DOI 10.1136/qshc.2006.021113; Odar-Cederlof Ingegerd, 2008, Lakartidningen, V105, P890; Oskarsson P, 2007, SVENSKA LAKARESALLSK, V116, P72, DOI 10.1093/humrep/deu149; Paul Esbjorn, 2008, Lakartidningen, V105, P2338; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Ulrika Eriksson, 2009, NATIONELL LAKEMEDELS; von Euler M, 2006, PHARMACOEPIDEM DR S, V15, P179, DOI 10.1002/pds.1154; Wagner MM, 1996, J AM MED INFORM ASSN, V3, P234, DOI 10.1136/jamia.1996.96310637; Wettermark B, 2006, PUBLIC HEALTH, V120, P451, DOI 10.1016/j.puhe.2005.10.011; Wettermark B, 2013, PHARMACOEPIDEM DR S, V22, P691, DOI 10.1002/pds.3457; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; WHO Collaborating Centre for Drug Statistics Methodology, 2009, GUID ATC CLASS DDD A	27	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128716	10.1371/journal.pone.0128716	http://dx.doi.org/10.1371/journal.pone.0128716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068920	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000025
J	Guo, MM; Duan, XN; Cui, SD; Tian, FG; Cao, XC; Geng, CZ; Fan, ZM; Wang, X; Wang, S; Jiang, HC; Zhang, JG; Jin, F; Tang, JH; Liang, H; Yang, ZL; Wang, HB; Wang, QT; Li, GL; Li, L; Zhu, SG; Zuo, WS; Liu, LY; Wang, L; Ma, DD; Liu, SC; Xiang, YJ; Liu, L; Ye, CM; Zhou, WZ; Wang, F; Yu, LX; Ma, ZB; Yu, ZG				Guo, Ming-ming; Duan, Xue-ning; Cui, Shu-de; Tian, Fu-guo; Cao, Xu-chen; Geng, Cui-zhi; Fan, Zhi-min; Wang, Xiang; Wang, Shu; Jiang, Hong-chuan; Zhang, Jian-guo; Jin, Feng; Tang, Jin-hai; Liang, Hong; Yang, Zhen-lin; Wang, Hai-bo; Wang, Qi-tang; Li, Guo-lou; Li, Liang; Zhu, Shi-guang; Zuo, Wen-shu; Liu, Li-yuan; Wang, Lu; Ma, Dan-dan; Liu, Shu-chen; Xiang, Yu-juan; Liu, Lu; Ye, Chun-miao; Zhou, Wen-zhong; Wang, Fei; Yu, Li-xiang; Ma, Zhong-bing; Yu, Zhi-gang			Circulating High-Molecular-Weight (HMW) Adiponectin Level Is Related with Breast Cancer Risk Better than Total Adiponectin: A Case-Control Study	PLOS ONE			English	Article							COMPLEX; PROTEIN	The level of total adiponectin, a mixture of different adiponectin forms, has been reported associated with breast cancer risk with inconsistent results. Whether the different forms play different roles in breast cancer risk prediction is unclear. To examine this, we measured total and high molecular weight (HMW) adiponectin in a case-control study (1167 sets). Higher circulating HMW adiponectin was negatively associated with breast cancer risk after adjusting for menopausal status and family history of breast cancer (P=0.024). We analyzed the relationship between adiponectin and breast cancer risk in 6 subgroups. Higher circulating HMW adiponectin was also negatively associated with breast cancer risk (P=0.020, 0.014, 0.035) in the subgroups of postmenopausal women, negative family history of breast cancer, BMI>=24.0. Total adiponectin was positively associated with breast cancer (P=0.028) in the subgroup of BMI<=24.0. Higher HMW/total adiponectin ratio was negatively associated with breast cancer (P=0.019) in the subgroup of postmenopausal women. Interestingly, in the subgroup of women with family history of breast cancer, higher circulating total and HMW adiponectin were positively associated with breast cancer risk (P=0.034, 0.0116). This study showed different forms of circulating adiponectin levels might play different roles in breast cancer risk. A higher circulating HMW adiponectin is associated with a decreased breast cancer risk, especially in postmenopausal, without family history of breast cancer or BMI>=24.0 subgroups, whereas higher circulating HMW adiponectin levels is a risk factor in women with a family history of breast cancer. Further investigation of different forms of adiponectin on breast cancer risk is needed.	[Guo, Ming-ming; Ma, Dan-dan; Liu, Shu-chen; Liu, Lu; Ye, Chun-miao; Zhou, Wen-zhong] Shandong Univ, Sch Med, Jinan 250100, Shandong, Peoples R China; [Guo, Ming-ming; Xiang, Yu-juan; Wang, Fei; Yu, Li-xiang; Ma, Zhong-bing; Yu, Zhi-gang] Shandong Univ, Hosp 2, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China; [Duan, Xue-ning] Peking Univ, Hosp 1, Breast Dis Ctr, Beijing 100871, Peoples R China; [Cui, Shu-de] Zhengzhou Univ, Affiliated Tumor Hosp, Dept Breast Surg, Zhengzhou 450052, Henan, Peoples R China; [Tian, Fu-guo] Shanxi Canc Hosp, Dept Breast Surg, Taiyuan, Shanxi, Peoples R China; [Cao, Xu-chen] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Geng, Cui-zhi] Hebei Med Univ, Hosp 4, Breast Ctr, Shijiazhuang, Hebei, Peoples R China; [Fan, Zhi-min] Jilin Univ, Hosp 1, Dept Breast Surg, Changchun 130023, Jilin, Peoples R China; [Wang, Xiang] Chinese Acad Med Sci, Canc Hosp, Dept Breast Surg, Beijing 100730, Peoples R China; [Wang, Shu] Peking Univ, Peoples Hosp, Breast Dis Ctr, Beijing 100871, Peoples R China; [Jiang, Hong-chuan] Beijing Chaoyang Hosp, Dept Gen Surg, Beijing, Peoples R China; [Zhang, Jian-guo] Harbin Med Univ, Affiliated Hosp 2, Dept Gen Surg, Harbin, Heilongjiang, Peoples R China; [Jin, Feng] China Med Univ, Affiliated Hosp 1, Dept Breast Surg, Shenyang 110001, Liaoning, Peoples R China; [Tang, Jin-hai] Nanjing Med Univ, Affiliated Canc Hosp, Canc Inst Jiangsu Prov, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Liang, Hong] Linyi Peoples Hosp, Dept Gen Surg, Linyi, Shandong, Peoples R China; [Yang, Zhen-lin] Binzhou Med Univ, Affiliated Hosp 1, Dept Thyroid & Breast Surg, Binzhou, Shandong, Peoples R China; [Wang, Hai-bo] Qingdao Univ, Affiliated Hosp, Breast Ctr, Qingdao 266071, Shandong, Peoples R China; [Wang, Qi-tang] Qingdao Cent Hosp, Qingdao Med Coll, Affiliated Hosp 2, Dept Breast Surg, Qingdao, Shandong, Peoples R China; [Li, Guo-lou] Weifang Tradit Chinese Hosp, Dept Breast & Thyroid Surg, Weifang, Shandong, Peoples R China; [Li, Liang] Zibo Cent Hosp, Dept Breast & Thyroid Surg, Zibo, Shandong, Peoples R China; [Zhu, Shi-guang] Yantai Yuhuangding Hosp, Dept Breast Surg, Yantai, Shandong, Peoples R China; [Zuo, Wen-shu] Shandong Canc Hosp, Breast Canc Ctr, Jinan, Shandong, Peoples R China; [Liu, Li-yuan] Shandong Univ, Sch Publ Hlth, Inst Epidemiol, Jinan 250100, Shandong, Peoples R China; [Wang, Lu] Shandong Univ, Sch Publ Hlth, Div Epidemiol & Biostat, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Peking University; Zhengzhou University; Tianjin Medical University; Hebei Medical University; Jilin University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking University; Harbin Medical University; China Medical University; Nanjing Medical University; Binzhou Medical University; Qingdao University; Qingdao University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Yu, ZG (corresponding author), Shandong Univ, Hosp 2, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China.	yzg@medmail.com.cn	YU, ZHIGANG/AAA-4679-2022; Wang, Lu/O-7732-2019	Wang, Lu/0000-0003-0245-7226; zhou, wenzhong/0000-0002-1359-2784; liu, liyuan/0000-0002-9862-7471; Wang, Xiang/0000-0002-0913-0501	Key Project of the Natural Science Foundation of Shandong Province, China [ZR2014HZ004]; Clinical Scientific Research Project of Science and Technology Agency of Jiangsu Province, China [BL2014055]	Key Project of the Natural Science Foundation of Shandong Province, China; Clinical Scientific Research Project of Science and Technology Agency of Jiangsu Province, China	This study is supported by two programs: one is the Key Project of the Natural Science Foundation of Shandong Province, China (ZR2014HZ004, http://www.sdnsf.gov.cn/portal/); another one is the Clinical Scientific Research Project of Science and Technology Agency of Jiangsu Province, China (BL2014055, http://www.jstd.gov.cn/). ZGY is the author who received the funding above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; Ebinuma H, 2007, CLIN CHEM, V53, P1541, DOI 10.1373/clinchem.2007.085654; Elkum N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-788; Engl J, 2007, OBESITY, V15, P1172, DOI 10.1038/oby.2007.627; Fan L, 2014, LANCET ONCOL, V15, pE279, DOI 10.1016/S1470-2045(13)70567-9; Fisher FM, 2005, DIABETOLOGIA, V48, P1084, DOI 10.1007/s00125-005-1758-7; Goldstein BJ, 2004, J CLIN ENDOCR METAB, V89, P2563, DOI 10.1210/jc.2004-0518; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Isobe K, 2009, J ATHEROSCLER THROMB, V16, P442, DOI 10.5551/jat.No885; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Korner A, 2007, J CLIN ENDOCR METAB, V92, P1041, DOI 10.1210/jc.2006-1858; Ligibel JA, 2009, CANCER CAUSE CONTROL, V20, P1523, DOI 10.1007/s10552-009-9358-3; Liu LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073183; Llanos AA, 2014, J CLIN ENDOCR METAB, V99, P625, DOI 10.1210/jc.2013-3222; Macis D, 2014, INT J EPIDEMIOL, V43, P1226, DOI 10.1093/ije/dyu088; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Pinthus JH, 2008, EUR UROL, V54, P866, DOI 10.1016/j.eururo.2008.02.044; Reiser B, 2000, STAT MED, V19, P2115, DOI 10.1002/1097-0258(20000830)19:16<2115::AID-SIM529>3.0.CO;2-M; Scheid MP, 2014, REV ENDOCR METAB DIS, V15, P157, DOI 10.1007/s11154-013-9265-5; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sumie S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026840; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Tsao TS, 2002, J BIOL CHEM, V277, P29359, DOI 10.1074/jbc.C200312200; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Ye JJ, 2014, EUR J CANCER PREV, V23, P158, DOI 10.1097/CEJ.0b013e328364f293; Yu ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037784; Zhu N, 2010, J CLIN ENDOCR METAB, V95, P5097, DOI 10.1210/jc.2010-0716; Ziemke F, 2010, AM J CLIN NUTR, V91, p258S, DOI 10.3945/ajcn.2009.28449C	31	13	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129246	10.1371/journal.pone.0129246	http://dx.doi.org/10.1371/journal.pone.0129246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070203	Green Submitted, gold, Green Published			2022-12-27	WOS:000356327000057
J	Miles, LA; Brennen, WN; Rudin, CM; Poirier, JT				Miles, Linde A.; Brennen, W. Nathaniel; Rudin, Charles M.; Poirier, John T.			Seneca Valley Virus 3C(pro) Substrate Optimization Yields Efficient Substrates for Use in Peptide-Prodrug Therapy	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; MALTOSE-BINDING PROTEIN; ONCOLYTIC PICORNAVIRUS; ESCHERICHIA-COLI; EVOLUTIONARY OPTIMIZATION; PROTEOLYTIC CLEAVAGE; 3C PROTEASE; IN-VITRO; POLYPROTEIN; ENZYME	The oncolytic picornavirus Seneca Valley Virus (SVV-001) demonstrates anti-tumor activity in models of small cell lung cancer (SCLC), but may ultimately need to be combined with cytotoxic therapies to improve responses observed in patients. Combining SVV-001 virotherapy with a peptide prodrug activated by the viral protease 3C(pro) is a novel strategy that may increase the therapeutic potential of SVV-001. Using recombinant SVV-001 3C(pro), we measured cleavage kinetics of predicted SVV-001 3C(pro) substrates. An efficient substrate, L/VP4 (k(cat)/K-M = 1932 +/- 183 M(-1)s(-1)), was further optimized by a P2' N -> P substitution yielding L/VP4.1 (k(cat)/KM = 17446 +/- 2203 M(-1)s(-1)). We also determined essential substrate amino acids by sequential N-terminal deletion and substitution of amino acids found in other picornavirus genera. A peptide corresponding to the L/VP4.1 substrate was selectively cleaved by SVV-001 3C(pro) in vitro and was stable in human plasma. These data define an optimized peptide substrate for SVV-001 3C(pro), with direct implications for anti-cancer therapeutic development.	[Miles, Linde A.; Rudin, Charles M.] Johns Hopkins Univ, Dept Pharmacol & Mol Sci, Baltimore, MD USA; [Brennen, W. Nathaniel; Rudin, Charles M.; Poirier, John T.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Rudin, CM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	rudinc@mskcc.org; poirierj@mskcc.org	Rudin, Charles/R-2530-2019	Rudin, Charles/0000-0001-5204-3465; Poirier, John/0000-0001-9795-5644; Miles, Linde/0000-0003-3578-2842	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline; NIGMS NIH HHS [T32 GM008752] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNOLD E, 1987, P NATL ACAD SCI USA, V84, P21, DOI 10.1073/pnas.84.1.21; BAZAN JF, 1988, P NATL ACAD SCI USA, V85, P7872, DOI 10.1073/pnas.85.21.7872; Birtley JR, 2005, J BIOL CHEM, V280, P11520, DOI 10.1074/jbc.M413254200; Boulware KT, 2006, P NATL ACAD SCI USA, V103, P7583, DOI 10.1073/pnas.0511108103; Boulware KT, 2010, BIOTECHNOL BIOENG, V106, P339, DOI 10.1002/bit.22693; Brennen WN, 2012, JNCI-J NATL CANCER I, V104, P1320, DOI 10.1093/jnci/djs336; Choi KY, 2012, THERANOSTICS, V2, P156, DOI 10.7150/thno.4068; CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062; DeFeo-Jones D, 2000, NAT MED, V6, P1248, DOI 10.1038/81351; DeFeo-Jones D, 2002, MOL CANCER THER, V1, P451; Denmeade SR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003886; Denmeade SR, 1998, CANCER RES, V58, P2537; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Felber LM, 2004, BIOTECHNIQUES, V36, P878, DOI 10.2144/04365PT04; FREEMAN SM, 1993, CANCER RES, V53, P5274; GORBALENYA AE, 1986, FEBS LETT, V194, P253, DOI 10.1016/0014-5793(86)80095-3; Grove JI, 1999, ANTI-CANCER DRUG DES, V14, P461; Hales LM, 2008, J GEN VIROL, V89, P1265, DOI 10.1099/vir.0.83570-0; Hewitt SN, 2011, ACTA CRYSTALLOGR F, V67, P1006, DOI 10.1107/S1744309111022159; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Knox Richard J, 1997, Pathol Oncol Res, V3, P309; Liu BL, 1996, J VIROL, V70, P2605, DOI 10.1128/JVI.70.4.2605-2610.1996; Liu TC, 2007, NAT CLIN PRACT ONCOL, V4, P101, DOI 10.1038/ncponc0736; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; McNeish IA, 1998, GENE THER, V5, P1061, DOI 10.1038/sj.gt.3300744; Morton CL, 2010, PEDIATR BLOOD CANCER, V55, P295, DOI 10.1002/pbc.22535; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; PARKS GD, 1989, J VIROL, V63, P1054, DOI 10.1128/JVI.63.3.1054-1058.1989; Poirier JT, 2012, J GEN VIROL, V93, P2606, DOI 10.1099/vir.0.046011-0; Poirier JT, 2012, J NATL CANC I; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Reddy PS, 2007, J NATL CANCER I, V99, P1623, DOI 10.1093/jnci/djm198; Rudin CM, 2011, CLIN CANCER RES, V17, P888, DOI 10.1158/1078-0432.CCR-10-1706; Tropea J. E., 2007, GENERIC METHOD PRODU; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Venkataraman S, 2008, STRUCTURE, V16, P1555, DOI 10.1016/j.str.2008.07.013; Wadhwa L, 2007, CANCER RES, V67, P10653, DOI 10.1158/0008-5472.CAN-07-2352; YPMAWONG MF, 1988, VIROLOGY, V166, P265, DOI 10.1016/0042-6822(88)90172-9; YPMAWONG MF, 1988, J BIOL CHEM, V263, P17846; Yu LT, 2011, NEURO-ONCOLOGY, V13, P14, DOI 10.1093/neuonc/noq148	42	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129103	10.1371/journal.pone.0129103	http://dx.doi.org/10.1371/journal.pone.0129103			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069962	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000046
J	Seys, LJM; Verhamme, FM; Dupont, LL; Desauter, E; Duerr, J; Agircan, AS; Conickx, G; Joos, GF; Brusselle, GG; Mall, MA; Bracke, KR				Seys, Leen J. M.; Verhamme, Fien M.; Dupont, Lisa L.; Desauter, Elke; Duerr, Julia; Agircan, Ayca Seyhan; Conickx, Griet; Joos, Guy F.; Brusselle, Guy G.; Mall, Marcus A.; Bracke, Ken R.			Airway Surface Dehydration Aggravates Cigarette Smoke-Induced Hallmarks of COPD in Mice	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CYSTIC-FIBROSIS; LUNG-DISEASE; CHRONIC-BRONCHITIS; INDUCED EMPHYSEMA; MUCUS CLEARANCE; ANIMAL-MODELS; INFLAMMATION; CONDUCTANCE; HEALTH	Introduction Airway surface dehydration, caused by an imbalance between secretion and absorption of ions and fluid across the epithelium and/or increased epithelial mucin secretion, impairs mucociliary clearance. Recent evidence suggests that this mechanism may be implicated in chronic obstructive pulmonary disease (COPD). However, the role of airway surface dehydration in the pathogenesis of cigarette smoke (CS)-induced COPD remains unknown. Objective We aimed to investigate in vivo the effect of airway surface dehydration on several CS-induced hallmarks of COPD in mice with airway-specific overexpression of the beta-subunit of the epithelial Na+ channel (beta ENaC). Methods beta ENaC-Tg mice and wild-type (WT) littermates were exposed to air or CS for 4 or 8 weeks. Pathological hallmarks of COPD, including goblet cell metaplasia, mucin expression, pulmonary inflammation, lymphoid follicles, emphysema and airway wall remodelling were determined and lung function was measured. Results Airway surface dehydration in beta ENaC-Tg mice aggravated CS-induced airway inflammation, mucin expression and destruction of alveolar walls and accelerated the formation of pulmonary lymphoid follicles. Moreover, lung function measurements demonstrated an increased compliance and total lung capacity and a lower resistance and hysteresis in beta ENaC-Tg mice, compared to WT mice. CS exposure further altered lung function measurements. Conclusions We conclude that airway surface dehydration is a risk factor that aggravates CS-induced hallmarks of COPD.	[Seys, Leen J. M.; Verhamme, Fien M.; Dupont, Lisa L.; Desauter, Elke; Conickx, Griet; Joos, Guy F.; Brusselle, Guy G.; Bracke, Ken R.] Ghent Univ Hosp, Dept Resp Med, Lab Translat Res Obstruct Pulm Dis, Ghent, Belgium; [Duerr, Julia; Agircan, Ayca Seyhan; Mall, Marcus A.] Translat Lung Res Ctr Heidelberg TLRC, Dept Translat Pulmonol, Heidelberg, Germany	Ghent University; Ghent University Hospital	Bracke, KR (corresponding author), Ghent Univ Hosp, Dept Resp Med, Lab Translat Res Obstruct Pulm Dis, Ghent, Belgium.	ken.bracke@UGent.be	Duerr, Julia/J-9133-2015; Bracke, Ken R/GSN-7630-2022; Mall, Marcus A./AAA-1498-2022	Bracke, Ken R/0000-0001-5906-4605; Mall, Marcus A./0000-0002-4057-2199; Verhamme, Anne/0000-0002-2201-1865; Duerr, Julia/0000-0002-4862-9487; Brusselle, Guy/0000-0001-7021-8505; Conickx, Griet/0000-0002-9475-8749	Concerted Research Action of Ghent University (BOF/GOA) [01G02714]; Fund for Scientific Research in Flanders (FWO Vlaanderen) [G.0897.12]; Interuniversity Attraction Poles program (IUAP) [P7/30]; Deutsche Forschungsgemainschaft [MA 2081/3-2, 2081/4-1]	Concerted Research Action of Ghent University (BOF/GOA); Fund for Scientific Research in Flanders (FWO Vlaanderen)(FWO); Interuniversity Attraction Poles program (IUAP)(Belgian Federal Science Policy Office); Deutsche Forschungsgemainschaft(German Research Foundation (DFG))	The research described in this article was supported by the Concerted Research Action of Ghent University (BOF/GOA, 01G02714), by the Fund for Scientific Research in Flanders (FWO Vlaanderen, G.0897.12), by the Interuniversity Attraction Poles program (IUAP, P7/30) and the Deutsche Forschungsgemainschaft (MA 2081/3-2 and 2081/4-1 to MAM). Ken R. Bracke is a postdoctoral researcher of the fund for Scientific Research in Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bracke KR, 2006, J IMMUNOL, V177, P4350, DOI 10.4049/jimmunol.177.7.4350; Bracke KR, 2013, AM J RESP CRIT CARE, V188, P343, DOI 10.1164/rccm.201211-2055OC; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Chrysofakis G, 2004, CHEST, V125, P71, DOI 10.1378/chest.125.1.71; Churg A, 2005, CURR OPIN PULM MED, V11, P153, DOI 10.1097/01.mcp.0000149592.51761.e3; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Demoor T, 2009, EUR RESPIR J, V34, P405, DOI 10.1183/09031936.00101408; Downs CA, 2013, AM J RESP CELL MOL, V49, P251, DOI 10.1165/rcmb.2012-0234OC; Dransfield MT, 2013, CHEST; Ehre C, 2012, P NATL ACAD SCI USA, V109, P16528, DOI 10.1073/pnas.1206552109; Evans CM, 2009, PHARMACOL THERAPEUT, V121, P332, DOI 10.1016/j.pharmthera.2008.11.001; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Gehrig S, 2014, AM J RESP CRIT CARE, V189, P1082, DOI 10.1164/rccm.201311-1932OC; Global initiative for chronic obstructive pulmonary disease, GLOB STRAT DIAGN MAN; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; GRUBB BR, 1994, AM J PHYSIOL, V267, pC293, DOI 10.1152/ajpcell.1994.267.1.C293; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Henderson AG, 2014, J CLIN INVEST, V124, P3047, DOI 10.1172/JCI73469; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; Ji XL H.-L., 2014, AM J RESP CRIT CARE, V189, pA3020; Johannesson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044059; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Lambert JA, 2014, AM J RESP CELL MOL, V50, P549, DOI 10.1165/rcmb.2013-0228OC; Lanckacker EA, 2013, EUR RESPIR J, V41, P1189, DOI 10.1183/09031936.00096612; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall MA, 2008, J AEROSOL MED PULM D, V21, P13, DOI 10.1089/jamp.2007.0659; Mall MA, 2008, AM J RESP CRIT CARE, V177, P730, DOI 10.1164/rccm.200708-1233OC; Mall MA, 2014, EUR RESPIR J, V44, P1042, DOI 10.1183/09031936.00228013; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Rab A, 2013, AM J PHYSIOL-LUNG C, V305, pL530, DOI 10.1152/ajplung.00039.2013; Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcmb.2006-0082SF; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Saetta M, 2001, AM J RESP CRIT CARE, V163, P1304, DOI 10.1164/ajrccm.163.6.2009116; Sloane PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039809; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Trojanek JB, 2014, AM J RESP CELL MOL, V51, P709, DOI 10.1165/rcmb.2013-0407OC; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; Vermaelen K, 2004, CYTOM PART A, V61A, P170, DOI 10.1002/cyto.a.20064; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Wielputz MO, 2011, EUR RESPIR J, V38, P1060, DOI 10.1183/09031936.00149810; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008; Wright JL, 2008, PULM PHARMACOL THER, V21, P696, DOI 10.1016/j.pupt.2008.01.007; Xavier RF, 2013, RESPIRATION, V86, P479, DOI 10.1159/000348398	50	21	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129897	10.1371/journal.pone.0129897	http://dx.doi.org/10.1371/journal.pone.0129897			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066648	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000121
J	Sun, J; Li, C; Wang, SW				Sun, Jun; Li, Chen; Wang, Suwen			The Up-Regulation of Ribosomal Proteins Further Regulates Protein Expression Profile in Female Schistosoma japonicum after Pairing	PLOS ONE			English	Article							GENE-EXPRESSION; MANSONI; DNA; S3	Background Pairing of Schistosoma males and females leads to and maintains female sexual maturation. However, the mechanism by which pairing facilitates sexual maturation of females is not clear. An increasing body of evidence suggests that ribosomal proteins have regulatory rather than constitutive roles in protein translation. Methodology/Principal Findings To investigate the effect of ribosome regulation on female sex maturation, Solexa and iTRAQ techniques were used to analyze the relationship between ribosomal gene or protein expression and sexual development of Schistosoma females. In the present study, considerably higher number of ribosomal genes or proteins were found to be differentially expressed in paired 23-day-old females. Moreover, mature female-specific proteins associated with egg production, such as ferritin-1 heavy chain and superoxide dismutase, were selectively highly expressed in paired females, rather than higher level of protein synthesis of all transcripts compared with those in unpaired 23-day-old females. Furthermore, other developmental stages were utilized to investigate different expression pattern of ribosomal proteins in females by analysing 18-day-old female schistosomula from single- or double-sex infections to determine the relationship between ribosomal protein expression pattern and development. Results showed that undeveloped 18-day-old females from single-and double-sex infections, as well as 23-day-old unpaired females, possessed similar ribosomal protein expression patterns, which were distinct from those in 23-day-old paired females. Conclusions/Significance Our findings reveal that the pairing of females and males triggers a specialized ribosomal protein expression profile which further regulates the protein profile for sexual maturation in Schistosoma japonicum, based on its gene expression profile.	[Sun, Jun; Li, Chen; Wang, Suwen] Tongji Univ, Sch Med, Inst Infect Dis & Vaccine Dev, Shanghai 200092, Peoples R China	Tongji University	Sun, J (corresponding author), Tongji Univ, Sch Med, Inst Infect Dis & Vaccine Dev, Shanghai 200092, Peoples R China.	swksj@tongji.edu.cn		Sun, Jun/0000-0003-0720-1879	National Natural Science Foundation of China [81071383]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors were supported by the National Natural Science Foundation of China (No. 81071383), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Byrne ME, 2009, TRENDS PLANT SCI, V14, P512, DOI 10.1016/j.tplants.2009.06.009; Chang IF, 2005, PLANT PHYSIOL, V137, P848, DOI 10.1104/pp.104.053637; CLOUGH ER, 1981, J PARASITOL, V67, P535, DOI 10.2307/3280487; Dresios J, 2006, MOL MICROBIOL, V59, P1651, DOI 10.1111/j.1365-2958.2006.05054.x; Fitzpatrick JM, 2006, INT J PARASITOL, V36, P1081, DOI 10.1016/j.ijpara.2006.06.007; Giavalisco P, 2005, PLANT MOL BIOL, V57, P577, DOI 10.1007/s11103-005-0699-3; Gilbert WV, 2011, TRENDS BIOCHEM SCI, V36, P127, DOI 10.1016/j.tibs.2010.12.002; HE YX, 1980, ACTA ZOOL SINICA, V26, P32; Huang SCC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002996; Jang CY, 2012, BIOCHEM BIOPH RES CO, V429, P57, DOI 10.1016/j.bbrc.2012.10.093; Kaberdina AC, 2009, MOL CELL, V33, P227, DOI 10.1016/j.molcel.2008.12.014; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KIM J, 1995, J BIOL CHEM, V270, P13620, DOI 10.1074/jbc.270.23.13620; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Liu S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003856; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Lopez A, 2007, J MOL EVOL, V65, P687, DOI 10.1007/s00239-007-9047-3; Malygin AA, 2007, NUCLEIC ACIDS RES, V35, P6414, DOI 10.1093/nar/gkm701; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Naora H, 1998, J CELL BIOL, V141, P741, DOI 10.1083/jcb.141.3.741; Neumann F, 1997, EXP CELL RES, V230, P252, DOI 10.1006/excr.1996.3417; Ni JQ, 2006, GENE DEV, V20, P1959, DOI 10.1101/gad.390106; POPIEL I, 1984, J EXP ZOOL, V232, P141, DOI 10.1002/jez.1402320117; Qin W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100796; RAMAGOPAL S, 1981, P NATL ACAD SCI-BIOL, V78, P3083, DOI 10.1073/pnas.78.5.3083; SCHILLER EL, 1975, J PARASITOL, V61, P385, DOI 10.2307/3279308; SHAW JR, 1977, EXP PARASITOL, V41, P54, DOI 10.1016/0014-4894(77)90129-1; Sun J, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-177; Sun J, 2014, PARASITOL RES, V113, P881, DOI 10.1007/s00436-013-3719-2; Sun J, 2013, PARASITOL RES, V112, P2983, DOI 10.1007/s00436-013-3470-8; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Thomas G, 2000, NAT CELL BIOL, V2, pE71, DOI 10.1038/35010581; Uechi T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000037; VANLIJSEBETTENS M, 1994, EMBO J, V13, P3378, DOI 10.1002/j.1460-2075.1994.tb06640.x; VANOORDT BEP, 1985, MOL BIOCHEM PARASIT, V16, P117, DOI 10.1016/0166-6851(85)90080-5; VANOORDT BEP, 1989, PARASITOLOGY, V98, P409, DOI 10.1017/S0031182000061497; Vermeire JJ, 2006, MOL BIOCHEM PARASIT, V147, P39, DOI 10.1016/j.molbiopara.2006.01.006; Williams DL, 2007, EXP PARASITOL, V117, P246, DOI 10.1016/j.exppara.2007.05.001; WILSON DM, 1994, J BIOL CHEM, V269, P25359; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8	44	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129626	10.1371/journal.pone.0129626	http://dx.doi.org/10.1371/journal.pone.0129626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070205	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000098
J	Dahlui, M; Jahan, NK; Majid, HA; Jalaludin, MY; Murray, L; Cantwell, M; Su, TT; Al-Sadat, N				Dahlui, M.; Jahan, N. K.; Majid, H. A.; Jalaludin, M. Y.; Murray, L.; Cantwell, M.; Su, T. T.; Al-Sadat, N.		MyHeARTs Grp	Risk and Protective Factors for Cigarette Use in Young Adolescents in a School Setting: What Could Be Done Better?	PLOS ONE			English	Article							SMOKING INITIATION; METABOLIC SYNDROME; PARENTAL SMOKING; PEER INFLUENCE; MALAYSIA; PREVALENCE; STUDENTS; HEALTH; CESSATION; DISTRICT	Smoking among Malaysian adolescents remains a public health concern despite concerted efforts in tobacco control. The aims of this study were to examine the prevalence and determinants of current-smoking status in young adolescents. This cross sectional study used the first round of the Malaysian Health and Adolescents Research Team's prospective cohort study. It was conducted in three States of the Central and Northern regions of Peninsular Malaysia between March and May 2012. The study used the multistage stratified sampling design. A total of 1,342 adolescents of both sexes, aged 12-13 years, were sampled from randomly selected urban and rural national schools. Information on current smoking status and associated factors were collected by a self-administered, pre-tested, validated, structured questionnaire. Seven percent of the samples were current-smokers; the majority (62%) of them started smoking at the age of 11 years or below. The prevalence of current smoking was significantly higher in males (odds ratio [OR] = 2.37; 95% CI: 1.46, 3.84), those who were influenced by smoker friends (OR = 8.35; 95% CI: 4.90, 14.25), who were unaware of the health risks of smoking (OR = 1.85; 95% CI: 1.02, 3.36) and who reported a lack of satisfaction about their overall life (OR = 3.26; 95% CI: 1.73, 6.12). The study findings provide valuable information to strengthen the existing school-based smoking prevention program through integration of social competence and social influence curricula. The program should empower the young adolescents to refuse tobacco offers, to overcome social influences and to resist peer pressure to avoid starting smoking. Particular focuses to include mental health service to prevent both emotional and behavioural problems are needed.	[Dahlui, M.; Majid, H. A.; Su, T. T.; Al-Sadat, N.] Univ Malaya, Fac Med, Ctr Populat Hlth CePH, Kuala Lumpur, Malaysia; [Dahlui, M.; Majid, H. A.; Su, T. T.; Al-Sadat, N.] Univ Malaya, Dept Social & Prevent Med, Fac Med, Kuala Lumpur, Malaysia; [Jahan, N. K.] Monash Univ Malaysia, SEACO, Segamat, Malaysia; [Jahan, N. K.] Monash Univ Malaysia, Sch Med & Hlth Sci, Segamat, Malaysia; [Jalaludin, M. Y.] Univ Malaya, Fac Med, Dept Paediat, Kuala Lumpur, Malaysia; [Murray, L.; Cantwell, M.] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland	Universiti Malaya; Universiti Malaya; Universiti Malaya; Queens University Belfast	Dahlui, M (corresponding author), Univ Malaya, Fac Med, Ctr Populat Hlth CePH, Kuala Lumpur, Malaysia.	maznahd@ummc.edu.my	Dahlui, Maznah/F-9665-2010; SU, TIN TIN/B-9968-2010; Sutan, Rosnah/F-4732-2017; Jalaludin, Muhammad Yazid/B-9172-2010; DAHLUI, MAZNAH/B-8976-2010; Abdul Majid, Hazreen/B-8619-2010	Sutan, Rosnah/0000-0001-9956-4727; Jalaludin, Muhammad Yazid/0000-0003-4513-8444; DAHLUI, MAZNAH/0000-0003-4923-9410; Abdul Majid, Hazreen/0000-0002-2718-8424; Jahan, Nowrozy Kamar/0000-0001-6584-5010; Su, Tin Tin/0000-0003-0387-6406	University of Malaya [RG299-11HTM, UMQUB3D-2011]	University of Malaya(Universiti Malaya)	This project was sponsored by a University of Malaya Research Grant (RG299-11HTM) and Vice Chancellor Research Grant (UMQUB3D-2011).	[Anonymous], 2008, WORLD HLTH STAT 2008; [Anonymous], 2011, NONC DIS NCD COUNTR; Beal AC, 2001, J ADOLESCENT HEALTH, V28, P474, DOI 10.1016/S1054-139X(01)00194-X; Belva F, 2012, HUM REPROD, V27, P3100, DOI 10.1093/humrep/des259; Blebil AQ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-460; Breslau N, 1996, AM J PUBLIC HEALTH, V86, P214, DOI 10.2105/AJPH.86.2.214; Campbell R, 2008, LANCET, V371, P1595, DOI 10.1016/S0140-6736(08)60692-3; Cavalca E, 2013, DRUG ALCOHOL DEPEN, V129, P163, DOI 10.1016/j.drugalcdep.2012.09.020; Cheah YK, 2012, ASIAN PAC J CANCER P, V13, P1125, DOI 10.7314/APJCP.2012.13.4.1125; Chen J, 1998, Health Rep, V9, P39; Chong Hon Loon, 2012, Med J Malaysia, V67, P147; DiFranza J, 2000, WOMENS HLTH RES FAC; Doubeni CA, 2010, PEDIATRICS, V125, P1127, DOI 10.1542/peds.2009-0238; Fadzlina AA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-S3-S7; Ghani WMN, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-207; Gilman SE, 2009, PEDIATRICS, V123, pE274, DOI 10.1542/peds.2008-2251; Hazreen MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-S3-S6; Hoffman BR, 2007, ADDICT BEHAV, V32, P1546, DOI 10.1016/j.addbeh.2006.11.016; Hollingworth W, 2012, NICOTINE TOB RES, V14, P161, DOI 10.1093/ntr/ntr155; Huang GC, 2014, J ADOLESCENT HEALTH, V54, P508, DOI 10.1016/j.jadohealth.2013.07.001; Institute for Public Health, 2011, NAT HLTH MORB SURV 2, Vll, P188; Jessor R., 2014, PROBLEM BEHAV THEORY; Khairani O, 2007, MED HEALTH-KUALA LUM, V2, P80; Kin F, 2008, SMOKING GIRLS YOUNG; KROHN MD, 1985, SOC PROBL, V32, P455, DOI 10.1525/sp.1985.32.5.03a00050; Lim KH, 2006, TROP BIOMED, V23, P75; Lim KH, 2010, TROP BIOMED, V27, P394; Ministry of Health Malaysia, 2010, COUNT HLTH PLAN 10 M; Mohammadpoorasl Asghar, 2010, Addict Health, V2, P49; Naing Nyi Nyi, 2004, Tob Induc Dis, V2, P133, DOI 10.1186/1617-9625-2-3-133; Otten R, 2007, J BEHAV MED, V30, P143, DOI 10.1007/s10865-006-9090-3; Patton GC, 1998, AM J PUBLIC HEALTH, V88, P1518, DOI 10.2105/AJPH.88.10.1518; Peterson AV, 2006, ADDICT BEHAV, V31, P788, DOI 10.1016/j.addbeh.2005.06.003; Rissanen T, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-140; Rones M, 2000, Clin Child Fam Psychol Rev, V3, P223, DOI 10.1023/A:1026425104386; Sankaranarayanan A, 2014, INT J ENV RES PUB HE, V11, P4125, DOI 10.3390/ijerph110404125; Stallard Paul, 2013, Br J Psychiatry Suppl, V54, ps18, DOI 10.1192/bjp.bp.112.119172; Taras HL, 2004, PEDIATRICS, V113, P1839; Tee GH, 2014, ASIA-PAC J PUBLIC HE, V26, p70S, DOI 10.1177/1010539514540468; Teh JKL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091328; Thomas RE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001293.pub3; Wee BS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-333; WHO, 2011, GLOBAL STATUS REPORT; World health organization, 2013, WORLD HLTH STAT 2013; Zain FM, 2012, 2 ANN REPORT DIABETE	45	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129628	10.1371/journal.pone.0129628	http://dx.doi.org/10.1371/journal.pone.0129628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK3FB	26068668	gold, Green Published, Green Submitted			2022-12-27	WOS:000356100900064
J	Kerkhofs, J; Geris, L				Kerkhofs, Johan; Geris, Liesbet			A Semiquantitative Framework for Gene Regulatory Networks: Increasing the Time and Quantitative Resolution of Boolean Networks	PLOS ONE			English	Article							CELLULAR SIGNALING NETWORKS; GROWTH-PLATE; QUALITATIVE SIMULATION; TRANSCRIPTION FACTOR; FUNCTIONAL-ANALYSIS; CONTINUOUS MODELS; SYSTEMS BIOLOGY; CYCLE NETWORK; EXPRESSION; TRANSDUCTION	Boolean models have been instrumental in predicting general features of gene networks and more recently also as explorative tools in specific biological applications. In this study we introduce a basic quantitative and a limited time resolution to a discrete ( Boolean) framework. Quantitative resolution is improved through the employ of normalized variables in unison with an additive approach. Increased time resolution stems from the introduction of two distinct priority classes. Through the implementation of a previously published chondrocyte network and T helper cell network, we show that this addition of quantitative and time resolution broadens the scope of biological behaviour that can be captured by the models. Specifically, the quantitative resolution readily allows models to discern qualitative differences in dosage response to growth factors. The limited time resolution, in turn, can influence the reachability of attractors, delineating the likely long term system behaviour. Importantly, the information required for implementation of these features, such as the nature of an interaction, is typically obtainable from the literature. Nonetheless, a trade-off is always present between additional computational cost of this approach and the likelihood of extending the model's scope. Indeed, in some cases the inclusion of these features does not yield additional insight. This framework, incorporating increased and readily available time and semiquantitative resolution, can help in substantiating the litmus test of dynamics for gene networks, firstly by excluding unlikely dynamics and secondly by refining falsifiable predictions on qualitative behaviour.	[Kerkhofs, Johan; Geris, Liesbet] Univ Liege, Biomech Res Unit, Liege, Belgium; [Kerkhofs, Johan; Geris, Liesbet] Katholieke Univ Leuven, Biomech Sect, Leuven, Belgium; [Kerkhofs, Johan; Geris, Liesbet] Katholieke Univ Leuven, Prometheus, Leuven, Belgium	University of Liege; KU Leuven; KU Leuven	Geris, L (corresponding author), Univ Liege, Biomech Res Unit, Liege, Belgium.	liesbet.geris@ulg.ac.be	geris, liesbet/D-2343-2016	geris, liesbet/0000-0002-8180-1445	European Research Council under the European Union [279100]	European Research Council under the European Union(European Research Council (ERC))	Johan Kerkhofs is a PhD fellow of the research Foundation Flanders (FWO-Vlaanderen). This work is part of Prometheus, the KU Leuven R&D division for skeletal tissue engineering (http://www.kuleuven.be/prometheus). The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement n. 279100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-16; Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Aldridge BB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000340; Alexopoulos LG, 2010, MOL CELL PROTEOMICS, V9, P1849, DOI 10.1074/mcp.M110.000406; [Anonymous], 2004, P WORKSH TUT 9 INT C; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Chaouiya C, 2003, LECT NOTES CONTROL I, V294, P830, DOI DOI 10.1007/978-3-540-44928-7; Darabos C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025110; De Jong H, 2004, B MATH BIOL, V66, P301, DOI 10.1016/j.bulm.2003.08.010; de Jong H, 2003, BIOINFORMATICS, V19, P336, DOI 10.1093/bioinformatics/btf851; Di Cara A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-462; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Faure A, 2009, MOL BIOSYST, V5, P1787, DOI [10.1039/b910101m, 10.1039/B910101m]; Franke R, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-151; Garg A, 2008, BIOINFORMATICS, V24, P1917, DOI 10.1093/bioinformatics/btn336; Ghaffarizadeh A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S7; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; Griffiths AJ, 2007, INTRO GENETIC ANAL; Helikar T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-58; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kerkhofs J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034729; Kestler HA, 2008, BIOESSAYS, V30, P1110, DOI 10.1002/bies.20834; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Klemm K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.055101; Klipp E, 2009, SYSTEMS BIOL; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Krumsiek J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-233; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Liu ZY, 2006, J BIOL CHEM, V281, P17156, DOI 10.1074/jbc.M513812200; Machado D, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-45; Martinez-Sosa P, 2013, BIOSYSTEMS, V113, P96, DOI 10.1016/j.biosystems.2013.05.007; Melas IN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003204; Mendoza L, 2006, BIOSYSTEMS, V84, P101, DOI 10.1016/j.biosystems.2005.10.004; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Morris MK, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001099; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Mussel C, 2010, BIOINFORMATICS, V26, P1378, DOI 10.1093/bioinformatics/btq124; Naldi A, 2009, BIOSYSTEMS, V97, P134, DOI 10.1016/j.biosystems.2009.04.008; Nilsson O, 2007, J ENDOCRINOL, V193, P75, DOI 10.1677/joe.1.07099; Oktem H, 2003, CHAOS, V13, P1167, DOI 10.1063/1.1608671; Oshin AO, 2007, VET COMP ORTHOPAED, V20, P185, DOI 10.1160/VCOT-07-07-0061; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; Park S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.2; Plahte E, 1998, J MATH BIOL, V36, P321, DOI 10.1007/s002850050103; Remy E, 2003, BIOINFORMATICS, V19, pII172, DOI 10.1093/bioinformatics/btg1075; Ruz GA, 2014, BIOSYSTEMS, V115, P23, DOI 10.1016/j.biosystems.2013.10.007; Saadatpour A, 2013, METHODS, V62, P3, DOI 10.1016/j.ymeth.2012.10.012; Saadatpour A, 2010, J THEOR BIOL, V266, P641, DOI 10.1016/j.jtbi.2010.07.022; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Samaga R, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-43; Schivo S, 2014, IEEE J BIOMED HEALTH, V18, P832, DOI 10.1109/JBHI.2013.2292880; Schlatter R, 2012, BRIEF BIOINFORM, V13, P365, DOI 10.1093/bib/bbr065; Schlatter R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000595; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Scholma J, 2014, GENE, V533, P379, DOI 10.1016/j.gene.2013.10.010; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Shmulevich I, 2015, PBN MATLAB TOOLBOX; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Stoll G, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-116; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Terfve C, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-133; Thieffry D, 2007, BRIEF BIOINFORM, V8, P220, DOI 10.1093/bib/bbm028; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Tran TD, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0771; Torres-Sosa C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002669; van der Kraan PM, 2009, OSTEOARTHR CARTILAGE, V17, P1539, DOI 10.1016/j.joca.2009.06.008; Villaverde AF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0505; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wang RS, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055001; Westerhoff HV, 2004, NAT BIOTECHNOL, V22, P1249, DOI 10.1038/nbt1020; Wittmann DM, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-98; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680	79	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130033	10.1371/journal.pone.0130033	http://dx.doi.org/10.1371/journal.pone.0130033			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067297	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900094
J	Killilea, DW; Westropp, JL; Shiraki, R; Mellema, M; Larsen, J; Kahn, AJ; Kapahi, P; Chi, T; Stoller, ML				Killilea, David W.; Westropp, Jodi L.; Shiraki, Ryoji; Mellema, Matthew; Larsen, Jennifer; Kahn, Arnold J.; Kapahi, Pankaj; Chi, Thomas; Stoller, Marshall L.			Elemental Content of Calcium Oxalate Stones from a Canine Model of Urinary Stone Disease	PLOS ONE			English	Article							DIETARY CALCIUM; TRACE-ELEMENTS; RISK-FACTORS; DOGS; UROLITHIASIS; MAGNESIUM; PHOSPHATE; HEALTHY; CALCULI; ZINC	One of the most common types of urinary stones formed in humans and some other mammals is composed of calcium oxalate in ordered hydrated crystals. Many studies have reported a range of metals other than calcium in human stones, but few have looked at stones from animal models such as the dog. Therefore, we determined the elemental profile of canine calcium oxalate urinary stones and compared it to reported values from human stones. The content of 19 elements spanning 7-orders of magnitude was quantified in calcium oxalate stones from 53 dogs. The elemental profile of the canine stones was highly overlapping with human stones, indicating similar inorganic composition. Correlation and cluster analysis was then performed on the elemental profile from canine stones to evaluate associations between the elements and test for potential subgrouping based on elemental content. No correlations were observed with the most abundant metal calcium. However, magnesium and sulfur content correlated with the mineral hydration form, while phosphorous and zinc content correlated with the neuter status of the dog. Inter-elemental correlation analysis indicated strong associations between barium, phosphorous, and zinc content. Additionally, cluster analysis revealed subgroups within the stones that were also based primarily on barium, phosphorous, and zinc. These data support the use of the dog as a model to study the effects of trace metal homeostasis in urinary stone disease.	[Killilea, David W.] Childrens Hosp Oakland Res Inst, Nutr & Metab Ctr, Oakland, CA USA; [Westropp, Jodi L.; Shiraki, Ryoji] Univ Calif Davis, Sch Vet Med, Med & Epidemiol, Davis, CA USA; [Mellema, Matthew] Univ Calif Davis, Sch Vet Med, Surg & Radiol Sci, Davis, CA USA; [Larsen, Jennifer] Univ Calif Davis, Sch Vet Med, Mol Biosci, Davis, CA USA; [Kahn, Arnold J.; Kapahi, Pankaj] Buck Inst Res Aging, Novato, CA USA; [Killilea, David W.; Kapahi, Pankaj; Chi, Thomas; Stoller, Marshall L.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Buck Institute for Research on Aging; University of California System; University of California San Francisco	Stoller, ML (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA.	mstoller@urology.ucsf.edu		Gonzalez, Katty/0000-0001-5197-5703; Killilea, David/0000-0002-8929-6527	National Institute of Health [RFA-DK-12-003]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P20DK100863, K12DK083021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045835] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by National Institute of Health RFA-DK-12-003, www.nih.gov (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Gawad M, 2014, J PEDIATR UROL, V10, P1267, DOI 10.1016/j.jpurol.2014.06.022; Adams LG, 2008, JAVMA-J AM VET MED A, V232, P1680, DOI 10.2460/javma.232.11.1680; Arulpragasam SP, 2013, JAVMA-J AM VET MED A, V243, P703, DOI 10.2460/javma.243.5.703; Atakan IH, 2007, INT UROL NEPHROL, V39, P351, DOI 10.1007/s11255-006-9050-4; Atmani F, 1998, UROL RES, V26, P201, DOI 10.1007/s002400050047; Bagga HS, 2013, UROL CLIN N AM, V40, P1, DOI 10.1016/j.ucl.2012.09.006; Blaschko SD, 2013, J UROLOGY, V189, P735, DOI 10.1016/j.juro.2012.08.199; Canales BK, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.05.005; CURHAN GC, 1993, NEW ENGL J MED, V328, P833, DOI 10.1056/NEJM199303253281203; Dijcker JC, 2012, VET REC, V171, P46, DOI 10.1136/vr.100293; DRETLER SP, 1988, J UROLOGY, V139, P1124, DOI 10.1016/S0022-5347(17)42801-1; DURAK I, 1988, BRIT J UROL, V62, P203, DOI 10.1111/j.1464-410X.1988.tb04318.x; DURAK I, 1992, UROL RES, V20, P23, DOI 10.1007/BF00294330; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fang X, 2005, LASER MED SCI, V20, P132, DOI 10.1007/s10103-005-0356-8; FLEISCH H, 1978, KIDNEY INT, V13, P361, DOI 10.1038/ki.1978.54; Furrow E, 2015, J VET INTERN MED, V29, P113, DOI 10.1111/jvim.12527; Giannossi ML, 2013, J TRACE ELEM MED BIO, V27, P91, DOI 10.1016/j.jtemb.2012.09.004; Heilberg IP, 2013, ADV CHRONIC KIDNEY D, V20, P165, DOI 10.1053/j.ackd.2012.12.001; Houston DM, 2004, CAN VET J, V45, P225; Keshavarzi B, 2014, ENV GEOCHEM HLTH; Lekcharoensuk C, 2002, AM J VET RES, V63, P163, DOI 10.2460/ajvr.2002.63.163; Lekcharoensuk C, 2002, AM J VET RES, V63, P330, DOI 10.2460/ajvr.2002.63.330; Lekcharoensuk C, 2000, J AM VET MED ASSOC, V217, P515, DOI 10.2460/javma.2000.217.515; Lewandowski S, 2004, CLIN CHIM ACTA, V345, P17, DOI 10.1016/j.cccn.2004.03.009; Ling GV, 2003, J VET INTERN MED, V17, P817, DOI 10.1892/0891-6640(2003)017&lt;0817:CIPOCU&gt;2.3.CO;2; Low WW, 2010, JAVMA-J AM VET MED A, V236, P193, DOI 10.2460/javma.236.2.193; Lulich JP, 2001, J AM VET MED ASSOC, V218, P1583, DOI 10.2460/javma.2001.218.1583; Madaan S, 2007, CURR OPIN UROL, V17, P109, DOI 10.1097/MOU.0b013e32802b70bc; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; NAGY Z, 1963, Z Urol, V56, P186; Osborne CA, 1999, VET CLIN N AM-SMALL, V29, P17, DOI 10.1016/S0195-5616(99)50002-8; Osborne CA, 2009, VET CLIN N AM-SMALL, V39, P127, DOI 10.1016/j.cvsm.2008.10.001; PRIEN EL, 1947, J UROLOGY, V57, P949, DOI 10.1016/S0022-5347(17)69732-5; Ramello A, 2000, J NEPHROL, V13, pS45; Riley JM, 2013, J ENDOUROL, V27, P1487, DOI 10.1089/end.2013.0173; Rodgers A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103602; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; Slojewski M, 2011, CENT EUR J UROL, V64, P58, DOI 10.5173/ceju.2011.02.art1; Slojewski M, 2010, BIOL TRACE ELEM RES, V137, P301, DOI 10.1007/s12011-009-8584-6; Stevenson AE, 2004, VET THER, V5, P218; Stevenson AE, 2003, RES VET SCI, V75, P33, DOI 10.1016/S0034-5288(03)00042-0; Tang YZ, 2009, BIOMATERIALS, V30, P2864, DOI 10.1016/j.biomaterials.2009.01.043; TISELIUS HG, 1993, UROL RES, V21, P175, DOI 10.1007/BF00590033; Turgut M, 2008, UROL RES, V36, P31, DOI 10.1007/s00240-007-0133-1; Wisener LV, 2010, AM J VET RES, V71, P1045, DOI 10.2460/ajvr.71.9.1045	46	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128374	10.1371/journal.pone.0128374	http://dx.doi.org/10.1371/journal.pone.0128374			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066810	Green Published, gold			2022-12-27	WOS:000356100900020
J	Baker, CP; Kulkarni, B; Radhakrishna, KV; Charyulu, MS; Gregson, J; Matsuzaki, M; Taylor, AE; Prabhakaran, D; Mamidi, RS; Wells, J; Wilkinson, I; McEniery, C; Yasmin; Smith, GD; Ben-Shlomo, Y; Kuper, H; Kinra, S				Baker, Christopher Paul; Kulkarni, Bharati; Radhakrishna, K. V.; Charyulu, M. S.; Gregson, John; Matsuzaki, Mika; Taylor, Amy E.; Prabhakaran, Dorairaj; Mamidi, Raja Sriswan; Wells, Jonathan; Wilkinson, Ian; McEniery, Carmel; Yasmin; Smith, George Davey; Ben-Shlomo, Yoav; Kuper, Hannah; Kinra, Sanjay			Is the Association between Vitamin D and Cardiovascular Disease Risk Confounded by Obesity? Evidence from the Andhra Pradesh Children and Parents Study (APCAPS)	PLOS ONE			English	Article							MENDELIAN RANDOMIZATION; PARATHYROID-HORMONE; 25-HYDROXYVITAMIN D; D DEFICIENCY; OLDER MEN; PREVALENCE; MORTALITY; METAANALYSIS; OUTCOMES; INDIANS	Background Evidence of an association between serum vitamin D and cardiovascular disease risk is inconsistent and comes predominantly from studies in high-income settings. We assessed the association between serum levels of 25-hydroxyvitamin D-3 (25(OH) D) and cardiovascular disease risk factors in a population of young Indian adults. Methods Cross-sectional analyses of data from APCAPS (Andhra Pradesh Children and Parents Study); a prospective birth cohort study in rural south India. Participants were 1038 (40.3% females) adults aged 18-24 years. Main outcome measures were blood pressures, fasting serum lipids (cholesterols and triglycerides), fasting glucose, insulin, measures of arterial stiffness (aortic augmentation index and aortic pulse wave velocity (aPWV)), carotid intima-media thickness, body mass index (BMI) and body fat (dual X-ray absorptiometry). Results Vitamin D deficiency (<= 20ng/ml) was observed in 41.1% of this lean (mean BMI: 19.5) and active (mean minutes of moderate or vigorous physical activity per day: 186) population. Vitamin D deficiency was associated with higher median body fat in both males (15.9% body fat in vitamin D deficient males vs. 14.6% in non-deficient males, p<0.05) and females (29.1% body fat in vitamin D deficient females vs. 27.8% in non-deficient females, p<0.05) but no associations were observed between vitamin D deficiency and mean BMI or median fat mass index (FMI). Except a weak inverse association with fasting insulin in males, there was no clear association between serum vitamin D levels and cardiovascular disease risk factors in fully adjusted models. Conclusions We did not find clear evidence for an association between serum vitamin D levels and cardiovascular disease risk factors. Our results, consistent with the limited evidence from randomised trials of vitamin D supplementation and Mendelian randomisation experiments, suggest that the postulated link between serum vitamin D and cardiovascular disease may be non-causal. Instead, it may be attributable to confounding by lifestyle factors such as obesity and physical inactivity which may provide more fruitful targets for cardiovascular disease prevention.	[Baker, Christopher Paul; Gregson, John; Matsuzaki, Mika; Kinra, Sanjay] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Kulkarni, Bharati; Radhakrishna, K. V.; Charyulu, M. S.; Mamidi, Raja Sriswan] Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India; [Taylor, Amy E.] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Wells, Jonathan] UCL, Inst Child Hlth, Childhood Nutr Res Ctr, London, England; [Wilkinson, Ian; McEniery, Carmel; Yasmin] Univ Cambridge, Div Expt Med & Immunotherapeut, Cambridge, England; [Smith, George Davey; Ben-Shlomo, Yoav] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Kuper, Hannah] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); University of Bristol; University of London; University College London; University of Cambridge; University of Bristol; University of London; London School of Hygiene & Tropical Medicine	Baker, CP (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England.	chris.baker@lshtm.ac.uk	Davey Smith, George/A-7407-2013; Ben-Shlomo, Yoav/ABD-2004-2021; Mamidi, Raja/AAG-4801-2019; Prabhakaran, Dorairaj/B-4147-2011; Kulkarni, Bharati/ABB-3188-2020; Wells, Jonathan/A-4604-2009	Davey Smith, George/0000-0002-1407-8314; Ben-Shlomo, Yoav/0000-0001-6648-3007; Prabhakaran, Dorairaj/0000-0002-3172-834X; Kulkarni, Bharati/0000-0003-0636-318X; wilkinson, ian/0000-0001-6598-9399; Wells, Jonathan/0000-0003-0411-8025; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Bhogadi, Santhi/0000-0002-7713-8804	Indian Council of Medical Research; US Agency for International Development; Royal College of Physicians, United Kingdom; Wellcome Trust (United Kingdom) [083707]; MRC [MC_UU_12013/1] Funding Source: UKRI; Medical Research Council [MC_UU_12013/1] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); US Agency for International Development(United States Agency for International Development (USAID)); Royal College of Physicians, United Kingdom; Wellcome Trust (United Kingdom)(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The Hyderabad Nutrition Trial was funded jointly by the Indian Council of Medical Research and the US Agency for International Development. The first follow-up study (2003-2005) was funded by a personal fellowship to SK (Eden Fellowship in Paediatrics, granted by the Royal College of Physicians, United Kingdom), and the second follow-up study (2009-2010) was funded by the Wellcome Trust (United Kingdom) (Grant: 083707; Principal Investigator: HK). The National Institute of Nutrition (Indian Council of Medical Research) provided infrastructural support.	Afzal S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6330; Afzal S, 2014, LANCET DIABETES ENDO, V2, P298, DOI 10.1016/S2213-8587(13)70200-6; Annuzzi G, 2012, CURR ATHEROSCLER REP, V14, P525, DOI 10.1007/s11883-012-0281-9; Arunabh S, 2003, J CLIN ENDOCR METAB, V88, P157, DOI 10.1210/jc.2002-020978; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Bolland MJ, 2010, AM J CLIN NUTR, V91, P82, DOI 10.3945/ajcn.2009.28424; Cawthon PM, 2010, J CLIN ENDOCR METAB, V95, P4625, DOI 10.1210/jc.2010-0638; CLEMENS TL, 1982, LANCET, V1, P74; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goswami R, 2000, AM J CLIN NUTR, V72, P472; Grandi NC, 2010, PREV MED, V51, P228, DOI 10.1016/j.ypmed.2010.06.013; Gunta SS, 2013, NAT REV NEPHROL, V9, P337, DOI 10.1038/nrneph.2013.74; Harinarayan CV, 2007, AM J CLIN NUTR, V85, P1062, DOI 10.1093/ajcn/85.4.1062; Harvey NC, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4695; Hickson SS, 2009, HYPERTENS RES, V32, P1079, DOI 10.1038/hr.2009.154; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Kienreich K, 2013, NUTRIENTS, V5, P3005, DOI 10.3390/nu5083005; Kinra S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a605; Kinra S, 2014, INT J EPIDEMIOL, V43, P1417, DOI 10.1093/ije/dyt128; Macro IIfPSIaO, 2000, NAT FAM HLTH SURV NF; Marwaha RK, 2005, AM J CLIN NUTR, V82, P477, DOI 10.1093/ajcn/82.2.477; Miettinen ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100235; Parker J, 2010, MATURITAS, V65, P225, DOI 10.1016/j.maturitas.2009.12.013; Pilz S, 2011, CLIN ENDOCRINOL, V75, P575, DOI 10.1111/j.1365-2265.2011.04147.x; Pilz S, 2009, CLIN ENDOCRINOL, V71, P666, DOI 10.1111/j.1365-2265.2009.03548.x; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; Prentice A M, 2001, Obes Rev, V2, P141, DOI 10.1046/j.1467-789x.2001.00031.x; Scragg R, 1992, Ann Epidemiol, V2, P697; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Snijder MB, 2005, J CLIN ENDOCR METAB, V90, P4119, DOI 10.1210/jc.2005-0216; Sokol SI, 2011, CARDIOL REV, V19, P192, DOI 10.1097/CRD.0b013e31821da9a5; Sullivan R, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-13; Taylor AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051042; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; TRINDER P, 1969, J CLIN PATHOL, V22, P158, DOI 10.1136/jcp.22.2.158; VANITALLIE TB, 1990, AM J CLIN NUTR, V52, P953, DOI 10.1093/ajcn/52.6.953; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Vupputuri MR, 2006, AM J CLIN NUTR, V83, P1411; Wang L, 2012, CIRC-CARDIOVASC QUAL, V5, P819, DOI 10.1161/CIRCOUTCOMES.112.967604; Zargar AH, 2007, POSTGRAD MED J, V83, P713, DOI 10.1136/pgmj.2007.059113	40	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129468	10.1371/journal.pone.0129468	http://dx.doi.org/10.1371/journal.pone.0129468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079685	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000356542300023
J	Sommerauer, M; Graf, C; Schafer, N; Huber, G; Schneider, P; Wuthrich, R; Schmid, C; Steinert, H				Sommerauer, Michael; Graf, Carmen; Schaefer, Niklaus; Huber, Gerhard; Schneider, Paul; Wuethrich, Rudolf; Schmid, Christoph; Steinert, Hans			Sensitivity and Specificity of Dual-Isotope Tc-99m-Tetrofosmin and I-123 Sodium Iodide Single Photon Emission Computed Tomography (SPECT) in Hyperparathyroidism	PLOS ONE			English	Article							PARATHYROID SCINTIGRAPHY; SECONDARY HYPERPARATHYROIDISM; TC-99M-SESTAMIBI SPECT/CT; PHASE TC-99M-SESTAMIBI; C-11-METHIONINE PET/CT; SUBTRACTION SPECT; SESTAMIBI; SURGERY; I-123/TC-99M-SESTAMIBI; EXPLORATIONS	Purpose Despite recommendations for Tc-99m-tetrofosmin dual tracer imaging for hyperparathyroidism in current guidelines, no report was published on dual-isotope Tc-99m-tetrofosmin and I-123 sodium iodide single-photon-emission-computed-tomography (SPECT). We evaluated diagnostic accuracy and the impact of preoperative SPECT on the surgical procedures and disease outcomes. Methods Analysis of 70 consecutive patients with primary hyperparathyroidism and 20 consecutive patients with tertiary hyperparathyroidism. Imaging findings were correlated with surgical results. Concomitant thyroid disease, pre- and postoperative laboratory measurements, histopathological results, type and duration of surgery were assessed. Results In primary hyperparathyroidism, SPECT had a sensitivity of 80% and a positive predictive value of 93% in patient-based analysis. Specificity was 99% in lesion-based analysis. Patients with positive SPECT elicit higher levels of parathyroid hormone and higher weight of resected parathyroids than SPECT-negative patients. Duration of parathyroid surgery was on average, approximately 40 minutes shorter in SPECT-positive than in SPECT-negative patients (89 +/- 46 vs. 129 +/- 41 minutes, p=0.006); 86% of SPECT-positive and 50% of SPECT-negative patients had minimal invasive surgery (p = 0.021). SPECT had lower sensitivity (60%) in patients with tertiary hyperparathyroidism; however, 90% of these patients had multiple lesions and all of these patients had bilateral lesions. Conclusion Dual-isotope SPECT with Tc-99m-tetrofosmin and I-123 sodium iodide has a high diagnostic value in patients with primary hyperparathyroidism and allows for saving of operation time. Higher levels of parathyroid hormone and higher glandular weight facilitated detection of parathyroid lesion. Diagnostic accuracy of preoperative imaging was lower in patients with tertiary hyperparathyroidism.	[Sommerauer, Michael; Graf, Carmen; Schaefer, Niklaus; Steinert, Hans] Univ Zurich Hosp, Dept Nucl Med, CH-8091 Zurich, Switzerland; [Huber, Gerhard] Univ Zurich Hosp, Dept Otorhinolaryngol Head & Neck Surg, CH-8091 Zurich, Switzerland; [Schneider, Paul] Univ Zurich Hosp, Dept Gen Visceral & Transplant Surg, CH-8091 Zurich, Switzerland; [Wuethrich, Rudolf] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Schmid, Christoph] Univ Zurich Hosp, Div Endocrinol & Diabetol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Sommerauer, M (corresponding author), Univ Zurich Hosp, Dept Nucl Med, Ramistr 100, CH-8091 Zurich, Switzerland.	michael.sommerauer@usz.ch		Schmid, Christoph/0000-0003-2080-4439; Schaefer, Niklaus/0000-0002-9732-7696				Ciappuccini R, 2012, CLIN NUCL MED, V37, P223, DOI 10.1097/RLU.0b013e31823362e5; Dewberry LK, 2014, AM SURGEON, V80, P646; Fahy BN, 2002, ARCH SURG-CHICAGO, V137, P917, DOI 10.1001/archsurg.137.8.917; Fjeld JG, 1997, J NUCL MED, V38, P831; Gayed IW, 2005, J NUCL MED, V46, P248; Harris L, 2008, HEAD NECK-J SCI SPEC, V30, P509, DOI 10.1002/hed.20727; Hassler S, 2014, CLIN NUCL MED, V39, P32, DOI 10.1097/RLU.0000000000000272; Hindie E, 2000, ARCH SURG-CHICAGO, V135, P1461, DOI 10.1001/archsurg.135.12.1461; Hindie E, 1999, LANCET, V353, P2200, DOI 10.1016/S0140-6736(98)09089-8; Hindie E, 2009, EUR J NUCL MED MOL I, V36, P1201, DOI 10.1007/s00259-009-1131-z; Lavely WC, 2007, J NUCL MED, V48, P1084, DOI 10.2967/jnumed.107.040428; Leslie WD, 2002, EUR J NUCL MED MOL I, V29, P1566, DOI 10.1007/s00259-002-0944-9; Mihai R, 2009, LANGENBECK ARCH SURG, V394, P765, DOI 10.1007/s00423-009-0534-4; Neumann DR, 2008, J NUCL MED, V49, P2012, DOI 10.2967/jnumed.108.054858; Neumann DR, 1997, AM J ROENTGENOL, V169, P1671, DOI 10.2214/ajr.169.6.9393188; Neumann DR, 1998, J CLIN ENDOCR METAB, V83, P3867, DOI 10.1210/jc.83.11.3867; Pattou F, 1998, BRIT J SURG, V85, P1605; Quak E, 2013, J CLIN ENDOCR METAB, V98, P3111, DOI 10.1210/jc.2013-2084; Rink T, 2002, J NUCL MED, V43, P1175; Schalin-Jantti C, 2013, J NUCL MED, V54, P739, DOI 10.2967/jnumed.112.109561; Schmidt MC, 2011, CLIN NUCL MED, V36, P1153, DOI 10.1097/RLU.0b013e31823360ee; Solorzano CC, 2008, ARCH SURG-CHICAGO, V143, P659, DOI 10.1001/archsurg.143.7.659; Swanson TW, 2010, AM J SURG, V199, P614, DOI 10.1016/j.amjsurg.2010.02.001; Taieb D, 2012, CLIN NUCL MED, V37, P568, DOI 10.1097/RLU.0b013e318251e408; Torney MVU, 2012, SURG ENDOSC, V26, P2579, DOI 10.1007/s00464-012-2236-1; Tunninen Virpi, 2013, Int J Mol Imaging, V2013, P921260, DOI 10.1155/2013/921260; Udelsman R, 2002, ANN SURG, V235, P665, DOI 10.1097/00000658-200205000-00008; Udelsman R, 2000, ANN SURG, V232, P331, DOI 10.1097/00000658-200009000-00005; UDEN P, 1992, WORLD J SURG, V16, P791, DOI 10.1007/BF02067389; Ugur O, 2006, OTOLARYNG HEAD NECK, V134, P316, DOI 10.1016/j.otohns.2005.08.010	30	7	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129194	10.1371/journal.pone.0129194	http://dx.doi.org/10.1371/journal.pone.0129194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079132	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000356542300018
J	van der Meer, S; Jacquemyn, H				van der Meer, Sascha; Jacquemyn, Hans			Genetic Diversity and Spatial Genetic Structure of the Grassland Perennial Saxifraga granulata along Two River Systems	PLOS ONE			English	Article							RIPARIAN PLANT; POPULATION; PATTERNS; FLOW; DIFFERENTIATION; METAPOPULATION; EXTINCTION; CONSERVATION; CONSEQUENCES; DISPERSAL	Due to changes in land use, the natural habitats of an increasing number of plant species have become more and more fragmented. In landscapes that consist of patches of suitable habitat, the frequency and extent of long-distance seed dispersal can be expected to be an important factor determining local genetic diversity and regional population structure of the remaining populations. In plant species that are restricted to riparian habitats, rivers can be expected to have a strong impact on the dynamics and spatial genetic structure of populations as they may enable long-distance seed dispersal and thus maintain gene flow between fragmented populations. In this study, we used polymorphic microsatellite markers to investigate the genetic diversity and the spatial genetic structure of 28 populations of Saxifraga granulata along two rivers in central Belgium. We hypothesized that rivers might be essential for gene flow among increasingly isolated populations of this species. Genetic diversity was high (H-S = 0.68), which to a certain extent can be explained by the octoploid nature of S. granulata in the study area. Populations along the Dijle and Demer rivers were also highly differentiated (G ''(ST) = 0.269 and 0.164 and D-EST = 0.190 and 0.124, respectively) and showed significant isolation-by-distance, indicating moderate levels of gene flow primarily between populations that are geographically close to each other. Along the river Demer population genetic diversity was higher upstream than downstream, suggesting that seed dispersal via the water was not the primary mode of dispersal. Overall, these results indicate that despite increasing fragmentation populations along both rivers were highly genetically diverse. The high ploidy level and longevity of S. granulata have most likely buffered negative effects of fragmentation on genetic diversity and the spatial genetic structure of populations in riparian grasslands.	[van der Meer, Sascha; Jacquemyn, Hans] Katholieke Univ Leuven, Lab Plant Conservat & Populat Biol, Heverlee, Belgium	KU Leuven	van der Meer, S (corresponding author), Katholieke Univ Leuven, Lab Plant Conservat & Populat Biol, Kasteelpark Arenberg 31 Bus 02435, Heverlee, Belgium.	sascha.vandermeer@bio.kuleuven.be	Jacquemyn, Hans/AAC-4875-2019	Jacquemyn, Hans/0000-0001-9600-5794	Fonds Wetenschappelijk onderzoek project [11G1715N]; European Research Council ERC starting grant [260601 - MYCASOR]	Fonds Wetenschappelijk onderzoek project; European Research Council ERC starting grant(European Research Council (ERC))	This work was supported by the Fonds Wetenschappelijk onderzoek project 11G1715N to SM (http://www.fwo.be/), and the European Research Council ERC starting grant 260601 - MYCASOR to HJ (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto M, 1998, MOL ECOL, V7, P1371, DOI 10.1046/j.1365-294x.1998.00485.x; Andersson S, 1996, HEREDITY, V77, P217, DOI 10.1038/hdy.1996.127; Bauwens W, 1985, WATER, V23, P125; Breckpot M, 2013, CONTROL ENG PRACT, V21, P1776, DOI 10.1016/j.conengprac.2013.08.008; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; De Becker P, 1999, APPL VEG SCI, V2, P215, DOI 10.2307/1478985; De Becker P, 2013, ADVIES BETREFFENDE V; De Becker P, 2006, ATLAS FLORA VLAADERE, P799; De Silva HN, 2005, HEREDITY, V95, P327, DOI 10.1038/sj.hdy.6800728; De Vries H, 2006, WAARNEMINGEN; DeWoody J, 2004, CONSERV GENET, V5, P603, DOI 10.1007/s10592-004-1985-3; HANSEN JEL, 1994, NORD J BOT, V14, P257, DOI 10.1111/j.1756-1051.1994.tb00597.x; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; Higgins SI, 2002, J ECOL, V90, P616, DOI 10.1046/j.1365-2745.2002.00694.x; Honnay O, 2009, J ECOL, V97, P131, DOI 10.1111/j.1365-2745.2008.01452.x; Honnay O, 2010, J BIOGEOGR, V37, P1730, DOI 10.1111/j.1365-2699.2010.02331.x; Imbert E, 2003, J ECOL, V91, P447, DOI 10.1046/j.1365-2745.2003.00772.x; INBO, 2006, ROD LIJST HOG PLANT; James EA, 2013, FRESHWATER BIOL, V58, P2102, DOI 10.1111/fwb.12194; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2012, TUTORIAL SPATIAL ANA; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kudoh H, 1997, AM J BOT, V84, P1285, DOI 10.2307/2446054; Lande R, 1998, RES POPUL ECOL, V40, P259, DOI 10.1007/BF02763457; LANDE R, 1992, EVOLUTION, V46, P381, DOI 10.1111/j.1558-5646.1992.tb02046.x; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Liu YF, 2006, AM J BOT, V93, P206, DOI 10.3732/ajb.93.2.206; Lundqvist E, 2001, HEREDITAS, V135, P75, DOI 10.1111/j.1601-5223.2001.00075.x; Markwith SH, 2007, AM J BOT, V94, P151, DOI 10.3732/ajb.94.2.151; MARSDENJONES EM, 1947, J GENET, V48, P206, DOI 10.1007/BF02989381; Meirmans PG, 2013, HEREDITY, V110, P131, DOI 10.1038/hdy.2012.80; Meirmans PG, 2012, J HERED, V103, P744, DOI 10.1093/jhered/ess047; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; MOODY ME, 1993, GENETICS, V134, P649; Munzbergova Z, 2013, PLANT BIOLOGY, V15, P195, DOI 10.1111/j.1438-8677.2012.00601.x; Nei M., 1987, MOL EVOLUTIONARY GEN; NILSSON C, 1989, ECOLOGY, V70, P77, DOI 10.2307/1938414; Nilsson C, 2010, BIOL REV, V85, P837, DOI 10.1111/j.1469-185X.2010.00129.x; Pollux BJA, 2007, MOL ECOL, V16, P313, DOI 10.1111/j.1365-294X.2006.03146.x; Prentis PJ, 2008, FRESHWATER BIOL, V53, P973, DOI 10.1111/j.1365-2427.2008.01953.x; QGIS Development Team, 2009, QGIS GEOGR INF SYST; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RITLAND K, 1989, CAN J BOT, V67, P2017, DOI 10.1139/b89-255; Russell JR, 1999, MOL ECOL, V8, P199, DOI 10.1046/j.1365-294X.1999.00551.x; Schleuning M, 2011, J ECOL, V99, P373, DOI 10.1111/j.1365-2745.2010.01775.x; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; SLATKIN M, 1977, THEOR POPUL BIOL, V12, P253, DOI 10.1016/0040-5809(77)90045-4; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Smulders MJM, 2008, FOREST ECOL MANAG, V255, P1388, DOI 10.1016/j.foreco.2007.10.063; Soons MB, 2008, J ECOL, V96, P619, DOI 10.1111/j.1365-2745.2008.01372.x; Tero N, 2003, MOL ECOL, V12, P2073, DOI 10.1046/j.1365-294X.2003.01898.x; Trapnell DW, 2011, J HERED, V102, P473, DOI 10.1093/jhered/esr045; van der Meer S, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400040; Van Looy K, 2006, J BIOGEOGR, V33, P1615, DOI 10.1111/j.1365-2699.2006.01536.x; Van Looy K, 2009, BIOL CONSERV, V142, P870, DOI 10.1016/j.biocon.2008.12.006; Walisch TJ, 2012, AM J BOT, V99, P1300, DOI 10.3732/ajb.1100479; Ward JV, 1998, BIOL CONSERV, V83, P269, DOI 10.1016/S0006-3207(97)00083-9; Werth S, 2014, FRESHWATER BIOL, V59, P2502, DOI 10.1111/fwb.12449; Werth S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099400; Wetzel RG, 2001, MORPHOLOGY FLOW RIVE, VThird, P18; WHITLOCK MC, 1990, EVOLUTION, V44, P1717, DOI [10.2307/2409501, 10.1111/j.1558-5646.1990.tb05243.x]; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8	64	7	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0130463	10.1371/journal.pone.0130463	http://dx.doi.org/10.1371/journal.pone.0130463			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079603	Green Published, gold, Green Submitted			2022-12-27	WOS:000356542300044
J	Bouman, AC; ten Cate-Hoek, AJ; Ramaekers, BLT; Joore, MA				Bouman, A. C.; ten Cate-Hoek, A. J.; Ramaekers, B. L. T.; Joore, M. A.			Sample Size Estimation for Non-Inferiority Trials: Frequentist Approach versus Decision Theory Approach	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; RANDOMIZED CONTROLLED-TRIALS; POSTTHROMBOTIC SYNDROME; INFORMATION ANALYSIS; VENOUS THROMBOSIS; EXPECTED VALUE; COMPRESSION STOCKINGS; PULMONARY-EMBOLISM; ECONOMIC BURDEN; CLINICAL-TRIALS	Background Non-inferiority trials are performed when the main therapeutic effect of the new therapy is expected to be not unacceptably worse than that of the standard therapy, and the new therapy is expected to have advantages over the standard therapy in costs or other (health) consequences. These advantages however are not included in the classic frequentist approach of sample size calculation for non-inferiority trials. In contrast, the decision theory approach of sample size calculation does include these factors. The objective of this study is to compare the conceptual and practical aspects of the frequentist approach and decision theory approach of sample size calculation for non-inferiority trials, thereby demonstrating that the decision theory approach is more appropriate for sample size calculation of non-inferiority trials. Methods The frequentist approach and decision theory approach of sample size calculation for non-inferiority trials are compared and applied to a case of a non-inferiority trial on individually tailored duration of elastic compression stocking therapy compared to two years elastic compression stocking therapy for the prevention of post thrombotic syndrome after deep vein thrombosis. Results The two approaches differ substantially in conceptual background, analytical approach, and input requirements. The sample size calculated according to the frequentist approach yielded 788 patients, using a power of 80% and a one-sided significance level of 5%. The decision theory approach indicated that the optimal sample size was 500 patients, with a net value of (sic)92 million. Conclusions This study demonstrates and explains the differences between the classic frequentist approach and the decision theory approach of sample size calculation for non-inferiority trials. We argue that the decision theory approach of sample size estimation is most suitable for sample size calculation of non-inferiority trials.	[Bouman, A. C.; Ramaekers, B. L. T.; Joore, M. A.] Maastricht Univ, Med Ctr, Dept Clin Epidemiol & Med Technol Assessment KEMT, NL-6200 MD Maastricht, Netherlands; [Bouman, A. C.; ten Cate-Hoek, A. J.] Maastricht Univ, Med Ctr, Lab Thrombosis & Hemostasis, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University	Bouman, AC (corresponding author), Maastricht Univ, Med Ctr, Dept Clin Epidemiol & Med Technol Assessment KEMT, NL-6200 MD Maastricht, Netherlands.	annemieke.bouman@maastrichtuniversity.nl		Ramaekers, Bram/0000-0001-5785-9228; Joore, Manuela/0000-0002-5649-6768	Zorgonderzoek Nederland/Medische Wetenschappen (ZonMW) the Netherlands [171102007]	Zorgonderzoek Nederland/Medische Wetenschappen (ZonMW) the Netherlands	AB, AtC, and MJ received funding from Zorgonderzoek Nederland/Medische Wetenschappen (ZonMW) (http://www.zonmw.nl/nl/) the Netherlands grant number 171102007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades AE, 2004, MED DECIS MAKING, V24, P207, DOI 10.1177/0272989X04263162; [Anonymous], 2006, STAT MED, V25, P1628; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; Blattler W, 1999, Wien Med Wochenschr, V149, P61; Boivin A, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.034835; Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; Briggs A, 2006, DECISION MODELLING H; Briggs AH, 2012, VALUE HEALTH, V15, P835, DOI 10.1016/j.jval.2012.04.014; Buller HR, 2007, NEW ENGL J MED, V357, P1094; Buller HR, 2012, LANCET, V379, P123, DOI 10.1016/S0140-6736(11)61505-5; Buxton MJ, 2006, PHARMACOECONOMICS, V24, P1133, DOI 10.2165/00019053-200624110-00009; Caprini JA, 2003, VALUE HEALTH, V6, P59, DOI 10.1046/j.1524-4733.2003.00204.x; Casparie A F, 1998, Ned Tijdschr Geneeskd, V142, P2075; Claxton K, 1996, HEALTH ECON, V5, P513, DOI 10.1002/(SICI)1099-1050(199611)5:6<513::AID-HEC237>3.0.CO;2-9; Claxton K, 2013, CHE RESEARCH PAPER 8; DETSKY AS, 1985, J CHRON DIS, V38, P753, DOI 10.1016/0021-9681(85)90118-3; Eckermann S, 2007, HEALTH ECON, V16, P195, DOI 10.1002/hec.1161; Eddy DM, 2012, VALUE HEALTH, V15, P843, DOI 10.1016/j.jval.2012.04.012; Gelderblom GJ, 2005, KOUSEN UITTREKHULPMI; Grutters JPC, 2011, ONCOLOGIST, V16, P1752, DOI 10.1634/theoncologist.2011-0029; Julious SA, 2011, STAT METHODS MED RES, V20, P595, DOI 10.1177/0962280210378945; Kahn SR, 2008, J THROMB HAEMOST, V6, P1105, DOI 10.1111/j.1538-7836.2008.03002.x; Kahn SR, 2008, ANN INTERN MED, V149, P698, DOI 10.7326/0003-4819-149-10-200811180-00004; Kent S, 2013, INT J TECHNOL ASSESS, V29, P435, DOI 10.1017/S0266462313000433; KIND P, 1999, 172 U YORK CTR HLTH; Koerkamp BG, 2008, RADIOLOGY, V246, P420, DOI [10.1148/radiol.2462070093, 10.1148/radio1.2462070093]; Koerkamp BG, 2010, VALUE HEALTH, V13, P242, DOI 10.1111/j.1524-4733.2009.00656.x; Krahn M, 2008, JAMA-J AM MED ASSOC, V300, P436, DOI 10.1001/jama.300.4.436; Laster LL, 2006, STAT MED, V25, P1115, DOI 10.1002/sim.2476; Laster LL, 2003, STAT MED, V22, P187, DOI 10.1002/sim.1137; Lindley DV, 1997, J ROY STAT SOC D-STA, V46, P129; MacDougall DA, 2006, AM J HEALTH-SYST PH, V63, pS5, DOI 10.2146/ajhp060388; McKenna C, 2011, MED DECIS MAKING, V31, P853, DOI 10.1177/0272989X11399921; Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x; Oostenbrink JB, 2002, PHARMACOECONOMICS, V20, P443, DOI 10.2165/00019053-200220070-00002; Prandoni P, 2004, ANN INTERN MED, V141, P249, DOI 10.7326/0003-4819-141-4-200408170-00004; Ramacciotti E, 2006, THROMB RES, V118, P699, DOI 10.1016/j.thromres.2005.12.005; Retel VP, 2013, VALUE HEALTH, V16, P720, DOI 10.1016/j.jval.2013.04.013; Roberts M, 2012, VALUE HEALTH, V15, P804, DOI 10.1016/j.jval.2012.06.016; Rothmann Mark D, 2003, J Biopharm Stat, V13, P565, DOI 10.1081/BIP-120022775; Schulman S, 2013, NEW ENGL J MED, V368, P709, DOI 10.1056/NEJMoa1113697; Schumi J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-106; Smith RD, 2005, HEALTH POLICY, V74, P77, DOI 10.1016/j.healthpol.2004.12.009; Soonawala D, 2010, INT J EPIDEMIOL, V39, P1567, DOI 10.1093/ije/dyq136; Sullivan PW, 2011, MED DECIS MAKING, V31, P800, DOI 10.1177/0272989X11401031; ten Cate-Hoek AJ, 2009, J THROMB HAEMOST, V7, P2042, DOI 10.1111/j.1538-7836.2009.03627.x; Ten Cate-Hoek AJ, 2014, BMJ OPEN; ten Cate-Hoek AJ, 2010, J VASC SURG, V52, P132, DOI 10.1016/j.jvs.2010.01.089; Thariani R, 2013, J COMP EFFECT RES, V2, P325, DOI [10.2217/CER.13.15, 10.2217/cer.13.15]; Welton NJ, 2011, RHEUMATOLOGY, V50, piv19, DOI 10.1093/rheumatology/ker242; Willan AR, 2007, CLIN TRIALS, V4, P279, DOI 10.1177/1740774507079237; Zorgverzekeringen Cv, 2004, HANDLEIDING KOSTENON	52	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130531	10.1371/journal.pone.0130531	http://dx.doi.org/10.1371/journal.pone.0130531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076354	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900177
J	Chang, L; Monteiro, MJ				Chang, Lydia; Monteiro, Mervyn J.			Defective Proteasome Delivery of Polyubiquitinated Proteins by Ubiquilin-2 Proteins Containing ALS Mutations	PLOS ONE			English	Article							DEGRADATION; UBIQUITINATION; IDENTIFICATION	Ubiquilin proteins facilitate delivery of ubiquitinated proteins to the proteasome for degradation. Interest in the proteins has been heightened by the discovery that gene mutations in UBQLN2 cause dominant inheritance of amyotrophic lateral sclerosis (ALS). However, the mechanisms by which the mutations cause ALS are not known. Here we report on the underlying defect of ubiquilin-2 proteins containing ALS-linked mutations in affecting proteasome-mediated degradation. We found that overexpression of ubiquilin-2 proteins containing any one of five different ALS mutations slow degradation of Myc, a prototypic proteasome substrate. Examination of coprecipitating proteins indicated that the mutant proteins are generally capable of binding polyubiquitinated proteins, but defective in binding the proteasome. GST-pulldown studies revealed that many of the mutants bind weaker to the S5a subunit of the proteasome, compared with wild type (WT) ubiquilin-2 protein. The results suggest the mutant proteins are unable to deliver their captured cargo to the proteasome for degradation, which presumably leads to toxicity. Quantification of cell death is consistent with this idea. Measurement of protein turnover further indicated the mutant proteins have longer half-lives than WT ubiquilin-2. Our studies provide novel insight into the mechanism by which ALS-linked mutations in UBQLN2 interfere with protein degradation.	[Chang, Lydia; Monteiro, Mervyn J.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Monteiro, Mervyn J.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Monteiro, MJ (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.	monteiro@umaryland.edu						Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Fahed AC, 2014, ANN NEUROL, V75, P793, DOI 10.1002/ana.24164; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Ford DL, 2007, BIOCHEMISTRY-US, V46, P8827, DOI 10.1021/bi700604q; Gellera C, 2013, J NEUROL NEUROSUR PS, V84, P183, DOI 10.1136/jnnp-2012-303433; Gilpin KM, 2015, HUM MOL GENET, V24, P2565, DOI 10.1093/hmg/ddv020; Gorrie GH, 2014, P NATL ACAD SCI USA, V111, P14524, DOI 10.1073/pnas.1405741111; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Kim TY, 2008, BIOCHEM BIOPH RES CO, V369, P741, DOI 10.1016/j.bbrc.2008.02.086; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Lee DY, 2012, BIOL CHEM, V393, P441, DOI 10.1515/hsz-2012-0120; Liang J, 2006, J CELL SCI, V119, P4011, DOI 10.1242/jcs.03163; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Massey LK, 2004, J ALZHEIMERS DIS, V6, P79; Monteiro MJ, 1996, EXP CELL RES, V223, P443, DOI 10.1006/excr.1996.0100; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Rothenberg C, 2010, AUTOPHAGY, V6, P979, DOI 10.4161/auto.6.7.13118; Rothenberg C, 2010, HUM MOL GENET, V19, P3219, DOI 10.1093/hmg/ddq231; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Safren N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087513; Synofzik M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.07.002; Ugolino J, 2011, HUM MOL GENET, V20, P3565, DOI 10.1093/hmg/ddr274; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wu AL, 1999, MOL CELL, V4, P619, DOI 10.1016/S1097-2765(00)80212-9; Wu QX, 2015, ACTA NEUROPATHOL, V129, P417, DOI 10.1007/s00401-014-1367-y; Xia YX, 2014, J NEUROCHEM, V129, P99, DOI 10.1111/jnc.12606	32	53	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130162	10.1371/journal.pone.0130162	http://dx.doi.org/10.1371/journal.pone.0130162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075709	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900146
J	Kertho, A; Mamidi, S; Bonman, JM; McClean, PE; Acevedo, M				Kertho, Albert; Mamidi, Sujan; Bonman, J. Michael; McClean, Phillip E.; Acevedo, Maricelis			Genome-Wide Association Mapping for Resistance to Leaf and Stripe Rust in Winter-Habit Hexaploid Wheat Landraces	PLOS ONE			English	Article							F-SP TRITICI; TURGIDUM SSP DICOCCOIDES; PUCCINIA-STRIIFORMIS; DISEASE-RESISTANCE; CHROMOSOMAL LOCATION; HIGH-TEMPERATURE; LINKAGE DISEQUILIBRIUM; UNITED-STATES; MODEL; GENE	Leaf rust, caused by Puccinia triticina (Pt), and stripe rust, caused by P. striiformis f. sp. tritici (Pst), are destructive foliar diseases of wheat worldwide. Breeding for disease resistance is the preferred strategy of managing both diseases. The continued emergence of new races of Pt and Pst requires a constant search for new sources of resistance. Here we report a genome-wide association analysis of 567 winter wheat (Triticum aestivum) land-race accessions using the Infinium iSelect 9K wheat SNP array to identify loci associated with seedling resistance to five races of Pt (MDCL, MFPS, THBL, TDBG, and TBDJ) and one race of Pst (PSTv-37) frequently found in the Northern Great Plains of the United States. Mixed linear models identified 65 and eight significant markers associated with leaf rust and stripe rust, respectively. Further, we identified 31 and three QTL associated with resistance to Pt and Pst, respectively. Eleven QTL, identified on chromosomes 3A, 4A, 5A, and 6D, are previously unknown for leaf rust resistance in T. aestivum.	[Kertho, Albert; Acevedo, Maricelis] N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA; [Mamidi, Sujan; McClean, Phillip E.] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; [Bonman, J. Michael] USDA ARS, Small Grains & Potato Germplasm Res Unit, Aberdeen, ID USA	North Dakota State University Fargo; North Dakota State University Fargo; United States Department of Agriculture (USDA)	Acevedo, M (corresponding author), N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA.	maricelis.acevedo@ndsu.edu	mamidi, sujan/P-7009-2018	mamidi, sujan/0000-0002-3837-6121; Bonman, John/0000-0002-7414-044X	Ducks Unlimited, Inc.; Triticeae CAP; ARS [ARS-0424394] Funding Source: Federal RePORTER	Ducks Unlimited, Inc.; Triticeae CAP; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by Ducks Unlimited, Inc. (http://www.ducks.org/); and Triticeae CAP (http://www.triticeaecap.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, ANN STAT, V29, P1165; Bolton MD, 2008, MOL PLANT PATHOL, V9, P563, DOI [10.1111/j.1364-3703.2008.00487.x, 10.1111/J.1364-3703.2008.00487.X]; Bonman JM, 2007, CROP SCI, V47, P1955, DOI 10.2135/cropsci2007.01.0028; Brueggeman R, 2002, P NATL ACAD SCI USA, V99, P9328, DOI 10.1073/pnas.142284999; Bux H, 2012, CAN J PLANT PATHOL, V34, P68, DOI 10.1080/07060661.2012.662998; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; Chen XM, 2002, PLANT DIS, V86, P39, DOI 10.1094/PDIS.2002.86.1.39; Chen XM, 1996, PHYTOPATHOLOGY, V86, P1228, DOI 10.1094/Phyto-86-1228; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P375, DOI 10.1094/Phyto-85-375; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P1362, DOI 10.1094/Phyto-85-1362; Dadrezaei S. T., 2013, American Journal of Plant Sciences, V4, P1821, DOI 10.4236/ajps.2013.49224; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Ghavami F, 2011, G3-GENES GENOM GENET, V1, P209, DOI 10.1534/g3.111.000489; Guo YH, 2009, NEW PHYTOL, V183, P62, DOI 10.1111/j.1469-8137.2009.02838.x; Gurung S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108179; Jin Y, 2010, PHYTOPATHOLOGY, V100, P432, DOI 10.1094/PHYTO-100-5-0432; Kollers S, 2014, MOL BREEDING, V34, P363, DOI 10.1007/s11032-014-0039-x; Kolmer JA, 2006, PLANT DIS, V90, P1219, DOI 10.1094/PD-90-1219; Kolmer JA, 2005, CURR OPIN PLANT BIOL, V8, P441, DOI 10.1016/j.pbi.2005.05.001; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Line RF, 2002, ANNU REV PHYTOPATHOL, V40, P75, DOI 10.1146/annurev.phyto.40.020102.111645; LONG DL, 1989, PHYTOPATHOLOGY, V79, P525, DOI 10.1094/Phyto-79-525; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Mamidi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107469; Mamidi S, 2011, PLANT GENOME-US, V4, P154, DOI 10.3835/plantgenome2011.04.0011; Markell SG, 2008, PHYTOPATHOLOGY, V98, P632, DOI 10.1094/PHYTO-98-6-0632; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; McIntosh R., 2013, CATALOGUE GENE SYMBO; McIntosh RA, 2012, KOMUGI INTEGRATED WH; McIntosh Wellings RC, 1995, WHEAT RUSTS ATLAS RE; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Newcomb M, 2013, PLANT DIS, V97, P882, DOI 10.1094/PDIS-02-12-0200-RE; Newton AC, 2010, TRENDS MICROBIOL, V18, P365, DOI 10.1016/j.tim.2010.06.002; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; QAYOUM A, 1985, PHYTOPATHOLOGY, V75, P1121, DOI 10.1094/Phyto-75-1121; Reif JC, 2005, THEOR APPL GENET, V110, P859, DOI 10.1007/s00122-004-1881-8; Roelfs A. P., 1985, CEREAL RUSTS, V2; Saintenac C, 2013, G3-GENES GENOM GENET, V3, P1105, DOI 10.1534/g3.113.005819; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Sela H, 2014, THEOR APPL GENET, V127, P2453, DOI 10.1007/s00122-014-2389-5; Tameling WIL, 2007, PHYSIOL MOL PLANT P, V71, P126, DOI 10.1016/j.pmpp.2007.12.006; Uauy C, 2005, THEOR APPL GENET, V112, P97, DOI 10.1007/s00122-005-0109-x; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Wan A, 2014, PLANT DIS, P1; Wang LF, 2002, EUPHYTICA, V124, P71, DOI 10.1023/A:1015689817857; William M, 2003, PHYTOPATHOLOGY, V93, P153, DOI 10.1094/PHYTO.2003.93.2.153; Yahyaoui A., 2012, P 2 3 4 REG C YELL R; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zegeye H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105593; Zhang DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103747; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zurn JD, 2014, MOL BREEDING, V34, P871, DOI 10.1007/s11032-014-0081-8	58	61	61	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129580	10.1371/journal.pone.0129580	http://dx.doi.org/10.1371/journal.pone.0129580			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076040	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900085
J	Li, SH; Wang, QX; Sun, P; Li, Q; Yang, ZY; Shi, M; Wei, W; Guo, RP				Li Shaohua; Wang Qiaoxuan; Sun Peng; Li Qing; Yang Zhongyuan; Shi Ming; Wei Wei; Guo Rongping			Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis	PLOS ONE			English	Article							ARTERIAL INFUSION CHEMOTHERAPY; LONG-TERM OUTCOMES; MAJOR PORTAL-VEIN; NATURAL-HISTORY; PROGNOSTIC-FACTORS; RESECTION; SURVIVAL; EFFICACY; INVASION; CHEMOEMBOLIZATION	Background Portal/hepatic vein tumor thrombosis (PVTT/HVTT) in hepatocellular carcinoma (HCC) is a sign of advanced stage disease and is associated with poor prognosis. This study investigated the surgical outcomes of patients with HCC and PVTT/HVTT to determine the most appropriate surgical treatment strategy for these patients. Materials and Methods The study population included 77 HCC patients from January 2004 to June 2009 who underwent hepatectomy in our department and were diagnosed with PVTT/HVTT based on pathological examination. The patients were divided into two groups: in group 1, PVTT/HVTT was located in the hepatic resection area and removed with the tumor en bloc (38 cases); in group 2, PVTT/x HVTT was beyond the resection line and removed by suction or thrombectomy (39 cases). Concerning the factor of surgical margins, the patients were further divided into four subgroups: group 1A: patients in group 1 with surgical margins <= 1 cm (28 cases); group 1B: patients in group 1 with surgical margins >1 cm (9 cases); group 2A: patients in group 2 with surgical margins <= 1 cm (28 cases); and group 2B: patients in group 2 with surgical margins >1 cm (9 cases). Results Most of the characteristics of groups 1 and 2 were similar. Patients in group 2 had significantly higher median blood loss (p=0.002) and higher blood transfusion rate (p=0.002) during the operation, which were not considered prognostic factors (p=0.323 and 0.571, respectively). The median overall survival (OS) duration in group 1 was significantly longer than that in group 2 (14.3 vs. 10.4 months, p=0.047). The median OS durations in groups 1A, 1B, 2A, and 2B were 14.3, 42.7, 7.5, and 18.0 months, respectively, which were significantly different (p=0.018). Conclusions When PVTT/HVTT is located in the hepatic resection area and removed with the tumor en bloc, the median OS duration is longer. Based on this finding, widening the surgical margins when technically possible may increase OS.	[Li Shaohua; Shi Ming; Wei Wei; Guo Rongping] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China; [Li Shaohua; Wang Qiaoxuan; Sun Peng; Li Qing; Yang Zhongyuan; Shi Ming; Wei Wei; Guo Rongping] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Wang Qiaoxuan] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Sun Peng] Sun Yat Sen Univ, Ctr Canc, Dept Anesthesia, Guangzhou 510275, Guangdong, Peoples R China; [Li Qing] Sun Yat Sen Univ, Ctr Canc, Dept Ultrasound, Guangzhou 510275, Guangdong, Peoples R China; [Yang Zhongyuan] Sun Yat Sen Univ, Ctr Canc, Dept Head & Neck Surg, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Wei, W (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China.	weiwei@sysucc.org.cn; guorp@sysucc.org.cn		Guo, Rongping/0000-0003-2799-3463	Science and Technology Planning Project of Guangdong Province [2013B021800159]; Guangzhou Municipal Science and Technology Project of China [2012J4100078]	Science and Technology Planning Project of Guangdong Province; Guangzhou Municipal Science and Technology Project of China	This study was supported by Science and Technology Planning Project of Guangdong Province (No. 2013B021800159) and Guangzhou Municipal Science and Technology Project of China (No. 2012J4100078).	Aldrighetti L, 2009, ANN SURG ONCOL, V16, P1254, DOI 10.1245/s10434-009-0383-y; Amitrano L, 2004, J HEPATOL, V40, P736, DOI 10.1016/j.jhep.2004.01.001; Ando E, 2002, CANCER-AM CANCER SOC, V95, P588, DOI 10.1002/cncr.10694; Bruix J, 2012, J HEPATOL, V57, P821, DOI 10.1016/j.jhep.2012.06.014; CALVET X, 1990, J HEPATOL, V10, P311, DOI 10.1016/0168-8278(90)90138-H; Chen JS, 2012, J SURG RES, V175, P243, DOI 10.1016/j.jss.2011.03.072; Chen XP, 2006, ANN SURG ONCOL, V13, P940, DOI 10.1245/ASO.2006.08.007; Cheong JY, 2005, HEPATOL RES, V32, P127, DOI 10.1016/j.hepres.2005.01.015; Chok KSH, 2014, WORLD J SURG, V38, P490, DOI 10.1007/s00268-013-2290-4; CHUNG JW, 1995, AM J ROENTGENOL, V165, P315, DOI 10.2214/ajr.165.2.7618547; COHEN J, 1992, AM J MED, V92, P173, DOI 10.1016/0002-9343(92)90109-O; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Eshkenazy Rony, 2014, Hepatobiliary Surg Nutr, V3, P303, DOI 10.3978/j.issn.2304-3881.2014.09.08; Fan J, 2005, WORLD J GASTROENTERO, V11, P1215, DOI 10.3748/wjg.v11.i8.1215; Fatourou Evangelia M, 2014, Hepatobiliary Surg Nutr, V3, P415, DOI 10.3978/j.issn.2304-3881.2014.07.01; Georgiades CS, 2005, J VASC INTERV RADIOL, V16, P1653, DOI 10.1097/01.RVI.0000182185.47500.7A; Ikai I, 2006, J AM COLL SURGEONS, V202, P431, DOI 10.1016/j.jamcollsurg.2005.11.012; Itamoto T, 2002, J SURG ONCOL, V80, P143, DOI 10.1002/jso.10116; Kauffmann Rondi, 2014, Hepatobiliary Surg Nutr, V3, P238, DOI 10.3978/j.issn.2304-3881.2014.09.01; Kim JM, 2013, WORLD J SURG ONCOL, V11; Le Treut YP, 2006, J GASTROINTEST SURG, V10, P855, DOI 10.1016/j.gassur.2005.12.011; Lin CS, 2006, JPN J CLIN ONCOL, V36, P212, DOI 10.1093/jjco/hyl006; Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145; Minagawa M, 2001, ANN SURG, V233, P379, DOI 10.1097/00000658-200103000-00012; Minagawa M, 2006, WORLD J GASTROENTERO, V12, P7561, DOI 10.3748/wjg.v12.i47.7561; Niguma T, 2005, J HEPATO-BILIARY-PAN, V12, P249, DOI 10.1007/s00534-004-0969-5; NONAMI T, 1992, HEPATOLOGY, V16, P1195, DOI 10.1016/0270-9139(92)90014-Z; Ohkubo T, 2000, J AM COLL SURGEONS, V191, P657, DOI 10.1016/S1072-7515(00)00740-7; OKADA S, 1992, HEPATOLOGY, V16, P112, DOI 10.1002/hep.1840160119; Ota H, 2005, BRIT J CANCER, V93, P557, DOI 10.1038/sj.bjc.6602742; Pawarode A, 1998, AM J CLIN ONCOL-CANC, V21, P386, DOI 10.1097/00000421-199808000-00014; Pawlik TM, 2005, SURGERY, V137, P403, DOI 10.1016/j.surg.2004.12.012; Peng BG, 2009, AM J SURG, V198, P313, DOI 10.1016/j.amjsurg.2008.09.026; Poon RTP, 1999, ANN SURG, V229, P216, DOI 10.1097/00000658-199902000-00009; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; RAOUL JL, 1994, J NUCL MED, V35, P1782; Salem R, 2010, GASTROENTEROLOGY, V138, P52, DOI 10.1053/j.gastro.2009.09.006; Sangro B, 2011, HEPATOLOGY, V54, P868, DOI 10.1002/hep.24451; Shi J, 2011, J HEPATO-BIL-PAN SCI, V18, P74, DOI 10.1007/s00534-010-0314-0; Song DS, 2014, J GASTROENTEROL; Takizawa D, 2007, DIGEST DIS SCI, V52, P3290, DOI 10.1007/s10620-007-9808-2; Tarantino L, 2006, ABDOM IMAGING, V31, P537, DOI 10.1007/s00261-005-0150-x; VILANA R, 1993, AM J ROENTGENOL, V160, P1285, DOI 10.2214/ajr.160.6.8388621; YAMADA R, 1983, RADIOLOGY, V148, P397, DOI 10.1148/radiology.148.2.6306721; Zeng ZC, 2005, INT J RADIAT ONCOL, V61, P432, DOI 10.1016/j.ijrobp.2004.05.025	45	35	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130021	10.1371/journal.pone.0130021	http://dx.doi.org/10.1371/journal.pone.0130021			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076461	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900124
J	Liu, JHK; Mansouri, K; Weinreb, RN				Liu, John H. K.; Mansouri, Kaweh; Weinreb, Robert N.			Estimation of 24-Hour Intraocular Pressure Peak Timing and Variation Using a Contact Lens Sensor	PLOS ONE			English	Article							PRIMARY OPEN-ANGLE; 20-4-HOUR PATTERN; GLAUCOMA PATIENTS; HEALTHY-SUBJECTS; RHYTHM; POSITION; EYES	Purpose To compare estimates of 24-hour intraocular pressure (IOP) peak timing and variation obtained using a contact lens sensor (CLS) and using a pneumatonometer. Methods Laboratory data collected from 30 healthy volunteers (ages, 20-66 years) in a randomized, controlled clinical trial were analyzed. Participants were housed for 24 hours in a sleep laboratory. One randomly selected right or left eye was fitted with a CLS that monitored circumferential curvature in the corneoscleral region related to the change of IOP. Electronic output signals of 30 seconds were averaged and recorded every 5 minutes. In the contralateral eye, habitual IOP measurements were taken using a pneumatonometer once every two hours. Simulated 24-hour rhythms in both eyes were determined by cosinor fitting. Simulated peak timings (acrophases) and simulated data variations (amplitudes) were compared between the paired eyes. Results Bilateral change patterns of average 24-hour data for the group were in parallel. The simulated peak timing in the CLS fitted eye occurred at 4: 44 AM +/- 210 min (mean +/- SD) and the IOP peak timing in the contralateral eye at 4: 11 AM +/- 120 min (P=0.256, Wilcoxon signed-rank test). There was no significant correlation between the simulated data variations in the paired eyes (P=0.820, linear regression). Conclusions The 24-hour CLS data showed a simulated peak timing close to the 24-hour IOP peak timing obtained using the pneumatonometer. However, the simulated variations of 24-hour data in the paired eyes were not correlated. Estimated 24-hour IOP rhythms using the two devices should not be considered interchangeable.	[Liu, John H. K.; Mansouri, Kaweh; Weinreb, Robert N.] Univ Calif San Diego, Dept Ophthalmol, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA; [Mansouri, Kaweh] Univ Hosp Geneva, Div Ophthalmol, Glaucoma Sect, Geneva, Switzerland	University of California System; University of California San Diego; University of Geneva	Liu, JHK (corresponding author), Univ Calif San Diego, Dept Ophthalmol, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA.	joliu@ucsd.edu			Sensimed AG, Lausanne, Switzerland	Sensimed AG, Lausanne, Switzerland	This study utilized data from a clinical trial sponsored by Sensimed AG, Lausanne, Switzerland (JHKL). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnifili L, 2015, ACTA OPHTHALMOL, V93, pE14, DOI 10.1111/aos.12408; Aptel F, 2014, JAMA OPHTHALMOL, V132, P1232, DOI 10.1001/jamaophthalmol.2014.1761; Bagga H, 2009, CURR OPIN OPHTHALMOL, V20, P79, DOI 10.1097/ICU.0b013e32831eef4f; Barkana Y, 2006, ARCH OPHTHALMOL-CHIC, V124, P793, DOI 10.1001/archopht.124.6.793; Coleman AL, 2008, SURV OPHTHALMOL, V53, pS3, DOI 10.1016/j.survophthal.2008.08.006; Currie BD, 2011, J GLAUCOMA, V20, P465, DOI 10.1097/IJG.0b013e3181f46324; De Smedt S, 2012, J GLAUCOMA, V21, P539, DOI 10.1097/IJG.0b013e31821dac43; Faschinger C, 2013, JAMA OPHTHALMOL, V131, P696, DOI 10.1001/jamaophthalmol.2013.2874; Freiberg FJ, 2012, ACTA OPHTHALMOL, V90, pE534, DOI 10.1111/j.1755-3768.2012.02495.x; Grippo TM, 2013, INVEST OPHTH VIS SCI, V54, P512, DOI 10.1167/iovs.12-10709; Hubanova R, 2014, ACTA OPHTHALMOL, V92, pE119, DOI 10.1111/aos.12241; Kida T, 2006, INVEST OPHTH VIS SCI, V47, P4422, DOI 10.1167/iovs.06-0507; Lee YR, 2012, INVEST OPHTH VIS SCI, V53, P881, DOI 10.1167/iovs.11-7846; Leonardi M, 2004, INVEST OPHTH VIS SCI, V45, P3113, DOI 10.1167/iovs.04-0015; Leonardi M, 2009, ACTA OPHTHALMOL, V87, P433, DOI 10.1111/j.1755-3768.2008.01404.x; Liu H, 2011, ARCH OPHTHALMOL-CHIC, V129, P269, DOI 10.1001/archophthalmol.2011.4; Liu JHK, 2003, INVEST OPHTH VIS SCI, V44, P1586, DOI 10.1167/iovs.02-0666; Liu JHK, 1998, INVEST OPHTH VIS SCI, V39, P2707; Liu JHK, 1999, INVEST OPHTH VIS SCI, V40, P2912; Liu JHK, 2014, INVEST OPHTH VIS SCI, V55, P7398, DOI 10.1167/iovs.14-14464; Liu JHK, 2011, BRIT J OPHTHALMOL, V95, P599, DOI 10.1136/bjo.2010.199737; Lorenz K, 2013, J GLAUCOMA, V22, P311, DOI 10.1097/IJG.0b013e318241b874; Malihi M, 2012, OPHTHALMOLOGY, V119, P987, DOI 10.1016/j.ophtha.2011.11.024; Mansouri K, 2008, BRIT J OPHTHALMOL, V92, P332, DOI 10.1136/bjo.2007.123042; Mansouri K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125530; Mansouri K, 2012, INVEST OPHTH VIS SCI, V53, P8050, DOI 10.1167/iovs.12-10569; Mansouri K, 2012, ARCH OPHTHALMOL-CHIC, V130, P1534, DOI [10.1001/archophthalmol.2012.2280, 10.1001/jamaophthalmol.2013.1350]; Mansouri K, 2012, INVEST OPHTH VIS SCI, V53, P112, DOI 10.1167/iovs.11-8763; Mansouri K, 2011, BRIT J OPHTHALMOL, V95, P627, DOI 10.1136/bjo.2010.192922; Mottet B, 2013, JAMA OPHTHALMOL, V131, P1507, DOI 10.1001/jamaophthalmol.2013.5297; Mottet B, 2012, INVEST OPHTH VIS SCI, V53, P8186, DOI 10.1167/iovs.12-10877; Pajic B, 2011, CURR EYE RES, V36, P1129, DOI 10.3109/02713683.2011.608240; Pickering TG, 2006, NEW ENGL J MED, V354, P2368, DOI 10.1056/NEJMra060433; Quaranta L, 2013, SURV OPHTHALMOL, V58, P26, DOI 10.1016/j.survophthal.2012.05.003; Sit AJ, 2009, J GLAUCOMA, V18, P272, DOI 10.1097/IJG.0b013e3181862490; Sultan MB, 2009, SURV OPHTHALMOL, V54, P643, DOI 10.1016/j.survophthal.2009.05.001; Todani A, 2011, INVEST OPHTH VIS SCI, V52, P9573, DOI 10.1167/iovs.11-7878; Tojo N, 2014, GRAEF ARCH CLIN EXP, V252, P1463, DOI 10.1007/s00417-014-2666-7; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Zar JH., 2010, BIOSTAT ANAL, V5th	40	24	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129529	10.1371/journal.pone.0129529	http://dx.doi.org/10.1371/journal.pone.0129529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076472	Green Published, gold			2022-12-27	WOS:000356329900080
J	Scharinger, C; Kammerer, Y; Gerjets, P				Scharinger, Christian; Kammerer, Yvonne; Gerjets, Peter			Pupil Dilation and EEG Alpha Frequency Band Power Reveal Load on Executive Functions for Link-Selection Processes during Text Reading	PLOS ONE			English	Article							WORKING-MEMORY; TASK-DIFFICULTY; EYE-MOVEMENTS; COMPREHENSION; BRAIN; SYNCHRONIZATION; OSCILLATIONS; THETA; SIZE; DESYNCHRONIZATION	Executive working memory functions play a central role in reading comprehension. In the present research we were interested in additional load imposed on executive functions by link-selection processes during computer-based reading. For obtaining process measures, we used a methodology of concurrent electroencephalographic (EEG) and eye-tracking data recording that allowed us to compare epochs of pure text reading with epochs of hyperlink-like selection processes in an online reading situation. Furthermore, this methodology allowed us to directly compare the two physiological load-measures EEG alpha frequency band power and pupil dilation. We observed increased load on executive functions during hyperlink-like selection processes on both measures in terms of decreased alpha frequency band power and increased pupil dilation. Surprisingly however, the two measures did not correlate. Two additional experiments were conducted that excluded potential perceptual, motor, or structural confounds. In sum, EEG alpha frequency band power and pupil dilation both turned out to be sensitive measures for increased load during hyperlink-like selection processes in online text reading.	[Scharinger, Christian; Kammerer, Yvonne; Gerjets, Peter] Knowledge Media Res Ctr, Tubingen, Germany	Eberhard Karls University of Tubingen; Leibniz Institut fur Wissensmedien	Scharinger, C (corresponding author), Knowledge Media Res Ctr, Tubingen, Germany.	c.scharinger@iwm-kmrc.de	Gerjets, Peter/AAD-2017-2020		Leibniz ScienceCampus Tuebingen Informational Environments; Leibniz ScienceCampus	Leibniz ScienceCampus Tuebingen Informational Environments; Leibniz ScienceCampus	This research was funded by the Leibniz ScienceCampus Tuebingen Informational Environments (http://www.wissenschaftscampus-tuebingen.de/www/en/index.html). CS was funded as a doctoral student within the Leibniz ScienceCampus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadieu F, 2009, LEARN INSTR, V19, P376, DOI 10.1016/j.learninstruc.2009.02.005; Andreass J. L., 2007, PSYCHOPHYSIOLOGY HUM, P289; [Anonymous], 2006, F SHAPED PATTERN REA; Antonenko P, 2010, EDUC PSYCHOL REV, V22, P425, DOI 10.1007/s10648-010-9130-y; Antonenko PD, 2010, COMPUT HUM BEHAV, V26, P140, DOI 10.1016/j.chb.2009.10.014; Arrington CN, 2014, SCI STUD READ, V18, P325, DOI 10.1080/10888438.2014.902461; Baccino Thierry, 2012, OXFORD HDB EYE MOVEM, DOI [10.1093/oxfordhb/9780199539789.013.0047, DOI 10.1093/OXFORDHB/9780199539789.013.0047]; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Basar E, 2012, INT J PSYCHOPHYSIOL, V86, P25, DOI 10.1016/j.ijpsycho.2012.07.001; Beatty J., 2000, HDB PSYCHOPHYSIOL, V2, P142; Brouwer AM, 2014, INT J PSYCHOPHYSIOL, V93, P242, DOI 10.1016/j.ijpsycho.2014.05.004; Cangoz B., 2012, CONT ED TECHNOLOGY, V3, P81, DOI 10.30935/cedtech/6070; Carr N., 2010, SHALLOWS WHAT INTERN; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DeStefano D, 2007, COMPUT HUM BEHAV, V23, P1616, DOI 10.1016/j.chb.2005.08.012; Di Stasi LL, 2011, INT J IND ERGONOM, V41, P298, DOI 10.1016/j.ergon.2011.02.008; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dimigen O, 2011, J EXP PSYCHOL GEN, V140, P552, DOI 10.1037/a0023885; Duggan GB, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P1141; Duggan GB, 2009, J EXP PSYCHOL-APPL, V15, P228, DOI 10.1037/a0016995; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; ERICSSON KA, 1995, PSYCHOL REV, V102, P211, DOI 10.1037/0033-295X.102.2.211; Erping Zhu, 1999, Journal of Educational Multimedia and Hypermedia, V8, P331; Ewing K., 2010, HUMAN FACTORS SYSTEM, P423; Fisk JE, 2004, J CLIN EXP NEUROPSYC, V26, P874, DOI 10.1080/13803390490510680; Fitzsimmons G, 2013, P 5 ANN ACM WEB SCI, P65, DOI [10.1145/2464464, DOI 10.1145/2464464.2464501]; Frey A, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00039; Gerjets P, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00385; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gevins A, 2000, CEREB CORTEX, V10, P829, DOI 10.1093/cercor/10.9.829; Gevins A. S., 2003, THEORETICAL ISSUES E, V4, P113, DOI [DOI 10.1080/14639220210159717, 10.1080/14639220210159717]; Granholm E, 2004, INT J PSYCHOPHYSIOL, V52, P1, DOI 10.1016/j.ijpsycho.2003.12.001; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; HESS EH, 1960, SCIENCE, V132, P349, DOI 10.1126/science.132.3423.349; Hong LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091321; Iqbal S.T., 2004, P 2004 C HUMAN FACTO, P1477, DOI [10.1145/985921.986094, DOI 10.1145/985921.986094]; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Kahneman D, 1973, SERIES EXPT PSYCHOL; Kendeou P, 2014, LEARN DISABIL RES PR, V29, P10, DOI 10.1111/ldrp.12025; KIM H, 1995, BEHAV INFORM TECHNOL, V14, P239, DOI 10.1080/01449299508914637; KINTSCH W, 1988, PSYCHOL REV, V95, P163, DOI 10.1037/0033-295X.95.2.163; Kintsch W., 1991, ADV PSYCHOL, V79, P107, DOI [DOI 10.1016/S0166-4115(08)61551-4, 10.1016/S0166-4115(08)61551-4]; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kliegl R, 2012, PSYCHOL RES-PSYCH FO, V76, P145, DOI 10.1007/s00426-011-0376-x; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2006, PROG BRAIN RES, V159, P151, DOI 10.1016/S0079-6123(06)59010-7; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Krause C.M., 2003, EXPT METHODS NEUROPS, VVolume 1, P111, DOI [10.1007/978-1-4615-1163-2, DOI 10.1007/978-1-4615-1163-2]; Kretzschmar F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056178; Kruger J.-L., 2013, P EYE TRACK S AFR, P62, DOI 10.1145/2509315.2509331; Kuipers Jan Rouke, 2011, Front Hum Neurosci, V5, P61, DOI 10.3389/fnhum.2011.00061; Kuipers JR, 2013, CORTEX, V49, P2853, DOI 10.1016/j.cortex.2013.01.012; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Laeng B, 2011, COGN PROCESS, V12, P13, DOI 10.1007/s10339-010-0370-z; McNamara DS, 2009, PSYCHOL LEARN MOTIV, V51, P297, DOI 10.1016/S0079-7421(09)51009-2; Mehta RK, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00889; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Murphy PR, 2011, PSYCHOPHYSIOLOGY, V48, P1531, DOI 10.1111/j.1469-8986.2011.01226.x; Nee DE, 2013, CEREB CORTEX, V23, P264, DOI 10.1093/cercor/bhs007; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Parasuraman R, 2008, HUM FACTORS, V50, P511, DOI 10.1518/001872008X312198; Parasuraman R, 2011, CURR DIR PSYCHOL SCI, V20, P181, DOI 10.1177/0963721411409176; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; Pfurtscheller G, 1998, ELECTROMYOGR MOTOR C, V109, P154, DOI 10.1016/S0924-980X(97)00070-2; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Piquado T, 2010, PSYCHOPHYSIOLOGY, V47, P560, DOI 10.1111/j.1469-8986.2009.00947.x; Reader WR, 2007, HUM-COMPUT INTERACT, V22, P263; Reiter A, 2005, DYSLEXIA, V11, P116, DOI 10.1002/dys.289; Salmeron L, 2015, INFANC APRENDIZ, V38, P435, DOI 10.1080/02103702.2015.1016750; Scheiter K, 2007, EDUC PSYCHOL REV, V19, P285, DOI 10.1007/s10648-007-9046-3; Scheiter K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00268; Schneider W, 2007, DTSCH SCHULTESTS; Sesma HW, 2009, CHILD NEUROPSYCHOL, V15, P232, DOI 10.1080/09297040802220029; Smith ME, 2001, HUM FACTORS, V43, P366, DOI 10.1518/001872001775898287; Spironelli C, 2010, BIOL PSYCHOL, V85, P258, DOI 10.1016/j.biopsycho.2010.07.011; St John M, 2004, INT J HUM-COMPUT INT, V17, P131, DOI 10.1207/s15327590ijhc1702_2; Stipacek A, 2003, NEUROSCI LETT, V353, P193, DOI 10.1016/j.neulet.2003.09.044; Strauss A, 2014, NEUROIMAGE, V97, P387, DOI 10.1016/j.neuroimage.2014.04.005; Van Gerven PWM, 2004, PSYCHOPHYSIOLOGY, V41, P167, DOI 10.1111/j.1469-8986.2003.00148.x; Verhoeven L, 2008, APPL COGNITIVE PSYCH, V22, P293, DOI 10.1002/acp.1417; Zwaan RA, 1998, PSYCHOL BULL, V123, P162, DOI 10.1037/0033-2909.123.2.162	85	49	49	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130608	10.1371/journal.pone.0130608	http://dx.doi.org/10.1371/journal.pone.0130608			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076026	Green Submitted, gold, Green Published			2022-12-27	WOS:000356329900184
J	Sheth, SA; Iavarone, AT; Liebeskind, DS; Won, SJ; Swanson, RA				Sheth, Sunil A.; Iavarone, Anthony T.; Liebeskind, David S.; Won, Seok Joon; Swanson, Raymond A.			Targeted Lipid Profiling Discovers Plasma Biomarkers of Acute Brain Injury	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; INFARCT VOLUME; WHITE-MATTER; SPHINGOLIPIDS; INTERVENTION; ASSOCIATION; GUIDELINES; PROGNOSIS	Prior efforts to identify a blood biomarker of brain injury have relied almost exclusively on proteins; however their low levels at early time points and poor correlation with injury severity have been limiting. Lipids, on the other hand, are the most abundant molecules in the brain and readily cross the blood-brain barrier. We previously showed that certain sphingolipid (SL) species are highly specific to the brain. Here we examined the feasibility of using SLs as biomarkers for acute brain injury. A rat model of traumatic brain injury (TBI) and a mouse model of stroke were used to identify candidate SL species though our mass-spectrometry based lipid profiling approach. Plasma samples collected after TBI in the rat showed large increases in many circulating SLs following injury, and larger lesions produced proportionately larger increases. Plasma samples collected 24 hours after stroke in mice similarly revealed a large increase in many SLs. We constructed an SL score (sum of the two SL species showing the largest relative increases in the mouse stroke model) and then evaluated the diagnostic value of this score on a small sample of patients (n = 14) who presented with acute stroke symptoms. Patients with true stroke had significantly higher SL scores than patients found to have non-stroke causes of their symptoms. The SL score correlated with the volume of ischemic brain tissue. These results demonstrate the feasibility of using lipid biomarkers to diagnose brain injury. Future studies will be needed to further characterize the diagnostic utility of this approach and to transition to an assay method applicable to clinical settings.	[Sheth, Sunil A.; Liebeskind, David S.] Univ Calif Los Angeles, Comprehens Stroke Ctr, Los Angeles, CA 90095 USA; [Sheth, Sunil A.; Liebeskind, David S.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Iavarone, Anthony T.] Univ Calif Berkeley, Chem Mass Spectrometry Facil QB3, Berkeley, CA 94720 USA; [Won, Seok Joon; Swanson, Raymond A.] Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, Neurol & Rehabil Serv, San Francisco, CA 94143 USA; [Won, Seok Joon; Swanson, Raymond A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Berkeley; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Sheth, SA (corresponding author), Univ Calif Los Angeles, Comprehens Stroke Ctr, Los Angeles, CA 90095 USA.	ssheth@post.harvard.edu			NIH [NS041421]; Department of Defense (RAS) [W81XWH-13-2-0091]; Department of Veterans Affairs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081149, R01NS041421] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (RAS); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the NIH (NS041421), Department of Defense (RAS, grant W81XWH-13-2-0091) and the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Adibhatla RM, 2006, AAPS J, V8, pE314; Ahmad O, 2012, CEREBROVASC DIS, V33, P47, DOI 10.1159/000332810; Anand N, 2005, CEREBROVASC DIS; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Dassan P, 2009, CEREBROVASC DIS, V27, P295, DOI 10.1159/000199468; del Zoppo GJ, 2009, STROKE, V40, P2945, DOI 10.1161/STROKEAHA.109.192535; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fassbender K, 1997, J NEUROL SCI, V148, P101, DOI 10.1016/S0022-510X(96)05351-8; Hamilton JA, 2007, J MOL NEUROSCI, V33, P2, DOI 10.1007/s12031-007-0060-1; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Jain M, 2014, AM J PHYSIOL-ENDOC M, V306, pE854, DOI 10.1152/ajpendo.00371.2013; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kihara Y, 2009, P NATL ACAD SCI USA, V106, P21807, DOI 10.1073/pnas.0906891106; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Kuntz M, 2014, J CEREBR BLOOD F MET, V34, P95, DOI 10.1038/jcbfm.2013.169; Laskowitz DT, 2009, STROKE, V40, P77, DOI 10.1161/STROKEAHA.108.516377; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Merrill AH, 2009, J LIPID RES, V50, pS97, DOI 10.1194/jlr.R800073-JLR200; Nickel CH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-7; Nicoli F, 2014, NEURORADIOLOGY, V56, P117, DOI 10.1007/s00234-013-1310-2; Niedermeyer THJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044913; O'Brien J. S, 1965, J LIPID RES; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; ROUSER G, 1965, J AM OIL CHEM SOC, V42, P404, DOI 10.1007/BF02635576; SASTRY PS, 1985, PROG LIPID RES, V24, P69, DOI 10.1016/0163-7827(85)90011-6; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; van den Boorn JG, 2011, NAT BIOTECHNOL, V29, P325, DOI 10.1038/nbt.1830; Whiteley W, 2009, STROKE, V40, pE380, DOI 10.1161/STROKEAHA.108.528752; Won SJ, 2011, ANN NEUROL, V70, P583, DOI 10.1002/ana.22538; Wunderlich MT, 2006, EUR J NEUROL, V13, P1118, DOI 10.1111/j.1468-1331.2006.01435.x; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	38	39	40	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129735	10.1371/journal.pone.0129735	http://dx.doi.org/10.1371/journal.pone.0129735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076478	gold, Green Published			2022-12-27	WOS:000356329900098
J	Wang, GN; Gao, H; Chen, L; Mensah, DNA; Fu, Y				Wang, Guan-Nan; Gao, Hui; Chen, Lian; Mensah, Dennis N. A.; Fu, Yan			Predicting Positive and Negative Relationships in Large Social Networks	PLOS ONE			English	Article							STRUCTURAL BALANCE; LINK-PREDICTION	In a social network, users hold and express positive and negative attitudes (e.g. support/opposition) towards other users. Those attitudes exhibit some kind of binary relationships among the users, which play an important role in social network analysis. However, some of those binary relationships are likely to be latent as the scale of social network increases. The essence of predicting latent binary relationships have recently began to draw researchers' attention. In this paper, we propose a machine learning algorithm for predicting positive and negative relationships in social networks inspired by structural balance theory and social status theory. More specifically, we show that when two users in the network have fewer common neighbors, the prediction accuracy of the relationship between them deteriorates. Accordingly, in the training phase, we propose a segment-based training framework to divide the training data into two subsets according to the number of common neighbors between users, and build a prediction model for each subset based on support vector machine (SVM). Moreover, to deal with large-scale social network data, we employ a sampling strategy that selects small amount of training data while maintaining high accuracy of prediction. We compare our algorithm with traditional algorithms and adaptive boosting of them. Experimental results of typical data sets show that our algorithm can deal with large social networks and consistently outperforms other methods.	[Wang, Guan-Nan; Gao, Hui; Chen, Lian; Mensah, Dennis N. A.; Fu, Yan] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Web Sci Ctr, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China	Gao, H (corresponding author), Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Web Sci Ctr, Chengdu 610054, Peoples R China.	ahuigao@163.com			National Natural Science Foundation of China [61003231, 61103109, 60903073]; University-enterprise Cooperation Foundation [YBCB2011057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University-enterprise Cooperation Foundation	This work was partially supported by the National Natural Science Foundation of China under Grant Nos. 61003231, 61103109, and 60903073. (http://www.nsfc.gov.cn/publish/portal1/) University-enterprise Cooperation Foundation under Grant No. YBCB2011057. GNW, HG, LC, YF, DW received those fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Hur A, 2005, BIOINFORMATICS, V21, pI38, DOI 10.1093/bioinformatics/bti1016; Bengio Y, 2004, J MACH LEARN RES, V5, P1089; Bleakley K, 2007, BIOINFORMATICS, V23, pI57, DOI 10.1093/bioinformatics/btm204; Bo Pang, 2008, Foundations and Trends in Information Retrieval, V2, P1, DOI 10.1561/1500000001; CARTWRIGHT D, 1956, PSYCHOL REV, V63, P277, DOI 10.1037/h0046049; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Coleman J., 1994, FDN SOCIAL THEORY; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; DAVIS JA, 1963, AM J SOCIOL, V68, P444, DOI 10.1086/223401; Davis JA, 1972, SOCIOLOGICAL THEORIE, V2, P218; Easley D, 2010, NETWORKS CROWDS MARK; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Grabowicz PA, 2013, DYN COMPLEX NETWORKS, V2, P3, DOI [10.1007/978-1-4614-6729-8_1, DOI 10.1007/978-1-4614-6729-8_1]; GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311; Guha R., 2004, P 13 INT C WORLD WID, P403, DOI [10.1145/988672.988727, DOI 10.1145/988672.988727]; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hasan M., 2006, SDM WORKSH LINK AN C; Hoff PD, 2002, J AM STAT ASSOC, V97, P1090, DOI 10.1198/016214502388618906; Hsu W C, 2003, PRACTICAL GUIDE SUPP; Leskovec J., 2010, P INT C WORLD WID WE, P641, DOI DOI 10.1109/ICDE.2018.00077; Leskovec J, 2006, P 12 ACM SIGKDD INT, P631; Leskovec J, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1361; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Li Y., 2013, P 6 ACM INT C WEB SE, P657, DOI DOI 10.1145/2433396.2433478; Liao H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112022; Liao H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097146; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Mo Yu, 2013, Social Computing, Behavioral-Cultural Modeling and Prediction. 6th International Conference, SBP 2013. Proceedings, P231, DOI 10.1007/978-3-642-37210-0_25; O'Madadhain J., 2005, ACM SIGKDD EXPLORATI, V7, P23, DOI DOI 10.1145/1117454.1117458; Popescul A., 2003, IJCAI WORKSH LEARN S, V2003; Richardson M, 2003, LECT NOTES COMPUT SC, V2870, P351; Scholkopf B., 1999, ADV KERNEL METHODS S; Scott J. P., 2011, BOOK SOCIAL NETWORK; Uzzi B, 1996, AM SOCIOL REV, V61, P674, DOI 10.2307/2096399; Vapnik V., 1998, STAT LEARNING THEORY; Ye Jihang, 2013, P 22 INT C WORLD WID, P1477; Zhang QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055437	39	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129530	10.1371/journal.pone.0129530	http://dx.doi.org/10.1371/journal.pone.0129530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26075404	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900081
J	Dong, DX; Chen, BL; Chen, P				Dong, Dexian; Chen, Baoling; Chen, P.			Bacterial Acclimation Inside an Aqueous Battery	PLOS ONE			English	Article							DIRECT ELECTRIC-CURRENT; LIFE; INACTIVATION; STRESS; CELLS; ACID	Specific environmental stresses may lead to induced genomic instability in bacteria, generating beneficial mutants and potentially accelerating the breeding of industrial microorganisms. The environmental stresses inside the aqueous battery may be derived from such conditions as ion shuttle, pH gradient, free radical reaction and electric field. In most industrial and medical applications, electric fields and direct currents are used to kill bacteria and yeast. However, the present study focused on increasing bacterial survival inside an operating battery. Using a bacterial acclimation strategy, both Escherichia coli and Bacillus subtilis were acclimated for 10 battery operation cycles and survived in the battery for over 3 days. The acclimated bacteria changed in cell shape, growth rate and colony color. Further analysis indicated that electrolyte concentration could be one of the major factors determining bacterial survival inside an aqueous battery. The acclimation process significantly improved the viability of both bacteria E. coliand B. subtilis. The viability of acclimated strains was not affected under battery cycle conditions of 0.18-0.80 mA cm(-2) and 1.4-2.1 V. Bacterial addition within 1.0x10(10) cells mL(-1) did not significantly affect battery performance. Because the environmental stress inside the aqueous battery is specific, the use of this battery acclimation strategy may be of great potential for the breeding of industrial microorganisms.	[Dong, Dexian; Chen, Baoling; Chen, P.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Chen, P (corresponding author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.	p4chen@uwaterloo.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Natural Sciences and Engineering Research Council of Canada (PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birbir Y, 2008, J ELECTROSTAT, V66, P355, DOI 10.1016/j.elstat.2008.03.002; Boutte CC, 2013, TRENDS MICROBIOL, V21, P174, DOI 10.1016/j.tim.2013.01.002; Cauet E, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3421542; Drees KP, 2003, WATER RES, V37, P2291, DOI 10.1016/S0043-1354(03)00009-5; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Gigova A, 2006, J POWER SOURCES, V158, P1054, DOI 10.1016/j.jpowsour.2005.11.006; Grahl T, 1996, APPL MICROBIOL BIOT, V45, P148, DOI 10.1007/s002530050663; Harrison JP, 2013, TRENDS MICROBIOL, V21, P204, DOI 10.1016/j.tim.2013.01.006; Liu WK, 1997, J ANTIMICROB CHEMOTH, V39, P687, DOI 10.1093/jac/39.6.687; Luo QS, 2005, APPL ENVIRON MICROB, V71, P423, DOI 10.1128/AEM.71.1.423-427.2005; MIZUNO A, 1988, IEEE T IND APPL, V24, P387, DOI 10.1109/28.2886; Moreno-Garrido I, 2013, METHODS MOL BIOL, V1051, P327, DOI 10.1007/978-1-62703-550-7_22; Nakanishi K, 1998, J FERMENT BIOENG, V85, P250, DOI 10.1016/S0922-338X(97)86778-5; Oren A, 2011, ENVIRON MICROBIOL, V13, P1908, DOI 10.1111/j.1462-2920.2010.02365.x; Petit L, 2008, J PHYS CHEM B, V112, P10603, DOI 10.1021/jp8017106; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Sandvik EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055118; Stancik LM, 2002, J BACTERIOL, V184, P4246, DOI 10.1128/JB.184.15.4246-4258.2002; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; Wei V, 2011, WATER RES, V45, P5058, DOI 10.1016/j.watres.2011.07.011; Wilks JC, 2009, APPL ENVIRON MICROB, V75, P981, DOI 10.1128/AEM.01652-08; Yan J, 2012, J POWER SOURCES, V216, P222, DOI 10.1016/j.jpowsour.2012.05.063	22	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129130	10.1371/journal.pone.0129130	http://dx.doi.org/10.1371/journal.pone.0129130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070088	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000051
J	Gonzalez-Vargas, J; Dosen, S; Amsuess, S; Yu, WW; Farina, D				Gonzalez-Vargas, Jose; Dosen, Strahinja; Amsuess, Sebastian; Yu, Wenwei; Farina, Dario			Human-Machine Interface for the Control of Multi-Function Systems Based on Electrocutaneous Menu: Application to Multi-Grasp Prosthetic Hands	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; OF-THE-ART; PATTERN-RECOGNITION; MYOELECTRIC CONTROL; STIMULATION; REHABILITATION; DISCRIMINATE; VIABILITY; DISPLAY; DESIGN	Modern assistive devices are very sophisticated systems with multiple degrees of freedom. However, an effective and user-friendly control of these systems is still an open problem since conventional human-machine interfaces (HMI) cannot easily accommodate the system's complexity. In HMIs, the user is responsible for generating unique patterns of command signals directly triggering the device functions. This approach can be difficult to implement when there are many functions (necessitating many command patterns) and/or the user has a considerable impairment (limited number of available signal sources). In this study, we propose a novel concept for a general-purpose HMI where the controller and the user communicate bidirectionally to select the desired function. The system first presents possible choices to the user via electro-tactile stimulation; the user then acknowledges the desired choice by generating a single command signal. Therefore, the proposed approach simplifies the user communication interface (one signal to generate), decoding (one signal to recognize), and allows selecting from a number of options. To demonstrate the new concept the method was used in one particular application, namely, to implement the control of all the relevant functions in a state of the art commercial prosthetic hand without using any myoelectric channels. We performed experiments in healthy subjects and with one amputee to test the feasibility of the novel approach. The results showed that the performance of the novel HMI concept was comparable or, for some outcome measures, better than the classic myoelectric interfaces. The presented approach has a general applicability and the obtained results point out that it could be used to operate various assistive systems (e.g., prosthesis vs. wheelchair), or it could be integrated into other control schemes (e.g., myoelectric control, brain-machine interfaces) in order to improve the usability of existing low-bandwidth HMIs.	[Gonzalez-Vargas, Jose; Yu, Wenwei] Chiba Univ, Ctr Frontier Med Engn, Chiba, Japan; [Dosen, Strahinja; Amsuess, Sebastian; Farina, Dario] Univ Med Gottingen, Dept Neurorehabil, Gottingen, Germany	Chiba University; University of Gottingen	Farina, D (corresponding author), Univ Med Gottingen, Dept Neurorehabil, Gottingen, Germany.	dario.farina@bccn.uni-goettingen.de	Yu, Wenwei/AAI-1296-2019; Farina, Dario/AAB-2648-2019; Gonzalez, Jose/M-2629-2014	Gonzalez, Jose/0000-0002-3448-7393; Dosen, Strahinja/0000-0003-3035-147X	Japanese Society for Promotion of Science (JSPS) Grant for Researcher Dispatch Program-International Network of Advanced Medical Engineering using Bio-robotics Technology; European Commission under MYOSENS [FP7-PEOPLE-2011-IAPP-286208]; German Ministry for Education and Research (BMBF) via Bernstein Focus Neurotechnology (BFNT) Gottingen [01GQ0810]	Japanese Society for Promotion of Science (JSPS) Grant for Researcher Dispatch Program-International Network of Advanced Medical Engineering using Bio-robotics Technology; European Commission under MYOSENS; German Ministry for Education and Research (BMBF) via Bernstein Focus Neurotechnology (BFNT) Gottingen	This work was supported by the Japanese Society for Promotion of Science (JSPS) Grant for Researcher Dispatch Program-International Network of Advanced Medical Engineering using Bio-robotics Technology (2009-2012), European Commission under the MYOSENS (FP7-PEOPLE-2011-IAPP-286208) project and by the German Ministry for Education and Research (BMBF) via the Bernstein Focus Neurotechnology (BFNT) Gottingen under Grant 01GQ0810.	ANANI AB, 1977, MED BIOL ENG COMPUT, V15, P363, DOI 10.1007/BF02457988; Antfolk C, 2010, J MED BIOL ENG, V30, P355, DOI 10.5405/jmbe.766; Becedas J, 2012, IEEE T SYST MAN CY C, V42, P825, DOI 10.1109/TSMCC.2012.2203301; Belter JT, 2013, J REHABIL RES DEV, V50, P599, DOI 10.1682/JRRD.2011.10.0188; Bradberry TJ, 2010, J NEUROSCI, V30, P3432, DOI 10.1523/JNEUROSCI.6107-09.2010; Brouwer AM, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00019; Buma DG, 2007, IEEE T NEUR SYS REH, V15, P435, DOI 10.1109/TNSRE.2007.903942; Carrozza MC, 2005, INT C REHAB ROBOT, P109; Cipriani C, 2008, IEEE T ROBOT, V24, P170, DOI 10.1109/TRO.2007.910708; Cipriani C, 2012, IEEE T BIO-MED ENG, V59, P400, DOI 10.1109/TBME.2011.2173342; CUTKOSKY MR, 1989, IEEE T ROBOTIC AUTOM, V5, P269, DOI 10.1109/70.34763; D'Alonzo M, 2013, IEEE T HAPTICS, P1; D'Alonzo M, 2014, IEEE T NEUR SYS REH, V22, P290, DOI 10.1109/TNSRE.2013.2266482; Dermitzakis K, 2011, IEEE ENG MED BIO, P4530, DOI 10.1109/IEMBS.2011.6091122; Dosen S, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-138; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Flor H, 2001, LANCET, V357, P1763, DOI 10.1016/S0140-6736(00)04890-X; Ganin IP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077755; Geng B, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-97; Geng YJ, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-74; Gonzalez J, 2011, J MED IMAG HEALTH IN, V1, P325, DOI 10.1166/jmihi.2011.1051; Hahne JM, 2012, IEEE T BIO-MED ENG, V59, P1436, DOI 10.1109/TBME.2012.2188799; Hao YY, 2013, IEEE ROBOT AUTOM MAG, V20, P40, DOI 10.1109/MRA.2012.2229949; Hartmann C, 2014, IEEE T NEUR IN PRESS; Heo P, 2012, INT J PRECIS ENG MAN, V13, P807, DOI 10.1007/s12541-012-0107-2; Iturrate I, 2009, IEEE T ROBOT, V25, P614, DOI 10.1109/TRO.2009.2020347; Jiang Ning, 2010, Critical Reviews in Biomedical Engineering, V38, P381, DOI 10.1615/CritRevBiomedEng.v38.i4.30; Jiang N, 2009, IEEE T BIO-MED ENG, V56, P1070, DOI 10.1109/TBME.2008.2007967; Johansen D., 2012, INT J ENG MANUF, V2, P14; KACZMAREK KA, 1991, IEEE T BIO-MED ENG, V38, P1, DOI 10.1109/10.68204; KACZMAREK KA, 1992, IEEE T BIO-MED ENG, V39, P701, DOI 10.1109/10.142645; Kamavuako E. N., 2013, IEEE T NEUR SYS REH, V21, P1, DOI DOI 10.1109/TNSRE.2012.2211036; Kingdom FAA, 2009, PSYCHOPHYSICS PRACTI; Kubler A, 2005, PROG BRAIN RES, V150, P513, DOI 10.1016/S0079-6123(05)50035-9; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Lo HS, 2012, MED ENG PHYS, V34, P261, DOI 10.1016/j.medengphy.2011.10.004; Lundborg G, 1999, J HAND SURG-AM, V24A, P219, DOI 10.1053/jhsu.1999.0219; Mainardi E, 2007, P ANN INT IEEE EMBS, P3035, DOI 10.1109/IEMBS.2007.4352968; Markovic M, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046001; Onose G, 2012, SPINAL CORD, V50, P599, DOI 10.1038/sc.2012.14; Ortiz-Catalan M, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-33; Pedrocchi A, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-66; Ramos-Murguialday A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047048; Raspopovic S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006820; Resnik L, 2014, PROSTHET ORTHOT INT, V38, P492, DOI 10.1177/0309364613506913; Scheme E, 2011, J REHABIL RES DEV, V48, P643, DOI 10.1682/JRRD.2010.09.0177; Schill O, 2011, BIOMED TECH, V56, P35, DOI 10.1515/BMT.2010.056; Simon AM, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2155063; Smith LH, 2013, IEEE ENG MED BIO, P4223, DOI 10.1109/EMBC.2013.6610477; SZETO AYJ, 1985, ANN BIOMED ENG, V13, P373, DOI 10.1007/BF02407767; SZETO AYJ, 1982, IEEE T BIO-MED ENG, V29, P300, DOI 10.1109/TBME.1982.324948; Witteveen HJB, 2012, IEEE T BIO-MED ENG, V59, P2219, DOI 10.1109/TBME.2012.2200678; Yatsenko D, 2007, P ANN INT IEEE EMBS, P6134	53	12	12	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0127528	10.1371/journal.pone.0127528	http://dx.doi.org/10.1371/journal.pone.0127528			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069961	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000009
J	Muka, T; Trajanoska, K; Kiefte-de Jong, JC; Oei, L; Uitterlinden, AG; Hofman, A; Dehghan, A; Zillikens, MC; Franco, OH; Rivadeneira, F				Muka, Taulant; Trajanoska, Katerina; Kiefte-de Jong, Jessica C.; Oei, Ling; Uitterlinden, Andre G.; Hofman, Albert; Dehghan, Abbas; Zillikens, M. Carola; Franco, Oscar H.; Rivadeneira, Fernando			The Association between Metabolic Syndrome, Bone Mineral Density, Hip Bone Geometry and Fracture Risk: The Rotterdam Study	PLOS ONE			English	Article							BODY-MASS INDEX; ELDERLY-MEN; OSTEOPOROTIC FRACTURE; FEMORAL-NECK; WOMEN; POPULATION; POSTMENOPAUSAL; COMPONENTS; MORTALITY; ADULTS	The association between metabolic syndrome (MS) and bone health remains unclear. We aimed to study the association between MS and hip bone geometry (HBG), femoral neck bone mineral density (FN-BMD), and the risk of osteoporosis and incident fractures. Data of 2040 women and 1510 men participants in the third visit (1997-1999) of the Rotterdam Study (RSI-3), a prospective population based cohort, were available (mean follow-up 6.7 years). MS was defined according to the recent harmonized definition. HBG parameters were measured at the third round visit whereas FN-BMD was assessed at the third round and 5 years later. Incident fractures were identified from medical registry data. After correcting for age, body mass index (BMI), lifestyle factors and medication use, individuals with MS had lower bone width (beta = -0.054, P = 0.003), lower cortical buckling ratio (beta = -0.81, P = 0.003) and lower odds of having osteoporosis (odds ratio = 0.56, P = 0.007) in women but not in men. Similarly, MS was associated with higher FN-BMD only in women (beta = 0.028, P = 0.001). In the analyses of MS components, the glucose component (unrelated to diabetes status) was positively associated with FN-BMD in both genders (beta = 0.016, P = 0.01 for women and beta = 0.022, P = 0.004 for men). In men, waist circumference was inversely associated with FN-BMD (beta = -0.03, P = 0.004). No association was observed with fracture risk in either sex. In conclusion, women with MS had higher FN-BMD independent of BMI. The glucose component of MS was associated with high FN-BMD in both genders, highlighting the need to preserve glycemic control to prevent skeletal complications.	[Muka, Taulant; Trajanoska, Katerina; Kiefte-de Jong, Jessica C.; Oei, Ling; Uitterlinden, Andre G.; Hofman, Albert; Dehghan, Abbas; Franco, Oscar H.; Rivadeneira, Fernando] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Trajanoska, Katerina; Oei, Ling; Uitterlinden, Andre G.; Zillikens, M. Carola; Rivadeneira, Fernando] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Oei, Ling; Uitterlinden, Andre G.; Hofman, Albert; Dehghan, Abbas; Zillikens, M. Carola; Franco, Oscar H.; Rivadeneira, Fernando] Netherlands Consortium Hlth Ageing, Netherlands Genom Inititiat, The Hague, Netherlands; [Oei, Ling] IJsselland Hosp, Dept Internal Med, Capelle Aan Den Ijssel, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Rivadeneira, F (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.	f.rivadeneira@erasmusmc.nl	Franco, Óscar H/ABE-2305-2020; Dehghan, Abbas/ABE-7377-2020; Oei, Ling/E-8163-2013; Rivadeneira, Fernando/O-5385-2015; Kiefte-de Jong, Jessica/GLV-3216-2022; Dehghan, Abbas/B-9896-2008	Franco, Óscar H/0000-0002-4606-4929; Oei, Ling/0000-0003-3523-458X; Rivadeneira, Fernando/0000-0001-9435-9441; Kiefte-de Jong, Jessica/0000-0002-8136-0918; Trajanoska, Katerina/0000-0002-3792-4296; Dehghan, Abbas/0000-0001-6403-016X	Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; AXA; Netherlands Organization for Health Research (NWO) [016.136.367, 916.12.154]; EUR Fellowship	Nestle Nutrition (Nestec Ltd.)(Nestle SA); Metagenics Inc.; AXA; Netherlands Organization for Health Research (NWO); EUR Fellowship	TM, JCK and OHF work in ErasmusAGE, a center for aging research across the life course funded by Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; and AXA. Additional support from the Netherlands Organization for Health Research (NWO) was provided to FR (ZonMw VIDI 016.136.367) and AD (ZonMW VENI 916.12.154) who also received an EUR Fellowship. These funding sources had no role in design and conduct of this manuscript; collection, management, analysis, and interpretation of the data; and preparation, review or approval of this manuscript.	Adami S, 2004, CALCIFIED TISSUE INT, V74, P136, DOI 10.1007/s00223-003-0050-4; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; BarrettConnor E, 1996, DIABETES CARE, V19, P1388, DOI 10.2337/diacare.19.12.1388; Beck TJ, 2000, J BONE MINER RES, V15, P2297, DOI 10.1359/jbmr.2000.15.12.2297; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Burger H, 1998, AM J EPIDEMIOL, V147, P871, DOI 10.1093/oxfordjournals.aje.a009541; Campos RMS, 2012, ENDOCRINE, V42, P146, DOI 10.1007/s12020-012-9613-3; Cappuccio FP, 1999, LANCET, V354, P971, DOI 10.1016/S0140-6736(99)01437-3; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; EDELSTEIN SL, 1993, AM J EPIDEMIOL, V138, P160, DOI 10.1093/oxfordjournals.aje.a116842; Gnudi S, 2009, J BONE MINER METAB, V27, P479, DOI 10.1007/s00774-009-0056-8; Hernandez JL, 2011, MATURITAS, V68, P217, DOI 10.1016/j.maturitas.2010.12.010; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Holmberg AH, 2008, J CLIN ENDOCR METAB, V93, P815, DOI 10.1210/jc.2007-0843; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Jankowska EA, 2001, ANDROLOGIA, V33, P384, DOI 10.1046/j.1439-0272.2001.00469.x; Kim HY, 2010, CALCIFIED TISSUE INT, V86, P350, DOI 10.1007/s00223-010-9347-2; Kim H, 2013, J BONE MINER METAB, V31, P571, DOI 10.1007/s00774-013-0446-9; Kinjo M, 2007, J CLIN ENDOCR METAB, V92, P4161, DOI 10.1210/jc.2007-0757; Klipstein-Grobusch K, 1998, EUR J CLIN NUTR, V52, P588, DOI 10.1038/sj.ejcn.1600611; Krall EA, 1997, J GERONTOL A-BIOL, V52, pM61, DOI 10.1093/gerona/52A.2.M61; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Ma LL, 2012, EUR J EPIDEMIOL, V27, P319, DOI 10.1007/s10654-012-9674-x; Makovey J, 2005, OSTEOPOROSIS INT, V16, P1495, DOI 10.1007/s00198-005-1841-4; Margolis KL, 2014, J GEN INTERN MED; Nelson LR, 2001, J AM ACAD DERMATOL, V45, pS116, DOI 10.1067/mjd.2001.117432; Oei L, 2013, DIABETES CARE, V36, P1619, DOI 10.2337/dc12-1188; OHTA H, 1993, BONE, V14, P111, DOI 10.1016/8756-3282(93)90236-4; Rivadeneira F, 2007, J BONE MINER RES, V22, P1781, DOI 10.1359/JBMR.070712; Schott AM, 1998, OSTEOPOROSIS INT, V8, P247, DOI 10.1007/s001980050061; Schwartz AV, 2011, JAMA-J AM MED ASSOC, V305, P2184, DOI 10.1001/jama.2011.715; Smith BJ, 2006, BONE, V38, P378, DOI 10.1016/j.bone.2005.09.008; Spaine LA, 1996, INJURY, V27, P687, DOI 10.1016/S0020-1383(96)00136-2; Sun K, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-13; Tsuda K, 2001, AM J HYPERTENS, V14, P704, DOI 10.1016/S0895-7061(01)01303-6; Vestergaard P, 2009, CALCIFIED TISSUE INT, V84, P103, DOI 10.1007/s00223-008-9198-2; Xu SH, 2006, BIOPHYS J, V91, P4221, DOI [10.1529/biophysj.105.075804, 10.1529/biophysj.106.075804]; Xue P, 2012, ENDOCRINE, V42, P546, DOI 10.1007/s12020-012-9684-1; Yamaguchi T, 2002, ENDOCR J, V49, P211, DOI 10.1507/endocrj.49.211; Yamaguchi T, 2009, BONE, V45, P174, DOI 10.1016/j.bone.2009.05.003; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	42	44	46	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129116	10.1371/journal.pone.0129116	http://dx.doi.org/10.1371/journal.pone.0129116			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066649	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000047
J	Ronning, SB; Carlson, CR; Stang, E; Kolset, SO; Hollung, K; Pedersen, ME				Ronning, Sissel B.; Carlson, Cathrine R.; Stang, Espen; Kolset, Svein O.; Hollung, Kristin; Pedersen, Mona E.			Syndecan-4 Regulates Muscle Differentiation and Is Internalized from the Plasma Membrane during Myogenesis	PLOS ONE			English	Article							FIBROBLAST GROWTH-FACTOR; FOCAL ADHESION KINASE; CYTOPLASMIC DOMAIN; SATELLITE CELLS; MYOBLAST FUSION; ALPHA-ACTININ; PROTEOGLYCANS; LOCALIZATION; EXPRESSION; ACTIVATION	The cell surface proteoglycan syndecan-4 has been reported to be crucial for muscle differentiation, but the molecular mechanisms still remain to be fully understood. During in vitro differentiation of bovine muscle cells immunocytochemical analyses showed strong labelling of syndecan-4 intracellularly, in close proximity with Golgi structures, in membranes of intracellular vesicles and finally, in the nuclear area including the nuclear envelope. Chase experiments showed that syndecan-4 was internalized from the plasma membrane during this process. Furthermore, when syndecan-4 was knocked down by siRNA more myotubes were formed, and the expression of myogenic transcription factors, beta 1-integrin and actin was influenced. However, when bovine muscle cells were treated with a cell-penetrating peptide containing the cytoplasmic region of syndecan-4, myoblast fusion and thus myo-tube formation was blocked, both in normal cells and in syndecan-4 knock down cells. Altogether this suggests that the cytoplasmic domain of syndecan-4 is important in regulation of myogenesis. The internalization of syndecan-4 from the plasma membrane during muscle differentiation and the nuclear localization of syndecan-4 in differentiated muscle cells may be part of this regulation, and is a novel aspect of syndecan biology which merits further studies.	[Ronning, Sissel B.; Hollung, Kristin; Pedersen, Mona E.] Nofima AS, NO-1431 As, Norway; [Carlson, Cathrine R.] Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway; [Carlson, Cathrine R.] Univ Oslo, Oslo, Norway; [Carlson, Cathrine R.] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Carlson, Cathrine R.] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Stang, Espen] Oslo Univ Hosp, Rikshosp, Dept Pathol, N-0424 Oslo, Norway; [Kolset, Svein O.] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway	Nofima; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo	Ronning, SB (corresponding author), Nofima AS, Pb 210, NO-1431 As, Norway.	sissel.ronning@nofima.no		Ronning, Sissel Beate/0000-0002-2255-0172	Fund for Research Levy on Agricultural Products in Norway; Norwegian Research Council [203697/O99]; Throne Holst Foundation	Fund for Research Levy on Agricultural Products in Norway; Norwegian Research Council(Research Council of NorwayEuropean Commission); Throne Holst Foundation	This work was supported by grants from the Fund for Research Levy on Agricultural Products in Norway, the Norwegian Research Council (203697/O99) and the Throne Holst Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Brandan E, 2013, MATRIX BIOL, V32, P289, DOI 10.1016/j.matbio.2013.03.007; BRUNETTI A, 1990, J BIOL CHEM, V265, P5960; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Carvallo L, 2010, J BIOL CHEM, V285, P29546, DOI 10.1074/jbc.M110.155812; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Choi Y, 2008, EUR J CELL BIOL, V87, P807, DOI 10.1016/j.ejcb.2008.04.005; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Couchman JR, 2012, J HISTOCHEM CYTOCHEM, V60, P885, DOI 10.1369/0022155412464638; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Finsen AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028302; Forterre A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084153; Fuentealba L, 1999, J BIOL CHEM, V274, P37876, DOI 10.1074/jbc.274.53.37876; Gopal S, 2010, J BIOL CHEM, V285, P14247, DOI 10.1074/jbc.M109.056945; GRIFFITHS G, 1984, J ULTRA MOL STRUCT R, V89, P65, DOI 10.1016/S0022-5320(84)80024-6; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; Kwon MJ, 2012, FEBS LETT, V586, P2207, DOI 10.1016/j.febslet.2012.05.037; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Lendorf ME, 2011, J HISTOCHEM CYTOCHEM, V59, P615, DOI 10.1369/0022155411405057; Letoha T, 2010, BBA-BIOMEMBRANES, V1798, P2258, DOI 10.1016/j.bbamem.2010.01.022; Lim ST, 2003, J BIOL CHEM, V278, P13795, DOI 10.1074/jbc.M208300200; Madaro L, 2011, MOL BIOL CELL, V22, P1409, DOI 10.1091/mbc.E10-10-0821; Multhaupt HAB, 2009, J PHYSIOL PHARMACOL, V60, P31; Pisconti Addolorata, 2012, Muscles Ligaments Tendons J, V2, P1; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; Quach NL, 2009, MOL BIOL CELL, V20, P3422, DOI 10.1091/mbc.E09-02-0175; Richardson TP, 2001, J CELL SCI, V114, P1613; Ronning SB, 2013, DIFFERENTIATION, V86, P13, DOI 10.1016/j.diff.2013.06.006; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Shin J, 2012, POULTRY SCI, V91, P201, DOI 10.3382/ps.2011-01695; Shin J, 2013, MOL CELL BIOCHEM, V375, P115, DOI 10.1007/s11010-012-1534-1; Shin JH, 2012, MOL CELL BIOCHEM, V363, P437, DOI 10.1007/s11010-011-1198-2; Shin NY, 2014, J CELL BIOL, V207, P73, DOI 10.1083/jcb.201401137; Song Y, 2012, CELL BIOL INT, V36, P433, DOI 10.1042/CBI20110467; Stewart MD, 2014, MATRIX BIOL, V35, P56, DOI 10.1016/j.matbio.2013.10.009; Xian XJ, 2010, CELL TISSUE RES, V339, P31, DOI 10.1007/s00441-009-0829-3; Yoneda A, 2003, MATRIX BIOL, V22, P25, DOI 10.1016/S0945-053X(03)00010-6; Zhang XF, 2008, MATRIX BIOL, V27, P619, DOI 10.1016/j.matbio.2008.06.002; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zong F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014816; Zong F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007346	45	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129288	10.1371/journal.pone.0129288	http://dx.doi.org/10.1371/journal.pone.0129288			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068620	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000356327000060
J	Sexton, TJ; Van Gelder, RN				Sexton, Timothy J.; Van Gelder, Russell N.			G-Protein Coupled Receptor Kinase 2 Minimally Regulates Melanopsin Activity in Intrinsically Photosensitive Retinal Ganglion Cells	PLOS ONE			English	Article							LIGHT; PHOSPHORYLATION; DESENSITIZATION; ADAPTATION; DIVERSITY; RESPONSES; MICE	Phosphorylation is a primary modulator of mammalian G-protein coupled receptor (GPCR) activity. The GPCR melanopsin is the photopigment of intrinsically photosensitive retinal ganglion cells (ipRGCs) in the mammalian retina. Recent evidence from in vitro experiments suggests that the G-protein coupled receptor kinase 2 (GRK2) phosphorylates melanopsin and reduces its activity following light exposure. Using an ipRGC-specific GRK2 loss-of-function mouse, we show that GRK2 loss alters melanopsin response dynamics and termination time in postnatal day 8 (P8) ipRGCs but not in older animals. However, the alterations are small in comparison to the changes reported for other opsins with loss of their cognate GRK. These results suggest GRK2 contributes to melanopsin deactivation, but that other mechanisms account for most of modulation of melanopsin activity in ipRGCs.	[Sexton, Timothy J.; Van Gelder, Russell N.] Univ Washington, Sch Med, Dept Ophthalmol, Seattle, WA 98195 USA; [Sexton, Timothy J.] Univ Washington, Sch Med, Program Neurobiol & Behav, Seattle, WA 98195 USA; [Van Gelder, Russell N.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Van Gelder, Russell N.] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Van Gelder, RN (corresponding author), Univ Washington, Sch Med, Dept Ophthalmol, Seattle, WA 98195 USA.	russvg@uw.edu	Van Gelder, Russell/ABB-4225-2021	Van Gelder, Russell/0000-0001-5368-3659	National Institute of Health grants [EY009339, T32EY07031, P30EY001730]; Research to Prevent Blindness; Burroughs-Welcome Translational Scientist Award; Richard M. and Maude Ferry Charitable Foundation; NATIONAL EYE INSTITUTE [T32EY007031, P30EY001730, R01EY009339] Funding Source: NIH RePORTER	National Institute of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Burroughs-Welcome Translational Scientist Award; Richard M. and Maude Ferry Charitable Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institute of Health grants [http://www.nih.gov/] EY009339 (RVG, TJS), T32EY07031 (TJS), P30EY001730 (RVG) in addition to support from an unrestricted grant from Research to Prevent Blindness [http://www.rpbusa.org/rpb/], the Burroughs-Welcome Translational Scientist Award [http://www.bwfund.org/grant-programs/translationalresearch/clinical-scientist-awards-translationalresearch](RVG), and the Richard M. and Maude Ferry Charitable Foundation.	Aiyar N, 2000, EUR J PHARMACOL, V403, P1, DOI 10.1016/S0014-2999(00)00419-2; Blasic JR, 2014, BIOCHEMISTRY-US, V53, P2644, DOI 10.1021/bi401724r; Blasic JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045387; Blasic JR, 2012, CELLULAR MOL LIFE SC, V69, P10; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Chew KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098356; Do MTH, 2013, P NATL ACAD SCI USA, V110, P7470, DOI 10.1073/pnas.1304039110; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Fahrenkrug J, 2014, J BIOL CHEM, V289, P35482, DOI 10.1074/jbc.M114.586529; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Iacovelli L, 1999, FASEB J, V13, P1; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Luo DG, 2008, SENSES COMPREHENSIVE, V1, P32; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Sexton T, 2012, J BIOL CHEM, V287, P1649, DOI 10.1074/jbc.R111.301226; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Vinge LE, 2007, MOL PHARMACOL, V72, P582, DOI 10.1124/mol.107.035766; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029	23	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128690	10.1371/journal.pone.0128690	http://dx.doi.org/10.1371/journal.pone.0128690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069965	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000023
J	Tsai, FC; Ho, HT; Chang, JP; Tsai, FC; Chu, JJ; Lin, PJ				Tsai, Feng-Chun; Ho, Heng-Tsan; Chang, Jen-Ping; Tsai, Feng-Chang; Chu, Jaw-Ji; Lin, Pyng-Jing			The Prognostic Scoring System Establishment and Validation for Chronic Atrial Fibrillation Patients Receiving Modified Cox-Maze IV and Concomitant Cardiac Surgery	PLOS ONE			English	Article							SURGICAL-TREATMENT; LATE RECURRENCE; SINUS RHYTHM; SIZE; PREDICTOR; SUCCESS; REDUCTION; ABLATION; IMPACT	Objectives Traditional Cox maze III is the gold standard for treatment of atrial fibrillation (AF). Because of its invasiveness, it has been replaced by a simplified procedure involving radiofrequency ablation of modified Cox maze IV. Although the modified Cox maze IV has the advantages of simplicity and less morbidity, a lower rate of sinus rhythm conversion has been reported. We try to establish a scoring system to predict the outcome of this procedure. Methods and Results The derivation group consisted of 287 patients with structural heart disease and chronic AF who underwent cardiac surgery and modified Cox-maze IV procedure between August 2005 and March 2013. Demographics, clinical and laboratory variables were retrospectively collected as sinus conversional predictors. Overall sinus conversion rate was 75.8%. The parameters of the Soft Markers Scoring system included AF duration, preoperative left atrial (LA) size, rheumatic pathology and postoperative LA remodeling. We compared 80 patients from another hospital between January 2004 and December 2011 as a validation group to evaluate the power of the scoring system. Soft Markers Score indicated a good discriminative power by using the areas under the receiver operating characteristic curve (AUROC: 0.759 +/- 0.032). The score was further divided into three groups: low (0-2), intermediate (3-5), and high (6-10), with predicted sinus conversion rates of 92.4%, 74.2%, and 47.8%, respectively. Conclusions In patients with chronic AF receiving modified Cox-maze IV procedure, the Soft Markers Score demonstrated good discriminative power of predicting sinus recovery in our patients and applied well to the other validation populations.	[Tsai, Feng-Chun; Chu, Jaw-Ji; Lin, Pyng-Jing] Chang Gung Mem Hosp, Dept Cardiothorac & Vasc Surg, Linkou, Taiwan; [Tsai, Feng-Chun; Chang, Jen-Ping; Chu, Jaw-Ji; Lin, Pyng-Jing] Chang Gung Univ Med, Taoyuan, Taiwan; [Ho, Heng-Tsan] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Tsai, Feng-Chun; Chang, Jen-Ping] Chang Gung Mem Hosp, Dept Cardiothorac & Vasc Surg, Kaohsiung, Taiwan; [Tsai, Feng-Chang] Chang Gung Mem Hosp, Formosa Biomed Technol, Taoyuan, Taiwan; [Tsai, Feng-Chang] Chang Gung Univ, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Tsai, FC (corresponding author), Chang Gung Mem Hosp, Dept Cardiothorac & Vasc Surg, Linkou, Taiwan.	lutony@cgmh.org.tw			national science council in Taiwan [NMRP 99-2314-B-182A-050-MY2, NMRP 102-2314-B-182A-049-MY2]; Formosa Biomedical Technology	national science council in Taiwan(Ministry of Science and Technology, Taiwan); Formosa Biomedical Technology	This study was supported by funds from the national science council in Taiwan (NMRP 99-2314-B-182A-050-MY2 and NMRP 102-2314-B-182A-049-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Feng-Chang Tsai, an expert in statistical analysis, took part in data analysis and statistical methods verification. He received the salaries from Formosa Biomedical Technology, but this commercial company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa M, 2009, CIRC J, V73, P269, DOI 10.1253/circj.CJ-08-0281; Basu S, 2012, INTERACT CARDIOV TH, V15, P741, DOI 10.1093/icvts/ivs311; Beukema WP, 2008, EUR J CARDIO-THORAC, V34, P771, DOI 10.1016/j.ejcts.2008.07.026; Chaiyaroj Suchart, 2008, Asian Cardiovasc Thorac Ann, V16, P292; Chen MC, 2004, CHEST, V125, P2129, DOI 10.1378/chest.125.6.2129; Chen MC, 2001, J CARDIOVASC ELECTR, V12, P867, DOI 10.1046/j.1540-8167.2001.00867.x; Cox JL, 1999, J THORAC CARDIOV SUR, V118, P833, DOI 10.1016/S0022-5223(99)70052-8; Damiano Jr RJ, 2004, OPERATIVE TECHNIQUES, V9, P24; Damiano RJ, 2011, J THORAC CARDIOV SUR, V141, P113, DOI 10.1016/j.jtcvs.2010.08.067; Gaynor SL, 2005, J THORAC CARDIOV SUR, V129, P104, DOI 10.1016/j.jtcvs.2004.08.042; HENRY WL, 1976, CIRCULATION, V53, P273, DOI 10.1161/01.CIR.53.2.273; Khargi K, 2005, EUR J CARDIO-THORAC, V27, P258, DOI 10.1016/j.ejcts.2004.11.003; Kim YH, 2007, J THORAC CARDIOV SUR, V134, P448, DOI 10.1016/j.jtcvs.2007.02.031; Lee JW, 2003, ANN THORAC SURG, V75, P57, DOI 10.1016/S0003-4975(02)04319-9; Marui A, 2008, J THORAC CARDIOV SUR, V135, P1297, DOI 10.1016/j.jtcvs.2008.02.026; Polyakova V, 2008, J CELL MOL MED, V12, P189, DOI 10.1111/j.1582-4934.2008.00219.x; Sunderland N, 2011, INTERACT CARDIOV TH, V13, P332, DOI 10.1510/icvts.2011.271999; Tsao HM, 2005, J CARDIOVASC ELECTR, V16, P7, DOI 10.1046/j.1540-8167.2005.04407.x; Wang X, 2013, CARDIOLOGY, V126, P62, DOI 10.1159/000351980	19	1	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0126300	10.1371/journal.pone.0126300	http://dx.doi.org/10.1371/journal.pone.0126300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067656	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900008
J	Bhowmik, AK; Schafer, RB				Bhowmik, Avit Kumar; Schaefer, Ralf B.			Large Scale Relationship between Aquatic Insect Traits and Climate	PLOS ONE			English	Article							MACROINVERTEBRATE COMMUNITIES; STREAM MACROINVERTEBRATES; PATTERNS; INVERTEBRATES; VULNERABILITY; SENSITIVITY; EVOLUTION; IMPACTS; ECOLOGY; OXYGEN	Climate is the predominant environmental driver of freshwater assemblage pattern on large spatial scales, and traits of freshwater organisms have shown considerable potential to identify impacts of climate change. Although several studies suggest traits that may indicate vulnerability to climate change, the empirical relationship between freshwater assemblage trait composition and climate has been rarely examined on large scales. We compared the responses of the assumed climate-associated traits from six grouping features to 35 bioclimatic indices (similar to 18 km resolution) for five insect orders (Diptera, Ephemeroptera, Odonata, Plecoptera and Trichoptera), evaluated their potential for changing distribution pattern under future climate change and identified the most influential bioclimatic indices. The data comprised 782 species and 395 genera sampled in 4,752 stream sites during 2006 and 2007 in Germany (similar to 357,000 km(2) spatial extent). We quantified the variability and spatial autocorrelation in the traits and orders that are associated with the combined and individual bioclimatic indices. Traits of temperature preference grouping feature that are the products of several other underlying climate-associated traits, and the insect order Ephemeroptera exhibited the strongest response to the bioclimatic indices as well as the highest potential for changing distribution pattern. Regarding individual traits, insects in general and ephemeropterans preferring very cold temperature showed the highest response, and the insects preferring cold and trichopterans preferring moderate temperature showed the highest potential for changing distribution. We showed that the seasonal radiation and moisture are the most influential bioclimatic aspects, and thus changes in these aspects may affect the most responsive traits and orders and drive a change in their spatial distribution pattern. Our findings support the development of trait-based metrics to predict and detect climate-related changes of freshwater assemblages.	[Bhowmik, Avit Kumar; Schaefer, Ralf B.] Univ Koblenz Landau, Inst Environm Sci, Quantitat Landscape Ecol, Landau In Der Pfalz, Germany	University of Koblenz & Landau	Bhowmik, AK (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Quantitat Landscape Ecol, Landau In Der Pfalz, Germany.	bhowmik@uni-landau.de	Bhowmik, Avit/C-4820-2013; Bhowmik, Avit/AEW-6934-2022; Schaefer, Ralf/E-1926-2011	Bhowmik, Avit/0000-0002-7137-0741; Schaefer, Ralf/0000-0003-3510-1701				AQEM CONSORTIUM, 2002, MAN APPL AQ SYST COM; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Biss R, 2006, 29824777 UMW BUND UM, P1; Bivand RS, 2008, USE R, P1; Bonada N, 2007, GLOBAL CHANGE BIOL, V13, P1658, DOI 10.1111/j.1365-2486.2007.01375.x; Bonada N, 2012, J BIOGEOGR, V39, P56, DOI 10.1111/j.1365-2699.2011.02562.x; Brittain JE., 2008, INT ADV ECOLOGY ZOOG, P1, DOI DOI 10.1525/CALIFORNIA/9780520098688.003.0001; Conti L, 2014, HYDROBIOLOGIA, V721, P297, DOI 10.1007/s10750-013-1690-7; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Department of Applied Zoology/Hydrobiology University Duisburg- Essen Germany (DZHUDE), 2008, DEV TEST INT ASS SYS; Deutscher Wetterdienst (DW), 2014, WEATH CLIM DTSCH WET; Doledec S, 2006, J N AM BENTHOL SOC, V25, P44, DOI 10.1899/0887-3593(2006)25[44:COSAFA]2.0.CO;2; Domisch S, 2013, GLOBAL CHANGE BIOL, V19, P752, DOI 10.1111/gcb.12107; Domisch S, 2011, FRESHWATER BIOL, V56, P2009, DOI 10.1111/j.1365-2427.2011.02631.x; Dray S, 2012, ECOL MONOGR, V82, P257, DOI 10.1890/11-1183.1; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Durance I, 2007, GLOBAL CHANGE BIOL, V13, P942, DOI 10.1111/j.1365-2486.2007.01340.x; Floury M, 2013, GLOBAL CHANGE BIOL, V19, P1085, DOI 10.1111/gcb.12124; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Harrison JF, 2010, P ROY SOC B-BIOL SCI, V277, P1937, DOI 10.1098/rspb.2010.0001; Heino J, 2013, FRESHWATER BIOL, V58, P1539, DOI 10.1111/fwb.12164; Hering D, 2009, AQUAT SCI, V71, P3, DOI 10.1007/s00027-009-9159-5; Hershkovitz Y, 2015, ECOL INDIC, V50, P150, DOI 10.1016/j.ecolind.2014.10.023; Hijmans R.J., 2010, RASTER GEOGRAPHIC AN; Kotiaho JS, 2005, P NATL ACAD SCI USA, V102, P1963, DOI 10.1073/pnas.0406718102; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Lancaster J, 2010, RIVER RES APPL, V26, P921, DOI 10.1002/rra.1425; Lancaster J, 2010, RIVER RES APPL, V26, P385, DOI 10.1002/rra.1274; Larsen S, 2010, BIOL CONSERV, V143, P2638, DOI 10.1016/j.biocon.2010.07.006; Lawrence JE, 2010, J N AM BENTHOL SOC, V29, P1424, DOI 10.1899/09-178.1; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Lewin-Koh N., 2011, MAPTOOLS TOOLS READI; Ministry of Economy Trade and Industry, 2020, ENV MANAGEMENT ACCOU; Mlambo MC, 2014, BIODIVERS CONSERV, V23, P781, DOI 10.1007/s10531-014-0618-5; Nishii R, 2013, ENVIRON ECOL STAT, V20, P315, DOI 10.1007/s10651-012-0227-y; Oksanen J., 2007, COMMUN ECOL PACK, P631; Ospina R, 2012, COMPUT STAT DATA AN, V56, P1609, DOI 10.1016/j.csda.2011.10.005; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; Poff NL, 2010, J N AM BENTHOL SOC, V29, P1441, DOI 10.1899/10-030.1; R Core Team, 2021, R LANGUAGE ENV STAT; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Rolauffs P, 2003, UMWELTBUNDESAMT TEXT, P1; Sandin L, 2014, CURR ZOOL, V60, P221, DOI 10.1093/czoolo/60.2.221; Schmera D, 2015, FRESHW SCI, V34, P823, DOI 10.1086/681623; Schmera D, 2014, FRESHWATER BIOL, V59, P1551, DOI 10.1111/fwb.12369; Schmidt-Kloiber A, 2004, HYDROBIOLOGIA, V516, P269, DOI 10.1023/B:HYDR.0000025270.10807.10; Schmidt-Kloiber A, 2015, ECOL INDIC, V53, P271, DOI 10.1016/j.ecolind.2015.02.007; Stamp JD, 2010, J N AM BENTHOL SOC, V29, P1410, DOI 10.1899/10-003.1; Statzner B, 2010, FRESHWATER BIOL, V55, P80, DOI 10.1111/j.1365-2427.2009.02369.x; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; de Figueroa JMT, 2010, BIODIVERS CONSERV, V19, P1269, DOI 10.1007/s10531-009-9753-9; Usseglio-Polatera P, 2000, HYDROBIOLOGIA, V422, P153, DOI 10.1023/A:1017042921298; Vandewalle M, 2010, BIODIVERS CONSERV, V19, P2921, DOI 10.1007/s10531-010-9798-9; Verberk WCEP, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0473; Verberk WCEP, 2013, FUNCT ECOL, V27, P1275, DOI 10.1111/1365-2435.12152; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487; Zeuss D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4874	62	15	14	5	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0130025	10.1371/journal.pone.0130025	http://dx.doi.org/10.1371/journal.pone.0130025			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080074	Green Published, Green Submitted, gold			2022-12-27	WOS:000356542300038
J	Guo, L; Du, XY; Lu, CY; Zhang, WH				Guo, Lan; Du, Xueying; Lu, Ciyong; Zhang, Wei-Hong			Association between Insulin-Like Growth Factor 1 Gene rs12423791 or rs6214 Polymorphisms and High Myopia: A Meta-Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HIGH-GRADE MYOPIA; FACTOR-I POLYMORPHISMS; REFRACTIVE ERROR; POPULATION; EYE; ENVIRONMENT; PREVALENCE; RECEPTOR; SUSCEPTIBILITY	Objective To evaluate the association of insulin-like growth factor 1 gene rs12423791 and rs6214 polymorphisms with high myopia. Methods An electronic search was conducted on PubMed, Embase, the Cochrane Library and the Chinese Biological Abstract Database for articles published prior to May 6, 2014. A meta-analysis was performed using Revman 5.1 and Stata 12.0, and the odds ratios with 95% confidence intervals were calculated in fixed or random effects models based on the results of the Q test. The subgroup analysis was conducted on the basis of the various regions, the sensitivity analysis was also performed to evaluate the stability of the results, and the publication bias was evaluated by a funnel plot and Egger's linear regression analysis. Results This comprehensive meta-analysis included 2808 high myopia patients and 2778 controls from five unrelated studies. The results demonstrated that the significant association was not present in any genetic models between IGF-1 rs12423791 or rs6214 and high myopia. However, subgroup analysis indicated that rs12423791 polymorphism was associated with high myopia in the Chinese populations in the allelic contrast model (C vs. G: OR=1.24, 95% CI=1.04-1.48 in the fixed-effects model), the dominant model (CC+CG vs. GG: OR=1.40, 95% CI=1.16-1.69 in the fixed-effects model), and the codominant model (CG vs. GG: OR=1.37, 95% CI=1.12-1.68 in the fixed-effects model). Additionally, none of the individual studies significantly affected the association between IGF-1 rs12423791 and high myopia, according to sensitivity analysis. Conclusion This meta-analysis shows that IGF-1 rs12423791 or rs6214 gene polymorphism is not associated with high myopia.	[Guo, Lan; Lu, Ciyong] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510080, Guangdong, Peoples R China; [Du, Xueying] Ctr Primary & Secondary Sch Hlth Promot, Dept Lab, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Wei-Hong] Univ Libre Bruxelles, Sch Publ Hlth, Epidemiol Biostat & Clin Res Ctr, Brussels, Belgium	Sun Yat Sen University; Universite Libre de Bruxelles	Lu, CY (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510080, Guangdong, Peoples R China.	luciyong@mail.sysu.edu.cn		Zhang, Wei-Hong/0000-0003-0380-770X	School of Public Health, Sun Yat-sen University, People's Republic of China	School of Public Health, Sun Yat-sen University, People's Republic of China	This study was supported by School of Public Health, Sun Yat-sen University, People's Republic of China.	Chen YP, 2011, INVEST OPHTH VIS SCI, V52, P4003, DOI 10.1167/iovs.10-7044; Cheng CY, 2013, AM J HUM GENET, V93, P264, DOI 10.1016/j.ajhg.2013.06.016; Cordain L, 2002, ACTA OPHTHALMOL SCAN, V80, P125, DOI 10.1034/j.1600-0420.2002.800203.x; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P1232; He MG, 2009, OPTOMETRY VISION SCI, V86, P40, DOI 10.1097/OPX.0b013e3181940719; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jacobi FK, 2005, CELL MOL LIFE SCI, V62, P800, DOI 10.1007/s00018-004-4353-z; Kita Y, 2014, CLIN EXP OPHTHALMOL, V42, P722, DOI 10.1111/ceo.12318; Li YJ, 2011, OPHTHALMOLOGY, V118, P368, DOI 10.1016/j.ophtha.2010.06.016; Li ZQ, 2011, HUM MOL GENET, V20, P2861, DOI 10.1093/hmg/ddr169; Lyhne N, 2001, BRIT J OPHTHALMOL, V85, P1470, DOI 10.1136/bjo.85.12.1470; Mak JYY, 2012, ARCH OPHTHALMOL-CHIC, V130, P209, DOI 10.1001/archophthalmol.2011.365; Meng WH, 2012, INVEST OPHTH VIS SCI, V53, P7983, DOI 10.1167/iovs.12-10409; Metlapally R, 2010, INVEST OPHTH VIS SCI, V51, P4476, DOI 10.1167/iovs.09-4912; Miyake M, 2013, MOL VIS, V19, P1074; Mutti DO, 2002, INVEST OPHTH VIS SCI, V43, P3633; Nikolakopoulou A, 2014, EVID-BASED MENT HEAL, V17, P64, DOI 10.1136/eb-2014-101794; Paluru P, 2003, INVEST OPHTH VIS SCI, V44, P1830, DOI 10.1167/iovs.02-0697; Penha AM, 2011, MOL VIS, V17, P1436; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Ritchey ER, 2012, EXP EYE RES, V99, P1, DOI 10.1016/j.exer.2012.03.019; Rose KA, 2008, ARCH OPHTHALMOL-CHIC, V126, P527, DOI 10.1001/archopht.126.4.527; Rydzanicz M, 2011, MOL VIS, V17, P2428; Saw S. M., 2000, Annals Academy of Medicine Singapore, V29, P290; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Seet B, 2001, BRIT J OPHTHALMOL, V85, P521, DOI 10.1136/bjo.85.5.521; Shimizu N, 2003, JPN J OPHTHALMOL, V47, P6, DOI 10.1016/S0021-5155(02)00620-2; Simpson CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107110; Subramani R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097016; Sun J, 2012, INVEST OPHTH VIS SCI, V53, P7504, DOI 10.1167/iovs.11-8343; Tsujikawa A, 2006, CLIN EXP OPHTHALMOL, V34, P430, DOI 10.1111/j.1442-9071.2006.01235.x; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Vitale S, 2008, ARCH OPHTHALMOL-CHIC, V126, P1111, DOI 10.1001/archopht.126.8.1111; WATANABE Y, 1994, ENDOCRINOLOGY, V134, P358, DOI 10.1210/en.134.1.358; Wu JL, 2006, DEVELOPMENT, V133, P3651, DOI 10.1242/dev.02547; Yoshida M, 2013, CLIN OPHTHALMOL, V7, P2057, DOI 10.2147/OPTH.S52726; Young TL, 2007, ARCH OPHTHALMOL-CHIC, V125, P38, DOI 10.1001/archopht.125.1.38; Young TL, 1998, AM J HUM GENET, V63, P1419, DOI 10.1086/302111; Zhao Jing-jing, 2013, Zhonghua Yan Ke Za Zhi, V49, P334; Zhuang WJ, 2012, MOL VIS, V18, P634	40	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129707	10.1371/journal.pone.0129707	http://dx.doi.org/10.1371/journal.pone.0129707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076017	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900094
J	Sattler, DN; McKnight, PE; Naney, L; Mathis, R				Sattler, David N.; McKnight, Patrick E.; Naney, Linda; Mathis, Randy			Grant Peer Review: Improving Inter-Rater Reliability with Training	PLOS ONE			English	Review							VALIDITY	This study developed and evaluated a brief training program for grant reviewers that aimed to increase inter-rater reliability, rating scale knowledge, and effort to read the grant review criteria. Enhancing reviewer training may improve the reliability and accuracy of research grant proposal scoring and funding recommendations. Seventy-five Public Health professors from U.S. research universities watched the training video we produced and assigned scores to the National Institutes of Health scoring criteria proposal summary descriptions. For both novice and experienced reviewers, the training video increased scoring accuracy (the percentage of scores that reflect the true rating scale values), inter-rater reliability, and the amount of time reading the review criteria compared to the no video condition. The increase in reliability for experienced reviewers is notable because it is commonly assumed that reviewers-especially those with experience-have good understanding of the grant review rating scale. The findings suggest that both experienced and novice reviewers who had not received the type of training developed in this study may not have appropriate understanding of the definitions and meaning for each value of the rating scale and that experienced reviewers may overestimate their knowledge of the rating scale. The results underscore the benefits of and need for specialized peer reviewer training.	[Sattler, David N.] Western Washington Univ, Dept Psychol, Bellingham, WA 98225 USA; [McKnight, Patrick E.] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Naney, Linda; Mathis, Randy] Oak Ridge Associated Univ, Oak Ridge, TN USA	Western Washington University; George Mason University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Sattler, DN (corresponding author), Western Washington Univ, Dept Psychol, Bellingham, WA 98225 USA.	David.Sattler@wwu.edu; pmckmigh@gmu.edu		McKnight, Patrick/0000-0002-9067-9066	U.S. Department of Energy; ORAU [DE-AC05-06OR23100]	U.S. Department of Energy(United States Department of Energy (DOE)); ORAU	This document was prepared under contract number DE-AC05-06OR23100 between the U.S. Department of Energy and ORAU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornmann L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014331; Danziger S, 2011, P NATL ACAD SCI USA, V108, P6889, DOI 10.1073/pnas.1018033108; Gwet K. L., 2014, HDB INTERRATER RELIA; Hammond J.S., 1999, SMART CHOICES PRACTI; Ismail S., 2009, EVALUATING GRANT PEE; Jackson JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022475; Jayasinghe UW, 2001, EDUC EVAL POLICY AN, V23, P343, DOI 10.3102/01623737023004343; Marsh HW, 2008, AM PSYCHOL, V63, P160, DOI 10.1037/0003-066X.63.3.160; Marsh HW, 1999, MULTIVAR BEHAV RES, V34, P1, DOI 10.1207/s15327906mbr3401_1; Mitton C, 2007, MILBANK Q, V85, P729, DOI 10.1111/j.1468-0009.2007.00506.x; MULLER R, 1994, STAT MED, V13, P2465, DOI 10.1002/sim.4780132310; Mutz R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048509; Naqvi N, 2006, CURR DIR PSYCHOL SCI, V15, P260, DOI 10.1111/j.1467-8721.2006.00448.x; National Institutes of Health, 2014, APPL GUID; Nicolai A.T., 2015, INCENTIVES PERFORMAN, P107, DOI [DOI 10.1007/978-3-319-09785-5_7, 10.1007/978-3-319-09785-5_7]; Schroter S, 2004, BRIT MED J, V328, P673, DOI 10.1136/bmj.38023.700775.AE; Sechrest L, 1996, AM PSYCHOL, V51, P1065, DOI 10.1037/0003-066X.51.10.1065; Shoukri MM, 2010, CH CRC BIOSTAT SER, P1, DOI 10.1201/b10433; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Wessely S, 1999, PEER REV HLTH SCI, P14	20	37	38	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130450	10.1371/journal.pone.0130450	http://dx.doi.org/10.1371/journal.pone.0130450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26075884	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900174
J	Hoe, E; Boelsen, LK; Toh, ZQ; Sun, GW; Koo, GC; Balloch, A; Marimla, R; Dunne, EM; Tikoduadua, L; Russell, FM; Satzke, C; Mulholland, EK; Licciardi, PV				Hoe, Edwin; Boelsen, Laura K.; Toh, Zheng Quan; Sun, Guang Wen; Koo, Ghee Chong; Balloch, Anne; Marimla, Rachel; Dunne, Eileen M.; Tikoduadua, Lisi; Russell, Fiona M.; Satzke, Catherine; Mulholland, E. Kim; Licciardi, Paul V.			Reduced IL-17A Secretion Is Associated with High Levels of Pneumococcal Nasopharyngeal Carriage in Fijian Children	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; TH17; CELLS; COLONIZATION; SEVERITY; ADULTS	Streptococcus pneumonia (the pneumococcus) is the leading vaccine preventable cause of serious infections in infants under 5 years of age. The major correlate of protection for pneumococcal infections is serotype-specific IgG antibody. More recently, antibody-independent mechanisms of protection have also been identified. Preclinical studies have found that IL-17 secreting CD4+ Th17 cells in reducing pneumococcal colonisation. This study assessed IL-17A levels in children from Fiji with high and low pneumococcal carriage density, as measured by quantitative real-time PCR (qPCR). We studied Th17 responses in 54 children who were designated as high density carriers (N=27, > 8.21x10(5) CFU/ml) or low density carriers (N=27, < 1.67x10(5) CFU/ml). Blood samples were collected, and isolated peripheral blood mononuclear cells (PBMCs) were stimulated for 6 days. Supernatants were harvested for cytokine analysis by multiplex bead array and/or ELISA. Th17 cytokines assayed included IL-17A, IL-21, IL-22 as well as TNF-alpha, IL-10, TGF-beta, IL-6, IL-23 and IFN gamma. Cytokine levels were significantly lower in children with high density pneumococcal carriage compared with children with low density carriage for IL-17A (p=0.002) and IL-23 (p=0.04). There was a trend towards significance for IL-22 (p=0.057) while no difference was observed for the other cytokines. These data provide further support for the role of Th17-mediated protection in humans and suggest that these cytokines may be important in the defence against pneumococcal carriage.	[Hoe, Edwin; Boelsen, Laura K.; Toh, Zheng Quan; Balloch, Anne; Marimla, Rachel; Dunne, Eileen M.; Russell, Fiona M.; Satzke, Catherine; Mulholland, E. Kim; Licciardi, Paul V.] Murdoch Childrens Res Inst, Pneumococcal Res, Melbourne, Vic, Australia; [Boelsen, Laura K.; Satzke, Catherine; Licciardi, Paul V.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Sun, Guang Wen; Koo, Ghee Chong] Republ Polytech, Sch Appl Sci, Singapore, Singapore; [Tikoduadua, Lisi] Minist Hlth, Suva, Fiji; [Russell, Fiona M.] Univ Melbourne, Dept Paediat, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Satzke, Catherine] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Mulholland, E. Kim] London Sch Hyg & Trop Med, London WC1, England	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University of Melbourne; University of London; London School of Hygiene & Tropical Medicine	Licciardi, PV (corresponding author), Murdoch Childrens Res Inst, Pneumococcal Res, Melbourne, Vic, Australia.	paul.licciardi@mcri.edu.au	Satzke, Catherine/D-6501-2013; Boelsen, Laura Kate/ABA-7442-2021; Dunne, Eileen M/M-3203-2019	Satzke, Catherine/0000-0003-3164-8849; Boelsen, Laura Kate/0000-0002-2480-0753; Dunne, Eileen M/0000-0001-5542-0780; Koo, Ghee Chong/0000-0001-6569-0098	National Institute of Allergy Infectious Diseases [1R01AI085198-01A1]; Victorian Government; National Health and Medical Research Council (NHMRC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085198] Funding Source: NIH RePORTER	National Institute of Allergy Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Victorian Government; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by National Institute of Allergy Infectious Diseases (Grant number: 1R01AI085198-01A1). This study was supported in part by the Victorian Government's Operational Infrastructure Support Program. Paul V. Licciardi is the recipient of a National Health and Medical Research Council (NHMRC) Early Career Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005953; Alizadeh D, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/957878; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Basset A, 2007, INFECT IMMUN, V75, P5460, DOI 10.1128/IAI.00773-07; Bermejo DA, 2013, NAT IMMUNOL, V14, P514, DOI 10.1038/ni.2569; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Chen Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018139; Crome SQ, 2010, J IMMUNOL, V185, P3199, DOI 10.4049/jimmunol.1000557; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Dunne EM, 2012, J CLIN MICROBIOL, V50, P1034, DOI 10.1128/JCM.06589-11; Eyerich S, 2010, TRENDS IMMUNOL, V31, P354, DOI 10.1016/j.it.2010.06.004; Henriques-Normark B, 2013, COLD SPRING HARBOR P, V3; Hoe E, 2015, J IMMUNE RES, V2, P1015; Hsieh YC, 2014, PEDIAT INFECT DIS J; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Jin W, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.58; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lundgren A, 2012, VACCINE, V30, P3897, DOI 10.1016/j.vaccine.2012.03.082; Malley R, 2010, J MOL MED, V88, P135, DOI 10.1007/s00109-009-0579-4; Moffitt KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043445; Moffitt KL, 2011, CELL HOST MICROBE, V9, P158, DOI 10.1016/j.chom.2011.01.007; Mulholland K, 2012, LANCET, V379, P1387, DOI 10.1016/S0140-6736(12)60588-1; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Pido-Lopez J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002396; Rello J, 2009, CHEST, V136, P832, DOI 10.1378/chest.09-0258; Russell FM, 2009, VACCINE, V27, P5685, DOI 10.1016/j.vaccine.2009.06.098; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Shak JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098829; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; van der Linden M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060848; Werno AM, 2012, J MED MICROBIOL, V61, P1129, DOI 10.1099/jmm.0.044107-0; Zhang QB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002175; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731; Zheng SG, 2013, AM J CLIN EXP IMMUNO, V2, P94	38	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129199	10.1371/journal.pone.0129199	http://dx.doi.org/10.1371/journal.pone.0129199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069966	Green Published, gold, Green Accepted			2022-12-27	WOS:000356327000054
J	Kumar, J; Namsechi, R; Sim, VL				Kumar, Jitendra; Namsechi, Risa; Sim, Valerie L.			Structure-Based Peptide Design to Modulate Amyloid Beta Aggregation and Reduce Cytotoxicity	PLOS ONE			English	Article							SOLID-STATE NMR; ALZHEIMERS-DISEASE; FIBRIL FORMATION; CASCADE HYPOTHESIS; PROTEIN; OLIGOMERS; REAPPRAISAL; INHIBITORS; FRAGMENT; NEURONS	The deposition of A beta peptide in the brain is the key event in Alzheimer disease progression. Therefore, the prevention of A beta self assembly into disease-associated oligomers is a logical strategy for treatment. p stacking is known to provide structural stability to many amyloids; two phenylalanine residues within the A beta 14-23 self recognition element are in such an arrangement in many solved structures. Therefore, we targeted this structural stacking by substituting these two phenylalanine residues with their D-enantiomers. The resulting peptides were able to modulate A beta aggregation in vitro and reduce A beta cytotoxicity in primary neuronal cultures. Using kinetic analysis of fibril formation, electron microscopy and dynamic light scattering characterization of oligomer size distributions, we demonstrate that, in addition to altering fibril structural characteristics, these peptides can induce the formation of larger amorphous aggregates which are protective against toxic oligomers, possibly because they are able to sequester the toxic oligomers during co-incubation. Alternatively, they may alter the surface structure of the oligomers such that they can no longer interact with cells to induce toxic pathways.	[Kumar, Jitendra; Namsechi, Risa; Sim, Valerie L.] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Kumar, Jitendra; Namsechi, Risa; Sim, Valerie L.] Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada; [Sim, Valerie L.] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Sim, VL (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.	valerie.sim@ualberta.ca	Sim, Valerie/C-4137-2013	Sim, Valerie/0000-0002-0088-8666	University of Alberta Faculty of Medicine Dentistry	University of Alberta Faculty of Medicine Dentistry	RN received funding from the University of Alberta Faculty of Medicine & Dentistry as a summer studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Amritraj A, 2013, J BIOL CHEM, V288, P3136, DOI 10.1074/jbc.M112.412460; Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330; Balbach JJ, 2002, BIOPHYS J, V83, P1205, DOI 10.1016/S0006-3495(02)75244-2; Bernstein SL, 2005, J AM CHEM SOC, V127, P2075, DOI 10.1021/ja044531p; Bu ZM, 2007, BIOPHYS J, V92, P594, DOI 10.1529/biophysj.106.091017; Capone R, 2012, BIOCHEMISTRY-US, V51, P776, DOI 10.1021/bi2017427; Chalifour RJ, 2003, J BIOL CHEM, V278, P34874, DOI 10.1074/jbc.M212694200; Chen YR, 2011, BIOCHEM BIOPH RES CO, V405, P91, DOI 10.1016/j.bbrc.2010.12.133; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cruz M, 2004, J PEPT RES, V63, P324, DOI 10.1111/j.1399-3011.2004.00156.x; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Frydman-Marom A, 2009, ANGEW CHEM INT EDIT, V48, P1981, DOI 10.1002/anie.200802123; Goure WF, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt272; Gupta S, 2012, NAT STRUCT MOL BIOL, V19, P72, DOI 10.1038/nsmb.2175; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2014, J INTERN MED, V275, P296, DOI 10.1111/joim.12192; Hardy J, 2002, NEUROBIOL AGING, V23, P1073, DOI 10.1016/S0197-4580(02)00042-8; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy J, 2006, J ALZHEIMERS DIS, V9, P151; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; HILBICH C, 1991, J MOL BIOL, V218, P149, DOI 10.1016/0022-2836(91)90881-6; Inouye H, 2010, PROTEINS, V78, P2306, DOI 10.1002/prot.22743; Lindberg DJ, 2015, BIOCHEM BIOPH RES CO, V458, P418, DOI 10.1016/j.bbrc.2015.01.132; Liu HM, 2010, REJUV RES, V13, P210, DOI 10.1089/rej.2009.0926; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Makarava N, 2006, PROTEIN SCI, V15, P1334, DOI 10.1110/ps.052013106; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; Nadai M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052994; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Paivio A, 2004, PROTEIN SCI, V13, P1251, DOI 10.1110/ps.03442404; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Reches M, 2006, NAT NANOTECHNOL, V1, P195, DOI 10.1038/nnano.2006.139; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Sikorski P, 2003, STRUCTURE, V11, P915, DOI 10.1016/S0969-2126(03)00149-7; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504; Teplow DB, 2006, METHOD ENZYMOL, V413, P20, DOI 10.1016/S0076-6879(06)13002-5; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Zheng WH, 2002, NEUROSCIENCE, V115, P201, DOI 10.1016/S0306-4522(02)00404-9	50	30	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129087	10.1371/journal.pone.0129087	http://dx.doi.org/10.1371/journal.pone.0129087			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070139	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000043
J	Shuvy, M; Abedat, S; Mustafa, M; Duvdevan, N; Meir, K; Beeri, R; Lotan, C				Shuvy, Mony; Abedat, Suzan; Mustafa, Mahmoud; Duvdevan, Nitsan; Meir, Karen; Beeri, Ronen; Lotan, Chaim			Cellular Changes during Renal Failure-Induced Inflammatory Aortic Valve Disease	PLOS ONE			English	Article							VASCULAR CELLS; MATRIX; CALCIFICATION; STENOSIS; EXPRESSION; GROWTH; DIFFERENTIATION; PROGRESSION	Background Aortic valve calcification (AVC) secondary to renal failure (RF) is an inflammation-regulated process, but its pathogenesis remains unknown. We sought to assess the cellular processes that are involved in the early phases of aortic valve disease using a unique animal model of RF-associated AVC. Methods Aortic valves were obtained from rats that were fed a uremia-inducing diet exclusively for 2, 3, 4, 5, and 6 weeks as well as from controls. Pathological examination of the valves included histological characterization, von Kossa staining, and antigen expression analyses. Results After 2 weeks, we noted a significant increase in urea and creatinine levels, reflecting RF. RF parameters exacerbated until the Week 5 and plateaued. Whereas no histological changes or calcification was observed in the valves of any study group, macrophage accumulation became apparent as early as 2 weeks after the diet was started and rose after 3 weeks. By western blot, osteoblast markers were expressed after 2 weeks on the diet and decreased after 6 weeks. Collagen 3 was up-regulated after 3 weeks, plateauing at 4 weeks, whereas collagen 1 levels peaked at 2 and 4 weeks. Fibronectin levels increased gradually until Week 5 and decreased at 6 weeks. We observed early activation of the ERK pathway, whereas other pathways remained unchanged. Conclusions We concluded that RF induces dramatic changes at the cellular level, including macrophage accumulation, activation of cell signaling pathway and extracellular matrix modification. These changes precede valve calcification and may increase propensity for calcification, and have to be investigated further.	[Shuvy, Mony] Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Toronto, ON M4N 3M5, Canada; [Shuvy, Mony; Abedat, Suzan; Mustafa, Mahmoud; Duvdevan, Nitsan; Beeri, Ronen; Lotan, Chaim] Hadassah Hebrew Univ Med Ctr, Cardiovasc Res Ctr, Jerusalem, Israel; [Meir, Karen] Hadassah Hebrew Univ Med Ctr, Dept Pathol, Jerusalem, Israel	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Shuvy, M (corresponding author), Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Toronto, ON M4N 3M5, Canada.	monysh@gmail.com	Beeri, Ronen/A-4035-2009	Beeri, Ronen/0000-0002-8014-0702				Agmon Y, 2001, J AM COLL CARDIOL, V38, P827, DOI 10.1016/S0735-1097(01)01422-X; CAREY DJ, 1991, ANNU REV PHYSIOL, V53, P161, DOI 10.1146/annurev.physiol.53.1.161; Chan KL, 2010, CIRCULATION, V121, P306, DOI 10.1161/CIRCULATIONAHA.109.900027; Chen JH, 2011, CIRC RES, V108, P1510, DOI 10.1161/CIRCRESAHA.110.234237; Fondard O, 2005, EUR HEART J, V26, P1333, DOI 10.1093/eurheartj/ehi248; Helske S, 2006, ARTERIOSCL THROM VAS, V26, P1791, DOI 10.1161/01.ATV.0000228824.01604.63; Hjortnaes J, 2010, EUR HEART J, V31, P1975, DOI 10.1093/eurheartj/ehq237; Kume T, 2006, J AM SOC ECHOCARDIOG, V19, P914, DOI 10.1016/j.echo.2006.01.026; Latif N, 2005, J HEART VALVE DIS, V14, P218; LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Mohler ER, 2001, CIRCULATION, V103, P1522, DOI 10.1161/01.cir.103.11.1522; NAVAB M, 1995, AM J CARDIOL, V76, pC18, DOI 10.1016/S0002-9149(99)80466-4; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; Raines EW, 2000, ANN NY ACAD SCI, V902, P39; Rajamannan NM, 2006, CIRCULATION, V114, P2007, DOI 10.1161/CIRCULATIONAHA.106.657759; Rajamannan NM, 2009, ARTERIOSCL THROM VAS, V29, P162, DOI 10.1161/ATVBAHA.107.156752; Rajamannan NM, 2005, CIRCULATION, V111, P3296, DOI 10.1161/CIRCULATIONAHA.104.473165; Rajamannan NM, 2005, HEART, V91, P806, DOI 10.1136/hrt.2003.029785; Rajamannan NM, 2003, CIRCULATION, V107, P2181, DOI 10.1161/01.CIR.0000070591.21548.69; Rajamannan NM, 2002, CIRCULATION, V105, P2660, DOI 10.1161/01.CIR.0000017435.87463.72; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Satta J, 2003, ANN THORAC SURG, V76, P681, DOI 10.1016/S0003-4975(03)00529-0; Shuvy M, 2011, AM J PHYSIOL-HEART C, V300, pH1829, DOI 10.1152/ajpheart.00240.2010; Shuvy M, 2011, EXP TOXICOL PATHOL, V63, P303, DOI 10.1016/j.etp.2010.02.002; Shuvy M, 2008, CARDIOVASC RES, V79, P492, DOI 10.1093/cvr/cvn088; Watson KE, 1998, ARTERIOSCL THROM VAS, V18, P1964, DOI 10.1161/01.ATV.18.12.1964; Yang XP, 2009, J AM COLL CARDIOL, V53, P491, DOI 10.1016/j.jacc.2008.09.052	29	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129725	10.1371/journal.pone.0129725	http://dx.doi.org/10.1371/journal.pone.0129725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070132	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000101
J	Son, H; Jang, J; Kim, H; Kang, S				Son, Hyeonuk; Jang, Jaewon; Kim, Heetae; Kang, Sungho			Histogram-Based Calibration Method for Pipeline ADCs	PLOS ONE			English	Article							HYBRID BUS	Measurement and calibration of an analog-to-digital converter (ADC) using a histogram-based method requires a large volume of data and a long test duration, especially for a high resolution ADC. A fast and accurate calibration method for pipelined ADCs is proposed in this research. The proposed calibration method composes histograms through the outputs of each stage and calculates error sources. The digitized outputs of a stage are influenced directly by the operation of the prior stage, so the results of the histogram provide the information of errors in the prior stage. The composed histograms reduce the required samples and thus calibration time being implemented by simple modules. For 14-bit resolution pipelined ADC, the measured maximum integral non-linearity (INL) is improved from 6.78 to 0.52 LSB, and the spurious-free dynamic range (SFDR) and signal-to-noise-and-distortion ratio (SNDR) are improved from 67.0 to 106.2dB and from 65.6 to 84.8dB, respectively.	[Son, Hyeonuk; Jang, Jaewon; Kim, Heetae; Kang, Sungho] Yonsei Univ, Dept Elect & Elect Engn, Seoul 134, South Korea	Yonsei University	Kang, S (corresponding author), Yonsei Univ, Dept Elect & Elect Engn, 120-749 Seodaemoon Gu Shinchon Dong, Seoul 134, South Korea.	shkang@yonsei.ac.kr			National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2015R1A2A1A13001751]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (no. 2015R1A2A1A13001751).	Azais F, 2000, IEEE EUROPEAN TEST WORKSHOP, PROCEEDINGS, P53, DOI 10.1109/ETW.2000.873779; Brooks L, 2008, IEEE T CIRCUITS-I, V55, P2969, DOI 10.1109/TCSI.2008.925373; Gines A, 2014, DES AUT TEST EUROPE; Grace CR, 2005, IEEE J SOLID-ST CIRC, V40, P1038, DOI 10.1109/JSSC.2005.845972; Hamed SM, 2013, INT CONF COMM INF T, P366, DOI 10.1109/ICCITechnology.2013.6579581; Hu XS, 2015, IEEE-ASME T MECH, V20, P457, DOI 10.1109/TMECH.2014.2336264; Hu XS, 2014, IEEE T INTELL TRANSP, V15, P1193, DOI 10.1109/TITS.2013.2294675; Lee KH, 2009, ELECTRON LETT, V45, P1067, DOI 10.1049/el.2009.2013; Lee SC, 2007, ETRI J, V29, P408, DOI 10.4218/etrij.07.0206.0180; LEE SH, 1992, IEEE J SOLID-ST CIRC, V27, P1679, DOI 10.1109/4.173093; Lin JF, 2011, IEEE T VLSI SYST, V19, P2158, DOI 10.1109/TVLSI.2010.2089543; Mrak P, 2010, ETRI J, V32, P154, DOI 10.4218/etrij.10.0209.0285; Ravi C, 2014, I CONF VLSI DESIGN, P569, DOI 10.1109/VLSID.2014.105; Van de Vel H, 2009, IEEE J SOLID-ST CIRC, V44, P1047, DOI 10.1109/JSSC.2009.2014702; Yuan J, 2012, IEEE T INSTRUM MEAS, V61, P17, DOI 10.1109/TIM.2011.2161026	15	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129736	10.1371/journal.pone.0129736	http://dx.doi.org/10.1371/journal.pone.0129736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070196	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000102
J	Stoffels, RJ				Stoffels, Rick J.			Physiological Trade-Offs Along a Fast-Slow Lifestyle Continuum in Fishes: What Do They Tell Us about Resistance and Resilience to Hypoxia?	PLOS ONE			English	Article							COMMUNITY ECOLOGY; CLIMATE-CHANGE; SWIMMING PERFORMANCE; FUNCTIONAL TRAITS; METABOLIC-RATE; FRESH-WATER; ENVIRONMENTAL HYPOXIA; TROPICAL BIRDS; BODY-MASS; DROUGHT	It has recently been suggested that general rules of change in ecological communities might be found through the development of functional relationships between species traits and performance. The physiological, behavioural and life-history traits of fishes are often organised along a fast-slow lifestyle continuum (FSLC). With respect to resistance (capacity for population to resist change) and resilience (capacity for population to recover from change) to environmental hypoxia, the literature suggests that traits enhancing resilience may come at the expense of traits promoting resistance to hypoxia; a trade-off may exist. Here I test whether three fishes occupying different positions along the FSLC trade-off resistance and resilience to environmental hypoxia. Static respirometry experiments were used to determine resistance, as measured by critical oxygen tension (P-crit), and capacity for (RC) and magnitude of metabolic reduction (RM). Swimming respirometry experiments were used to determine aspects of resilience: critical (U-crit) and optimal swimming speed (U-opt), and optimal cost of transport (COTopt). Results pertaining to metabolic reduction suggest a resistance gradient across species described by the inequality Melanotaenia fluviatilis (fast lifestyle) < Hypseleotris sp. (intermediate lifestyle) < Mogurnda adspersa (slow lifestyle). The U-crit and COTopt data suggest a resilience gradient described by the reverse inequality, and so the experiments generally indicate that three fishes occupying different positions on the FSLC trade-off resistance and resilience to hypoxia. However, the scope of inferences that can be drawn from an individual study is narrow, and so steps towards general, traitbased rules of fish community change along environmental gradients are discussed.	[Stoffels, Rick J.] CSIRO, Murray Darling Freshwater Res Ctr, Land & Water, Wodonga, Vic, Australia; [Stoffels, Rick J.] La Trobe Univ, Dept Ecol Environm & Evolut, Wodonga, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Murray Darling Basin Authority; La Trobe University	Stoffels, RJ (corresponding author), CSIRO, Murray Darling Freshwater Res Ctr, Land & Water, Wodonga, Vic, Australia.	rick.stoffels@csiro.au	Stoffels, Rick/H-3595-2011	Stoffels, Rick/0000-0003-4888-5875	New South Wales Office of Water; CSIRO Land and Water; Murray-Darling Freshwater Research Centre	New South Wales Office of Water; CSIRO Land and Water(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Murray-Darling Freshwater Research Centre	This work was funded by the New South Wales Office of Water, CSIRO Land and Water and the Murray-Darling Freshwater Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Ankins S, 2012, J FISH BIOL, V80, P195, DOI 10.1111/j.1095-8649.2011.03166.x; Allison G, 2004, ECOL MONOGR, V74, P117, DOI 10.1890/02-0681; Beamish F.W., 1979, FISH PHYSL LOCOMOTIO, P101, DOI DOI 10.1139/cjfas-2015-0209; BELL WH, 1970, FISH RES BD CAN TECH, V195, P1; Bertozzi T, 2000, MAR FRESHWATER RES, V51, P805, DOI 10.1071/MF00039; Bickler PE, 2007, ANNU REV PHYSIOL, V69, P145, DOI 10.1146/annurev.physiol.69.031905.162529; Bond NR, 2008, HYDROBIOLOGIA, V600, P3, DOI 10.1007/s10750-008-9326-z; Bonsall MB, 2004, SCIENCE, V306, P111, DOI 10.1126/science.1100680; BRAND MD, 1990, J THEOR BIOL, V145, P267, DOI 10.1016/S0022-5193(05)80131-6; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Brill RW, 1996, COMP BIOCHEM PHYS A, V113, P3, DOI 10.1016/0300-9629(95)02064-0; Careau V, 2009, FUNCT ECOL, V23, P150, DOI 10.1111/j.1365-2435.2008.01468.x; Careau V, 2012, PHYSIOL BIOCHEM ZOOL, V85, P543, DOI 10.1086/666970; Chapman LJ, 2009, FISH PHYSIOL, V27, P25, DOI 10.1016/S1546-5098(08)00002-2; Chown SL, 2012, PHILOS T R SOC B, V367, P1615, DOI 10.1098/rstb.2011.0422; Claireaux G, 2006, J EXP BIOL, V209, P3420, DOI 10.1242/jeb.02346; Clark TD, 2013, J EXP BIOL, V216, P2771, DOI 10.1242/jeb.084251; Dodds WK, 2004, BIOSCIENCE, V54, P205, DOI 10.1641/0006-3568(2004)054[0205:LOTETE]2.0.CO;2; Downs CJ, 2008, FUNCT ECOL, V22, P239, DOI 10.1111/j.1365-2435.2007.01371.x; Dwyer GK, 2014, FRESHWATER BIOL, V59, P819, DOI 10.1111/fwb.12306; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fu SJ, 2009, J EXP BIOL, V212, P2296, DOI 10.1242/jeb.027102; Fu SJ, 2009, J COMP PHYSIOL B, V179, P509, DOI 10.1007/s00360-008-0337-x; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; GOOLISH EM, 1991, PHYSIOL ZOOL, V64, P485, DOI 10.1086/physzool.64.2.30158187; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Helmuth B, 2009, J EXP BIOL, V212, P753, DOI 10.1242/jeb.023861; Herbert NA, 2005, MAR BIOL, V147, P1403, DOI 10.1007/s00227-005-0003-8; Herbert NA, 2006, MAR BIOL, V149, P1217, DOI 10.1007/s00227-006-0284-6; Herbert NA, 2006, PHYSIOL BIOCHEM ZOOL, V79, P909, DOI 10.1086/506000; Higham TE, 2005, J EXP BIOL, V208, P2653, DOI 10.1242/jeb.01682; Higham TE, 2006, J EXP BIOL, V209, P2713, DOI 10.1242/jeb.02315; HUEY RB, 1981, ECOLOGY, V62, P991, DOI 10.2307/1936998; Hughes L, 2003, AUSTRAL ECOL, V28, P423, DOI 10.1046/j.1442-9993.2003.01300.x; Humphries MM, 2014, J ANIM ECOL, V83, P7, DOI 10.1111/1365-2656.12124; Johnston IA, 1998, J EXP BIOL, V201, P1; Kearney M, 2010, PHILOS T R SOC B, V365, P3469, DOI 10.1098/rstb.2010.0034; Killen SS, 2010, ECOL LETT, V13, P184, DOI 10.1111/j.1461-0248.2009.01415.x; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; Korsmeyer KE, 2002, J EXP BIOL, V205, P1253; Lake PS, 2003, FRESHWATER BIOL, V48, P1161, DOI 10.1046/j.1365-2427.2003.01086.x; Langerhans RB, 2008, INTEGR COMP BIOL, V48, P750, DOI 10.1093/icb/icn092; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; Litchman E, 2007, ECOL LETT, V10, P1170, DOI 10.1111/j.1461-0248.2007.01117.x; Lowe TE, 2000, MAR BIOL, V136, P1087, DOI 10.1007/s002270000255; MACGILLIVRAY CW, 1995, FUNCT ECOL, V9, P640, DOI 10.2307/2390156; Mandic M, 2009, P ROY SOC B-BIOL SCI, V276, P735, DOI 10.1098/rspb.2008.1235; Matthews W. J., 1998, PATTERNS FRESHWATER; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Mol JH, 2000, ENVIRON BIOL FISH, V59, P429, DOI 10.1023/A:1026529200610; MOYES CD, 1992, CAN J ZOOL, V70, P1246, DOI 10.1139/z92-172; Nilsson GE, 2004, J EXP BIOL, V207, P3131, DOI 10.1242/jeb.00979; Nilsson GE, 2007, J EXP BIOL, V210, P2403, DOI 10.1242/jeb.000281; Ohlberger J, 2006, J COMP PHYSIOL B, V176, P17, DOI 10.1007/s00360-005-0024-0; Palzenberger M., 1992, Reviews in Fish Biology and Fisheries, V2, P187, DOI 10.1007/BF00045037; Perkins SE, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053361; PETERSON CG, 1992, ECOLOGY, V73, P1445, DOI 10.2307/1940689; Pettersson LB, 2000, P ROY SOC B-BIOL SCI, V267, P759, DOI 10.1098/rspb.2000.1068; Pusey B., 2004, FRESHWATER FISHES OF; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; SCHOENER TW, 1986, AM ZOOL, V26, P81; Seneviratne SI, 2014, NAT CLIM CHANGE, V4, P161, DOI 10.1038/nclimate2145; Simberloff D, 2004, AM NAT, V163, P787, DOI 10.1086/420777; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Sousa PM, 2011, NAT HAZARD EARTH SYS, V11, P33, DOI 10.5194/nhess-11-33-2011; STEFFENSEN JF, 1989, FISH PHYSIOL BIOCHEM, V6, P49, DOI 10.1007/BF02995809; Steffensen JF, 2007, FISH PHYSIOLOGY TOXI, P239; Svendsen JC, 2012, CAN J ZOOL, V90, P1, DOI [10.1139/z11-095, 10.1139/Z11-095]; Tieleman BI, 2005, P ROY SOC B-BIOL SCI, V272, P1715, DOI 10.1098/rspb.2005.3155; VIDELER JJ, 1990, COMP BIOCHEM PHYS A, V97, P91, DOI 10.1016/0300-9629(90)90155-L; Wainwright PC, 2005, INTEGR COMP BIOL, V45, P256, DOI 10.1093/icb/45.2.256; WEBB PW, 1984, AM ZOOL, V24, P107; Wells RMG, 2005, COMP BIOCHEM PHYS A, V141, P87, DOI 10.1016/j.cbpb.2005.04.005; Wells RMG, 2009, FISH PHYSIOL, V27, P255, DOI 10.1016/S1546-5098(08)00006-X; West J, 2003, COMMENTARY, V115, P17; Whitworth KL, 2012, J HYDROL, V450, P190, DOI 10.1016/j.jhydrol.2012.04.057; Wiersma P, 2007, P NATL ACAD SCI USA, V104, P9340, DOI 10.1073/pnas.0702212104; Winemiller KO, 2005, CAN J FISH AQUAT SCI, V62, P872, DOI 10.1139/F05-040; Yan GJ, 2013, J EVOLUTION BIOL, V26, P1802, DOI 10.1111/jeb.12182; YEAGER DP, 1989, PHYSIOL ZOOL, V62, P888, DOI 10.1086/physzool.62.4.30157935	85	19	20	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130303	10.1371/journal.pone.0130303	http://dx.doi.org/10.1371/journal.pone.0130303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070078	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000154
J	Sunyer, P; Boixadera, E; Munoz, A; Bonal, R; Espelta, JM				Sunyer, Pau; Boixadera, Ester; Munoz, Alberto; Bonal, Raul; Maria Espelta, Josep			The Interplay among Acorn Abundance and Rodent Behavior Drives the Spatial Pattern of Seedling Recruitment in Mature Mediterranean Oak Forests	PLOS ONE			English	Article							QUERCUS-ILEX RECRUITMENT; BOAR SUS-SCROFA; INTERSPECIFIC DIFFERENCES; CACHE PROTECTION; SMALL MAMMALS; DISPERSAL; PREDATION; SIZE; ESTABLISHMENT; HETEROGENEITY	The patterns of seedling recruitment in animal-dispersed plants result from the interactions among environmental and behavioral variables. However, we know little on the contribution and combined effect of both kinds of variables. We designed a field study to assess the interplay between environment (vegetation structure, seed abundance, rodent abundance) and behavior (seed dispersal and predation by rodents, and rooting by wild boars), and their contribution to the spatial patterns of seedling recruitment in a Mediterranean mixed-oak forest. In a spatially explicit design, we monitored intensively all environmental and behavioral variables in fixed points at a small spatial scale from autumn to spring, as well as seedling emergence and survival. Our results revealed that the spatial patterns of seedling emergence were strongly related to acorn availability on the ground, but not by a facilitationeffect of vegetation cover. Rodents changed seed shadows generated by mother trees by dispersing most seeds from shrubby to open areas, but the spatial patterns of acorn dispersal/predation had no direct effect on recruitment. By contrast, rodents had a strong impact on recruitment as pilferers of cached seeds. Rooting by wild boars also reduced recruitment by reducing seed abundance, but also by changing rodent's behavior towards higher consumption of acorns in situ. Hence, seed abundance and the foraging behavior of scatter-hoarding rodents and wild boars are driving the spatial patterns of seedling recruitment in this mature oak forest, rather than vegetation features. The contribution of vegetation to seedling recruitment (e.g. facilitation by shrubs) may be context dependent, having a little role in closed forests, or being overridden by directed seed dispersal from shrubby to open areas. We warn about the need of using broad approaches that consider the combined action of environment and behavior to improve our knowledge on the dynamics of natural regeneration in forests.	[Sunyer, Pau; Munoz, Alberto; Bonal, Raul; Maria Espelta, Josep] CREAF, Cerdanyola Del Valles, Catalonia, Spain; [Boixadera, Ester] Univ Autonoma Barcelona, Serv Estat Aplicada, Cerdanyola Del Valles, Catalonia, Spain; [Munoz, Alberto] Univ Complutense Madrid, Fac Educ, Dept Didact Ciencias Expt, Madrid, Spain; [Bonal, Raul] Univ Extremadura, Forest Res Grp GIF INDEHESA, Plasencia, Spain; [Bonal, Raul] Univ Castilla La Mancha, DITEG Res Grp, Toledo, Spain	Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona; Complutense University of Madrid; Universidad de Extremadura; Universidad de Castilla-La Mancha	Sunyer, P (corresponding author), CREAF, Cerdanyola Del Valles, Catalonia, Spain.	p.sunyer@creaf.uab.cat	Muñoz, Alberto/H-5026-2015; Espelta, Josep M/I-3891-2016	Muñoz, Alberto/0000-0002-1152-7444; Espelta, Josep M/0000-0002-0242-4988; Boixadera Planas, Ester/0000-0002-3995-6750; BONAL, RAUL/0000-0002-6084-1771	project NOVFORESTS [CGL2012-33398]; Generalitat de Catalunya [SGR 913]; Juan de la Cierva contract; Programme Atraccion de Talento Investigador (Government of Extremadura)	project NOVFORESTS; Generalitat de Catalunya(Generalitat de Catalunya); Juan de la Cierva contract; Programme Atraccion de Talento Investigador (Government of Extremadura)	This research was funded by project NOVFORESTS (CGL2012-33398) and project SGR 913 of the Generalitat de Catalunya. AM was funded by a Juan de la Cierva contract. RB was funded by a contract of the Programme Atraccion de Talento Investigador (Government of Extremadura). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, SAS 9 3 SYST OPT REF; Arrieta S, 2005, FOREST ECOL MANAG, V205, P267, DOI 10.1016/j.foreco.2004.10.009; Beckage B, 2003, ECOLOGY, V84, P1849, DOI 10.1890/0012-9658(2003)084[1849:SSAGOT]2.0.CO;2; Bonal R, 2007, OECOLOGIA, V152, P533, DOI 10.1007/s00442-007-0672-8; BRAN D, 1990, VEGETATIO, V87, P45, DOI 10.1007/BF00045654; Cahill S, 2003, WILDLIFE BIOL, V9, P3, DOI 10.2981/wlb.2003.058; Calvino-Cancela M, 2002, J ECOL, V90, P775, DOI 10.1046/j.1365-2745.2002.00711.x; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; CRAWLEY MJ, 1995, J ECOL, V83, P683, DOI 10.2307/2261636; Dally JM, 2006, ANIM BEHAV, V72, P13, DOI 10.1016/j.anbehav.2005.08.020; ESPELTA JM, 1995, J VEG SCI, V6, P465, DOI 10.2307/3236344; Espelta JM, 2005, ECOSCIENCE, V12, P447, DOI 10.2980/i1195-6860-12-4-447.1; Espelta JM, 2009, J ECOL, V97, P1416, DOI 10.1111/j.1365-2745.2009.01564.x; Espelta JM, 2008, ECOLOGY, V89, P805, DOI 10.1890/07-0217.1; Focardi S, 2000, J ZOOL, V250, P329, DOI 10.1111/j.1469-7998.2000.tb00777.x; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Gomez JM, 2008, FOREST ECOL MANAG, V256, P1384, DOI 10.1016/j.foreco.2008.06.045; Gomez JM, 2008, OECOLOGIA, V155, P529, DOI 10.1007/s00442-007-0928-3; Gomez-Aparicio L, 2005, ECOGRAPHY, V28, P757, DOI 10.1111/j.2005.0906-7590.04337.x; Gomez-Aparicio L, 2008, J VEG SCI, V19, P161, DOI 10.3170/2008-8-18347; Gonzalez-Rodriguez V, 2011, ANN FOREST SCI, V68, P1217, DOI 10.1007/s13595-011-0069-z; Huang ZY, 2011, ANIM BEHAV, V81, P831, DOI 10.1016/j.anbehav.2011.01.018; HUGHES JJ, 1994, ECOLOGY, V75, P1397, DOI 10.2307/1937463; Jurena PN, 2003, ECOLOGY, V84, P907, DOI 10.1890/0012-9658(2003)084[0907:WPEASH]2.0.CO;2; Lookingbill TR, 2000, J VEG SCI, V11, P607, DOI 10.2307/3246590; Manson RH, 1998, OIKOS, V82, P37, DOI 10.2307/3546915; Espelta JM, 2009, OECOLOGIA, V161, P559, DOI 10.1007/s00442-009-1394-x; Munoz A, 2007, OIKOS, V116, P1631, DOI [10.1111/j.2007.0030-1299.15710.x, 10.1111/j.0030-1299.2007.15710.x]; Munoz A, 2014, FOREST ECOL MANAG, V322, P98, DOI 10.1016/j.foreco.2014.02.039; Munoz A, 2011, J ECOL, V99, P1016, DOI 10.1111/j.1365-2745.2011.01818.x; Munoz A, 2009, BASIC APPL ECOL, V10, P151, DOI 10.1016/j.baae.2008.01.003; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Peguero G, 2013, REV CHIL HIST NAT, V86, P161, DOI 10.4067/S0716-078X2013000200005; Perea R, 2014, FOREST ECOL MANAG, V312, P47, DOI 10.1016/j.foreco.2013.10.022; Perea R, 2012, EUR J FOREST RES, V131, P623, DOI 10.1007/s10342-011-0536-y; Perea R, 2011, ANIM BEHAV, V82, P717, DOI 10.1016/j.anbehav.2011.07.001; Perea R, 2011, J ECOL, V99, P194, DOI 10.1111/j.1365-2745.2010.01749.x; Perez-Ramos IM, 2008, OIKOS, V117, P1386, DOI 10.1111/j.0030-1299.2008.16370.x; Perez-Ramos IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077197; Perez-Ramos IM, 2013, PERSPECT PLANT ECOL, V15, P106, DOI 10.1016/j.ppees.2012.12.005; Puerta-Pinero C, 2010, OIKOS, V119, P179, DOI 10.1111/j.1600-0706.2009.17793.x; Pulido FJ, 2005, ECOSCIENCE, V12, P92, DOI 10.2980/i1195-6860-12-1-92.1; Retana J, 1999, ECOL STU AN, V137, P89; Rey PJ, 2000, J ECOL, V88, P622, DOI 10.1046/j.1365-2745.2000.00472.x; Smit C, 2008, J VEG SCI, V19, P193, DOI 10.3170/2007-8-18352; Smit C, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009028; Spiegel O, 2012, J ECOL, V100, P392, DOI 10.1111/j.1365-2745.2011.01886.x; Steele MA, 2014, BEHAV ECOL, V25, P206, DOI 10.1093/beheco/art107; Steele MA, 2011, ACTA OECOL, V37, P554, DOI 10.1016/j.actao.2011.05.002; Sunyer P, 2014, BEHAV ECOL SOCIOBIOL, V68, P1205, DOI 10.1007/s00265-014-1731-x; Sunyer P, 2013, FUNCT ECOL, V27, P1313, DOI 10.1111/1365-2435.12143; Urbieta IR, 2008, CAN J FOREST RES, V38, P2382, DOI 10.1139/X08-089; Vander Wall S. B., 2003, BEHAV ECOL, V84, P487; Vander Wall S. B., 1990, FOOD HOARDING ANIMAL, P3; Vander Wall SB, 2002, ECOLOGY, V83, P3508, DOI 10.2307/3072099; Wang B, 2013, OIKOS, V122, P1027, DOI 10.1111/j.1600-0706.2012.20823.x; Wang B, 2009, ECOLOGY, V90, P3023, DOI 10.1890/08-2188.1; Xiao ZS, 2013, J ECOL, V101, P1256, DOI 10.1111/1365-2745.12113; Xiao ZS, 2013, BEHAV ECOL SOCIOBIOL, V67, P1067, DOI 10.1007/s00265-013-1531-8; Xiao ZS, 2006, FOREST ECOL MANAG, V223, P18, DOI 10.1016/j.foreco.2005.10.054; Yan C, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2797; Zavala MA, 2000, BOT REV, V66, P119, DOI 10.1007/BF02857785; Zavala MA, 2011, CAN J FOREST RES, V41, P1432, DOI [10.1139/X11-050, 10.1139/x11-050]	64	22	22	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129844	10.1371/journal.pone.0129844	http://dx.doi.org/10.1371/journal.pone.0129844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070129	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000113
J	Wojczewski, S; Pentz, S; Blacklock, C; Hoffmann, K; Peersman, W; Nkomazana, O; Kutalek, R				Wojczewski, Silvia; Pentz, Stephen; Blacklock, Claire; Hoffmann, Kathryn; Peersman, Wim; Nkomazana, Oathokwa; Kutalek, Ruth			African Female Physicians and Nurses in the Global Care Chain: Qualitative Explorations from Five Destination Countries	PLOS ONE			English	Article							NATIONAL-HEALTH-SERVICE; SUB-SAHARAN AFRICA; FUTURE-DIRECTIONS; OVERSEAS NURSES; BRAIN-DRAIN; MIGRATION; GENDER; DISCRIMINATION; WOMEN; EXPERIENCES	Migration of health professionals is an important policy issue for both source and destination countries around the world. The majority of migrant care workers in industrialized countries today are women. However, the dimension of mobility of highly skilled females from countries of the global south has been almost entirely neglected for many years. This paper explores the experiences of high-skilled female African migrant health-workers (MHW) utilising the framework of Global Care Chain (GCC) research. In the frame of the EU-project HURAPRIM (Human Resources for Primary Health Care in Africa), the research team conducted 88 semi-structured interviews with female and male African MHWs in five countries (Botswana, South Africa, Belgium, Austria, UK) from July 2011 until April 2012. For this paper we analysed the 34 interviews with female physicians and nurses using the qualitative framework analysis approach and the software atlas.ti. In terms of the effect of the migration on their career, almost all of the respondents experienced short-term, long-term or permanent inability to work as health-care professionals; few however also reported a positive career development post-migration. Discrimination based on a foreign nationality, race or gender was reported by many of our respondents, physicians and nurses alike, whether they worked in an African or a European country. Our study shows that in addition to the phenomenon of deskilling often reported in GCC research, many female MHW are unable to work according to their qualifications due to the fact that their diplomas are not recognized in the country of destination. Policy strategies are needed regarding integration of migrants in the labour market and working against discrimination based on race and gender.	[Wojczewski, Silvia; Hoffmann, Kathryn; Kutalek, Ruth] Med Univ Vienna, Dept Gen Practice & Family Med, Ctr Publ Hlth, A-1090 Vienna, Austria; [Pentz, Stephen] Univ Witwatersrand, Dept Family Med, Johannesburg, South Africa; [Blacklock, Claire] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, Oxford OX2 6GG, England; [Peersman, Wim] Univ Ghent, Univ Hosp, Dept Family Med & Primary Healthcare, B-9000 Ghent, Belgium; [Nkomazana, Oathokwa] Univ Botswana, Sch Med, Med Educ Partnership Initiat Principal Investigat, Gaborone, Botswana	Medical University of Vienna; University of Witwatersrand; University of Oxford; Ghent University; Ghent University Hospital; University of Botswana	Wojczewski, S (corresponding author), Med Univ Vienna, Dept Gen Practice & Family Med, Ctr Publ Hlth, Kinderspitalgasse 15, A-1090 Vienna, Austria.	silvia.wojczewski@meduniwien.ac.at	Nkomazana, Oathokwa/AAP-7953-2020; Hoffmann, Kathryn/AAK-9099-2021; Peersman, Wim/K-3576-2019; Pentz, Stephen/C-8841-2013	Peersman, Wim/0000-0002-4276-7408; Wojczewski, Silvia/0000-0002-0065-7550; Hoffmann, Kathryn/0000-0001-8760-4250; Nkomazana, Oathokwa/0000-0002-2040-4059; Pentz, Stephen/0000-0001-6089-3988	European Union [265727]	European Union(European Commission)	The research leading to these results was done in the framework of the HURAPRIM project, which received funding from the European Union's Seventh Framework Programme (FP7-AFRICA-2010) under grant agreement no 265727.	Aboderin I, 2007, J CLIN NURS, V16, P2237, DOI 10.1111/j.1365-2702.2007.01999.x; Affairs CoEaJ, 1994, WOMEN HEALTH ISS, V4, P1; Aginam O, HUMNA COST AFRICAN M, V12007, P65, DOI [10.1080/19440049.2012.719644, DOI 10.1080/19440049.2012.719644]; Ahmad OB, 2004, B WORLD HEALTH ORGAN, V82, P797; AHO, 2009, AN SUMM HLTH WORKF; Astor A, 2005, SOC SCI MED, V61, P2492, DOI 10.1016/j.socscimed.2005.05.003; Awumbila M, 2008, CTR MIGRATION STUDIE; Awumbila M, 2008, NORSK GEOGR TIDSSKR, V62, P171, DOI 10.1080/00291950802335772; Batnitzky A, 2011, SOC CULT GEOGR, V12, P181, DOI 10.1080/14649365.2011.545142; Benatar S, 2011, GLOBAL HEALTH AND GLOBAL HEALTH ETHICS, P1, DOI 10.1017/CBO9780511984792; Bidwell P, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24194; Carr PL, 2000, ANN INTERN MED, V132, P889, DOI 10.7326/0003-4819-132-11-200006060-00007; Clemens MA, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-1; Commission E, 2012, COMMISSION STAFF DOC; Crenshaw K., 1991, STANFORD LAW REV, V43, P1241, DOI [https://doi.org/10.2307/1229039, DOI 10.2307/1229039]; Crompton R, 2005, WORK EMPLOY SOC, V19, P213, DOI 10.1177/0950017005053168; Cuban S, 2013, DESKILLING MIGRANT WOMEN IN THE GLOBAL CARE INDUSTRY, P1, DOI 10.1057/9781137305619; Do Health, 2010, GUIDELIENS APPL FORE; Do Health, 2010, S AFRICA DEP HLTH, P10; Dumont J.-C., 2007, IZA DISCUSSION PAPER; Ebermann E, 2002, AFRIKANER WIEN ZWIEC, P3; Eckenwiler L., 2014, WOMENS STUDIES INT F; Eckenwiler L, 2011, INT J FEM APPROACHES, V4, P1; England K, 2013, SOC CULT GEOGR, V14, P558, DOI 10.1080/14649365.2013.786789; Essed P., 2001, 45 SESS US COMM STAT; Eurofound, 2012, TREND JOB EUR; Fauvelle-Aymar C, 2014, MIGRATION EMPLOYEMEN; Garcia-Perez MA, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-201; Geets J, 2008, MEDISCHEN VERPLEEGKU; George SM, 2005, WHEN WOMEN COME FIRST: GENDER AND CLASS IN TRANSNATIONAL MIGRATION, P1; Gibbs G, 2008, ANAL QUALITATIVE DAT; Hagopian Amy, 2004, Hum Resour Health, V2, P17, DOI 10.1186/1478-4491-2-17; Herfs PGP, 2007, MED TEACH, V29, P383, DOI 10.1080/01421590701477399; Hochschild A.R., 2000, EDGE LIVING GLOBAL C, P130, DOI DOI 10.4324/9781315633794-21; Hofman NG, 2010, CULT DYN, V22, P179, DOI 10.1177/0921374010383852; Huish R, 2009, SOC SCI MED, V69, P301, DOI 10.1016/j.socscimed.2009.03.004; Iredale R, 2009, RECOGNITION SKILLS A; Jirovsky E, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0737-z; Juss Satvinder, 2006, INT MIGRATION GLOBAL; King R, 2009, GEOGR ANN B, V91B, P19, DOI 10.1111/j.1468-0467.2009.00304.x; Kirby KE, 2012, HEALTH CARE ANAL, V20, P152, DOI 10.1007/s10728-011-0178-8; Kluge S., 2010, EINZELFALL TYPUS FAL; Kofman E, 2005, GEOFORUM, V36, P149, DOI 10.1016/j.geoforum.2004.06.001; Konig R. S., 2010, INT J, V3, P1, DOI DOI 10.1080/17528630903368232; Likupe G, 2006, J CLIN NURS, V15, P1213, DOI 10.1111/j.1365-2702.2006.01380.x; Lutz H, 2012, SOC POLIT, V19, P15, DOI 10.1093/sp/jxr026; MAKINWAADEBUSOYE PK, 1994, INT SOCIOL, V9, P223, DOI 10.1177/026858094009002007; McNay L, 2000, GENDER AGENCY RECONF; Meares C, 2010, WOMEN STUD INT FORUM, V33, P473, DOI 10.1016/j.wsif.2010.06.001; Meghani Z., 2009, INT J FEM APPROACHES, V2, P77, DOI [10.3138/ijfab.2.1.77, DOI 10.3138/IJFAB.2.1.77]; Moosa S, 2014, BRIT J GEN PRACT, V64, pE321, DOI 10.3399/bjgp14X680089; Morrison A, 2008, INT MIGRATION WOMEN; Nkomazana O, 2014, AFR J PRIM HEALTH CA, V6, DOI 10.4102/phcfm.v6i1.716; O'Brien T, 2007, J CLIN NURS, V16, P2229, DOI 10.1111/j.1365-2702.2007.02096.x; Oosthuizen M., 2007, Health SA Gesondheid, V12, P14; Ouali N, 2012, CAN J WOMEN LAW, V24, P27, DOI 10.3138/cjwl.24.1.027; Pfeiffer L, 2008, INT MIGRATION WOMEN; Phoenix A, 2006, EUR J WOMENS STUD, V13, P187, DOI 10.1177/1350506806065751; Poppe A, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24071; Prescott M, 2014, SOC SCI MED, V107, P113, DOI 10.1016/j.socscimed.2014.02.026; Purkayastha B, 2005, GEOFORUM, V36, P181, DOI 10.1016/j.geoforum.2003.11.006; Raghuram P, 2009, GEOFORUM, V40, P25, DOI 10.1016/j.geoforum.2008.03.005; Raghuram P, 2007, J CLIN NURS, V16, P2246, DOI 10.1111/j.1365-2702.2007.02097.x; Raghuram P, 2009, GEOFORUM, V40, P5, DOI 10.1016/j.geoforum.2008.07.007; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Rodriguez A, 2011, INT MIGRATION DEV RE; Sabban R, 2002, GENDER PROMOTION PRO; Salami B, 2014, NURS INQ, V21, P153, DOI 10.1111/nin.12029; Schultheiss Katrin, 2010, Policy Polit Nurs Pract, V11, P151, DOI 10.1177/1527154410377356; Skeggs B, 2013, CLASS SELF; Smith P, 2007, J CLIN NURS, V16, P2213, DOI 10.1111/j.1365-2702.2007.01984.x; Smith P, 2007, J CLIN NURS, V16, P2185, DOI 10.1111/j.1365-2702.2006.01849.x; Spivak GC, 1988, CAN SUBALTERN SPECAK; Tjadens F., 2013, PROFESSIONALS HLTH S, P33; UNFPA IOM, 2006, FEM MIGR BRIDG GAPS; United Nations, 2013, INT MIGR REP 2013; Vaittinen T., 2014, WOMENS STUDIES INT F; Valiani Salimah, 2012, RETHINKING UNEQUAL E; WHO, 2006, WORK TOG HLTH WORLD; Williams F, 2010, SOC POLICY SOC, V9, P385, DOI 10.1017/S1474746410000102; Wismar M., 2011, HLTH PROFESSIONAL MO; Wright D, 2008, BRAIN DRAIN PHYS HIS, V3; Yasukawa K, 2014, TOHOKU J EXP MED, V232, P35, DOI 10.1620/tjem.232.35; Yeates N., 2005, GLOBAL CARE CHAINS C, V44; Yeates N, 2012, GLOBAL NETW, V12, P135, DOI 10.1111/j.1471-0374.2012.00344.x; Yeates Nicola., 2004, INT FEM J POLIT, V6, P369, DOI [10.1080/1461674042000235573, DOI 10.1080/1461674042000235573]; Yeoh BSA, 2005, GEOFORUM, V36, P211, DOI 10.1016/j.geoforum.2003.07.004	87	23	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129464	10.1371/journal.pone.0129464	http://dx.doi.org/10.1371/journal.pone.0129464			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26068218	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000078
J	Dileepan, T; Kim, HO; Cleary, PP; Skinner, PJ				Dileepan, Thamotharampillai; Kim, Hyeon O.; Cleary, P. Patrick; Skinner, Pamela J.			In Situ Peptide-MHC-II Tetramer Staining of Antigen-Specific CD4(+) T Cells in Tissues	PLOS ONE			English	Article								The invention of peptide-MHC-tetramer technology to label antigen-specific T cells has led to an enhanced understanding of T lymphocyte biology. Here we describe the development of an in situ pMHC-II tetramer staining method to visualize antigen-specific CD4(+) T cells in tissues. This method complements other methods developed that similarly use MHC class II reagents to stain antigen-specific CD4(+) T cells in situ. In this study, we used group A streptococcus (GAS) expressing a surrogate peptide (2W) to inoculate C57BL/6 mice, and used fresh nasal-associated lymphoid tissues (NALT) in optimizing the in situ staining of 2W:I-A(b) specific CD4(+) T cells. The results showed 2W:I-A(b) tetramer-binding CD4(+) T cells in GAS-2W but not GAS infected mice. This method holds promise to be broadly applicable to study the localization, abundance, and phenotype of antigen-specific CD4(+) T cells in undisrupted tissues.	[Dileepan, Thamotharampillai; Cleary, P. Patrick] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Kim, Hyeon O.; Skinner, Pamela J.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Skinner, PJ (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	skinn002@umn.edu		DILEEPAN, THAMOTHARAMPILLAI/0000-0002-2810-6996; Skinner, Pamela/0000-0003-3388-1687	Venture Research Project grant from the Wisconsin National Primate Research Center; NIH [P30 CA77598]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	Venture Research Project grant from the Wisconsin National Primate Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Venture Research Project grant from the Wisconsin National Primate Research Center (PJS) and in part by NIH P30 CA77598 utilizing the Masonic Cancer Center, University of Minnesota shared flow cytometer resource. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischof F, 2004, J IMMUNOL, V172, P2878, DOI 10.4049/jimmunol.172.5.2878; Dileepan T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002252; Dombek PE, 1999, MOL MICROBIOL, V31, P859, DOI 10.1046/j.1365-2958.1999.01223.x; Li Y, 2011, IMMUNOBIOLOGY, V216, P947, DOI 10.1016/j.imbio.2011.01.003; Massilamany C, 2014, JOVE-J VIS EXP, DOI 10.3791/51679; Massilamany C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087519; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Skinner PJ, 2000, J IMMUNOL, V165, P613, DOI 10.4049/jimmunol.165.2.613; Skinner PJ, 2002, J IMMUNOL METHODS, V268, P29, DOI 10.1016/S0022-1759(02)00197-7; Skinner PJ, 2005, CURR PROTOC IMMUNOL; Wang BN, 2010, P NATL ACAD SCI USA, V107, P5937, DOI 10.1073/pnas.0904831107	14	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128862	10.1371/journal.pone.0128862	http://dx.doi.org/10.1371/journal.pone.0128862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067103	gold, Green Submitted, Green Published			2022-12-27	WOS:000356100900032
J	Priestley, M; Mesoudi, A				Priestley, Maria; Mesoudi, Alex			Do Online Voting Patterns Reflect Evolved Features of Human Cognition? An Exploratory Empirical Investigation	PLOS ONE			English	Article							SOCIAL-INFLUENCE; EVOLUTION; CULTURE; PSYCHOLOGY; PUNISHMENT; SELECTION; PRESTIGE; BIAS	Online votes or ratings can assist internet users in evaluating the credibility and appeal of the information which they encounter. For example, aggregator websites such as Reddit allow users to up-vote submitted content to make it more prominent, and down-vote content to make it less prominent. Here we argue that decisions over what to up-or down-vote may be guided by evolved features of human cognition. We predict that internet users should be more likely to up-vote content that others have also up-voted (social influence), content that has been submitted by particularly liked or respected users (model-based bias), content that constitutes evolutionarily salient or relevant information (content bias), and content that follows group norms and, in particular, prosocial norms. 489 respondents from the online social voting community Reddit rated the extent to which they felt different traits influenced their voting. Statistical analyses confirmed that norm-following and prosociality, as well as various content biases such as emotional content and originality, were rated as important motivators of voting. Social influence had a smaller effect than expected, while attitudes towards the submitter had little effect. This exploratory empirical investigation suggests that online voting communities can provide an important test-bed for evolutionary theories of human social information use, and that evolved features of human cognition may guide online behaviour just as it guides behaviour in the offline world.	[Priestley, Maria; Mesoudi, Alex] Univ Durham, Dept Anthropol, Durham, England	Durham University	Mesoudi, A (corresponding author), Univ Durham, Dept Anthropol, Durham, England.	a.mesoudi@exeter.ac.uk	Mesoudi, Alex/K-4410-2012	Mesoudi, Alex/0000-0002-7740-1625				Allport GW, 1947, THE PSYCHOLOGY OF RU; Aoki K., 2013, THEORETICAL POPULATI, V90, P64, DOI DOI 10.1016/J.TPB.2013.09.002; Atkisson C, 2012, EVOL PSYCHOL-US, V10, P519, DOI 10.1177/147470491201000309; Bandura Albert, 1977, SOCIAL LEARNING THEO; Berger J, 2012, J MARKETING RES, V49, P192, DOI 10.1509/jmr.10.0353; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; BOYD R, 1995, ETHOL SOCIOBIOL, V16, P125, DOI 10.1016/0162-3095(94)00073-G; Boyd R., 1985, CULTURE EVOLUTIONARY; Bressler ER, 2006, EVOL HUM BEHAV, V27, P121, DOI 10.1016/j.evolhumbehav.2005.09.001; Cao Q, 2011, DECIS SUPPORT SYST, V50, P511, DOI 10.1016/j.dss.2010.11.009; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Christensen R. H. B., 2014, ORDINAL REGRESSION M, P11; Chudek M, 2012, EVOL HUM BEHAV, V33, P46, DOI 10.1016/j.evolhumbehav.2011.05.005; Chudek M, 2011, TRENDS COGN SCI, V15, P218, DOI 10.1016/j.tics.2011.03.003; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Di Stefano C., 2009, PRACT ASSESS RES EVA, V14, P11; Eriksson K, 2014, J COGN CULT, V14, P1, DOI 10.1163/15685373-12342107; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Gachter S, 2010, PHILOS T R SOC B, V365, P2651, DOI 10.1098/rstb.2010.0135; Gilbert Eric, 2013, P 2013 C COMP SUPP C, P803, DOI DOI 10.1145/2441776.2441866; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; Heath C, 2001, J PERS SOC PSYCHOL, V81, P1028, DOI 10.1037//0022-3514.81.6.1028; Henrich J, 2003, EVOL ANTHROPOL, V12, P123, DOI 10.1002/evan.10110; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Jessen J, 2012, FIRST MONDAY, P17; Laland KN, 2004, LEARN BEHAV, V32, P4; McElreath R, 2008, PHILOS T R SOC B, V363, P3515, DOI 10.1098/rstb.2008.0131; Mesoudi A, 2011, CULTURAL EVOLUTION; Mesoudi A, 2008, AM ANTIQUITY, V73, P3, DOI 10.2307/25470456; Mesoudi A, 2006, BRIT J PSYCHOL, V97, P405, DOI 10.1348/000712605X85871; Mesoudi A, 2011, EVOL HUM BEHAV, V32, P334, DOI 10.1016/j.evolhumbehav.2010.12.001; Mesoudi A, 2009, PSYCHOL REV, V116, P929, DOI 10.1037/a0017062; Morgan TJH, 2012, P ROY SOC B-BIOL SCI, V279, P653, DOI 10.1098/rspb.2011.1172; Muchnik L, 2013, SCIENCE, V341, P647, DOI 10.1126/science.1240466; Mundry R, 2009, AM NAT, V173, P119, DOI 10.1086/593303; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Norenzayan A, 2006, COGNITIVE SCI, V30, P531, DOI 10.1207/s15516709cog0000_68; R Core Team, 2014, R A LANGUAGE AND ENV, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Rakoczy H, 2008, DEV PSYCHOL, V44, P875, DOI 10.1037/0012-1649.44.3.875; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Rendell L, 2011, TRENDS COGN SCI, V15, P68, DOI 10.1016/j.tics.2010.12.002; Revelle W, 2014, PSYCH PROCEDURES FOR; Richerson PJ., 2013, CULTURAL EVOLUTION S; Richerson PJ, 2005, NOT BY GENES ALONE; Saldana J, 2012, THE CODING MANUAL FO; Salganik MJ, 2009, TOP COGN SCI, V1, P439, DOI 10.1111/j.1756-8765.2009.01030.x; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Sperber D, 2004, TRENDS COGN SCI, V8, P40, DOI 10.1016/j.tics.2003.11.002; Sperber D., 1985, RELEVANCE COMMUNICAT, VSecond; Sperber Dan, 1996, EXPLAINING CULTURE A; Sripada C. S., 2007, INNATE MIND CULTURE, V2, P280; Stubbersfield JM, 2015, BRIT J PSYCHOL, V106, P288, DOI 10.1111/bjop.12073; Tomasello M., 1999, THE CULTURAL ORIGINS; West SA, 2011, EVOL HUM BEHAV, V32, P231, DOI 10.1016/j.evolhumbehav.2010.08.001; Whiten A., 2012, CULTURE EVOLVES	57	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129703	10.1371/journal.pone.0129703	http://dx.doi.org/10.1371/journal.pone.0129703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK3FB	26066657	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000356100900072
J	Tsuchiya, M; Giuliani, A; Hashimoto, M; Erenpreisa, J; Yoshikawa, K				Tsuchiya, Masa; Giuliani, Alessandro; Hashimoto, Midori; Erenpreisa, Jekaterina; Yoshikawa, Kenichi			Emergent Self-Organized Criticality in Gene Expression Dynamics: Temporal Development of Global Phase Transition Revealed in a Cancer Cell Line	PLOS ONE			English	Article							NETWORKS; NORMALIZATION; EPIGENETICS; HYPOTHESIS; RANGE	Background The underlying mechanism of dynamic control of the genome-wide expression is a fundamental issue in bioscience. We addressed it in terms of phase transition by a systemic approach based on both density analysis and characteristics of temporal fluctuation for the time-course mRNA expression in differentiating MCF-7 breast cancer cells. Methodology In a recent work, we suggested criticality as an essential aspect of dynamic control of genome-wide gene expression. Criticality was evident by a unimodal-bimodal transition through flattened unimodal expression profile. The flatness on the transition suggests the existence of a critical transition at which up- and down-regulated expression is balanced. Mean field (averaging) behavior of mRNAs based on the temporal expression changes reveals a sandpile type of transition in the flattened profile. Furthermore, around the transition, a self-similar unimodal-bimodal transition of the whole expression occurs in the density profile of an ensemble of mRNA expression. These singular and scaling behaviors identify the transition as the expression phase transition driven by self-organized criticality (SOC). Principal Findings Emergent properties of SOC through a mean field approach are revealed: i) SOC, as a form of genomic phase transition, consolidates distinct critical states of expression, ii) Coupling of coherent stochastic oscillations between critical states on different time-scales gives rise to SOC, and iii) Specific gene clusters (barcode genes) ranging in size from kbp to Mbp reveal similar SOC to genome-wide mRNA expression and ON-OFF synchronization to critical states. This suggests that the cooperative gene regulation of topological genome sub-units is mediated by the coherent phase transitions of megadomain-scaled conformations between compact and swollen chromatin states. Conclusion and Significance In summary, our study provides not only a systemic method to demonstrate SOC in whole-genome expression, but also introduces novel, physically grounded concepts for a breakthrough in the study of biological regulation.	[Tsuchiya, Masa] Keio Univ, Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan; [Giuliani, Alessandro] Ist Super Sanit, Environm & Hlth Dept, Rome, Italy; [Hashimoto, Midori] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Erenpreisa, Jekaterina] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Yoshikawa, Kenichi] Doshisha Univ, Fac Life & Med Sci, Kyotanabe, Japan	Keio University; Istituto Superiore di Sanita (ISS); University of Tokyo; Latvian Biomedical Research & Study Centre; Doshisha University	Tsuchiya, M (corresponding author), Keio Univ, Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan.	tsuchiya.masa@gmail.com; alessandro.giuliani@iss.it; keyoshik@mail.doshisha.ac.jp	Giuliani, Alessandro/K-7589-2016; Giuliani, Alessandro/AAF-1740-2020; Yoshikawa, Kenichi/N-1867-2019	Giuliani, Alessandro/0000-0002-4640-804X; Giuliani, Alessandro/0000-0002-4640-804X; Yoshikawa, Kenichi/0000-0002-2751-7136	Japan Society for the Promotion of Science (KAKENHI) [15H02121, 2510301]; European Social Fund, Latvia [1DP/1.1.1.2/APIA/VIAA/037]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); European Social Fund, Latvia	This study was supported in part by Japan Society for the Promotion of Science (Grants-in-Aid, KAKENHI: Nos. 15H02121 and 2510301) and by European Social Fund (grant Nr 1DP/1.1.1.2/APIA/VIAA/037), Latvia.	Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; Bachmann M., 2014, THERMODYNAMICS STAT; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Barbieri M, 2012, P NATL ACAD SCI USA, V109, P16173, DOI 10.1073/pnas.1204799109; BEEBE KR, 1987, ANAL CHEM, V59, pA1007, DOI 10.1021/ac00144a725; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bornfleth H, 1999, BIOPHYS J, V77, P2871, DOI 10.1016/S0006-3495(99)77119-5; Censi F, 2011, IEEE T BIO-MED ENG, V58, P2943, DOI 10.1109/TBME.2011.2150747; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; FITZHUGH R, 1955, B MATH BIOL, V17, P257, DOI DOI 10.1007/BF02477753; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Ginzburg V.L., 1950, J. Exp. Theor. Phys, V20, P1064, DOI DOI 10.1007/978-3-540-68008-6_4; Giuliani A, 2014, ADV SYST BIO, V3, P3; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; IZHIKEVICH E. M., 2006, SCHOLARPEDIA, V1, P1349, DOI 10.4249/scholarpedia.1349; Jensen H.J., 1998, SELF ORG CRITICALITY; Kauffman S.A., 1993, ORIGINS ORDER; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Koren A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-164; Laue T, 2011, NAT CHEM BIOL, V7, P331, DOI 10.1038/nchembio.575; Ld L, 1937, ZH EXPER THEOR FIZ, V7, P19, DOI DOI 10.1038/138840A0; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Markovic D, 2014, PHYS REP, V536, P41, DOI 10.1016/j.physrep.2013.11.002; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; Mirkin SM, 2001, ENCYCLOPEDIA OF LIFE; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Plenz D., 2014, CRITICALITY NEURAL S; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rosenfeld S, 2011, GENE REGUL SYST BIO, V5, P27, DOI 10.4137/GRSB.S6804; Saeki Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-545; Sexton T, 2009, SEMIN CELL DEV BIOL, V20, P849, DOI 10.1016/j.semcdb.2009.06.004; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Shu GP, 2003, COMP FUNCT GENOM, V4, P287, DOI 10.1002/cfg.290; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Takagi S, 1999, LANGMUIR, V15, P4143, DOI 10.1021/la981158o; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takenaka Y, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.031905; Tompa P, 2011, PROTEIN SCI, V20, P2074, DOI 10.1002/pro.747; Tsuchiya M., 2012, Proceedings of the 2012 ICME International Conference on Complex Medical Engineering (CME), P744, DOI 10.1109/ICCME.2012.6275649; Tsuchiya M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097411; Tsuchiya M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012116; Tsuchiya M, 2009, PHYSICA A, V388, P1738, DOI 10.1016/j.physa.2008.12.030; Tsuchiya M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004905; Van Bortle K, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r82; Waddington C H, 1957, STRATEGY GENES DISCU; WEINBERG AM, 1982, INTERDISCIPL SCI REV, V7, P47, DOI 10.1179/030801882789801322; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yasar F, 2005, INT J MOD PHYS C, V16, P427, DOI 10.1142/S0129183105007224; Yoshikawa K, 1999, CHEM PHYS LETT, V303, P10, DOI 10.1016/S0009-2614(99)00203-1; Yoshikawa K, 2002, J BIOL PHYS, V28, P701, DOI 10.1023/A:1021251125101; Yoshikawa K., 2002, PHARM PROPERTIES NUC, P137; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; [No title captured]; [No title captured]	64	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128565	10.1371/journal.pone.0128565	http://dx.doi.org/10.1371/journal.pone.0128565			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067993	Green Submitted, gold, Green Published			2022-12-27	WOS:000356100900025
J	Zhao, LS; Xiong, ZL; Lu, XM; Zheng, SN; Wang, F; Ge, L; Su, GY; Yang, JY; Wu, CF				Zhao, Longshan; Xiong, Zhili; Lu, Xiumei; Zheng, Shuning; Wang, Fang; Ge, Lin; Su, Guangyue; Yang, Jingyu; Wu, Chunfu			Metabonomic Evaluation of Chronic Unpredictable Mild Stress-Induced Changes in Rats by Intervention of Fluoxetine by HILIC-UHPLC/MS	PLOS ONE			English	Article							AMINO-ACIDS; METABOLOMICS; CHROMATOGRAPHY; HOMOCYSTEINE; SERINE; METABOLISM; DEPRESSION; SEPARATION; GLYCINE; SYSTEMS	Hydrophilic interaction-ultra high performance liquid chromatography (HILIC-UHPLC) allows the analysis of highly polar metabolites, providing complementary information to reversed-phase (RP) chromatography. By optimization of the preparation and analytical conditions in HILIC mode, HILIC-UHPLC/MS was applied for the global metabolic profiling of rat plasma samples generated in an experimental model of chronic unpredictable mild stress (CUMS), and the concomitant investigation of the protective effect of fluoxetine was also evaluated. Identification of plasma metabolic profiles indicated that significant changes in specific metabolites occurred after fluoxetine exposure, including increased phenylalanine, serine, acetyl-L-carnitine, carnitine and decreased creatine, betaine, proline, tryptophan, tyrosine, C16:0 LPC. Some novel biomarkers from this HILIC-UHPLC/MS approach were betaine, proline, tyrosine creatine and serine compared with the results of RP-UHPLC/ MS. The complementary nature of this technique is confirmed and is on agreement with previously published studies.	[Zhao, Longshan; Xiong, Zhili; Lu, Xiumei; Zheng, Shuning] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Liaoning, Peoples R China; [Wang, Fang; Ge, Lin; Yang, Jingyu; Wu, Chunfu] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang, Liaoning, Peoples R China; [Su, Guangyue] Shenyang Pharmaceut Univ, Dept Tradit Chinese Mat Med, Shenyang, Peoples R China	Shenyang Pharmaceutical University; Shenyang Pharmaceutical University; Shenyang Pharmaceutical University	Xiong, ZL (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Liaoning, Peoples R China.	bearry200@126.com; chunfuw@gmail.com	Su, Guangyue/FHL-9255-2022	, Jingyu Yang/0000-0002-2791-5281	Key project of National Natural Science Foundation of China, P.R. China [81130071]	Key project of National Natural Science Foundation of China, P.R. China	Key project of National Natural Science Foundation of China (81130071), P.R. China.	ALPERT AJ, 1990, J CHROMATOGR, V499, P177, DOI 10.1016/S0021-9673(00)96972-3; Altamura C, 1995, EUR NEUROPSYCHOPHARM, V5, P71, DOI 10.1016/0924-977X(95)00033-L; Dimopoulos N, 2007, CLIN BIOCHEM, V40, P604, DOI 10.1016/j.clinbiochem.2007.01.007; Dunn WB, 2012, BIOANALYSIS, V4, P2249, DOI [10.4155/BIO.12.204, 10.4155/bio.12.204]; Evans CR, 2014, J PROTEOME RES, V13, P640, DOI 10.1021/pr4007624; Fei F, 2014, ANAL BIOANAL CHEM, V406, P3723, DOI 10.1007/s00216-014-7797-5; HASHIMOTO R, 1990, NEUROPSYCHOBIOLOGY, V23, P140, DOI 10.1159/000119441; Hoekstra R, 2001, PSYCHIAT RES, V103, P115, DOI 10.1016/S0165-1781(01)00282-7; Koek MM, 2006, ANAL CHEM, V78, P1272, DOI 10.1021/ac051683+; Li X, 2010, METABOLOMICS, V6, P109, DOI 10.1007/s11306-009-0184-0; Lin YP, 2009, TOXICOLOGY, V256, P191, DOI 10.1016/j.tox.2008.11.018; Liu XY, 2012, J ETHNOPHARMACOL, V139, P311, DOI 10.1016/j.jep.2011.11.017; Lutz U, 2006, ANAL CHEM, V78, P4564, DOI 10.1021/ac0522299; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Perna AF, 2003, AMINO ACIDS, V25, P409, DOI 10.1007/s00726-003-0026-8; SAKS VA, 1985, J BIOL CHEM, V260, P7757; Santos PM, 2009, BRAIN RES BULL, V80, P327, DOI 10.1016/j.brainresbull.2009.09.007; SCHILDKRAUT JJ, 1965, AM J PSYCHIAT, V122, P509, DOI 10.1176/ajp.122.5.509; Serviere C, 2005, MECH SYST SIGNAL PR, V19, P1293, DOI 10.1016/j.ymssp.2005.08.001; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Sumiyoshi T, 2004, INT J NEUROPSYCHOPH, V7, P1, DOI 10.1017/S1461145703003900; Sun H, 2014, APPL BIOCHEM BIOTECH, V173, P857, DOI 10.1007/s12010-014-0903-5; Tang DQ, 2016, MASS SPECTROM REV, V35, P574, DOI 10.1002/mas.21445; Tian N, 2013, METABOLOMICS, V9, P1228, DOI 10.1007/s11306-013-0535-8; Tolmunen T, 2004, AM J CLIN NUTR, V80, P1574, DOI 10.1093/ajcn/80.6.1574; Tonoli D, 2012, CHIMIA, V66, P218, DOI 10.2533/chimia.2012.218; Wang JS, 2009, METABOLOMICS, V5, P407, DOI 10.1007/s11306-009-0165-3; WAZIRI R, 1984, PSYCHIAT RES, V12, P121, DOI 10.1016/0165-1781(84)90012-X; Zhang AH, 2012, APPL BIOCHEM BIOTECH, V168, P1718, DOI 10.1007/s12010-012-9891-5; Zhao LS, 2014, TRAC-TREND ANAL CHEM, V63, P170, DOI 10.1016/j.trac.2014.08.006; Zheng SN, 2011, METABOLOMICS, V7, P413, DOI 10.1007/s11306-010-0261-4	32	7	8	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129146	10.1371/journal.pone.0129146	http://dx.doi.org/10.1371/journal.pone.0129146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080063	Green Published, Green Submitted, gold			2022-12-27	WOS:000356542300016
J	Finiguerra, M; Avery, DE; Dam, HG				Finiguerra, Michael; Avery, David E.; Dam, Hans G.			Determining the Advantages, Costs, and Trade-Offs of a Novel Sodium Channel Mutation in the Copepod Acartia hudsonica to Paralytic Shellfish Toxins (PST)	PLOS ONE			English	Article							ALEXANDRIUM-FUNDYENSE; FEEDING-BEHAVIOR; BINDING-PROTEIN; EGG-PRODUCTION; RESISTANCE; ZOOPLANKTON; SELECTION; DINOFLAGELLATE; MECHANISMS; TOLERANCE	The marine copepod Acartia hudsonica was shown to be adapted to dinoflagellate prey, Alexandrium fundyense, which produce paralytic shellfish toxins (PST). Adaptation to PSTs in other organisms is caused by a mutation in the sodium channel. Recently, a mutation in the sodium channel in A. hudsonica was found. In this study, we rigorously tested for advantages, costs, and trade-offs associated with the mutant isoform of A. hudsonica under toxic and non-toxic conditions. We combined fitness with wild-type: mutant isoform ratio measurements on the same individual copepod to test our hypotheses. All A. hudsonica copepods express both the wild-type and mutant sodium channel isoforms, but in different proportions; some individuals express predominantly mutant (PMI) or wild-type isoforms (PWI), while most individuals express relatively equal amounts of each (EI). There was no consistent pattern of improved performance as a function of toxin dose for egg production rate (EPR), ingestion rate (I), and gross growth efficiency (GGE) for individuals in the PMI group relative to individuals in the PWI expression group. Neither was there any evidence to indicate a fitness benefit to the mutant isoform at intermediate toxin doses. No clear advantage under toxic conditions was associated with the mutation. Using a mixed-diet approach, there was also no observed relationship between individual wild-type: mutant isoform ratios and among expression groups, on both toxic and non-toxic diets, for eggs produced over three days. Lastly, expression of the mutant isoform did not mitigate the negative effects of the toxin. That is, the reductions in EPR from a toxic to non-toxic diet for copepods were independent of expression groups. Overall, the results did not support our hypotheses; the mutant sodium channel isoform does not appear to be related to adaptation to PST in A. hudsonica. Other potential mechanisms responsible for the adaptation are discussed.	[Finiguerra, Michael; Avery, David E.; Dam, Hans G.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	University of Connecticut	Finiguerra, M (corresponding author), Univ Connecticut, Ecol & Evolutionary Biol, 1080 Shennecosset Rd, Groton, CT 06435 USA.	Michael.finiguerra@uconn.edu	Dam, Hans G/A-9723-2015	Dam, Hans G/0000-0001-6121-5038	National Science Foundation [IOS-0950852]; Direct For Biological Sciences [0950852] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation #IOS-0950852 awarded to HD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agra AR, 2010, ENVIRON TOXICOL CHEM, V29, P939, DOI 10.1002/etc.97; Anderson PAV, 2005, HARMFUL ALGAE, V4, P95, DOI 10.1016/j.hal.2003.12.007; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Avery DE, 2007, LIMNOL OCEANOGR, V52, P2099, DOI 10.4319/lo.2007.52.5.2099; Bamstedt U., 2000, P297; BANSE K, 1995, ICES J MAR SCI, V52, P265, DOI 10.1016/1054-3139(95)80043-3; Barata C, 2002, ENVIRON TOXICOL CHEM, V21, P1058, DOI [10.1897/1551-5028(2002)021<1058:AAWPVI>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;1058:AAWPVI&gt;2.0.CO;2]; Barreiro A, 2006, MAR ECOL PROG SER, V316, P115, DOI 10.3354/meps316115; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Besiktepe S, 2002, MAR ECOL PROG SER, V229, P151, DOI 10.3354/meps229151; Bricelj VM, 2005, NATURE, V434, P763, DOI 10.1038/nature03415; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Chen L, 2010, MOL APPROACH STUDY S; Chen L, 2015, J EXP MAR BIOL ECOL; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Colin SP, 2007, HARMFUL ALGAE, V6, P875, DOI 10.1016/j.hal.2007.05.003; Colin Sean P., 2002, Harmful Algae, V1, P113, DOI 10.1016/S1568-9883(02)00007-0; Colin SP, 2004, EVOL ECOL, V18, P355, DOI 10.1007/s10682-004-2369-3; Colin SP, 2003, MAR ECOL PROG SER, V248, P55, DOI 10.3354/meps248055; Colin SP, 2002, LIMNOL OCEANOGR, V47, P1430, DOI 10.4319/lo.2002.47.5.1430; Connell LB, 2007, MAR BIOL, V150, P1227, DOI 10.1007/s00227-006-0432-z; Coustau C, 2000, TRENDS ECOL EVOL, V15, P378, DOI 10.1016/S0169-5347(00)01929-7; Dam HG, 2013, ANNU REV MAR SCI, V5, P349, DOI 10.1146/annurev-marine-121211-172229; Dam HG, 2011, HARMFUL ALGAE, V10, P245, DOI 10.1016/j.hal.2010.10.004; Falconer DS, 1996, INTRODUCTION TO QUAN; Fallang A, 2005, DIS AQUAT ORGAN, V65, P129, DOI 10.3354/dao065129; Finiguerra MB, 2013, DETERMINING THE ROLE; Finiguerra M, 2014, ECOL EVOL, V4, P3470, DOI 10.1002/ece3.1197; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Geffeney S, 2002, SCIENCE, V297, P1336, DOI 10.1126/science.1074310; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Gustafsson S, 2004, AQUAT ECOL, V38, P37, DOI 10.1023/B:AECO.0000020985.47348.5e; Hairston NG, 2001, EVOLUTION, V55, P2203, DOI 10.1111/j.0014-3820.2001.tb00736.x; Hattenrath-Lehmann TK, 2011, HARMFUL ALGAE, V11, P106, DOI 10.1016/j.hal.2011.08.005; Hirst AG, 2001, MAR ECOL PROG SER, V223, P179, DOI 10.3354/meps223179; Horn R, 2007, NATURE, V446, P32, DOI 10.1038/446032a; HUMES AG, 1994, HYDROBIOLOGIA, V293, P1, DOI 10.1007/BF00229916; IVES JD, 1987, J EXP MAR BIOL ECOL, V112, P131, DOI 10.1016/0022-0981(87)90113-4; KIORBOE T, 1985, MAR ECOL PROG SER, V26, P85, DOI 10.3354/meps026085; Kwok KWH, 2009, ECOTOX ENVIRON SAFE, V72, P358, DOI 10.1016/j.ecoenv.2008.03.014; Lenarcic B, 2000, J BIOL CHEM, V275, P15572, DOI 10.1074/jbc.M001406200; Lenz PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088589; LERCHE H, 1993, J PHYSIOL-LONDON, V470, P13, DOI 10.1113/jphysiol.1993.sp019843; Liebeskind BJ, 2012, MOL BIOL EVOL, V29, P3613, DOI 10.1093/molbev/mss182; Llewellyn LE, 2009, SODIUM CHANNEL INHIB; Meyer JN, 2003, ECOL APPL, V13, P490, DOI 10.1890/1051-0761(2003)013[0490:HAAFCI]2.0.CO;2; MORABITO MA, 1994, P NATL ACAD SCI USA, V91, P2478, DOI 10.1073/pnas.91.7.2478; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; PRIGOGINE I, 1972, PHYS TODAY, V25, P38; Purrington CB, 2000, CURR OPIN PLANT BIOL, V3, P305, DOI 10.1016/S1369-5266(00)00085-6; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Reinikainen M, 1998, ECOTOX ENVIRON SAFE, V40, P77, DOI 10.1006/eesa.1998.1645; Rigby MC, 2002, TRENDS PARASITOL, V18, P116, DOI 10.1016/S1471-4922(01)02203-6; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Senft C, 2011, HARMFUL ALGAE, V10, P804, DOI 10.1016/j.hal.2011.06.014; Senft-Batoh C, 2012, GRAZER INDUCED TOXIN; Senft-Batoh CD, 2015, LIMNOL OCEANOGR, V60, P318, DOI 10.1002/lno.10027; Shirley MDF, 1999, EVOLUTION, V53, P826, DOI 10.1111/j.1558-5646.1999.tb05376.x; SHUMWAY S E, 1990, Journal of the World Aquaculture Society, V21, P65, DOI 10.1111/j.1749-7345.1990.tb00529.x; Sokal RR, 1995, BIOMETRY; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Teegarden GJ, 1999, MAR ECOL PROG SER, V181, P163, DOI 10.3354/meps181163; Teegarden GJ, 2001, MAR ECOL PROG SER, V218, P213, DOI 10.3354/meps218213; Teegarden GJ, 2008, HARMFUL ALGAE, V7, P33, DOI 10.1016/j.hal.2007.05.010; Turner JT, 2005, DEEP-SEA RES PT II, V52, P2801, DOI 10.1016/j.dsr2.2005.06.011; Turner JT, 1997, LIMNOL OCEANOGR, V42, P1203, DOI 10.4319/lo.1997.42.5_part_2.1203; Turner JT, 1984, THE FEEDING ECOLOGY; Urbani A, 2000, EUR J NEUROSCI, V12, P3567, DOI 10.1046/j.1460-9568.2000.00242.x; UYE S, 1990, MAR ECOL PROG SER, V59, P97, DOI 10.3354/meps059097; Yotsu-Yamashita M, 2001, EUR J BIOCHEM, V268, P5937, DOI 10.1046/j.0014-2956.2001.02547.x; Zhang H, 2013, J EXP MAR BIOL ECOL, V446, P57, DOI 10.1016/j.jembe.2013.04.021	72	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130097	10.1371/journal.pone.0130097	http://dx.doi.org/10.1371/journal.pone.0130097			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075900	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900138
J	Kotzen, M; Sell, J; Mathes, RW; Dentinger, C; Lee, L; Schiff, C; Weiss, D				Kotzen, Mollie; Sell, Jessica; Mathes, Robert W.; Dentinger, Catherine; Lee, Lillian; Schiff, Corinne; Weiss, Don			Using Syndromic Surveillance to Investigate Tattoo-Related Skin Infections in New leYork City	PLOS ONE			English	Article								In response to two isolated cases of Mycobacterium chelonae infections in tattoo recipients where tap water was used to dilute ink, the New York City (NYC) Department of Health and Mental Hygiene conducted an investigation using Emergency Department (ED) syndromic surveillance to assess whether an outbreak was occuring. ED visits with chief complaints containing the key word "tattoo" from November 1, 2012 to March 18, 2013 were selected for study. NYC laboratories were also contacted and asked to report skin or soft tissue cultures in tattoo recipients that were positive for non-tuberculosis mycobacterial infection (NTM). Thirty-one TREDV were identified and 14 (45%) were interviewed to determine if a NTM was the cause for the visit. One ED visit met the case definition and was referred to a dermatologist. This individual was negative for NTM. No tattoo-associated NTM cases were reported by NYC laboratories. ED syndromic surveillance was utilized to investigate a non-reportable condition for which no other data source existed. The results were reassuring that an outbreak of NTM in tattoo recipients was not occurring. In response to concerns about potential NTM infections, the department sent a letter to all licensed tattoo artists advising them not to dilute tattoo ink with tap water.	[Kotzen, Mollie; Sell, Jessica; Mathes, Robert W.; Dentinger, Catherine; Lee, Lillian; Schiff, Corinne; Weiss, Don] New York City Dept Hlth & Mental Hyg, Queens, NY 11101 USA; [Dentinger, Catherine] Ctr Dis Control & Prevent, Atlanta, GA USA; [Kotzen, Mollie] NYU, New York, NY USA	New York City Department of Health & Mental Hygiene; Centers for Disease Control & Prevention - USA; New York University	Mathes, RW (corresponding author), New York City Dept Hlth & Mental Hyg, Queens, NY 11101 USA.	rmathes@health.nyc.gov						Braverman S, 2012, HARRIS INTERACTICVE, V22, DOI [10.1186/1687-9856-2012-22, DOI 10.1186/1687-9856-2012-22]; (CDC) CfDCaP, 2004, MMWR MORB MORTAL WKL, V53, P95; Kennedy BS, 2012, NEW ENGL J MED, V367, P1020, DOI 10.1056/NEJMoa1205114; Kluger N, 2012, AM J EMERG MED, V30, P2055, DOI 10.1016/j.ajem.2012.06.014; Laumann AE, 2006, J AM ACAD DERMATOL, V55, P413, DOI 10.1016/j.jaad.2006.03.026; Tohme RA, 2012, CLIN INFECT DIS, V54, P1167, DOI 10.1093/cid/cir991; Urdang M, 2011, WEST J EMERG MED, V12, P393, DOI 10.5811/westjem.2011.4.2268	7	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130468	10.1371/journal.pone.0130468	http://dx.doi.org/10.1371/journal.pone.0130468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076006	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900175
J	Liu, ZL; Shen, F; Zhu, XM; Li, FJ; Tan, MQ				Liu, Ziliang; Shen, Fang; Zhu, Xiaomin; Li, Fengjie; Tan, Mengqi			Formation Conditions and Sedimentary Characteristics of a Triassic Shallow Water Braided Delta in the Yanchang Formation, Southwest Ordos Basin, China	PLOS ONE			English	Article							SEQUENCE STRATIGRAPHY; LACUSTRINE; FACIES; ARCHITECTURE; MARGIN	A large, shallow braided river delta sedimentary system developed in the Yanchang Formation during the Triassic in the southwest of the Ordos basin. In this braided delta system, abundant oil and gas resources have been observed, and the area is a hotspot for oil and gas resource exploration. Through extensive field work on outcrops and cores and analyses of geophysical data, it was determined that developments in the Late Triassic produced favorable geological conditions for the development of shallow water braided river deltas. Such conditions included a large basin, flat terrain, and wide and shallow water areas; wet and dry cyclical climate changes; ancient water turbulence; dramatic depth cycle changes; ancient uplift development; strong weathering of parent rock; and abundant supply. The shallow water braided river delta showed grain sediment granularity, plastic debris, and sediment with mature composition and structure that reflected the strong hydrodynamic environment of large tabular cross-bedding, wedge cross-bedding, and multiple positive rhythms superimposed to form a thick sand body layer. The branch river bifurcation developed underwater, and the thickness of the sand body increased further, indicating that the slope was slow and located in shallow water. The seismic responses of the braided river delta reflected strong shallow water performance, indicated by a progradation seismic reflection phase axis that was relatively flat; in addition, the seismic reflection amplitude was strong and continuous with a low angle and extended over considerable distances (up to 50 km). The sedimentary center was close to the provenance, the width of the river was large, and a shallow sedimentary structure and a sedimentary rhythm were developed. The development of the delta was primarily controlled by tectonic activity and changes in the lake level; as a result, the river delta sedimentary system eventually presented a " small plain, big front" character.	[Liu, Ziliang; Shen, Fang] Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China; [Liu, Ziliang; Tan, Mengqi] Chengdu Univ Technol, Sch Energy, Chengdu, Peoples R China; [Zhu, Xiaomin] China Univ Petr, State Key Lab Geol Proc & Mineral Resources, Beijing, Peoples R China; [Li, Fengjie] Chengdu Univ Technol, Inst Sedimentary Geol, Chengdu, Peoples R China	Chengdu University of Technology; Chengdu University of Technology; China University of Petroleum; Chengdu University of Technology	Liu, ZL (corresponding author), Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China.	bugliu2001@163.com; xmzhu@cup.edu.cn		li, feng jie/0000-0001-8900-4064	National Natural Science Foundation of China [41272133]; National Demonstration Project of China [2008ZX05044-1-3-2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Demonstration Project of China	This research was financially supported jointly by the National Natural Science Foundation of China (grant no. 41272133) and the National Demonstration Project of China (grant no. 2008ZX05044-1-3-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Donaldson A.C., 1974, SPECIAL PAPERS GEOLO, V148, P47, DOI DOI 10.1130/SPE148-P47; Fisk H.N., 1954, J SEDIMENT PETROL, V24, P76, DOI [10.1306/D4269661-2B26-11D7-8648000102C1865D, DOI 10.1306/D4269661-2B26-11D7-8648000102C1865D]; Garcia-Garcia F, 2006, SEDIMENT GEOL, V185, P79, DOI 10.1016/j.sedgeo.2005.10.010; Gong SL, 1986, COAL GEOLOGY EXPLORA, P2; Guo ZM, 1989, TECTONIC CHARACTERIS; Hu JY, 1992, THEORETICAL BASIS NO; [吉利明 JI Liming], 2006, [沉积学报, Acta Sedimentologica Sinica], V24, P426; Keumsuk L., 2007, J SEDIMENT RES, V77, P284; Kostic B, 2005, SEDIMENT GEOL, V181, P147, DOI 10.1016/j.sedgeo.2005.07.004; Lemons DR, 1999, AAPG BULL, V83, P635; [李洁 Li Jie], 2011, [成都理工大学学报. 自然科学版, Journal of Chengdu University of Technology. Science & Technonogy Edition], V38, P132; [李相博 Li Xiangbo], 2011, [地球科学进展, Advance in Earth Sciences], V26, P286; Li Y, 2013, GEOLOGICAL J CHINA U, P23; Li ZX, 1995, COAL GEOLOGY EXPLORA, V2, P7; Liao J, 2013, DIXUE QIANYUAN, V20, P1; [刘柳红 LIU Liu-hong], 2009, [现代地质, Geoscience], V23, P667; Liu Y. P., 2010, J ADV SIGNAL PROCESS, V2010, P1, DOI DOI 10.1038/TPJ.2009.55; Liu ZL, 2005, ACTA SEDIMENTOLOGICA, V24, P248; Longhitano SG, 2008, SEDIMENT GEOL, V210, P87, DOI 10.1016/j.sedgeo.2008.07.004; Lou Z., 1999, ACTA GEOL SIN-ENGL, V73, P83; Lu J, 2010, SCI TECHNOLOGY ENG, V10, P8407; [罗静兰 LUO Jinglan], 2008, [地质通报, Geological Bulletin of China], V27, P101; Olariu C, 2006, J SEDIMENT RES, V76, P212, DOI 10.2110/jsr.2006.026; Postma G, 1990, TERRA NOVA, V2, P124, DOI 10.1111/j.1365-3121.1990.tb00052.x; Su CQ, 1993, J CHANGAN U, V15, P23; Sun Yu, 2010, Dizhi Xuebao, V84, P1502; [王昌勇 WANG Changyong], 2011, [石油天然气学报, Journal of Oil and Gas Technology], V33, P11; Wang J., 2007, LITHOL RESERV CHIN, V19, P28; Wang Jia-hao, 2012, Earth Science - Journal of China University of Geosciences, V37, P556, DOI 10.3799/dqkx.2012.062; [王立武 Wang Liwu], 2012, [沉积学报, Acta Sedimentologica Sinica], V30, P1053; Xiao DS, 2011, SCI TECHNOLOGY ENG, V11, P4986; Ya DJ, 2011, PERIODICAL OCEAN U C, P299; [杨华 Yang Hua], 2013, [地学前缘, Earth Science Frontiers], V20, P10; Zhai GM, 1992, PETROLEUM GEOLOGY CH, V12; Zhang SN, 2000, J MINERALOGY PETROLO, V20, P25; Zhang XM, 2011, J CHONGQING U SCI TE, V13, P47; [赵宝峰 Zhao Baofeng], 2012, [沉积学报, Acta Sedimentologica Sinica], V30, P511; [朱筱敏 Zhu Xiaomin], 2013, [地学前缘, Earth Science Frontiers], V20, P19; [朱筱敏 Zhu Xiaomin], 2012, [地学前缘, Earth Science Frontiers], V19, P89	39	8	8	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0119704	10.1371/journal.pone.0119704	http://dx.doi.org/10.1371/journal.pone.0119704			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075611	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900001
J	Sakaguchi, M; Kim, K; Yu, LMY; Hashikawa, Y; Sekine, Y; Okumura, Y; Kawano, M; Hayashi, M; Kumar, D; Boyden, ES; McHugh, TJ; Hayashi, Y				Sakaguchi, Masanori; Kim, Karam; Yu, Lily Mae Yee; Hashikawa, Yoshiko; Sekine, Yukiko; Okumura, Yuki; Kawano, Masako; Hayashi, Masanobu; Kumar, Deependra; Boyden, Edward S.; McHugh, Thomas J.; Hayashi, Yasunori			Inhibiting the Activity of CA1 Hippocampal Neurons Prevents the Recall of Contextual Fear Memory in Inducible ArchT Transgenic Mice	PLOS ONE			English	Article							OPTICAL ACTIVATION; PYRAMIDAL CELLS; IN-VIVO; STRATEGIES; CORTEX; CONSOLIDATION; MICROCIRCUIT; EXPRESSION; RETRIEVAL; DYNAMICS	The optogenetic manipulation of light- activated ion- channels/pumps (i.e., opsins) can reversibly activate or suppress neuronal activity with precise temporal control. Therefore, optogenetic techniques hold great potential to establish causal relationships between specific neuronal circuits and their function in freely moving animals. Due to the critical role of the hippocampal CA1 region in memory function, we explored the possibility of targeting an inhibitory opsin, ArchT, to CA1 pyramidal neurons in mice. We established a transgenic mouse line in which tetracycline trans- activator induces ArchT expression. By crossing this line with a CaMKIIa- tTA transgenic line, the delivery of light via an implanted optrode inhibits the activity of excitatory CA1 neurons. We found that light delivery to the hippocampus inhibited the recall of a contextual fear memory. Our results demonstrate that this optogenetic mouse line can be used to investigate the neuronal circuits underlying behavior.	[Sakaguchi, Masanori; Kim, Karam; Yu, Lily Mae Yee; Hashikawa, Yoshiko; Sekine, Yukiko; Okumura, Yuki; Kawano, Masako; McHugh, Thomas J.; Hayashi, Yasunori] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Sakaguchi, Masanori; Hayashi, Masanobu; Kumar, Deependra] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan; [Boyden, Edward S.] MIT, Media Lab, Synthet Neurobiol Grp, Cambridge, MA 02139 USA; [Hayashi, Yasunori] Saitama Univ, Saitama Univ Brain Sci Inst, Saitama 3388570, Japan	RIKEN; University of Tsukuba; Massachusetts Institute of Technology (MIT); Saitama University	Sakaguchi, M (corresponding author), RIKEN, Brain Sci Inst, Wako, Saitama, Japan.	masanori.sakaguchi@gmail.com; yhayashi@brain.riken.jp	Kim, Karam/K-1412-2018; McHugh, Thomas J/A-6693-2010; Hayashi, Yasunori/AAF-1408-2019; Kumar, Deependra/G-3510-2018; McHugh, Thomas/M-6159-2019; Hayashi, Yasunori/C-2249-2008	Kim, Karam/0000-0002-1886-5163; McHugh, Thomas J/0000-0002-1243-5189; Hayashi, Yasunori/0000-0002-7560-3004; McHugh, Thomas/0000-0002-1243-5189; Hayashi, Yasunori/0000-0002-7560-3004; Sakaguchi, Masanori/0000-0002-7211-9452; Kumar, Deependra/0000-0003-1529-7567	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan Society for the Promotion of Science KAKENHI [26115502, 25116530, 24700340]; RIKEN Special Postdoctoral Fellowship; strategic program for R&D (President's discretionary fund) of RIKEN; Uehara Memorial Foundation; Takeda Science Foundation; Brain Science Foundation; Research Foundation for Optoscience and Technology; Japan Foundation for Applied Enzymology; RIKEN, U.S. National Institutes of Health [R01DA17310]; MEXT, Human Frontier Science Program; Takeda Pharmaceutical Co. Ltd.; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017310] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15K14330, 26115502] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan Society for the Promotion of Science KAKENHI; RIKEN Special Postdoctoral Fellowship; strategic program for R&D (President's discretionary fund) of RIKEN; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Brain Science Foundation; Research Foundation for Optoscience and Technology; Japan Foundation for Applied Enzymology; RIKEN, U.S. National Institutes of Health; MEXT, Human Frontier Science Program; Takeda Pharmaceutical Co. Ltd.(Takeda Pharmaceutical Company Ltd); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by the World Premier International Research Center Initiative and Grants for Excellent Graduate Schools from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan Society for the Promotion of Science KAKENHI grants (numbers 26115502, 25116530, and 24700340), RIKEN Special Postdoctoral Fellowship, the strategic program for R&D (President's discretionary fund) of RIKEN, Uehara Memorial Foundation, Takeda Science Foundation, Brain Science Foundation, Research Foundation for Optoscience and Technology, and Japan Foundation for Applied Enzymology to MS and by RIKEN, U.S. National Institutes of Health (R01DA17310), Grant-in-Aid for Scientific Research (A), Scientific Research on Innovative Area 'Foundation of Synapse and Neurocircuit Pathology' from MEXT, Human Frontier Science Program, Takeda Pharmaceutical Co. Ltd., and Fujitsu Laboratories to Y. Hayashi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arruda-Carvalho M, 2011, J NEUROSCI, V31, P15113, DOI 10.1523/JNEUROSCI.3432-11.2011; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; Ferenczi E, 2012, NAT NEUROSCI, V15, P1058, DOI 10.1038/nn.3172; Fukaya M, 2005, EUR J NEUROSCI, V21, P1432, DOI 10.1111/j.1460-9568.2005.03957.x; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Huff ML, 2013, P NATL ACAD SCI USA, V110, P3597, DOI 10.1073/pnas.1219593110; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; Raimondo JV, 2012, NAT NEUROSCI, V15, P1102, DOI 10.1038/nn.3143; Sakaguchi M, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-32; Tanaka KZ, 2014, NEURON, V84, P347, DOI 10.1016/j.neuron.2014.09.037; Tanaka KF, 2012, CELL REP, V2, P397, DOI 10.1016/j.celrep.2012.06.011; Tsunematsu T, 2013, BEHAV BRAIN RES, V255, P64, DOI 10.1016/j.bbr.2013.05.021; Van den Oever MC, 2013, J NEUROSCI, V33, P18225, DOI 10.1523/JNEUROSCI.2412-13.2013; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	30	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130163	10.1371/journal.pone.0130163	http://dx.doi.org/10.1371/journal.pone.0130163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075894	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900147
J	Zhao, XB; Wang, AY; Walter, V; Patel, NM; Eberhard, DA; Hayward, MC; Salazar, AH; Jo, H; Soloway, MG; Wilkerson, MD; Parker, JS; Yin, XY; Zhang, GS; Siegel, MB; Rosson, GB; Earp, HS; Sharpless, NE; Gulley, ML; Weck, KE; Hayes, DN; Moschos, SJ				Zhao, Xiaobei; Wang, Anyou; Walter, Vonn; Patel, Nirali M.; Eberhard, David A.; Hayward, Michele C.; Salazar, Ashley H.; Jo, Heejoon; Soloway, Matthew G.; Wilkerson, Matthew D.; Parker, Joel S.; Yin, Xiaoying; Zhang, Guosheng; Siegel, Marni B.; Rosson, Gary B.; Earp, H. Shelton, III; Sharpless, Norman E.; Gulley, Margaret L.; Weck, Karen E.; Hayes, D. Neil; Moschos, Stergios J.			Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLC	PLOS ONE			English	Article							COPY-NUMBER ALTERATION; MUTATIONS; KRAS; ACCURATE; LANDSCAPE; REARRANGEMENT; VALIDATION; DATABASE; VARIANTS; FORMAT	The recent FDA approval of the MiSeqDx platform provides a unique opportunity to develop targeted next generation sequencing (NGS) panels for human disease, including cancer. We have developed a scalable, targeted panel-based assay termed UNCseq, which involves a NGS panel of over 200 cancer-associated genes and a standardized downstream bioinformatics pipeline for detection of single nucleotide variations (SNV) as well as small insertions and deletions (indel). In addition, we developed a novel algorithm, NGScopy, designed for samples with sparse sequencing coverage to detect large-scale copy number variations (CNV), similar to human SNP Array 6.0 as well as small-scale intragenic CNV. Overall, we applied this assay to 100 snap-frozen lung cancer specimens lacking same-patient germline DNA (07-0120 tissue cohort) and validated our results against Sanger sequencing, SNP Array, and our recently published integrated DNA-seq/RNA-seq assay, UNCqeR, where RNA-seq of same-patient tumor specimens confirmed SNV detected by DNA-seq, if RNA-seq coverage depth was adequate. In addition, we applied the UNCseq assay on an independent lung cancer tumor tissue collection with available same-patient germline DNA (11-1115 tissue cohort) and confirmed mutations using assays performed in a CLIA-certified laboratory. We conclude that UNCseq can identify SNV, indel, and CNV in tumor specimens lacking germline DNA in a cost-efficient fashion.	[Zhao, Xiaobei; Wang, Anyou; Walter, Vonn; Patel, Nirali M.; Eberhard, David A.; Hayward, Michele C.; Salazar, Ashley H.; Jo, Heejoon; Soloway, Matthew G.; Wilkerson, Matthew D.; Parker, Joel S.; Yin, Xiaoying; Zhang, Guosheng; Rosson, Gary B.; Earp, H. Shelton, III; Sharpless, Norman E.; Gulley, Margaret L.; Weck, Karen E.; Hayes, D. Neil; Moschos, Stergios J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Patel, Nirali M.; Eberhard, David A.; Gulley, Margaret L.; Weck, Karen E.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Siegel, Marni B.; Rosson, Gary B.] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Wilkerson, Matthew D.; Sharpless, Norman E.; Hayes, D. Neil] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Earp, H. Shelton, III; Sharpless, Norman E.; Hayes, D. Neil; Moschos, Stergios J.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Earp, H. Shelton, III] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Jo, Heejoon] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Moschos, SJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	moschos@med.unc.edu	Walter, Vonn/AAI-3450-2021; Parker, Joel/AAG-1108-2019; W, Andrew/ABE-8298-2020	Walter, Vonn/0000-0001-6114-6714; W, Andrew/0000-0002-4981-3606; Patel, Nirali/0000-0002-2683-4789; McClure, Marni/0000-0002-0807-4368; Sharpless, Norman/0000-0001-7078-9455	NCI Cancer Clinical Investigator Team Leadership Award; University Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA163896, T32CA071341] Funding Source: NIH RePORTER	NCI Cancer Clinical Investigator Team Leadership Award; University Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the NCI Cancer Clinical Investigator Team Leadership Award (SJM) and the University Cancer Research Fund.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Altimari A, 2013, ONCOTARGETS THER, V6, P1057, DOI 10.2147/OTT.S42369; Anderson SM, 2011, EXPERT REV MOL DIAGN, V11, P635, DOI [10.1586/erm.11.42, 10.1586/ERM.11.42]; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Chiogna M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-61; Choudhary A, 2014, BMC MED GENOMICS, V7, DOI 10.1186/s12920-014-0062-0; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Collins FS, 2013, NEW ENGL J MED, V369, P2369, DOI 10.1056/NEJMp1314561; CORNFIELD J, 1951, J NATL CANCER I, V11, P1269; Cottrell CE, 2014, J MOL DIAGN, V16, P89, DOI 10.1016/j.jmoldx.2013.10.002; Duan JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059128, 10.1371/journal.pone.0062087]; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Foreman Ann Katherine M, 2013, N C Med J, V74, P500; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Garralda E, 2014, CLIN CANCER RES, V20, P2476, DOI 10.1158/1078-0432.CCR-13-3047; Gerstung M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1814; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gnad F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S7; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Guo Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/915636; Hagemann IS, 2015, CANCER-AM CANCER SOC, V121, P631, DOI 10.1002/cncr.29089; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Iwakawa R, 2013, GENE CHROMOSOME CANC, V52, P802, DOI 10.1002/gcc.22076; Jayaraman SS, 2014, J INVEST DERMATOL, V134, P213, DOI 10.1038/jid.2013.276; Jeck WR, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12238; Jour G, 2014, HUM PATHOL, V45, P1563, DOI 10.1016/j.humpath.2014.04.012; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038892; Lee SE, 2015, MODERN PATHOL, V28, P468, DOI 10.1038/modpathol.2014.107; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004144; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Marioni JC, 2006, BIOINFORMATICS, V22, P1144, DOI 10.1093/bioinformatics/btl089; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mose LE, 2014, BIOINFORMATICS, V30, P2813, DOI 10.1093/bioinformatics/btu376; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nair KR, 1940, SANKHYA, V4, P551; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Singh RR, 2014, BRIT J CANCER, V111, P2014, DOI 10.1038/bjc.2014.518; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tembe WD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-824; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; Tuononen K, 2013, GENE CHROMOSOME CANC, V52, P503, DOI 10.1002/gcc.22047; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wilkerson MD, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku489; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Yi ES, 2012, MOL DIAGN THER, V16, P143, DOI 10.2165/11632830-000000000-00000; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	61	28	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129280	10.1371/journal.pone.0129280	http://dx.doi.org/10.1371/journal.pone.0129280			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076459	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900061
J	Flegel, C; Schobel, N; Altmuller, J; Becker, C; Tannapfel, A; Hatt, H; Gisselmann, G				Flegel, Caroline; Schoebel, Nicole; Altmueller, Janine; Becker, Christian; Tannapfel, Andrea; Hatt, Hanns; Gisselmann, Guenter			RNA-Seq Analysis of Human Trigeminal and Dorsal Root Ganglia with a Focus on Chemoreceptors	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; NICOTINIC ACETYLCHOLINE-RECEPTORS; DOMAIN POTASSIUM CHANNELS; LINGUAL NERVE NEUROMAS; POTENTIAL VANILLOID 1; RAT SENSORY NEURONS; TRANSIENT RECEPTOR; OLFACTORY RECEPTOR; CAPSAICIN-RECEPTOR; ION-CHANNEL	The chemosensory capacity of the somatosensory system relies on the appropriate expression of chemoreceptors, which detect chemical stimuli and transduce sensory information into cellular signals. Knowledge of the complete repertoire of the chemoreceptors expressed in human sensory ganglia is lacking. This study employed the next-generation sequencing technique (RNA-Seq) to conduct the first expression analysis of human trigeminal ganglia (TG) and dorsal root ganglia (DRG). We analyzed the data with a focus on G-protein coupled receptors (GPCRs) and ion channels, which are (potentially) involved in chemosensation by somatosensory neurons in the human TG and DRG. For years, transient receptor potential (TRP) channels have been considered the main group of receptors for chemosensation in the trigeminal system. Interestingly, we could show that sensory ganglia also express a panel of different olfactory receptors (ORs) with putative chemosensory function. To characterize OR expression in more detail, we performed microarray, semiquantitative RT-PCR experiments, and immunohistochemical staining. Additionally, we analyzed the expression data to identify further known or putative classes of chemoreceptors in the human TG and DRG. Our results give an overview of the major classes of chemoreceptors expressed in the human TG and DRG and provide the basis for a broader understanding of the reception of chemical cues.	[Flegel, Caroline; Hatt, Hanns; Gisselmann, Guenter] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany; [Schoebel, Nicole] Ruhr Univ Bochum, Dept Anim Physiol, Bochum, Germany; [Altmueller, Janine; Becker, Christian] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Tannapfel, Andrea] Ruhr Univ Bochum, Inst Pathol, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; University of Cologne; Ruhr University Bochum	Gisselmann, G (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Univ Str 150, Bochum, Germany.	Guenter.Gisselmann@rub.de		Altmuller, Janine/0000-0003-4372-1521	Heinrich und Alma Vogelsang Stiftung; DFG-Sonderforschungsbereich [642]	Heinrich und Alma Vogelsang Stiftung; DFG-Sonderforschungsbereich(German Research Foundation (DFG))	Caroline Flegel was funded by Heinrich und Alma Vogelsang Stiftung. Hanns Hatt was funded by DFG-Sonderforschungsbereich 642 "GTP- and ATP dependent membrane processes." The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram SE, 2006, ANESTHESIOLOGY, V105, P146, DOI 10.1097/00000542-200607000-00024; Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Alimohammadi H, 2000, CHEM SENSES, V25, P61, DOI 10.1093/chemse/25.1.61; Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Anand U, 2008, NEUROSCI LETT, V438, P221, DOI 10.1016/j.neulet.2008.04.007; Asai H, 1996, BIOCHEM BIOPH RES CO, V221, P240, DOI 10.1006/bbrc.1996.0580; Axelsson HE, 2009, NEUROSCIENCE, V162, P1322, DOI 10.1016/j.neuroscience.2009.05.052; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Beltran LR, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00141; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; Biggs JE, 2007, BRAIN RES, V1127, P59, DOI 10.1016/j.brainres.2006.10.014; Bonaventure P, 1998, NEUROREPORT, V9, P641, DOI 10.1097/00001756-199803090-00015; Bonigk W, 1999, J NEUROSCI, V19, P5332; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Burnstock G, 2009, CURR PHARM DESIGN, V15, P1717, DOI 10.2174/138161209788186335; Busse D, 2014, J INVEST DERMATOL; Martinez-Garcia MC, 2013, HISTOL HISTOPATHOL, V28, P1507, DOI 10.14670/HH-28.1507; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chen G, 2000, MOL PHARMACOL, V57, P125; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Coughlin SR, 2003, J CLIN INVEST, V111, P25, DOI 10.1172/JCI200317564; Devor M, 1999, PAIN, pS27, DOI 10.1016/S0304-3959(99)00135-9; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Domotor Andras, 2005, Inflammopharmacology, V13, P161, DOI 10.1163/156856005774423737; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; Duran C, 2012, AM J PHYSIOL-CELL PH, V302, pC482, DOI 10.1152/ajpcell.00140.2011; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Facer P, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-11; Faussone-Pellegrini MS, 2005, HISTOCHEM CELL BIOL, V124, P61, DOI 10.1007/s00418-005-0025-9; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Ferrero DM, 2011, P NATL ACAD SCI USA, V108, P11235, DOI 10.1073/pnas.1103317108; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Flockerzi V., 2007, V179, P1; Fusi C, 2014, J INVEST DERMATOL, V134, P2408, DOI 10.1038/jid.2014.145; Gabashvili IS, 2007, JARO-J ASSOC RES OTO, V8, P305, DOI 10.1007/s10162-007-0082-y; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Gerhold KA, 2009, ANN NY ACAD SCI, V1170, P184, DOI 10.1111/j.1749-6632.2009.03895.x; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Gopinath Preethi, 2005, BMC Womens Health, V5, P2, DOI 10.1186/1472-6874-5-2; Grosser BI, 2000, PSYCHONEUROENDOCRINO, V25, P289, DOI 10.1016/S0306-4530(99)00056-6; Gu X, 2013, AM J RESP CELL MOL B; GU YP, 1994, J NEUROSCI, V14, P4561; Guarino MPL, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2010.01514.x; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hartmann C, 2013, CHEMPLUSCHEM, V78, P695, DOI 10.1002/cplu.201300008; Hou MY, 2002, NEUROSCI LETT, V330, P223, DOI 10.1016/S0304-3940(02)00741-3; Hummel T, 2005, CHEM SENSES, V30, pI205, DOI 10.1093/chemse/bjh186; Hummel T, 2011, INT J PSYCHOPHYSIOL, V81, P116, DOI 10.1016/j.ijpsycho.2011.05.002; Ibarra-Soria X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004593; Ichikawa H, 2000, NEUROSCIENCE, V101, P719, DOI 10.1016/S0306-4522(00)00427-9; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Johnson KW, 1998, PROG DRUG RES, V51, P219; Kanageswaran N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113170; Keydar I, 2013, HUM MUTAT, V34, P32, DOI 10.1002/humu.22212; Kilic G, 2010, PSYCHIAT RES, V175, P43, DOI 10.1016/j.psychres.2008.10.001; KOBAL G, 1988, ELECTROEN CLIN NEURO, V71, P241, DOI 10.1016/0168-5597(88)90023-8; Kunzelmann K, 2012, EXP PHYSIOL, V97, P184, DOI 10.1113/expphysiol.2011.058206; Lafreniere RG, 2010, NAT MED, V16, P1157, DOI 10.1038/nm.2216; Laska M, 1997, CHEM SENSES, V22, P447, DOI 10.1093/chemse/22.4.447; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Li WG, 2011, ACS CHEM NEUROSCI, V2, P26, DOI 10.1021/cn100094b; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, ANN NY ACAD SCI, V1170, P168, DOI 10.1111/j.1749-6632.2009.04014.x; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liibbert M, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00064; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Liu L, 1998, CHEM SENSES, V23, P125, DOI 10.1093/chemse/23.2.125; Liu L, 1998, BRAIN RES, V809, P238, DOI 10.1016/S0006-8993(98)00862-2; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Lubbert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077998; Mainland JD, 2014, NAT NEUROSCI, V17, P114, DOI 10.1038/nn.3598; Mandadi S, 2009, PFLUG ARCH EUR J PHY, V458, P1093, DOI 10.1007/s00424-009-0703-x; Manteniotis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079523; MASON JR, 1983, BRAIN RES, V269, P196; Massberg D, 2015, ARCH BIOCHEM BIOPHYS, V566, P100, DOI 10.1016/j.abb.2014.12.004; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Morgan CR, 2009, NEUROSCI LETT, V465, P189, DOI 10.1016/j.neulet.2009.08.055; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Ohkawara S, 2010, BIOL PHARM BULL, V33, P1434, DOI 10.1248/bpb.33.1434; Padilla F, 2007, MOL CELL NEUROSCI, V35, P138, DOI 10.1016/j.mcn.2007.02.008; Pan AH, 2012, PURINERG SIGNAL, V8, P245, DOI 10.1007/s11302-011-9277-0; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Pecze L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003419; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Rodriguez I, 2000, NAT GENET, V26, P18, DOI 10.1038/79124; Rothermel M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026158; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Schobel N, 2014, CHEM SENSES; Schobel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048005; Schreiner BSP, 2014, EUR J PHARM; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Seki N, 2006, RHINOLOGY, V44, P128; Sherkheli MA, 2010, J PHARM PHARM SCI, V13, P242, DOI 10.18433/J3N88N; Shiao MS, 2012, GENOME BIOL EVOL, V4, P703, DOI 10.1093/gbe/evs039; Shinohara T, 2004, J BIOL CHEM, V279, P23559, DOI 10.1074/jbc.M314240200; Shirokova E, 2008, FASEB J, V22, P1416, DOI 10.1096/fj.07-9233com; SILVER WL, 1991, BRAIN RES, V561, P212, DOI 10.1016/0006-8993(91)91597-T; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Solinski HJ, 2012, J BIOL CHEM, V287, P40956, DOI 10.1074/jbc.M112.408617; Sondersorg AC, 2014, J BIOL CHEM; Spehr J, 2004, EUR J NEUROSCI, V19, P2497, DOI 10.1111/j.0953-816X.2004.03329.x; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Stotz SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002082; Strickland IT, 2008, EUR J PAIN, V12, P564, DOI 10.1016/j.ejpain.2007.09.001; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Subramanian H, 2011, MOL PHARMACOL, V79, P1005, DOI 10.1124/mol.111.071472; Suzuki M, 2003, NEUROSCI LETT, V353, P189, DOI 10.1016/j.neulet.2003.09.041; Szallasi A, 1995, Acta Physiol Scand Suppl, V629, P1; Takeda M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-5; Tatemoto K, 2006, BIOCHEM BIOPH RES CO, V349, P1322, DOI 10.1016/j.bbrc.2006.08.177; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Thuerauf N, 1999, PSYCHOPHARMACOLOGY, V142, P236, DOI 10.1007/s002130050885; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van Haute C, 2010, THESCIENTIFICWORLDJO, V10, P1597, DOI 10.1100/tsw.2010.149; Vandewauw I, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-21; Veitinger T, 2011, J BIOL CHEM, V286, P17311, DOI 10.1074/jbc.M110.211524; Verbeurgt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096333; Viana F, 2011, ACS CHEM NEUROSCI, V2, P38, DOI 10.1021/cn100102c; Vogt-Eisele AK, 2007, BRIT J PHARMACOL, V151, P530, DOI 10.1038/sj.bjp.0707245; Vrontou S, 2013, NATURE, V493, P669, DOI 10.1038/nature11810; Wallrabenstein I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054950; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yiangou YG, 2001, EUR J GASTROEN HEPAT, V13, P891, DOI 10.1097/00042737-200108000-00003; Yilmaz Z, 2007, J CLIN NEUROSCI, V14, P864, DOI 10.1016/j.jocn.2006.09.002; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhang Y, 2006, PLOS COMPUT BIOL, V2, P88, DOI 10.1371/journal.pcbi.0020013; Zhu JJ, 1998, NEUROSCIENCE, V87, P767, DOI 10.1016/S0306-4522(98)00209-7	155	116	116	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128951	10.1371/journal.pone.0128951	http://dx.doi.org/10.1371/journal.pone.0128951			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070209	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000036
J	Kwon, YS; Kim, YH; Jeon, K; Jeong, BH; Ryu, YJ; Choi, JC; Kim, HC; Koh, WJ				Kwon, Yong-Soo; Kim, Yee Hyung; Jeon, Kyeongman; Jeong, Byeong-Ho; Ryu, Yon Ju; Choi, Jae Chol; Kim, Ho Cheol; Koh, Won-Jung			Factors that Predict Negative Results of QuantiFERON-TB Gold In-Tube Test in Patients with Culture-Confirmed Tuberculosis: A Multicenter Retrospective Cohort Study	PLOS ONE			English	Article							INTERFERON-GAMMA RELEASE; PULMONARY TUBERCULOSIS; ACTIVE TUBERCULOSIS; INCOME COUNTRIES; TB-2G TEST; ASSAYS; DIAGNOSIS; PERFORMANCE	Background Interferon-gamma release assays such as the QuantiFERON-TB Gold In-Tube Test (QFT-GIT) are designed to detect Mycobacterium tuberculosis infections, whether latent or manifesting as disease. However, a substantial number of persons with culture-confirmed tuberculosis (TB) have negative QFT-GITs. Information on host factors contributing to false-negative and indeterminate results are limited. Methods A multicenter retrospective cohort study was performed with 1,264 culture-confirmed TB patients older than 18 years who were subjected to the QFT-GIT at one of the six hospitals between May 2007 and February 2014. Patients with human immunodeficiency virus infection were excluded. Clinical and laboratory data were collected in South Korea. Results Of all patients, 87.6% (1,107/1,264) were diagnosed with pulmonary TB and 12.4% (157/1,264) with extrapulmonary TB. The rate of negative results was 14.4% (182/1,264). The following factors were highly correlated with false-negative results in the QFT-GIT: advanced age (age >= 65 years, odds ratio [OR] 1.57, 95% confidence interval [CI] 1.03-2.39), bilateral disease as determined by chest radiography (OR 1.75, 95% CI 1.13-2.72), malignancy (OR 2.42, 95% CI 1.30-4.49), and lymphocytopenia (total lymphocyte count < 1.0 x 10(9)/L, OR 1.86, 95% CI 1.21-2.87). Conclusions Consequently, QFT-GIT results need to be interpreted with caution in patients with these host risk factors such as the elderly, bilateral disease on chest radiography, or malignancy, or lymphocytopenia.	[Kwon, Yong-Soo] Chonnam Natl Univ Hosp, Dept Internal Med, Kwangju, South Korea; [Kim, Yee Hyung] Kyung Hee Univ, Sch Med, Kyung Hee Univ Hosp Gangdong, Dept Pulm & Crit Care Med, Seoul, South Korea; [Jeon, Kyeongman; Jeong, Byeong-Ho; Koh, Won-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea; [Ryu, Yon Ju] Ewha Womans Univ, Sch Med, Mokdong Hosp, Div Pulm & Crit Care Med,Dept Med,Ewha Med Ctr, Seoul, South Korea; [Ryu, Yon Ju] Ewha Womans Univ, Sch Med, Mokdong Hosp, Ewha Med Res Inst, Seoul, South Korea; [Choi, Jae Chol] Chung Ang Univ, Sch Med, Dept Internal Med, Seoul 156756, South Korea; [Kim, Ho Cheol] Gyeongsang Natl Univ, Gyeongsang Inst Hlth Sci, Coll Med, Dept Internal Med, Jinju, South Korea	Chonnam National University; Chonnam National University Hospital; Kyung Hee University; Kyung Hee University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Ewha Womans University; Ewha Womans University; Chung Ang University; Chung Ang University Hospital; Gyeongsang National University	Koh, WJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea.	wjkoh@skku.edu	Koh, Won-Jung/D-9586-2018; Koh, Won Jung/C-9595-2011; Kwon, Yong-Soo/AAH-6718-2019; Jeon, Kyeongman/F-5963-2019	Koh, Won-Jung/0000-0002-4756-3527; Jeon, Kyeongman/0000-0002-4822-1772; Jeong, Byeong-Ho/0000-0002-3124-1718; Kwon, Yong-Soo/0000-0001-5121-4488	Korean Health technology R&D Project, Ministry for Health & Welfare, Republic of Korea [HI13C0871]	Korean Health technology R&D Project, Ministry for Health & Welfare, Republic of Korea	This work was supported by the Korean Health technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI13C0871).	ABER VR, 1980, TUBERCLE, V61, P123, DOI 10.1016/0041-3879(80)90001-X; [Anonymous], GLOB TUB REP; Cho K, 2012, TUBERC RESPIR DIS, V72, P416, DOI 10.4046/trd.2012.72.5.416; Dalmasso G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019293, 10.1371/journal.pone.0023806]; de Visser V, 2015, EUR RESPIR J, V45, P279, DOI 10.1183/09031936.00120214; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Faurholt-Jepsen D, 2014, SCAND J INFECT DIS, V46, P384, DOI 10.3109/00365548.2014.885657; Gan SH, 2014, EUR RESPIR J, V44, P805, DOI 10.1183/09031936.00226613; Jung JY, 2012, J INFECTION, V64, P188, DOI 10.1016/j.jinf.2011.09.008; Jung YJ, 2014, INT J TUBERC LUNG D, V18, P428, DOI 10.5588/ijtld.13.0644; Kim EY, 2011, DIAGN MICR INFEC DIS, V70, P324, DOI 10.1016/j.diagmicrobio.2011.02.011; Kobashi Y, 2008, CHEST, V133, P1196, DOI 10.1378/chest.07-1995; Kobashi Y, 2009, JPN J INFECT DIS, V62, P300; Kumar NP, 2014, J INFECT DIS, V210, P1670, DOI 10.1093/infdis/jiu329; La Jeon Y, 2013, J INFECTION, V67, P288, DOI 10.1016/j.jinf.2013.06.005; Lai CC, 2011, DIAGN MICR INFEC DIS, V71, P139, DOI 10.1016/j.diagmicrobio.2011.05.013; Lee YJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-107; Liao CH, 2009, J INFECTION, V59, P421, DOI 10.1016/j.jinf.2009.09.012; Ling DI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001536; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Sodhi A, 1997, CLIN INFECT DIS, V25, P617, DOI 10.1086/513769; URBANCZIK R, 1985, ZBL BAKT-INT J MED M, V260, P81; Vallerskog T, 2010, J IMMUNOL, V184, P6275, DOI 10.4049/jimmunol.1000304; Walsh MC, 2011, INT J TUBERC LUNG D, V15, P179; WHO, 2004, GLOB STAT REP ALC; World Health Organization, HAEM CONC DIAGN AN A	31	25	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129792	10.1371/journal.pone.0129792	http://dx.doi.org/10.1371/journal.pone.0129792			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070207	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000106
J	Roa, PL; Perez-Granda, MJ; Munoz, P; Catalan, P; Alonso, R; Sanchez-Perez, E; Novoa, E; Bouza, E				Lopez Roa, Paula; Jesus Perez-Granda, Maria; Munoz, Patricia; Catalan, Pilar; Alonso, Roberto; Sanchez-Perez, Eduardo; Novoa, Emma; Bouza, Emilio			A Prospective Monitoring Study of Cytomegalovirus Infection in Non-Immunosuppressed Critical Heart Surgery Patients	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; SOLID-ORGAN TRANSPLANTATION; INTENSIVE-CARE PATIENTS; ILL SURGICAL-PATIENTS; NOSOCOMIAL INFECTIONS; DIABETES-MELLITUS; CARDIAC-SURGERY; REACTIVATION; MORTALITY; OUTCOMES	Background Reactivation cytomegalovirus (CMV) has been reported occasionally in immnunocompetent patients in the intensive care unit (ICU). The epidemiology and association of CMV infection with adverse outcome is not well defined in this population. Patients undergoing major heart surgery (MHS) are at a particularly high risk of infection. CMV infection has not been systematically monitored in MSH-ICU patients. Methods We assessed CMV plasma viremia weekly using a quantitative polymerase chain reaction assay in a prospective cohort of immunocompetent adults admitted to the MHS-ICU for at least 72 hours between October 2012 and May 2013. Risk factors for CMV infection and its potential association with continued hospitalization or death by day 30 (composited endpoint) were assessed using univariate and multivariate logistic regression analyses. Results CMV viremia at any level was recorded in 16.5% of patients at a median of 17 days (range, 3-54 days) after admission to the MHS-ICU. Diabetes (adjusted OR, 5.6; 95% CI, 1.8-17.4; p=0.003) and transfusion requirement (>10 units) (adjusted OR, 13.7; 95% CI, 3.9-47.8; p<0.001) were independent risk factors associated with CMV reactivation. Reactivation of CMV at any level was independently associated with the composite endpoint (adjusted OR, 12.1; 95% CI, 2.3-64; p= 0.003). Conclusion Reactivation of CMV is relatively frequent in immunocompetent patients undergoing MHS and is associated with prolonged hospitalization or death.	[Lopez Roa, Paula; Munoz, Patricia; Catalan, Pilar; Alonso, Roberto; Bouza, Emilio] Hosp Gen Univ Gregorio Maranon, Dept Clin Microbiol & Infect Dis, Madrid, Spain; [Lopez Roa, Paula; Jesus Perez-Granda, Maria; Munoz, Patricia; Alonso, Roberto; Bouza, Emilio] Inst Invest Biomed Gregorio Maranon, Madrid, Spain; [Jesus Perez-Granda, Maria; Munoz, Patricia; Bouza, Emilio] Univ Complutense, Sch Med, Dept Med, E-28040 Madrid, Spain; [Jesus Perez-Granda, Maria; Sanchez-Perez, Eduardo; Novoa, Emma] Hosp Gen Univ Gregorio Maranon, Dept Anesthesiol, Madrid, Spain	General University Gregorio Maranon Hospital; Complutense University of Madrid; General University Gregorio Maranon Hospital	Roa, PL (corresponding author), Hosp Gen Univ Gregorio Maranon, Dept Clin Microbiol & Infect Dis, Madrid, Spain.	plroa@salud.madrid.org	Roa, Paula Lopez/D-5041-2016; Bouza, Emilio/D-8661-2014; Muñoz, Patricia/E-9431-2017; GRANDA, MARIA JESUS mjpg PEREZ/L-3040-2015	Roa, Paula Lopez/0000-0002-7989-4275; Bouza, Emilio/0000-0001-6967-9267; Muñoz, Patricia/0000-0001-5706-5583; GRANDA, MARIA JESUS mjpg PEREZ/0000-0002-0613-2122				Angele MK, 2002, CRIT CARE, V6, P298, DOI 10.1186/cc1514; Benhammane H, 2012, CASE REP ONCOL MED, V2012, DOI 10.1155/2012/137291; Blyth D, 2012, TRANSPL INFECT DIS, V14, P149, DOI 10.1111/j.1399-3062.2011.00705.x; Boeckh Michael, 2003, Herpes, V10, P12; Bouza E, 2006, J HOSP INFECT, V64, P224, DOI 10.1016/j.jhin.2006.06.019; CAUL EO, 1971, LANCET, V1, P777; Cervia JS, 2007, CLIN INFECT DIS, V45, P1008, DOI 10.1086/521896; Cook CH, 1998, AM J SURG, V176, P357, DOI 10.1016/S0002-9610(98)00205-0; Cook CH, 2003, CRIT CARE MED, V31, P1923, DOI 10.1097/01.CCM.0000070222.11325.C4; De Vlieger G, 2012, CRIT CARE MED, V40, P36, DOI 10.1097/CCM.0b013e31822b50ae; DOMART Y, 1990, CHEST, V97, P18, DOI 10.1378/chest.97.1.18; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Harvala H, 2013, J MED VIROL, V85, P893, DOI 10.1002/jmv.23539; Heininger A, 2001, CRIT CARE MED, V29, P541, DOI 10.1097/00003246-200103000-00012; Heininger A, 2011, CRIT CARE, V15, DOI 10.1186/cc10069; Jaber S, 2005, CHEST, V127, P233, DOI 10.1378/chest.127.1.233; Kalil AC, 2009, CRIT CARE MED, V37, P2350, DOI 10.1097/CCM.0b013e3181a3aa43; Kijpittayarit-Arthurs S, 2007, J HEART LUNG TRANSPL, V26, P1019, DOI 10.1016/j.healun.2007.07.016; KOLLEF MH, 1993, JAMA-J AM MED ASSOC, V270, P1965, DOI 10.1001/jama.270.16.1965; Kollef MH, 1997, CHEST, V112, P666, DOI 10.1378/chest.112.3.666; Kutza AST, 1998, CLIN INFECT DIS, V26, P1076, DOI 10.1086/520307; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Limaye AP, 2010, REV MED VIROL, V20, P372, DOI 10.1002/rmv.664; Linares L, 2011, TRANSPL P, V43, P2145, DOI 10.1016/j.transproceed.2011.05.007; Osawa R, 2009, CRIT CARE, V13, DOI 10.1186/cc7875; PUGIN J, 1991, AM REV RESPIR DIS, V143, P1121, DOI 10.1164/ajrccm/143.5_Pt_1.1121; Roberts BW, 2005, SOUTH MED J, V98, P686, DOI 10.1097/01.SMJ.0000163310.12516.2D; Snyder LD, 2010, AM J RESP CRIT CARE, V181, P1391, DOI 10.1164/rccm.200911-1786OC; Sodano L, 2004, Ann Ig, V16, P735; Stephan F, 1996, INTENS CARE MED, V22, P1244, DOI 10.1007/s001340050245; Visseren FLJ, 1997, DIABETES RES CLIN PR, V36, P49, DOI 10.1016/S0168-8227(97)00027-2; Ziemann M, 2008, CRIT CARE MED, V36, P3145, DOI 10.1097/CCM.0b013e31818f3fc4; Ziemann M, 2014, TRANSFUS MED HEMOTH, V41, P40, DOI 10.1159/000357102	33	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129447	10.1371/journal.pone.0129447	http://dx.doi.org/10.1371/journal.pone.0129447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070136	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000076
J	Mun, PS; Ting, HN; Ong, TA; Wong, CM; Ng, KH; Chong, YB				Mun, Peck Shen; Ting, Hua Nong; Ong, Teng Aik; Wong, Chew Ming; Ng, Kwan Hong; Chong, Yip Boon			A Study of Dielectric Properties of Proteinuria between 0.2 GHz and 50 GHz	PLOS ONE			English	Article							TISSUES; PERMITTIVITY; HEMATOCRIT; BLOOD; WATER; RISK	This paper investigates the dielectric properties of urine in normal subjects and subjects with chronic kidney disease (CKD) at microwave frequency of between 0.2 GHz and 50 GHz. The measurements were conducted using an open-ended coaxial probe at room temperature (25 degrees C), at 30 degrees C and at human body temperature (37 degrees C). There were statistically significant differences in the dielectric properties of the CKD subjects compared to those of the normal subjects. Statistically significant differences in dielectric properties were observed across the temperatures for normal subjects and CKD subjects. Pearson correlation test showed the significant correlation between proteinuria and dielectric properties. The experimental data closely matched the single-pole Debye model. The relaxation dispersion and relaxation time increased with the proteinuria level, while decreasing with the temperature. As for static conductivity, it increased with proteinuria level and temperature.	[Mun, Peck Shen; Ting, Hua Nong] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia; [Ong, Teng Aik] Univ Malaya, Fac Med, Dept Surg, Kuala Lumpur, Malaysia; [Wong, Chew Ming] Univ Malaya, Fac Med, Fac Med, Kuala Lumpur, Malaysia; [Ng, Kwan Hong] Univ Malaya, Fac Med, Dept Biomed Imaging, Kuala Lumpur, Malaysia; [Chong, Yip Boon] Damansara Specialist Hosp, Petaling Jaya, Selangor, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Ting, HN (corresponding author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia.	tinghn@um.edu.my	Ng, Kwan Hoong/D-2231-2009; Ong, Teng Aik/B-5321-2010; Ong, Teng Aik/B-2284-2010; TING, HUA NONG/B-5255-2010; Wong, Chew Ming/F-8822-2010	Ong, Teng Aik/0000-0002-0207-8966; Wong, Chew Ming/0000-0003-4406-4850; Ting, Hua Nong/0000-0001-6295-1651	University of Malaya [PG036-2013A]	University of Malaya(Universiti Malaya)	This work was supported by grants from University of Malaya (PG036-2013A). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla S, 2011, AIP ADV, V1, DOI 10.1063/1.3556986; Abdalla S, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3458908; ALISON JM, 1993, PHYS MED BIOL, V38, P971, DOI 10.1088/0031-9155/38/7/007; Boresch S, 2000, J PHYS CHEM B, V104, P8743, DOI 10.1021/jp0008905; Desouky OS, 2009, ROMANIAN J BIOPHYSIC, V19, P239; Ellison WJ, 2007, J PHYS CHEM REF DATA, V36, P1, DOI 10.1063/1.2360986; Ferry JD, 1938, J AM CHEM SOC, V60, P1123, DOI 10.1021/ja01272a036; Gabriel C, 2006, PHYS MED BIOL, V51, P6033, DOI 10.1088/0031-9155/51/23/006; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; GRANT EH, 1968, J PHYS CHEM-US, V72, P4373, DOI 10.1021/j100859a004; Ikeda K, 2012, PROTEINS PROTEOMICS, P1; Iseki K, 2004, AM J KIDNEY DIS, V44, P806, DOI 10.1016/S0272-6386(04)01080-7; Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012; Jaspard F, 2003, PHYSIOL MEAS, V24, P137, DOI 10.1088/0967-3334/24/1/310; Komarov V, 2005, ENCY RF MICROWAVE EN; Lamb EJ, 2009, ANN CLIN BIOCHEM, V46, P205, DOI 10.1258/acb.2009.009007; Matyushov DV, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/32/325105; Nandi N, 1998, J PHYS CHEM A, V102, P8217, DOI 10.1021/jp983327j; Nortemann K, 1997, J PHYS CHEM A, V101, P6864, DOI 10.1021/jp971623a; Oncley JL, 1938, J AM CHEM SOC, V60, P1115, DOI 10.1021/ja01272a035; PETHIG R, 1987, PHYS MED BIOL, V32, P933, DOI 10.1088/0031-9155/32/8/001; Peyman A, 2012, PHYS MED BIOL, V57, pN339, DOI 10.1088/0031-9155/57/19/N339; Peyman A, 2010, PHYS MED BIOL, V55, pN413, DOI 10.1088/0031-9155/55/15/N02; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Rodriguez-Arteche I, 2012, PHYS CHEM CHEM PHYS, V14, P11352, DOI 10.1039/c2cp41496a; Shim S, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4774304; Smulders PFM, 2013, MICROW OPT TECHN LET, V55, P1916, DOI 10.1002/mop.27672; SUROWIEC A, 1985, PHYS MED BIOL, V30, P1131, DOI 10.1088/0031-9155/30/10/012; Wentholt IME, 2008, DIABETOLOGIA, V51, P183, DOI 10.1007/s00125-007-0842-6; Zhadobov M, 2012, BIOELECTROMAGNETICS, V33, P346, DOI 10.1002/bem.20713	31	6	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130011	10.1371/journal.pone.0130011	http://dx.doi.org/10.1371/journal.pone.0130011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066351	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000133
J	Nilsson, L; Appel, CF; Hultkvist, H; Vanky, F				Nilsson, Lennart; Appel, Carl-Fredrik; Hultkvist, Henrik; Vanky, Farkas			Evaluation of the Valve Academic Research Consortium-2 Criteria for Myocardial Infarction in Transcatheter Aortic Valve Implantation: A Prospective Observational Study	PLOS ONE			English	Article							UNIVERSAL DEFINITION; CONSENSUS DOCUMENT; CLINICAL-OUTCOMES; SELECTION; STENOSIS; FUTURE	Objective To evaluate the relevance of the individual components of the Valve Academic Research Consortium (VARC)-2 criteria for periprocedural myocardial infarction (MI) in transcatheter aortic valve implantation (TAVI). The association between biomarkers and adverse procedural outcome has been established. However, the additive prognostic importance of signs and symptoms are more uncertain. Methods A total of 125 consecutive TAVI patients were prospectively included in this study. Biomarkers for MI were analyzed and signs and symptoms according to VARC-2 criteria were collected from clinical records. Results The criteria of elevated biomarkers and of signs or symptoms were found in 27 (22%) and 32 (26%) of the patients, respectively. According to VARC-2 definition, 12 (10%) had MI. VARC-2 definition of MI, Troponin T (TnT) > 600 ng/L, and presence of signs or symptoms correlated with 6 months mortality, prolonged ICU stay, elevation of N-terminal prohormone brain natriuretic peptide, and renal impairment. No signs or symptoms were found in 7 (44%) of the patients who fulfilled the criterion of elevated TnT > 600 ng/L. In the group with positive TnT criterion, there were no significant differences between those with and without signs or symptoms in respect to levels of TnT (1014 [585-1720] ng/L versus 704 [515-905] ng/L, p = 0.17) or creatine kinase-MB (36 [25-52] mu g/L versus 29 [25-39] mu g/L, p = 0.32). In the multivariate Cox regression analysis, TnT > 600 ng/L was the only significant independent variable associated with 6-months postprocedural mortality. Conclusions Myocardial injury in TAVI, measured with biomarkers, correlates well with adverse procedural outcome. In this study it is also the strongest predictor for early postprocedural mortality. The additional requirement of signs or symptoms for the diagnosis of MI results in omission of a considerable number of clinically significant MI.	[Nilsson, Lennart] Linkoping Univ Hosp, Dept Cardiol, S-58185 Linkoping, Sweden; [Appel, Carl-Fredrik; Hultkvist, Henrik; Vanky, Farkas] Linkoping Univ Hosp, Dept Thorac & Vasc Surg, S-58185 Linkoping, Sweden; [Nilsson, Lennart; Appel, Carl-Fredrik; Hultkvist, Henrik; Vanky, Farkas] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University	Vanky, F (corresponding author), Linkoping Univ Hosp, Dept Thorac & Vasc Surg, S-58185 Linkoping, Sweden.	farkas.vanky@regionostergotland.se		Vanky, Farkas/0000-0003-1005-091X	Medical Research Council of Southeast Sweden [FORSS-12657, FORSS-23891, FORSS-159851, FORSS-311341]; ALF founding, County Council of Ostergotland, Sweden	Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ALF founding, County Council of Ostergotland, Sweden	Financial support was received by FV from The Medical Research Council of Southeast Sweden FORSS-12657, -23891, -159851, -311341), (http://www.researchweb.org/is/forss), The ALF founding, County Council of Ostergotland, Sweden.(http://www. fou.nu/is/lio) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attar N, 2009, ANN THORAC SURG, V87, P1757, DOI 10.1016/j.athoracsur.2009.03.047; Appel CF, 2012, SCAND CARDIOVASC J, V46, P301, DOI 10.3109/14017431.2012.699636; Bleiziffer S, 2012, J THORAC CARDIOV SUR, V143, P310, DOI 10.1016/j.jtcvs.2011.10.060; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; Fassa AA, 2013, NAT REV CARDIOL, V10, P685, DOI 10.1038/nrcardio.2013.156; Genereux P, 2012, J AM COLL CARDIOL, V59, P2317, DOI 10.1016/j.jacc.2012.02.022; Gutierrez M, 2009, AM HEART J, V158, P302, DOI 10.1016/j.ahj.2009.05.029; Jaffe AS, 2006, J AM COLL CARDIOL, V48, P1, DOI 10.1016/j.jacc.2006.02.056; Kappetein AP, 2013, J THORAC CARDIOV SUR, V145, P6, DOI 10.1016/j.jtcvs.2012.09.002; Lange R, 2012, J AM COLL CARDIOL, V59, P280, DOI 10.1016/j.jacc.2011.10.868; Moussa ID, 2013, J AM COLL CARDIOL, V62, P1563, DOI 10.1016/j.jacc.2013.08.720; Rodes-Cabau J, 2011, J AM COLL CARDIOL, V57, P1989, DOI 10.1016/j.jacc.2010.11.060; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Thygesen K, 2010, EUR HEART J, V31, P2197, DOI 10.1093/eurheartj/ehq251	15	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130423	10.1371/journal.pone.0130423	http://dx.doi.org/10.1371/journal.pone.0130423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069958	gold, Green Submitted, Green Published			2022-12-27	WOS:000356327000157
J	Sunde, RA; Sunde, GR; Sunde, CM; Sunde, ML; Evenson, JK				Sunde, Roger A.; Sunde, Gavin R.; Sunde, Colin M.; Sunde, Milton L.; Evenson, Jacqueline K.			Cloning, Sequencing, and Expression of Selenoprotein Transcripts in the Turkey (Meleagris gallopavo)	PLOS ONE			English	Article							HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; MESSENGER-RNA LEVELS; SELENIUM DEFICIENCY; GENES; SELENOCYSTEINE; EVOLUTION; CHICKS; LIVER; RATS	The minimum Se requirement for male turkey poults is 0.3 mu g Se/g - three times higher than requirements found in rodents - based on liver and gizzard glutathione peroxidase-4 (GPX4) and GPX1 activities. In addition, turkey liver GPX4 activity is 10-fold higher and GPX1 activity is 10-fold lower than in rats, and both GPX1 and GPX4 mRNA levels are dramatically down-regulated by Se deficiency. Currently, the sequences of all annotated turkey selenoprotein transcripts and proteins in the NCBI database are only "predicted." Thus we initiated cloning and sequencing of the full turkey selenoprotein transcriptome to demonstrate expression of selenoprotein transcripts in the turkey, and to develop tools to investigate Se regulation of the full selenoproteome. Total RNA was isolated from six tissues of Se-adequate adult tom turkeys, and used to prepare reverse-transcription cDNA libraries. PCR primers were designed, based initially on chicken, rodent, porcine, bovine and human sequences and later on turkey shotgun cloning sequences. We report here the cloning of full transcript sequences for 9 selenoproteins, and 3'UTR portions for 15 additional selenoproteins, which include SECIS elements in 22 3'UTRs, and in-frame Sec (UGA) codons within coding regions of 19 selenoproteins, including 12 Sec codons in SEPP1. In addition, we sequenced the gap between two contigs from the shotgun cloning of the turkey genome, and found the missing sequence for the turkey Sec-tRNA. RTPCR was used to determine the relative transcript expression in 6 tissues. GPX3 expression was high in all tissues except kidney, GPX1 expression was high in kidney, SEPW1 expression was high in heart, gizzard and muscle, and SELU expression was high in liver. SEPP2, a selenoprotein not found in mammals, was highly expressed in liver but not in other tissues. In summary, transcripts for 24 selenoproteins are expressed in the turkey, not just predicted.	[Sunde, Roger A.; Sunde, Gavin R.; Sunde, Colin M.; Evenson, Jacqueline K.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Sunde, Milton L.] Univ Wisconsin, Dept Anim Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sunde, RA (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	sunde@nutrisci.wisc.edu			National Institute of Food and Agriculture, United States Department of Agriculture; Hatch [0201908, 233618, 1004389]; Wisconsin Alumni Foundation	National Institute of Food and Agriculture, United States Department of Agriculture(United States Department of Agriculture (USDA)); Hatch(United States Department of Agriculture (USDA)); Wisconsin Alumni Foundation	This Research was supported by the National Institute of Food and Agriculture, United States Department of Agriculture (www.csrees.usda.gov), Hatch projects 0201908, 233618, and 1004389, and by the Wisconsin Alumni Foundation (http://www.uwalumni.com) Selenium Nutrition Research Fund.	Ausubel FM, 1988, MOL REPROD DEV; AVISSAR N, 1989, BLOOD, V73, P318; Barnes KM, 2009, J NUTR, V139, P199, DOI 10.3945/jn.108.098624; Castellano S, 2004, EMBO REP, V5, P71, DOI 10.1038/sj.embor.7400036; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Fischer J, 2008, ARCH ANIM NUTR, V62, P485, DOI 10.1080/17450390802453468; Hadley KB, 1997, TRACE ELEMENTS IN MAN AND ANIMALS - 9, P59; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HATFIELD DL, 1983, P NATL ACAD SCI-BIOL, V80, P4940, DOI 10.1073/pnas.80.16.4940; Hatfield DL, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P1, DOI 10.1007/978-1-4614-1025-6; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Huang JQ, 2011, J NUTR, V141, P1605, DOI 10.3945/jn.111.145722; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; LEI XG, 1995, J NUTR, V125, P1438; Liu CP, 2014, BIOL TRACE ELEM RES, V159, P192, DOI 10.1007/s12011-014-0005-9; Lobanov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r62; LOWRY OH, 1951, J BIOL CHEM, V193, P265; National Research Council, 1994, NUTR REQ POULTR; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; PESTI GM, 1979, POULTRY SCI, V58, P1541, DOI 10.3382/ps.0581541; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SUNDE RA, 1987, J BIOL CHEM, V262, P933; Sunde RA, 2010, EXP BIOL MED, V235, P23, DOI 10.1258/ebm.2009.009262; Tamura T, 2004, P NATL ACAD SCI USA, V101, P16162, DOI 10.1073/pnas.0406313101; Yao HD, 2014, BIOL TRACE ELEM RES, V161, P318, DOI 10.1007/s12011-014-0125-2	25	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129801	10.1371/journal.pone.0129801	http://dx.doi.org/10.1371/journal.pone.0129801			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070131	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000109
J	Agnew, AM; Betsinger, TK; Justus, HM				Agnew, Amanda M.; Betsinger, Tracy K.; Justus, Hedy M.			Post-Cranial Traumatic Injury Patterns in Two Medieval Polish Populations: The Effects of Lifestyle Differences	PLOS ONE			English	Article							NONFATAL FARM INJURIES; OSTEOPOROTIC FRACTURES; VERTEBRAL FRACTURE; AGE ESTIMATION; PHASE-ANALYSIS; RIB FRACTURES; ENGLAND; YORK	Traumatic injuries can be used as general indicators of activity patterns in past populations. This study tests the hypothesis that contemporaneous (10th-12th century) rural and urban populations in medieval Poland will have a significantly different prevalence of non-violent fractures. Traumatic injuries to the post-cranial skeleton were recorded for 180 adults from rural Giecz and for 96 adults from urban Poznan-Srodka. They were statistically analyzed by body region and individual skeletal element. Results reveal that Giecz had a significantly higher rate of trunk fractures than Poznan-Srodka (Fisher's exact, p<0.05). In particular, rib and vertebral fractures were more common in Giecz males and females than in their Poznan-Srodka counterparts. Traumatic injuries in the extremities were comparable between the two samples, suggesting similar risks of trauma to these regions. These results indicate that in early medieval Poland, activities associated with a rural lifestyle resulted in more injuries. These stress or accidental fractures, which are related to a high-risk setting, were not consistent with an urban lifestyle. Overall, agricultural populations like Giecz were engaged in a laborious lifestyle, reflected in a variety of injuries related to repetitive, high-risk activities. Although urban populations like Poznan engaged in craft specialization participated in repetitive activities, their lifestyle resulted in lesser fracture-risk.	[Agnew, Amanda M.] Ohio State Univ, Div Anat, Skeletal Biol Res Lab, Columbus, OH 43210 USA; [Agnew, Amanda M.; Justus, Hedy M.] Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; [Betsinger, Tracy K.] SUNY Coll Oneonta, Dept Anthropol, Oneonta, NY 13820 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; State University of New York (SUNY) System	Agnew, AM (corresponding author), Ohio State Univ, Div Anat, Skeletal Biol Res Lab, Columbus, OH 43210 USA.	amanda.agnew@osumc.edu	Agnew, Amanda M/E-2619-2011		Global History of Health Project; Ohio State University	Global History of Health Project; Ohio State University(Ohio State University)	This study and all authors were supported in part by the Global History of Health Project. TKB received an Alumni Grant from the The Ohio State University to support her role in this project. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acsadi G., 1970, HIST HUMAN LIFE SPAN; AGNEW AM, 2014, ANTHROPOL REV, V77, P189, DOI DOI 10.2478/anre-2014-0015; Barford PM, 2005, EAST CENTRAL & EASTERN EUROPE IN THE EARLY MIDDLE AGES, P60; Bass W. M., 2005, HUMAN OSTEOLOGY LAB, V5th; Betsinger T.K., 2007, THESIS OHIO STATE U; Brickley M, 2006, INT J OSTEOARCHAEOL, V16, P61, DOI 10.1002/oa.809; Brooks S, 1990, J HUM EVOL, V5, P227, DOI DOI 10.1007/BF02437238; Buikstra J. E., 1994, STANDARDS DATA COLLE; Buko A, 2005, East Central & Eastern Europe in the Early Middle Ages, P162; Buko A, 2005, ARCHEOLOGIA POLSKI W; Buko A, 2008, E CENTRAL E EUROPE M, P450; Burrell L, 1986, HUMAN EVOLUTION, V1, P495, DOI DOI 10.1007/BF02437466; Connolly LP, 2004, CLIN NUCL MED, V29, P614, DOI 10.1097/00003072-200410000-00002; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; Davies N, 1982, PIAST POLANIAN DYNAS; Dembinska M., 1999, FOOD DRINK MEDIEVAL; Djuric MR, 2006, AM J PHYS ANTHROPOL, V130, P167, DOI 10.1002/ajpa.20270; Geber J, INT J OSTEO IN PRESS, DOI [10.1002/0a.2281, DOI 10.1002/0A.2281]; Giecz Krysztofiak T., 2009, CUSTODIA MEMORIAE MU, P111; Gieysztor A., 1968, HIST OF POLAND; Gorecki P., 1992, EC SOC LORDSHIP MEDI; Grauer AL, 1996, AM J PHYS ANTHROPOL, V100, P531, DOI 10.1002/(SICI)1096-8644(199608)100:4<531::AID-AJPA7>3.0.CO;2-T; Hwang SA, 2001, AM J IND MED, V40, P32, DOI 10.1002/ajim.1069; ISCAN MY, 1985, J FORENSIC SCI, V30, P853; ISCAN MY, 1984, J FORENSIC SCI, V29, P1094; JONSSON B, 1992, OSTEOPOROSIS INT, V2, P269, DOI 10.1007/BF01623181; Judd MA, 1999, AM J PHYS ANTHROPOL, V109, P229, DOI 10.1002/(SICI)1096-8644(199906)109:2<229::AID-AJPA7>3.0.CO;2-Y; Kilgore L, 1997, INT J OSTEOARCHAEOL, V7, P103, DOI 10.1002/(SICI)1099-1212(199703)7:2<103::AID-OA319>3.0.CO;2-5; Kostrzewski B, 1966, GROD PIASTOWSKI GIEC; Kostrzewski B, 1964, ARCHAEOL POLONA, V6, P234; Kostrzewski J., 1962, KULTURA PRAPOLSKA; KRYSZTOFIAK T, 2008, SLAVIA PROJECT HDB, P43; Larsen C.S., 1997, BIOARCHAEOLOGY INTER; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P15, DOI 10.1002/ajpa.1330680103; Lovell NC, 1997, YEARB PHYS ANTHROPOL, V40, P139; LUKERT BP, 1994, GERIATRICS, V49, P22; Magocsi PR, 1993, HIST ATLAS CENTRAL E; Manteuffel T, 1982, FORMATION POLISH STA; Matos V, 2009, AM J PHYS ANTHROPOL, V140, P25, DOI 10.1002/ajpa.21032; McCurdy SA, 2000, AM J IND MED, V38, P463, DOI 10.1002/1097-0274(200010)38:4&lt;463::AID-AJIM13&gt;3.0.CO;2-N; McKern T.W., 1957, EP45 QUART RES DEV C; Merbs CF, 1996, YEARB PHYS ANTHROPOL, V39, P201; Myers ER, 1997, SPINE, V22, p25S, DOI 10.1097/00007632-199712151-00005; Myers J, 1994, INJURIES FARM WORKER; Nevitt MC, 2005, J BONE MINER RES, V20, P131, DOI 10.1359/JBMR.041003; Pawlak P, 1998, SLAVIA ANTIQUA, V39, P215; Pawlak P., 2005, CIVITAS POSNANIENSIS, P59; Pawlak P, 2005, COMMUNICATION; PHENICE TW, 1969, AM J PHYS ANTHROPOL, V30, P297, DOI 10.1002/ajpa.1330300214; PICKETT W, 1995, ACCIDENT ANAL PREV, V27, P425, DOI 10.1016/0001-4575(94)00080-6; Polcyn M., 1994, Botanical Journal of Scotland, V46, P533; Roberts Charlotte, 2005, ARCHAEOLOGY DIS; Scheuer L., 2000, DEV JUVENILE OSTEOLO; Scott RM, 2010, AM J PHYS ANTHROPOL, V142, P509, DOI 10.1002/ajpa.21250; Singman J. L., 1999, DAILY LIFE MEDIEVAL; Sirmali M, 2003, EUR J CARDIO-THORAC, V24, P133, DOI 10.1016/S1010-7940(03)00256-2; STALLONES L, 1990, AM J IND MED, V18, P223, DOI 10.1002/ajim.4700180214; Steckel R.H., 2006, GLOBAL HIST HLTH PRO; Stewart TD., 1979, ESSENTIALS FORENSIC; Stirland A, 1988, HUMAN PALEOPATHOLOGY, P40; Todd TW, 1921, AM J PHYS ANTHROPOL, V4, P1, DOI 10.1002/ajpa.1330040102; Todd TW, 1920, AM J PHYS ANTHROPOL, V3, P285, DOI 10.1002/ajpa.1330030301; WAKELY J, 1996, INT J OSTEOARCHAEOL, V6, P76; Waldron T, 2009, CAMB MAN ARCHAEOL, P1	65	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129458	10.1371/journal.pone.0129458	http://dx.doi.org/10.1371/journal.pone.0129458			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK3FB	26068106	Green Published, gold			2022-12-27	WOS:000356100900055
J	Aarstad, HH; Vintermyr, OK; Ulvestad, E; Kross, K; Heimdal, JH; Aarstad, HJ				Aarstad, Helene Hersvik; Vintermyr, Olav Karsten; Ulvestad, Elling; Kross, Kenneth; Heimdal, John Helge; Aarstad, Hans Jorgen			In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; HUMAN-PAPILLOMAVIRUS; PROGNOSTIC MARKER; CANCER PATIENTS; LUNG-CANCER; INFLAMMATION; HPV; PHOSPHORYLATION; EXPRESSION; PROFILE	The study was performed in order to determine whether peripheral blood monocyte in vitro function, and lymphocyte in vivo activation at diagnosis, was associated with HPV tumor infection status and 15-year survival in head and neck squamous cell carcinoma (HNSCC) patients. Sixty-five patients from a consecutive cohort of newly diagnosed HNSCCs, together with 18 control patients, were included in the study. Monocyte responsiveness was assessed by measuring monocyte in vitro interleukin (IL)-6 secretions after 24 hours of LPS stimulation in cultures with a serum-free medium. T lymphocyte activation was determined as the fraction of CD71-positive cells on CD3-positive cells by flow cytometry, whereas HPV infection was determined by PCR on formalin-fixed paraffin-embedded (FFPE) tumor tissue. Disease-specific survivals and overall survivals were determined 15 years following inclusion. HPV-positive HNSCC patients had a lower monocyte LPS-stimulated IL-6 response. A high LPS-stimulated monocyte IL-6 response predicted a decreased survival rate (P=0.019). A high percentage of CD71-positive T lymphocytes also predicted an impaired prognosis (P=0.021). The predictive power of IL-6 monocyte LPS-stimulated responses was retained when adjusted for age, gender and TNM stage of the patients. The monocyte and T lymphocyte survival predictions were independent of each other. The survival was particularly low with a combined high activated monocyte and T lymphocyte status. In a multivariate analysis, IL-6 secretion and the percentage of CD71-positive T lymphocytes both uniquely predicted survival independent of HPV infection status. It is postulated that the natural and adaptive immune systems are separately and additionally linked to the clinical aggressiveness of HNSCCs.	[Aarstad, Helene Hersvik; Vintermyr, Olav Karsten; Heimdal, John Helge; Aarstad, Hans Jorgen] Univ Bergen, Fac Med & Dent, Dept Clin Med, Bergen, Norway; [Aarstad, Helene Hersvik; Heimdal, John Helge; Aarstad, Hans Jorgen] Haukeland Hosp, Dept Otolaryngol Head & Neck Surg, N-5021 Bergen, Norway; [Vintermyr, Olav Karsten] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Ulvestad, Elling] Haukeland Hosp, Dept Microbiol, N-5021 Bergen, Norway; [Ulvestad, Elling] Univ Bergen, Fac Med & Dent, Dept Clin Sci, Bergen, Norway; [Kross, Kenneth] Maastricht Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, NL-6200 MD Maastricht, Netherlands	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Maastricht University	Aarstad, HJ (corresponding author), Univ Bergen, Fac Med & Dent, Dept Clin Med, Bergen, Norway.	hans.aarstad@uib.no			Norwegian Cancer Society	Norwegian Cancer Society(Norwegian Cancer Society)	The laboratories were in general supported by the Norwegian Cancer Society.	Aarstad HJ, 2006, ACTA OTO-LARYNGOL, V126, P1326, DOI 10.1080/00016480600702092; Aarstad HJ, 2015, APMIS; Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; Andersen AS, 2014, INT J CANCER, V134, P2755, DOI 10.1002/ijc.28411; Ang KK, 2012, SEMIN RADIAT ONCOL, V22, P128, DOI 10.1016/j.semradonc.2011.12.004; Blitzer GC, 2014, INT J RADIAT ONCOL, V88, P761, DOI 10.1016/j.ijrobp.2013.08.029; Chang CH, 2013, INT J CANCER, V132, P1977, DOI 10.1002/ijc.27892; Chiba T, 2012, GASTROENTEROLOGY, V143, P550, DOI 10.1053/j.gastro.2012.07.009; Cho WCS, 2011, EXPERT OPIN THER TAR, V15, P1127, DOI 10.1517/14728222.2011.599801; Costa NL, 2013, ORAL ONCOL, V49, P216, DOI 10.1016/j.oraloncology.2012.09.012; Davidson HC, 2009, ORAL ONCOL, V45, P747, DOI 10.1016/j.oraloncology.2009.02.009; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Feller L, 2013, ORAL ONCOL, V49, P887, DOI 10.1016/j.oraloncology.2013.07.003; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Heimdal JH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-34; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hong SH, 2000, FASEB J, V14, P1499, DOI 10.1096/fj.99-0802com; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Kipanyula MJ, 2013, CELL SIGNAL, V25, P403, DOI 10.1016/j.cellsig.2012.10.014; Kross KW, 2008, SCAND J IMMUNOL, V67, P392, DOI 10.1111/j.1365-3083.2008.02072.x; Kross KW, 2010, EUR ARCH OTO-RHINO-L, V267, P335, DOI 10.1007/s00405-009-1153-y; Kundu JK, 2012, FREE RADICAL BIO MED, V52, P2013, DOI 10.1016/j.freeradbiomed.2012.02.035; Ljokjel B, 2014, ACTA OTO-LARYNGOL, V134, P1, DOI [10.3109/00016489.2013.840922, DOI 10.3109/00016489.2013.840922]; Ljokjel B, 2014, ACTA OTO-LARYNGOL, V134, P636, DOI 10.3109/00016489.2014.886336; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Millrud CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051120; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Olsnes C, 2011, SCAND J IMMUNOL, V74, P114, DOI 10.1111/j.1365-3083.2011.02555.x; Olsnes C, 2013, APMIS, V121, P299, DOI 10.1111/j.1600-0463.2012.02969.x; Reddy M, 2004, J IMMUNOL METHODS, V293, P127, DOI 10.1016/j.jim.2004.07.006; Shipkova M, 2012, CLIN CHIM ACTA, V413, P1338, DOI 10.1016/j.cca.2011.11.006; Starska K, 2011, FOLIA HISTOCHEM CYTO, V49, P593, DOI 10.5603/FHC.2011.0082; Tartour E, 2001, LANCET, V357, P1263, DOI 10.1016/S0140-6736(00)04420-2; Vermeer DW, 2013, INT J CANCER, V133, P120, DOI 10.1002/ijc.28015; Ward MJ, 2014, BRIT J CANCER, V110, P489, DOI 10.1038/bjc.2013.639; Whiteside TL, 2005, CANCER METAST REV, V24, P95, DOI 10.1007/s10555-005-5050-6	37	5	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129724	10.1371/journal.pone.0129724	http://dx.doi.org/10.1371/journal.pone.0129724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079381	gold, Green Submitted, Green Published			2022-12-27	WOS:000356542300031
J	Aguado-Fraile, E; Ramos, E; Conde, E; Rodriguez, M; Martin-Gomez, L; Lietor, A; Candela, A; Ponte, B; Liano, F; Garcia-Bermejo, ML				Aguado-Fraile, Elia; Ramos, Edurne; Conde, Elisa; Rodriguez, Macarena; Martin-Gomez, Laura; Lietor, Aurora; Candela, Angel; Ponte, Belen; Liano, Fernando; Laura Garcia-Bermejo, Maria			A Pilot Study Identifying a Set of microRNAs As Precise Diagnostic Biomarkers of Acute Kidney Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; DEFINITION; EXPRESSION; URINE	In the last decade, Acute Kidney Injury (AKI) diagnosis and therapy have not notably improved probably due to delay in the diagnosis, among other issues. Precocity and accuracy should be critical parameters in novel AKI biomarker discovery. microRNAs are key regulators of cell responses to many stimuli and they can be secreted to the extracellular environment. Therefore, they can be detected in body fluids and are emerging as novel disease biomarkers. We aimed to identify and validate serum miRNAs useful for AKI diagnosis and management. Using qRT-PCR arrays in serum samples, we determined miRNAs differentially expressed between AKI patients and healthy controls. Statistical and target prediction analysis allowed us to identify a panel of 10 serum miRNAs. This set was further validated, by qRT-PCR, in two independent cohorts of patients with relevant morbi-mortality related to AKI: Intensive Care Units (ICU) and Cardiac Surgery (CS). Statistical correlations with patient clinical parameter were performed. Our results demonstrated that the 10 selected miRNAs (miR-101-3p, miR-127-3p, miR-210-3p, miR-126-3p, miR-26b-5p, miR-29a-3p, miR-146a-5p, miR-27a-3p, miR-93-3p and miR-10a-5p) were diagnostic biomarkers of AKI in ICU patients, exhibiting areas under the curve close to 1 in ROC analysis. Outstandingly, serum miRNAs estimated before CS predicted AKI development later on, thus becoming biomarkers to predict AKI predisposition. Moreover, after surgery, the expression of the miRNAs was modulated days before serum creatinine increased, demonstrating early diagnostic value. In summary, we have identified a set of serum miRNAs as AKI biomarkers useful in clinical practice, since they demonstrate early detection and high diagnostic value and they recognize patients at risk.	[Aguado-Fraile, Elia; Ramos, Edurne; Conde, Elisa; Rodriguez, Macarena; Martin-Gomez, Laura; Laura Garcia-Bermejo, Maria] IRYCIS, miRNAs Based Biomarkers & Therapeut Targets Unit, Madrid, Spain; [Lietor, Aurora] Univ Hosp Ramon y Cajal, Dept Intens Med, Madrid, Spain; [Candela, Angel] Univ Hosp Ramon y Cajal, Dept Anesthesia & Reanimat, Madrid, Spain; [Ponte, Belen] Univ Hosp Geneve, Dept Internal Med, Geneva, Switzerland; [Liano, Fernando] Univ Hosp Ramon y Cajal, IRYCIS, Dept Nephrol, Madrid, Spain	Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal; University of Geneva; Hospital Universitario Ramon y Cajal	Garcia-Bermejo, ML (corresponding author), IRYCIS, miRNAs Based Biomarkers & Therapeut Targets Unit, Madrid, Spain.	garciabermejo@gmail.com	García-Bermejo, María Laura/E-1542-2015; rodriguez, macarena/E-8790-2018; MORENO, ELISA CONDE/H-7853-2017; Conde-Moreno, Elisa/AAG-2295-2021	García-Bermejo, María Laura/0000-0002-8167-2276; rodriguez, macarena/0000-0003-3499-5926; MORENO, ELISA CONDE/0000-0002-3751-9602; Conde-Moreno, Elisa/0000-0002-3751-9602; Ramos, Edurne/0000-0001-5388-0281	Instituto de Salud Carlos III (ISCIII) [FIS PS09/02183, PS12/00094]; Comunidad de MAdrid-Consorcio de Investigacion en Fracaso Renal Agudo (CAM-CIFRA) [S2010/BMD-2378]; CAM-CIFRA [S2010/BMD-2378]; Eusebio Martin Escudero Foundation Fellowship; Red de Investigacion Renal (REDINREN) [RD12/0021/0020]; ISCIII [CA11/00491]	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Comunidad de MAdrid-Consorcio de Investigacion en Fracaso Renal Agudo (CAM-CIFRA); CAM-CIFRA; Eusebio Martin Escudero Foundation Fellowship; Red de Investigacion Renal (REDINREN); ISCIII(Instituto de Salud Carlos III)	This work was supported by grants FIS PS09/02183 and PS12/00094 by Instituto de Salud Carlos III (ISCIII) and Comunidad de MAdrid-Consorcio de Investigacion en Fracaso Renal Agudo (CAM-CIFRA, S2010/BMD-2378). EAF was supported by CAM-CIFRA (S2010/BMD-2378) and is currently funded by Eusebio Martin Escudero Foundation Fellowship, ER was funded by Red de Investigacion Renal (REDINREN, RD12/0021/0020), MR was recipient of contract from ISCIII (CA11/00491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado-Fraile E, 2013, NEFROLOGIA, V33, P826, DOI 10.3265/Nefrologia.pre2013.Aug.12198; Aguado-Fraile E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044305; Bagshaw SM, 2008, NEPHROL DIAL TRANSPL, V23, P1569, DOI 10.1093/ndt/gfn009; Bellinger MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093297; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Devarajan P, 2014, NEPHRON CLIN PRACT, V127, P176, DOI 10.1159/000363206; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Haase M, 2010, CONTRIB NEPHROL, V165, P33, DOI 10.1159/000313742; Hu Guoku, 2012, Frontiers in Genetics, V3, P56, DOI 10.3389/fgene.2012.00056; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Koyner JL, 2010, CLIN J AM SOC NEPHRO, V5, P2154, DOI 10.2215/CJN.00740110; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee CG, 2014, KIDNEY INT, V86, P943, DOI 10.1038/ki.2014.117; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Mariscalco G, 2011, ANN THORAC SURG, V92, P1539, DOI 10.1016/j.athoracsur.2011.04.123; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Saikumar J, 2014, CLIN CHEM, V60, P1158, DOI 10.1373/clinchem.2013.216044; Siew ED, 2011, J AM SOC NEPHROL, V22, P810, DOI 10.1681/ASN.2010080796; Sirota JC, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/328120; Soto K, 2010, CLIN J AM SOC NEPHRO, V5, P1745, DOI 10.2215/CJN.00690110; Srisawat N, 2011, CURR OPIN CRIT CARE, V17, P548, DOI 10.1097/MCC.0b013e32834cd349; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Trionfini P, 2015, NAT REV NEPHROL, V11, P23, DOI 10.1038/nrneph.2014.202; Waikar SS, 2009, J AM SOC NEPHROL, V20, P672, DOI 10.1681/ASN.2008070669; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wang G, 2011, DIS MARKERS, V30, P171, DOI [10.3233/DMA-2011-0766, 10.1155/2011/304852]	36	91	98	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0127175	10.1371/journal.pone.0127175	http://dx.doi.org/10.1371/journal.pone.0127175			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079930	Green Published, gold, Green Submitted			2022-12-27	WOS:000356542300003
J	Baumer, N; Baumer, S; Haak, M; Koschmieder, S; Schonig, K; Berdel, WE; Muller-Tidow, C				Baeumer, Nicole; Baeumer, Sebastian; Haak, Miriam; Koschmieder, Steffen; Schoenig, Kai; Berdel, Wolfgang E.; Mueller-Tidow, Carsten			A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE PROMYELOCYTIC LEUKEMIA; HEMATOPOIETIC STEM-CELLS; PML-RAR-ALPHA; A1-CDK2 COMPLEX; MOUSE MODEL; EXPRESSION; CANCER; OVEREXPRESSION; PROLIFERATION	The quest for novel therapeutic targets in acute myeloid leukemia (AML) is still ongoing. One of such targets, cyclin A1, was shown to be overexpressed in AML including AML stem cells. However, the function of cyclin A1 in AML is largely unknown, and the data on its impact on patients' survival remain controversial. Therefore, we developed a transgenic mouse model of stem cell-directed inducible cyclin A1 overexpression and crossed these mice with PML-RAR alpha-knockin mice, which develop an AML M3-like phenotype. To observe the effects of cyclin A1 loss-of-function, we also crossed PML-RAR alpha-knockin mice to cyclin A1-knockout mice. Neither overexpression nor loss of cyclin A1 significantly altered leuke-mogenesis in PML-RAR alpha-knockin mice. These findings imply that upregulation of cyclin A1 is not essential for leukemogenesis. Our data suggest that cyclin A1 does not represent a suitable target for AML therapy.	[Baeumer, Nicole; Baeumer, Sebastian; Haak, Miriam; Berdel, Wolfgang E.; Mueller-Tidow, Carsten] Univ Munster, Dept Med A, Hematol Oncol, D-48149 Munster, Germany; [Haak, Miriam] Miltenyi Biotec GmbH, Bergisch Gladbach, Germany; [Koschmieder, Steffen] Rhein Westfal TH Aachen, Fac Med, Dept Med, Hematol Oncol Hemostaseol & SCT, Aachen, Germany; [Schoenig, Kai] Heidelberg Univ, Dept Mol Biol, Cent Inst Mental Hlth, Mannheim, Germany; [Mueller-Tidow, Carsten] Univ Halle Wittenberg, Dept Med 4, Hematol & Oncol, D-06108 Halle, Germany	University of Munster; Miltenyi Biotec; RWTH Aachen University; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Martin Luther University Halle Wittenberg	Baumer, N (corresponding author), Univ Munster, Dept Med A, Hematol Oncol, D-48149 Munster, Germany.	nbaeumer@uni-muenster.de; Carsten.Mueller-Tidow@UK-Halle.de	Müller-Tidow, Carsten/O-7207-2018; Baeumer, Sebastian/GYU-0544-2022	Müller-Tidow, Carsten/0000-0002-7166-5232; Koschmieder, Steffen/0000-0002-1011-8171	Deutsche Forschungsgemeinschaft [Mu 1328/2-3]; Deutsche Krebshilfe [10-1539-Mu3]; Miltenyi Biotec GmbH	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Miltenyi Biotec GmbH	This study was supported by grants from the Deutsche Forschungsgemeinschaft (Mu 1328/2-3; www.dfg.de) and the Deutsche Krebshilfe (10-1539-Mu3; www.krebshilfe.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Miltenyi Biotec GmbH provided support in the form of salary for author "MH," but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Baumer N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094993; Baumer N, 2011, J BIOL CHEM, V286, P28210, DOI 10.1074/jbc.M110.203471; Bruyere C, 2013, CURR OPIN CELL BIOL, V25, P772, DOI 10.1016/j.ceb.2013.08.004; Diederichs S, 2005, INT J CANCER, V116, P207, DOI 10.1002/ijc.21034; Diederichs S, 2004, J BIOL CHEM, V279, P33727, DOI 10.1074/jbc.M401708200; Ekberg J, 2005, EUR J HAEMATOL, V75, P106, DOI 10.1111/j.1600-0609.2005.00473.x; Gopinathan L, 2014, CANCER RES, V74, P3870, DOI 10.1158/0008-5472.CAN-13-3440; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hebestreit K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039148; Holm C, 2006, LEUKEMIA RES, V30, P254, DOI 10.1016/j.leukres.2005.07.010; Iida H, 1997, BLOOD, V90, P3707, DOI 10.1182/blood.V90.9.3707; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Kelly LM, 2002, P NATL ACAD SCI USA, V99, P8283, DOI 10.1073/pnas.122233699; Khaja ASS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072210; Koschmieder S, 2005, BLOOD, V105, P324, DOI 10.1182/blood-2003-12-4369; Liao C, 2001, P NATL ACAD SCI USA, V98, P6853, DOI 10.1073/pnas.121540098; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Liu Y, 2013, MOL CELL BIOCHEM, V384, P221, DOI 10.1007/s11010-013-1801-9; Muller C, 2000, BLOOD, V96, P3894, DOI 10.1182/blood.V96.12.3894.h8003894_3894_3899; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P8917, DOI 10.1128/MCB.24.20.8917-8928.2004; Munari E, 2015, HISTOPATHOLOGY, V66, P262, DOI 10.1111/his.12499; Ochsenreither S, 2012, BLOOD, V119, P5492, DOI 10.1182/blood-2011-07-365890; Schemionek M, 2010, BLOOD, V115, P3185, DOI 10.1182/blood-2009-04-215376; Schonig K, 2011, TRANSGENIC RES, V20, P709, DOI 10.1007/s11248-010-9427-0; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; van der Meer T, 2004, REPRODUCTION, V127, P503, DOI 10.1530/rep.1.00131; Vukman KV, 2014, BIOPROTOCOL, V4, pe1052; Wegiel B, 2008, JNCI-J NATL CANCER I, V100, P1022, DOI 10.1093/jnci/djn214; Westervelt P, 2003, BLOOD, V102, P1857, DOI 10.1182/blood-2002-12-3779; Yang R, 1999, BLOOD, V93, P2067; Yu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006445	31	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129147	10.1371/journal.pone.0129147	http://dx.doi.org/10.1371/journal.pone.0129147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080083	Green Published, gold			2022-12-27	WOS:000356542300017
J	Ducken, DR; Brown, WC; Alperin, DC; Brayton, KA; Reif, KE; Turse, JE; Palmer, GH; Noh, SM				Ducken, Deirdre R.; Brown, Wendy C.; Alperin, Debra C.; Brayton, Kelly A.; Reif, Kathryn E.; Turse, Joshua E.; Palmer, Guy H.; Noh, Susan M.			Subdominant Outer Membrane Antigens in Anaplasma marginale: Conservation, Antigenicity, and Protective Capacity Using Recombinant Protein	PLOS ONE			English	Article							MAMMALIAN HOST-CELLS; MAJOR SURFACE PROTEIN-2; BOOPHILUS-MICROPLUS; VACCINE DEVELOPMENT; IMMUNOGENICITY; IMMUNITY; IDENTIFICATION; INFECTION; SUPERINFECTION; TRANSMISSION	Anaplasma marginale is a tick-borne rickettsial pathogen of cattle with a worldwide distribution. Currently a safe and efficacious vaccine is unavailable. Outer membrane protein (OMP) extracts or a defined surface protein complex reproducibly induce protective immunity. However, there are several knowledge gaps limiting progress in vaccine development. First, are these OMPs conserved among the diversity of A. marginale strains circulating in endemic regions? Second, are the most highly conserved outer membrane proteins in the immunogens recognized by immunized and protected animals? Lastly, can this subset of OMPs recognized by antibody from protected vaccinates and conserved among strains recapitulate the protection of outer membrane vaccines? To address the first goal, genes encoding OMPs AM202, AM368, AM854, AM936, AM1041, and AM1096, major subdominant components of the outer membrane, were cloned and sequenced from geographically diverse strains and isolates. AM202, AM936, AM854, and AM1096 share 99.9 to 100% amino acid identity. AM1041 has 97.1 to 100% and AM368 has 98.3 to 99.9% amino acid identity. While all four of the most highly conserved OMPs were recognized by IgG from animals immunized with outer membranes, linked surface protein complexes, or unlinked surface protein complexes and shown to be protected from challenge, the highest titers and consistent recognition among vaccinates were to AM854 and AM936. Consequently, animals were immunized with recombinant AM854 and AM936 and challenged. Recombinant vaccinates and purified outer membrane vaccinates had similar IgG and IgG2 responses to both proteins. However, the recombinant vaccinates developed higher bacteremia after challenge as compared to adjuvant-only controls and outer membrane vaccinates. These results provide the first evidence that vaccination with specific antigens may exacerbate disease. Progressing from the protective capacity of outer membrane formulations to recombinant vaccines requires testing of additional antigens, optimization of the vaccine formulation and a better understanding of the protective immune response.	[Ducken, Deirdre R.; Noh, Susan M.] USDA ARS, Anim Dis Res Unit, Pullman, WA 99164 USA; [Ducken, Deirdre R.; Brown, Wendy C.; Alperin, Debra C.; Brayton, Kelly A.; Reif, Kathryn E.; Turse, Joshua E.; Noh, Susan M.] Washington State Univ, Dept Vet Microbiol & Pathol, Program Vector Borne Dis, Pullman, WA 99164 USA; [Brayton, Kelly A.; Noh, Susan M.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	United States Department of Agriculture (USDA); Washington State University; Washington State University	Noh, SM (corresponding author), USDA ARS, Anim Dis Res Unit, Pullman, WA 99164 USA.	snoh@vetmed.wsu.edu	, 0000-0001-7041-1823/B-9144-2014	, 0000-0001-7041-1823/0000-0001-7041-1823	United States Department of Agriculture-Agricultural Research Service [5348-32000-033-00D, 5348-3200-033-03S]; National Institutes of Health [R37 AI44005]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044005, T32AI007025] Funding Source: NIH RePORTER	United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the United States Department of Agriculture-Agricultural Research Service grant 5348-32000-033-00D, United States Department of Agriculture-Agricultural Research Service cooperative agreement 5348-3200-033-03S, and National Institutes of Health R37 AI44005.	Abbott JR, 2004, INFECT IMMUN, V72, P7360, DOI 10.1128/IAI.72.12.7360-7366.2004; Agnes JT, 2011, INFECT IMMUN, V79, P1311, DOI 10.1128/IAI.01174-10; Albarrak SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046372; Ayalew S, 2011, CLIN VACCINE IMMUNOL, V18, P2067, DOI 10.1128/CVI.05332-11; Barfod L, 2011, P NATL ACAD SCI USA, V108, P12485, DOI 10.1073/pnas.1103708108; Bock RE, 2003, VET PARASITOL, V118, P121, DOI 10.1016/j.vetpar.2003.08.011; Brayton KA, 2005, P NATL ACAD SCI USA, V102, P844, DOI 10.1073/pnas.0406656102; Brown WC, 1998, INFECT IMMUN, V66, P5406, DOI 10.1128/IAI.66.11.5406-5413.1998; Couzin-Frankel J, 2013, SCIENCE, V342, P68, DOI 10.1126/science.342.6154.68; Dark MJ, 2011, VACCINE, V29, P4923, DOI 10.1016/j.vaccine.2011.04.131; Dark MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-16; de Echaide ST, 1998, J CLIN MICROBIOL, V36, P777, DOI 10.1128/JCM.36.3.777-782.1998; ERDILE LF, 1993, INFECT IMMUN, V61, P81, DOI 10.1128/IAI.61.1.81-90.1993; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Kahlon A, 2013, INFECT IMMUN, V81, P65, DOI 10.1128/IAI.00932-12; Kazimirova M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00043; Knight J, 2003, NATURE, V422, P554, DOI 10.1038/422554a; KUTTLER KL, 1984, VET MICROBIOL, V9, P181, DOI 10.1016/0378-1135(84)90033-6; Little SF, 2011, FEMS IMMUNOL MED MIC, V62, P11, DOI 10.1111/j.1574-695X.2011.00782.x; Lopez JE, 2005, INFECT IMMUN, V73, P8109, DOI 10.1128/IAI.73.12.8109-8118.2005; MANSON LA, 1991, IMMUNOL TODAY, V12, P352, DOI 10.1016/0167-5699(91)90065-2; Miltiadou D, 2003, TISSUE ANTIGENS, V62, P55, DOI 10.1034/j.1399-0039.2003.00080.x; Mudenda L, 2014, INT J PARASITOL, V44, P1029, DOI 10.1016/j.ijpara.2014.07.003; Nelson HS, 2007, J ALLERGY CLIN IMMUN, V119, P769, DOI 10.1016/j.jaci.2007.01.036; Noh SM, 2008, INFECT IMMUN, V76, P2219, DOI 10.1128/IAI.00008-08; Noh SM, 2006, INFECT IMMUN, V74, P3471, DOI 10.1128/IAI.01843-05; Noh SM, 2013, CLIN VACCINE IMMUNOL, V20, P651, DOI 10.1128/CVI.00600-12; Noh SM, 2010, VACCINE, V28, P3741, DOI 10.1016/j.vaccine.2010.02.067; Ojogun N, 2012, INFECT IMMUN, V80, P3748, DOI 10.1128/IAI.00654-12; PALMER GH, 1995, VET PARASITOL, V57, P233, DOI 10.1016/0304-4017(94)03123-E; Palmer GH, 2012, FEMS IMMUNOL MED MIC, V64, P115, DOI 10.1111/j.1574-695X.2011.00878.x; PIPANO E, 1995, VET PARASITOL, V57, P213, DOI 10.1016/0304-4017(94)03122-D; POTGIETER FT, 1983, ONDERSTEPOORT J VET, V50, P29; Ramabu SS, 2010, INFECT IMMUN, V78, P3047, DOI 10.1128/IAI.00300-10; Ren CC, 2014, APPL MICROBIOL BIOT, V98, P6353, DOI 10.1007/s00253-014-5678-7; Rodriguez JL, 2005, GENE, V361, P127, DOI 10.1016/j.gene.2005.06.038; RODRIGUEZ M, 1995, VET PARASITOL, V57, P339, DOI 10.1016/0304-4017(94)00678-6; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Seidman D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004669; Seidman D, 2014, CELL MICROBIOL, V16, P1133, DOI 10.1111/cmi.12286; Shkap V, 2009, VET MICROBIOL, V134, P254, DOI 10.1016/j.vetmic.2008.08.004; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Takeshima SN, 2011, TISSUE ANTIGENS, V78, P208, DOI 10.1111/j.1399-0039.2011.01708.x; TEBELE N, 1991, INFECT IMMUN, V59, P3199, DOI 10.1128/IAI.59.9.3199-3204.1991; Telford JL, 2008, CELL HOST MICROBE, V3, P408, DOI 10.1016/j.chom.2008.05.004; Ubol S, 2010, CLIN VACCINE IMMUNOL, V17, P1829, DOI 10.1128/CVI.00316-10; Ueti MW, 2012, INFECT IMMUN, V80, P2354, DOI 10.1128/IAI.00341-12; Weiser JN, 2003, P NATL ACAD SCI USA, V100, P4215, DOI 10.1073/pnas.0637469100	48	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129309	10.1371/journal.pone.0129309	http://dx.doi.org/10.1371/journal.pone.0129309			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079491	Green Published, gold, Green Submitted			2022-12-27	WOS:000356542300021
J	Fousteri, G; Jofra, T; Di Fonte, R; Battaglia, M				Fousteri, Georgia; Jofra, Tatiana; Di Fonte, Roberta; Battaglia, Manuela			Combination of an Antigen-Specific Therapy and an Immunomodulatory Treatment to Simultaneous Block Recurrent Autoimmunity and Alloreactivity in Non-Obese Diabetic Mice	PLOS ONE			English	Article							TRANSPLANTATION TOLERANCE INDUCTION; ALLOGENEIC ISLET TRANSPLANTATION; T-CELL COSTIMULATION; PANCREAS TRANSPLANTATION; NOD MICE; GRAFT-SURVIVAL; PRONE MICE; TYPE-1; IMMUNOSUPPRESSION; RESPONSES	Restoration of endogenous insulin production by islet transplantation is considered a curative option for patients with type 1 diabetes. However, recurrent autoimmunity and alloreactivity cause graft rejection hindering successful transplantation. Here we tested whether transplant tolerance to allogeneic islets could be achieved in non-obese diabetic (NOD) mice by simultaneously tackling autoimmunity via antigen-specific immunization, and alloreactivity via granulocyte colony stimulating factor (G-CSF) and rapamycin (RAPA) treatment. Immunization with insB(9-23) peptide alone or in combination with two islet peptides (IGRP(206-214) and GAD(524-543)) in incomplete Freund's adjuvant (IFA) were tested for promoting syngeneic pancreatic islet engraftment in spontaneously diabetic NOD mice. Treatment with G-CSF/RAPA alone or in combination with insB(9-23)/IFA was examined for promoting allogeneic islet engraftment in the same mouse model. InsB(9-23)/IFA immunization significantly prolonged syngeneic pancreatic islet survival in NOD mice by a mechanism that necessitated the presence of CD4(+)CD25(+)T regulatory (Treg) cells, while combination of three islet epitopes was less efficacious in controlling recurrent autoimmunity. G-CSF/RAPA treatment was unable to reverse T1D or control recurrent autoimmunity but significantly prolonged islet allograft survival in NOD mice. Blockade of interleukin-10 (IL-10) during G-CSF/RAPA treatment resulted in allograft rejection suggesting that IL-10-producing cells were fundamental to achieve transplant tolerance. G-CSF/RAPA treatment combined with insB(9-23)/IFA did not further increase the survival of allogeneic islets. Thus, insB(9-23)/IFA immunization controls recurrent autoimmunity and G-CSF/RAPA treatment limits alloreactivity, however their combination does not further promote allogeneic pancreatic islet engraftment in NOD mice.	[Fousteri, Georgia; Jofra, Tatiana; Di Fonte, Roberta; Battaglia, Manuela] Ist Sci San Raffaele, IRCCS, DRI, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Fousteri, G (corresponding author), Ist Sci San Raffaele, IRCCS, DRI, Via Olgettina 58, I-20132 Milan, Italy.	fousteri.georgia@hsr.it; battaglia.manuela@hsr.it	Di Fonte, Roberta/AAC-5886-2020; Jofra, Tatiana/AAN-4727-2020; Fousteri, Georgia/B-1226-2012	Di Fonte, Roberta/0000-0002-8541-686X; Jofra, Tatiana/0000-0003-2825-155X; Battaglia, Manuela/0000-0003-4535-3152; Fousteri, Georgia/0000-0001-7745-7517	Juvenile Diabetes Research Foundation (JDRF) [10-2012-204]; Telethon-JDRF [JT-01]	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Telethon-JDRF(Juvenile Diabetes Research Foundation)	This work was supported by grants: Juvenile Diabetes Research Foundation (JDRF) advanced postdoctoral fellowship (10-2012-204) to G. Fousteri and Telethon-JDRF (JT-01) career development award to M. Battaglia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JRF, 2013, CURR DIABETES REP, V13, P704, DOI 10.1007/s11892-013-0399-3; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Bresson D, 2009, DIABETES CARE, V32, P1753, DOI 10.2337/dc09-0373; Burke GW, 2011, CURR DIABETES REP, V11, P413, DOI 10.1007/s11892-011-0206-y; Chujo D, 2012, CELL TRANSPLANT, V21, P2783, DOI 10.3727/096368912X654993; Coppieters KT, 2013, CLIN IMMUNOL, V149, P345, DOI 10.1016/j.clim.2013.02.002; Fousteri G, 2010, DIABETOLOGIA, V53, P1958, DOI 10.1007/s00125-010-1777-x; Fousteri G, 2007, ADV EXP MED BIOL, V601, P313; Fousteri G, 2010, DIABETES, V59, P3148, DOI 10.2337/db10-0561; Fousteri G, 2009, J AUTOIMMUN, V32, P70, DOI 10.1016/j.jaut.2008.12.001; Gagliani N, 2013, AM J TRANSPLANT, V13, P1963, DOI 10.1111/ajt.12333; Gagliani N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028434; Gruessner RWG, 2013, NAT REV ENDOCRINOL, V9, P555, DOI 10.1038/nrendo.2013.138; Han BY, 2005, NAT MED, V11, P645, DOI 10.1038/nm1250; Kimelman M, 2013, CURR OPIN ORGAN TRAN, V18, P76, DOI 10.1097/MOT.0b013e32835c6eda; Kirk AD, 2006, TRANSPLANTATION, V82, P593, DOI 10.1097/01.tp.0000234905.56926.7f; Krishnamurthy B, 2006, J CLIN INVEST, V116, P3258, DOI 10.1172/JCI29602; Larsen CP, 2006, AM J TRANSPLANT, V6, P876, DOI 10.1111/j.1600-6143.2006.01259.x; Laughlin E, 2008, CLIN IMMUNOL, V128, P23, DOI 10.1016/j.clim.2008.03.459; Lutterotti A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006168; Makhlouf L, 2002, DIABETES, V51, P3202, DOI 10.2337/diabetes.51.11.3202; Markees TG, 1999, DIABETES, V48, P967, DOI 10.2337/diabetes.48.5.967; Molano RD, 2001, DIABETES, V50, P270, DOI 10.2337/diabetes.50.2.270; Monti P, 2008, J CLIN INVEST, V118, P1806, DOI 10.1172/JCI35197; Olcott AP, 2005, J IMMUNOL, V175, P1991, DOI 10.4049/jimmunol.175.3.1991; Orlando G, 2014, DIABETES, V63, P1433, DOI 10.2337/db13-1742; Peakman M, 2010, DIABETES, V59, P2087, DOI 10.2337/db10-0630; Pearson T, 2003, ANN NY ACAD SCI, V1005, P148, DOI 10.1196/annals.1288.016; Pearson T, 2003, DIABETES, V52, P321, DOI 10.2337/diabetes.52.2.321; Ramesh A, 2013, CURR DIABETES REV, V9, P294, DOI 10.2174/15733998113099990063; Ravanan R, 2007, CLIN EXP IMMUNOL, V148, P368, DOI 10.1111/j.1365-2249.2007.03358.x; Rayat GR, 2000, TRANSPLANTATION, V70, P976, DOI 10.1097/00007890-200009270-00016; Roep BO, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007781; Rossini AA, 2001, TRANSPLANTATION, V72, pS43; Ryden AKE, 2014, HUM VACC IMMUNOTHER, V10, P838, DOI 10.4161/hv.26890; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Shapiro A M James, 2012, Rev Diabet Stud, V9, P385, DOI 10.1900/RDS.2012.9.385; Shoda LKM, 2005, IMMUNITY, V23, P115, DOI 10.1016/j.immuni.2005.08.002; Stegall MD, 1996, TRANSPLANTATION, V61, P1272, DOI 10.1097/00007890-199604270-00027; Stratta RJ, 2014, EXPERT REV CLIN IMMU, V10, P117, DOI 10.1586/1744666X.2014.853616; Tian J, 2002, J IMMUNOL, V169, P6564, DOI 10.4049/jimmunol.169.11.6564; Tian JD, 1996, J EXP MED, V183, P1561, DOI 10.1084/jem.183.4.1561; Tian JD, 1996, NAT MED, V2, P1348, DOI 10.1038/nm1296-1348; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; van de Linde Pieter, 2005, Am J Ther, V12, P573, DOI 10.1097/01.mjt.0000178768.44987.cb; Vendrame F, 2010, DIABETES, V59, P947, DOI 10.2337/db09-0498; Yoon JW, 1999, SCIENCE, V284, P1183, DOI 10.1126/science.284.5417.1183	47	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0127631	10.1371/journal.pone.0127631	http://dx.doi.org/10.1371/journal.pone.0127631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080071	Green Published, gold, Green Submitted			2022-12-27	WOS:000356542300005
J	Guo, SG; Sun, HH; Zhang, HY; Liu, JA; Ren, Y; Gong, GY; Jiao, C; Zheng, Y; Yang, WC; Fei, ZJ; Xu, Y				Guo, Shaogui; Sun, Honghe; Zhang, Haiying; Liu, Jingan; Ren, Yi; Gong, Guoyi; Jiao, Chen; Zheng, Yi; Yang, Wencai; Fei, Zhangjun; Xu, Yong			Comparative Transcriptome Analysis of Cultivated and Wild Watermelon during Fruit Development	PLOS ONE			English	Article							ALKALINE ALPHA-GALACTOSIDASE; WALL DISASSEMBLY EVENTS; CUCUMIS-MELO L; CITRULLUS-LANATUS; EXPRESSION ANALYSIS; RUBUS-IDAEUS; RNA-SEQ; ETHYLENE; TOMATO; METABOLISM	Watermelon [Citrullus lanatus (Thunb.) Matsum. & Nakai] is an important vegetable crop world-wide. Watermelon fruit quality is a complex trait determined by various factors such as sugar content, flesh color and flesh texture. Fruit quality and developmental process of cultivated and wild watermelon are highly different. To systematically understand the molecular basis of these differences, we compared transcriptome profiles of fruit tissues of cultivated watermelon 97103 and wild watermelon PI296341-FR. We identified 2,452, 826 and 322 differentially expressed genes in cultivated flesh, cultivated mesocarp and wild flesh, respectively, during fruit development. Gene ontology enrichment analysis of these genes indicated that biological processes and metabolic pathways related to fruit quality such as sweetness and flavor were significantly changed only in the flesh of 97103 during fruit development, while those related to abiotic stress response were changed mainly in the flesh of PI296341-FR. Our comparative transcriptome profiling analysis identified critical genes potentially involved in controlling fruit quality traits including alpha-galactosidase, invertase, UDP-galactose/glucose pyrophosphorylase and sugar transporter genes involved in the determination of fruit sugar content, phytoene synthase, beta-carotene hydroxylase, 9-cis-epoxycarotenoid dioxygenase and carotenoid cleavage dioxygenase genes involved in carotenoid metabolism, and 4-coumarate: coenzyme A ligase, cellulose synthase, pectinesterase, pectinesterase inhibitor, polygalacturonase inhibitor and alpha-mannosidase genes involved in the regulation of flesh texture. In addition, we found that genes in the ethylene biosynthesis and signaling pathway including ACC oxidase, ethylene receptor and ethylene responsive factor showed highly ripening-associated expression patterns, indicating a possible role of ethylene in fruit development and ripening of watermelon, a non-climacteric fruit. Our analysis provides novel insights into watermelon fruit quality and ripening biology. Furthermore, the comparative expression profile data we developed provides a valuable resource to accelerate functional studies in watermelon and facilitate watermelon crop improvement.	[Guo, Shaogui; Yang, Wencai] China Agr Univ, Coll Agron & Biotechnol, Dept Vegetable Sci, Beijing Key Lab Growth & Dev Regulat Protected Ve, Beijing 100094, Peoples R China; [Guo, Shaogui; Sun, Honghe; Zhang, Haiying; Liu, Jingan; Ren, Yi; Gong, Guoyi; Xu, Yong] Natl Engn Res Ctr Vegetables, Key Lab Biol & Genet Improvement Hort Crops North, Beijing, Peoples R China; [Sun, Honghe; Jiao, Chen; Zheng, Yi; Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Fei, Zhangjun] USDA, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA	China Agricultural University; Beijing Academy of Agriculture & Forestry; Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA)	Fei, ZJ (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	zf25@cornell.edu; xuyong@nercv.org	Yang, Wencai/G-6517-2011; Jiao, Chen/F-7882-2013; Zheng, Yi/F-6150-2016; Fei, Zhangjun/H-5152-2012; Jiao, Chen/AAM-7701-2020	Yang, Wencai/0000-0001-5369-2555; Zheng, Yi/0000-0002-8042-7770; Jiao, Chen/0000-0002-3327-0547	Ministry of Science and Technology of the People's Republic of China [2012AA100103, 2012AA100101, 2012AA100105, 2012BAD02B03, 2013BAD01B04-13, 2012BAD50G01, 2011BAD35B07]; National Natural Science Foundation of China [31272184, 31171980, 31401893, 31301783, 31361140355]; Beijing Natural Science Foundation [6141001, 6144023]; Ministry of Agriculture of the People's Republic of China [CARS-26]; Beijing Municipal Science and Technology Commission of China [Z121105002512037, Z131100003113012]; Beijing Excellent Talents Programme Foundation [2014000021223TD03, 2013D002020000003]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs); Beijing Municipal Science and Technology Commission of China; Beijing Excellent Talents Programme Foundation	This work was funded by the Ministry of Science and Technology of the People's Republic of China (2012AA100103, 2012AA100101, 2012AA100105, 2012BAD02B03, 2013BAD01B04-13, 2012BAD50G01 and 2011BAD35B07), National Natural Science Foundation of China (31272184, 31171980, 31401893, 31301783, 31361140355), Beijing Natural Science Foundation (6141001, 6144023), the Ministry of Agriculture of the People's Republic of China (CARS-26), the Beijing Municipal Science and Technology Commission of China (Z121105002512037, Z131100003113012) and the Beijing Excellent Talents Programme Foundation (2014000021223TD03, 2013D002020000003) to YX, HZ and SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Avila C, 2001, PLANT J, V25, P93, DOI 10.1046/j.1365-313x.2001.00938.x; BARTLEY IM, 1982, FOOD CHEM, V9, P47, DOI 10.1016/0308-8146(82)90068-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brownleader MD, 1999, CRIT REV FOOD SCI, V39, P149, DOI 10.1080/10408399908500494; Brummell DA, 2006, FUNCT PLANT BIOL, V33, P103, DOI 10.1071/FP05234; Brummell DA, 2004, J EXP BOT, V55, P2029, DOI 10.1093/jxb/erh227; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021; Carmi N, 2003, PLANT J, V33, P97, DOI 10.1046/j.1365-313X.2003.01609.x; Castro-Rodriguez V, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-119; Chung MY, 2010, PLANT J, V64, P936, DOI 10.1111/j.1365-313X.2010.04384.x; Dai N, 2006, PLANT PHYSIOL, V142, P294, DOI 10.1104/pp.106.083634; Di Matteo A, 2005, PLANT CELL, V17, P849, DOI 10.1105/tpc.104.028886; ELKASHIF ME, 1988, PHYSIOL PLANTARUM, V73, P432, DOI 10.1111/j.1399-3054.1988.tb00622.x; FRASER PD, 1994, PLANT PHYSIOL, V105, P405, DOI 10.1104/pp.105.1.405; Gao ZF, 1999, PLANT PHYSIOL, V119, P979, DOI 10.1104/pp.119.3.979; Godt DE, 1997, PLANT PHYSIOL, V115, P273, DOI 10.1104/pp.115.1.273; Grassi S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-781; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; Holden Joanne M., 1999, Journal of Food Composition and Analysis, V12, P169, DOI 10.1006/jfca.1999.0827; HUBBARD NL, 1989, PLANT PHYSIOL, V91, P1527, DOI 10.1104/pp.91.4.1527; Iannetta PPM, 2006, PHYSIOL PLANTARUM, V127, P247, DOI 10.1111/j.1399-3054.2006.00656.x; Jolie RP, 2010, CARBOHYD RES, V345, P2583, DOI 10.1016/j.carres.2010.10.002; Joung JG, 2009, PLANT PHYSIOL, V151, P1758, DOI 10.1104/pp.109.145169; Karakurt Y, 2002, PHYSIOL PLANTARUM, V116, P398, DOI 10.1034/j.1399-3054.2002.1160316.x; Katz E, 2004, PLANTA, V219, P243, DOI 10.1007/s00425-004-1228-3; Koenig D, 2013, P NATL ACAD SCI USA, V110, pE2655, DOI 10.1073/pnas.1309606110; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JM, 2012, PLANT J, V70, P191, DOI 10.1111/j.1365-313X.2011.04863.x; Lelievre JM, 1997, PHYSIOL PLANTARUM, V101, P727, DOI 10.1111/j.1399-3054.1997.tb01057.x; Li Q, 2012, J PLANT PHYSIOL, V169, P78, DOI 10.1016/j.jplph.2011.08.005; Liu JingAn, 2013, Journal of Fruit Science, V30, P813; Liu JA, 2013, ACTA PHYSIOL PLANT, V35, P3213, DOI 10.1007/s11738-013-1356-0; Meli VS, 2010, P NATL ACAD SCI USA, V107, P2413, DOI 10.1073/pnas.0909329107; MITCHELL DE, 1992, PLANT PHYSIOL, V99, P959, DOI 10.1104/pp.99.3.959; Pinzon-Latorre D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-742; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012; Ren Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-33; Saxena IM, 2005, ANN BOT-LONDON, V96, P9, DOI 10.1093/aob/mci155; Schaffer A.A., 1996, PHOTOASSIMILATE DIST, P729; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwartz SH, 2003, PLANT PHYSIOL, V131, P1591, DOI 10.1104/pp.102.017921; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soltani BM, 2006, PLANTA, V224, P1226, DOI 10.1007/s00425-006-0296-y; Tang GQ, 1999, PLANT CELL, V11, P177, DOI 10.1105/tpc.11.2.177; Trainotti L, 2005, J EXP BOT, V56, P2037, DOI 10.1093/jxb/eri202; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vicente AR, 2007, J AGR FOOD CHEM, V55, P4119, DOI 10.1021/jf063547r; Vicente AR, 2007, FUNCT PLANT BIOL, V34, P614, DOI 10.1071/FP07002; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wechter WP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-275; Winterhalter P., 2002, ACS SYM SER, P1; Xiao YY, 2013, J EXP BOT, V64, P2499, DOI 10.1093/jxb/ert108; Yashoda HM, 2007, FOOD CHEM, V102, P691, DOI 10.1016/j.foodchem.2006.06.001; Yativ M, 2010, J PLANT PHYSIOL, V167, P589, DOI 10.1016/j.jplph.2009.11.009; Zhong Silin, 2011, Cold Spring Harb Protoc, V2011, P940, DOI 10.1101/pdb.prot5652	62	68	75	6	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0130267	10.1371/journal.pone.0130267	http://dx.doi.org/10.1371/journal.pone.0130267			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079257	Green Submitted, gold, Green Published			2022-12-27	WOS:000356542300041
J	Bae, S; Lim, YH; Kashima, S; Yorifuji, T; Honda, Y; Kim, H; Hong, YC				Bae, Sanghyuk; Lim, Youn-Hee; Kashima, Saori; Yorifuji, Takashi; Honda, Yasushi; Kim, Ho; Hong, Yun-Chul			Non-Linear Concentration-Response Relationships between Ambient Ozone and Daily Mortality	PLOS ONE			English	Article							TIME-SERIES ANALYSES; AIR-POLLUTION; PARTICULATE MATTER; EXPOSURE; HEALTH; ASSOCIATIONS; METAANALYSIS; COMMUNITIES; POPULATIONS; PROJECT	Background Ambient ozone (O-3) concentration has been reported to be significantly associated with mortality. However, linearity of the relationships and the presence of a threshold has been controversial. Objectives The aim of the present study was to examine the concentration-response relationship and threshold of the association between ambient O-3 concentration and non-accidental mortality in 13 Japanese and Korean cities from 2000 to 2009. Methods We selected Japanese and Korean cities which have population of over 1 million. We constructed Poisson regression models adjusting daily mean temperature, daily mean PM10, humidity, time trend, season, year, day of the week, holidays and yearly population. The association between O-3 concentration and mortality was examined using linear, spline and linear-threshold models. The thresholds were estimated for each city, by constructing linear-threshold models. We also examined the city-combined association using a generalized additive mixed model. Results The mean O-3 concentration did not differ greatly between Korea and Japan, which were 26.2 ppb and 24.2 ppb, respectively. Seven out of 13 cities showed better fits for the spline model compared with the linear model, supporting a non-linear relationships between O-3 concentration and mortality. All of the 7 cities showed J or U shaped associations suggesting the existence of thresholds. The range of city-specific thresholds was from 11 to 34 ppb. The city-combined analysis also showed a non-linear association with a threshold around 30-40 ppb. Conclusion We have observed non-linear concentration-response relationship with thresholds between daily mean ambient O-3 concentration and daily number of non-accidental death in Japanese and Korean cities.	[Bae, Sanghyuk] Seoul Natl Univ Hosp, Publ Hlth Med Serv, Seoul 110744, South Korea; [Bae, Sanghyuk; Lim, Youn-Hee; Hong, Yun-Chul] Seoul Natl Univ, Ctr Environm Hlth, Coll Med, Seoul, South Korea; [Kashima, Saori] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan; [Yorifuji, Takashi] Okayama Univ, Dept Human Ecol, Grad Sch Environm & Life Sci, Okayama, Japan; [Honda, Yasushi] Univ Tsukuba, Fac Med, Dept Hlth Care Policy & Hlth Econ, Tsukuba, Ibaraki, Japan; [Kim, Ho] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Epidemiol & Biostat, Seoul, South Korea; [Hong, Yun-Chul] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Hong, Yun-Chul] Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Hiroshima University; Okayama University; University of Tsukuba; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Hong, YC (corresponding author), Seoul Natl Univ, Ctr Environm Hlth, Coll Med, Seoul, South Korea.	ychong1@snu.ac.kr	Kim, Ho/AAS-2402-2021; Bae, Sanghyuk/AAQ-6635-2020; Kashima, Saori/B-4524-2010; Hong, Yun-Chul/J-5725-2012	Kim, Ho/0000-0001-7472-3752; Bae, Sanghyuk/0000-0002-4995-6543; Kashima, Saori/0000-0002-3401-8191; Lim, Youn-Hee/0000-0002-1290-5814				Akaike H., 1976, MATH SCI, V14, P5; Anderson HR, 1996, BMJ-BRIT MED J, V312, P665; [Anonymous], 2014, STAT KOR; Atkinson RW, 2012, ENVIRON HEALTH PERSP, V120, P1411, DOI 10.1289/ehp.1104108; BALMES JR, 1993, ENVIRON HEALTH PERSP, V101, P219, DOI 10.2307/3431683; Bell ML, 2006, ENVIRON HEALTH PERSP, V114, P532, DOI 10.1289/ehp.8816; Bell ML, 2005, EPIDEMIOLOGY, V16, P436, DOI 10.1097/01.ede.0000165817.40152.85; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Brauer M, 2002, RISK ANAL, V22, P1183, DOI 10.1111/1539-6924.00282; Canty A, 2014, BOOT BOOTSTRAP FUNCT; Chen R, 2014, AM J EPIDEMIOLOGY; Goldberg MS, 2001, AM J EPIDEMIOL, V154, P817, DOI 10.1093/aje/154.9.817; Gryparis A, 2004, AM J RESP CRIT CARE, V170, P1080, DOI 10.1164/rccm.200403-333OC; Hazucha MJ, 2007, ATMOS ENVIRON, V41, P4559, DOI 10.1016/j.atmosenv.2007.03.052; Hong YC, 1999, J KOREAN MED SCI, V14, P239, DOI 10.3346/jkms.1999.14.3.239; Hunova I, 2013, INT ARCH OCC ENV HEA, V86, P89, DOI 10.1007/s00420-012-0751-y; Ito K, 2005, EPIDEMIOLOGY, V16, P446, DOI 10.1097/01.ede.0000165821.90114.7f; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Kim SY, 2004, ENVIRON RES, V94, P113, DOI 10.1016/j.envres.2003.09.006; Lim Y.H, 2013, HEAT HLTH EFFECTS AI; McDonnell WF, 2012, INHAL TOXICOL, V24, P619, DOI 10.3109/08958378.2012.705919; Moolgavkar SH, 2013, ENVIRON HEALTH PERSP, V121, P73, DOI 10.1289/ehp.1104507; Ren C, 2008, ENVIRON INT, V34, P451, DOI 10.1016/j.envint.2007.10.001; Samoli E, 2005, ENVIRON HEALTH PERSP, V113, P88, DOI 10.1289/ehp.7387; Simpson R, 2000, J EXPO ANAL ENV EPID, V10, P488, DOI 10.1038/sj.jea.7500137; Simpson R, 2005, AUST NZ J PUBL HEAL, V29, P205, DOI 10.1111/j.1467-842X.2005.tb00758.x; Smith RL, 2009, INHAL TOXICOL; Statistics Bureau, 2014, STAT JAP; Stylianou M, 2009, ENVIRON POLLUT, V157, P2216, DOI 10.1016/j.envpol.2009.04.011; U.S. EPA, 2013, EPA600R20012; Urch B, 2010, INHAL TOXICOL, V22, P210, DOI 10.3109/08958370903173666; Vingarzan R, 2004, ATMOS ENVIRON, V38, P3431, DOI 10.1016/j.atmosenv.2004.03.030; Watkinson WP, 2001, ENVIRON HEALTH PERSP, V109, P539, DOI 10.2307/3454666; WHO, 2006, REPORT WORKING GROUP; Williams ML, 2014, AIR QUAL ATMOS HLTH, V7, P407, DOI 10.1007/s11869-014-0249-8; Wood S., 2013, GAMM4 GEN ADDITIVE M; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; WOODWARD A, 1995, J EPIDEMIOL COMMUN H, V49, P401, DOI 10.1136/jech.49.4.401; Yang Z, 2005, DRUG DISCOV TODAY DI, V2, P71	39	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129423	10.1371/journal.pone.0129423	http://dx.doi.org/10.1371/journal.pone.0129423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076447	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900070
J	Chen, J; Fang, M; Zhao, YP; Yi, CH; Ji, J; Cheng, C; Wang, MM; Gu, X; Sun, QS; Chen, XL; Gao, CF				Chen, Jie; Fang, Meng; Zhao, Yun-Peng; Yi, Chang-Hong; Ji, Jun; Cheng, Cheng; Wang, Meng-Meng; Gu, Xing; Sun, Quan-Sheng; Chen, Xiao-Ling; Gao, Chun-Fang			Serum N-Glycans: A New Diagnostic Biomarker for Light Chain Multiple Myeloma	PLOS ONE			English	Article							MONOCLONAL GAMMOPATHY; RHEUMATOID-ARTHRITIS; RISK; GLYCOSYLATION; ASSOCIATION; PROGRESSION; CARCINOMA; SURVIVAL; DIMERS; IGG	The aim of this study was to evaluate the diagnostic and differential diagnostic power of serum N-glycans for light chain multiple myeloma (LCMM). A total of 167 cases of subjects, including 42 LCMM, 42 IgG myeloma, 41 IgA myeloma, and 42 healthy controls were recruited in this study. DNA sequencer-assisted fluorophore-assisted capillary electrophoresis (DSA-FACE) was applied to determine the quantitive abundance of serum N-glycans. The core fucosylated, bisecting and sialylated modifications were analyzed in serum of LCMM patients (n=20) and healthy controls (n=20) randomly selected from the same cohort by lectin blot. Moreover, serum sialic acid (SA) level was measured by enzymatic method. We found two N-glycan structures (NG1A2F, Peak3; NA2FB, Peak7) showed the optimum diagnostic efficacy with area under the ROC curve (AUC) 0.939 and 0.940 between LCMM and healthy control. The sensitivity and specificity of Peak3 were 88.1% and 92.9%, while Peak7 were 92.9% and 97.6%, respectively. The abundance of Peak3 could differentiate LCMM from IgG myeloma with AUC 0.899, sensitivity 100% and specificity 76.2%, and Peak7 could be used to differentiate LCMM from IgA myeloma with AUC 0.922, sensitivity 92.9% and specificity 82.9%. Serum SA level was significantly higher in patients with LCMM than that in healthy controls. Moreover, the decreased core fucosylation, bisecting and increased sialylation characters of serum glycoproteins were observed in patients with LCMM. We concluded that serum N-glycan could provide a simple, reliable and non-invasive biomarker for LCMM diagnosis and abnormal glycosylation might imply a new potential therapeutic target in LCMM.	[Chen, Jie; Fang, Meng; Zhao, Yun-Peng; Yi, Chang-Hong; Ji, Jun; Cheng, Cheng; Wang, Meng-Meng; Gu, Xing; Sun, Quan-Sheng; Gao, Chun-Fang] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Lab Med, Shanghai, Peoples R China; [Chen, Xiao-Ling] Shanghai Zhabei Dist Cent Hosp, Dept Hematol, Shanghai, Peoples R China	Naval Medical University	Gao, CF (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Lab Med, Shanghai, Peoples R China.	gaocf1115@163.com			Natural Science Foundation of China [81101639, 81271925, 81301877]; Science and Technology Commission of Shanghai Municipality [2010-04]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The study was supported by Natural Science Foundation of China (No, 81101639, 81271925, 81301877); and the Science and Technology Commission of Shanghai Municipality (grants 2010-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CL, 2006, TRENDS IMMUNOL, V27, P343, DOI 10.1016/j.it.2006.05.004; Bradwell AR, 2003, LANCET, V361, P489, DOI 10.1016/S0140-6736(03)12457-9; Callewaert N, 2004, NAT MED, V10, P429, DOI 10.1038/nm1006; Chen NF, 2011, CHINESE LABORATORY D, V15, P1896; Cunningham S, 2010, ANALYST, V135, P2471, DOI 10.1039/c0an00276c; Dispenzieri A, 2009, LEUKEMIA, V23, P215, DOI 10.1038/leu.2008.307; Drayson M, 2001, BLOOD, V97, P2900, DOI 10.1182/blood.V97.9.2900; Drayson M, 2006, BLOOD, V108, P2013, DOI 10.1182/blood-2006-03-008953; Fang M, 2010, INT J CANCER, V127, P148, DOI 10.1002/ijc.25030; Feizi T, 2000, IMMUNOL REV, V173, P79, DOI 10.1034/j.1600-065X.2000.917310.x; Glavey SV, 2014, BLOOD, V124, P1765, DOI 10.1182/blood-2014-03-560862; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Holland M, 2002, CLIN EXP IMMUNOL, V129, P183, DOI 10.1046/j.1365-2249.2002.01864.x; Kaplan B, 2011, THESCIENTIFICWORLDJO, V11, P726, DOI 10.1100/tsw.2011.65; Kyle RA, 2009, LEUKEMIA, V23, P3, DOI 10.1038/leu.2008.291; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Lachmann HJ, 2003, BRIT J HAEMATOL, V122, P78, DOI 10.1046/j.1365-2141.2003.04433.x; Lauc G, 2012, BBA-GEN SUBJECTS, V1820, P1305, DOI 10.1016/j.bbagen.2012.03.001; Li C, 2011, CLIN LAB, V57, P53; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077821; Liu XE, 2007, HEPATOLOGY, V46, P1426, DOI 10.1002/hep.21855; Mead GP, 2004, BRIT J HAEMATOL, V126, P348, DOI 10.1111/j.1365-2141.2004.05045.x; Mead GP, 2009, BLOOD, V114, P1717, DOI 10.1182/blood-2009-06-225854; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Pilkington C, 1995, AUTOIMMUNITY, V22, P107, DOI 10.3109/08916939508995306; Rajkumar SV, 2004, BRIT J HAEMATOL, V127, P308, DOI 10.1111/j.1365-2141.2004.05169.x; Rajkumar SV, 2005, BLOOD, V106, P812, DOI 10.1182/blood-2005-03-1038; Reinders J, 2007, BIOMOL ENG, V24, P169, DOI 10.1016/j.bioeng.2007.03.002; Saldova R, 2014, J PROTEOME RES, V13, P2314, DOI 10.1021/pr401092y; Shaheen SP, 2009, CLIN CHIM ACTA, V406, P162, DOI 10.1016/j.cca.2009.04.024; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Vanhooren V, 2009, MECH AGEING DEV, V130, P92, DOI 10.1016/j.mad.2008.11.008; Zhao YP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094536; Zhao YP, 2012, CANCER-AM CANCER SOC, V118, P639, DOI 10.1002/cncr.26342	34	16	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0127022	10.1371/journal.pone.0127022	http://dx.doi.org/10.1371/journal.pone.0127022			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075387	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900009
J	Delgado-Sanchez, G; Garcia-Garcia, L; Castellanos-Joya, M; Cruz-Hervert, P; Ferreyra-Reyes, L; Ferreira-Guerrero, E; Hernandez, A; Ortega-Baeza, VM; Montero-Campos, R; Sulca, JA; Martinez-Olivares, MD; Mongua-Rodriguez, N; Baez-Saldana, R; Gonzalez-Roldan, JF; Lopez-Gatell, H; Ponce-de-Leon, A; Sifuentes-Osornio, J; Jimenez-Corona, ME				Delgado-Sanchez, Guadalupe; Garcia-Garcia, Lourdes; Castellanos-Joya, Martin; Cruz-Hervert, Pablo; Ferreyra-Reyes, Leticia; Ferreira-Guerrero, Elizabeth; Hernandez, Andres; Manuel Ortega-Baeza, Victor; Montero-Campos, Rogelio; Antonio Sulca, Jose; de Lourdes Martinez-Olivares, Ma.; Mongua-Rodriguez, Norma; Baez-Saldana, Renata; Felipe Gonzalez-Roldan, Jesus; Lopez-Gatell, Hugo; Ponce-de-Leon, Alfredo; Sifuentes-Osornio, Jose; Eugenia Jimenez-Corona, Maria			Association of Pulmonary Tuberculosis and Diabetes in Mexico: Analysis of the National Tuberculosis Registry 2000-2012	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; SOUTHERN MEXICO; RISK-FACTORS; MELLITUS; IMPACT; CELLS; POPULATION; MORTALITY; MONOCYTES	Background Tuberculosis (TB) remains a public health problem in Mexico while the incidence of diabetes mellitus type 2 (DM) has increased rapidly in recent years. Objective To describe the trends of incidence rates of pulmonary TB associated with DM and not associated with DM and to compare the results of treatment outcomes in patients with and without DM. Materials and Methods We analysed the National Tuberculosis Registry from 2000 to 2012 including patients with pulmonary TB among individuals older than 20 years of age. The association between DM and treatment failure was analysed using logistic regression, accounting for clustering due to regional distribution. Results In Mexico from 2000 to 2012, the incidence rates of pulmonary TB associated to DM increased by 82.64%, (p < 0.001) in contrast to rates of pulmonary TB rate without DM, which decreased by 26.77%, (p < 0.001). Patients with a prior diagnosis of DM had a greater likelihood of failing treatment (adjusted odds ratio, 1.34 (1.11-1.61) p < 0.002) compared with patients who did not have DM. There was statistical evidence of interaction between DM and sex. The odds of treatment failure were increased in both sexes. Conclusion Our data suggest that the growing DM epidemic has an impact on the rates of pulmonary TB. In addition, patients who suffer from both diseases have a greater probability of treatment failure.	[Delgado-Sanchez, Guadalupe; Garcia-Garcia, Lourdes; Cruz-Hervert, Pablo; Ferreyra-Reyes, Leticia; Ferreira-Guerrero, Elizabeth; Manuel Ortega-Baeza, Victor; Montero-Campos, Rogelio; Mongua-Rodriguez, Norma; Baez-Saldana, Renata; Lopez-Gatell, Hugo] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico; [Castellanos-Joya, Martin; Antonio Sulca, Jose; de Lourdes Martinez-Olivares, Ma.] Ctr Nacl Programas Prevent & Control Enfermedades, Direcc Micobacteriosis, Mexico City, DF, Mexico; [Hernandez, Andres] Inst Nacl Enfermedades Resp, Dept Epidemiol, Mexico City, DF, Mexico; [Felipe Gonzalez-Roldan, Jesus] Ctr Nacl Programas Prevent & Control Enfermedades, Direcc Gen, Mexico City, DF, Mexico; [Ponce-de-Leon, Alfredo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Microbiol Lab, Mexico City, DF, Mexico; [Sifuentes-Osornio, Jose] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Direcc Med, Mexico City, DF, Mexico; [Eugenia Jimenez-Corona, Maria] Direcc Gen Epidemiol, Direcc Gen Adjunta Epidemiol, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Garcia-Garcia, L (corresponding author), Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.	garcigarml@gmail.com	HERNANDEZ-GARCIA, ANDRES/B-9051-2014; Cruz-Hervert, Luis Pablo/AEI-4595-2022; JIMENEZ-CORONA, MARIA-EUGENIA/AAC-1892-2021; García, Maria de Lourdes/I-2724-2019	HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; Cruz-Hervert, Luis Pablo/0000-0002-6094-958X; García, Maria de Lourdes/0000-0001-5262-1157; Sifuentes-Osornio, Jose/0000-0001-9584-1360; Jimenez-Corona, Maria-Eugenia/0000-0002-3804-9761; Ponce-de-Leon, Alfredo/0000-0003-2640-2916				Al-Attiyah RJ, 2009, CLIN EXP IMMUNOL, V158, P64, DOI 10.1111/j.1365-2249.2009.04000.x; Alisjahbana B, 2006, INT J TUBERC LUNG D, V10, P696; [Anonymous], GLOB TUB CONTR WHO R; Babalik A, 2013, ANTIMICROB AGENTS CH, V57, P5740, DOI 10.1128/AAC.01345-13; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Barquera S, 2003, ARCH MED RES, V34, P407, DOI 10.1016/S0188-4409(03)00075-4; Bashar M, 2001, CHEST, V120, P1514, DOI 10.1378/chest.120.5.1514; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P8; DOLHOFER R, 1985, BIOL CHEM H-S, V366, P361, DOI 10.1515/bchm3.1985.366.1.361; Dye C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021161; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Ferreira-Guerrero E, 1994, MANUAL SISTEMA VIGIL; Fisher-Hoch SP, 2008, SCAND J INFECT DIS, V40, P888, DOI 10.1080/00365540802342372; Garcia-Garcia MD, 2000, ARCH INTERN MED, V160, P630, DOI 10.1001/archinte.160.5.630; Gomez DI, 2013, TUBERCULOSIS, V93, P192, DOI 10.1016/j.tube.2012.10.003; Gonzalez Y, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-19; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Hernandez-Avila M, 2013, SALUD PUBLICA MEXICO, V55, pS129, DOI 10.21149/spm.v55s2.5108; Hicks RM, 2014, INT J TUBERC LUNG D, V18, P1074, DOI 10.5588/ijtld.14.0231; Instituto Nacional de Estadistica y Geografia, CENS CONT POBL VIV; Instituto Nacional de Salud Publica, VIV POBL UT SERV SAL; International Diabetes Federation, 2013, IDF DIABETES ATLAS; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jimenez-Corona ME, 2006, THORAX, V61, P348, DOI 10.1136/thx.2005.049452; Jung RS, 2010, PUBLIC HEALTH REP, V125, P389, DOI 10.1177/003335491012500307; Kumar NP, 2013, J INFECT DIS, V208, P739, DOI 10.1093/infdis/jit241; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Murray M, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P64, DOI 10.5588/ijtld.10.0535; Peyffer GE, 2011, MANUAL CLIN MICROBIO, V1, P472, DOI DOI 10.1128/9781555816728.CH28; Ponce-De-Leon A, 2004, DIABETES CARE, V27, P1584, DOI 10.2337/diacare.27.7.1584; Restrepo BI, 2007, EPIDEMIOL INFECT, V135, P483, DOI 10.1017/S0950268806006935; Restrepo BI, 2008, CLIN INFECT DIS, V47, P634, DOI 10.1086/590565; Restrepo BI, 2013, TUBERCULOSIS, V93, pS10, DOI 10.1016/S1472-9792(13)70004-0; Secretaria de Salud, 2000, NOM015SSA21994 SECR; Secretaria de Salud, 1994, NOM017SSA21994 SECR; Secretaria de Salud, 2005, NOM006SSA21993 SECR; Secretaria de Salud. Modificacion a la Norma Oficial Mexicana, 2000, NOM006SSA21993 SECR; Singla R, 2006, INT J TUBERC LUNG D, V10, P74; Stevenson CR, 2007, CHRONIC ILLN, V3, P228, DOI 10.1177/1742395307081502; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Tsukaguchi Katsuhiko, 2002, Kekkaku, V77, P409; Vallerskog T, 2010, J IMMUNOL, V184, P6275, DOI 10.4049/jimmunol.1000304; Villalpando S, 2010, SALUD PUBLICA MEXICO, V52, pS72; Wang C.-H., 1999, Tubercle and Lung Disease, V79, P235, DOI 10.1054/tuld.1998.0167	45	29	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129312	10.1371/journal.pone.0129312	http://dx.doi.org/10.1371/journal.pone.0129312			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075393	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900063
J	Gadoev, J; Asadov, D; Tillashaykhov, M; Tayler-Smith, K; Isaakidis, P; Dadu, A; De Colombani, P; Hinderaker, SG; Parpieva, N; Ulmasova, D; Jalolov, A; Hamraev, A; Ali, E; van den Boom, M; Hammerich, A; Gozalov, O; Dara, M				Gadoev, Jamshid; Asadov, Damin; Tillashaykhov, Mirzagolib; Tayler-Smith, Katie; Isaakidis, Petros; Dadu, Andrei; De Colombani, Pierpaolo; Hinderaker, Sven Gudmund; Parpieva, Nargiza; Ulmasova, Dilrabo; Jalolov, Avazbek; Hamraev, Atadjan; Ali, Engy; van den Boom, Martin; Hammerich, Asmus; Gozalov, Ogtay; Dara, Masoud			Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS	Background TB is one of the main health priorities in Uzbekistan and relatively high rates of unfavorable treatment outcomes have recently been reported. This requires closer analysis to explain the reasons and recommend interventions to improve the situation. Thus, by using countrywide data this study sought to determine trends in unfavorable outcomes (lost-to-follow-ups, deaths and treatment failures) and describe their associations with socio-demographic and clinical factors. Method A countrywide retrospective cohort study of all new and previously treated TB patients registered in the National Tuberculosis programme between January 2006 and December 2010. Results Among 107,380 registered patients, 67% were adults, with smaller proportions of children (10%), adolescents (4%) and elderly patients (19%). Sixty per cent were male, 66% lived in rural areas, 1% were HIV-infected and 1% had a history of imprisonment. Pulmonary TB (PTB) was present in 77%, of which 43% were smear-positive and 53% were smear-negative. Overall, 83% of patients were successfully treated, 6% died, 6% were lost-to-follow-up, 3% failed treatment and 2% transferred out. Factors associated with death included being above 55 years of age, HIV-positive, sputum smear positive, previously treated, jobless and living in certain provinces. Factors associated with lost-to-follow-up were being male, previously treated, jobless, living in an urban area, and living in certain provinces. Having smear positive PTB, being an adolescent, being urban population, being HIV-negative, previously treated, jobless and residing in particular provinces were associated with treatment failure. Conclusion Overall, 83% treatment success rate was achieved. However, our study findings highlight the need to improve TB services for certain vulnerable groups and in specific areas of the country. They also emphasize the need to develop unified monitoring and evaluation tools for drug-susceptible and drug-resistant TB, and call for better TB surveillance and coordination between provinces and neighbouring countries.	[Gadoev, Jamshid; Ulmasova, Dilrabo; Hammerich, Asmus; Gozalov, Ogtay] World Hlth Org Country Off Tashkent, Tashkent, Uzbekistan; [Asadov, Damin] State Post Grad Inst Med Educ, Tashkent, Uzbekistan; [Tillashaykhov, Mirzagolib] Republican Specialized TB Ctr, Tashkent, Uzbekistan; [Tayler-Smith, Katie; Isaakidis, Petros; Ali, Engy] MSF Luxembourg, Operat Res Unit, Operat Ctr Brussels, MSF, Luxembourg, Luxembourg; [Dadu, Andrei; De Colombani, Pierpaolo; van den Boom, Martin; Dara, Masoud] WHO Reg Off Europe, TBM Dept, Copenhagen, Denmark; [Hinderaker, Sven Gudmund] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Parpieva, Nargiza] Tashkent Med Acad, Tashkent, Uzbekistan; [Jalolov, Avazbek] Republican DOTS Ctr, Tashkent, Uzbekistan; [Hamraev, Atadjan] Tashkent State Pediat Inst, Nukus Branch, Nukus, Karakalpakstan, Uzbekistan	World Health Organization; Doctors Without Borders; World Health Organization; University of Bergen; Tashkent Medical Academy; Tashkent Pediatric Medical Institute	Gadoev, J (corresponding author), World Hlth Org Country Off Tashkent, Tashkent, Uzbekistan.	jag@euro.who.int	Parpieva, Nargiza/ABD-1085-2020; Tillyashaikhov, Mirzagaleb/AAU-8946-2021	Tillyashaikhov, Mirzagaleb/0000-0001-6428-9550; Asadov, Damin/0000-0003-2192-1418; Isaakidis, Petros/0000-0002-7881-1554; Gadoev, Jamshid/0000-0003-3998-5786; DADU, Andrei/0000-0002-3080-8321	International Union Against Tuberculosis and Lung Disease; Department for International Development (DFID); WHO; Medecins Sans Frontieres	International Union Against Tuberculosis and Lung Disease; Department for International Development (DFID); WHO(World Health Organization); Medecins Sans Frontieres	The programme was funded by Medecins Sans Frontieres, International Union Against Tuberculosis and Lung Disease, the Department for International Development (DFID) and WHO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067288; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Cox HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001126; Dara M, 2011, ROADMAP PREVENT COMB; Fenner L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034186; Gaur S. N., 2004, Indian Journal of Tuberculosis, V51, P83; Hamusse SD, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25382; Hasker E, 2010, INT J TUBERC LUNG D, V14, P1132; Hasker E, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-97; Isaakidis P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068869; Kherosheva T, 2003, INT J TUBERC LUNG D, V7, P1045; Kilicaslan Z, 2003, INT J TUBERC LUNG D, V7, P1059; Lalor MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078364; Multidrug and extensively drug-resistant TB (M/XDR-TB), 2010, GLOBAL REPORT SURVEI; Pande JN, 1996, THORAX, V51, P132, DOI 10.1136/thx.51.2.132; Perez-Guzman C, 1999, CHEST, V116, P961, DOI 10.1378/chest.116.4.961; Reed GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058044; Sanchez Mauro, 2012, PLoS One, V7, pe33129, DOI 10.1371/journal.pone.0033129; Tweya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056248; Ulmasova DJ, 2013, EUROSURVEILLANCE, V18, P5, DOI 10.2807/1560-7917.ES2013.18.42.20609; van Hest R, 2013, EUR RESPIR J, V41, P635, DOI 10.1183/09031936.00030612; Velayutham BRV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088045; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2013, GLOB TUB CONTR 2013	24	31	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128907	10.1371/journal.pone.0128907	http://dx.doi.org/10.1371/journal.pone.0128907			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075615	gold, Green Submitted, Green Published			2022-12-27	WOS:000356329900037
J	Gritsenko, V; Dailey, E; Kyle, N; Taylor, M; Whittacre, S; Swisher, AK				Gritsenko, Valeriya; Dailey, Eric; Kyle, Nicholas; Taylor, Matt; Whittacre, Sean; Swisher, Anne K.			Feasibility of Using Low-Cost Motion Capture for Automated Screening of Shoulder Motion Limitation after Breast Cancer Surgery	PLOS ONE			English	Article							MICROSOFT KINECT; TERM MORBIDITY; NODE BIOPSY; UPPER-LIMB; REHABILITATION; PHYSIOTHERAPY; DISSECTION; VALIDITY; SYSTEM; CARE	Objective To determine if a low-cost, automated motion analysis system using Microsoft Kinect could accurately measure shoulder motion and detect motion impairments in women following breast cancer surgery. Design Descriptive study of motion measured via 2 methods. Setting Academic cancer center oncology clinic. Participants 20 women (mean age = 60 yrs) were assessed for active and passive shoulder motions during a routine post-operative clinic visit (mean = 18 days after surgery) following mastectomy (n = 4) or lumpectomy (n = 16) for breast cancer. Interventions Participants performed 3 repetitions of active and passive shoulder motions on the side of the breast surgery. Arm motion was recorded using motion capture by Kinect for Windows sensor and on video. Goniometric values were determined from video recordings, while motion capture data were transformed to joint angles using 2 methods (body angle and projection angle). Main Outcome Measure Correlation of motion capture with goniometry and detection of motion limitation. Results Active shoulder motion measured with low-cost motion capture agreed well with goniometry (r = 0.70-0.80), while passive shoulder motion measurements did not correlate well. Using motion capture, it was possible to reliably identify participants whose range of shoulder motion was reduced by 40% or more. Conclusions Low-cost, automated motion analysis may be acceptable to screen for moderate to severe motion impairments in active shoulder motion. Automatic detection of motion limitation may allow quick screening to be performed in an oncologist's office and trigger timely referrals for rehabilitation.	[Gritsenko, Valeriya; Dailey, Eric; Kyle, Nicholas; Taylor, Matt; Whittacre, Sean; Swisher, Anne K.] W Virginia Univ, Div Phys Therapy, Morgantown, WV 26506 USA	West Virginia University	Gritsenko, V (corresponding author), W Virginia Univ, Div Phys Therapy, Morgantown, WV 26506 USA.	vgritsenko@hsc.wvu.edu	Gritsenko, Valeriya/G-9232-2012	Gritsenko, Valeriya/0000-0001-5302-4004; Gritsenko, Valeriya/0000-0002-6408-9433	WVU School of Medicine; WVU; WVU/NSF ADVANCE program [HRD-100797]	WVU School of Medicine; WVU; WVU/NSF ADVANCE program(National Science Foundation (NSF)NSF - Office of the Director (OD))	VG received the following funding: Departmental Start-up Fund from WVU School of Medicine; Research Funding Development Grant from WVU (www.hsc.wvu.edu/ResOff/Pages/Research/Internal-Funding-Sources/Research-Funding-Development-Grants); WVU/NSF ADVANCE program HRD-100797 (advance.wvu.edu).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2012, CANCER TREATMENT SUR; Blomqvist L, 2004, ACTA ONCOL, V43, P280, DOI 10.1080/02841860410026170; Boulos MNK, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-18; Caimmi M, 2008, NEUROREHAB NEURAL RE, V22, P31, DOI 10.1177/1545968307302923; Chang YJ, 2013, RES DEV DISABIL, V34, P3654, DOI 10.1016/j.ridd.2013.08.021; Chang YJ, 2011, RES DEV DISABIL, V32, P2566, DOI 10.1016/j.ridd.2011.07.002; Cismas A, 2011, TIMISOARA PHYS EDU R, V4, P35; Clark RA, 2013, GAIT POSTURE, V38, P1064, DOI 10.1016/j.gaitpost.2013.03.029; Clark RA, 2013, J BIOMECH, V46, P2722, DOI 10.1016/j.jbiomech.2013.08.011; Crane-Okada R, 2008, ANN SURG ONCOL, V15, P1996, DOI 10.1245/s10434-008-9909-y; Karki A, 2005, J REHABIL MED, V37, P180, DOI 10.1080/16501970410024181; Kolber MJ, 2012, INT J SPORTS PHYS TH, V7, P306; Kootstra JJ, 2013, BREAST CANCER RES TR, V139, P125, DOI 10.1007/s10549-013-2509-y; Lange B, 2011, IEEE ENG MED BIO, P1831, DOI 10.1109/IEMBS.2011.6090521; Lauridsen MC, 2005, ACTA ONCOL, V44, P449, DOI 10.1080/02841860510029905; Lauridsen MC, 2000, BREAST, V9, P45, DOI 10.1054/brst.1999.0087; McAnaw Maire B, 2002, Breast Dis, V16, P163; Olesh EV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104487; do Rosario JLP, 2014, J BODYW MOV THER, V18, P368, DOI 10.1016/j.jbmt.2013.11.018; Rietman JS, 2003, CANCER, V98, P690, DOI 10.1002/cncr.11545; Shum HPH, 2013, IEEE T CYBERNETICS, V43, P1357, DOI 10.1109/TCYB.2013.2275945; Stone EE, 2011, IEEE ENG MED BIO, P6491, DOI 10.1109/IEMBS.2011.6091602; Swisher AK, 2010, REHABIL ONCOL, V28, P3, DOI 10.1097/01893697-201028010-00001; Taylor MJD, 2011, J REHABIL RES DEV, V48, P1171, DOI 10.1682/JRRD.2010.09.0171; Thomas-MacLean RL, 2008, ONCOL NURS FORUM, V35, P65, DOI 10.1188/08.ONF.65-71; Verbelen H, 2014, BREAST CANCER RES TR, V144, P21, DOI 10.1007/s10549-014-2846-5; Webster D, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-108; Wise CH, 2009, REHABIL ONCOL, V27, P14, DOI 10.1097/01893697-200927010-00003	28	12	13	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128809	10.1371/journal.pone.0128809	http://dx.doi.org/10.1371/journal.pone.0128809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076031	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900031
J	He, JB; Li, JJ; Huang, ZW; Zhao, TJ; Xing, GN; Gai, JY; Guan, RZ				He, Jianbo; Li, Jijie; Huang, Zhongwen; Zhao, Tuanjie; Xing, Guangnan; Gai, Junyi; Guan, Rongzhan			Composite Interval Mapping Based on Lattice Design for Error Control May Increase Power of Quantitative Trait Locus Detection	PLOS ONE			English	Article							BAYESIAN LASSO; GENETIC ARCHITECTURE; ASSOCIATION; RESISTANCE; IMPROVEMENT; STRATEGIES; SEARCH; PLANTS; CROSS; RUST	Experimental error control is very important in quantitative trait locus (QTL) mapping. Although numerous statistical methods have been developed for QTL mapping, a QTL detection model based on an appropriate experimental design that emphasizes error control has not been developed. Lattice design is very suitable for experiments with large sample sizes, which is usually required for accurate mapping of quantitative traits. However, the lack of a QTL mapping method based on lattice design dictates that the arithmetic mean or adjusted mean of each line of observations in the lattice design had to be used as a response variable, resulting in low QTL detection power. As an improvement, we developed a QTL mapping method termed composite interval mapping based on lattice design (CIMLD). In the lattice design, experimental errors are decomposed into random errors and block-within-replication errors. Four levels of block-within-replication errors were simulated to show the power of QTL detection under different error controls. The simulation results showed that the arithmetic mean method, which is equivalent to a method under random complete block design (RCBD), was very sensitive to the size of the block variance and with the increase of block variance, the power of QTL detection decreased from 51.3% to 9.4%. In contrast to the RCBD method, the power of CIMLD and the adjusted mean method did not change for different block variances. The CIMLD method showed 1.2- to 7.6-fold higher power of QTL detection than the arithmetic or adjusted mean methods. Our proposed method was applied to real soybean (Glycine max) data as an example and 10 QTLs for biomass were identified that explained 65.87% of the phenotypic variation, while only three and two QTLs were identified by arithmetic and adjusted mean methods, respectively.	[He, Jianbo; Li, Jijie; Zhao, Tuanjie; Xing, Guangnan; Gai, Junyi; Guan, Rongzhan] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [He, Jianbo; Zhao, Tuanjie; Xing, Guangnan; Gai, Junyi; Guan, Rongzhan] Minist Agr, Natl Ctr Soybean Improvement, Nanjing, Jiangsu, Peoples R China; [He, Jianbo; Zhao, Tuanjie; Xing, Guangnan; Gai, Junyi; Guan, Rongzhan] Minist Agr, Key Lab Biol & Genet Improvement Soybean, Nanjing, Jiangsu, Peoples R China; [Huang, Zhongwen] Henan Inst Sci & Technol, Collaborat Innovat Ctr Modern Biol Breeding, Dept Agron, Xinxiang, Henan, Peoples R China	Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Henan Institute of Science & Technology	Guan, RZ (corresponding author), Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	guanrzh@njau.edu.cn	He, Jianbo/H-4917-2018	He, Jianbo/0000-0002-9685-7564; Guan, Rongzhan/0000-0001-9177-6610	National Basic Research Program of China (973 Program) [2011CB109300]; Fundamental Research Funds for the Central Universities of China in China [KJQN201423, KYZ201202-7]; Open Research Fund of State Key Laboratory of Crop Genetics and Germplasm Enhancement [ZW2011006]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Fundamental Research Funds for the Central Universities of China in China; Open Research Fund of State Key Laboratory of Crop Genetics and Germplasm Enhancement; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Basic Research Program of China (973 Program) (No. 2011CB109300), the Fundamental Research Funds for the Central Universities of China (KJQN201423 and KYZ201202-7) in China, the Open Research Fund of State Key Laboratory of Crop Genetics and Germplasm Enhancement (ZW2011006), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal U, 2014, THEOR APPL GENET, V127, P1441, DOI 10.1007/s00122-014-2311-1; Barriere Y, 2012, THEOR APPL GENET, V125, P531, DOI 10.1007/s00122-012-1851-5; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Broman KW, 2006, USE HIDDEN MARKOV MO, V125; Cai XD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-211; CHURCHILL GA, 1994, GENETICS, V138, P963; Cobb JN, 2013, THEOR APPL GENET, V126, P867, DOI 10.1007/s00122-013-2066-0; Dixit S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109574; Dixit S, 2012, THEOR APPL GENET, V125, P155, DOI 10.1007/s00122-012-1823-9; Doerge RW, 1997, STAT SCI, V12, P195; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Fu WQ, 2013, CURR OPIN GENET DEV, V23, P678, DOI 10.1016/j.gde.2013.10.008; HANSON C. H., 1956, AGRON JOUR, V48, P268; Hinkelmann K., 2007, DESIGN ANAL EXPT INT, V1; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Huang ZW, 2014, BRIEF BIOINFORM, V15, P562, DOI 10.1093/bib/bbt019; Hung HY, 2012, HEREDITY, V108, P490, DOI 10.1038/hdy.2011.103; JANSEN RC, 1993, GENETICS, V135, P205; Kempthorne, 2005, DESIGN ANAL EXPT ADV, V2; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Li HY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001245; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Lin Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0250-2; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Mutshinda CM, 2010, GENETICS, V186, P1067, DOI 10.1534/genetics.110.119586; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; Sen S, 2001, GENETICS, V159, P371; Sillanpaa MJ, 1998, GENETICS, V148, P1373; Strigens A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057234; Wang S., WINDOWS QTL CARTOGRA; Wen ZX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-809; Xu S., 2013, PRINCIPLES STAT GENO, P109; Yates F, 1936, J AGR SCI, V26, P424, DOI 10.1017/S0021859600022760; Yi NJ, 2008, GENETICS, V179, P1045, DOI 10.1534/genetics.107.085589; Yi NJ, 2003, GENETICS, V164, P1129; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zhang WK, 2004, THEOR APPL GENET, V108, P1131, DOI 10.1007/s00122-003-1527-2	42	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130125	10.1371/journal.pone.0130125	http://dx.doi.org/10.1371/journal.pone.0130125			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076140	Green Submitted, Green Published, gold			2022-12-27	WOS:000356329900140
J	Hopstaken, JF; Wanmaker, S; van der Linden, D; Bakker, AB				Hopstaken, Jesper F.; Wanmaker, Sabine; van der Linden, Dimitri; Bakker, Arnold B.			Does Dysphoria Lead to Divergent Mental Fatigue Effects on a Cognitive Task?	PLOS ONE			English	Article							DEPRESSIVE-DISORDERS; PUPIL DIAMETER; RISK-FACTOR; PERFORMANCE; RUMINATION; PREVALENCE; ATTENTION; DISTRESS; IMPACT; SELF	Objective Tiredness, low energy, and listlessness are common symptoms to be associated with depression. The question remains to what extent these symptoms influence the effects of fatigue on sustained performance tasks, such as impaired task engagement and performance. Based on earlier findings, it was hypothesized that dysphoric (i.e., mildly depressed) individuals, compared to healthy controls, would display earlier fatigue onset and more severe fatigue effects on task engagement and performance during a cognitive task. Methods Sixty-one dysphoric and twenty-one non-dysphoric control participants were compared during one hour of continuous performance on a 2-back task. During the task subjective fatigue, subjective engagement, objective task performance, baseline pupil diameter and stimulus-evoked pupil dilation were measured. Results While we found that the dysphoric group reported relatively higher subjective fatigue than the healthy control group at the start of the experiment, we did not find any other divergent fatigue effects during the experimental task. Conclusion One explanation for the absence of divergent effect is that dysphoria may not have such a profound impact on available cognitive resources, like attention, as initially thought. Based on the results of the present study, we conclude that dysphoria is not necessarily an increased risk factor for impaired sustained performance on cognitive tasks that may induce mental fatigue.	[Hopstaken, Jesper F.; van der Linden, Dimitri; Bakker, Arnold B.] Erasmus Univ, Inst Psychol, Dept Work & Org Psychol, Rotterdam, Netherlands; [Wanmaker, Sabine] Erasmus Univ, Inst Psychol, Dept Clin Psychol, Rotterdam, Netherlands; [Bakker, Arnold B.] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	Erasmus University Rotterdam; Erasmus University Rotterdam; King Abdulaziz University	Hopstaken, JF (corresponding author), Erasmus Univ, Inst Psychol, Dept Work & Org Psychol, Rotterdam, Netherlands.	jesperhopstaken@gmail.com	Bakker, Arnold B./F-8494-2010	Bakker, Arnold B./0000-0003-1489-1847; Hopstaken, Jesper/0000-0001-9465-2103; Van der Linden, Dimitri/0000-0001-7098-8948				Ayuso-Mateos JL, 2001, BRIT J PSYCHIAT, V179, P308, DOI 10.1192/bjp.179.4.308; BARGH JA, 1988, J PERS SOC PSYCHOL, V54, P925, DOI 10.1037/0022-3514.54.6.925; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Beck AT, 1996, PSYCHOL ASSESS; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Bultmann U, 2002, J PSYCHOSOM RES, V52, P445, DOI 10.1016/S0022-3999(01)00228-8; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; de Lecea L, 2012, BIOL PSYCHIAT, V71, P1046, DOI 10.1016/j.biopsych.2012.01.032; Demyttenaere K, 2005, INT J NEUROPSYCHOPH, V8, P93, DOI 10.1017/S1461145704004729; Does A.J.W, 2002, BDI 2 NL HANDLEIDING, Vsecond; Doris A, 1999, LANCET, V354, P1369, DOI 10.1016/S0140-6736(99)03121-9; Evers A, 2005, DOCUMENTATIE TESTS T; Fan ZJ, 2012, AM J IND MED, V55, P893, DOI 10.1002/ajim.22094; Frojd SA, 2008, J ADOLESCENCE, V31, P485, DOI 10.1016/j.adolescence.2007.08.006; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; HAYSLIP B, 1990, EXP AGING RES, V16, P111, DOI 10.1080/07340669008251537; Hockey GRJ, 1997, BIOL PSYCHOL, V45, P73; Hopstaken JF, 2015, PSYCHOPHYSIOLOGY, V52, P305, DOI 10.1111/psyp.12339; Hysenbegasi A, 2005, J MENT HEALTH POLICY, V8, P145; Jepma M, 2011, J COGNITIVE NEUROSCI, V23, P1587, DOI 10.1162/jocn.2010.21548; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Kahneman D, 1973, AM J PSYCHOL; Kim Oksoo, 2003, Taehan Kanho Hakhoe Chi, V33, P618; Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x; Lerner D, 2010, AM J HEALTH PROMOT, V24, P205, DOI 10.4278/ajhp.090313-QUAN-103; Lorist MM, 2000, PSYCHOPHYSIOLOGY, V37, P614, DOI 10.1111/1469-8986.3750614; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Lyubomirsky S, 2003, COGNITIVE THER RES, V27, P309, DOI 10.1023/A:1023918517378; LYUBOMIRSKY S, 1995, J PERS SOC PSYCHOL, V69, P176, DOI 10.1037/0022-3514.69.1.176; Massar SA, 2010, PSYCHOPHYSIOLOGY, V47, P1119, DOI 10.1111/j.1469-8986.2010.01028.x; Meijman TF, 1997, INT J IND ERGONOM, V20, P31, DOI 10.1016/S0169-8141(96)00029-7; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; Owens M, 2013, ACTA PSYCHOL, V142, P323, DOI 10.1016/j.actpsy.2013.01.008; Owens M, 2013, PSYCHOPHYSIOLOGY, V50, P297, DOI 10.1111/psyp.12010; Stahl SM, 2002, J CLIN PSYCHIAT, V63, P7, DOI 10.4088/JCP.v63n0102; Stern RM., 2000, PSYCHOPHYSIOLOGICAL, DOI 10.1093/acprof:oso/9780195113594.001.0001; Szulecka T. K., 1987, BRIT J GUID COUNS SP, V15, P82, DOI [DOI 10.1080/03069888708251646, 10.1080/03069888708251646]; van der Linden D, 2003, ACTA PSYCHOL, V113, P45, DOI 10.1016/S0001-6918(02)00150-6; Watter S, 2001, PSYCHOPHYSIOLOGY, V38, P998, DOI 10.1111/1469-8986.3860998; Wickens T.D., 2001, ELEMENTARY SIGNAL DE, DOI [10.1093/acprof:oso/9780195092509.001.0001, DOI 10.1093/ACPROF:OSO/9780195092509.001.0001]	43	3	3	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130304	10.1371/journal.pone.0130304	http://dx.doi.org/10.1371/journal.pone.0130304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26075389	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900162
J	Toyama, Y; Tanizawa, K; Kubo, T; Chihara, Y; Harada, Y; Murase, K; Azuma, M; Hamada, S; Hitomi, T; Handa, T; Oga, T; Chiba, T; Mishima, M; Chin, K				Toyama, Yoshiro; Tanizawa, Kiminobu; Kubo, Takeshi; Chihara, Yuichi; Harada, Yuka; Murase, Kimihiko; Azuma, Masanori; Hamada, Satoshi; Hitomi, Takefumi; Handa, Tomohiro; Oga, Toru; Chiba, Tsutomu; Mishima, Michiaki; Chin, Kazuo			Impact of Obstructive Sleep Apnea on Liver Fat Accumulation According to Sex and Visceral Obesity	PLOS ONE			English	Article							CHRONIC INTERMITTENT HYPOXIA; POSITIVE AIRWAY PRESSURE; CARDIOVASCULAR RISK-FACTORS; NONALCOHOLIC STEATOHEPATITIS; HEART-FAILURE; INSULIN-RESISTANCE; METABOLIC SYNDROME; HEPATIC STEATOSIS; DISEASE; CT	Rationale Associations between obstructive sleep apnea (OSA) and liver fat accumulation have been frequently investigated because both morbidities are common. Visceral fat was reported to be closely related to OSA and liver fat accumulation. Recently, sex differences in the association between OSA and mortality have gained much attention. Objectives To investigate the associations among OSA, liver fat accumulation as determined by computed tomography, and visceral fat area and their sex differences. Methods Studied were 188 males and 62 females who consecutively underwent polysomnography and computed tomography. Results Although the apnea-hypopnea index was positively correlated with liver fat accumulation in the total males, none of the OSA-related factors was independently associated with liver fat accumulation in either the total male or female participants in the multivariate analyses. When performing subanalyses using a specific definition for Japanese of obesity or visceral obesity (body mass index (BMI) >= 25 kg/m(2) or visceral fat area >= 100 cm(2)), in only males without visceral obesity, percent sleep time with oxygen saturation <90%, in addition to BMI, insulin resistance, and serum triglyceride values, was independently correlated with liver fat accumulation (R-2 = 15.1%, P<0.001). In males, percent sleep time of oxygen saturation <90% was also a determining factor for alanine aminotransferase values regardless of visceral fat area. In contrast, OSA was not associated with liver fat accumulation or alanine aminotransferase values in females whether or not visceral obesity was absent. Conclusions Sex differences in the visceral fat-dependent impact of OSA on liver fat accumulation existed. Although the mechanisms are not known and ethnic differences may exist in addition to the specific criteria of visceral obesity in Japan, the treatment of male patients with OSA might be favorable from the viewpoint of preventing liver fat accumulation and liver dysfunction even in patients without obvious visceral fat accumulation.	[Toyama, Yoshiro; Murase, Kimihiko; Azuma, Masanori; Hamada, Satoshi; Handa, Tomohiro; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Tanizawa, Kiminobu; Oga, Toru; Chin, Kazuo] Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan; [Kubo, Takeshi] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Chihara, Yuichi] Otsu Red Cross Hosp, Dept Resp Med, Shiga, Japan; [Harada, Yuka] Kansai Elect Power Hosp, Dept Resp Med, Osaka, Japan; [Hitomi, Takefumi] Kyoto Univ, Dept Clin Lab, Grad Sch Med, Kyoto, Japan; [Chiba, Tsutomu] Kyoto Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University	Chin, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan.	chink@kuhp.kyoto-u.ac.jp	Tanizawa, Kiminobu/GPC-4728-2022; Chihara, Yuichi/AAK-3397-2020	Tanizawa, Kiminobu/0000-0002-5719-0744	Japanese Ministry of Education, Culture, Sports, Science and Technology; Philips-Respironics; Teijin Pharma; Fukuda Denshi	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Philips-Respironics; Teijin Pharma; Fukuda Denshi	This work was partly supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology and Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare of Japan. The Department of Respiratory Care and Sleep Control Medicine is funded by endowments from Philips-Respironics, Teijin Pharma, and Fukuda Denshi to Kyoto University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron-Wisnewsky J, 2012, J HEPATOL, V56, P225, DOI 10.1016/j.jhep.2011.04.022; Barcelo A, 2011, EUR RESPIR J, V37, P1418, DOI 10.1183/09031936.00050410; Campos GM, 2008, HEPATOLOGY, V47, P1916, DOI 10.1002/hep.22241; Chihara Y, 2013, EUR RESPIR J, V42, P1563, DOI 10.1183/09031936.00133512; Chin K, 2003, AM J MED, V114, P370, DOI 10.1016/S0002-9343(02)01570-X; Chin KZ, 1999, CIRCULATION, V100, P706, DOI 10.1161/01.CIR.100.7.706; Corey KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062504; Daltro C, 2010, OBES SURG, V20, P1536, DOI 10.1007/s11695-010-0212-1; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Eguchi M, 2007, HYPERTENS RES, V30, P315, DOI 10.1291/hypres.30.315; Finelli C, 2012, J GASTROINTEST LIVER, V21, P207; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Harada Yuka, 2014, Ann Am Thorac Soc, V11, P383, DOI 10.1513/AnnalsATS.201306-182OC; Harsch IA, 2004, AM J RESP CRIT CARE, V169, P156, DOI 10.1164/rccm.200302-206OC; Hashimoto E, 2011, J GASTROENTEROL, V46, P63, DOI 10.1007/s00535-010-0311-8; Hiuge-Shimizu A, 2012, ANN MED, V44, P82, DOI 10.3109/07853890.2010.526138; Hoyos CM, 2012, THORAX, V67, P1081, DOI 10.1136/thoraxjnl-2011-201420; Iber C., 2007, AASM MANUAL SCORING; Iwasaki M, 2004, TRANSPLANTATION, V78, P1501, DOI 10.1097/01.TP.0000140499.23683.0D; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Jouet P, 2007, OBES SURG, V17, P478, DOI 10.1007/s11695-007-9085-3; Jun JC, 2011, SLEEP, V34, P1207, DOI 10.5665/SLEEP.1240; Kashihara H, 2009, CIRC J, V73, P1881, DOI 10.1253/circj.CJ-09-0183; Kim CW, 2013, J HEPATOL, V59, P351, DOI 10.1016/j.jhep.2013.03.035; Kodama Y, 2007, AM J ROENTGENOL, V188, P1307, DOI 10.2214/AJR.06.0992; Li JG, 2005, J APPL PHYSIOL, V99, P1643, DOI 10.1152/japplphysiol.00522.2005; Li JG, 2005, CIRC RES, V97, P698, DOI 10.1161/01.RES.0000183879.60089.a9; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Mauvoisin D, 2011, BIOCHIMIE, V93, P78, DOI 10.1016/j.biochi.2010.08.001; Ministry of Health Labor and Welfare of Japan, 2014, SUMM NAT HLTH NUTR S; Ministry of Health Labour and Welfare, 2008, SUMM NAT HLTH NUTR S; Minville C, 2014, CHEST, V145, P525, DOI 10.1378/chest.13-0938; Mishra P, 2008, LIVER INT, V28, P1080, DOI 10.1111/j.1478-3231.2008.01822.x; Murase Kimihiko, 2014, Ann Am Thorac Soc, V11, P375, DOI 10.1513/AnnalsATS.201306-144OC; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Park SH, 2006, RADIOLOGY, V239, P105, DOI 10.1148/radiol.2391050361; Polotsky VY, 2009, AM J RESP CRIT CARE, V179, P228, DOI 10.1164/rccm.200804-608OC; Poynard T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030325; Punjabi NM, 2008, AM J RESP CRIT CARE, V177, P1150, DOI 10.1164/rccm.200712-1884OC; Reinke C, 2011, J APPL PHYSIOL, V111, P881, DOI 10.1152/japplphysiol.00492.2011; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Ryo M, 2014, INTERNAL MED, V53, P299, DOI 10.2169/internalmedicine.53.9476; Savransky V, 2008, CIRC RES, V103, P1173, DOI 10.1161/CIRCRESAHA.108.178533; Shimizu I, 2007, WORLD J GASTROENTERO, V13, P4295, DOI 10.3748/wjg.v13.i32.4295; Shinohara E, 1997, J INTERN MED, V241, P11, DOI 10.1046/j.1365-2796.1997.63889000.x; Tachikawa R, 2014, AM J CARDIOL, V114, P618, DOI 10.1016/j.amjcard.2014.05.044; Tanne F, 2005, HEPATOLOGY, V41, P1290, DOI 10.1002/hep.20725; Tatsumi K, 2005, HEPATOL RES, V33, P100, DOI 10.1016/j.hepres.2005.09.014; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; Xu JW, 2012, MOL BIOL REP, V39, P8177, DOI 10.1007/s11033-012-1665-1; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080	54	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129513	10.1371/journal.pone.0129513	http://dx.doi.org/10.1371/journal.pone.0129513			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076443	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900079
J	Zautra, EK; Zautra, AJ; Gallardo, CE; Velasco, L				Zautra, Eva K.; Zautra, Alex J.; Gallardo, Carmen Ecija; Velasco, Lilian			Can We Learn to Treat One Another Better? A Test of a Social Intelligence Curriculum	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; PERSPECTIVE-TAKING; PHYSICAL-ACTIVITY; EMPATHY; HEALTH; INTERVENTION; AGGRESSION; RESPONSES; STUDENTS; PROGRAM	This paper reports on the first test of the value of an online curriculum in social intelligence (SI). Built from current social and cognitive neuroscience research findings, the 50 session SI program was administered, with facilitation in Spanish by classroom instructors, to 207 students from Universidad Rey Juan Carlos in Madrid as part of their undergraduate classes. All materials were translated into Castilian Spanish, including outcome measures of SI that have been used in prior studies to provide valid estimates of two key components of social intelligence: 1) Sensitivity to others and 2) confidence in one's capacity to manage social situations. Pre- and Posttest were administered to participants in the SI training, and also to 87 students in similar classes who did not receive the program who served as the control group. Gender and emotional intelligence levels at pretest also were examined as potential individual differences that might affect the impact of the program on study outcomes. Repeated measures ANOVAs on study outcomes revealed significant increases, from pre to post, in most measures of social intelligence for program participants in comparison to controls, with no effects of gender or age on program effectiveness. Prior scores on emotional intelligence were not a prerequisite for learning from the program. Some findings suggest ways the program may be improved to have stronger effects. Nonetheless, the findings indicate that the SI program tested here shows considerable promise as a means to increase the willingness of young adults to take the perspective of others and enhance their efficacy for initiating and sustaining positive social connections.	[Zautra, Eva K.] Social Intelligence Inst, Phoenix, AZ USA; [Zautra, Alex J.] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA; [Gallardo, Carmen Ecija; Velasco, Lilian] Univ Rey Juan Carlos, Dept Psychol, Madrid, Spain	Arizona State University; Arizona State University-Tempe; Universidad Rey Juan Carlos	Zautra, AJ (corresponding author), Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA.	atajz@asu.edu			Department of Psychology at Arizona State University; Social Intelligence Institute	Department of Psychology at Arizona State University; Social Intelligence Institute	The authors wish to acknowledge the support of the Department of Psychology at Arizona State University and the Social Intelligence Institute for their support of this research. There were no grant numbers associated with this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-On R., 2007, ED PEOPLE BE EMOTION, P1; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Bayer JB, 2013, SCIENCE, V339, P1385, DOI 10.1126/science.1235516; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Blackwell LS, 2007, CHILD DEV, V78, P246, DOI 10.1111/j.1467-8624.2007.00995.x; Bonanno RA, 2010, MERRILL PALMER QUART, V56, P420, DOI 10.1353/mpq.0.0051; Bowlby J., 1992, ATTACHMENT LOSS, V1; Brouwer W, 2011, J MED INTERNET RES, V13, P23, DOI 10.2196/jmir.1639; Brown S.L., 2012, MOVING SELF INTEREST, P75; Burns E.E., 2010, J AGGRESS MALTREAT T, V19, P801, DOI DOI 10.1080/10926771.2010.522947; Castillo R, 2013, J ADOLESCENCE, V36, P883, DOI 10.1016/j.adolescence.2013.07.001; Crisp RJ, 2009, AM PSYCHOL, V64, P231, DOI 10.1037/a0014718; Cugelman B, 2011, J MED INTERNET RES, V13, P84, DOI 10.2196/jmir.1367; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; De Waal F., 2009, AGE EMPATHY NATURES, DOI [10.3389/fnhum.2013.00236, DOI 10.3389/FNHUM.2013.00236]; Durlak JA, 2011, CHILD DEV, V82, P405, DOI 10.1111/j.1467-8624.2010.01564.x; Extremera N, 2006, PSICOTHEMA, V18, P42; Fredrickson BL, 2008, J PERS SOC PSYCHOL, V95, P1045, DOI 10.1037/a0013262; Galinsky AD, 2005, GROUP PROCESS INTERG, V8, P109, DOI 10.1177/1368430205051060; Galinsky AD, 2000, J PERS SOC PSYCHOL, V78, P708, DOI 10.1037//0022-3514.78.4.708; Gazzaniga M., 2011, WHOS CHARGE FREE SCI; Goleman D., 2006, WORKING EMOTIONAL IN; Guo P., 2013, OPTIMAL VIDEO LENGTH; Halifax J., INSIDE COMPASSION UD; Harris LT, 2006, PSYCHOL SCI, V17, P847, DOI 10.1111/j.1467-9280.2006.01793.x; Haslam N, 2006, PERS SOC PSYCHOL REV, V10, P252, DOI 10.1207/s15327957pspr1003_4; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Hawkley LC, 2009, HEALTH PSYCHOL, V28, P354, DOI 10.1037/a0014400; Hedman E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018001; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Hemingway A, 2012, PUBLIC HEALTH, V126, P448, DOI 10.1016/j.puhe.2012.01.014; Hendel-Giller R, 2011, NEUROSCIENCE LEARNIN; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOUSE JS, 1988, ANNU REV SOCIOL, V14, P293, DOI 10.1146/annurev.so.14.080188.001453; Hughes C, 2007, DEV PSYCHOL, V43, P1447, DOI 10.1037/0012-1649.43.6.1447; Humphrey NK, 2002, THE MIND MADE FLESH, P65; Jolliffe D, 2011, J ADOLESCENCE, V34, P59, DOI 10.1016/j.adolescence.2010.02.001; Kahneman D., 2011, THINKING FAST SLOW; Kihlstrom J. F., 2011, CAMBRIDGE HDB INTELL, P564, DOI [DOI 10.1017/CB09780511977244.029, 10.1017/CBO9780511977244.029, DOI 10.1017/CBO9780511977244.029]; Kitwood T, 1990, AGEING SOC, V10, P177, DOI [10.1017/S0144686X00008060, DOI 10.1017/S0144686X00008060]; Klimecki OM, 2014, SOC COGN AFFECT NEUR, V9, P873, DOI 10.1093/scan/nst060; Kolb B, 2003, CURR DIR PSYCHOL SCI, V12, P1, DOI 10.1111/1467-8721.01210; Konrath SH, 2011, PERS SOC PSYCHOL REV, V15, P180, DOI 10.1177/1088868310377395; LENNOX RD, 1984, J PERS SOC PSYCHOL, V46, P1349, DOI 10.1037/0022-3514.46.6.1349; Lieberman M. D., 2013, SOCIAL WHY OUR BRAIN; Masi CM, 2011, PERS SOC PSYCHOL REV, V15, P219, DOI 10.1177/1088868310377394; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Matsushima R, 2003, SOC BEHAV PERSONAL, V31, P323, DOI 10.2224/sbp.2003.31.4.323; Mikulincer M, 2005, J PERS SOC PSYCHOL, V89, P817, DOI 10.1037/0022-3514.89.5.817; Mikulincer M., 2007, ATTACHMENT ADULTHOOD; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; Nyqvist F, 2013, AGING MENT HEALTH, V17, P394, DOI 10.1080/13607863.2012.742490; Pluess M, 2013, PSYCHOL BULL, V139, P901, DOI 10.1037/a0030196; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Riess H, 2012, J GEN INTERN MED, V27, P1280, DOI 10.1007/s11606-012-2063-z; Ritterband LM, 2009, ANN BEHAV MED, V38, P18, DOI 10.1007/s12160-009-9133-4; Robroek SJW, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1788; Salovey P., 1990, IMAGINATION COGNITIO, V9, P185, DOI [https://doi.org/10.2190/DUGG-P24E-52WK-6CDG, 10.2190/DUGG-P24E-52WK-6CDG, DOI 10.2190/DUGG-P24E-52WK-6CDG]; Sandstrom GM, 2014, SOC PSYCHOL PERS SCI, V5, P437, DOI 10.1177/1948550613502990; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Seppala E., 2013, COMPASSIONATE MIND; Shields A, 1998, J CLIN CHILD PSYCHOL, V27, P381, DOI 10.1207/s15374424jccp2704_2; Silvera DH, 2001, SCAND J PSYCHOL, V42, P313, DOI 10.1111/1467-9450.00242; Snow N. E., 2010, VIRTUE SOCIAL INTELL; Social and Character Development Research Consortium, 2010, EFF SCHOOLW PROGR PR; Steele RM, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-7; Thorndike E.L., 1920, HARPERS MAGAZINE, V140, P227, DOI DOI 10.1234/12345678; Vaillant G., 2012, TRIMPHS EXPERIENCE M; van den Bos W, 2011, PSYCHOL SCI, V22, P60, DOI 10.1177/0956797610391102; Walton GM, 2014, CURR DIR PSYCHOL SCI, V23, P73, DOI 10.1177/0963721413512856; Wang J, 2009, J ADOLESCENT HEALTH, V45, P368, DOI 10.1016/j.jadohealth.2009.03.021; Ybarra O, 2008, PERS SOC PSYCHOL B, V34, P248, DOI 10.1177/0146167207310454; Ybarra O, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00075; Zautra AJ, 2013, HDB RESILIENCE APPRO; Zautra AJ, NEW DEV EMOTIONAL AG; Zautra AJ, 2012, J PSYCHOTHER INTEGR, V22, P206, DOI 10.1037/a0029573	76	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128638	10.1371/journal.pone.0128638	http://dx.doi.org/10.1371/journal.pone.0128638			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076133	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900023
J	Karisola, P; Lehto, M; Kinaret, P; Ahonen, N; Haapakoski, R; Anthoni, M; Taniguchi, M; Wolff, H; Puustinen, A; Alenius, H				Karisola, Piia; Lehto, Maili; Kinaret, Pia; Ahonen, Niina; Haapakoski, Rita; Anthoni, Minna; Taniguchi, Masaru; Wolff, Henrik; Puustinen, Anne; Alenius, Harri			Invariant Natural Killer T Cells Play a Role in Chemotaxis, Complement Activation and Mucus Production in a Mouse Model of Airway Hyperreactivity and Inflammation	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; ASTHMA; PROTEOME; MICE; EXPRESSION; BIOMARKERS; PROTEINS; ALLERGEN	CD1d-restricted invariant natural killer T ( iNKT) cells play a critical role in the induction of airway hyperreactivity (AHR). After intranasal alpha-galactosylceramide (a-GalCer) administration, bronchoalveolar lavage fluid (BALF) proteins from mouse lung were resolved by two-dimensional differential gel electrophoresis (2D-DIGE), and identified by tandem mass spectroscopy. A lack of iNKT cells prevented the development of airway responses including AHR, neutrophilia and the production of the proinflammatory cytokines in lungs. Differentially abundant proteins in the BALF proteome of alpha-GalCer-treated wild type mice included lungkine (CXCL15), pulmonary surfactant-associated protein D (SFTPD), calcium-activated chloride channel regulator 1 (CLCA1), fragments of complement 3, chitinase 3-like proteins 1 (CH3LI) and 3 (CH3L3) and neutrophil gelatinase-associated lipocalin (NGAL). These proteins may contribute to iNKT regulated AHR via several mechanisms: altering leukocyte chemotaxis, increasing airway mucus production and possibly via complement activation.	[Karisola, Piia; Lehto, Maili; Kinaret, Pia; Ahonen, Niina; Haapakoski, Rita; Anthoni, Minna; Wolff, Henrik; Puustinen, Anne; Alenius, Harri] Finnish Inst Occupat Hlth, Unit Syst Toxicol, Helsinki, Finland; [Taniguchi, Masaru] RIKEN, Ctr Integrat Med Sci, Lab Immune Regulat, RCAI Kanagawa, Kanagawa, Japan	Finnish Institute of Occupational Health; RIKEN	Karisola, P (corresponding author), Finnish Inst Occupat Hlth, Unit Syst Toxicol, Helsinki, Finland.	Piia.Karisola@ttl.fi		Alenius, Harri/0000-0003-0106-8923; Puustinen, Anne/0000-0002-0262-9975; Karisola, Piia/0000-0003-0635-2704; Haapakoski, Rita/0000-0001-5263-0870; Kinaret, Pia/0000-0002-3312-5331	Academy of Finland [121025]; Grants-in-Aid for Scientific Research [23229005] Funding Source: KAKEN	Academy of Finland(Academy of Finland); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded by the Academy of Finland (decision number 121025, www.aka.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Anderson L, 2014, J PROTEOMICS, V107, P24, DOI 10.1016/j.jprot.2014.03.005; Bargagli E, 2008, INFLAMMATION, V31, P351, DOI 10.1007/s10753-008-9085-z; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Chen SC, 2001, J IMMUNOL, V166, P3362, DOI 10.4049/jimmunol.166.5.3362; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Gerszten RE, 2011, CIRC RES, V109, P463, DOI 10.1161/CIRCRESAHA.110.225003; Gharib SA, 2011, J ALLERGY CLIN IMMUN, V128, P1176, DOI 10.1016/j.jaci.2011.07.053; Haapakoski R, 2011, AM J RESP CELL MOL, V44, P639, DOI 10.1165/rcmb.2009-0355OC; Hachem P, 2005, EUR J IMMUNOL, V35, P2793, DOI 10.1002/eji.200535268; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Hortobagyi L, 2008, J ALLERGY CLIN IMMUN, V122, P521, DOI 10.1016/j.jaci.2008.05.002; Hoshino M, 2002, AM J RESP CRIT CARE, V165, P1132, DOI 10.1164/ajrccm.165.8.2107068; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kang XD, 2010, PROTEOMICS, V10, P520, DOI 10.1002/pmic.200900573; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kim JO, 2004, J ALLERGY CLIN IMMUN, V114, P1332, DOI 10.1016/j.jaci.2004.09.004; Konradsen JR, 2013, J ALLERGY CLIN IMMUN, V132, P328, DOI 10.1016/j.jaci.2013.03.003; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Leverkoehne I, 2002, J HISTOCHEM CYTOCHEM, V50, P829, DOI 10.1177/002215540205000609; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Matsuda H, 2005, AM J RESP CELL MOL, V33, P22, DOI 10.1165/rcmb.2004-0010OC; Meyer EH, 2006, P NATL ACAD SCI USA, V103, P2782, DOI 10.1073/pnas.0510282103; Nakanishi A, 2001, P NATL ACAD SCI USA, V98, P5175, DOI 10.1073/pnas.081510898; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Rostila A, 2012, LUNG CANCER, V77, P450, DOI 10.1016/j.lungcan.2012.03.024; Rydman EM, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0048-2; Scanlon ST, 2011, J EXP MED, V208, P2113, DOI 10.1084/jem.20110522; Schroll A, 2012, EUR J IMMUNOL, V42, P3346, DOI 10.1002/eji.201142351; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Umetsu DT, 2010, J ALLERGY CLIN IMMUN, V125, P975, DOI 10.1016/j.jaci.2010.02.006; Umetsu DT, 2010, INT J BIOCHEM CELL B, V42, P529, DOI 10.1016/j.biocel.2009.10.022; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wong WSF, 2007, EUR J PHARMACOL, V575, P134, DOI 10.1016/j.ejphar.2007.07.027; Zhang LF, 2009, J PROTEOME RES, V8, P1631, DOI 10.1021/pr800685h; Zhang X, 2010, EXPERT REV CLIN IMMU, V6, P269, DOI 10.1586/ECI.09.84; Zhao J, 2005, PROTEOMICS, V5, P2799, DOI 10.1002/pmic.200401169; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhou YH, 2001, AM J RESP CELL MOL, V25, P486, DOI 10.1165/ajrcmb.25.4.4578	44	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129446	10.1371/journal.pone.0129446	http://dx.doi.org/10.1371/journal.pone.0129446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067998	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000075
J	La Gerche, A; Inder, WJ; Roberts, TJ; Brosnan, MJ; Heidbuchel, H; Prior, DL				La Gerche, Andre; Inder, Warrick J.; Roberts, Timothy J.; Brosnan, Maria J.; Heidbuchel, Hein; Prior, David L.			Relationship between Inflammatory Cytokines and Indices of Cardiac Dysfunction following Intense Endurance Exercise	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MUSCLE-DERIVED INTERLEUKIN-6; VENTRICULAR DYSFUNCTION; ATRIAL-FIBRILLATION; PROLONGED EXERCISE; IRONMAN TRIATHLON; TROPONIN-T; HEART; ARRHYTHMIAS; METAANALYSIS	Objectives Pro-inflammatory cytokines have been noted to increase following exercise but their relationship to exercise-induced cardiac dysfunction has not previously been investigated. We sought to evaluate whether exercise-induced cardiac dysfunction was associated with increases in cytokines, particularly the pro-inflammatory cytokines IL-1 beta, IL-12p70 and TNF alpha, which have been most implicated in cardiac pathology. Methods 40 well-trained endurance athletes underwent evaluation prior to and immediately following one of four endurance sporting events ranging from 3 to 11 hours duration. Cytokines (IL-1 beta, IL-6, IL-8, IL-10, IL-12p70 and TNF alpha) were analyzed by flow cytometry from serum samples collected within 50 minutes of race completion. Cardiac troponin (cTnI) and B-type natriuretic peptide were combined with an echocardiographic assessment of cardiac function, and a composite of cTnI > 0.04 mu g/L, BNP increase > 10 ng/L and a decrease in right ventricular ejection (RVEF) > 10% were prospectively defined as evidence of myocardial dysfunction. Results Relative to baseline, IL-6 IL-8 and IL-10 increased 8.5-, 2.9-, and 7.1-fold, respectively, P<0.0001. Thirty-one (78%), 19 (48%) and 18 (45%) of the athletes met the pre-specified criteria for significant cTnI, BNP and RVEF changes, respectively. TNF alpha, IL-12p70 were univariate predictors of Delta RVEF and Delta BNP whilst none of the anti-inflammatory cytokines were significantly associated with these measures. Ten athletes (25%, all athletes competing in the endurance event of longest duration) met criteria for exercise-induced myocardial dysfunction. In these 10 athletes with myocardial dysfunction, as compared to those without, there was significantly greater post-race expression of the pro-inflammatory cytokines IL-12p70 (8.1 +/- 3.8pg/ml vs. 2.5 +/- 2.6pg/ml, P<0.0001) and TNF alpha (6.5 +/- 3.1pg/ml vs. 2.0 +/- 2.5pg/ml, P<0.0001). Conclusion Cardiac dysfunction following intense endurance exercise was associated with increased expression of pro-inflammatory cytokines. This does not prove a causal relationship but provides rationale for further investigations into whether inflammation mediates exercise-induced myocardial dysfunction.	[La Gerche, Andre] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [La Gerche, Andre; Roberts, Timothy J.; Brosnan, Maria J.; Prior, David L.] St Vincents Hosp Melbourne, Fitzroy, Vic, Australia; [La Gerche, Andre] Katholieke Univ Leuven, Univ Hosp Leuven, Louvain, Belgium; [Roberts, Timothy J.; Brosnan, Maria J.; Prior, David L.] Univ Melbourne, St Vincents Dept Med, Fitzroy, Vic 3065, Australia; [Inder, Warrick J.] Univ Queensland, Brisbane, Qld, Australia; [Inder, Warrick J.] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Heidbuchel, Hein] Hasselt Univ & Heart Ctr, Hasselt, Belgium	Baker Heart and Diabetes Institute; St Vincent's Hospital Melbourne; KU Leuven; University Hospital Leuven; University of Melbourne; University of Queensland; Hasselt University	La Gerche, A (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	andre.lagerche@bakeridi.edu.au	La Gerche, Andre/O-4733-2017; Heidbuchel, Hein/AAU-2711-2021; Inder, Warrick/C-7121-2014; Heidbuchel, Hein/C-2331-2019	La Gerche, Andre/0000-0002-3906-3784; Heidbuchel, Hein/0000-0001-9301-8127; Inder, Warrick/0000-0001-5078-4980; Heidbuchel, Hein/0000-0001-9301-8127	Pfizer International; Career Development Fellowship from National Health and Medical Research Council; Future Leader Fellowship from Heart Foundation of Australia	Pfizer International(Pfizer); Career Development Fellowship from National Health and Medical Research Council; Future Leader Fellowship from Heart Foundation of Australia	This study was funded by a competitive and unrestricted CVL Grant sponsored by Pfizer International (http://www.pfizergrants.com.au/Grants/CardiovascularLipid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A La Gerche is supported by a Career Development Fellowship from the National Health and Medical Research Council and a Future Leader Fellowship from the Heart Foundation of Australia.	Abdulla J, 2009, EUROPACE, V11, P1156, DOI 10.1093/europace/eup197; Banerjee I, 2009, AM J PHYSIOL-HEART C, V296, pH1694, DOI 10.1152/ajpheart.00908.2008; Benito B, 2011, CIRCULATION, V123, P13, DOI 10.1161/CIRCULATIONAHA.110.938282; Bryant D, 1998, CIRCULATION, V97, P1375, DOI 10.1161/01.CIR.97.14.1375; Chen YJ, 2000, J APPL PHYSIOL, V88, P1749, DOI 10.1152/jappl.2000.88.5.1749; Deswal A, 2001, CIRCULATION, V103, P2055; DOUGLAS PS, 1990, J AM COLL CARDIOL, V15, P64, DOI 10.1016/0735-1097(90)90176-P; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Fischer CP, 2007, SCAND J MED SCI SPOR, V17, P580, DOI 10.1111/j.1600-0838.2006.00602.x; Foote RS, 2004, J AM COLL CARDIOL, V44, P1980, DOI 10.1016/j.jacc.2004.08.045; Guasch E, 2013, J AM COLL CARDIOL, V62, P68, DOI 10.1016/j.jacc.2013.01.091; Heidbuchel H, 2003, EUR HEART J, V24, P1473, DOI 10.1016/S0195-668X(03)00282-3; Jiang BB, 2010, J CARDIOVASC TRANSL, V3, P410, DOI 10.1007/s12265-010-9193-7; Kapadia SR, 1997, CIRC RES, V81, P187, DOI 10.1161/01.RES.81.2.187; KINUGAWA K, 1994, CIRC RES, V75, P285, DOI 10.1161/01.RES.75.2.285; La Gerche A, 2008, HEART, V94, P860, DOI 10.1136/hrt.2006.101063; La Gerche A, 2010, HEART, V96, P1268, DOI 10.1136/hrt.2009.189621; La Gerche A, 2014, CIRCULATION, V130, P992, DOI 10.1161/CIRCULATIONAHA.114.008141; La Gerche A, 2013, EUR HEART J, V34, P3599, DOI 10.1093/eurheartj/eht265; La Gerche A, 2012, EUR HEART J, V33, P998, DOI 10.1093/eurheartj/ehr397; Marcus GM, 2008, AM HEART J, V155, P303, DOI 10.1016/j.ahj.2007.09.006; Markel TA, 2007, AM J PHYSIOL-REG I, V293, pR1893, DOI 10.1152/ajpregu.00359.2007; Marklund P, 2013, J APPL PHYSIOL, V114, P66, DOI 10.1152/japplphysiol.01538.2011; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Middleton N, 2006, MED SCI SPORT EXER, V38, P681, DOI 10.1249/01.mss.0000210203.10200.12; Mont L, 2010, HEART, V96, P398, DOI 10.1136/hrt.2008.160903; Mousavi N, 2009, AM J CARDIOL, V103, P1467, DOI 10.1016/j.amjcard.2009.01.294; Neilan TG, 2006, CIRCULATION, V114, P2325, DOI 10.1161/CIRCULATIONAHA.106.647461; Neubauer O, 2008, EUR J APPL PHYSIOL, V104, P417, DOI 10.1007/s00421-008-0787-6; Nielsen HB, 1996, AM J PHYSIOL-REG I, V271, pR222, DOI 10.1152/ajpregu.1996.271.1.R222; Niemann PS, 2007, J AM COLL CARDIOL, V50, P1668, DOI 10.1016/j.jacc.2007.07.031; Ostrowski K, 1999, J PHYSIOL-LONDON, V515, P287, DOI 10.1111/j.1469-7793.1999.287ad.x; Peake JM, 2005, EUR J APPL PHYSIOL, V95, P514, DOI 10.1007/s00421-005-0035-2; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2006, ESSAYS BIOCHEM, V42, P105, DOI 10.1042/bse0420105; Rifai N, 1999, AM J CARDIOL, V83, P1085, DOI 10.1016/S0002-9149(99)00020-X; Sabatine MS, 2004, J AM COLL CARDIOL, V44, P1988, DOI 10.1016/j.jacc.2004.07.057; Serrano E, 2010, J SPORT SCI, V28, P1047, DOI 10.1080/02640414.2010.484067; Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Trivax JE, 2010, J APPL PHYSIOL, V108, P1148, DOI 10.1152/japplphysiol.01151.2009; Wardyn GG, 2008, EXP HEMATOL, V36, P216, DOI 10.1016/j.exphem.2007.10.003	42	40	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130031	10.1371/journal.pone.0130031	http://dx.doi.org/10.1371/journal.pone.0130031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070197	Green Published, gold			2022-12-27	WOS:000356327000137
J	Rosche, KL; Aljasham, AT; Kipfer, JN; Piatkowski, BT; Konjufca, V				Rosche, Kristin L.; Aljasham, Alanoud T.; Kipfer, James N.; Piatkowski, Bryan T.; Konjufca, Vjollca			Infection with Salmonella enterica Serovar Typhimurium Leads to Increased Proportions of F4/80(+) Red Pulp Macrophages and Decreased Proportions of B and T Lymphocytes in the Spleen	PLOS ONE			English	Article							MURINE TYPHOID-FEVER; PROTECTIVE IMMUNITY; CUTTING EDGE; SPI-C; MICE; CELLS; ERYTHROPOIETIN; MONOCYTE; SURVIVAL; ALPHA	Infection of mice with Salmonella enterica serovar Typhimurium (Salmonella) causes systemic inflammatory disease and enlargement of the spleen (splenomegaly). Splenomegaly has been attributed to a general increase in the numbers of phagocytes, lymphocytes, as well as to the expansion of immature CD71(+)Ter119(+) reticulocytes. The spleen is important for recycling senescent red blood cells (RBCs) and for the capture and eradication of blood-borne pathogens. Conservation of splenic tissue architecture, comprised of the white pulp (WP), marginal zone (MZ), and red pulp (RP) is essential for initiation of adaptive immune responses to captured pathogens. Using flow cytometry and four color immunofluorescence microscopy (IFM), we show that Salmonella-induced splenomegaly is characterized by drastic alterations of the splenic tissue architecture and cell population proportions, as well as in situ cell distributions. A major cause of splenomegaly appears to be the significant increase in immature RBC precursors and F4/80(+) macrophages that are important for recycling of heme-associated iron. In contrast, the proportions of B220(+), CD4(+) and CD8(+) lymphocytes, as well as MZ MOMA(+) macrophages decrease significantly as infection progresses. Spleen tissue sections show visible tears and significantly altered tissue architecture with F4/80(+) macrophages and RBCs expanding beyond the RP and taking over most of the spleen tissue. Additionally, F4/80(+) macrophages actively phagocytose not only RBCs, but also lymphocytes, indicating that they may contribute to declining lymphocyte proportions during Salmonella infection. Understanding how these alterations of spleen microarchitecture impact the generation of adaptive immune responses to Salmonella has implications for understanding Salmonella pathogenesis and for the design of more effective Salmonella-based vaccines.	[Rosche, Kristin L.; Aljasham, Alanoud T.; Kipfer, James N.; Konjufca, Vjollca] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA; [Piatkowski, Bryan T.] So Illinois Univ, Dept Plant Biol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Konjufca, V (corresponding author), So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA.	vjollca@micro.siu.edu		Konjufca, Vjollca/0000-0002-7736-5097; Piatkowski, Bryan/0000-0002-1334-8431	Southern Illinois University	Southern Illinois University	This work was funded by start-up funds provided to VK by Southern Illinois University.	Aoshiba K, 2009, CRIT CARE MED, V37, P889, DOI 10.1097/CCM.0b013e31819b8371; Benedict CA, 2006, PLOS PATHOG, V2, P164, DOI 10.1371/journal.ppat.0020016; Brendt P, 2009, ANESTH ANALG, V109, P705, DOI 10.1213/ane.0b013e3181adc80f; Brines M, 2012, MOL MED, V18, P486, DOI 10.2119/molmed.2011.00414; Brown DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009441; Bueno SM, 2007, IMMUNOL LETT, V111, P14, DOI 10.1016/j.imlet.2007.05.003; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; COLLINS FM, 1972, INFECT IMMUN, V5, P191, DOI 10.1128/IAI.5.2.191-198.1972; Curtiss R, 2010, CRIT REV IMMUNOL, V30, P255, DOI 10.1615/CritRevImmunol.v30.i3.30; den Haan JMM, 2012, J INNATE IMMUN, V4, P437, DOI 10.1159/000335216; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; Engwerda CR, 2002, AM J PATHOL, V161, P429, DOI 10.1016/S0002-9440(10)64199-5; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Hess J, 1996, J IMMUNOL, V156, P3321; Hyland L, 2005, EXP HEMATOL, V33, P1477, DOI 10.1016/j.exphem.2005.09.005; Jackson A, 2010, J IMMUNOL, V185, P6198, DOI 10.4049/jimmunol.1001198; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Konjufca V, 2008, INFECT IMMUN, V76, P5745, DOI 10.1128/IAI.00897-08; Konjufca V, 2006, INFECT IMMUN, V74, P6785, DOI 10.1128/IAI.00851-06; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Kullas AL, 2012, CELL HOST MICROBE, V12, P791, DOI 10.1016/j.chom.2012.10.018; Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8; LACOMBE C, 1991, AM J KIDNEY DIS, V18, P14; LACOMBE C, 1988, J CLIN INVEST, V81, P620, DOI 10.1172/JCI113363; Lang F, 2012, BLOOD PURIFICAT, V33, P125, DOI 10.1159/000334163; Li YH, 2009, P NATL ACAD SCI USA, V106, P593, DOI 10.1073/pnas.0811697106; Lifshitz L, 2010, HAEMATOL-HEMATOL J, V95, P1823, DOI 10.3324/haematol.2010.025015; Luu RA, 2006, J IMMUNOL, V177, P1516, DOI 10.4049/jimmunol.177.3.1516; MATSUI K, 1993, FEMS MICROBIOL LETT, V112, P113; McCoy MW, 2012, INFECT IMMUN, V80, P3642, DOI 10.1128/IAI.00656-12; McLaughlin LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000671; McSorley SJ, 2014, IMMUNOL REV, V260, P168, DOI 10.1111/imr.12184; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mittrucker HW, 2000, J IMMUNOL, V164, P1648, DOI 10.4049/jimmunol.164.4.1648; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Nanton MR, 2012, J IMMUNOL, V189, P5503, DOI 10.4049/jimmunol.1201413; NAUCIEL C, 1990, J IMMUNOL, V145, P1265; Nix RN, 2007, PLOS PATHOG, V3, P1982, DOI 10.1371/journal.ppat.0030193; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Perez-Lopez A, 2013, J IMMUNOL, V190, P1201, DOI 10.4049/jimmunol.1200415; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Rabsch W, 2002, INFECT IMMUN, V70, P2249, DOI 10.1128/IAI.70.5.2249-2255.2002; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Rosales-Reyes R, 2005, INFECT IMMUN, V73, P3937, DOI 10.1128/IAI.73.7.3937-3944.2005; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593	50	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130092	10.1371/journal.pone.0130092	http://dx.doi.org/10.1371/journal.pone.0130092			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068006	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000139
J	Vilar, S; Lorberbaum, T; Hripcsak, G; Tatonetti, NP				Vilar, Santiago; Lorberbaum, Tal; Hripcsak, George; Tatonetti, Nicholas P.			Improving Detection of Arrhythmia Drug-Drug Interactions in Pharmacovigilance Data through the Implementation of Similarity-Based Modeling	PLOS ONE			English	Article							SIGNAL-DETECTION; PREDICTION; INHIBITORS	Identification of Drug-Drug Interactions (DDIs) is a significant challenge during drug development and clinical practice. DDIs are responsible for many adverse drug effects (ADEs), decreasing patient quality of life and causing higher care expenses. DDIs are not systematically evaluated in pre-clinical or clinical trials and so the FDA U.S. Food and Drug Administration relies on post-marketing surveillance to monitor patient safety. However, existing pharmacovigilance algorithms show poor performance for detecting DDIs exhibiting prohibitively high false positive rates. Alternatively, methods based on chemical structure and pharmacological similarity have shown promise in adverse drug event detection. We hypothesize that the use of chemical biology data in a post hoc analysis of pharmacovigilance results will significantly improve the detection of dangerous interactions. Our model integrates a reference standard of DDIs known to cause arrhythmias with drug similarity data. To compare similarity between drugs we used chemical structure (both 2D and 3D molecular structure), adverse drug side effects, chemogenomic targets, drug indication classes, and known drug-drug interactions. We evaluated the method on external reference standards. Our results showed an enhancement of sensitivity, specificity and precision in different top positions with the use of similarity measures to rank the candidates extracted from pharmacovigilance data. For the top 100 DDI candidates, similarity-based modeling yielded close to twofold precision enhancement compared to the proportional reporting ratio (PRR). Moreover, the method helps in the DDI decision making through the identification of the DDI in the reference standard that generated the candidate.	[Vilar, Santiago; Lorberbaum, Tal; Hripcsak, George; Tatonetti, Nicholas P.] Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA; [Vilar, Santiago; Lorberbaum, Tal; Tatonetti, Nicholas P.] Columbia Univ, Dept Syst Biol, New York, NY USA; [Vilar, Santiago; Hripcsak, George; Tatonetti, Nicholas P.] Observat Hlth Data Sci & Informat, New York, NY USA; [Tatonetti, Nicholas P.] Columbia Univ, Dept Med, New York, NY USA	Columbia University; Columbia University; Columbia University	Vilar, S (corresponding author), Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA.	sv2348@cumc.columbia.edu		Tatonetti, Nicholas/0000-0002-2700-2597; Lorberbaum, Tal/0000-0002-4772-7392	National Library of Medicine [R01 LM006910]; Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Research Starter Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107145, T32GM082797] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006910] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Research Starter Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grant R01 LM006910 (GH) "Discovering and Applying Knowledge in Clinical Databases" from the National Library of Medicine, and Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Research Starter Award (NPT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzelius L, 2001, MOL PHARMACOL, V59, P909, DOI 10.1124/mol.59.4.909; [Anonymous], 2011, MICR HEALTHC SER; [Anonymous], 2011, SCHROD PACK VERS 9 2; [Anonymous], FDA ADV EV REP SYST; Cheng FX, 2014, J AM MED INFORM ASSN, V21, pE278, DOI 10.1136/amiajnl-2013-002512; Crouch MA, 2003, PHARMACOTHERAPY, V23, P881, DOI 10.1592/phco.23.7.881.32730; De Rienzo F, 2000, J COMPUT AID MOL DES, V14, P93, DOI 10.1023/A:1008187802746; Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r; Gottlieb A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.26; Harpaz R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S9-S7; Korhonen LE, 2005, J MED CHEM, V48, P3808, DOI 10.1021/jm0489713; Krishna G, 2012, EXPERT OPIN DRUG MET, V8, P1, DOI 10.1517/17425255.2012.639360; Olvey EL, 2010, CLIN PHARMACOL THER, V87, P48, DOI 10.1038/clpt.2009.198; Percha B, 2013, TRENDS PHARMACOL SCI, V34, P178, DOI 10.1016/j.tips.2013.01.006; Percha B, 2012, BIOCOMPUT-PAC SYM, P410; Pirmohamed M., 1998, MI O DRUG INTERACTIO; Rahnasto M, 2005, J MED CHEM, V48, P440, DOI 10.1021/jm049536b; Rice PJ, 2003, BRIT DENT J, V194, P411, DOI 10.1038/sj.bdj.4810049; Tari L, 2010, BIOINFORMATICS, V26, pi547, DOI 10.1093/bioinformatics/btq382; Tatonetti NP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003377; Tatonetti NP, 2012, J AM MED INFORM ASSN, V19, P79, DOI 10.1136/amiajnl-2011-000214; Vilar S, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2014.35; Vilar S, 2014, CURR DRUG METAB, V15, P490, DOI 10.2174/138920021505141126102223; Vilar S, 2014, NAT PROTOC, V9, P2147, DOI 10.1038/nprot.2014.151; Vilar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058321; Vilar S, 2012, J AM MED INFORM ASSN, V19, P1066, DOI 10.1136/amiajnl-2012-000935; Vilar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041471; Vilar S, 2011, J AM MED INFORM ASSN, V18, pI73, DOI 10.1136/amiajnl-2011-000417; Yap CW, 2005, J CHEM INF MODEL, V45, P982, DOI 10.1021/ci0500536	29	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129974	10.1371/journal.pone.0129974	http://dx.doi.org/10.1371/journal.pone.0129974			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068584	gold, Green Submitted, Green Published			2022-12-27	WOS:000356327000129
J	Yeom, KW; Straka, M; Iv, M; Moseley, ME; Barnes, PD; Skare, S; Holdsworth, SJ				Yeom, Kristen W.; Straka, Matus; Iv, Michael; Moseley, Michael E.; Barnes, Patrick D.; Skare, Stefan; Holdsworth, Samantha J.			Intensity-Corrected Dual-Echo Echo-Planar Imaging (DE-EPI) for Improved Pediatric Brain Diffusion Imaging	PLOS ONE			English	Article							WEIGHTED MRI; CEREBRAL INFARCTION; 1.5 T; SPECTROSCOPY; MATURATION; CHILDHOOD; CHILDREN; STROKE; IMAGES; GLIOMA	Here we investigate the utility of a dual-echo Echo-Planar Imaging (DE-EPI) Diffusion Weighted Imaging (DWI) approach to improve lesion conspicuity in pediatric imaging. This method delivers two 'echo images' for one diffusion-preparation period. We also demonstrate how the echoes can be utilized to remove transmit/receive coil-induced and static magnetic field intensity modulations on both echo images, which often mimic pathology and thereby pose diagnostic challenges. DE-EPI DWI data were acquired in 18 pediatric patients with abnormal diffusion lesions, and 46 pediatric patient controls at 3T. Echo1 [TE = 45ms] and Echo2 [TE = 86ms] were corrected for signal intensity variation across the images by exploiting the images equivalent coil-sensitivity and susceptibility-induced modulations. Two neuroradiologists independently reviewed Echo1 and Echo2 and their intensity-corrected variants (cEcho1 and cEcho2) on a 7-point Likert scale, with grading on lesion conspicuity diagnostic confidence. The apparent diffusion coefficient (ADC) map from Echo1 was used to validate presence of true pathology. Echo2 was unanimously favored over Echo1 for its sensitivity for detecting acute brain injury, with a mean respective lesion conspicuity of 5.7/4.4 (p < 0.005) and diagnostic confidence of 5.1/4.3 (p = 0.025). cEcho2 was rated higher than cEcho1, with a mean respective lesion conspicuity of 5.5/4.3 (p < 0.005) and diagnostic confidence of 5.4/4.4 (p < 0.005). cEcho2 was favored over all echoes for its diagnostic reliability, particularly in regions close to the head coil. This work concludes that DE-EPI DWI is a useful alternative to conventional single-echo EPI DWI, whereby Echo2 and cEcho2 allows for improved lesion detection and overall higher diagnostic confidence.	[Yeom, Kristen W.; Barnes, Patrick D.] Stanford Univ, Lucile Packard Childrens Hosp, Dept Radiol, Stanford, CA 94305 USA; [Straka, Matus] Kantonsspital Winterthur, Inst Radiol & Nukl Med, Winterthur, Switzerland; [Iv, Michael] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Moseley, Michael E.; Holdsworth, Samantha J.] Stanford Univ, Lucas Ctr Imaging, Dept Radiol, Stanford, CA 94305 USA; [Skare, Stefan] Karolinska Inst, Clin Neurosci, Stockholm, Sweden	Lucile Packard Children's Hospital (LPCH); Stanford University; Stanford University; Stanford University; Karolinska Institutet	Holdsworth, SJ (corresponding author), Stanford Univ, Lucas Ctr Imaging, Dept Radiol, Stanford, CA 94305 USA.	sholdsworth@stanford.edu		Yeom, Kristen/0000-0001-9860-3368; Holdsworth, Samantha/0000-0002-2929-1169	National Institutes of Health [2RO1 NS047607-06]; Center of Advanced MR Technology at Stanford [P41 EB015891]; Lucas Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Advanced MR Technology at Stanford; Lucas Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health 2RO1 NS047607-06, the Center of Advanced MR Technology at Stanford (P41 EB015891), Lucas Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre JB, 2012, AM J NEURORADIOL, V33, P1337, DOI 10.3174/ajnr.A2980; AUTTI T, 1994, NEURORADIOLOGY, V36, P649, DOI 10.1007/BF00600432; Barkovich AJ, 2001, AM J NEURORADIOL, V22, P1786; BARKOVICH AJ, 1988, RADIOLOGY, V166, P173, DOI 10.1148/radiology.166.1.3336675; Burdette JH, 1999, RADIOLOGY, V212, P333, DOI 10.1148/radiology.212.2.r99au36333; Chan YL, 2003, PEDIATR RADIOL, V33, P574, DOI 10.1007/s00247-003-0949-y; Chang YW, 2003, PEDIATR RADIOL, V33, P836, DOI 10.1007/s00247-003-0968-8; Conturo TE, 1996, MAGNET RESON MED, V35, P399, DOI 10.1002/mrm.1910350319; De Vries LS, 2005, NEUROPEDIATRICS, V36, P12, DOI 10.1055/s-2005-837544; Engelbrecht V, 2002, RADIOLOGY, V222, P410, DOI 10.1148/radiol.2222010492; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Holdsworth SJ, 2014, AM J NEURORADIOL, V35, P1293, DOI 10.3174/ajnr.A3921; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Leite CC, 2005, RADIOLOGY, V235, P190, DOI 10.1148/radiol.2351031963; Lober RM, 2014, J NEURO-ONCOL, V117, P175, DOI 10.1007/s11060-014-1375-8; Mader I, 2002, STROKE, V33, P1142, DOI 10.1161/hs0402.105883; Majoie CB, 2002, AM J NEURORADIOL, V23, P813; Moritani T, 2004, CLIN IMAG, V28, P261, DOI 10.1016/S0899-7071(03)00191-8; Mukherjee P, 2001, RADIOLOGY, V221, P349, DOI 10.1148/radiol.2212001702; Qu P, 2005, J MAGN RESON, V174, P60, DOI 10.1016/j.jmr.2005.01.015; Rollins N, 2004, AM J NEURORADIOL, V25, P1688; Skare S, 2007, MAGN RESON MED, V57, P881, DOI 10.1002/mrm.21176; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Teixeira J, 2001, NEURORADIOLOGY, V43, P1031, DOI 10.1007/s002340100625; Wright PJ, 2008, MAGN RESON MATER PHY, V21, P121, DOI 10.1007/s10334-008-0104-8; Yeom KW, 2013, J NEURO-ONCOL, V113, P479, DOI 10.1007/s11060-013-1140-4	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129325	10.1371/journal.pone.0129325	http://dx.doi.org/10.1371/journal.pone.0129325			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069959	Green Published, Green Submitted, gold			2022-12-27	WOS:000356327000065
J	Ceperuelo-Mallafre, V; Ejarque, M; Duran, X; Pachon, G; Vazquez-Carballo, A; Roche, K; Nunez-Roa, C; Garrido-Sanchez, L; Tinahones, FJ; Vendrell, J; Fernandez-Veledo, S				Ceperuelo-Mallafre, Victoria; Ejarque, Miriam; Duran, Xavier; Pachon, Gisela; Vazquez-Carballo, Ana; Roche, Kelly; Nunez-Roa, Catalina; Garrido-Sanchez, Lourdes; Tinahones, Francisco J.; Vendrell, Joan; Fernandez-Veledo, Sonia			Zinc-alpha 2-Glycoprotein Modulates AKT-Dependent Insulin Signaling in Human Adipocytes by Activation of the PP2A Phosphatase	PLOS ONE			English	Article							LIPID MOBILIZING FACTOR; NECROSIS-FACTOR-ALPHA; SKELETAL-MUSCLE; ADIPOSE-TISSUE; GLUCOSE-UPTAKE; ZINC-ALPHA(2)-GLYCOPROTEIN; RESISTANCE; LIPOLYSIS; PATHWAYS; WEIGHT	Objective Evidence from mouse models suggests that zinc-alpha 2-glycoprotein (ZAG) is a novel anti-obesity adipokine. In humans, however, data are controversial and its physiological role in adipose tissue (AT) remains unknown. Here we explored the molecular mechanisms by which ZAG regulates carbohydrate metabolism in human adipocytes. Methods ZAG action on glucose uptake and insulin action was analyzed. beta 1 and beta 2-adrenoreceptor (AR) antagonists and siRNA targeting PP2A phosphatase were used to examine the mechanisms by which ZAG modulates insulin sensitivity. Plasma levels of ZAG were measured in a lean patient cohort stratified for HOMA-IR. Results ZAG treatment increased basal glucose uptake, correlating with an increase in GLUT expression, but induced insulin resistance in adipocytes. Pretreatment of adipocytes with propranolol and a specific beta 1-AR antagonist demonstrated that ZAG effects on basal glucose uptake and GLUT4 expression are mediated via beta 1-AR, whereas inhibition of insulin action is dependent on beta 2-AR activation. ZAG treatment correlated with an increase in PP2A activity. Silencing of the PP2A catalytic subunit abrogated the negative effect of ZAG on insulin-stimulated AKT phosphorylation and glucose uptake but not on GLUT4 expression and basal glucose uptake. ZAG circulating levels were unchanged in a lean patient cohort stratified for HOMA-IR. Neither glucose nor insulin was associated with plasma ZAG. Conclusions ZAG inhibits insulin-induced glucose uptake in human adipocytes by impairing insulin signaling at the level of AKT in a beta 2-AR- and PP2A-dependent manner.	[Ceperuelo-Mallafre, Victoria; Ejarque, Miriam; Pachon, Gisela; Roche, Kelly; Nunez-Roa, Catalina; Vendrell, Joan; Fernandez-Veledo, Sonia] Univ Rovira & Virgili, Hosp Univ Tarragona Joan XXIII, Inst Invest Sanitaria Pere Virgili, E-43007 Tarragona, Spain; [Ceperuelo-Mallafre, Victoria; Ejarque, Miriam; Duran, Xavier; Pachon, Gisela; Roche, Kelly; Nunez-Roa, Catalina; Garrido-Sanchez, Lourdes; Tinahones, Francisco J.; Vendrell, Joan; Fernandez-Veledo, Sonia] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Vazquez-Carballo, Ana] Univ Complutense, Dept Biochem & Mol Biol 2, Sch Pharm, Inst Invest Sanitaria,Hosp Clin San Carlos, E-28040 Madrid, Spain; [Garrido-Sanchez, Lourdes; Tinahones, Francisco J.] Hosp Univ Virgen de la Victoria, Inst Invest Biomed Malaga, Malaga, Spain; [Garrido-Sanchez, Lourdes; Tinahones, Francisco J.] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain	Universitat Rovira i Virgili; Hospital Universitari De Tarragona Joan XXIII; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Complutense University of Madrid; Hospital Clinico San Carlos; Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Vendrell, J (corresponding author), Univ Rovira & Virgili, Hosp Univ Tarragona Joan XXIII, Inst Invest Sanitaria Pere Virgili, E-43007 Tarragona, Spain.	jvortega2002@gmail.com; sonia.fernandezveledo@gmail.com	Fernández-Veledo, Sonia/V-4625-2018; Vendrell, Joan j/V-4034-2018; Ejarque, Miriam/H-1503-2015; Tinahones, Francisco José/AAB-2882-2020; Ceperuelo-Mallafré, Victòria/A-4615-2017	Fernández-Veledo, Sonia/0000-0003-2906-3788; Vendrell, Joan j/0000-0002-6994-6115; Ejarque, Miriam/0000-0003-0545-9817; Ceperuelo-Mallafré, Victòria/0000-0002-4460-9761; Tinahones, Francisco J/0000-0001-6871-4403	Spanish Ministry of Economy and Competitiveness [SAF2012-36186, CP10/00438, PI11/0085, PI12/02355]; "Miguel Servet" tenure track program from Fondo de Investigacioin Sanitaria (FIS) - European Regional Development Fund (ERDF) [CP10/00438, CP13/00188]	Spanish Ministry of Economy and Competitiveness(Spanish Government); "Miguel Servet" tenure track program from Fondo de Investigacioin Sanitaria (FIS) - European Regional Development Fund (ERDF)	This study was supported by grants from the Spanish Ministry of Economy and Competitiveness (SAF2012-36186 and CP10/00438 to SF-V, PI11/0085 to JV and PI12/02355 to FJT). CIBER de Diabetes y Enfermedades Metabolicas asociadas (CB07708/0012) is an initiative of the Instituto de Salud Carlos III. SF-V and LG-S acknowledge support from the "Miguel Servet" tenure track program (CP10/00438 and CP13/00188 respectively), from the Fondo de Investigacioin Sanitaria (FIS,) co-financed by the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflaki E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008659; Arch J R, 2001, Rev Endocr Metab Disord, V2, P385, DOI 10.1023/A:1011852500209; Balaz M, 2014, OBESITY, DOI [10.1002/oby.20764, DOI 10.1002/0BY.20764]; Bao Y, 2005, FEBS LETT, V579, P41, DOI 10.1016/j.febslet.2004.11.042; Bing C, 2004, P NATL ACAD SCI USA, V101, P2500, DOI 10.1073/pnas.0308647100; Bing C, 2010, INT J OBESITY, V34, P1559, DOI 10.1038/ijo.2010.105; Blouin CM, 2010, DIABETES, V59, P600, DOI 10.2337/db09-0897; Capel F, 2009, DIABETES, V58, P1558, DOI 10.2337/db09-0033; Ceperuelo-Mallafre V, 2012, HIV MED, V13, P297, DOI 10.1111/j.1468-1293.2011.00976.x; Ceperuelo-Mallafre V, 2009, J CLIN ENDOCR METAB, V94, P5062, DOI 10.1210/jc.2009-0764; Ceperuelo-Mallafre V, 2014, J CLIN ENDOCR METAB, V99, pE908, DOI 10.1210/jc.2013-3350; Chernogubova E, 2004, ENDOCRINOLOGY, V145, P269, DOI 10.1210/en.2003-0857; Deepa SS, 2011, MOL ENDOCRINOL, V25, P1773, DOI 10.1210/me.2011-0082; Fernandez-Veledo S, 2008, J CLIN ENDOCR METAB, V93, P2866, DOI 10.1210/jc.2007-2472; Fernandez-Veledo S, 2009, J CLIN ENDOCR METAB, V94, P3583, DOI 10.1210/jc.2009-0558; Garrido-Sanchez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033264; Ge S, 2014, METABOLISM, V63, P995, DOI 10.1016/j.metabol.2014.04.013; Gong FY, 2009, INT J OBESITY, V33, P1023, DOI 10.1038/ijo.2009.141; Kazantzis Melissa, 2012, Front Endocrinol (Lausanne), V3, P13, DOI 10.3389/fendo.2012.00013; Lansey MN, 2012, AM J PHYSIOL-ENDOC M, V303, pE1273, DOI 10.1152/ajpendo.00316.2012; Mracek T, 2010, J ENDOCRINOL, V204, P165, DOI 10.1677/JOE-09-0299; Mracek T, 2011, BRIT J CANCER, V104, P441, DOI 10.1038/sj.bjc.6606083; Nevzorova J, 2006, BRIT J PHARMACOL, V147, P446, DOI 10.1038/sj.bjp.0706626; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Rolli V, 2007, FEBS LETT, V581, P394, DOI 10.1016/j.febslet.2006.12.047; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Russell ST, 2004, BBA-MOL CELL BIOL L, V1636, P59, DOI 10.1016/j.bbalip.2003.12.004; Russell ST, 2002, BRIT J CANCER, V86, P424, DOI 10.1038/sj.bjc.6600086; Russell ST, 2010, ENDOCRINOLOGY, V151, P4696, DOI 10.1210/en.2010-0532; Russell ST, 2010, ENDOCRINOLOGY, V151, P948, DOI 10.1210/en.2009-0827; Russell ST, 2012, BBA-MOL CELL BIOL L, V1821, P590, DOI 10.1016/j.bbalip.2011.12.003; Ryden M, 2012, J INTERN MED, V271, P414, DOI 10.1111/j.1365-2796.2011.02441.x; Sanders PM, 2004, CANCER LETT, V212, P71, DOI 10.1016/j.canlet.2004.03.021; Selva DM, 2009, J CLIN ENDOCR METAB, V94, P4499, DOI 10.1210/jc.2009-0758; Tedeschi S, 2012, METABOLISM, V61, P37, DOI 10.1016/j.metabol.2011.05.011; Usui I, 2005, MOL ENDOCRINOL, V19, P2760, DOI 10.1210/me.2004-0429; Vazquez-Carballo A, 2013, AM J PHYSIOL-ENDOC M, V305, pE101, DOI 10.1152/ajpendo.00589.2012; Wargent ET, 2013, J ENDOCRINOL, V216, P157, DOI 10.1530/JOE-12-0402; Yang ML, 2013, DIABETES CARE, V36, P1074, DOI 10.2337/dc12-0940; Yeung DCY, 2009, J CLIN ENDOCR METAB, V94, P2531, DOI 10.1210/jc.2009-0058; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	41	13	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129644	10.1371/journal.pone.0129644	http://dx.doi.org/10.1371/journal.pone.0129644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068931	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900066
J	Field, J; Shahijanian, F; Schibeci, S; Johnson, L; Gresle, M; Laverick, L; Parnell, G; Stewart, G; McKay, F; Kilpatrick, T; Butzkueven, H; Booth, D				Field, Judith; Shahijanian, Fernando; Schibeci, Stephen; Johnson, Laura; Gresle, Melissa; Laverick, Louise; Parnell, Grant; Stewart, Graeme; McKay, Fiona; Kilpatrick, Trevor; Butzkueven, Helmut; Booth, David		Australia New Zealand MS Genetics	The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene Function	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; REGULATORY T-CELLS; MESSENGER-RNA; MULTIPLE-SCLEROSIS; GRAVES-DISEASE; PATHWAYS; TISSUE; PROMOTES; ANTIBODY	Human genetic and animal studies have implicated the costimulatory molecule CD40 in the development of multiple sclerosis (MS). We investigated the cell specific gene and protein expression variation controlled by the CD40 genetic variant(s) associated with MS, i.e. the T-allele at rs1883832. Previously we had shown that the risk allele is expressed at a lower level in whole blood, especially in people with MS. Here, we have defined the immune cell subsets responsible for genotype and disease effects on CD40 expression at the mRNA and protein level. In cell subsets in which CD40 is most highly expressed, B lymphocytes and dendritic cells, the MS-associated risk variant is associated with reduced CD40 cell-surface protein expression. In monocytes and dendritic cells, the risk allele additionally reduces the ratio of expression of full-length versus truncated CD40 mRNA, the latter encoding secreted CD40. We additionally show that MS patients, regardless of genotype, express significantly lower levels of CD40 cell-surface protein compared to unaffected controls in B lymphocytes. Thus, both genotype-dependent and independent down-regulation of cell-surface CD40 is a feature of MS. Lower expression of a co-stimulator of T cell activation, CD40, is therefore associated with increased MS risk despite the same CD40 variant being associated with reduced risk of other inflammatory autoimmune diseases. Our results highlight the complexity and likely individuality of autoimmune pathogenesis, and could be consistent with antiviral and/or immunoregulatory functions of CD40 playing an important role in protection from MS.	[Field, Judith; Johnson, Laura; Kilpatrick, Trevor] Univ Melbourne, Multiple Sclerosis Div, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Shahijanian, Fernando; Schibeci, Stephen; Parnell, Grant; Stewart, Graeme; McKay, Fiona; Booth, David] Univ Sydney, Westmead Millennium Inst, Ctr Immunol & Allergy Res, Sydney, NSW 2006, Australia; [Gresle, Melissa; Laverick, Louise; Kilpatrick, Trevor; Butzkueven, Helmut] Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Parkville, Vic, Australia; [Gresle, Melissa; Laverick, Louise; Butzkueven, Helmut] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Kilpatrick, Trevor] Univ Melbourne, Melbourne Neurosci Inst, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Sydney; Westmead Institute for Medical Research; Royal Melbourne Hospital; University of Melbourne; University of Melbourne; University of Melbourne	Field, J (corresponding author), Univ Melbourne, Multiple Sclerosis Div, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia.	judith.field@florey.edu.au	Baxter, Alan G/A-1412-2010; Charlesworth, Jac/J-7661-2014; Brown, Matthew A/E-5749-2010; Kermode, Allan/G-3568-2019; Parnell, Grant/AAB-8155-2021; Scott, Rodney/B-2827-2013; Slee, Mark/J-4731-2015	Baxter, Alan G/0000-0002-6960-9821; Charlesworth, Jac/0000-0001-6201-3518; Brown, Matthew A/0000-0003-0538-8211; Kermode, Allan/0000-0002-4476-4016; Griffiths, Lyn/0000-0002-6774-5475; Kilpatrick, Trevor/0000-0003-3999-085X; Lechner-Scott, Jeannette/0000-0002-3850-447X; Booth, David/0000-0001-8580-2384; McKay, Fiona Catherine/0000-0002-9610-0668; Butzkueven, Helmut/0000-0003-3940-8727; Moscato, Pablo/0000-0003-2570-5966; Parnell, Grant/0000-0002-2898-0253; Scott, Rodney/0000-0001-7724-3404; Vucic, Steve/0000-0002-8323-873X; Wiley, James/0000-0001-9421-4154; Slee, Mark/0000-0003-4323-2453	National Health and Medical Research Council of Australia (NHMRC) [633275, 1065157]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC) (grant numbers 633275 and 1065157).	Adorini L, 2003, J CELL BIOCHEM, V88, P227, DOI 10.1002/jcb.10340; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Barbe-Tuana FM, 2006, DIABETES, V55, P2437, DOI 10.2337/db05-1673; Becher B, 2001, J EXP MED, V193, P967, DOI 10.1084/jem.193.8.967; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Blanco-Kelly F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011520; Boon L, 2001, J IMMUNOL, V167, P2942, DOI 10.4049/jimmunol.167.5.2942; Buck D, 2006, TISSUE ANTIGENS, V68, P335, DOI 10.1111/j.1399-0039.2006.00672.x; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; GALY AHM, 1992, J IMMUNOL, V149, P775; Gandhi KS, 2010, HUM MOL GENET, V19, P2134, DOI 10.1093/hmg/ddq090; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; Graham JP, 2010, IMMUNOL REV, V237, P226, DOI 10.1111/j.1600-065X.2010.00932.x; Griffin MD, 2001, P NATL ACAD SCI USA, V98, P6800, DOI 10.1073/pnas.121172198; Hoe E, 2010, J IMMUNOL, V184, P2512, DOI 10.4049/jimmunol.0902900; Huang WX, 2000, MULT SCLER, V6, P61, DOI 10.1177/135245850000600201; Huber AK, 2012, J IMMUNOL, V189, P3043, DOI 10.4049/jimmunol.1200311; Jacobson EM, 2007, GENES IMMUN, V8, P205, DOI 10.1038/sj.gene.6364375; Jacobson EM, 2005, ENDOCRINOLOGY, V146, P2684, DOI 10.1210/en.2004-1617; Kim DY, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-25; Li G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003487; Li M, 2012, ENDOCR J, V59, P1041, DOI 10.1507/endocrj.EJ12-0126; Lundstrom W, 2013, P NATL ACAD SCI USA, V110, pE1761, DOI 10.1073/pnas.1222303110; Orozco G, 2010, ANN RHEUM DIS, V69, P813, DOI 10.1136/ard.2009.109579; Parnell G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023162; Parnell GP, 2014, MULT SCLER J, V20, P675, DOI 10.1177/1352458513507819; Pender MP, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/189096; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Reichardt P, 2007, BLOOD, V110, P1519, DOI 10.1182/blood-2006-10-053793; Rubicz R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003147; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shahijanian F, 2014, HUM MOL GENET, V23, P1425, DOI 10.1093/hmg/ddt529; Smith TJ, 1999, THYROID, V9, P749, DOI 10.1089/thy.1999.9.749; Sokolova EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061032; van der Linden MPM, 2009, ARTHRITIS RHEUM, V60, P2242, DOI 10.1002/art.24721; Vazgiourakis VM, 2011, ANN RHEUM DIS, V70, P2184, DOI 10.1136/ard.2010.146530; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001; Yang J, 2012, ENDOCRINE, V41, P111, DOI 10.1007/s12020-011-9510-1	43	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0127080	10.1371/journal.pone.0127080	http://dx.doi.org/10.1371/journal.pone.0127080			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068105	Green Published, Green Accepted, gold			2022-12-27	WOS:000356100900011
J	Ram, PK; DiVita, MA; Khatun-e-Jannat, K; Islam, M; Krytus, K; Cercone, E; Sohel, BM; Ahmed, M; Rahman, AMQ; Rahman, M; Yu, J; Brooks, WA; Azziz-Baumgartner, E; Fry, AM; Luby, SP				Ram, Pavani K.; DiVita, Margaret A.; Khatun-e-Jannat, Kaniz; Islam, Manoshi; Krytus, Kimberly; Cercone, Emily; Sohel, Badrul Munir; Ahmed, Makhdum; Rahman, Abid Mahmud Quaiyum; Rahman, Mustafizur; Yu, Jihnhee; Brooks, W. Abdullah; Azziz-Baumgartner, Eduardo; Fry, Alicia M.; Luby, Stephen P.			Impact of Intensive Handwashing Promotion on Secondary Household Influenza-Like Illness in Rural Bangladesh: Findings from a Randomized Controlled Trial	PLOS ONE			English	Article							NONPHARMACEUTICAL INTERVENTIONS; PANDEMIC INFLUENZA; SEASONAL INFLUENZA; HEALTHY-CHILDREN; GLOBAL BURDEN; HAND HYGIENE; TRANSMISSION; URBAN	Rationale There is little evidence for the efficacy of handwashing for prevention of influenza transmission in resource-poor settings. We tested the impact of intensive handwashing promotion on household transmission of influenza-like illness and influenza in rural Bangladesh. Methods In 2009-10, we identified index case-patients with influenza-like illness (fever with cough or sore throat) who were the only symptomatic person in their household. Household compounds of index case-patients were randomized to control or intervention (soap and daily handwashing promotion). We conducted daily surveillance and collected oropharyngeal specimens. Secondary attack ratios (SAR) were calculated for influenza and ILI in each arm. Among controls, we investigated individual risk factors for ILI among household contacts of index case-patients. Results Among 377 index case-patients, the mean number of days between fever onset and study enrollment was 2.1 (SD 1.7) among the 184 controls and 2.6 (SD 2.9) among 193 intervention case-patients. Influenza infection was confirmed in 20% of controls and 12% of intervention index case-patients. The SAR for influenza-like illness among household contacts was 9.5% among intervention (158/1661) and 7.7% among control households (115/1498) SAR ratio 1.24, 95% CI 0.92-1.65). The SAR ratio for influenza was 2.40 (95% CI 0.68-8.47). In the control arm, susceptible contacts < 2 years old (RRadj 5.51, 95% CI 3.43-8.85), those living with an index case-patient enrolled <= 24 hours after symptom onset (RRadj 1.91, 95% CI 1.18-3.10), and those who reported multiple daily interactions with the index case-patient (RRadj 1.94, 95% CI 1.71-3.26) were at increased risk of influenza-like illness. Discussion Handwashing promotion initiated after illness onset in a household member did not protect against influenza-like illness or influenza. Behavior may not have changed rapidly enough to curb transmission between household members. A reactive approach to reduce household influenza transmission through handwashing promotion may be ineffective in the context of rural Bangladesh.	[Ram, Pavani K.; DiVita, Margaret A.; Krytus, Kimberly; Cercone, Emily] SUNY Buffalo, Dept Epidemiol & Environm Hlth, Buffalo, NY 14260 USA; [Khatun-e-Jannat, Kaniz; Islam, Manoshi; Sohel, Badrul Munir; Ahmed, Makhdum; Rahman, Abid Mahmud Quaiyum; Rahman, Mustafizur; Brooks, W. Abdullah; Azziz-Baumgartner, Eduardo; Luby, Stephen P.] Int Ctr Diarrhoeal Dis Res, Ctr Communicable Dis, Dhaka 1000, Bangladesh; [Yu, Jihnhee] SUNY Buffalo, Dept Biostat, Buffalo, NY 14260 USA; [Fry, Alicia M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; International Centre for Diarrhoeal Disease Research (ICDDR); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Centers for Disease Control & Prevention - USA	Ram, PK (corresponding author), SUNY Buffalo, Dept Epidemiol & Environm Hlth, Buffalo, NY 14260 USA.	pkram@buffalo.edu	Ahmed, Makhdum/D-2615-2012; Brooks, W. Abdullah/AAD-3876-2021	Ahmed, Makhdum/0000-0002-0772-8710; Brooks, W. Abdullah/0000-0001-9871-5546; DiVita, Margaret/0000-0002-4878-2959; Luby, Stephen/0000-0001-5385-899X	US Centers for Disease Control and Prevention through a cooperative agreement with ICDDR, B [3U01CI000628]; National Center for Preparedness, Detection, and Control of Infectious Diseases [U01CI000628] Funding Source: NIH RePORTER	US Centers for Disease Control and Prevention through a cooperative agreement with ICDDR, B; National Center for Preparedness, Detection, and Control of Infectious Diseases(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for this project was provided by the US Centers for Disease Control and Prevention through a cooperative agreement with ICDDR, B (Grant number 3U01CI000628). CDC staff were collaborators on this project. Colleagues from the funder, the US Centers for Disease Control and Prevention (EAB, AMF, SPL), were involved in study design, oversight of data collection, interpretation of data, and reviews of manuscript drafts.	Aiello AE, 2010, J INFECT DIS, V201, P491, DOI 10.1086/650396; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Bell D, 2006, EMERG INFECT DIS, V12, P81; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; CDC, 2009, CDC PROT REALT RTPCR; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Cowling BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002101; Glanz K., 2008, HLTH BEHAV HLTH ED T; Gurley E. S., 2012, ENV RES; Kerry SM, 1998, BRIT MED J, V316, P549, DOI 10.1136/bmj.316.7130.549; Larson EL, 2010, PUBLIC HEALTH REP, V125, P178, DOI 10.1177/003335491012500206; Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7; Luby SP, 2004, JAMA-J AM MED ASSOC, V291, P2547, DOI 10.1001/jama.291.21.2547; Luby SP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001052; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray EL, 2011, INDOOR AIR; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nasreen S, 2010, TROP MED INT HEALTH, V15, P762, DOI 10.1111/j.1365-3156.2010.02531.x; *NAT I POP RES TRA, 2005, BANGL DEM HLTH SURV; Principi N, 2004, ARCH DIS CHILD, V89, P1002, DOI 10.1136/adc.2003.045401; Ram PK, 2014, AM J TROP MED HYG, V90, P968, DOI 10.4269/ajtmh.13-0532; Ram PK, 2010, AM J TROP MED HYG, V83, P1070, DOI 10.4269/ajtmh.2010.09-0763; Simmerman JM, 2011, INFLUENZA OTHER RESP, V5, P256, DOI 10.1111/j.1750-2659.2011.00205.x; Talaat M, 2011, EMERG INFECT DIS, V17, P619, DOI 10.3201/eid1704.101353; Tsolia MN, 2006, VACCINE, V24, P5970, DOI 10.1016/j.vaccine.2006.05.006; Zaman RU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008452	26	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0125200	10.1371/journal.pone.0125200	http://dx.doi.org/10.1371/journal.pone.0125200			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066651	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900004
J	Tommasino, F; Friedrich, T; Jakob, B; Meyer, B; Durante, M; Scholz, M				Tommasino, Francesco; Friedrich, Thomas; Jakob, Burkhard; Meyer, Barbara; Durante, Marco; Scholz, Michael			Induction and Processing of the Radiation-Induced Gamma-H2AX Signal and Its Link to the Underlying Pattern of DSB: A Combined Experimental and Modelling Study	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; PHOSPHORYLATED HISTONE H2AX; STRUCTURE-DEPENDENT REPAIR; DNA-DAMAGE; IONIZING-RADIATION; DOSE-DISTRIBUTION; X-RAYS; CELL-SURVIVAL; HIGH-LET; CHROMATIN	We present here an analysis of DSB induction and processing after irradiation with X-rays in an extended dose range based on the use of the gamma H2AX assay. The study was performed by quantitative flow cytometry measurements, since the use of foci counting would result in reasonable accuracy only in a limited dose range of a few Gy. The experimental data are complemented by a theoretical analysis based on the GLOBLE model. In fact, original aim of the study was to test GLOBLE predictions against new experimental data, in order to contribute to the validation of the model. Specifically, the gamma H2AX signal kinetics has been investigated up to 24 h after exposure to increasing photon doses between 2 and 500 Gy. The prolonged persistence of the signal at high doses strongly suggests dose dependence in DSB processing after low LET irradiation. Importantly, in the framework of our modelling analysis, this is related to a gradually increased fraction of DSB clustering at the micrometre scale. The parallel study of gamma H2AX dose response curves shows the onset of a pronounced saturation in two cell lines at a dose of about 20 Gy. This dose is much lower than expected according to model predictions based on the values usually adopted for the DSB induction yield (approximate to 30 DSB/Gy) and for the gamma H2AX foci extension of approximately 2 Mbp around the DSB. We show and discuss how theoretical predictions and experimental findings can be in principle reconciled by combining an increased DSB induction yield with the assumption of a larger genomic extension for the single phosphorylated regions. As an alternative approach, we also considered in our model the possibility of a 3D spreading-mechanism of the H2AX phosphorylation around the induced DSB, and applied it to the analysis of both the aspects considered. Our results are found to be supportive for the basic assumptions on which GLOBLE is built. Apart from giving new insights into the H2AX phosphorylation process, experiments performed at high doses are of relevance in the context of radiation therapy, where hypo-fractionated schemes become increasingly popular.	[Tommasino, Francesco; Friedrich, Thomas; Jakob, Burkhard; Meyer, Barbara; Durante, Marco; Scholz, Michael] GSI Helmholtzzentrum Schwerionenforsch, Dept Biophys, Darmstadt, Germany; [Meyer, Barbara] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA; [Durante, Marco] Tech Univ Darmstadt, Inst Festkorperphys, Darmstadt, Germany	Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Washington University (WUSTL); Technical University of Darmstadt	Tommasino, F (corresponding author), GSI Helmholtzzentrum Schwerionenforsch, Dept Biophys, Darmstadt, Germany.	f.tommasino@gsi.de	Friedrich, Thomas/K-6748-2013; Durante, Marco/L-4795-2017; Jakob, Burkhard/D-2047-2013	Friedrich, Thomas/0000-0003-0074-6390; Durante, Marco/0000-0002-4615-553X; Jakob, Burkhard/0000-0003-2404-377X; Scholz, Michael/0000-0002-6382-6737; Tommasino, Francesco/0000-0002-8684-9261	DFG [GRK 1657]; GSI	DFG(German Research Foundation (DFG)); GSI	This work was supported by a DFG-funded Graduiertenkolleg (GRK 1657) and by GSI. The work is part of HGS-HIRe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banath JP, 2004, CANCER RES, V64, P7144, DOI 10.1158/0008-5472.CAN-04-1433; Barnard S, 2014, RAD PROT DOSIMETRY; Belli M, 2002, INT J RADIAT BIOL, V78, P475, DOI 10.1080/09553000210123676; Belov OV, 2014, J THEOR BIOL; Bijlani A, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00077; BLOCHER D, 1982, INT J RADIAT BIOL, V42, P329, DOI 10.1080/09553008214551241; Botchway SW, 1997, RADIAT RES, V148, P317, DOI 10.2307/3579516; Chappell LJ, 2010, RADIAT RES, V174, P691, DOI 10.1667/RR2204.1; Costes SV, 2010, MUTAT RES-REV MUTAT, V704, P78, DOI 10.1016/j.mrrev.2009.12.006; Costes SV, 2006, RADIAT RES, V165, P505, DOI 10.1667/RR3538.1; Cucinotta FA, 2000, INT J RADIAT BIOL, V76, P1463, DOI 10.1080/09553000050176225; Cucinotta FA, 2008, RADIAT RES, V169, P214, DOI 10.1667/RR1035.1; DahmDaphi J, 1996, INT J RADIAT BIOL, V69, P615, DOI 10.1080/095530096145625; Elsasser T, 2010, INT J RADIAT ONCOL, V78, P1177, DOI 10.1016/j.ijrobp.2010.05.014; Friedland W, 2006, RADIAT PROT DOSIM, V122, P116, DOI 10.1093/rpd/ncl451; Friedrich T, 2012, RADIAT RES, V178, P385, DOI 10.1667/RR2964.1; Friedrich T, 2012, INT J RADIAT BIOL, V88, P103, DOI 10.3109/09553002.2011.611213; Gauter B, 2002, RADIAT RES, V157, P721, DOI 10.1667/0033-7587(2002)157[0721:RORIDD]2.0.CO;2; Georgakilas AG, 2013, RADIAT RES, V180, P100, DOI 10.1667/RR3041.1; Goodarzi AA, 2010, DNA REPAIR, V9, P1273, DOI 10.1016/j.dnarep.2010.09.013; Grun R, 2012, PHYS MED BIOL, V57, P7261, DOI 10.1088/0031-9155/57/22/7261; Grun R, 2013, MED PHYS, V40, DOI 10.1118/1.4824321; Hill MA, 2004, RADIAT PROT DOSIM, V112, P471, DOI 10.1093/rpd/nch091; Horn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025113; Hufnagl A, 2015, DNA REPAIR, V27, P28, DOI 10.1016/j.dnarep.2015.01.002; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jakob B, 2003, RADIAT RES, V159, P676, DOI 10.1667/0033-7587(2003)159[0676:BIOHCT]2.0.CO;2; Jakob B, 2009, RADIAT RES, V171, P405, DOI 10.1667/RR1520.1; Johnston PJ, 1998, RADIAT RES, V149, P533, DOI 10.2307/3579899; JOHNSTON PJ, 1994, INT J RADIAT BIOL, V66, P531, DOI 10.1080/09553009414551571; Johnston PJ, 1998, RADIAT RES, V149, P455, DOI 10.2307/3579785; Kataoka Y, 2006, J RADIAT RES, V47, P245, DOI 10.1269/jrr.0628; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Lobrich M, 1995, P NATL ACAD SCI USA, V92, P12050, DOI 10.1073/pnas.92.26.12050; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; MacPhail SH, 2003, RADIAT RES, V159, P759, DOI 10.1667/RR3003; Mirzayans R, 2006, INT J RADIAT ONCOL, V66, P1498, DOI 10.1016/j.ijrobp.2006.08.064; Munoz DP, 2013, NUCLEIC ACIDS RES, V41, P2894, DOI 10.1093/nar/gks1478; Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108; Nikjoo H, 2001, RADIAT RES, V156, P577, DOI 10.1667/0033-7587(2001)156[0577:CAFDTS]2.0.CO;2; Olive PL, 2004, CANCER RES, V64, P5363, DOI 10.1158/0008-5472.CAN-04-0729; OTTOLENGHI A, 1995, RADIAT ENVIRON BIOPH, V34, P239, DOI 10.1007/BF01209749; Ponomarev AL, 2008, INT J RADIAT BIOL, V84, P916, DOI 10.1080/09553000802499212; Prise KM, 2001, RADIAT RES, V156, P572, DOI 10.1667/0033-7587(2001)156[0572:AROSOI]2.0.CO;2; Radulescu I, 2004, RADIAT RES, V161, P1, DOI 10.1667/RR3094; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rothkamm K, 2009, ANN I SUPER SANITA, V45, P265; Sak A, 2007, INT J RADIAT BIOL, V83, P639, DOI 10.1080/09553000701596118; Savic Velibor, 2013, Frontiers in Genetics, V4, P139, DOI 10.3389/fgene.2013.00139; Schipler A, 2013, NUCLEIC ACIDS RES, V41, P7589, DOI 10.1093/nar/gkt556; Schmid TE, 2012, FRONT ONCOL, V2, P15, DOI 10.3389/fonc.2012.00080; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Singh SK, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-77; Singh SK, 2011, NUCLEIC ACIDS RES, V39, P8416, DOI 10.1093/nar/gkr463; Solovjeva L, 1998, CHROMOSOME RES, V6, P595, DOI 10.1023/A:1009293108736; Splinter J, 2010, MUTAGENESIS, V25, P289, DOI 10.1093/mutage/geq005; Stenerlow B, 2003, RADIAT RES, V159, P502, DOI 10.1667/0033-7587(2003)159[0502:MOPDDS]2.0.CO;2; Sutherland BM, 2000, P NATL ACAD SCI USA, V97, P103, DOI 10.1073/pnas.97.1.103; Tommasino F, 2013, RADIAT RES, V180, P524, DOI 10.1667/RR13389.1; Tommasino F, 2014, RAD PROT DOSIM UNPUB; Vadhavkar N, 2014, RADIAT RES, V182, P273, DOI 10.1667/RR13792.1; Wada S, 2005, J VET MED SCI, V67, P1089, DOI 10.1292/jvms.67.1089; WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401; Whalen MK, 2008, RADIAT RES, V170, P353, DOI 10.1667/RR1354.1; YOKOTA H, 1995, J CELL BIOL, V130, P1239, DOI 10.1083/jcb.130.6.1239; Zwicker F, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-62	68	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129416	10.1371/journal.pone.0129416	http://dx.doi.org/10.1371/journal.pone.0129416			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067661	Green Submitted, gold, Green Published			2022-12-27	WOS:000356100900054
J	Towers, S; Afzal, S; Bernal, G; Bliss, N; Brown, S; Espinoza, B; Jackson, J; Judson-Garcia, J; Khan, M; Lin, M; Mamada, R; Moreno, VM; Nazari, F; Okuneye, K; Ross, ML; Rodriguez, C; Medlock, J; Ebert, D; Castillo-Chavez, C				Towers, Sherry; Afzal, Shehzad; Bernal, Gilbert; Bliss, Nadya; Brown, Shala; Espinoza, Baltazar; Jackson, Jasmine; Judson-Garcia, Julia; Khan, Maryam; Lin, Michael; Mamada, Robert; Moreno, Victor M.; Nazari, Fereshteh; Okuneye, Kamaldeen; Ross, Mary L.; Rodriguez, Claudia; Medlock, Jan; Ebert, David; Castillo-Chavez, Carlos			Mass Media and the Contagion of Fear: The Case of Ebola in America	PLOS ONE			English	Article							WEB	Background In the weeks following the first imported case of Ebola in the U.S. on September 29, 2014, coverage of the very limited outbreak dominated the news media, in a manner quite disproportionate to the actual threat to national public health; by the end of October, 2014, there were only four laboratory confirmed cases of Ebola in the entire nation. Public interest in these events was high, as reflected in the millions of Ebola-related Internet searches and tweets performed in the month following the first confirmed case. Use of trending Internet searches and tweets has been proposed in the past for real-time prediction of outbreaks (a field referred to as "digital epidemiology"), but accounting for the biases of public panic has been problematic. In the case of the limited U.S. Ebola outbreak, we know that the Ebola-related searches and tweets originating the U.S. during the outbreak were due only to public interest or panic, providing an unprecedented means to determine how these dynamics affect such data, and how news media may be driving these trends. Methodology We examine daily Ebola-related Internet search and Twitter data in the U.S. during the six week period ending Oct 31, 2014. TV news coverage data were obtained from the daily number of Ebola-related news videos appearing on two major news networks. We fit the parameters of a mathematical contagion model to the data to determine if the news coverage was a significant factor in the temporal patterns in Ebola-related Internet and Twitter data. Conclusions We find significant evidence of contagion, with each Ebola-related news video inspiring tens of thousands of Ebola-related tweets and Internet searches. Between 65% to 76% of the variance in all samples is described by the news media contagion model.	[Towers, Sherry; Bernal, Gilbert; Bliss, Nadya; Brown, Shala; Espinoza, Baltazar; Jackson, Jasmine; Judson-Garcia, Julia; Khan, Maryam; Lin, Michael; Mamada, Robert; Moreno, Victor M.; Nazari, Fereshteh; Okuneye, Kamaldeen; Ross, Mary L.; Rodriguez, Claudia; Castillo-Chavez, Carlos] Arizona State Univ, Tempe, AZ 85281 USA; [Afzal, Shehzad; Ebert, David] Purdue Univ, W Lafayette, IN 47907 USA; [Medlock, Jan] Oregon State Univ, Corvallis, OR 97331 USA	Arizona State University; Arizona State University-Tempe; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Oregon State University	Towers, S (corresponding author), Arizona State Univ, Tempe, AZ 85281 USA.	smtowers@asu.edu	Afzal, Shehzad/AAI-5276-2021; Castillo-Chavez, Carlos/E-1412-2014	Castillo-Chavez, Carlos/0000-0002-1046-3901; Espinoza, Baltazar/0000-0002-6280-3277; Afzal, Shehzad/0000-0002-9712-3618; Ebert, David/0000-0001-6177-1296	Western Alliance to Expand Student Opportunities (WAESO) Louis Stokes Alliance for Minority Participation (LSAMP) Bridge [HRD-1401190]; Offices of the President and Provost of Arizona State University; U.S. Department of Homeland Security (DHS) VACCINE Center award [2009-ST-061-CI0001-06]; National Institute of General Medical Sciences (NIGMS) at the National Institutes of Health [1R01GM100471-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100471] Funding Source: NIH RePORTER	Western Alliance to Expand Student Opportunities (WAESO) Louis Stokes Alliance for Minority Participation (LSAMP) Bridge; Offices of the President and Provost of Arizona State University; U.S. Department of Homeland Security (DHS) VACCINE Center award(United States Department of Homeland Security (DHS)); National Institute of General Medical Sciences (NIGMS) at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The parameter optimization portion of the analysis was made possible with education allocation #DMS140043 of super-computing resources from National Science Foundation Extreme Science and Engineering Discovery Environment (XSEDE) high-performance computing initiative (ST GB NB SB BE JJ JJG MK ML RM VMM FN KO MLR CR CCC). This research was also partially supported by the Western Alliance to Expand Student Opportunities (WAESO) Louis Stokes Alliance for Minority Participation (LSAMP) Bridge to the Doctorate (BD) National Science Foundation (NSF) "Multidisciplinary STEM Solutions LSAMP Bridge to the Doctorate" grant #HRD-1401190 (GB SB JJ JJG MLR CR), and the Offices of the President and Provost of Arizona State University. This work was funded in part by the U.S. Department of Homeland Security (DHS) VACCINE Center award #2009-ST-061-CI0001-06 (SA DE), and was also made possible by grant #1R01GM100471-01 from the National Institute of General Medical Sciences (NIGMS) at the National Institutes of Health (CCC). The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592; Bettencourt LMA, 2006, PHYSICA A, V364, P513, DOI 10.1016/j.physa.2005.08.083; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Cha M, 2012, IEEE T SYST MAN CY A, V42, P991, DOI 10.1109/TSMCA.2012.2183359; Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Cowan G, 1998, STAT DATA ANAL; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157; Gallup, 2013, TV IS AM MAIN SOURC; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hay SI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001413; McCullagh P, 1989, GEN LINEAR MODELS; Metaxas P., 2011, 2011 IEEE 3 INT C PR, P165, DOI [10.1109/PASSAT/SocialCom.2011.98, DOI 10.1109/PASSAT/SOCIALCOM.2011.98]; MOSEGAARD K, 1995, J GEOPHYS RES-SOL EA, V100, P12431, DOI 10.1029/94JB03097; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Pew Research Center, 2014, KEY IND MED NEWS; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Salathe M, 2013, EPJ DATA SCI, V2, DOI 10.1140/epjds16; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Schmidt CW, 2012, ENVIRON HEALTH PERSP, V120, pA30, DOI 10.1289/ehp.120-a30; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Tausczik Y, 2012, HEALTH COMMUN, V27, P179, DOI 10.1080/10410236.2011.571759; Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]; Zhou XC, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2132132	33	155	158	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129179	10.1371/journal.pone.0129179	http://dx.doi.org/10.1371/journal.pone.0129179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067433	Green Published, gold			2022-12-27	WOS:000356100900044
J	Zhu, Q; Zhu, P; Zhang, YL; Li, J; Ma, XJ; Li, N; Wang, Q; Xue, XJ; Luo, L; Li, ZZ; Ring, HJZ; Ring, BZ; Su, L				Zhu, Qian; Zhu, Peng; Zhang, Yilei; Li, Jie; Ma, Xuejun; Li, Ning; Wang, Qi; Xue, Xiujuan; Luo, Le; Li, Zizhao; Ring, Huijun Z.; Ring, Brian Z.; Su, Li			Analysis of Social and Genetic Factors Influencing Heterosexual Transmission of HIV within Serodiscordant Couples in the Henan Cohort	PLOS ONE			English	Article							EDUCATIONAL-ATTAINMENT; ANTIRETROVIRAL THERAPY; VIRAL LOAD; INFECTION; CCR5; ASSOCIATIONS; RESTRICTION; HAPLOTYPES; VARIANTS; PLASMA	There is considerable variability between individuals in susceptibility to infection by human immunodeficiency virus (HIV). Many social, clinical and genetic factors are known to contribute to the likelihood of HIV transmission, but there is little consensus on the relative importance and potential interaction of these factors. Additionally, recent studies of several variants in chemokine receptors have identified alleles that may be predictive of HIV transmission and disease progression; however the strengths and directions of the associations of these genetic markers with HIV transmission have markedly varied between studies. To better identify factors that predict HIV transmission in a Chinese population, 180 cohabiting serodiscordant couples were enrolled for study by the Henan Center for Disease Prevention and Control, and transmission and progression of HIV infection were regularly measured. We found that anti-retroviral therapy, education level, and condom use were the most significant factors in determining likelihood of HIV transmission in this study. We also assessed ten variants in three genes (CXCL12, CCR2, and CCR5) that have been shown to influence HIV transmission. We found two tightly linked variants in CCR2 and CCR5, rs1799864 and rs1800024, have a significant positive association with transmission as recessive models (OR>10, P value=0.011). Mixed effects models showed that these genetic variants both retained significance when assessed with either treatment or condom use. These markers of transmission susceptibility may therefore serve to help stratify individuals by risk for HIV transmission.	[Zhu, Qian; Li, Jie; Li, Ning; Wang, Qi; Xue, Xiujuan] Henan Ctr Dis Prevent & Control, Inst AIDS STD Prevent & Control, Zhengzhou, Peoples R China; [Zhu, Peng; Zhang, Yilei; Su, Li] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China; [Ma, Xuejun; Luo, Le] Chinese Ctr Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Li, Zizhao] Hlth Dept Henan Prov, Zhengzhou, Peoples R China; [Ring, Huijun Z.; Ring, Brian Z.] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Inst Genom & Personalized Med, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Huazhong University of Science & Technology	Ring, BZ (corresponding author), Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Inst Genom & Personalized Med, Wuhan 430074, Peoples R China.	bzring@mail.hust.edu.cn; lisu@mail.hust.edu.cn	Zhang, Yilei/I-8997-2014	Zhang, Yilei/0000-0003-1407-0301	China Mega-Project for Infectious Diseases [2009ZX10017-016, 2011ZX10004-001, 2012ZX10004-215]	China Mega-Project for Infectious Diseases	This study was supported by grants from the China Mega-Project for Infectious Diseases (2009ZX10017-016, 2011ZX10004-001 and 2012ZX10004-215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth M, 1998, WHO IS MOST LIKELY D; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; An P, 2010, TRENDS GENET, V26, P119, DOI 10.1016/j.tig.2010.01.002; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burkett K, 2006, J STAT SOFTW, V16, P1; de Walque D, 2007, J DEV ECON, V84, P686, DOI 10.1016/j.jdeveco.2006.12.003; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; Dou ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013737; Downs AM, 1996, J ACQ IMMUN DEF SYND, V11, P388, DOI 10.1097/00042560-199604010-00010; Doyle AM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000287; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P489, DOI 10.1046/j.1365-3156.2002.00889.x; Hothorn T, 2008, J STAT SOFTW, V28, P1; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Jia ZW, 2013, LANCET, V382, P1195, DOI 10.1016/S0140-6736(12)61898-4; Jin QW, 2008, J GEN VIROL, V89, P2611, DOI 10.1099/vir.0.2008/003624-0; Lee TH, 1996, J ACQ IMMUN DEF SYND, V12, P427, DOI 10.1097/00042560-199608010-00015; Lu JP, 2012, GENET TEST MOL BIOMA, V16, P1369, DOI 10.1089/gtmb.2012.0235; Malhotra R, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-22; Martinson JJ, 2000, AIDS, V14, P483, DOI 10.1097/00002030-200003310-00003; Ministry of Health of the People's Republic of China, 2012, 2012 CHIN AIDS RESP; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Ross DA, 2007, AIDS, V21, P1943, DOI 10.1097/QAD.0b013e3282ed3cf5; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Vandemoortele J, 2000, CURRENT ISSUES COMP, V3, P6; Wang FS, 2003, JAIDS-J ACQ IMM DEF, V32, P124, DOI 10.1097/00126334-200302010-00002; Wilen CB, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006866; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Zapata W, 2013, AIDS RES HUM RETROV, V29, P1594, DOI [10.1089/aid.2012.0299, 10.1089/AID.2012.0299]; Zhu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055197; Zhu TF, 2005, CELL RES, V15, P833, DOI 10.1038/sj.cr.7290355	36	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129979	10.1371/journal.pone.0129979	http://dx.doi.org/10.1371/journal.pone.0129979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068906	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900089
J	Adamo, HH; Bergstrom, SH; Bergh, A				Adamo, Hanibal Hani; Bergstrom, Sofia Halin; Bergh, Anders			Characterization of a Gene Expression Signature in Normal Rat Prostate Tissue Induced by the Presence of a Tumor Elsewhere in the Organ	PLOS ONE			English	Article							LYSYL OXIDASE; PROGNOSTIC-SIGNIFICANCE; BENIGN PROSTATE; CANCER; GROWTH; PERIOSTIN; PROGRESSION; RECEPTOR; STROMA; CELLS	Implantation of rat prostate cancer cells into the normal rat prostate results in tumor-stimulating changes in the tumor-bearing organ, for example growth of the vasculature, an altered extracellular matrix, and influx of inflammatory cells. To investigate this response further, we compared prostate morphology and the gene expression profile of tumor-bearing normal rat prostate tissue (termed tumor-instructed/indicating normal tissue (TINT)) with that of prostate tissue from controls. Dunning rat AT-1 prostate cancer cells were injected into rat prostate and tumors were established after 10 days. As controls we used intact animals, animals injected with heat-killed AT-1 cells or cell culture medium. None of the controls showed morphological TINT-changes. A rat Illumina whole-genome expression array was used to analyze gene expression in AT-1 tumors, TINT, and in medium injected prostate tissue. We identified 423 upregulated genes and 38 downregulated genes (p<0.05, >= 2-fold change) in TINT relative to controls. Quantitative RT-PCR analysis verified key TINT-changes, and they were not detected in controls. Expression of some genes was changed in a manner similar to that in the tumor, whereas other changes were exclusive to TINT. Ontological analysis using GeneGo software showed that the TINT gene expression profile was coupled to processes such as inflammation, immune response, and wounding. Many of the genes whose expression is altered in TINT have well-established roles in tumor biology, and the present findings indicate that they may also function by adapting the surrounding tumor-bearing organ to the needs of the tumor. Even though a minor tumor cell contamination in TINT samples cannot be ruled out, our data suggest that there are tumor-induced changes in gene expression in the normal tumor-bearing organ which can probably not be explained by tumor cell contamination. It is important to validate these changes further, as they could hypothetically serve as novel diagnostic and prognostic markers of prostate cancer.	[Adamo, Hanibal Hani; Bergstrom, Sofia Halin; Bergh, Anders] Umea Univ, Dept Med Biosci, Pathol, Umea, Sweden	Umea University	Adamo, HH (corresponding author), Umea Univ, Dept Med Biosci, Pathol, Umea, Sweden.	hani.adamo@medbio.umu.se		Halin Bergstrom, Sofia/0000-0003-3475-3230	Swedish Research Council [Co257301]; Swedish Cancer Foundation [130293]; Lion's Cancer Research Foundation in Umea [101857]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Lion's Cancer Research Foundation in Umea	This work was supported by grants from the Swedish Research Council(AB) [Grant numbers: Co257301 (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html]), the Swedish Cancer Foundation(AB) [Grant numbers: 130293 (http://www.cancerfonden.se/sv/Information-inEnglish/)], and the Lion's Cancer Research Foundation in Umea (HA) [Grant numbers: LP 101857 (http://www.cancerforskningsfond-umea.lions.se)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JN, 2014, CANCER IMMUNOL RES, V2, P121, DOI 10.1158/2326-6066.CIR-13-0150; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Chandran UR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-45; Dahlman A, 2011, MODERN PATHOL, V24, P708, DOI 10.1038/modpathol.2010.238; Denko NC, 2003, ONCOGENE, V22, P5907, DOI 10.1038/sj.onc.1206703; Drabsch Y, 2012, CANCER METAST REV, V31, P553, DOI 10.1007/s10555-012-9375-7; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Erler JT, 2006, CANCER RES, V66, P10238, DOI 10.1158/0008-5472.CAN-06-3197; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Forootan SS, 2006, INT J CANCER, V118, P2255, DOI 10.1002/ijc.21619; Hagglof Christina, 2012, Cancers (Basel), V4, P531, DOI 10.3390/cancers4020531; Hagglof C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010747; Halin S, 2007, PROSTATE, V67, P370, DOI 10.1002/pros.20473; Halin Sofia, 2011, Expert Opin Med Diagn, V5, P37, DOI 10.1517/17530059.2011.540009; Halin S, 2009, NEOPLASIA, V11, P177, DOI 10.1593/neo.81338; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; Johansson A, 2010, AM J PATHOL, V177, P1031, DOI 10.2353/ajpath.2010.100070; Josefsson A, 2012, SCAND J UROL NEPHROL, V46, P247, DOI 10.3109/00365599.2012.669791; Josefsson A, 2011, AM J PATHOL, V179, P1961, DOI 10.1016/j.ajpath.2011.06.005; Kosari F, 2012, AM J PATHOL, V181, P34, DOI 10.1016/j.ajpath.2012.03.043; Latil A, 2003, INT J CANCER, V103, P306, DOI 10.1002/ijc.10821; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; LILJA H, 1992, CANCER, V70, P230, DOI 10.1002/1097-0142(19920701)70:1+<230::AID-CNCR2820701310>3.0.CO;2-Y; Macoska JA, 2011, DIFFERENTIATION, V82, P253, DOI 10.1016/j.diff.2011.04.003; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; Morra L, 2011, VIRCHOWS ARCH, V459, P465, DOI 10.1007/s00428-011-1151-5; Nelson WG, 2009, ENDOCRINOLOGY, V150, P3991, DOI 10.1210/en.2009-0573; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Pritchard CC, 2008, DIFFERENTIATION, V76, P624, DOI 10.1111/j.1432-0436.2008.00274.x; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ren CZ, 1998, CANCER RES, V58, P1285; Risk MC, 2010, CLIN CANCER RES, V16, P5414, DOI 10.1158/1078-0432.CCR-10-0272; Rizzi F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003617; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sfanos KS, 2012, HISTOPATHOLOGY, V60, P199, DOI 10.1111/j.1365-2559.2011.04033.x; Sleeman JP, 2012, CANCER METAST REV, V31, P429, DOI 10.1007/s10555-012-9373-9; Stenman K, 2011, BIOMARK INSIGHTS, V6, P39, DOI 10.4137/BMI.S6794; Sun CY, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-99; Taylor MA, 2011, NEOPLASIA, V13, P406, DOI 10.1593/neo.101086; Thoms JW, 2012, BRIT J CANCER, V107, P840, DOI 10.1038/bjc.2012.345; Tidehag V, 2014, EUR J CANCER IN PRES; Tischler V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-273; Troester MA, 2009, CLIN CANCER RES, V15, P7020, DOI 10.1158/1078-0432.CCR-09-1126; Tsunoda T, 2009, PROSTATE, V69, P1398, DOI 10.1002/pros.20988; Van Neste L, 2012, PROSTATE, V72, P1248, DOI 10.1002/pros.22459; Vindrieux D, 2009, ENDOCR-RELAT CANCER, V16, P663, DOI 10.1677/ERC-09-0109; Was H, 2010, CURR DRUG TARGETS, V11, P1551, DOI 10.2174/1389450111009011551; Whitaker HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013363; Wikstrom P, 2009, PROSTATE, V69, P799, DOI 10.1002/pros.20927; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhang J, 2010, CYTOKINE GROWTH F R, V21, P41, DOI 10.1016/j.cytogfr.2009.11.009; Zhou J, 2005, CANCER RES, V65, P9906, DOI 10.1158/0008-5472.CAN-05-1481	59	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130076	10.1371/journal.pone.0130076	http://dx.doi.org/10.1371/journal.pone.0130076			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076453	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900133
J	Almeida, I; Soares, SC; Castelo-Branco, M				Almeida, Ines; Soares, Sandra C.; Castelo-Branco, Miguel			The Distinct Role of the Amygdala, Superior Colliculus and Pulvinar in Processing of Central and Peripheral Snakes	PLOS ONE			English	Article							RIGHT-HEMISPHERE DOMINANCE; RAPID DETECTION; FACIAL EXPRESSIONS; EMOTIONAL STIMULI; EVOLVED MODULE; NEURAL SYSTEMS; BASAL GANGLIA; EYE-MOVEMENT; ATTENTION; FEAR	Introduction Visual processing of ecologically relevant stimuli involves a central bias for stimuli demanding detailed processing (e.g., faces), whereas peripheral object processing is based on coarse identification. Fast detection of animal shapes holding a significant phylogenetic value, such as snakes, may benefit from peripheral vision. The amygdala together with the pulvinar and the superior colliculus are implicated in an ongoing debate regarding their role in automatic and deliberate spatial processing of threat signals. Methods Here we tested twenty healthy participants in an fMRI task, and investigated the role of spatial demands (the main effect of central vs. peripheral vision) in the processing of fear-relevant ecological features. We controlled for stimulus dependence using true or false snakes; snake shapes or snake faces and for task constraints (implicit or explicit). The main idea justifying this double task is that amygdala and superior colliculus are involved in both automatic and controlled processes. Moreover the explicit/implicit instruction in the task with respect to emotion is not necessarily equivalent to explicit vs. implicit in the sense of endogenous vs. exogenous attention, or controlled vs. automatic processes. Results We found that stimulus-driven processing led to increased amygdala responses specifically to true snake shapes presented in the centre or in the peripheral left hemifield (right hemisphere). Importantly, the superior colliculus showed significantly biased and explicit central responses to snake-related stimuli. Moreover, the pulvinar, which also contains foveal representations, also showed strong central responses, extending the results of a recent single cell pulvinar study in monkeys. Similar hemispheric specialization was found across structures: increased amygdala responses occurred to true snake shapes presented to the right hemisphere, with this pattern being closely followed by the superior colliculus and the pulvinar. Conclusion These results show that subcortical structures containing foveal representations such as the amygdala, pulvinar and superior colliculus play distinct roles in the central and peripheral processing of snake shapes. Our findings suggest multiple phylogenetic fingerprints in the responses of subcortical structures to fear-relevant stimuli.	[Almeida, Ines; Soares, Sandra C.; Castelo-Branco, Miguel] Univ Coimbra, Fac Med, IBILI, Coimbra, Portugal; [Soares, Sandra C.] Univ Aveiro, Dept Educ, P-3800 Aveiro, Portugal	Universidade de Coimbra; Universidade de Aveiro	Castelo-Branco, M (corresponding author), Univ Coimbra, Fac Med, IBILI, Coimbra, Portugal.	mcbranco@fmed.uc.pt	Castelo-Branco, Miguel/F-3866-2019; Almeida, Ines A. T./U-9150-2017; Soares, Sandra C./K-5576-2013	Castelo-Branco, Miguel/0000-0003-4364-6373; Almeida, Ines A. T./0000-0003-0230-3075; Soares, Sandra C./0000-0002-0346-7840	Portuguese Foundation for Science and Technology (FCT) [PEst-C/SAU/UI3282/2013, CENTRO-07-ST24-FEDER-00205, FP7-HEALTH-2013-INNOVATION-1-602186, SFRH/BD/35973/2007]; Bial Foundation [132/133-2013]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Bial Foundation(Bial Foundation)	This work was supported by grants of the Portuguese Foundation for Science and Technology (FCT) [PEst-C/SAU/UI3282/2013, CENTRO-07-ST24-FEDER-00205, FP7-HEALTH-2013-INNOVATION-1-602186, SFRH/BD/35973/2007 to I.A.] and the Bial Foundation [132/133-2013]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Almeida I, 2013, NEUROPSYCHOLOGIA, V51, P2120, DOI 10.1016/j.neuropsychologia.2013.07.007; Andrew R. J., 2002, COMP LATERALIZATION, P95; Arend I, 2008, PROG BRAIN RES, V171, P475, DOI 10.1016/S0079-6123(08)00669-9; Atkinson AP, 2013, EMOT REV, V5, P30, DOI 10.1177/1754073912457226; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Balderston NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063220; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; Bishop SJ, 2004, J NEUROSCI, V24, P10364, DOI 10.1523/JNEUROSCI.2550-04.2004; Calvo MG, 2005, J EXP PSYCHOL HUMAN, V31, P502, DOI 10.1037/0096-1523.31.3.502; Canli T, 1998, NEUROREPORT, V9, P3233, DOI 10.1097/00001756-199810050-00019; Carretie L, 2014, COGN AFFECT BEHAV NE, V14, P1228, DOI 10.3758/s13415-014-0270-2; Carretie L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037082; Chica AB, 2013, BEHAV BRAIN RES, V237, P107, DOI 10.1016/j.bbr.2012.09.027; COOK M, 1989, J ABNORM PSYCHOL, V98, P448, DOI 10.1037/0021-843X.98.4.448; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Courtney CG, 2010, INT J PSYCHOPHYSIOL, V78, P107, DOI 10.1016/j.ijpsycho.2010.06.028; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.3.CO;2-Q; Davidson RJ, 2000, BIOL PSYCHIAT, V47, P85, DOI 10.1016/S0006-3223(99)00222-X; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Fischer J, 2009, HUM BRAIN MAPP, V30, P101, DOI 10.1002/hbm.20485; FREDRIKSON M, 1993, PSYCHOPHYSIOLOGY, V30, P126; Grieve KL, 2000, TRENDS NEUROSCI, V23, P35, DOI 10.1016/S0166-2236(99)01482-4; Grosbras MN, 2005, HUM BRAIN MAPP, V25, P140, DOI 10.1002/hbm.20145; Habel U, 2007, NEUROPSYCHOLOGIA, V45, P2369, DOI 10.1016/j.neuropsychologia.2007.01.023; Hamame CM, 2014, NEUROIMAGE, V95, P276, DOI 10.1016/j.neuroimage.2014.03.025; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Huijding J, 2011, EMOTION, V11, P666, DOI 10.1037/a0022996; Isbell L. A., 2009, FRUIT TREE SERPENT W; Isbell LA, 2006, J HUM EVOL, V51, P1, DOI 10.1016/j.jhevol.2005.12.012; Juttner M, 2000, EUR J NEUROSCI, V12, P353, DOI 10.1046/j.1460-9568.2000.00907.x; Kanwisher N, 2001, NAT NEUROSCI, V4, P455, DOI 10.1038/87399; Kennedy DP, 2010, NEUROPSYCHOLOGIA, V48, P3392, DOI 10.1016/j.neuropsychologia.2010.06.025; Killgore WDS, 2007, SOC COGN AFFECT NEUR, V2, P240, DOI 10.1093/scan/nsm020; KLORMAN R, 1974, BEHAV THER, V5, P401, DOI 10.1016/S0005-7894(74)80008-0; LeDoux J.E., 2008, HDB EMOTIONS, P159; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lerner Y, 2006, NEUROIMAGE, V33, P169, DOI 10.1016/j.neuroimage.2006.06.026; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Liu LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009790; Lobue V, 2014, EMOTION, V14, P816, DOI 10.1037/a0035869; Lori NF, 2002, NMR BIOMED, V15, P493, DOI 10.1002/nbm.779; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; MERCKELBACH H, 1989, ACTA PSYCHOL, V70, P147, DOI 10.1016/0001-6918(89)90017-6; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Morawetz C, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00226; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 2002, NEUROIMAGE, V17, P214, DOI 10.1006/nimg.2002.1220; MUNOZ DP, 1992, J NEUROPHYSIOL, V67, P1000, DOI 10.1152/jn.1992.67.4.1000; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Ohman A, 2003, CURR DIR PSYCHOL SCI, V12, P5, DOI 10.1111/1467-8721.01211; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Ohman A, 2007, PHYSIOL BEHAV, V92, P180, DOI 10.1016/j.physbeh.2007.05.057; Ohman A, 2012, J COGN PSYCHOL, V24, P17, DOI 10.1080/20445911.2011.629603; Padmala S, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00064; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Peelen MV, 2007, SOC COGN AFFECT NEUR, V2, P274, DOI 10.1093/scan/nsm023; Penkunas MJ, 2013, J EXP CHILD PSYCHOL, V114, P522, DOI 10.1016/j.jecp.2012.10.001; Pessoa L, 2003, J NEUROSCI, V23, P3990; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Provost F., 1997, Proceedings of the Third International Conference on Knowledge Discovery and Data Mining, P43; Rigoulot S, 2008, BRAIN TOPOGR, V20, P216, DOI 10.1007/s10548-008-0050-9; Rinck M, 2006, J ABNORM PSYCHOL, V115, P231, DOI 10.1037/0021-843X.115.2.231; Rohner JC, 2002, COGNITION EMOTION, V16, P837, DOI 10.1080/02699930143000572; Rolls ET, 2007, NEUROPSYCHOLOGIA, V45, P124, DOI 10.1016/j.neuropsychologia.2006.04.019; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Sayette MA, 2010, NICOTINE TOB RES, V12, P1068, DOI 10.1093/ntr/ntq159; Schneider KA, 2005, J NEUROPHYSIOL, V94, P2491, DOI 10.1152/jn.00288.2005; Shipp S, 2003, PHILOS T R SOC B, V358, P1605, DOI 10.1098/rstb.2002.1213; Shulman GL, 2010, J NEUROSCI, V30, P3640, DOI 10.1523/JNEUROSCI.4085-09.2010; Siman-Tov T, 2007, J NEUROSCI, V27, P11271, DOI 10.1523/JNEUROSCI.0599-07.2007; Siman-Tov T, 2009, J COGNITIVE NEUROSCI, V21, P1782, DOI 10.1162/jocn.2009.21120; Siniscalchi M, 2010, BEHAV BRAIN RES, V208, P516, DOI 10.1016/j.bbr.2009.12.042; Soares SC, 2013, PSYCH J, V2, P11, DOI 10.1002/pchj.18; Soares SC, 2012, EVOL PSYCHOL-US, V10, P187, DOI 10.1177/147470491201000202; Spence S, 1996, PSYCHOPHYSIOLOGY, V33, P112, DOI 10.1111/j.1469-8986.1996.tb02115.x; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Strasburger H, 2011, J VISION, V11, DOI 10.1167/11.5.13; Tamietto M, 2012, CURR BIOL, V22, P1449, DOI 10.1016/j.cub.2012.06.006; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Thorpe SJ, 2001, EUR J NEUROSCI, V14, P869, DOI 10.1046/j.0953-816x.2001.01717.x; Vallortigara G, 1998, NEUROREPORT, V9, P3341, DOI 10.1097/00001756-199810050-00035; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; van Asselen M, 2012, J INT NEUROPSYCH SOC, V18, P689, DOI 10.1017/S1355617712000288; van Asselen M, 2009, NEUROPSYCHOLOGIA, V47, P1269, DOI 10.1016/j.neuropsychologia.2009.01.008; van Asselen M, 2009, ATTEN PERCEPT PSYCHO, V71, P76, DOI 10.3758/APP.71.1.76; Van Le Q, 2013, P NATL ACAD SCI USA, V110, P19000, DOI 10.1073/pnas.1312648110; Villeneuve MY, 2012, EUR J NEUROSCI, V36, P2849, DOI 10.1111/j.1460-9568.2012.08205.x; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Ward R, 2007, NEUROPSYCHOLOGIA, V45, P1973, DOI 10.1016/j.neuropsychologia.2006.09.017; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; White B.J., 2011, OXFORD HDB EYE MOVEM, P195, DOI [10.1093/oxfordhb/9780199539789.013.0011, DOI 10.1093/OXFORDHB/9780199539789.013.0011]	98	43	43	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129949	10.1371/journal.pone.0129949	http://dx.doi.org/10.1371/journal.pone.0129949			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26075614	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900118
J	Hinriksdottir, G; Tryggvadottir, A; Olafsdottir, AS; Arngrimsson, SA				Hinriksdottir, Gunnhildur; Tryggvadottir, Agusta; Olafsdottir, Anna Sigriour; Arngrimsson, Sigurbjoern Arni			Fatness but Not Fitness Relative to the Fat-Free Mass Is Related to C-Reactive Protein in 18 Year-Old Adolescents	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; LOW-GRADE INFLAMMATION; PHYSICAL-ACTIVITY; AEROBIC POWER; WEIGHT-LOSS; TRENDS; INTERVENTION; CHILDHOOD; EXERCISE; MARKER	Introduction The interaction between fatness, fitness, and C-reactive protein (CRP) in adolescents is not well characterized but may be important to prevent low grade inflammation. The purpose of this study was to assess the relationship between adiposity, different expressions of fitness, and CRP in late adolescence using direct measures of fitness and fatness. Methods Anthropometric measurements were taken on 245 eighteen-year-old participants (116 girls). Fasting CRP, glucose, and insulin were measured and homeostatic model assessment (HOMA) calculated. Body composition was estimated via dual energy X-ray absorptiometry. Fitness was assessed with maximal oxygen uptake (VO(2)max) during a treadmill test and also expressed relative to the fat-free mass (VO(2)max(FFM)). Results Prevalence of overweight/obesity based on body mass index (BMI) was 20.7% and 25.6% among girls and boys, respectively (p = 0.407), but 42.5% and 58.1% when based on body fat percentage (%fat, p = 0.015). Higher proportion of boys (81.3%) than girls (54.5%) were highly fit (p<0.001), but the percentage of girls with high levels of CRP was greater (12.1% vs 6.2%, p = 0.028). Adiposity, indicated with BMI, waist circumference, fat mass, android fat mass (aFM), or %fat, was positively associated with CRP independent of VO(2)max (r = 0.13-0.18, p<0.05) and VO(2)max(FFM) (r = 0.24-0.32, p<0.001). VO(2)max, was negatively associated with CRP independent only of BMI and waist circumference (r = -0.21, p = 0.001), but not % fat, fat mass or aFM (r = -0.08 to -0.12, p>0.05). VO(2)max(FFM) was unrelated to CRP with (r = -0.07 to -0.11, p>0.05) or without (r = -0.10, p = 0.142) adjustment for adiposity. Additional adjustment for HOMA did not change any of the relationships, although the coefficients were attenuated. Conclusions Fatness has a greater association with CRP than fitness in late adolescence. However, VO(2)max(FFM), which is truly independent of adiposity, is unrelated to CRP, indicating that the effects of fitness might be mediated via the fatness component embedded in fitness expressed relative to body mass.	[Hinriksdottir, Gunnhildur; Tryggvadottir, Agusta; Olafsdottir, Anna Sigriour; Arngrimsson, Sigurbjoern Arni] Univ Iceland, Ctr Sport & Hlth Sci, Laugarvatn, Iceland	University of Iceland	Hinriksdottir, G (corresponding author), Univ Iceland, Ctr Sport & Hlth Sci, Laugarvatn, Iceland.	ghinriks@hi.is	Olafsdottir, Anna/A-8804-2013	Olafsdottir, Anna/0000-0002-7258-1727	Ministry of Education Sports Fund; University of Iceland Research Fund	Ministry of Education Sports Fund; University of Iceland Research Fund	This work was supported by the Ministry of Education Sports Fund (no grant number) to SAA ASO, (http://en.rannis.is/funding/youth-sport/theicelandic-sport-fund/) and the University of Iceland Research Fund (no grant number) to SAA ASO. (http://sjodir.hi.is/node/16131) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellaoui A, 2007, EUR J VASC ENDOVASC, V34, P18, DOI 10.1016/j.ejvs.2006.10.040; Arikawa AY, 2011, MED SCI SPORT EXER, V43, P1002, DOI 10.1249/MSS.0b013e3182059eda; Arsenault BJ, 2009, AM J CARDIOL, V104, P240, DOI 10.1016/j.amjcard.2009.03.027; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Barlow CE, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001354; Belalcazar LM, 2010, DIABETES CARE, V33, P2297, DOI 10.2337/dc10-0728; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Campbell KL, 2008, CANCER EPIDEM BIOMAR, V17, P1714, DOI 10.1158/1055-9965.EPI-08-0088; Church TS, 2010, MED SCI SPORT EXER, V42, P708, DOI 10.1249/MSS.0b013e3181c03a43; Duncan GE, 1997, MED SCI SPORT EXER, V29, P273, DOI 10.1097/00005768-199702000-00017; Dyrstad SM, 2012, SCAND J MED SCI SPOR, V22, P822, DOI 10.1111/j.1600-0838.2011.01315.x; Eisenmann JC, 2005, AM HEART J, V149, P46, DOI 10.1016/j.ahj.2004.07.016; Ekblom OB, 2011, ACTA PAEDIATR, V100, P565, DOI 10.1111/j.1651-2227.2010.02135.x; Friedenreich CM, 2012, CANCER PREV RES, V5, P98, DOI 10.1158/1940-6207.CAPR-11-0369; Gutin B, 2011, INT J PEDIAT, V2011, DOI 10.1155/2011/219268; Hamer M, 2007, PREV MED, V44, P3, DOI 10.1016/j.ypmed.2006.09.005; Hamer M, 2009, AM J CLIN NUTR, V89, P85, DOI 10.3945/ajcn.2008.26779; Huotan PRT, 2010, BRIT J SPORT MED, V44, P968, DOI 10.1136/bjsm.2008.055913; Isasi CR, 2003, PEDIATRICS, V111, P332, DOI 10.1542/peds.111.2.332; Johannsson E, 2006, INT J OBESITY, V30, P1265, DOI 10.1038/sj.ijo.0803253; LOHMAN TG, 1997, ACSMS HEALTH FIT J, V1, P30; Lucia A, 2006, INT J SPORTS MED, V27, P984, DOI 10.1055/s-2006-923833; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Martinez-Gomez D, 2010, INT J OBESITY, V34, P1501, DOI 10.1038/ijo.2010.114; Martinez-Gomez D, 2012, ATHEROSCLEROSIS, V221, P260, DOI 10.1016/j.atherosclerosis.2011.12.032; MCCONNELL TR, 1988, SPORTS MED, V5, P57, DOI 10.2165/00007256-198805010-00005; McMurray RG, 2011, ANN HUM BIOL, V38, P647, DOI 10.3109/03014460.2011.598561; McVean JJF, 2009, J PEDIATR ENDOCR MET, V22, P153; Nemet D, 2013, HORM RES PAEDIAT, V79, P325, DOI 10.1159/000348732; Ondrak KS, 2007, J ADOLESCENT HEALTH, V41, P146, DOI 10.1016/j.jadohealth.2007.03.008; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Parrett AL, 2010, MED SCI SPORT EXER, V42, P1981, DOI 10.1249/MSS.0b013e3181e0355e; Puder JJ, 2011, INT J PEDIATR OBES, V6, pE297, DOI 10.3109/17477166.2010.533774; Radak Z, 2004, FASEB J, V18, P749, DOI 10.1096/fj.03-0509fje; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Rietzschel E, 2012, BIOMARK MED, V6, P19, DOI [10.2217/BMM.11.108, 10.2217/bmm.11.108]; Ruiz JR, 2007, INT J OBESITY, V31, P1545, DOI 10.1038/sj.ijo.0803693; Skinner JS, 2003, MED SCI SPORT EXER, V35, P1908, DOI 10.1249/01.MSS.0000093607.57995.E3; Steingrimsdottir L, 2014, LAEKNABLADID, V100, P659, DOI 10.17992/lbl.2014.12.571; Stewart LK, 2010, MED SCI SPORT EXER, V42, P701, DOI 10.1249/MSS.0b013e3181c03a2b; Thompson W. R., 2009, ACSMS GUIDELINES EXE; Thorsson B, 2009, LAEKNABLADID, V95, P259; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; Valentine RJ, 2009, MENOPAUSE, V16, P84, DOI 10.1097/gme.0b013e31817fcb8f; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3	46	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130597	10.1371/journal.pone.0130597	http://dx.doi.org/10.1371/journal.pone.0130597			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075745	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900182
J	Ligtenberg, MA; Cinar, O; Holmdahl, R; Mougiakakos, D; Kiessling, R				Ligtenberg, Maarten A.; Cinar, Ozcan; Holmdahl, Rikard; Mougiakakos, Dimitrios; Kiessling, Rolf			Methylcholanthrene-Induced Sarcomas Develop Independently from NOX2-Derived ROS	PLOS ONE			English	Article							REGULATORY T-CELLS; OXIDATIVE STRESS; SUPPRESSOR-CELLS; HYDROGEN-PEROXIDE; TUMOR-GROWTH; CANCER; INHIBITION; INFLAMMATION; APOPTOSIS; MODEL	Reactive oxygen species (ROS) produced by the inducible NADPH oxidase type 2 (NOX2) complex are essential for clearing certain infectious organisms but may also have a role in regulating inflammation and immune response. For example, ROS is involved in myeloid derived suppressor cell (MDSC)- and regulatory T cell (T-reg) mediated T- and NK-cell suppression. However, abundant ROS produced within the tumor microenvironment, or by the tumor itself may also yield oxidative stress, which can blunt anti-tumor immune responses as well as eventually leading to tumor toxicity. In this study we aimed to decipher the role of NOX2-derived ROS in a chemically (by methylcholanthrene (MCA)) induced sarcoma model. Superoxide production by NOX2 requires the p47(phox) (NCF1) subunit to organize the formation of the NOX2 complex on the cell membrane. Homozygous mutant mice (NCF1*(/)*) have a functional loss of their super oxide burst while heterozygous mice (NCF1*(/+)) retain this key function. Mice harboring either a homo- or a heterozygous mutation were injected intramuscularly with MCA to induce sarcoma formation. We found that NOX2 functionality does not determine tumor incidence in the tested MCA model. Comprehensive immune monitoring in tumor bearing mice showed that infiltrating immune cells experienced an increase in their oxidative state regardless of the NOX2 functionality. While MCA-induced sarcomas where characterized by a T-reg and MDSC accumulation, no significant differences could be found between NCF1*(/)* and NCF1*(/+) mice. Furthermore, infiltrating T cells showed an increase in effector-memory cell phenotype markers in both NCF1*(/)* and NCF1*(/+) mice. Tumors established from both NCF1*(/)* and NCF1*(/+) mice were tested for their in vitro proliferative capacity as well as their resistance to cisplatin and radiation therapy, with no differences being recorded. Overall our findings indicate that NOX2 activity does not play a key role in tumor development or immune cell infiltration in the chemically induced MCA sarcoma model.	[Ligtenberg, Maarten A.; Cinar, Ozcan; Kiessling, Rolf] Karolinska Inst, Canc Ctr Karolinska, Dept Pathol & Oncol, Stockholm, Sweden; [Holmdahl, Rikard] Karolinska Inst, Dept Med Biochem & Biophys, Div Med Inflammat Res, Stockholm, Sweden; [Mougiakakos, Dimitrios] Univ Erlangen Nurnberg, Dept Internal Med 5, Haematol & Oncol, Nurnberg, Germany	Karolinska Institutet; Karolinska Institutet; University of Erlangen Nuremberg	Kiessling, R (corresponding author), Karolinska Inst, Canc Ctr Karolinska, Dept Pathol & Oncol, Stockholm, Sweden.	rolf.kiessling@ki.se	Holmdahl, Rikard/AAI-7682-2020	ligtenberg, maarten/0000-0002-0020-1043; Cinar, Ozcan/0000-0001-5297-127X	Swedish Medical Research Council [K2011-66X-15387-07-3]; Swedish Cancer Society [12 0598]; Cancer Society of Stockholm [121103]; ALF-Project grant from Stockholm City Council [20110070]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Cancer Society(Swedish Cancer Society); Cancer Society of Stockholm; ALF-Project grant from Stockholm City Council	Research described here have been supported by grants to R.K. from The Swedish Medical Research Council (K2011-66X-15387-07-3 VR), The Swedish Cancer Society (12 0598 Cancerfonden), The Cancer Society of Stockholm (121103 Cancerforeningen, Radiumhemmets Forskningsfonder), ALF-Project grant from Stockholm City Council (20110070 ALF Medicin 2012).	ALFRED LJ, 1983, IMMUNOLOGY, V50, P207; Brandes RP, 2014, FREE RADICAL BIO MED, V76, P208, DOI 10.1016/j.freeradbiomed.2014.07.046; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; DuPage M, 2015, EXPRESSION TUMOUR SP, V482, P405; FOLEY EJ, 1953, CANCER RES, V13, P835; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Highfill SL, 2014, SCI TRANSL MED, V6, DOI [10.1126/scitranslmed.3008639, DOI 10.1126/SCITRANSLMED.3008639]; Holmdahl R, 2013, ANTIOXID REDOX SIGN, V18, P1463, DOI 10.1089/ars.2012.4734; Horiguchi S, 1999, CANCER RES, V59, P2950; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; INDROVA M, 1979, NEOPLASMA, V26, P405; Jitschin R, 2014, BLOOD, V123, P2663, DOI 10.1182/blood-2013-10-532200; Kelkka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084148; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Kiessling R, 1999, CANCER IMMUNOL IMMUN, V48, P353, DOI 10.1007/s002620050586; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; KLEIN G, 1960, CANCER RES, V20, P1561; KONO K, 1995, CANCER RES, V55, P5648; Kono K, 1996, EUR J IMMUNOL, V26, P1308, DOI 10.1002/eji.1830260620; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Liu-Smith F, 2015, EXP DERMATOL, V24, P171, DOI 10.1111/exd.12559; Lu JP, 2010, PROSTATE CANCER P D, V13, P39, DOI 10.1038/pcan.2009.24; Mailloux AW, 2010, INT J CANCER, V127, P2598, DOI 10.1002/ijc.25281; Mak IWY, 2014, AM J TRANSL RES, V6, P114; Mao Y, 2014, J INTERN MED, V276, P154, DOI 10.1111/joim.12229; Maraldi T, 2009, FREE RADICAL RES, V43, P1111, DOI 10.1080/10715760903186132; Matsushita H, 2014, CANC EXOME ANAL REVE, V482, P400; Mehrotra S, 2009, ADV CANCER RES, V102, P197, DOI 10.1016/S0065-230X(09)02006-5; Milkovic L, 2014, CURR PHARM DESIGN, V20, P6529, DOI 10.2174/1381612820666140826152822; Mishra SK, 2013, MOL CELLS, V36, P219, DOI 10.1007/s10059-013-0050-9; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Mougiakakos D, 2010, REGULATORY T CELLS C, P1; Mougiakakos D, 2009, BLOOD, V113, P3542, DOI 10.1182/blood-2008-09-181040; Ngiow SF, 2014, ONCOIMMUNOLOGY, V2; Nishigori C, 2004, ANTIOXID REDOX SIGN, V6, P561, DOI 10.1089/152308604773934314; Pagano G, 2014, OXIDATIVE MED CELLUL, V2014, P1; PREHN RT, 1957, J NATL CANCER I, V18, P769; Rao, 2010, INT J ONCOL, V37; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; ROSENAU W, 1966, J NATL CANCER I, V36, P825; Sareila O, 2011, ANTIOXID REDOX SIGNA; Sareila O, 2013, J LEUKOCYTE BIOL, V93, P427, DOI 10.1189/jlb.1211588; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Swann JB, 2008, P NATL ACAD SCI USA, V105, P652, DOI 10.1073/pnas.0708594105; Tawara I, 2002, JPN J CANCER RES, V93, P911, DOI 10.1111/j.1349-7006.2002.tb01337.x; Ushmorov A, 1999, CANCER RES, V59, P3527; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zhang H, 2013, BLOOD, V122, P1105, DOI 10.1182/blood-2012-08-449413	50	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129786	10.1371/journal.pone.0129786	http://dx.doi.org/10.1371/journal.pone.0129786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076008	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900103
J	Ullmann, AJ; Russell, TM; Dolan, MC; Williams, M; Hojgaard, A; Weiner, ZP; Johnson, BJB				Ullmann, Amy J.; Russell, Theresa M.; Dolan, Marc C.; Williams, Martin; Hojgaard, Andrias; Weiner, Zachary P.; Johnson, Barbara J. B.			Evaluation of Borrelia burgdorferi BbHtrA Protease as a Vaccine Candidate for Lyme Borreliosis in Mice	PLOS ONE			English	Article							ORIENTIA-TSUTSUGAMUSHI; 47-KILODALTON ANTIGEN; DISEASE; PROTEINS	Borrelia burgdorferi synthesizes an HtrA protease (BbHtrA) which is a surface-exposed, conserved protein within Lyme disease spirochetes with activity toward CheX and BmpD of Borrelia spp, as well as aggrecan, fibronectin and proteoglycans found in skin, joints and neural tissues of vertebrates. An antibody response against BbHtrA is observed in Lyme disease patients and in experimentally infected laboratory mice and rabbits. Given the surface location of BbHtrA on B. burgdorferi and its ability to elicit an antibody response in infected hosts, we explored recombinant BbHtrA as a potential vaccine candidate in a mouse model of tick-transmitted Lyme disease. We immunized mice with two forms of BbHtrA: the proteolytically active native form and BbHtrA ablated of activity by a serine to alanine mutation at amino acid 226 (BbHtrA(S226A)). Although inoculation with either BbHtrA or BbHtrA(S226A) produced high-titer antibody responses in C3H/HeJ mice, neither antigen was successful in protecting mice from B. burgdorferi challenge. These results indicate that the search for novel vaccine candidates against Lyme borreliosis remains a challenge.	[Ullmann, Amy J.; Russell, Theresa M.; Dolan, Marc C.; Williams, Martin; Hojgaard, Andrias; Weiner, Zachary P.; Johnson, Barbara J. B.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Bacterial Dis Branch, Ft Collins, CO 80521 USA	Centers for Disease Control & Prevention - USA	Ullmann, AJ (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Bacterial Dis Branch, Ft Collins, CO 80521 USA.	aff1@cdc.gov			federal government	federal government	All authors are government employees and the research was funded by the federal government.	Bartolini E, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20181; Centers for Disease Control and Prevention, 2014, MMWR Morb Mortal Wkly Rep, V63, P702; Chen HW, 2009, INFECT IMMUN, V77, P2311, DOI 10.1128/IAI.01298-08; Coleman JL, 2013, MOL MICROBIOL, V88, P619, DOI 10.1111/mmi.12213; Cribbs DH, 2003, INT IMMUNOL, V15, P505, DOI 10.1093/intimm/dxg049; deSilva AM, 1996, J EXP MED, V183, P271, DOI 10.1084/jem.183.1.271; Finco O, 2011, P NATL ACAD SCI USA, V108, P9969, DOI 10.1073/pnas.1101756108; He P, 2015, HUM VACC IMMUNOTHER, V11, P477, DOI 10.1080/21645515.2014.1004026; Hinckley AF, 2014, CLIN INFECT DIS, V59, P676, DOI 10.1093/cid/ciu397; HogenEsch H, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00406; Hojgaard A, 2014, TICKS TICK-BORNE DIS, V5, P349, DOI 10.1016/j.ttbdis.2013.12.001; Kung F, 2013, FUTURE MICROBIOL, V8, P41, DOI [10.2217/FMB.12.121, 10.2217/fmb.12.121]; Loosmore SM, 1998, INFECT IMMUN, V66, P899, DOI 10.1128/IAI.66.3.899-906.1998; Masuzawa T, 2004, JPN J INFECT DIS, V57, P229; Merdanovic M, 2011, ANNU REV MICROBIOL, V65, P149, DOI 10.1146/annurev-micro-090110-102925; Ohnishi J, 2001, P NATL ACAD SCI USA, V98, P670, DOI 10.1073/pnas.98.2.670; PIESMAN J, 1993, J MED ENTOMOL, V30, P199, DOI 10.1093/jmedent/30.1.199; Rizzoli A, 2011, EUROSURVEILLANCE, V16, P2; Russell TM, 2013, MOL MICROBIOL, V90, P241, DOI 10.1111/mmi.12377; Russell TM, 2013, MOL MICROBIOL, V90, P228, DOI 10.1111/mmi.12276; Sigal LH, 1998, NEW ENGL J MED, V339, P216, DOI 10.1056/NEJM199807233390402; SINSKY RJ, 1989, J CLIN MICROBIOL, V27, P1723, DOI 10.1128/JCM.27.8.1723-1727.1989; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; Tokarz R, 2004, INFECT IMMUN, V72, P5419, DOI 10.1128/IAI.72.9.5419-5432.2004; Willyard C, 2014, NAT MED, V20, P698, DOI 10.1038/nm0714-698; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Yu YF, 2005, AM J TROP MED HYG, V72, P458, DOI 10.4269/ajtmh.2005.72.458	27	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128868	10.1371/journal.pone.0128868	http://dx.doi.org/10.1371/journal.pone.0128868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076465	Green Published, Green Submitted, gold			2022-12-27	WOS:000356329900034
J	Xu, LH; Mu, FF; Zhao, JH; He, Q; Cao, CL; Yang, H; Liu, Q; Liu, XH; Sun, SJ				Xu, Li-Hui; Mu, Fang-Fang; Zhao, Jian-Hong; He, Qiang; Cao, Cui-Li; Yang, Hui; Liu, Qi; Liu, Xue-Hui; Sun, Su-Ju			Lead Induces Apoptosis and Histone Hyperacetylation in Rat Cardiovascular Tissues	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; DEACETYLASE INHIBITOR; BLOOD-PRESSURE; NITRIC-OXIDE; INDUCED HYPERTENSION; DEPENDENT APOPTOSIS; LEUKEMIA-CELLS; MELANOMA-CELLS; VALPROIC ACID; EXPOSURE	Acute and chronic lead (Pb) exposure might cause hypertension and cardiovascular diseases. The purpose of this study was to evaluate the effects of early acute exposure to Pb on the cellular morphology, apoptosis, and proliferation in rats and to elucidate the early mechanisms involved in the development of Pb-induced hypertension. Very young Sprague-Dawley rats were allowed to drink 1% Pb acetate for 12 and 40 days. Western blot analysis indicated that the expression of proliferating cell nuclear antigen (PCNA) decreased in the tissues of the abdominal and thoracic aortas and increased in the cardiac tissue after 12 and 40 days of Pb exposure, respectively. Bax was upregulated and Bcl-2 was downregulated in vascular and cardiac tissues after 40 days of Pb exposure. In addition, an increase in caspase-3 activity was observed after 40 days of exposure to Pb. In terms of morphology, we found that the internal elastic lamina (IEL) of aorta lost the original curve and the diameter of cardiac cell was enlarged after 40 days. Furthermore, the exposure led to a marked increase in acetylated histone H3 levels in the aortas and cardiac tissue after 12 and 40 days, than that in the control group. These findings indicate that Pb might increase the level of histone acetylation and induce apoptosis in vascular and cardiac tissues. However, the mechanism involved need to be further investigated.	[Xu, Li-Hui] Hebei Med Univ, Dept Biochem & Mol Biol, Shijiazhuang 050017, Peoples R China; [Mu, Fang-Fang; Yang, Hui; Liu, Qi; Liu, Xue-Hui; Sun, Su-Ju] Hebei Med Univ, Coll Publ Hlth, Shijiazhuang 050017, Peoples R China; [Zhao, Jian-Hong; He, Qiang] Hebei Med Univ, Hosp 2, Shijiazhuang 050000, Peoples R China; [Cao, Cui-Li] Hebei Med Univ, Inst Basic Med, Neurobiol Lab, Shijiazhuang 050017, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University	Sun, SJ (corresponding author), Hebei Med Univ, Coll Publ Hlth, Shijiazhuang 050017, Peoples R China.	Sun_suju@163.com						Alghasham AA, 2011, INT J HEALTH SCI-IJH, V5, P19; Bagchi D, 2005, J INORG BIOCHEM, V99, P1155, DOI 10.1016/j.jinorgbio.2005.02.011; Ballew C, 1999, J PEDIATR-US, V134, P623, DOI 10.1016/S0022-3476(99)70250-7; Cao XBX, 2001, AM J RESP CELL MOL, V25, P562, DOI 10.1165/ajrcmb.25.5.4539; CARSIA RV, 1995, P SOC EXP BIOL MED, V210, P180; Doi S, 2004, MOL CANCER THER, V3, P1397; Duan H, 2005, MOL CELL BIOL, V25, P1608, DOI 10.1128/MCB.25.5.1608-1619.2005; Dursun N, 2005, BIOL TRACE ELEM RES, V104, P141, DOI 10.1385/BTER:104:2:141; Ethier AA, 2012, NEUROTOXICOLOGY, V33, P1075, DOI 10.1016/j.neuro.2012.05.010; Eum KD, 2014, ENVIRON HEALTH PERSP, V122, P229, DOI 10.1289/ehp.1206399; FUJIWARA Y, 1995, TOXICOLOGY, V98, P105, DOI 10.1016/0300-483X(94)02984-3; Gonick HC, 1997, HYPERTENSION, V30, P1487, DOI 10.1161/01.HYP.30.6.1487; Herold C, 2002, J HEPATOL, V36, P233, DOI 10.1016/S0168-8278(01)00257-4; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Huang PC, 2012, ENVIRON INT, V40, P88, DOI 10.1016/j.envint.2011.10.011; Kasten-Jolly J, 2011, J BIOCHEM MOL TOXIC, V25, P41, DOI 10.1002/jbt.20358; Krepela E, 2001, NEOPLASMA, V48, P332; Kwon SH, 2002, J BIOL CHEM, V277, P2073, DOI 10.1074/jbc.M106699200; Lockshin Richard A., 2005, Journal de la Societe de Biologie, V199, P169, DOI 10.1051/jbio:2005017; Martin D, 2006, AM J EPIDEMIOL, V163, P467, DOI 10.1093/aje/kwj060; Nash D, 2003, JAMA-J AM MED ASSOC, V289, P1523, DOI 10.1001/jama.289.12.1523; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Prozialeck WC, 2008, TOXICOL SCI, V102, P207, DOI 10.1093/toxsci/kfm263; Pulido MD, 2003, MUTAT RES-FUND MOL M, V533, P227, DOI 10.1016/j.mrfmmm.2003.07.015; Rossi-George A, 2011, NEUROTOXICOLOGY, V32, P83, DOI 10.1016/j.neuro.2010.09.004; Ryu JK, 2006, CANCER LETT, V237, P143, DOI 10.1016/j.canlet.2005.05.040; Sandow SL, 2009, J ANAT, V214, P258, DOI 10.1111/j.1469-7580.2008.01020.x; Shirsath N, 2013, LUNG CANCER, V82, P214, DOI 10.1016/j.lungcan.2013.08.010; Tang R, 2004, LEUKEMIA, V18, P1246, DOI 10.1038/sj.leu.2403390; Telisman S, 2004, AM J IND MED, V45, P446, DOI 10.1002/ajim.20006; Robles HV, 2007, HUM EXP TOXICOL, V26, P499, DOI 10.1177/0960327106077597; Vaziri ND, 1999, KIDNEY INT, V56, P1492, DOI 10.1046/j.1523-1755.1999.00670.x; Venza I, 2014, INT IMMUNOPHARMACOL, V21, P439, DOI 10.1016/j.intimp.2014.05.024; Venza M, 2015, TOXICOL IN VITRO, V29, P242, DOI 10.1016/j.tiv.2014.10.020; Venza M, 2014, CURR GENOMICS, V15, P420, DOI 10.2174/138920291506150106145932; Walsh K, 2000, CIRC RES, V87, P184, DOI 10.1161/01.RES.87.3.184; WEILER E, 1990, CLIN SCI, V79, P185, DOI 10.1042/cs0790185; Zeller I, 2010, ARTERIOSCL THROM VAS, V30, P1733, DOI 10.1161/ATVBAHA.110.211011; Zhang XD, 2004, MOL CANCER THER, V3, P425; Zuscik MJ, 2007, ENVIRON HEALTH PERSP, V115, P1276, DOI 10.1289/ehp.10028	41	17	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129091	10.1371/journal.pone.0129091	http://dx.doi.org/10.1371/journal.pone.0129091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075388	gold, Green Published, Green Submitted			2022-12-27	WOS:000356329900045
J	Yamasaki, T; Fujinaga, M; Yui, J; Wakizaka, H; Ohya, T; Nengaki, N; Ogawa, M; Ikoma, Y; Hatori, A; Xie, L; Kawamura, K; Zhang, MR				Yamasaki, Tomoteru; Fujinaga, Masayuki; Yui, Joji; Wakizaka, Hidekatsu; Ohya, Tomoyuki; Nengaki, Nobuki; Ogawa, Masanao; Ikoma, Yoko; Hatori, Akiko; Xie, Lin; Kawamura, Kazunori; Zhang, Ming-Rong			Improved Visualization and Specific Binding for Metabotropic Glutamate Receptor Subtype 1 (mGluR1) Using [C-11]ITMM with Ultra-High Specific Activity in Small-Animal PET	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; RAT-BRAIN; SIGNAL-TRANSDUCTION; IN-VITRO; LIGAND; TYPE-1; QUANTIFICATION; KINETICS; AFFINITY; DENSITY	Metabotropic glutamate receptor subtype 1 (mGluR1) is a crucial target in the development of new medications to treat central nervous system(CNS) disorders. Recently, we developed N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-4-[C-11]methoxy-N-methyl-benzamide ([C-11]ITMM) as a useful positron emission tomography (PET) probe for mGluR1 in clinical studies. Here, we aimed to improve visualization and threshold of specific binding for mGluR1 using [C-11] ITMM with ultra-high specific activity (SA) of > 3,500 GBq/mu mol in rat brains. A two-tissue compartment model indicated large differences between the two SAs in the constants k(3) and k(4), representing binding ability for mGluR1, while constants K-1 and k(2) showed no differences. The total distribution volume (V-T) values of conventional and ultra-high SA were 9.1 and 11.2 in the thalamus, 7.7 and 9.7 in the striatum, and 6.4 and 8.5 mL/cm(3) in the substantia nigra, respectively. The specific binding of [C-11] ITMM with ultra-high SA was significantly higher than the conventional SA, especially in the basal ganglia. Parametric PET images scaled with VT of the ultra-high SA clearly identified regional differences in the rat brain. In conclusion, PET studies using [C-11] ITMM with ultra-high SA could sufficiently improve visualization and specific binding for mGluR1, which could help further understanding for mGluR1 functions in CNS disorders.	[Yamasaki, Tomoteru; Fujinaga, Masayuki; Yui, Joji; Wakizaka, Hidekatsu; Ohya, Tomoyuki; Nengaki, Nobuki; Ogawa, Masanao; Ikoma, Yoko; Hatori, Akiko; Xie, Lin; Kawamura, Kazunori; Zhang, Ming-Rong] Natl Inst Radiol Sci, Mol Probe Program, Mol Imaging Ctr, Chiba 260, Japan	National Institutes for Quantum Science & Technology	Yamasaki, T (corresponding author), Natl Inst Radiol Sci, Mol Probe Program, Mol Imaging Ctr, Chiba 260, Japan.	yamato@nirs.go.jp		, Lin/0000-0002-6472-322X	National Institute of Radiological Sciences; cyclotron operation; radioisotope production; radiosynthesis	National Institute of Radiological Sciences; cyclotron operation; radioisotope production; radiosynthesis	We thank the staff at the National Institute of Radiological Sciences for their support with the cyclotron operation, radioisotope production, radiosynthesis, and animal experiments.	Akaike H., 1974, IEEE T AUTOMAT CONTR, V19, P8; ARAMORI I, 1992, NEURON, V8, P757, DOI 10.1016/0896-6273(92)90096-V; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; De Vry J, 2001, EUR J PHARMACOL, V428, P203, DOI 10.1016/S0014-2999(01)01296-1; Di Matteo V, 2001, TRENDS PHARMACOL SCI, V22, P229, DOI 10.1016/S0165-6147(00)01688-6; Ferraguti F, 2008, PHARMACOL REV, V60, P536, DOI 10.1124/pr.108.000166; Francesconi A, 1998, J BIOL CHEM, V273, P5615, DOI 10.1074/jbc.273.10.5615; Fujimura Y, 2010, NUCL MED BIOL, V37, P831, DOI 10.1016/j.nucmedbio.2010.04.138; Fujinaga M, 2012, J NEUROCHEM, V121, P115, DOI 10.1111/j.1471-4159.2011.07348.x; Fujinaga M, 2012, J MED CHEM, V55, P2342, DOI 10.1021/jm201590g; Ginovart N, 2006, J CEREBR BLOOD F MET, V26, P330, DOI 10.1038/sj.jcbfm.9600197; Hermans E, 1998, NEUROPHARMACOLOGY, V37, P1645, DOI 10.1016/S0028-3908(98)00132-4; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Hostetler ED, 2011, SYNAPSE, V65, P125, DOI 10.1002/syn.20826; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Kaneda K, 2005, EUR J NEUROSCI, V22, P3241, DOI 10.1111/j.1460-9568.2005.04488.x; Kawamura K, 2012, NUCL MED BIOL, V39, P199, DOI 10.1016/j.nucmedbio.2011.07.008; KEYES JW, 1995, J NUCL MED, V36, P1836; KOEPPE RA, 1991, J CEREBR BLOOD F MET, V11, P735, DOI 10.1038/jcbfm.1991.130; Kohara A, 2008, BRAIN RES, V1191, P168, DOI 10.1016/j.brainres.2007.11.035; Lesage A, 2010, EUR J PHARMACOL, V639, P2, DOI 10.1016/j.ejphar.2009.12.043; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Makarewicz D, 2006, NEUROCHEM INT, V48, P485, DOI 10.1016/j.neuint.2005.12.022; MINTUN MA, 1984, ANN NEUROL, V15, P217, DOI 10.1002/ana.410150302; Noguchi J, 2003, NUCL MED BIOL, V30, P335, DOI 10.1016/S0969-8051(02)00422-5; Noguchi J, 2008, NUCL MED BIOL, V35, P19, DOI 10.1016/j.nucmedbio.2007.09.009; Prabhakaran J, 2010, BIOORG MED CHEM LETT, V20, P3499, DOI 10.1016/j.bmcl.2010.04.146; Satoh A, 2009, BIOORG MED CHEM LETT, V19, P5464, DOI 10.1016/j.bmcl.2009.07.097; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Suhara T, 1999, INT J NEUROPSYCHOP, V2, P73, DOI 10.1017/S1461145799001431; SUZUKI K, 1985, INT J APPL RADIAT IS, V36, P971, DOI 10.1016/0020-708X(85)90258-3; Takei M, 2001, APPL RADIAT ISOTOPES, V55, P229, DOI 10.1016/S0969-8043(00)00392-4; Toyohara J, 2013, J NUCL MED, V54, P1302, DOI 10.2967/jnumed.113.119891; Toyohara J, 2013, NUCL MED BIOL, V40, P214, DOI 10.1016/j.nucmedbio.2012.11.008; Yamasaki T, 2014, AM J NUCL MED MOLEC, V4, P260; Yamasaki T, 2012, J NUCL MED, V53, P1601, DOI 10.2967/jnumed.112.105908; Yamasaki T, 2011, BIOORG MED CHEM LETT, V21, P2998, DOI 10.1016/j.bmcl.2011.03.046; Yanamoto K, 2010, NUCL MED BIOL, V37, P615, DOI 10.1016/j.nucmedbio.2010.03.002; Yui J, 2013, STROKE, V44, P2567, DOI 10.1161/STROKEAHA.113.001178; Yui J, 2011, NEUROIMAGE, V54, P123, DOI 10.1016/j.neuroimage.2010.08.010	40	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130006	10.1371/journal.pone.0130006	http://dx.doi.org/10.1371/journal.pone.0130006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076143	Green Published, gold, Green Submitted			2022-12-27	WOS:000356329900122
J	Blondel, M; Onogi, A; Iwata, H; Ueda, N				Blondel, Mathieu; Onogi, Akio; Iwata, Hiroyoshi; Ueda, Naonori			A Ranking Approach to Genomic Selection	PLOS ONE			English	Article							QUANTITATIVE TRAITS; RIDGE-REGRESSION; GENOMEWIDE SELECTION; VARIABLE SELECTION; BAYESIAN LASSO; COMPLEX TRAITS; PREDICTION; ASSOCIATION; EFFICIENCY; INFERENCE	Background Genomic selection (GS) is a recent selective breeding method which uses predictive models based on whole-genome molecular markers. Until now, existing studies formulated GS as the problem of modeling an individual's breeding value for a particular trait of interest, i.e., as a regression problem. To assess predictive accuracy of the model, the Pearson correlation between observed and predicted trait values was used. Contributions In this paper, we propose to formulate GS as the problem of ranking individuals according to their breeding value. Our proposed framework allows us to employ machine learning methods for ranking which had previously not been considered in the GS literature. To assess ranking accuracy of a model, we introduce a new measure originating from the information retrieval literature called normalized discounted cumulative gain (NDCG). NDCG rewards more strongly models which assign a high rank to individuals with high breeding value. Therefore, NDCG reflects a prerequisite objective in selective breeding: accurate selection of individuals with high breeding value. Results We conducted a comparison of 10 existing regression methods and 3 new ranking methods on 6 datasets, consisting of 4 plant species and 25 traits. Our experimental results suggest that tree-based ensemble methods including McRank, Random Forests and Gradient Boosting Regression Trees achieve excellent ranking accuracy. RKHS regression and RankSVM also achieve good accuracy when used with an RBF kernel. Traditional regression methods such as Bayesian lasso, wBSR and BayesC were found less suitable for ranking. Pearson correlation was found to correlate poorly with NDCG. Our study suggests two important messages. First, ranking methods are a promising research direction in GS. Second, NDCG can be a useful evaluation measure for GS.	[Blondel, Mathieu; Ueda, Naonori] NTT Commun Sci Labs, Kyoto, Japan; [Onogi, Akio; Iwata, Hiroyoshi] Univ Tokyo, Tokyo, Japan	Nippon Telegraph & Telephone Corporation; University of Tokyo	Iwata, H (corresponding author), Univ Tokyo, Tokyo, Japan.	aiwata@mail.ecc.u-tokyo.ac.jp			FIRST (funding program for world-leading R&D on science and technology) program; NTT Communication Science Laboratories;  [26.10661]; Grants-in-Aid for Scientific Research [25252002] Funding Source: KAKEN	FIRST (funding program for world-leading R&D on science and technology) program; NTT Communication Science Laboratories; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MB was funded by the FIRST (funding program for world-leading R&D on science and technology) program (http://www.jst.go.jp/first/english/en-about-us/). AO received grant-in-aid for Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp/english/index.html, grant 26.10661). HI and NU did not receive specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NTT Communication Science Laboratories provided support in the form of salaries for authors MB and NU, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buitinck L., 2013, ECML PKDD WORKSH LAN, DOI DOI 10.48550/ARXIV.1309.0238; Burges C.J., 2005, P ICML, DOI DOI 10.1145/1102351.1102363; Burges C. J. C, 2010, MSRTR201082; Carbonetto P, 2012, BAYESIAN ANAL, V7, P73, DOI 10.1214/12-BA703; Chapelle O., 2011, JMLR P TRACK, P1; Cossock D, 2008, IEEE T INFORM THEORY, V54, P5140, DOI 10.1109/TIT.2008.929939; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Falconer DS, 1981, INTRODUCTION TO QUAN; Freund Y, 2004, J MACH LEARN RES, V4, P933, DOI 10.1162/1532443041827916; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; GEORGE EI, 1993, J AM STAT ASSOC, V88, P881, DOI 10.2307/2290777; Gianola D, 2008, GENETICS, V178, P2289, DOI 10.1534/genetics.107.084285; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Gonzalez-Recio O, 2008, GENETICS, V178, P2305, DOI 10.1534/genetics.107.084293; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hayashi Takeshi, 2010, BMC Genet, V11, P3, DOI 10.1186/1471-2156-11-3; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2013, TRENDS GENET, V29, P206, DOI 10.1016/j.tig.2012.11.009; Herbrich R, 2000, ADV NEUR IN, P115; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Hofheinz N, 2014, G3-GENES GENOM GENET, V4, P539, DOI 10.1534/g3.113.010025; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Jarvelin K, 2000, P 23 ANN INT ACM SIG, P41; Kendall M. G., 1938, NEW MEASURE RANK COR; Kumar GR, 2010, BIOTECHNOL ADV, V28, P451, DOI 10.1016/j.biotechadv.2010.02.007; Kuo TM, 2014, PROCEEDINGS OF SIAM; Lee CP, 2014, NEURAL COMPUT, V26, P781, DOI 10.1162/NECO_a_00571; Li H, 2011, IEICE T INF SYST, VE94D, P1854, DOI 10.1587/transinf.E94.D.1854; LI P, 2008, ADV NEURAL INFORM PR, V20, P897; Li ZT, 2012, GENETICS, V190, P231, DOI 10.1534/genetics.111.134866; LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116; Liu T.-Y., 2009, FOUND TRENDS INF RET, V3, P225, DOI [DOI 10.1561/1500000016, DOI 10.1007/978-3-642-14267-3]; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Louppe G., 2014, ARXIV; Luan T, 2009, GENETICS, V183, P1119, DOI 10.1534/genetics.109.107391; Meuwissen THE, 2001, GENETICS, V157, P1819; Mutshinda CM, 2010, GENETICS, V186, P1067, DOI 10.1534/genetics.110.119586; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Perez-Rodriguez P, 2012, G3-GENES GENOM GENET, V2, P1595, DOI 10.1534/g3.112.003665; Piepho HP, 2009, CROP SCI, V49, P1165, DOI 10.2135/cropsci2008.10.0595; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Scholkopf B, 2001, LECT NOTES ARTIF INT, V2111, P416, DOI 10.1007/3-540-44581-1_27; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wahba G, 1990, SPLINE MODELS FOR OB, V59; Wu Q., 2008, MSRTR2008109; Yi NJ, 2008, GENETICS, V179, P1045, DOI 10.1534/genetics.107.085589; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780	58	25	25	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128570	10.1371/journal.pone.0128570	http://dx.doi.org/10.1371/journal.pone.0128570			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068103	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000019
J	Gachter, S; Starmer, C; Tufano, F				Gaechter, Simon; Starmer, Chris; Tufano, Fabio			Measuring the Closeness of Relationships: A Comprehensive Evaluation of the 'Inclusion of the Other in the Self' Scale	PLOS ONE			English	Article							MECHANICAL TURK; DICTATOR GAMES; ALTRUISM	Understanding the nature and influence of social relationships is of increasing interest to behavioral economists, and behavioral scientists more generally. In turn, this creates a need for tractable, and reliable, tools for measuring fundamental aspects of social relationships. We provide a comprehensive evaluation of the 'Inclusion of the Other in the Self' (IOS) Scale, a handy pictorial tool for measuring the subjectively perceived closeness of a relationship. The tool is highly portable, very easy for subjects to understand and takes less than 1 minute to administer. Across our three online studies with a diverse adult population (n = 772) we show that six different scales designed to measure relationship closeness are all highly significantly positively correlated with the IOS Scale. We then conduct a Principal Component Analysis to construct an Index of Relationship Closeness and find that it correlates very strongly (rho = 85) with the IOS Scale. We conclude that the IOS Scale is a psychologically meaningful and highly reliable measure of the subjective closeness of relationships.	[Gaechter, Simon; Starmer, Chris; Tufano, Fabio] Univ Nottingham, Sch Econ, Ctr Decis Res & Expt Econ, Nottingham NG7 2RD, England; [Gaechter, Simon] CESifo Network, Munich, Germany; [Gaechter, Simon] IZA Network, Bonn, Germany	University of Nottingham; Ifo Institut; IZA Institute Labor Economics	Gachter, S (corresponding author), Univ Nottingham, Sch Econ, Ctr Decis Res & Expt Econ, Univ Pk, Nottingham NG7 2RD, England.	simon.gaechter@nottingham.ac.uk	Starmer, Chris/K-8891-2018; Gachter, Simon/C-9787-2009	Starmer, Chris/0000-0001-7705-0127; Gachter, Simon/0000-0002-7182-8505; Tufano, Fabio/0000-0002-7774-5647	European Research Council [295707]; UK Economic and Social Research Coincil [ES/K002201/1]; ESRC [ES/K002201/1] Funding Source: UKRI; Economic and Social Research Council [ES/K002201/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); UK Economic and Social Research Coincil; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Funding was received from the European Research Council (http://erc.europa.eu/) Advanced Investigator Grant COOPERATION 295707 and the UK Economic and Social Research Coincil (http://www.esrc.ac.uk/) grant ES/K002201/1 (Network for Integrated Behavioural Science). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031461; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; ARON A, 1991, J PERS SOC PSYCHOL, V60, P241, DOI 10.1037/0022-3514.60.2.241; Banerjee A, 2013, SCIENCE, V341, P363, DOI 10.1126/science.1236498; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; BERSCHEID E, 1989, J PERS SOC PSYCHOL, V57, P792, DOI 10.1037/0022-3514.57.5.792; Bohnet I, 1999, J ECON BEHAV ORGAN, V38, P43, DOI 10.1016/S0167-2681(98)00121-8; Branas-Garza P, 2010, GAME ECON BEHAV, V69, P249, DOI 10.1016/j.geb.2009.10.014; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cialdini RB, 1997, J PERS SOC PSYCHOL, V73, P481, DOI 10.1037/0022-3514.73.3.481; Fehr E, 2000, J ECON PERSPECT, V14, P159, DOI 10.1257/jep.14.3.159; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Gintis H., 2005, MORAL SENTIMENTS MAT; Goeree JK, 2010, AM ECON J-MICROECON, V2, P183, DOI 10.1257/mic.2.1.183; Goodman JK, 2013, J BEHAV DECIS MAKING, V26, P213, DOI 10.1002/bdm.1753; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Hoffman E, 1996, AM ECON REV, V86, P653; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; John O. P., 2000, HDB RES METHODS SOCI, P339; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Paolacci G, 2014, CURR DIR PSYCHOL SCI, V23, P184, DOI 10.1177/0963721414531598; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; PAULHUS DL, 1991, J PERS SOC PSYCHOL, V60, P307, DOI 10.1037/0022-3514.60.2.307; Peterson D.R., 1983, CLOSE RELATIONSHIPS; RUBIN Z, 1970, J PERS SOC PSYCHOL, V16, P265, DOI 10.1037/h0029841; Starzyk KB, 2006, J PERS SOC PSYCHOL, V90, P833, DOI 10.1037/0022-3514.90.5.833	27	109	111	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129478	10.1371/journal.pone.0129478	http://dx.doi.org/10.1371/journal.pone.0129478			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26068873	gold, Green Published, Green Submitted			2022-12-27	WOS:000356327000081
J	Han, P; Liu, SB; Zhang, MT; Zhao, J; Wang, YQ; Wu, GC; Mi, WL				Han, Ping; Liu, Shenbin; Zhang, Mengting; Zhao, Jing; Wang, Yanqing; Wu, Gencheng; Mi, Wenli			Inhibition of Spinal Interlukin-33/ST2 Signaling and Downstream ERK and JNK Pathways in Electroacupuncture Analgesia in Formalin Mice	PLOS ONE			English	Article							INDUCED INFLAMMATORY PAIN; ADJUNCTIVE THERAPY; ANTI-HYPERALGESIA; CONTROLLED-TRIAL; ACUPUNCTURE; RATS; INTERLEUKIN-33; MODEL; IL-33; INVOLVEMENT	Although acupuncture is widely used to manage pain, it remains highly controversial, largely due to the lack of a clear mechanism for its benefits. Here, we investigated the role of IL-33, a novel interleukin (IL)-1 family member, and its receptor ST2 in the analgesic effects of electroacupuncture (EA) on formalin-induced inflammatory pain. The results showed that 1) EA stimulation of ipsilateral Zusanli (ST 36) and Yanglingquan (GB 34) acupoints for 30 min remarkably suppressed the two phases of formalin-induced spontaneous pain; 2) subcutaneous or intrathecal administration of recombinant IL-33 (rIL-33) significantly inhibited the analgesic effect of EA, whereas the ST2 antibody potentiated EA analgesia in formalin mice; 3) EA treatment decreased the up-regulation of IL-33 and ST2 protein following formalin injection; and 4) the suppression of the formalin-induced expression of spinal phosphorylated ERK and JNK induced by EA treatment was significantly attenuated following subcutaneous rIL-33 delivery, and was further decreased by the ST2 antibody. These data suggest that EA alleviates formalin-induced inflammatory pain, at least partially, by inhibiting of spinal IL-33/ST2 signaling and the downstream ERK and JNK pathways.	[Han, Ping; Liu, Shenbin; Zhang, Mengting; Zhao, Jing; Wang, Yanqing; Wu, Gencheng; Mi, Wenli] Fudan Univ, Dept Integrat Med & Neurobiol, Collaborat Innovat Ctr Brain Sci, Sch Basic Med Sci,State Key Lab Med Neurobiol,Ins, Shanghai 200433, Peoples R China; [Han, Ping] Shanghai Jiao Tong Univ, Med X Res Inst, Neurosci & Neuroengn Ctr, Shanghai 200030, Peoples R China	Fudan University; Shanghai Jiao Tong University	Mi, WL (corresponding author), Fudan Univ, Dept Integrat Med & Neurobiol, Collaborat Innovat Ctr Brain Sci, Sch Basic Med Sci,State Key Lab Med Neurobiol,Ins, Shanghai 200433, Peoples R China.	wenlimi@fudan.edu.cn	Mi, Wenli/P-5541-2019; Han, Ping/GYD-5588-2022	Han, Ping/0000-0001-7945-2613	National Key Basic Research Program of China [2013CB531906]; National Natural Science Foundation of China [31000495, 81171045, 81371247, 81473749]; National Natural Science Foundation of Shanghai [15ZR1402800]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Shanghai	This work was supported by the National Key Basic Research Program of China (2013CB531906), the National Natural Science Foundation of China (31000495, 81171045, 81371247, and 81473749) and the National Natural Science Foundation of Shanghai (15ZR1402800).	Andre R, 2005, J NEUROCHEM, V95, P324, DOI 10.1111/j.1471-4159.2005.03364.x; Berman BM, 2004, ANN INTERN MED, V141, P901, DOI 10.7326/0003-4819-141-12-200412210-00006; Chang KH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/324039; Chen XY, 2013, J PAIN, V14, P1310, DOI 10.1016/j.jpain.2013.05.011; Choi SS, 2006, BRAIN RES, V1108, P28, DOI 10.1016/j.brainres.2006.06.048; Crown ED, 2012, EXP NEUROL, V234, P330, DOI 10.1016/j.expneurol.2011.10.019; Du Jing, 2008, Zhen Ci Yan Jiu, V33, P37; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Fang JQ, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-13; Funakoshi-Tago M, 2011, CELL SIGNAL, V23, P363, DOI 10.1016/j.cellsig.2010.10.006; Goldman N, 2010, NAT NEUROSCI, V13, P883, DOI 10.1038/nn.2562; Han JS, 2003, TRENDS NEUROSCI, V26, P17, DOI 10.1016/S0166-2236(02)00006-1; Han P, 2013, NEUROSCIENCE, V241, P59, DOI 10.1016/j.neuroscience.2013.03.019; Han P, 2011, NEUROSCI BULL, V27, P351, DOI 10.1007/s12264-011-1025-5; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Jiang HR, 2012, EUR J IMMUNOL, V42, P1804, DOI 10.1002/eji.201141947; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Lee JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073948; Leung L, 2012, J ACUPUNCT MERIDIAN, V5, P261, DOI 10.1016/j.jams.2012.07.017; Magro DAC, 2013, BRAZ J MED BIOL RES, V46, P601, DOI 10.1590/1414-431X20132894; Mao-Ying QL, 2006, EUR J PAIN, V10, P689, DOI 10.1016/j.ejpain.2005.11.001; Martin MU, 2013, SEMIN IMMUNOL, V25, P449, DOI 10.1016/j.smim.2013.10.006; Mavrommatis CI, 2012, PAIN, V153, P1720, DOI 10.1016/j.pain.2012.05.005; Mi WL, 2008, BRAIN RES BULL, V77, P98, DOI 10.1016/j.brainresbull.2008.04.008; Mi WL, 2011, J PAIN, V12, P974, DOI 10.1016/j.jpain.2011.03.002; Miller AM, 2011, PHARMACOL THERAPEUT, V131, P179, DOI 10.1016/j.pharmthera.2011.02.005; Park JY, 2014, J PAIN; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Song MJ, 2009, BRAIN RES BULL, V78, P335, DOI 10.1016/j.brainresbull.2008.10.009; Su TF, 2012, EUR J PAIN, V16, P624, DOI 10.1002/j.1532-2149.2011.00055.x; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Vas J, 2012, PAIN, V153, P1883, DOI 10.1016/j.pain.2012.05.033; Verri WA, 2008, P NATL ACAD SCI USA, V105, P2723, DOI 10.1073/pnas.0712116105; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; Villarreal DO, 2014, CURR OPIN IMMUNOL, V28, P102, DOI 10.1016/j.coi.2014.03.004; Yasuoka S, 2011, BRAIN RES, V1385, P8, DOI 10.1016/j.brainres.2011.02.045; Yi M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-61; Zarpelon AC, 2013, BRIT J PHARMACOL, V169, P90, DOI 10.1111/bph.12110; Zhang RX, 2014, ANESTHESIOLOGY, V120, P482, DOI 10.1097/ALN.0000000000000101; Zhao J, 2013, NEUROSCIENCE, V253, P172, DOI 10.1016/j.neuroscience.2013.08.026; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	42	24	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129576	10.1371/journal.pone.0129576	http://dx.doi.org/10.1371/journal.pone.0129576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067287	Green Published, gold, Green Submitted			2022-12-27	WOS:000356327000092
J	Lopez-Panades, E; Gavis, ER; Casacuberta, E				Lopez-Panades, Elisenda; Gavis, Elizabeth R.; Casacuberta, Elena			Specific Localization of the Drosophila Telomere Transposon Proteins and RNAs, Give Insight in Their Behavior, Control and Telomere Biology in This Organism	PLOS ONE			English	Article							HET-A; GAG PROTEINS; RETROTRANSPOSONS; ELEMENTS; MELANOGASTER; CHROMOSOME; EXPRESSION; PATHWAY; MAINTENANCE; ELONGATION	Drosophila telomeres constitute a remarkable exception to the telomerase mechanism. Although maintaining the same cytological and functional properties as telomerase maintain telomeres, Drosophila telomeres embed the telomere retrotransposons whose specific and highly regulated terminal transposition maintains the appropriate telomere length in this organism. Nevertheless, our current understanding of how the mechanism of the retrotransposon telomere works and which features are shared with the telomerase system is very limited. We report for the first time a detailed study of the localization of the main components that constitute the telomeres in Drosophila, HeT-A and TART RNAs and proteins. Our results in wild type and mutant strains reveal localizations of HeT-A Gag and TART Pol that give insight in the behavior of the telomere retrotransposons and their control. We find that TART Pol and HeT-A Gag only co-localize at the telomeres during the interphase of cells undergoing mitotic cycles. In addition, unexpected protein and RNA localizations with a well-defined pattern in cells such as the ovarian border cells and nurse cells, suggest possible strategies for the telomere transposons to reach the oocyte, and/or additional functions that might be important for the correct development of the organism. Finally, we have been able to visualize the telomere RNAs at different ovarian stages of development in wild type and mutant lines, demonstrating their presence in spite of being tightly regulated by the piRNA mechanism.	[Lopez-Panades, Elisenda; Casacuberta, Elena] CSIC, UPF, Inst Evolutionary Biol, Dept Comparat Genom, Barcelona, Spain; [Gavis, Elizabeth R.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Princeton University	Casacuberta, E (corresponding author), CSIC, UPF, Inst Evolutionary Biol, Dept Comparat Genom, Barcelona, Spain.	elena.casacuberta@ibe.upf-csic.es		Casacuberta, Elena/0000-0002-8203-8357; Gavis, Elizabeth/0000-0003-0251-0760	Spanish Ministry of Science and Innovation [BFU2009-08318/BMC]; National Institutes of Health [R01GM067758]; Ruth Lee Kennedy (Fulbright) Fellowship; EMBO short term Fellowship; Journal Cell Science traveling Fellowship; Spanish Society of Genetics traveling fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061107, R01GM067758] Funding Source: NIH RePORTER	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth Lee Kennedy (Fulbright) Fellowship; EMBO short term Fellowship(European Molecular Biology Organization (EMBO)); Journal Cell Science traveling Fellowship; Spanish Society of Genetics traveling fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Spanish Ministry of Science and Innovation BFU2009-08318/BMC to EC. A National Institutes of Health grant R01GM067758 to ERG. EL-P acknowledges the following short term Fellowships: Ruth Lee Kennedy (Fulbright), EMBO short term, Journal Cell Science traveling Fellowship, and the Spanish Society of Genetics traveling fellowship.	Arbouzova NI, 2006, CURR BIOL, V16, P80, DOI 10.1016/j.cub.2005.11.033; Becalska AN, 2009, DEVELOPMENT, V136, P2493, DOI 10.1242/dev.032391; Bilder D, 2012, DEV CELL, V22, P12, DOI 10.1016/j.devcel.2011.12.003; Casacuberta E, 2005, CYTOGENET GENOME RES, V110, P152, DOI 10.1159/000084947; Casacuberta E, 2003, P NATL ACAD SCI USA, V100, P14091, DOI 10.1073/pnas.1936193100; Casacuberta E, 2003, P NATL ACAD SCI USA, V100, P3363, DOI 10.1073/pnas.0230353100; Casacuberta E, 2002, GENETICS, V161, P1113; Casacuberta E, 2007, P NATL ACAD SCI USA, V104, P8391, DOI 10.1073/pnas.0702566104; Cenci G, 2003, NAT CELL BIOL, V5, P82, DOI 10.1038/ncb902; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Danilevskaya ON, 1999, MOL CELL BIOL, V19, P873; Dufourt J, 2014, NUCLEIC ACIDS RES, V42, P2512, DOI 10.1093/nar/gkt1184; George JA, 2003, GENETICS, V163, P625; George JA, 2006, GENOME RES, V16, P1231, DOI 10.1101/gr.5348806; Gonzalez J, 2012, METHODS MOL BIOL, V855, P361, DOI 10.1007/978-1-61779-582-4_13; Guzzardo PM, 2013, CURR OPIN GENET DEV, V23, P44, DOI 10.1016/j.gde.2012.12.003; Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515; Hrdlickova R, 2012, MOL CELL BIOL, V32, P4283, DOI 10.1128/MCB.00550-12; Montell DJ, 2012, NAT REV MOL CELL BIO, V13, P631, DOI 10.1038/nrm3433; Ovando-Roche P, 2014, STEM CELLS, V32, P2111, DOI 10.1002/stem.1725; Pardue ML, 2008, FLY, V2, P101, DOI 10.4161/fly.6393; Petit N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037405; Pickett HA, 2012, CELL CYCLE, V11, P1309, DOI 10.4161/cc.19632; Pineyro D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-573; Rashkova S, 2003, J VIROL, V77, P6376, DOI 10.1128/JVI.77.11.6376-6384.2003; Rashkova S, 2002, J CELL BIOL, V159, P397, DOI 10.1083/jcb.200205039; Sahara K, 1999, CHROMOSOME RES, V7, P449, DOI 10.1023/A:1009297729547; Savitsky M, 2006, GENE DEV, V20, P345, DOI 10.1101/gad.370206; SCHUPBACH T, 1991, GENETICS, V129, P1119; Shpiz Sergey, 2011, Mob Genet Elements, V1, P274; Shpiz S, 2011, NUCLEIC ACIDS RES, V39, P8703, DOI 10.1093/nar/gkr552; Shpiz S, 2009, NUCLEIC ACIDS RES, V37, P268, DOI 10.1093/nar/gkn960; Silva-Sousa R, 2012, GENOME DYNAM, V7, P46, DOI 10.1159/000337127; Silva-Sousa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081543; Silva-Sousa R, 2013, MOBILE DNA-UK, V4, DOI 10.1186/1759-8753-4-18; Silva-Sousa R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003153; Siriaco GM, 2002, GENETICS, V160, P235; Veraksa A, 2005, DEV DYNAM, V232, P827, DOI 10.1002/dvdy.20272; Villasante A, 2007, GENOME RES, V17, P1909, DOI 10.1101/gr.6365107; Wesolowska N, 2013, GENETICS, V195, P381, DOI 10.1534/genetics.113.155408; Wong LH, 2010, EPIGENOMICS-UK, V2, P639, DOI [10.2217/epi.10.49, 10.2217/EPI.10.49]; Wu XD, 2008, SEMIN CELL DEV BIOL, V19, P271, DOI 10.1016/j.semcdb.2008.01.004; Ye J, 2014, NAT REV GENET, V15, P491, DOI 10.1038/nrg3743; Zhang L, 2014, EMBO J, V33, P1148, DOI 10.1002/embj.201386940; Zhao ZR, 2014, J CELL PHYSIOL, V229, P1323, DOI 10.1002/jcp.24537	46	7	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128573	10.1371/journal.pone.0128573	http://dx.doi.org/10.1371/journal.pone.0128573			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068215	Green Submitted, Green Published, gold			2022-12-27	WOS:000356327000020
J	Je, IG; Kim, DS; Kim, SW; Lee, S; Lee, HS; Park, EK; Khang, D; Kim, SH				Je, In-Gyu; Kim, Duk-Sil; Kim, Sung-Wan; Lee, Soyoung; Lee, Hyun-Shik; Park, Eui Kyun; Khang, Dongwoo; Kim, Sang-Hyun			Tyrosol Suppresses Allergic Inflammation by Inhibiting the Activation of Phosphoinositide 3-Kinase in Mast Cells	PLOS ONE			English	Article							HISTAMINE-RELEASE; EFFECTOR; CALCIUM; ANAPHYLAXIS; MECHANISMS; IGE	Allergic diseases such as atopic dermatitis, rhinitis, asthma, and anaphylaxis are attractive research areas. Tyrosol (2-(4-hydroxyphenyl)ethanol) is a polyphenolic compound with diverse biological activities. In this study, we investigated whether tyrosol has anti-allergic inflammatory effects. Ovalbumin-induced active systemic anaphylaxis and immunoglobulin E-mediated passive cutaneous anaphylaxis models were used for the immediate-type allergic responses. Oral administration of tyrosol reduced the allergic symptoms of hypothermia and pigmentation in both animal models. Mast cells that secrete allergic mediators are key regulators on allergic inflammation. Tyrosol dose-dependently decreased mast cell degranulation and expression of inflammatory cytokines. Intracellular calcium levels and activation of inhibitor of kappa B kinase (IKK) regulate cytokine expression and degranulation. Tyrosol blocked calcium influx and phosphorylation of the IKK complex. To define the molecular target for tyrosol, various signaling proteins involved in mast cell activation such as Lyn, Syk, phosphoinositide 3-kinase (PI3K), and Akt were examined. Our results showed that PI3K could be a molecular target for tyrosol in mast cells. Taken together, these findings indicated that tyrosol has anti-allergic inflammatory effects by inhibiting the degranulation of mast cells and expression of inflammatory cytokines; these effects are mediated via PI3K. Therefore, we expect tyrosol become a potential therapeutic candidate for allergic inflammatory disorders.	[Je, In-Gyu; Lee, Soyoung; Kim, Sang-Hyun] Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Daegu 700422, South Korea; [Kim, Duk-Sil; Kim, Sung-Wan] CHA Univ, CHA Gumi Med Ctr, Dept Thorac & Cardiovasc Surg, Gumi 730040, South Korea; [Lee, Hyun-Shik] Kyungpook Natl Univ, Sch Life Sci, Daegu 702701, South Korea; [Park, Eui Kyun] Kyungpook Natl Univ, Sch Dent, Dept Oral Pathol & Regenerat Med, Daegu 700412, South Korea; [Khang, Dongwoo] Gachon Univ, Sch Med, Dept Mol Med, Inchon 406840, South Korea	Kyungpook National University; Pochon Cha University; Kyungpook National University; Kyungpook National University; Gachon University	Kim, SH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Daegu 700422, South Korea.	shkim72@knu.ac.kr		Khang, Dongwoo/0000-0003-2353-8017	National Research Foundation of Korea - Korea government [2014R1A5A2009242, 2013R1A1A3009525]	National Research Foundation of Korea - Korea government(National Research Foundation of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea grant funded by the Korea government (2014R1A5A2009242 and 2013R1A1A3009525). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Bae Y, 2011, TOXICOL APPL PHARM, V254, P56, DOI 10.1016/j.taap.2011.04.008; Beghdadi W, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00037; Bertelli AAE, 2002, ANN NY ACAD SCI, V957, P295, DOI 10.1111/j.1749-6632.2002.tb02929.x; Blank U, 2002, MOL IMMUNOL, V38, P1341, DOI 10.1016/S0161-5890(02)00085-8; Brandt Eric B, 2011, J Clin Cell Immunol, V2; Choi JK, 2014, AM J CHINESE MED, V42, P967, DOI 10.1142/S0192415X1450061X; Finkelman FD, 2005, J ALLERGY CLIN IMMUN, V115, P449, DOI 10.1016/j.jaci.2004.12.1125; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Ishikawa R, 2010, BIOCHEM BIOPH RES CO, V402, P742, DOI 10.1016/j.bbrc.2010.10.098; Je IG, 2015, EXP BIOL MED, V240, P631, DOI 10.1177/1535370214555663; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kambayashi T, 2007, J ALLERGY CLIN IMMUN, V119, P544, DOI 10.1016/j.jaci.2007.01.017; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kim HH, 2014, TOXICOL APPL PHARM, V274, P455, DOI 10.1016/j.taap.2013.12.006; Kim HH, 2013, FOOD CHEM TOXICOL, V57, P209, DOI 10.1016/j.fct.2013.03.015; Kim SH, 2006, TOXICOL SCI, V91, P123, DOI 10.1093/toxsci/kfj063; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Krause K, 2012, CURR OPIN ALLERGY CL, V12, P477, DOI 10.1097/ACI.0b013e3283574d0c; Lecci RM, 2014, ANTI-CANCER AGENT ME, V14, P1363, DOI 10.2174/1871520614666140922121014; Li JX, 2013, ADV IMMUNOL, V119, P135, DOI 10.1016/B978-0-12-407707-2.00005-9; Lu J, 2013, FOOD CHEM TOXICOL, V62, P172, DOI 10.1016/j.fct.2013.08.031; Manikandan J, 2012, CELL MOL LIFE SCI, V69, P1917, DOI 10.1007/s00018-011-0886-0; Palmieri D, 2012, MICROVASC RES, V83, P281, DOI 10.1016/j.mvr.2012.02.010; Ribeiro J, 2014, J ETHNOPHARMACOL, V155, P1118, DOI 10.1016/j.jep.2014.06.041; Seo BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095588; Sismanopoulos N, 2012, CURR PHARM DESIGN, V18, P2261, DOI 10.2174/138161212800165997; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Tanaka S, 2005, EUR J IMMUNOL, V35, P460, DOI 10.1002/eji.200425622; Tuck KL, 2002, J NUTR BIOCHEM, V13, P636, DOI 10.1016/S0955-2863(02)00229-2; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; WERSHIL BK, 1995, J IMMUNOL, V154, P1391	36	28	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129829	10.1371/journal.pone.0129829	http://dx.doi.org/10.1371/journal.pone.0129829			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068872	gold, Green Submitted, Green Published			2022-12-27	WOS:000356100900081
J	Kimura, T; Takahashi, S; Takahashi, I; Nishibuchi, I; Doi, Y; Kenjo, M; Murakami, Y; Honda, Y; Aikata, H; Chayama, K; Nagata, Y				Kimura, Tomoki; Takahashi, Shigeo; Takahashi, Ippei; Nishibuchi, Ikuno; Doi, Yoshiko; Kenjo, Masahiro; Murakami, Yuji; Honda, Yohji; Aikata, Hiroshi; Chayama, Kazuaki; Nagata, Yasushi			The Time Course of Dynamic Computed Tomographic Appearance of Radiation Injury to the Cirrhotic Liver Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma	PLOS ONE			English	Article							GD-EOB-DTPA; RADIOTHERAPY; CT; HEPATITIS; DISEASE	This study aimed to evaluate the dynamic computed tomographic (CT) appearance of focal radiation injury to cirrhotic liver tissue around the tumor following stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC). Seventy-seven patients with 92 HCCs were observed for >6 months. Sixty-four and 13 patients belonged to Child-Pugh class A and B, respectively. The median SBRT dose was 48 Gy/4fr. Dynamic CT scans were performed in non-enhanced, arterial, portal, and venous phases. The median follow-up period was 18 months. Dynamic CT appearances were classified into 3 types: type 1, hyperdensity in all enhanced phases; type 2, hypodensity in arterial and portal phases; type 3, isodensity in all enhanced phases. Half of the type 2 or 3 appearances significantly changed to type 1, particularly in patients belonging to Child-Pugh class A. After 3-6 months, Child-Pugh class B was a significant factor in type 3 patients. Thus, dynamic CT appearances were classified into 3 patterns and significantly changed over time into the enhancement group (type 1) in most patients belonging to Child-Pugh class A. Child-Pugh class B was a significant factor in the non-enhancement group (type 3).	[Kimura, Tomoki; Takahashi, Ippei; Nishibuchi, Ikuno; Doi, Yoshiko; Kenjo, Masahiro; Murakami, Yuji; Nagata, Yasushi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Radiat Oncol, Hiroshima, Japan; [Takahashi, Shigeo] Kagawa Univ Hosp, Dept Radiat Oncol, Takamatsu, Kagawa, Japan; [Honda, Yohji; Aikata, Hiroshi; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Div Frontier Med Sci, Dept Med & Mol Sci, Hiroshima, Japan	Hiroshima University; Kagawa University; Hiroshima University	Kimura, T (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Radiat Oncol, Hiroshima, Japan.	tkkimura@hiroshima-u.ac.jp	Chayama, Kazuaki/B-2493-2016	Chayama, Kazuaki/0000-0002-5530-5341; Takahashi, Shigeo/0000-0002-1043-3171	Ministry of Education, Culture, Sports, Science and Technology of Japan [22591385]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant no. 22591385).	Andolino DL, 2011, INT J RADIAT ONCOL, V81, pE447, DOI 10.1016/j.ijrobp.2011.04.011; Fukumitsu N, 2009, INT J RADIAT ONCOL, V74, P831, DOI 10.1016/j.ijrobp.2008.10.073; Guha C, 2011, SEMINARS RAD ONCOLOG, V21, P236; Hashimoto K, 2006, ONCOL REP, V16, P677; Herfarth KK, 2003, INT J RADIAT ONCOL, V57, P444, DOI 10.1016/S0360-3016(03)00586-8; Kato H, 2004, INT J RADIAT ONCOL, V59, P1468, DOI 10.1016/j.ijrobp.2004.01.032; Kimura T, 2004, INT J RADIAT ONCOL, V60, P1307, DOI 10.1016/j.ijrobp.2004.07.718; Kimura T, 2013, HEPATOL RES, V43, P717, DOI 10.1111/hepr.12007; LEEN E, 1993, GUT, V34, P554, DOI 10.1136/gut.34.4.554; Motosugi U, 2009, J MAGN RESON IMAGING, V30, P1042, DOI 10.1002/jmri.21956; OKUMURA T, 1994, J COMPUT ASSIST TOMO, V18, P821, DOI 10.1097/00004728-199409000-00025; Olsen CC, 2009, INT J RADIAT ONCOL, V73, P1414, DOI 10.1016/j.ijrobp.2008.07.032; REICHEN J, 1988, J CLIN INVEST, V82, P2069, DOI 10.1172/JCI113828; Sanuki N, 2014, INT J RADIAT ONCOL, V88, P306, DOI 10.1016/j.ijrobp.2013.10.045; Sanuki-Fujimoto N, 2010, BRIT J RADIOL, V83, P1063, DOI 10.1259/bjr/74105551; Sempoux C, 1997, HEPATOLOGY, V26, P128; Takeda A, 2008, HEPATOL RES, V38, P60, DOI 10.1111/j.1872-034X.2007.00084.x; UNGER EC, 1987, J COMPUT ASSIST TOMO, V11, P264, DOI 10.1097/00004728-198703000-00013; Willemart S, 2000, BRIT J RADIOL, V73, P544, DOI 10.1259/bjr.73.869.10884753; Wulf J, 2005, STEROTACTIC BODY RADIATION THERAPY, P39	20	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0125231	10.1371/journal.pone.0125231	http://dx.doi.org/10.1371/journal.pone.0125231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067065	gold, Green Submitted, Green Published			2022-12-27	WOS:000356100900005
J	Maurya, DK; Henriques, T; Marini, M; Pedemonte, N; Galietta, LJV; Rock, JR; Harfe, BD; Menini, A				Maurya, Devendra Kumar; Henriques, Tiago; Marini, Monica; Pedemonte, Nicoletta; Galietta, Luis J. V.; Rock, Jason R.; Harfe, Brian D.; Menini, Anna			Development of the Olfactory Epithelium and Nasal Glands in TMEM16A(-/-) and TMEM16A(+/+) Mice	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; CA2+-ACTIVATED CL-CHANNEL; GLOBOSE BASAL-CELLS; ANOCTAMIN 1; TRANSMEMBRANE PROTEIN; MOUSE; EXPRESSION; ANO1; CANCER; MARKER	TMEM16A/ANO1 is a calcium-activated chloride channel expressed in several types of epithelia and involved in various physiological processes, including proliferation and development. During mouse embryonic development, the expression of TMEM16A in the olfactory epithelium is dynamic. TMEM16A is expressed at the apical surface of the entire olfactory epithelium at embryonic day E12.5 while from E16.5 its expression is restricted to a region near the transition zone with the respiratory epithelium. To investigate whether TMEM16A plays a role in the development of the mouse olfactory epithelium, we obtained the first immunohistochemistry study comparing the morphological properties of the olfactory epithelium and nasal glands in TMEM16A(-/-) and TMEM16A(+/+) littermate mice. A comparison between the expression of the olfactory marker protein and adenylyl cyclase III shows that genetic ablation of TMEM16A did not seem to affect the maturation of olfactory sensory neurons and their ciliary layer. As TMEM16A is expressed at the apical part of supporting cells and in their microvilli, we used ezrin and cytokeratin 8 as markers of microvilli and cell body of supporting cells, respectively, and found that morphology and development of supporting cells were similar in TMEM16A(-/-) and TMEM16A(+/+) littermate mice. The average number of supporting cells, olfactory sensory neurons, horizontal and globose basal cells were not significantly different in the two types of mice. Moreover, we also observed that the morphology of Bowman's glands, nasal septal glands and lateral nasal glands did not change in the absence of TMEM16A. Our results indicate that the development of mouse olfactory epithelium and nasal glands does not seem to be affected by the genetic ablation of TMEM16A.	[Maurya, Devendra Kumar; Henriques, Tiago; Menini, Anna] Scuola Int Super Studi Avanzati, SISSA, Lab Olfactory Transduct, Trieste, Italy; [Marini, Monica; Pedemonte, Nicoletta; Galietta, Luis J. V.] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Rock, Jason R.] UCSF Sch Med, Dept Anat, San Francisco, CA USA; [Harfe, Brian D.] Univ Florida, Coll Med, Dept Mol Genet, Gainesville, FL USA; [Harfe, Brian D.] Univ Florida, Coll Med, Microbiol Genet Inst, Gainesville, FL USA	International School for Advanced Studies (SISSA); University of Genoa; IRCCS Istituto Giannina Gaslini; University of California System; University of California San Francisco; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Menini, A (corresponding author), Scuola Int Super Studi Avanzati, SISSA, Lab Olfactory Transduct, Trieste, Italy.	menini@sissa.it	Galietta, Luis JV/HCG-8692-2022; Henriques, Tiago/AAE-2951-2019; Maurya, Devendra Kumar/GZL-1112-2022; Pedemonte, Nicoletta/B-3607-2010	Henriques, Tiago/0000-0001-6075-2368; Maurya, Devendra Kumar/0000-0001-6052-4314; Pedemonte, Nicoletta/0000-0002-5161-1720; Menini, Anna/0000-0001-9304-0412; Galietta, Luis/0000-0001-8686-3461	Italian Ministry of Education, Universities, and Research (MIUR)	Italian Ministry of Education, Universities, and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by a grant (to AM) from the Italian Ministry of Education, Universities, and Research (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablimit A, 2006, ARCH HISTOL CYTOL, V69, P1, DOI 10.1679/aohc.69.1; Ayoub C, 2010, BRIT J CANCER, V103, P715, DOI 10.1038/sj.bjc.6605823; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; CASANOVA L, 1995, J CELL SCI, V108, P811; Chen MF, 2014, J NEUROSCI, V34, P8268, DOI 10.1523/JNEUROSCI.0240-14.2014; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Coulombe PA, 1993, CURR OPIN CELL BIOL, V5, P17, DOI 10.1016/S0955-0674(05)80004-3; CUSCHIERI A, 1975, J ANAT, V119, P277; Dal Col JA, 2007, DEVELOPMENT, V134, P2481, DOI 10.1242/dev.006346; Dauner K, 2012, CELL TISSUE RES, V347, P327, DOI 10.1007/s00441-012-1324-9; Dibattista M, 2012, J GEN PHYSIOL, V140, P3, DOI 10.1085/jgp.201210780; DRENCKHAHN D, 1988, J CELL BIOL, V107, P1037, DOI 10.1083/jcb.107.3.1037; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; Espinosa I, 2008, AM J SURG PATHOL, V32, P210, DOI 10.1097/PAS.0b013e3181238cec; Farbman Albert I., 1994, Seminars in Cell Biology, V5, P3; Fletcher RB, 2011, NEURON, V72, P748, DOI 10.1016/j.neuron.2011.09.009; FRANKE WW, 1982, DIFFERENTIATION, V23, P43, DOI 10.1111/j.1432-0436.1982.tb01266.x; FRISCH D, 1967, AM J ANAT, V121, P87, DOI 10.1002/aja.1001210107; Galindo BE, 2005, INT J MOL MED, V16, P919; GETCHELL TV, 1984, PROG NEUROBIOL, V23, P317, DOI 10.1016/0301-0082(84)90008-X; Gokoffski KK, 2011, DEVELOPMENT, V138, P4131, DOI 10.1242/dev.065870; Gritli-Linde A, 2009, GENE EXPR PATTERNS, V9, P178, DOI 10.1016/j.gep.2008.11.002; Guo Z, 2010, J COMP NEUROL, V518, P4395, DOI 10.1002/cne.22463; HOLBROOK EH, 1995, J COMP NEUROL, V363, P129, DOI 10.1002/cne.903630111; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Huang X, 2006, GENE CHROMOSOME CANC, V45, P1058, DOI 10.1002/gcc.20371; Jang W, 2014, J COMP NEUROL, V522, P731, DOI 10.1002/cne.23470; Jang Y, 2014, CELL CALCIUM, V55, P355, DOI 10.1016/j.ceca.2014.02.006; Jeon JH, 2013, PLOS ONE, V6, P1, DOI DOI 10.1371/J0UR-NAL.P0NE.0067989; Jeon JH, 2011, CELL TISSUE RES, V345, P223, DOI 10.1007/s00441-011-1206-6; Kashyap MK, 2009, CANCER BIOL THER, V8, P36, DOI 10.4161/cbt.8.1.7090; KELLER A, 1975, J NEUROCHEM, V24, P1101, DOI 10.1111/j.1471-4159.1975.tb03883.x; Krolewski RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051737; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Maurya DK, 2014, DEV NEUROBIOL, V74, P657, DOI 10.1002/dneu.22159; Mazzone A, 2011, J BIOL CHEM, V286, P13393, DOI 10.1074/jbc.M110.196089; Mercer AJ, 2011, J NEUROPHYSIOL, V105, P321, DOI 10.1152/jn.00332.2010; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Ohta Y, 2000, ANN OTO RHINOL LARYN, V109, P1046, DOI 10.1177/000348940010901110; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Perez-Cornejo P, 2012, P NATL ACAD SCI USA, V109, P10376, DOI 10.1073/pnas.1200174109; Qu ZQ, 2014, CANCER MED-US, V3, P453, DOI 10.1002/cam4.232; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Ruiz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043265; Ruppersburg CC, 2014, MOL BIOL CELL, V25, P1793, DOI 10.1091/mbc.E13-10-0599; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; SMART IHM, 1971, J ANAT, V109, P243; Solbu TT, 2012, CHEM SENSES, V37, P35, DOI 10.1093/chemse/bjr063; Stanich JE, 2011, AM J PHYSIOL-GASTR L, V301, pG1044, DOI 10.1152/ajpgi.00196.2011; Taniguchi K, 2008, J VET MED SCI, V70, P57, DOI 10.1292/jvms.70.57; Tsutsumi S, 2004, AM J HUM GENET, V74, P1255, DOI 10.1086/421527; Wanitchakool P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0096; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yi Eunyoung, 2013, Exp Neurobiol, V22, P322, DOI 10.5607/en.2013.22.4.322; Zou DJ, 2007, J NEUROSCI, V27, P6675, DOI 10.1523/JNEUROSCI.0699-07.2007	64	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129171	10.1371/journal.pone.0129171	http://dx.doi.org/10.1371/journal.pone.0129171			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067252	Green Published, gold, Green Submitted			2022-12-27	WOS:000356100900043
J	Verschueren, E; Spiess, M; Gkourtsa, A; Avula, T; Landgraf, C; Mancilla, VT; Huber, A; Volkmer, R; Winsor, B; Serrano, L; Hochstenbach, F; Distel, B				Verschueren, Erik; Spiess, Matthias; Gkourtsa, Areti; Avula, Teja; Landgraf, Christiane; Mancilla, Victor Tapia; Huber, Aline; Volkmer, Rudolf; Winsor, Barbara; Serrano, Luis; Hochstenbach, Frans; Distel, Ben			Evolution of the SH3 Domain Specificity Landscape in Yeasts	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; MYOSIN-I; ACTIN CYTOSKELETON; GENOME SEQUENCE; ARP2/3 COMPLEX; BAR; FISSION; BINDING; RVS167P; ENDOCYTOSIS	To explore the conservation of Src homology 3 (SH3) domain-mediated networks in evolution, we compared the specificity landscape of these domains among four yeast species, Saccharomyces cerevisiae, Ashbya gossypii, Candida albicans, and Schizosaccharomyces pombe, encompassing 400 million years of evolution. We first aligned and catalogued the families of SH3-containing proteins in these four species to determine the relationships between homologous domains. Then, we tagged and purified all soluble SH3 domains (82 in total) to perform a quantitative peptide assay (SPOT) for each SH3 domain. All SPOT read-outs were hierarchically clustered and we observed that the organization of the SH3 specificity landscape in three distinct profile classes remains conserved across these four yeast species. We also produced a specificity profile for each SH3 domain from manually aligned top SPOT hits and compared the within-family binding motif consensus. This analysis revealed a striking example of binding motif divergence in a C. albicans Rvs167 paralog, which cannot be explained by overall SH3 sequence or interface residue divergence, and we validated this specificity change with a yeast two-hybrid (Y2H) assay. In addition, we show that position-weighted matrices (PWM) compiled from SPOT assays can be used for binding motif screening in potential binding partners and present cases where motifs are either conserved or lost among homologous SH3 interacting proteins. Finally, by comparing pairwise SH3 sequence identity to binding profile correlation we show that for similar to 75% of all analyzed families the SH3 specificity profile was remarkably conserved over a large evolutionary distance. Thus, a high sequence identity within an SH3 domain family predicts conserved binding specificity, whereas divergence in sequence identity often coincided with a change in binding specificity within this family. As such, our results are important for future studies aimed at unraveling complex specificity networks of peptide recognition domains in higher eukaryotes, including mammals.	[Verschueren, Erik; Serrano, Luis] Ctr Genom Regulat CRG, EMBL CRG Syst Biol Res Unit, Barcelona, Spain; [Spiess, Matthias; Mancilla, Victor Tapia; Huber, Aline; Winsor, Barbara] Univ Strasbourg, Dept Mol & Cellular Genet, UMR7156, Strasbourg, France; [Spiess, Matthias; Mancilla, Victor Tapia; Huber, Aline; Winsor, Barbara] CNRS, Strasbourg, France; [Gkourtsa, Areti; Avula, Teja; Hochstenbach, Frans; Distel, Ben] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Landgraf, Christiane; Mancilla, Victor Tapia; Volkmer, Rudolf] Humboldt Univ, Inst Med Immunol, D-10099 Berlin, Germany	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Amsterdam; Academic Medical Center Amsterdam; Humboldt University of Berlin	Distel, B (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	b.distel@amc.uva.nl	Serrano, Luis/B-3355-2013	Serrano, Luis/0000-0002-5276-1392; Volkmer, Rudolf/0000-0003-4710-1143	European Union (Marie Curie Research Training Network Penelope) [MRTN-CT-2006-036076]	European Union (Marie Curie Research Training Network Penelope)	LS, BW, FH and BD received funding from the European Union (Marie Curie Research Training Network Penelope; MRTN-CT-2006-036076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson BL, 1998, J CELL BIOL, V141, P1357, DOI 10.1083/jcb.141.6.1357; Bon E, 2000, YEAST, V16, P1229, DOI 10.1002/1097-0061(20000930)16:13<1229::AID-YEA618>3.0.CO;2-Q; Borth N, 2010, MICROBIOL-SGM, V156, P2962, DOI 10.1099/mic.0.041707-0; Chae M, 2013, J BIOL CHEM, V288, P6427, DOI 10.1074/jbc.M112.449629; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Colwill K, 1999, GENETICS, V152, P881; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Dislich B, 2011, BIOCHEM J, V433, P75, DOI 10.1042/BJ20100709; Douangamath A, 2002, MOL CELL, V10, P1007, DOI 10.1016/S1097-2765(02)00749-9; Douglas LM, 2009, INFECT IMMUN, V77, P4150, DOI 10.1128/IAI.00683-09; Fernandez-Ballester G, 2004, J MOL BIOL, V335, P619, DOI 10.1016/j.jmb.2003.10.060; Fernandez-Ballester G, 2009, J MOL BIOL, V388, P902, DOI 10.1016/j.jmb.2009.03.038; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Friesen H, 2006, MOL BIOL CELL, V17, P1306, DOI 10.1091/mbc.e05-06-0476; Friesen H, 2005, GENETICS, V170, P555, DOI 10.1534/genetics.104.040063; Geli MI, 1996, SCIENCE, V272, P533, DOI 10.1126/science.272.5261.533; Geli MI, 2000, EMBO J, V19, P4281, DOI 10.1093/emboj/19.16.4281; Gfeller D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.18; Giblin J, 2011, BIOCHEM SOC T, V39, P1185, DOI 10.1042/BST0391185; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gkourtsa A, 2015, EUKARYOT CELL, V14, P182, DOI 10.1128/EC.00282-14; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Grotsch H, 2010, EMBO J, V29, P2899, DOI 10.1038/emboj.2010.159; Huang TY, 2005, J CELL SCI, V118, P199, DOI 10.1242/jcs.01608; Huerta-Cepas J, 2011, NUCLEIC ACIDS RES, V39, pD556, DOI 10.1093/nar/gkq1109; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jia CYH, 2005, MOL CELL PROTEOMICS, V4, P1155, DOI 10.1074/mcp.M500108-MCP200; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kim JM, 2008, J MOL BIOL, V377, P889, DOI 10.1016/j.jmb.2008.01.063; Kim SV, 2008, CELL MOL LIFE SCI, V65, P2128, DOI 10.1007/s00018-008-7435-5; Kramer A, 1998, METH MOL B, V87, P25; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Lechler T, 2000, J CELL BIOL, V148, P363, DOI 10.1083/jcb.148.2.363; Lee WL, 2000, J CELL BIOL, V151, P789, DOI 10.1083/jcb.151.4.789; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lila T, 1997, MOL BIOL CELL, V8, P367, DOI 10.1091/mbc.8.2.367; Madania A, 1999, MOL BIOL CELL, V10, P3521, DOI 10.1091/mbc.10.10.3521; Mayer BJ, 2001, J CELL SCI, V114, P1253; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oberholzer U, 2004, EUKARYOT CELL, V3, P1272, DOI 10.1128/EC.3.5.1272-1286.2004; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; POLLARD TD, 1991, ANNU REV PHYSIOL, V53, P653, DOI 10.1146/annurev.ph.53.030191.003253; Prigent M, 2011, TRAFFIC, V12, P1084, DOI 10.1111/j.1600-0854.2011.01218.x; Pryszcz LP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq953; Reijnst P, 2010, FEMS YEAST RES, V10, P452, DOI 10.1111/j.1567-1364.2010.00624.x; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Ren LP, 2015, MOL BIOL CELL, V26, P256, DOI 10.1091/mbc.E14-10-1451; Routhier EL, 2003, ONCOGENE, V22, P637, DOI 10.1038/sj.onc.1206162; SIMON JA, 1995, CHEM BIOL, V2, P53, DOI 10.1016/1074-5521(95)90080-2; Sipiczki M, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-2-reviews1011, DOI 10.1186/GB-2000-1-2-REVIEWS1011]; Sirotkin V, 2005, J CELL BIOL, V170, P637, DOI 10.1083/jcb.200502053; SPARKS AB, 1994, J BIOL CHEM, V269, P23853; Talarek N, 2005, CELL BIOCHEM FUNCT, V23, P253, DOI 10.1002/cbf.1146; Tian LJ, 2006, FASEB J, V20, P2588, DOI 10.1096/fj.06-6152fje; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Walther A, 2004, J CELL SCI, V117, P4947, DOI 10.1242/jcs.01377; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Xin XF, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.9; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	66	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129229	10.1371/journal.pone.0129229	http://dx.doi.org/10.1371/journal.pone.0129229			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068101	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900047
J	Wang, Y; Mi, JX; Lu, K; Lu, YX; Wang, KW				Wang, Ying; Mi, Jianxun; Lu, Ka; Lu, Yanxin; Wang, KeWei			Comparison of Gating Properties and Use-Dependent Block of Na(v)1.5 and Na(v)1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine	PLOS ONE			English	Article							COMMON MOLECULAR DETERMINANTS; LOCAL-ANESTHETIC AFFINITIES; PAIN DISORDER MUTATIONS; SODIUM-CHANNEL; SLOW INACTIVATION; NA+ CHANNELS; STATE; SCN5A; ERYTHROMELALGIA; NERVE	Mexiletine and lidocaine are widely used class IB anti-arrhythmic drugs that are considered to act by blocking voltage-gated open sodium currents for treatment of ventricular arrhythmias and relief of pain. To gain mechanistic insights into action of anti-arrhythmics, we characterized biophysical properties of Na(v)1.5 and Na(v)1.7 channels stably expressed in HEK293 cells and compared their use-dependent block in response to mexiletine and lidocaine using whole-cell patch clamp recordings. While the voltage-dependent activation of Na(v)1.5 or Na(v)1.7 was not affected by mexiletine and lidocaine, the steady-state fast and slow inactivation of Na(v)1.5 and Na(v)1.7 were significantly shifted to hyperpolarized direction by either mexiletine or lidocaine in dose-dependent manner. Both mexiletine and lidocaine enhanced the slow component of closed-state inactivation, with mexiletine exerting stronger inhibition on either Na(v)1.5 or Na(v)1.7. The recovery from inactivation of Na(v)1.5 or Na(v)1.7 was significantly prolonged by mexiletine compared to lidocaine. Furthermore, mexiletine displayed a pronounced and prominent use-dependent inhibition of Na(v)1.5 than lidocaine, but not Na(v)1.7 channels. Taken together, our findings demonstrate differential responses to blockade by mexiletine and lidocaine that preferentially affect the gating of Na(v)1.5, as compared to Na(v)1.7; and mexiletine exhibits stronger use-dependent block of Na(v)1.5. The differential gating properties of Na(v)1.5 and Na(v)1.7 in response to mexiletine and lidocaine may help explain the drug effectiveness and advance in new designs of safe and specific sodium channel blockers for treatment of cardiac arrhythmia or pain.	[Wang, Ying; Lu, Yanxin; Wang, KeWei] Shenzhen Peking Univ, Hong Kong Univ Sci & Technol, Med Ctr, Biomed Res Inst, Shenzhen 518036, Peoples R China; [Mi, Jianxun] Chongqing Univ Posts & Telecommun, Coll Comp Sci & Technol, Key Lab Computat Intelligence, Chongqing 400065, Peoples R China; [Lu, Ka; Lu, Yanxin; Wang, KeWei] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Dept Mol & Cellular Pharmacol, Beijing 100191, Peoples R China; [Wang, KeWei] Qingdao Univ, Sch Pharm, Dept Pharmacol, Qingdao 266021, Peoples R China	Hong Kong University of Science & Technology; Chongqing University of Posts & Telecommunications; Peking University; Qingdao University	Wang, KW (corresponding author), Shenzhen Peking Univ, Hong Kong Univ Sci & Technol, Med Ctr, Biomed Res Inst, Shenzhen 518036, Peoples R China.	wangkw@hsc.pku.edu.cn	Mi, Jianxun/U-3642-2019		National Natural Scientific Foundation of China [81301103]; Ministry of Science and Technology of China [2013CB531302, 2014ZX09507]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by research grants to YW from the National Natural Scientific Foundation of China (81301103) and KWW from the Ministry of Science and Technology of China (2013CB531302 and 2014ZX09507). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Shardonofsky Martin, 2012, Biophys J, V102, P951, DOI 10.1016/j.bpj.2012.01.032; Bahring R, 2011, J PHYSIOL-LONDON, V589, P461, DOI 10.1113/jphysiol.2010.191965; Black JA, 1996, MOL BRAIN RES, V43, P117, DOI 10.1016/S0169-328X(96)00163-5; Catterall WA, 2014, EXP PHYSIOL, V99, P35, DOI 10.1113/expphysiol.2013.071969; Chatelier A, 2008, J NEUROPHYSIOL, V99, P2241, DOI 10.1152/jn.01350.2007; Chen ZH, 2000, J PHYSIOL-LONDON, V524, P37, DOI 10.1111/j.1469-7793.2000.t01-1-00037.x; Cheng XD, 2011, PROG MOL BIOL TRANSL, V101, P1, DOI 10.1016/B978-0-12-387685-0.00001-9; Chevrier P, 2004, BRIT J PHARMACOL, V142, P576, DOI 10.1038/sj.bjp.0705796; Choi JS, 2009, EXP NEUROL, V216, P383, DOI 10.1016/j.expneurol.2008.12.012; COURTNEY KR, 1975, J PHARMACOL EXP THER, V195, P225; Dib-Hajj SD, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-37; Estacion M, 2008, J NEUROSCI, V28, P11079, DOI 10.1523/JNEUROSCI.3443-08.2008; Fredj S, 2006, BRIT J PHARMACOL, V148, P16, DOI 10.1038/sj.bjp.0706709; Fukuda K, 2005, J PHYSIOL-LONDON, V564, P21, DOI 10.1113/jphysiol.2004.081646; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Grillo JA, 2001, RESUSCITATION, V50, P331, DOI 10.1016/S0300-9572(01)00355-0; Hanck DA, 2009, CIRC RES, V105, P492, DOI 10.1161/CIRCRESAHA.109.198572; Head CE, 2005, J CARDIOVASC ELECTR, V16, P1329, DOI 10.1111/j.1540-8167.2005.00200.x; Jarecki BW, 2008, J PHYSIOL-LONDON, V586, P4137, DOI 10.1113/jphysiol.2008.154906; Karoly R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000818; Kass RS, 2006, HANDB EXP PHARMACOL, V171, P287; Li HL, 1999, MOL PHARMACOL, V55, P134, DOI 10.1124/mol.55.1.134; Liu HJ, 2003, J GEN PHYSIOL, V121, P199, DOI 10.1085/jgp.20028723; LIU LJ, 1994, J CARDIOVASC PHARM, V24, P803, DOI 10.1097/00005344-199424050-00016; LUI HK, 1986, AM HEART J, V112, P1153, DOI 10.1016/0002-8703(86)90343-1; Nuss HB, 1995, J GEN PHYSIOL, V106, P1171, DOI 10.1085/jgp.106.6.1171; Nuss HB, 2000, BIOPHYS J, V78, P200, DOI 10.1016/S0006-3495(00)76585-4; Nuss HB, 1995, J GEN PHYSIOL, V106, P1193, DOI 10.1085/jgp.106.6.1193; Ong BH, 2000, J GEN PHYSIOL, V116, P653, DOI 10.1085/jgp.116.5.653; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Priori SG, 1996, CIRC RES, V78, P1009, DOI 10.1161/01.RES.78.6.1009; Ragsdale DS, 1996, P NATL ACAD SCI USA, V93, P9270, DOI 10.1073/pnas.93.17.9270; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Ruan YF, 2007, CIRCULATION, V116, P1137, DOI 10.1161/CIRCULATIONAHA.107.707877; Sasaki K, 2004, MOL PHARMACOL, V66, P330, DOI 10.1124/mol.66.2.330; SCHWARTZ PJ, 1995, CIRCULATION, V92, P3381, DOI 10.1161/01.CIR.92.12.3381; Sheets MF, 2010, TRENDS CARDIOVAS MED, V20, P16, DOI 10.1016/j.tcm.2010.03.002; Sheets PL, 2007, J PHYSIOL-LONDON, V581, P1019, DOI 10.1113/jphysiol.2006.127027; Sheets PL, 2011, BRIT J PHARMACOL, V164, P719, DOI 10.1111/j.1476-5381.2011.01209.x; Ulbricht W, 2005, PHYSIOL REV, V85, P1271, DOI 10.1152/physrev.00024.2004; Venmans A, 2010, AM J NEURORADIOL, V31, P830, DOI 10.3174/ajnr.A1942; Vijayaragavan K, 2001, J NEUROSCI, V21, P7909, DOI 10.1523/JNEUROSCI.21-20-07909.2001; Wang DW, 1996, BIOPHYS J, V70, P1700, DOI 10.1016/S0006-3495(96)79732-1; Wang GK, 2008, MOL PHARMACOL, V73, P940, DOI 10.1124/mol.107.041541; Wu MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055212; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207	47	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128653	10.1371/journal.pone.0128653	http://dx.doi.org/10.1371/journal.pone.0128653			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068619	Green Published, Green Submitted, gold			2022-12-27	WOS:000356100900027
